<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<html>
 <body>
  <pmc-articleset>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Vector Borne Zoonotic Dis
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Vector Borne Zoonotic Dis
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       vbz
      </journal-id>
      <journal-title-group>
       <journal-title>
        Vector Borne and Zoonotic Diseases
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       1530-3667
      </issn>
      <issn pub-type="epub">
       1557-7759
      </issn>
      <publisher>
       <publisher-name>
        Mary Ann Liebert, Inc., publishers
       </publisher-name>
       <publisher-loc>
        140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA
       </publisher-loc>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       30676269
      </article-id>
      <article-id pub-id-type="pmc">
       6396572
      </article-id>
      <article-id pub-id-type="publisher-id">
       10.1089/vbz.2017.2191
      </article-id>
      <article-id pub-id-type="doi">
       10.1089/vbz.2017.2191
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Review
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Dawson
         </surname>
         <given-names>
          Patrick
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Malik
         </surname>
         <given-names>
          Mamunur Rahman
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Parvez
         </surname>
         <given-names>
          Faruque
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
         <sup>
          3
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Morse
         </surname>
         <given-names>
          Stephen S.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
        <xref ref-type="corresp" rid="corr1">
        </xref>
       </contrib>
       <aff id="aff1">
        <label>
         <sup>
          1
         </sup>
        </label>
        Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
       </aff>
       <aff id="aff2">
        <label>
         <sup>
          2
         </sup>
        </label>
        Infectious Hazard Management, Department of Health Emergency, World Health Organization Eastern Mediterranean Regional Office (WHO/EMRO), Cairo, Egypt.
       </aff>
       <aff id="aff3">
        <label>
         <sup>
          3
         </sup>
        </label>
        Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
       </aff>
      </contrib-group>
      <author-notes>
       <corresp id="corr1">
        Address correspondence to: Stephen S. Morse, Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032
        <email>
         ssm20@cumc.columbia.edu
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="ppub">
       <day>
        01
       </day>
       <month>
        3
       </month>
       <year>
        2019
       </year>
       <!--string-date: March 2019-->
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        26
       </day>
       <month>
        2
       </month>
       <year>
        2019
       </year>
      </pub-date>
      <pub-date pub-type="pmc-release">
       <day>
        26
       </day>
       <month>
        2
       </month>
       <year>
        2019
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>
       19
      </volume>
      <issue>
       3
      </issue>
      <fpage>
       174
      </fpage>
      <lpage>
       192
      </lpage>
      <permissions>
       <copyright-statement>
        © Patrick Dawson et al. 2019; Published by Mary Ann Liebert, Inc.
       </copyright-statement>
       <copyright-year>
        2019
       </copyright-year>
       <license license-type="open-access">
        <license-p>
         This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (
         <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          http://creativecommons.org/licenses/by-nc/4.0/
         </ext-link>
         ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited.
        </license-p>
       </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="vbz.2017.2191.pdf" xlink:type="simple">
      </self-uri>
      <abstract>
       <title>
        Abstract
       </title>
       <p>
        <bold>
         <italic>
          Background:
         </italic>
        </bold>
        Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in humans in 2012. A systematic literature review was conducted to synthesize current knowledge and identify critical knowledge gaps.
       </p>
       <p>
        <bold>
         <italic>
          Materials and Methods:
         </italic>
        </bold>
        We conducted a systematic review on MERS-CoV using PRISMA guidelines. We identified 407 relevant, peer-reviewed publications and selected 208 of these based on their contributions to four key areas: virology; clinical characteristics, outcomes, therapeutic and preventive options; epidemiology and transmission; and animal interface and the search for natural hosts of MERS-CoV.
       </p>
       <p>
        <bold>
         <italic>
          Results:
         </italic>
        </bold>
        Dipeptidyl peptidase 4 (DPP4/CD26) was identified as the human receptor for MERS-CoV, and a variety of molecular and serological assays developed. Dromedary camels remain the only documented zoonotic source of human infection, but MERS-like CoVs have been detected in bat species globally, as well as in dromedary camels throughout the Middle East and Africa. However, despite evidence of camel-to-human MERS-CoV transmission and cases apparently related to camel contact, the source of many primary cases remains unknown. There have been sustained health care-associated human outbreaks in Saudi Arabia and South Korea, the latter originating from one traveler returning from the Middle East. Transmission mechanisms are poorly understood; for health care, this may include environmental contamination. Various potential therapeutics have been identified, but not yet evaluated in human clinical trials. At least one candidate vaccine has progressed to Phase I trials.
       </p>
       <p>
        <bold>
         <italic>
          Conclusions:
         </italic>
        </bold>
        There has been substantial MERS-CoV research since 2012, but significant knowledge gaps persist, especially in epidemiology and natural history of the infection. There have been few rigorous studies of baseline prevalence, transmission, and spectrum of disease. Terms such as “camel exposure” and the epidemiological relationships of cases should be clearly defined and standardized. We strongly recommend a shared and accessible registry or database. Coronaviruses will likely continue to emerge, arguing for a unified “One Health” approach.
       </p>
      </abstract>
      <kwd-group kwd-group-type="author">
       <title>
        Keywords
       </title>
       <kwd>
        MERS
       </kwd>
       <kwd>
        MERS-CoV
       </kwd>
       <kwd>
        coronaviruses
       </kwd>
       <kwd>
        zoonotic disease
       </kwd>
       <kwd>
        severe acute respiratory infection (SARI)
       </kwd>
       <kwd>
        MERS epidemiology
       </kwd>
      </kwd-group>
      <counts>
       <fig-count count="2">
       </fig-count>
       <table-count count="1">
       </table-count>
       <ref-count count="255">
       </ref-count>
       <page-count count="19">
       </page-count>
      </counts>
     </article-meta>
    </front>
    <sec id="s001" sec-type="intro">
     <title>
      Introduction
     </title>
     <p>
      September 2012 saw the identification of a novel human coronavirus, now known as Middle East respiratory syndrome coronavirus (MERS-CoV) (ProMED-mail 2012, Zaki et al.
      <xref ref-type="bibr" rid="B250">
       2012
      </xref>
      ). MERS-CoV is a beta-coronavirus distinct from but genetically related to the SARS (severe acute respiratory syndrome) coronavirus (Hilgenfeld and Peiris
      <xref ref-type="bibr" rid="B110">
       2013
      </xref>
      , de Wit et al.
      <xref ref-type="bibr" rid="B75">
       2016
      </xref>
      ).
     </p>
     <p>
      As MERS was identified a few years after the 2003 SARS outbreak, which spread across continents and raised pandemic concerns, there has been continuing concern about the pandemic potential of MERS-CoV (Hilgenfeld and Peiris
      <xref ref-type="bibr" rid="B110">
       2013
      </xref>
      , de Wit et al.
      <xref ref-type="bibr" rid="B75">
       2016
      </xref>
      ). To assess and anticipate potential epidemic spread of MERS-CoV, it is essential to better understand the virology; human clinical characteristics, possible therapeutic and preventive options; epidemiology and transmission; and animal interfaces and possible origins and natural hosts.
     </p>
     <p>
      MERS was first identified in a patient with lower respiratory disease by a physician in Saudi Arabia, and subsequently, the virus was identified and characterized from this patient's sputum sample by researchers in Saudi Arabia and at Erasmus Medical Center in the Netherlands. Since then (to December 2018), 2266 laboratory-confirmed MERS-CoV cases and 804 deaths across 27 countries (35.5% crude case fatality rate [CFR]) have been reported to the WHO (
      <xref ref-type="fig" rid="f1">
       Fig. 1
      </xref>
      ), with the majority of cases (1888) and deaths (730) reported from Saudi Arabia (World Health Organization
      <xref ref-type="bibr" rid="B239">
       2018a
      </xref>
      , World Health Organization/EMRO
      <xref ref-type="bibr" rid="B241">
       2018
      </xref>
      ). Cases continue to occur (World Health Organization/EMRO
      <xref ref-type="bibr" rid="B241">
       2018
      </xref>
      ).
     </p>
     <fig fig-type="figure" id="f1" orientation="portrait" position="float">
      <label>
       <bold>
        FIG. 1.
       </bold>
      </label>
      <caption>
       <p>
        <bold>
         (A)
        </bold>
        Map of countries having at least one laboratory-confirmed human MERS-CoV case, 2012–2016.
        <italic>
         Darker shades
        </italic>
        indicate greater numbers of laboratory-confirmed cases.
        <bold>
         (B)
        </bold>
        <italic>
         Inset
        </italic>
        of
        <xref ref-type="fig" rid="f1">
         Fig. 1A
        </xref>
        showing Gulf countries having at least one laboratory-confirmed human MERS-CoV case.
        <italic>
         Darker shades
        </italic>
        indicate greater numbers of laboratory-confirmed cases. Data Source: World Health Organization (
        <uri xlink:href="http://www.who.int/emergencies/mers-cov/en" xlink:type="simple">
         www.who.int/emergencies/mers-cov/en
        </uri>
        <italic>
         and
        </italic>
        <uri xlink:href="http://www.who.int/emergencies/mers-cov/risk-assessment-july-2017.pdf" xlink:type="simple">
         www.who.int/emergencies/mers-cov/risk-assessment-july-2017.pdf
        </uri>
        ). This map was generated using R software (
        <italic>
         R Foundation
        </italic>
        for Statistical Computing, Vienna, Austria) and the “googleVis” package (Gesmann et al.
        <xref ref-type="bibr" rid="B95">
         2017
        </xref>
        ). MERS-CoV, Middle East respiratory syndrome coronavirus.
       </p>
      </caption>
      <graphic xlink:href="fig-1">
      </graphic>
     </fig>
     <p>
      Although the first known MERS-CoV cases were from Jordan (confirmed retrospectively, and the source is still unknown) (Hijawi et al.
      <xref ref-type="bibr" rid="B109">
       2013
      </xref>
      ), about 80% of MERS-CoV cases originate from or passed through Saudi Arabia. The infection is likely zoonotic; although origins and transmission are poorly understood, the dromedary camel is the one documented source of human zoonotic infection (Memish et al.
      <xref ref-type="bibr" rid="B160">
       2014e
      </xref>
      ).
     </p>
     <p>
      A systematic review of MERS-CoV research was conducted to survey our current understanding of MERS-CoV and to identify research gaps in four major areas: (1) virology; (2) clinical characteristics, outcomes, and therapeutic and preventive options; (3) epidemiology and transmission; and (4) animal interface and the search for natural hosts of MERS-CoV.
     </p>
    </sec>
    <sec id="s002" sec-type="materials|methods">
     <title>
      Materials and Methods
     </title>
     <p>
      We conducted a systematic literature review, using Embase, Google Scholar, MEDLINE/PubMed, supplemented by Thomson-Reuters “Web of Science”™ (all databases), to identify peer-reviewed published articles on MERS-CoV available by July 14, 2017. All searches were for articles published from 2012 onward, since MERS was first identified in 2012. The following search terms were used in all the databases for matches in title only (Google Scholar), title or abstract (Embase and MEDLINE/PubMed), or topic (“Web of Science”): “novel coronavirus,” “novel coronavirus EMC,” “novel coronavirus Erasmus,” “hCoV-EMC,” “MERS-CoV” (a PubMed “MeSH” term), “MERS coronavirus,” “Middle East Respiratory Syndrome,” and “Middle East Respiratory Syndrome Coronavirus” (a PubMed MeSH term).
     </p>
     <p>
      We reviewed the titles and abstracts of all resulting citations to identify relevant articles for this systematic review, following PRISMA guidelines (
      <xref ref-type="fig" rid="f2">
       Fig. 2
      </xref>
      ) (Moher et al.
      <xref ref-type="bibr" rid="B169">
       2009
      </xref>
      ). For all nonduplicate articles, excluding opinion and editorial pieces, on MERS-CoV or a related topic, we retrieved the full-text version and indexed the citation. Inclusion criteria were peer-reviewed primary research articles about MERS-CoV published between 2012 and mid-July 2017 (inclusive, with periodic updates to 2018) and adding unique information about MERS-CoV to the knowledge base within at least one of the four key themes: (1) virology; (2) clinical characteristics, outcomes, and therapeutic and preventive options; (3) epidemiology and transmission; and (4) animal interface and search for natural hosts of MERS-CoV.
     </p>
     <fig fig-type="figure" id="f2" orientation="portrait" position="float">
      <label>
       <bold>
        FIG. 2.
       </bold>
      </label>
      <caption>
       <p>
        Study selection diagram for systematic literature review on MERS-CoV (*For complete search terms and applicable date ranges, see the
        <xref ref-type="sec" rid="s002">
         Materials and Methods
        </xref>
        section.).
       </p>
      </caption>
      <graphic xlink:href="fig-2">
      </graphic>
     </fig>
     <p>
      Only English language publications (or with an English-language abstract available) were included. Of the 3364 titles retrieved, 407 were unique (nonduplicate), scientific research works relevant to MERS-CoV, and of these, 208 were originally included in the review based on the inclusion criteria (some interim updates have been made during article preparation).
     </p>
    </sec>
    <sec id="s003" sec-type="results">
     <title>
      Results
     </title>
     <sec id="s004">
      <title>
       Virology
      </title>
      <p>
       The pathogen causing MERS has been identified as a coronavirus, now named MERS-CoV, classified in the family
       <italic>
        Coronaviridae
       </italic>
       (subfamily
       <italic>
        Coronavirinae
       </italic>
       ) (ICTV
       <xref ref-type="bibr" rid="B118">
        2016
       </xref>
       ). Coronaviruses are a family of enveloped, approximately spherical, positive-sense, single-stranded RNA viruses with genome length 26–32 kilobases (kb). Of the four described coronavirus genera, alpha- and beta-coronaviruses are believed to originate from bat species, whereas gamma- and delta-coronaviruses are believed to be of avian origin (Woo et al.
       <xref ref-type="bibr" rid="B236">
        2012
       </xref>
       ).
      </p>
      <p>
       Within the beta-coronavirus genus, four lineages have been described: A, B (which includes SARS-CoV), C, and D. MERS-CoV is a beta-coronavirus of lineage C (Cotten et al.
       <xref ref-type="bibr" rid="B69">
        2013
       </xref>
       ), the first of this lineage known to infect humans. There are two main recognized clades (genetic sublineages) of MERS-CoV, clade A, which includes the earliest known MERS-CoV strains (EMC/2012 and Jordan-N3/2012), and clade B, which includes newer cases (Cotten et al.
       <xref ref-type="bibr" rid="B69">
        2013
       </xref>
       ), although additional genotypes are revealed by genomic sequencing (Chu et al.
       <xref ref-type="bibr" rid="B56">
        2015
       </xref>
       ), suggesting the existence of additional clades.
      </p>
      <p>
       The genome of MERS-CoV is ∼30 kb and encodes 10 proteins: 2 replicase polyproteins (ORFs 1a and 1b), including the RNA-dependent RNA polymerase (RdRp); 4 structural proteins: envelope (E), M (membrane), N (nucleocapsid), and S (surface spike glycoprotein), and 4 nonstructural proteins (ORFs 3, 4a, 4b, and 5) (Kim et al.
       <xref ref-type="bibr" rid="B128">
        2015
       </xref>
       ; review: de Wit et al.
       <xref ref-type="bibr" rid="B75">
        2016
       </xref>
       ).
      </p>
      <p>
       Particular attention has understandably focused on the S (spike) surface protein, which confers receptor specificity (Qian et al.
       <xref ref-type="bibr" rid="B200">
        2013
       </xref>
       ) and is considered the major determinant of coronavirus host range (Graham and Baric
       <xref ref-type="bibr" rid="B99">
        2010
       </xref>
       , Hulswit et al.
       <xref ref-type="bibr" rid="B116">
        2016
       </xref>
       ). The main route of entry for MERS-CoV is dipeptidyl peptidase 4 (DPP4, also known as CD26) on the host cell surface (Raj et al.
       <xref ref-type="bibr" rid="B202">
        2013
       </xref>
       ), which is utilized by the receptor-binding domain of the MERS-CoV spike protein (Chen et al.
       <xref ref-type="bibr" rid="B54">
        2013
       </xref>
       , Raj et al.
       <xref ref-type="bibr" rid="B202">
        2013
       </xref>
       ,
       <xref ref-type="bibr" rid="B203">
        2014
       </xref>
       ).
      </p>
      <p>
       The virus readily replicates in A549 (human lung), Huh-7 (human liver), and the widely used Vero E6 (African green monkey kidney) cell lines (Raj et al.
       <xref ref-type="bibr" rid="B202">
        2013
       </xref>
       , Eckerle et al.
       <xref ref-type="bibr" rid="B85">
        2014
       </xref>
       ), among others. Culture,
       <italic>
        in vitro
       </italic>
       and
       <italic>
        ex vivo
       </italic>
       , has also been used to help determine cell tropism and identify potential natural hosts of the virus. MERS-CoV can infect a variety of human cell types and tissues in culture, including macrophages, fibroblasts, and endothelial cells (Scobey et al.
       <xref ref-type="bibr" rid="B214">
        2013
       </xref>
       , Tao et al.
       <xref ref-type="bibr" rid="B226">
        2013
       </xref>
       , Hin et al.
       <xref ref-type="bibr" rid="B111">
        2016
       </xref>
       ). In an
       <italic>
        ex vivo
       </italic>
       study using human lung explants, MERS-CoV infected both alveolar epithelial cells and macrophages (Type II pneumocytes), with resulting alveolar damage (Hocke et al.
       <xref ref-type="bibr" rid="B112">
        2013
       </xref>
       ).
      </p>
      <p>
       Interestingly, although kidney failure is frequently described in fatal cases and the virus grows well in a number of kidney and liver cell lines, in the one autopsy report that has been published, viral antigen was detected by immunohistochemical staining only in pneumocytes and lung interstitial epithelial cells, and not in the kidney or other extrapulmonary sites (Ng et al.
       <xref ref-type="bibr" rid="B179">
        2016
       </xref>
       ).
      </p>
      <p>
       Replication was demonstrated in goat, camel (Eckerle et al.
       <xref ref-type="bibr" rid="B85">
        2014
       </xref>
       ), and equid origin cell lines (Meyer et al.
       <xref ref-type="bibr" rid="B163">
        2015
       </xref>
       ), but was not detected in cattle, sheep, or rodent cell lines tested (Eckerle et al.
       <xref ref-type="bibr" rid="B85">
        2014
       </xref>
       ).
      </p>
      <p>
       Given the interest in bats as a natural host for many coronaviruses, especially since SARS, and the currently unknown origin of MERS-CoV, several bat cell lines have been tested to determine if they could support MERS-CoV replication (Müller et al.
       <xref ref-type="bibr" rid="B177">
        2012
       </xref>
       , Cai et al.
       <xref ref-type="bibr" rid="B46">
        2014
       </xref>
       , Eckerle et al.
       <xref ref-type="bibr" rid="B85">
        2014
       </xref>
       ).
      </p>
      <p>
       As a broad generalization, the virus was reported to replicate well (roughly comparable with growth in Vero E6 cells) in kidney and lung cells from
       <italic>
        Rousettus aegyptiacus
       </italic>
       and other Old World pteropid (fruit) bats (Müller et al.
       <xref ref-type="bibr" rid="B177">
        2012
       </xref>
       , Cai et al.
       <xref ref-type="bibr" rid="B46">
        2014
       </xref>
       ), to a lesser degree in cell lines from Old World insectivorous bats (Müller et al.
       <xref ref-type="bibr" rid="B177">
        2012
       </xref>
       , Eckerle et al.
       <xref ref-type="bibr" rid="B85">
        2014
       </xref>
       ), and very little, if at all, in lung cells from several New World bats (Müller et al.
       <xref ref-type="bibr" rid="B177">
        2012
       </xref>
       , Cai et al.
       <xref ref-type="bibr" rid="B46">
        2014
       </xref>
       ). However, as a caveat, no replication was found in the
       <italic>
        Rousettus aegyptiacus
       </italic>
       embryo cell lines tested (Cai et al.
       <xref ref-type="bibr" rid="B46">
        2014
       </xref>
       ).
      </p>
      <p>
       Adaptation to cells from other bat species that are normally refractory to infection because of having a somewhat different DPP4 protein was recently demonstrated
       <italic>
        in vitro
       </italic>
       (Letko et al.
       <xref ref-type="bibr" rid="B142">
        2018
       </xref>
       ), resulting from selection of spike protein mutations that permitted binding to the new DPP4. A similar change, from bat to human-type receptor, was observed with SARS in 2003 (Letko et al.
       <xref ref-type="bibr" rid="B142">
        2018
       </xref>
       ).
      </p>
      <p>
       Animal models for MERS-CoV include transgenic mice expressing human DPP4 (Cockrell et al.
       <xref ref-type="bibr" rid="B59">
        2014
       </xref>
       , Zhao et al.
       <xref ref-type="bibr" rid="B253">
        2014
       </xref>
       , Agrawal et al.
       <xref ref-type="bibr" rid="B8">
        2015
       </xref>
       ), which develop respiratory disease and are the most widely used model; marmosets (Falzarano et al.
       <xref ref-type="bibr" rid="B88">
        2014
       </xref>
       ); rhesus macaques (de Wit et al.
       <xref ref-type="bibr" rid="B74">
        2013
       </xref>
       , Munster et al.
       <xref ref-type="bibr" rid="B178">
        2013
       </xref>
       , Yao et al.
       <xref ref-type="bibr" rid="B247">
        2014
       </xref>
       ); camels (Barlan et al.
       <xref ref-type="bibr" rid="B37">
        2014
       </xref>
       ); horses (Barlan et al.
       <xref ref-type="bibr" rid="B37">
        2014
       </xref>
       ), and alpacas (Adney et al.
       <xref ref-type="bibr" rid="B6">
        2016
       </xref>
       ). However, there is no animal model that clearly mimics human clinical MERS (review: Baseler et al.
       <xref ref-type="bibr" rid="B38">
        2016
       </xref>
       ).
      </p>
      <sec id="s005">
       <title>
        Diagnostic assays
       </title>
       <p>
        The main laboratory assays for MERS-CoV are molecular tests to detect viral RNA, and serology (for prior infection) (CDC
        <xref ref-type="bibr" rid="B49">
         2014
        </xref>
        , World Health Organization
        <xref ref-type="bibr" rid="B240">
         2018b
        </xref>
        ).
       </p>
       <p>
        Reverse transcription PCR either real time or conventional, is now standard. For diagnostic screening, PCR primer sets to regions upstream of the E gene (“up-E”) are most frequently used, with ORF1a or ORF1b for confirmation (Corman et al.
        <xref ref-type="bibr" rid="B61">
         2012a
        </xref>
        ,
        <xref ref-type="bibr" rid="B62">
         2012b
        </xref>
        ). Sensitivity was reported as ∼3.4 viral gene copies/25 μL reaction for up-E and ∼64 copies for ORF1b, with specificity approaching 100% using a test panel of other known coronaviruses and clinical respiratory samples (Corman et al.
        <xref ref-type="bibr" rid="B61">
         2012a
        </xref>
        ). ORF1a PCR was reported to have comparable sensitivity and specificity to up-E (Corman et al.
        <xref ref-type="bibr" rid="B62">
         2012b
        </xref>
        ). Commercial kits are available, with comparable results reported (Corman et al.
        <xref ref-type="bibr" rid="B66">
         2014c
        </xref>
        , Seong et al.
        <xref ref-type="bibr" rid="B216">
         2016
        </xref>
        , Mohamed et al.
        <xref ref-type="bibr" rid="B168">
         2017
        </xref>
        ).
       </p>
       <p>
        For sequencing, tests have been developed that may be better suited for strain differentiation, targeting regions of the RdRp (RNA polymerase) or N (nucleocapsid) genes (Corman et al.
        <xref ref-type="bibr" rid="B62">
         2012b
        </xref>
        ); there are a number of publications reporting on their use (Corman et al.
        <xref ref-type="bibr" rid="B62">
         2012b
        </xref>
        ; CDC
        <xref ref-type="bibr" rid="B49">
         2014
        </xref>
        , Lu et al.
        <xref ref-type="bibr" rid="B145">
         2014
        </xref>
        ).
       </p>
       <p>
        Another PCR test, targeting the S (spike) region, was developed to monitor circulation of MERS-CoV variants (Abd et al.
        <xref ref-type="bibr" rid="B1">
         2013
        </xref>
        , Smits et al.
        <xref ref-type="bibr" rid="B221">
         2015
        </xref>
        ). Other types of nucleic acid tests have also been used (Shirato et al.
        <xref ref-type="bibr" rid="B219">
         2014
        </xref>
        ), as has immunohistochemistry (Ng et al.
        <xref ref-type="bibr" rid="B179">
         2016
        </xref>
        ).
       </p>
       <p>
        Serologic samples are usually screened using enzyme-linked immunosorbent assay (ELISA) (Reusken et al.
        <xref ref-type="bibr" rid="B205">
         2013a
        </xref>
        ). If the sample is ELISA positive, CDC and other agencies formerly recommended confirmatory testing, first by immunofluorescence assay (IFA) and then by the gold standard plaque-reduction neutralization test or microneutralization (CDC
        <xref ref-type="bibr" rid="B49">
         2014
        </xref>
        ), but now recommend going directly to microneutralization assay (CDC
        <xref ref-type="bibr" rid="B49">
         2014
        </xref>
        , revised). Other serological tests such as pseudoparticle neutralization (Perera et al.
        <xref ref-type="bibr" rid="B194">
         2013
        </xref>
        ) and array-based serology (Reusken et al.
        <xref ref-type="bibr" rid="B205">
         2013a
        </xref>
        ) have also been developed.
       </p>
       <p>
        Unfortunately, there are pitfalls in serology, including cross-reactivity and false negatives. In 2014, CDC preliminarily reported a MERS-CoV case with a positive ELISA and IFA, but later retracted the case report due to a negative microneutralization result (Breakwell et al.
        <xref ref-type="bibr" rid="B42">
         2015
        </xref>
        ). Consequently, CDC no longer recommends IFA but instead now recommends using two different ELISA tests, with microneutralization for confirmation (CDC
        <xref ref-type="bibr" rid="B49">
         2014
        </xref>
        , revised). Conversely, low or waning antibody response after infection, which would yield false negatives, has also been reported (Alshukairi et al.
        <xref ref-type="bibr" rid="B24">
         2016
        </xref>
        , Choe et al.
        <xref ref-type="bibr" rid="B55">
         2017
        </xref>
        ). False negatives are further discussed below in the section on Host Response.
       </p>
      </sec>
     </sec>
     <sec id="s006">
      <title>
       Clinical characteristics and outcomes
      </title>
      <p>
       Clinical findings have been described and reviewed in detail (Assiri et al.
       <xref ref-type="bibr" rid="B32">
        2013a
       </xref>
       , Saad et al.
       <xref ref-type="bibr" rid="B212">
        2014
       </xref>
       , Rasmussen et al.
       <xref ref-type="bibr" rid="B204">
        2015
       </xref>
       , World Health Organization
       <xref ref-type="bibr" rid="B238">
        2015
       </xref>
       ). The incubation period is ∼5–7 days (in some cases up to 12 days) (Assiri et al.
       <xref ref-type="bibr" rid="B32">
        2013a
       </xref>
       ,
       <xref ref-type="bibr" rid="B33">
        2013b
       </xref>
       ). Fever, cough, shortness of breath, and pneumonia (with abnormal chest radiography) are the most frequently noted signs; myalgia, diarrhea, vomiting, abdominal pain, chills or rigors, or malaise are also seen (Assiri et al.
       <xref ref-type="bibr" rid="B32">
        2013a
       </xref>
       , Drosten et al.
       <xref ref-type="bibr" rid="B80">
        2013
       </xref>
       , Eckerle et al.
       <xref ref-type="bibr" rid="B86">
        2013
       </xref>
       , Guery et al.
       <xref ref-type="bibr" rid="B100">
        2013
       </xref>
       , Ajlan et al.
       <xref ref-type="bibr" rid="B9">
        2014
       </xref>
       , Arabi et al.
       <xref ref-type="bibr" rid="B30">
        2014
       </xref>
       , Faure et al.
       <xref ref-type="bibr" rid="B90">
        2014
       </xref>
       , Kapoor et al.
       <xref ref-type="bibr" rid="B122">
        2014
       </xref>
       , Scheuplein et al.
       <xref ref-type="bibr" rid="B213">
        2015
       </xref>
       , Hunter et al.
       <xref ref-type="bibr" rid="B117">
        2016
       </xref>
       ). Renal failure or pulmonary failure and shock were commonly described in severe and fatal cases. Overall CFR is ∼35.5% (World Health Organization
       <xref ref-type="bibr" rid="B239">
        2018a
       </xref>
       ).
      </p>
      <p>
       Viral excretion from the respiratory tract has been documented through the first month of illness (Memish et al.
       <xref ref-type="bibr" rid="B159">
        2014d
       </xref>
       , Poissy et al.
       <xref ref-type="bibr" rid="B195">
        2014
       </xref>
       , Spanakis et al.
       <xref ref-type="bibr" rid="B223">
        2014
       </xref>
       ), with greater viral loads detected in lower respiratory tract specimens compared with upper respiratory tract (Drosten et al.
       <xref ref-type="bibr" rid="B80">
        2013
       </xref>
       , Guery et al.
       <xref ref-type="bibr" rid="B100">
        2013
       </xref>
       , Kapoor et al.
       <xref ref-type="bibr" rid="B122">
        2014
       </xref>
       ). Viral excretion for short periods was reported in urine and stool, although viral loads were low (Drosten et al.
       <xref ref-type="bibr" rid="B80">
        2013
       </xref>
       ). There was at least one report that MERS-CoV secondary cases (individuals infected by a primary case) clear infection earlier than primary cases (Memish et al.
       <xref ref-type="bibr" rid="B159">
        2014d
       </xref>
       ).
      </p>
      <p>
       Disease outcomes differed by age and comorbidities (Assiri et al.
       <xref ref-type="bibr" rid="B32">
        2013a
       </xref>
       ,
       <xref ref-type="bibr" rid="B33">
        2013b
       </xref>
       , Khalid et al.
       <xref ref-type="bibr" rid="B124">
        2014
       </xref>
       , Saad et al.
       <xref ref-type="bibr" rid="B212">
        2014
       </xref>
       , Alsahafi and Cheng
       <xref ref-type="bibr" rid="B22">
        2016
       </xref>
       ). Most cases in Saudi Arabia have occurred among men, ages 45 or older, and those living in areas of lower relative humidity and high temperature (Alghamdi et al.
       <xref ref-type="bibr" rid="B17">
        2014
       </xref>
       ). A review of 939 cases in Saudi Arabia found that CFR increases with age, from 12.5% among those 19 years or younger to 86.2% among those 80 years or older (Alsahafi and Cheng
       <xref ref-type="bibr" rid="B22">
        2016
       </xref>
       ). Mortality was more frequent and rapid in individuals with comorbidities such as diabetes, chronic renal disease, and, in one study, higher body mass index (Assiri et al.
       <xref ref-type="bibr" rid="B32">
        2013a
       </xref>
       ,
       <xref ref-type="bibr" rid="B33">
        2013b
       </xref>
       , Al-Tawfiq et al.
       <xref ref-type="bibr" rid="B13">
        2014
       </xref>
       , Khalid et al.
       <xref ref-type="bibr" rid="B124">
        2014
       </xref>
       , Saad et al.
       <xref ref-type="bibr" rid="B212">
        2014
       </xref>
       , Alsahafi and Cheng
       <xref ref-type="bibr" rid="B22">
        2016
       </xref>
       ). More severe disease has been associated with higher viral load (Feikin et al.
       <xref ref-type="bibr" rid="B91">
        2015
       </xref>
       ).
      </p>
      <p>
       There are a handful of case reports on MERS outcomes in other vulnerable populations, including three cases in pregnant women and one in an HIV-positive individual.
      </p>
      <p>
       In the three documented cases of pregnant women with MERS-CoV infection, one woman in her second trimester of pregnancy (∼5 months) experienced a stillbirth; the mother survived (Payne et al.
       <xref ref-type="bibr" rid="B191">
        2014
       </xref>
       ). The two other women were reported to be in their third trimester (32 weeks) when they presented with MERS. A healthy infant was delivered in each of these cases, although one mother died despite interferon (IFN) treatment (Malik et al.
       <xref ref-type="bibr" rid="B152">
        2016
       </xref>
       ), and one recovered despite the severity of her symptoms (Alserehi et al.
       <xref ref-type="bibr" rid="B23">
        2016
       </xref>
       ). Both were apparently healthy before infection and in their 30s. It is therefore possible that infection during the third trimester may be associated with better fetal outcomes, while other factors may be more critical for maternal outcome, but the numbers are too small to generalize.
      </p>
      <p>
       There has been at least one published case of an individual with HIV/AIDS acquiring MERS-CoV (Shalhoub et al.
       <xref ref-type="bibr" rid="B217">
        2015
       </xref>
       ). This patient was probably infected with MERS-CoV during a hospital stay and subsequently shed virus for 38 days. The patient recovered after treatment (Shalhoub et al.
       <xref ref-type="bibr" rid="B217">
        2015
       </xref>
       ).
      </p>
     </sec>
     <sec id="s007">
      <title>
       Host response
      </title>
      <p>
       There have been a number of studies on immune function (Corman et al.
       <xref ref-type="bibr" rid="B63">
        2016
       </xref>
       , Zhao et al.
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ). Neutralizing antibodies were detected in many patients, but several studies suggested that neutralizing antibodies induced during infection did not appear to be protective (Corman et al.
       <xref ref-type="bibr" rid="B63">
        2016
       </xref>
       , Zhao et al.
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ), and it has been suggested that higher antibody titers may be more closely correlated with greater viral load and consequently worse prognosis (Zhao et al.
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ).
      </p>
      <p>
       Kinetics of response may also be important. An antibody kinetics study with 17 patients in South Korea (from the same research group that later reported waning antibody titers in patients over a 1-year follow-up) found that most patients produced a robust neutralizing IgG antibody response beginning at about 2 weeks and peaking by about 3 weeks; delayed response was generally correlated with a less favorable prognosis (Park et al.
       <xref ref-type="bibr" rid="B188">
        2015
       </xref>
       ).
      </p>
      <p>
       Persistence of antibody generally seems to follow a similar pattern. Detectable neutralizing antibody titers (≥20) have been reported in some patients up to 34 months (Payne et al.
       <xref ref-type="bibr" rid="B192">
        2016
       </xref>
       ). However, results varied considerably even within this group, and most reports indicate that duration of antibody response, as well as its magnitude, seemed most closely correlated with disease severity and that antibodies could be low or even absent in mild or asymptomatic infection (Alshukairi et al.
       <xref ref-type="bibr" rid="B24">
        2016
       </xref>
       , Choe et al.
       <xref ref-type="bibr" rid="B55">
        2017
       </xref>
       ). These reports of low or waning antibody titers, especially in asymptomatic or mildly symptomatic individuals, may make serology problematic as a marker of population prevalence.
      </p>
      <p>
       There is evidence that innate immunity, including IFNs and cytokines, and cellular immunity by CD8
       <sup>
        +
       </sup>
       (presumably “killer”) T cells may play important roles in host defense and recovery (Faure et al.
       <xref ref-type="bibr" rid="B90">
        2014
       </xref>
       , Zhao et al.
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ). Zhao et al. (
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ) compared the role of antibodies and T cells in human MERS cases, and found that survivors mounted a vigorous CD8
       <sup>
        +
       </sup>
       T cell response even in the absence of a detectable antibody response.
      </p>
      <p>
       Macrophages also appear to play an important role, but there are limited and somewhat ambiguous data from the mouse model (Coleman et al.
       <xref ref-type="bibr" rid="B60">
        2017
       </xref>
       ), human cells (Zhou et al.
       <xref ref-type="bibr" rid="B255">
        2014
       </xref>
       ), and patients (Faure et al.
       <xref ref-type="bibr" rid="B90">
        2014
       </xref>
       ). With a number of viruses, it is not unusual for resting macrophages to be permissive for replication but for macrophages to show antiviral activity after activation (such as by IFN-γ) (Morse and Morahan
       <xref ref-type="bibr" rid="B173">
        1981
       </xref>
       ). Dendritic cells have been reported to produce IFN in response to infection (Scheuplein et al.
       <xref ref-type="bibr" rid="B213">
        2015
       </xref>
       ).
      </p>
      <p>
       One challenge to overcome is the effect of the virus on host defenses. A caveat is that much of this research (although not all) has been done
       <italic>
        in vitro
       </italic>
       and may not necessarily be comparable with the immunological results described above in patients. MERS-CoV has been reported to inhibit host innate immunity (Lau et al.
       <xref ref-type="bibr" rid="B133">
        2013
       </xref>
       ). Impaired IFN and cytokine responses may mediate some of these effects, based on assays on cells from MERS patients (Faure et al.
       <xref ref-type="bibr" rid="B90">
        2014
       </xref>
       , Scheuplein et al.
       <xref ref-type="bibr" rid="B213">
        2015
       </xref>
       ), although the numbers of patients were small.
       <italic>
        In vitro
       </italic>
       studies have shown that MERS-CoV could downregulate expression of IFN-stimulated gene subsets (Yang et al.
       <xref ref-type="bibr" rid="B246">
        2013
       </xref>
       ), chemokines (Mielech et al.
       <xref ref-type="bibr" rid="B165">
        2014
       </xref>
       ), and IFN-β. Another study found that MERS-CoV may cause delayed induction of proinflammatory cytokines together with suppression of the host's innate antiviral response (Lau et al.
       <xref ref-type="bibr" rid="B134">
        2013
       </xref>
       ).
      </p>
      <p>
       Virus replication in human monocyte-derived macrophages has been described, with increased expression of tumor necrosis factor α (up to a 3-fold increase over normal levels), interleukin 6 (up to almost a 6-fold increase), interleukin 12, IFN-γ, and chemokines (some at a 10-fold or more increase and even more prominently than with SARS-CoV) being reported (Zhou et al.
       <xref ref-type="bibr" rid="B255">
        2014
       </xref>
       ).
      </p>
     </sec>
     <sec id="s008">
      <title>
       Therapeutic and preventive options
      </title>
      <p>
       Currently, the main treatment strategy is symptomatic supportive care; mechanical ventilation and ICU admission are usually required for severe cases.
      </p>
      <p>
       Published data on applied therapeutic regimens for MERS-CoV patients are scarce, but there have been efforts to develop interventions.
      </p>
      <p>
       Two case reports have documented the use of a combination of ribavirin and IFN α2b as a therapy for MERS-CoV patients, with divergent results. In one report, this therapy was given to five patients but all five died. However, all five patients had comorbidities and were diagnosed late in the course of their illness, suggesting the therapy may have been delivered too late to prove effective (Al-Tawfiq et al.
       <xref ref-type="bibr" rid="B13">
        2014
       </xref>
       ). In another report, this therapy was given to one patient who eventually recovered (Khalid et al.
       <xref ref-type="bibr" rid="B123">
        2015
       </xref>
       ).
      </p>
      <p>
       In a retrospective cohort study of 44 patients with severe MERS (requiring ventilatory support), treatment with ribavirin and pegylated IFN α2a (note, not 2b) appeared to increase short-term survival (14 days), although by 28 days only 10 of the patients were still living (6/20 survivors in treated group compared with 4/24 surviving in the comparison group) (Omrani et al.
       <xref ref-type="bibr" rid="B186">
        2014
       </xref>
       ).
      </p>
      <p>
       Among promising studies evaluating therapies in animal models, one
       <italic>
        in vivo
       </italic>
       study found that the combination of ribavirin and IFN α2b therapy significantly improved outcomes among MERS-CoV-infected rhesus monkeys (Falzarano et al.
       <xref ref-type="bibr" rid="B87">
        2013
       </xref>
       ). In another study, using the common marmoset model, lopinavir/ritonavir and IFN α1b (separately and in combination) also proved promising (Chan et al.
       <xref ref-type="bibr" rid="B51">
        2015
       </xref>
       ).
      </p>
      <p>
       Although neutralizing antibodies induced during infection did not appear to be protective during natural infection (Corman et al.
       <xref ref-type="bibr" rid="B63">
        2016
       </xref>
       , Zhao et al.
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ), human convalescent sera containing neutralizing antibodies conferred dose-dependent protection in a mouse model (Zhao et al.
       <xref ref-type="bibr" rid="B252">
        2017
       </xref>
       ). The readily available sera from MERS-immune camels apparently were also an effective treatment for MERS-infected mice and reduced the severity of pathological changes in murine lung tissue (Zhao et al.
       <xref ref-type="bibr" rid="B254">
        2015
       </xref>
       ). Several monoclonal antibodies (mAbs) (Mou et al.
       <xref ref-type="bibr" rid="B174">
        2013
       </xref>
       , Ohnuma et al.
       <xref ref-type="bibr" rid="B184">
        2013
       </xref>
       , Du et al.
       <xref ref-type="bibr" rid="B83">
        2014
       </xref>
       , Jiang et al.
       <xref ref-type="bibr" rid="B120">
        2014
       </xref>
       , Tang et al.
       <xref ref-type="bibr" rid="B225">
        2014
       </xref>
       , Ying et al.
       <xref ref-type="bibr" rid="B249">
        2014
       </xref>
       , Houser et al.
       <xref ref-type="bibr" rid="B114">
        2016
       </xref>
       ) and conventional antibodies (Zhao et al.
       <xref ref-type="bibr" rid="B251">
        2013
       </xref>
       ) have demonstrated effective neutralization of MERS-CoV, and could serve as potential therapeutic agents, at least in the interim.
      </p>
      <p>
       High-throughput screening and other methods have identified additional promising compounds in several classes (Chan et al.
       <xref ref-type="bibr" rid="B52">
        2013
       </xref>
       , de Wilde et al.
       <xref ref-type="bibr" rid="B73">
        2013
       </xref>
       ,
       <xref ref-type="bibr" rid="B72">
        2014
       </xref>
       , Gao et al.
       <xref ref-type="bibr" rid="B93">
        2013
       </xref>
       , Shirato et al.
       <xref ref-type="bibr" rid="B218">
        2013
       </xref>
       , Adedeji et al.
       <xref ref-type="bibr" rid="B5">
        2014
       </xref>
       , Dyall et al.
       <xref ref-type="bibr" rid="B84">
        2014
       </xref>
       , Hart et al.
       <xref ref-type="bibr" rid="B103">
        2014
       </xref>
       , Lu et al.
       <xref ref-type="bibr" rid="B146">
        2014
       </xref>
       , Lundin et al.
       <xref ref-type="bibr" rid="B147">
        2014
       </xref>
       , Tao et al.
       <xref ref-type="bibr" rid="B227">
        2014
       </xref>
       , Wrensch et al.
       <xref ref-type="bibr" rid="B242">
        2014
       </xref>
       , Corti et al.
       <xref ref-type="bibr" rid="B68">
        2015
       </xref>
       , Liu et al.
       <xref ref-type="bibr" rid="B143">
        2015
       </xref>
       ). These include inhibitors against both viral (Kilianski et al.
       <xref ref-type="bibr" rid="B126">
        2013
       </xref>
       , Lei et al.
       <xref ref-type="bibr" rid="B139">
        2014
       </xref>
       , Kumar et al.
       <xref ref-type="bibr" rid="B131">
        2017
       </xref>
       ) and host (Gierer et al.
       <xref ref-type="bibr" rid="B97">
        2015
       </xref>
       ) proteases needed to process the virus. However, it was reported that inhibiting proprotein convertases inhibits host cell processing of the spike protein but did not affect viral infectivity or cell-to-cell spread (Gierer et al.
       <xref ref-type="bibr" rid="B97">
        2015
       </xref>
       ).
      </p>
      <p>
       Other targets studied have included viral entry inhibitors (Zhao et al.
       <xref ref-type="bibr" rid="B251">
        2013
       </xref>
       , Du et al. 2015) and protein 4a, which the researchers found suppressed innate antiviral response (Siu et al.
       <xref ref-type="bibr" rid="B220">
        2014
       </xref>
       ).
      </p>
      <sec id="s009">
       <title>
        Vaccine development
       </title>
       <p>
        Development of a human (and possibly camel) vaccine for MERS-CoV should be a key priority, given concerns about its spread and pandemic potential, but vaccine development can be a long process that is often driven by economics (Modjarrad
        <xref ref-type="bibr" rid="B167">
         2016
        </xref>
        ).
       </p>
       <p>
        Much of the focus thus far has centered on the identification of the residues within the receptor-binding domain of the spike protein, conferring the best chance of protection (Du et al.
        <xref ref-type="bibr" rid="B81">
         2013a
        </xref>
        ,
        <xref ref-type="bibr" rid="B82">
         2013b
        </xref>
        , Lan et al.
        <xref ref-type="bibr" rid="B132">
         2014
        </xref>
        , Ma et al.
        <xref ref-type="bibr" rid="B148">
         2014a
        </xref>
        ,
        <xref ref-type="bibr" rid="B149">
         2014b
        </xref>
        ). A number of other antigens, some in viral vectors, have been tested in the laboratory (Song et al.
        <xref ref-type="bibr" rid="B222">
         2013
        </xref>
        , Kim et al.
        <xref ref-type="bibr" rid="B127">
         2014
        </xref>
        ).
       </p>
       <p>
        A replication defective full-length cDNA clone of the MERS-CoV genome has been developed for identifying future vaccine candidates (Almazán et al.
        <xref ref-type="bibr" rid="B20">
         2013
        </xref>
        ). Vaccine candidates for dromedary camels have also been investigated, and have been reported to elicit protective responses (using the MERS-CoV spike protein in a poxvirus vector) (Haagmans et al.
        <xref ref-type="bibr" rid="B102">
         2016
        </xref>
        ).
       </p>
       <p>
        There are special challenges to developing a MERS vaccine. The sporadic nature of human MERS-CoV infection and the difficulty of identifying suitable animal models for challenge studies make controlled trials difficult. Disease in camels usually appears mild (Adney et al.
        <xref ref-type="bibr" rid="B7">
         2014
        </xref>
        ), reducing the economic incentive for immunization. A camel vaccine could also be given in combination with a required vaccine, e.g., rabies, as suggested by Wirblich et al. (
        <xref ref-type="bibr" rid="B235">
         2017
        </xref>
        ), or camelpox, as suggested by Haagmans et al. (
        <xref ref-type="bibr" rid="B102">
         2016
        </xref>
        ).
       </p>
       <p>
        Correlates of protection and duration of immunity are also uncertain. There are reports of strong antibody responses (Haagmans et al.
        <xref ref-type="bibr" rid="B102">
         2016
        </xref>
        ), but it has been suggested that the presence of neutralizing antibodies may not be protective in camels (Hemida et al.
        <xref ref-type="bibr" rid="B107">
         2014
        </xref>
        ) or humans (Corman et al.
        <xref ref-type="bibr" rid="B63">
         2016
        </xref>
        , Zhao et al.
        <xref ref-type="bibr" rid="B252">
         2017
        </xref>
        ), and waning antibody titers have been reported in humans who have recovered from MERS-CoV infection (Choe et al.
        <xref ref-type="bibr" rid="B55">
         2017
        </xref>
        ). On the contrary, the reports of protection of mice by passive transfer of neutralizing antibodies suggest that this might be overcome by optimizing timing and dose (Zhao et al.
        <xref ref-type="bibr" rid="B252">
         2017
        </xref>
        ).
       </p>
       <p>
        Research on MERS-CoV vaccine candidates is ongoing, and at least one candidate vaccine has now progressed to a Phase I human clinical trial (Modjarrad
        <xref ref-type="bibr" rid="B167">
         2016
        </xref>
        , CEPI
        <xref ref-type="bibr" rid="B50">
         2017
        </xref>
        ). In a promising development, the recently launched Coalition for Epidemic Preparedness Innovations (CEPI) has listed MERS vaccine as one of its initial targets.
       </p>
      </sec>
     </sec>
     <sec id="s010">
      <title>
       Epidemiology and transmission
      </title>
      <p>
       The source of infection for most primary cases (the first known human case in a potential or putative chain of transmission) remains unknown. Baseline incidence and prevalence are unknown as only clinical cases or those found through contact tracing are generally identified. The few population-based studies that have been done appear to show low prevalence in the general population. A serological study of 10,009 individuals in Saudi Arabia found 15 seropositive for MERS-CoV, 7 of whom were occupationally camel-exposed (shepherds and slaughterhouse workers) (Müller et al.
       <xref ref-type="bibr" rid="B176">
        2015
       </xref>
       ), although the occupational samples were collected for a separate study and therefore may not be representative. In another study of 57,363 persons with suspected MERS-CoV infection tested by Saudi Arabia from April 2015 to February 2016, only 384 (0.7%) tested positive (Bin Saeed et al.
       <xref ref-type="bibr" rid="B41">
        2017
       </xref>
       ).
      </p>
      <p>
       Most work has been done on symptomatic MERS patients because they are most likely to be detected and identified. Even so, one analysis suggested that at least 62% of even symptomatic cases were undetected (Cauchemez et al.
       <xref ref-type="bibr" rid="B48">
        2014
       </xref>
       ), and a study using data from travelers suggested that there may have been as many as 3250 severe cases from September 2012 to January 2016, about 2.3 times the number of cases confirmed (O'Hagan et al.
       <xref ref-type="bibr" rid="B182">
        2016
       </xref>
       ).
      </p>
      <p>
       Determination of primary versus secondary cases is also challenging. One estimate is that 61% of MERS-CoV are primary cases, who tend to be mostly middle-aged males, compared with secondary cases who tend to be younger and distributed more evenly by sex (Gossner et al.
       <xref ref-type="bibr" rid="B98">
        2016
       </xref>
       ). The official overall CFR stands at ∼35.5% (World Health Organization
       <xref ref-type="bibr" rid="B239">
        2018a
       </xref>
       ). However, it has been suggested that the CFR among primary cases, estimated to be 74%, is likely inflated due to detection bias; CFR among secondary cases is estimated to be 20% (Cauchemez et al.
       <xref ref-type="bibr" rid="B48">
        2014
       </xref>
       ).
      </p>
      <p>
       The main known exposures are health care-associated infections and contact with camels. Aside from the health care setting, the mechanisms for the introduction of the virus into human populations are poorly understood. Occupational exposure risks are also poorly characterized, both in health care and for those who work with camels.
      </p>
      <p>
       As with SARS, many cases have been health care facility-associated (Drosten et al.
       <xref ref-type="bibr" rid="B79">
        2015
       </xref>
       ), but the mechanism of infection is unclear for many individuals (Fanoy et al.
       <xref ref-type="bibr" rid="B89">
        2014
       </xref>
       ). Active case finding, typically among perceived risk groups or those hospitalized with pneumonia, has been used with varying success to identify cases (Gierer et al.
       <xref ref-type="bibr" rid="B96">
        2013
       </xref>
       , Aburizaiza et al.
       <xref ref-type="bibr" rid="B4">
        2014
       </xref>
       , Memish et al.
       <xref ref-type="bibr" rid="B156">
        2014a
       </xref>
       ).
      </p>
      <p>
       Nosocomial transmission due to inadequate infection control is well established as a significant driver of MERS-CoV infections in humans (Al-Abdallat et al.
       <xref ref-type="bibr" rid="B11">
        2014
       </xref>
       , Maltezou and Tsiodras
       <xref ref-type="bibr" rid="B154">
        2014
       </xref>
       , Oboho et al.
       <xref ref-type="bibr" rid="B183">
        2015
       </xref>
       , Alraddadi et al.
       <xref ref-type="bibr" rid="B21">
        2016
       </xref>
       , Assiri et al.
       <xref ref-type="bibr" rid="B31">
        2016
       </xref>
       , Hastings et al.
       <xref ref-type="bibr" rid="B104">
        2016
       </xref>
       ), notably during the spring 2014 outbreak in Saudi Arabia and the late spring 2015 outbreak in South Korea. A review (Maltezou and Tsiodras
       <xref ref-type="bibr" rid="B154">
        2014
       </xref>
       ) of 536 known MERS-CoV cases at the time of the review using publicly available data found 11 possible or confirmed health care-associated transmission events leading to substantial morbidity and mortality, often involving patients having comorbidities.
      </p>
      <p>
       Infection control lapses were apparently responsible for virtually all reported health care transmission events, highlighting the need for strengthened infection control capacity worldwide. However, specific breaches in infection control were usually not identified and probably varied (Maltezou and Tsiodras
       <xref ref-type="bibr" rid="B154">
        2014
       </xref>
       ). Some high-risk procedures were identified, usually aerosol generating procedures, including hemodialysis and respiratory intensive care (Assiri et al.
       <xref ref-type="bibr" rid="B33">
        2013b
       </xref>
       ).
      </p>
      <p>
       Secondarily infected health care workers tended to have milder symptoms and better prognoses. In the 2014 outbreak in Saudi Arabia, one study analyzed 191 symptomatic cases of MERS-CoV and found that 20.9% were health care workers (additional infected health care workers were asymptomatic, so that 30.6% of the 255 total cases analyzed were health care workers), and most patients had contact with a health care facility (Oboho et al.
       <xref ref-type="bibr" rid="B183">
        2015
       </xref>
       ). In a cluster of 9 MERS-CoV cases in Jordan, 6 were health care workers at the outbreak hospital, and no MERS-CoV transmission was detected at 2 transfer hospitals with adequate infection control (Al-Abdallat et al.
       <xref ref-type="bibr" rid="B11">
        2014
       </xref>
       ).
      </p>
      <p>
       A health care-associated outbreak occurred in South Korea in the late spring of 2015 through July 2015, arising from one infected individual returning from the Gulf states (Cowling et al.
       <xref ref-type="bibr" rid="B71">
        2015
       </xref>
       , Hui et al.
       <xref ref-type="bibr" rid="B115">
        2015
       </xref>
       , Park et al.
       <xref ref-type="bibr" rid="B189">
        2015
       </xref>
       ). An analysis of 185 South Korean MERS-CoV cases using publicly available data delineated three generations of secondary infections (more than half of the cases were from the second generation) (Lee and Wong
       <xref ref-type="bibr" rid="B138">
        2015
       </xref>
       ). Overall, 154 cases were hospital-associated (Lee and Wong
       <xref ref-type="bibr" rid="B138">
        2015
       </xref>
       ), primarily affecting non-health care workers, spread by conditions such as close contact with the patients in crowded hospital or emergency rooms (Lee
       <xref ref-type="bibr" rid="B137">
        2015b
       </xref>
       ) and patients switching facilities (Lee
       <xref ref-type="bibr" rid="B136">
        2015a
       </xref>
       ,
       <xref ref-type="bibr" rid="B137">
        2015b
       </xref>
       ).
      </p>
      <p>
       Direct contact could be inferred in only about 10% of the cases, and some authors suggested that fomite transmission could be important (Lee and Wong
       <xref ref-type="bibr" rid="B138">
        2015
       </xref>
       , Seo et al.
       <xref ref-type="bibr" rid="B215">
        2016
       </xref>
       , also reviewed in Otter et al.
       <xref ref-type="bibr" rid="B187">
        2016
       </xref>
       ). Earlier reports demonstrated that MERS-CoV is relatively stable in the environment, reported recoverable on surfaces after 48 h at 20°C and 48% relative humidity and for at least 12 h at 30°C with 30% humidity (van Doremalen et al.
       <xref ref-type="bibr" rid="B231">
        2013
       </xref>
       ), or in liquid at 25°C after 2 h (Leclercq et al.
       <xref ref-type="bibr" rid="B135">
        2014
       </xref>
       ). In a study of four laboratory-confirmed MERS-CoV patient rooms in two South Korean hospitals, MERS-CoV viral RNA was found on environmental surfaces, including bedsheets and medical equipment, up to 5 days after a patient's last PCR-positive respiratory specimen; viable virus was also detected (Seo et al.
       <xref ref-type="bibr" rid="B215">
        2016
       </xref>
       ).
      </p>
      <p>
       However, there were apparently few reports of infections in hospital laundry or maintenance workers, contrary to what would be expected for environmental transmission. It is possible that they were not identified or reported. We could find only two publications specifically mentioning infection in hospital cleaners (Hastings et al.
       <xref ref-type="bibr" rid="B104">
        2016
       </xref>
       , Liu et al.
       <xref ref-type="bibr" rid="B144">
        2016
       </xref>
       ). Hastings et al. (
       <xref ref-type="bibr" rid="B104">
        2016
       </xref>
       ) investigated a 2014 outbreak in King Fahd General Hospital and reported 1 MERS-CoV case among 1295 maintenance or housekeeping personnel. However, it appears that only symptomatic cases were tested, and specific details on this case were not provided.
      </p>
      <p>
       Many reports from contact tracing identified family members, friends, coworkers, and other persons who had close contact with the patient. These include reports from Saudi Arabia (Memish et al.
       <xref ref-type="bibr" rid="B162">
        2013b
       </xref>
       , Omrani et al.
       <xref ref-type="bibr" rid="B185">
        2013
       </xref>
       , Drosten et al.
       <xref ref-type="bibr" rid="B77">
        2014
       </xref>
       ), as well as the United Kingdom (Pebody et al.
       <xref ref-type="bibr" rid="B193">
        2012
       </xref>
       , Health Protection Agency (HPA) UK Novel Coronavirus Investigation Team
       <xref ref-type="bibr" rid="B105">
        2013
       </xref>
       , Thomas et al.
       <xref ref-type="bibr" rid="B228">
        2014
       </xref>
       ), Iran (Yavarian et al.
       <xref ref-type="bibr" rid="B248">
        2015
       </xref>
       ), Tunisia (Abroug et al.
       <xref ref-type="bibr" rid="B3">
        2014
       </xref>
       ), China (Wu et al.
       <xref ref-type="bibr" rid="B243">
        2015
       </xref>
       ), Greece (Tsiodras et al.
       <xref ref-type="bibr" rid="B229">
        2014
       </xref>
       ), Germany (Buchholz et al.
       <xref ref-type="bibr" rid="B45">
        2013
       </xref>
       , Reuss et al.
       <xref ref-type="bibr" rid="B211">
        2014
       </xref>
       ), Malaysia (Premila Devi et al.
       <xref ref-type="bibr" rid="B197">
        2014
       </xref>
       ), France (Mailles et al.
       <xref ref-type="bibr" rid="B150">
        2013
       </xref>
       ), and Italy (Puzelli et al.
       <xref ref-type="bibr" rid="B199">
        2013
       </xref>
       ).
      </p>
      <p>
       Family clusters were identified in a number of these reports, but at most only a small percentage of contacts became cases, suggesting that close contact is not as important a risk factor as health care-associated transmission, and direct human-to-human transmission appears limited. Although the outbreak in South Korea also involved close contact among family members and other patients in hospital rooms, this may be more appropriately categorized as health care-associated transmission (Kang et al.
       <xref ref-type="bibr" rid="B121">
        2017
       </xref>
       ).
      </p>
      <p>
       However, there is relatively little information on asymptomatic individuals, most of whom are detected by contact tracing. In one study, an asymptomatic health care worker excreted MERS-CoV for over 5 weeks (Al-Gethamy et al.
       <xref ref-type="bibr" rid="B12">
        2015
       </xref>
       ). In the spring 2014 outbreak in Saudi Arabia, an estimated 25.1% of laboratory-confirmed MERS-CoV was asymptomatic (Oboho et al.
       <xref ref-type="bibr" rid="B183">
        2015
       </xref>
       ). An analysis of 65 MERS-CoV patients in United Arab Emirates found that 35% were asymptomatic, and 1 individual yielded positive lower respiratory tract specimens for more than 2 weeks (Hosani et al.
       <xref ref-type="bibr" rid="B113">
        2016
       </xref>
       ). Al Hammadi et al. reported two asymptomatic men who had contact with infected camels; infection was confirmed by PCR in both men, and in all eight camels in the group (Al Hammadi et al.
       <xref ref-type="bibr" rid="B10">
        2015
       </xref>
       ). However, the actual frequency of asymptomatic individuals compared with symptomatic individuals is largely unknown.
      </p>
      <p>
       Parameters for transmission dynamics are important for mathematical modeling of spread. Due to the heterogeneity in transmission, an important characteristic of infection dynamics, R
       <sub>
        0
       </sub>
       (the basic reproductive rate in a susceptible population), has been difficult to pinpoint. Estimates have ranged from 0.50 to 0.69 (Breban et al.
       <xref ref-type="bibr" rid="B43">
        2013
       </xref>
       , Poletto et al.
       <xref ref-type="bibr" rid="B196">
        2014
       </xref>
       ) to between 0.8 and 1.3 (Cauchemez et al.
       <xref ref-type="bibr" rid="B48">
        2014
       </xref>
       ). R
       <sub>
        0
       </sub>
       &gt; 1 is required for an outbreak to be self-sustaining (Anderson and May
       <xref ref-type="bibr" rid="B25">
        1991
       </xref>
       ). For specific locations, one model suggested an R
       <sub>
        0
       </sub>
       of 3.5–6.7 in Jeddah and 2.0–2.8 in Riyadh (Majumder et al.
       <xref ref-type="bibr" rid="B151">
        2014
       </xref>
       ), but these likely did not correct for effect of superspreading in health care settings (Kucharski and Althaus
       <xref ref-type="bibr" rid="B130">
        2015
       </xref>
       ). One mathematical model suggested the risk of secondary transmission following an imported MERS-CoV case is 22.7% (95% CI: 19.2–25.1%), with the risks of generations 2, 3, and 4 estimated to be 10.5%, 6.1%, and 3.9%, respectively (Nishiura et al.
       <xref ref-type="bibr" rid="B180">
        2015
       </xref>
       ).
      </p>
      <sec id="s011">
       <title>
        Travel-related cases
       </title>
       <p>
        Despite the mass gathering of individuals at the annual Hajj pilgrimage (Khan et al.
        <xref ref-type="bibr" rid="B125">
         2013
        </xref>
        ), to date it has not resulted in any known MERS-CoV transmission events (Barasheed et al.
        <xref ref-type="bibr" rid="B36">
         2014
        </xref>
        , Benkouiten et al.
        <xref ref-type="bibr" rid="B40">
         2014
        </xref>
        , Gautret et al.
        <xref ref-type="bibr" rid="B94">
         2014
        </xref>
        , Memish et al.
        <xref ref-type="bibr" rid="B157">
         2014b
        </xref>
        ,
        <xref ref-type="bibr" rid="B158">
         2014c
        </xref>
        , Aberle et al.
        <xref ref-type="bibr" rid="B2">
         2015
        </xref>
        , Annan et al.
        <xref ref-type="bibr" rid="B26">
         2015
        </xref>
        ), confirming modeling estimates for the 2014 Hajj (Lessler et al.
        <xref ref-type="bibr" rid="B141">
         2014
        </xref>
        ). Two travelers returning to the Netherlands from a separate pilgrimage (Umrah) in May 2014 were found to have MERS-CoV (Kraaij-Dirkzwager et al.
        <xref ref-type="bibr" rid="B129">
         2014
        </xref>
        ). Many of the travel-related cases have been tabulated (Pavli et al.
        <xref ref-type="bibr" rid="B190">
         2014
        </xref>
        , Sridhar et al.
        <xref ref-type="bibr" rid="B224">
         2015
        </xref>
        , Carias et al.
        <xref ref-type="bibr" rid="B47">
         2016
        </xref>
        ). In all these cases, casual transmission (outside of family and health care settings) has not been observed.
       </p>
      </sec>
     </sec>
     <sec id="s012">
      <title>
       The animal interface and search for natural and reservoir hosts of MERS-CoV
      </title>
      <p>
       Dromedary camels are the only documented zoonotic source of human infection, and there is considerable circumstantial evidence supporting camel-to-human transmission, including evidence of camels and humans becoming infected with an identical MERS-CoV (Azhar et al.
       <xref ref-type="bibr" rid="B34">
        2014
       </xref>
       , Ferguson and Kerkhove
       <xref ref-type="bibr" rid="B92">
        2014
       </xref>
       , Memish et al.
       <xref ref-type="bibr" rid="B160">
        2014e
       </xref>
       ). Identical genomic sequences of MERS-CoV were isolated from a camel owner who died from MERS-CoV and his camel who had rhinorrhea at that time; identical MERS-CoV RNA fragments were later detected in the air at the camel barn (Azhar et al.
       <xref ref-type="bibr" rid="B35">
        2014
       </xref>
       ). Serology suggested that the camel was infected before the owner (Azhar et al.
       <xref ref-type="bibr" rid="B34">
        2014
       </xref>
       ). Critics have suggested that the identical sequences may be due to cross-contamination (Drosten et al.
       <xref ref-type="bibr" rid="B78">
        2014
       </xref>
       ), but the authors maintain that the isolates were collected on different days and processed in different facilities. Other epidemiologic investigations have found similar evidence, but directionality was not implied (Ferguson and Kerkhove
       <xref ref-type="bibr" rid="B92">
        2014
       </xref>
       , Memish et al.
       <xref ref-type="bibr" rid="B160">
        2014e
       </xref>
       ).
      </p>
      <p>
       In outbreak sites, viral genomic sequences from camels have matched those published for humans, and one analysis of MERS-CoV among camels showed that many of the camel viruses can be classified into clades that correlate with human outbreaks (Alagaili et al.
       <xref ref-type="bibr" rid="B15">
        2014
       </xref>
       ). Interestingly, three dromedary camel strains of MERS-CoV had similar viral replication competence to human strains in Vero-E6 cells and human respiratory tract explants (Chan et al.
       <xref ref-type="bibr" rid="B53">
        2014
       </xref>
       ).
      </p>
      <p>
       This evidence suggests that camels would appear involved in cross-species transmission of MERS-CoV, although the precise mechanism and frequency remain uncertain.
      </p>
      <p>
       Occupational exposure to camels would seem a particularly strong risk factor for infection, but its relative importance and relative risk of different exposures are not well documented (Hemida et al.
       <xref ref-type="bibr" rid="B106">
        2015
       </xref>
       ). As camels are widely used in the region for a variety of purposes, many people have contact with camels, and exposure is often invoked in nonoccupational primary cases. Assessment of camel exposure is further complicated by the varying and sometimes vague definitions used to classify camel exposure, and the multiple types of possible exposures. Even so, it has been hypothesized that camel exposure is commonly underreported (Gossner et al.
       <xref ref-type="bibr" rid="B98">
        2016
       </xref>
       ). There is a critical need for clearer definitions and measurements of “camel exposure,” and to standardize methodology.
      </p>
      <p>
       Evidence to date indicates that MERS-like coronaviruses have been circulating in camels since at least the 1980s, before the first detection of MERS-CoV in humans (Müller et al.
       <xref ref-type="bibr" rid="B175">
        2014
       </xref>
       ). Seropositivity has been found consistently in African and Middle Eastern camels since 1983 (
       <xref ref-type="table" rid="T1">
        Table 1
       </xref>
       ). There is virologic evidence of MERS-CoV infection in camels in Qatar (Ferguson and Kerkhove
       <xref ref-type="bibr" rid="B92">
        2014
       </xref>
       , Haagmans et al.
       <xref ref-type="bibr" rid="B101">
        2014
       </xref>
       , Raj et al.
       <xref ref-type="bibr" rid="B201">
        2014
       </xref>
       ), Egypt (Chu et al.
       <xref ref-type="bibr" rid="B58">
        2014
       </xref>
       , Ali et al.
       <xref ref-type="bibr" rid="B18">
        2017a
       </xref>
       , 2017b), Oman (Nowotny and Kolodziejek
       <xref ref-type="bibr" rid="B181">
        2014
       </xref>
       ), Saudi Arabia (Hemida et al.
       <xref ref-type="bibr" rid="B107">
        2014
       </xref>
       ), Sudan, and elsewhere (Chu et al.
       <xref ref-type="bibr" rid="B56">
        2015
       </xref>
       , Ali et al.
       <xref ref-type="bibr" rid="B18">
        2017a
       </xref>
       ).
      </p>
      <table-wrap id="T1" orientation="portrait" position="float">
       <label>
        Table 1.
       </label>
       <caption>
        <p>
         Location, Methods, and Results of Recent Middle East Respiratory Syndrome Coronavirus Camel Seroprevalence Studies
        </p>
       </caption>
       <!--OASIS TABLE HERE-->
       <table frame="hsides" rules="groups">
        <colgroup>
         <col align="left"/>
         <col align="left"/>
         <col align="left"/>
         <col align="left"/>
         <col align="left"/>
        </colgroup>
        <thead>
         <tr>
          <th align="left">
           <italic>
            Countries (reference)
           </italic>
          </th>
          <th align="center">
           <italic>
            Year(s)
           </italic>
          </th>
          <th align="center">
           <italic>
            Test(s) used
           </italic>
           <sup>
            <xref ref-type="table-fn" rid="tf1">
             a
            </xref>
           </sup>
          </th>
          <th align="center">
           <italic>
            No. of samples
           </italic>
          </th>
          <th align="center">
           <italic>
            No. of positives (%)
           </italic>
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td align="left">
           Egypt (Perera et al.
           <xref ref-type="bibr" rid="B194">
            2013
           </xref>
           )
          </td>
          <td align="center">
           2013
          </td>
          <td align="left">
           ppNT
          </td>
          <td align="center">
           110
          </td>
          <td align="center">
           108 (98.2)
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="2">
           Egypt, Somalia, Sudan (Müller et al.
           <xref ref-type="bibr" rid="B175">
            2014
           </xref>
           )
          </td>
          <td align="center" rowspan="2">
           1983–1997
          </td>
          <td align="left">
           rELISA
          </td>
          <td align="center" rowspan="2">
           189
          </td>
          <td align="center">
           159 (84.1)
          </td>
         </tr>
         <tr>
          <td align="left">
           MNT
          </td>
          <td align="center">
           153 (81.0)
          </td>
         </tr>
         <tr>
          <td align="left">
           Egypt, Sudan, others (Ali et al.
           <xref ref-type="bibr" rid="B18">
            2017a
           </xref>
           )
          </td>
          <td align="center">
           2015–2016
          </td>
          <td align="left">
           MNT
          </td>
          <td align="center">
           1031
          </td>
          <td align="center">
           871 (84.5)
           <sup>
            <xref ref-type="table-fn" rid="tf2">
             b
            </xref>
           </sup>
          </td>
         </tr>
         <tr>
          <td align="left">
           Ethiopia (Reusken et al.
           <xref ref-type="bibr" rid="B208">
            2014b
           </xref>
           )
          </td>
          <td align="center">
           2010–2011
          </td>
          <td align="left">
           S1 microarray
          </td>
          <td align="center">
           188
          </td>
          <td align="center">
           181 (96.3)
           <sup>
            <xref ref-type="table-fn" rid="tf3">
             c
            </xref>
           </sup>
          </td>
         </tr>
         <tr>
          <td align="left">
           Jordan (Reusken et al.
           <xref ref-type="bibr" rid="B206">
            2013b
           </xref>
           )
          </td>
          <td align="center">
           2013
          </td>
          <td align="left">
           Nt
          </td>
          <td align="center">
           11
          </td>
          <td align="center">
           11 (100.0)
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="3">
           Kenya (Corman et al.
           <xref ref-type="bibr" rid="B65">
            2014b
           </xref>
           )
          </td>
          <td align="center" rowspan="3">
           1992–2013
          </td>
          <td align="left">
           rELISA
          </td>
          <td align="center" rowspan="3">
           774
          </td>
          <td align="center">
           228 (29.5)
          </td>
         </tr>
         <tr>
          <td align="left">
           IFA
          </td>
          <td align="center">
           213 (27.5)
          </td>
         </tr>
         <tr>
          <td align="left">
           MNT
          </td>
          <td align="center">
           133 (17.2)
          </td>
         </tr>
         <tr>
          <td align="left">
           Nigeria (Reusken et al.
           <xref ref-type="bibr" rid="B208">
            2014b
           </xref>
           )
          </td>
          <td align="center">
           2010–2011
          </td>
          <td align="left">
           S1 microarray
          </td>
          <td align="center">
           358
          </td>
          <td align="center">
           337 (94.1)
           <sup>
            <xref ref-type="table-fn" rid="tf3">
             c
            </xref>
           </sup>
          </td>
         </tr>
         <tr>
          <td align="left">
           Oman (Reusken et al.
           <xref ref-type="bibr" rid="B209">
            2013c
           </xref>
           )
          </td>
          <td align="center">
           2013
          </td>
          <td align="left">
           PRNT
          </td>
          <td align="center">
           50
          </td>
          <td align="center">
           50 (100.0)
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="2">
           Saudi Arabia (Alagaili et al.
           <xref ref-type="bibr" rid="B15">
            2014
           </xref>
           )
          </td>
          <td align="center">
           1992–2010
          </td>
          <td align="left">
           ELISA
          </td>
          <td align="center">
           264
          </td>
          <td align="center">
           230 (87.1)
          </td>
         </tr>
         <tr>
          <td align="center">
           2013
          </td>
          <td align="left">
           ELISA
          </td>
          <td align="center">
           203
          </td>
          <td align="center">
           150 (73.9)
          </td>
         </tr>
         <tr>
          <td align="left">
           Saudi Arabia (Hemida et al.
           <xref ref-type="bibr" rid="B107">
            2014
           </xref>
           )
          </td>
          <td align="center">
           1993
          </td>
          <td align="left">
           ppNT
          </td>
          <td align="center">
           131
          </td>
          <td align="center">
           118 (90.1)
          </td>
         </tr>
         <tr>
          <td align="left">
           Saudi Arabia (Hemida et al.
           <xref ref-type="bibr" rid="B108">
            2013
           </xref>
           )
          </td>
          <td align="center">
           2012–2013
          </td>
          <td align="left">
           ppNT
          </td>
          <td align="center">
           310
          </td>
          <td align="center">
           280 (90.3)
          </td>
         </tr>
         <tr>
          <td align="left">
           Tunisia (Reusken et al.
           <xref ref-type="bibr" rid="B208">
            2014b
           </xref>
           )
          </td>
          <td align="center">
           2009
          </td>
          <td align="left">
           S1 microarray
          </td>
          <td align="center">
           204
          </td>
          <td align="center">
           99 (48.5)
           <sup>
            <xref ref-type="table-fn" rid="tf3">
             c
            </xref>
           </sup>
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="2">
           United Arab Emirates (Meyer et al.
           <xref ref-type="bibr" rid="B164">
            2014
           </xref>
           )
          </td>
          <td align="center" rowspan="2">
           2003, 2013
          </td>
          <td align="left">
           rIFA
          </td>
          <td align="center" rowspan="2">
           651
          </td>
          <td align="center">
           632 (97.1)
          </td>
         </tr>
         <tr>
          <td align="left">
           Nt
          </td>
          <td align="center">
           509 (80.5)
          </td>
         </tr>
         <tr>
          <td align="left">
           United Arab Emirates (Alexandersen et al.
           <xref ref-type="bibr" rid="B16">
            2014
           </xref>
           )
          </td>
          <td align="center">
           2005
          </td>
          <td align="left">
           Nt
          </td>
          <td align="center">
           11
          </td>
          <td align="center">
           9 (81.8)
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn id="tf1">
         <label>
          <sup>
           a
          </sup>
         </label>
         <p>
          ppNT, pseudoparticle neutralization; rELISA, recombinant enzyme-linked immunosorbent assay; MNT, microneutralization; PRNT, plaque reduction neutralization test; rIFA, recombinant immunofluorescence assay; Nt, serum neutralization.
         </p>
        </fn>
        <fn id="tf2">
         <label>
          <sup>
           b
          </sup>
         </label>
         <p>
          Seroprevalence reported higher in camels imported from Sudan (543/594; 88.7%) and East Africa (71/98; 72.4%) than resident (257/339; 5.8%); total 41/1078 nasal swabs reported PCR positive, 35/41 from Sudan.
         </p>
        </fn>
        <fn id="tf3">
         <label>
          <sup>
           c
          </sup>
         </label>
         <p>
          The exact number was not reported, and has been imputed from the reported percentages.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
      <p>
       Increasing genomic evidence suggests a diversity of coronaviruses in camels throughout the Middle East and Africa, including in major source countries for camel imports to the Middle East, cross-neutralizing with MERS-CoV but having divergent sequences and probably not human pathogens (Chu et al.
       <xref ref-type="bibr" rid="B56">
        2015
       </xref>
       ,
       <xref ref-type="bibr" rid="B57">
        2018
       </xref>
       ). This may explain the high apparent seropositivity in camels in Africa in the absence of known human cases of MERS.
      </p>
      <p>
       Maintenance of the virus in the camel population remains an open question. Symptomatic MERS-CoV infection has been documented in both calves and adult camels (Adney et al.
       <xref ref-type="bibr" rid="B7">
        2014
       </xref>
       ), and viral shedding was detected in nasal secretions up to 7 days postinoculation with MERS-CoV (Adney et al.
       <xref ref-type="bibr" rid="B7">
        2014
       </xref>
       ), as well as in milk and possibly feces (Hemida et al.
       <xref ref-type="bibr" rid="B107">
        2014
       </xref>
       , Reusken et al.
       <xref ref-type="bibr" rid="B207">
        2014a
       </xref>
       ). Camel milk has been suggested as a possible source of infection for both humans and camel foals (Hemida et al.
       <xref ref-type="bibr" rid="B107">
        2014
       </xref>
       , Reusken et al.
       <xref ref-type="bibr" rid="B207">
        2014a
       </xref>
       , van Doremalen et al.
       <xref ref-type="bibr" rid="B230">
        2014
       </xref>
       ). One study demonstrated that added MERS-CoV can survive in milk for at least 48 h at both 4°C and 22°C, although not detected after pasteurization (van Doremalen et al.
       <xref ref-type="bibr" rid="B232">
        2014
       </xref>
       ).
      </p>
      <p>
       Other possible livestock hosts for MERS-CoV have been investigated, and have generally been negative (Hemida et al.
       <xref ref-type="bibr" rid="B108">
        2013
       </xref>
       , Perera et al.
       <xref ref-type="bibr" rid="B194">
        2013
       </xref>
       , Reusken et al.
       <xref ref-type="bibr" rid="B206">
        2013b
       </xref>
       ,
       <xref ref-type="bibr" rid="B209">
        2013c
       </xref>
       , Alagaili et al.
       <xref ref-type="bibr" rid="B15">
        2014
       </xref>
       , Alexandersen et al.
       <xref ref-type="bibr" rid="B16">
        2014
       </xref>
       , van Doremalen et al.
       <xref ref-type="bibr" rid="B230">
        2014
       </xref>
       , Meyer et al.
       <xref ref-type="bibr" rid="B163">
        2015
       </xref>
       ). One study found 15 seropositive alpacas, which are members of the camelid family, in Qatar (Reusken et al.
       <xref ref-type="bibr" rid="B210">
        2016
       </xref>
       ). Experimentally infected alpacas in one study demonstrated upper respiratory tract infection, viral shedding, and transmission to other alpacas (Adney et al.
       <xref ref-type="bibr" rid="B6">
        2016
       </xref>
       ).
      </p>
      <p>
       The search for the origins and natural hosts of MERS-CoV continues. Bat species across the world are known to host a wide variety of coronaviruses, including beta-coronaviruses (the genus to which MERS-CoV belongs) (Anthony et al.
       <xref ref-type="bibr" rid="B29">
        2013
       </xref>
       , Corman et al.
       <xref ref-type="bibr" rid="B67">
        2013
       </xref>
       , Lelli et al.
       <xref ref-type="bibr" rid="B140">
        2013
       </xref>
       , Memish et al.
       <xref ref-type="bibr" rid="B161">
        2013a
       </xref>
       ), and bats tend to show greater coronavirus diversity than other mammals (Drexler et al.
       <xref ref-type="bibr" rid="B76">
        2014
       </xref>
       , Anthony et al.
       <xref ref-type="bibr" rid="B27">
        2017
       </xref>
       ). Consequently, much research has focused on the possible origin of MERS-CoV in bats. Possibly further supporting this hypothesis, in bat cell lines MERS-CoV has been reported to replicate only in those cell lines that express DPP4, the functional human receptor for the virus, and not in bat cell lines lacking DPP4 expression (Raj et al.
       <xref ref-type="bibr" rid="B202">
        2013
       </xref>
       , Cai et al.
       <xref ref-type="bibr" rid="B46">
        2014
       </xref>
       ).
      </p>
      <p>
       It is possible that MERS-CoV itself may be a relatively new introduction in humans. A phylogenetic analysis utilizing 65 complete or partially complete MERS-CoV genomic sequences (32 from Saudi Arabian cases in 2013) estimated that the most recent common ancestor was in March 2012 (95% CI: December 2011–June 2012) (Cotten et al.
       <xref ref-type="bibr" rid="B70">
        2014
       </xref>
       ).
      </p>
      <p>
       One study, from analysis of an S1 subunit in its spike gene, suggested that MERS-CoV may have arisen from intraspike recombination between two ancestral coronaviruses (Corman et al. 2014).
      </p>
      <p>
       The virus has not been isolated from a bat, although a portion of MERS-CoV RNA sequence apparently was identified in a bat (the insectivorous bat
       <italic>
        Taphozous perforatus
       </italic>
       , the Egyptian tomb bat) in Saudi Arabia in the same site as an early human case (100% nucleotide match, although this was only ∼180 nucleotides in the relatively well-conserved RdRp region) (Memish et al.
       <xref ref-type="bibr" rid="B161">
        2013a
       </xref>
       ). MERS-like coronaviruses, including the closely related HKU4, which also uses a DPP4 receptor, and HKU5, first identified by Woo et al. in 2006 (Woo et al.
       <xref ref-type="bibr" rid="B237">
        2006
       </xref>
       , Lau et al.
       <xref ref-type="bibr" rid="B133">
        2013
       </xref>
       , Matthews et al.
       <xref ref-type="bibr" rid="B155">
        2014
       </xref>
       , Wang et al.
       <xref ref-type="bibr" rid="B234">
        2014
       </xref>
       ), and others have been identified in bat species in China (Matthews et al.
       <xref ref-type="bibr" rid="B155">
        2014
       </xref>
       , Yang et al.
       <xref ref-type="bibr" rid="B244">
        2014
       </xref>
       ), Mexico (Anthony et al.
       <xref ref-type="bibr" rid="B29">
        2013
       </xref>
       ), South Africa (Ithete et al.
       <xref ref-type="bibr" rid="B119">
        2013
       </xref>
       , Corman et al.
       <xref ref-type="bibr" rid="B64">
        2014a
       </xref>
       ), and Uganda (Anthony et al.
       <xref ref-type="bibr" rid="B28">
        2017
       </xref>
       ).
      </p>
     </sec>
    </sec>
    <sec id="s013" sec-type="discussion">
     <title>
      Discussion and Conclusions
     </title>
     <p>
      Since the detection of MERS-CoV in 2012, a large body of research has been amassed, as evidenced by the hundreds of unique results from our database searches. The virus has rapidly been characterized, and its functional human receptor swiftly identified. Species and cellular tropism studies have complemented clinical investigations, and laboratory work has provided further insights on MERS-CoV pathogenesis.
     </p>
     <p>
      Observational research from outbreaks in the Middle East and South Korea has generated a growing repository of clinical data, basic epidemiology, and genome sequences. Other studies have evaluated the roles of human/animal interfaces, health care settings, family clusters, and travel in MERS-CoV transmission. Furthermore, bats have been implicated as the possible origin of MERS-CoV, while dromedary camels have been shown to be likely sources of many human infections. There has been progress in developing therapeutics and vaccines. Although these have not yet progressed to full clinical trials, they could in the foreseeable future.
     </p>
     <p>
      A major reason we undertook this review was to determine what gaps still exist. Of the publications we originally identified, the largest category (80 publications) was in laboratory or basic science studies, followed by surveillance (59), animal interfaces (55), clinical aspects and health care (50), therapeutics and vaccines (42), while human transmission and epidemiology was one of the sparsest (35, including investigations of hospital outbreaks and travel-related cases), noting that these categories are not necessarily exclusive and there is overlap.
     </p>
     <p>
      In general, continued surveillance for MERS-CoV in affected countries should continue, prioritizing surveillance in humans, camels, and bats, given their apparent importance. As serology may not be reliable, due to cross-reactions and possibly waning antibodies, virologic surveillance and sequencing should also be attempted on selected specimens whenever feasible.
     </p>
     <p>
      Although the role of bats is yet to be fully elucidated, and evidence is lacking that bats are a source of human infection, the diversity of coronaviruses, including MERS-like coronaviruses, in bat species across the globe indicates that continued research and ongoing surveillance of coronaviruses in bats are justified (Lau et al.
      <xref ref-type="bibr" rid="B133">
       2013
      </xref>
      , Lelli et al.
      <xref ref-type="bibr" rid="B140">
       2013
      </xref>
      , Yang et al.
      <xref ref-type="bibr" rid="B245">
       2014
      </xref>
      ).
     </p>
     <p>
      A number of key gaps remain in epidemiology, including transmission, population-based incidence or prevalence rates, and geographic and demographic distributions of infections. Based on the limited human seroprevalence data so far, it seems likely that population prevalence is low, but the baseline should be established. It is also not clear whether seropositivity is a reliable indicator of prior infection. The finding of variable low antibody titers at 1 year postinfection (Choe et al.
      <xref ref-type="bibr" rid="B55">
       2017
      </xref>
      ) indicates that methods other than traditional serosurveys may be required (Reusken et al.
      <xref ref-type="bibr" rid="B205">
       2013a
      </xref>
      , Malik et al.
      <xref ref-type="bibr" rid="B153">
       2016
      </xref>
      ). If serology is not reliable, this raises the question of how to screen populations. There are methods that are both more sensitive and more specific for antibody detection (Mishra et al.
      <xref ref-type="bibr" rid="B166">
       2018
      </xref>
      ), as well as assays of cellular immunity (Zhao et al.
      <xref ref-type="bibr" rid="B252">
       2017
      </xref>
      ), but are costlier and more difficult for population screening.
     </p>
     <p>
      Contact tracing has identified asymptomatic infections, but studies of their frequency and transmissibility have been limited. Many of those infected are health care workers in whom these questions could be systematically studied. Relatively little is known about the natural history of human asymptomatic infections. Further studies of virus shedding, seroconversion, and transmission in asymptomatic infections are needed. Some evidence suggests that secondary cases have lower average CFRs and that subsequent links in the chain of MERS-CoV infection may decrease in severity.
     </p>
     <p>
      Exposure in most primary cases is still largely inferential at best. While camels are apparently often the likely source, the definitions of camel exposure are varied, preventing clear epidemiological inferences. Definitions of the exposures and the methodology and metrics for determining exposure should be clarified and standardized. Even if camels are a principal source of human infections, this would still not explain a substantial portion of primary human cases that did not have apparent camel exposure before infection. This raises questions about how and where these other primary cases acquired MERS-CoV infection, whether through other animal species, unidentified zoonotic exposure, unrecognized infectious persons (such as asymptomatic infectious individuals), or environmental contamination.
     </p>
     <p>
      Consequently, clarifying the routes of transmission remains crucial and should receive emphasis. To date, there is no compelling evidence of direct human-to-human transmission, such as through droplets, but secondary infection has been reported. It is often unclear how health care workers become infected. There is possible evidence of environmental contamination (fomites) in health care settings (nosocomial transmission) and close contact with an active MERS-CoV case.
     </p>
     <p>
      Various infection control lapses have been documented, but rarely a specific event or route (Ben Embarek and Van Kerkhove
      <xref ref-type="bibr" rid="B39">
       2015
      </xref>
      , Alraddadi et al.
      <xref ref-type="bibr" rid="B21">
       2016
      </xref>
      , Van Kerkhove et al.
      <xref ref-type="bibr" rid="B233">
       2016
      </xref>
      ). Rigorous infection control therefore remains essential and could prevent many secondary cases. In the interim, better documentation or identification of the specific lapses that led to infection would be of great value in understanding mechanisms of transmission and is one of the greatest knowledge gaps. Much of the evidence for fomite transmission, for example, remains anecdotal (Van Kerkhove et al.
      <xref ref-type="bibr" rid="B233">
       2016
      </xref>
      ).
     </p>
     <p>
      The mechanisms supporting chains of human MERS-CoV transmission need to be more fully evaluated. These gaps indicate a need for additional research, and also for consistent terminology and clear definitions. Although the epidemiological literature on MERS-CoV is large, much of it is fragmented and inconsistently reported. It is often difficult to deduce the sequence of infections, relationships between cases, or specific exposures. A comprehensive and consistent database or registry should be a priority.
     </p>
     <p>
      Genome sequencing has proved useful in several respects. Genome sequencing was used to help determine viral circulation and ancestry (Cotten et al.
      <xref ref-type="bibr" rid="B70">
       2014
      </xref>
      ), and to differentiate apparently similar and serologically cross-reacting coronaviruses in camels, addressing the (still unresolved) question of why MERS seems regionally limited, while many camels are imported from other places (Chu et al.
      <xref ref-type="bibr" rid="B56">
       2015
      </xref>
      ,
      <xref ref-type="bibr" rid="B57">
       2018
      </xref>
      ). It has also been used to reconstruct the transmission events and help to establish chains of infection (Assiri et al.
      <xref ref-type="bibr" rid="B33">
       2013b
      </xref>
      , Cotten et al.
      <xref ref-type="bibr" rid="B69">
       2013
      </xref>
      ), but it must be noted that there is a pressing need for more rigorous conventional epidemiology as well to validate the methodologies. These approaches might well serve a complementary function in advancing our understanding.
     </p>
     <p>
      There remains a need for effective therapeutics and vaccines. Treatment remains symptomatic, with insufficient clinical data on other therapeutic options. These options will always be limited in number, but their development should be approached more systematically with shared protocols and critical comparison of results. As a number of drug and vaccine candidates have been identified, there may be more options available for future clinical trials. There appear to be efforts underway to develop some clinical trials based on standardized protocols. This is needed, despite the challenges presented by the sporadic nature of the cases, and the relative rarity of clinical MERS.
     </p>
     <p>
      There were several limitations in this systematic review of MERS-CoV. Only publications in English or with English language abstracts were eligible for inclusion, although most of the cases have been in Arabic-speaking areas and Korea. However, hundreds of English language reports were available from countries around the world, including the Middle East and South Korea, minimizing this concern. Second, this review contains publications indexed by these databases by July 2017, so it is possible that some publications, especially recently published articles or manuscripts still in production, were unintentionally excluded from the review. We updated our literature review periodically during the preparation of this article to minimize the number of missed publications. Third, “gray literature” was not included, such as government reports and technical documents, and most meeting abstracts, although it is likely that important findings would have been submitted for journal publication.
     </p>
     <p>
      As an emerging infection of zoonotic origin (Morse
      <xref ref-type="bibr" rid="B170">
       1995
      </xref>
      ), a unified One Health approach that engages the human health, livestock and companion animal, wildlife, and environment sectors will be crucial in dealing with MERS (Morse
      <xref ref-type="bibr" rid="B171">
       2012
      </xref>
      , Morse et al.
      <xref ref-type="bibr" rid="B172">
       2012
      </xref>
      ). It could serve as an excellent case study for epidemiology and response to a new zoonotic, or emerging, infection.
     </p>
    </sec>
    <back>
     <ack>
      <title>
       Acknowledgments
      </title>
      <p>
       We thank the WHO/EMRO for commissioning this work, and the anonymous reviewers of the article for thoughtful and incisive suggestions. SSM gratefully acknowledges support by the Arts &amp; Letters Foundation.
      </p>
     </ack>
     <sec id="s014">
      <title>
       Disclaimer
      </title>
      <p>
       The funder had no role in developing the content of this article. The contents are the responsibility of the authors and do not necessarily reflect the views of the entities with which they are affiliated.
      </p>
     </sec>
     <sec id="s015" sec-type="COI-statement">
      <title>
       Author Disclosure Statement
      </title>
      <p>
       No competing financial interests exist.
      </p>
     </sec>
     <ref-list content-type="parsed">
      <title>
       References
      </title>
      <ref id="B1">
       <mixed-citation publication-type="web">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abd El Wahed
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Patel
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Heidenreich
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hufert
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Reverse transcription recombinase polymerase amplification assay for the detection of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         PLoS Curr Outbreaks
        </source>
        <year>
         2013
        </year>
        ; Available at:
        <uri xlink:href="http://currents.plos.org/outbreaks/index.html%3Fp=22591.html" xlink:type="simple">
         http://currents.plos.org/outbreaks/index.html%3Fp=22591.html
        </uri>
        accessed
        <date-in-citation>
         <month>
          1
         </month>
         ,
         <year>
          2019
         </year>
        </date-in-citation>
       </mixed-citation>
      </ref>
      <ref id="B2">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aberle
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Popow-Kraupp
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kreidl
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Laferl
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Influenza A and B viruses but not MERS-CoV in Hajj Pilgrims, Austria, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         726
        </fpage>
        –
        <lpage>
         727
        </lpage>
        <pub-id pub-id-type="pmid">
         25811672
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B3">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abroug
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Slim
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ouanes-Besbes
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kacem
          </surname>
          <given-names>
           M-AH
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1527
        </fpage>
        –
        <lpage>
         1530
        </lpage>
        <pub-id pub-id-type="pmid">
         25148113
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B4">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aburizaiza
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mattes
          </surname>
          <given-names>
           FM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hassan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Investigation of anti–Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, Fall 2012
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         209
        </volume>
        :
        <fpage>
         243
        </fpage>
        –
        <lpage>
         246
        </lpage>
        <pub-id pub-id-type="pmid">
         24218504
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B5">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Adedeji
          </surname>
          <given-names>
           AO
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Singh
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kassim
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Coleman
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Evaluation of SSYA10–001 as a replication inhibitor of Severe Acute Respiratory Syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses
        </article-title>
        .
        <source>
         Antimicrob Agents Chemother
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         58
        </volume>
        :
        <fpage>
         4894
        </fpage>
        –
        <lpage>
         4898
        </lpage>
        <pub-id pub-id-type="pmid">
         24841268
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B6">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Adney
          </surname>
          <given-names>
           DR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bielefeldt-Ohmann
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hartwig
          </surname>
          <given-names>
           AE
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bowen
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Infection, replication, and transmission of Middle East respiratory syndrome coronavirus in alpacas
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         1031
        </fpage>
        –
        <lpage>
         1037
        </lpage>
        <pub-id pub-id-type="pmid">
         27070385
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B7">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Adney
          </surname>
          <given-names>
           DR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           VR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1999
        </fpage>
        –
        <lpage>
         2005
        </lpage>
        <pub-id pub-id-type="pmid">
         25418529
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B8">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Agrawal
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Garron
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tao
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peng
          </surname>
          <given-names>
           B-H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         89
        </volume>
        :
        <fpage>
         3659
        </fpage>
        –
        <lpage>
         3670
        </lpage>
        <pub-id pub-id-type="pmid">
         25589660
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B9">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ajlan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ahyad
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jamjoom
          </surname>
          <given-names>
           LG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alharthy
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) infection: Chest CT findings
        </article-title>
        .
        <source>
         AJR Am J Roentgenol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         203
        </volume>
        :
        <fpage>
         782
        </fpage>
        –
        <lpage>
         787
        </lpage>
        <pub-id pub-id-type="pmid">
         24918624
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B10">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Hammadi
          </surname>
          <given-names>
           ZM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Eltahir
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hosani
          </surname>
          <given-names>
           FA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Asymptomatic MERS-CoV infection in humans possibly linked to infected dromedaries imported from Oman to United Arab Emirates, May 2015
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         2197
        </fpage>
        –
        <lpage>
         2200
        </lpage>
        <pub-id pub-id-type="pmid">
         26584223
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B11">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Abdallat
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rha
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: A serologic, epidemiologic, and clinical description
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         59
        </volume>
        :
        <fpage>
         1225
        </fpage>
        –
        <lpage>
         1233
        </lpage>
        <pub-id pub-id-type="pmid">
         24829216
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B12">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Gethamy
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         60
        </volume>
        :
        <fpage>
         973
        </fpage>
        –
        <lpage>
         974
        </lpage>
        <pub-id pub-id-type="pmid">
         25516193
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B13">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hinedi
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ghandour
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Khairalla
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: A case-control study of hospitalized patients
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         59
        </volume>
        :
        <fpage>
         160
        </fpage>
        –
        <lpage>
         165
        </lpage>
        <pub-id pub-id-type="pmid">
         24723278
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B14">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Momattin
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dib
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: An observational study
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         42
        </fpage>
        –
        <lpage>
         46
        </lpage>
        <pub-id pub-id-type="pmid">
         24406736
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B15">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alagaili
          </surname>
          <given-names>
           AN
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Briese
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kapoor
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e00884
        </fpage>
        –
        <lpage>
         00814
        </lpage>
        <pub-id pub-id-type="pmid">
         24570370
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B16">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alexandersen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kobinger
          </surname>
          <given-names>
           GP
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Soule
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005
        </article-title>
        .
        <source>
         Transbound Emerg Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         61
        </volume>
        :
        <fpage>
         105
        </fpage>
        –
        <lpage>
         108
        </lpage>
        <pub-id pub-id-type="pmid">
         24456414
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B17">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alghamdi
          </surname>
          <given-names>
           IG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           II
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Almalki
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alghamdi
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: A descriptive epidemiological analysis of data from the Saudi Ministry of Health
        </article-title>
        .
        <source>
         Int J Gen Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         7
        </volume>
        :
        <fpage>
         417
        </fpage>
        –
        <lpage>
         423
        </lpage>
        <pub-id pub-id-type="pmid">
         25187734
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B18">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ali
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           El-Shesheny
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kandeil
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shehata
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2017a
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         30487
        </fpage>
        <pub-id pub-id-type="pmid">
         28333616
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B19">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ali
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shehata
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gomaa
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kandeil
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
        </article-title>
        .
        <source>
         Emerg Microbes Infect.
        </source>
        <year>
         2017
        </year>
        <month>
         1
        </month>
        <day>
         4
        </day>
        ;
        <volume>
         6
        </volume>
        (
        <issue>
         1
        </issue>
        ):
        <fpage>
         e1
        </fpage>
        . doi:
        <pub-id pub-id-type="doi">
         10.1038/emi.2016.130
        </pub-id>
        <pub-id pub-id-type="pmid">
         28050021
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B20">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Almazán
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           DeDiego
          </surname>
          <given-names>
           ML
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sola
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zuñiga
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         4
        </volume>
        :
        <fpage>
         e00650
        </fpage>
        –
        <lpage>
         00613
        </lpage>
        <pub-id pub-id-type="pmid">
         24023385
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B21">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alraddadi
          </surname>
          <given-names>
           BM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           JT
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Almarashi
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abedi
          </surname>
          <given-names>
           GR
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         49
        </fpage>
        –
        <lpage>
         55
        </lpage>
        <pub-id pub-id-type="pmid">
         26692185
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B22">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alsahafi
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           AC
          </given-names>
         </name>
        </person-group>
        <article-title>
         The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012–2015
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         45
        </volume>
        :
        <fpage>
         1
        </fpage>
        –
        <lpage>
         4
        </lpage>
        <pub-id pub-id-type="pmid">
         26875601
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B23">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alserehi
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wali
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alshukairi
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alraddadi
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        <article-title>
         Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome
        </article-title>
        .
        <source>
         BMC Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         16
        </volume>
        :
        <fpage>
         105
        </fpage>
        <pub-id pub-id-type="pmid">
         26936356
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B24">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alshukairi
          </surname>
          <given-names>
           AN
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Khalid
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ahmed
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dada
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Antibody response and disease severity in healthcare worker MERS survivors
        </article-title>
        .
        <source>
         Emerg infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         1113
        </fpage>
        –
        <lpage>
         1115
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B25">
       <mixed-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           RM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           May
          </surname>
          <given-names>
           RM
          </given-names>
         </name>
        </person-group>
        <source>
         Infectious Diseases of Humans: Dynamics and Control
        </source>
        .
        <publisher-loc>
         Oxford, UK
        </publisher-loc>
        :
        <publisher-name>
         Oxford University Press
        </publisher-name>
        ,
        <year>
         1991
        </year>
       </mixed-citation>
      </ref>
      <ref id="B26">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Annan
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Owusu
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Marfo
          </surname>
          <given-names>
           KS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Larbi
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013
        </article-title>
        .
        <source>
         Trop Med Int Health
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         807
        </fpage>
        –
        <lpage>
         812
        </lpage>
        <pub-id pub-id-type="pmid">
         25688471
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B27">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Anthony
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gilardi
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Menachery
          </surname>
          <given-names>
           VD
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Goldstein
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         8
        </volume>
        :
        <fpage>
         e00373
        </fpage>
        –
        <lpage>
         17
        </lpage>
        <pub-id pub-id-type="pmid">
         28377531
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B28">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Anthony
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Johnson
          </surname>
          <given-names>
           CK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Greig
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kramer
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Global patterns in coronavirus diversity
        </article-title>
        .
        <source>
         Virus Evol
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         3
        </volume>
        :
        <fpage>
         vex012
        </fpage>
        <pub-id pub-id-type="pmid">
         28630747
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B29">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Anthony
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ojeda-Flores
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rico-Chavez
          </surname>
          <given-names>
           O
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Navarrete-Macias
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Coronaviruses in bats from Mexico
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         94
        </volume>
        :
        <fpage>
         1028
        </fpage>
        –
        <lpage>
         1038
        </lpage>
        <pub-id pub-id-type="pmid">
         23364191
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B30">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arabi
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Arifi
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Balkhy
          </surname>
          <given-names>
           HH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Najm
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Ann Intern Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         160
        </volume>
        :
        <fpage>
         389
        </fpage>
        –
        <lpage>
         397
        </lpage>
        <pub-id pub-id-type="pmid">
         24474051
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B31">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abedi
          </surname>
          <given-names>
           GR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Saeed
          </surname>
          <given-names>
           AAB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abdalla
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Multifacility outbreak of Middle East respiratory syndrome in Taif, Saudi Arabia
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         32
        </fpage>
        –
        <lpage>
         40
        </lpage>
        <pub-id pub-id-type="pmid">
         26692003
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B32">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Rabiah
          </surname>
          <given-names>
           FA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2013a
        </year>
        ;
        <volume>
         13
        </volume>
        :
        <fpage>
         752
        </fpage>
        –
        <lpage>
         761
        </lpage>
        <pub-id pub-id-type="pmid">
         23891402
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B33">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           McGeer
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perl
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Price
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Hospital outbreak of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2013b
        </year>
        ;
        <volume>
         369
        </volume>
        :
        <fpage>
         407
        </fpage>
        –
        <lpage>
         416
        </lpage>
        <pub-id pub-id-type="pmid">
         23782161
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B34">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           El-Kafrawy
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Farraj
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hassan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Evidence for camel-to-human transmission of MERS coronavirus
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         370
        </volume>
        :
        <fpage>
         2499
        </fpage>
        –
        <lpage>
         2506
        </lpage>
        <pub-id pub-id-type="pmid">
         24896817
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B35">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hashem
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           El-Kafrawy
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sohrab
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e01450
        </fpage>
        –
        <lpage>
         01414
        </lpage>
        <pub-id pub-id-type="pmid">
         25053787
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B36">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barasheed
          </surname>
          <given-names>
           O
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rashid
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alfelali
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tashani
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Viral respiratory infections among Hajj pilgrims in 2013
        </article-title>
        .
        <source>
         Virol Sin
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         29
        </volume>
        :
        <fpage>
         364
        </fpage>
        –
        <lpage>
         371
        </lpage>
        <pub-id pub-id-type="pmid">
         25413828
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B37">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barlan
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sarkar
          </surname>
          <given-names>
           MK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         4953
        </fpage>
        –
        <lpage>
         4961
        </lpage>
        <pub-id pub-id-type="pmid">
         24554656
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B38">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Baseler
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Feldmann
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        <article-title>
         A comparative review of animal models of Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Vet Pathol
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         53
        </volume>
        :
        <fpage>
         521
        </fpage>
        –
        <lpage>
         531
        </lpage>
        <pub-id pub-id-type="pmid">
         26869154
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B39">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ben Embarek
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Van Kerkhove
          </surname>
          <given-names>
           MD
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV): Current situation 3 years after the virus was first identified
        </article-title>
        .
        <source>
         Wkly Epidemiol Rec
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         90
        </volume>
        :
        <fpage>
         245
        </fpage>
        –
        <lpage>
         250
        </lpage>
        <pub-id pub-id-type="pmid">
         25980038
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B40">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Benkouiten
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Belhouchat
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Drali
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Respiratory viruses and bacteria among pilgrims during the 2013 Hajj
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1821
        </fpage>
        –
        <lpage>
         1827
        </lpage>
        <pub-id pub-id-type="pmid">
         25341199
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B41">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bin Saeed
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abedi
          </surname>
          <given-names>
           GR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alzahrani
          </surname>
          <given-names>
           AG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Salameh
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Surveillance and testing for Middle East respiratory syndrome coronavirus, Saudi Arabia, April 2015–February 2016
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         23
        </volume>
        :
        <fpage>
         682
        </fpage>
        –
        <lpage>
         685
        </lpage>
        <pub-id pub-id-type="pmid">
         28322710
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B42">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Breakwell
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pringle
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chea
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Allen
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Lack of transmission among close contacts of patient with case of Middle East Respiratory Syndrome imported into the United States, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         1128
        </fpage>
        –
        <lpage>
         1134
        </lpage>
        <pub-id pub-id-type="pmid">
         26079176
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B43">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Breban
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Riou
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fontanet
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interhuman transmissibility of Middle East respiratory syndrome coronavirus: Estimation of pandemic risk
        </article-title>
        .
        <source>
         Lancet
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         382
        </volume>
        :
        <fpage>
         694
        </fpage>
        –
        <lpage>
         699
        </lpage>
        <pub-id pub-id-type="pmid">
         23831141
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B44">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Briese
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jain
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zalmout
          </surname>
          <given-names>
           IS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e01146
        </fpage>
        –
        <lpage>
         01114
        </lpage>
        <pub-id pub-id-type="pmid">
         24781747
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B45">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Buchholz
          </surname>
          <given-names>
           U
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Nitsche
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sanewski
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October–November 2012
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20406
        </fpage>
        <pub-id pub-id-type="pmid">
         23449231
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B46">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cai
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Postnikova
          </surname>
          <given-names>
           EN
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mazur
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         CD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection
        </article-title>
        .
        <source>
         PLoS One
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         9
        </volume>
        :
        <fpage>
         e112060
        </fpage>
        <pub-id pub-id-type="pmid">
         25409519
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B47">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carias
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           O'Hagan
          </surname>
          <given-names>
           JJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jewett
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gambhir
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Exportations of symptomatic cases of MERS-CoV infection to countries outside the Middle East
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         723
        </fpage>
        –
        <lpage>
         725
        </lpage>
        <pub-id pub-id-type="pmid">
         27358972
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B48">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cauchemez
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fraser
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Van Kerkhove
          </surname>
          <given-names>
           MD
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Donnelly
          </surname>
          <given-names>
           CA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: Quantification of the extent of the epidemic, surveillance biases, and transmissibility
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         50
        </fpage>
        –
        <lpage>
         56
        </lpage>
        <pub-id pub-id-type="pmid">
         24239323
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B49">
       <mixed-citation publication-type="web">
        <collab>
         CDC
        </collab>
        .
        <article-title>
         CDC Laboratory Testing for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
        </article-title>
        <year>
         2014
        </year>
        (updated
        <month>
         6
        </month>
        <day>
         26
        </day>
        ,
        <year>
         2018
        </year>
        ). Available at:
        <uri xlink:href="http://www.cdc.gov/coronavirus/mers/lab/lab-testing.html" xlink:type="simple">
         www.cdc.gov/coronavirus/mers/lab/lab-testing.html
        </uri>
        (Accessed
        <date-in-citation>
         <month>
          8
         </month>
         <day>
          1
         </day>
         ,
         <year>
          2017
         </year>
         and
         <month>
          7
         </month>
         <day>
          23
         </day>
         ,
         <year>
          2018
         </year>
        </date-in-citation>
        )
       </mixed-citation>
      </ref>
      <ref id="B50">
       <mixed-citation publication-type="web">
        <collab>
         CEPI (Coalition for Epidemic Preparedness Innovations)
        </collab>
        .
        <article-title>
         Pipeline dataset for MERS-CoV
        </article-title>
        . Available at:
        <uri xlink:href="http://cepi.net/sites/default/files/Pipeline" xlink:type="simple">
         http://cepi.net/sites/default/files/Pipeline
        </uri>
        dataset for
        <uri xlink:href="http://MERS-CoV.pdf" xlink:type="simple">
         MERS-CoV.pdf
        </uri>
        (Accessed
        <date-in-citation>
         <season>
          Aug.
         </season>
         <day>
          1
         </day>
         ,
         <year>
          2017
         </year>
         and
         <month>
          8
         </month>
         <day>
          8
         </day>
         ,
         <year>
          2018
         </year>
        </date-in-citation>
        )
       </mixed-citation>
      </ref>
      <ref id="B51">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JF-W
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yeung
          </surname>
          <given-names>
           M-L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         212
        </volume>
        :
        <fpage>
         1904
        </fpage>
        –
        <lpage>
         1913
        </lpage>
        <pub-id pub-id-type="pmid">
         26198719
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B52">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JFW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K-H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kao
          </surname>
          <given-names>
           RYT
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           To
          </surname>
          <given-names>
           KKW
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Broad-spectrum antivirals for the emerging Middle East respiratory syndrome
        </article-title>
        .
        <source>
         J Infect
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         67
        </volume>
        :
        <fpage>
         606
        </fpage>
        –
        <lpage>
         616
        </lpage>
        <pub-id pub-id-type="pmid">
         24096239
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B53">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           RWY
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kayali
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: An in-vitro and ex-vivo study
        </article-title>
        .
        <source>
         Lancet Respir Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         2
        </volume>
        :
        <fpage>
         813
        </fpage>
        –
        <lpage>
         822
        </lpage>
        <pub-id pub-id-type="pmid">
         25174549
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B54">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rajashankar
          </surname>
          <given-names>
           KR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Agnihothram
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         10777
        </fpage>
        –
        <lpage>
         10783
        </lpage>
        <pub-id pub-id-type="pmid">
         23903833
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B55">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Choe
          </surname>
          <given-names>
           PG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           K-H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         23
        </volume>
        :
        <fpage>
         1079
        </fpage>
        –
        <lpage>
         1084
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B56">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Oladipo
          </surname>
          <given-names>
           JO
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kuranga
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         30086
        </fpage>
       </mixed-citation>
      </ref>
      <ref id="B57">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           KPY
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Miguel
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2018
        </year>
        ;
        <volume>
         115
        </volume>
        :
        <fpage>
         3144
        </fpage>
        –
        <lpage>
         3149
        </lpage>
        <pub-id pub-id-type="pmid">
         29507189
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B58">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LLM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gomaa
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shehata
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS coronaviruses in dromedary camels, Egypt
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1049
        </fpage>
        –
        <lpage>
         1053
        </lpage>
        <pub-id pub-id-type="pmid">
         24856660
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B59">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cockrell
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peck
          </surname>
          <given-names>
           KM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yount
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Agnihothram
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         5195
        </fpage>
        –
        <lpage>
         5199
        </lpage>
        <pub-id pub-id-type="pmid">
         24574399
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B60">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Coleman
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sisk
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Halasz
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhong
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         CD8
         <sup>
          +
         </sup>
         T cells and macrophages regulate pathogenesis in a mouse model of Middle East respiratory syndrome
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         91
        </volume>
        :
        <fpage>
         e01825
        </fpage>
        –
        <lpage>
         16
        </lpage>
        <pub-id pub-id-type="pmid">
         27795435
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B61">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bleicker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Detection of a novel human coronavirus by realtime reverse-transcription polymerase chain reaction
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2012a
        </year>
        ;
        <volume>
         17
        </volume>
        :
        <fpage>
         20285
        </fpage>
        <pub-id pub-id-type="pmid">
         23041020
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B62">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Costabel
          </surname>
          <given-names>
           U
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Timm
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2012b
        </year>
        ;
        <volume>
         17
        </volume>
        :
        <fpage>
         20334
        </fpage>
        <pub-id pub-id-type="pmid">
         23231891
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B63">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         62
        </volume>
        :
        <fpage>
         477
        </fpage>
        –
        <lpage>
         483
        </lpage>
        <pub-id pub-id-type="pmid">
         26565003
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B64">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ithete
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Richards
          </surname>
          <given-names>
           LR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Schoeman
          </surname>
          <given-names>
           MC
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014a
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         11297
        </fpage>
        –
        <lpage>
         11303
        </lpage>
        <pub-id pub-id-type="pmid">
         25031349
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B65">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jores
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Younan
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014b
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1319
        </fpage>
        –
        <lpage>
         1322
        </lpage>
        <pub-id pub-id-type="pmid">
         25075637
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B66">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ölschläger
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wendtner
          </surname>
          <given-names>
           C-M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Drexler
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Performance and clinical validation of the RealStar
         <sup>
          ®
         </sup>
         MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA
        </article-title>
        .
        <source>
         J Clin Virol
        </source>
        <year>
         2014c
        </year>
        ;
        <volume>
         60
        </volume>
        :
        <fpage>
         168
        </fpage>
        –
        <lpage>
         171
        </lpage>
        <pub-id pub-id-type="pmid">
         24726679
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B67">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasche
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Diallo
          </surname>
          <given-names>
           TD
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cottontail
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Highly diversified coronaviruses in neotropical bats
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         94
        </volume>
        :
        <fpage>
         1984
        </fpage>
        –
        <lpage>
         1994
        </lpage>
        <pub-id pub-id-type="pmid">
         23761408
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B68">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corti
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pedotti
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Simonelli
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         112
        </volume>
        :
        <fpage>
         10473
        </fpage>
        –
        <lpage>
         10478
        </lpage>
        <pub-id pub-id-type="pmid">
         26216974
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B69">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kellam
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: A descriptive genomic study
        </article-title>
        .
        <source>
         Lancet
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         382
        </volume>
        :
        <fpage>
         1993
        </fpage>
        –
        <lpage>
         2002
        </lpage>
        <pub-id pub-id-type="pmid">
         24055451
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B70">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e01062
        </fpage>
        –
        <lpage>
         01013
        </lpage>
        <pub-id pub-id-type="pmid">
         24549846
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B71">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cowling
          </surname>
          <given-names>
           BJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fang
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         21163
        </fpage>
        <pub-id pub-id-type="pmid">
         26132767
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B72">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wilde
          </surname>
          <given-names>
           AH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jochmans
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Posthuma
          </surname>
          <given-names>
           CC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zevenhoven-Dobbe
          </surname>
          <given-names>
           JC
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture
        </article-title>
        .
        <source>
         Antimicrob Agents Chemother
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         58
        </volume>
        :
        <fpage>
         4875
        </fpage>
        –
        <lpage>
         4884
        </lpage>
        <pub-id pub-id-type="pmid">
         24841269
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B73">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wilde
          </surname>
          <given-names>
           AH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Oudshoorn
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-a treatment
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         94
        </volume>
        :
        <fpage>
         1749
        </fpage>
        –
        <lpage>
         1760
        </lpage>
        <pub-id pub-id-type="pmid">
         23620378
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B74">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         110
        </volume>
        :
        <fpage>
         16598
        </fpage>
        –
        <lpage>
         16603
        </lpage>
        <pub-id pub-id-type="pmid">
         24062443
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B75">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         SARS and MERS: Recent insights into emerging coronaviruses
        </article-title>
        .
        <source>
         Nat Rev Microbiol
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         523
        </fpage>
        –
        <lpage>
         534
        </lpage>
        <pub-id pub-id-type="pmid">
         27344959
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B76">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drexler
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
        </article-title>
        .
        <source>
         Antiviral Res
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         101
        </volume>
        :
        <fpage>
         45
        </fpage>
        –
        <lpage>
         56
        </lpage>
        <pub-id pub-id-type="pmid">
         24184128
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B77">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kellam
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence for camel-to-human transmission of MERS coronavirus (Letter)
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         371
        </volume>
        :
        <fpage>
         1359
        </fpage>
        –
        <lpage>
         1360
        </lpage>
        <pub-id pub-id-type="pmid">
         25271615
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B78">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Transmission of MERS-coronavirus in household contacts
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         371
        </volume>
        :
        <fpage>
         828
        </fpage>
        –
        <lpage>
         835
        </lpage>
        <pub-id pub-id-type="pmid">
         25162889
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B79">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         60
        </volume>
        :
        <fpage>
         369
        </fpage>
        –
        <lpage>
         377
        </lpage>
        <pub-id pub-id-type="pmid">
         25323704
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B80">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Seilmaier
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hartmann
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         13
        </volume>
        :
        <fpage>
         745
        </fpage>
        –
        <lpage>
         751
        </lpage>
        <pub-id pub-id-type="pmid">
         23782859
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B81">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kou
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tao
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: Implication for developing therapeutics and vaccines
        </article-title>
        .
        <source>
         PLoS One
        </source>
        <year>
         2013a
        </year>
        ;
        <volume>
         8
        </volume>
        :
        <fpage>
         e81587
        </fpage>
        <pub-id pub-id-type="pmid">
         24324708
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B82">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        , G,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kou
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013b
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         9939
        </fpage>
        –
        <lpage>
         9942
        </lpage>
        <pub-id pub-id-type="pmid">
         23824801
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B83">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Qiu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         7045
        </fpage>
        –
        <lpage>
         7053
        </lpage>
        <pub-id pub-id-type="pmid">
         24719424
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B84">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dyall
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Coleman
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hart
          </surname>
          <given-names>
           BJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Venkataraman
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Antimicrob Agents Chemother
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         58
        </volume>
        :
        <fpage>
         4885
        </fpage>
        –
        <lpage>
         4893
        </lpage>
        <pub-id pub-id-type="pmid">
         24841273
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B85">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lenk
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Replicative capacity of MERS coronavirus in livestock cell lines
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         276
        </fpage>
        –
        <lpage>
         279
        </lpage>
        <pub-id pub-id-type="pmid">
         24457147
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B86">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kallies
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gotthardt
          </surname>
          <given-names>
           DN
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection
        </article-title>
        .
        <source>
         Virol J
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         10
        </volume>
        :
        <fpage>
         359
        </fpage>
        <pub-id pub-id-type="pmid">
         24364985
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B87">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Feldmann
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
        </article-title>
        .
        <source>
         Nat Med
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1313
        </fpage>
        –
        <lpage>
         1318
        </lpage>
        <pub-id pub-id-type="pmid">
         24013700
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B88">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wit
          </surname>
          <given-names>
           Ed
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Feldmann
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Infection with MERS-CoV causes lethal pneumonia in the common marmoset
        </article-title>
        .
        <source>
         PLoS Pathog
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         10
        </volume>
        :
        <fpage>
         e1004250
        </fpage>
        <pub-id pub-id-type="pmid">
         25144235
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B89">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fanoy
          </surname>
          <given-names>
           EB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van der Sande
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kraaij-Dirkzwager
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dirksen
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Travel-related MERS-CoV cases: An assessment of exposures and risk factors in a group of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014
        </article-title>
        .
        <source>
         Emerg Themes Epidemiol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         11
        </volume>
        :
        <fpage>
         16
        </fpage>
        <pub-id pub-id-type="pmid">
         25328533
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B90">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Faure
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Goffard
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fournier
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside?
        </article-title>
        <source>
         PLoS One
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         9
        </volume>
        :
        <fpage>
         e88716
        </fpage>
        <pub-id pub-id-type="pmid">
         24551142
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B91">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Feikin
          </surname>
          <given-names>
           DR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alraddadi
          </surname>
          <given-names>
           BM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Qutub
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shabouni
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         2029
        </fpage>
        –
        <lpage>
         2035
        </lpage>
        <pub-id pub-id-type="pmid">
         26488195
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B92">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ferguson
          </surname>
          <given-names>
           NM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kerkhove
          </surname>
          <given-names>
           MDV
          </given-names>
         </name>
        </person-group>
        <article-title>
         Identification of MERS-CoV in dromedary camels
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         93
        </fpage>
        –
        <lpage>
         94
        </lpage>
        <pub-id pub-id-type="pmid">
         24355867
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B93">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Qi
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         13134
        </fpage>
        –
        <lpage>
         13140
        </lpage>
        <pub-id pub-id-type="pmid">
         24067982
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B94">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Benkouiten
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Belhouchat
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         728
        </fpage>
        –
        <lpage>
         730
        </lpage>
        <pub-id pub-id-type="pmid">
         24656283
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B95">
       <mixed-citation publication-type="web">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gesmann
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           de Castillo
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        <article-title>
         Introduction to googleVis 0.6.2
        </article-title>
        .
        <year>
         2017
        </year>
        Available at
        <uri xlink:href="http://cran.r-project.org/web/packages/googleVis/vignettes/googleVis.pdf" xlink:type="simple">
         https://cran.r-project.org/web/packages/googleVis/vignettes/googleVis.pdf
        </uri>
        [E-pub online]
       </mixed-citation>
      </ref>
      <ref id="B96">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gierer
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hofmann-Winkler
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Albuali
          </surname>
          <given-names>
           WH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bertram
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Lack of MERS coronavirus neutralizing antibodies in humans, Eastern Province, Saudi Arabia
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         2034
        </fpage>
        –
        <lpage>
         2036
        </lpage>
        <pub-id pub-id-type="pmid">
         24274664
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B97">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gierer
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Heurich
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ritz
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Inhibition of proprotein convertases abrogates processing of the Middle Eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         211
        </volume>
        :
        <fpage>
         889
        </fpage>
        –
        <lpage>
         897
        </lpage>
        <pub-id pub-id-type="pmid">
         25057042
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B98">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gossner
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Danielson
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gervelmeyer
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Berthe
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Zoonoses Public Health
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         63
        </volume>
        :
        <fpage>
         1
        </fpage>
        –
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="pmid">
         25545147
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B99">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Graham
          </surname>
          <given-names>
           RL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baric
          </surname>
          <given-names>
           RS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recombination, reservoirs, and the modular Spike: Mechanisms of coronavirus cross-species transmission
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2010
        </year>
        ;
        <volume>
         84
        </volume>
        :
        <fpage>
         3134
        </fpage>
        –
        <lpage>
         3146
        </lpage>
        <pub-id pub-id-type="pmid">
         19906932
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B100">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guery
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           el Mansouf
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Séjourné
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: A report of nosocomial transmission
        </article-title>
        .
        <source>
         Lancet
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         381
        </volume>
        :
        <fpage>
         2265
        </fpage>
        –
        <lpage>
         2272
        </lpage>
        <pub-id pub-id-type="pmid">
         23727167
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B101">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Dhahiry
          </surname>
          <given-names>
           SHS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         140
        </fpage>
        –
        <lpage>
         145
        </lpage>
        <pub-id pub-id-type="pmid">
         24355866
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B102">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van den Brand
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Volz
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
        </article-title>
        .
        <source>
         Science
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         351
        </volume>
        :
        <fpage>
         77
        </fpage>
        –
        <lpage>
         81
        </lpage>
        <pub-id pub-id-type="pmid">
         26678878
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B103">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hart
          </surname>
          <given-names>
           BJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dyall
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Postnikova
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         95
        </volume>
        :
        <fpage>
         571
        </fpage>
        –
        <lpage>
         577
        </lpage>
        <pub-id pub-id-type="pmid">
         24323636
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B104">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hastings
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tokars
          </surname>
          <given-names>
           JI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abdel Aziz
          </surname>
          <given-names>
           IZAM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alkhaldi
          </surname>
          <given-names>
           KZ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Outbreak of Middle East respiratory syndrome at tertiary care hospital, Jeddah, Saudi Arabia, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         794
        </fpage>
        –
        <lpage>
         801
        </lpage>
        <pub-id pub-id-type="pmid">
         27089550
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B105">
       <mixed-citation publication-type="journal">
        <collab>
         Health Protection Agency (HPA) UK Novel Coronavirus Investigation Team
        </collab>
        .
        <article-title>
         Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         8
        </volume>
        :
        <fpage>
         20427
        </fpage>
       </mixed-citation>
      </ref>
      <ref id="B106">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Naeem
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chin
          </surname>
          <given-names>
           AWH
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Lack of Middle East respiratory syndrome coronavirus transmission from infected camels
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         699
        </fpage>
        –
        <lpage>
         701
        </lpage>
        <pub-id pub-id-type="pmid">
         25811546
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B107">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LLM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS coronavirus in dromedary camel herd, Saudi Arabia
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1231
        </fpage>
        –
        <lpage>
         1234
        </lpage>
        <pub-id pub-id-type="pmid">
         24964193
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B108">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alhammadi
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20659
        </fpage>
        <pub-id pub-id-type="pmid">
         24342517
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B109">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hijawi
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abdallat
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sayaydeh
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Novel coronavirus infections in Jordan, April 2012: Epidemiological findings from a retrospective investigation
        </article-title>
        .
        <source>
         East Mediterr Health J
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         S12
        </fpage>
        –
        <lpage>
         S18
        </lpage>
        <pub-id pub-id-type="pmid">
         23888790
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B110">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hilgenfeld
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
        </article-title>
        .
        <source>
         Antiviral Res
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         100
        </volume>
        :
        <fpage>
         286
        </fpage>
        –
        <lpage>
         295
        </lpage>
        <pub-id pub-id-type="pmid">
         24012996
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B111">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hin Chu
          </surname>
          <given-names>
           JZ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           BH-Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JF-W
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         213
        </volume>
        :
        <fpage>
         904
        </fpage>
        –
        <lpage>
         914
        </lpage>
        <pub-id pub-id-type="pmid">
         26203058
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B112">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hocke
          </surname>
          <given-names>
           AC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Becher
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Knepper
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peter
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Emerging human Middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs
        </article-title>
        .
        <source>
         Am J Respir Crit Care Med
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         188
        </volume>
        :
        <fpage>
         882
        </fpage>
        –
        <lpage>
         886
        </lpage>
        <pub-id pub-id-type="pmid">
         24083868
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B113">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hosani
          </surname>
          <given-names>
           FIA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pringle
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mulla
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Response to emergence of Middle East respiratory syndrome coronavirus, Abu Dhabi, United Arab Emirates, 2013–2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         1162
        </fpage>
        –
        <lpage>
         1168
        </lpage>
        <pub-id pub-id-type="pmid">
         27314227
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B114">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Houser
          </surname>
          <given-names>
           KV
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gretebeck
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ying
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)–specific human monoclonal antibody protects rabbits from MERS-CoV infection
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         213
        </volume>
        :
        <fpage>
         1
        </fpage>
        –
        <lpage>
         5
        </lpage>
        <pub-id pub-id-type="pmid">
         26452396
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B115">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           DS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perlman
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Spread of MERS to South Korea and China
        </article-title>
        .
        <source>
         Lancet Respir Med
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         3
        </volume>
        :
        <fpage>
         509
        </fpage>
        –
        <lpage>
         510
        </lpage>
        <pub-id pub-id-type="pmid">
         26050550
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B116">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hulswit
          </surname>
          <given-names>
           RJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           de Haan
          </surname>
          <given-names>
           CA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bosch
          </surname>
          <given-names>
           BJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus spike protein and tropism changes
        </article-title>
        .
        <source>
         Adv Virus Res
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         96
        </volume>
        :
        <fpage>
         29
        </fpage>
        –
        <lpage>
         57
        </lpage>
        <pub-id pub-id-type="pmid">
         27712627
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B117">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hunter
          </surname>
          <given-names>
           JC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Nguyen
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Aden
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Bandar
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         647
        </fpage>
        –
        <lpage>
         656
        </lpage>
        <pub-id pub-id-type="pmid">
         26981708
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B118">
       <mixed-citation publication-type="web">
        <collab>
         ICTV
        </collab>
        .
        <article-title>
         Virus Taxonomy: 2016 Release
        </article-title>
        . Available at:
        <uri xlink:href="http://talk.ictvonline.org/taxonomy" xlink:type="simple">
         https://talk.ictvonline.org/taxonomy
        </uri>
        (Accessed
        <date-in-citation>
         <month>
          8
         </month>
         <day>
          1
         </day>
         ,
         <year>
          2017
         </year>
        </date-in-citation>
        )
       </mixed-citation>
      </ref>
      <ref id="B119">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ithete
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Stoffberg
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cottontail
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Close relative of Human Middle East respiratory syndrome coronavirus in bat, South Africa
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1698
        </fpage>
        –
        <lpage>
         1699
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B120">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zuo
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shi
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein
        </article-title>
        .
        <source>
         Sci Transl Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         6
        </volume>
        :
        <fpage>
         234
        </fpage>
        –
        <lpage>
         259
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B121">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           CK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           KH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Choe
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea
        </article-title>
        .
        <source>
         J Korean Med Sci
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         32
        </volume>
        :
        <fpage>
         744
        </fpage>
        –
        <lpage>
         749
        </lpage>
        <pub-id pub-id-type="pmid">
         28378546
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B122">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kapoor
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pringle
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kumar
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dearth
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         59
        </volume>
        :
        <fpage>
         1511
        </fpage>
        –
        <lpage>
         1518
        </lpage>
        <pub-id pub-id-type="pmid">
         25100864
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B123">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khalid
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Rabiah
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Mobeireek
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Ribavirin and interferon-a2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: A preliminary report of two cases
        </article-title>
        .
        <source>
         Antivir Ther
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         87
        </fpage>
        –
        <lpage>
         91
        </lpage>
        <pub-id pub-id-type="pmid">
         24831606
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B124">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khalid
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabiah
          </surname>
          <given-names>
           FA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alismaili
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle Eastern respiratory syndrome corona virus (MERS CoV): Case reports from a tertiary care hospital in Saudi Arabia
        </article-title>
        .
        <source>
         Ann Saudi Med
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         34
        </volume>
        :
        <fpage>
         396
        </fpage>
        –
        <lpage>
         400
        </lpage>
        <pub-id pub-id-type="pmid">
         25827696
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B125">
       <mixed-citation publication-type="web">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sears
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hu
          </surname>
          <given-names>
           V
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Brownstein
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Potential for the international spread of Middle East respiratory syndrome in association with mass gatherings in Saudi Arabia
        </article-title>
        .
        <source>
         PLoS Currents Outbreaks
        </source>
        <year>
         2013
        </year>
        ; Available at:
        <uri xlink:href="http://currents.plos.org/outbreaks/index.html%3Fp=21609.html" xlink:type="simple">
         http://currents.plos.org/outbreaks/index.html%3Fp=21609.html
        </uri>
        accessed
        <date-in-citation>
         <month>
          1
         </month>
         ,
         <year>
          2019
         </year>
        </date-in-citation>
       </mixed-citation>
      </ref>
      <ref id="B126">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kilianski
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mielech
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baker
          </surname>
          <given-names>
           SC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         11955
        </fpage>
        –
        <lpage>
         11962
        </lpage>
        <pub-id pub-id-type="pmid">
         23986593
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B127">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Okada
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kenniston
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB/c mice
        </article-title>
        .
        <source>
         Vaccine
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         32
        </volume>
        :
        <fpage>
         5975
        </fpage>
        –
        <lpage>
         5982
        </lpage>
        <pub-id pub-id-type="pmid">
         25192975
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B128">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           Y-J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cho
          </surname>
          <given-names>
           Y-J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           D-W
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           J-S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, isolated in South Korea
        </article-title>
        .
        <source>
         Genome Announc
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         3
        </volume>
        :
        <fpage>
         e00787
        </fpage>
        –
        <lpage>
         00715
        </lpage>
        <pub-id pub-id-type="pmid">
         26272558
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B129">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kraaij-Dirkzwager
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Timen
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dirksen
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gelinck
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20817
        </fpage>
        <pub-id pub-id-type="pmid">
         24906375
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B130">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kucharski
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Althaus
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         21167
        </fpage>
        <pub-id pub-id-type="pmid">
         26132768
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B131">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kumar
          </surname>
          <given-names>
           V
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shin
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shie
          </surname>
          <given-names>
           JJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ku
          </surname>
          <given-names>
           KB
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL(Pro) inhibitors
        </article-title>
        .
        <source>
         Antiviral Res
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         141
        </volume>
        :
        <fpage>
         101
        </fpage>
        –
        <lpage>
         106
        </lpage>
        <pub-id pub-id-type="pmid">
         28216367
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B132">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lan
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen
        </article-title>
        .
        <source>
         PLoS One
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         9
        </volume>
        :
        <fpage>
         e112602
        </fpage>
        <pub-id pub-id-type="pmid">
         25405618
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B133">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           CCY
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K-H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           CPY
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         94
        </volume>
        :
        <fpage>
         2679
        </fpage>
        –
        <lpage>
         2690
        </lpage>
        <pub-id pub-id-type="pmid">
         24077366
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B134">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           KSM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           AKL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           CSF
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Genetic characterization of Betacoronavirus Lineage C viruses in bats reveals marked sequence divergence in the spike protein of
         <italic>
          Pipistrellus
         </italic>
         bat coronavirus HKU5 in Japanese pipistrelle: Implications for the origin of the novel Middle East Respiratory Syndrome coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         8638
        </fpage>
        –
        <lpage>
         8650
        </lpage>
        <pub-id pub-id-type="pmid">
         23720729
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B135">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Leclercq
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Batejat
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Burguiere
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Manuguerra
          </surname>
          <given-names>
           J-C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Heat inactivation of the Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         Influenza Other Respir Viruses
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         8
        </volume>
        :
        <fpage>
         585
        </fpage>
        –
        <lpage>
         586
        </lpage>
        <pub-id pub-id-type="pmid">
         25074677
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B136">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        <article-title>
         Better understanding on MERS corona virus outbreak in Korea
        </article-title>
        .
        <source>
         J Korean Med Sci
        </source>
        <year>
         2015a
        </year>
        ;
        <volume>
         30
        </volume>
        :
        <fpage>
         835
        </fpage>
        –
        <lpage>
         836
        </lpage>
        <pub-id pub-id-type="pmid">
         26130942
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B137">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           KH
          </given-names>
         </name>
        </person-group>
        <article-title>
         Emergency medical services in response to the Middle East respiratory syndrome outbreak in Korea
        </article-title>
        .
        <source>
         J Korean Med Assoc
        </source>
        <year>
         2015b
        </year>
        ;
        <volume>
         58
        </volume>
        :
        <fpage>
         611
        </fpage>
        –
        <lpage>
         616
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B138">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           NS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         38
        </volume>
        :
        <fpage>
         65
        </fpage>
        –
        <lpage>
         67
        </lpage>
        <pub-id pub-id-type="pmid">
         26216766
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B139">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lei
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mesters
          </surname>
          <given-names>
           JR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Anemüller
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
        </article-title>
        .
        <source>
         Antiviral Res
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         109
        </volume>
        :
        <fpage>
         72
        </fpage>
        –
        <lpage>
         82
        </lpage>
        <pub-id pub-id-type="pmid">
         24992731
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B140">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lelli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Papetti
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sabelli
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rosti
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Detection of coronaviruses in bats of various species in Italy
        </article-title>
        .
        <source>
         Viruses
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         2679
        </fpage>
        –
        <lpage>
         2689
        </lpage>
        <pub-id pub-id-type="pmid">
         24184965
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B141">
       <mixed-citation publication-type="web">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lessler
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ridriguez-Barraquer
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cummings
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Garske
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Estimating potential incidence of MERS-CoV associated with Hajj pilgrims to Saudi Arabia, 2014
        </article-title>
        .
        <source>
         PLoS Currents Outbreaks
        </source>
        <year>
         2014
        </year>
        Available at:
        <uri xlink:href="http://currents.plos.org/outbreaks/index.html%3Fp=44225.html" xlink:type="simple">
         http://currents.plos.org/outbreaks/index.html%3Fp=44225.html
        </uri>
        accessed
        <date-in-citation>
         <month>
          1
         </month>
         ,
         <year>
          2019
         </year>
        </date-in-citation>
       </mixed-citation>
      </ref>
      <ref id="B142">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Letko
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Miazgowicz
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           McMinn
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Seifert
          </surname>
          <given-names>
           SN
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Adaptive evolution of MERS-CoV to species variation in DPP4
        </article-title>
        .
        <source>
         Cell Rep
        </source>
        <year>
         2018
        </year>
        ;
        <volume>
         24
        </volume>
        :
        <fpage>
         1730
        </fpage>
        –
        <lpage>
         1737
        </lpage>
        <pub-id pub-id-type="pmid">
         30110630
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B143">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Xia
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sun
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry
        </article-title>
        .
        <source>
         Antimicrob Agents Chemother
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         59
        </volume>
        :
        <fpage>
         742
        </fpage>
        –
        <lpage>
         744
        </lpage>
        <pub-id pub-id-type="pmid">
         25331705
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B144">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           T-C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           Y-T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu J
          </surname>
          <given-names>
           T-S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Comparative epidemiology of human infections with Middle East respiratory syndrome and Severe Acute respiratory syndrome coronaviruses among healthcare personnel
        </article-title>
        .
        <source>
         PLoS One
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         11
        </volume>
        :
        <fpage>
         e0149988
        </fpage>
        <pub-id pub-id-type="pmid">
         26930074
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B145">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K-H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
        </article-title>
        .
        <source>
         Nat Commun
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         3067
        </fpage>
        <pub-id pub-id-type="pmid">
         24473083
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B146">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Whitaker
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sakthivel
          </surname>
          <given-names>
           SKK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kamili
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Clin Microbiol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         52
        </volume>
        :
        <fpage>
         67
        </fpage>
        –
        <lpage>
         75
        </lpage>
        <pub-id pub-id-type="pmid">
         24153118
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B147">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lundin
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dijkman
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bergstrom
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kann
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus
        </article-title>
        .
        <source>
         PLoS Pathog
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         10
        </volume>
        :
        <fpage>
         e1004166
        </fpage>
        <pub-id pub-id-type="pmid">
         24874215
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B148">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
        </article-title>
        .
        <source>
         Vaccine
        </source>
        <year>
         2014a
        </year>
        ;
        <volume>
         32
        </volume>
        :
        <fpage>
         2100
        </fpage>
        –
        <lpage>
         2108
        </lpage>
        <pub-id pub-id-type="pmid">
         24560617
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B149">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tao
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design
        </article-title>
        .
        <source>
         Vaccine
        </source>
        <year>
         2014b
        </year>
        ;
        <volume>
         32
        </volume>
        :
        <fpage>
         6170
        </fpage>
        –
        <lpage>
         6176
        </lpage>
        <pub-id pub-id-type="pmid">
         25240756
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B150">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mailles
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Blanckaert
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chaud
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van der Werf
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20502
        </fpage>
        <pub-id pub-id-type="pmid">
         23787161
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B151">
       <mixed-citation publication-type="web">
        <person-group person-group-type="author">
         <name>
          <surname>
           Majumder
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rivers
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lofgren
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fisman
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        <article-title>
         Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: Insights from publicly available data
        </article-title>
        .
        <source>
         PLoS Currents Outbreaks
        </source>
        <year>
         2014
        </year>
        ; Available at:
        <uri xlink:href="http://currents.plos.org/outbreaks/index.html%3Fp=40801.html" xlink:type="simple">
         http://currents.plos.org/outbreaks/index.html%3Fp=40801.html
        </uri>
        accessed
        <date-in-citation>
         <month>
          1
         </month>
         ,
         <year>
          2019
         </year>
        </date-in-citation>
       </mixed-citation>
      </ref>
      <ref id="B152">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Malik
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           El Masry
          </surname>
          <given-names>
           KM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ravi
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sayed
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         515
        </fpage>
        –
        <lpage>
         517
        </lpage>
        <pub-id pub-id-type="pmid">
         26890613
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B153">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Malik
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Elkholy
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           W
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hassounah
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: Current knowledge and future considerations
        </article-title>
        .
        <source>
         East Mediterr Health J
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         537
        </fpage>
        –
        <lpage>
         546
        </lpage>
        <pub-id pub-id-type="pmid">
         27714748
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B154">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Maltezou
          </surname>
          <given-names>
           HC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: Implications for health care facilities
        </article-title>
        .
        <source>
         Am J Infect Control
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         42
        </volume>
        :
        <fpage>
         1261
        </fpage>
        –
        <lpage>
         1265
        </lpage>
        <pub-id pub-id-type="pmid">
         25465253
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B155">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Matthews
          </surname>
          <given-names>
           KL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Coleman
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van der Meer
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Snijder
          </surname>
          <given-names>
           EJ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         94
        </volume>
        :
        <fpage>
         874
        </fpage>
        –
        <lpage>
         882
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B156">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: A prospective descriptive study
        </article-title>
        .
        <source>
         Clin Microbiol Infect
        </source>
        <year>
         2014a
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         469
        </fpage>
        –
        <lpage>
         474
        </lpage>
        <pub-id pub-id-type="pmid">
         24460984
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B157">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Almasri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Turkestani
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Shangiti
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Etiology of severe community-acquired pneumonia during the 2013 Hajj—Part of the MERS-CoV surveillance program
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2014b
        </year>
        ;
        <volume>
         25
        </volume>
        :
        <fpage>
         186
        </fpage>
        –
        <lpage>
         190
        </lpage>
        <pub-id pub-id-type="pmid">
         24970703
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B158">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Almasri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2014c
        </year>
        ;
        <volume>
         210
        </volume>
        :
        <fpage>
         1067
        </fpage>
        –
        <lpage>
         1072
        </lpage>
        <pub-id pub-id-type="pmid">
         24620019
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B159">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfi
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: An observational analysis with infection control implications
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2014d
        </year>
        ;
        <volume>
         29
        </volume>
        :
        <fpage>
         307
        </fpage>
        –
        <lpage>
         308
        </lpage>
        <pub-id pub-id-type="pmid">
         25448335
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B160">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014e
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1012
        </fpage>
        –
        <lpage>
         1015
        </lpage>
        <pub-id pub-id-type="pmid">
         24857749
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B161">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Olival
          </surname>
          <given-names>
           KJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fagbo
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in bats, Saudi Arabia
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2013a
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1819
        </fpage>
        –
        <lpage>
         1823
        </lpage>
        <pub-id pub-id-type="pmid">
         24206838
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B162">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Hakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2013b
        </year>
        ;
        <volume>
         368
        </volume>
        :
        <fpage>
         2487
        </fpage>
        –
        <lpage>
         2494
        </lpage>
        <pub-id pub-id-type="pmid">
         23718156
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B163">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           García-Bocanegra
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Serologic assessment of possibility for MERS-CoV infection in equids
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         181
        </fpage>
        –
        <lpage>
         182
        </lpage>
        <pub-id pub-id-type="pmid">
         25531820
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B164">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Antibodies against MERS coronavirus in dromedaries, United Arab Emirates, 2003 and 2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         552
        </fpage>
        –
        <lpage>
         558
        </lpage>
        <pub-id pub-id-type="pmid">
         24655412
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B165">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mielech
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kilianski
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baez-Santos
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mesecar
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
        </article-title>
        .
        <source>
         Virology
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         450–451
        </volume>
        :
        <fpage>
         64
        </fpage>
        –
        <lpage>
         70
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B166">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Caciula
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Price
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Thakkar
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Diagnosis of Zika virus infection by peptide array and enzyme-linked immunosorbent assay
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2018
        </year>
        ;
        <volume>
         9
        </volume>
        :
        <fpage>
         e00095
        </fpage>
        –
        <lpage>
         18
        </lpage>
        <pub-id pub-id-type="pmid">
         29511073
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B167">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Modjarrad
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS-CoV vaccine candidates in development: The current landscape
        </article-title>
        .
        <source>
         Vaccine
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         34
        </volume>
        :
        <fpage>
         2982
        </fpage>
        –
        <lpage>
         2987
        </lpage>
        <pub-id pub-id-type="pmid">
         27083424
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B168">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mohamed
          </surname>
          <given-names>
           DH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           AlHetheel
          </surname>
          <given-names>
           AF
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mohamud
          </surname>
          <given-names>
           HS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Aldosari
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical validation of 3 commercial real-time reverse transcriptase polymerase chain reaction assays for the detection of Middle East respiratory syndrome coronavirus from upper respiratory tract specimens
        </article-title>
        .
        <source>
         Diagn Microbiol Infect Dis
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         320
        </fpage>
        –
        <lpage>
         324
        </lpage>
        <pub-id pub-id-type="pmid">
         28104327
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B169">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Moher
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Liberati
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tetzlaff
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Altman
          </surname>
          <given-names>
           DG
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
        </article-title>
        .
        <source>
         BMJ
        </source>
        <year>
         2009
        </year>
        ;
        <volume>
         339
        </volume>
        :
        <fpage>
         b2535
        </fpage>
        <pub-id pub-id-type="pmid">
         19622551
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B170">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morse
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Factors in the emergence of infectious diseases
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         1995
        </year>
        ;
        <volume>
         1
        </volume>
        :
        <fpage>
         7
        </fpage>
        –
        <lpage>
         15
        </lpage>
        <pub-id pub-id-type="pmid">
         8903148
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B171">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morse
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Public health disease surveillance networks
        </article-title>
        .
        <source>
         Microbiol Spectr
        </source>
        <year>
         2012
        </year>
        ;
        <volume>
         1
        </volume>
        :OH-0002-2012
       </mixed-citation>
      </ref>
      <ref id="B172">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morse
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mazet
          </surname>
          <given-names>
           JAK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Woolhouse
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Parrish
          </surname>
          <given-names>
           CR
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Prediction and prevention of the next pandemic zoonosis
        </article-title>
        .
        <source>
         Lancet
        </source>
        <year>
         2012
        </year>
        ;
        <volume>
         380
        </volume>
        :
        <fpage>
         1956
        </fpage>
        –
        <lpage>
         1965
        </lpage>
        <pub-id pub-id-type="pmid">
         23200504
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B173">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morse
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Morahan
          </surname>
          <given-names>
           PS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Activated macrophages mediate interferon-independent inhibition of Herpes simplex virus
        </article-title>
        .
        <source>
         Cell Immunol
        </source>
        <year>
         1981
        </year>
        ;
        <volume>
         58
        </volume>
        :
        <fpage>
         72
        </fpage>
        –
        <lpage>
         84
        </lpage>
        <pub-id pub-id-type="pmid">
         6164494
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B174">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mou
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van Kuppeveld
          </surname>
          <given-names>
           FJM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rottier
          </surname>
          <given-names>
           PJM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         9379
        </fpage>
        –
        <lpage>
         9383
        </lpage>
        <pub-id pub-id-type="pmid">
         23785207
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B175">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jores
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983–1997
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         2093
        </fpage>
        –
        <lpage>
         2095
        </lpage>
        <pub-id pub-id-type="pmid">
         25425139
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B176">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: A nationwide, cross-sectional, serological study
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         15
        </volume>
        :
        <fpage>
         559
        </fpage>
        –
        <lpage>
         564
        </lpage>
        <pub-id pub-id-type="pmid">
         25863564
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B177">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Human coronavirus EMC does not require the SARS-Coronavirus receptor and maintains broad replicative capability in mammalian cell lines
        </article-title>
        .
        <source>
         MBio
        </source>
        <year>
         2012
        </year>
        ;
        <volume>
         3
        </volume>
        :
        <fpage>
         e00515
        </fpage>
        –
        <lpage>
         12
        </lpage>
        <pub-id pub-id-type="pmid">
         23232719
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B178">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Feldmann
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pneumonia from human coronavirus in a macaque model
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         368
        </volume>
        :
        <fpage>
         1560
        </fpage>
        –
        <lpage>
         1562
        </lpage>
       </mixed-citation>
      </ref>
      <ref id="B179">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Hosani
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Keating
          </surname>
          <given-names>
           MK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gerber
          </surname>
          <given-names>
           SI
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014
        </article-title>
        .
        <source>
         Am J Pathol
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         186
        </volume>
        :
        <fpage>
         652
        </fpage>
        –
        <lpage>
         658
        </lpage>
        <pub-id pub-id-type="pmid">
         26857507
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B180">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nishiura
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mizumoto
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ejima
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhong
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Assessing the risk of observing multiple generations of Middle East respiratory syndrome (MERS) cases given an imported case
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         21181
        </fpage>
        <pub-id pub-id-type="pmid">
         26212063
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B181">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nowotny
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kolodziejek
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20781
        </fpage>
        <pub-id pub-id-type="pmid">
         24786259
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B182">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           O'Hagan
          </surname>
          <given-names>
           JJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Carias
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rudd
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pham
          </surname>
          <given-names>
           HT
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Estimation of severe Middle East respiratory syndrome cases in the Middle East, 2012–2016
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         1797
        </fpage>
        –
        <lpage>
         1799
        </lpage>
        <pub-id pub-id-type="pmid">
         27648640
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B183">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Oboho
          </surname>
          <given-names>
           IK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tomczyk
          </surname>
          <given-names>
           SM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Asmari
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Banjar
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         2014 MERS-CoV outbreak in Jeddah—A link to health care facilities
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         372
        </volume>
        :
        <fpage>
         846
        </fpage>
        –
        <lpage>
         854
        </lpage>
        <pub-id pub-id-type="pmid">
         25714162
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B184">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ohnuma
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hatano
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Inhibition of Middle East respiratory syndrome coronavirus infection by Anti-CD26 monoclonal antibody
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         13892
        </fpage>
        –
        <lpage>
         13899
        </lpage>
        <pub-id pub-id-type="pmid">
         24067970
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B185">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Matin
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Haddad
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Nakhli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         17
        </volume>
        :
        <fpage>
         e668
        </fpage>
        –
        <lpage>
         e672
        </lpage>
        <pub-id pub-id-type="pmid">
         23916548
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B186">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baig
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bahloul
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         1090
        </fpage>
        –
        <lpage>
         1095
        </lpage>
        <pub-id pub-id-type="pmid">
         25278221
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B187">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Donskey
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Douthwaite
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination
        </article-title>
        .
        <source>
         J Hosp Infect
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         92
        </volume>
        :
        <fpage>
         235
        </fpage>
        –
        <lpage>
         250
        </lpage>
        <pub-id pub-id-type="pmid">
         26597631
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B188">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           HY
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           EJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ryu
          </surname>
          <given-names>
           YW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         21169
        </fpage>
        <pub-id pub-id-type="pmid">
         26132766
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B189">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Choe
          </surname>
          <given-names>
           PG
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           EH
          </given-names>
         </name>
        </person-group>
        <article-title>
         Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         2186
        </fpage>
        –
        <lpage>
         2189
        </lpage>
        <pub-id pub-id-type="pmid">
         26583829
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B190">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pavli
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Maltezou
          </surname>
          <given-names>
           HC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV): Prevention in travelers
        </article-title>
        .
        <source>
         Travel Med Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         12
        </volume>
        :
        <fpage>
         602
        </fpage>
        –
        <lpage>
         608
        </lpage>
        <pub-id pub-id-type="pmid">
         25457301
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B191">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Iblan
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Nsour
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Stillbirth during infection with Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         209
        </volume>
        :
        <fpage>
         1870
        </fpage>
        –
        <lpage>
         1872
        </lpage>
        <pub-id pub-id-type="pmid">
         24474813
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B192">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Iblan
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Persistence of antibodies against Middle East Respiratory Syndrome coronavirus
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         1824
        </fpage>
        –
        <lpage>
         1826
        </lpage>
        <pub-id pub-id-type="pmid">
         27332149
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B193">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pebody
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chand
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Thomas
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2012
        </year>
        ;
        <volume>
         17
        </volume>
        :
        <fpage>
         20292
        </fpage>
        <pub-id pub-id-type="pmid">
         23078799
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B194">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gomaa
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           El-Shesheny
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20574
        </fpage>
        <pub-id pub-id-type="pmid">
         24079378
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B195">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Goffard
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Parmentier-Decrucq
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Favory
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases
        </article-title>
        .
        <source>
         J Clin Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         61
        </volume>
        :
        <fpage>
         275
        </fpage>
        –
        <lpage>
         278
        </lpage>
        <pub-id pub-id-type="pmid">
         25073585
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B196">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poletto
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pelat
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lévy-Bruhl
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yazdanpanah
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20699
        </fpage>
        <pub-id pub-id-type="pmid">
         24556346
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B197">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Premila Devi
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Noraini
          </surname>
          <given-names>
           W
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Norhayati
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chee Kheong
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: Preparedness and response, April 2014
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20797
        </fpage>
        <pub-id pub-id-type="pmid">
         24832116
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B198">
       <mixed-citation publication-type="book">
        <collab>
         ProMED-mail
        </collab>
        .
        <publisher-name>
         NOVEL CORONAVIRUS—SAUDI ARABIA: HUMAN ISOLATE
        </publisher-name>
        Available at
        <uri xlink:href="http://www.promedmail.org/direct.php?id=20120920.1302733" xlink:type="simple">
         www.promedmail.org/direct.php?id=20120920.1302733
        </uri>
        Archive Number: 20120920.21302733. (Accessed
        <date-in-citation>
         <month>
          8
         </month>
         <day>
          1
         </day>
         ,
         <year>
          2017
         </year>
        </date-in-citation>
        )
       </mixed-citation>
      </ref>
      <ref id="B199">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Puzelli
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Azzi
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Santini
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Di Martino
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20564
        </fpage>
        <pub-id pub-id-type="pmid">
         23987829
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B200">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Qian
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dominguez
          </surname>
          <given-names>
           SR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Holmes
          </surname>
          <given-names>
           KV
          </given-names>
         </name>
        </person-group>
        <article-title>
         Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation
        </article-title>
        .
        <source>
         PLoS One
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         8
        </volume>
        :
        <fpage>
         e76469
        </fpage>
        <pub-id pub-id-type="pmid">
         24098509
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B201">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EABA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lamers
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Isolation of MERS coronavirus from dromedary camel, Qatar, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1339
        </fpage>
        –
        <lpage>
         1342
        </lpage>
        <pub-id pub-id-type="pmid">
         25075761
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B202">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mou
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Smits
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Dekkers
          </surname>
          <given-names>
           DHW
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
        </article-title>
        .
        <source>
         Nature
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         495
        </volume>
        :
        <fpage>
         251
        </fpage>
        –
        <lpage>
         254
        </lpage>
        <pub-id pub-id-type="pmid">
         23486063
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B203">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Smits
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Provacia
          </surname>
          <given-names>
           LB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van den Brand
          </surname>
          <given-names>
           JMA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         1834
        </fpage>
        –
        <lpage>
         1838
        </lpage>
        <pub-id pub-id-type="pmid">
         24257613
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B204">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gerber
          </surname>
          <given-names>
           SI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Swerdlow
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: Update for clinicians
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         60
        </volume>
        :
        <fpage>
         1686
        </fpage>
        –
        <lpage>
         1689
        </lpage>
        <pub-id pub-id-type="pmid">
         25701855
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B205">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mou
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van der Hoek
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Specific serology for emerging human coronaviruses by protein microarray
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013a
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20441
        </fpage>
        <pub-id pub-id-type="pmid">
         23594517
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B206">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ababneh
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013b
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20662
        </fpage>
        <pub-id pub-id-type="pmid">
         24342516
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B207">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jonges
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2014a
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20829
        </fpage>
        <pub-id pub-id-type="pmid">
         24957745
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B208">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Feyisa
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Messadi
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ularamu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Geographic distribution of MERS coronavirus among dromedary camels, Africa
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014b
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1370
        </fpage>
        –
        <lpage>
         1374
        </lpage>
        <pub-id pub-id-type="pmid">
         25062254
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B209">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gutierrez
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2013c
        </year>
        ;
        <volume>
         13
        </volume>
        :
        <fpage>
         859
        </fpage>
        –
        <lpage>
         866
        </lpage>
        <pub-id pub-id-type="pmid">
         23933067
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B210">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Schilp
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bruin
          </surname>
          <given-names>
           ED
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS-CoV infection of alpaca in a region where MERS-CoV is endemic
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         22
        </volume>
        :
        <fpage>
         1129
        </fpage>
        –
        <lpage>
         1131
        </lpage>
        <pub-id pub-id-type="pmid">
         27070501
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B211">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reuss
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Litterst
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Seilmaier
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Contact investigation for imported case of Middle East respiratory syndrome, Germany
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         620
        </fpage>
        –
        <lpage>
         625
        </lpage>
        <pub-id pub-id-type="pmid">
         24655721
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B212">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrania
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baig
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bahloul
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         29
        </volume>
        :
        <fpage>
         301
        </fpage>
        –
        <lpage>
         306
        </lpage>
        <pub-id pub-id-type="pmid">
         25303830
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B213">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Scheuplein
          </surname>
          <given-names>
           VA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Seifried
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Malczyk
          </surname>
          <given-names>
           AH
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Miller
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         89
        </volume>
        :
        <fpage>
         3859
        </fpage>
        –
        <lpage>
         3869
        </lpage>
        <pub-id pub-id-type="pmid">
         25609809
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B214">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Scobey
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yount
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Sims
          </surname>
          <given-names>
           AC
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Donaldson
          </surname>
          <given-names>
           EF
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         110
        </volume>
        :
        <fpage>
         16157
        </fpage>
        –
        <lpage>
         16162
        </lpage>
        <pub-id pub-id-type="pmid">
         24043791
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B215">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seo
          </surname>
          <given-names>
           YB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Heo
          </surname>
          <given-names>
           JY
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           M-S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         62
        </volume>
        :
        <fpage>
         755
        </fpage>
        –
        <lpage>
         760
        </lpage>
        <pub-id pub-id-type="pmid">
         26679623
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B216">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seong
          </surname>
          <given-names>
           M-W
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Cho
          </surname>
          <given-names>
           SI
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ko
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         External quality assessment of MERS-CoV molecular diagnostics during the 2015 Korean outbreak
        </article-title>
        .
        <source>
         Ann Lab Med
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         36
        </volume>
        :
        <fpage>
         230
        </fpage>
        –
        <lpage>
         234
        </lpage>
        <pub-id pub-id-type="pmid">
         26915611
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B217">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shalhoub
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           AlZahrani
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Simhairi
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mushtaq
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: A case report
        </article-title>
        .
        <source>
         J Clin Virol
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         62
        </volume>
        :
        <fpage>
         69
        </fpage>
        –
        <lpage>
         71
        </lpage>
        <pub-id pub-id-type="pmid">
         25542475
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B218">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shirato
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kawase
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Matsuyama
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         12552
        </fpage>
        –
        <lpage>
         12561
        </lpage>
        <pub-id pub-id-type="pmid">
         24027332
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B219">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shirato
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yano
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Senba
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Akachi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)
        </article-title>
        .
        <source>
         Virol J
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         11
        </volume>
        :
        <fpage>
         139
        </fpage>
        <pub-id pub-id-type="pmid">
         25103205
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B220">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Siu
          </surname>
          <given-names>
           K-L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yeung
          </surname>
          <given-names>
           ML
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kok
          </surname>
          <given-names>
           K-H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K-S
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         4866
        </fpage>
        –
        <lpage>
         4876
        </lpage>
        <pub-id pub-id-type="pmid">
         24522921
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B221">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Smits
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Reliable typing of MERS-CoV variants with a small genome fragment
        </article-title>
        .
        <source>
         J Clin Virol
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         64
        </volume>
        :
        <fpage>
         83
        </fpage>
        –
        <lpage>
         87
        </lpage>
        <pub-id pub-id-type="pmid">
         25728084
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B222">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Fux
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Provacia
          </surname>
          <given-names>
           LB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Volz
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         11950
        </fpage>
        –
        <lpage>
         11954
        </lpage>
        <pub-id pub-id-type="pmid">
         23986586
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B223">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Spanakis
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
        </article-title>
        .
        <source>
         Int J Antimicrob Agents
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         44
        </volume>
        :
        <fpage>
         528
        </fpage>
        –
        <lpage>
         532
        </lpage>
        <pub-id pub-id-type="pmid">
         25288266
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B224">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sridhar
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Brouqui
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Parola
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        <article-title>
         Imported cases of Middle East respiratory syndrome: An update
        </article-title>
        .
        <source>
         Travel Med Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         13
        </volume>
        :
        <fpage>
         106
        </fpage>
        –
        <lpage>
         109
        </lpage>
        <pub-id pub-id-type="pmid">
         25477148
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B225">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           X-C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Agnihothram
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Jiao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Stanhope
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         111
        </volume>
        :
        <fpage>
         e2018
        </fpage>
        –
        <lpage>
         e2026
        </lpage>
        <pub-id pub-id-type="pmid">
         24778221
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B226">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tao
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Hill
          </surname>
          <given-names>
           TE
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Morimoto
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peters
          </surname>
          <given-names>
           CJ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         87
        </volume>
        :
        <fpage>
         9953
        </fpage>
        –
        <lpage>
         9958
        </lpage>
        <pub-id pub-id-type="pmid">
         23824802
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B227">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tao
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mei
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Agrawal
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peters
          </surname>
          <given-names>
           CJ
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         3902
        </fpage>
        –
        <lpage>
         3910
        </lpage>
        <pub-id pub-id-type="pmid">
         24453361
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B228">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Thomas
          </surname>
          <given-names>
           HL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           HK
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Boddington
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Enhanced MERS coronavirus surveillance of travelers from the Middle East to England
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1562
        </fpage>
        –
        <lpage>
         1564
        </lpage>
        <pub-id pub-id-type="pmid">
         25148267
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B229">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baka
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Mentis
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Iliopoulos
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         A case of imported Middle East respiratory syndrome coronavirus infection and public health response, Greece, April 2014
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20782
        </fpage>
        <pub-id pub-id-type="pmid">
         24786258
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B230">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Karesh
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus in milk
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1263
        </fpage>
        –
        <lpage>
         1264
        </lpage>
        <pub-id pub-id-type="pmid">
         24960335
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B231">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20590
        </fpage>
        <pub-id pub-id-type="pmid">
         24084338
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B232">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Miazgowicz
          </surname>
          <given-names>
           KL
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Milne-Price
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         9220
        </fpage>
        –
        <lpage>
         9232
        </lpage>
        <pub-id pub-id-type="pmid">
         24899185
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B233">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Van Kerkhove
          </surname>
          <given-names>
           MD
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           MJS
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Malik
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ben Embarek
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interpreting results from environmental contamination studies of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        <year>
         2016
        </year>
        ;
        <volume>
         63
        </volume>
        :
        <fpage>
         1142
        </fpage>
        <pub-id pub-id-type="pmid">
         27432840
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B234">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Qi
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yuan
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Xuan
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26
        </article-title>
        .
        <source>
         Cell Host Microbe
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         16
        </volume>
        :
        <fpage>
         328
        </fpage>
        –
        <lpage>
         337
        </lpage>
        <pub-id pub-id-type="pmid">
         25211075
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B235">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wirblich
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Coleman
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Drishya
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Abraham
          </surname>
          <given-names>
           TS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         One-health: A safe, efficient, dual-use vaccine for humans and animals against Middle East respiratory syndrome coronavirus and rabies virus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         91
        </volume>
        :
        <fpage>
         e02040
        </fpage>
        –
        <lpage>
         16
        </lpage>
        <pub-id pub-id-type="pmid">
         27807241
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B236">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2012
        </year>
        ;
        <volume>
         86
        </volume>
        :
        <fpage>
         3995
        </fpage>
        –
        <lpage>
         4008
        </lpage>
        <pub-id pub-id-type="pmid">
         22278237
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B237">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           PCY
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           KSM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           RWS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Molecular diversity of coronaviruses in bats
        </article-title>
        .
        <source>
         Virology
        </source>
        <year>
         2006
        </year>
        ;
        <volume>
         351
        </volume>
        :
        <fpage>
         180
        </fpage>
        –
        <lpage>
         187
        </lpage>
        <pub-id pub-id-type="pmid">
         16647731
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B238">
       <mixed-citation publication-type="web">
        <collab>
         World Health Organization
        </collab>
        <year>
         2015
        </year>
        <article-title>
         Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected
        </article-title>
        .
        <year>
         2015
        </year>
        Available at [E-pub online:
        <uri xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en" xlink:type="simple">
         www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en
        </uri>
        ]
       </mixed-citation>
      </ref>
      <ref id="B239">
       <mixed-citation publication-type="book">
        <collab>
         World Health Organization
        </collab>
        <year>
         2018a
        </year>
        <article-title>
         WHO MERS-CoV global summary and assessment of risk—August 2018
        </article-title>
        . Available at [E-pub online:
        <uri xlink:href="http://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf" xlink:type="simple">
         www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf
        </uri>
        ;
        <publisher-name>
         MERS
        </publisher-name>
        webpage online:
        <uri xlink:href="http://www.who.int/emergencies/mers-cov/en" xlink:type="simple">
         www.who.int/emergencies/mers-cov/en
        </uri>
        ]
       </mixed-citation>
      </ref>
      <ref id="B240">
       <mixed-citation publication-type="web">
        <collab>
         World Health Organization
        </collab>
        <year>
         2018b
        </year>
        <article-title>
         Laboratory testing for Middle East respiratory syndrome coronavirus—Interim guidance (revised), January 2018
        </article-title>
        . Available at [E-pub online:
        <uri xlink:href="http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en" xlink:type="simple">
         www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en
        </uri>
        ]
       </mixed-citation>
      </ref>
      <ref id="B241">
       <mixed-citation publication-type="web">
        <collab>
         World Health Organization/EMRO (Eastern Mediterranean Regional Office)
        </collab>
        <year>
         2018
        </year>
        Available at MERS situation update [E-pub online:
        <uri xlink:href="http://www.emro.who.int/health-topics/mers-cov/situation-update.html" xlink:type="simple">
         www.emro.who.int/health-topics/mers-cov/situation-update.html
        </uri>
        ]
       </mixed-citation>
      </ref>
      <ref id="B242">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wrensch
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Winkler
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Pöhlmann
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: Evidence for cholesterol-independent mechanisms
        </article-title>
        .
        <source>
         Viruses
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         6
        </volume>
        :
        <fpage>
         3683
        </fpage>
        –
        <lpage>
         3698
        </lpage>
        <pub-id pub-id-type="pmid">
         25256397
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B243">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yi
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zou
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhong
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Imported case of MERS-CoV infection identified in China, May 2015: Detection and lesson learned
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         21158
        </fpage>
        <pub-id pub-id-type="pmid">
         26111235
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B244">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ren
          </surname>
          <given-names>
           X
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         MERS-related betacoronavirus in
         <italic>
          Vespertilio superans
         </italic>
         bats, China
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1260
        </fpage>
        –
        <lpage>
         1262
        </lpage>
        <pub-id pub-id-type="pmid">
         24960574
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B245">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         111
        </volume>
        :
        <fpage>
         12516
        </fpage>
        –
        <lpage>
         12521
        </lpage>
        <pub-id pub-id-type="pmid">
         25114257
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B246">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Geng
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
        </article-title>
        .
        <source>
         Protein Cell
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         4
        </volume>
        :
        <fpage>
         951
        </fpage>
        –
        <lpage>
         961
        </lpage>
        <pub-id pub-id-type="pmid">
         24318862
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B247">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bao
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           W
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         209
        </volume>
        :
        <fpage>
         236
        </fpage>
        –
        <lpage>
         242
        </lpage>
        <pub-id pub-id-type="pmid">
         24218506
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B248">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yavarian
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Rezaei
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Shadab
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Soroush
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Cluster of middle east respiratory syndrome coronavirus infections in Iran, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         362
        </fpage>
        –
        <lpage>
         364
        </lpage>
        <pub-id pub-id-type="pmid">
         25626079
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B249">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ying
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ju
          </surname>
          <given-names>
           TW
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Prabakaran
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         7796
        </fpage>
        –
        <lpage>
         7805
        </lpage>
        <pub-id pub-id-type="pmid">
         24789777
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B250">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           ADME
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
        </article-title>
        .
        <source>
         N Engl J Med
        </source>
        <year>
         2012
        </year>
        ;
        <volume>
         367
        </volume>
        :
        <fpage>
         1814
        </fpage>
        –
        <lpage>
         1820
        </lpage>
        <pub-id pub-id-type="pmid">
         23075143
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B251">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
        </article-title>
        .
        <source>
         Virol J
        </source>
        <year>
         2013
        </year>
        ;
        <volume>
         10
        </volume>
        :
        <fpage>
         266
        </fpage>
        <pub-id pub-id-type="pmid">
         23978242
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B252">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Alshukairi
          </surname>
          <given-names>
           AN
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Baharoon
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Ahmed
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
        </article-title>
        .
        <source>
         Sci Immunol
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         2
        </volume>
        :
        <fpage>
         eaan5393
        </fpage>
        <pub-id pub-id-type="pmid">
         28778905
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B253">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wohlford-Lenane
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Agnihothram
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Rapid generation of a mouse model for Middle East respiratory syndrome
        </article-title>
        .
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         111
        </volume>
        :
        <fpage>
         4970
        </fpage>
        –
        <lpage>
         4975
        </lpage>
        <pub-id pub-id-type="pmid">
         24599590
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B254">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Kayali
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyerholz
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         J Virol
        </source>
        <year>
         2015
        </year>
        ;
        <volume>
         89
        </volume>
        :
        <fpage>
         6117
        </fpage>
        –
        <lpage>
         6120
        </lpage>
        <pub-id pub-id-type="pmid">
         25787284
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="B255">
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        ,
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           BH
          </given-names>
         </name>
         ,
         <etal>
          et al.
         </etal>
        </person-group>
        <article-title>
         Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        ;
        <volume>
         209
        </volume>
        :
        <fpage>
         1331
        </fpage>
        –
        <lpage>
         1342
        </lpage>
        <pub-id pub-id-type="pmid">
         24065148
        </pub-id>
       </mixed-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Virol J
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Virol. J
      </journal-id>
      <journal-title-group>
       <journal-title>
        Virology Journal
       </journal-title>
      </journal-title-group>
      <issn pub-type="epub">
       1743-422X
      </issn>
      <publisher>
       <publisher-name>
        BioMed Central
       </publisher-name>
       <publisher-loc>
        London
       </publisher-loc>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       26695637
      </article-id>
      <article-id pub-id-type="pmc">
       4687373
      </article-id>
      <article-id pub-id-type="publisher-id">
       439
      </article-id>
      <article-id pub-id-type="doi">
       10.1186/s12985-015-0439-5
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Review
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        MERS coronavirus: diagnostics, epidemiology and transmission
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" corresp="yes">
        <name>
         <surname>
          Mackay
         </surname>
         <given-names>
          Ian M.
         </given-names>
        </name>
        <address>
         <email>
          ian.mackay.im@gmail.com
         </email>
        </address>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff2">
         2
        </xref>
        <xref ref-type="aff" rid="Aff3">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Arden
         </surname>
         <given-names>
          Katherine E.
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">
         2
        </xref>
       </contrib>
       <aff id="Aff1">
        <label>
         1
        </label>
        Department of Health, Public and Environmental Health Virology Laboratory, Forensic and Scientific Services, Archerfield, QLD Australia
       </aff>
       <aff id="Aff2">
        <label>
         2
        </label>
        <institution-wrap>
         <institution-id institution-id-type="GRID">
          grid.1003.2
         </institution-id>
         <institution-id institution-id-type="ISNI">
          0000000093207537
         </institution-id>
         <institution>
          The University of Queensland,
         </institution>
        </institution-wrap>
        St Lucia, QLD Australia
       </aff>
       <aff id="Aff3">
        <label>
         3
        </label>
        <institution-wrap>
         <institution-id institution-id-type="GRID">
          grid.1024.7
         </institution-id>
         <institution-id institution-id-type="ISNI">
          0000000089150953
         </institution-id>
         <institution>
          Queensland University of Technology,
         </institution>
        </institution-wrap>
        George St, Brisbane, QLD Australia
       </aff>
      </contrib-group>
      <pub-date pub-type="epub">
       <day>
        22
       </day>
       <month>
        12
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <pub-date pub-type="pmc-release">
       <day>
        22
       </day>
       <month>
        12
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <pub-date pub-type="collection">
       <year>
        2015
       </year>
      </pub-date>
      <volume>
       12
      </volume>
      <elocation-id>
       222
      </elocation-id>
      <history>
       <date date-type="received">
        <day>
         14
        </day>
        <month>
         9
        </month>
        <year>
         2015
        </year>
       </date>
       <date date-type="accepted">
        <day>
         27
        </day>
        <month>
         11
        </month>
        <year>
         2015
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © Mackay and Arden. 2015
       </copyright-statement>
       <license license-type="OpenAccess">
        <license-p>
         <bold>
          Open Access
         </bold>
         This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
         <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          http://creativecommons.org/licenses/by/4.0/
         </ext-link>
         ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
         <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">
          http://creativecommons.org/publicdomain/zero/1.0/
         </ext-link>
         ) applies to the data made available in this article, unless otherwise stated.
        </license-p>
       </license>
      </permissions>
      <abstract id="Abs1">
       <p id="Par1">
        The first known cases of Middle East respiratory syndrome (MERS), associated with infection by a novel coronavirus (CoV), occurred in 2012 in Jordan but were reported retrospectively. The case first to be publicly reported was from Jeddah, in the Kingdom of Saudi Arabia (KSA). Since then, MERS-CoV sequences have been found in a bat and in many dromedary camels (DC). MERS-CoV is enzootic in DC across the Arabian Peninsula and in parts of Africa, causing mild upper respiratory tract illness in its camel reservoir and sporadic, but relatively rare human infections. Precisely how virus transmits to humans remains unknown but close and lengthy exposure appears to be a requirement. The KSA is the focal point of MERS, with the majority of human cases. In humans, MERS is mostly known as a lower respiratory tract (LRT) disease involving fever, cough, breathing difficulties and pneumonia that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20 % to 40 % of those infected. However, MERS-CoV has also been detected in mild and influenza-like illnesses and in those with no signs or symptoms. Older males most obviously suffer severe disease and MERS patients often have comorbidities. Compared to severe acute respiratory syndrome (SARS), another sometimes- fatal zoonotic coronavirus disease that has since disappeared, MERS progresses more rapidly to respiratory failure and acute kidney injury (it also has an affinity for growth in kidney cells under laboratory conditions), is more frequently reported in patients with underlying disease and is more often fatal. Most human cases of MERS have been linked to lapses in infection prevention and control (IPC) in healthcare settings, with approximately 20 % of all virus detections reported among healthcare workers (HCWs) and higher exposures in those with occupations that bring them into close contact with camels. Sero-surveys have found widespread evidence of past infection in adult camels and limited past exposure among humans. Sensitive, validated reverse transcriptase real-time polymerase chain reaction (RT-rtPCR)-based diagnostics have been available almost from the start of the emergence of MERS. While the basic virology of MERS-CoV has advanced over the past three years, understanding of the interplay between camel, environment, and human remains limited.
       </p>
       <sec>
        <title>
         Electronic supplementary material
        </title>
        <p>
         The online version of this article (doi:10.1186/s12985-015-0439-5) contains supplementary material, which is available to authorized users.
        </p>
       </sec>
      </abstract>
      <kwd-group xml:lang="en">
       <title>
        Keywords
       </title>
       <kwd>
        Middle East respiratory syndrome
       </kwd>
       <kwd>
        Coronavirus
       </kwd>
       <kwd>
        MERS
       </kwd>
       <kwd>
        Epidemiology
       </kwd>
       <kwd>
        Diagnostics
       </kwd>
       <kwd>
        Transmission
       </kwd>
      </kwd-group>
      <custom-meta-group>
       <custom-meta>
        <meta-name>
         issue-copyright-statement
        </meta-name>
        <meta-value>
         © The Author(s) 2015
        </meta-value>
       </custom-meta>
      </custom-meta-group>
     </article-meta>
    </front>
    <sec id="Sec1" sec-type="introduction">
     <title>
      Background
     </title>
     <p id="Par40">
      An email from Dr Ali Mohamed Zaki, an Egyptian virologist working at the Dr Soliman Fakeeh Hospital in Jeddah in the Kingdom of Saudi Arabia (KSA) announced the first culture of a new coronavirus to the world. The email was published on the website of the professional emerging diseases (ProMED) network on 20
      <sup>
       th
      </sup>
      September 2012 [
      <xref ref-type="bibr" rid="CR1">
       1
      </xref>
      ] (Fig.
      <xref ref-type="fig" rid="Fig1">
       1
      </xref>
      ) and described the first reported case, a 60 year old man from Bisha in the KSA. This information led to the rapid discovery of a second case of the virus, this time in an ill patient in the United Kingdom, who had been transferred from Qatar for care [
      <xref ref-type="bibr" rid="CR2">
       2
      </xref>
      ]. The new virus was initially called novel coronavirus (nCoV) and subsequentlty entitled the Middle East respiratoy syndrome coronavirus (MERS-CoV). As of 2
      <sup>
       nd
      </sup>
      of September 2015, there have been 1,493 detections of viral RNA or virus-specific antibodies across 26 countries (Additional file
      <xref ref-type="media" rid="MOESM1">
       1
      </xref>
      : Figure S1) confirmed by the World Health Organization (WHO), with over a third of the positive people dying (at least 527, 35 %) [
      <xref ref-type="bibr" rid="CR3">
       3
      </xref>
      ].
      <fig id="Fig1">
       <label>
        Fig. 1
       </label>
       <caption>
        <p>
         A timeline of some key scientific milestones, mass gatherings of relevance and clusters and outbreaks of interest to the understanding of MERS-CoV infection among humans and transmission from animals to humans. A yellow circle indicates when a country reported a laboratory confirmed detection and an orange circle denotes ensuing local transmission. A sample of the mentions of DC contact prior to disease is indicated by a black camel icon. DPP4-dipeptidyl peptidase 4; KSA-the Kingdom of Saudi Arabia; Mab-monoclonal antibody; rAdV-recombinant adenovirus; rMVA-recombinant modified vaccinia virus Ankara; UAE-United Arab Emirates
        </p>
       </caption>
       <graphic id="MO1" xlink:href="12985_2015_439_Fig1_HTML">
       </graphic>
      </fig>
     </p>
     <p id="Par41">
      Since that first report, a slow discovery process over the following two to three years revealed a virus that had infected over 90 % of adult dromedary camels (DC;
      <italic>
       Camelus dromedarius
      </italic>
      ) in the KSA [
      <xref ref-type="bibr" rid="CR4">
       4
      </xref>
      ], also DCs across the Arabian Peninsula and parts of Africa that are a source of DC imports for the KSA [
      <xref ref-type="bibr" rid="CR5">
       5
      </xref>
      ]. To date, MERS-CoV has not been detected in DCs tested in zoos or herds from other parts of the world [
      <xref ref-type="bibr" rid="CR6">
       6
      </xref>
      –
      <xref ref-type="bibr" rid="CR9">
       9
      </xref>
      ]. Occasionally, virus is transmitted from infected DCs to exposed humans. Subsequent transmission to other humans requires relatively close and prolonged exposure [
      <xref ref-type="bibr" rid="CR10">
       10
      </xref>
      ].
     </p>
     <p id="Par42">
      The first viral isolate was patented and concerns were raised that this would restrict access to both the virus and to viral diagnostics [
      <xref ref-type="bibr" rid="CR11">
       11
      </xref>
      ,
      <xref ref-type="bibr" rid="CR12">
       12
      </xref>
      ]. However, sensitive, validated reverse transcriptase real-time polymerase chain reaction (RT-rtPCR)-based diagnostics were quickly described and virus was made freely available subject to routine biosafety considerations [
      <xref ref-type="bibr" rid="CR13">
       13
      </xref>
      ]. Subsequent epidemiology and research has identified the cell receptor as exopeptidase dipeptidyl peptidase 4 (DPP4; also called CD26); that MERS-CoV has a broad tropism, replicating better in some cells lines and eliciting a more proinflammatory response than SARS-CoV; is widespread in DCs; has the potential to infect other animals and that MERS kills its human host more often than SARS did (20-40 % versus 9 % for SARS [
      <xref ref-type="bibr" rid="CR14">
       14
      </xref>
      ]) [
      <xref ref-type="bibr" rid="CR15">
       15
      </xref>
      –
      <xref ref-type="bibr" rid="CR19">
       19
      </xref>
      ].
     </p>
     <p id="Par43">
      In humans, overt disease was given the name Middle East respiratory syndrome, with the acronym MERS. From intermittent animal-to-human spill-over events, the MERS-CoV spreads sporadically among people, causing more severe disease among older adults, especially males, with pre-existing diseases. The spread of MERS-CoV among humans has often been associated with outbreaks in hospitals, with around 20 % of all cases to date involving healthcare workers (HCWs).
     </p>
    </sec>
    <sec id="Sec2">
     <title>
      The Middle East Respiratory Syndrome (MERS)
     </title>
     <p id="Par44">
      Although DCs appear to suffer the equivalent of a ‘common cold’ from MERS-CoV infection, in humans, the virus can be a more serious and opportunistic pathogen associated with the death of up to 40 % of reported cases. It has yet to be established whether infections thought to have been acquired from an animal source produce a more severe outcome than those spread between humans [
      <xref ref-type="bibr" rid="CR20">
       20
      </xref>
      ]. Studies have established that the mean incubation period for MERS is five to six days, ranging from two to 16 days, with 13 to 14 days between when illness begins in one person and subsequently spreads to another [
      <xref ref-type="bibr" rid="CR21">
       21
      </xref>
      –
      <xref ref-type="bibr" rid="CR24">
       24
      </xref>
      ]. Among those with progressive illness, the median time to death is 11 to 13 days, ranging from five to 27 days [
      <xref ref-type="bibr" rid="CR23">
       23
      </xref>
      ,
      <xref ref-type="bibr" rid="CR24">
       24
      </xref>
      ]. Fever and gastrointestinal symptoms may form a prodrome, after which symptoms decline, only to be followed by a more severe systemic and respiratory syndrome [
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
      ,
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
      ].
     </p>
     <sec id="Sec3">
      <title>
       The definition of a case
      </title>
      <p id="Par45">
       The first WHO case definition [
       <xref ref-type="bibr" rid="CR27">
        27
       </xref>
       ] defined probable cases of MERS based on the presence of febrile illness, cough and requirement for hospitalization with suspicion of lower respiratory tract (LRT) involvement. It also included roles for contact with a probable or confirmed case or for travel or residence within the Arabian Peninsula. If strictly adhered to, only the severe syndrome would be subject to laboratory testing, which was the paradigm early on [
       <xref ref-type="bibr" rid="CR21">
        21
       </xref>
       ]. From July 2013, the revised WHO case definition included the importance of seeking out and understanding the role of asymptomatic cases and from June 2014, the WHO definition more clearly stated that a confirmed case included any person whose sample was RT-PCR positive for MERS-CoV, or who produced a seroconversion, irrespective of clinical signs and symptoms. [
       <xref ref-type="bibr" rid="CR28">
        28
       </xref>
       –
       <xref ref-type="bibr" rid="CR30">
        30
       </xref>
       ] Apart from the WHO and the KSA Ministry of Health reports, asymptomatic or subclinical cases of MERS-CoV infection were documented in the scientific literature although not always as often as occurred early on [
       <xref ref-type="bibr" rid="CR31">
        31
       </xref>
       ,
       <xref ref-type="bibr" rid="CR32">
        32
       </xref>
       ]. The KSA definition of a case became more strict on 13
       <sup>
        th
       </sup>
       May 2014, relying on the presence of both clinical features and laboratory confirmation [
       <xref ref-type="bibr" rid="CR33">
        33
       </xref>
       ]. Testing of asymptomatic people was recommended against from December 2014 [
       <xref ref-type="bibr" rid="CR34">
        34
       </xref>
       ], reinforced by a case definition released by the KSA Ministry of Health in June 2015 [
       <xref ref-type="bibr" rid="CR35">
        35
       </xref>
       ].
      </p>
      <p id="Par46">
       The KSA has been the source of 79 % of human cases. Severe MERS is notable for its impact among older men with comorbid diseases including diabetes mellitus, cirrhosis and various lung, renal and cardiac conditions [
       <xref ref-type="bibr" rid="CR36">
        36
       </xref>
       –
       <xref ref-type="bibr" rid="CR38">
        38
       </xref>
       ]. Interestingly in June 2015, an outbreak in South Korea followed a similar distribution [
       <xref ref-type="bibr" rid="CR39">
        39
       </xref>
       ,
       <xref ref-type="bibr" rid="CR40">
        40
       </xref>
       ]. Among laboratory confirmed cases, fever, cough and upper respiratory tract (URT) signs and symptoms usually occur first, followed within a week by progressive LRT distress and lymphopaenia [
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
       ]. Patients often present to a hospital with pneumonia, or worse, and secondary bacterial infections have been reported [
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
       ,
       <xref ref-type="bibr" rid="CR41">
        41
       </xref>
       ]. Disease can progress to acute respiratory distress syndrome and multiorgan system failure [
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
       ]. MERS has reportedly killed approximately 35 % of all reported cases, 42 % of cases in the KSA, yet only 19 % of cases in South Korea, where mortality ranged from 7 % among younger age groups to 40 % among those aged 60 years and above [
       <xref ref-type="bibr" rid="CR42">
        42
       </xref>
       ]; all may be inflated values with asymptomatic or mild infections sometimes not sought or not reported [
       <xref ref-type="bibr" rid="CR34">
        34
       </xref>
       ]. General supportive care is key to managing severe cases [
       <xref ref-type="bibr" rid="CR43">
        43
       </xref>
       ]. Children under the age of 14 years are rarely reported to be positive for MERS-CoV, comprising only 1.1 % (n = 16) of total reported cases. Between 1
       <sup>
        st
       </sup>
       September 2012 and 2
       <sup>
        nd
       </sup>
       December 2013, a study described the then tally of paediatric cases in the KSA, which stood at 11 (two to 16 years of age; median 13 years); nine were asymptomatic (72 %) and one infant died [
       <xref ref-type="bibr" rid="CR44">
        44
       </xref>
       ]. In Amman, Jordan, 1,005 samples from hospitalized children under the age of two years with fever and/or respiratory signs and symptoms were tested but none were positive for MERS-CoV RNA, despite being collected at a similar time to the first known outbreak of MERS-CoV in the neighbouring town of Al-Zarqa [
       <xref ref-type="bibr" rid="CR45">
        45
       </xref>
       ]. A second trimester stillbirth occurred in a pregnant woman during an acute respiratory illness and while not RT-rtPCR positive, the mother did subsequently develop antibodies to MERS-CoV, suggestive of recent infection [
       <xref ref-type="bibr" rid="CR46">
        46
       </xref>
       ]. Her exposure history to a MERS-CoV RT-rtPCR positive relative and an antibody-reactive husband, her incubation period and her symptom history met the WHO criteria for being a probable MERS-CoV case [
       <xref ref-type="bibr" rid="CR46">
        46
       </xref>
       ].
      </p>
     </sec>
    </sec>
    <sec id="Sec4">
     <title>
      Laboratory testing to confirm past or present MERS-CoV infection
     </title>
     <p id="Par47">
      Diagnostic methods were published within days of the ProMED email announcing the first MERS case [
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ], including several now gold standard in-house RT-rtPCR assays (Fig.
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      ) as well as virus culture in Vero and LLC-MK2 cells [
      <xref ref-type="bibr" rid="CR18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ]. A colorectal adenocarcinoma (Caco-2) epithelial cell line has since been recommended for isolation of infections MERS-CoV [
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ]. We previously reviewed the broad tropism of MERS-CoV [
      <xref ref-type="bibr" rid="CR5">
       5
      </xref>
      ]. However, as is well described, cell culture is a slow, specialised and insensitive method [
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
      ] while PCR-based techniques are the preferred method for MERS-CoV detection.
      <fig id="Fig2">
       <label>
        Fig. 2
       </label>
       <caption>
        <p>
         Schematic of MERS-CoV genome drawn to scale (EMC/2012; JX869059 [
         <xref ref-type="bibr" rid="CR18">
          18
         </xref>
         ].). Open reading frames are indicated as yellow rectangles bracketed by terminal untranslated regions (UTR;
         <italic>
          grey rectangles
         </italic>
         ). FS-frame-shift. Predicted regions encompassing recombination break-points are indicated by orange pills. Created using Geneious v8.1 [
         <xref ref-type="bibr" rid="CR211">
          211
         </xref>
         ] and annotated using Adobe Illustrator. Beneath this is a schematic depicting the location of RT-PCR primers (
         <italic>
          blue arrows
         </italic>
         indicate direction) and oligoprobes (
         <italic>
          green rectangles
         </italic>
         ) used in the earliest RT-rtPCR screening assays and conventional, semi-nested (three primers) RT-PCR confirmatory sequencing assays [
         <xref ref-type="bibr" rid="CR47">
          47
         </xref>
         ,
         <xref ref-type="bibr" rid="CR48">
          48
         </xref>
         ]. Publication order is noted by first [27
         <sup>
          th
         </sup>
         September 2012; red] and second [6
         <sup>
          th
         </sup>
         December 2012; orange] coloured rectangles; both from Corman et al. [
         <xref ref-type="bibr" rid="CR47">
          47
         </xref>
         ,
         <xref ref-type="bibr" rid="CR48">
          48
         </xref>
         ] Those assays recommended by the WHO are highlighted underneath by yellow dots [
         <xref ref-type="bibr" rid="CR53">
          53
         </xref>
         ]. The NSeq reverse primer has consistently contained one sequence mismatch with some MERS-CoV variants. An altered version of that from Mackay IM, Arden KE. Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd. Virus Res 2015 Vol 202:60–88 with permission from Elsevier [
         <xref ref-type="bibr" rid="CR5">
          5
         </xref>
         ]
        </p>
       </caption>
       <graphic id="MO2" xlink:href="12985_2015_439_Fig2_HTML">
       </graphic>
      </fig>
     </p>
     <sec id="Sec5">
      <title>
       Molecular detection of MERS-CoV RNA in real time
      </title>
      <p id="Par48">
       The first open reading frames (ORF 1a and 1b; Fig.
       <xref ref-type="fig" rid="Fig2">
        2
       </xref>
       ) have become a key diagnostic and taxonomic target for CoV species identification. With less than 80 % identity between the amino acid sequence of MERS ORF 1ab and betacoronavirus relatives,
       <italic>
        Tylonycteris
       </italic>
       bat HKU4 and
       <italic>
        Pipistrellus
       </italic>
       bat HKU5, it can be concluded that it is a novel and distinct virus. MERS-CoV is predicted to encode ten open reading frames with 5’ and 3’ untranslated regions [
       <xref ref-type="bibr" rid="CR51">
        51
       </xref>
       ]. The structural proteins include the spike (S), envelope (E), membrane (M) and nucleocapsid (N) [
       <xref ref-type="bibr" rid="CR52">
        52
       </xref>
       ]. The products of ORF1a and ORF1b are predicted to encode nonstructural proteins.
      </p>
      <p id="Par49">
       The majority of specimen testing to date has employed validated RT-rtPCR assays shown to be sensitive and specific [
       <xref ref-type="bibr" rid="CR47">
        47
       </xref>
       ,
       <xref ref-type="bibr" rid="CR48">
        48
       </xref>
       ,
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ]. The RealStar® kit uses these WHO-recommended assays [
       <xref ref-type="bibr" rid="CR54">
        54
       </xref>
       ]. The target sequences of these screening assays have not changed among genomes examined until at least mid-2015 (IMM observation). Other RT-rtPCR assays have been developed and validated for use as laboratory-based diagnostic tools [
       <xref ref-type="bibr" rid="CR55">
        55
       </xref>
       –
       <xref ref-type="bibr" rid="CR57">
        57
       </xref>
       ]. Additionally, loop-mediated [
       <xref ref-type="bibr" rid="CR58">
        58
       </xref>
       ,
       <xref ref-type="bibr" rid="CR59">
        59
       </xref>
       ] or recombinase polymerase [
       <xref ref-type="bibr" rid="CR60">
        60
       </xref>
       ] isothermal assays have been designed for field deployment.
      </p>
     </sec>
     <sec id="Sec6">
      <title>
       MERS-CoV antigen detection
      </title>
      <p id="Par50">
       The detection of MERS-CoV antigen has not been common to date but the combination of short turnaround time from test to result, high throughput and identification of viral proteins makes this an attractive option. Detection of viral proteins rather than viral RNA indicates the likely presence of infectious virus. The first rapid immunochromatographic tool described could detect recombinant MERS-CoV nucleocapsid protein from DC nasal swabs with 94 % sensitivity and 100 % specificity compared to RT-rtPCR [
       <xref ref-type="bibr" rid="CR61">
        61
       </xref>
       ]. A different approach used a monoclonal antibody-based capture ELISA targeting the MERS-CoV nucleocapsid protein with a sensitivity of 10
       <sup>
        3
       </sup>
       TCID
       <sub>
        50
       </sub>
       and 100 % specificity [
       <xref ref-type="bibr" rid="CR62">
        62
       </xref>
       ].
      </p>
     </sec>
     <sec id="Sec7">
      <title>
       Assays to identify a humoral response to prior MERS-CoV infection among humans
      </title>
      <p id="Par51">
       Demonstration of a seroconversion to a MERS-CoV infection meets the current WHO definition of a case so optimized and thoroughly validated sero-assays employed alongside good clinical histories are useful to both identify prior MERS-CoV infection and help support transmission studies. Because serology testing is, by its nature, retrospective, it is usual to detect a viral footprint, in the form of antibodies, in the absence of any signs or symptoms of disease and often in the absence of any viral RNA [
       <xref ref-type="bibr" rid="CR63">
        63
       </xref>
       ].
      </p>
      <p id="Par52">
       Strategic, widespread sero-surveys of humans using samples collected after 2012 are infrequent. Much of the Arabian Peninsula and all of the Horn of Africa lack baseline data describing the proportion of the community who may have been infected by a MERS-CoV. However, sero-surveys have had widespread use in elucidating the role of DCs as a transmission source for MERS-CoV. Because of the identity shared between DC and human MERS-CoV (see
       <italic>
        Molecular epidemiology: using genomes to understand outbreaks
       </italic>
       ), serological assays for DC sero-surveys should be transferrable to human screening with minimal re-configuration. Also, no diagnostically relevant variation in neutralization activity have been found from among a range of circulating tested MERS-CoV isolates and sera, so whole virus or specific protein-based sero-assays should perform equivalently in detecting serological responses to the single MERS-CoV serotype [
       <xref ref-type="bibr" rid="CR49">
        49
       </xref>
       ]. The development of robust serological assays requires reliable panels of well-characterized animal or human sera, including those positive for antibodies specific to MERS-CoV, as well as to likely sources of cross-reaction [
       <xref ref-type="bibr" rid="CR64">
        64
       </xref>
       ]. Obtaining these materials was problematic and slowed the development and commercialization of antibody detection assays for human testing [
       <xref ref-type="bibr" rid="CR64">
        64
       </xref>
       ]. A number of commercial ELISA kits, immunofluorescent assays (IFA) kits, recombinant proteins and monoclonal antibodies have been released [
       <xref ref-type="bibr" rid="CR31">
        31
       </xref>
       ,
       <xref ref-type="bibr" rid="CR65">
        65
       </xref>
       –
       <xref ref-type="bibr" rid="CR68">
        68
       </xref>
       ]. Initially, conventional IFAs were used for human sero-surveys. These relied on MERS-CoV-infected cell culture as an antigen source, detecting the presence of human anti-MERS-CoV IgG, IgM or neutralizing antibodies in human samples [
       <xref ref-type="bibr" rid="CR18">
        18
       </xref>
       ,
       <xref ref-type="bibr" rid="CR48">
        48
       </xref>
       ,
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ]. No sign of MERS-CoV antibodies was found among 2,400 sera from patients visiting Hospital in Jeddah, from 2010 through 2012, prior to the description of MERS-CoV [
       <xref ref-type="bibr" rid="CR18">
        18
       </xref>
       ]. Nor did IFA methods detect any sign of prior MERS-CoV infection among a small sample of 130 healthy blood donors from another Hospital in Jeddah (collected between Jan and Dec 2012) [
       <xref ref-type="bibr" rid="CR70">
        70
       </xref>
       ]. Of 226 slaughterhouse workers, only eight (3.5 %) were positive by IFA, and those sera could not be confirmed by virus neutralization (NT) test. The study indicated that HCoV-HKU1 was a likely source of cross-reactive antigen in the whole virus IFA [
       <xref ref-type="bibr" rid="CR70">
        70
       </xref>
       ]. Whole virus MERS-CoV IFA also suffered from some cross-reactivity with convalescent SARS patient sera and this could not be resolved by an NT test which was also cross-reactive [
       <xref ref-type="bibr" rid="CR71">
        71
       </xref>
       ]. IFA using recombinant proteins instead of whole-virus IFA, has been shown to be a more specific tool [
       <xref ref-type="bibr" rid="CR31">
        31
       </xref>
       ]. Since asymptomatic zoonoses have been posited [
       <xref ref-type="bibr" rid="CR72">
        72
       </xref>
       ], an absence of antibodies to MERS-CoV among some humans who have regular and close contact with camels may reflect the rarity of actively infected animals at butcheries, a limited transmission risk associated with slaughtering DCs [
       <xref ref-type="bibr" rid="CR70">
        70
       </xref>
       ], a pre-existing cross-protective immune status or some other factor(s) resulting in a low risk of disease and concurrent seroconversion developing after exposure in this group. IFA using recombinant proteins instead.
      </p>
      <p id="Par53">
       Some sero-assays have bypassed the risks of working with infectious virus by creating transfected cells expressing recombinant portions of the MERS-CoV nucleocapsid and spike proteins [
       <xref ref-type="bibr" rid="CR48">
        48
       </xref>
       ,
       <xref ref-type="bibr" rid="CR73">
        73
       </xref>
       ], or using a recombinant lentivirus expressing MERS-CoV spike protein and luciferase [
       <xref ref-type="bibr" rid="CR74">
        74
       </xref>
       ,
       <xref ref-type="bibr" rid="CR75">
        75
       </xref>
       ]. A pseudo particle neutralization (ppNT) assay has seen widespread used in animal studies and was at least as sensitive as the traditional microneutralization (MNT) test. [
       <xref ref-type="bibr" rid="CR10">
        10
       </xref>
       ,
       <xref ref-type="bibr" rid="CR74">
        74
       </xref>
       ,
       <xref ref-type="bibr" rid="CR76">
        76
       </xref>
       –
       <xref ref-type="bibr" rid="CR78">
        78
       </xref>
       ] Studies using small sample numbers and ppNT found no evidence of MERS-CoV neutralizing antibody in sera from 158 children with LRT infections between May 2010 and May 2011, 110 sera from 19 to 52 year old male blood donors and 300 self-identified animal workers from the Jazan Region of the KSA during 2012 [
       <xref ref-type="bibr" rid="CR79">
        79
       </xref>
       ,
       <xref ref-type="bibr" rid="CR80">
        80
       </xref>
       ]. Similarly, a study of four herdsmen in contact with an infected DC herd in Al-Ahsa, eight people who had intermittent contact with the herd, 30 veterinary surgeons and support staff who were not exposed to the herd, three unprotected abattoir workers in Al-Ahsa and 146 controls who were not exposed to DCs in any professional role, found none with serological evidence of past MERS-CoV infection using the ppNT assay [
       <xref ref-type="bibr" rid="CR10">
        10
       </xref>
       ]. A delay in the neutralizing antibody response to MERS-CoV infection was associated with increased disease severity in South Korea cases with most responses detectable by week three of illness while others, even though disease was severe, did not respond for four or more weeks [
       <xref ref-type="bibr" rid="CR81">
        81
       </xref>
       ]. The implications for our ability to detect any response in mild or asymptomatic cases was not explored but may be a signifcant factor in understanding exposure in the wider community.
      </p>
      <p id="Par54">
       A Jordanian outbreak of acute LRT disease in a hospital in 2012 was retrospectively found to be associated with MERS-CoV infection, initially using RT-rtPCR, but subsequently, and on a larger scale, through positivity by ELISA and IFA or MNT test. [
       <xref ref-type="bibr" rid="CR46">
        46
       </xref>
       ,
       <xref ref-type="bibr" rid="CR82">
        82
       </xref>
       ,
       <xref ref-type="bibr" rid="CR83">
        83
       </xref>
       ] This outbreak predated the first case of MERS in the KSA. The ELISA used a recombinant nucleocapsid protein from the group 2 betacoronavirus bat-CoV HKU5 to identify antibodies against the equivalent cross-reactive MERS-CoV protein [
       <xref ref-type="bibr" rid="CR71">
        71
       </xref>
       ]. It was validated using 545 sera collected from people with prior HCoV-OC43, HCoV-229E, SARS-CoV, HCoV-NL63, HRV, HMPV or influenza A(H1N1) infections but was reportedly less specific than the recombinant IFA discussed above. It was still considered an applicable tool for screening large sample numbers [
       <xref ref-type="bibr" rid="CR82">
        82
       </xref>
       ]. A protein microarray expressing the S1 protein subunit has also been validated and widely used for DC testing [
       <xref ref-type="bibr" rid="CR5">
        5
       </xref>
       ,
       <xref ref-type="bibr" rid="CR84">
        84
       </xref>
       ]. Detection of MERS-CoV infection using ELISA or S1 subunit protein microarray [
       <xref ref-type="bibr" rid="CR84">
        84
       </xref>
       ] is usually followed by confirmatory IFA and/or a plaque-reduction neutralization (PRNT) [
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ,
       <xref ref-type="bibr" rid="CR70">
        70
       </xref>
       ,
       <xref ref-type="bibr" rid="CR85">
        85
       </xref>
       ] or MNT test. [
       <xref ref-type="bibr" rid="CR74">
        74
       </xref>
       ,
       <xref ref-type="bibr" rid="CR85">
        85
       </xref>
       ,
       <xref ref-type="bibr" rid="CR86">
        86
       </xref>
       ] This confirmatory process aims toensure the antibodies detected are able to specifically neutralize the intended virus and are not more broadly reactive to other coronaviruses found in DCs (bovine CoV, BCoV) or humans (HCoV-OC43, HCoV-229E, HCoV-NL63, HCoV-HKU1, SARS-CoV). In the largest study of human sera, a tiered diagnostic process assigned both recombinant IFA and recombinant ELISA positive sera to ‘stage 1’ seropositivity. A stage 2 seropositive result additionally required a suitably titred PRNT result [
       <xref ref-type="bibr" rid="CR87">
        87
       </xref>
       ]. The study found 15 sera collected in 2012 to 2013 from 10,009 (0.2 %) people in 13 KSA provinces contained MERS-CoV antibodies, but significantly higher proportions in occurred in camel shepherds (two of 87; 2.3 %) and slaughterhouse workers (five of 140; 3.6 %) [
       <xref ref-type="bibr" rid="CR87">
        87
       </xref>
       ]. Contemporary surveys are needed.
      </p>
      <p id="Par55">
       MERS-CoV does not appear to be easily transmitted from DCs to humans, or perhaps it is [
       <xref ref-type="bibr" rid="CR72">
        72
       </xref>
       ], but generally does not trigger a detectable immune response if only mild disease or asymptomatic infection results. Serology assays are in need of further validation in this area so care is required when moving newly developed diagnostic serology algorithms from a research setting to one that informs public health decisions. This was reinforced when a false positive US case, purported to have been infected after a handshake and two face-to-face meetings, did not withstand further confirmatory analysis using a more specific, NT assay and was subsequently retracted [
       <xref ref-type="bibr" rid="CR88">
        88
       </xref>
       ,
       <xref ref-type="bibr" rid="CR89">
        89
       </xref>
       ].
      </p>
     </sec>
     <sec id="Sec8">
      <title>
       Specimen types for RT-PCR and length of viral shedding
      </title>
      <p id="Par56">
       The WHO recommends sampling from the LRT for MERS-CoV RT-rtPCR testing, especially when sample collection is delayed by a week or more after onset of symptoms. [
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ] LRT samples are also best for attempting isolation of infectious virus, although the success of culture is reduced when disease persists [
       <xref ref-type="bibr" rid="CR49">
        49
       </xref>
       ]. Recommended sample types include bronchoalveolar lavage (BAL), tracheal/tracheobronchial aspirate, pleural fluid and sputum [
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ,
       <xref ref-type="bibr" rid="CR90">
        90
       </xref>
       ]. Fresh samples yield better diagnostic results than refrigerated material [
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ] and if delays in testing of ≥72 h are likely, samples (except for blood) should be frozen at −70 °C [
       <xref ref-type="bibr" rid="CR90">
        90
       </xref>
       ]. If available, lung biopsy or autopsy tissues can also be tested [
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ]. The URT is a less invasive and more convenient sampling site however, and an oropharyngeal and throat swab or a nasopharyngeal aspirate/wash are recommended when URT sampling is to be conducted [
       <xref ref-type="bibr" rid="CR90">
        90
       </xref>
       ]. Paired sera, collected two to three weeks apart are preferable for serological testing while a single sample is suggested to be sufficient if collected two weeks after onset of disease or a single serum collected during the first 10–12 days if conducting RT-rtPCR [
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ,
       <xref ref-type="bibr" rid="CR90">
        90
       </xref>
       ]. Human urine and stool have been found to contain MERS-CoV RNA 12 to 26 days after symptom onset [
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ,
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ,
       <xref ref-type="bibr" rid="CR91">
        91
       </xref>
       ] and are listed as samples that should be considered [
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ,
       <xref ref-type="bibr" rid="CR90">
        90
       </xref>
       ]. In two cases that arrived in the Netherlands, urine was RT-rtPCR negative but faeces was weakly positive and sera were RT-rtPCR positive for five days or more [
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ]. The finding of MERS-CoV viral RNA in serum provides an avenue for retrospective PCR-based studies if respiratory samples are unavailable [
       <xref ref-type="bibr" rid="CR83">
        83
       </xref>
       ]. RNAaemia may also correlate with disease severity; signs of virus were cleared from the serum of a recovered patient, yet lingered until the death of another [
       <xref ref-type="bibr" rid="CR92">
        92
       </xref>
       ].
      </p>
      <p id="Par57">
       Clinically suspected MERS cases may return negative results by RT-rtPCR. Data have shown one or more negative URT samples may be contradicted by further URT sampling or the use of LRT samples, which is preferred [
       <xref ref-type="bibr" rid="CR2">
        2
       </xref>
       ,
       <xref ref-type="bibr" rid="CR43">
        43
       </xref>
       ,
       <xref ref-type="bibr" rid="CR93">
        93
       </xref>
       ]. Higher viral loads occur in the LRT compared to the URT. [
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
       ,
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ,
       <xref ref-type="bibr" rid="CR88">
        88
       </xref>
       ,
       <xref ref-type="bibr" rid="CR94">
        94
       </xref>
       ] This fits with the observation that the majority of disease symptoms are reported to manifest as systemic and LRT disease [
       <xref ref-type="bibr" rid="CR21">
        21
       </xref>
       ]. However, on occasion, even LRT specimens from MERS cases may initially be negative, only to later become positive by RT-PCR [
       <xref ref-type="bibr" rid="CR95">
        95
       </xref>
       ]. This may be due to poor sampling when a cough is absent or non-productive or because the viral load is low [
       <xref ref-type="bibr" rid="CR95">
        95
       </xref>
       ]. Despite this both the largest human MERS-CoV studies [
       <xref ref-type="bibr" rid="CR32">
        32
       </xref>
       ,
       <xref ref-type="bibr" rid="CR96">
        96
       </xref>
       –
       <xref ref-type="bibr" rid="CR98">
        98
       </xref>
       ] and smaller ones [
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
       ,
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ,
       <xref ref-type="bibr" rid="CR99">
        99
       </xref>
       ], use samples from the URT. It is then noteworthy that one study reported an association between higher loads in the URT and worse clinical outcome including intensive care and death [
       <xref ref-type="bibr" rid="CR94">
        94
       </xref>
       ]. At writing, no human data exist to define whether the virus replicates solely or preferentially in the LRT or URT, or replicates in other human tissues in vivo although MERS-CoV RNA has been detected from both the URT and LRT in a macaque monkey model [
       <xref ref-type="bibr" rid="CR100">
        100
       </xref>
       ].The distribution of DPP4 in the human upper airways is also not well described.
      </p>
      <p id="Par58">
       Individual human case studies report long periods of viral shedding, sometimes intermittently and not necessarily linked to the presence of disease symptoms. [
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ,
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ,
       <xref ref-type="bibr" rid="CR99">
        99
       </xref>
       ,
       <xref ref-type="bibr" rid="CR101">
        101
       </xref>
       ] In one instance, a HCW shed viral RNA for 42 days in the absence of disease [
       <xref ref-type="bibr" rid="CR99">
        99
       </xref>
       ]. It is an area of high priority to better understand whether such cases are able to infect others. Over three quarters of MERS cases shed viral RNA in their LRT specimens (tracheal aspirates and sputum) for at least 30 days, while only 30 % of contacts were still shedding RNA in their URT specimens [
       <xref ref-type="bibr" rid="CR91">
        91
       </xref>
       ,
       <xref ref-type="bibr" rid="CR102">
        102
       </xref>
       ].
      </p>
      <p id="Par59">
       In the only study to examine the effect of sample type on molecular analysis, 64 nasopharyngeal aspirates (NPA; an URT sample), 30 tracheal aspirates, 13 sputa and three BAL were examined. The tracheal aspirates and BAL returned the highest viral load values followed by NPA and sputum. Unsurprisingly, higher viral loads generally paralleled whole genome sequencing and culture success and, in NPA testing, were significantly correlated with severe disease and death [
       <xref ref-type="bibr" rid="CR49">
        49
       </xref>
       ,
       <xref ref-type="bibr" rid="CR94">
        94
       </xref>
       ,
       <xref ref-type="bibr" rid="CR103">
        103
       </xref>
       ]. This study demonstrated the importance of LRT sampling for whole genome sequencing.
      </p>
     </sec>
     <sec id="Sec9">
      <title>
       MERS-CoV and concurrent infections
      </title>
      <p id="Par60">
       When tested, samples positive for MERS-CoV are often negative for other pathogens [
       <xref ref-type="bibr" rid="CR2">
        2
       </xref>
       ,
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ,
       <xref ref-type="bibr" rid="CR93">
        93
       </xref>
       ,
       <xref ref-type="bibr" rid="CR104">
        104
       </xref>
       ]. However, many studies make no mention of additional testing for endemic human respiratory viruses [
       <xref ref-type="bibr" rid="CR21">
        21
       </xref>
       ,
       <xref ref-type="bibr" rid="CR23">
        23
       </xref>
       ,
       <xref ref-type="bibr" rid="CR73">
        73
       </xref>
       ,
       <xref ref-type="bibr" rid="CR105">
        105
       </xref>
       ]. When viruses are sought, they have included human herpesvirus (HHV), rhinoviruses (HRV), enteroviruses (EV), respiratory syncytial virus (RSV), parainfluenzavirus types 1, 2 and 3 (PIVs),influenzaviruses (IFVs), endemic HCoVs, adenoviruses (AdVs) metapneumovirus (MPV) and influenza A\H1N1 virus; co-detections with MERS-CoV have been found on occasion [
       <xref ref-type="bibr" rid="CR2">
        2
       </xref>
       ,
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
       ,
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
       ,
       <xref ref-type="bibr" rid="CR69">
        69
       </xref>
       ,
       <xref ref-type="bibr" rid="CR97">
        97
       </xref>
       ]. Bacterial testing is sometimes included (for example, for
       <italic>
        Legionella
       </italic>
       and
       <italic>
        Pneumococcus
       </italic>
       ) but the impact of bacterial co-presence is also unclear [
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
       ,
       <xref ref-type="bibr" rid="CR104">
        104
       </xref>
       –
       <xref ref-type="bibr" rid="CR106">
        106
       </xref>
       ]. Further testing of the LRT sample from the first MERS case used IFA to screen for some viruses (negative for IFV, PIVs, RSV and AdVs) and RT-PCR for others (negative for AdV, EVs, MPV and HHVs) [
       <xref ref-type="bibr" rid="CR18">
        18
       </xref>
       ]. RT-PCR also detected MERS-CoV. The WHO strongly recommends testing for other respiratory pathogens [
       <xref ref-type="bibr" rid="CR53">
        53
       </xref>
       ] but with this recommendation often discounted, there are limited data to address the occurrence and impact of co-infections or alternative viral diagnoses among both MERS cases and their contacts. Little is known of other causes of MERS-like pneumonia in the KSA or of the general burden of disease due to the known classical respiratory viruses.
      </p>
     </sec>
    </sec>
    <sec id="Sec10">
     <title>
      Mass MERS-CoV screening studies
     </title>
     <p id="Par61">
      Testing of adult pilgrims performing the Hajj in 2012 to 2014 has not detected any MERS-CoV. In 2012, nasal swabs from 154 pilgrims collected prior to leaving for or departing from the KSA were tested [
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ]. In 2013, testing was significantly scaled up with 5,235 nasopharyngeal swabs from 3,210 incoming pilgrims and 2,025 swabs from outgoing pilgrims tested [
      <xref ref-type="bibr" rid="CR98">
       98
      </xref>
      ]. It should be noted that most pilgrims arrived from MERS-free countries. A further 114 swabs were taken from pilgrims with influenza-like illness [
      <xref ref-type="bibr" rid="CR96">
       96
      </xref>
      ,
      <xref ref-type="bibr" rid="CR107">
       107
      </xref>
      ]. In earlier Hajj gatherings, it was found that influenza viruses circulated widely, whilst other viruses, often rhinoviruses, circulated more selectively, interpreted as indicating their importation along with foreign pilgrims. [
      <xref ref-type="bibr" rid="CR107">
       107
      </xref>
      –
      <xref ref-type="bibr" rid="CR109">
       109
      </xref>
      ] Over time, increased influenza vaccination has been credited for a fall in the prevalence of influenza like illnesses among Hajj pilgrims. [
      <xref ref-type="bibr" rid="CR110">
       110
      </xref>
      ] A LRT sample is often not collected for these studies [
      <xref ref-type="bibr" rid="CR98">
       98
      </xref>
      ,
      <xref ref-type="bibr" rid="CR107">
       107
      </xref>
      ,
      <xref ref-type="bibr" rid="CR109">
       109
      </xref>
      ], so false negative findings are a possibility although little is known about the initial site of MERS-CoV infection and replication; it may have been assumed it was the LRT because disease was first noticed there but the URT may be the site of the earliest replication.
     </p>
     <p id="Par62">
      In Jeddah between March and July 2014 (hereafter called the Jeddah-2014 outbreak; Fig.
      <xref ref-type="fig" rid="Fig3">
       3
      </xref>
      ), there was a rapid increase in MERS cases, accompanied by intense screening; approximately 5,000 samples from in and around the region were tested in a month yielding around 140 MERS-CoV detections (~3 % prevalence) [
      <xref ref-type="bibr" rid="CR111">
       111
      </xref>
      ]. Among 5,065 individuals sampled and tested across the KSA between October 2012 and September 2013,108 (2.1 %) detections were made in a hospital-centric population which included hospitalized cases (n = 2,908; 57.4 %), their families (n = 462; 9.1 %) and associated HCWs (n = 1,695; 33.5 %) [
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
      ]. Among the detections, 19 (17.8 %) were HCWs and 10 (9.3 %) were family contacts [
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
      ].
      <fig id="Fig3">
       <label>
        Fig. 3
       </label>
       <caption>
        <p>
         Monthly detections of MERS-CoV (
         <italic>
          blue bars
         </italic>
         ) and of cases who died (
         <italic>
          red bars
         </italic>
         ) with some dates of interest marked for 2012 to 4
         <sup>
          th
         </sup>
         September 2015. An approximation of when DC calving season [
         <xref ref-type="bibr" rid="CR128">
          128
         </xref>
         ] and when recently born DCs are weaned is indicated. Spring (
         <italic>
          green
         </italic>
         ) and summer (
         <italic>
          orange
         </italic>
         ) in the Arabian Peninsula are also shaded. Note the left-hand y-axis scale for 2014 and 2015 which is greater than for 2012/13. Sources of these public data include the WHO, Ministries of Health and FluTrackers [
         <xref ref-type="bibr" rid="CR207">
          207
         </xref>
         –
         <xref ref-type="bibr" rid="CR209">
          209
         </xref>
         ]. Earlier and subsequent versions of this chart are maintained on a personal blog [
         <xref ref-type="bibr" rid="CR210">
          210
         </xref>
         ]. Modified and reprinted from Mackay IM, Arden KE. Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd. Virus Res 2015 Vol 202:60–88 with permission from Elsevier [
         <xref ref-type="bibr" rid="CR5">
          5
         </xref>
         ]
        </p>
       </caption>
       <graphic id="MO3" xlink:href="12985_2015_439_Fig3_HTML">
       </graphic>
      </fig>
     </p>
     <p id="Par63">
      The 2-3 % prevalence of active MERS-CoV infections is not dissimilar to the hospital-based prevalence of other human CoVs. [
      <xref ref-type="bibr" rid="CR112">
       112
      </xref>
      ] However, the proportion of deaths among those infected with MERS-CoV is much higher than that known for the HCoVs NL63, HKU1, 229E or OC43 in other countries, and even above that for SARS-CoV; it is not a virus that could reasonably be described as a “storm in a teacup”. It is the low transmission rate that has prevented worldwide spread, despite many “opportunities”.
     </p>
    </sec>
    <sec id="Sec11">
     <title>
      Sporadic spill-over and facilitated outbreaks
     </title>
     <p id="Par64">
      Very early in the MERS outbreak, some animals were highly regarded as either the reservoir or intermediate host(s) of MERS-CoV with three of the first five cases having contact with DCs [
      <xref ref-type="bibr" rid="CR73">
       73
      </xref>
      ,
      <xref ref-type="bibr" rid="CR113">
       113
      </xref>
      ,
      <xref ref-type="bibr" rid="CR114">
       114
      </xref>
      ]. Today, animal MERS-CoV infections must be reported to the world organization for animal health as an emerging disease [
      <xref ref-type="bibr" rid="CR115">
       115
      </xref>
      ]. A summary of the first MERS cases reported by the WHO defined animal contact with humans as being direct and within 10 days prior to symptom onset [
      <xref ref-type="bibr" rid="CR20">
       20
      </xref>
      ]. This definition made no specific allowance for acquisition from DCs through a droplet-based route, which is very likely route for acquisition of a virus that initially and predominantly causes respiratory disease [
      <xref ref-type="bibr" rid="CR23">
       23
      </xref>
      ]. Camels are known to produce high levels of MERS-CoV RNA in their URT and lungs [
      <xref ref-type="bibr" rid="CR116">
       116
      </xref>
      ]. Providing support for a droplet transmission route and perhaps indicating the presence of RNA in smaller, drier droplet nuclei, MERS-CoV RNA was identified in a high volume air sample collected from a barn housing an infected DC [
      <xref ref-type="bibr" rid="CR117">
       117
      </xref>
      ]. The precise source from which humans acquire MERS-CoV remains poorly studied but it seems likely that animal and human behavioural factors may play roles (Fig.
      <xref ref-type="fig" rid="Fig3">
       3
      </xref>
      ) [
      <xref ref-type="bibr" rid="CR118">
       118
      </xref>
      ]. These factors may prove important for human cases who do not describe any DC contact [
      <xref ref-type="bibr" rid="CR119">
       119
      </xref>
      ] nor any contact with a confirmed case. Whether the WHO definition of animal contact is sufficient to identify exposure to this respiratory virus remains unclear. Wording focuses on consumption of DC products but does not specifically ascribe risk to a droplet route for acquisition of MERS-CoV from DC [
      <xref ref-type="bibr" rid="CR120">
       120
      </xref>
      ]. Some MERS patients are listed in WHO disease notices as being in proximity to DCs or farms, but the individuals have not described coming into contact with the animals. No alternative path for acquiring infection is reported in many of these instances. What constitutes a definition of “contact” during these interviews has been defined for one study [
      <xref ref-type="bibr" rid="CR72">
       72
      </xref>
      ]. Despite this lack of clarity, the WHO consider that evidence linking MERS-CoV transmission between DCs to humans is irrefutable (Fig.
      <xref ref-type="fig" rid="Fig4">
       4
      </xref>
      ) [
      <xref ref-type="bibr" rid="CR120">
       120
      </xref>
      ].
      <fig id="Fig4">
       <label>
        Fig. 4
       </label>
       <caption>
        <p>
         A speculative series of how humans and DCs contribute to the global tally of MERS cases.
         <bold>
          a
         </bold>
         . Risks for acquiring MERS-CoV from a DC. This illustration highlights risks that may originate from a droplet transmission component (be they larger, heavier wet droplets or the drier, airborne gel-like droplet nuclei) or a direct contact component (within the
         <italic>
          green circle
         </italic>
         ). No routes of MERS-CoV acquisition to or between humans have been proven to date. Modified and reprinted from Mackay IM, Arden KE. Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd. Virus Res 2015 Vol 202:60–88 with permission from Elsevier [
         <xref ref-type="bibr" rid="CR5">
          5
         </xref>
         ].
         <bold>
          b
         </bold>
         Camel-to-human infections appear to be infrequent, while human-to-human spread of infection is regularly facilitated by poor IPC in healthcare settings where transmission is amplified, accounting for the bulk of cases. There are human MERS cases that do not fall into either category of source and it is unclear if these acquired infection through some entirely separate route, or from cases that escaped diagnosis.
         <bold>
          c
         </bold>
         Hypothetical ways in which subclinical (when infection may not meet a previously defined clinical threshold of signs and/or symptoms) or asymptomatic (no obvious signs or measured, noticed or recalled symptoms of illness) MERS-CoV infection may be implicated in transmission
        </p>
       </caption>
       <graphic id="MO4" xlink:href="12985_2015_439_Fig4_HTML">
       </graphic>
      </fig>
     </p>
     <p id="Par65">
      The possibility that bats were an animal host of MERS-CoV was initially widely discussed because of the existing diversity of coronaviruses known to reside among them [
      <xref ref-type="bibr" rid="CR121">
       121
      </xref>
      –
      <xref ref-type="bibr" rid="CR124">
       124
      </xref>
      ]. Conclusive evidence supporting bats as a source for human infections by MERS-CoV has yet to be found, but bats do appear to host ancestral representatives [
      <xref ref-type="bibr" rid="CR53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="CR125">
       125
      </xref>
      ]. However, these are not variants of the same virus nor always within the same phylogenetic lineage as MERS-CoV; they are each a genetically distinct virus. Bat-to-human infection by MERS-CoV is a purely speculative event. The only piece of MERS-CoV-specific evidence pointing to bats originates from amplification of a 190 nt fragment of the RNA-dependent RNA polymerase gene of the MERS-CoV genome, identified in a faecal pellet from an insectivorous
      <italic>
       Emballonuridae
      </italic>
      bat,
      <italic>
       Taphozous perforatus
      </italic>
      found in Bisha, the KSA [
      <xref ref-type="bibr" rid="CR121">
       121
      </xref>
      ]. While very short, the sequence of the fragment defined it as a diagnostic discovery. Subsequently a link to DCs was reported [
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
      ] and that link has matured into a verified association [
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
      ,
      <xref ref-type="bibr" rid="CR126">
       126
      </xref>
      ] (Fig.
      <xref ref-type="fig" rid="Fig4">
       4
      </xref>
      ).
     </p>
     <p id="Par66">
      DCs, which make up 95 % of all camels, have a central presence in the Arabian Peninsula where human-DC contact ranges from little to close [
      <xref ref-type="bibr" rid="CR119">
       119
      </xref>
      ]. Contact may be commonplace and could occur in variety of ways (Fig.
      <xref ref-type="fig" rid="Fig4">
       4a
      </xref>
      ). There are several large well-attended festivals, races, sales and parades which feature DCs and DCs are also kept and bred close to populated areas in the KSA [
      <xref ref-type="bibr" rid="CR127">
       127
      </xref>
      ,
      <xref ref-type="bibr" rid="CR128">
       128
      </xref>
      ]. DC milk and meat are widely consumed and the older DC is an animal of ritual significance after the Hajj pilgrimage [
      <xref ref-type="bibr" rid="CR129">
       129
      </xref>
      ]. However, MERS-CoV infection frequency is reportedly much lower than is the widespread and frequent habit of eating, drinking and preparing DC products. Daily ingestion of fresh unpasteurized DC milk is common among the desert Bedouin and many others in the KSA. DC urine is also consumed or used for supposed health benefits. Despite camel butchery being a local occupation, neither butchers nor other at-risk groups are identifiable among MERS cases; this may simply be a reporting issue rather than an unexplainable absence of MERS. A small case–control study published in 2015 identified direct DC contact, and not ingestion of products, to be associated with onset of MERS [
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
      ].
     </p>
     <p id="Par67">
      The first sero-survey of livestock living in the Middle East region was conducted during 2012–2013 [
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
      ]. DCs were sampled from a mostly Canary Island-born herd and from Omani DCs (originally imported from the Horn of Africa) [
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
      ]. A neutralising antibody assay found only 10 % of strongly seropositive Canary Island DC sera could neutralise MERS-CoV while all Omani DC sera had high levels of specific MERS-CoV neutralizing antibody [
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
      ]. This indicated that DCs had in the past been infected by MERS-CoV, or a very similar virus.
     </p>
     <p id="Par68">
      Since this study, a host of peer-reviewed reports have looked at both DCs and other animals, and the possibility that they may host MERS-CoV infection. Seropositive DCs have been found throughout the Arabian Peninsula including Oman, the KSA, Qatar, Jordan, the United Arab Emirates (UAE), Kuwait as well as Sudan, Somalia, Egypt, Tunisia, Nigeria, Kenya and Ethiopia in Africa and the Canary Islands [
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
      ,
      <xref ref-type="bibr" rid="CR130">
       130
      </xref>
      –
      <xref ref-type="bibr" rid="CR134">
       134
      </xref>
      ]. Other animals tested include sheep, cows, pigs, horses, donkeys, mules, birds, water buffalo, goats, Bactrian camels, llamas and guanaco (south American camelids) but none had detectable neutralising antibody against MERS-CoV [
      <xref ref-type="bibr" rid="CR4">
       4
      </xref>
      ,
      <xref ref-type="bibr" rid="CR74">
       74
      </xref>
      ,
      <xref ref-type="bibr" rid="CR78">
       78
      </xref>
      ,
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
      ,
      <xref ref-type="bibr" rid="CR86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="CR135">
       135
      </xref>
      ,
      <xref ref-type="bibr" rid="CR136">
       136
      </xref>
      ]. No virology or serology studies of human samples from areas in Africa where there are camels with a history of MERS-CoV have been reported to date. However,an absence of unexplained pneumonia that may be attributable to MERS-CoV infection may not signal the absence of virus among humans in each country but simply reflect a lack of expensive epidemiology studies conducted by resource-poor countries.﻿ It is thus unclear whether MERS-CoV, or an antigenically related CoV, is an unrecognized pathogen in these regions, perhaps circulating for even longer than it has been known in the Arabian Peninsula [
      <xref ref-type="bibr" rid="CR133">
       133
      </xref>
      ].
     </p>
     <p id="Par69">
      MERS-CoV RNA has also been detected in DC samples, and recovery of infectious virus has also been achieved from DC samples [
      <xref ref-type="bibr" rid="CR4">
       4
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="CR117">
       117
      </xref>
      ,
      <xref ref-type="bibr" rid="CR132">
       132
      </xref>
      ,
      <xref ref-type="bibr" rid="CR137">
       137
      </xref>
      –
      <xref ref-type="bibr" rid="CR141">
       141
      </xref>
      ]. From some of these, full or majority length genomes of MERS-CoV have been sequenced [
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="CR137">
       137
      </xref>
      ,
      <xref ref-type="bibr" rid="CR138">
       138
      </xref>
      ]. DC versions of MERS-CoV were found to be as similar to each other, as were variants detected from different humans over time and across distance.
     </p>
     <p id="Par70">
      Antibody screening assays have also detected cross-reactive antibodies in sera. These were identified as such by screening sera against similar viruses, for example BCoV or HCoV-OC43 (as an antigenic facsimile for BCoV). It is possible that other MERS-CoV-like viruses also reside within DCs, but this does not detract from the definitive finding of MERS-CoV genetic sequences in both DCs and humans [
      <xref ref-type="bibr" rid="CR117">
       117
      </xref>
      ,
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ,
      <xref ref-type="bibr" rid="CR143">
       143
      </xref>
      ].
     </p>
     <p id="Par71">
      Screening studies have shown that juvenile DCs are more often positive for virus or viral RNA while older DCs are more likely to be seropositive and RNA or virus negative [
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="CR144">
       144
      </xref>
      ]. In adult DCs, MERS-CoV RNA has been detected among animals with pre-existing antibody, suggesting re-infection is possible [
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="CR144">
       144
      </xref>
      ]. Viral loads among positive DCs can be very high [
      <xref ref-type="bibr" rid="CR4">
       4
      </xref>
      ,
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="CR139">
       139
      </xref>
      ,
      <xref ref-type="bibr" rid="CR144">
       144
      </xref>
      ] and DCs have been found positive both when ill with URT respiratory signs [
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="CR117">
       117
      </xref>
      ,
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ,
      <xref ref-type="bibr" rid="CR145">
       145
      </xref>
      ] or when apparently healthy [
      <xref ref-type="bibr" rid="CR137">
       137
      </xref>
      ]. These findings indicate DCs host natural MERS-CoV infections. Furthermore, stored DC sera have revealed signs of MERS-CoV in DCs which date back over three decades (the earliest collected in 1983) [
      <xref ref-type="bibr" rid="CR4">
       4
      </xref>
      ,
      <xref ref-type="bibr" rid="CR133">
       133
      </xref>
      ,
      <xref ref-type="bibr" rid="CR135">
       135
      </xref>
      ]. Older sera have not been tested and so precisely how long DCs have been afflicted by MERS-CoV, whether the virus is enzootic among them, introduced to them decades or centuries ago from bats in Africa or the Arabian Peninsula, or they are the subject of regular but short-lived viral incursions from an as yet unknown host, cannot be answered.
     </p>
     <p id="Par72">
      Researchers sought to determine a direction for infection; were DCs transmitting virus to humans or were humans infecting DCs? At a Qatari site, a farm owner and his employee became ill in mid-October 2013 and tested positive for MERS-CoV RNA in a sputum and throat swab sample, respectively. RT-rtPCRs found MERS-CoV RNA in 11 of 14 positive DC nasal swabs at the farm; six (43 %) positive by two or more assays [
      <xref ref-type="bibr" rid="CR138">
       138
      </xref>
      ]. The results indicated a recent outbreak had occurred in this herd; the first indication of MERS-CoV RNA found within DCs with a temporal association to human infections. Three positive DC samples were confirmed by sequencing a 358 nt portion of the spike gene; these sequences were identical to each other, again with close homology to other human and DC MERS-CoV sequences [
      <xref ref-type="bibr" rid="CR138">
       138
      </xref>
      ]. The DCs and human contacts yielded ORF1a and ORF4b sequences differing by only a single nucleotide each, clustering closely with the Hafr-Al-Batin_1_2013 variant [
      <xref ref-type="bibr" rid="CR138">
       138
      </xref>
      ]. Subsequent case studies found evidence of a concurrent human and DC infection and the direction of that infection was inferred to be from the ill DCs and to their human owners [
      <xref ref-type="bibr" rid="CR117">
       117
      </xref>
      ,
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ,
      <xref ref-type="bibr" rid="CR146">
       146
      </xref>
      ]. Partial genome sequences indicated that a human and a MERS-CoV RT-rtPCR positive DC had been infected by a variant of the same virus, harbouring the same distinct pattern of nucleotide polymorphisms. [
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ] All nine DC in the owner’s herd, serially sampled, reacted in a recombinant S1 antigen ELISA, with the two animals that had been RT-rtPCR positive showing a small, verifiable rise in antibody titre [
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ]. A rise in titre theoretically begins 10 to 21 days after DC infection [
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ]. The authors suggested that the rise in titre in DC sera which occurred alongside a declining RNA load, while the patient was actively ill and hospitalized, indicated that the DCs were infected first followed by the owner [
      <xref ref-type="bibr" rid="CR117">
       117
      </xref>
      ,
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ]. BCoV antibodies were also present, and rising in one of the two RT-rtPCR positive animals but no animal’s antibodies could neutralise BCoV infection [
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ].
     </p>
     <p id="Par73">
      Camel calving season occurs in the winter months (between late October and late February; Fig.
      <xref ref-type="fig" rid="Fig3">
       3
      </xref>
      ) and this may be a time when there is increased risk to humans of spill-over due to new infections among naïve DC populations [
      <xref ref-type="bibr" rid="CR128">
       128
      </xref>
      ]. What role maternal camel antibody might play in delaying infection of calves remains unknown [
      <xref ref-type="bibr" rid="CR128">
       128
      </xref>
      ,
      <xref ref-type="bibr" rid="CR142">
       142
      </xref>
      ]. Juvenile DCs appear to host active infection more often than adult DCs and thus the sacrificial slaughter of DCs, which must be five years of age or older (termed a thane), may not be accompanied by significant risk of exposure to infection. In contrast to earlier results, slaughterhouse workers who kill both younger and older DCs, may be an occupational group with significantly higher incidence of seropositivity to MERS-CoV when animals have active MERS-CoV infections [
      <xref ref-type="bibr" rid="CR129">
       129
      </xref>
      ,
      <xref ref-type="bibr" rid="CR139">
       139
      </xref>
      ,
      <xref ref-type="bibr" rid="CR147">
       147
      </xref>
      –
      <xref ref-type="bibr" rid="CR149">
       149
      </xref>
      ]. Expanded virological investigations of African DCs may lead to more seropositive animals and geographic areas in which humans may be at risk. It is possible that there are areas where humans already harbour MERS-CoV infections that have not been identified because of an absence of laboratory surveillance. Virological investigations of bats may lead to findings of ancestral viruses and viral 'missing links' and identifying any other animal sources of zoonotic spread is important to inform options for reducing human exposures [
      <xref ref-type="bibr" rid="CR56">
       56
      </xref>
      ,
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ].
     </p>
     <sec id="Sec12">
      <title>
       Virus survival in the environment
      </title>
      <p id="Par74">
       Infectious MERS-CoV added to DC, goat or cow milk and stored at 4 °C could be recovered at least 72 h later and, if stored at 22 °C, recovery was possible for up to 48 h [
       <xref ref-type="bibr" rid="CR150">
        150
       </xref>
       ]. MERS-CoV titre decreased somewhat when recovered from milk at 22 °C but pasteurization completely ablated MERS-CoV infectivity [
       <xref ref-type="bibr" rid="CR150">
        150
       </xref>
       ]. In a subsequent study, MERS-CoV RNA was identified in the milk, nasal secretion and faeces of DCs from Qatar [
       <xref ref-type="bibr" rid="CR151">
        151
       </xref>
       ].
      </p>
      <p id="Par75">
       A single study has examined the ability of MERS-CoV to survive in the environment [
       <xref ref-type="bibr" rid="CR150">
        150
       </xref>
       ]. Plastic or steel surfaces were inoculated with 10
       <sup>
        6
       </sup>
       TCID
       <sub>
        50
       </sub>
       of MERS-CoV at different temperature and relative humidity (RH) and virus recovery was attempted in cell culture. At high ambient temperature (30 °C) and low RH (30 %) MERS-CoV remained viable for 24 h [
       <xref ref-type="bibr" rid="CR150">
        150
       </xref>
       ]. By comparison, a well known and efficently transmitted respiratory virus, influenza A virus, could not be recovered in culture beyond four hours under any conditions [
       <xref ref-type="bibr" rid="CR150">
        150
       </xref>
       ]. Aerosol experiments found MERS-CoV viability only decreased 7 % at low RH at 20 °C. In comparison, influenza A virus decreased by 95 % [
       <xref ref-type="bibr" rid="CR150">
        150
       </xref>
       ]. MERS-CoV survival is inferior to that previously demonstrated for SARS-CoV [
       <xref ref-type="bibr" rid="CR152">
        152
       </xref>
       ]. For context, pathogenic bacteria can remain viable and airborne for 45 min in a coughed aerosol and can spread 4 m. MERS-CoV’s ability to remain viable over long time periods gives it the capacity to thoroughly contaminate a room’s surfaces when occupied by an infected and symptomatic patient [
       <xref ref-type="bibr" rid="CR153">
        153
       </xref>
       ]. Whether MERS-CoV can remain adrift and infectious for extended periods (truly airborne) remains unknown. Such findings expand our understanding of the possibilities for droplets to transmit respiratory viruses in many settings, including hospital waiting rooms, emergency departments, treatment rooms, open intensive care facilities and private patient rooms. The nature and quality of air exchange, circulation and filtration are important variables in risk measurement and reduction as is the use of negative pressure rooms to contain known cases. Droplet spread between humans is considered the mechanism of human-to-human transmission and the need for droplet precautions was emphasized after the Al-Ahsa hospital, the KSA and the South Korean outbreaks [
       <xref ref-type="bibr" rid="CR21">
        21
       </xref>
       ,
       <xref ref-type="bibr" rid="CR23">
        23
       </xref>
       ,
       <xref ref-type="bibr" rid="CR154">
        154
       </xref>
       ,
       <xref ref-type="bibr" rid="CR155">
        155
       </xref>
       ]. By extrapolation, aerosol-generating events involving DCs (urination, defecation, and preparation and consumption of DC products) should be factored into risk measurement and reduction efforts and messaged using appropriate context. The provision of evidence supporting the best formulation of personal protective equipment to be worn by HCWs who receive, manage or conduct procedures on infectious cases remains a priority.
      </p>
     </sec>
     <sec id="Sec13">
      <title>
       Transmission of MERS-CoV among humans
      </title>
      <p id="Par76">
       MERS-CoV was found and characterized because of its apparent association with severe, and therefore more obvious, illness in humans; we were the canaries in the coal mine. Sero-assays and prospective cohort studies have yet to determine the extent to which milder or asymptomatic cases contribute to MERS-CoV transmission chains. However, transmission of MERS-CoV is defined as sporadic (not sustained), intra-familial, often healthcare associated, inefficient and requiring close and prolonged contact [
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
       ,
       <xref ref-type="bibr" rid="CR31">
        31
       </xref>
       ,
       <xref ref-type="bibr" rid="CR63">
        63
       </xref>
       ,
       <xref ref-type="bibr" rid="CR93">
        93
       </xref>
       ,
       <xref ref-type="bibr" rid="CR97">
        97
       </xref>
       ,
       <xref ref-type="bibr" rid="CR102">
        102
       </xref>
       ,
       <xref ref-type="bibr" rid="CR156">
        156
       </xref>
       ] In a household study, 14 of 280 (5 %) contacts of 26 MERS-CoV positive index patients were RNA or antibody positive; the rate of general transmission, even in outbreaks is around 3 % [
       <xref ref-type="bibr" rid="CR31">
        31
       </xref>
       ]. It seems that the majority of human cases of MERS-CoV, even when numbers appear to increase suddenly, do not readily transmit to more than one other human so to date, the localized epidemic of MERS-CoV has not been self-sustaining [
       <xref ref-type="bibr" rid="CR157">
        157
       </xref>
       –
       <xref ref-type="bibr" rid="CR161">
        161
       </xref>
       ]. That is to say, the basic reproduction number (R
       <sub>
        0
       </sub>
       ) - the average number of infections caused by one infected individual in a fully susceptible population – has been close to one throughout various clusters and outbreaks. If R
       <sub>
        0
       </sub>
       was greater than 1, a sustained increase in case numbers would be expected. Some R
       <sub>
        o
       </sub>
       calculations may be affected by incomplete case contact tracing, limited community testing and how a case is defined. That MERS has had a constant presence in the Arabian Peninsula since 2012 is due to ongoing, sporadic spill-over events from DCs amplified by poorly controlled hospital outbreaks.
      </p>
      <p id="Par77">
       The first known MERS human-to-human transmission event was one characterized by acute LRT disease in a healthcare setting in Jordan. In stark contrast, a sero-survey of HCW who were sometimes in close and prolonged contact with the first, fatal MERS-CoV case in 2012 [
       <xref ref-type="bibr" rid="CR162">
        162
       </xref>
       ], found none of the HCW had seroconverted four months later, despite an absence of eye protection and variable compliance with required PPE standards [
       <xref ref-type="bibr" rid="CR162">
        162
       </xref>
       ].
      </p>
      <p id="Par78">
       Early on in the MERS story, samples for testing were mostly collected from patients with severe illness and not those with milder acute respiratory tract infections. Contacts of confirmed MERS cases were often observed for clinical illness, but not tested. These omissions may have confounded our understanding of MERS-CoV transmission and biased early data towards higher numbers of seriously ill and hospitalized patients, inflating the apparent proportion of fatal cases. Case–control studies were not a focus. As testing paradigms changed and contacts were increasingly tested, more asymptomatic and mild infections were recognized [
       <xref ref-type="bibr" rid="CR163">
        163
       </xref>
       ].
      </p>
      <p id="Par79">
       A rise in the cases termed asymptomatic (which enlarge the denominator for calculations of the proportion of fatal cases, defined in [
       <xref ref-type="bibr" rid="CR164">
        164
       </xref>
       ]) resulted in a drop in the proportion of fatal cases during the Jeddah-2014 outbreak. Historically, such rises are consistent with changing definitions and laboratory responses and clinical management of a newly discovered virus infection that was first noted only among the severely ill. Upon follow-up, over three-quarters of such MERS-CoV RNA positive people did recall having one or more symptoms at the time, despite being reported as asymptomatic [
       <xref ref-type="bibr" rid="CR165">
        165
       </xref>
       ] raising some question over the reliability of other reported data.
      </p>
      <p id="Par80">
       The proportion of fatal MERS cases within the KSA compared to outside the KSA, as well as the age, and sex distribution change in different ways when comparing MERS outbreaks. Approximately 43 % of MERS cases (549 of 1277) in the KSA were fatal betwen 2012 and December 2015 while 21 % (72 of 330) died among those occurring outside of the KSA. The total number of male cases always outnumber females and the proportion of male deaths is always greater than the proportion of females who die. However the proportion of male deaths from total males with MERS is a similar figure to that for females. In the KSA, there is a greater proportion of younger males among cases and deaths than were observed from the 2015 South Korean or the Jeddah-2014 outbreaks (Additional file
       <xref ref-type="media" rid="MOESM2">
        2
       </xref>
       : Figure S2). Why these aspects have differed may be due to differences in the time to presentation and diagnosis, the nature and quality of supportive care, the way a person became infected (habits, exposure to a human or zoonotic source, viral load, route of infection) or the extent to which different populations are burdened by underlying diseases [
       <xref ref-type="bibr" rid="CR40">
        40
       </xref>
       ].
      </p>
      <p id="Par81">
       As a group, HCWs comprised 16 % of MERS cases in the KSA and South Korea. It is apparent that the weekly proportion of infected HCWs increases alongside each steep rise in overall detections (Fig.
       <xref ref-type="fig" rid="Fig5">
        5
       </xref>
       ). In May 2013, the WHO published guidelines for IPC during care of probable or confirmed cases of MERS-CoV infection in a healthcare setting [
       <xref ref-type="bibr" rid="CR166">
        166
       </xref>
       ]. This is explainable because to date, each case rise has been intimately associated with healthcare-facility related outbreaks [
       <xref ref-type="bibr" rid="CR118">
        118
       </xref>
       ]. These rises in MERS-CoV detections can decrease the average age during each event because HCWs are usually younger than inpatients with MERS. Healthcare facilities have been a regular target for suggested improvements aimed at improving infection prevention and control (IPC) procedures [
       <xref ref-type="bibr" rid="CR115">
        115
       </xref>
       ,
       <xref ref-type="bibr" rid="CR118">
        118
       </xref>
       ].
       <fig id="Fig5">
        <label>
         Fig. 5
        </label>
        <caption>
         <p>
          Data on MERS-CoV detections among HCWs based on publicly described laboratory confirmed cases collated into the author’s curated line list as at 4
          <sup>
           th
          </sup>
          September 2015. Sources of these public data include the WHO, Ministries of Health and FluTrackers [
          <xref ref-type="bibr" rid="CR207">
           207
          </xref>
          –
          <xref ref-type="bibr" rid="CR209">
           209
          </xref>
          ]. Earlier and subsequent versions of this chart are maintained on a personal blog [
          <xref ref-type="bibr" rid="CR210">
           210
          </xref>
          ]
         </p>
        </caption>
        <graphic id="MO5" xlink:href="12985_2015_439_Fig5_HTML">
        </graphic>
       </fig>
      </p>
     </sec>
     <sec id="Sec14">
      <title>
       Molecular epidemiology: using genomes to understand outbreaks
      </title>
      <p id="Par82">
       Most of the analysis of MERS-CoV genetics has been performed using high throughput or “deep” sequencing methods for complete genome deduction [
       <xref ref-type="bibr" rid="CR167">
        167
       </xref>
       –
       <xref ref-type="bibr" rid="CR169">
        169
       </xref>
       ]. MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic length coverage in a single experiment with highly repetitious measurement of each nucleotide position [
       <xref ref-type="bibr" rid="CR52">
        52
       </xref>
       ,
       <xref ref-type="bibr" rid="CR140">
        140
       </xref>
       ]. Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV characterization [
       <xref ref-type="bibr" rid="CR48">
        48
       </xref>
       ]. As more genomes from both humans and DCs have been characterized, two clades have become apparent; A and B (Fig.
       <xref ref-type="fig" rid="Fig6">
        6
       </xref>
       ). Clade A contains only human-derived MERS-CoV genomes from Jordan, while Clade B comprises the majority of human and camel genomes deduced thus far [
       <xref ref-type="bibr" rid="CR168">
        168
       </xref>
       ].
       <fig id="Fig6">
        <label>
         Fig. 6
        </label>
        <caption>
         <p>
          The genetic relationship between MERS-CoV nucleotide sequences (downloaded from GenBank using the listed accession numbers and from virological.org [
          <xref ref-type="bibr" rid="CR212">
           212
          </xref>
          ]). This neighbour joining tree was created in MEGA v6 using an alignment of human and DC-derived MERS-CoV sequences (Geneious v8.1 [
          <xref ref-type="bibr" rid="CR211">
           211
          </xref>
          ]). Clades are indicated next to dark (Clade A) or pale (Clade B) blue vertical bars. Camel icons denote genomes from DCs. Healthcare or community outbreaks are boxed and labelled using previously described schemes [
          <xref ref-type="bibr" rid="CR212">
           212
          </xref>
          ,
          <xref ref-type="bibr" rid="CR213">
           213
          </xref>
          ]
         </p>
        </caption>
        <graphic id="MO6" xlink:href="12985_2015_439_Fig6_HTML">
        </graphic>
       </fig>
      </p>
      <p id="Par83">
       Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained &gt;99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur [
       <xref ref-type="bibr" rid="CR170">
        170
       </xref>
       –
       <xref ref-type="bibr" rid="CR172">
        172
       </xref>
       ]. Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC virus sequenced on different occasions did not change at all indicating a degree of genomic stability in its host, supporting that DCs are the natural, rather than intermediate, host for the MERS-CoV we know today [
       <xref ref-type="bibr" rid="CR77">
        77
       </xref>
       ]. To date, recombination has been localised to breakpoints near the boundary between ORF1a and ORF1b regions, within the spike gene [
       <xref ref-type="bibr" rid="CR170">
        170
       </xref>
       ] and in the ORF1b region (Fig.
       <xref ref-type="fig" rid="Fig2">
        2
       </xref>
       ) [
       <xref ref-type="bibr" rid="CR172">
        172
       </xref>
       ]. It is not unexpected that recombination should occur since it is well known among other CoVs [
       <xref ref-type="bibr" rid="CR124">
        124
       </xref>
       ] and because the majority of MERS-CoV whole genomes collected from samples spanning three years (2012–2015) and from humans, camels and different countries have shown close genetic identity to each other, with just enough subtle variation to support outbreak investigations so long as whole genome sequencing is applied [
       <xref ref-type="bibr" rid="CR52">
        52
       </xref>
       ,
       <xref ref-type="bibr" rid="CR77">
        77
       </xref>
       ,
       <xref ref-type="bibr" rid="CR135">
        135
       </xref>
       ,
       <xref ref-type="bibr" rid="CR138">
        138
       </xref>
       ,
       <xref ref-type="bibr" rid="CR168">
        168
       </xref>
       ,
       <xref ref-type="bibr" rid="CR173">
        173
       </xref>
       –
       <xref ref-type="bibr" rid="CR175">
        175
       </xref>
       ].
      </p>
      <p id="Par84">
       Changes in genome sequence may herald alterations to virus transmissibility, replication, persistence, lethality or response to future drugs. If we have prior knowledge of the impact of genetic changes because of thorough characterization studies, we can closely monitor the genomic regions and better understand any changes in transmission or disease patterns as they occur. Genetic mutations noted during the largest of human outbreaks, Jeddah-2014, did not impart any major replicative or immunomodulatory changes when compared to earlier viral variants in vitro [
       <xref ref-type="bibr" rid="CR156">
        156
       </xref>
       ,
       <xref ref-type="bibr" rid="CR176">
        176
       </xref>
       ]. However, we understand very little of the phenotypic outcomes that result from subtle genetic change in MERS-CoV genomes. To date no clinical relevance or obvious in vivo changes to viral replication, shedding or transmission has been reported or attributed to mutations or to new recombinant viruses [
       <xref ref-type="bibr" rid="CR156">
        156
       </xref>
       ]. But vigilance and larger, more contemporary and in vivo studies are needed.
      </p>
      <p id="Par85">
       Genome sequence located to a distinct clade were identified from an Egyptian DC that was probably imported from Sudan. This does not fit into either of the current clades [
       <xref ref-type="bibr" rid="CR125">
        125
       </xref>
       ,
       <xref ref-type="bibr" rid="CR168">
        168
       </xref>
       ,
       <xref ref-type="bibr" rid="CR177">
        177
       </xref>
       ]. A virus sequenced from a
       <italic>
        Neoromicia capensis
       </italic>
       bat was more closely related to MERS-CoV than other large bat-derived sequences had been to that point, but the genome of a variant of a MERS-CoV has yet to be discovered and deduced from any bat [
       <xref ref-type="bibr" rid="CR125">
        125
       </xref>
       ].
      </p>
      <p id="Par86">
       Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome (Fig.
       <xref ref-type="fig" rid="Fig2">
        2
       </xref>
       ), which encodes the spike protein and accessory proteins [
       <xref ref-type="bibr" rid="CR168">
        168
       </xref>
       ]. At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain (RBD) of the spike protein and codons 158 (N-terminal region), 460 (RBD), 1020 (in heptad repeat 1), 1202 and 1208 bear investigation as markers of adaptive change [
       <xref ref-type="bibr" rid="CR140">
        140
       </xref>
       ,
       <xref ref-type="bibr" rid="CR169">
        169
       </xref>
       ]. The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV genomes, among South Korean variants [
       <xref ref-type="bibr" rid="CR172">
        172
       </xref>
       ,
       <xref ref-type="bibr" rid="CR178">
        178
       </xref>
       ]. This highlights that subgenomic regions may not always contain enough genetic diversity to prove useful for differentiating viral variants. Despite this, one assay amplifying a 615 nucleotide fragment of the spike S2 domain gene for Sanger sequencing agreed with the results generated by the sequencing of a some full genomes and was useful to define additional sequence groupings [
       <xref ref-type="bibr" rid="CR177">
        177
       </xref>
       ].
      </p>
      <p id="Par87">
       Genomic sequence can also be used to define the geographic boundaries of a cluster or outbreak and monitor its progress, based on the similarity of the variants found among infected humans and animals when occurring together, or between different sites and times (Fig.
       <xref ref-type="fig" rid="Fig6">
        6
       </xref>
       ) [
       <xref ref-type="bibr" rid="CR169">
        169
       </xref>
       ]. This approach was employed when defining the geographically constrained MERS hospital outbreak in Al-Ahsa, which occurred between 1
       <sup>
        st
       </sup>
       April and 23
       <sup>
        rd
       </sup>
       May 2013, as well as clusters in Buraidah and a community outbreak in Hafr Al-Batin, the KSA. Genomic sequencing identified that approximately 12 MERS-CoV detections from a community outbreak in Hafr Al-Batin between June and August 2013 may have been triggered by an index case becoming infected through DC contact [
       <xref ref-type="bibr" rid="CR175">
        175
       </xref>
       ]. Sequencing MERS-CoV genomes from the 2013 Al-Ahsa hospital outbreak indicated that multiple viral variants contributed to the cases but that most were similar enough to each other to be consistent with human-to-human transmission. Molecular epidemiology has revealed otherwise hidden links in transmission chains encompassing a period of up to five months [
       <xref ref-type="bibr" rid="CR179">
        179
       </xref>
       ]. However, most outbreaks have not continued for longer than two to three months and so opportunities for the virus to adapt further to humans through co-infection and sustained serial passage have been rare [
       <xref ref-type="bibr" rid="CR169">
        169
       </xref>
       ]. In Riyadh-2014, genetic evidence supported the likelihood of multiple external introductions of virus, implicating a range of healthcare facilities in an event that otherwise looked contiguous [
       <xref ref-type="bibr" rid="CR23">
        23
       </xref>
       ,
       <xref ref-type="bibr" rid="CR168">
        168
       </xref>
       ,
       <xref ref-type="bibr" rid="CR179">
        179
       </xref>
       ]. Riyadh is a nexus for camel and human travel and has had more MERS cases than any other region of the KSA to date but also harbours a wide range of MERS-CoV variants [
       <xref ref-type="bibr" rid="CR128">
        128
       </xref>
       ,
       <xref ref-type="bibr" rid="CR167">
        167
       </xref>
       ,
       <xref ref-type="bibr" rid="CR179">
        179
       </xref>
       ]. However the South Korean outbreak originated from a single infected person, resulting in three to four generations of cases [
       <xref ref-type="bibr" rid="CR180">
        180
       </xref>
       ,
       <xref ref-type="bibr" rid="CR181">
        181
       </xref>
       ]. Studies of this apparently recombinant viral variant did not find an increased evolutionary rate and no sign of virus adaptation thus the outbreak seems to have been driven by circumstance rather than circumstance together with mutation [
       <xref ref-type="bibr" rid="CR181">
        181
       </xref>
       ].
      </p>
     </sec>
     <sec id="Sec15">
      <title>
       Contact tracing and the possible importance of asymptomatic cases
      </title>
      <p id="Par88">
       For many MERS cases detected outside the Arabian Peninsula, extensive contact tracing has been performed and the results described in detail. Contact tracing is essential to contain the emergence and transmission of a new virus and today it is supported by molecular epidemiology. Although it is an expensive and time consuming process, contact tracing can identify potential new infections and through active or passive monitoring, react more rapidly if disease does develop. Results of contact tracing to date have found that onward transmission among humans is an infrequent event. For example, there were 83 contacts, both symptomatic and asymptomatic, of a case treated in Germany who travelled from the UAE but no sign of virus or antibody were found in any of them [
       <xref ref-type="bibr" rid="CR73">
        73
       </xref>
       ]. The very first MERS case had made contact with 56 HCWs and 48 others, but none developed any indication of infection [
       <xref ref-type="bibr" rid="CR162">
        162
       </xref>
       ]. In a study of 123 contacts of a case treated in France, only seven matched the definition for a possible case and were tested; one who had shared a 20 m
       <sup>
        2
       </sup>
       hospital room while in a bed 1.5 m away from the index case for a prolonged period was positive [
       <xref ref-type="bibr" rid="CR26">
        26
       </xref>
       ]. None of the contacts of the first two MERS cases imported into the USA in 2014 contained any MERS-CoV footprint [
       <xref ref-type="bibr" rid="CR182">
        182
       </xref>
       ] and none of the 131 contacts of two travellers returning to the Netherlands developed MERS-CoV antibodies or tested RNA positive [
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ,
       <xref ref-type="bibr" rid="CR183">
        183
       </xref>
       ]. Analyses of public data reveal many likely instances of nosocomial acquisition of infection in the Arabian Peninsula and these data may be accompanied by some details noting contact with a known case or facility. One example identified the likely role of a patient with a subclinical infection, present in a hospital during their admission for other reasons, as the likeliest index case triggering a family cluster [
       <xref ref-type="bibr" rid="CR93">
        93
       </xref>
       ]. Contact tracing was a significant factor in the termination of a 2015 outbreak involving multiple South Korean hospitals [
       <xref ref-type="bibr" rid="CR184">
        184
       </xref>
       ]. Such studies demonstrate the necessity of finding and understanding a role for mild and asymptomatic cases, together with restricting close contact or prolonged exposure of infected people to others, especially older family members and friends with underlying disease (Fig.
       <xref ref-type="fig" rid="Fig4">
        4c
       </xref>
       ).
      </p>
     </sec>
     <sec id="Sec16">
      <title>
       Hospital associated MERS outbreaks
      </title>
      <p id="Par89">
       The hospital-associated outbreak in Jeddah in 2014 was the largest and most rapid accumulation of MERS-CoV detections to date. The greatest number of MERS-CoV detections of any month on record occurred in Jeddah in April. The outbreak was mostly (&gt;60 % of cases) associated with human-to-human spread within hospital environments and resulted from a lack of, or breakdown in, infection prevention and control [
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
       ,
       <xref ref-type="bibr" rid="CR185">
        185
       </xref>
       ,
       <xref ref-type="bibr" rid="CR186">
        186
       </xref>
       ]. A rise in fatalities followed the rapid increase in case numbers.
      </p>
      <p id="Par90">
       In 2015 two large outbreaks occurred. South Korea was the site of the first large scale outbreak outside the Arabian Peninsula and produced the first cases in both South Korea and China, occurring between May and July 2015. This was closely followed by a distinct outbreak in Ar Riyad province in the KSA which appeared to come under control in early November.
      </p>
      <p id="Par91">
       After staying in Bahrain for two weeks, a 68 year old male (68 M) travelled home to South Korea via Qatar, arriving free of symptoms on the 4
       <sup>
        th
       </sup>
       May 2015 [
       <xref ref-type="bibr" rid="CR187">
        187
       </xref>
       ]. He developed fever, myalgia and a cough nearly a week later (11
       <sup>
        th
       </sup>
       ). He visited a clinic as an outpatient between the 12
       <sup>
        th
       </sup>
       and 15
       <sup>
        th
       </sup>
       of May and was admitted to Hospital A on the 15
       <sup>
        th
       </sup>
       [
       <xref ref-type="bibr" rid="CR188">
        188
       </xref>
       ]. He was discharged from Hospital A on the 17
       <sup>
        th
       </sup>
       then visited and was admitted to the emergency department of Hospital B on the 18
       <sup>
        th
       </sup>
       . During this second stay, a sputum sample was taken and tested positive for MERS-CoV on the 20
       <sup>
        th
       </sup>
       [
       <xref ref-type="bibr" rid="CR187">
        187
       </xref>
       ,
       <xref ref-type="bibr" rid="CR188">
        188
       </xref>
       ], triggering transfer to the designated isolation treatment facility. Over a period of 10 days, the index case was seen at three different hospitals, demonstrating a key feature of “hospital shopping” that shaped the South Korean outbreak. Approximately 34 people were infected during this time [
       <xref ref-type="bibr" rid="CR187">
        187
       </xref>
       ]. In total 186 cases were generated in this outbreak, all linked through a single transmission chain to 68 M; 37 cases died [
       <xref ref-type="bibr" rid="CR189">
        189
       </xref>
       ]. In South Korea, the national health insurance system provides for relatively low cost medical care, defraying some costs by making family members responsible for a portion of the ministration of the sick, resulting in them sometimes staying for long periods in the rooms that often have more than four beds in them [
       <xref ref-type="bibr" rid="CR24">
        24
       </xref>
       ]. Other factors thought to have enabled this outbreak included unfamiliarity of local clinicians with MERS, ease with which the public can visit and be treated by tertiary hospitals, the custom of visiting sick friends and relatives in hospitals, the hierarchical nature of Korean society, crowded emergency rooms, poor IPC measures, a lack of negative pressure isolation rooms and poor inter-hospital communication of patient disease histories [
       <xref ref-type="bibr" rid="CR24">
        24
       </xref>
       ,
       <xref ref-type="bibr" rid="CR190">
        190
       </xref>
       –
       <xref ref-type="bibr" rid="CR192">
        192
       </xref>
       ]. All of the reported transmission occurred across three or four generations and apart from one unknown source, were all hospital-acquired [
       <xref ref-type="bibr" rid="CR24">
        24
       </xref>
       ,
       <xref ref-type="bibr" rid="CR120">
        120
       </xref>
       ,
       <xref ref-type="bibr" rid="CR181">
        181
       </xref>
       ,
       <xref ref-type="bibr" rid="CR193">
        193
       </xref>
       –
       <xref ref-type="bibr" rid="CR195">
        195
       </xref>
       ]. Few clinical details about these cases have been reported to date and detail on transmission and contact tracing is minimal. The hospitals involved were initially not identified, governmental guidance and actions produced confusing messages and there was very limited communication at all early on which resulted in unnecessary concern, distrust and a distinct economic impact [
       <xref ref-type="bibr" rid="CR191">
        191
       </xref>
       ,
       <xref ref-type="bibr" rid="CR196">
        196
       </xref>
       –
       <xref ref-type="bibr" rid="CR198">
        198
       </xref>
       ]. Early in the outbreak, a infected traveller, the son of an identified case in South Korea, passed through Hong Kong on his way to China where he was located, isolated and cared for in China [
       <xref ref-type="bibr" rid="CR91">
        91
       </xref>
       ,
       <xref ref-type="bibr" rid="CR199">
        199
       </xref>
       ,
       <xref ref-type="bibr" rid="CR200">
        200
       </xref>
       ]. No contacts became ill. The outbreak was brought under control in late July/ early August [
       <xref ref-type="bibr" rid="CR201">
        201
       </xref>
       ] after improved IPC measures were employed, strong contact tracing monitoring and quarantine, expanded laboratory testing, hospitals were better secured, specialized personnel were dispatched to manage cases and international cooperation increased [
       <xref ref-type="bibr" rid="CR202">
        202
       </xref>
       ,
       <xref ref-type="bibr" rid="CR203">
        203
       </xref>
       ]. A review of public data showed that, as for MERS in the KSA, older age and the presence of underlying disease were significantly associated with a fatal outcome in South Korea. [
       <xref ref-type="bibr" rid="CR40">
        40
       </xref>
       ] Even though R
       <sub>
        0
       </sub>
       is &lt;1, super-spreading events facilitated by circumstances created in healthcare settings and characterized by cluster sizes over 150, such as this one, are not unexpected from MERS-CoV infection [
       <xref ref-type="bibr" rid="CR204">
        204
       </xref>
       ]. The dynamic of an outbreak depends on the R
       <sub>
        0
       </sub>
       and an individual’s viral shedding patterns, contact type and frequency, hospital procedures and population structure and density [
       <xref ref-type="bibr" rid="CR204">
        204
       </xref>
       ].
      </p>
      <p id="Par92">
       In the region of Ar Riyad, including the capital city of Riyadh, a hospital based cluster began, within a single hospital, from late June 2015 [
       <xref ref-type="bibr" rid="CR205">
        205
       </xref>
       ]. By mid-September there had been approximately170 cases reported but the outbreak appeared to been brought under control in November.
      </p>
     </sec>
    </sec>
    <sec id="Sec17" sec-type="conclusion">
     <title>
      Conclusions
     </title>
     <p id="Par93">
      It became apparent early on that MERS-CoV spread relatively ineffectively from human-to-human. Despite ongoing and possibly seasonal introduction of virus to the human population via infected DCs and perhaps other animals yet to be identified, the vast majority of MERS-CoV transmission has occurred from infected to uninfected humans in close and prolonged contact through circumstances created by poor infection control in health care settings. This opportunistic virus has had its greatest impact on those with underlying diseases and such vulnerable people, sometimes suffering multiple comorbidities, have been most often associated with hospitals, creating a perfect storm of exposure, transmission and mortality. It remains unclear if this group are uniquely affected by MERS-CoV or if other respiratory virus infections, including those from HCoVs, produce a similarly serious impact. In South Korea, a single imported case created an outbreak of 185 cases and 36 deaths that had a disproportionate impact on economic performance, community behaviour and trust in government and the health care system. Household human-to human transmission occurs but is also limited. Educational programs will be essential tools for combatting the spread of MERS-CoV both within urban and regional communities and for the health care setting.
     </p>
     <p id="Par94">
      Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears to be the best tool for the job.
     </p>
     <p id="Par95">
      MERS and SARS have some clinical similarities but they also diverge significantly [
      <xref ref-type="bibr" rid="CR206">
       206
      </xref>
      ]. Defining characteristics include the higher PFC among MERS cases (above 50 % in 2013 and currently at 30-40 %; well above the 9 % of SARS) and the higher association between fatal MERS and older males with underlying comorbidities. For the viruses, MERS-CoV has a broader tropism, grows more rapidly in vitro, more rapidly induces cytopathogenic change, triggers distinct transcriptional responses, makes use of a different receptor, induces a more proinflammatory state and has a delayed innate antiviral response compared to SARS-CoV.
     </p>
     <p id="Par96">
      There appears to be a 2-3 % prevalence of MERS-CoV in the KSA with a 5 % chance of secondary transmission within the household. There is an increased risk of infection through certain occupations at certain times and a much greater chance for spread to other humans during circumstances created by humans, which drives more effective transmission than any R
      <sub>
       0
      </sub>
      would predict on face value. Nonetheless, despite multiple mass gatherings that have afforded the virus many millions of opportunities to spread, there have remarkably been no reported outbreaks of MERS or MERS-CoV during or immediately after these events. There is no evidence that MERS-CoV is a virus of pandemic concern. Nonetheless, hospital settings continue to describe MERS cases and outbreaks in the Arabian Peninsula. As long as we facilitate the spread of MERS-CoV among our most vulnerable populations, the world must remain on alert for cases which may be exported more frequently when a host country with infected camel reservoirs is experiencing human clusters or outbreaks.
     </p>
     <p id="Par97">
      The MERS-CoV appears to be an enzootic virus infecting the DC URT with evidence of recent genetic recombination. It may once have had its origins among bats, but evidence is lacking and the relevance of that to today’s ongoing epidemic is academic. Thanks to quick action, the sensitive and rapid molecular diagnostic tools required to achieve rapid and sensitive detection goal have been in place and made widely available since the virus was reported in 2012. RT-PCR testing of LRT samples remains the gold standard for MERS-CoV confirmation. Serological tools continue to emerge but they are in need of further validation using samples from mild and asymptomatic infections and a densely sampled cohort study to follow contacts of new cases may address this need. Similarly, the important question of whether those who do shed MERS-CoV RNA for extended periods are infectious while appearing well, continues to go unanswered. It is even unclear just how many ‘asymptomatic’ infections have been described and reported correctly which in turn raises questions about the reliability of other clinical data collection to date. While the basic virology of MERS-CoV has advanced over the course of the past three years, understanding what is happening in, and the interplay between, camel, environment and human is still in its infancy.
     </p>
    </sec>
    <sec sec-type="supplementary-material">
     <title>
      Additional files
     </title>
     <sec id="Sec18">
      <p>
       <supplementary-material content-type="local-data" id="MOESM1">
        <media xlink:href="12985_2015_439_MOESM1_ESM.eps">
         <label>
          Additional file 1: Figure S1.
         </label>
         <caption>
          <p>
           The 26 countries in which MERS-CoV has been identified and a guide as to the number of cases at each location. Local transmission in 13 countries is highlighted (blue star) as are countries with DCs that contain antibodies reactive with MERS-CoV, viral RNA or infectious virus (camel icon). Correct as of the 29
           <sup>
            th
           </sup>
           August, 2015. Adapted and reprinted from Mackay IM, Arden KE. Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd. Virus Res 2015 Vol 202:60–88 with permission from Elsevier [
           <xref ref-type="bibr" rid="CR5">
            5
           </xref>
           ]. (EPS 41077 kb)
          </p>
         </caption>
        </media>
       </supplementary-material>
       <supplementary-material content-type="local-data" id="MOESM2">
        <media xlink:href="12985_2015_439_MOESM2_ESM.eps">
         <label>
          Additional file 2: Figure S2.
         </label>
         <caption>
          <p>
           MERS-CoV detections, age and sex pyramids. A) All MERS-CoV detections worldwide and B) those with fatal outcomes; C) The distribution of detections limited to the KSA cases only and D) those with a fatal outcome; E) The distribution resulting from the Jeddah-2014 outbreak, arbitrarily defined as spanning from the week beginning 17
           <sup>
            th
           </sup>
           March 2014 and ending in the week beginning 7th July 2014 and F) those with a fatal outcome; G) the distribution resulting from the South Korean-2015 outbreak and H) those with a fatal outcome; I) the distribution during the Riyadh-2015 outbreak and J) those with a fatal outcome; data are based on laboratory confirmed cases collated into the author’s curated line list as at 4
           <sup>
            th
           </sup>
           September 2015. Note the changed x-axis scale between A-D and E-J. Sources of these public data include the WHO, Ministries of Health and FluTrackers [
           <xref ref-type="bibr" rid="CR206">
            206
           </xref>
           –
           <xref ref-type="bibr" rid="CR208">
            208
           </xref>
           ]. Earlier and subsequent versions of this chart are maintained on a personal blog [
           <xref ref-type="bibr" rid="CR209">
            209
           </xref>
           ]. (EPS 6702 kb)
          </p>
         </caption>
        </media>
       </supplementary-material>
      </p>
     </sec>
    </sec>
    <back>
     <glossary>
      <title>
       Abbreviations
      </title>
      <def-list>
       <def-item>
        <term>
         AdV
        </term>
        <def>
         <p id="Par2">
          adenovirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         BCoV
        </term>
        <def>
         <p id="Par3">
          bovine coronavirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         CoV
        </term>
        <def>
         <p id="Par4">
          coronavirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         DC
        </term>
        <def>
         <p id="Par5">
          dromedary camel
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         DPP4
        </term>
        <def>
         <p id="Par6">
          dipeptidyl peptidase 4
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         ELISA
        </term>
        <def>
         <p id="Par7">
          enzyme linked immunosorbent assay
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         EV
        </term>
        <def>
         <p id="Par8">
          enterovirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         HCoV
        </term>
        <def>
         <p id="Par9">
          human coronavirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         HCW
        </term>
        <def>
         <p id="Par10">
          healthcare worker
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         HHV
        </term>
        <def>
         <p id="Par11">
          human herpesvirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         HRV
        </term>
        <def>
         <p id="Par12">
          human rhinovirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         IFA
        </term>
        <def>
         <p id="Par13">
          immunofluorescent assay
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         IFV
        </term>
        <def>
         <p id="Par14">
          influenza virus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         Ig
        </term>
        <def>
         <p id="Par15">
          immunoglobulin
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         IPC
        </term>
        <def>
         <p id="Par16">
          infection prevention and control
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         KSA
        </term>
        <def>
         <p id="Par17">
          Kingdom of Saudi Arabia
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         LRT
        </term>
        <def>
         <p id="Par18">
          lower respiratory tract
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         MERS
        </term>
        <def>
         <p id="Par19">
          Middle East respiratory syndrome
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         MNT
        </term>
        <def>
         <p id="Par20">
          microneutralization
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         MPV
        </term>
        <def>
         <p id="Par21">
          human metapneumovirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         nCoV
        </term>
        <def>
         <p id="Par22">
          novel coronavirus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         NT
        </term>
        <def>
         <p id="Par23">
          neutralization
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         ORF
        </term>
        <def>
         <p id="Par24">
          open reading frame
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         PCR
        </term>
        <def>
         <p id="Par25">
          polymerase chain reaction
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         PIV
        </term>
        <def>
         <p id="Par26">
          parainfluenza virus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         PPE
        </term>
        <def>
         <p id="Par27">
          personal protective equipment
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         ppNT
        </term>
        <def>
         <p id="Par28">
          pseudo particle neutralization
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         R
         <sub>
          0
         </sub>
        </term>
        <def>
         <p id="Par29">
          basic reproduction number
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         RBD
        </term>
        <def>
         <p id="Par30">
          receptor binding domain
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         RH
        </term>
        <def>
         <p id="Par31">
          relative humidity
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         RNA
        </term>
        <def>
         <p id="Par32">
          ribonucleic acid
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         RSV
        </term>
        <def>
         <p id="Par33">
          respiratory syncytial virus
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         RT-rtPCR
        </term>
        <def>
         <p id="Par34">
          reverse transcriptase real-time polymerase chain reaction
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         SARS
        </term>
        <def>
         <p id="Par35">
          Severe acute respiratory syndrome
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         TCID
         <sub>
          50
         </sub>
        </term>
        <def>
         <p id="Par36">
          50 % tissue culture infectious dose
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         UAE
        </term>
        <def>
         <p id="Par37">
          United Arab Emirates
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         URT
        </term>
        <def>
         <p id="Par38">
          upper respiratory tract
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         US
        </term>
        <def>
         <p id="Par98">
          United States of America
         </p>
        </def>
       </def-item>
       <def-item>
        <term>
         WHO
        </term>
        <def>
         <p id="Par39">
          World Health Organization
         </p>
        </def>
       </def-item>
      </def-list>
     </glossary>
     <fn-group>
      <fn>
       <p>
        <bold>
         Competing interests
        </bold>
       </p>
       <p>
        The authors declare that they have no competing interests.
       </p>
      </fn>
      <fn>
       <p>
        <bold>
         Author’s contributions
        </bold>
       </p>
       <p>
        IMM and KEA contributed equally to this work and read an approved the final manuscript.
       </p>
      </fn>
     </fn-group>
     <ack>
      <title>
       Acknowledgements
      </title>
      <p>
       Any unreferenced opinions expressed herein are those of the authors and do not necessarily represent the views of any employer or institution. Our thanks go to Andrew Rambaut, Maia Majumder, Marion Koopmans and Hale Abdali for helpful discussions on social media and CMAM and RIAM for patience.
      </p>
     </ack>
     <ref-list id="Bib1">
      <title>
       References
      </title>
      <ref id="CR1">
       <label>
        1.
       </label>
       <mixed-citation publication-type="other">
        NOVEL CORONAVIRUS - SAUDI ARABIA: HUMAN ISOLATE. [
        <ext-link ext-link-type="uri" xlink:href="http://www.promedmail.org/direct.php?id=20120920.1302733">
         http://www.promedmail.org/direct.php?id=20120920.1302733
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR2">
       <label>
        2.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bermingham
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Chand
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         <name>
          <surname>
           Aarons
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Langrish
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2012
        </year>
        <volume>
         17
        </volume>
        <fpage>
         20290
        </fpage>
        <pub-id pub-id-type="pmid">
         23078800
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR3">
       <label>
        3.
       </label>
       <mixed-citation publication-type="other">
        Middle East Respiratory Syndrome coronavirus (MERS-CoV) – Saudi Arabia | 2 September 2015 [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/02-september-2015-mers-saudi-arabia/en/">
         http://www.who.int/csr/don/02-september-2015-mers-saudi-arabia/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR4">
       <label>
        4.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alagaili
          </surname>
          <given-names>
           AN
          </given-names>
         </name>
         <name>
          <surname>
           Briese
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Kapoor
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <name>
          <surname>
           Sameroff
          </surname>
          <given-names>
           SC
          </given-names>
         </name>
         <name>
          <surname>
           Burbelo
          </surname>
          <given-names>
           PD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2014
        </year>
        <volume>
         5
        </volume>
        <fpage>
         e00884
        </fpage>
        <lpage>
         00814
        </lpage>
        <pub-id pub-id-type="pmid">
         24570370
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR5">
       <label>
        5.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mackay
          </surname>
          <given-names>
           IM
          </given-names>
         </name>
         <name>
          <surname>
           Arden
          </surname>
          <given-names>
           KE
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd
        </article-title>
        <source>
         Virus Res
        </source>
        <year>
         2015
        </year>
        <volume>
         202
        </volume>
        <fpage>
         60
        </fpage>
        <lpage>
         88
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virusres.2015.01.021
        </pub-id>
        <pub-id pub-id-type="pmid">
         25656066
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR6">
       <label>
        6.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           SM
          </given-names>
         </name>
         <name>
          <surname>
           Damdinjav
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
         <name>
          <surname>
           Khishgee
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Enkhbold
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1269
        </fpage>
        <lpage>
         1271
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2107.150178
        </pub-id>
        <pub-id pub-id-type="pmid">
         26080032
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR7">
       <label>
        7.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Al Jassim
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Kayali
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Siu
          </surname>
          <given-names>
           LY
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        <volume>
         19
        </volume>
        <issue>
         23
        </issue>
        <fpage>
         1
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2014.19.23.20828
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR8">
       <label>
        8.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shirato
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Azumano
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Nakao
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Hagihara
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Ishida
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Tamai
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection not found in camels in Japan
        </article-title>
        <source>
         Jpn J Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         68
        </volume>
        <fpage>
         256
        </fpage>
        <lpage>
         258
        </lpage>
        <pub-id pub-id-type="doi">
         10.7883/yoken.JJID.2015.094
        </pub-id>
        <pub-id pub-id-type="pmid">
         25993975
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR9">
       <label>
        9.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Crameri
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Durr
          </surname>
          <given-names>
           PA
          </given-names>
         </name>
         <name>
          <surname>
           Barr
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Graham
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Williams
          </surname>
          <given-names>
           OJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Absence of MERS-CoV antibodies in feral camels in Australia: implications for the pathogen’s origin and spread
        </article-title>
        <source>
         One Health
        </source>
        <year>
         2015
        </year>
        <volume>
         1
        </volume>
        <fpage>
         76
        </fpage>
        <lpage>
         82
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.onehlt.2015.10.003
        </pub-id>
        <pub-id pub-id-type="pmid">
         28616468
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR10">
       <label>
        10.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         <name>
          <surname>
           Al-Naeem
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
         <name>
          <surname>
           Chin
          </surname>
          <given-names>
           AWH
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LLM
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         4
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2104.141949
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR11">
       <label>
        11.
       </label>
       <mixed-citation publication-type="other">
        Tensions linger over discovery of coronavirus [
        <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/news/tensions-linger-over-discovery-of-coronavirus-1.12108">
         http://www.nature.com/news/tensions-linger-over-discovery-of-coronavirus-1.12108
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR12">
       <label>
        12.
       </label>
       <mixed-citation publication-type="other">
        As Outbreak Continues, Confusion Reigns Over Virus Patents [
        <ext-link ext-link-type="uri" xlink:href="http://news.sciencemag.org/people-events/2013/05/outbreak-continues-confusion-reigns-over-virus-patents">
         http://news.sciencemag.org/people-events/2013/05/outbreak-continues-confusion-reigns-over-virus-patents
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR13">
       <label>
        13.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abdel-Moneim
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations
        </article-title>
        <source>
         Arch Virol
        </source>
        <year>
         2014
        </year>
        <volume>
         159
        </volume>
        <fpage>
         1575
        </fpage>
        <lpage>
         1584
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s00705-014-1995-5
        </pub-id>
        <pub-id pub-id-type="pmid">
         24515532
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR14">
       <label>
        14.
       </label>
       <mixed-citation publication-type="other">
        Cumulative Number of Reported Probable Cases Of SARS [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/country/2003_06_02/en/">
         http://www.who.int/csr/sars/country/2003_06_02/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR15">
       <label>
        15.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Kallies
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Gotthardt
          </surname>
          <given-names>
           DN
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection
        </article-title>
        <source>
         Virol J
        </source>
        <year>
         2013
        </year>
        <volume>
         10
        </volume>
        <fpage>
         359
        </fpage>
        <pub-id pub-id-type="doi">
         10.1186/1743-422X-10-359
        </pub-id>
        <pub-id pub-id-type="pmid">
         24364985
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR16">
       <label>
        16.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Lenk
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Ulrich
          </surname>
          <given-names>
           RG
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Replicative Capacity of MERS Coronavirus in Livestock Cell Lines
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         276
        </fpage>
        <lpage>
         279
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2002.131182
        </pub-id>
        <pub-id pub-id-type="pmid">
         24457147
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR17">
       <label>
        17.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Kallies
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Smits
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2012
        </year>
        <volume>
         3
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         e00515
        </fpage>
        <lpage>
         12
        </lpage>
        <pub-id pub-id-type="pmid">
         23232719
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR18">
       <label>
        18.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           van BS
          </surname>
         </name>
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2012
        </year>
        <volume>
         367
        </volume>
        <fpage>
         1814
        </fpage>
        <lpage>
         1820
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1211721
        </pub-id>
        <pub-id pub-id-type="pmid">
         23075143
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR19">
       <label>
        19.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zielecki
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Eickmann
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Spiegelberg
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Matrosovich
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus
        </article-title>
        <source>
         J Virol
        </source>
        <year>
         2013
        </year>
        <volume>
         87
        </volume>
        <fpage>
         5300
        </fpage>
        <lpage>
         5304
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.03496-12
        </pub-id>
        <pub-id pub-id-type="pmid">
         23449793
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR20">
       <label>
        20.
       </label>
       <mixed-citation publication-type="other">
        The WHO MERS-CoV Research Group. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr. 2013; Edition 1.
       </mixed-citation>
      </ref>
      <ref id="CR21">
       <label>
        21.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabiah
          </surname>
          <given-names>
           FA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Hajjar
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Al-Barrak
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         13
        </volume>
        <fpage>
         752
        </fpage>
        <lpage>
         761
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(13)70204-4
        </pub-id>
        <pub-id pub-id-type="pmid">
         23891402
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR22">
       <label>
        22.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         <name>
          <surname>
           Al-Hakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Stephens
          </surname>
          <given-names>
           GM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2013
        </year>
        <volume>
         368
        </volume>
        <fpage>
         2487
        </fpage>
        <lpage>
         2494
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1303729
        </pub-id>
        <pub-id pub-id-type="pmid">
         23718156
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR23">
       <label>
        23.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           McGeer
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Perl
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
         <name>
          <surname>
           Price
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         <name>
          <surname>
           Al Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Cummings
          </surname>
          <given-names>
           DA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Hospital outbreak of Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         N Engl JMed
        </source>
        <year>
         2013
        </year>
        <volume>
         369
        </volume>
        <fpage>
         407
        </fpage>
        <lpage>
         416
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1306742
        </pub-id>
        <pub-id pub-id-type="pmid">
         23782161
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR24">
       <label>
        24.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ki
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         2015 MERS outbreak in Korea: hospital-to-hospital transmission
        </article-title>
        <source>
         Epidemiol Health
        </source>
        <year>
         2015
        </year>
        <volume>
         37
        </volume>
        <fpage>
         e2015033
        </fpage>
        <pub-id pub-id-type="doi">
         10.4178/epih/e2015033
        </pub-id>
        <pub-id pub-id-type="pmid">
         26212508
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR25">
       <label>
        25.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kraaij-Dirkzwager
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Timen
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Dirksen
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Gelnick
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Leyten
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Groeneveld
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        <volume>
         19
        </volume>
        <fpage>
         20817
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2014.19.21.20817
        </pub-id>
        <pub-id pub-id-type="pmid">
         24906375
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR26">
       <label>
        26.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mailles
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Blanckaert
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Chaud
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           van der
          </surname>
          <given-names>
           WS
          </given-names>
         </name>
         <name>
          <surname>
           Lina
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Caro
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013
        </article-title>
        <source>
         EuroSurveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         24
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR27">
       <label>
        27.
       </label>
       <mixed-citation publication-type="other">
        Case definition for case finding severe respiratory disease associated with novel coronavirus [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition_25_09_2012/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition_25_09_2012/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR28">
       <label>
        28.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus Case definition for reporting to WHO. Interim case definition as of 14 July 2014 [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition_jul2014/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition_jul2014/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR29">
       <label>
        29.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus | Case definition for reporting to WHO 14 July 2015 [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR30">
       <label>
        30.
       </label>
       <mixed-citation publication-type="other">
        Revised interim case definition for reporting to WHO - Middle East respiratory syndrome coronavirus (MERS-CoV): Interim case definition as of July 2013 [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition_03_07_2014/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition_03_07_2014/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR31">
       <label>
        31.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Al-Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Hossain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Transmission of MERS-coronavirus in household contacts
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        <volume>
         371
        </volume>
        <fpage>
         828
        </fpage>
        <lpage>
         835
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1405858
        </pub-id>
        <pub-id pub-id-type="pmid">
         25162889
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR32">
       <label>
        32.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study
        </article-title>
        <source>
         Clin Microbiol Infect
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         469
        </fpage>
        <lpage>
         74
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/1469-0691.12562
        </pub-id>
        <pub-id pub-id-type="pmid">
         24460984
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR33">
       <label>
        33.
       </label>
       <mixed-citation publication-type="other">
        Case Definition and Surveillance Guidance for MERS-CoV Testing in Saudi Arabia - 13 May 2014 [
        <ext-link ext-link-type="uri" xlink:href="http://www.moh.gov.sa/en/Documents/MoHCaseDefinitionMERSCoVVersionMay132014.pdf">
         http://www.moh.gov.sa/en/Documents/MoHCaseDefinitionMERSCoVVersionMay132014.pdf
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR34">
       <label>
        34.
       </label>
       <mixed-citation publication-type="other">
        Infection prevention/control and management guidelines for patients with Middle East Respitaory Syndrome Coronavius (MERS-CoV) infection [
        <ext-link ext-link-type="uri" xlink:href="http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/Documents/GuidelinesforCoronaPatients.pdf">
         http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/Documents/GuidelinesforCoronaPatients.pdf
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR35">
       <label>
        35.
       </label>
       <mixed-citation publication-type="other">
        Infection Prevention and Control Guidelines for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection [
        <ext-link ext-link-type="uri" xlink:href="http://www.gdipc.org/mers-cov.html">
         http://www.gdipc.org/mers-cov.html
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR36">
       <label>
        36.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Thabet
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Chehab
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Bafaqih
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           AlMohaimeed
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in children
        </article-title>
        <source>
         Saudi Med J
        </source>
        <year>
         2015
        </year>
        <volume>
         36
        </volume>
        <fpage>
         484
        </fpage>
        <lpage>
         486
        </lpage>
        <pub-id pub-id-type="doi">
         10.15537/smj.2015.4.10243
        </pub-id>
        <pub-id pub-id-type="pmid">
         25828287
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR37">
       <label>
        37.
       </label>
       <mixed-citation publication-type="other">
        Al-Hameed F, Wahla AS, Siddiqui S, Ghabashi A, Al-Shomrani M, Al-Thaqafi A, et al. Characteristics and Outcomes of Middle East Respiratory Syndrome Coronavirus Patients Admitted to an Intensive Care Unit in Jeddah, Saudi Arabia. J Intensive Care Med. 2015. [epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="CR38">
       <label>
        38.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alraddadi
          </surname>
          <given-names>
           BM
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           JT
          </given-names>
         </name>
         <name>
          <surname>
           Almarashi
          </surname>
          <given-names>
           GRA
          </given-names>
         </name>
         <name>
          <surname>
           Turkistani
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Sadran
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Housa
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2016
        </year>
        <volume>
         22
        </volume>
        <fpage>
         1
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2201.151340
        </pub-id>
        <pub-id pub-id-type="pmid">
         26694983
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR39">
       <label>
        39.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cowling
          </surname>
          <given-names>
           BJ
          </given-names>
         </name>
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Fang
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           GM
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           JT
          </given-names>
         </name>
        </person-group>
        <article-title>
         Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        <volume>
         20
        </volume>
        <issue>
         25
        </issue>
        <fpage>
         2
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2015.20.25.21163
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR40">
       <label>
        40.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Majumder
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         <name>
          <surname>
           Kluberg
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Mekaru
          </surname>
          <given-names>
           SR
          </given-names>
         </name>
         <name>
          <surname>
           Brownstein
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Mortality Risk Factors for Middle East Respiratory Syndrome Outbreak, South Korea, 2015
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         11
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2111.151231
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR41">
       <label>
        41.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arabi
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
         <name>
          <surname>
           Arifi
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Balkhy
          </surname>
          <given-names>
           HH
          </given-names>
         </name>
         <name>
          <surname>
           Najm
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Aldawood
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         <name>
          <surname>
           Ghabashi
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
        </article-title>
        <source>
         Ann Intern Med
        </source>
        <year>
         2014
        </year>
        <volume>
         160
        </volume>
        <fpage>
         389
        </fpage>
        <lpage>
         397
        </lpage>
        <pub-id pub-id-type="doi">
         10.7326/M13-2486
        </pub-id>
        <pub-id pub-id-type="pmid">
         24474051
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR42">
       <label>
        42.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mizumoto
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Saitoh
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Chowell
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Miyamatsu
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Nishiura
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        <article-title>
         Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         39
        </volume>
        <fpage>
         7
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ijid.2015.08.005
        </pub-id>
        <pub-id pub-id-type="pmid">
         26275845
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR43">
       <label>
        43.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Invited Editorial: MERS-CoV An Emerging Viral Zoonotic Disease: Three Years After and Counting
        </article-title>
        <source>
         Recent Pat Antiinfect Drug Discov
        </source>
        <year>
         2014
        </year>
        <volume>
         9
        </volume>
        <fpage>
         159
        </fpage>
        <lpage>
         160
        </lpage>
        <pub-id pub-id-type="doi">
         10.2174/1574891X10666150408155131
        </pub-id>
        <pub-id pub-id-type="pmid">
         25851253
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR44">
       <label>
        44.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           AlRabiah
          </surname>
          <given-names>
           FA
          </given-names>
         </name>
         <name>
          <surname>
           Hajjar
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome Coronavirus Disease in Children
        </article-title>
        <source>
         PediatrInfect Dis J
        </source>
        <year>
         2014
        </year>
        <volume>
         33
        </volume>
        <issue>
         9
        </issue>
        <fpage>
         904
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="doi">
         10.1097/INF.0000000000000325
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR45">
       <label>
        45.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khuri-Bulos
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Faouri
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012
        </article-title>
        <source>
         Clin MicrobiolInfect
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         678
        </fpage>
        <lpage>
         82
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR46">
       <label>
        46.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
         <name>
          <surname>
           Iblan
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Al
          </surname>
          <given-names>
           NM
          </given-names>
         </name>
         <name>
          <surname>
           Rha
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Tohme
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus
        </article-title>
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         209
        </volume>
        <issue>
         12
        </issue>
        <fpage>
         1870
        </fpage>
        <lpage>
         2
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/infdis/jiu068
        </pub-id>
        <pub-id pub-id-type="pmid">
         24474813
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR47">
       <label>
        47.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Bleicker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Landt
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         <name>
          <surname>
           Eschbach-Bludau
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
        </article-title>
        <source>
         EuroSurveill
        </source>
        <year>
         2012
        </year>
        <volume>
         17
        </volume>
        <fpage>
         39
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR48">
       <label>
        48.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Costabel
          </surname>
          <given-names>
           U
          </given-names>
         </name>
         <name>
          <surname>
           Timm
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Binger
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
        </article-title>
        <source>
         EuroSurveill
        </source>
        <year>
         2012
        </year>
        <volume>
         17
        </volume>
        <issue>
         49
        </issue>
        <fpage>
         1
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR49">
       <label>
        49.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Al-Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Farah
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <year>
         2015
        </year>
        <volume>
         53
        </volume>
        <fpage>
         2951
        </fpage>
        <lpage>
         2955
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JCM.01368-15
        </pub-id>
        <pub-id pub-id-type="pmid">
         26157150
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR50">
       <label>
        50.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corless
          </surname>
          <given-names>
           CE
          </given-names>
         </name>
         <name>
          <surname>
           Guiver
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Borrow
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Edwards-Jones
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <name>
          <surname>
           Fox
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         <name>
          <surname>
           Kaczmarski
          </surname>
          <given-names>
           EB
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Development and evaluation of a 'real-time' RT-PCR for the detection of enterovirus and parechovirus RNA in CSF and throat swab samples
        </article-title>
        <source>
         J Med Virol
        </source>
        <year>
         2002
        </year>
        <volume>
         67
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         555
        </fpage>
        <lpage>
         562
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.10138
        </pub-id>
        <pub-id pub-id-type="pmid">
         12116004
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR51">
       <label>
        51.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS: emergence of a novel human coronavirus
        </article-title>
        <source>
         Curr Opin Virol
        </source>
        <year>
         2014
        </year>
        <volume>
         5C
        </volume>
        <fpage>
         58
        </fpage>
        <lpage>
         62
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.coviro.2014.01.010
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR52">
       <label>
        52.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           de Graaf
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Lauber
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans
        </article-title>
        <source>
         MBio
        </source>
        <year>
         2012
        </year>
        <volume>
         3
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         e00472
        </fpage>
        <lpage>
         12
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR53">
       <label>
        53.
       </label>
       <mixed-citation publication-type="other">
        Laboratory testing for Middle East Respiratory Syndrome Coronavirus | Interim guidance. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en/">
         http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR54">
       <label>
        54.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Olschlager
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Wendtner
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
         <name>
          <surname>
           Drexler
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
         <name>
          <surname>
           Hess
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA
        </article-title>
        <source>
         J Clin Virol
        </source>
        <year>
         2014
        </year>
        <volume>
         60
        </volume>
        <fpage>
         168
        </fpage>
        <lpage>
         171
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jcv.2014.03.012
        </pub-id>
        <pub-id pub-id-type="pmid">
         24726679
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR55">
       <label>
        55.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Whitaker
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Sakthivel
          </surname>
          <given-names>
           SK
          </given-names>
         </name>
         <name>
          <surname>
           Kamili
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Rose
          </surname>
          <given-names>
           LE
          </given-names>
         </name>
         <name>
          <surname>
           Lowe
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <year>
         2014
        </year>
        <volume>
         52
        </volume>
        <fpage>
         67
        </fpage>
        <lpage>
         75
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JCM.02533-13
        </pub-id>
        <pub-id pub-id-type="pmid">
         24153118
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR56">
       <label>
        56.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shahkarami
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Yen
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Glaser
          </surname>
          <given-names>
           CA
          </given-names>
         </name>
         <name>
          <surname>
           Xia
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Watt
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Wadford
          </surname>
          <given-names>
           DA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Laboratory Testing for Middle East Respiratory Syndrome Coronavirus, California, USA, 2013–2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1664
        </fpage>
        <lpage>
         1666
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2109.150476
        </pub-id>
        <pub-id pub-id-type="pmid">
         26291839
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR57">
       <label>
        57.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
         <name>
          <surname>
           Choi
          </surname>
          <given-names>
           GK
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           AK
          </given-names>
         </name>
         <name>
          <surname>
           Tee
          </surname>
          <given-names>
           KM
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           HY
          </given-names>
         </name>
         <name>
          <surname>
           Yip
          </surname>
          <given-names>
           CC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <year>
         2015
        </year>
        <volume>
         53
        </volume>
        <fpage>
         2722
        </fpage>
        <lpage>
         2726
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JCM.01224-15
        </pub-id>
        <pub-id pub-id-type="pmid">
         26019210
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR58">
       <label>
        58.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bhadra
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           YS
          </given-names>
         </name>
         <name>
          <surname>
           Kumar
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         <name>
          <surname>
           Johnson
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         <name>
          <surname>
           Hensley
          </surname>
          <given-names>
           LE
          </given-names>
         </name>
         <name>
          <surname>
           Ellington
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
        </person-group>
        <article-title>
         Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)
        </article-title>
        <source>
         PLoS One
        </source>
        <year>
         2015
        </year>
        <volume>
         10
        </volume>
        <fpage>
         e0123126
        </fpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pone.0123126
        </pub-id>
        <pub-id pub-id-type="pmid">
         25856093
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR59">
       <label>
        59.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Hughes
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Bhadra
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           YS
          </given-names>
         </name>
         <name>
          <surname>
           Ellington
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           B
          </given-names>
         </name>
        </person-group>
        <article-title>
         A Sweet Spot for Molecular Diagnostics: Coupling Isothermal Amplification and Strand Exchange Circuits to Glucometers
        </article-title>
        <source>
         Sci Rep
        </source>
        <year>
         2015
        </year>
        <volume>
         5
        </volume>
        <fpage>
         11039
        </fpage>
        <pub-id pub-id-type="doi">
         10.1038/srep11039
        </pub-id>
        <pub-id pub-id-type="pmid">
         26050646
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR60">
       <label>
        60.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abd El Wahed
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Patel
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Heidenreich
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Hufert
          </surname>
          <given-names>
           FT
          </given-names>
         </name>
         <name>
          <surname>
           Weidmann
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         PLoS Curr
        </source>
        <year>
         2013
        </year>
        <volume>
         5
        </volume>
        <fpage>
         12
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR61">
       <label>
        61.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Ha
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Serhan
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Eltahir
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Yusof
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Hashem
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Development and validation of a rapid immunochromatographic assay for detection of Middle East respiratory syndrome coronavirus antigen in dromedary camels
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <year>
         2015
        </year>
        <volume>
         53
        </volume>
        <fpage>
         1178
        </fpage>
        <lpage>
         1182
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JCM.03096-14
        </pub-id>
        <pub-id pub-id-type="pmid">
         25631809
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR62">
       <label>
        62.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           K-H
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Luk
          </surname>
          <given-names>
           HKH
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           RWS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         Emerg Microbes Infect
        </source>
        <year>
         2015
        </year>
        <volume>
         4
        </volume>
        <fpage>
         e26
        </fpage>
        <pub-id pub-id-type="doi">
         10.1038/emi.2015.26
        </pub-id>
        <pub-id pub-id-type="pmid">
         26421268
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR63">
       <label>
        63.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Puzelli
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Azzi
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Santini
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         <name>
          <surname>
           Di
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Facchini
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Castrucci
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013
        </article-title>
        <source>
         EuroSurveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <issue>
         34
        </issue>
        <fpage>
         1
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2013.18.34.20564
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR64">
       <label>
        64.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Serological assays for emerging coronaviruses: Challenges and pitfalls
        </article-title>
        <source>
         Virus Res
        </source>
        <year>
         2014
        </year>
        <volume>
         194
        </volume>
        <fpage>
         175
        </fpage>
        <lpage>
         83
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virusres.2014.03.018
        </pub-id>
        <pub-id pub-id-type="pmid">
         24670324
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR65">
       <label>
        65.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus Immunoassays. [
        <ext-link ext-link-type="uri" xlink:href="http://www.komabiotech.co.kr/www/product/productdesc.phtml?seq=783">
         http://www.komabiotech.co.kr/www/product/productdesc.phtml?seq=783
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR66">
       <label>
        66.
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          AGf EML
         </collab>
        </person-group>
        <source>
         Test Characteristics: Anti-MERS-CoV ELISA Camel (IgG)
        </source>
        <year>
         2014
        </year>
       </element-citation>
      </ref>
      <ref id="CR67">
       <label>
        67.
       </label>
       <mixed-citation publication-type="other">
        Recombivirus Anti-Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA kits. [
        <ext-link ext-link-type="uri" xlink:href="http://www.4adi.com/commerce/catalog/srhkeyword.cz;jsessionid=A9E3E77486C7EFF9A31C3FD5C0EBE654">
         http://www.4adi.com/commerce/catalog/srhkeyword.cz;jsessionid=A9E3E77486C7EFF9A31C3FD5C0EBE654
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR68">
       <label>
        68.
       </label>
       <mixed-citation publication-type="other">
        MERS-CoV (NCoV / Novel coronavirus) Nucleocapsid Antibody, Mouse MAb. [
        <ext-link ext-link-type="uri" xlink:href="http://www.sinobiological.com/Anti-Novel-coronavirus-HCoV-EMC-2012-Nucleocapsid-Antibody-g-17613.html">
         http://www.sinobiological.com/Anti-Novel-coronavirus-HCoV-EMC-2012-Nucleocapsid-Antibody-g-17613.html
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR69">
       <label>
        69.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Is MERS another SARS?
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         13
        </volume>
        <fpage>
         727
        </fpage>
        <lpage>
         728
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(13)70159-2
        </pub-id>
        <pub-id pub-id-type="pmid">
         23891403
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR70">
       <label>
        70.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aburizaiza
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         <name>
          <surname>
           Mattes
          </surname>
          <given-names>
           FM
          </given-names>
         </name>
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
         <name>
          <surname>
           Hassan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012
        </article-title>
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         209
        </volume>
        <fpage>
         243
        </fpage>
        <lpage>
         246
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/infdis/jit589
        </pub-id>
        <pub-id pub-id-type="pmid">
         24218504
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR71">
       <label>
        71.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           KH
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
         <name>
          <surname>
           Tse
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           CC
          </given-names>
         </name>
         <name>
          <surname>
           Cai
          </surname>
          <given-names>
           JP
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
        </article-title>
        <source>
         J Infect
        </source>
        <year>
         2013
        </year>
        <volume>
         67
        </volume>
        <fpage>
         130
        </fpage>
        <lpage>
         140
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jinf.2013.03.015
        </pub-id>
        <pub-id pub-id-type="pmid">
         23583636
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR72">
       <label>
        72.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al Hammadi
          </surname>
          <given-names>
           ZM
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
         <name>
          <surname>
           Eltahir
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
         <name>
          <surname>
           Al Hosani
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Al Mulla
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Tarnini
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Camels Imported from Oman to United Arab Emirates, May 2015
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         12
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2112.151132
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR73">
       <label>
        73.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reuss
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Litterst
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Seilmaier
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Bohmer
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Graf
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Contact investigation for imported case of Middle East respiratory syndrome, Germany
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         620
        </fpage>
        <lpage>
         625
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2004.131375
        </pub-id>
        <pub-id pub-id-type="pmid">
         24655721
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR74">
       <label>
        74.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Gomaa
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         <name>
          <surname>
           El-Shesheny
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Kandeil
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Bagato
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         ii
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2013.18.36.20574
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR75">
       <label>
        75.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           VK
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
        </article-title>
        <source>
         Virol J
        </source>
        <year>
         2013
        </year>
        <volume>
         10
        </volume>
        <fpage>
         266
        </fpage>
        <pub-id pub-id-type="doi">
         10.1186/1743-422X-10-266
        </pub-id>
        <pub-id pub-id-type="pmid">
         23978242
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR76">
       <label>
        76.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Alhammadi
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Siu
          </surname>
          <given-names>
           LY
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         20659
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2013.18.50.20659
        </pub-id>
        <pub-id pub-id-type="pmid">
         24342517
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR77">
       <label>
        77.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LLM
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
         <name>
          <surname>
           Alhammadi
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           HY
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         MERS Coronavirus in dromedary camel herd, Saudi Arabia
        </article-title>
        <source>
         Emerg Inf Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         7
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2007.140571
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR78">
       <label>
        78.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Ababneh
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Eljarah
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Abutarbush
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         20662
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2013.18.50.20662
        </pub-id>
        <pub-id pub-id-type="pmid">
         24342516
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR79">
       <label>
        79.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gierer
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Hofmann-Winkler
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Albuali
          </surname>
          <given-names>
           WH
          </given-names>
         </name>
         <name>
          <surname>
           Bertram
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rubaish
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Yousef
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         19
        </volume>
        <fpage>
         2034
        </fpage>
        <lpage>
         2036
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1912.130701
        </pub-id>
        <pub-id pub-id-type="pmid">
         24274664
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR80">
       <label>
        80.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Alsahly
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Masri
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Heil
          </surname>
          <given-names>
           GL
          </given-names>
         </name>
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           BD
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012
        </article-title>
        <source>
         Influenza Other Respir Viruses
        </source>
        <year>
         2015
        </year>
        <volume>
         9
        </volume>
        <fpage>
         64
        </fpage>
        <lpage>
         67
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/irv.12287
        </pub-id>
        <pub-id pub-id-type="pmid">
         25470665
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR81">
       <label>
        81.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
         <name>
          <surname>
           Choe
          </surname>
          <given-names>
           PG
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           EHY
          </given-names>
         </name>
         <name>
          <surname>
           Choi
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <name>
          <surname>
           Chun
          </surname>
          <given-names>
           JY
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         12
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2112.151421
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR82">
       <label>
        82.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Abdallat
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Rha
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Tohme
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         <name>
          <surname>
           Abedi
          </surname>
          <given-names>
           GR
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Hospital-associated outbreak of Middle East Respiratory Syndrome Coronavirus: A serologic, epidemiologic, and clinical description
        </article-title>
        <source>
         ClinInfect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         59
        </volume>
        <issue>
         9
        </issue>
        <fpage>
         1225
        </fpage>
        <lpage>
         33
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR83">
       <label>
        83.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hijawi
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Abdallat
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Sayaydeh
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Haddadin
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Jaarour
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation
        </article-title>
        <source>
         East Mediterr Health J
        </source>
        <year>
         2013
        </year>
        <volume>
         19
        </volume>
        <issue>
         Suppl 1
        </issue>
        <fpage>
         S12
        </fpage>
        <lpage>
         S18
        </lpage>
        <pub-id pub-id-type="pmid">
         23888790
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR84">
       <label>
        84.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Mou
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <name>
          <surname>
           van der HL
          </surname>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Specific serology for emerging human coronaviruses by protein microarray
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         20441
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2013.18.14.20441
        </pub-id>
        <pub-id pub-id-type="pmid">
         23594517
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR85">
       <label>
        85.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Gutierrez
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         13
        </volume>
        <fpage>
         859
        </fpage>
        <lpage>
         866
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(13)70164-6
        </pub-id>
        <pub-id pub-id-type="pmid">
         23933067
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR86">
       <label>
        86.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Ritz
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         552
        </fpage>
        <lpage>
         559
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2004.131746
        </pub-id>
        <pub-id pub-id-type="pmid">
         24655412
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR87">
       <label>
        87.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Al-Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Turkestani
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Ritz
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         15
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         559
        </fpage>
        <lpage>
         564
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(15)70090-3
        </pub-id>
        <pub-id pub-id-type="pmid">
         25863564
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR88">
       <label>
        88.
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          Centers for Disease Control and Prevention
         </collab>
        </person-group>
        <source>
         CDC concludes Indiana MERS patient did not spread virus to Illinois business associate
        </source>
        <year>
         2014
        </year>
       </element-citation>
      </ref>
      <ref id="CR89">
       <label>
        89.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sampathkumar
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome: what clinicians need to know
        </article-title>
        <source>
         Mayo Clin Proc
        </source>
        <year>
         2014
        </year>
        <volume>
         89
        </volume>
        <fpage>
         1153
        </fpage>
        <lpage>
         1158
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.mayocp.2014.06.008
        </pub-id>
        <pub-id pub-id-type="pmid">
         25034307
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR90">
       <label>
        90.
       </label>
       <mixed-citation publication-type="other">
        Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Version 2.1 [
        <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html">
         http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR91">
       <label>
        91.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Da Guan
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Mok
          </surname>
          <given-names>
           CK
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           ZL
          </given-names>
         </name>
         <name>
          <surname>
           Feng
          </surname>
          <given-names>
           LQ
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           ZT
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           JC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         2278
        </fpage>
        <lpage>
         2280
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2112.151232
        </pub-id>
        <pub-id pub-id-type="pmid">
         26583433
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR92">
       <label>
        92.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Faure
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Goffard
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Fournier
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Kipnis
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Titecat
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?
        </article-title>
        <source>
         PLoS One
        </source>
        <year>
         2014
        </year>
        <volume>
         9
        </volume>
        <fpage>
         e88716
        </fpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pone.0088716
        </pub-id>
        <pub-id pub-id-type="pmid">
         24551142
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR93">
       <label>
        93.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         <name>
          <surname>
           Matin
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Haddad
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         <name>
          <surname>
           Al-Nakhli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        <article-title>
         A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         17
        </volume>
        <fpage>
         e668
        </fpage>
        <lpage>
         e672
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ijid.2013.07.001
        </pub-id>
        <pub-id pub-id-type="pmid">
         23916548
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR94">
       <label>
        94.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Feikin
          </surname>
          <given-names>
           DR
          </given-names>
         </name>
         <name>
          <surname>
           Alraddadi
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Qutub
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Shabouni
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         <name>
          <surname>
           Curns
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Oboho
          </surname>
          <given-names>
           IK
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         11
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2111.150764
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR95">
       <label>
        95.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           HB
          </given-names>
         </name>
        </person-group>
        <article-title>
         An Appropriate Lower Respiratory Tract Specimen Is Essential for Diagnosis of Middle East Respiratory Syndrome (MERS)
        </article-title>
        <source>
         J Korean Med Sci
        </source>
        <year>
         2015
        </year>
        <volume>
         30
        </volume>
        <fpage>
         1207
        </fpage>
        <lpage>
         1208
        </lpage>
        <pub-id pub-id-type="doi">
         10.3346/jkms.2015.30.8.1207
        </pub-id>
        <pub-id pub-id-type="pmid">
         26240502
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR96">
       <label>
        96.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Belhouchat
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Drali
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Benkouiten
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Nougairede
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms
        </article-title>
        <source>
         Clin Microbiol Infect
        </source>
        <year>
         2013
        </year>
        <volume>
         19
        </volume>
        <fpage>
         E315
        </fpage>
        <lpage>
         E317
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/1469-0691.12174
        </pub-id>
        <pub-id pub-id-type="pmid">
         23452263
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR97">
       <label>
        97.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <collab>
          Health Protection Agency UKNCIT
         </collab>
        </person-group>
        <article-title>
         Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         20427
        </fpage>
        <pub-id pub-id-type="pmid">
         23517868
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR98">
       <label>
        98.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Almasri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         <name>
          <surname>
           Turkestani
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Al Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Prevalence of MERS-CoV Nasal Carriage and Compliance With the Saudi Health Recommendations Among Pilgrims Attending the 2013 Hajj
        </article-title>
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         210
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         1067
        </fpage>
        <lpage>
         72
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/infdis/jiu150
        </pub-id>
        <pub-id pub-id-type="pmid">
         24620019
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR99">
       <label>
        99.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Gethamy
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         60
        </volume>
        <fpage>
         973
        </fpage>
        <lpage>
         974
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/cid/ciu1135
        </pub-id>
        <pub-id pub-id-type="pmid">
         25516193
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR100">
       <label>
        100.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         <name>
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Feldmann
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Brining
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques
        </article-title>
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2013
        </year>
        <volume>
         110
        </volume>
        <fpage>
         16598
        </fpage>
        <lpage>
         16603
        </lpage>
        <pub-id pub-id-type="doi">
         10.1073/pnas.1310744110
        </pub-id>
        <pub-id pub-id-type="pmid">
         24062443
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR101">
       <label>
        101.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Spanakis
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Pontikis
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Koutsoukou
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
        </article-title>
        <source>
         Int J Antimicrob Agents
        </source>
        <year>
         2014
        </year>
        <volume>
         44
        </volume>
        <fpage>
         528
        </fpage>
        <lpage>
         532
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ijantimicag.2014.07.026
        </pub-id>
        <pub-id pub-id-type="pmid">
         25288266
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR102">
       <label>
        102.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications
        </article-title>
        <source>
         IntJ Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         29
        </volume>
        <fpage>
         307
        </fpage>
        <lpage>
         308
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ijid.2014.10.002
        </pub-id>
        <pub-id pub-id-type="pmid">
         25448335
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR103">
       <label>
        103.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Respiratory Tract Samples, Viral Load and Genome Fraction Yield in patients with Middle East Respiratory Syndrome
        </article-title>
        <source>
         J Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         210
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         1590
        </fpage>
        <lpage>
         4
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/infdis/jiu292
        </pub-id>
        <pub-id pub-id-type="pmid">
         24837403
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR104">
       <label>
        104.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Momattin
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Dib
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
        </article-title>
        <source>
         IntJ Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         42
        </fpage>
        <lpage>
         46
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ijid.2013.12.003
        </pub-id>
        <pub-id pub-id-type="pmid">
         24406736
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR105">
       <label>
        105.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Devi
          </surname>
          <given-names>
           JP
          </given-names>
         </name>
         <name>
          <surname>
           Noraini
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Norhayati
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Kheong
          </surname>
          <given-names>
           CC
          </given-names>
         </name>
         <name>
          <surname>
           Badrul
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         <name>
          <surname>
           Zainah
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: Preparedness and response, April 2014
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        <volume>
         19
        </volume>
        <fpage>
         20797
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2014.19.18.20797
        </pub-id>
        <pub-id pub-id-type="pmid">
         24832116
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR106">
       <label>
        106.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Baka
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Mentis
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Iliopoulos D, Dedoukou X, Papamavrou G, et al. A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014
        </article-title>
        <source>
         EuroSurveill
        </source>
        <year>
         2014
        </year>
        <volume>
         19
        </volume>
        <issue>
         16
        </issue>
        <fpage>
         20782
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2014.19.16.20782
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR107">
       <label>
        107.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barasheed
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         <name>
          <surname>
           Rashid
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Alfelali
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Tashani
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Azeem
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Bokhary
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Viral respiratory infections among Hajj pilgrims in 2013
        </article-title>
        <source>
         Virol Sin
        </source>
        <year>
         2014
        </year>
        <volume>
         29
        </volume>
        <fpage>
         364
        </fpage>
        <lpage>
         371
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s12250-014-3507-x
        </pub-id>
        <pub-id pub-id-type="pmid">
         25413828
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR108">
       <label>
        108.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aberle
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         <name>
          <surname>
           Popow-Kraupp
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Kreidl
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Laferl
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Heinz
          </surname>
          <given-names>
           FX
          </given-names>
         </name>
         <name>
          <surname>
           Aberle
          </surname>
          <given-names>
           SW
          </given-names>
         </name>
        </person-group>
        <article-title>
         Influenza A and B Viruses but Not MERS-CoV in Hajj Pilgrims, Austria, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         726
        </fpage>
        <lpage>
         727
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2104.141745
        </pub-id>
        <pub-id pub-id-type="pmid">
         25811672
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR109">
       <label>
        109.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           German
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Olsha
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Kristjanson
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Marchand-Austin
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Peci
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Winter
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Acute Respiratory Infections in Travelers Returning from MERS-CoV-Affected Areas
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1654
        </fpage>
        <lpage>
         1656
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2109.150472
        </pub-id>
        <pub-id pub-id-type="pmid">
         26291541
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR110">
       <label>
        110.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alfelali
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Barasheed
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         <name>
          <surname>
           Tashani
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Azeem
          </surname>
          <given-names>
           MI
          </given-names>
         </name>
         <name>
          <surname>
           El Bashir
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data
        </article-title>
        <source>
         Vaccine
        </source>
        <year>
         2015
        </year>
        <volume>
         33
        </volume>
        <fpage>
         2562
        </fpage>
        <lpage>
         2569
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.vaccine.2015.04.006
        </pub-id>
        <pub-id pub-id-type="pmid">
         25887084
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR111">
       <label>
        111.
       </label>
       <mixed-citation publication-type="other">
        Soaring MERS Cases Cause Pandemic Jitters, but Causes Are Unclear. [
        <ext-link ext-link-type="uri" xlink:href="http://news.sciencemag.org/health/2014/04/soaring-mers-cases-cause-pandemic-jitters-causes-are-unclear">
         http://news.sciencemag.org/health/2014/04/soaring-mers-cases-cause-pandemic-jitters-causes-are-unclear
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR112">
       <label>
        112.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mackay
          </surname>
          <given-names>
           IM
          </given-names>
         </name>
         <name>
          <surname>
           Arden
          </surname>
          <given-names>
           KE
          </given-names>
         </name>
         <name>
          <surname>
           Speicher
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
         <name>
          <surname>
           O'Neill
          </surname>
          <given-names>
           NT
          </given-names>
         </name>
         <name>
          <surname>
           McErlean
          </surname>
          <given-names>
           PK
          </given-names>
         </name>
         <name>
          <surname>
           Greer
          </surname>
          <given-names>
           RM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004
        </article-title>
        <source>
         Viruses
        </source>
        <year>
         2012
        </year>
        <volume>
         4
        </volume>
        <fpage>
         637
        </fpage>
        <lpage>
         653
        </lpage>
        <pub-id pub-id-type="doi">
         10.3390/v4040637
        </pub-id>
        <pub-id pub-id-type="pmid">
         22590689
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR113">
       <label>
        113.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Stephens
          </surname>
          <given-names>
           GM
          </given-names>
         </name>
         <name>
          <surname>
           Hewson
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recovery from severe novel coronavirus infection
        </article-title>
        <source>
         Saudi Med J
        </source>
        <year>
         2012
        </year>
        <volume>
         33
        </volume>
        <fpage>
         1265
        </fpage>
        <lpage>
         1269
        </lpage>
        <pub-id pub-id-type="pmid">
         23232672
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR114">
       <label>
        114.
       </label>
       <mixed-citation publication-type="other">
        NOVEL CORONAVIRUS - SAUDI ARABIA: HUMAN ISOLATE [
        <ext-link ext-link-type="uri" xlink:href="http://www.promedmail.org/direct.php?id=20120920.1302733">
         http://www.promedmail.org/direct.php?id=20120920.1302733
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR115">
       <label>
        115.
       </label>
       <mixed-citation publication-type="other">
        WHO statement on the Fifth Meeting of the IHR Emergency Committee concerning MERS-CoV | WHO Statement. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/news/statements/2014/mers-20140514/en/">
         http://www.who.int/mediacentre/news/statements/2014/mers-20140514/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR116">
       <label>
        116.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khalafalla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Al-Mubarak
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         <name>
          <surname>
           Dalab
          </surname>
          <given-names>
           AH
          </given-names>
         </name>
         <name>
          <surname>
           Al-Busadah
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           DD
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013–2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1153
        </fpage>
        <lpage>
         1158
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2107.150070
        </pub-id>
        <pub-id pub-id-type="pmid">
         26079346
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR117">
       <label>
        117.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
         <name>
          <surname>
           El-Kafrawy
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Farraj
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Hassan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Al-Saeed
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         <name>
          <surname>
           Hashem
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evidence for camel-to-human transmission of MERS coronavirus
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        <volume>
         370
        </volume>
        <fpage>
         2499
        </fpage>
        <lpage>
         2505
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1401505
        </pub-id>
        <pub-id pub-id-type="pmid">
         24896817
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR118">
       <label>
        118.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Penttinen
          </surname>
          <given-names>
           PM
          </given-names>
         </name>
         <name>
          <surname>
           Kaasik-Aaslav
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Friaux
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Donachie
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Sudre
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Mato-Gauci
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing?
        </article-title>
        <source>
         EuroSurveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <issue>
         39
        </issue>
        <fpage>
         3
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2013.18.39.20596
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR119">
       <label>
        119.
       </label>
       <mixed-citation publication-type="other">
        Gossner C, Danielson N, Gervelmeyer A, Berthe F, Faye B, Kaasik AK, et al. Human-Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection. Zoonoses Public Health. 2014. doi:10.1111/zph.12171. [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="CR120">
       <label>
        120.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus (MERS-CoV). Summary of Current Situation, Literature Update and Risk Assessment. 7 July 2015. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/risk-assessment-7july2015/en/">
         http://www.who.int/csr/disease/coronavirus_infections/risk-assessment-7july2015/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR121">
       <label>
        121.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Olival
          </surname>
          <given-names>
           KJ
          </given-names>
         </name>
         <name>
          <surname>
           Fagbo
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
         <name>
          <surname>
           Kapoor
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <name>
          <surname>
           Epstein
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in bats, Saudi Arabia
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         19
        </volume>
        <fpage>
         1819
        </fpage>
        <lpage>
         1823
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1911.131172
        </pub-id>
        <pub-id pub-id-type="pmid">
         24206838
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR122">
       <label>
        122.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shi
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
        </person-group>
        <article-title>
         Emerging infectious diseases associated with bat viruses
        </article-title>
        <source>
         Sci China Life Sci
        </source>
        <year>
         2013
        </year>
        <volume>
         56
        </volume>
        <fpage>
         678
        </fpage>
        <lpage>
         682
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s11427-013-4517-x
        </pub-id>
        <pub-id pub-id-type="pmid">
         23917838
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR123">
       <label>
        123.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           LF
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bats and their virome: an important source of emerging viruses capable of infecting humans
        </article-title>
        <source>
         Curr Opin Virol
        </source>
        <year>
         2013
        </year>
        <volume>
         3
        </volume>
        <fpage>
         84
        </fpage>
        <lpage>
         91
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.coviro.2012.11.006
        </pub-id>
        <pub-id pub-id-type="pmid">
         23265969
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR124">
       <label>
        124.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           PC
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SK
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           KY
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus diversity, phylogeny and interspecies jumping
        </article-title>
        <source>
         Exp Biol Med (Maywood)
        </source>
        <year>
         2009
        </year>
        <volume>
         234
        </volume>
        <fpage>
         1117
        </fpage>
        <lpage>
         1127
        </lpage>
        <pub-id pub-id-type="doi">
         10.3181/0903-MR-94
        </pub-id>
        <pub-id pub-id-type="pmid">
         19546349
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR125">
       <label>
        125.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Ithete
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
         <name>
          <surname>
           Richards
          </surname>
          <given-names>
           LR
          </given-names>
         </name>
         <name>
          <surname>
           Schoeman
          </surname>
          <given-names>
           MC
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat
        </article-title>
        <source>
         J Virol
        </source>
        <year>
         2014
        </year>
        <volume>
         88
        </volume>
        <fpage>
         11297
        </fpage>
        <lpage>
         11303
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.01498-14
        </pub-id>
        <pub-id pub-id-type="pmid">
         25031349
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR126">
       <label>
        126.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JFW
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
         <name>
          <surname>
           To
          </surname>
          <given-names>
           KKW
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           VCC
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           PCY
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K-Y
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
        </article-title>
        <source>
         Clin Microbiol Rev
        </source>
        <year>
         2015
        </year>
        <volume>
         28
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         465
        </fpage>
        <lpage>
         522
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/CMR.00102-14
        </pub-id>
        <pub-id pub-id-type="pmid">
         25810418
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR127">
       <label>
        127.
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Mukhtar
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Estimo
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        <source>
         Link between MERS virus and camels worries breeders
        </source>
        <year>
         2014
        </year>
       </element-citation>
      </ref>
      <ref id="CR128">
       <label>
        128.
       </label>
       <mixed-citation publication-type="other">
        Hemida MG, Elmoslemany A, Al-Hizab F, Alnaeem A, Almathen F, Faye B, et al. Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Transbound Emerg Dis. 2015. doi:10.1111/tbed.12401. [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="CR129">
       <label>
        129.
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sabiq
          </surname>
          <given-names>
           A-S
          </given-names>
         </name>
        </person-group>
        <article-title>
         FIQH us-SUNNAH
        </article-title>
        <source>
         FIQH us-SUNNAH
        </source>
        <year>
         1992
        </year>
        <publisher-loc>
         Indianapolis
        </publisher-loc>
        <publisher-name>
         American Trust Publishers
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="CR130">
       <label>
        130.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Jores
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Younan
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Liljander
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Said
          </surname>
          <given-names>
           MY
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Antibodies against MERS Coronavirus in Dromedary Camels,Kenya, 1992–2013
        </article-title>
        <source>
         Emerg Inf Dis.
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         8
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2008.140596
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR131">
       <label>
        131.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
         <name>
          <surname>
           Messadi
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Feyisa
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Ularamu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <name>
          <surname>
           Danmarwa
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Geographic distribution of MERS Coronavirus among dromedary camels, Africa
        </article-title>
        <source>
         Emerg Inf Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         8
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2008.140590
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR132">
       <label>
        132.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           EY
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           AK
          </given-names>
         </name>
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SK
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Acute middle East respiratory syndrome coronavirus infection in livestock Dromedaries, Dubai, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1019
        </fpage>
        <lpage>
         1022
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2106.150038
        </pub-id>
        <pub-id pub-id-type="pmid">
         25989145
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR133">
       <label>
        133.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Jores
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Younan
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Liljander
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983–1997
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         2093
        </fpage>
        <lpage>
         2095
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2012.141026
        </pub-id>
        <pub-id pub-id-type="pmid">
         25425139
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR134">
       <label>
        134.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Deem
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
         <name>
          <surname>
           Fevre
          </surname>
          <given-names>
           EM
          </given-names>
         </name>
         <name>
          <surname>
           Kinnaird
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Browne
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         <name>
          <surname>
           Muloi
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, Kenya
        </article-title>
        <source>
         PLoS One
        </source>
        <year>
         2015
        </year>
        <volume>
         10
        </volume>
        <fpage>
         e0140125
        </fpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pone.0140125
        </pub-id>
        <pub-id pub-id-type="pmid">
         26473733
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR135">
       <label>
        135.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alexandersen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Kobinger
          </surname>
          <given-names>
           GP
          </given-names>
         </name>
         <name>
          <surname>
           Soule
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005
        </article-title>
        <source>
         Transbound Emerg Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         61
        </volume>
        <fpage>
         105
        </fpage>
        <lpage>
         108
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/tbed.12212
        </pub-id>
        <pub-id pub-id-type="pmid">
         24456414
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR136">
       <label>
        136.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Garcia-Bocanegra
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Sieberg
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Serologic Assessment of Possibility for MERS-CoV Infection in Equids
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         181
        </fpage>
        <lpage>
         182
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2101.141342
        </pub-id>
        <pub-id pub-id-type="pmid">
         25531820
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR137">
       <label>
        137.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LLM
          </given-names>
         </name>
         <name>
          <surname>
           Gomaa
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         <name>
          <surname>
           Shehata
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           RAPM
          </given-names>
         </name>
         <name>
          <surname>
           Zeid
          </surname>
          <given-names>
           DA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         MERS coronaviruses in dromedary camels, Egypt
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         6
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2006.140299
        </pub-id>
        <pub-id pub-id-type="pmid">
         24377419
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR138">
       <label>
        138.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         <name>
          <surname>
           Al Dhahiry
          </surname>
          <given-names>
           SH
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Galiano
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Myers
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
        </article-title>
        <source>
         Lancet InfectDis
        </source>
        <year>
         2014
        </year>
        <volume>
         14
        </volume>
        <fpage>
         140
        </fpage>
        <lpage>
         145
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(13)70690-X
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR139">
       <label>
        139.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nowotny
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Kolodziejek
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        <volume>
         19
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         6
        </fpage>
        <pub-id pub-id-type="pmid">
         25138971
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR140">
       <label>
        140.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EABA
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
         <name>
          <surname>
           Lamers
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         <name>
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         <name>
          <surname>
           Voermans
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Isolation of MERS Coronavirus from a Dromedary Camel, Qatar, 2014
        </article-title>
        <source>
         Emerg Inf Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         8
        </fpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2008.140663
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR141">
       <label>
        141.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yusof
          </surname>
          <given-names>
           MF
          </given-names>
         </name>
         <name>
          <surname>
           Eltahir
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
         <name>
          <surname>
           Serhan
          </surname>
          <given-names>
           WS
          </given-names>
         </name>
         <name>
          <surname>
           Hashem
          </surname>
          <given-names>
           FM
          </given-names>
         </name>
         <name>
          <surname>
           Elsayed
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         <name>
          <surname>
           Marzoug
          </surname>
          <given-names>
           BA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates
        </article-title>
        <source>
         Virus Genes
        </source>
        <year>
         2015
        </year>
        <volume>
         50
        </volume>
        <fpage>
         509
        </fpage>
        <lpage>
         513
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s11262-015-1174-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         25653016
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR142">
       <label>
        142.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <name>
          <surname>
           Alsahafi
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         <name>
          <surname>
           Al Rabeeh
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
        </article-title>
        <source>
         Emerg Inf Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         1012
        </fpage>
        <lpage>
         1015
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2006.140402
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR143">
       <label>
        143.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
         <name>
          <surname>
           Hashem
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           El-Kafrawy
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Sohrab
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         <name>
          <surname>
           Aburizaiza
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         <name>
          <surname>
           Farraj
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2014
        </year>
        <volume>
         5
        </volume>
        <fpage>
         e01450
        </fpage>
        <lpage>
         01414
        </lpage>
        <pub-id pub-id-type="pmid">
         25053787
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR144">
       <label>
        144.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         <name>
          <surname>
           Mohran
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
         <name>
          <surname>
           Stalin Raj
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <name>
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014
        </article-title>
        <source>
         Infect Ecol Epidemiol
        </source>
        <year>
         2015
        </year>
        <volume>
         5
        </volume>
        <fpage>
         28305
        </fpage>
        <pub-id pub-id-type="pmid">
         26183160
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR145">
       <label>
        145.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Adney
          </surname>
          <given-names>
           DR
          </given-names>
         </name>
         <name>
          <surname>
           van DN
          </surname>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           VR
          </given-names>
         </name>
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Scott
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           de WE
          </surname>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         1999
        </fpage>
        <lpage>
         2005
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2012.141280
        </pub-id>
        <pub-id pub-id-type="pmid">
         25418529
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR146">
       <label>
        146.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Kellam
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence for camel-to-human transmission of MERS coronavirus
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        <volume>
         371
        </volume>
        <fpage>
         1359
        </fpage>
        <lpage>
         1360
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1405858
        </pub-id>
        <pub-id pub-id-type="pmid">
         25271615
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR147">
       <label>
        147.
       </label>
       <mixed-citation publication-type="other">
        The Holy Qur'an. [
        <ext-link ext-link-type="uri" xlink:href="http://mquran.org/content/view/2631/4/">
         http://mquran.org/content/view/2631/4/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR148">
       <label>
        148.
       </label>
       <mixed-citation publication-type="other">
        Sacrificing an animal at Mina. [
        <ext-link ext-link-type="uri" xlink:href="http://www.sistani.org/english/book/47/2108/">
         http://www.sistani.org/english/book/47/2108/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR149">
       <label>
        149.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         <name>
          <surname>
           Mohran
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013–2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1422
        </fpage>
        <lpage>
         1425
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2108.150481
        </pub-id>
        <pub-id pub-id-type="pmid">
         26196891
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR150">
       <label>
        150.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2013
        </year>
        <volume>
         18
        </volume>
        <fpage>
         38
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR151">
       <label>
        151.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         <name>
          <surname>
           Jonges
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <name>
          <surname>
           El-Sayed
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2014
        </year>
        <volume>
         19
        </volume>
        <fpage>
         23
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2014.19.23.20829
        </pub-id>
        <pub-id pub-id-type="pmid">
         25138973
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR152">
       <label>
        152.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           KH
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           SY
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           KY
          </given-names>
         </name>
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           WH
          </given-names>
         </name>
        </person-group>
        <article-title>
         The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus
        </article-title>
        <source>
         Adv Virol
        </source>
        <year>
         2011
        </year>
        <volume>
         2011
        </volume>
        <fpage>
         734690
        </fpage>
        <pub-id pub-id-type="doi">
         10.1155/2011/734690
        </pub-id>
        <pub-id pub-id-type="pmid">
         22312351
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR153">
       <label>
        153.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Knibbs
          </surname>
          <given-names>
           LD
          </given-names>
         </name>
         <name>
          <surname>
           Johnson
          </surname>
          <given-names>
           GR
          </given-names>
         </name>
         <name>
          <surname>
           Kidd
          </surname>
          <given-names>
           TJ
          </given-names>
         </name>
         <name>
          <surname>
           Cheney
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Grimwood
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Kattenbelt
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
        </article-title>
        <source>
         Thorax
        </source>
        <year>
         2014
        </year>
        <volume>
         69
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         740
        </fpage>
        <lpage>
         5
        </lpage>
        <pub-id pub-id-type="doi">
         10.1136/thoraxjnl-2014-205213
        </pub-id>
        <pub-id pub-id-type="pmid">
         24743559
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR154">
       <label>
        154.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution
        </article-title>
        <source>
         Trends Microbiol
        </source>
        <year>
         2014
        </year>
        <volume>
         22
        </volume>
        <fpage>
         573
        </fpage>
        <lpage>
         579
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.tim.2014.08.001
        </pub-id>
        <pub-id pub-id-type="pmid">
         25178651
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR155">
       <label>
        155.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup?
        </article-title>
        <source>
         Eur Respir J
        </source>
        <year>
         2014
        </year>
        <volume>
         43
        </volume>
        <fpage>
         1243
        </fpage>
        <lpage>
         1248
        </lpage>
        <pub-id pub-id-type="doi">
         10.1183/09031936.00227213
        </pub-id>
        <pub-id pub-id-type="pmid">
         24627533
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR156">
       <label>
        156.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           al MM
          </surname>
         </name>
         <name>
          <surname>
           Hajomar
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         An observational, laboratory-based study of outbreaks of MERS-coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         60
        </volume>
        <fpage>
         369
        </fpage>
        <lpage>
         377
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/cid/ciu812
        </pub-id>
        <pub-id pub-id-type="pmid">
         25323704
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR157">
       <label>
        157.
       </label>
       <mixed-citation publication-type="other">
        Assessment of the MERS-CoV epidemic situation in the Middle East region.
        <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1311.1481">
         http://arxiv.org/abs/1311.1481
        </ext-link>
       </mixed-citation>
      </ref>
      <ref id="CR158">
       <label>
        158.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bauch
          </surname>
          <given-names>
           CT
          </given-names>
         </name>
         <name>
          <surname>
           Oraby
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        <article-title>
         Assessing the pandemic potential of MERS-CoV
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2013
        </year>
        <volume>
         382
        </volume>
        <fpage>
         662
        </fpage>
        <lpage>
         664
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(13)61504-4
        </pub-id>
        <pub-id pub-id-type="pmid">
         23831143
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR159">
       <label>
        159.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Breban
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Riou
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Fontanet
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2013
        </year>
        <volume>
         382
        </volume>
        <fpage>
         694
        </fpage>
        <lpage>
         699
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(13)61492-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         23831141
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR160">
       <label>
        160.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cauchemez
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Fraser
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Van
          </surname>
          <given-names>
           KMD
          </given-names>
         </name>
         <name>
          <surname>
           Donnelly
          </surname>
          <given-names>
           CA
          </given-names>
         </name>
         <name>
          <surname>
           Riley
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Rambaut
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         14
        </volume>
        <fpage>
         50
        </fpage>
        <lpage>
         56
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(13)70304-9
        </pub-id>
        <pub-id pub-id-type="pmid">
         24239323
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR161">
       <label>
        161.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chowell
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Nishiura
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission dynamics and control of Ebola virus disease (EVD): a review
        </article-title>
        <source>
         BMC Med
        </source>
        <year>
         2014
        </year>
        <volume>
         12
        </volume>
        <fpage>
         196
        </fpage>
        <pub-id pub-id-type="doi">
         10.1186/s12916-014-0196-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         25300956
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR162">
       <label>
        162.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         <name>
          <surname>
           Tokars
          </surname>
          <given-names>
           JI
          </given-names>
         </name>
         <name>
          <surname>
           Badreddine
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           ZB
          </given-names>
         </name>
         <name>
          <surname>
           Furukawa
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <name>
          <surname>
           Al Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Health care worker contact with MERS patient, Saudi Arabia
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         2148
        </fpage>
        <lpage>
         2151
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2012.141211
        </pub-id>
        <pub-id pub-id-type="pmid">
         25418612
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR163">
       <label>
        163.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: epidemiology and disease control measures
        </article-title>
        <source>
         Infect Drug Resist
        </source>
        <year>
         2014
        </year>
        <volume>
         7
        </volume>
        <fpage>
         281
        </fpage>
        <lpage>
         287
        </lpage>
        <pub-id pub-id-type="pmid">
         25395865
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR164">
       <label>
        164.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dudley
          </surname>
          <given-names>
           JP
          </given-names>
         </name>
         <name>
          <surname>
           Mackay
          </surname>
          <given-names>
           IM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Age-specific and sex-specific morbidity and mortality from avian influenza A(H7N9)
        </article-title>
        <source>
         J Clin Virol
        </source>
        <year>
         2013
        </year>
        <volume>
         58
        </volume>
        <fpage>
         568
        </fpage>
        <lpage>
         570
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jcv.2013.09.004
        </pub-id>
        <pub-id pub-id-type="pmid">
         24091087
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR165">
       <label>
        165.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Oboho
          </surname>
          <given-names>
           IK
          </given-names>
         </name>
         <name>
          <surname>
           Tomczyk
          </surname>
          <given-names>
           SM
          </given-names>
         </name>
         <name>
          <surname>
           Al-Asmari
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Banjar
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Al-Mugti
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Aloraini
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         MERS-CoV outbreak in Jeddah--a link to health care facilities
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        <volume>
         2015
        </volume>
        <issue>
         372
        </issue>
        <fpage>
         846
        </fpage>
        <lpage>
         854
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR166">
       <label>
        166.
       </label>
       <mixed-citation publication-type="other">
        Infection prevention and control during health care for probable or confirmed cases of novel coronavirus (nCoV) infection. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/IPCnCoVguidance_06May13.pdf?ua=1">
         http://www.who.int/csr/disease/coronavirus_infections/IPCnCoVguidance_06May13.pdf?ua=1
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR167">
       <label>
        167.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           TT
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <name>
          <surname>
           Palser
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         <name>
          <surname>
           Petrova
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <name>
          <surname>
           Grant
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         19
        </volume>
        <fpage>
         736
        </fpage>
        <lpage>
         742B
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1905.130057
        </pub-id>
        <pub-id pub-id-type="pmid">
         23693015
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR168">
       <label>
        168.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <name>
          <surname>
           Kellam
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2013
        </year>
        <volume>
         382
        </volume>
        <fpage>
         1993
        </fpage>
        <lpage>
         2002
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(13)61887-5
        </pub-id>
        <pub-id pub-id-type="pmid">
         24055451
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR169">
       <label>
        169.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
         <name>
          <surname>
           Palser
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         <name>
          <surname>
           Ong
          </surname>
          <given-names>
           SH
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2014
        </year>
        <volume>
         5
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         e01062
        </fpage>
        <lpage>
         13
        </lpage>
        <pub-id pub-id-type="pmid">
         24549846
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR170">
       <label>
        170.
       </label>
       <mixed-citation publication-type="other">
        MERS-CoV recombination: implications about the reservoir and potential for adaptation. [
        <ext-link ext-link-type="uri" xlink:href="http://biorxiv.org/content/early/2015/06/12/020834">
         http://biorxiv.org/content/early/2015/06/12/020834
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR171">
       <label>
        171.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lipkin
          </surname>
          <given-names>
           WI
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome Coronavirus Recombination and the Evolution of Science and Public Health in China
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2015
        </year>
        <volume>
         6
        </volume>
        <fpage>
         e01381
        </fpage>
        <lpage>
         01315
        </lpage>
        <pub-id pub-id-type="pmid">
         26350973
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR172">
       <label>
        172.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Shi
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2015
        </year>
        <volume>
         6
        </volume>
        <fpage>
         e01280
        </fpage>
        <lpage>
         01215
        </lpage>
        <pub-id pub-id-type="pmid">
         26350969
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR173">
       <label>
        173.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kossyvakis
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Tao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Pogka
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Emmanouil
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Laboratory investigation and phylogenetic analysis of an imported Middle East respiratory syndrome coronavirus case in Greece
        </article-title>
        <source>
         PLoS One
        </source>
        <year>
         2015
        </year>
        <volume>
         10
        </volume>
        <fpage>
         e0125809
        </fpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pone.0125809
        </pub-id>
        <pub-id pub-id-type="pmid">
         25919137
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR174">
       <label>
        174.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Briese
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Jain
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Zalmout
          </surname>
          <given-names>
           IS
          </given-names>
         </name>
         <name>
          <surname>
           Jabado
          </surname>
          <given-names>
           OJ
          </given-names>
         </name>
         <name>
          <surname>
           Karesh
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia
        </article-title>
        <source>
         M Bio
        </source>
        <year>
         2014
        </year>
        <volume>
         5
        </volume>
        <fpage>
         e01146
        </fpage>
        <lpage>
         01114
        </lpage>
        <pub-id pub-id-type="pmid">
         24781747
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR175">
       <label>
        175.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <name>
          <surname>
           Kellam
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         23
        </volume>
        <fpage>
         63
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ijid.2014.03.1372
        </pub-id>
        <pub-id pub-id-type="pmid">
         24699184
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR176">
       <label>
        176.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update-as of 9 May 2014. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_09_May_2014.pdf?ua=1">
         http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_09_May_2014.pdf?ua=1
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR177">
       <label>
        177.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Smits
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         <name>
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           CBEM
          </given-names>
         </name>
         <name>
          <surname>
           Mohran
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           EABA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Reliable typing of MERS-CoV variants with a small genome fragment
        </article-title>
        <source>
         J Clin Virol
        </source>
        <year>
         2015
        </year>
        <volume>
         64
        </volume>
        <fpage>
         83
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jcv.2014.12.006
        </pub-id>
        <pub-id pub-id-type="pmid">
         25728084
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR178">
       <label>
        178.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           D-W
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           Y-J
          </given-names>
         </name>
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Yun
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           HJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015
        </article-title>
        <source>
         Emerg Infect Dis.
        </source>
        <year>
         2015
        </year>
        <volume>
         22
        </volume>
        <fpage>
         1
        </fpage>
        <pub-id pub-id-type="doi">
         10.1097/INF.0000000000000967
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR179">
       <label>
        179.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fagbo
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
         <name>
          <surname>
           Skakni
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
         <name>
          <surname>
           Garbati
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Joseph
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Molecular Epidemiology of Hospital Outbreak of Middle East
        </article-title>
        <source>
         Respiratory Syndrome, Riyadh, Saudi Arabia
        </source>
        <year>
         2014
        </year>
        <volume>
         21
        </volume>
        <fpage>
         11
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR180">
       <label>
        180.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus (MERS-CoV) in the Republic of Korea. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/news/situation-assessments/2-june-2015-south-korea/en/">
         http://www.who.int/mediacentre/news/situation-assessments/2-june-2015-south-korea/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR181">
       <label>
        181.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seong
          </surname>
          <given-names>
           MW
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           SY
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           TS
          </given-names>
         </name>
         <name>
          <surname>
           Cho
          </surname>
          <given-names>
           SI
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           MJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         22
        </volume>
        <fpage>
         2
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR182">
       <label>
        182.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bialek
          </surname>
          <given-names>
           SR
          </given-names>
         </name>
         <name>
          <surname>
           Allen
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           varado-Ramy
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Arthur
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Balajee
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Bell
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities - May 2014
        </article-title>
        <source>
         MMWR Morb Mortal Wkly Rep
        </source>
        <year>
         2014
        </year>
        <volume>
         63
        </volume>
        <fpage>
         431
        </fpage>
        <lpage>
         436
        </lpage>
        <pub-id pub-id-type="pmid">
         24827411
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR183">
       <label>
        183.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mollers
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Jonges
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         <name>
          <surname>
           van der Eijk
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         <name>
          <surname>
           Dirksen
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Jansen
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Follow-up of Contacts of Middle East Respiratory Syndrome Coronavirus-Infected Returning Travelers, the Netherlands, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         21
        </volume>
        <fpage>
         1667
        </fpage>
        <lpage>
         1669
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid2109.150560
        </pub-id>
        <pub-id pub-id-type="pmid">
         26291986
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR184">
       <label>
        184.
       </label>
       <mixed-citation publication-type="other">
        Press Release - WHO, Korea-WHO Joint Mission on MERS CoV. [
        <ext-link ext-link-type="uri" xlink:href="http://www.takeshima.or.jp/Government/Current-Affairs/Others/view?affairId=472&amp;subId=499&amp;articleId=15903">
         http://www.takeshima.or.jp/Government/Current-Affairs/Others/view?affairId=472&amp;subId=499&amp;articleId=15903
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR185">
       <label>
        185.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Call for infection control to stem MERS
        </article-title>
        <source>
         CMAJ
        </source>
        <year>
         2014
        </year>
        <volume>
         186
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         E349
        </fpage>
        <pub-id pub-id-type="doi">
         10.1503/cmaj.109-4806
        </pub-id>
        <pub-id pub-id-type="pmid">
         24847147
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR186">
       <label>
        186.
       </label>
       <mixed-citation publication-type="other">
        Zumla A, Hui DS. Infection control and MERS-CoV in health workers. Lancet.
       </mixed-citation>
      </ref>
      <ref id="CR187">
       <label>
        187.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Choi
          </surname>
          <given-names>
           JY
          </given-names>
         </name>
        </person-group>
        <article-title>
         An Outbreak of Middle East Respiratory Syndrome Coronavirus Infection in South Korea, 2015
        </article-title>
        <source>
         Yonsei Med J
        </source>
        <year>
         2015
        </year>
        <volume>
         56
        </volume>
        <fpage>
         1174
        </fpage>
        <lpage>
         1176
        </lpage>
        <pub-id pub-id-type="doi">
         10.3349/ymj.2015.56.5.1174
        </pub-id>
        <pub-id pub-id-type="pmid">
         26256957
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR188">
       <label>
        188.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus (MERS-CoV) – Republic of Korea. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/24-may-2015-mers-korea/en/">
         http://www.who.int/csr/don/24-may-2015-mers-korea/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR189">
       <label>
        189.
       </label>
       <mixed-citation publication-type="other">
        <ext-link ext-link-type="uri" xlink:href="http://english.yonhapnews.co.kr/national/2015/10/25/99/0302000000AEN20151025002300320F.html">
         http://english.yonhapnews.co.kr/national/2015/10/25/99/0302000000AEN20151025002300320F.html
        </ext-link>
        .
       </mixed-citation>
      </ref>
      <ref id="CR190">
       <label>
        190.
       </label>
       <mixed-citation publication-type="other">
        Samsung hospital to invest W100b in post-MERS improvements. [
        <ext-link ext-link-type="uri" xlink:href="http://www.koreaherald.com/view.php?ud=20150902001169">
         http://www.koreaherald.com/view.php?ud=20150902001169
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR191">
       <label>
        191.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jack
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Why the panic? South Korea's MERS response questioned
        </article-title>
        <source>
         BMJ
        </source>
        <year>
         2015
        </year>
        <volume>
         350
        </volume>
        <fpage>
         h3403
        </fpage>
        <pub-id pub-id-type="doi">
         10.1136/bmj.h3403
        </pub-id>
        <pub-id pub-id-type="pmid">
         26108610
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR192">
       <label>
        192.
       </label>
       <mixed-citation publication-type="other">
        Intensified public health measures help control MERS-CoV outbreak in the Republic of Korea. [
        <ext-link ext-link-type="uri" xlink:href="http://www.wpro.who.int/mediacentre/releases/2015/20150728/en/">
         http://www.wpro.who.int/mediacentre/releases/2015/20150728/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR193">
       <label>
        193.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Butler
          </surname>
          <given-names>
           D
          </given-names>
         </name>
        </person-group>
        <article-title>
         South Korean MERS outbreak spotlights lack of research
        </article-title>
        <source>
         Nature
        </source>
        <year>
         2015
        </year>
        <volume>
         522
        </volume>
        <fpage>
         139
        </fpage>
        <lpage>
         140
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/522139a
        </pub-id>
        <pub-id pub-id-type="pmid">
         26062490
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR194">
       <label>
        194.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           YJ
          </given-names>
         </name>
         <name>
          <surname>
           Cho
          </surname>
          <given-names>
           YJ
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           DW
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus KOR/KNIH/002_05_2015, Isolated in South Korea
        </article-title>
        <source>
         Genome Announc
        </source>
        <year>
         2015
        </year>
        <volume>
         3
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         e00787
        </fpage>
        <lpage>
         15
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/genomeA.00787-15
        </pub-id>
        <pub-id pub-id-type="pmid">
         26272558
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR195">
       <label>
        195.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Nie
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Su
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from the First Imported MERS-CoV Case in China
        </article-title>
        <source>
         Genome Announc
        </source>
        <year>
         2015
        </year>
        <volume>
         3
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         e00818
        </fpage>
        <lpage>
         15
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/genomeA.00818-15
        </pub-id>
        <pub-id pub-id-type="pmid">
         26272560
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR196">
       <label>
        196.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cho
          </surname>
          <given-names>
           SI
          </given-names>
         </name>
        </person-group>
        <article-title>
         Urgent Call for Research on Middle East Respiratory Syndrome (MERS) in Korea
        </article-title>
        <source>
         J Prev Med Public Health
        </source>
        <year>
         2015
        </year>
        <volume>
         48
        </volume>
        <fpage>
         179
        </fpage>
        <pub-id pub-id-type="doi">
         10.3961/jpmph.15.047
        </pub-id>
        <pub-id pub-id-type="pmid">
         26265662
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR197">
       <label>
        197.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           PL
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome (MERS) in Asia: lessons gleaned from the South Korean outbreak
        </article-title>
        <source>
         Trans R Soc Trop Med Hyg
        </source>
        <year>
         2015
        </year>
        <volume>
         109
        </volume>
        <fpage>
         541
        </fpage>
        <lpage>
         542
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/trstmh/trv064
        </pub-id>
        <pub-id pub-id-type="pmid">
         26286944
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR198">
       <label>
        198.
       </label>
       <mixed-citation publication-type="other">
        No Respite for Korean Economy Even as MERS Patients Recover. [
        <ext-link ext-link-type="uri" xlink:href="http://www.bloomberg.com/news/articles/2015-07-22/no-respite-yet-for-korean-economy-even-as-mers-patients-recover">
         http://www.bloomberg.com/news/articles/2015-07-22/no-respite-yet-for-korean-economy-even-as-mers-patients-recover
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR199">
       <label>
        199.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus (MERS-CoV) – China. [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/30-may-2015-mers-china/en/">
         http://www.who.int/csr/don/30-may-2015-mers-china/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR200">
       <label>
        200.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Su
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Gao
          </surname>
          <given-names>
           GF
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Bi
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS in South Korea and China: a potential outbreak threat?
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2015
        </year>
        <volume>
         385
        </volume>
        <fpage>
         2349
        </fpage>
        <lpage>
         2350
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(15)60859-5
        </pub-id>
        <pub-id pub-id-type="pmid">
         26088634
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR201">
       <label>
        201.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nishiura
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Miyamatsu
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Mizumoto
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        <article-title>
         Objective Determination of End of MERS Outbreak, South Korea, 2015
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2015
        </year>
        <volume>
         22
        </volume>
        <fpage>
         1
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR202">
       <label>
        202.
       </label>
       <mixed-citation publication-type="other">
        Updates on MERS Outbreak (as of 6:00 on July 23). [
        <ext-link ext-link-type="uri" xlink:href="http://english.mw.go.kr/front_eng/sg/ssg0111vw.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100111&amp;page=4&amp;CONT_SEQ=324451">
         http://english.mw.go.kr/front_eng/sg/ssg0111vw.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100111&amp;page=4&amp;CONT_SEQ=324451
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR203">
       <label>
        203.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bae
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Surveillance operation for the 141st confirmed case of Middle East Respiratory Syndrome coronavirus in response to the patient's prior travel to Jeju Island
        </article-title>
        <source>
         Epidemiol Health
        </source>
        <year>
         2015
        </year>
        <volume>
         37
        </volume>
        <fpage>
         e2015035
        </fpage>
        <pub-id pub-id-type="doi">
         10.4178/epih/e2015035
        </pub-id>
        <pub-id pub-id-type="pmid">
         26300437
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR204">
       <label>
        204.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kucharski
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         <name>
          <surname>
           Althaus
          </surname>
          <given-names>
           CL
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission
        </article-title>
        <source>
         Euro Surveill
        </source>
        <year>
         2015
        </year>
        <volume>
         20
        </volume>
        <issue>
         25
        </issue>
        <fpage>
         3
        </fpage>
        <pub-id pub-id-type="doi">
         10.2807/1560-7917.ES2015.20.25.21167
        </pub-id>
        <pub-id pub-id-type="pmid">
         25719962
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR205">
       <label>
        205.
       </label>
       <mixed-citation publication-type="other">
        MOH Holds the First Press Conference to Update Community and Media on MERS. [
        <ext-link ext-link-type="uri" xlink:href="http://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2015-08-23-001.aspx">
         http://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2015-08-23-001.aspx
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR206">
       <label>
        206.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           DS
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome vs. the Middle East respiratory syndrome
        </article-title>
        <source>
         Curr Opin Pulm Med
        </source>
        <year>
         2014
        </year>
        <volume>
         20
        </volume>
        <fpage>
         233
        </fpage>
        <lpage>
         241
        </lpage>
        <pub-id pub-id-type="doi">
         10.1097/MCP.0000000000000046
        </pub-id>
        <pub-id pub-id-type="pmid">
         24626235
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR207">
       <label>
        207.
       </label>
       <mixed-citation publication-type="other">
        Middle East respiratory syndrome coronavirus (MERS-CoV). [
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/emergencies/mers-cov/en/">
         http://www.who.int/emergencies/mers-cov/en/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR208">
       <label>
        208.
       </label>
       <mixed-citation publication-type="other">
        Statistics. [
        <ext-link ext-link-type="uri" xlink:href="http://www.moh.gov.sa/en/CCC/pressreleases/pages/default.aspx">
         http://www.moh.gov.sa/en/CCC/pressreleases/pages/default.aspx
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR209">
       <label>
        209.
       </label>
       <mixed-citation publication-type="other">
        2012–2015 Case List of MoH/WHO Novel Coronavirus MERS nCoV Announced Cases. [
        <ext-link ext-link-type="uri" xlink:href="https://flutrackers.com/forum/forum/novel-coronavirus-ncov-mers-2012-2014/146270-2012-2015-case-list-of-moh-who-novel-coronavirus-mers-ncov-announced-cases?t=205075">
         https://flutrackers.com/forum/forum/novel-coronavirus-ncov-mers-2012-2014/146270-2012-2015-case-list-of-moh-who-novel-coronavirus-mers-ncov-announced-cases?t=205075
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR210">
       <label>
        210.
       </label>
       <mixed-citation publication-type="other">
        Virology Down Under. [
        <ext-link ext-link-type="uri" xlink:href="http://virologydownunder.blogspot.com.au/">
         http://virologydownunder.blogspot.com.au/
        </ext-link>
        ]
       </mixed-citation>
      </ref>
      <ref id="CR211">
       <label>
        211.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kearse
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Moir
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Stones-Havas
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Sturrock
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data
        </article-title>
        <source>
         Bioinformatics
        </source>
        <year>
         2012
        </year>
        <volume>
         28
        </volume>
        <fpage>
         1647
        </fpage>
        <lpage>
         1649
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/bioinformatics/bts199
        </pub-id>
        <pub-id pub-id-type="pmid">
         22543367
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR212">
       <label>
        212.
       </label>
       <mixed-citation publication-type="other">
        Barry MA, AL Subaie SS, Somily AM, BinSaeed AA, Alzamil FA, Al-Jahdali IA, et al. Recent evolution patterns of the Middle East respiratory syndrome coronavirus (MERS-CoV). 2015.
        <ext-link ext-link-type="uri" xlink:href="http://virological.org/t/new-mers-cov-sequences-april-nov-2014-and-preliminary-analysis/114">
         http://virological.org/t/new-mers-cov-sequences-april-nov-2014-and-preliminary-analysis/114
        </ext-link>
        .
       </mixed-citation>
      </ref>
      <ref id="CR213">
       <label>
        213.
       </label>
       <mixed-citation publication-type="other">
        Preliminary analysis of Middle East respiratory syndrome coronavirus (MERS-CoV) sequences from Korea and China. [
        <ext-link ext-link-type="uri" xlink:href="http://virological.org/t/preliminary-analysis-of-middle-east-respiratory-syndrome-coronavirus-mers-cov-sequences-from-korea-and-china/143">
         http://virological.org/t/preliminary-analysis-of-middle-east-respiratory-syndrome-coronavirus-mers-cov-sequences-from-korea-and-china/143
        </ext-link>
        ].
       </mixed-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       J Hosp Infect
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       J. Hosp. Infect
      </journal-id>
      <journal-title-group>
       <journal-title>
        The Journal of Hospital Infection
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0195-6701
      </issn>
      <issn pub-type="epub">
       1532-2939
      </issn>
      <publisher>
       <publisher-name>
        The Healthcare Infection Society. Published by Elsevier Ltd.
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       26597631
      </article-id>
      <article-id pub-id-type="pmc">
       7114921
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0195-6701(15)00367-9
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.jhin.2015.08.027
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination
        <sup>
         <xref ref-type="fn" rid="d32e2222">
          ☆
         </xref>
        </sup>
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="au1">
        <name>
         <surname>
          Otter
         </surname>
         <given-names>
          J.A.
         </given-names>
        </name>
        <email>
         jon.otter@imperial.nhs.uk
        </email>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
        <xref ref-type="corresp" rid="cor1">
         ∗
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au2">
        <name>
         <surname>
          Donskey
         </surname>
         <given-names>
          C.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au3">
        <name>
         <surname>
          Yezli
         </surname>
         <given-names>
          S.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au4">
        <name>
         <surname>
          Douthwaite
         </surname>
         <given-names>
          S.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         d
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au5">
        <name>
         <surname>
          Goldenberg
         </surname>
         <given-names>
          S.D.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         d
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au6">
        <name>
         <surname>
          Weber
         </surname>
         <given-names>
          D.J.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff5">
         e
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        a
       </label>
       Imperial College Healthcare NHS Trust, London, UK
      </aff>
      <aff id="aff2">
       <label>
        b
       </label>
       Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA
      </aff>
      <aff id="aff3">
       <label>
        c
       </label>
       Global Centre for Mass Gatherings Medicine, Riyadh, Saudi Arabia
      </aff>
      <aff id="aff4">
       <label>
        d
       </label>
       Centre for Clinical Infection and Diagnostics Research (CIDR), Guy's and St Thomas NHS Foundation Trust &amp; King's College London, UK
      </aff>
      <aff id="aff5">
       <label>
        e
       </label>
       Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA
      </aff>
      <author-notes>
       <corresp id="cor1">
        <label>
         ∗
        </label>
        Corresponding author. Address: Infection Prevention and Control, 6th Floor, Clarence Wing, St. Mary's Hospital, Praed Street, London W2 1NY, UK. Tel.: +44 (0)203 3133271.
        <email>
         jon.otter@imperial.nhs.uk
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        3
       </day>
       <month>
        10
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <month>
        3
       </month>
       <year>
        2016
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        3
       </day>
       <month>
        10
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <volume>
       92
      </volume>
      <issue>
       3
      </issue>
      <fpage>
       235
      </fpage>
      <lpage>
       250
      </lpage>
      <history>
       <date date-type="received">
        <day>
         24
        </day>
        <month>
         7
        </month>
        <year>
         2015
        </year>
       </date>
       <date date-type="accepted">
        <day>
         28
        </day>
        <month>
         8
        </month>
        <year>
         2015
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2015
       </copyright-year>
       <copyright-holder>
        The Healthcare Infection Society
       </copyright-holder>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract id="abs0010">
       <title>
        Summary
       </title>
       <p>
        Viruses with pandemic potential including H1N1, H5N1, and H5N7 influenza viruses, and severe acute respiratory syndrome (SARS)/Middle East respiratory syndrome (MERS) coronaviruses (CoV) have emerged in recent years. SARS-CoV, MERS-CoV, and influenza virus can survive on surfaces for extended periods, sometimes up to months. Factors influencing the survival of these viruses on surfaces include: strain variation, titre, surface type, suspending medium, mode of deposition, temperature and relative humidity, and the method used to determine the viability of the virus. Environmental sampling has identified contamination in field-settings with SARS-CoV and influenza virus, although the frequent use of molecular detection methods may not necessarily represent the presence of viable virus. The importance of indirect contact transmission (involving contamination of inanimate surfaces) is uncertain compared with other transmission routes, principally direct contact transmission (independent of surface contamination), droplet, and airborne routes. However, influenza virus and SARS-CoV may be shed into the environment and be transferred from environmental surfaces to hands of patients and healthcare providers. Emerging data suggest that MERS-CoV also shares these properties. Once contaminated from the environment, hands can then initiate self-inoculation of mucous membranes of the nose, eyes or mouth. Mathematical and animal models, and intervention studies suggest that contact transmission is the most important route in some scenarios. Infection prevention and control implications include the need for hand hygiene and personal protective equipment to minimize self-contamination and to protect against inoculation of mucosal surfaces and the respiratory tract, and enhanced surface cleaning and disinfection in healthcare settings.
       </p>
      </abstract>
      <kwd-group id="kwrds0010">
       <title>
        Keywords
       </title>
       <kwd>
        Healthcare-associated infection
       </kwd>
       <kwd>
        Influenza virus
       </kwd>
       <kwd>
        MERS-CoV
       </kwd>
       <kwd>
        SARS-CoV
       </kwd>
       <kwd>
        Surface contamination
       </kwd>
       <kwd>
        Transmission
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <sec id="sec1">
     <title>
      Introduction
     </title>
     <p id="p0010">
      A number of viruses with pandemic potential have emerged in recent years. The 2002 emergence of severe acute respiratory syndrome coronavirus (SARS-CoV), 2009 pandemic of H1N1 influenza, continued circulation of influenza H5N1 and H5N7 strains, and the recent emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV) illustrate the current threat of these viruses.
      <xref ref-type="bibr" rid="bib1">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="bib2">
       2
      </xref>
      ,
      <xref ref-type="bibr" rid="bib3">
       3
      </xref>
      ,
      <xref ref-type="bibr" rid="bib4">
       4
      </xref>
     </p>
     <p id="p0015">
      Despite fundamental differences in their structure and epidemiology, these pandemic viral threats share a number of important properties. They are zoonotic enveloped RNA respiratory viruses that rarely transmit between humans in their native form, but could mutate to allow more efficient human-to-human transmission. This was illustrated by the 2002–2003 SARS pandemic and the 2009 H1N1 influenza pandemic.
      <xref ref-type="bibr" rid="bib3">
       3
      </xref>
      ,
      <xref ref-type="bibr" rid="bib4">
       4
      </xref>
      Frequent and accepted transmission routes are ‘droplet transmission’, where droplets (&gt;5 μm diameter, travelling &lt;1 m) containing viable viruses make contact with the nose, mouth, eyes, or upper respiratory tract, and ‘airborne transmission’, where droplet nuclei (≤5 μm diameter, which can travel &gt;1 m) are inhaled by susceptible individuals (
      <xref ref-type="fig" rid="fig1">
       Figure 1
      </xref>
      ).
      <xref ref-type="bibr" rid="bib5">
       5
      </xref>
      ,
      <xref ref-type="bibr" rid="bib6">
       6
      </xref>
      ,
      <xref ref-type="bibr" rid="bib7">
       7
      </xref>
      ,
      <xref ref-type="bibr" rid="bib8">
       8
      </xref>
      The role of ‘direct contact transmission’ (not involving contaminated surfaces) and ‘indirect contact transmission’ (involving contaminated surfaces) in the spread of these viruses with pandemic potential has been controversial (
      <xref ref-type="fig" rid="fig1">
       Figure 1
      </xref>
      ).
      <xref ref-type="bibr" rid="bib6">
       6
      </xref>
      ,
      <xref ref-type="bibr" rid="bib7">
       7
      </xref>
      ,
      <xref ref-type="bibr" rid="bib8">
       8
      </xref>
      However, several reviews and models have suggested that indirect contact transmission is the predominant transmission route for some respiratory viruses, including influenza, in some settings.
      <xref ref-type="bibr" rid="bib7">
       7
      </xref>
      ,
      <xref ref-type="bibr" rid="bib8">
       8
      </xref>
      ,
      <xref ref-type="bibr" rid="bib9">
       9
      </xref>
      <fig id="fig1">
       <label>
        Figure 1
       </label>
       <caption>
        <p>
         Transmission routes: droplet, airborne, direct contact, and indirect contact. (Indirect contact: routes involving a combination of hand and surface.) Definitions of ‘droplet’ and ‘droplet nuclei’ are from Atkinson
         <italic>
          et al
         </italic>
         .
         <xref ref-type="bibr" rid="bib5">
          <sup>
           5
          </sup>
         </xref>
        </p>
       </caption>
       <graphic xlink:href="gr1_lrg">
       </graphic>
      </fig>
     </p>
     <p id="p0020">
      Contaminated surfaces are an established route of transmission for important nosocomial pathogens including
      <italic>
       Clostridium difficile
      </italic>
      , meticillin-resistant
      <italic>
       Staphylococcus aureus
      </italic>
      (MRSA), vancomycin-resistant enterococci (VRE),
      <italic>
       Acinetobacter baumannii
      </italic>
      and norovirus, which share the capacity to survive on surfaces for extended periods.
      <xref ref-type="bibr" rid="bib10">
       10
      </xref>
      ,
      <xref ref-type="bibr" rid="bib11">
       11
      </xref>
      ,
      <xref ref-type="bibr" rid="bib12">
       12
      </xref>
      There is a general perception that enveloped viruses, such as influenza and human coronaviruses including MERS-CoV and SARS-CoV, have a very limited capacity to survive on dry surfaces.
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      ,
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib15">
       15
      </xref>
      However, several studies suggest that SARS-CoV, MERS-CoV and influenza virus have the capacity to survive on dry surfaces for a sufficient duration to facilitate onward transmission.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      SARS-CoV and surrogates, and influenza virus can also survive in environmental reservoirs such as water, on foods, and in sewage for extended periods.
      <xref ref-type="bibr" rid="bib19">
       19
      </xref>
      ,
      <xref ref-type="bibr" rid="bib20">
       20
      </xref>
      ,
      <xref ref-type="bibr" rid="bib21">
       21
      </xref>
      ,
      <xref ref-type="bibr" rid="bib22">
       22
      </xref>
      ,
      <xref ref-type="bibr" rid="bib23">
       23
      </xref>
      ,
      <xref ref-type="bibr" rid="bib24">
       24
      </xref>
      ,
      <xref ref-type="bibr" rid="bib25">
       25
      </xref>
      Here, we review the studies evaluating influenza and human coronavirus survival on dry surfaces, field investigations that have performed surface sampling for these viruses, and we consider the importance of contaminated surfaces in the transmission of these viruses.
     </p>
    </sec>
    <sec id="sec2">
     <title>
      Search strategy
     </title>
     <p id="p0025">
      PubMed searches without date or language restrictions were performed on November 22nd, 2014 using the following search terms: [coronavirus or influenza] survival surface OR fomite transmission OR surface contamination OR disinfection transmission. Studies evaluating contamination of any surface were included. A total of 254 articles were identified using these search terms (
      <xref ref-type="sec" rid="appsec1">
       Appendix A
      </xref>
      ). Articles were also identified by hand-searching of bibliographies and related articles on PubMed.
     </p>
    </sec>
    <sec id="sec3">
     <title>
      Survival on dry surfaces
     </title>
     <p id="p0030">
      <xref ref-type="table" rid="tbl1">
       Table I
      </xref>
      ,
      <xref ref-type="table" rid="tbl2">
       Table II
      </xref>
      summarize in-vitro studies evaluating the capacity of human coronaviruses (including SARS-CoV and MERS-CoV) and influenza to survive when inoculated on to dry surfaces. Important methodological differences include variation in the choice of virus species and strain, method used to detect virus, deposition mode, titre and volume applied, surface substrate, suspending medium, temperate and relative humidity (RH), and drying time. These differences mean that direct comparison of reported survival times between studies is often not meaningful. In some of the reviewed studies, these factors have been experimental variables, allowing comment on the influence of the method used to detect virus, species and strain, titre, substrate, suspending medium, and temperature/RH on drying time (
      <xref ref-type="table" rid="tbl1">
       Table I
      </xref>
      ,
      <xref ref-type="table" rid="tbl2">
       Table II
      </xref>
      ).
      <table-wrap id="tbl1" position="float">
       <label>
        Table I
       </label>
       <caption>
        <p>
         Survival of SARS-CoV, MERS-CoV, and surrogates on dry surfaces
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
           Study
          </th>
          <th>
           Year
          </th>
          <th>
           Location
          </th>
          <th>
           Test virus
          </th>
          <th>
           Load applied
          </th>
          <th>
           Substrate(s)
          </th>
          <th>
           Suspending medium
          </th>
          <th>
           Volume applied (μL)
          </th>
          <th>
           Temperature (°C)/RH (%)
          </th>
          <th>
           Drying time (min) for time 0 sample
          </th>
          <th>
           Results
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td>
           van Doremalen
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib16">
            <sup>
             16
            </sup>
           </xref>
          </td>
          <td align="char">
           2013
          </td>
          <td>
           USA
          </td>
          <td>
           MERS-CoV
          </td>
          <td>
           10
           <sup>
            5
           </sup>
          </td>
          <td>
           Steel and plastic
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           100
          </td>
          <td>
           Variable
          </td>
          <td>
           10
          </td>
          <td>
           Viable virus detected after 48 h at 20°C/40% RH. Less survival at 30°C/80% RH (8 h) and 30°C/30% RH (24 h). Half-life ranged from ∼0.5 to 1 h.
          </td>
         </tr>
         <tr>
          <td>
           Chan
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib17">
            <sup>
             17
            </sup>
           </xref>
          </td>
          <td align="char">
           2011
          </td>
          <td>
           Hong Kong
          </td>
          <td>
           SARS-CoV
          </td>
          <td>
           10
           <sup>
            5
           </sup>
          </td>
          <td>
           Plastic
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           10
          </td>
          <td>
           Variable
          </td>
          <td>
           Until visibly dry
          </td>
          <td>
           SARS-CoV survived for 5 days with &lt;10-fold reduction in titre at room temperature and humidity, and was viable for &gt;20 days. The virus was more stable at lower temperatures (28 vs 38°C) and lower humidity (80–89% vs &gt;95%). The reduction in viral titre was similar in suspension compared with virus dried on surfaces.
          </td>
         </tr>
         <tr>
          <td>
           Casanova
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib26">
            <sup>
             26
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           USA
          </td>
          <td>
           TGEV
          </td>
          <td>
           &gt;10
           <sup>
            3
           </sup>
          </td>
          <td>
           Latex/nitrile gloves, N95 respirator, hospital scrubs, isolation gowns
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           10
          </td>
          <td>
           20/50
          </td>
          <td>
           0
          </td>
          <td>
           TGEV survived with &lt;10
           <sup>
            2
           </sup>
           reduction on all items after 4 h and was detected on some items after 24 h
          </td>
         </tr>
         <tr>
          <td>
           Casanova
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib19">
            <sup>
             19
            </sup>
           </xref>
          </td>
          <td align="char">
           2009
          </td>
          <td>
           USA
          </td>
          <td>
           TGEV, MHV
          </td>
          <td>
           10
           <sup>
            5
           </sup>
          </td>
          <td>
           Stainless steel discs
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           10
          </td>
          <td>
           Variable
          </td>
          <td>
           Until visibly dry
          </td>
          <td>
           Both TGEV and MHV could survive in excess of 28 days under some conditions, with lower temperature and relative humidity resulting in improved survival. TGEV and MHV did not differ significantly in their survival properties.
          </td>
         </tr>
         <tr>
          <td>
           Muller
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib27">
            <sup>
             27
            </sup>
           </xref>
          </td>
          <td align="char">
           2008
          </td>
          <td>
           Germany
          </td>
          <td>
           HCoV-NL63, human metapneumovirus
          </td>
          <td>
           Not specified
          </td>
          <td>
           Latex gloves, thermometer caps, stethoscopes, plastic table
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           Not specified
          </td>
          <td>
           Ambient
          </td>
          <td>
           Not specified
          </td>
          <td>
           Viable virus not detected after drying; viral RNA detectable for up to 7 days
          </td>
         </tr>
         <tr>
          <td>
           Rabenau
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib28">
            <sup>
             28
            </sup>
           </xref>
          </td>
          <td align="char">
           2005
          </td>
          <td>
           Germany
          </td>
          <td>
           SARS-CoV, HCoV-229E, herpes simplex virus, adenovirus
          </td>
          <td>
           10
           <sup>
            6
           </sup>
           –10
           <sup>
            7
           </sup>
          </td>
          <td>
           Polystyrene Petri dish
          </td>
          <td>
           Cell culture medium ±20% fetal calf serum
          </td>
          <td>
           500
          </td>
          <td>
           Ambient
          </td>
          <td>
           Until visibly dry
          </td>
          <td>
           SARS-CoV, adenovirus and herpes simplex virus survived &gt;6 days. HCoV-229E survived for &lt;72 h. The addition of FCS made little impact on survival times.
          </td>
         </tr>
         <tr>
          <td>
           Lai
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib29">
            <sup>
             29
            </sup>
           </xref>
          </td>
          <td align="char">
           2005
          </td>
          <td>
           China
          </td>
          <td>
           SARS-CoV
          </td>
          <td>
           Dilution series (10
           <sup>
            2
           </sup>
           –10
           <sup>
            4
           </sup>
           )
          </td>
          <td>
           Paper, disposable gowns, cotton gowns
          </td>
          <td>
           Cell culture medium + 2% fetal calf serum
          </td>
          <td>
           5
          </td>
          <td>
           Ambient
          </td>
          <td>
           Until visibly dry
          </td>
          <td>
           There was a dose response in terms of survival times of all materials, with more concentrated inocula surviving longer. Survival times ranged from 5 min (10
           <sup>
            2
           </sup>
           load on a cotton gown) to 2 days (10
           <sup>
            4
           </sup>
           load on disposable gown).
          </td>
         </tr>
         <tr>
          <td>
           Duan
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib30">
            <sup>
             30
            </sup>
           </xref>
          </td>
          <td align="char">
           2003
          </td>
          <td>
           China
          </td>
          <td>
           SARS-CoV
          </td>
          <td>
           10
           <sup>
            6
           </sup>
          </td>
          <td>
           Wood board, glass, mosiac, metal, cloth, paper, filter paper, plastic
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           300
          </td>
          <td>
           Ambient
          </td>
          <td>
           No time 0 sample
          </td>
          <td>
           Viability was assessed semiquantitatively and SARS-CoV was able to survive, albeit with reduced infectivity, for &gt;72 h on all surfaces tested, and for &gt;120 h on metal, cloth and filter paper. Additionally, virus survived for &gt;72 h on cotton cloth in an experimentally dried enclosure.
          </td>
         </tr>
         <tr>
          <td>
           Sizun
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib31">
            <sup>
             31
            </sup>
           </xref>
          </td>
          <td align="char">
           2000
          </td>
          <td>
           Canada
          </td>
          <td>
           HCoV-229E, HCoV-OC43
          </td>
          <td>
           10
           <sup>
            3
           </sup>
          </td>
          <td>
           Aluminium, cotton gauze, latex gloves
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           10
          </td>
          <td>
           Ambient
          </td>
          <td>
           Until visibly dry (15–45 min)
          </td>
          <td>
           Viability fell to below detectable levels after 6 h for 229E and 2 h for HCoV-OC43.
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          SARS, severe acute respiratory syndrome; CoV, human coronavirus; MERS, Middle East respiratory syndrome; RH, relative humidity; TGEV, transmissible gastroenteritis coronavirus; MHV, mouse hepatitis virus.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
      <table-wrap id="tbl2" position="float">
       <label>
        Table II
       </label>
       <caption>
        <p>
         Survival of influenza viruses on dry surfaces
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
           Study
          </th>
          <th>
           Year
          </th>
          <th>
           Location
          </th>
          <th>
           Test virus
          </th>
          <th>
           Load applied
          </th>
          <th>
           Substrate (s)
          </th>
          <th>
           Suspending medium
          </th>
          <th>
           Volume applied (μL)
          </th>
          <th>
           Temp (°C)/RH (%)
          </th>
          <th>
           Drying time (min) for time 0 sample
          </th>
          <th>
           Results
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td>
           van Doremalen
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib16">
            <sup>
             16
            </sup>
           </xref>
          </td>
          <td align="char">
           2013
          </td>
          <td>
           USA
          </td>
          <td>
           H1N1 (human isolate)
          </td>
          <td>
           10
           <sup>
            5
           </sup>
          </td>
          <td>
           Steel and plastic
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           100
          </td>
          <td>
           Variable
          </td>
          <td>
           10
          </td>
          <td>
           No viable virus recovered after 4 h. No difference between plastic and steel.
          </td>
         </tr>
         <tr>
          <td>
           Coulliette
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib18">
            <sup>
             18
            </sup>
           </xref>
          </td>
          <td align="char">
           2013
          </td>
          <td>
           USA
          </td>
          <td>
           H1N1 (pandemic strain)
          </td>
          <td>
           10
           <sup>
            4
           </sup>
          </td>
          <td>
           Coupons from N95 respirators
          </td>
          <td>
           Cell culture medium/2% FBS/mucin
          </td>
          <td>
           100
          </td>
          <td>
           Variable
          </td>
          <td>
           60
          </td>
          <td>
           10
           <sup>
            2
           </sup>
           TCID
           <sub>
            50
           </sub>
           per coupon recovered from time 0 samples (after drying). Viable virus was recovered after 6 days with a 10-fold reduction. Viral survival was longer in FBS and mucin compared with cell culture medium. Lower absolute humidity favoured longer survival.
          </td>
         </tr>
         <tr>
          <td>
           Zuo
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib32">
            <sup>
             32
            </sup>
           </xref>
          </td>
          <td align="char">
           2013
          </td>
          <td>
           USA
          </td>
          <td>
           Avian influenza H9N9
          </td>
          <td>
           Liquid spike (10
           <sup>
            4
           </sup>
           –10
           <sup>
            5
           </sup>
           )
          </td>
          <td>
           Three non-woven fabrics
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           20
          </td>
          <td>
           Ambient
          </td>
          <td>
           0 min; until visibly dry; 30 min after visibly dry
          </td>
          <td>
           Viable virus survival for &gt;1 h on each of the materials tested; survival times varied significantly by material. Survival on hydrophilic nylon lower than on hydrophobic materials. Choice of eluent did not significantly affect recovery. Virus recovery following deposition as an aerosol was considerably lower.
          </td>
         </tr>
         <tr>
          <td rowspan="2">
           Mukherjee
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib33">
            <sup>
             33
            </sup>
           </xref>
          </td>
          <td align="char" rowspan="2">
           2012
          </td>
          <td rowspan="2">
           USA
          </td>
          <td>
           Field study of 20 influenza-infected individuals
          </td>
          <td>
           Participants coughed or sneezed on hands then touched surfaces
          </td>
          <td>
           Door handle, telephone, pillowcase, cotton handkerchief
          </td>
          <td>
           n/a
          </td>
          <td>
           n/a
          </td>
          <td>
           Ambient
          </td>
          <td>
           n/a
          </td>
          <td>
           Virus RNA recovered from three door handles and one telephone; no samples were tissue culture positive.
          </td>
         </tr>
         <tr>
          <td>
           H1N1 (recovered from two participants)
          </td>
          <td>
           Dilution series (10–10
           <sup>
            5
           </sup>
           )
          </td>
          <td>
           Formica, vinyl, stainless steel, cotton pillowcase, facial tissue
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           20
          </td>
          <td>
           Ambient
          </td>
          <td>
           5
          </td>
          <td>
           Viable virus detected by tissue culture from some hard surfaces at higher applied load for up to 1 h; no viable virus detectable by tissue culture after 1 h; virus RNA detectable after 1 h on some surfaces.
          </td>
         </tr>
         <tr>
          <td rowspan="2">
           Greatorex
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib34">
            <sup>
             34
            </sup>
           </xref>
          </td>
          <td align="char" rowspan="2">
           2011
          </td>
          <td rowspan="2">
           UK
          </td>
          <td>
           H1N1 (PR8)
          </td>
          <td>
           10
           <sup>
            6
           </sup>
          </td>
          <td>
           Common porous and non-porous household materials
          </td>
          <td>
           Cell culture medium plus 1% bovine serum albumin
          </td>
          <td>
           10
          </td>
          <td>
           17–21/23–24
          </td>
          <td>
           0 (drying times ranged from 5 min to 7 h)
          </td>
          <td>
           Viral RNA detected with minimal reduction on most surfaces over 24 h; viral infectivity falls away more rapidly, with infective virus at low titre detectable from most surfaces at 4 h but from only stainless steel at 9 h
          </td>
         </tr>
         <tr>
          <td>
           H1N1 (AH04): recent clinical isolate
          </td>
          <td>
           10
           <sup>
            4
           </sup>
          </td>
          <td>
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
          </td>
          <td>
          </td>
          <td>
          </td>
          <td>
           Semiquantitative fluorescence assay indicated the presence of virus at 4–24 h on hard surfaces but &lt;4 h on porous surfaces.
          </td>
         </tr>
         <tr>
          <td>
           Dublineau
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib35">
            <sup>
             35
            </sup>
           </xref>
          </td>
          <td align="char">
           2011
          </td>
          <td>
           Paris
          </td>
          <td>
           H1N1 seasonal and pandemic strains
          </td>
          <td>
           10
           <sup>
            5
           </sup>
           –10
           <sup>
            6
           </sup>
          </td>
          <td>
           Watch glass
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           50
          </td>
          <td>
           Variable
          </td>
          <td>
           5–17 h
          </td>
          <td>
           Both viruses survived for &gt;3 days under all conditions tested; pandemic H1N1 survived for &gt;7 days at 35°C and 2 months at 4°C.
          </td>
         </tr>
         <tr>
          <td>
           Wood
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib36">
            <sup>
             36
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           USA
          </td>
          <td>
           H5N1
          </td>
          <td>
           10
           <sup>
            6
           </sup>
          </td>
          <td>
           Glass and galvanized steel
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           100
          </td>
          <td>
           4/variable
          </td>
          <td>
           60
          </td>
          <td>
           Influenza stable at low temperature, regardless of humidity, with 13-day survival and reduction by factor of &lt;1 on both substrates. Surface survival not tested at room temperature.
          </td>
         </tr>
         <tr>
          <td>
           Sakaguchi
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib37">
            <sup>
             37
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           Japan
          </td>
          <td>
           H1N1
          </td>
          <td>
           10
           <sup>
            4
           </sup>
          </td>
          <td>
           Personal protective equipment: rubber gloves, N95 mask, surgical mask, Tyvek gown, coated wood, steel
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           500
          </td>
          <td>
           25.2/55
          </td>
          <td>
           0
          </td>
          <td>
           The haemagglutinin titre of the virus remained stable on all surfaces up to 24 h. The virus remained infective by TCID
           <sub>
            50
           </sub>
           on all materials up to 8 h, and on rubber for up to 24 h.
          </td>
         </tr>
         <tr>
          <td>
           McDevitt
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib38">
            <sup>
             38
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           USA
          </td>
          <td>
           H1N1 (PR8)
          </td>
          <td>
           10
           <sup>
            4
           </sup>
           –10
           <sup>
            5
           </sup>
          </td>
          <td>
           Stainless steel
          </td>
          <td>
           Purchased virus suspension
          </td>
          <td>
           50
          </td>
          <td>
           Variable
          </td>
          <td>
           Until visibly dry (∼30 min)
          </td>
          <td>
           Virus survival assessed at 15, 30 and 60 min at variable temperature 55–65°C) and relative humidity (25–75%). Virus survived for &gt;60 min with a 10
           <sup>
            1.5
           </sup>
           reduction at the lowest temperature/humidity combination (55°C/25%). Linear association between increasing humidity and logarithmic reduction.
          </td>
         </tr>
         <tr>
          <td rowspan="3">
           Thomas
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib39">
            <sup>
             39
            </sup>
           </xref>
          </td>
          <td align="char" rowspan="3">
           2008
          </td>
          <td rowspan="3">
           Switzerland
          </td>
          <td>
           H3N2 (2 strains), H1N1 and influenza B
          </td>
          <td>
           10
           <sup>
            3
           </sup>
           –10
           <sup>
            8
           </sup>
          </td>
          <td>
           Bank notes
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           50
          </td>
          <td>
           21–28 (avg. 22)/30–50
          </td>
          <td>
           Dried under laminar airflow; time not specified
          </td>
          <td>
           Survival varied by strain from 3 h to 3 days, depending on the virus tested.
          </td>
         </tr>
         <tr>
          <td>
           Spiked pooled negative nasopharyngeal secretions
          </td>
          <td>
          </td>
          <td>
           Bank notes
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           50
          </td>
          <td>
           21–28 (avg. 22)/30–50
          </td>
          <td>
           Dried under laminar airflow; time not specified
          </td>
          <td>
           Higher inocula survived for longer on surfaces; the addition of respiratory mucus significantly increased survival, usually from hours to up to 17 days.
          </td>
         </tr>
         <tr>
          <td>
           Influenza-positive nasopharyngeal secretions
          </td>
          <td>
          </td>
          <td>
           Bank notes
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           50
          </td>
          <td>
           21–28 (avg. 22)/30–50
          </td>
          <td>
           Dried under laminar airflow; time not specified
          </td>
          <td>
           Infective influenza recovered from 7/14 (50%) of notes after 24 h, 5/14 (36%) of notes after 48 h, and in one case, after 12 days.
          </td>
         </tr>
         <tr>
          <td>
           Noyce
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib40">
            <sup>
             40
            </sup>
           </xref>
          </td>
          <td align="char">
           2007
          </td>
          <td>
           UK
          </td>
          <td>
           H1N1
          </td>
          <td>
           10
           <sup>
            6
           </sup>
          </td>
          <td>
           Stainless steel or copper
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           20
          </td>
          <td>
           20–24/50–60
          </td>
          <td>
           Not specified
          </td>
          <td>
           10
           <sup>
            5
           </sup>
           viable virus recovered from stainless steel after 24 h vs 10
           <sup>
            2
           </sup>
           viable virus on copper after 6 h
          </td>
         </tr>
         <tr>
          <td>
           Tiwari
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib41">
            <sup>
             41
            </sup>
           </xref>
          </td>
          <td align="char">
           2006
          </td>
          <td>
           USA
          </td>
          <td>
           Avian influenza virus, avian metapneumovirus
          </td>
          <td>
           10
           <sup>
            4
           </sup>
          </td>
          <td>
           Steel, wood, tile, tire, gumboot, feather, egg shell, egg tray, plastic, latex, cotton and polyester
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           10
          </td>
          <td>
           Ambient
          </td>
          <td>
           Until visibly dry (∼30–40 min)
          </td>
          <td>
           Both viruses survive for up to 72 h on most surfaces tested. Influenza survived for up to 6 days on latex and feather.
          </td>
         </tr>
         <tr>
          <td>
           Bean
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib42">
            <sup>
             42
            </sup>
           </xref>
          </td>
          <td align="char">
           1982
          </td>
          <td>
           USA
          </td>
          <td>
           H1N1 and influenza B clinical isolates
          </td>
          <td>
           10
           <sup>
            2
           </sup>
           –10
           <sup>
            4
           </sup>
          </td>
          <td>
           Steel, plastic, cotton handkerchief, paper tissue, magazine page, cotton panamas
          </td>
          <td>
           Cell culture medium only
          </td>
          <td>
           100
          </td>
          <td>
           26–29/35–56
          </td>
          <td>
           Up to 1.5 h
          </td>
          <td>
           Viruses survived for 48–72 h on non-porous surfaces (steel and plastic) and for shorter periods on porous surfaces. Influenza A survived significantly longer than influenza B. Viruses dried on to surfaces could be transferred to hands from all surfaces for 15 min, and from steel for 24 h.
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          FBS, fetal bovine serum; TCID, tissue culture infectious dose; avg., average.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
     </p>
     <p id="p0035">
      Notwithstanding differences in methodology, some common themes emerge. Survival times for SARS-CoV, MERS-CoV, and surrogates such as transmissible gastroenteritis virus (TGEV) are generally measured in days, weeks, or months.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="bib28">
       28
      </xref>
      ,
      <xref ref-type="bibr" rid="bib29">
       29
      </xref>
      ,
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      Survival times for influenza virus are generally shorter, often measured in hours rather than days.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib32">
       32
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib34">
       34
      </xref>
      However, some studies have reported considerably longer survival times for influenza virus, measured in days rather than hours.
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="bib40">
       40
      </xref>
      ,
      <xref ref-type="bibr" rid="bib41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="bib42">
       42
      </xref>
      This apparent conflict is most likely explained by experimental factors. The difference in survival capacity between influenza virus and that of SARS-CoV and MERS-CoV is best illustrated by van Doremalen
      <italic>
       et al.
      </italic>
      who tested both H1N1 influenza and MERS-CoV.
      <xref ref-type="bibr" rid="bib16">
       <sup>
        16
       </sup>
      </xref>
      Viable MERS-CoV was recovered after 48 h, with a half-life ranging from ∼0.5 to 1 h. By contrast, no viable H1N1 was recovered after 1 h under any of the conditions tested.
     </p>
     <p id="p0040">
      SARS-CoV and MERS-CoV appear to have an unusual capacity to survive on dry surfaces compared with other human coronaviruses (229E, OC43, and NL63).
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib28">
       28
      </xref>
      ,
      <xref ref-type="bibr" rid="bib27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="bib31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      SARS-CoV, like the non-enveloped adenovirus comparator, survived for more than six days when dried on to Petri dishes compared with human coronavirus HCoV-229E, which survived for less than 72 h.
      <xref ref-type="bibr" rid="bib28">
       <sup>
        28
       </sup>
      </xref>
      Although data are limited, it appears that MERS-CoV may survive on surfaces for longer than most human coronaviruses.
      <xref ref-type="bibr" rid="bib16">
       <sup>
        16
       </sup>
      </xref>
      Since other human coronaviruses do not share the unusual survival properties of SARS-CoV, TGEV and mouse hepatitis virus (MHV) are often used as surrogates.
      <xref ref-type="bibr" rid="bib26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="bib45">
       45
      </xref>
     </p>
     <p id="p0045">
      No study has tested more than one strain of SARS-CoV or MERS-CoV. However, some studies have tested more than one strain of influenza, highlighting considerable strain variation.
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="bib42">
       42
      </xref>
      Further work is necessary to evaluate the importance of strain variation in influenza and coronavirus survival.
     </p>
     <p id="p0050">
      There appears to be a ‘dose response’ in terms of survival, with more concentrated viral suspensions surviving longer than less concentrated suspensions.
      <xref ref-type="bibr" rid="bib29">
       29
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      For example, SARS-CoV survived on disposable gowns for 1 h at 10
      <sup>
       4
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL vs 2 days at 10
      <sup>
       6
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL.
      <xref ref-type="bibr" rid="bib29">
       <sup>
        29
       </sup>
      </xref>
      Similarly, H3N2 influenza survived on bank notes for 1 h at 1.1×10
      <sup>
       5
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL vs 2 days at 8.9×10
      <sup>
       5
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL.
      <xref ref-type="bibr" rid="bib39">
       <sup>
        39
       </sup>
      </xref>
     </p>
     <p id="p0055">
      Substantial variation in survival times is evident for coronaviruses and influenza on different surface substrates.
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      ,
      <xref ref-type="bibr" rid="bib34">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="bib37">
       37
      </xref>
      ,
      <xref ref-type="bibr" rid="bib41">
       41
      </xref>
      Coronaviruses and influenza both have the capacity to survive on a wide range of porous and non-porous materials, including metals, plastics (such as light switches, telephones, perspex, latex, rubber, and polystyrene), woven and non-woven fabrics (including cotton, polyester, handkerchiefs, and disposable tissues), paper (including magazine pages), wood, glass, stethoscopes, tissue, Formica
      <sup>
       ®
      </sup>
      , bank notes, tiles, eggs, feathers, and soft toys.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="bib31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="bib32">
       32
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib34">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="bib41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      The properties of different surfaces are likely to influence survival times. For example, the survival of influenza dried on to copper surfaces was considerably shorter than on stainless steel.
      <xref ref-type="bibr" rid="bib40">
       <sup>
        40
       </sup>
      </xref>
     </p>
     <p id="p0060">
      Several studies have evaluated the capacity for SARS-CoV (and the surrogate TGEV), and influenza virus to survive on materials widely used as personal protective equipment (PPE) such as gowns, gloves, and respirators.
      <xref ref-type="bibr" rid="bib29">
       29
      </xref>
      ,
      <xref ref-type="bibr" rid="bib37">
       37
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      For example, TGEV survived on isolation gowns, nitrile and latex gloves, N95 respirators, and scrubs with a &lt;10
      <sup>
       2
      </sup>
      reduction for &gt;4 h, and was detected on some items after 24 h.
      <xref ref-type="bibr" rid="bib43">
       <sup>
        43
       </sup>
      </xref>
      One study showed that H1N1 influenza virus dried on to various materials could be transferred to the hands of volunteers for at least 24 h following inoculation on some surfaces, with clear implications for the acquisition of viable viruses on the hands of healthcare personnel during the removal of PPE.
      <xref ref-type="bibr" rid="bib42">
       <sup>
        42
       </sup>
      </xref>
      A more recent study identified viable pandemic H1N1 influenza after six days on coupons made from N95 respirators.
      <xref ref-type="bibr" rid="bib18">
       <sup>
        18
       </sup>
      </xref>
     </p>
     <p id="p0065">
      The suspending medium used to dry the viruses on to surfaces is another important factor influencing survival times.
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib28">
       28
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="bib46">
       46
      </xref>
      For example, adding mucus increased the survival time of influenza dried on bank notes from hours to up to 17 days.
      <xref ref-type="bibr" rid="bib39">
       <sup>
        39
       </sup>
      </xref>
      A related variable is the mode of deposition of the viruses. Most studies dried a small volume of a known concentration of virus in a cell culture medium. However, several studies have evaluated the use of deposited virus from clinical specimens, which may be more representative of the clinical scenario and tends to result in shorter survival times.
      <xref ref-type="bibr" rid="bib32">
       32
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
     </p>
     <p id="p0070">
      In all studies that tested varying temperature and RH, lower temperature and RH favoured the survival of both coronaviruses and influenza.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="bib38">
       38
      </xref>
     </p>
     <p id="p0075">
      Different methods have been applied to detect virus – most often cell culture assays but also RNA detection using polymerase chain reaction (PCR) or indirect methods such as fluorescence or haemagglutinin assays.
      <xref ref-type="bibr" rid="bib27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib34">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="bib37">
       37
      </xref>
      ,
      <xref ref-type="bibr" rid="bib40">
       40
      </xref>
      Intact viral RNA appears to remain detectable on surfaces for longer than viruses that retain the ability to infect cells.
      <xref ref-type="bibr" rid="bib32">
       32
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib42">
       42
      </xref>
      Since PCR assays only detect a small portion of RNA they cannot be used to replace culture-based methods in determining viability.
     </p>
     <p id="p0080">
      Experimental factors that have been shown to influence virus viability
      <italic>
       in vitro
      </italic>
      are likely to have important implications for virus survival on hospital surfaces. For example, the titre and volume of virus applied to surfaces will be influenced by the type and volume of respiratory secretion, as will the suspending medium. The temperature and RH of the hospital environment is likely to be controlled to comfortable levels, meaning that some of the extremes of temperature and relative humidity tested
      <italic>
       in vitro
      </italic>
      may not be so relevant in the field.
     </p>
    </sec>
    <sec id="sec4">
     <title>
      Survival in aerosols
     </title>
     <p id="p0085">
      Respiratory virus symptoms such as sneezing and coughing result in the generation of virus-containing particles, in a size continuum from 1 to 500 μm.
      <xref ref-type="bibr" rid="bib47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="bib48">
       48
      </xref>
      Whereas the generation of small droplet nuclei has traditionally been associated with ‘aerosol-generating procedures’, several recent studies have identified aerosols (droplet nuclei, ≤5 μm diameter) in the vicinity of patients infected with influenza who are not undergoing recognized aerosol-generating procedures.
      <xref ref-type="bibr" rid="bib49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="bib50">
       50
      </xref>
      ,
      <xref ref-type="bibr" rid="bib51">
       51
      </xref>
      Coronaviruses especially have the ability to survive for long periods in aerosols. For example, HCoV-229E aerosol remained infectious for six days at 20°C and 50% RH.
      <xref ref-type="bibr" rid="bib52">
       <sup>
        52
       </sup>
      </xref>
      One study has evaluated the survival of MERS-CoV aerosols, finding a 7% reduction over 10 min (at 40% RH).
      <xref ref-type="bibr" rid="bib16">
       <sup>
        16
       </sup>
      </xref>
      By contrast, H1N1 suffered a 95% reduction over the same time period, suggesting that influenza virus may be less robust as an aerosol than coronaviruses. However, other studies have shown extended survival times for influenza aerosols (surviving up to 36 h).
      <xref ref-type="bibr" rid="bib53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="bib54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="bib55">
       55
      </xref>
     </p>
    </sec>
    <sec id="sec5">
     <title>
      Environmental contamination in field settings
     </title>
     <p id="p0090">
      A number of studies have performed environmental sampling for influenza or SARS in field settings (
      <xref ref-type="table" rid="tbl3">
       Table III
      </xref>
      ). No studies have yet been published evaluating MERS-CoV contamination in field settings.
      <table-wrap id="tbl3" position="float">
       <label>
        Table III
       </label>
       <caption>
        <p>
         Field sampling for influenza and human coronaviruses including SARS-CoV environmental contamination
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
           Study
          </th>
          <th>
           Year
          </th>
          <th>
           Setting and location
          </th>
          <th>
           Sites sampled
          </th>
          <th>
           Sampling method
          </th>
          <th>
           No. of samples
          </th>
          <th>
           No. positive (%)
          </th>
          <th>
           Notes
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td colspan="8">
           Influenza
          </td>
         </tr>
         <tr>
          <td rowspan="2">
           Indriani
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib56">
            <sup>
             56
            </sup>
           </xref>
          </td>
          <td align="char" rowspan="2">
           2010
          </td>
          <td>
           Live-bird markets, Indonesia
          </td>
          <td>
           27 sites were sampled at 83 live-bird markets for avian influenza (H5N1)
          </td>
          <td>
           Cotton swabs; PCR for viral RNA and viral culture
          </td>
          <td>
           1862 (PCR)
          </td>
          <td align="char">
           280 (15)
          </td>
          <td>
           39 (47%) markets contaminated at one or more site. Structured questionnaire to assess risk factors for contamination. One province and markets that slaughtered birds associated with contamination; zoning of poultry activities and daily disposal of solid waste were protective.
          </td>
         </tr>
         <tr>
          <td>
          </td>
          <td>
          </td>
          <td>
          </td>
          <td>
           280 (culture)
          </td>
          <td align="char">
           13 (4.6)
          </td>
          <td>
          </td>
         </tr>
         <tr>
          <td>
           Killingley
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib57">
            <sup>
             57
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           Influenza-infected adults in hospital and community settings in and around Nottingham, UK
          </td>
          <td>
           19 patients (daily) and their immediate environment (every other day) were sampled.
          </td>
          <td>
           Moistened cotton swabs; PCR for viral RNA and viral culture
          </td>
          <td>
           397
          </td>
          <td align="char">
           2 (0.5)
          </td>
          <td>
           Live virus recovered from 1/2 positive surfaces. 54% of subjects took an antiviral drug, which may have influenced shedding. Duration of virus shedding had a mean of 6.2 days and a range of 3–10 days.
          </td>
         </tr>
         <tr>
          <td>
           Simmerman
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib58">
            <sup>
             58
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           90 children with influenza in Bangkok, Thailand. Households were randomized to obtain handwashing education or not.
          </td>
          <td>
           Six household items in 90 households
          </td>
          <td>
           Moistened rayon tipped swabs; PCR for viral RNA and viral culture
          </td>
          <td>
           540
          </td>
          <td align="char">
           18 (3.3)
          </td>
          <td>
           16 (17.8%) of the 90 households had one or more samples positive for influenza by PCR. Nine TV remotes, six toys, two bathroom knobs and one light switch had positive results. No viable virus was detected by culture.
          </td>
         </tr>
         <tr>
          <td>
           Pappas
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib59">
            <sup>
             59
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           Toys in the waiting room of a general paediatric practice in Virginia, USA
          </td>
          <td>
           Hard surfaces and fabric toy samples on three separate occasions
          </td>
          <td>
           Moistened swab; samples tested for picornavirus, RSV and influenza by PCR
          </td>
          <td>
           52
          </td>
          <td align="char">
           1 (1.9)
          </td>
          <td>
           19.2% of the toys were contaminated with picornavirus RNA.
          </td>
         </tr>
         <tr>
          <td>
           Bright
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib60">
            <sup>
             60
            </sup>
           </xref>
          </td>
          <td align="char">
           2010
          </td>
          <td>
           Surfaces in three elementary school classrooms in Seattle, Washington, USA
          </td>
          <td>
           Standardized surfaces sampled in the morning, at midday and in the afternoon.
          </td>
          <td>
           Moistened swabs; PCR for viral RNA
          </td>
          <td>
           54
          </td>
          <td align="char">
           13 (24.1)
          </td>
          <td>
           Also, norovirus RNA was found on 16.4% of 55 surfaces sampled.
          </td>
         </tr>
         <tr>
          <td>
           Macias
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib61">
            <sup>
             61
            </sup>
           </xref>
          </td>
          <td align="char">
           2009
          </td>
          <td>
           Hospital in Mexico City, Mexico
          </td>
          <td>
           Samples collected from hands and surfaces in the rooms of patients with confirmed influenza
          </td>
          <td>
           Swabs; PCR for viral RNA
          </td>
          <td>
           13
          </td>
          <td align="char">
           5 (38.5)
          </td>
          <td>
           In one case, 1/5 surfaces (a bed rail) was positive from a patient's room 72 h after patient discharge and terminal cleaning. 5/6 samples from patient hands were positive for influenza.
          </td>
         </tr>
         <tr>
          <td rowspan="2">
           Boone and Gerba
           <xref ref-type="bibr" rid="bib62">
            <sup>
             62
            </sup>
           </xref>
          </td>
          <td align="char" rowspan="2">
           2005
          </td>
          <td rowspan="2">
           Homes and day-care centres in Tucson, Arizona, USA
          </td>
          <td>
           Samples from eight homes
          </td>
          <td>
           Moistened swabs; PCR for viral RNA
          </td>
          <td>
           92
          </td>
          <td align="char">
           35 (38.0)
          </td>
          <td>
           None of 33 surfaces sampled during summer months vs 59% of 59 samples during March.
          </td>
         </tr>
         <tr>
          <td>
           Samples from 14 day-care centres
          </td>
          <td>
          </td>
          <td>
           218
          </td>
          <td>
           –
          </td>
          <td>
           Influenza was detected on 23% of surfaces during the autumn and 53% during the spring.
          </td>
         </tr>
         <tr>
          <td colspan="8">
           Human coronavirus
          </td>
         </tr>
         <tr>
          <td>
           Booth
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib63">
            <sup>
             63
            </sup>
           </xref>
          </td>
          <td align="char">
           2005
          </td>
          <td>
           Hospitals in Toronto, Canada
          </td>
          <td>
           19 rooms in SARS units and ‘control’ areas not housing SARS patients
          </td>
          <td>
           Moistened swabs; PCR for viral RNA and viral culture
          </td>
          <td>
           85
          </td>
          <td align="char">
           3 (3.5)
          </td>
          <td>
           Positive sites were a bed table, a television remote control and a refrigerator handle in a nurses' medication station. All swabs were culture negative. Two (5%) of 40 air-slit samples were positive for SARS-CoV.
          </td>
         </tr>
         <tr>
          <td rowspan="2">
           Dowell
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib44">
            <sup>
             44
            </sup>
           </xref>
          </td>
          <td align="char" rowspan="2">
           2004
          </td>
          <td rowspan="2">
           Hospitals in Bangkok, Thailand and Taipei, Taiwan
          </td>
          <td>
           SARS-infected patient areas (patient rooms, nursing stations, emergency department)
          </td>
          <td>
           Moistened swabs; PCR for viral RNA and viral culture
          </td>
          <td>
           63
          </td>
          <td align="char">
           24 (38.1)
          </td>
          <td>
           All swabs were culture negative.
          </td>
         </tr>
         <tr>
          <td>
           Public areas
          </td>
          <td>
          </td>
          <td>
           31
          </td>
          <td align="char">
           2 (6.4)
          </td>
          <td>
          </td>
         </tr>
         <tr>
          <td>
           Memish
           <italic>
            et al.
           </italic>
           <xref ref-type="bibr" rid="bib64">
            <sup>
             64
            </sup>
           </xref>
          </td>
          <td align="char">
           2014
          </td>
          <td>
           Jeddah airport, Saudi Arabia
          </td>
          <td>
           Various frequently touched items in public areas
          </td>
          <td>
           Moistened swabs; PCR panel for viral culture
          </td>
          <td>
           40
          </td>
          <td align="char">
           3 (7.5)
          </td>
          <td>
           Human coronavirus (OC43/HKU1) RNA was identified from surfaces. Influenza B virus RNA was identified from 1/18 air samples, but was not identified on surfaces.
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          SARS-CoV, severe acute respiratory syndrome coronavirus; PCR, polymerase chain reaction.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
     </p>
     <p id="p0095">
      The major limitation with field studies is the use of PCR to detect viral RNA, which is best seen as a marker of virus shedding rather than indicating the presence of viable virus on surfaces, which must be confirmed by the recovery of viruses able to infect cells. In a number of influenza virus studies, a considerably lower rate of detection was identified by viral culture than by PCR, and in one study no viable virus was detected by culture despite the detection of influenza virus RNA.
      <xref ref-type="bibr" rid="bib56">
       56
      </xref>
      ,
      <xref ref-type="bibr" rid="bib57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="bib58">
       58
      </xref>
      Similarly, regarding SARS, two studies have detected environmental reservoirs of SARS-CoV RNA by PCR, but no viable virus by culture.
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="bib63">
       63
      </xref>
     </p>
     <p id="p0100">
      Three studies have evaluated influenza contamination of surfaces in healthcare settings. A UK study detected influenza virus RNA on two (0.5%) of 397 samples from surfaces around infected individuals, one of which grew viable influenza.
      <xref ref-type="bibr" rid="bib57">
       <sup>
        57
       </sup>
      </xref>
      More than half of the patients in the study were receiving antiviral medication, which may have reduced shedding. Influenza virus RNA was recovered from 38.5% of 13 environmental surfaces around hospitalized patients in Mexico.
      <xref ref-type="bibr" rid="bib61">
       <sup>
        61
       </sup>
      </xref>
      In one case, one out of five surfaces (a bed rail) was positive from a patient's room 72 h after patient discharge and terminal cleaning. Pappas
      <italic>
       et al.
      </italic>
      sampled toys in the waiting room of a general paediatric practice, finding that only one out of 59 toys was contaminated with influenza RNA.
      <xref ref-type="bibr" rid="bib59">
       <sup>
        59
       </sup>
      </xref>
      However, a higher proportion of toys was contaminated with picornavirus RNA (19.2%), including four out of 15 after cleaning. The identification of viral RNA on surfaces after cleaning and disinfection may be a marker of ineffective cleaning and disinfection.
     </p>
     <p id="p0105">
      Several studies have evaluated influenza RNA or viable influenza in homes, day-care centres and elementary schools.
      <xref ref-type="bibr" rid="bib58">
       58
      </xref>
      ,
      <xref ref-type="bibr" rid="bib60">
       60
      </xref>
      ,
      <xref ref-type="bibr" rid="bib62">
       62
      </xref>
      The proportion of sites contaminated with influenza virus RNA varied from 3% to &gt;50% in these studies, with evidence of seasonal variation in the study by Boone
      <italic>
       et al.
      </italic>
      <xref ref-type="bibr" rid="bib62">
       <sup>
        62
       </sup>
      </xref>
      In Bangkok, households randomized to a handwashing intervention had a lower proportion of sites contaminated with influenza virus RNA than did control households (11.1% of 45 vs 24.4% of 45).
      <xref ref-type="bibr" rid="bib58">
       <sup>
        58
       </sup>
      </xref>
     </p>
     <p id="p0110">
      Influenza RNA was detected on 15% of the 1862 environmental samples collected from bird markets in Indonesia, and almost half of the markets (47%) were contaminated at one or more site(s).
      <xref ref-type="bibr" rid="bib56">
       <sup>
        56
       </sup>
      </xref>
      Viable influenza was cultured from 4.6% of 280 samples tested. Markets that slaughtered birds, as well as one particular province, were associated with contamination, whereas zoning of poultry activities and daily disposal of solid waste were protective.
     </p>
     <p id="p0115">
      Two studies have evaluated SARS-CoV contamination. A study of areas used to care for patients with SARS in Bangkok and Taipei found that 38.1% of 63 sites were contaminated with SARS-CoV RNA.
      <xref ref-type="bibr" rid="bib44">
       <sup>
        44
       </sup>
      </xref>
      Furthermore, 6.4% of 31 public areas were also contaminated with SARS-CoV RNA. A lower rate of contamination was identified at a Canadian hospital, where 3.5% of 85 surfaces in SARS units were contaminated with SARS-CoV RNA.
      <xref ref-type="bibr" rid="bib63">
       <sup>
        63
       </sup>
      </xref>
      Viral culture did not detect viable SARS-CoV from any of the surfaces in these studies. A study of public surfaces in Jeddah Airport, Saudi Arabia, identified human coronavirus RNA from three (7.5%) of 40 surface samples. No viral culture was performed in the study.
      <xref ref-type="bibr" rid="bib64">
       <sup>
        64
       </sup>
      </xref>
     </p>
    </sec>
    <sec id="sec6">
     <title>
      Importance of contaminated surfaces in transmission
     </title>
     <p id="p0120">
      Direct and indirect contact transmission is an established transmission route for several respiratory and gastrointestinal viruses, including rhinovirus, respiratory syncytial virus, norovirus, and rotavirus.
      <xref ref-type="bibr" rid="bib7">
       7
      </xref>
      ,
      <xref ref-type="bibr" rid="bib47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="bib65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="bib66">
       66
      </xref>
      ,
      <xref ref-type="bibr" rid="bib67">
       67
      </xref>
      However, the importance of indirect contact transmission (contact transmission involving contaminated surfaces;
      <xref ref-type="fig" rid="fig1">
       Figure 1
      </xref>
      ) in the spread of respiratory viruses, including influenza, SARS-CoV and MERS-CoV, compared with other transmission routes is uncertain.
      <xref ref-type="bibr" rid="bib6">
       6
      </xref>
      ,
      <xref ref-type="bibr" rid="bib7">
       7
      </xref>
      ,
      <xref ref-type="bibr" rid="bib8">
       8
      </xref>
      ,
      <xref ref-type="bibr" rid="bib68">
       68
      </xref>
     </p>
     <p id="p0125">
      For contaminated surfaces to play a role in transmission, a respiratory pathogen must be shed into the environment, have the capacity to survive on surfaces, transfer to hands or other equipment at a concentration above the infectious dose, and be able to initiate infection through contact with the eyes, nose or mouth.
      <xref ref-type="bibr" rid="bib11">
       <sup>
        11
       </sup>
      </xref>
     </p>
     <p id="p0130">
      Human coronaviruses and influenza are shed in respiratory secretions.
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib69">
       69
      </xref>
      They can also survive in the gastrointestinal tract and have been associated with diarrhoea, which causes widespread environmental dissemination.
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib69">
       69
      </xref>
      ,
      <xref ref-type="bibr" rid="bib70">
       70
      </xref>
      ,
      <xref ref-type="bibr" rid="bib71">
       71
      </xref>
      ,
      <xref ref-type="bibr" rid="bib72">
       72
      </xref>
      ,
      <xref ref-type="bibr" rid="bib73">
       73
      </xref>
      ,
      <xref ref-type="bibr" rid="bib74">
       74
      </xref>
      In the case of SARS-CoV, viral loads in nasopharyngeal (up to 10
      <sup>
       6
      </sup>
      /mL) and stool (up to 10
      <sup>
       9
      </sup>
      /g) specimens may be high.
      <xref ref-type="bibr" rid="bib69">
       <sup>
        69
       </sup>
      </xref>
      Titres of influenza in nasopharyngeal specimens (generally ranging from 10
      <sup>
       5
      </sup>
      to 10
      <sup>
       7
      </sup>
      , but can be up to 10
      <sup>
       11
      </sup>
      copies/mL) and stool specimens (up to 10
      <sup>
       7
      </sup>
      /g) exhibit a similar range.
      <xref ref-type="bibr" rid="bib57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="bib74">
       74
      </xref>
      ,
      <xref ref-type="bibr" rid="bib75">
       75
      </xref>
      ,
      <xref ref-type="bibr" rid="bib76">
       76
      </xref>
      Emerging data suggest that MERS-CoV are shed in approximately equal quantities to SARS-CoV.
      <xref ref-type="bibr" rid="bib77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="bib78">
       78
      </xref>
      By contrast with the high titre shed from the respiratory and gastrointestinal tracts, the infectious dose may be low. For example, the infectious dose for influenza can be &lt;1 TCID
      <sub>
       50
      </sub>
      , and &lt;20 plaque-forming units for SARS-CoV.
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      ,
      <xref ref-type="bibr" rid="bib79">
       79
      </xref>
     </p>
     <p id="p0135">
      SARS-CoV, MERS-CoV and influenza virus can survive on dry surfaces for extended periods, particularly when suspended in human secretions (
      <xref ref-type="table" rid="tbl1">
       Table I
      </xref>
      ,
      <xref ref-type="table" rid="tbl2">
       Table II
      </xref>
      ), and may contaminate hand-touch sites in the field (
      <xref ref-type="table" rid="tbl3">
       Table III
      </xref>
      ).
     </p>
     <p id="p0140">
      Viral and bacterial surface contamination can be transferred to hands, and serial transfer to a number of surfaces from contaminated hands may occur.
      <xref ref-type="bibr" rid="bib11">
       11
      </xref>
      ,
      <xref ref-type="bibr" rid="bib42">
       42
      </xref>
      ,
      <xref ref-type="bibr" rid="bib80">
       80
      </xref>
      ,
      <xref ref-type="bibr" rid="bib81">
       81
      </xref>
      ,
      <xref ref-type="bibr" rid="bib82">
       82
      </xref>
      ,
      <xref ref-type="bibr" rid="bib83">
       83
      </xref>
      ,
      <xref ref-type="bibr" rid="bib84">
       84
      </xref>
      ,
      <xref ref-type="bibr" rid="bib85">
       85
      </xref>
      For example, Bean
      <italic>
       et al.
      </italic>
      calculated that an infectious dose of virus could be transmitted for at least 2 h and possibly up to 8 h from stainless steel surfaces to hands.
      <xref ref-type="bibr" rid="bib42">
       <sup>
        42
       </sup>
      </xref>
     </p>
     <p id="p0145">
      In order for the virus to initiate indirect contact transmission, oral inoculation or contact with mucous membranes must occur to transfer sufficient viruses. Nasal inoculation is a frequent route for establishing influenza and SARS infection.
      <xref ref-type="bibr" rid="bib86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="bib87">
       87
      </xref>
      ,
      <xref ref-type="bibr" rid="bib88">
       88
      </xref>
      ,
      <xref ref-type="bibr" rid="bib89">
       89
      </xref>
      ,
      <xref ref-type="bibr" rid="bib90">
       90
      </xref>
      Whereas oral inoculation has not been reported for SARS, it may occur for influenza and other viruses.
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      ,
      <xref ref-type="bibr" rid="bib91">
       91
      </xref>
      ,
      <xref ref-type="bibr" rid="bib92">
       92
      </xref>
     </p>
     <p id="p0150">
      Thus, the steps necessary to facilitate indirect contact transmission of both SARS-CoV and influenza are established. Although data are more limited for MERS-CoV, it appears to have the key properties to facilitate indirect contact transmission.
     </p>
     <p id="p0155">
      Determining which route is most important is challenging, but it seems that direct contact, indirect contact, droplet and airborne transmission do occur with both SARS-CoV and influenza viruses on occasion.
      <xref ref-type="bibr" rid="bib8">
       8
      </xref>
      ,
      <xref ref-type="bibr" rid="bib68">
       68
      </xref>
      Few data are available evaluating transmission routes for coronaviruses, but the relative importance of the various routes for influenza virus has been evaluated through mathematical models, animal models, and intervention studies.
      <xref ref-type="bibr" rid="bib9">
       9
      </xref>
      ,
      <xref ref-type="bibr" rid="bib93">
       93
      </xref>
      ,
      <xref ref-type="bibr" rid="bib94">
       94
      </xref>
     </p>
     <p id="p0160">
      Several mathematical models have been applied to SARS transmission, but none has considered an environmental route.
      <xref ref-type="bibr" rid="bib93">
       93
      </xref>
      ,
      <xref ref-type="bibr" rid="bib95">
       95
      </xref>
      However, some influenza transmission models have evaluated the relative importance of airborne, droplet, and contact influenza transmission.
      <xref ref-type="bibr" rid="bib9">
       9
      </xref>
      ,
      <xref ref-type="bibr" rid="bib96">
       96
      </xref>
      ,
      <xref ref-type="bibr" rid="bib97">
       97
      </xref>
      Two of these models conclude that contact transmission of influenza is at least as important as airborne or droplet spread, whereas one study found that contact transmission was negligible compared with other routes.
      <xref ref-type="bibr" rid="bib9">
       9
      </xref>
      ,
      <xref ref-type="bibr" rid="bib96">
       96
      </xref>
      ,
      <xref ref-type="bibr" rid="bib97">
       97
      </xref>
      However, it is important to note that the relative contribution of contact, droplet, and airborne transmission depends on a combination of viral factors (e.g. capacity to survive on surfaces), host factors (e.g. frequency of hand contact with the nose) and environmental factors (e.g. size of enclosure and density of shedders). Varying these and other parameters will change the relative contribution of the various transmission routes.
      <xref ref-type="bibr" rid="bib9">
       <sup>
        9
       </sup>
      </xref>
     </p>
     <p id="p0165">
      Several influenza transmission models have compared the importance of indirect contact transmission (involving surface contamination) with direct contact transmission (that occurs independently of surface contamination).
      <xref ref-type="bibr" rid="bib98">
       98
      </xref>
      ,
      <xref ref-type="bibr" rid="bib99">
       99
      </xref>
      One model indicates that indirect transmission via contaminated surfaces generates touch frequency-dependent patterns whereas transmission via the air generates human density-dependent patterns.
      <xref ref-type="bibr" rid="bib98">
       <sup>
        98
       </sup>
      </xref>
      Another model compared the involvement of droplet-contaminated versus hand-contaminated surfaces.
      <xref ref-type="bibr" rid="bib99">
       <sup>
        99
       </sup>
      </xref>
      Droplet-contaminated surfaces were more likely to be involved in transmission than hand-contaminated surfaces (∼10-fold difference), and large surfaces (such as table tops) had a higher transmission potential than small surfaces (such as door handles). A number of simplifying assumptions were made, which may be unsound – for example, that people touch portions of the fomite homogeneously, and that pathogens on fomites are homogeneously distributed. Also, transportation of contamination from one type of fomite to another via human hands was not modelled. Notwithstanding these limitations, the study provides some useful data on indirect contact transmission of influenza.
     </p>
     <p id="p0170">
      An alternative approach is the use of animal models. For example, a guinea-pig model evaluated the relative contribution of airborne, droplet, and indirect contact transmission.
      <xref ref-type="bibr" rid="bib94">
       <sup>
        94
       </sup>
      </xref>
      Indirect contact transmission was evaluated by placing uninfected animals in cages vacated by experimentally infected animals without changing bedding, food dishes, and water bottles. Animals were exposed to these cages for 24 h and tested for infection using nasal washings. Around a quarter of exposed guinea-pigs became infected, which was less efficient than transmission through airborne and droplet experiments (25–100% efficiency). Experimental contamination of surfaces in the cages was unable to establish infection. Another guinea-pig model showed that increasing the temperature to 30°C blocked aerosol but not contact transmission of influenza.
      <xref ref-type="bibr" rid="bib100">
       <sup>
        100
       </sup>
      </xref>
      This provides further evidence that the relative importance of the various transmission routes is context dependent.
     </p>
     <p id="p0175">
      A small number of studies have demonstrated that interventions in field settings to improve surface or hand hygiene reduce influenza transmission, demonstrating the importance of contact transmission.
      <xref ref-type="bibr" rid="bib63">
       63
      </xref>
      ,
      <xref ref-type="bibr" rid="bib101">
       101
      </xref>
      ,
      <xref ref-type="bibr" rid="bib102">
       102
      </xref>
      For example, introducing regular cleaning using disinfectant wipes reduced the rate of respiratory and diarrhoeal disease in elementary schools.
      <xref ref-type="bibr" rid="bib60">
       <sup>
        60
       </sup>
      </xref>
     </p>
    </sec>
    <sec id="sec7">
     <title>
      Implications for cleaning and disinfection, and infection prevention and control in healthcare settings
     </title>
     <p id="p0180">
      The likely contribution of droplet, direct and indirect contact, and to a lesser extent the airborne route in the transmission of influenza, SARS and MERS dictates that each route must be separately addressed by infection prevention and control interventions. The use of a surgical mask will protect the respiratory tract from droplets, an N95 (FFP3) respirator will protect the respiratory tract from droplet nuclei, and gloves, gowns and eye protection will prevent contact with mucous membranes and contamination of clothing or hands for subsequent nasal inoculation.
      <xref ref-type="bibr" rid="bib103">
       <sup>
        103
       </sup>
      </xref>
      Emerging literature suggests that doffing PPE presents a challenging risk for the acquisition of important viruses on hands.
      <xref ref-type="bibr" rid="bib104">
       104
      </xref>
      ,
      <xref ref-type="bibr" rid="bib105">
       105
      </xref>
      Thus, protocols should be in place for minimizing the risk of contamination of hands and clothing, and hand hygiene should be performed following removal of PPE.
     </p>
     <p id="p0185">
      The extended survival of influenza virus, SARS-CoV and MERS-CoV on surfaces (
      <xref ref-type="table" rid="tbl1">
       Table I
      </xref>
      ,
      <xref ref-type="table" rid="tbl2">
       Table II
      </xref>
      ) and some evidence of contamination in field settings (
      <xref ref-type="table" rid="tbl3">
       Table III
      </xref>
      ) argue for enhanced disinfection, particularly at the time of patient discharge.
      <xref ref-type="bibr" rid="bib59">
       59
      </xref>
      ,
      <xref ref-type="bibr" rid="bib61">
       61
      </xref>
      A range of hospital disinfectants are active against SARS-CoV and surrogates, and influenza, including alcohol, hypochlorites (bleach), quaternary ammonium compounds, and hydrogen peroxide, although inactivation is time and concentration dependent and will be influenced by other factors such as type of contaminated surface, specific product, and protein load.
      <xref ref-type="bibr" rid="bib28">
       28
      </xref>
      ,
      <xref ref-type="bibr" rid="bib45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="bib106">
       106
      </xref>
      ,
      <xref ref-type="bibr" rid="bib107">
       107
      </xref>
      However, in-vitro disinfectant effectiveness is a poor predictor for the elimination of contamination from surfaces if cleaning/disinfection is inadequate, which is often the case in hospitals.
      <xref ref-type="bibr" rid="bib108">
       108
      </xref>
      ,
      <xref ref-type="bibr" rid="bib109">
       109
      </xref>
      Thus, there may be a role for automated room disinfection (ARD) systems, such as hydrogen peroxide vapour and ultraviolet (UV) light, when patients known to be infected with pandemic influenza or coronaviruses are discharged.
      <xref ref-type="bibr" rid="bib45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="bib108">
       108
      </xref>
     </p>
     <p id="p0190">
      There may be the potential for extended survival of an infectious viral aerosol in patients' rooms following their discharge. Using MERS-CoV as an illustrative example, infectious aerosol above the infectious dose could be present after the discharge of the patient for up to 26 h, assuming no air changes in the room and depending on the shed titre (
      <xref ref-type="table" rid="tbl4">
       Table IV
      </xref>
      ). ARD systems address both contaminated air and surfaces, which may be important if infectious aerosol above the infectious dose remains following patient discharge.
      <table-wrap id="tbl4" position="float">
       <label>
        Table IV
       </label>
       <caption>
        <p>
         Calculating the time that an infectious aerosol shed by a patient infected with Middle East respiratory syndrome coronavirus could survive
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
           Shed titre
          </th>
          <th>
           Time to reach 20 virus particles
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td>
           1,000,000
          </td>
          <td>
           26 h
          </td>
         </tr>
         <tr>
          <td>
           100,000
          </td>
          <td>
           20 h
          </td>
         </tr>
         <tr>
          <td>
           10,000
          </td>
          <td>
           15 h
          </td>
         </tr>
         <tr>
          <td>
           1000
          </td>
          <td>
           9 h
          </td>
         </tr>
         <tr>
          <td>
           100
          </td>
          <td>
           4 h
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          The calculation assumes an infectious dose equal to severe acute respiratory syndrome coronavirus (&lt;20 plaque-forming units) and a decay rate of 7% over 10 min in a room with no air changes.
          <xref ref-type="bibr" rid="bib13">
           13
          </xref>
          ,
          <xref ref-type="bibr" rid="bib16">
           16
          </xref>
          The calculation used the following equation: P(
          <italic>
           t
          </italic>
          ) = P
          <sub>
           0
          </sub>
          e −
          <italic>
           rt
          </italic>
          , where P(
          <italic>
           t
          </italic>
          ) = the amount of some quantity at time
          <italic>
           t
          </italic>
          , P
          <sub>
           0
          </sub>
          = initial amount at time
          <italic>
           t
          </italic>
          = 0,
          <italic>
           r
          </italic>
          = the decay rate,
          <italic>
           t
          </italic>
          = time (number of periods).
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
     </p>
     <p id="p0195">
      Another consideration is the requirement for large quantities of N95 (FFP3) respirators in the event of a pandemic of influenza or MERS/SARS. Stockpiles of N95 respirators required for a pandemic are large, and stock shortages were acknowledged during the 2009 N1H1 influenza pandemic.
      <xref ref-type="bibr" rid="bib110">
       <sup>
        110
       </sup>
      </xref>
      Both influenza virus and SARS-CoV surrogates have been shown to survive for extended periods on N95 respirator material.
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib37">
       37
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      This survival represents a barrier to the reuse of N95 respirators. One approach is to disinfect the N95 respirators. Several candidate technologies have been evaluated for the disinfection of N95 respirators; UV light, hydrogen peroxide vapour, and ethylene oxide show most promise.
      <xref ref-type="bibr" rid="bib111">
       <sup>
        111
       </sup>
      </xref>
     </p>
    </sec>
    <sec id="sec8">
     <title>
      Conclusion
     </title>
     <p id="p0200">
      We reviewed the capacity of viruses with pandemic potential, influenza SARS-CoV and MERS-CoV, to survive on dry surfaces. The experimental methods used to test survival are important, but it seems that surface survival of SARS/MERS-CoV is greater than that of influenza virus. Important factors that influence the survival of these viruses on surfaces include: strain variations, a ‘dose–response’ relationship between the titre applied and survival time, the surface substrate (including the ability to survive on materials used to make PPE), the suspending medium (with the addition of mucus increasing substantially the survival time of influenza), the mode of deposition, temperature and RH, and the method used to determine the presence of the virus (specifically culture versus the use of PCR to detect viral RNA). All three viruses are able to survive in an aerosol for a considerable length of time (&gt;24 h), which may have important infection control implications.
     </p>
     <p id="p0205">
      Environmental sampling has been performed for influenza virus and human coronaviruses (including SARS-CoV) in a number of field settings. Most studies have used PCR to detect viral RNA, which may not necessarily represent the presence of viable virus, but should be seen as a marker of virus shedding. Some studies have demonstrated the presence of viable influenza virus on surfaces using cell culture. There is a wide range in terms of the frequency of sites contaminated with influenza virus or SARS-CoV RNA, ranging from &lt;5% to &gt;50%, including hand-touch sites.
     </p>
     <p id="p0210">
      The importance of indirect contact transmission is uncertain compared with other transmission routes, principally direct contact transmission, droplet, and airborne routes. Influenza virus, SARS-CoV and probably MERS-CoV are shed into the environment at concentrations far in excess of the infective dose, they can survive for extended periods on surfaces, and sampling has identified contamination of hospital surfaces. Contaminated surfaces could result in onward contamination of hands or equipment, which could then initiate inoculation through contact with the nose, eyes, or mouth. Thus, the steps required for indirect contact transmission are established. Mathematical modelling, animal models, and intervention trials suggest that contact transmission may be the most important route for influenza, but that this is context dependent.
     </p>
     <p id="p0215">
      The infection prevention and control implications of these findings include the need to wear appropriate PPE to account for contact, droplet and airborne routes, paying particular attention to the risk of contamination of hands and clothing during PPE removal. The potential for inadequate distribution and contact time during manual cleaning and disinfection, combined with the risk of extended survival of infectious aerosol, may argue for the use of ARD systems. These systems may also have a role in disinfection and reuse of N95/FFP3 respirators.
     </p>
     <p id="p0220">
      Viruses with pandemic potential including influenza, MERS-CoV, and SARS-CoV can survive for extended periods on dry surfaces, cause contamination in field settings and may require enhanced cleaning and disinfection to assure effective infection prevention and control.
     </p>
    </sec>
    <sec id="sec9">
     <title>
      Conflict of interest statement
     </title>
     <p id="p0225">
      J.A.O. is a consultant to Gama Healthcare. All other authors have no conflict to declare.
     </p>
    </sec>
    <sec id="sec10">
     <title>
      Funding sources
     </title>
     <p id="p0230">
      None.
     </p>
    </sec>
    <back>
     <ref-list id="cebib0010">
      <title>
       References
      </title>
      <ref id="bib1">
       <label>
        1
       </label>
       <element-citation id="sref1" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Groot
          </surname>
          <given-names>
           R.J.
          </given-names>
         </name>
         <name>
          <surname>
           Baker
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
         <name>
          <surname>
           Baric
          </surname>
          <given-names>
           R.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome Coronavirus (MERS-CoV); Announcement of the Coronavirus Study Group
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         87
        </volume>
        <year>
         2013
        </year>
        <fpage>
         7790
        </fpage>
        <lpage>
         7792
        </lpage>
        <pub-id pub-id-type="pmid">
         23678167
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib2">
       <label>
        2
       </label>
       <element-citation id="sref2" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         367
        </volume>
        <year>
         2012
        </year>
        <fpage>
         1814
        </fpage>
        <lpage>
         1820
        </lpage>
        <pub-id pub-id-type="pmid">
         23075143
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib3">
       <label>
        3
       </label>
       <element-citation id="sref3" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fineberg
          </surname>
          <given-names>
           H.V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pandemic preparedness and response – lessons from the H1N1 influenza of 2009
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         370
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1335
        </fpage>
        <lpage>
         1342
        </lpage>
        <pub-id pub-id-type="pmid">
         24693893
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib4">
       <label>
        4
       </label>
       <element-citation id="sref4" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hayden
          </surname>
          <given-names>
           F.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Respiratory viral threats
        </article-title>
        <source>
         Curr Opin Infect Dis
        </source>
        <volume>
         19
        </volume>
        <year>
         2006
        </year>
        <fpage>
         169
        </fpage>
        <lpage>
         178
        </lpage>
        <pub-id pub-id-type="pmid">
         16514342
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib5">
       <label>
        5
       </label>
       <element-citation id="sref5" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Annex C: Respiratory droplets
        </chapter-title>
        <person-group person-group-type="editor">
         <name>
          <surname>
           Atkinson
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Chartier
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Pessoa-Silva
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
        </person-group>
        <source>
         Natural ventilation for infection control in health-care settings
        </source>
        <year>
         2009
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
       </element-citation>
      </ref>
      <ref id="bib6">
       <label>
        6
       </label>
       <element-citation id="sref6" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bridges
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Kuehnert
          </surname>
          <given-names>
           M.J.
          </given-names>
         </name>
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission of influenza: implications for control in health care settings
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         37
        </volume>
        <year>
         2003
        </year>
        <fpage>
         1094
        </fpage>
        <lpage>
         1101
        </lpage>
        <pub-id pub-id-type="pmid">
         14523774
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib7">
       <label>
        7
       </label>
       <element-citation id="sref7" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boone
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Significance of fomites in the spread of respiratory and enteric viral disease
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         73
        </volume>
        <year>
         2007
        </year>
        <fpage>
         1687
        </fpage>
        <lpage>
         1696
        </lpage>
        <pub-id pub-id-type="pmid">
         17220247
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib8">
       <label>
        8
       </label>
       <element-citation id="sref8" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Brankston
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Gitterman
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Hirji
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Lemieux
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Gardam
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission of influenza A in human beings
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         7
        </volume>
        <year>
         2007
        </year>
        <fpage>
         257
        </fpage>
        <lpage>
         265
        </lpage>
        <pub-id pub-id-type="pmid">
         17376383
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib9">
       <label>
        9
       </label>
       <element-citation id="sref9" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Spicknall
          </surname>
          <given-names>
           I.H.
          </given-names>
         </name>
         <name>
          <surname>
           Koopman
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Nicas
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Pujol
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Eisenberg
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Informing optimal environmental influenza interventions: how the host, agent, and environment alter dominant routes of transmission
        </article-title>
        <source>
         PLoS Comput Biol
        </source>
        <volume>
         6
        </volume>
        <year>
         2010
        </year>
        <fpage>
         e1000969
        </fpage>
        <pub-id pub-id-type="pmid">
         21060854
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib10">
       <label>
        10
       </label>
       <element-citation id="sref10" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Salkeld
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           French
          </surname>
          <given-names>
           G.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         41
        </volume>
        <year>
         2013
        </year>
        <fpage>
         S6
        </fpage>
        <lpage>
         S11
        </lpage>
        <pub-id pub-id-type="pmid">
         23622751
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib11">
       <label>
        11
       </label>
       <element-citation id="sref11" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           French
          </surname>
          <given-names>
           G.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role played by contaminated surfaces in the transmission of nosocomial pathogens
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <volume>
         32
        </volume>
        <year>
         2011
        </year>
        <fpage>
         687
        </fpage>
        <lpage>
         699
        </lpage>
        <pub-id pub-id-type="pmid">
         21666400
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib12">
       <label>
        12
       </label>
       <element-citation id="sref12" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Miller
          </surname>
          <given-names>
           M.B.
          </given-names>
         </name>
         <name>
          <surname>
           Huslage
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Sickbert-Bennett
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus,
         <italic>
          Clostridium difficile
         </italic>
         , and
         <italic>
          Acinetobacter
         </italic>
         species
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         38
        </volume>
        <year>
         2010
        </year>
        <fpage>
         S25
        </fpage>
        <lpage>
         S33
        </lpage>
        <pub-id pub-id-type="pmid">
         20569853
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib13">
       <label>
        13
       </label>
       <element-citation id="sref13" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment
        </article-title>
        <source>
         Food Environ Microbiol
        </source>
        <volume>
         3
        </volume>
        <year>
         2011
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         30
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib14">
       <label>
        14
       </label>
       <element-citation id="sref14" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Geller
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Varbanov
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Duval
          </surname>
          <given-names>
           R.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies
        </article-title>
        <source>
         Viruses
        </source>
        <volume>
         4
        </volume>
        <year>
         2012
        </year>
        <fpage>
         3044
        </fpage>
        <lpage>
         3068
        </lpage>
        <pub-id pub-id-type="pmid">
         23202515
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib15">
       <label>
        15
       </label>
       <element-citation id="sref15" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kramer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Schwebke
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Kampf
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
        </article-title>
        <source>
         BMC Infect Dis
        </source>
        <volume>
         6
        </volume>
        <year>
         2006
        </year>
        <fpage>
         130
        </fpage>
        <pub-id pub-id-type="pmid">
         16914034
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib16">
       <label>
        16
       </label>
       <element-citation id="sref16" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           V.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <comment>
         pii: 20590
        </comment>
       </element-citation>
      </ref>
      <ref id="bib17">
       <label>
        17
       </label>
       <element-citation id="sref17" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           S.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The effects of temperature and relative humidity on the viability of the SARS Coronavirus
        </article-title>
        <source>
         Adv Virol
        </source>
        <volume>
         734690
        </volume>
        <year>
         2011
        </year>
       </element-citation>
      </ref>
      <ref id="bib18">
       <label>
        18
       </label>
       <element-citation id="sref18" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Coulliette
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
         <name>
          <surname>
           Perry
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
         <name>
          <surname>
           Edwards
          </surname>
          <given-names>
           J.R.
          </given-names>
         </name>
         <name>
          <surname>
           Noble-Wang
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Persistence of the 2009 pandemic influenza A (H1N1) virus on N95 respirators
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         79
        </volume>
        <year>
         2013
        </year>
        <fpage>
         2148
        </fpage>
        <lpage>
         2155
        </lpage>
        <pub-id pub-id-type="pmid">
         23335770
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib19">
       <label>
        19
       </label>
       <element-citation id="sref19" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of surrogate coronaviruses in water
        </article-title>
        <source>
         Water Res
        </source>
        <volume>
         43
        </volume>
        <year>
         2009
        </year>
        <fpage>
         1893
        </fpage>
        <lpage>
         1898
        </lpage>
        <pub-id pub-id-type="pmid">
         19246070
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib20">
       <label>
        20
       </label>
       <element-citation id="sref20" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mullis
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Saif
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Azevedo
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of bovine coronavirus on lettuce surfaces under household refrigeration conditions
        </article-title>
        <source>
         Food Microbiol
        </source>
        <volume>
         30
        </volume>
        <year>
         2012
        </year>
        <fpage>
         180
        </fpage>
        <lpage>
         186
        </lpage>
        <pub-id pub-id-type="pmid">
         22265299
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib21">
       <label>
        21
       </label>
       <element-citation id="sref21" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yepiz-Gomez
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
         <name>
          <surname>
           Bright
          </surname>
          <given-names>
           K.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of respiratory viruses on fresh produce
        </article-title>
        <source>
         Food Environ Virol
        </source>
        <year>
         2013
        </year>
       </element-citation>
      </ref>
      <ref id="bib22">
       <label>
        22
       </label>
       <element-citation id="sref22" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           X.W.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Guo
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital of the Chinese People's Liberation Army
        </article-title>
        <source>
         Water Sci Technol
        </source>
        <volume>
         52
        </volume>
        <year>
         2005
        </year>
        <fpage>
         213
        </fpage>
        <lpage>
         221
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib23">
       <label>
        23
       </label>
       <element-citation id="sref23" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shigematsu
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Dublineau
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sawoo
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Influenza A virus survival in water is influenced by the origin species of the host cell
        </article-title>
        <source>
         Influenza Other Respir Viruses
        </source>
        <volume>
         8
        </volume>
        <year>
         2014
        </year>
        <fpage>
         123
        </fpage>
        <lpage>
         130
        </lpage>
        <pub-id pub-id-type="pmid">
         24112132
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib24">
       <label>
        24
       </label>
       <element-citation id="sref24" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chmielewski
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Swayne
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Avian influenza: public health and food safety concerns
        </article-title>
        <source>
         Annu Rev Food Sci Technol
        </source>
        <volume>
         2
        </volume>
        <year>
         2011
        </year>
        <fpage>
         37
        </fpage>
        <lpage>
         57
        </lpage>
        <pub-id pub-id-type="pmid">
         22129374
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib25">
       <label>
        25
       </label>
       <element-citation id="sref25" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nazir
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Haumacher
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Ike
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Stumpf
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Bohm
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Marschang
          </surname>
          <given-names>
           R.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Long-term study on tenacity of avian influenza viruses in water (distilled water, normal saline, and surface water) at different temperatures
        </article-title>
        <source>
         Avian Dis
        </source>
        <volume>
         54
        </volume>
        <year>
         2010
        </year>
        <fpage>
         720
        </fpage>
        <lpage>
         724
        </lpage>
        <pub-id pub-id-type="pmid">
         20521721
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib26">
       <label>
        26
       </label>
       <element-citation id="sref26" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Jeon
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effects of air temperature and relative humidity on coronavirus survival on surfaces
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         76
        </volume>
        <year>
         2010
        </year>
        <fpage>
         2712
        </fpage>
        <lpage>
         2717
        </lpage>
        <pub-id pub-id-type="pmid">
         20228108
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib27">
       <label>
        27
       </label>
       <element-citation id="sref27" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Tillmann
          </surname>
          <given-names>
           R.L.
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Simon
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Schildgen
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of human metapneumovirus and human coronavirus NL63 on medical instruments and in the patient environment
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         69
        </volume>
        <year>
         2008
        </year>
        <fpage>
         406
        </fpage>
        <lpage>
         408
        </lpage>
        <pub-id pub-id-type="pmid">
         18541340
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib28">
       <label>
        28
       </label>
       <element-citation id="sref28" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.F.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bauer
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability and inactivation of SARS coronavirus
        </article-title>
        <source>
         Med Microbiol Immunol
        </source>
        <volume>
         194
        </volume>
        <year>
         2005
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         15118911
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib29">
       <label>
        29
       </label>
       <element-citation id="sref29" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           M.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of severe acute respiratory syndrome coronavirus
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         41
        </volume>
        <year>
         2005
        </year>
        <fpage>
         e67
        </fpage>
        <lpage>
         71
        </lpage>
        <pub-id pub-id-type="pmid">
         16142653
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib30">
       <label>
        30
       </label>
       <element-citation id="sref30" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Duan
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           X.S.
          </given-names>
         </name>
         <name>
          <surname>
           Wen
          </surname>
          <given-names>
           R.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation
        </article-title>
        <source>
         Biomed Environ Sci
        </source>
        <volume>
         16
        </volume>
        <year>
         2003
        </year>
        <fpage>
         246
        </fpage>
        <lpage>
         255
        </lpage>
        <pub-id pub-id-type="pmid">
         14631830
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib31">
       <label>
        31
       </label>
       <element-citation id="sref31" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M.W.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         46
        </volume>
        <year>
         2000
        </year>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="pmid">
         11023724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib32">
       <label>
        32
       </label>
       <element-citation id="sref32" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zuo
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           de Abin
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Chander
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kuehn
          </surname>
          <given-names>
           T.H.
          </given-names>
         </name>
         <name>
          <surname>
           Goyal
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Pui
          </surname>
          <given-names>
           D.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Comparison of spike and aerosol challenge tests for the recovery of viable influenza virus from non-woven fabrics
        </article-title>
        <source>
         Influenza Other Respi Viruses
        </source>
        <year>
         2013
        </year>
       </element-citation>
      </ref>
      <ref id="bib33">
       <label>
        33
       </label>
       <element-citation id="sref33" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mukherjee
          </surname>
          <given-names>
           D.V.
          </given-names>
         </name>
         <name>
          <surname>
           Cohen
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bovino
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Desai
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Whittier
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Larson
          </surname>
          <given-names>
           E.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of influenza virus on hands and fomites in community and laboratory settings
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         40
        </volume>
        <year>
         2012
        </year>
        <fpage>
         590
        </fpage>
        <lpage>
         594
        </lpage>
        <pub-id pub-id-type="pmid">
         22264744
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib34">
       <label>
        34
       </label>
       <element-citation id="sref34" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Greatorex
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Digard
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Curran
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of influenza A (H1N1) on materials found in households: implications for infection control
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         6
        </volume>
        <year>
         2011
        </year>
        <fpage>
         e27932
        </fpage>
        <pub-id pub-id-type="pmid">
         22132172
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib35">
       <label>
        35
       </label>
       <element-citation id="sref35" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dublineau
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Batejat
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Pinon
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Burguiere
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Leclercq
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Manuguerra
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Persistence of the 2009 pandemic influenza A (H1N1) virus in water and on non-porous surface
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         6
        </volume>
        <year>
         2011
        </year>
        <fpage>
         e28043
        </fpage>
        <pub-id pub-id-type="pmid">
         22132205
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib36">
       <label>
        36
       </label>
       <element-citation id="sref36" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wood
          </surname>
          <given-names>
           J.P.
          </given-names>
         </name>
         <name>
          <surname>
           Choi
          </surname>
          <given-names>
           Y.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chappie
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Rogers
          </surname>
          <given-names>
           J.V.
          </given-names>
         </name>
         <name>
          <surname>
           Kaye
          </surname>
          <given-names>
           J.Z.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental persistence of a highly pathogenic avian influenza (H5N1) virus
        </article-title>
        <source>
         Environ Sci Technol
        </source>
        <volume>
         44
        </volume>
        <year>
         2010
        </year>
        <fpage>
         7515
        </fpage>
        <lpage>
         7520
        </lpage>
        <pub-id pub-id-type="pmid">
         20815380
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib37">
       <label>
        37
       </label>
       <element-citation id="sref37" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sakaguchi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Wada
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Kajioka
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Maintenance of influenza virus infectivity on the surfaces of personal protective equipment and clothing used in healthcare settings
        </article-title>
        <source>
         Environ Health Prev Med
        </source>
        <volume>
         15
        </volume>
        <year>
         2010
        </year>
        <fpage>
         344
        </fpage>
        <lpage>
         349
        </lpage>
        <pub-id pub-id-type="pmid">
         21432565
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib38">
       <label>
        38
       </label>
       <element-citation id="sref38" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McDevitt
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Rudnick
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           First
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Spengler
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Role of absolute humidity in the inactivation of influenza viruses on stainless steel surfaces at elevated temperatures
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         76
        </volume>
        <year>
         2010
        </year>
        <fpage>
         3943
        </fpage>
        <lpage>
         3947
        </lpage>
        <pub-id pub-id-type="pmid">
         20435770
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib39">
       <label>
        39
       </label>
       <element-citation id="sref39" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Thomas
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Vogel
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Wunderli
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of influenza virus on banknotes
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         74
        </volume>
        <year>
         2008
        </year>
        <fpage>
         3002
        </fpage>
        <lpage>
         3007
        </lpage>
        <pub-id pub-id-type="pmid">
         18359825
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib40">
       <label>
        40
       </label>
       <element-citation id="sref40" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Noyce
          </surname>
          <given-names>
           J.O.
          </given-names>
         </name>
         <name>
          <surname>
           Michels
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Keevil
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of influenza A virus on copper versus stainless steel surfaces
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         73
        </volume>
        <year>
         2007
        </year>
        <fpage>
         2748
        </fpage>
        <lpage>
         2750
        </lpage>
        <pub-id pub-id-type="pmid">
         17259354
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib41">
       <label>
        41
       </label>
       <element-citation id="sref41" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tiwari
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Patnayak
          </surname>
          <given-names>
           D.P.
          </given-names>
         </name>
         <name>
          <surname>
           Chander
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Parsad
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Goyal
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of two avian respiratory viruses on porous and nonporous surfaces
        </article-title>
        <source>
         Avian Dis
        </source>
        <volume>
         50
        </volume>
        <year>
         2006
        </year>
        <fpage>
         284
        </fpage>
        <lpage>
         287
        </lpage>
        <pub-id pub-id-type="pmid">
         16863083
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib42">
       <label>
        42
       </label>
       <element-citation id="sref42" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bean
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Moore
          </surname>
          <given-names>
           B.M.
          </given-names>
         </name>
         <name>
          <surname>
           Sterner
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Peterson
          </surname>
          <given-names>
           L.R.
          </given-names>
         </name>
         <name>
          <surname>
           Gerding
          </surname>
          <given-names>
           D.N.
          </given-names>
         </name>
         <name>
          <surname>
           Balfour
          </surname>
          <given-names>
           H.H.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
        </person-group>
        <article-title>
         Survival of influenza viruses on environmental surfaces
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         146
        </volume>
        <year>
         1982
        </year>
        <fpage>
         47
        </fpage>
        <lpage>
         51
        </lpage>
        <pub-id pub-id-type="pmid">
         6282993
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib43">
       <label>
        43
       </label>
       <element-citation id="sref43" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus survival on healthcare personal protective equipment
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <volume>
         31
        </volume>
        <year>
         2010
        </year>
        <fpage>
         560
        </fpage>
        <lpage>
         561
        </lpage>
        <pub-id pub-id-type="pmid">
         20350196
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib44">
       <label>
        44
       </label>
       <element-citation id="sref44" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dowell
          </surname>
          <given-names>
           S.F.
          </given-names>
         </name>
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus on hospital surfaces
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         39
        </volume>
        <year>
         2004
        </year>
        <fpage>
         652
        </fpage>
        <lpage>
         657
        </lpage>
        <pub-id pub-id-type="pmid">
         15356778
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib45">
       <label>
        45
       </label>
       <element-citation id="sref45" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Goyal
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chander
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluating the virucidal efficacy of hydrogen peroxide vapour
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         86
        </volume>
        <year>
         2014
        </year>
        <fpage>
         255
        </fpage>
        <lpage>
         259
        </lpage>
        <pub-id pub-id-type="pmid">
         24656442
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib46">
       <label>
        46
       </label>
       <element-citation id="sref46" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Parker
          </surname>
          <given-names>
           E.R.
          </given-names>
         </name>
         <name>
          <surname>
           Dunham
          </surname>
          <given-names>
           W.B.
          </given-names>
         </name>
         <name>
          <surname>
           MacNeal
          </surname>
          <given-names>
           W.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Resistance of the Melbourne strain of influenza virus to desiccation
        </article-title>
        <source>
         J Lab Clin Med
        </source>
        <volume>
         29
        </volume>
        <year>
         1944
        </year>
        <fpage>
         37
        </fpage>
        <lpage>
         42
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib47">
       <label>
        47
       </label>
       <element-citation id="sref47" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Musher
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         How contagious are common respiratory tract infections?
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         348
        </volume>
        <year>
         2003
        </year>
        <fpage>
         1256
        </fpage>
        <lpage>
         1266
        </lpage>
        <pub-id pub-id-type="pmid">
         12660390
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib48">
       <label>
        48
       </label>
       <element-citation id="sref48" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gerone
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
         <name>
          <surname>
           Couch
          </surname>
          <given-names>
           R.B.
          </given-names>
         </name>
         <name>
          <surname>
           Keefer
          </surname>
          <given-names>
           G.V.
          </given-names>
         </name>
         <name>
          <surname>
           Douglas
          </surname>
          <given-names>
           R.G.
          </given-names>
         </name>
         <name>
          <surname>
           Derrenbacher
          </surname>
          <given-names>
           E.B.
          </given-names>
         </name>
         <name>
          <surname>
           Knight
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Assessment of experimental and natural viral aerosols
        </article-title>
        <source>
         Bacteriol Rev
        </source>
        <volume>
         30
        </volume>
        <year>
         1966
        </year>
        <fpage>
         576
        </fpage>
        <lpage>
         588
        </lpage>
        <pub-id pub-id-type="pmid">
         5917337
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib49">
       <label>
        49
       </label>
       <element-citation id="sref49" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tran
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Cimon
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Severn
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Pessoa-Silva
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Conly
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         7
        </volume>
        <year>
         2012
        </year>
        <fpage>
         e35797
        </fpage>
        <pub-id pub-id-type="pmid">
         22563403
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib50">
       <label>
        50
       </label>
       <element-citation id="sref50" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bischoff
          </surname>
          <given-names>
           W.E.
          </given-names>
         </name>
         <name>
          <surname>
           Swett
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Leng
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Peters
          </surname>
          <given-names>
           T.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Exposure to influenza virus aerosols during routine patient care
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         207
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1037
        </fpage>
        <lpage>
         1046
        </lpage>
        <pub-id pub-id-type="pmid">
         23372182
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib51">
       <label>
        51
       </label>
       <element-citation id="sref51" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Thompson
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
         <name>
          <surname>
           Pappachan
          </surname>
          <given-names>
           J.V.
          </given-names>
         </name>
         <name>
          <surname>
           Bennett
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic – the risk of aerosol generation during medical procedures
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         8
        </volume>
        <year>
         2013
        </year>
        <fpage>
         e56278
        </fpage>
        <pub-id pub-id-type="pmid">
         23418548
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib52">
       <label>
        52
       </label>
       <element-citation id="sref52" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ijaz
          </surname>
          <given-names>
           M.K.
          </given-names>
         </name>
         <name>
          <surname>
           Brunner
          </surname>
          <given-names>
           A.H.
          </given-names>
         </name>
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Nair
          </surname>
          <given-names>
           R.C.
          </given-names>
         </name>
         <name>
          <surname>
           Johnson-Lussenburg
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival characteristics of airborne human coronavirus 229E
        </article-title>
        <source>
         J Gen Virol
        </source>
        <volume>
         66
        </volume>
        <issue>
         Pt 12
        </issue>
        <year>
         1985
        </year>
        <fpage>
         2743
        </fpage>
        <lpage>
         2748
        </lpage>
        <pub-id pub-id-type="pmid">
         2999318
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib53">
       <label>
        53
       </label>
       <element-citation id="sref53" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Schaffer
          </surname>
          <given-names>
           F.L.
          </given-names>
         </name>
         <name>
          <surname>
           Soergel
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Straube
          </surname>
          <given-names>
           D.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids
        </article-title>
        <source>
         Arch Virol
        </source>
        <volume>
         51
        </volume>
        <year>
         1976
        </year>
        <fpage>
         263
        </fpage>
        <lpage>
         273
        </lpage>
        <pub-id pub-id-type="pmid">
         987765
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib54">
       <label>
        54
       </label>
       <element-citation id="sref54" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mitchell
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
         <name>
          <surname>
           Guerin
          </surname>
          <given-names>
           L.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Influenza A of human, swine, equine and avian origin: comparison of survival in aerosol form
        </article-title>
        <source>
         Can J Comp Med
        </source>
        <volume>
         36
        </volume>
        <year>
         1972
        </year>
        <fpage>
         9
        </fpage>
        <lpage>
         11
        </lpage>
        <pub-id pub-id-type="pmid">
         4258552
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib55">
       <label>
        55
       </label>
       <element-citation id="sref55" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tellier
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Review of aerosol transmission of influenza A virus
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         12
        </volume>
        <year>
         2006
        </year>
        <fpage>
         1657
        </fpage>
        <lpage>
         1662
        </lpage>
        <pub-id pub-id-type="pmid">
         17283614
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib56">
       <label>
        56
       </label>
       <element-citation id="sref56" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Indriani
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Samaan
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Gultom
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental sampling for avian influenza virus A (H5N1) in live-bird markets, Indonesia
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         16
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1889
        </fpage>
        <lpage>
         1895
        </lpage>
        <pub-id pub-id-type="pmid">
         21122218
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib57">
       <label>
        57
       </label>
       <element-citation id="sref57" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Killingley
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Greatorex
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Cauchemez
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
        </article-title>
        <source>
         Health Technol Assess
        </source>
        <volume>
         14
        </volume>
        <year>
         2010
        </year>
        <fpage>
         237
        </fpage>
        <lpage>
         354
        </lpage>
        <pub-id pub-id-type="pmid">
         20923613
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib58">
       <label>
        58
       </label>
       <element-citation id="sref58" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Suntarattiwong
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Levy
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Influenza virus contamination of common household surfaces during the 2009 influenza A (H1N1) pandemic in Bangkok, Thailand: implications for contact transmission
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         51
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1053
        </fpage>
        <lpage>
         1061
        </lpage>
        <pub-id pub-id-type="pmid">
         20879867
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib59">
       <label>
        59
       </label>
       <element-citation id="sref59" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pappas
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Hendley
          </surname>
          <given-names>
           J.O.
          </given-names>
         </name>
         <name>
          <surname>
           Schwartz
          </surname>
          <given-names>
           R.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Respiratory viral RNA on toys in pediatric office waiting rooms
        </article-title>
        <source>
         Pediatr Infect Dis J
        </source>
        <volume>
         29
        </volume>
        <year>
         2010
        </year>
        <fpage>
         102
        </fpage>
        <lpage>
         104
        </lpage>
        <pub-id pub-id-type="pmid">
         20135827
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib60">
       <label>
        60
       </label>
       <element-citation id="sref60" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bright
          </surname>
          <given-names>
           K.R.
          </given-names>
         </name>
         <name>
          <surname>
           Boone
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Occurrence of bacteria and viruses on elementary classroom surfaces and the potential role of classroom hygiene in the spread of infectious diseases
        </article-title>
        <source>
         J Sch Nurs
        </source>
        <volume>
         26
        </volume>
        <year>
         2010
        </year>
        <fpage>
         33
        </fpage>
        <lpage>
         41
        </lpage>
        <pub-id pub-id-type="pmid">
         19903773
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib61">
       <label>
        61
       </label>
       <element-citation id="sref61" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Macias
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           de la Torre
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Moreno-Espinosa
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Leal
          </surname>
          <given-names>
           P.E.
          </given-names>
         </name>
         <name>
          <surname>
           Bourlon
          </surname>
          <given-names>
           M.T.
          </given-names>
         </name>
         <name>
          <surname>
           Ruiz-Palacios
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Controlling the novel A (H1N1) influenza virus: don't touch your face!
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         73
        </volume>
        <year>
         2009
        </year>
        <fpage>
         280
        </fpage>
        <lpage>
         281
        </lpage>
        <pub-id pub-id-type="pmid">
         19699011
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib62">
       <label>
        62
       </label>
       <element-citation id="sref62" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boone
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The occurrence of influenza A virus on household and day care center fomites
        </article-title>
        <source>
         J Infect
        </source>
        <volume>
         51
        </volume>
        <year>
         2005
        </year>
        <fpage>
         103
        </fpage>
        <lpage>
         109
        </lpage>
        <pub-id pub-id-type="pmid">
         16038759
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib63">
       <label>
        63
       </label>
       <element-citation id="sref63" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Booth
          </surname>
          <given-names>
           T.F.
          </given-names>
         </name>
         <name>
          <surname>
           Kournikakis
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bastien
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         191
        </volume>
        <year>
         2005
        </year>
        <fpage>
         1472
        </fpage>
        <lpage>
         1477
        </lpage>
        <pub-id pub-id-type="pmid">
         15809906
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib64">
       <label>
        64
       </label>
       <element-citation id="sref64" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Almasri
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Assirri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental sampling for respiratory pathogens in Jeddah airport during the 2013 Hajj season
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         42
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1266
        </fpage>
        <lpage>
         1269
        </lpage>
        <pub-id pub-id-type="pmid">
         25465254
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib65">
       <label>
        65
       </label>
       <element-citation id="sref65" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gwaltney
          </surname>
          <given-names>
           J.M.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
         <name>
          <surname>
           Hendley
          </surname>
          <given-names>
           J.O.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission of experimental rhinovirus infection by contaminated surfaces
        </article-title>
        <source>
         Am J Epidemiol
        </source>
        <volume>
         116
        </volume>
        <year>
         1982
        </year>
        <fpage>
         828
        </fpage>
        <lpage>
         833
        </lpage>
        <pub-id pub-id-type="pmid">
         6293304
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib66">
       <label>
        66
       </label>
       <element-citation id="sref66" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abad
          </surname>
          <given-names>
           F.X.
          </given-names>
         </name>
         <name>
          <surname>
           Pinto
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
         <name>
          <surname>
           Bosch
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of enteric viruses on environmental fomites
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <volume>
         60
        </volume>
        <year>
         1994
        </year>
        <fpage>
         3704
        </fpage>
        <lpage>
         3710
        </lpage>
        <pub-id pub-id-type="pmid">
         7986043
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib67">
       <label>
        67
       </label>
       <element-citation id="sref67" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Respiratory syncytial virus: its transmission in the hospital environment
        </article-title>
        <source>
         Yale J Biol Med
        </source>
        <volume>
         55
        </volume>
        <year>
         1982
        </year>
        <fpage>
         219
        </fpage>
        <lpage>
         223
        </lpage>
        <pub-id pub-id-type="pmid">
         6758370
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib68">
       <label>
        68
       </label>
       <element-citation id="sref68" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           J.W.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           D.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         SARS: clinical presentation, transmission, pathogenesis and treatment options
        </article-title>
        <source>
         Clin Sci (Lond)
        </source>
        <volume>
         110
        </volume>
        <year>
         2006
        </year>
        <fpage>
         193
        </fpage>
        <lpage>
         204
        </lpage>
        <pub-id pub-id-type="pmid">
         16411895
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib69">
       <label>
        69
       </label>
       <element-citation id="sref69" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viral loads in clinical specimens and SARS manifestations
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <year>
         2004
        </year>
        <fpage>
         1550
        </fpage>
        <lpage>
         1557
        </lpage>
        <pub-id pub-id-type="pmid">
         15498155
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib70">
       <label>
        70
       </label>
       <element-citation id="sref70" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.M.
          </given-names>
         </name>
         <name>
          <surname>
           Herbst
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Kousoulas
          </surname>
          <given-names>
           K.G.
          </given-names>
         </name>
         <name>
          <surname>
           Storz
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child
        </article-title>
        <source>
         J Med Virol
        </source>
        <volume>
         44
        </volume>
        <year>
         1994
        </year>
        <fpage>
         152
        </fpage>
        <lpage>
         161
        </lpage>
        <pub-id pub-id-type="pmid">
         7852955
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib71">
       <label>
        71
       </label>
       <element-citation id="sref71" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Dina
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gouarin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Petitjean
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Corbet
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of the new human coronavirus HKU1: a report of 6 cases
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         42
        </volume>
        <year>
         2006
        </year>
        <fpage>
         634
        </fpage>
        <lpage>
         639
        </lpage>
        <pub-id pub-id-type="pmid">
         16447108
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib72">
       <label>
        72
       </label>
       <element-citation id="sref72" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <year>
         2003
        </year>
        <fpage>
         1767
        </fpage>
        <lpage>
         1772
        </lpage>
        <pub-id pub-id-type="pmid">
         12781535
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib73">
       <label>
        73
       </label>
       <element-citation id="sref73" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pinsky
          </surname>
          <given-names>
           B.A.
          </given-names>
         </name>
         <name>
          <surname>
           Mix
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rowe
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Ikemoto
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Baron
          </surname>
          <given-names>
           E.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Long-term shedding of influenza A virus in stool of immunocompromised child
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         16
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1165
        </fpage>
        <lpage>
         1167
        </lpage>
        <pub-id pub-id-type="pmid">
         20587197
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib74">
       <label>
        74
       </label>
       <element-citation id="sref74" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           M.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           T.F.
          </given-names>
         </name>
         <name>
          <surname>
           Sung
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms
        </article-title>
        <source>
         J Clin Virol
        </source>
        <volume>
         45
        </volume>
        <year>
         2009
        </year>
        <fpage>
         208
        </fpage>
        <lpage>
         211
        </lpage>
        <pub-id pub-id-type="pmid">
         19540157
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib75">
       <label>
        75
       </label>
       <element-citation id="sref75" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kaiser
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Fritz
          </surname>
          <given-names>
           R.S.
          </given-names>
         </name>
         <name>
          <surname>
           Straus
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Gubareva
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Hayden
          </surname>
          <given-names>
           F.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses
        </article-title>
        <source>
         J Med Virol
        </source>
        <volume>
         64
        </volume>
        <year>
         2001
        </year>
        <fpage>
         262
        </fpage>
        <lpage>
         268
        </lpage>
        <pub-id pub-id-type="pmid">
         11424113
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib76">
       <label>
        76
       </label>
       <element-citation id="sref76" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Douglas
          </surname>
          <given-names>
           R.G.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
         <name>
          <surname>
           Geiman
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Meagher
          </surname>
          <given-names>
           M.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viral shedding patterns of children with influenza B infection
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         140
        </volume>
        <year>
         1979
        </year>
        <fpage>
         610
        </fpage>
        <lpage>
         613
        </lpage>
        <pub-id pub-id-type="pmid">
         512419
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib77">
       <label>
        77
       </label>
       <element-citation id="sref77" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Seilmaier
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         13
        </volume>
        <year>
         2013
        </year>
        <fpage>
         745
        </fpage>
        <lpage>
         751
        </lpage>
        <pub-id pub-id-type="pmid">
         23782859
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib78">
       <label>
        78
       </label>
       <element-citation id="sref78" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guery
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           el Mansouf
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         381
        </volume>
        <year>
         2013
        </year>
        <fpage>
         2265
        </fpage>
        <lpage>
         2272
        </lpage>
        <pub-id pub-id-type="pmid">
         23727167
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib79">
       <label>
        79
       </label>
       <element-citation id="sref79" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Watanabe
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Bartrand
          </surname>
          <given-names>
           T.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weir
          </surname>
          <given-names>
           M.H.
          </given-names>
         </name>
         <name>
          <surname>
           Omura
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Haas
          </surname>
          <given-names>
           C.N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of a dose–response model for SARS coronavirus
        </article-title>
        <source>
         Risk Anal
        </source>
        <volume>
         30
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1129
        </fpage>
        <lpage>
         1138
        </lpage>
        <pub-id pub-id-type="pmid">
         20497390
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib80">
       <label>
        80
       </label>
       <element-citation id="sref80" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Oelberg
          </surname>
          <given-names>
           D.G.
          </given-names>
         </name>
         <name>
          <surname>
           Joyner
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Laborde
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Islam
          </surname>
          <given-names>
           M.P.
          </given-names>
         </name>
         <name>
          <surname>
           Pickering
          </surname>
          <given-names>
           L.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of pathogen transmission in neonatal nurseries using DNA markers as surrogate indicators
        </article-title>
        <source>
         Pediatrics
        </source>
        <volume>
         105
        </volume>
        <year>
         2000
        </year>
        <fpage>
         311
        </fpage>
        <lpage>
         315
        </lpage>
        <pub-id pub-id-type="pmid">
         10654947
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib81">
       <label>
        81
       </label>
       <element-citation id="sref81" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barker
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Vipond
          </surname>
          <given-names>
           I.B.
          </given-names>
         </name>
         <name>
          <surname>
           Bloomfield
          </surname>
          <given-names>
           S.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         58
        </volume>
        <year>
         2004
        </year>
        <fpage>
         42
        </fpage>
        <lpage>
         49
        </lpage>
        <pub-id pub-id-type="pmid">
         15350713
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib82">
       <label>
        82
       </label>
       <element-citation id="sref82" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guerrero
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Nerandzic
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Jury
          </surname>
          <given-names>
           L.A.
          </given-names>
         </name>
         <name>
          <surname>
           Jinno
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Donskey
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acquisition of spores on gloved hands after contact with the skin of patients with
         <italic>
          Clostridium difficile
         </italic>
         infection and with environmental surfaces in their rooms
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         40
        </volume>
        <year>
         2012
        </year>
        <fpage>
         556
        </fpage>
        <lpage>
         558
        </lpage>
        <pub-id pub-id-type="pmid">
         21982209
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib83">
       <label>
        83
       </label>
       <element-citation id="sref83" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rusin
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Maxwell
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Comparative surface-to-hand and fingertip-to-mouth transfer efficiency of gram-positive bacteria, gram-negative bacteria, and phage
        </article-title>
        <source>
         J Appl Microbiol
        </source>
        <volume>
         93
        </volume>
        <year>
         2002
        </year>
        <fpage>
         585
        </fpage>
        <lpage>
         592
        </lpage>
        <pub-id pub-id-type="pmid">
         12234341
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib84">
       <label>
        84
       </label>
       <element-citation id="sref84" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Dai
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Goldblatt
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pathogen transmission in child care settings studied by using a cauliflower virus DNA as a surrogate marker
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         177
        </volume>
        <year>
         1998
        </year>
        <fpage>
         881
        </fpage>
        <lpage>
         888
        </lpage>
        <pub-id pub-id-type="pmid">
         9534959
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib85">
       <label>
        85
       </label>
       <element-citation id="sref85" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rheinbaben
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Schunemann
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Gross
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Wolff
          </surname>
          <given-names>
           M.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission of viruses via contact in a household setting: experiments using bacteriophage straight phiX174 as a model virus
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         46
        </volume>
        <year>
         2000
        </year>
        <fpage>
         61
        </fpage>
        <lpage>
         66
        </lpage>
        <pub-id pub-id-type="pmid">
         11023725
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib86">
       <label>
        86
       </label>
       <element-citation id="sref86" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nagata
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Iwata
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Hasegawa
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes
        </article-title>
        <source>
         Int J Exp Pathol
        </source>
        <volume>
         88
        </volume>
        <year>
         2007
        </year>
        <fpage>
         403
        </fpage>
        <lpage>
         414
        </lpage>
        <pub-id pub-id-type="pmid">
         18039277
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib87">
       <label>
        87
       </label>
       <element-citation id="sref87" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McAuliffe
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Vogel
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Roberts
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
        </article-title>
        <source>
         Virology
        </source>
        <volume>
         330
        </volume>
        <year>
         2004
        </year>
        <fpage>
         8
        </fpage>
        <lpage>
         15
        </lpage>
        <pub-id pub-id-type="pmid">
         15527829
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib88">
       <label>
        88
       </label>
       <element-citation id="sref88" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Henle
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Henle
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Stokes
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Maris
          </surname>
          <given-names>
           E.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Experimental exposure of human subjects to viruses of influenza
        </article-title>
        <source>
         J Immunol
        </source>
        <volume>
         52
        </volume>
        <year>
         1946
        </year>
        <fpage>
         145
        </fpage>
        <lpage>
         165
        </lpage>
        <pub-id pub-id-type="pmid">
         21018818
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib89">
       <label>
        89
       </label>
       <element-citation id="sref89" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Frankova
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inhalatory infection of mice with influenza A0/PR8 virus. I. The site of primary virus replication and its spread in the respiratory tract
        </article-title>
        <source>
         Acta Virol
        </source>
        <volume>
         19
        </volume>
        <year>
         1975
        </year>
        <fpage>
         29
        </fpage>
        <lpage>
         34
        </lpage>
        <pub-id pub-id-type="pmid">
         235194
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib90">
       <label>
        90
       </label>
       <element-citation id="sref90" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Qin
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Wei
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
        </person-group>
        <article-title>
         An animal model of SARS produced by infection of
         <italic>
          Macaca mulatta
         </italic>
         with SARS coronavirus
        </article-title>
        <source>
         J Pathol
        </source>
        <volume>
         206
        </volume>
        <year>
         2005
        </year>
        <fpage>
         251
        </fpage>
        <lpage>
         259
        </lpage>
        <pub-id pub-id-type="pmid">
         15892035
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib91">
       <label>
        91
       </label>
       <element-citation id="sref91" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Quan
          </surname>
          <given-names>
           F.S.
          </given-names>
         </name>
         <name>
          <surname>
           Compans
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Oral vaccination with inactivated influenza vaccine induces cross-protective immunity
        </article-title>
        <source>
         Vaccine
        </source>
        <volume>
         30
        </volume>
        <year>
         2012
        </year>
        <fpage>
         180
        </fpage>
        <lpage>
         188
        </lpage>
        <pub-id pub-id-type="pmid">
         22107852
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib92">
       <label>
        92
       </label>
       <element-citation id="sref92" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           VanDalen
          </surname>
          <given-names>
           K.K.
          </given-names>
         </name>
         <name>
          <surname>
           Franklin
          </surname>
          <given-names>
           A.B.
          </given-names>
         </name>
         <name>
          <surname>
           Mooers
          </surname>
          <given-names>
           N.L.
          </given-names>
         </name>
         <name>
          <surname>
           Sullivan
          </surname>
          <given-names>
           H.J.
          </given-names>
         </name>
         <name>
          <surname>
           Shriner
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Shedding light on avian influenza H4N6 infection in mallards: modes of transmission and implications for surveillance
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         5
        </volume>
        <year>
         2010
        </year>
        <fpage>
         e12851
        </fpage>
        <pub-id pub-id-type="pmid">
         20877466
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib93">
       <label>
        93
       </label>
       <element-citation id="sref93" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Kleef
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Robotham
          </surname>
          <given-names>
           J.V.
          </given-names>
         </name>
         <name>
          <surname>
           Jit
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Deeny
          </surname>
          <given-names>
           S.R.
          </given-names>
         </name>
         <name>
          <surname>
           Edmunds
          </surname>
          <given-names>
           W.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Modelling the transmission of healthcare associated infections: a systematic review
        </article-title>
        <source>
         BMC Infect Dis
        </source>
        <volume>
         13
        </volume>
        <year>
         2013
        </year>
        <fpage>
         294
        </fpage>
        <pub-id pub-id-type="pmid">
         23809195
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib94">
       <label>
        94
       </label>
       <element-citation id="sref94" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mubareka
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Lowen
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Steel
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Coates
          </surname>
          <given-names>
           A.L.
          </given-names>
         </name>
         <name>
          <surname>
           Garcia-Sastre
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Palese
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission of influenza virus via aerosols and fomites in the guinea pig model
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         199
        </volume>
        <year>
         2009
        </year>
        <fpage>
         858
        </fpage>
        <lpage>
         865
        </lpage>
        <pub-id pub-id-type="pmid">
         19434931
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib95">
       <label>
        95
       </label>
       <element-citation id="sref95" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kwok
          </surname>
          <given-names>
           K.O.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           W.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Riley
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Using models to identify routes of nosocomial infection: a large hospital outbreak of SARS in Hong Kong
        </article-title>
        <source>
         Proc Biol Sci
        </source>
        <volume>
         274
        </volume>
        <year>
         2007
        </year>
        <fpage>
         611
        </fpage>
        <lpage>
         617
        </lpage>
        <pub-id pub-id-type="pmid">
         17254984
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib96">
       <label>
        96
       </label>
       <element-citation id="sref96" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Atkinson
          </surname>
          <given-names>
           M.P.
          </given-names>
         </name>
         <name>
          <surname>
           Wein
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Quantifying the routes of transmission for pandemic influenza
        </article-title>
        <source>
         Bull Math Biol
        </source>
        <volume>
         70
        </volume>
        <year>
         2008
        </year>
        <fpage>
         820
        </fpage>
        <lpage>
         867
        </lpage>
        <pub-id pub-id-type="pmid">
         18278533
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib97">
       <label>
        97
       </label>
       <element-citation id="sref97" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nicas
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Jones
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Relative contributions of four exposure pathways to influenza infection risk
        </article-title>
        <source>
         Risk Anal
        </source>
        <volume>
         29
        </volume>
        <year>
         2009
        </year>
        <fpage>
         1292
        </fpage>
        <lpage>
         1303
        </lpage>
        <pub-id pub-id-type="pmid">
         19558389
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib98">
       <label>
        98
       </label>
       <element-citation id="sref98" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Eisenberg
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
         <name>
          <surname>
           Spicknall
          </surname>
          <given-names>
           I.H.
          </given-names>
         </name>
         <name>
          <surname>
           Koopman
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Dynamics and control of infections transmitted from person to person through the environment
        </article-title>
        <source>
         Am J Epidemiol
        </source>
        <volume>
         170
        </volume>
        <year>
         2009
        </year>
        <fpage>
         257
        </fpage>
        <lpage>
         265
        </lpage>
        <pub-id pub-id-type="pmid">
         19474071
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib99">
       <label>
        99
       </label>
       <element-citation id="sref99" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Eisenberg
          </surname>
          <given-names>
           J.E.
          </given-names>
         </name>
         <name>
          <surname>
           Spicknall
          </surname>
          <given-names>
           I.H.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Koopman
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Model analysis of fomite mediated influenza transmission
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         7
        </volume>
        <year>
         2012
        </year>
        <fpage>
         e51984
        </fpage>
        <pub-id pub-id-type="pmid">
         23300585
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib100">
       <label>
        100
       </label>
       <element-citation id="sref100" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lowen
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Steel
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Mubareka
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Palese
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         82
        </volume>
        <year>
         2008
        </year>
        <fpage>
         5650
        </fpage>
        <lpage>
         5652
        </lpage>
        <pub-id pub-id-type="pmid">
         18367530
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib101">
       <label>
        101
       </label>
       <element-citation id="sref101" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cowling
          </surname>
          <given-names>
           B.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Fang
          </surname>
          <given-names>
           V.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial
        </article-title>
        <source>
         Ann Intern Med
        </source>
        <volume>
         151
        </volume>
        <year>
         2009
        </year>
        <fpage>
         437
        </fpage>
        <lpage>
         446
        </lpage>
        <pub-id pub-id-type="pmid">
         19652172
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib102">
       <label>
        102
       </label>
       <element-citation id="sref102" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Apisarnthanarak
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Apisarnthanarak
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Cheevakumjorn
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Mundy
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Intervention with an infection control bundle to reduce transmission of influenza-like illnesses in a Thai preschool
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <volume>
         30
        </volume>
        <year>
         2009
        </year>
        <fpage>
         817
        </fpage>
        <lpage>
         822
        </lpage>
        <pub-id pub-id-type="pmid">
         19614542
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib103">
       <label>
        103
       </label>
       <element-citation id="sref103" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <year>
         2003
        </year>
        <fpage>
         1519
        </fpage>
        <lpage>
         1520
        </lpage>
        <pub-id pub-id-type="pmid">
         12737864
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib104">
       <label>
        104
       </label>
       <element-citation id="sref104" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Beam
          </surname>
          <given-names>
           E.L.
          </given-names>
         </name>
         <name>
          <surname>
           Gibbs
          </surname>
          <given-names>
           S.G.
          </given-names>
         </name>
         <name>
          <surname>
           Boulter
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Beckerdite
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           P.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A method for evaluating health care workers' personal protective equipment technique
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         39
        </volume>
        <year>
         2011
        </year>
        <fpage>
         415
        </fpage>
        <lpage>
         420
        </lpage>
        <pub-id pub-id-type="pmid">
         21255874
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib105">
       <label>
        105
       </label>
       <element-citation id="sref105" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Johnson
          </surname>
          <given-names>
           D.W.
          </given-names>
         </name>
         <name>
          <surname>
           Sullivan
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
         <name>
          <surname>
           Piquette
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lessons learned: critical care management of patients with Ebola in the United States
        </article-title>
        <source>
         Crit Care Med
        </source>
        <volume>
         43
        </volume>
        <year>
         2015
        </year>
        <fpage>
         1157
        </fpage>
        <lpage>
         1164
        </lpage>
        <pub-id pub-id-type="pmid">
         25756410
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib106">
       <label>
        106
       </label>
       <element-citation id="sref106" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hulkower
          </surname>
          <given-names>
           R.L.
          </given-names>
         </name>
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of surrogate coronaviruses on hard surfaces by health care germicides
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         39
        </volume>
        <year>
         2011
        </year>
        <fpage>
         401
        </fpage>
        <lpage>
         407
        </lpage>
        <pub-id pub-id-type="pmid">
         21256627
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib107">
       <label>
        107
       </label>
       <element-citation id="sref107" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jeong
          </surname>
          <given-names>
           E.K.
          </given-names>
         </name>
         <name>
          <surname>
           Bae
          </surname>
          <given-names>
           J.E.
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           I.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of influenza A virus H1N1 by disinfection process
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         38
        </volume>
        <year>
         2010
        </year>
        <fpage>
         354
        </fpage>
        <lpage>
         360
        </lpage>
        <pub-id pub-id-type="pmid">
         20430477
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib108">
       <label>
        108
       </label>
       <element-citation id="sref108" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Perl
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Barbut
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           French
          </surname>
          <given-names>
           G.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Is there a role for “no-touch” automated room disinfection systems in infection prevention and control?
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         83
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         13
        </lpage>
        <pub-id pub-id-type="pmid">
         23195691
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib109">
       <label>
        109
       </label>
       <element-citation id="sref109" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carling
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Parry
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Rupp
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Po
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Dick
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Von Beheren
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Improving cleaning of the environment surrounding patients in 36 acute care hospitals
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <volume>
         29
        </volume>
        <year>
         2008
        </year>
        <fpage>
         1035
        </fpage>
        <lpage>
         1041
        </lpage>
        <pub-id pub-id-type="pmid">
         18851687
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib110">
       <label>
        110
       </label>
       <element-citation id="sref110" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Anonymous
          </surname>
         </name>
        </person-group>
        <article-title>
         Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel
        </article-title>
        <source>
         Miss RN
        </source>
        <volume>
         71
        </volume>
        <year>
         2009
        </year>
        <fpage>
         13
        </fpage>
        <lpage>
         18
        </lpage>
        <pub-id pub-id-type="pmid">
         20066893
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib111">
       <label>
        111
       </label>
       <element-citation id="sref111" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Viscusi
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Bergman
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
         <name>
          <surname>
           Eimer
          </surname>
          <given-names>
           B.C.
          </given-names>
         </name>
         <name>
          <surname>
           Shaffer
          </surname>
          <given-names>
           R.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of five decontamination methods for filtering facepiece respirators
        </article-title>
        <source>
         Ann Occup Hyg
        </source>
        <volume>
         53
        </volume>
        <year>
         2009
        </year>
        <fpage>
         815
        </fpage>
        <lpage>
         827
        </lpage>
        <pub-id pub-id-type="pmid">
         19805391
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
     <sec id="appsec1">
      <label>
       Appendix A
      </label>
      <title>
       PubMed searches
      </title>
      <p id="p0235">
       coronavirus survival surfaces (June 11th, 2013: 9 studies)
      </p>
      <p id="p0240">
       influenza survival surfaces (June 11th, 2013: 29 studies)
      </p>
      <p id="p0245">
       coronavirus fomite transmission (June 20th, 2013: 8 studies)
      </p>
      <p id="p0250">
       influenza virus fomite transmission (June 20th, 2013: 43 studies)
      </p>
      <p id="p0255">
       coronavirus surface contamination (June 20th, 2013: 4 studies)
      </p>
      <p id="p0260">
       influenza virus surface contamination (June 20th, 2013: 14 studies)
      </p>
      <p id="p0265">
       disinfection influenza transmission (June 04th, 2014: 112 studies)
      </p>
      <p id="p0270">
       disinfection SARS transmission (June 04th, 2014: 35 studies)
      </p>
      <p id="p0275">
       Updated May 21st, 2014
      </p>
     </sec>
     <fn-group>
      <fn id="d32e2222">
       <label>
        ☆
       </label>
       <p id="ntpara0010">
        This work was presented in part at the Infection Prevention Society Conference, Glasgow, September 29th to October 1st, 2014.
       </p>
      </fn>
     </fn-group>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Food Microbiol
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Food Microbiol
      </journal-id>
      <journal-title-group>
       <journal-title>
        Food Microbiology
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0740-0020
      </issn>
      <issn pub-type="epub">
       1095-9998
      </issn>
      <publisher>
       <publisher-name>
        Elsevier
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       22265299
      </article-id>
      <article-id pub-id-type="pmc">
       4980993
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0740-0020(11)00281-4
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.fm.2011.12.009
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Stability of bovine coronavirus on lettuce surfaces under household refrigeration conditions
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="au1">
        <name>
         <surname>
          Mullis
         </surname>
         <given-names>
          Lisa
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au2">
        <name>
         <surname>
          Saif
         </surname>
         <given-names>
          Linda J.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au3">
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          Yongbin
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au4">
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          Xuming
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au5">
        <name>
         <surname>
          Azevedo
         </surname>
         <given-names>
          Marli S.P.
         </given-names>
        </name>
        <email>
         marli.azevedo@fda.hhs.gov
        </email>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
        <xref ref-type="corresp" rid="cor1">
         ∗
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        a
       </label>
       National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA
      </aff>
      <aff id="aff2">
       <label>
        b
       </label>
       Food Animal Health Research Program, OARDC, The Ohio State University, Wooster, OH 44691, USA
      </aff>
      <aff id="aff3">
       <label>
        c
       </label>
       Department of Microbiology and Immunology, University of Arkansas for Medical Science, Little Rock, AR 72205, USA
      </aff>
      <author-notes>
       <corresp id="cor1">
        <label>
         ∗
        </label>
        Corresponding author. 3900 NCTR Rd, HFT-250, Division of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079-9502, USA. Tel.: +1 870 543 7779; fax: +1 870 543 7307.
        <email>
         marli.azevedo@fda.hhs.gov
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        13
       </day>
       <month>
        12
       </month>
       <year>
        2011
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <month>
        5
       </month>
       <year>
        2012
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        13
       </day>
       <month>
        12
       </month>
       <year>
        2011
       </year>
      </pub-date>
      <volume>
       30
      </volume>
      <issue>
       1
      </issue>
      <fpage>
       180
      </fpage>
      <lpage>
       186
      </lpage>
      <history>
       <date date-type="received">
        <day>
         19
        </day>
        <month>
         5
        </month>
        <year>
         2011
        </year>
       </date>
       <date date-type="rev-recd">
        <day>
         31
        </day>
        <month>
         10
        </month>
        <year>
         2011
        </year>
       </date>
       <date date-type="accepted">
        <day>
         6
        </day>
        <month>
         12
        </month>
        <year>
         2011
        </year>
       </date>
      </history>
      <permissions>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract>
       <p>
        Fecal suspensions with an aerosol route of transmission were responsible for a cluster of severe acute respiratory syndrome (SARS) cases in 2003 in Hong Kong. Based on that event, the World Health Organization recommended that research be implemented to define modes of transmission of SARS coronavirus through sewage, feces, food and water. Environmental studies have shown that animal coronaviruses remain infectious in water and sewage for up to a year depending on the temperature and humidity. In this study, we examined coronavirus stability on lettuce surfaces. A cell culture adapted bovine coronavirus, diluted in growth media or in bovine fecal suspensions to simulate fecal contamination was used to spike romaine lettuce. qRT-PCR detected viral RNA copy number ranging from 6.6 × 10
        <sup>
         4
        </sup>
        to 1.7 × 10
        <sup>
         6
        </sup>
        throughout the experimental period of 30 days. Whereas infectious viruses were detected for at least 14 days, the amount of infectious virus varied, depending upon the diluent used for spiking the lettuce. UV and confocal microscopic observation indicated attachment of residual labeled virions to the lettuce surface after the elution procedure, suggesting that rates of inactivation or detection of the virus may be underestimated. Thus, it is possible that contaminated vegetables may be potential vehicles for coronavirus zoonotic transmission to humans.
       </p>
      </abstract>
      <abstract abstract-type="graphical">
       <title>
        Highlights
       </title>
       <p>
        ► Coronavirus viral RNA was stable in lettuce surface for 30 days. ► Infectious coronaviruses were detected for at least 14 days. ► Residual virus remained attached to the lettuce surface after elution. ► Fresh produce may be potential vehicles for coronavirus zoonotic transmission.
       </p>
      </abstract>
      <kwd-group>
       <title>
        Keywords
       </title>
       <kwd>
        Coronavirus
       </kwd>
       <kwd>
        Enveloped virus
       </kwd>
       <kwd>
        Environmental survival
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <sec id="sec1">
     <label>
      1
     </label>
     <title>
      Introduction
     </title>
     <p id="p0010">
      Coronavirus (CoV) is an enveloped, single-stranded, positive-sense RNA virus. Although respiratory CoVs are largely secreted by the nasal route, the role of fecal/oral transmission has not been fully explored. Earlier studies have demonstrated that CoV stability largely depends on environmental temperature (
      <xref ref-type="bibr" rid="bib13">
       Ijaz et al., 1985
      </xref>
      ;
      <xref ref-type="bibr" rid="bib22">
       Siddell et al., 1983
      </xref>
      ;
      <xref ref-type="bibr" rid="bib24">
       Tennant et al., 1994
      </xref>
      ). CoVs are inactivated at 56 °C within 10–15 min, at 37 °C after several days, and at 4 °C after several months. However, at −60 °C, CoVs can survive for many years without loss of infectivity (
      <xref ref-type="bibr" rid="bib1">
       Andries et al., 1978
      </xref>
      ;
      <xref ref-type="bibr" rid="bib16">
       McIntosh et al., 1974
      </xref>
      ;
      <xref ref-type="bibr" rid="bib22">
       Siddell et al., 1983
      </xref>
      ). Survival studies of human coronavirus (HCoV)-229E and HCoV-OC43 demonstrated that both viruses survived in a saline solution up to 6 days at room temperature, but after drying on hospital surfaces, they survived as long as 3 h; although survival differences between the two viruses were observed (
      <xref ref-type="bibr" rid="bib23">
       Sizun et al., 2000
      </xref>
      ). These findings suggest that surfaces and suspensions can be sources of contamination for hospital-acquired CoV infections (
      <xref ref-type="bibr" rid="bib23">
       Sizun et al., 2000
      </xref>
      ).
     </p>
     <p id="p0015">
      During the Severe Acute Respiratory Syndrome (SARS) epidemic in Hong Kong, it was thought that aerosolized droplets of feces were responsible for the transmission of a cluster of 420 SARS cases (
      <xref ref-type="bibr" rid="bib17">
       McKinney et al., 2006
      </xref>
      ). Consequently, the World Health Organization (WHO) urged that research be undertaken to better define the modes of transmission of SARS-CoV through sewage, feces, food and water (
      <xref ref-type="bibr" rid="bib26">
       WHO, 2003
      </xref>
      ). A more recent WHO report has listed hepatitis E virus (HEV), Highly Pathogenic Avian Influenza (HPAI) virus H5N1, SARS-CoV and Nipah virus as having the potential for foodborne transmission. Initial foodborne transmission is a route to enter the human population, which can then shift and spread through human-to-human transmission. Furthermore, virus long-term survival would not be a requirement when contamination occurs at the end of the food processing chain or in fresh produce (
      <xref ref-type="bibr" rid="bib7">
       FAO/WHO, 2008
      </xref>
      ). The risks of contamination of agricultural fields and field workers by animal enteric/respiratory CoV cannot be ignored. Furthermore, in times of outbreaks food handlers may also be responsible for food contamination with CoV. Because human enteric coronavirus causes a mild disease of lower incidence, foodborne transmission of CoV has not compelled an investigation.
     </p>
     <p id="p0020">
      A recent environmental survival study of two animal CoVs demonstrated that these viruses remained infectious in water and sewage at 27 °C for periods of weeks and at 4 °C for up to a year (
      <xref ref-type="bibr" rid="bib3">
       Casanova et al., 2009
      </xref>
      ). However, the role of ready-to-consume produce as a vehicle for potential zoonotic transmission or a source for genetic recombination during co-infections between animal and human CoVs has not yet been investigated.
     </p>
     <p id="p0025">
      The potential zoonotic transmission of CoVs was first suggested by studies in which human enteric coronavirus (HECoV)-4408 isolated from a diarrheic child was found to be indistinguishable genetically, antigenically and cytopathogenically from bovine CoV (BCoV) (
      <xref ref-type="bibr" rid="bib28">
       Zhang et al., 1994
      </xref>
      ) and retained infectivity and pathogenicity when inoculated into gnotobiotic calves (
      <xref ref-type="bibr" rid="bib10">
       Han et al., 2006
      </xref>
      ). In addition, BCoV is evolutionarily closely related to HCoV-OC43 (
      <xref ref-type="bibr" rid="bib25">
       Vijgen et al., 2005
      </xref>
      ) and to a lesser extent to SARS-CoV (
      <xref ref-type="bibr" rid="bib29">
       Zhang et al., 2005
      </xref>
      ). Therefore, in the present study, we used BCoV strain 88 as a model to examine the stability and the potential for foodborne transmission of CoV.
     </p>
    </sec>
    <sec id="sec2">
     <label>
      2
     </label>
     <title>
      Materials and methods
     </title>
     <sec id="sec2.1">
      <label>
       2.1
      </label>
      <title>
       Virus spiking
      </title>
      <p id="p0030">
       A total of 10 Romaine lettuce heads were purchased in separate occasions from local markets and used immediately. Undamaged leaves were chosen for use in the experiments. Prior to use, the leaves were washed twice in deionized water; the water was drained and the leaves were air-dried. Leaves were surface-sterilized with UV light for 20 min on each side and then cut into 4 × 4 cm sections. The cell adapted bovine coronavirus strain 88 (BCoV-88) was propagated in human rectal tumor (HRT)-18 cells, diluted to a final concentration of 1.2 × 10
       <sup>
        5
       </sup>
       plaque forming units (PFU) in either minimum essential medium (MEM) or a bovine fecal suspension. Two bovine fecal suspensions (0.1% and 10%) were used to dilute the virus, representing light and heavy fecal contaminations (1 ppm and 100 ppm), respectively. Because enteric viruses are shed in titers up to 10
       <sup>
        11
       </sup>
       particles per gram of feces, the virus was diluted to simulate 1 ppm of viral contamination. Each piece of prepared lettuce was spiked with 100 μl of the virus preparation, allowed to dry for 2 h in a biosafety cabinet and then stored at 4 °C in a refrigerator until elution. Bovine feces were obtained from a healthy cow, resuspended at 0.1% and 10% in minimum essential medium (MEM), centrifuged at 3000×
       <italic>
        g
       </italic>
       and filtered through a 0.2 μM syringe filter. The suspensions were confirmed to be BCoV negative by qRT-PCR before being used, as described later. Experiments were duplicated using feces from a healthy young calf, also confirmed negative for BCoV by qRT-PCR.
      </p>
     </sec>
     <sec id="sec2.2">
      <label>
       2.2
      </label>
      <title>
       Virus elution
      </title>
      <p id="p0035">
       To establish an optimal elution method, a pilot procedure was conducted on day 0. Virus from triplicate lettuce pieces was eluted with MEM + 2% fetal bovine serum (FBS, Gibco), Tris-glycine + 1% FBS or phosphate-buffered saline (PBS)-Triton X-100 + 0.5% FBS, immediately following the drying step. The eluents were then precipitated with 10% polyethylene glycol (PEG) 6000 (Calbiochem, EMD Biosciences, La Jolla, CA) and 2.5% NaCl at 4 °C with agitation for 2 h followed by centrifugation at 3500×
       <italic>
        g
       </italic>
       for 30 min at 4 °C. The pellet was reconstituted with MEM + 2% FBS and subsequently analyzed by qRT-PCR for detecting viral genomic RNA. Similar results were obtained with both MEM + 2% FBS and Tris-glycine + 1% FBS elution buffers. However, significantly lower viral RNA copy numbers were detected when the elution buffer containing Triton X-100 was used (data not shown). Because MEM + 2% FBS would interfere less with an infectivity assay than the buffer containing Tris-glycine, MEM + 2% FBS was selected as the eluent in subsequent experiments. Virus was eluted in triplicate samples on days 0, 2, 5, 7, 12, 14, 20, 26 and 30. Twenty milliliters of elution buffer was added to each lettuce piece in a 50 ml conical tube which was agitated for 15 min on an orbital shaker at 100 rpm at room temperature. Virus was then precipitated with 10% PEG 6000 and 2.5% NaCl, as described. The pellet was reconstituted with the elution buffer (MEM + 2% FBS) to 250 μl and stored at −70 °C. Experiments were repeated on three different occasions, with 9 samples per time point for each group. To estimate the amount of virus particles lost during drying and elution, each virus dilution was kept at 4 °C, sampled in triplicate at each time point, precipitated and reconstituted in the same way as the lettuce spiked virus.
      </p>
     </sec>
     <sec id="sec2.3">
      <label>
       2.3
      </label>
      <title>
       Viral RNA extraction and qRT-PCR
      </title>
      <p id="p0040">
       Viral RNA was extracted from 90 μl of resuspended pellet using the MagMax™ viral RNA isolation kit and the MagMAX™ Express Magnetic Particle Processor (Applied Biosystems/Ambion, Austin, TX). Extracted RNA samples were either analyzed immediately by qRT-PCR or stored at −80 °C until use. For qRT-PCR, we used primers and a Locked Nucleic Acid (LNA) Cy5 labeled fluorescent probe (Integrated DNA Technology, Coralville, IA) for the open reading frame (ORF) 1b region of CoV genomic RNA (
       <xref ref-type="bibr" rid="bib6">
        Escutenaire et al., 2007
       </xref>
       ;
       <xref ref-type="bibr" rid="bib18">
        Muradrasoli et al., 2009
       </xref>
       ). A synthetic oligonucleotide complementary to the probe was used to generate a standard curve (
       <xref ref-type="bibr" rid="bib6">
        Escutenaire et al., 2007
       </xref>
       ). Primers and probes for human 18S RNA (Cat# 4308329, Applied Biosystems, Foster City, CA) were used as internal controls (
       <xref ref-type="bibr" rid="bib20">
        Poon et al., 2004
       </xref>
       ). BCoV-88 RNA was used as a positive control. RNA from mock infected cell supernatant was used as a negative control and RNAse-free water was used as a non-template control. For all assays, 8 μl of RNA was transferred to a Qiagen Rotor-Gene strip tube containing 12 μl of the Rotor Gene™ Multiplex qRT-PCR mix (Qiagen, Valencia, CA). Cycling conditions were 50 °C for 30 min, 95 °C for 10 min, 5 touchdown amplification steps of 94 °C for 30 s and 56 °C for 30 s, decreasing by 2 °C every second cycle down to 48 °C for 30 s, and then 50 cycles of 94 °C for 30 s and 46 °C for 60 s. Amplification was detected using a Rotor Gene Q 6 plex machine from Qiagen.
      </p>
     </sec>
     <sec id="sec2.4">
      <label>
       2.4
      </label>
      <title>
       Virus plaque assay
      </title>
      <p id="p0045">
       A plaque assay (
       <xref ref-type="bibr" rid="bib11">
        Hasoksuk et al., 2008
       </xref>
       ) was used to quantify infectious virus recovered from the lettuce surface. Briefly, 6-well plates containing 3-to 5-day-old monolayers of HRT-18 cells were rinsed and incubated with FBS-free MEM for 3 h at 37 °C in a 5% CO
       <sub>
        2
       </sub>
       atmosphere. The culture medium was then aspirated and serial dilutions of the recovered virus preparations from the lettuce leaves were added to duplicate wells. Following virus adsorption for 1.5 h at 37 °C in a 5% CO
       <sub>
        2
       </sub>
       atmosphere, the inoculum was removed and the cell monolayer was rinsed with FBS-free MEM. The plates were then overlaid with MEM containing 0.8% Noble agar, 0.1% neutral red, 0.15 μg/ml of trypsin (Cat#1426 – Sigma, St. Louis, MO), 1% diethylaminoethyl dextran, 1% antibiotic-antimycotic (Gibco, Carlsbad, CA) and 3% sodium bicarbonate. Trypsin was added to the overlay media to mimic host cell proteases by activating viral spike protein, increasing coronavirus infectivity (
       <xref ref-type="bibr" rid="bib2">
        Bertram et al., 2011
       </xref>
       ;
       <xref ref-type="bibr" rid="bib9">
        Gaertner et al., 1991
       </xref>
       ;
       <xref ref-type="bibr" rid="bib12">
        Holmes, 2001
       </xref>
       ). After solidification of the agar, the plates were inverted and incubated at 37 °C. Plaques were counted from days 4–6. The final titers were calculated by averaging counted plaques on duplicate wells of the highest dilution.
      </p>
     </sec>
     <sec id="sec2.5">
      <label>
       2.5
      </label>
      <title>
       Cell culture immunofluorescence (CCIF) assay
      </title>
      <p id="p0050">
       Because of the long period of incubation required for plaque formation in the plaque assay, cell toxicity was observed when the recovered virus was originally diluted in fecal suspensions, despite rinsing the monolayer with FBS-free MEM after adsorption. A cell culture immunofluorescence assay was used to circumvent this problem. Briefly, 3–4-day-old 96-well plates containing monolayers of HRT-18 cells were rinsed with FBS-free MEM and incubated for 3 h at 37 °C in a 5% CO
       <sub>
        2
       </sub>
       atmosphere. Serial dilutions of recovered virus were added to duplicate wells, followed by the addition of 0.04 μg trypsin per well. Plates were then centrifuged for 1 h at 500×
       <italic>
        g
       </italic>
       at room temperature and incubated at 37 °C, 5% CO
       <sub>
        2
       </sub>
       for 20 h. Plates were then fixed with 80% acetone in water, stained with guinea pig anti-BCoV antiserum (BEI Resources cat# NR-455) and FITC-conjugated goat anti-guinea pig IgG (KPL, Inc, Gaithersburg, MD), and observed using an inverted UV microscope. The final titers were calculated by averaging counted fluorescing cells in duplicate wells of the highest dilution of the virus where fluorescing cells were observed.
      </p>
     </sec>
     <sec id="sec2.6">
      <label>
       2.6
      </label>
      <title>
       Presence of residual virus
      </title>
      <p id="p0055">
       To determine if residual virus would remain on the lettuce surface after the elution procedure, BCoV-88 was concentrated by ultracentrifugation onto a 20% sucrose cushion, labeled with SYBR-Gold (Invitrogen, Carlsbad, CA) and purified using a 20–60% continuous sucrose gradient at 105,000×
       <italic>
        g
       </italic>
       for 18 h using a Beckman SW41TI rotor. Labeled virus was diluted in MEM + 2% FBS, 0.1% fecal suspension or 10% fecal suspension and was spiked onto the lettuce. After drying, the virus was eluted from the lettuce surface as described. Lettuce pieces were then observed using a UV microscope and/or fluorescence confocal microscope for detection of residual virus on lettuce leaves.
      </p>
     </sec>
     <sec id="sec2.7">
      <label>
       2.7
      </label>
      <title>
       Statistical analysis
      </title>
      <p id="p0060">
       Results from (log-transformed) qRT-PCR and infectivity assays were compared among and within the groups using two way ANOVA testing for group, time, and the interaction of group and time, using the SigmaStat® program (Systat Inc). Statistical significance was assessed at
       <italic>
        p
       </italic>
       &lt; 0.05.
      </p>
     </sec>
    </sec>
    <sec id="sec3">
     <label>
      3
     </label>
     <title>
      Results
     </title>
     <sec id="sec3.1">
      <label>
       3.1
      </label>
      <title>
       Viral genomic RNA was detected from the lettuce surface after spiking and storage in a refrigerator
      </title>
      <p id="p0065">
       To determine the stability of the viral genomic RNA on the lettuce surface under household refrigeration conditions, we used qRT-PCR to detect and quantify viral RNA at various time points after storage of virus-spiked lettuce at 4 °C (
       <xref ref-type="fig" rid="fig1">
        Fig. 1
       </xref>
       A). Whereas viral RNA was detected from the lettuce surface at all time points (up to 30 days) throughout the experiment, RNA levels varied significantly among the different experimental groups (6.6 × 10
       <sup>
        4
       </sup>
       to 1.7 × 10
       <sup>
        6
       </sup>
       copy numbers). In general, viral RNA levels were significantly higher (
       <italic>
        p
       </italic>
       &lt; 0.05) when the spiked virus was diluted with MEM + 2% FBS than when diluted with fecal suspensions (
       <xref ref-type="fig" rid="fig1">
        Fig. 1
       </xref>
       A). Analysis of variance within groups showed a significant decrease (
       <italic>
        p
       </italic>
       &lt; 0.05) in the amount of RNA detected from lettuce after day 5 for MEM + 2% FBS and 0.1% fecal suspensions, and after day 12 for 10% fecal suspensions.
       <fig id="fig1">
        <label>
         Fig. 1
        </label>
        <caption>
         <p>
          Viral RNA recovered from spiked lettuce or from virus stored in suspension detected by real-time RT-PCR for coronavirus. A. Log
          <sub>
           10
          </sub>
          of viral RNA copy number recovered from the lettuce surface over time after elution; B. Log
          <sub>
           10
          </sub>
          of viral RNA copy number recovered from virus stored in suspension over time; C. Log
          <sub>
           10
          </sub>
          of viral RNA copy number recovered from the lettuce surface over time after elution normalized to 100% at day 0; D. Log
          <sub>
           10
          </sub>
          of viral RNA copy number recovered from virus stored in suspension over time normalized to 100% at day 0. Different letters denote statistically significant differences at
          <italic>
           p
          </italic>
          &lt; 0.05 (Two way ANOVA using all pairwise multiple comparison procedures: Holm–Sidak method) among groups at same time point. Statistical symbols: A is statistically different from B at
          <italic>
           p
          </italic>
          &lt; 0.05. Legend: -♦- CoV in MEM + 2% FBS; -○- CoV in 0.1% fecal suspension; -□- CoV in 10% fecal suspension.
         </p>
        </caption>
        <graphic xlink:href="gr1">
        </graphic>
       </fig>
      </p>
      <p id="p0070">
       When the virus was stored in suspensions at 4 °C, there was no significant decrease in the amount of viral RNA detected throughout the 30 day experimental period between MEM + 2% FBS and 0.1% fecal suspension (
       <xref ref-type="fig" rid="fig1">
        Fig. 1
       </xref>
       B). However, the amount of viral RNA detected from the 10% fecal suspension was generally lower at all time points, and significantly lower (
       <italic>
        p
       </italic>
       &lt; 0.05) at days 0, 2, 14, 20, 26 and 30, when compared to the 0.1% fecal suspension or MEM + 2% FBS treatment.
      </p>
      <p id="p0075">
       To better estimate long-term stability of coronavirus RNA, the recovery of viral RNA was expressed as a percentage of the log10 copy number of viral RNA revered at various time points relative to the viral RNA recovered at day 0 which was normalized to 100%. As shown in
       <xref ref-type="fig" rid="fig1">
        Fig. 1
       </xref>
       C and D, there was less than 20% reduction in viral RNA recovery from spiked lettuce or stored in suspension for 30 days. These results demonstrate that CoV RNA was stable on the lettuce surface and in the suspensions tested throughout the 30 days period.
      </p>
     </sec>
     <sec id="sec3.2">
      <label>
       3.2
      </label>
      <title>
       Infectious virus was detected from lettuce after spiking and storage in a refrigerator
      </title>
      <p id="p0080">
       To assess the stability of infectious virus on the lettuce surface, we used a plaque assay to detect and quantify infectious virus recovered from lettuce after spiking and storage at 4 °C for various periods of time. The infectivity of recovered virus varied significantly depending upon the type of diluent used (
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       A). Overall, the infectivity (PFU) was significantly higher at each time point for virus diluted in MEM + 2% FBS than for those in either of the two fecal suspensions. Specifically, virus infectivity from MEM + 2% FBS decreased gradually from approximately 10,000 PFU on day 0–10 PFU on day 20 and was below the detectable level by day 25, whereas the CoV infectivity from the 0.1% fecal suspension decreased similarly until day 12, but was no longer detectable by day 14. In contrast, no infectious virus was recovered from lettuce spiked with virus diluted in a 10% fecal suspension from day 2 onward. When the virus was stored in MEM + 2% FBS or in 0.1% fecal suspension, the reduction of infectivity over 30 days was much slower than that on the lettuce surface, but it was similar on the lettuce surface and in the 10% fecal suspension (
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       B). Virus infectivity did not change significantly in MEM + 2% FBS diluent from day 0 to day 25, decreasing slightly by day 30. When the number of plaque forming units was normalized to 100% recovery at day 0 (
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       C and D), a 90% reduction (1 log) every 5–6 days was observed in infectious virus recovered from lettuce surfaces spiked with CoV in MEM + 2% FBS or 0.1% fecal suspension. A 90% reduction in recovery was observed every 14 days from virus stored in 0.1% fecal suspension, and 30 days if stored in MEM + 2% FBS. These results demonstrate that infectious virions are more stable in suspension than when dried on the lettuce surface and that viral stability is influenced by the type of diluent used in the study.
       <fig id="fig2">
        <label>
         Fig. 2
        </label>
        <caption>
         <p>
          Infectious coronavirus recovered from spiked lettuce or stored in suspensions, detected by plaque assay. A. Plaque forming unit (PFU) [log
          <sub>
           10
          </sub>
          ] of infectious virus recovered from the lettuce surface over time after elution; B. PFU (log
          <sub>
           10
          </sub>
          ) of infectious virus recovered from virus stored in suspensions over time; C. PFU [log
          <sub>
           10
          </sub>
          ] of infectious virus recovered from the lettuce surface over time after elution normalized to 100% at day 0; B. PFU (log
          <sub>
           10
          </sub>
          ) of infectious virus recovered from virus stored in suspensions over time normalized to 100% at day 0. Different letters denote statistically significant differences at
          <italic>
           p
          </italic>
          &lt; 0.05 (Two way ANOVA using all pairwise multiple comparison procedures: Holm–Sidak method) among groups at same time point. Statistical symbols: A is statistically different from B and C; B is statistically different from C at
          <italic>
           p
          </italic>
          &lt; 0.05. Legend: -♦- CoV in MEM + 2% FBS; -○- CoV in 0.1% fecal suspension; -□- CoV in 10% fecal suspension.
         </p>
        </caption>
        <graphic xlink:href="gr2">
        </graphic>
       </fig>
      </p>
      <p id="p0085">
       These results also suggest that the 10% fecal suspension might contain factors that can inactivate virus during storage, thus reducing infectivity, or inhibiting plaque formation during a plaque assay. To distinguish these two possibilities, we used an immunofluorescence assay to determine the fluorescence foci following infection of cell cultures with the recovered virus. We found that overall there were more focus forming units (FFU) than PFU detected by the plaque assay (
       <xref ref-type="fig" rid="fig3">
        Fig. 3
       </xref>
       vs
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       ). However, significant amounts of infectious virus (∼3 log
       <sub>
        10
       </sub>
       FFU) were detected by the cell culture fluorescence assay at day 14 in samples recovered from both lettuce spiked with virus diluted in 10% fecal suspension (
       <xref ref-type="fig" rid="fig3">
        Fig. 3
       </xref>
       ) and the corresponding diluent, whereas the plaque assay resulted in no detectable levels of virus infectivity at day 2 (
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       ). When the number of fluorescent foci was normalized to 100% at day 0 (
       <xref ref-type="fig" rid="fig3">
        Fig. 3
       </xref>
       C), a 90% decrease in recovery was observed every 7 days for virus recovered from spiked lettuce of all three diluents. Similar observation was made from virus stored in 0.1 and 10% fecal suspensions (
       <xref ref-type="fig" rid="fig3">
        Fig. 3
       </xref>
       D), whereas reduction of 90% was only observed after 25 days for virus stored in MEM + 2% FBS. Combined with data in
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       ,
       <xref ref-type="fig" rid="fig3">
        Fig. 3
       </xref>
       , these results indicate that viral infectivity was less stable in fecal suspensions than in MEM + 2% FBS and that an immunofluorescence assay may be more sensitive than the plaque assay for quantifying infectious virus. An immunofluorescence assay may be particularly useful with samples containing higher concentrations of feces that could interfere with plaque formation.
       <fig id="fig3">
        <label>
         Fig. 3
        </label>
        <caption>
         <p>
          Infectious coronavirus recovered from spiked lettuce or stored in suspensions and detected by cell culture immunofluorescence (CCIF) assay. A. Focus forming unit (FFU) (log
          <sub>
           10
          </sub>
          ) of infectious virus recovered from the lettuce surface over time after elution; B. FFU (log
          <sub>
           10
          </sub>
          ) of infectious virus, recovered from virus stored in suspensions over time; C. FFU (log
          <sub>
           10
          </sub>
          ) of infectious virus recovered from the lettuce surface over time after elution normalized to 100% at day 0; D. FFU (log
          <sub>
           10
          </sub>
          ) of infectious virus, recovered from virus stored in suspensions over time normalized to 100% at day 0. Different letters denote statistically significant differences at
          <italic>
           p
          </italic>
          &lt; 0.05 (Two way ANOVA using all pairwise multiple comparison procedures: Holm–Sidak method) among groups at same time point. Statistical symbols: A is statistically different from B at
          <italic>
           p
          </italic>
          &lt; 0.05. Legend: -♦- CoV in MEM + 2% FBS; -○- CoV in 0.1% fecal suspension; -□- CoV in 10% fecal suspension.
         </p>
        </caption>
        <graphic xlink:href="gr3">
        </graphic>
       </fig>
      </p>
     </sec>
     <sec id="sec3.3">
      <label>
       3.3
      </label>
      <title>
       Residual coronavirus remained on the lettuce surface after elution procedure
      </title>
      <p id="p0090">
       To determine the efficiency of elution and to test the hypothesis that the degree of fecal contamination could affect the effectiveness of virus elution, we used SYBR-Gold to label virus particles, then diluted the labeled virus with one of three diluents and spiked the virus onto the lettuce surface. Following the same procedure for processing, storage and virus elution as described earlier, residual virus particles on the lettuce surface were subjected to microscopic examination. Results confirmed that residual coronavirus was present on the lettuce surface after elution (
       <xref ref-type="fig" rid="fig4">
        Fig. 4
       </xref>
       ) with increased virus accumulation on the lettuce veins (
       <xref ref-type="fig" rid="fig4">
        Fig. 4
       </xref>
       E–G). It appears that slightly more residual virus remained on the lettuce surface when the spiked virus was diluted in fecal suspensions (Comparing panels C and D with B in
       <xref ref-type="fig" rid="fig4">
        Fig. 4
       </xref>
       ).
       <fig id="fig4">
        <label>
         Fig. 4
        </label>
        <caption>
         <p>
          Residual SYBR-Gold labeled coronavirus on the lettuce surface after elution with MEM + 2% FBS. A–D images were acquired using a Nikon Eclipse TS100 UV microscope using the Image NIS element program with a 40× objective. E–H images are confocal micrographs using an Olympus Fluoview™ FV 1000 confocal microscope. The laser setting was the excitation filter DM 488 and the Emission filters BA (505–525 nm) and BA (560–620 nm). The objective setting was 10× in the image; 100 μm marker bars are shown. A, E. Lettuce leaf spiked with CoV SYBR-Gold labeled, diluted in MEM + 2% FBS before elution; B, F. Lettuce leaf spiked with CoV SYBR-Gold labeled diluted, in MEM + 2% FBS after elution C, G. Lettuce leaf spiked with CoV SYBR-Gold labeled, diluted in 0.1% fecal suspension after elution and D, H. Lettuce leaf spiked with CoV SYBR-gold labeled diluted in 10% fecal suspension after elution. Arrows indicate labeled virus particles.
         </p>
        </caption>
        <graphic xlink:href="gr4">
        </graphic>
       </fig>
      </p>
     </sec>
    </sec>
    <sec id="sec4">
     <label>
      4
     </label>
     <title>
      Discussion
     </title>
     <p id="p0095">
      In this study, we tested the hypothesis that contaminated vegetables may serve as a vehicle for coronavirus transmission to humans through consumption of produce. Specifically we used BCoV as a surrogate of the Genus
      <italic>
       Betacoronavirus
      </italic>
      , which includes SARS-CoV, to evaluate the stability of coronaviruses on the lettuce surface under household refrigeration conditions. Our data showed that BCoV on lettuce retained infectivity for at least 14 days. We also observed that higher numbers of infectious particles were detected using fluorescent focus forming assay compared to plaque assay. Plaque assay relies on the induction of cell death to form plaques and is sensitive to changes in the assay condition, whereas fluorescent focus assay relies on the detection of virus antigen within infected cells, which may increase the detection and visualization of the infectious virus particles (
      <xref ref-type="bibr" rid="bib8">
       Flint et al., 2009
      </xref>
      ). Interestingly, as assessed by a plaque assay, significantly lower amounts of infectious virus were recovered from lettuce surfaces spiked with virus samples that were diluted in a 10% fecal suspension as compared to those diluted in MEM + 2% FBS and a 0.1% fecal suspension (
      <xref ref-type="fig" rid="fig2">
       Fig. 2
      </xref>
      ). The reason for such a rapid reduction in infectivity in virus diluted in 10% fecal suspensions is not known. It is possible that the high fecal concentration contains inhibitory factors, such as intestinal proteases or lipases. The abundant proteolytic or lipolytic enzymes present in the intestine, including those from bacterial flora, are required for digestion of food and may destroy the virion surface spike glycoprotein, which is sensitive to protease cleavage and the virus envelope, which is sensitive to lipases (
      <xref ref-type="bibr" rid="bib5">
       Chen, 1985
      </xref>
      ;
      <xref ref-type="bibr" rid="bib14">
       Krempl et al., 2000
      </xref>
      ). Thus, the proteolytic and lipolytic effects of fecal suspensions might render BCoV less infectious. A similar finding has been reported for canine CoV: at 4 °C, fecal dilutions of 1:1 resulted in a rapid loss of viral infectivity, but a fecal dilution of 1:1000 preserved infectivity (
      <xref ref-type="bibr" rid="bib24">
       Tennant et al., 1994
      </xref>
      ). However, viral genomic RNA levels were more stable and steady on the lettuce surface for the duration of the experiment, compared to infectious virus. This suggests that the rapid decrease in CoV infectivity in the 10% fecal suspension was not due mainly to degradation of the viral genome, but more likely due to the loss of a functional spike glycoprotein on the virion surface that confers infectivity or to the loss of the virus envelope. However, neither the structure of the spike glycoprotein, nor the integrity of the virions or the viral genomic RNA recovered from the lettuce surface was determined in this study.
     </p>
     <p id="p0100">
      Microscopic observation of labeled virus on the lettuce surface indicates that some residual virus particles remained attached after elution, suggesting that virus elution was incomplete (
      <xref ref-type="fig" rid="fig4">
       Fig. 4
      </xref>
      ). A quantitative assay to enumerate virus particles on the lettuce surface after elution may be required to establish if the differences in infectivity among the three diluents are the result of time-related inactivation or time-increased attachment. However, qRT-PCR results for detecting viral genomic RNA after virus elution from the lettuce surface support the former possibility because the difference in viral genome copies among the three diluents was lower than that for CoV titers in viral infectivity assay and remained relatively constant throughout the 30 days (comparing
      <xref ref-type="fig" rid="fig1">
       Fig. 1
      </xref>
      ,
      <xref ref-type="fig" rid="fig2">
       Fig. 2
      </xref>
      ). It is not clear, however, whether the lower levels of viral genomic RNA, especially in the 10% fecal suspensions after elution (
      <xref ref-type="fig" rid="fig1">
       Fig. 1
      </xref>
      ) resulted from RNA degradation or incomplete elution (
      <xref ref-type="fig" rid="fig4">
       Fig. 4
      </xref>
      ). For non-enveloped viruses, the presence of biosolids increased viral attachment to the lettuce surface (
      <xref ref-type="bibr" rid="bib27">
       Wei et al., 2009
      </xref>
      ). Adsorption of non-enveloped virus particles may be linked to the virus adsorbent isoelectric point, hydrophobicity and ionic strength (
      <xref ref-type="bibr" rid="bib4">
       Charles et al., 2008
      </xref>
      ). Similar studies are needed for enveloped viruses and also to establish the role of biosolids on coronavirus environmental maintenance and survival.
     </p>
     <p id="p0105">
      Our results demonstrate that coronavirus was stable during the shelf-life of romaine lettuce, and that a wash procedure (elution) did not completely remove residual viruses. Thus, it is possible that contaminated ready-to-consume produce may be a potential vehicle for zoonotic transmission of coronaviruses to humans. However, the epidemiologic significance of the amount of recovered infectious particles cannot be evaluated, since the coronavirus infectious dose is unknown. Developing countries have an increasing role in food production for the world market thus increasing the necessity of monitoring food production beyond our borders (
      <xref ref-type="bibr" rid="bib19">
       Newell et al., 2010
      </xref>
      ). Although the probability of foodborne transmission of certain newly emerging viruses may be low, this transmission route may cause higher rates of disease and morbidity (
      <xref ref-type="bibr" rid="bib7">
       FAO/WHO, 2008
      </xref>
      ). Awareness regarding the possible roles of water, fresh produce and fecal contamination in coronavirus transmission is required at times of human coronavirus outbreaks.
     </p>
     <p id="p0110">
      Several coronaviruses can replicate in the epithelial cells of the respiratory tract as well as the enteric tract, and they can be transmitted by the respiratory route (
      <xref ref-type="bibr" rid="bib12">
       Holmes, 2001
      </xref>
      ). Bovine coronavirus has been described as a pneumoenteric virus that infects the upper and lower respiratory tract and intestine of cattle and wild ruminants. It is shed in feces and nasal secretions, causing respiratory and enteric syndromes such as shipping fever and winter dysentery in cattle (
      <xref ref-type="bibr" rid="bib21">
       Saif, 2010
      </xref>
      ). During the SARS outbreak, diarrhea was a common symptom of SARS, occurring in approximately 38% of the patients, demonstrating that SARS also had an intestinal tropism (
      <xref ref-type="bibr" rid="bib15">
       Leung et al., 2003
      </xref>
      ). However, foodborne transmission of SARS Coronavirus was not documented during the SARS outbreak and oral-fecal transmission of SARS is yet to be explored.
     </p>
    </sec>
    <sec id="sec5">
     <title>
      Disclaimer
     </title>
     <p id="p0115">
      “The views presented in this article do not necessarily reflect those of the Food and Drug Administration.”
     </p>
    </sec>
    <back>
     <ref-list id="cebib0010">
      <title>
       References
      </title>
      <ref id="bib1">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Andries
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Pensaert
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Callebaut
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pathogenicity of hemagglutinating encephalomyelitis (vomiting and wasting disease) virus of pigs, using different routes of inoculation
        </article-title>
        <source>
         Zentralbl Veterinarmed B
        </source>
        <volume>
         25
        </volume>
        <issue>
         6
        </issue>
        <year>
         1978
        </year>
        <fpage>
         461
        </fpage>
        <lpage>
         468
        </lpage>
        <pub-id pub-id-type="pmid">
         212905
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib2">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bertram
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Glowacka
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Lavender
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Gnirss
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Nehlmeier
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cleavage and activation of the SARS-coronavirus spike-protein by human airway trypsin-like protease (HAT)
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2011
        </year>
       </element-citation>
      </ref>
      <ref id="bib3">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of surrogate coronaviruses in water
        </article-title>
        <source>
         Water Res.
        </source>
        <volume>
         43
        </volume>
        <issue>
         7
        </issue>
        <year>
         2009
        </year>
        <fpage>
         1893
        </fpage>
        <lpage>
         1898
        </lpage>
        <pub-id pub-id-type="pmid">
         19246070
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib4">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Charles
          </surname>
          <given-names>
           K.J.
          </given-names>
         </name>
         <name>
          <surname>
           Souter
          </surname>
          <given-names>
           F.C.
          </given-names>
         </name>
         <name>
          <surname>
           Baker
          </surname>
          <given-names>
           D.L.
          </given-names>
         </name>
         <name>
          <surname>
           Davies
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Schijven
          </surname>
          <given-names>
           J.F.
          </given-names>
         </name>
         <name>
          <surname>
           Roser
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Fate and transport of viruses during sewage treatment in a mound system
        </article-title>
        <source>
         Water Res.
        </source>
        <volume>
         42
        </volume>
        <issue>
         12
        </issue>
        <year>
         2008
        </year>
        <fpage>
         3047
        </fpage>
        <lpage>
         3056
        </lpage>
        <pub-id pub-id-type="pmid">
         18486962
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib5">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Enzymatic and acidic sensitivity profiles of selected virulent and attenuated transmissible gastroenteritis viruses of swine
        </article-title>
        <source>
         Am. J. Vet. Res.
        </source>
        <volume>
         46
        </volume>
        <issue>
         3
        </issue>
        <year>
         1985
        </year>
        <fpage>
         632
        </fpage>
        <lpage>
         636
        </lpage>
        <pub-id pub-id-type="pmid">
         2986496
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib6">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Escutenaire
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Mohamed
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Isaksson
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Thoren
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Klingeborn
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Belak
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         SYBR Green real-time reverse transcription-polymerase chain reaction assay for the generic detection of coronaviruses
        </article-title>
        <source>
         Arch. Virol.
        </source>
        <volume>
         152
        </volume>
        <issue>
         1
        </issue>
        <year>
         2007
        </year>
        <fpage>
         41
        </fpage>
        <lpage>
         58
        </lpage>
        <pub-id pub-id-type="pmid">
         16941059
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib7">
       <mixed-citation publication-type="other">
        FAO/WHO, 2008. Viruses in food: scientific advice to support risk management activities: Meeting Report.
       </mixed-citation>
      </ref>
      <ref id="bib8">
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Flint
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Enquist
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Racaniello
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Skalka
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         The infectious cycle
        </chapter-title>
        <series>
         Principles of Virology
        </series>
        <volume>
         vol. 1
        </volume>
        <year>
         2009
        </year>
        <publisher-name>
         ASM Press
        </publisher-name>
        <publisher-loc>
         Washington, DC
        </publisher-loc>
        <fpage>
         24
        </fpage>
        <lpage>
         49
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib9">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gaertner
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           A.L.
          </given-names>
         </name>
         <name>
          <surname>
           Paturzo
          </surname>
          <given-names>
           F.X.
          </given-names>
         </name>
         <name>
          <surname>
           Jacoby
          </surname>
          <given-names>
           R.O.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Susceptibility of rodent cell lines to rat coronaviruses and differential enhancement by trypsin or DEAE-dextran
        </article-title>
        <source>
         Arch. Virol.
        </source>
        <volume>
         118
        </volume>
        <issue>
         1–2
        </issue>
        <year>
         1991
        </year>
        <fpage>
         57
        </fpage>
        <lpage>
         66
        </lpage>
        <pub-id pub-id-type="pmid">
         2048975
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib10">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Cheon
          </surname>
          <given-names>
           D.S.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Saif
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cross-protection against a human enteric coronavirus and a virulent bovine enteric coronavirus in gnotobiotic calves
        </article-title>
        <source>
         J. Virol.
        </source>
        <volume>
         80
        </volume>
        <issue>
         24
        </issue>
        <year>
         2006
        </year>
        <fpage>
         12350
        </fpage>
        <lpage>
         12356
        </lpage>
        <pub-id pub-id-type="pmid">
         16971444
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib11">
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hasoksuk
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Vlasova
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Saif
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Detection of group 2a coronaviruses with emphasis on bovine and wild ruminant strains. Virus isolation and detection of antibody, antigen, and nucleic acid
        </chapter-title>
        <person-group person-group-type="editor">
         <name>
          <surname>
           Kavanaugh
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <series>
         Methods in Molecular Biology
        </series>
        <volume>
         vol. 464
        </volume>
        <year>
         2008
        </year>
        <publisher-name>
         Humana Press
        </publisher-name>
        <fpage>
         43
        </fpage>
        <lpage>
         59
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib12">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Holmes
          </surname>
          <given-names>
           K.V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Enteric infections with coronaviruses and toroviruses
        </article-title>
        <source>
         Novartis Found. Symp.
        </source>
        <volume>
         238
        </volume>
        <year>
         2001
        </year>
        <fpage>
         258
        </fpage>
        <lpage>
         269
        </lpage>
        <comment>
         discussion 269–275
        </comment>
        <pub-id pub-id-type="pmid">
         11444030
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib13">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ijaz
          </surname>
          <given-names>
           M.K.
          </given-names>
         </name>
         <name>
          <surname>
           Brunner
          </surname>
          <given-names>
           A.H.
          </given-names>
         </name>
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Nair
          </surname>
          <given-names>
           R.C.
          </given-names>
         </name>
         <name>
          <surname>
           Johnson-Lussenburg
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival characteristics of airborne human coronavirus 229E
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <volume>
         66
        </volume>
        <issue>
         Pt 12
        </issue>
        <year>
         1985
        </year>
        <fpage>
         2743
        </fpage>
        <lpage>
         2748
        </lpage>
        <pub-id pub-id-type="pmid">
         2999318
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib14">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Krempl
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Ballesteros
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Zimmer
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Enjuanes
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Klenk
          </surname>
          <given-names>
           H.D.
          </given-names>
         </name>
         <name>
          <surname>
           Herrler
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <volume>
         81
        </volume>
        <issue>
         Pt 2
        </issue>
        <year>
         2000
        </year>
        <fpage>
         489
        </fpage>
        <lpage>
         496
        </lpage>
        <pub-id pub-id-type="pmid">
         10644848
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib15">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <name>
          <surname>
           To
          </surname>
          <given-names>
           K.F.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           H.L.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection
        </article-title>
        <source>
         Gastroenterology
        </source>
        <volume>
         125
        </volume>
        <issue>
         4
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1011
        </fpage>
        <lpage>
         1017
        </lpage>
        <pub-id pub-id-type="pmid">
         14517783
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib16">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McIntosh
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Chao
          </surname>
          <given-names>
           R.K.
          </given-names>
         </name>
         <name>
          <surname>
           Krause
          </surname>
          <given-names>
           H.E.
          </given-names>
         </name>
         <name>
          <surname>
           Wasil
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Mocega
          </surname>
          <given-names>
           H.E.
          </given-names>
         </name>
         <name>
          <surname>
           Mufson
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus infection in acute lower respiratory tract disease of infants
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <volume>
         130
        </volume>
        <issue>
         5
        </issue>
        <year>
         1974
        </year>
        <fpage>
         502
        </fpage>
        <lpage>
         507
        </lpage>
        <pub-id pub-id-type="pmid">
         4371278
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib17">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McKinney
          </surname>
          <given-names>
           K.R.
          </given-names>
         </name>
         <name>
          <surname>
           Gong
          </surname>
          <given-names>
           Y.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lewis
          </surname>
          <given-names>
           T.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental transmission of SARS at Amoy Gardens
        </article-title>
        <source>
         J. Environ. Health
        </source>
        <volume>
         68
        </volume>
        <issue>
         9
        </issue>
        <year>
         2006
        </year>
        <fpage>
         26
        </fpage>
        <lpage>
         30
        </lpage>
        <comment>
         quiz 51-2
        </comment>
       </element-citation>
      </ref>
      <ref id="bib18">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muradrasoli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Mohamed
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Hornyak
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Fohlman
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Olsen
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Belak
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Broadly targeted multiprobe QPCR for detection of coronaviruses: coronavirus is common among mallard ducks (Anas platyrhynchos)
        </article-title>
        <source>
         J. Virol. Methods
        </source>
        <volume>
         159
        </volume>
        <issue>
         2
        </issue>
        <year>
         2009
        </year>
        <fpage>
         277
        </fpage>
        <lpage>
         287
        </lpage>
        <pub-id pub-id-type="pmid">
         19406168
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib19">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Newell
          </surname>
          <given-names>
           D.G.
          </given-names>
         </name>
         <name>
          <surname>
           Koopmans
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Verhoef
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Duizer
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Aidara-Kane
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sprong
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Food-borne diseases – the challenges of 20 years ago still persist while new ones continue to emerge
        </article-title>
        <source>
         Int. J. Food. Microbiol.
        </source>
        <volume>
         139
        </volume>
        <issue>
         Suppl. 1
        </issue>
        <year>
         2010
        </year>
        <fpage>
         S3
        </fpage>
        <lpage>
         S15
        </lpage>
        <pub-id pub-id-type="pmid">
         20153070
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib20">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors
        </article-title>
        <source>
         J. Clin. Virol.
        </source>
        <volume>
         30
        </volume>
        <issue>
         3
        </issue>
        <year>
         2004
        </year>
        <fpage>
         214
        </fpage>
        <lpage>
         217
        </lpage>
        <pub-id pub-id-type="pmid">
         15135737
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib21">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saif
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bovine respiratory coronavirus
        </article-title>
        <source>
         Vet. Clin. North. Am. Food. Anim. Pract.
        </source>
        <volume>
         26
        </volume>
        <issue>
         2
        </issue>
        <year>
         2010
        </year>
        <fpage>
         349
        </fpage>
        <lpage>
         364
        </lpage>
        <pub-id pub-id-type="pmid">
         20619189
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib22">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Siddell
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Wege
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Ter Meulen
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The biology of coronaviruses
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <volume>
         64
        </volume>
        <issue>
         Pt 4
        </issue>
        <year>
         1983
        </year>
        <fpage>
         761
        </fpage>
        <lpage>
         776
        </lpage>
        <pub-id pub-id-type="pmid">
         6300299
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib23">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M.W.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         46
        </volume>
        <issue>
         1
        </issue>
        <year>
         2000
        </year>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="pmid">
         11023724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib24">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tennant
          </surname>
          <given-names>
           B.J.
          </given-names>
         </name>
         <name>
          <surname>
           Gaskell
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
         <name>
          <surname>
           Gaskell
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Studies on the survival of canine coronavirus under different environmental conditions
        </article-title>
        <source>
         Vet. Microbiol.
        </source>
        <volume>
         42
        </volume>
        <issue>
         2–3
        </issue>
        <year>
         1994
        </year>
        <fpage>
         255
        </fpage>
        <lpage>
         259
        </lpage>
        <pub-id pub-id-type="pmid">
         7886936
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib25">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vijgen
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Keyaerts
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Moes
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Thoelen
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Wollants
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Lemey
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event
        </article-title>
        <source>
         J. Virol.
        </source>
        <volume>
         79
        </volume>
        <issue>
         3
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1595
        </fpage>
        <lpage>
         1604
        </lpage>
        <pub-id pub-id-type="pmid">
         15650185
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib26">
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          WHO
         </collab>
        </person-group>
        <chapter-title>
         Final Report Amoy Gardens WHO Environmental Investigation
        </chapter-title>
        <year>
         2003
        </year>
        <publisher-name>
         World Health Organization
        </publisher-name>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://iapmo.org/common/pdf/ISS-Rome/SARS_Amoy_Gardens_HK.pdf">
         http://iapmo.org/common/pdf/ISS-Rome/SARS_Amoy_Gardens_HK.pdf
        </ext-link>
       </element-citation>
      </ref>
      <ref id="bib27">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wei
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Sims
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Kniel
          </surname>
          <given-names>
           K.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Manure- and biosolids-resident murine norovirus 1 attachment to and internalization by Romaine lettuce
        </article-title>
        <source>
         Appl. Environ. Microbiol.
        </source>
        <volume>
         76
        </volume>
        <issue>
         2
        </issue>
        <year>
         2009
        </year>
        <fpage>
         578
        </fpage>
        <lpage>
         583
        </lpage>
        <pub-id pub-id-type="pmid">
         19933344
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib28">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.M.
          </given-names>
         </name>
         <name>
          <surname>
           Herbst
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Kousoulas
          </surname>
          <given-names>
           K.G.
          </given-names>
         </name>
         <name>
          <surname>
           Storz
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <volume>
         44
        </volume>
        <issue>
         2
        </issue>
        <year>
         1994
        </year>
        <fpage>
         152
        </fpage>
        <lpage>
         161
        </lpage>
        <pub-id pub-id-type="pmid">
         7852955
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib29">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.W.
          </given-names>
         </name>
         <name>
          <surname>
           Yap
          </surname>
          <given-names>
           Y.L.
          </given-names>
         </name>
         <name>
          <surname>
           Danchin
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus
        </article-title>
        <source>
         Arch. Virol.
        </source>
        <volume>
         150
        </volume>
        <issue>
         1
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         20
        </lpage>
        <pub-id pub-id-type="pmid">
         15480857
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
     <ack>
      <title>
       Acknowledgements
      </title>
      <p>
       The following reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Polyclonal Anti-Bovine Coronavirus, Mebus (antiserum, Guinea Pig), NR-455. Part of this study was conducted in the Nanotechnology Core Facility (NanoCore) at the National Center for Toxicological Research, US Food and Drug Administration.
      </p>
      <p>
       This work was supported by the
       <funding-source id="gs1">
        Division of Microbiology, National Center for Toxicological Research, US Food and Drug Administration
       </funding-source>
       .
      </p>
     </ack>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Appl Environ Microbiol
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       aem
      </journal-id>
      <journal-title-group>
       <journal-title>
        Applied and Environmental Microbiology
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0099-2240
      </issn>
      <issn pub-type="epub">
       1098-5336
      </issn>
      <publisher>
       <publisher-name>
        American Society for Microbiology (ASM)
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       20228108
      </article-id>
      <article-id pub-id-type="pmc">
       2863430
      </article-id>
      <article-id pub-id-type="publisher-id">
       2291-09
      </article-id>
      <article-id pub-id-type="doi">
       10.1128/AEM.02291-09
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Public Health Microbiology
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces
        <xref ref-type="fn" rid="fn1">
         ▿
        </xref>
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Casanova
         </surname>
         <given-names>
          Lisa M.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
        <xref ref-type="corresp" rid="cor1">
         *
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Jeon
         </surname>
         <given-names>
          Soyoung
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Rutala
         </surname>
         <given-names>
          William A.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Weber
         </surname>
         <given-names>
          David J.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Sobsey
         </surname>
         <given-names>
          Mark D.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina,
       <label>
        1
       </label>
       Department of Statistics and Operations Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina,
       <label>
        2
       </label>
       Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
       <label>
        3
       </label>
      </aff>
      <author-notes>
       <corresp id="cor1">
        <label>
         *
        </label>
        Corresponding author. Mailing address: CB# 7431 McGavran-Greenberg Hall, Room 3206, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. E-mail:
        <email>
         casanova@unc.edu
        </email>
        . Phone: (919) 966-7317. Fax: (919) 966-7911
       </corresp>
      </author-notes>
      <pub-date pub-type="ppub">
       <month>
        5
       </month>
       <year>
        2010
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        12
       </day>
       <month>
        3
       </month>
       <year>
        2010
       </year>
      </pub-date>
      <volume>
       76
      </volume>
      <issue>
       9
      </issue>
      <fpage>
       2712
      </fpage>
      <lpage>
       2717
      </lpage>
      <history>
       <date date-type="received">
        <day>
         23
        </day>
        <month>
         9
        </month>
        <year>
         2009
        </year>
       </date>
       <date date-type="accepted">
        <day>
         26
        </day>
        <month>
         2
        </month>
        <year>
         2010
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        Copyright © 2010, American Society for Microbiology
       </copyright-statement>
       <copyright-year>
        2010
       </copyright-year>
      </permissions>
      <self-uri xlink:href="zam00910002712.pdf" xlink:title="pdf">
      </self-uri>
      <abstract>
       <p>
        Assessment of the risks posed by severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) on surfaces requires data on survival of this virus on environmental surfaces and on how survival is affected by environmental variables, such as air temperature (AT) and relative humidity (RH). The use of surrogate viruses has the potential to overcome the challenges of working with SARS-CoV and to increase the available data on coronavirus survival on surfaces. Two potential surrogates were evaluated in this study; transmissible gastroenteritis virus (TGEV) and mouse hepatitis virus (MHV) were used to determine effects of AT and RH on the survival of coronaviruses on stainless steel. At 4°C, infectious virus persisted for as long as 28 days, and the lowest level of inactivation occurred at 20% RH. Inactivation was more rapid at 20°C than at 4°C at all humidity levels; the viruses persisted for 5 to 28 days, and the slowest inactivation occurred at low RH. Both viruses were inactivated more rapidly at 40°C than at 20°C. The relationship between inactivation and RH was not monotonic, and there was greater survival or a greater protective effect at low RH (20%) and high RH (80%) than at moderate RH (50%). There was also evidence of an interaction between AT and RH. The results show that when high numbers of viruses are deposited, TGEV and MHV may survive for days on surfaces at ATs and RHs typical of indoor environments. TGEV and MHV could serve as conservative surrogates for modeling exposure, the risk of transmission, and control measures for pathogenic enveloped viruses, such as SARS-CoV and influenza virus, on health care surfaces.
       </p>
      </abstract>
     </article-meta>
    </front>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Colloids Surf B Biointerfaces
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Colloids Surf B Biointerfaces
      </journal-id>
      <journal-title-group>
       <journal-title>
        Colloids and Surfaces. B, Biointerfaces
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0927-7765
      </issn>
      <issn pub-type="epub">
       1873-4367
      </issn>
      <publisher>
       <publisher-name>
        Elsevier B.V.
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       30822681
      </article-id>
      <article-id pub-id-type="pmc">
       7127218
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0927-7765(19)30083-9
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.colsurfb.2019.02.009
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Self-disinfecting surfaces and infection control
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="aut0005">
        <name>
         <surname>
          Querido
         </surname>
         <given-names>
          Micaela Machado
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff0005">
         a
        </xref>
        <xref ref-type="aff" rid="aff0010">
         b
        </xref>
       </contrib>
       <contrib contrib-type="author" id="aut0010">
        <name>
         <surname>
          Aguiar
         </surname>
         <given-names>
          Lívia
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff0005">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="aut0015">
        <name>
         <surname>
          Neves
         </surname>
         <given-names>
          Paula
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff0005">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="aut0020">
        <name>
         <surname>
          Pereira
         </surname>
         <given-names>
          Cristiana Costa
         </given-names>
        </name>
        <email>
         cristianacostapereira@gmail.com
        </email>
        <xref ref-type="aff" rid="aff0005">
         a
        </xref>
        <xref ref-type="aff" rid="aff0010">
         b
        </xref>
        <xref ref-type="corresp" rid="cor0005">
         ⁎
        </xref>
       </contrib>
       <contrib contrib-type="author" id="aut0025">
        <name>
         <surname>
          Teixeira
         </surname>
         <given-names>
          João Paulo
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff0005">
         a
        </xref>
        <xref ref-type="aff" rid="aff0010">
         b
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff0005">
       <label>
        a
       </label>
       National Institute of Health, Environmental Health Department, Porto, Portugal
      </aff>
      <aff id="aff0010">
       <label>
        b
       </label>
       EPIUnit – Institute of Public Health, University of Porto, Porto, Portugal
      </aff>
      <author-notes>
       <corresp id="cor0005">
        <label>
         ⁎
        </label>
        Corresponding author at: National Institute of Health, Environmental Health Department, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal.
        <email>
         cristianacostapereira@gmail.com
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        16
       </day>
       <month>
        2
       </month>
       <year>
        2019
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <day>
        1
       </day>
       <month>
        6
       </month>
       <year>
        2019
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        16
       </day>
       <month>
        2
       </month>
       <year>
        2019
       </year>
      </pub-date>
      <volume>
       178
      </volume>
      <fpage>
       8
      </fpage>
      <lpage>
       21
      </lpage>
      <history>
       <date date-type="received">
        <day>
         9
        </day>
        <month>
         8
        </month>
        <year>
         2018
        </year>
       </date>
       <date date-type="rev-recd">
        <day>
         4
        </day>
        <month>
         2
        </month>
        <year>
         2019
        </year>
       </date>
       <date date-type="accepted">
        <day>
         5
        </day>
        <month>
         2
        </month>
        <year>
         2019
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © 2019 Elsevier B.V. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2019
       </copyright-year>
       <copyright-holder>
        Elsevier B.V.
       </copyright-holder>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract abstract-type="graphical" id="abs0005">
       <title>
        Graphical abstract
       </title>
       <fig id="fig0015" position="anchor">
        <graphic xlink:href="ga1_lrg">
        </graphic>
       </fig>
      </abstract>
      <abstract abstract-type="author-highlights" id="abs0010">
       <title>
        Highlights
       </title>
       <p>
        <list id="lis0005" list-type="simple">
         <list-item id="lsti0005">
          <label>
           •
          </label>
          <p id="par0005">
           4 million patients in the EU acquire a healthcare associated infection each year.
          </p>
         </list-item>
         <list-item id="lsti0010">
          <label>
           •
          </label>
          <p id="par0010">
           Public spaces and other highly occupied spaces are implicated in infection outbreak.
          </p>
         </list-item>
         <list-item id="lsti0015">
          <label>
           •
          </label>
          <p id="par0015">
           Surfaces are one of the major factors contributing to these patterns of infection.
          </p>
         </list-item>
         <list-item id="lsti0020">
          <label>
           •
          </label>
          <p id="par0020">
           Guidelines for microbiological assessment in these scenarios are scarce.
          </p>
         </list-item>
         <list-item id="lsti0025">
          <label>
           •
          </label>
          <p id="par0025">
           Self-disinfecting surfaces are an emergent technology to control infection.
          </p>
         </list-item>
        </list>
       </p>
      </abstract>
      <abstract id="abs0015">
       <p>
        According to World Health Organization, every year in the European Union, 4 million patients acquire a healthcare associated infection.
       </p>
       <p>
        Even though some microorganisms represent no threat to healthy people, hospitals harbor different levels of immunocompetent individuals, namely patients receiving immunosuppressors, with previous infections, or those with extremes of age (young children and elderly), requiring the implementation of effective control measures.
       </p>
       <p>
        Public spaces have also been found an important source of infectious disease outbreaks due to poor or none infection control measures applied.
       </p>
       <p>
        In both places, surfaces play a major role on microorganisms’ propagation, yet they are very often neglected, with very few guidelines about efficient cleaning measures and microbiological assessment available.
       </p>
       <p>
        To overcome surface contamination problems, new strategies are being designed to limit the microorganisms’ ability to survive over surfaces and materials.
       </p>
       <p>
        Surface modification and/or functionalization to prevent contamination is a hot-topic of research and several different approaches have been developed lately. Surfaces with anti-adhesive properties, with incorporated antimicrobial substances or modified with biological active metals are some of the strategies recently proposed.
       </p>
       <p>
        This review intends to summarize the problems associated with contaminated surfaces and their importance on infection spreading, and to present some of the strategies developed to prevent this public health problem, namely some already being commercialized.
       </p>
      </abstract>
      <kwd-group id="kwd0005">
       <title>
        Keywords
       </title>
       <kwd>
        Infection control
       </kwd>
       <kwd>
        Self-disinfecting surfaces
       </kwd>
       <kwd>
        Healthcare facilities
       </kwd>
       <kwd>
        Public spaces
       </kwd>
       <kwd>
        Microbiological risk assessment
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <sec id="sec0005">
     <label>
      1
     </label>
     <title>
      Introduction
     </title>
     <p id="par0030">
      Microorganisms’ spreading, and consequent infection propagation is a serious concern worldwide, yet there are still very few guidelines or legislation for infection propagation control in public spaces. The exception is made for healthcare facilities with the existence of few guidelines and orientations for infection prevention and control, nevertheless hospital acquired infection (HAI) remains a tremendous problem. One of the main causes for the high number of HAI reported by the World Health Organization (WHO) is related to the ability of the microorganisms to survive for long periods in hostile environments such as dry surfaces
      <xref ref-type="bibr" rid="bib0005">
       [1]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0010">
       [2]
      </xref>
      .
     </p>
     <p id="par0035">
      Rooms occupied with infected patients often have their surfaces contaminated with pathogens leading to the contamination of hands and gloves of medical staff, and consequent transfer of these microorganisms to patients or onto other surfaces. This cross-contamination mechanism has already been recognized and lead to the implementation of hygiene procedures for hands when contacting with patients. Still, it is more likely for a patient to get an infection when staying in a room previously occupied by an infected patient. Thus, infected patients are the primary source of surface and material contamination. Visitors and/or asymptomatic carriers also contribute to the spread of microorganisms, especially in situations where there is an apparent sense of safety
      <xref ref-type="bibr" rid="bib0015">
       [3]
      </xref>
      . As said before, there are guidelines for surface cleaning and disinfection in hospitals, however, those recommendations are not sufficient to solve such a problem and the incorrect following of the disinfection instructions can even cause greater contamination problems
      <xref ref-type="bibr" rid="bib0020">
       [4]
      </xref>
      .
     </p>
     <p id="par0040">
      This review considered English-language articles retrieved from PubMed database literature searches, bibliographies from published articles, and infection-control books and chapters, in a total of 205 references published between 2000 and 2018, considering the following criteria: the most recent studies performed on microbiological analysis on different surfaces reporting samplings performed on food contact surfaces, public spaces and hospital surfaces, where microorganisms occur naturally. For the antimicrobial and self-cleaning surfaces studies, the most recent and relevant works developed on surface modification or functionalization were selected and two main types of surfaces were considered for this review - anti-adhesive surfaces and antimicrobial surfaces, along with their subtypes. Finally, products already commercially available with enough reliable manufacturers’ information about the product and its adequacy to the topics discussed in this review were also included.
     </p>
    </sec>
    <sec id="sec0010">
     <label>
      2
     </label>
     <title>
      Role of surfaces in infection propagation: a public health problem
     </title>
     <p id="par0045">
      Contamination spreading by contact can occur either by direct contact with an infected patient, or indirectly through a contaminated object or surface
      <xref ref-type="bibr" rid="bib0025">
       [5]
      </xref>
      .
     </p>
     <p id="par0050">
      Surfaces represent an important way of transmission of diseases since they can act as a reservoir of microorganisms that may spread to whoever contacts with the surface. Especially in crowded spots as public transports or public spaces and places susceptible of the presence of microorganisms like healthcare facilities, surfaces may represent a serious source of infection spreading
      <xref ref-type="bibr" rid="bib0030">
       [6]
      </xref>
      .
      <xref ref-type="table" rid="tbl0005">
       Table 1
      </xref>
      describes the microorganisms detected in hospital, food handling, and other environmental surfaces.
      <table-wrap id="tbl0005" position="float">
       <label>
        Table 1
       </label>
       <caption>
        <p>
         Examples of microorganisms isolated from different surfaces and some of their associated pathologies.
        </p>
       </caption>
       <alt-text id="at0445">
        Table 1
       </alt-text>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th align="left">
           Microorganism
          </th>
          <th align="left">
           Surfaces where it was found
          </th>
          <th align="left">
           Associated pathologies
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td align="left">
           <italic>
            Acinetobacter
           </italic>
           spp.
          </td>
          <td align="left">
           Hospital surfaces (mattresses, medical charts …)
           <xref ref-type="bibr" rid="bib0165">
            [33]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0210">
            [42]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0715">
            [143]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0720">
            [144]
           </xref>
           <break>
           </break>
           Environmental surfaces (telephones)
           <xref ref-type="bibr" rid="bib0085">
            [17]
           </xref>
           <break>
           </break>
           Food-contact surfaces
           <xref ref-type="bibr" rid="bib0725">
            [145]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0730">
            [146]
           </xref>
          </td>
          <td align="left">
           Respiratory tract infection, pneumonia, wound infection, bacteremia
           <xref ref-type="bibr" rid="bib0735">
            [147]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0740">
            [148]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Aspergillus
           </italic>
           spp.
          </td>
          <td align="left">
           Hospital surfaces (cleaning towels, nursing stations, sink waste pipes, medical overalls…)
           <xref ref-type="bibr" rid="bib0195">
            [39]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0745">
            [149]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0750">
            [150]
           </xref>
          </td>
          <td align="left">
           Pulmonary infection, skin infection, central nervous system infection, endocarditis
           <xref ref-type="bibr" rid="bib0755">
            [151]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0760">
            [152]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0765">
            [153]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0770">
            [154]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Campylobacter
           </italic>
           spp.
          </td>
          <td align="left">
           Food-contact surfaces
           <xref ref-type="bibr" rid="bib0775">
            [155]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0780">
            [156]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0785">
            [157]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0790">
            [158]
           </xref>
          </td>
          <td align="left">
           Gastroenteritis (diarrhea)
           <xref ref-type="bibr" rid="bib0035">
            [7]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0795">
            [159]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Candida
           </italic>
           spp.
          </td>
          <td align="left">
           Hospital surfaces (sink, chairs…)
           <xref ref-type="bibr" rid="bib0720">
            [144]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0800">
            [160]
           </xref>
          </td>
          <td align="left">
           Oral and vaginal Candidiasis
           <xref ref-type="bibr" rid="bib0805">
            [161]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0810">
            [162]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Clostridium difficile
           </italic>
          </td>
          <td align="left">
           Hospital surfaces (bed rails, tables, call buttons, toilets, chairs…)
           <xref ref-type="bibr" rid="bib0140">
            [28]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0815">
            [163]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0820">
            [164]
           </xref>
           <break>
           </break>
           Environmental surfaces (toilets, sinks, vacuum cleaners, hotel room surfaces…)
           <xref ref-type="bibr" rid="bib0825">
            [165]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0830">
            [166]
           </xref>
          </td>
          <td align="left">
           Gastroenteritis (diarrhea), Pseudomembranous colitis
           <xref ref-type="bibr" rid="bib0835">
            [167]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           Coronavirus
          </td>
          <td align="left">
           Environmental surfaces (daycare center surfaces, university classroom surfaces)
           <xref ref-type="bibr" rid="bib0080">
            [16]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0840">
            [168]
           </xref>
           <break>
           </break>
           Hospital surfaces (bedrails, doorknobs, ventilator control panels, TV remote controls…)
           <xref ref-type="bibr" rid="bib0845">
            [169]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0850">
            [170]
           </xref>
          </td>
          <td align="left">
           SARS (severe acute respiratory syndrome) and MERS (middle east respiratory syndrome)
           <xref ref-type="bibr" rid="bib0855">
            [171]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Enterococcus
           </italic>
           spp. (including vancomycin-resistant enterococci)
          </td>
          <td align="left">
           Hospital surfaces (mattresses, medical charts…)
           <xref ref-type="bibr" rid="bib0165">
            [33]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0210">
            [42]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0715">
            [143]
           </xref>
           <break>
           </break>
           Environmental surfaces (fitness centers…)
           <xref ref-type="bibr" rid="bib0090">
            [18]
           </xref>
           <break>
           </break>
           Food-contact surfaces
           <xref ref-type="bibr" rid="bib0860">
            [172]
           </xref>
          </td>
          <td align="left">
           Endocarditis, meningitis, catheter-related infection
           <xref ref-type="bibr" rid="bib0865">
            [173]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0870">
            [174]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0875">
            [175]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Escherichia coli
           </italic>
          </td>
          <td align="left">
           Hospital surfaces (medical charts…)
           <xref ref-type="bibr" rid="bib0715">
            [143]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0720">
            [144]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0880">
            [176]
           </xref>
           <break>
           </break>
           Food-contact surfaces
           <xref ref-type="bibr" rid="bib0055">
            [11]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0775">
            [155]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0860">
            [172]
           </xref>
          </td>
          <td align="left">
           Gastroenteritis (diarrhea), peritonitis, urinary tract infection
           <xref ref-type="bibr" rid="bib0885">
            [177]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0890">
            [178]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0895">
            [179]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           Influenza virus
          </td>
          <td align="left">
           Environmental surfaces (toilets, toys, faucets, floors, door knobs, TV remote controls)
           <xref ref-type="bibr" rid="bib0900">
            [180]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0905">
            [181]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0910">
            [182]
           </xref>
           <break>
           </break>
           Hospital Surfaces
           <xref ref-type="bibr" rid="bib0905">
            [181]
           </xref>
          </td>
          <td align="left">
           Influenza (flu)
           <xref ref-type="bibr" rid="bib0915">
            [183]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Klebsiella
           </italic>
           spp.
          </td>
          <td align="left">
           Hospital surfaces (mattresses, medical charts …)
           <xref ref-type="bibr" rid="bib0160">
            [32]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0165">
            [33]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0715">
            [143]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0720">
            [144]
           </xref>
           <break>
           </break>
           Environmental surfaces (fitness centers…)
           <xref ref-type="bibr" rid="bib0090">
            [18]
           </xref>
           <break>
           </break>
           Food-contact surfaces
           <xref ref-type="bibr" rid="bib0730">
            [146]
           </xref>
          </td>
          <td align="left">
           Urinary tract infection, pneumonia, respiratory tract infection
           <xref ref-type="bibr" rid="bib0740">
            [148]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0885">
            [177]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           Norovirus
          </td>
          <td align="left">
           Hospital surfaces (door handles, taps, light switch, telephones…)
           <xref ref-type="bibr" rid="bib0920">
            [184]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0925">
            [185]
           </xref>
           <break>
           </break>
           Environmental surfaces (carpets, door handles, soft furnishing, toilet seats, tables…)
           <xref ref-type="bibr" rid="bib0930">
            [186]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0935">
            [187]
           </xref>
          </td>
          <td align="left">
           Gastroenteritis (diarrhea)
           <xref ref-type="bibr" rid="bib0940">
            [188]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Pseudomonas
           </italic>
           spp.
          </td>
          <td align="left">
           Hospital surfaces (mattresses, showers, taps, sinks, bed rails…)
           <xref ref-type="bibr" rid="bib0160">
            [32]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0165">
            [33]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0720">
            [144]
           </xref>
          </td>
          <td align="left">
           Wound infection, urinary tract infection, respiratory tract infection, pancreatitis, otitis, necrotizing pneumonia, bacteremia, sepsis
           <xref ref-type="bibr" rid="bib0945">
            [189]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0950">
            [190]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0955">
            [191]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0960">
            [192]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           Rotavirus
          </td>
          <td align="left">
           Hospital surfaces (bed rails, chairs, cardiac monitor keyboard, door handles, TV remote controls, telephones…)
           <xref ref-type="bibr" rid="bib0965">
            [193]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0970">
            [194]
           </xref>
          </td>
          <td align="left">
           Rotavirosis (acute diarrhea)
           <xref ref-type="bibr" rid="bib0795">
            [159]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Salmonella
           </italic>
           spp.
          </td>
          <td align="left">
           Food-contact surfaces
           <xref ref-type="bibr" rid="bib0730">
            [146]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0775">
            [155]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0785">
            [157]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0790">
            [158]
           </xref>
           <break>
           </break>
           Environmental surfaces (fitness centers, toilets…)
           <xref ref-type="bibr" rid="bib0090">
            [18]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0975">
            [195]
           </xref>
           <break>
           </break>
           Hospital Surfaces (curtains, stethoscope…)
           <xref ref-type="bibr" rid="bib0210">
            [42]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0980">
            [196]
           </xref>
          </td>
          <td align="left">
           Enteric fever, Gastroenteritis (diarrhea)
           <xref ref-type="bibr" rid="bib0035">
            [7]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0795">
            [159]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0985">
            [197]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Staphylococcus
           </italic>
           spp. (including MRSA)
          </td>
          <td align="left">
           Hospital surfaces (mattresses, curtains, ECG wires, medical charts …)
           <xref ref-type="bibr" rid="bib0160">
            [32]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0165">
            [33]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0180">
            [36]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0190">
            [38]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0715">
            [143]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0720">
            [144]
           </xref>
           <break>
           </break>
           Environmental surfaces (public telephones, fitness centers, elevator buttons, hotel room surfaces…)
           <xref ref-type="bibr" rid="bib0085">
            [17]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0090">
            [18]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0095">
            [19]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0830">
            [166]
           </xref>
           <break>
           </break>
           Food contact surfaces
           <xref ref-type="bibr" rid="bib0775">
            [155]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0860">
            [172]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0990">
            [198]
           </xref>
          </td>
          <td align="left">
           Gastroenteritis (diarrhea), skin infection, pneumonia, catheter infection
           <xref ref-type="bibr" rid="bib0035">
            [7]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib0995">
            [199]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib1000">
            [200]
           </xref>
           ,
           <xref ref-type="bibr" rid="bib1005">
            [201]
           </xref>
          </td>
         </tr>
        </tbody>
       </table>
      </table-wrap>
     </p>
     <sec id="sec0015">
      <label>
       2.1
      </label>
      <title>
       Food contact surfaces
      </title>
      <p id="par0055">
       It is estimated that each year, in the United States alone, 9.4 million episodes of foodborne illness occur resulting nearly 56,000 hospitalizations and over 1300 deaths. The microorganisms most commonly associated with this phenomenon are norovirus,
       <italic>
        Salmonella
       </italic>
       spp.,
       <italic>
        Clostridium perfringens
       </italic>
       and
       <italic>
        Campylobacter
       </italic>
       <xref ref-type="bibr" rid="bib0035">
        [7]
       </xref>
       .
      </p>
      <p id="par0060">
       Food contamination can result from several factors and occur at different points of the preparation process. From farming to the moment of consuming, food goes through several steps where contamination by microorganisms can occur. Temperature and storage conditions are important factors to prevent food spoilage however, there are other factors that can cause microbiological contamination
       <xref ref-type="bibr" rid="bib0040">
        [8]
       </xref>
       .
      </p>
      <p id="par0065">
       Food-contact surfaces’ contamination can cause food contamination with pathogens during processing or packaging. Bacteria are naturally present in plants and animals and it is easy for them to attach to a food contact surface during handling. Due to adhesion mechanisms bacteria can remain on the surfaces and contaminate other foods
       <xref ref-type="bibr" rid="bib0045">
        [9]
       </xref>
       . Chopping boards, knifes and preparation tables are just some of the food preparation instruments found contaminated with bacteria
       <xref ref-type="bibr" rid="bib0050">
        [10]
       </xref>
       .
      </p>
      <p id="par0070">
       Saad et al.
       <xref ref-type="bibr" rid="bib0055">
        [11]
       </xref>
       evaluated hygiene conditions on food preparation facilities by analysing food-contact surfaces and the results were quite adverse, suggesting fecal contamination. Coliform bacteria were found in dining tables (58%), food trays (33%), cooking pots (33%) and kitchen faucets (8%). In addition,
       <italic>
        E. coli
       </italic>
       was identified in some cooking pots.
      </p>
      <p id="par0075">
       In this study, surfaces with a count of total mesophilic aerobes of &gt;10 CFU/cm
       <sup>
        2
       </sup>
       or &gt;1 CFU/cm
       <sup>
        2
       </sup>
       for
       <italic>
        E. coli
       </italic>
       and coliforms were considered to fail hygiene criteria, according to the Commission of the European Communities guidelines
       <xref ref-type="bibr" rid="bib0060">
        [12]
       </xref>
       for hygiene conditions in fresh meat processing facilities.
      </p>
      <p id="par0080">
       Although most countries have guidelines about hygiene measures and good practice on food processing facilities not always the cleaning procedures are sufficient to prevent microorganisms propagation
       <xref ref-type="bibr" rid="bib0020">
        [4]
       </xref>
       . Most of the times the cleaning cloths used in cleaning can become contaminated if soaked with disinfectants in the wrong dilution (common fault in food handling facilities), contributing to microorganisms’ spread to previously uncontaminated surfaces
       <xref ref-type="bibr" rid="bib0065">
        [13]
       </xref>
       .
      </p>
      <p id="par0085">
       In the food industry, the occurrence of biofilm formation is also a common event due to inefficient cleaning and disinfection. The remaining microorganisms can survive on the surfaces, especially if food residues remain. This will promote the development and multiplication of bacteria with consequent biofilm formation that is extremely hard to eliminate, becoming even more difficult to disinfect the surface
       <xref ref-type="bibr" rid="bib0070">
        [14]
       </xref>
       .
      </p>
     </sec>
     <sec id="sec0020">
      <label>
       2.2
      </label>
      <title>
       Schools and public spaces
      </title>
      <p id="par0090">
       Schools and day-care centers are hot spots of infection spreading. Lack of hygiene habits, common among very young children, is one of the main causes of contamination between kids, leading to the contamination of other children, staff, parents or people in the community, either by direct contact or by contaminating surfaces.
       <xref ref-type="bibr" rid="bib0075">
        [15]
       </xref>
       .
      </p>
      <p id="par0095">
       Ibfelt et al.
       <xref ref-type="bibr" rid="bib0080">
        [16]
       </xref>
       evaluated the presence of bacteria and viruses in day-care centers in Denmark and different surfaces from toilets, kitchens and playrooms were analyzed. The results proved contamination by several bacteria and virus. Despite the main bacteria present were non-pathogenic, several surfaces revealed the presence of coliform and nasopharyngeal bacteria. Respiratory viruses were mainly present on toys but also on pillows and playroom tables. Gastrointestinal viruses although less prevalent were found in some surfaces, mainly on playroom pillows and toilet surfaces.
      </p>
      <p id="par0100">
       A study by Jerković-Mujkić et al.
       <xref ref-type="bibr" rid="bib0085">
        [17]
       </xref>
       analyzed potential contamination in 60 public telephones and the results showed high presence of microorganisms on the surfaces. S
       <italic>
        taphylococcus epidermidis
       </italic>
       (73.3%) and
       <italic>
        Bacillus subtilis
       </italic>
       (40%) were the most common bacteria identified, however more species were isolated.
      </p>
      <p id="par0105">
       Mukherjee et al.
       <xref ref-type="bibr" rid="bib0090">
        [18]
       </xref>
       evaluated the presence of microorganisms on different surfaces of a fitness center. The samples were collected from skin-contact surfaces as floor mats and exercise instruments, regularly shared by many people. In total, 63 species were identified with the presence of some pathogenic or potential pathogenic bacteria like
       <italic>
        Salmonella
       </italic>
       ,
       <italic>
        Staphylococcus
       </italic>
       or
       <italic>
        Klebsiella
       </italic>
       .
       <italic>
        Staphylococci
       </italic>
       were present in the majority of the surfaces being one the most prevalent species, namely
       <italic>
        S. aureus
       </italic>
       ,
       <italic>
        S. epidermidis
       </italic>
       and
       <italic>
        Staphyloccocus saprophyticus
       </italic>
       .
      </p>
      <p id="par0110">
       Kandel et al.
       <xref ref-type="bibr" rid="bib0095">
        [19]
       </xref>
       developed a study with stupefying results. They compared microbiological contamination of toilet surfaces with buttons on hospital elevators, and the buttons showed higher colonization (61%) than the toilets (43%). The most common bacteria on both surfaces were
       <italic>
        Staphylococcus
       </italic>
       and
       <italic>
        Streptococcus
       </italic>
       , however other bacterial species were founded, as wells as fungi.
      </p>
      <p id="par0115">
       Otter and French
       <xref ref-type="bibr" rid="bib0030">
        [6]
       </xref>
       studied the presence of microorganisms in hand-touch surface in public transport system. The samples were collected from several surfaces in trains, stations and buses of London. The presence of bacteria was confirmed, and most sites presented a median bacterial concentration of 12 CFU cm
       <sup>
        −2
       </sup>
       . Even though there are no guidelines for acceptable values for bacteria's presence on surfaces of public spaces this value is higher than the recommended for food-processing surfaces
       <xref ref-type="bibr" rid="bib0060">
        [12]
       </xref>
       and hospital hand-contact surfaces
       <xref ref-type="bibr" rid="bib0100">
        [20]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0105">
        [21]
       </xref>
       .
      </p>
     </sec>
     <sec id="sec0025">
      <label>
       2.3
      </label>
      <title>
       Hospital surfaces
      </title>
      <p id="par0120">
       It has been recognized that hospitals’ contaminated surfaces and medical equipment contribute to the contamination of patients and medical staff
       <xref ref-type="bibr" rid="bib0015">
        [3]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0025">
        [5]
       </xref>
       . Several factors contribute to this occurrence but the mains reason is associated with the high prevalence of microorganisms in healthcare facilities.
      </p>
      <p id="par0125">
       Pathogens with the ability to cause high rates of infection come from different sources such as patients’ endogenous flora (40–60%), hands of medical staff and assistants (20–40%), antibiotic-driven changes in patients’ flora (20–25%) and other, including contamination of the environment (20%)
       <xref ref-type="bibr" rid="bib0110">
        [22]
       </xref>
       .
      </p>
      <p id="par0130">
       Carling et al.
       <xref ref-type="bibr" rid="bib0115">
        [23]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0120">
        [24]
       </xref>
       have shown that in some cases less than 50% of hospital surfaces can be considered clean after terminal disinfection procedures. However, for specific surfaces the rate can be even more alarming with less than 30% of bedpan cleaners, bathroom hand-holds, light switches, and doorknobs being cleaned
       <xref ref-type="bibr" rid="bib0125">
        [25]
       </xref>
       . Contact between hands and gloves of medical staff with contaminated surfaces leads to pathogens’ spreading to other surfaces and people
       <xref ref-type="bibr" rid="bib0025">
        [5]
       </xref>
       . Particularly if they are immunocompromised patients, the risk of developing an infection is very high
       <xref ref-type="bibr" rid="bib0130">
        [26]
       </xref>
       .
      </p>
      <p id="par0135">
       Stiefel et al.
       <xref ref-type="bibr" rid="bib0135">
        [27]
       </xref>
       found out that the level of contamination of gloves on medical staff after contact with patients’ skin sites was actually quite similar (40% vs 45%) to the level of contamination after contacting with surfaces on methicillin- resistant
       <italic>
        Staphylocococcus aureus
       </italic>
       (MRSA) carriers’ rooms, suggesting that environmental surfaces may pose serious risks.
      </p>
      <p id="par0140">
       An identical study from Guerrero et al.
       <xref ref-type="bibr" rid="bib0140">
        [28]
       </xref>
       found similar results for
       <italic>
        C. difficile
       </italic>
       contamination, proving that the risk of hand contamination after contact with patients’ skin was the same than when contacting with rooms’ highly-touched surfaces (50% vs 50%).
      </p>
      <p id="par0145">
       This issue is also related to the compliance of hospital workers on performing disinfection protocols. A recent study from Stahmeyer et al.
       <xref ref-type="bibr" rid="bib0145">
        [29]
       </xref>
       showed that only 42% of healthcare workers washed their hands before contact with a patient, and 50% washed their hands after contact with the patient. Also, this study found out that 94.3% of healthcare workers’ hand hygiene procedure lasted less than 15 s (average 7.6 s), when the recommendations is that it should last around 30 s.
      </p>
      <p id="par0150">
       Another study evaluating disinfection compliance by healthcare workers showed that only 26% of the enquired radiologists affirmed to disinfect their workstation daily, 24% admitted never to have disinfected their workstation, and 100% said to have never received any recommendation on how to perform the disinfection
       <xref ref-type="bibr" rid="bib0150">
        [30]
       </xref>
       .
      </p>
      <p id="par0155">
       Several studies have proved that surfaces in rooms of patients infected with important pathogens are frequently contaminated, and that a person admitted to a room previously occupied by an infected patient has an increased likelihood of developing colonization or infection with that pathogen
       <xref ref-type="bibr" rid="bib0125">
        [25]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0155">
        [31]
       </xref>
       .
      </p>
      <p id="par0160">
       A study performed in Portugal by Geadas Farias et al.
       <xref ref-type="bibr" rid="bib0160">
        [32]
       </xref>
       revealed hospital surfaces’ contamination with different microorganisms, mostly
       <italic>
        Pseudomonas
       </italic>
       and
       <italic>
        Staphylococcus
       </italic>
       . Several surfaces were contaminated but some of those with higher microbiological presence were surfaces associated with water distribution system as sinks, taps, showers and drains.
      </p>
      <p id="par0165">
       Viana et al.
       <xref ref-type="bibr" rid="bib0165">
        [33]
       </xref>
       performed an analysis on hospital mattresses, and resistant bacteria were found on about 50% of the evaluated mattresses.
       <italic>
        A. baumannii
       </italic>
       was the main species found, being present in 73.1% of the mattresses, but also other pathogens were collected as
       <italic>
        K. pneumoniae
       </italic>
       and
       <italic>
        P. aeruginosa.
       </italic>
       This study also identified the microorganisms found on mattresses and showed that in 54% of the cases the microorganisms were not related to the current patient admitted in the room but to the previous one, concluding that even after cleaning microorganisms still remain on the mattresses being a possible source of contamination to other patients.
      </p>
      <p id="par0170">
       Despite most studies evaluating the effectiveness of room disinfection have focused on some specific surfaces considered dirty (sink, toilets, etc.), all spots must be considered since contamination can be present on unsuspected surfaces
       <xref ref-type="bibr" rid="bib0170">
        [34]
       </xref>
       . Actually, White et al.
       <xref ref-type="bibr" rid="bib0175">
        [35]
       </xref>
       found out in an hospital that microbiologically the sinks and floors were cleaner than hand touch sites as chairs, beds and cardiac monitors buttons.
      </p>
      <p id="par0175">
       Shek et al.
       <xref ref-type="bibr" rid="bib0180">
        [36]
       </xref>
       developed a study where hospital curtains of burn and plastic surgery units were microbiologically tested. The results proved a considerable presence of bacteria on the curtains, even multi resistant bacteria as MRSA.
      </p>
      <p id="par0180">
       Levin et al.
       <xref ref-type="bibr" rid="bib0185">
        [37]
       </xref>
       found that in situations of poor infection control practices it is possible for patients to become a source for unresolved contamination of portable radiographic equipment with pathogenic bacteria, namely resistant bacteria.
      </p>
      <p id="par0185">
       Lestari et al.
       <xref ref-type="bibr" rid="bib0190">
        [38]
       </xref>
       performed a similar study but evaluating ECG lead wires, and among the 451 lead wires analyzed only 2 were non-contaminated with some type of microorganism. Coagulase negative staphylococci and aerobic spore forming bacteria, two important types of pathogens, were present in 96% and 71% of the wires respectively. The ineffective cleaning associated with the ability of microorganisms to survive on surfaces under hostile conditions, for long periods of time, is a serious cause of pathogens spreading to people and to other surfaces
       <xref ref-type="bibr" rid="bib0155">
        [31]
       </xref>
       .
      </p>
      <p id="par0190">
       The presence of biofilms, the substances used in the cleaning process, and the method and frequency of cleaning, all interfere in the grade to which microorganisms resist to the cleaning and disinfection procedures. Badly executed cleaning procedures may bring bigger problems than not cleaning at all. The transmission of microorganisms from a contaminated surface to a clean one can occur if the cleaning method is not correct. Also, most detergents do not have antimicrobial activity they only act in the microorganisms’ removal, leading to the contamination of the cleaning cloths with viable microorganisms, and its consequent spread to non-contaminated surfaces
       <xref ref-type="bibr" rid="bib0195">
        [39]
       </xref>
       .
      </p>
      <p id="par0195">
       The frequency of cleaning is also an important factor, since surfaces such as toilets, sinks, and other known as dirty surfaces tend be cleaned frequently
       <xref ref-type="bibr" rid="bib0200">
        [40]
       </xref>
       . However, other surfaces thought safe but still highly touched are often neglected, being poorly cleaned. For example, according to the
       <italic>
        Practical Guidelines for Infection Control in Health Care Facilities
       </italic>
       <xref ref-type="bibr" rid="bib0205">
        [41]
       </xref>
       , mattresses without plastic covers must be steam cleaned if contaminated with body fluids. However, if body fluid contamination does not occur the mattresses are not so often cleaned, allowing microorganisms to accumulate with time and use, as proved by Viana et al.
       <xref ref-type="bibr" rid="bib0165">
        [33]
       </xref>
       . Also Geadas Farias et al.
       <xref ref-type="bibr" rid="bib0160">
        [32]
       </xref>
       have found that surfaces usually not considered dirty but highly touched as light switches or nursing trays were contaminated with several microorganisms.
      </p>
      <p id="par0200">
       A very recent study by Johani et al.
       <xref ref-type="bibr" rid="bib0210">
        [42]
       </xref>
       revealed the presence of biofilms in many surfaces of intensive care units despite regular disinfection procedures. Several highly touched surfaces were analyzed and in 70%, the presence of biofilm was proved by scanning electron microscopy.
      </p>
      <p id="par0205">
       In many situations the lack of adequate training of the environmental cleaning services or of the medical staff ultimately promotes the use of inappropriate detergents or germicides promoting the survival of microorganisms on the surfaces, even after cleaning
       <xref ref-type="bibr" rid="bib0215">
        [43]
       </xref>
       .
      </p>
      <p id="par0210">
       Among the most used disinfectants are substances based on hypochlorite, alcohols, aldehydes, phenols and quaternary ammonium compounds
       <xref ref-type="bibr" rid="bib0220">
        [44]
       </xref>
       . However, not all of these substances are efficient against some specific types of microorganisms, namely spore forming pathogens like
       <italic>
        C. difficile
       </italic>
       <xref ref-type="bibr" rid="bib0225">
        [45]
       </xref>
       . Some disinfectants may cause resistance on the microorganisms if not used within specific parameters
       <xref ref-type="bibr" rid="bib0230">
        [46]
       </xref>
       .
      </p>
      <p id="par0215">
       There are several guidelines
       <xref ref-type="bibr" rid="bib0205">
        [41]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0235">
        [47]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0240">
        [48]
       </xref>
       for infection control that suggest cleaning and disinfection methodologies to be applied in healthcare facilities. These guidelines not only suggest how to disinfect medical equipment but also how to clean environmental surfaces as floors, furniture or toilet seats. However, different guidelines present different opinions on the frequency of cleaning or advisable disinfectants/detergents for each situation since there is no standardization for the methods and cleaning agents to be used.
      </p>
      <p id="par0220">
       In addition, there is a lack of guidelines suggesting effective standardized methods to assess environmental cleaning. Visual evaluation is still the most used method to determine a surface cleanness, however even if a surface is apparently clean it can contain a high microbial load
       <xref ref-type="bibr" rid="bib0245">
        [49]
       </xref>
       .
      </p>
     </sec>
    </sec>
    <sec id="sec0030">
     <label>
      3
     </label>
     <title>
      Guidelines for microbiologic limit values on surfaces
     </title>
     <p id="par0225">
      According to the Commission of the European Communities
      <xref ref-type="bibr" rid="bib0060">
       [12]
      </xref>
      guidelines for hygiene conditions in fresh meat processing facilities, food-contact surfaces with &gt;10 CFU/cm
      <sup>
       2
      </sup>
      for total viable count and &gt;1 CFU/cm
      <sup>
       2
      </sup>
      for
      <italic>
       Enterobacteriaceae
      </italic>
      are considered unacceptable.
     </p>
     <p id="par0230">
      There are no established limit values for microorganisms on surfaces for Public spaces, and there is poor control on cleaning performance. As depicted in Section
      <xref ref-type="sec" rid="sec0020">
       2.2
      </xref>
      surfaces in these places are often contaminated showing values higher than those allowed on healthcare facilities (2.5–5 CFUs/cm
      <sup>
       2
      </sup>
      ). More regulation should be made to assess the cleaning and disinfection efficacy and compliance on such places, namely on spaces with more susceptible people as schools, day-care centers or elderly homes. More guidelines about how to clean and how often would be a good option, as well as a higher microbiological assessment on surfaces, that is rarely or never done in public spaces.
     </p>
     <p id="par0235">
      For healthcare facilities, there is some controversy about the acceptable number of microorganisms on surfaces since there are no established thresholds, only tentative suggestions from researchers.
     </p>
     <p id="par0240">
      For some authors, clean hand-contact surfaces in hospitals must have less than 5 CFUs/cm
      <sup>
       2
      </sup>
      , with an increased risk of infection for values above that
      <xref ref-type="bibr" rid="bib0100">
       [20]
      </xref>
      . Other researchers have proposed the maximum value of 2.5 CFUs/cm
      <sup>
       2
      </sup>
      as the limit level of contamination in clean hospital surfaces
      <xref ref-type="bibr" rid="bib0105">
       [21]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0250">
       [50]
      </xref>
      .
     </p>
     <p id="par0245">
      For some specific microorganisms, considered indicator organisms, the limit value must be even lower. The presence of such microorganisms (for example
      <italic>
       S. aureus
      </italic>
      ,
      <italic>
       C. difficile
      </italic>
      , vancomycin-resistant
      <italic>
       Enterococci
      </italic>
      or
      <italic>
       Acinetobacter
      </italic>
      spp.) is considered indicative of the need for cleaning even at levels of 1 CFUs/cm
      <sup>
       2
      </sup>
      <xref ref-type="bibr" rid="bib0100">
       [20]
      </xref>
      . Some reference limit-values either from governmental entities or from research studies are listed in
      <xref ref-type="table" rid="tbl0010">
       Table 2
      </xref>
      .
      <table-wrap id="tbl0010" position="float">
       <label>
        Table 2
       </label>
       <caption>
        <p>
         Limit values suggested for aerobic colony count of microorganisms in different types of surfaces.
        </p>
       </caption>
       <alt-text id="at0450">
        Table 2
       </alt-text>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th align="left">
           Local
          </th>
          <th align="left">
           Aerobic colony count (limit value)
          </th>
          <th align="left">
           Indicator microorganisms
          </th>
          <th align="left">
           Entity/Researcher
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td align="left">
           Food-contact surfaces
          </td>
          <td align="left">
           10 CFU/cm
           <sup>
            2
           </sup>
          </td>
          <td align="left">
           1 CFU/cm
           <sup>
            2
           </sup>
           for
           <italic>
            Enterobacteriaceae
           </italic>
          </td>
          <td align="left">
           <xref ref-type="bibr" rid="bib0060">
            [12]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           Public spaces’ surfaces
          </td>
          <td align="left">
           –
          </td>
          <td align="left">
           –
          </td>
          <td align="left">
           –
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="3" valign="middle">
           Hospital surfaces
          </td>
          <td align="left">
           5 CFU/cm
           <sup>
            2
           </sup>
          </td>
          <td align="left">
           1 CFU/cm
           <sup>
            2
           </sup>
           for
           <italic>
            S. aureus (including methicillin resistant)
           </italic>
           ,
           <italic>
            C. difficile
           </italic>
           , multiply resistant Gram-negative bacilli, vancomycin-resistant
           <italic>
            Enterococci
           </italic>
           ,
           <italic>
            Salmonella
           </italic>
           spp,
           <italic>
            Acinetobacter spp
           </italic>
          </td>
          <td align="left">
           <xref ref-type="bibr" rid="bib0100">
            [20]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           2.5 CFU/cm
           <sup>
            2
           </sup>
          </td>
          <td align="left">
           –
          </td>
          <td align="left">
           <xref ref-type="bibr" rid="bib0250">
            [50]
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           2.5 CFU/cm
           <sup>
            2
           </sup>
          </td>
          <td align="left">
           1 CFU/cm
           <sup>
            2
           </sup>
           for
           <italic>
            Enterobacteriaceae
           </italic>
           and
           <italic>
            S. aureus
           </italic>
          </td>
          <td align="left">
           <xref ref-type="bibr" rid="bib0105">
            [21]
           </xref>
          </td>
         </tr>
        </tbody>
       </table>
      </table-wrap>
     </p>
     <p id="par0250">
      The limit of &lt;1 CFUs/cm
      <sup>
       2
      </sup>
      for indicator microorganisms makes sense since it has been shown that an infectious dose of 1 CFUs/cm
      <sup>
       2
      </sup>
      was sufficient to cause
      <italic>
       C. difficile
      </italic>
      infection on mice
      <xref ref-type="bibr" rid="bib0225">
       [45]
      </xref>
      . Also, it was observed that very low doses of norovirus have the capacity to cause infection
      <xref ref-type="bibr" rid="bib0255">
       [51]
      </xref>
      . These results show that microbiological contamination on surfaces poses a real risk of infection, since the environmental infectious dose can be very low for some microorganisms.
     </p>
     <p id="par0255">
      There is still the need for reaching a consensus and creating general guidelines for healthcare facilities. Establishing clear limit values and implementing frequent microbiological assessment protocols are some of the steps that should be in the horizon.
     </p>
    </sec>
    <sec id="sec0035">
     <label>
      4
     </label>
     <title>
      Antimicrobial and self-cleaning surfaces
     </title>
     <p id="par0260">
      To avoid contamination and consequent infection propagation on surfaces, several alternative strategies have been developed recently. Application of aerosols or UV light on contaminated surfaces are good examples of no-touch strategies, and they seem to be a good option to be applied in hospital environment
      <xref ref-type="bibr" rid="bib0260">
       [52]
      </xref>
      . However, these approaches still present some limitations.
     </p>
     <p id="par0265">
      UV light, in hospital facilities, can only be applied in empty rooms, therefore it cannot be used for a daily cleaning routine. Also, it only disinfects areas directly reached by the UV light, so many objects and surfaces remain contaminated after this disinfection approach. Aerosols are efficient but take a long time to decontaminate the surfaces compared to conventional cleaning or UV light. Besides that, these strategies are also exclusively used in empty rooms. This factor increases the necessary time to do the final disinfection of the room and perform the beds turnover in hospitals
      <xref ref-type="bibr" rid="bib0265">
       [53]
      </xref>
      .
     </p>
     <p id="par0270">
      Cold plasma technology is another disinfection strategy that has recently been applied on surfaces. Plasma is the fourth state of mater and it can be generated from gases that became ionized with lots of ions, electrons and free radicals that will provide good electric conductivity. Plasma is known to have high levels of energy and it can change molecules composition making them highly ionized and with many free radicals moving randomly in all directions. For example, when a molecule of hydrogen peroxide is exposed to this technology the double bond on the molecule is broken, creating reactive oxygen species like hydroxyl radicals that in need to seek equilibrium will bind to surrounding microorganisms destroying them by oxidation
      <xref ref-type="bibr" rid="bib0270">
       [54]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0275">
       [55]
      </xref>
     </p>
     <p id="par0275">
      This technology has already been tested in food industry to decontaminate vegetables
      <xref ref-type="bibr" rid="bib0280">
       [56]
      </xref>
      and meat
      <xref ref-type="bibr" rid="bib0285">
       [57]
      </xref>
      with good results obtained and also to decontaminate surfaces as packaging materials. Puligundla et al.
      <xref ref-type="bibr" rid="bib0290">
       [58]
      </xref>
      have tested the elimination of different bacteria such as
      <italic>
       E. coli
      </italic>
      ,
      <italic>
       Salmonella typhimurium
      </italic>
      and
      <italic>
       S. aureus
      </italic>
      , from several materials often used on food packages such as glass, polypropylene, polyethylene, nylon and paper foil. The results were quite promising with several log reductions after 5 to 10 minutes of treatment. Even though the results of this emerging technology are quite encouraging as a possible strategy to disinfect surfaces, more studies are needed to assure its safety and profitability to disinfect larger surfaces.
     </p>
     <p id="par0280">
      Surface modification/functionalization is another common procedure to obtain anti-adhesive or antimicrobial properties on different materials. This approach has several advantages over conventional disinfection techniques. For example, antimicrobial surfaces are in constant process of activity oppositely to no-touch technologies or conventional cleaning. This way the antimicrobial charge on the surfaces is reduced immediately after contact preventing its propagation and consequent contamination of surrounding surfaces or people
      <xref ref-type="bibr" rid="bib0295">
       [59]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0300">
       [60]
      </xref>
      .
     </p>
     <p id="par0285">
      Other advantage is the possibility of these surfaces to be present in populated environments since they cause no harm to people with no need to remove people from the rooms to perform the disinfection. In addition, modified surfaces are not restricted to external surfaces. Medical devices such as urinary catheters, central venous catheters, prosthesis or contact lenses are some of the surfaces that have been functionalized to obtain better compatibility properties and lower infection risk when inserted on the human body
      <xref ref-type="bibr" rid="bib0305">
       [61]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0310">
       [62]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0315">
       [63]
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0320">
       [64]
      </xref>
      .
     </p>
     <p id="par0290">
      Self-disinfecting surfaces are an emerging topic with more and more products coming up. Some of the most recent strategies developed to obtain surfaces with anti-adhesive and antimicrobial properties are discussed below.
     </p>
     <sec id="sec0040">
      <label>
       4.1
      </label>
      <title>
       Anti-adhesive surfaces
      </title>
      <p id="par0295">
       Several natural surfaces have suffered diverse evolutionary processes that turned them resistant to microorganisms’ colonization. Natural and bio-mimicked surfaces of insects’ wings, sharks’ skin, and lotus’ leaves exhibit antibiofouling properties by preventing different cells, particles or microorganisms from attaching to their surface
       <xref ref-type="bibr" rid="bib0325">
        [65]
       </xref>
       . Considering this, some of these natural anti-adhesive or self-cleaning surfaces have been investigated for their potential application on micro/nanostructured surfaces development. However it is also possible to give anti-adhesive properties to a surface by modifying the material's chemistry, namely using self-assembled monolayers or polymer brushes immobilized on the surface (
       <xref ref-type="fig" rid="fig0005">
        Fig. 1
       </xref>
       ) (
       <xref ref-type="bibr" rid="bib0330">
        [66]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0335">
        [67]
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0340">
        [68]
       </xref>
       ).
       <fig id="fig0005">
        <label>
         Fig. 1
        </label>
        <caption>
         <p>
          Anti-adhesive surfaces produced by: (a) chemical and (b) physical modification.
         </p>
        </caption>
        <alt-text id="at0435">
         Fig. 1
        </alt-text>
        <graphic xlink:href="gr1_lrg">
        </graphic>
       </fig>
      </p>
      <sec id="sec0045">
       <label>
        4.1.1
       </label>
       <title>
        Chemical modification
       </title>
       <p id="par0300">
        There are several ways to produce materials with anti-fouling properties acting at the level of surface modification with chemical structures. Functional groups exhibited by the material's surface interact with those in the microorganism’ cells determining the kinetics of microbial adhesion.
       </p>
       <p id="par0305">
        For instance, surfaces highly negatively charged, i.e. polyanionic surfaces have the ability to repulse the bacteria with polyanionic glycocalice (most of gram-positive bacteria) through electrostatic interactions. However, gram-negative bacteria have policationic glycocalices, so this surface modification mechanism is only effective against some bacterial species and sometimes only against specific strain types
        <xref ref-type="bibr" rid="bib0345">
         [69]
        </xref>
        .
       </p>
       <p id="par0310">
        Zwitterionic materials, such as carboxybetaine, sulfobetaine, and phosphobetaine also have anti-fouling properties. Zwitterionic polymers have an equal number of anionic and cationic groups present in their repeating unit. This fact gives these polymers ultra-hydrophilicity and consequently great hydration ability
        <xref ref-type="bibr" rid="bib0350">
         [70]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0355">
         [71]
        </xref>
        . Studies concerning surface modification with zwitterionic polymers have proved to be a promising strategy to reduce microorganisms’ adhesion
        <xref ref-type="bibr" rid="bib0360">
         [72]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0365">
         [73]
        </xref>
        . Very recently, a study using a tyramine-conjugated sulfobetaine polymer, grafted on polyurethane showed a great reduction in
        <italic>
         S. aureus
        </italic>
        adhesion to the surface
        <xref ref-type="bibr" rid="bib0370">
         [74]
        </xref>
        .
       </p>
       <p id="par0315">
        Coating with polymeric brushes can also prevent microorganisms’ adhesion. Apart from avoiding direct contact between microorganisms and the surfaces, the polymers used for brushes are usually hydrophilic, so water will be attracted into the brush forming a repellent layer in aqueous environment. Proteins and microorganisms encountering the brush surface will be repelled by steric hindrance due to the water bound in the brush and the elasticity of the polymer chains
        <xref ref-type="bibr" rid="bib0375">
         [75]
        </xref>
        . Polyethylene oxide (PEO) and polyethylene glycol (PEG) are two examples of polymers used to produce hydrophilic brush coatings on biomaterials. In a recent study by. Hadjesfandiari et al.
        <xref ref-type="bibr" rid="bib0380">
         [76]
        </xref>
        it was proved that PEO brushes covalently immobilized reduced 98% the adhesion of
        <italic>
         Staphylococci
        </italic>
        and
        <italic>
         E. coli
        </italic>
        to a surface.
       </p>
      </sec>
      <sec id="sec0050">
       <label>
        4.1.2
       </label>
       <title>
        Physical modification
       </title>
       <p id="par0320">
        Apart from the chemistry, also topography of a surface can be structured to increase anti-adhesive properties. As an attempt to find efficient alternatives over more classic antimicrobials, micro/nanostructured materials present themselves as possible solutions. Recently, have been done an attempt to elucidate if alterations on micro or nanotopography of a surface could influence colonization and consequent contamination. An example of structure modification is the application of superficial nanostructures (nanoparticles, nanofibers or nanotubes) reducing the area available for microorganisms to attach
        <xref ref-type="bibr" rid="bib0385">
         [77]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0390">
         [78]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0395">
         [79]
        </xref>
        .
       </p>
       <p id="par0325">
        As said previously, mimicking the topography of anti-adhesive surfaces innately present in nature is an innovative way to obtain new self-disinfecting surfaces.
       </p>
       <p id="par0330">
        Many plants have special surface properties namely wettability. For instance, lotus leaves have micropapillae structures covered by nanostructures with fine branch-like shape. These structures along with epicuticular needle-shaped wax tubes that cover them give the lotus leaf a superhydrophobic surface and consequently antifouling properties. Water droplets roll down the lotus leaf due to its great hydrophobicity dragging out any possible particles present, and maintaining its surface clean
        <xref ref-type="bibr" rid="bib0400">
         [80]
        </xref>
        .
       </p>
       <p id="par0335">
        Other example of nature that inspired anti-adhesive surfaces’ coating is sharkskin. Sharks have a special scale micropattern, which consist of a rectangular base embedded in the skin with tiny spines on the surface. The ribbed texture of these scales is responsible for the self-cleaning, anti-biofouling, hydrophobic and drag reducing properties of shark skin
        <xref ref-type="bibr" rid="bib0405">
         [81]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0410">
         [82]
        </xref>
        . Such properties have made of sharkskin one of the most mimicked surfaces, not only in research environment but in industrial area too.
       </p>
       <p id="par0340">
        Sharklet AF (Sharklet Technologies, Alachua, FL, USA) is a company that uses shark skin topography in different surfaces in order to avoid bacterial adhesion and biofilm formation
        <xref ref-type="bibr" rid="bib0415">
         [83]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0420">
         [84]
        </xref>
        . A study comparing Sharklet micropattern surfaces with regular surfaces in a clinical simulated scenario proved that shark skin microtopography reduced the number of attached bacteria by about 5 fold
        <xref ref-type="bibr" rid="bib0425">
         [85]
        </xref>
        .
       </p>
      </sec>
     </sec>
     <sec id="sec0055">
      <label>
       4.2
      </label>
      <title>
       Antimicrobial surfaces
      </title>
      <p id="par0345">
       There are several materials with intrinsic antimicrobial properties, as silver, zinc, cooper, or chitosan. Nevertheless, materials can also be modified to acquire bactericidal activity
       <xref ref-type="bibr" rid="bib0430">
        [86]
       </xref>
       . Chemical or physical changes in the surface can produce antimicrobial effect. Chemical substances such as antibiotics or biocides can be incorporated in the materials to give it antimicrobial properties. However, a balance between these properties and biocompatibility must be observed since the materials will be in direct contact with users’ organism raising toxicity concerns. Photo-activated surfaces are also an example of self-disinfecting materials recently developed.
       <xref ref-type="fig" rid="fig0010">
        Fig. 2
       </xref>
       presents some examples of different types of antimicrobial surfaces.
       <fig id="fig0010">
        <label>
         Fig. 2
        </label>
        <caption>
         <p>
          Types of antimicrobial surfaces: (a) photo-activated, (b) with intrinsic antimicrobial properties, loaded with some antimicrobial, either by (c) incorporation or (d) coating.
         </p>
        </caption>
        <alt-text id="at0440">
         Fig. 2
        </alt-text>
        <graphic xlink:href="gr2_lrg">
        </graphic>
       </fig>
      </p>
      <sec id="sec0060">
       <label>
        4.2.1
       </label>
       <title>
        Intrinsically active antimicrobial materials
       </title>
       <p id="par0350">
        Some materials have intrinsic antimicrobial properties. They do not need antimicrobial loading to exert its activity since the material by itself has the natural ability to eliminate microorganisms. Among the most known natural materials with antimicrobial properties are metals as silver, copper, or zinc and polymers like chitosan
        <xref ref-type="bibr" rid="bib0340">
         [68]
        </xref>
        .
       </p>
       <p id="par0355">
        For many metals with antimicrobial properties, it is the ionic form that presents higher bactericidal activity and not the elemental metal. Silver and copper are good examples of that.
       </p>
       <p id="par0360">
        Silver has been used in medical field for many centuries due to its antimicrobial properties. Its bactericidal mechanism is based on the binding of silver atoms with thiol (SH) and disulfide (S–S) groups present in the proteins of bacterial cell membranes, leading to its disruption and eventual cell death
        <xref ref-type="bibr" rid="bib0435">
         [87]
        </xref>
        . Silver has been used for many applications on medical field especially when added in the form of silver sulfadiazine to creams or wound dressings
        <xref ref-type="bibr" rid="bib0440">
         [88]
        </xref>
        . Several wound dressing containing silver are available on market, however, not always they comply the expectations. Cavanagh et al.
        <xref ref-type="bibr" rid="bib0445">
         [89]
        </xref>
        analyzed 6 different silver dressings on market and only two of them showed bactericidal activity against
        <italic>
         S. aureus
        </italic>
        . Apart from that, silver dressing may be related with increased serum silver levels with an associated decrease on white blood cells
        <xref ref-type="bibr" rid="bib0450">
         [90]
        </xref>
        . This leads us to conclude that the delivery system of the antimicrobial is very important. A delivery mechanism that acts by contact without leaching silver ions to the surrounding areas or tissues would be good strategy to achieve antimicrobial action without compromise the safety of the product.
       </p>
       <p id="par0365">
        More recently, silver nanoparticles have been greatly studied and used to produce potential antimicrobial materials such as catheters and surgery sutures
        <xref ref-type="bibr" rid="bib0455">
         [91]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0460">
         [92]
        </xref>
        . However, for biomaterials implanted inside the organism there are some possible risks associated with releasing of silver ions causing local toxicity and possible accumulation in organs
        <xref ref-type="bibr" rid="bib0465">
         [93]
        </xref>
        . Silver may also have different ranges of efficacy according to the class of bacteria. Gram-positive bacteria's cell walls do not have an outer membrane as Gram-negative bacteria do, but they have several layers of peptidoglycans, making their cell wall thicker
        <xref ref-type="bibr" rid="bib0470">
         [94]
        </xref>
        ; this, along with their negative charge results in the trapping of silver ions (positively charged) preventing their entrance into the bacteria
        <xref ref-type="bibr" rid="bib0475">
         [95]
        </xref>
        .
       </p>
       <p id="par0370">
        AGC Glass (AGS Glass UK Ltd., Rugby, Great Britain) developed an antibacterial glass by incorporating Silver ions inside the glass. The company claims that this glass eliminates 99% of bacteria and prevents fungi proliferation which they demonstrated in the three bacterial and two fungi strains evaluated
        <xref ref-type="bibr" rid="bib0480">
         [96]
        </xref>
        .
       </p>
       <p id="par0375">
        Surfacine Development Company (Tyngsborough, MA, USA) is another company that developed a silver coating (Surfacine
        <sup>
         ®
        </sup>
        ) that can be applied in several materials, from medical devices to food preparations and packaging industry or water distribution systems. This coating showed good antimicrobial activity against several bacteria, fungi and yeast
        <xref ref-type="bibr" rid="bib0485">
         [97]
        </xref>
        .
       </p>
       <p id="par0380">
        Other company, PureThread Technologies Inc. (Cary, NC, USA) has developed PureThread
        <sup>
         ®
        </sup>
        , a system that embeds silver salts into textile fibers, obtaining antimicrobial textiles. According to the company this system does not weaken or disappears during washing and kills 99.9% of microorganisms after four hours of contact with the fabric
        <xref ref-type="bibr" rid="bib0490">
         [98]
        </xref>
        . A scientific paper about a study involving hospital curtains incorporating the antimicrobial textile developed by this company proved that those curtains take more time to be contaminated for the first time when compared to regular curtains
        <xref ref-type="bibr" rid="bib0495">
         [99]
        </xref>
        .
       </p>
       <p id="par0385">
        Similarly, to silver, copper has been used for many centuries as an antimicrobial agent especially for water treatment and transportation. Copper was also very used in the nautical field, to prevent adhesion and growth of organisms in hulls of ships
        <xref ref-type="bibr" rid="bib0500">
         [100]
        </xref>
        . The bactericide mechanism of copper is related to the release of copper ions that cause damage in the bacterial envelop and consequent leakage of the cell content and influx of copper ions into the bacteria. This will generate toxic radicals causing oxidative damage to cellular components and DNA degradation
        <xref ref-type="bibr" rid="bib0505">
         [101]
        </xref>
        .
       </p>
       <p id="par0390">
        More recently copper came up as an alternative for preventing hospital acquired infections through its application in hospital surfaces and medical equipment
        <xref ref-type="bibr" rid="bib0510">
         [102]
        </xref>
        . A study by Souli et al.
        <xref ref-type="bibr" rid="bib0515">
         [103]
        </xref>
        performed on a hospital intensive care unit, compared two rooms, one with copper coated equipment (beds, side table, intravenous pole stands, etc.) and the other with regular equipment. The copper coated equipment room presented a reduced percentage of colonized surfaces (55.6%) compared to the regular compartment (72.5%). This study showed both reductions in colonization by gram-negative and gram-positive bacteria and in total bioburden (2.9 vs 7.6 CFU/100 cm
        <sup>
         2
        </sup>
        ).
       </p>
       <p id="par0395">
        Sifri et al.
        <xref ref-type="bibr" rid="bib0300">
         [60]
        </xref>
        also developed a study where a section of an acute care unit was equipped with copper impregnated materials, hard surfaces and textiles-patients’ gowns, sinks, bed rails, tray tables, sheets and blankets. The results were quite promising with copper equipped section presenting patients’ infection reductions of 83% when caused by
        <italic>
         C. difficile
        </italic>
        and 68% when caused by multi drug resistant organisms, comparing to a non-modified section in the same hospital unit. Two companies that collaborate with each other, Cupron Medical Textiles (Cupron Inc., Richmond, VA, USA) and Cupron Enhanced EOS Surfaces (EOS Surfaces, Norfolk, VA, USA) provided the copper impregnated materials used for this study. The product developed is a hard-antimicrobial surface impregnated with copper that continuously kills 99.9% of harmful bacteria in two hours, according to its specifications. According to the company this surface is effective against
        <italic>
         S. aureus
        </italic>
        ,
        <italic>
         Enterobacter aerogenes
        </italic>
        , MRSA,
        <italic>
         E. coli
        </italic>
        and
        <italic>
         P. aeruginosa
        </italic>
        <xref ref-type="bibr" rid="bib0520">
         [104]
        </xref>
        .
       </p>
      </sec>
      <sec id="sec0065">
       <label>
        4.2.2
       </label>
       <title>
        Loading antimicrobial compounds into materials
       </title>
       <p id="par0400">
        There are several substances with antimicrobial activity that can be added to a surface to obtain an antimicrobial surface.
       </p>
       <p id="par0405">
        Antibiotics were one of the first substances to be applied to surfaces such as prosthesis or textiles for wound dressing production, to obtain antimicrobial action. Despite the promising results, it is well known that the major disadvantage of antibiotics use is the microorganisms’ ability to develop resistance. This drawback has led to an increasing search for alternatives to be used as antimicrobials. Quaternary ammonium compounds, chlorhexidine, benzalkonium chloride or nitric oxide are some examples of substances that were already tested as an alternative
        <xref ref-type="bibr" rid="bib0525">
         [105]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0530">
         [106]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0535">
         [107]
        </xref>
        . Quaternary ammonium compounds are disinfectants used in hospitals and healthcare facilities for several clinical purposes as disinfection of surfaces and medical material. However, more recently the quaternary ammonium compounds have been tested as antimicrobial loading agents to different surfaces and materials, namely polymers
        <xref ref-type="bibr" rid="bib0540">
         [108]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0545">
         [109]
        </xref>
        .
       </p>
       <p id="par0410">
        Antimicrobial peptides (AMPs) are a class of peptides, components of innate immune system, with a broad activity against bacteria, virus, fungus and more, providing a non-specific defense against a broad spectrum of invaders
        <xref ref-type="bibr" rid="bib0550">
         [110]
        </xref>
        . Recently, numerous studies
        <xref ref-type="bibr" rid="bib0555">
         [111]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0560">
         [112]
        </xref>
        refer its use as antimicrobial loading agents for their excellent characteristics, presenting several advantages over classic antibiotics, namely fast and broad spectrum of action with low susceptibility to induce bacterial resistance
        <xref ref-type="bibr" rid="bib0565">
         [113]
        </xref>
        . In contrast with the mechanisms of action of antibiotics, which are based in slow processes of enzymatic inhibition and target specific cellular activities as DNA or protein, the AMPs are effective against different species of microorganisms and also reduce the risk of resistance development
        <xref ref-type="bibr" rid="bib0565">
         [113]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0570">
         [114]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0575">
         [115]
        </xref>
        .
       </p>
       <p id="par0415">
        For all these reasons, AMPs are being applied in the production of antimicrobial surfaces, either by simple adsorption on the surface or covalent immobilization
        <xref ref-type="bibr" rid="bib0580">
         [116]
        </xref>
        . Nevertheless, studies suggest that covalent immobilization offers many advantages toward physical adsorption, including higher local and long-term stability, and lowering toxicity
        <xref ref-type="bibr" rid="bib0580">
         [116]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0585">
         [117]
        </xref>
        .
       </p>
       <p id="par0420">
        All those antimicrobial substances are loaded to the surface either by immobilization or by incorporation on the bulk material; recent studies on the application of each type of loading strategy are summarized next.
       </p>
       <sec id="sec0070">
        <label>
         4.2.2.1
        </label>
        <title>
         By incorporation
        </title>
        <p id="par0425">
         In materials’ incorporation process, the antimicrobial substances are added to the ingredients during the phase of production, to obtain a homogeneous mixture of the bulk material with the antimicrobial. This system allows antimicrobial activity throughout the bulk material, even in deeper layers and not only on the surface. This allows the material to retain its antimicrobial activity even when worn out
         <xref ref-type="bibr" rid="bib0590">
          [118]
         </xref>
         ,
         <xref ref-type="bibr" rid="bib0595">
          [119]
         </xref>
         .
        </p>
        <p id="par0430">
         In a very recent study, Ferreira et al.
         <xref ref-type="bibr" rid="bib0600">
          [120]
         </xref>
         used Levofloxacin to load a bone cement, achieving good results against
         <italic>
          S. aureus
         </italic>
         not only on its planktonic form but also on biofilm. That was quite positive since this bacterial strain is greatly associated with biofilm formation on bone implants.
        </p>
        <p id="par0435">
         Ciprofloxacin incorporation on textile fibers by electrospinning was tested by Li et al.
         <xref ref-type="bibr" rid="bib0395">
          [79]
         </xref>
         This strategy aimed to produce a bandage to prevent wound infection and the results in vivo (rats animal model) were quite positive for
         <italic>
          E. coli
         </italic>
         and
         <italic>
          S. aureus
         </italic>
         .
        </p>
        <p id="par0440">
         In Han et al.
         <xref ref-type="bibr" rid="bib0605">
          [121]
         </xref>
         study they incorporated quaternary ammonium methacrylates in dental adhesives to prevent caries by avoiding the accumulation of bacteria and biofilm formation on teeth, testing the presence of three Staphyloccocal species (
         <italic>
          Staphylococcus mutans
         </italic>
         ,
         <italic>
          Staphylococcus gordonii
         </italic>
         , and
         <italic>
          Staphylococcus sanguinis
         </italic>
         ) and the results showed a decreased biofilm formation for the adhesives containing the quaternary ammonium methacrylates.
        </p>
        <p id="par0445">
         Nanoparticles containing quaternary ammonium polyethylenimine were tested in a study about endodontic sealers by Barros et al.
         <xref ref-type="bibr" rid="bib0590">
          [118]
         </xref>
         . The results were quite positive for
         <italic>
          Enterococcus faecalis
         </italic>
         , with the endodontic sealers showing good antimicrobial activity.
        </p>
        <p id="par0450">
         The AMP, LL-37, was incorporated by Cassin et al.
         <xref ref-type="bibr" rid="bib0610">
          [122]
         </xref>
         in a membrane of collagen and hyaluronic acid for the production of anti-infective films to cover injured tissues.
        </p>
       </sec>
       <sec id="sec0075">
        <label>
         4.2.2.2
        </label>
        <title>
         By coating
        </title>
        <p id="par0455">
         Antimicrobial coatings can be obtained either by adsorption of the antimicrobial substance, by covalently binding it to the material or by immobilizing it using self-assembled monolayers. This strategy can be an advantage for some substances that are too toxic to be used as bulk material but that immobilized in small amounts as surface coatings can exert their antimicrobial activity without the toxicity drawback
         <xref ref-type="bibr" rid="bib0580">
          [116]
         </xref>
         ,
         <xref ref-type="bibr" rid="bib0615">
          [123]
         </xref>
         .
        </p>
        <p id="par0460">
         The coatings can also be divided according to their mechanism of action. They can deliver the antimicrobial substance by leaching, releasing it to the surrounding area or direct contact with the surface where the coating is immobilized.
        </p>
        <p id="par0465">
         Some coatings release substances with antibacterial properties that will interact with microorganisms acting away from the bulk. This leaching mechanism has the advantage of a larger perimeter of action around the surface where it is immobilized. It is important, though, that this release into the surrounding area is controlled to avoid toxic effects by excess of substance
         <xref ref-type="bibr" rid="bib0620">
          [124]
         </xref>
         .
        </p>
        <p id="par0470">
         Coatings can also attach certain antimicrobial molecules to the materials’ surface. Several coatings can be classified as “contact biocides” since they use non-leachable substances that kill by contact with the bacteria and with no need to be released from the surface. This strategy is very interesting for both the self-sterilizing effect and the long-lasting activity, acting just through a direct contact with bacteria without consuming itself releasing from the surface without need
         <xref ref-type="bibr" rid="bib0585">
          [117]
         </xref>
         ,
         <xref ref-type="bibr" rid="bib0625">
          [125]
         </xref>
         .
        </p>
        <p id="par0475">
         Alt et al.
         <xref ref-type="bibr" rid="bib0630">
          [126]
         </xref>
         realized a study where coating of Rifampicin and Fosfomycin was applied to prosthesis showing good efficacy against
         <italic>
          S. aureus
         </italic>
         , even the methicillin resistant strain, on a rabbit animal model. Neut et al.
         <xref ref-type="bibr" rid="bib0635">
          [127]
         </xref>
         performed a similar study using a gentamicin-releasing coating that was able to prevent
         <italic>
          Staphylococci
         </italic>
         growth on a prosthetic hip surface for at least 60 hours, showing promising results.
        </p>
        <p id="par0480">
         In a work by Iyamba et al.
         <xref ref-type="bibr" rid="bib0530">
          [106]
         </xref>
         , quaternary ammonium compounds (hexadecyltrimethyl ammonium bromide and hexadecylbetainate chloride) were immobilized on medical catheters reducing
         <italic>
          S. aureus
         </italic>
         adhesion to its surface. Zanini et al.
         <xref ref-type="bibr" rid="bib0640">
          [128]
         </xref>
         also developed a work in which quaternary ammonium silanes were used to coat polyurethane catheters. The results were promising with this coating proving its antimicrobial activity against
         <italic>
          E. coli
         </italic>
         bacteria.
        </p>
        <p id="par0485">
         In a recent study, Casciaro et al.
         <xref ref-type="bibr" rid="bib0555">
          [111]
         </xref>
         successfully covalently immobilized frog skin derived AMP on contact lenses. This strategy not only reduced the adhesion of
         <italic>
          P. aeruginosa
         </italic>
         , a species highly associated with contact lenses associated keratitis, but it also proved to be non-toxic to mammalian cells and it did not compromise the lenses physical properties.
        </p>
        <p id="par0490">
         AMPs have also been immobilized on nanoparticles as loading strategy. Ma et al.
         <xref ref-type="bibr" rid="bib0560">
          [112]
         </xref>
         immobilized the AMP HHC-36 on titanium oxide (TiO
         <sub>
          2
         </sub>
         ) nanotubes by physical adsorption with the nanotubes acting as nanocarriers for peptides delivery. They obtained an antimicrobial and anti-fouling surface showing a reduction in
         <italic>
          S. aureus
         </italic>
         adhesion and great antimicrobial activity (&gt;99% activity). Braun et al.
         <xref ref-type="bibr" rid="bib0645">
          [129]
         </xref>
         immobilized the human peptide LL-37 on porous silica nanoparticles, achieving an antimicrobial delivery system.
        </p>
        <p id="par0495">
         All the studies presented above prove the good potential of modified surfaces to be applied on infection control in different scenarios; still some aspects must be taken into account and more studies are still needed. Most studies evaluating the antimicrobial/anti-adhesive activity potential of engineered surfaces do not take into account realistic physiological environments. This can affect the results, since the host's conditioning film may affect the surface in many different ways, for example, covering the surface creating a deterrent layer preventing the antimicrobial substance to leach or to contact directly with the microorganisms, reducing its antimicrobial efficacy
         <xref ref-type="bibr" rid="bib0650">
          [130]
         </xref>
         .
        </p>
        <p id="par0500">
         In addition, the composition of the surface may determine which components of the conditioning film will adhere and that on its turn will influence other cells adhesion, as bacteria. Felgueiras et al.
         <xref ref-type="bibr" rid="bib0615">
          [123]
         </xref>
         showed that different concentrations of Octadecyl acrylate (C18) immobilized on polyurethane surfaces will affect the deposition of albumin and fibrinogen when the surface is in contact with human plasma, that on its turn will affect microorganisms’ adhesion to the surface since albumin avoids bacteria adhesion and fibrinogen promotes it. Besides, coatings with antimicrobial peptides can be degraded by some components of conditioning films such as proteases
         <xref ref-type="bibr" rid="bib0655">
          [131]
         </xref>
         .
        </p>
        <p id="par0505">
         Despite the pointed weaknesses there are already on the market some successful cases of such as Biocote Limited (Coventry, United Kingdom) that developed an antimicrobial additive technology, Biocote
         <sup>
          ®
         </sup>
         , that can be incorporated on textiles, polymers, ceramics and more. These additives are based on different antimicrobial substances such as silver, zinc or phenolic compounds, chosen according to their application and support material
         <xref ref-type="bibr" rid="bib0660">
          [132]
         </xref>
         .
        </p>
        <p id="par0510">
         Sanitized AG (Burgdorf, Switzerland) is another company that developed an antimicrobial additive that can be incorporated in polymers and textiles for different areas of application such as healthcare, public transportation and food industry. This additive technology, Sanitized
         <sup>
          ®
         </sup>
         , uses different active ingredients as silver, zinc pirithione, silane quat or isothiazolinone that can be added on liquid form, powder or paste according to specific production requirements of the final product
         <xref ref-type="bibr" rid="bib0665">
          [133]
         </xref>
         .
        </p>
       </sec>
      </sec>
      <sec id="sec0080">
       <label>
        4.2.3
       </label>
       <title>
        Photo-activated surfaces (TiO
        <sub>
         2
        </sub>
        )
       </title>
       <p id="par0515">
        Photo-activated materials have been used in different technological fields namely in antimicrobial surfaces development. The most studied material used in photo-activated surfaces production is TiO
        <sub>
         2
        </sub>
        . TiO
        <sub>
         2
        </sub>
        has high photocatalytic properties and is highly used in cosmetics and skin care products since it is not absorbed by human skin
        <xref ref-type="bibr" rid="bib0670">
         [134]
        </xref>
        becoming a very interesting material for development of antimicrobial surfaces.
       </p>
       <p id="par0520">
        In fact, its antimicrobial efficacy has already been proved against bacteria, fungi, protozoa and virus. The main advantage of this strategy is that TiO
        <sub>
         2
        </sub>
        is not degraded so its activity can be maintained for long periods. TiO
        <sub>
         2
        </sub>
        surfaces are only activated when irradiated by specific photon energy. When this irradiation occurs, reactions of photo-oxidation involving O
        <sub>
         2
        </sub>
        and H
        <sub>
         2
        </sub>
        O take place on the surface with consequent formation of oxygen free radicals. These free radicals will attack the cell wall and cytoplasmic membrane of the microorganism by peroxidizing its lipids, leading to leakage of cellular components and lately cell lysis
        <xref ref-type="bibr" rid="bib0675">
         [135]
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0680">
         [136]
        </xref>
        .
       </p>
       <p id="par0525">
        Recently, Adán et al.
        <xref ref-type="bibr" rid="bib0685">
         [137]
        </xref>
        published a study where a water microfiltration system using photocatalytic membranes produced with TiO
        <sub>
         2
        </sub>
        and porous steel showed good inactivation for the retained bacteria.
       </p>
       <p id="par0530">
        In another study by Joost et al.
        <xref ref-type="bibr" rid="bib0690">
         [138]
        </xref>
        thin films with TiO
        <sub>
         2
        </sub>
        nanoparticles were illuminated with UV light and after 20 min of exposure no bacteria (
        <italic>
         E. coli
        </italic>
        ) had survived. The analysis of bacterial cell membrane showed modifications in the chemical structure of unsaturated fatty acids and decomposition of saturated fatty acids faster than normal, confirming the peroxidation of membrane lipids.
       </p>
       <p id="par0535">
        In the market, there are already some products for microorganism elimination based on TiO
        <sub>
         2
        </sub>
        photocatalytic action. PureHealth™ (ORION, Florence, Italy) is a system developed by ORION that coats walls and floors and is activated by special lamps of solar spectrum. This system promises to eliminate virus and bacteria
        <xref ref-type="bibr" rid="bib0695">
         [139]
        </xref>
        .
       </p>
      </sec>
     </sec>
    </sec>
    <sec id="sec0085">
     <label>
      5
     </label>
     <title>
      Conclusion
     </title>
     <p id="par0540">
      This review points out the great contribution of surfaces for infection spreading, not only in healthcare facilities but also in other public spaces and food processing facilities.
     </p>
     <p id="par0545">
      There is an urgent need to pay more attention to surface contamination in different spaces since there is still a lack of guidelines for microbiologic assessment and established safe thresholds for health care facilities. In addition, it is important to establish infection control procedures for public spaces, namely schools since they often present high microbiological charges on surfaces, posing a real risk for children whose immunological system is still developing.
     </p>
     <p id="par0550">
      Both on public spaces and on healthcare facilities, it should be determined how to assess microbiologic presence on surfaces as well as how frequently this assessment should be made, and which methods should be used to obtain a realistic analysis rather than performing visual assessments. The implementation of standard acceptable limits of microorganisms on surfaces is also a key point for a better control of infection spreading. Standardized definition of which microorganisms can be considered indicator microorganisms should also be achieved.
     </p>
     <p id="par0555">
      The existing guidelines for cleaning and disinfection methodologies in healthcare facilities should come to a consensus about the disinfectants to be used in each setting, the frequency of cleaning and the methods to apply.
     </p>
     <p id="par0560">
      The implementation of self-disinfecting surfaces is a good strategy for infection control, and this review presents some successful research already developed in this area. These surfaces show clear advantages over the regular surfaces with traditional cleaning: the state of continuous disinfection and the antimicrobial activity that permanently eliminates the microorganisms.
     </p>
     <p id="par0565">
      There are still some issues to improve, like the long-term efficacy of the antimicrobial/anti-adhesive action, or the high cost of implementation of these surfaces in large areas.
     </p>
     <p id="par0570">
      Biomaterials, modified surfaces, or new scientific products in general, have to face some big challenges before they reach the market. Problems such as costs of manufacturability, scalability on production, intellectual property issues or regulatory aspects are just some of the main obstacles those products will have to overcome in order to be commercialized
      <xref ref-type="bibr" rid="bib0700">
       [140]
      </xref>
      . Some products even with great results on laboratory will fail when brought to larger scale due to their high cost of production, making them commercially unattractive. But, looking at the numbers nosocomial bacteremia alone can cost a hospital over 1 million euros per year
      <xref ref-type="bibr" rid="bib0705">
       [141]
      </xref>
      , and antibiotic resistance-associated infections may cost more than 900 million euros per year in European Union.
     </p>
     <p id="par0575">
      In fact the societal cost of infections due to the selected antibiotic-resistant bacteria were estimated at about EUR 1.5 billion each year, between hospital related costs and losses in productivity due to patients’ absence from work
      <xref ref-type="bibr" rid="bib0710">
       [142]
      </xref>
      . Therefore, maybe it is worthy to invest on new technologies, betting on infection prevention and control not only to avoid higher costs but also to avoid the harm and loss of human lives.
     </p>
     <p id="par0580">
      Self-disinfecting surfaces are a step forward to the future of infection control policies. More studies involving self-disinfecting surfaces should be performed in order to realize its full potential to improve infection control and safety strategies. The reports on the application of these materials in healthcare facilities show promising results and there are already few companies supplying products with self-disinfecting properties showing that investment on prevention may be the best way to reduce the tremendous problem of infection spreading.
     </p>
    </sec>
    <sec id="sec0090">
     <title>
      Conflict of interest
     </title>
     <p id="par0585">
      The authors declare no conflict of interest.
     </p>
    </sec>
    <back>
     <ref-list id="bibl0005">
      <title>
       References
      </title>
      <ref id="bib0005">
       <label>
        1
       </label>
       <element-citation id="sbref0005" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cardoso
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Almeida
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Carratalà
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Aragão
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Costa-Pereira
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sarmento
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           Azevedo
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review
        </article-title>
        <source>
         BMC Infect. Dis.
        </source>
        <volume>
         15
        </volume>
        <year>
         2015
        </year>
        <fpage>
         565
        </fpage>
        <pub-id pub-id-type="pmid">
         26653533
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0010">
       <label>
        2
       </label>
       <element-citation id="sbref0010" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role of the surface environment in healthcareassociated infections
        </article-title>
        <source>
         Curr. Opin. Infect. Dis.
        </source>
        <volume>
         26
        </volume>
        <year>
         2013
        </year>
        <fpage>
         345
        </fpage>
        <lpage>
         351
        </lpage>
        <pub-id pub-id-type="pmid">
         23806897
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0015">
       <label>
        3
       </label>
       <element-citation id="sbref0015" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           French
          </surname>
          <given-names>
           G.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role played by contaminated surfaces in the transmission of nosocomial pathogens
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         32
        </volume>
        <year>
         2011
        </year>
        <fpage>
         687
        </fpage>
        <lpage>
         699
        </lpage>
        <pub-id pub-id-type="pmid">
         21666400
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0020">
       <label>
        4
       </label>
       <element-citation id="sbref0020" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Guideline for disinfection and sterilization in health care facilities: what clinicians need to know
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <volume>
         39
        </volume>
        <year>
         2008
        </year>
        <fpage>
         702
        </fpage>
        <lpage>
         709
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0025">
       <label>
        5
       </label>
       <element-citation id="sbref0025" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morgan
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Rogawski
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Thom
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
         <name>
          <surname>
           Johnson
          </surname>
          <given-names>
           J.K.
          </given-names>
         </name>
         <name>
          <surname>
           Perencevich
          </surname>
          <given-names>
           E.N.
          </given-names>
         </name>
         <name>
          <surname>
           Shardell
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Leekha
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Harris
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transfer of multidrug-resistant bacteria to healthcare workers’ gloves and gowns after patient contact increases with environmental contamination
        </article-title>
        <source>
         Crit. Care Med.
        </source>
        <volume>
         40
        </volume>
        <year>
         2012
        </year>
        <fpage>
         1045
        </fpage>
        <lpage>
         1051
        </lpage>
        <pub-id pub-id-type="pmid">
         22202707
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0030">
       <label>
        6
       </label>
       <element-citation id="sbref0030" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           French
          </surname>
          <given-names>
           G.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bacterial contamination on touch surfaces in the public transport system and in public areas of a hospital in London
        </article-title>
        <source>
         Lett. Appl. Microbiol.
        </source>
        <volume>
         49
        </volume>
        <year>
         2009
        </year>
        <fpage>
         803
        </fpage>
        <lpage>
         805
        </lpage>
        <pub-id pub-id-type="pmid">
         19818007
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0035">
       <label>
        7
       </label>
       <element-citation id="sbref0035" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Scallan
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Hoekstra
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
         <name>
          <surname>
           Angulo
          </surname>
          <given-names>
           F.J.
          </given-names>
         </name>
         <name>
          <surname>
           Tauxe
          </surname>
          <given-names>
           R.V.
          </given-names>
         </name>
         <name>
          <surname>
           Widdowson
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Roy
          </surname>
          <given-names>
           S.L.
          </given-names>
         </name>
         <name>
          <surname>
           Jones
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Griffin
          </surname>
          <given-names>
           P.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Foodborne illness acquired in the United States—major pathogens
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <volume>
         17
        </volume>
        <year>
         2011
        </year>
        <fpage>
         7
        </fpage>
        <lpage>
         15
        </lpage>
        <pub-id pub-id-type="pmid">
         21192848
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0040">
       <label>
        8
       </label>
       <element-citation id="sbref0040" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wadamori
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Gooneratne
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Outbreaks and factors influencing microbiological contamination of fresh produce
        </article-title>
        <source>
         J. Sci. Food Agric.
        </source>
        <year>
         2016
        </year>
       </element-citation>
      </ref>
      <ref id="bib0045">
       <label>
        9
       </label>
       <element-citation id="sbref0045" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nguyen
          </surname>
          <given-names>
           V.T.
          </given-names>
         </name>
         <name>
          <surname>
           Fegan
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Turner
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
         <name>
          <surname>
           Dykes
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Role of attachment to surfaces on the prevalence and survival of
         <italic>
          Campylobacter
         </italic>
         through food systems
        </article-title>
        <source>
         J. Food Prot.
        </source>
        <volume>
         75
        </volume>
        <year>
         2012
        </year>
        <fpage>
         195
        </fpage>
        <lpage>
         206
        </lpage>
        <pub-id pub-id-type="pmid">
         22221378
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0050">
       <label>
        10
       </label>
       <element-citation id="sbref0050" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Osimani
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Garofalo
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Clementi
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Tavoletti
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Aquilanti
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bioluminescence ATP monitoring for the routine assessment of food contact surface cleanliness in a university canteen
        </article-title>
        <source>
         Int. J. Environ. Res. Public Health
        </source>
        <volume>
         11
        </volume>
        <year>
         2014
        </year>
        <fpage>
         10824
        </fpage>
        <lpage>
         10837
        </lpage>
        <pub-id pub-id-type="pmid">
         25329534
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0055">
       <label>
        11
       </label>
       <element-citation id="sbref0055" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           See
          </surname>
          <given-names>
           T.P.
          </given-names>
         </name>
         <name>
          <surname>
           Abdullah
          </surname>
          <given-names>
           M.F.F.
          </given-names>
         </name>
         <name>
          <surname>
           Nor
          </surname>
          <given-names>
           N.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Use of rapid microbial kits for regular monitoring of food-contact surfaces towards hygiene practices
        </article-title>
        <source>
         Procedia – Soc. Behav. Sci.
        </source>
        <volume>
         105
        </volume>
        <year>
         2013
        </year>
        <fpage>
         273
        </fpage>
        <lpage>
         283
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0060">
       <label>
        12
       </label>
       <element-citation id="sbref0060" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           T.C. of the E. Communities
          </surname>
         </name>
        </person-group>
        <article-title>
         Commission Decision of 8 June 2001
        </article-title>
        <source>
         Off. J. Eur. Comm.
        </source>
        <volume>
         165
        </volume>
        <year>
         2001
        </year>
        <fpage>
         48
        </fpage>
        <lpage>
         53
        </lpage>
        <ext-link ext-link-type="uri" id="intr0005" xlink:href="https://doi.org/http://eur-lex.europa.eu/pri/en/oj/dat/2003/l_285/l_28520031101en00330037.pdf">
         https://doi.org/http://eur-lex.europa.eu/pri/en/oj/dat/2003/l_285/l_28520031101en00330037.pdf
        </ext-link>
       </element-citation>
      </ref>
      <ref id="bib0065">
       <label>
        13
       </label>
       <element-citation id="sbref0065" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Masuku
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Babu
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Martin
          </surname>
          <given-names>
           E.M.
          </given-names>
         </name>
         <name>
          <surname>
           Koo
          </surname>
          <given-names>
           O.K.
          </given-names>
         </name>
         <name>
          <surname>
           O’Bryan
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
         <name>
          <surname>
           Crandall
          </surname>
          <given-names>
           P.G.
          </given-names>
         </name>
         <name>
          <surname>
           Ricke
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cleaning and decontamination efficacy of wiping cloths and silver dihydrogen citrate on food contact surfaces
        </article-title>
        <source>
         J. Appl. Microbiol.
        </source>
        <volume>
         113
        </volume>
        <year>
         2012
        </year>
        <fpage>
         89
        </fpage>
        <lpage>
         95
        </lpage>
        <pub-id pub-id-type="pmid">
         22519296
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0070">
       <label>
        14
       </label>
       <element-citation id="sbref0070" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Srey
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Jahid
          </surname>
          <given-names>
           I.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ha
          </surname>
          <given-names>
           S.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Biofilm formation in food industries: a food safety concern
        </article-title>
        <source>
         Food Control
        </source>
        <volume>
         31
        </volume>
        <year>
         2013
        </year>
        <fpage>
         572
        </fpage>
        <lpage>
         585
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0075">
       <label>
        15
       </label>
       <element-citation id="sbref0075" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           M.B.E.A.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Review of Enteric Outbreaks in Child Care Centers: Effective Infection Control Recommendations
        </chapter-title>
        <year>
         2008
        </year>
       </element-citation>
      </ref>
      <ref id="bib0080">
       <label>
        16
       </label>
       <element-citation id="sbref0080" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ibfelt
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Engelund
          </surname>
          <given-names>
           E.H.
          </given-names>
         </name>
         <name>
          <surname>
           Permin
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Schultz
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Andersen
          </surname>
          <given-names>
           L.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Presence of pathogenic bacteria and viruses in the daycare environment
        </article-title>
        <source>
         J. Environ. Health
        </source>
        <volume>
         78
        </volume>
        <year>
         2005
        </year>
        <fpage>
         24
        </fpage>
        <lpage>
         30
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0085">
       <label>
        17
       </label>
       <element-citation id="sbref0085" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jerković-Mujkić
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Besta
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Memisevic
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bacterial contamination of public telephones in the downtown area of Sarajevo
        </article-title>
        <source>
         Afr. J. Microbiol. Res.
        </source>
        <volume>
         7
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1664
        </fpage>
        <lpage>
         1667
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0090">
       <label>
        18
       </label>
       <element-citation id="sbref0090" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mukherjee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Dowd
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Wise
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Kedia
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Vohra
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Banerjee
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Diversity of bacterial communities of fitness center surfaces in a U.S. metropolitan area
        </article-title>
        <source>
         Int. J. Environ. Res. Public Health
        </source>
        <volume>
         11
        </volume>
        <year>
         2014
        </year>
        <fpage>
         12544
        </fpage>
        <lpage>
         12561
        </lpage>
        <pub-id pub-id-type="pmid">
         25479039
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0095">
       <label>
        19
       </label>
       <element-citation id="sbref0095" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kandel
          </surname>
          <given-names>
           C.E.
          </given-names>
         </name>
         <name>
          <surname>
           Simor
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           Redelmeier
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Elevator buttons as unrecognized sources of bacterial colonization in hospitals
        </article-title>
        <source>
         Open Med.
        </source>
        <volume>
         8
        </volume>
        <year>
         2014
        </year>
        <fpage>
         81
        </fpage>
        <lpage>
         86
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0100">
       <label>
        20
       </label>
       <element-citation id="sbref0100" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         56
        </volume>
        <year>
         2004
        </year>
        <fpage>
         10
        </fpage>
        <lpage>
         15
        </lpage>
        <pub-id pub-id-type="pmid">
         14706265
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0105">
       <label>
        21
       </label>
       <element-citation id="sbref0105" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lewis
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Griffith
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Gallo
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Weinbren
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A modified ATP benchmark for evaluating the cleaning of some hospital environmental surfaces
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         69
        </volume>
        <year>
         2008
        </year>
        <fpage>
         156
        </fpage>
        <lpage>
         163
        </lpage>
        <pub-id pub-id-type="pmid">
         18468725
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0110">
       <label>
        22
       </label>
       <element-citation id="sbref0110" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weinstein
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiology and control of nosocomial infections in adult intensive care units
        </article-title>
        <source>
         Am. J. Med.
        </source>
        <volume>
         91
        </volume>
        <year>
         1991
        </year>
        <fpage>
         179S
        </fpage>
        <lpage>
         184S
        </lpage>
        <pub-id pub-id-type="pmid">
         1928162
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0115">
       <label>
        23
       </label>
       <element-citation id="sbref0115" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carling
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Parry
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Rupp
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Po
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Dick
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Von Beheren
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Improving cleaning of the environment surrounding patients in 36 acute care hospitals
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         29
        </volume>
        <year>
         2008
        </year>
        <fpage>
         1035
        </fpage>
        <lpage>
         1041
        </lpage>
        <pub-id pub-id-type="pmid">
         18851687
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0120">
       <label>
        24
       </label>
       <element-citation id="sbref0120" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carling
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Parry
          </surname>
          <given-names>
           M.F.
          </given-names>
         </name>
         <name>
          <surname>
           Bruno-Murtha
          </surname>
          <given-names>
           L.A.
          </given-names>
         </name>
         <name>
          <surname>
           Dick
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission
        </article-title>
        <source>
         Crit. Care Med.
        </source>
        <volume>
         38
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1054
        </fpage>
        <lpage>
         1059
        </lpage>
        <pub-id pub-id-type="pmid">
         20081531
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0125">
       <label>
        25
       </label>
       <element-citation id="sbref0125" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Miller
          </surname>
          <given-names>
           M.B.
          </given-names>
         </name>
         <name>
          <surname>
           Huslage
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Sickbert-Bennett
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         38
        </volume>
        <year>
         2010
        </year>
        <fpage>
         S25
        </fpage>
        <lpage>
         S33
        </lpage>
        <pub-id pub-id-type="pmid">
         20569853
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0130">
       <label>
        26
       </label>
       <element-citation id="sbref0130" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characteristics of nosocomial infection and its effects on the survival of chemotherapy patients with advanced non-small cell lung cancer
        </article-title>
        <source>
         Oncol. Lett.
        </source>
        <volume>
         14
        </volume>
        <year>
         2017
        </year>
        <fpage>
         7379
        </fpage>
        <lpage>
         7383
        </lpage>
        <pub-id pub-id-type="pmid">
         29344177
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0135">
       <label>
        27
       </label>
       <element-citation id="sbref0135" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Stiefel
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
         <name>
          <surname>
           Cadnum
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Eckstein
          </surname>
          <given-names>
           B.C.
          </given-names>
         </name>
         <name>
          <surname>
           Guerrero
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Tima
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Donskey
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contamination of hands with methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         after contact with environmental surfaces and after contact with the skin of colonized patients
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         32
        </volume>
        <year>
         2011
        </year>
        <fpage>
         185
        </fpage>
        <lpage>
         187
        </lpage>
        <pub-id pub-id-type="pmid">
         21460476
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0140">
       <label>
        28
       </label>
       <element-citation id="sbref0140" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guerrero
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Nerandzic
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Jury
          </surname>
          <given-names>
           L.A.
          </given-names>
         </name>
         <name>
          <surname>
           Jinno
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Donskey
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acquisition of spores on gloved hands after contact with the skin of patients with
         <italic>
          Clostridium difficile
         </italic>
         infection and with environmental surfaces in their rooms
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         40
        </volume>
        <year>
         2012
        </year>
        <fpage>
         556
        </fpage>
        <lpage>
         558
        </lpage>
        <pub-id pub-id-type="pmid">
         21982209
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0145">
       <label>
        29
       </label>
       <element-citation id="sbref0145" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Stahmeyer
          </surname>
          <given-names>
           J.T.
          </given-names>
         </name>
         <name>
          <surname>
           Lutze
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           von Lengerke
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Chaberny
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Krauth
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hand hygiene in intensive care units: a matter of time?
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         95
        </volume>
        <year>
         2017
        </year>
        <fpage>
         338
        </fpage>
        <lpage>
         343
        </lpage>
        <pub-id pub-id-type="pmid">
         28246001
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0150">
       <label>
        30
       </label>
       <element-citation id="sbref0150" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Quon
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Dilauro
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ryan
          </surname>
          <given-names>
           J.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Disinfection of the radiologist workstation and radiologist hand hygiene: a single institution practice quality improvement project
        </article-title>
        <source>
         Can. Assoc. Radiol. J.
        </source>
        <volume>
         68
        </volume>
        <year>
         2017
        </year>
        <fpage>
         270
        </fpage>
        <lpage>
         275
        </lpage>
        <pub-id pub-id-type="pmid">
         28396006
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0155">
       <label>
        31
       </label>
       <element-citation id="sbref0155" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Salkeld
          </surname>
          <given-names>
           J.A.G.
          </given-names>
         </name>
         <name>
          <surname>
           French
          </surname>
          <given-names>
           G.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         41
        </volume>
        <year>
         2013
        </year>
        <fpage>
         S6
        </fpage>
        <lpage>
         S11
        </lpage>
        <pub-id pub-id-type="pmid">
         23622751
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0160">
       <label>
        32
       </label>
       <element-citation id="sbref0160" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Geadas Farias
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Gama
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Reis
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Alarico
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Empadinhas
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
         <name>
          <surname>
           de Almeida
          </surname>
          <given-names>
           A.F.
          </given-names>
         </name>
         <name>
          <surname>
           Morais
          </surname>
          <given-names>
           P.V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital microbial surface colonization revealed during monitoring of
         <italic>
          Klebsiella
         </italic>
         spp., Pseudomonas aeruginosa, and non-tuberculous mycobacteria. Antonie van Leeuwenhoek
        </article-title>
        <source>
         Int. J. Gen. Mol. Microbiol.
        </source>
        <volume>
         110
        </volume>
        <year>
         2017
        </year>
        <fpage>
         863
        </fpage>
        <lpage>
         876
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0165">
       <label>
        33
       </label>
       <element-citation id="sbref0165" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Viana
          </surname>
          <given-names>
           R.E.H.
          </given-names>
         </name>
         <name>
          <surname>
           dos Santos
          </surname>
          <given-names>
           S.G.
          </given-names>
         </name>
         <name>
          <surname>
           Oliveira
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recovery of resistant bacteria from mattresses of patients under contact precautions
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         44
        </volume>
        <year>
         2016
        </year>
        <fpage>
         465
        </fpage>
        <lpage>
         469
        </lpage>
        <pub-id pub-id-type="pmid">
         26739639
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0170">
       <label>
        34
       </label>
       <element-citation id="sbref0170" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Huslage
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Bennett
          </surname>
          <given-names>
           E.S.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A quantitative approach to defining “High-Touch” surfaces in hospitals
        </article-title>
        <source>
         Source Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         31
        </volume>
        <year>
         2010
        </year>
        <fpage>
         850
        </fpage>
        <lpage>
         853
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0175">
       <label>
        35
       </label>
       <element-citation id="sbref0175" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           White
          </surname>
          <given-names>
           L.F.
          </given-names>
         </name>
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
         <name>
          <surname>
           Robertson
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           McDonald
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Are hygiene standards useful in assessing infection risk?
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         36
        </volume>
        <year>
         2008
        </year>
        <fpage>
         381
        </fpage>
        <lpage>
         384
        </lpage>
        <pub-id pub-id-type="pmid">
         18538706
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0180">
       <label>
        36
       </label>
       <element-citation id="sbref0180" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shek
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Patidar
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Kohja
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Gawaziuk
          </surname>
          <given-names>
           J.P.
          </given-names>
         </name>
         <name>
          <surname>
           Gawthrop
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kumar
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Logsetty
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Rate of contamination of hospital privacy curtains on a burns and plastic surgery ward: a cross-sectional study
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         96
        </volume>
        <year>
         2017
        </year>
        <fpage>
         54
        </fpage>
        <lpage>
         58
        </lpage>
        <pub-id pub-id-type="pmid">
         28413115
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0185">
       <label>
        37
       </label>
       <element-citation id="sbref0185" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Levin
          </surname>
          <given-names>
           P.D.
          </given-names>
         </name>
         <name>
          <surname>
           Shatz
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Sviri
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Moriah
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Or-Barbash
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sprung
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Moses
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           Block
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contamination of portable radiograph equipment with resistant bacteria in the ICU
        </article-title>
        <source>
         Am. Coll. Chest Physicians
        </source>
        <volume>
         136
        </volume>
        <year>
         2009
        </year>
        <fpage>
         426
        </fpage>
        <lpage>
         432
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0190">
       <label>
        38
       </label>
       <element-citation id="sbref0190" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lestari
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Ryll
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Kramer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbial contamination of manually reprocessed, ready to use ECG lead wire in intensive care units
        </article-title>
        <source>
         GMS Hyg. Infect. Control
        </source>
        <volume>
         8
        </volume>
        <year>
         2013
        </year>
        <comment>
         Doc07
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0195">
       <label>
        39
       </label>
       <element-citation id="sbref0195" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sifuentes
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
         <name>
          <surname>
           Weart
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Engelbrecht
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Koenig
          </surname>
          <given-names>
           D.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbial contamination of hospital reusable cleaning towels
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         41
        </volume>
        <year>
         2013
        </year>
        <fpage>
         912
        </fpage>
        <lpage>
         915
        </lpage>
        <pub-id pub-id-type="pmid">
         23523522
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0200">
       <label>
        40
       </label>
       <element-citation id="sbref0200" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barker
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Alagoz
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Safdar
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interventions to reduce the incidence of hospital-onset
         <italic>
          Clostridium difficile
         </italic>
         infection: an agent-based modeling approach to evaluate clinical effectiveness in adult acute care hospitals
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         12
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0205">
       <label>
        41
       </label>
       <element-citation id="sbref0205" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Practical Guidelines for Infection Control in Health Care Facilities Practical Guidelines for Infection Control in Health Care Facilities
        </chapter-title>
        <year>
         2004
        </year>
        <publisher-name>
         World Health Organization
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="bib0210">
       <label>
        42
       </label>
       <element-citation id="sbref0210" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Johani
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Abualsaud
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Costa
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Hu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Whiteley
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Deva
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Vickery
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characterization of microbial community composition, antimicrobial resistance and biofilm on intensive care surfaces
        </article-title>
        <source>
         J. Infect. Public Health
        </source>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0215">
       <label>
        43
       </label>
       <element-citation id="sbref0215" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pappas
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Hendley
          </surname>
          <given-names>
           J.O.
          </given-names>
         </name>
         <name>
          <surname>
           Schwartz
          </surname>
          <given-names>
           R.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Respiratory viral RNA on toys in pediatric office waiting rooms
        </article-title>
        <source>
         Pediatr. Infect. Dis. J.
        </source>
        <volume>
         29
        </volume>
        <year>
         2010
        </year>
        <fpage>
         102
        </fpage>
        <lpage>
         104
        </lpage>
        <pub-id pub-id-type="pmid">
         20135827
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0220">
       <label>
        44
       </label>
       <element-citation id="sbref0220" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Promises and pitfalls of recent advances in chemical means of preventing the spread of nosocomial infections by environmental surfaces
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         38
        </volume>
        <year>
         2010
        </year>
        <fpage>
         S34
        </fpage>
        <lpage>
         S40
        </lpage>
        <pub-id pub-id-type="pmid">
         20569854
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0225">
       <label>
        45
       </label>
       <element-citation id="sbref0225" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lawley
          </surname>
          <given-names>
           T.D.
          </given-names>
         </name>
         <name>
          <surname>
           Clare
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Deakin
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Yen
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Raisen
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Brandt
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Lovell
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Cooke
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Clark
          </surname>
          <given-names>
           T.G.
          </given-names>
         </name>
         <name>
          <surname>
           Lawley
          </surname>
          <given-names>
           T.D.
          </given-names>
         </name>
         <name>
          <surname>
           Clare
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Deakin
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Goulding
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Yen
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Raisen
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Brandt
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Lovell
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Cooke
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Clark
          </surname>
          <given-names>
           T.G.
          </given-names>
         </name>
         <name>
          <surname>
           Dougan
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Use of purified
         <italic>
          Clostridium difficile
         </italic>
         spores to facilitate evaluation of health care disinfection regimens
        </article-title>
        <source>
         Appl. Environ. Microbiol.
        </source>
        <volume>
         76
        </volume>
        <year>
         2010
        </year>
        <fpage>
         6895
        </fpage>
        <lpage>
         6900
        </lpage>
        <pub-id pub-id-type="pmid">
         20802075
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0230">
       <label>
        46
       </label>
       <element-citation id="sbref0230" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hirose
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Nakaya
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Naito
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Daidoji
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Watanabe
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yasuda
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Konishi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Itoh
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viscosity is an important factor of resistance to alcohol-based disinfectants by pathogens present in mucus
        </article-title>
        <source>
         Sci. Rep.
        </source>
        <volume>
         7
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         12
        </lpage>
        <pub-id pub-id-type="pmid">
         28127051
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0235">
       <label>
        47
       </label>
       <element-citation id="sbref0235" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Centers for Disease Control and Prevention
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Basic Infection Control and Prevention Plan for Outpatient Oncology Settings
        </chapter-title>
        <year>
         2011
        </year>
       </element-citation>
      </ref>
      <ref id="bib0240">
       <label>
        48
       </label>
       <element-citation id="sbref0240" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Health Protection Scotland
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Standard Infection Control Precautions Literature Review: Routine Cleaning of the Environment in the Hospital Setting
        </chapter-title>
        <year>
         2017
        </year>
        <publisher-name>
         HPS
        </publisher-name>
        <publisher-loc>
         Glasgow
        </publisher-loc>
       </element-citation>
      </ref>
      <ref id="bib0245">
       <label>
        49
       </label>
       <element-citation id="sbref0245" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Watanabe
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Shimoda
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Yano
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Hayashi
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Nakamura
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Matsuo
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Yamaguchi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Visualization of hospital cleanliness in three Japanese hospitals with a tendency toward long-term care
        </article-title>
        <source>
         BMC Res. Notes
        </source>
        <volume>
         7
        </volume>
        <year>
         2014
        </year>
        <fpage>
         121
        </fpage>
        <pub-id pub-id-type="pmid">
         24593868
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0250">
       <label>
        50
       </label>
       <element-citation id="sbref0250" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Griffith
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
         <name>
          <surname>
           Cooper
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Gilmore
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Davies
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Lewis
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         An evaluation of hospital cleaning regimes and standards
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         45
        </volume>
        <year>
         2000
        </year>
        <fpage>
         19
        </fpage>
        <lpage>
         28
        </lpage>
        <pub-id pub-id-type="pmid">
         10833340
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0255">
       <label>
        51
       </label>
       <element-citation id="sbref0255" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Teunis
          </surname>
          <given-names>
           P.F.M.
          </given-names>
         </name>
         <name>
          <surname>
           Moe
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Miller
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Lindesmith
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Baric
          </surname>
          <given-names>
           R.S.
          </given-names>
         </name>
         <name>
          <surname>
           Pendu
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Calderon
          </surname>
          <given-names>
           R.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Norwalk virus: how infectious is it?
        </article-title>
        <source>
         Anticancer Res.
        </source>
        <volume>
         30
        </volume>
        <year>
         2010
        </year>
        <fpage>
         4799
        </fpage>
        <lpage>
         4804
        </lpage>
        <pub-id pub-id-type="pmid">
         21187455
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0260">
       <label>
        52
       </label>
       <element-citation id="sbref0260" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boyce
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals
        </article-title>
        <source>
         Antimicrob. Resist. Infect. Control
        </source>
        <volume>
         5
        </volume>
        <year>
         2016
        </year>
        <fpage>
         10
        </fpage>
        <pub-id pub-id-type="pmid">
         27069623
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0265">
       <label>
        53
       </label>
       <element-citation id="sbref0265" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Kanamori
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         ‘No touch’ technologies for environmental decontamination
        </article-title>
        <source>
         Curr. Opin. Infect. Dis.
        </source>
        <volume>
         29
        </volume>
        <year>
         2016
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         26658651
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0270">
       <label>
        54
       </label>
       <element-citation id="sbref0270" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chizoba Ekezie
          </surname>
          <given-names>
           F.G.
          </given-names>
         </name>
         <name>
          <surname>
           Sun
          </surname>
          <given-names>
           D.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A review on recent advances in cold plasma technology for the food industry: current applications and future trends
        </article-title>
        <source>
         Trends Food Sci. Technol.
        </source>
        <volume>
         69
        </volume>
        <year>
         2017
        </year>
        <fpage>
         46
        </fpage>
        <lpage>
         58
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0275">
       <label>
        55
       </label>
       <element-citation id="sbref0275" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Izadjoo
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Zack
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Skiba
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Medical applications of cold atmospheric plasma: state of the science
        </article-title>
        <source>
         J. Wound Care
        </source>
        <volume>
         27
        </volume>
        <issue>
         Sup9
        </issue>
        <year>
         2018
        </year>
       </element-citation>
      </ref>
      <ref id="bib0280">
       <label>
        56
       </label>
       <element-citation id="sbref0280" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Oh
          </surname>
          <given-names>
           Y.J.
          </given-names>
         </name>
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           A.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Min
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inhibition of
         <italic>
          Salmonella typhimurium
         </italic>
         on radish sprouts using nitrogen-cold plasma
        </article-title>
        <source>
         Int. J. Food Microbiol.
        </source>
        <volume>
         249
        </volume>
        <year>
         2017
        </year>
        <fpage>
         66
        </fpage>
        <lpage>
         71
        </lpage>
        <pub-id pub-id-type="pmid">
         28319800
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0285">
       <label>
        57
       </label>
       <element-citation id="sbref0285" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Ziuzina
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Heslin
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Boehm
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Patange
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sango
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Valdramidis
          </surname>
          <given-names>
           V.P.
          </given-names>
         </name>
         <name>
          <surname>
           Cullen
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
         <name>
          <surname>
           Bourke
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Controlling microbial safety challenges of meat using high voltage atmospheric cold plasma
        </article-title>
        <source>
         Front. Microbiol.
        </source>
        <volume>
         7
        </volume>
        <year>
         2016
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         12
        </lpage>
        <pub-id pub-id-type="pmid">
         26834723
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0290">
       <label>
        58
       </label>
       <element-citation id="sbref0290" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Puligundla
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Mok
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation effect of dielectric barrier discharge plasma against foodborne pathogens on the surfaces of different packaging materials
        </article-title>
        <source>
         Innov. Food Sci. Emerg. Technol.
        </source>
        <volume>
         36
        </volume>
        <year>
         2016
        </year>
        <fpage>
         221
        </fpage>
        <lpage>
         227
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0295">
       <label>
        59
       </label>
       <element-citation id="sbref0295" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hasan
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Crawford
          </surname>
          <given-names>
           R.J.
          </given-names>
         </name>
         <name>
          <surname>
           Ivanova
          </surname>
          <given-names>
           E.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibacterial surfaces: the quest for a new generation of biomaterials
        </article-title>
        <source>
         Trends Biotechnol.
        </source>
        <volume>
         31
        </volume>
        <year>
         2013
        </year>
        <fpage>
         295
        </fpage>
        <lpage>
         304
        </lpage>
        <pub-id pub-id-type="pmid">
         23434154
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0300">
       <label>
        60
       </label>
       <element-citation id="sbref0300" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sifri
          </surname>
          <given-names>
           C.D.
          </given-names>
         </name>
         <name>
          <surname>
           Burke
          </surname>
          <given-names>
           G.H.
          </given-names>
         </name>
         <name>
          <surname>
           Enfield
          </surname>
          <given-names>
           K.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Reduced health care-associated infections in an acute care community hospital using a combination of self-disinfecting copper-impregnated composite hard surfaces and linens
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         44
        </volume>
        <year>
         2016
        </year>
        <fpage>
         1565
        </fpage>
        <lpage>
         1571
        </lpage>
        <pub-id pub-id-type="pmid">
         27692785
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0305">
       <label>
        61
       </label>
       <element-citation id="sbref0305" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ferraris
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Spriano
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibacterial titanium surfaces for medical implants
        </article-title>
        <source>
         Mater. Sci. Eng. C
        </source>
        <volume>
         61
        </volume>
        <year>
         2016
        </year>
        <fpage>
         965
        </fpage>
        <lpage>
         978
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0310">
       <label>
        62
       </label>
       <element-citation id="sbref0310" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Chua
          </surname>
          <given-names>
           R.R.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Tambyah
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Hadinoto
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Leong
          </surname>
          <given-names>
           S.S.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         15
        </volume>
        <year>
         2015
        </year>
        <fpage>
         127
        </fpage>
        <lpage>
         138
        </lpage>
        <pub-id pub-id-type="pmid">
         25541344
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0315">
       <label>
        63
       </label>
       <element-citation id="sbref0315" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Querido
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Felgueiras
          </surname>
          <given-names>
           H.P.
          </given-names>
         </name>
         <name>
          <surname>
           Rai
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Costa
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Monteiro
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Borges
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Oliveira
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Ferreira
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Cristina
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Cecropin – Melittin Functionalized Polyurethane Surfaces Prevent
         <italic>
          Staphylococcus epidermidis
         </italic>
         Adhesion without Inducing Platelet Adhesion and Activation 1801390
        </chapter-title>
        <year>
         2018
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         10
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0320">
       <label>
        64
       </label>
       <element-citation id="sbref0320" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Willcox
          </surname>
          <given-names>
           M.D.P.
          </given-names>
         </name>
         <name>
          <surname>
           Hume
          </surname>
          <given-names>
           E.B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Aliwarga
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kumar
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Cole
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses
        </article-title>
        <source>
         J. Appl. Microbiol.
        </source>
        <volume>
         105
        </volume>
        <year>
         2008
        </year>
        <fpage>
         1817
        </fpage>
        <lpage>
         1825
        </lpage>
        <pub-id pub-id-type="pmid">
         19016975
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0325">
       <label>
        65
       </label>
       <element-citation id="sbref0325" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Dong
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Biomimetic self-cleaning surfaces: synthesis, mechanism and applications
        </article-title>
        <source>
         J. R. Soc. Interface
        </source>
        <volume>
         13
        </volume>
        <year>
         2016
        </year>
       </element-citation>
      </ref>
      <ref id="bib0330">
       <label>
        66
       </label>
       <element-citation id="sbref0330" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gao
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Kindrachuk
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Brooks
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Hancock
          </surname>
          <given-names>
           R.E.W.
          </given-names>
         </name>
         <name>
          <surname>
           Kizhakkedathu
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibacterial surfaces based on polymer brushes: investigation on the influence of brush properties on antimicrobial peptide immobilization and antimicrobial activity antibacterial surfaces based on polymer brushes: investigation on the influence of Bru
        </article-title>
        <source>
         Biomacromolecules
        </source>
        <year>
         2011
        </year>
       </element-citation>
      </ref>
      <ref id="bib0335">
       <label>
        67
       </label>
       <element-citation id="sbref0335" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Junter
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
         <name>
          <surname>
           Thébault
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Lebrun
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Polysaccharide-based antibiofilm surfaces
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         30
        </volume>
        <year>
         2016
        </year>
        <fpage>
         13
        </fpage>
        <lpage>
         25
        </lpage>
        <pub-id pub-id-type="pmid">
         26555378
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0340">
       <label>
        68
       </label>
       <element-citation id="sbref0340" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tripathy
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sen
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Su
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Briscoe
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Natural and bioinspired nanostructured bactericidal surfaces
        </article-title>
        <source>
         Adv. Colloid Interface Sci.
        </source>
        <volume>
         248
        </volume>
        <year>
         2017
        </year>
        <fpage>
         85
        </fpage>
        <lpage>
         104
        </lpage>
        <pub-id pub-id-type="pmid">
         28780961
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0345">
       <label>
        69
       </label>
       <element-citation id="sbref0345" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Campoccia
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Montanaro
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Arciola
          </surname>
          <given-names>
           C.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A review of the biomaterials technologies for infection-resistant surfaces
        </article-title>
        <source>
         Biomaterials
        </source>
        <volume>
         34
        </volume>
        <year>
         2013
        </year>
        <fpage>
         8533
        </fpage>
        <lpage>
         8554
        </lpage>
        <pub-id pub-id-type="pmid">
         23953781
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0350">
       <label>
        70
       </label>
       <element-citation id="sbref0350" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mi
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Integrated antimicrobial and nonfouling zwitterionic polymers
        </article-title>
        <source>
         Angew. Chem. Int. Ed.
        </source>
        <volume>
         53
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1746
        </fpage>
        <lpage>
         1754
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0355">
       <label>
        71
       </label>
       <element-citation id="sbref0355" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Schlenoff
          </surname>
          <given-names>
           J.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption
        </article-title>
        <source>
         Langmuir
        </source>
        <volume>
         30
        </volume>
        <year>
         2014
        </year>
        <fpage>
         9625
        </fpage>
        <lpage>
         9636
        </lpage>
        <pub-id pub-id-type="pmid">
         24754399
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0360">
       <label>
        72
       </label>
       <element-citation id="sbref0360" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Ge
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ren
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           H.H.K.
          </given-names>
         </name>
         <name>
          <surname>
           Peng
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Feng
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Weir
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Anti-caries effects of dental adhesives containing quaternary ammonium methacrylates with different chain lengths
        </article-title>
        <source>
         Materials (Basel)
        </source>
        <volume>
         10
        </volume>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0365">
       <label>
        73
       </label>
       <element-citation id="sbref0365" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Venault
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Subarja
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Zwitterionic polyhydroxybutyrate electrospun fibrous membranes with a compromise of bioinert control and tissue-cell growth
        </article-title>
        <source>
         Langmuir
        </source>
        <volume>
         33
        </volume>
        <year>
         2017
        </year>
        <fpage>
         2460
        </fpage>
        <lpage>
         2471
        </lpage>
        <pub-id pub-id-type="pmid">
         28177247
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0370">
       <label>
        74
       </label>
       <element-citation id="sbref0370" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kwon
          </surname>
          <given-names>
           H.J.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Phuong
          </surname>
          <given-names>
           L.T.
          </given-names>
         </name>
         <name>
          <surname>
           Seon
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yoon
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           K.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Zwitterionic sulfobetaine polymer-immobilized surface by simple tyrosinase-mediated grafting for enhanced antifouling property
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         61
        </volume>
        <year>
         2017
        </year>
        <fpage>
         169
        </fpage>
        <lpage>
         179
        </lpage>
        <pub-id pub-id-type="pmid">
         28782724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0375">
       <label>
        75
       </label>
       <element-citation id="sbref0375" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gao
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Lange
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Hilpert
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Kindrachuk
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Zou
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           J.T.J.
          </given-names>
         </name>
         <name>
          <surname>
           Kazemzadeh-Narbat
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Straus
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Brooks
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Chew
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Hancock
          </surname>
          <given-names>
           R.E.W.
          </given-names>
         </name>
         <name>
          <surname>
           Kizhakkedathu
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides
        </article-title>
        <source>
         Biomaterials
        </source>
        <volume>
         32
        </volume>
        <year>
         2011
        </year>
        <fpage>
         3899
        </fpage>
        <lpage>
         3909
        </lpage>
        <pub-id pub-id-type="pmid">
         21377727
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0380">
       <label>
        76
       </label>
       <element-citation id="sbref0380" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hadjesfandiari
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Mei
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kizhakkedathu
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Polymer brush-based approaches for the development of infection-resistant surfaces
        </article-title>
        <source>
         J. Mater. Chem. B
        </source>
        <volume>
         2
        </volume>
        <year>
         2014
        </year>
        <fpage>
         4968
        </fpage>
       </element-citation>
      </ref>
      <ref id="bib0385">
       <label>
        77
       </label>
       <element-citation id="sbref0385" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aslan
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Deneufchatel
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Hashmi
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Pfefferle
          </surname>
          <given-names>
           L.D.
          </given-names>
         </name>
         <name>
          <surname>
           Elimelech
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Pauthe
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Van Tassel
          </surname>
          <given-names>
           P.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Carbon nanotube-based antimicrobial biomaterials formed via layer-by-layer assembly with polypeptides
        </article-title>
        <source>
         J. Colloid Interface Sci.
        </source>
        <volume>
         388
        </volume>
        <year>
         2012
        </year>
        <fpage>
         268
        </fpage>
        <lpage>
         273
        </lpage>
        <pub-id pub-id-type="pmid">
         23006909
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0390">
       <label>
        78
       </label>
       <element-citation id="sbref0390" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Knetsch
          </surname>
          <given-names>
           M.L.W.
          </given-names>
         </name>
         <name>
          <surname>
           Koole
          </surname>
          <given-names>
           L.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles
        </article-title>
        <source>
         Polymers (Basel)
        </source>
        <volume>
         3
        </volume>
        <year>
         2011
        </year>
        <fpage>
         340
        </fpage>
        <lpage>
         366
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0395">
       <label>
        79
       </label>
       <element-citation id="sbref0395" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Williams
          </surname>
          <given-names>
           G.R.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Lv
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Sun
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Thermosensitive nanofibers loaded with ciprofloxacin as antibacterial wound dressing materials
        </article-title>
        <source>
         Int. J. Pharm.
        </source>
        <volume>
         517
        </volume>
        <year>
         2017
        </year>
        <fpage>
         135
        </fpage>
        <lpage>
         147
        </lpage>
        <pub-id pub-id-type="pmid">
         27940041
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0400">
       <label>
        80
       </label>
       <element-citation id="sbref0400" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yamamoto
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Nishikawa
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Mayama
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Nonomura
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yokojima
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Nakamura
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Uchida
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Theoretical explanation of the lotus effect: superhydrophobic property changes by removal of nanostructures from the surface of a lotus leaf
        </article-title>
        <source>
         Langmuir
        </source>
        <volume>
         31
        </volume>
        <year>
         2015
        </year>
        <fpage>
         7355
        </fpage>
        <lpage>
         7363
        </lpage>
        <pub-id pub-id-type="pmid">
         26075949
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0405">
       <label>
        81
       </label>
       <element-citation id="sbref0405" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jaggessar
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Shahali
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Mathew
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Yarlagadda
          </surname>
          <given-names>
           P.K.D.V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bio-mimicking nano and micro-structured surface fabrication for antibacterial properties in medical implants
        </article-title>
        <source>
         J. Nanobiotechnol.
        </source>
        <volume>
         15
        </volume>
        <year>
         2017
        </year>
        <fpage>
         64
        </fpage>
       </element-citation>
      </ref>
      <ref id="bib0410">
       <label>
        82
       </label>
       <element-citation id="sbref0410" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sullivan
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Regan
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The characterization, replication and testing of dermal denticles of
         <italic>
          Scyliorhinus canicula
         </italic>
         for physical mechanisms of biofouling prevention
        </article-title>
        <source>
         Bioinspir. Biomim.
        </source>
        <volume>
         6
        </volume>
        <year>
         2011
        </year>
       </element-citation>
      </ref>
      <ref id="bib0415">
       <label>
        83
       </label>
       <element-citation id="sbref0415" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mann
          </surname>
          <given-names>
           E.E.
          </given-names>
         </name>
         <name>
          <surname>
           Magin
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Mettetal
          </surname>
          <given-names>
           M.R.
          </given-names>
         </name>
         <name>
          <surname>
           May
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
         <name>
          <surname>
           Henry
          </surname>
          <given-names>
           M.K.M.
          </given-names>
         </name>
         <name>
          <surname>
           DeLoid
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Prater
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Sullivan
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Thomas
          </surname>
          <given-names>
           J.G.
          </given-names>
         </name>
         <name>
          <surname>
           Twite
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Parker
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           Brennan
          </surname>
          <given-names>
           A.B.
          </given-names>
         </name>
         <name>
          <surname>
           Reddy
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Micropatterned endotracheal tubes reduce secretion-related lumen occlusion
        </article-title>
        <source>
         Ann. Biomed. Eng.
        </source>
        <volume>
         44
        </volume>
        <year>
         2016
        </year>
        <fpage>
         3645
        </fpage>
        <lpage>
         3654
        </lpage>
        <pub-id pub-id-type="pmid">
         27535564
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0420">
       <label>
        84
       </label>
       <mixed-citation id="oref0420" publication-type="other">
        Sharklet Technologies, Inc. (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0010" xlink:href="https://www.sharklet.com/contact-us/">
         https://www.sharklet.com/contact-us/
        </ext-link>
        (accessed 10.12.17).
       </mixed-citation>
      </ref>
      <ref id="bib0425">
       <label>
        85
       </label>
       <element-citation id="sbref0425" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reddy
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Surface micropattern resists bacterial contamination transferred by healthcare practitioners
        </article-title>
        <source>
         J. Microbiol. Exp.
        </source>
        <volume>
         1
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         7
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0430">
       <label>
        86
       </label>
       <element-citation id="sbref0430" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wnek
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Bowlin
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Encyclopedia of Biomaterials and Biomedical Engineering
        </chapter-title>
        <year>
         2008
        </year>
        <publisher-name>
         Inf. Healthc.
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="bib0435">
       <label>
        87
       </label>
       <element-citation id="sbref0435" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gordon
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Slenters
          </surname>
          <given-names>
           T.V.
          </given-names>
         </name>
         <name>
          <surname>
           Brunetto
          </surname>
          <given-names>
           P.S.
          </given-names>
         </name>
         <name>
          <surname>
           Villaruz
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           Sturdevant
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Otto
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Landmann
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Fromm
          </surname>
          <given-names>
           K.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction
        </article-title>
        <source>
         Antimicrob. Agents Chemother.
        </source>
        <volume>
         54
        </volume>
        <year>
         2010
        </year>
        <fpage>
         4208
        </fpage>
        <lpage>
         4218
        </lpage>
        <pub-id pub-id-type="pmid">
         20660682
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0440">
       <label>
        88
       </label>
       <element-citation id="sbref0440" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shao
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Min
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of silver sulfadiazine loaded bacterial cellulose/sodium alginate composite films with enhanced antibacterial property
        </article-title>
        <source>
         Carbohydr. Polym.
        </source>
        <volume>
         132
        </volume>
        <year>
         2015
        </year>
        <fpage>
         351
        </fpage>
        <lpage>
         358
        </lpage>
        <pub-id pub-id-type="pmid">
         26256359
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0445">
       <label>
        89
       </label>
       <element-citation id="sbref0445" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cavanagh
          </surname>
          <given-names>
           M.H.
          </given-names>
         </name>
         <name>
          <surname>
           Burrell
          </surname>
          <given-names>
           R.E.
          </given-names>
         </name>
         <name>
          <surname>
           Nadworny
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluating antimicrobial efficacy of new commercially available silver dressings
        </article-title>
        <source>
         Int. Wound J.
        </source>
        <volume>
         7
        </volume>
        <year>
         2010
        </year>
        <fpage>
         394
        </fpage>
        <lpage>
         405
        </lpage>
        <pub-id pub-id-type="pmid">
         20626470
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0450">
       <label>
        90
       </label>
       <element-citation id="sbref0450" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Choi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Castillo
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Seminario-Vidal
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Silver absorption in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis treated with silver-impregnated dressings. A case series
        </article-title>
        <source>
         Int. Wound J.
        </source>
        <year>
         2018
        </year>
        <fpage>
         4
        </fpage>
        <lpage>
         6
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0455">
       <label>
        91
       </label>
       <element-citation id="sbref0455" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dhas
          </surname>
          <given-names>
           S.P.
          </given-names>
         </name>
         <name>
          <surname>
           Anbarasan
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Mukherjee
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Chandrasekaran
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Biobased silver nanocolloid coating on silk fibers for prevention of post-surgical wound infections
        </article-title>
        <source>
         Int. J. Nanomed.
        </source>
        <volume>
         10
        </volume>
        <year>
         2015
        </year>
        <fpage>
         159
        </fpage>
        <lpage>
         170
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0460">
       <label>
        92
       </label>
       <element-citation id="sbref0460" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antimicrobial activity and cytocompatibility of silver nanoparticles coated catheters via a biomimetic surface functionalization strategy
        </article-title>
        <source>
         Int. J. Nanomed.
        </source>
        <volume>
         10
        </volume>
        <year>
         2015
        </year>
        <fpage>
         7241
        </fpage>
        <lpage>
         7252
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0465">
       <label>
        93
       </label>
       <element-citation id="sbref0465" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hadrup
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           H.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Oral toxicity of silver ions, silver nanoparticles and colloidal silver – a review
        </article-title>
        <source>
         Regul. Toxicol. Pharmacol.
        </source>
        <volume>
         68
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         24231525
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0470">
       <label>
        94
       </label>
       <element-citation id="sbref0470" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Silhavy
          </surname>
          <given-names>
           T.J.
          </given-names>
         </name>
         <name>
          <surname>
           Kahne
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Walker
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The bacterial cell envelope
        </article-title>
        <source>
         Cold Spring Harb. Perspect. Biol.
        </source>
        <volume>
         2
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         16
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0475">
       <label>
        95
       </label>
       <element-citation id="sbref0475" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kawahara
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Tsuruda
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Morishita
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Uchida
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions
        </article-title>
        <source>
         Dent. Mater.
        </source>
        <volume>
         16
        </volume>
        <year>
         2000
        </year>
        <fpage>
         452
        </fpage>
        <lpage>
         455
        </lpage>
        <pub-id pub-id-type="pmid">
         10967196
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0480">
       <label>
        96
       </label>
       <mixed-citation id="oref0480" publication-type="other">
        AGS Glass (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0015" xlink:href="https://www.agc-yourglass.com/gb/en/brands/antibacterial-glass">
         https://www.agc-yourglass.com/gb/en/brands/antibacterial-glass
        </ext-link>
        (accessed 10.12.17).
       </mixed-citation>
      </ref>
      <ref id="bib0485">
       <label>
        97
       </label>
       <mixed-citation id="oref0485" publication-type="other">
        Surfacine (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0020" xlink:href="http://www.surfacine.com/">
         http://www.surfacine.com/
        </ext-link>
        (accessed 10.12.17).
       </mixed-citation>
      </ref>
      <ref id="bib0490">
       <label>
        98
       </label>
       <mixed-citation id="oref0490" publication-type="other">
        PureThread Technologies Inc. (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0025" xlink:href="http://www.purthread.com/">
         http://www.purthread.com/
        </ext-link>
        (accessed 02.09.18).
       </mixed-citation>
      </ref>
      <ref id="bib0495">
       <label>
        99
       </label>
       <element-citation id="sbref0495" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Schweizer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Graham
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ohl
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Heilmann
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Boyken
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Diekema
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Novel hospital curtains with antimicrobial properties: a randomized, controlled trial
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         33
        </volume>
        <year>
         2012
        </year>
        <fpage>
         1081
        </fpage>
        <lpage>
         1085
        </lpage>
        <pub-id pub-id-type="pmid">
         23041804
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0500">
       <label>
        100
       </label>
       <element-citation id="sbref0500" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vincent
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Hartemann
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Engels-Deutsch
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antimicrobial applications of copper
        </article-title>
        <source>
         Int. J. Hyg. Environ. Health
        </source>
        <volume>
         219
        </volume>
        <year>
         2016
        </year>
        <fpage>
         585
        </fpage>
        <lpage>
         591
        </lpage>
        <pub-id pub-id-type="pmid">
         27318723
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0505">
       <label>
        101
       </label>
       <element-citation id="sbref0505" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Luo
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Hein
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Mücklich
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Solioz
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Killing of bacteria by copper, cadmium, and silver surfaces reveals relevant physicochemical parameters
        </article-title>
        <source>
         Biointerphases
        </source>
        <volume>
         12
        </volume>
        <year>
         2017
        </year>
        <fpage>
         020301
        </fpage>
        <pub-id pub-id-type="pmid">
         28407716
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0510">
       <label>
        102
       </label>
       <element-citation id="sbref0510" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casey
          </surname>
          <given-names>
           A.L.
          </given-names>
         </name>
         <name>
          <surname>
           Adams
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Karpanen
          </surname>
          <given-names>
           T.J.
          </given-names>
         </name>
         <name>
          <surname>
           Lambert
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Cookson
          </surname>
          <given-names>
           B.D.
          </given-names>
         </name>
         <name>
          <surname>
           Nightingale
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Miruszenko
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Shillam
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Christian
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Elliott
          </surname>
          <given-names>
           T.S.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Role of copper in reducing hospital environment contamination
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         74
        </volume>
        <year>
         2010
        </year>
        <fpage>
         72
        </fpage>
        <lpage>
         77
        </lpage>
        <pub-id pub-id-type="pmid">
         19931938
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0515">
       <label>
        103
       </label>
       <element-citation id="sbref0515" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Souli
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Antoniadou
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Katsarolis
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Mavrou
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Paramythiotou
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Papadomichelakis
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Drogari-Apiranthitou
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Panagea
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Giamarellou
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Petrikkos
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Armaganidis
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Reduction of environmental contamination with multidrug-resistant bacteria by copper-alloy coating of surfaces in a highly endemic setting
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         38
        </volume>
        <year>
         2017
        </year>
        <fpage>
         765
        </fpage>
        <lpage>
         771
        </lpage>
        <pub-id pub-id-type="pmid">
         28473010
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0520">
       <label>
        104
       </label>
       <mixed-citation id="oref0520" publication-type="other">
        Cupron Enhanced EOS Surfaces (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0030" xlink:href="http://eoscu.com/the-product/">
         http://eoscu.com/the-product/
        </ext-link>
        (accessed 10.18.17).
       </mixed-citation>
      </ref>
      <ref id="bib0525">
       <label>
        105
       </label>
       <element-citation id="sbref0525" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gjorgievska
          </surname>
          <given-names>
           E.S.
          </given-names>
         </name>
         <name>
          <surname>
           Nicholson
          </surname>
          <given-names>
           J.W.
          </given-names>
         </name>
         <name>
          <surname>
           Coleman
          </surname>
          <given-names>
           N.J.
          </given-names>
         </name>
         <name>
          <surname>
           Booth
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Dimkov
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Hurt
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Component release and mechanical properties of endodontic sealers following incorporation of antimicrobial agents
        </article-title>
        <source>
         Biomed. Res. Int.
        </source>
        <volume>
         2017
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0530">
       <label>
        106
       </label>
       <element-citation id="sbref0530" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Iyamba
          </surname>
          <given-names>
           J.-M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Okombe
          </surname>
          <given-names>
           D.T.
          </given-names>
         </name>
         <name>
          <surname>
           Zakanda
          </surname>
          <given-names>
           F.N.
          </given-names>
         </name>
         <name>
          <surname>
           Malongo
          </surname>
          <given-names>
           T.K.
          </given-names>
         </name>
         <name>
          <surname>
           Unya
          </surname>
          <given-names>
           J.W.
          </given-names>
         </name>
         <name>
          <surname>
           Lukukula
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Balega
          </surname>
          <given-names>
           N.Z.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Adherence of
         <italic>
          Staphylococcus aureus
         </italic>
         to catheter tubing inhibition by quaternary ammonium compounds
        </article-title>
        <source>
         Pan Afr. Med. J.
        </source>
        <volume>
         26
        </volume>
        <year>
         2016
        </year>
        <fpage>
         25
        </fpage>
        <lpage>
         50
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0535">
       <label>
        107
       </label>
       <element-citation id="sbref0535" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pérez-Köhler
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           García-Moreno
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Bayon
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Pascual
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Bellón
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inhibition of
         <italic>
          Staphylococcus aureus
         </italic>
         adhesion to the surface of a reticular heavyweight polypropylene mesh soaked in a combination of chlorhexidine and allicin: an in vitro study
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         10
        </volume>
        <year>
         2015
        </year>
        <fpage>
         e0126711
        </fpage>
        <pub-id pub-id-type="pmid">
         25962163
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0540">
       <label>
        108
       </label>
       <element-citation id="sbref0540" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ji
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Koepsel
          </surname>
          <given-names>
           R.R.
          </given-names>
         </name>
         <name>
          <surname>
           Murata
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Zadan
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Campbell
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Russell
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bactericidal specificity and resistance profile of poly(quaternary ammonium) polymers and protein-poly(quaternary ammonium) conjugates
        </article-title>
        <source>
         Biomacromolecules
        </source>
        <volume>
         18
        </volume>
        <year>
         2017
        </year>
        <fpage>
         2583
        </fpage>
        <lpage>
         2593
        </lpage>
        <pub-id pub-id-type="pmid">
         28657716
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0545">
       <label>
        109
       </label>
       <element-citation id="sbref0545" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rego
          </surname>
          <given-names>
           G.F.
          </given-names>
         </name>
         <name>
          <surname>
           Vidal
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Viana
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Cabral
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Schneider
          </surname>
          <given-names>
           L.F.J.
          </given-names>
         </name>
         <name>
          <surname>
           Portela
          </surname>
          <given-names>
           M.B.
          </given-names>
         </name>
         <name>
          <surname>
           Cavalcante
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibiofilm properties of model composites containing quaternary ammonium methacrylates after surface texture modification
        </article-title>
        <source>
         Dent. Mater.
        </source>
        <volume>
         33
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1149
        </fpage>
        <lpage>
         1156
        </lpage>
        <pub-id pub-id-type="pmid">
         28822582
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0550">
       <label>
        110
       </label>
       <element-citation id="sbref0550" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Brogden
          </surname>
          <given-names>
           N.K.
          </given-names>
         </name>
         <name>
          <surname>
           Brogden
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
        </article-title>
        <source>
         Int. J. Antimicrob. Agents
        </source>
        <volume>
         38
        </volume>
        <year>
         2011
        </year>
        <fpage>
         217
        </fpage>
        <lpage>
         225
        </lpage>
        <pub-id pub-id-type="pmid">
         21733662
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0555">
       <label>
        111
       </label>
       <element-citation id="sbref0555" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casciaro
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Dutta
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Loffredo
          </surname>
          <given-names>
           M.R.
          </given-names>
         </name>
         <name>
          <surname>
           Marcheggiani
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Mcdermott
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Willcox
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Mangoni
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Esculentin-1a derived peptides kill
         <italic>
          Pseudomonas aeruginosa
         </italic>
         biofilm on soft contact lenses and retain antibacterial activity upon immobilization to the lens surface
        </article-title>
        <source>
         Biopolymers
        </source>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         9
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0560">
       <label>
        112
       </label>
       <element-citation id="sbref0560" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kazemzadeh-Narbat
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Ding
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           D.D.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Hancock
          </surname>
          <given-names>
           R.E.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Local delivery of antimicrobial peptides using self-organized TiO
         <sub>
          2
         </sub>
         nanotube arrays for peri-implant infections
        </article-title>
        <source>
         J. Biomed. Mater. Res. A
        </source>
        <volume>
         100A
        </volume>
        <year>
         2012
        </year>
        <fpage>
         278
        </fpage>
        <lpage>
         285
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0565">
       <label>
        113
       </label>
       <element-citation id="sbref0565" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sibel Akalın
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Dairy-derived antimicrobial peptides: action mechanisms, pharmaceutical uses and production proposals
        </article-title>
        <source>
         Trends Food Sci. Technol.
        </source>
        <volume>
         36
        </volume>
        <year>
         2014
        </year>
        <fpage>
         79
        </fpage>
        <lpage>
         95
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0570">
       <label>
        114
       </label>
       <element-citation id="sbref0570" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           K.N.
          </given-names>
         </name>
         <name>
          <surname>
           Aguilar
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure
        </chapter-title>
        <year>
         2016
        </year>
        <fpage>
         25
        </fpage>
        <lpage>
         39
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0575">
       <label>
        115
       </label>
       <element-citation id="sbref0575" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Monteiro
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Fernandes
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Pinheiro
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Maia
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Seabra
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ferreira-Da-Silva
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Costa
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Reis
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Gomes
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           M.C.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78
        </article-title>
        <source>
         Biochim. Biophys. Acta – Biomembr.
        </source>
        <volume>
         1848
        </volume>
        <year>
         2015
        </year>
        <fpage>
         1139
        </fpage>
        <lpage>
         1146
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0580">
       <label>
        116
       </label>
       <element-citation id="sbref0580" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Costa
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Carvalho
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Montelaro
          </surname>
          <given-names>
           R.C.
          </given-names>
         </name>
         <name>
          <surname>
           Gomes
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           M.C.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         7
        </volume>
        <year>
         2011
        </year>
        <fpage>
         1431
        </fpage>
        <lpage>
         1440
        </lpage>
        <pub-id pub-id-type="pmid">
         21056701
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0585">
       <label>
        117
       </label>
       <element-citation id="sbref0585" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Costa
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Maia
          </surname>
          <given-names>
           S.R.
          </given-names>
         </name>
         <name>
          <surname>
           Gomes
          </surname>
          <given-names>
           P.A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           M.C.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Dhvar5 antimicrobial peptide (AMP) chemoselective covalent immobilization results on higher antiadherence effect than simple physical adsorption
        </article-title>
        <source>
         Biomaterials
        </source>
        <volume>
         52
        </volume>
        <year>
         2015
        </year>
        <fpage>
         531
        </fpage>
        <lpage>
         538
        </lpage>
        <pub-id pub-id-type="pmid">
         25818458
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0590">
       <label>
        118
       </label>
       <element-citation id="sbref0590" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barros
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Silva
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Rodrigues
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Alves
          </surname>
          <given-names>
           F.R.F.
          </given-names>
         </name>
         <name>
          <surname>
           Lopes
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Pina-Vaz
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Siqueira
          </surname>
          <given-names>
           J.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibacterial, physicochemical and mechanical properties of endodontic sealers containing quaternary ammonium polyethylenimine nanoparticles
        </article-title>
        <source>
         Int. Endod. J.
        </source>
        <volume>
         47
        </volume>
        <year>
         2014
        </year>
        <fpage>
         725
        </fpage>
        <lpage>
         734
        </lpage>
        <pub-id pub-id-type="pmid">
         24134748
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0595">
       <label>
        119
       </label>
       <element-citation id="sbref0595" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cleophas
          </surname>
          <given-names>
           T.C.
          </given-names>
         </name>
         <name>
          <surname>
           Sjollema
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Busscher
          </surname>
          <given-names>
           H.J.
          </given-names>
         </name>
         <name>
          <surname>
           Kruijtzer
          </surname>
          <given-names>
           J.A.W.
          </given-names>
         </name>
         <name>
          <surname>
           Liskamp
          </surname>
          <given-names>
           R.M.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characterization and activities of a bactericidal PEG-hydrogel with immobilized antimicrobial peptide
        </article-title>
        <source>
         Biomac
        </source>
        <volume>
         15
        </volume>
        <year>
         2014
        </year>
        <fpage>
         3390
        </fpage>
        <lpage>
         3395
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0600">
       <label>
        120
       </label>
       <element-citation id="sbref0600" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ferreira
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Rzhepishevska
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Grenho
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Malheiros
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Gonçalves
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Almeida
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Jordão
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Ribeiro
          </surname>
          <given-names>
           I.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ramstedt
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Gomes
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Bettencourt
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Levofloxacin-loaded bone cement delivery system: highly effective against intracellular bacteria and Staphylococcus aureus biofilms
        </article-title>
        <source>
         Int. J. Pharm.
        </source>
        <volume>
         532
        </volume>
        <year>
         2017
        </year>
        <fpage>
         241
        </fpage>
        <lpage>
         248
        </lpage>
        <pub-id pub-id-type="pmid">
         28851574
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0605">
       <label>
        121
       </label>
       <element-citation id="sbref0605" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Shen
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bottom-up fabrication of zwitterionic polymer brushes on intraocular lens for improved biocompatibility
        </article-title>
        <source>
         Int. J. Nanomed.
        </source>
        <volume>
         12
        </volume>
        <year>
         2017
        </year>
        <fpage>
         127
        </fpage>
        <lpage>
         135
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0610">
       <label>
        122
       </label>
       <element-citation id="sbref0610" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cassin
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Ford
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Orbach
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Saverot
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Rajagopalan
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The design of antimicrobial LL37-modified collagen-hyaluronic acid detachable multilayers
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         40
        </volume>
        <year>
         2016
        </year>
        <fpage>
         119
        </fpage>
        <lpage>
         129
        </lpage>
        <pub-id pub-id-type="pmid">
         27109763
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0615">
       <label>
        123
       </label>
       <element-citation id="sbref0615" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Felgueiras
          </surname>
          <given-names>
           H.P.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Ren
          </surname>
          <given-names>
           K.F.
          </given-names>
         </name>
         <name>
          <surname>
           Querido
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Barbosa
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ji
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           M.C.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Octadecyl chains immobilized onto hyaluronic acid coatings by thiol–ene “Click Chemistry” increase the surface antimicrobial properties and prevent platelet adhesion and activation to polyurethane
        </article-title>
        <source>
         ACS Appl. Mater. Interfaces
        </source>
        <volume>
         9
        </volume>
        <year>
         2017
        </year>
        <fpage>
         7979
        </fpage>
        <lpage>
         7989
        </lpage>
        <pub-id pub-id-type="pmid">
         28165702
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0620">
       <label>
        124
       </label>
       <element-citation id="sbref0620" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seabra
          </surname>
          <given-names>
           A.B.
          </given-names>
         </name>
         <name>
          <surname>
           Da Rocha
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Eberlin
          </surname>
          <given-names>
           M.N.
          </given-names>
         </name>
         <name>
          <surname>
           De Oliveira
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release
        </article-title>
        <source>
         J. Pharm. Sci.
        </source>
        <volume>
         94
        </volume>
        <year>
         2005
        </year>
        <fpage>
         994
        </fpage>
        <lpage>
         1003
        </lpage>
        <pub-id pub-id-type="pmid">
         15793801
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0625">
       <label>
        125
       </label>
       <element-citation id="sbref0625" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rai
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Pinto
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Evangelista
          </surname>
          <given-names>
           M.B.
          </given-names>
         </name>
         <name>
          <surname>
           Gil
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Kallip
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Ferreira
          </surname>
          <given-names>
           M.G.S.
          </given-names>
         </name>
         <name>
          <surname>
           Ferreira
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         33
        </volume>
        <year>
         2016
        </year>
        <fpage>
         64
        </fpage>
        <lpage>
         77
        </lpage>
        <pub-id pub-id-type="pmid">
         26821340
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0630">
       <label>
        126
       </label>
       <element-citation id="sbref0630" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alt
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Kirchhof
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Seim
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Hrubesch
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Lips
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Mannel
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Domann
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Schnettler
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Rifampicin-fosfomycin coating for cementless endoprostheses: antimicrobial effects against methicillin-sensitive
         <italic>
          Staphylococcus aureus
         </italic>
         (MSSA) and methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         (MRSA)
        </article-title>
        <source>
         Acta Biomater.
        </source>
        <volume>
         10
        </volume>
        <year>
         2014
        </year>
        <fpage>
         4518
        </fpage>
        <lpage>
         4524
        </lpage>
        <pub-id pub-id-type="pmid">
         24948548
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0635">
       <label>
        127
       </label>
       <element-citation id="sbref0635" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Neut
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Dijkstra
          </surname>
          <given-names>
           R.J.B.
          </given-names>
         </name>
         <name>
          <surname>
           Thompson
          </surname>
          <given-names>
           J.I.
          </given-names>
         </name>
         <name>
          <surname>
           Van Der Mei
          </surname>
          <given-names>
           H.C.
          </given-names>
         </name>
         <name>
          <surname>
           Busscher
          </surname>
          <given-names>
           H.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A gentamicin-releasing coating for cementless hip prostheses-longitudinal evaluation of efficacy using in vitro bio-optical imaging and its wide-spectrum antibacterial efficacy
        </article-title>
        <source>
         J. Biomed. Mater. Res. A
        </source>
        <volume>
         100 A
        </volume>
        <year>
         2012
        </year>
        <fpage>
         3220
        </fpage>
        <lpage>
         3226
        </lpage>
        <pub-id pub-id-type="pmid">
         22733713
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0640">
       <label>
        128
       </label>
       <element-citation id="sbref0640" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zanini
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Polissi
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Maccagni
          </surname>
          <given-names>
           E.A.
          </given-names>
         </name>
         <name>
          <surname>
           Dell’Orto
          </surname>
          <given-names>
           E.C.
          </given-names>
         </name>
         <name>
          <surname>
           Liberatore
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Riccardi
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of antibacterial quaternary ammonium silane coatings on polyurethane catheters
        </article-title>
        <source>
         J. Colloid Interface Sci.
        </source>
        <volume>
         451
        </volume>
        <year>
         2015
        </year>
        <fpage>
         78
        </fpage>
        <lpage>
         84
        </lpage>
        <pub-id pub-id-type="pmid">
         25890115
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0645">
       <label>
        129
       </label>
       <element-citation id="sbref0645" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Braun
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Pochert
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Lindén
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Davoudi
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Schmidtchen
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Nordström
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Malmsten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides
        </article-title>
        <source>
         J. Colloid Interface Sci.
        </source>
        <volume>
         475
        </volume>
        <year>
         2016
        </year>
        <fpage>
         161
        </fpage>
        <lpage>
         170
        </lpage>
        <pub-id pub-id-type="pmid">
         27174622
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0650">
       <label>
        130
       </label>
       <element-citation id="sbref0650" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Slate
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Wickens
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Wilson-Nieuwenhuis
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Dempsey-Hibbert
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           West
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Kelly
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Verran
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Banks
          </surname>
          <given-names>
           C.E.
          </given-names>
         </name>
         <name>
          <surname>
           Whitehead
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The effects of blood conditioning films on the antimicrobial and retention properties of zirconium-nitride silver surfaces
        </article-title>
        <source>
         Colloids Surf. B Biointerfaces
        </source>
        <volume>
         173
        </volume>
        <year>
         2019
        </year>
        <fpage>
         303
        </fpage>
        <lpage>
         311
        </lpage>
        <pub-id pub-id-type="pmid">
         30308455
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0655">
       <label>
        131
       </label>
       <element-citation id="sbref0655" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ji
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Cao
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cecropin A-melittin mutant with improved proteolytic stability and enhanced antimicrobial activity against bacteria and fungi associated with gastroenteritis in vitro
        </article-title>
        <source>
         Biochem. Biophys. Res. Commun.
        </source>
        <volume>
         451
        </volume>
        <year>
         2014
        </year>
        <fpage>
         650
        </fpage>
        <lpage>
         655
        </lpage>
        <pub-id pub-id-type="pmid">
         25130460
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0660">
       <label>
        132
       </label>
       <mixed-citation id="oref0660" publication-type="other">
        Biocote Limited (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0035" xlink:href="https://www.biocote.com/">
         https://www.biocote.com/
        </ext-link>
        (accessed 01.3.18).
       </mixed-citation>
      </ref>
      <ref id="bib0665">
       <label>
        133
       </label>
       <mixed-citation id="oref0665" publication-type="other">
        Sanitized AG (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0040" xlink:href="https://www.sanitized.com/">
         https://www.sanitized.com/
        </ext-link>
        (accessed 01.02.18).
       </mixed-citation>
      </ref>
      <ref id="bib0670">
       <label>
        134
       </label>
       <element-citation id="sbref0670" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sadrieh
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Wokovich
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Gopee
          </surname>
          <given-names>
           N.V.
          </given-names>
         </name>
         <name>
          <surname>
           Zheng
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Haines
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Parmiter
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Siitonen
          </surname>
          <given-names>
           P.H.
          </given-names>
         </name>
         <name>
          <surname>
           Cozart
          </surname>
          <given-names>
           C.R.
          </given-names>
         </name>
         <name>
          <surname>
           Patri
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           McNeil
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Howard
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Doub
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
         <name>
          <surname>
           Buhse
          </surname>
          <given-names>
           L.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO
         <sub>
          2
         </sub>
         particles
        </article-title>
        <source>
         Toxicol. Sci.
        </source>
        <volume>
         115
        </volume>
        <year>
         2010
        </year>
        <fpage>
         156
        </fpage>
        <lpage>
         166
        </lpage>
        <pub-id pub-id-type="pmid">
         20156837
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0675">
       <label>
        135
       </label>
       <element-citation id="sbref0675" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Foster
          </surname>
          <given-names>
           H.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ditta
          </surname>
          <given-names>
           I.B.
          </given-names>
         </name>
         <name>
          <surname>
           Varghese
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Steele
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity
        </article-title>
        <source>
         Appl. Microbiol. Biotechnol.
        </source>
        <volume>
         90
        </volume>
        <year>
         2011
        </year>
        <fpage>
         1847
        </fpage>
        <lpage>
         1868
        </lpage>
        <pub-id pub-id-type="pmid">
         21523480
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0680">
       <label>
        136
       </label>
       <element-citation id="sbref0680" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kubacka
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Diez
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
         <name>
          <surname>
           Rojo
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Bargiela
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Ciordia
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Zapico
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Albar
          </surname>
          <given-names>
           J.P.
          </given-names>
         </name>
         <name>
          <surname>
           Barbas
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Martins Dos Santos
          </surname>
          <given-names>
           V.A.P.
          </given-names>
         </name>
         <name>
          <surname>
           Fernández-García
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ferrer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Understanding the antimicrobial mechanism of TiO
         <sub>
          2
         </sub>
         -based nanocomposite films in a pathogenic bacterium
        </article-title>
        <source>
         Sci. Rep.
        </source>
        <volume>
         4
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         9
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0685">
       <label>
        137
       </label>
       <element-citation id="sbref0685" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Adán
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Marugán
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Mesones
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Casado
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           van Grieken
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bacterial inactivation and degradation of organic molecules by titanium dioxide supported on porous stainless steel photocatalytic membranes
        </article-title>
        <source>
         Chem. Eng. J.
        </source>
        <volume>
         318
        </volume>
        <year>
         2017
        </year>
        <fpage>
         29
        </fpage>
        <lpage>
         38
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0690">
       <label>
        138
       </label>
       <element-citation id="sbref0690" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Joost
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
         <name>
          <surname>
           Juganson
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Visnapuu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Mortimer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kahru
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           N??mmiste
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Joost
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
         <name>
          <surname>
           Kisand
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Ivask
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Photocatalytic antibacterial activity of nano-TiO
         <sub>
          2
         </sub>
         (anatase)-based thin films: effects on
         <italic>
          Escherichia coli
         </italic>
         cells and fatty acids
        </article-title>
        <source>
         J. Photochem. Photobiol. B Biol.
        </source>
        <volume>
         142
        </volume>
        <year>
         2015
        </year>
        <fpage>
         178
        </fpage>
        <lpage>
         185
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0695">
       <label>
        139
       </label>
       <mixed-citation id="oref0695" publication-type="other">
        PureHealth (WWW Document), n.d.
        <ext-link ext-link-type="uri" id="intr0045" xlink:href="http://www.purehealth.it">
         http://www.purehealth.it
        </ext-link>
        (accessed 10.12.17).
       </mixed-citation>
      </ref>
      <ref id="bib0700">
       <label>
        140
       </label>
       <element-citation id="sbref0700" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Serban
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Translational biomaterials – the journey from the bench to the market – think “product”
        </article-title>
        <source>
         Curr. Opin. Biotechnol.
        </source>
        <volume>
         40
        </volume>
        <year>
         2016
        </year>
        <fpage>
         31
        </fpage>
        <lpage>
         34
        </lpage>
        <pub-id pub-id-type="pmid">
         26926461
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0705">
       <label>
        141
       </label>
       <element-citation id="sbref0705" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Riu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Chiarello
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Terradas
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Sala
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Garcia-Alzorriz
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Castells
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Grau
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Cots
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cost attributable to nosocomial bacteremia. Analysis according to microorganism and antimicrobial sensitivity in a university hospital in Barcelona
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         11
        </volume>
        <year>
         2016
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         12
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0710">
       <label>
        142
       </label>
       <element-citation id="sbref0710" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           European Center for Disease Prevention and Control Agency, E.M
          </surname>
         </name>
        </person-group>
        <chapter-title>
         The Bacterial Challenge: Time to React. Stockholm
        </chapter-title>
        <year>
         2009
        </year>
       </element-citation>
      </ref>
      <ref id="bib0715">
       <label>
        143
       </label>
       <element-citation id="sbref0715" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           L.R.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Y.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contamination of medical charts: an important source of potential infection in hospitals
        </article-title>
        <source>
         PLoS One
        </source>
        <volume>
         9
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         7
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0720">
       <label>
        144
       </label>
       <element-citation id="sbref0720" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yue
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Chai
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Luo
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital-wide comparison of health care-associated infection among 8 intensive care units: a retrospective analysis for 2010–2015
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         45
        </volume>
        <year>
         2017
        </year>
        <fpage>
         e7
        </fpage>
        <lpage>
         e13
        </lpage>
        <pub-id pub-id-type="pmid">
         27856076
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0725">
       <label>
        145
       </label>
       <element-citation id="sbref0725" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fagerlund
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Møretrø
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Heir
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Briandet
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Langsrud
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cleaning and disinfection of biofilms composed of listeria monocytogenes and background microbiota from meat processing surfaces
        </article-title>
        <source>
         Appl. Environ. Microbiol.
        </source>
        <volume>
         83
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         21
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0730">
       <label>
        146
       </label>
       <element-citation id="sbref0730" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Staskel
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Briley
          </surname>
          <given-names>
           M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Field
          </surname>
          <given-names>
           L.H.
          </given-names>
         </name>
         <name>
          <surname>
           Barth
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbial evaluation of foodservice surfaces in texas child-care centers
        </article-title>
        <source>
         J. Am. Diet. Assoc.
        </source>
        <volume>
         107
        </volume>
        <year>
         2007
        </year>
        <fpage>
         854
        </fpage>
        <lpage>
         859
        </lpage>
        <pub-id pub-id-type="pmid">
         17467385
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0735">
       <label>
        147
       </label>
       <element-citation id="sbref0735" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Güldoğan
          </surname>
          <given-names>
           C.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical infection in burn patients and the consequences
        </article-title>
        <source>
         Turk. J. Trauma Emerg. Surg.
        </source>
        <volume>
         23
        </volume>
        <year>
         2017
        </year>
        <fpage>
         2
        </fpage>
        <lpage>
         7
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0740">
       <label>
        148
       </label>
       <element-citation id="sbref0740" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Werarak
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Kiratisin
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Thamlikitkul
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance
        </article-title>
        <source>
         J. Med. Assoc. Thail.
        </source>
        <volume>
         93
        </volume>
        <year>
         2010
        </year>
        <fpage>
         126
        </fpage>
        <lpage>
         138
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0745">
       <label>
        149
       </label>
       <element-citation id="sbref0745" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alberti
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Bouakline
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Ribaud
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Lacroix
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Rousselot
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Leblanc
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Derouin
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         48
        </volume>
        <year>
         2001
        </year>
        <fpage>
         198
        </fpage>
        <lpage>
         206
        </lpage>
        <pub-id pub-id-type="pmid">
         11439007
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0750">
       <label>
        150
       </label>
       <element-citation id="sbref0750" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McLellan
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Fenton
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Fungal contamination of hospital healthcare workers’ overalls
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <volume>
         66
        </volume>
        <year>
         2007
        </year>
        <fpage>
         87
        </fpage>
        <lpage>
         88
        </lpage>
        <pub-id pub-id-type="pmid">
         17428578
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0755">
       <label>
        151
       </label>
       <element-citation id="sbref0755" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fukuda
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Homma
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Suzuki
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Takuma
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Tanaka
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Yokoe
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Ohnishi
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Niki
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Sagara
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         High burden of
         <italic>
          Aspergillus fumigatus
         </italic>
         infection among chronic respiratory diseases
        </article-title>
        <source>
         Chron. Respir. Dis.
        </source>
        <year>
         2018
        </year>
        <comment>
         147997231876165
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0760">
       <label>
        152
       </label>
       <element-citation id="sbref0760" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ortega-loubon
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Fernández-molina
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Tobar-ruiz
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Arce
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Fulquet-Carreras
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Rapid fulminant case of aspergillus prosthetic valve endocarditis
        </article-title>
        <source>
         Cureus
        </source>
        <volume>
         9
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         5
        </lpage>
        <ext-link ext-link-type="uri" id="intr0050" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/29142800">
         https://www.ncbi.nlm.nih.gov/pubmed/29142800
        </ext-link>
       </element-citation>
      </ref>
      <ref id="bib0765">
       <label>
        153
       </label>
       <element-citation id="sbref0765" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Schwartz
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Kontoyiannis
          </surname>
          <given-names>
           D.P.
          </given-names>
         </name>
         <name>
          <surname>
           Harrison
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Ruhnke
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Advances in the diagnosis and treatment of fungal infections of the CNS
        </article-title>
        <source>
         Lancet Glob. Health
        </source>
        <volume>
         4422
        </volume>
        <year>
         2018
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         11
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0770">
       <label>
        154
       </label>
       <element-citation id="sbref0770" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sharma
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Yenigalla
          </surname>
          <given-names>
           B.M.
          </given-names>
         </name>
         <name>
          <surname>
           Naidu
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Pidakala
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Primary cutaneous aspergillosis due to
         <italic>
          Aspergillus tamarii
         </italic>
         in an immunocompetent host
        </article-title>
        <source>
         BMJ Case Rep.
        </source>
        <year>
         2013
        </year>
        <fpage>
         2
        </fpage>
        <lpage>
         4
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0775">
       <label>
        155
       </label>
       <element-citation id="sbref0775" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Borrusso
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Quinlan
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Prevalence of pathogens and indicator organisms in home kitchens and correlation with unsafe food handling practices and conditions
        </article-title>
        <source>
         J. Food Prot.
        </source>
        <volume>
         80
        </volume>
        <year>
         2017
        </year>
        <fpage>
         590
        </fpage>
        <lpage>
         597
        </lpage>
        <pub-id pub-id-type="pmid">
         28271927
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0780">
       <label>
        156
       </label>
       <element-citation id="sbref0780" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guyard-Nicodème
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Tresse
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Houard
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Jugiau
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Courtillon
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           El Manaa
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Laisney
          </surname>
          <given-names>
           M.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chemaly
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characterization of
         <italic>
          Campylobacter
         </italic>
         spp. Transferred from naturally contaminated chicken legs to cooked chicken slices via a cutting board
        </article-title>
        <source>
         Int. J. Food Microbiol.
        </source>
        <volume>
         164
        </volume>
        <year>
         2013
        </year>
        <fpage>
         7
        </fpage>
        <lpage>
         14
        </lpage>
        <pub-id pub-id-type="pmid">
         23587707
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0785">
       <label>
        157
       </label>
       <element-citation id="sbref0785" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mattick
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Durham
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Hendrix
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Slader
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Griffith
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Sen
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Humphrey
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The microbiological quality of washing-up water and the environment in domestic and commercial kitchens
        </article-title>
        <source>
         J. Appl. Microbiol.
        </source>
        <volume>
         94
        </volume>
        <year>
         2003
        </year>
        <fpage>
         842
        </fpage>
        <lpage>
         848
        </lpage>
        <pub-id pub-id-type="pmid">
         12694449
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0790">
       <label>
        158
       </label>
       <element-citation id="sbref0790" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sarjit
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Dykes
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transfer of
         <italic>
          Campylobacter
         </italic>
         and
         <italic>
          Salmonella
         </italic>
         from poultry meat onto poultry preparation surfaces
        </article-title>
        <source>
         J. Food Prot.
        </source>
        <volume>
         80
        </volume>
        <year>
         2017
        </year>
        <fpage>
         750
        </fpage>
        <lpage>
         757
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0795">
       <label>
        159
       </label>
       <element-citation id="sbref0795" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Jing
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Yuan
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Etiology of diarrhea among children under the age five in China: results from a five-year surveillance
        </article-title>
        <source>
         J. Infect.
        </source>
        <volume>
         71
        </volume>
        <year>
         2015
        </year>
        <fpage>
         19
        </fpage>
        <lpage>
         27
        </lpage>
        <pub-id pub-id-type="pmid">
         25753104
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0800">
       <label>
        160
       </label>
       <element-citation id="sbref0800" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lesho
          </surname>
          <given-names>
           E.P.
          </given-names>
         </name>
         <name>
          <surname>
           Bronstein
          </surname>
          <given-names>
           M.Z.
          </given-names>
         </name>
         <name>
          <surname>
           Mcgann
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Stam
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Kwak
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Maybank
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Mcnamara
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Callahan
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Campbell
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Hinkle
          </surname>
          <given-names>
           M.K.
          </given-names>
         </name>
         <name>
          <surname>
           Walsh
          </surname>
          <given-names>
           E.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Importation, mitigation, and genomic epidemiology of
         <italic>
          Candida auris
         </italic>
         at a large teaching hospital
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         39
        </volume>
        <year>
         2018
        </year>
        <fpage>
         53
        </fpage>
        <lpage>
         57
        </lpage>
        <pub-id pub-id-type="pmid">
         29208056
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0805">
       <label>
        161
       </label>
       <element-citation id="sbref0805" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Achkar
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Fries
          </surname>
          <given-names>
           B.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Candida infections of the genitourinary tract
        </article-title>
        <source>
         Clin. Microbiol. Rev.
        </source>
        <volume>
         23
        </volume>
        <year>
         2010
        </year>
        <fpage>
         253
        </fpage>
        <lpage>
         273
        </lpage>
        <pub-id pub-id-type="pmid">
         20375352
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0810">
       <label>
        162
       </label>
       <element-citation id="sbref0810" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gaetti-Jardim
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Jardim
          </surname>
          <given-names>
           E.C.G.
          </given-names>
         </name>
         <name>
          <surname>
           Schweitzer
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           da Silva
          </surname>
          <given-names>
           J.C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Oliveira
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Masocatto
          </surname>
          <given-names>
           D.C.
          </given-names>
         </name>
         <name>
          <surname>
           dos Santos
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment
        </article-title>
        <source>
         Arch. Oral Biol.
        </source>
        <year>
         2018
        </year>
       </element-citation>
      </ref>
      <ref id="bib0815">
       <label>
        163
       </label>
       <element-citation id="sbref0815" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ali
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Muzslay
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A novel quantitative sampling technique for detection and monitoring of
         <italic>
          Clostridium difficile
         </italic>
         contamination in the clinical environment
        </article-title>
        <source>
         J. Clin. Microbiol.
        </source>
        <volume>
         53
        </volume>
        <year>
         2015
        </year>
        <fpage>
         2570
        </fpage>
        <lpage>
         2574
        </lpage>
        <pub-id pub-id-type="pmid">
         26041892
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0820">
       <label>
        164
       </label>
       <element-citation id="sbref0820" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yui
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Ali
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Muzslay
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Jeanes
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           A.P.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Identification of
         <italic>
          Clostridium difficile
         </italic>
         reservoirs in the patient environment and efficacy of aerial hydrogen peroxide decontamination
        </article-title>
        <source>
         Infect. Control Hosp. Epidemiol.
        </source>
        <volume>
         38
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1487
        </fpage>
        <lpage>
         1492
        </lpage>
        <pub-id pub-id-type="pmid">
         29143704
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0825">
       <label>
        165
       </label>
       <element-citation id="sbref0825" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shaughnessy
          </surname>
          <given-names>
           M.K.
          </given-names>
         </name>
         <name>
          <surname>
           Bobr
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Kuskowski
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Johnston
          </surname>
          <given-names>
           B.D.
          </given-names>
         </name>
         <name>
          <surname>
           Sadowsky
          </surname>
          <given-names>
           M.J.
          </given-names>
         </name>
         <name>
          <surname>
           Khoruts
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Johnson
          </surname>
          <given-names>
           J.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental contamination in households of patients with recurrent clostridium difficile infection
        </article-title>
        <source>
         Appl. Environ. Microbiol.
        </source>
        <volume>
         82
        </volume>
        <year>
         2016
        </year>
        <comment>
         AEM.03888-15
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0830">
       <label>
        166
       </label>
       <element-citation id="sbref0830" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Weese
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
         <name>
          <surname>
           Namvar
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Warriner
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Sanitary status and incidence of methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         and
         <italic>
          Clostridium difficile
         </italic>
         within Canadian hotel rooms
        </article-title>
        <source>
         J. Environ. Health
        </source>
        <volume>
         77
        </volume>
        <year>
         2015
        </year>
        <fpage>
         8
        </fpage>
        <lpage>
         15
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0835">
       <label>
        167
       </label>
       <element-citation id="sbref0835" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Burke
          </surname>
          <given-names>
           K.E.
          </given-names>
         </name>
         <name>
          <surname>
           Lamont
          </surname>
          <given-names>
           J.T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clostridium difficile infection: a worldwide disease
        </article-title>
        <source>
         Gut Liver
        </source>
        <volume>
         8
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         24516694
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0840">
       <label>
        168
       </label>
       <element-citation id="sbref0840" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bonny
          </surname>
          <given-names>
           T.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yezli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Lednicky
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation and identification of human coronavirus 229E from frequently touched environmental surfaces of a university classroom that is cleaned daily
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         46
        </volume>
        <year>
         2018
        </year>
        <fpage>
         105
        </fpage>
        <lpage>
         107
        </lpage>
        <pub-id pub-id-type="pmid">
         28893443
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0845">
       <label>
        169
       </label>
       <element-citation id="sbref0845" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Booth
          </surname>
          <given-names>
           T.F.
          </given-names>
         </name>
         <name>
          <surname>
           Kournikakis
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bastien
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Kobasa
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Stadnyk
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Spence
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Paton
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Henry
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Mederski
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           White
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Low
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           McGeer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Simor
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Vearncombe
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Downey
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Jamieson
          </surname>
          <given-names>
           F.B.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Plummer
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of airborne Severe Acute Respiratory Syndrome (SARS) Coronavirus and environmental contamination in SARS outbreak units
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <volume>
         191
        </volume>
        <year>
         2005
        </year>
        <fpage>
         1472
        </fpage>
        <lpage>
         1477
        </lpage>
        <pub-id pub-id-type="pmid">
         15809906
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0850">
       <label>
        170
       </label>
       <element-citation id="sbref0850" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dowell
          </surname>
          <given-names>
           S.F.
          </given-names>
         </name>
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D.D.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J.S.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chaovavanich
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Javadi
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           JyhYuan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           S.X.
          </given-names>
         </name>
         <name>
          <surname>
           MeiShang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus on hospital surfaces
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <volume>
         39
        </volume>
        <year>
         2004
        </year>
        <fpage>
         652
        </fpage>
        <lpage>
         657
        </lpage>
        <pub-id pub-id-type="pmid">
         15356778
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0855">
       <label>
        171
       </label>
       <element-citation id="sbref0855" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           D.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemic and emerging coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)
        </article-title>
        <source>
         Clin. Chest Med.
        </source>
        <volume>
         38
        </volume>
        <year>
         2017
        </year>
        <fpage>
         71
        </fpage>
        <lpage>
         86
        </lpage>
        <pub-id pub-id-type="pmid">
         28159163
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0860">
       <label>
        172
       </label>
       <element-citation id="sbref0860" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sampers
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Jacxsens
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Luning
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Marcelis
          </surname>
          <given-names>
           W.J.
          </given-names>
         </name>
         <name>
          <surname>
           Dumoulin
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Uyttendaele
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Performance of food safety management systems in poultry meat preparation processing plants in relation to
         <italic>
          Campylobacter
         </italic>
         spp. contamination
        </article-title>
        <source>
         J. Food Prot.
        </source>
        <volume>
         73
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1447
        </fpage>
        <lpage>
         1457
        </lpage>
        <pub-id pub-id-type="pmid">
         20819354
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0865">
       <label>
        173
       </label>
       <element-citation id="sbref0865" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Olmos
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Vilacosta
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Fernández-Pérez
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Bernal
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ferrera
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           García-Arribas
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Pérez-García
          </surname>
          <given-names>
           C.N.
          </given-names>
         </name>
         <name>
          <surname>
           San Román
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Maroto
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Macaya
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Elola
          </surname>
          <given-names>
           F.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The evolving nature of infective endocarditis in spain: a population-based study (2003 to 2014)
        </article-title>
        <source>
         J. Am. Coll. Cardiol.
        </source>
        <volume>
         70
        </volume>
        <year>
         2017
        </year>
        <fpage>
         2795
        </fpage>
        <lpage>
         2804
        </lpage>
        <pub-id pub-id-type="pmid">
         29191329
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0870">
       <label>
        174
       </label>
       <element-citation id="sbref0870" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pintado
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Cabellos
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Moreno
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Meseguer
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ayats
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Viladrich
          </surname>
          <given-names>
           P.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Enterococcal meningitis: a clinical study of 39 cases and review of the literature
        </article-title>
        <source>
         Medicine (Baltimore)
        </source>
        <volume>
         82
        </volume>
        <year>
         2003
        </year>
        <fpage>
         346
        </fpage>
        <lpage>
         364
        </lpage>
        <pub-id pub-id-type="pmid">
         14530784
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0875">
       <label>
        175
       </label>
       <element-citation id="sbref0875" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wagner
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Bonhoeffer
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Erb
          </surname>
          <given-names>
           T.O.
          </given-names>
         </name>
         <name>
          <surname>
           Glanzmann
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Häcker
          </surname>
          <given-names>
           F.M.
          </given-names>
         </name>
         <name>
          <surname>
           Paulussen
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Weibel
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Heininger
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Prospective study on central venous line associated bloodstream infections
        </article-title>
        <source>
         Arch. Dis. Child.
        </source>
        <volume>
         96
        </volume>
        <year>
         2011
        </year>
        <fpage>
         827
        </fpage>
        <lpage>
         831
        </lpage>
        <pub-id pub-id-type="pmid">
         21642273
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0880">
       <label>
        176
       </label>
       <element-citation id="sbref0880" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dziri
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Klibi
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Alonso
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
         <name>
          <surname>
           Jouini
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Ben Said
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Chairat
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Bellaaj
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Boudabous
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Ben Slama
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Torres
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of CTX-M-15-producing
         <italic>
          Escherichia coli
         </italic>
         isolates of lineages ST131-B2 and ST167-A in environmental samples of a Tunisian hospital
        </article-title>
        <source>
         Microb. Drug Resist.
        </source>
        <volume>
         22
        </volume>
        <year>
         2016
        </year>
        <fpage>
         399
        </fpage>
        <lpage>
         403
        </lpage>
        <pub-id pub-id-type="pmid">
         26958744
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0885">
       <label>
        177
       </label>
       <element-citation id="sbref0885" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Foxman
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Urinary tract infection syndromes. Occurrence, recurrence, bacteriology, risk factors, and disease burden
        </article-title>
        <source>
         Infect. Dis. Clin. N. Am.
        </source>
        <volume>
         28
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         13
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0890">
       <label>
        178
       </label>
       <element-citation id="sbref0890" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           García-Laorden
          </surname>
          <given-names>
           M.I.
          </given-names>
         </name>
         <name>
          <surname>
           Stroo
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Terpstra
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Florquin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Medema
          </surname>
          <given-names>
           J.P.
          </given-names>
         </name>
         <name>
          <surname>
           Vańt Veer
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           De Vos
          </surname>
          <given-names>
           A.F.
          </given-names>
         </name>
         <name>
          <surname>
           Van Der Poll
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Expression and function of granzymes A and B in
         <italic>
          Escherichia coli
         </italic>
         peritonitis and sepsis
        </article-title>
        <source>
         Mediators Inflamm.
        </source>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0895">
       <label>
        179
       </label>
       <element-citation id="sbref0895" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kim
          </surname>
          <given-names>
           H.-J.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Bae
          </surname>
          <given-names>
           K.-S.
          </given-names>
         </name>
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           S.B.
          </given-names>
         </name>
         <name>
          <surname>
           Jeong
          </surname>
          <given-names>
           D.C.
          </given-names>
         </name>
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Shin
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           G.D.
          </given-names>
         </name>
         <name>
          <surname>
           Yeon-Joon Park
          </surname>
         </name>
        </person-group>
        <article-title>
         Community-acquired
         <italic>
          Escherichia coli
         </italic>
         Enteritis in Korean children: the clinical application of a stool polymerase chain reaction assay
        </article-title>
        <source>
         Infect. Chemother.
        </source>
        <volume>
         49
        </volume>
        <year>
         2017
        </year>
        <fpage>
         275
        </fpage>
        <lpage>
         281
        </lpage>
        <pub-id pub-id-type="pmid">
         29299895
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0900">
       <label>
        180
       </label>
       <element-citation id="sbref0900" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boone
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Gerba
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The occurrence of influenza A virus on household and day care center fomites
        </article-title>
        <source>
         J. Infect.
        </source>
        <volume>
         51
        </volume>
        <year>
         2005
        </year>
        <fpage>
         103
        </fpage>
        <lpage>
         109
        </lpage>
        <pub-id pub-id-type="pmid">
         16038759
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0905">
       <label>
        181
       </label>
       <element-citation id="sbref0905" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Killingley
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Greatorex
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Digard
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Wise
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Garcia
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Varsani
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Cauchemez
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Enstone
          </surname>
          <given-names>
           J.E.
          </given-names>
         </name>
         <name>
          <surname>
           Hayward
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Curran
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Read
          </surname>
          <given-names>
           R.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.S.
          </given-names>
         </name>
         <name>
          <surname>
           Nicholson
          </surname>
          <given-names>
           K.G.
          </given-names>
         </name>
         <name>
          <surname>
           Nguyen-Van-Tam
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: implications for infection prevention and control
        </article-title>
        <source>
         J. Infect. Public Health
        </source>
        <volume>
         9
        </volume>
        <year>
         2016
        </year>
        <fpage>
         278
        </fpage>
        <lpage>
         288
        </lpage>
        <pub-id pub-id-type="pmid">
         26653976
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0910">
       <label>
        182
       </label>
       <element-citation id="sbref0910" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Suntarattiwong
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Levy
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gibbons
          </surname>
          <given-names>
           R.V.
          </given-names>
         </name>
         <name>
          <surname>
           Cruz
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Shaman
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Jarman
          </surname>
          <given-names>
           R.G.
          </given-names>
         </name>
         <name>
          <surname>
           Chotpitayasunondh
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Influenza virus contamination of common household surfaces during the 2009 Influenza A (H1N1) Pandemic in Bangkok, Thailand: implications for contact transmission
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <volume>
         51
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1053
        </fpage>
        <lpage>
         1061
        </lpage>
        <pub-id pub-id-type="pmid">
         20879867
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0915">
       <label>
        183
       </label>
       <element-citation id="sbref0915" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Xue
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Moncla
          </surname>
          <given-names>
           L.H.
          </given-names>
         </name>
         <name>
          <surname>
           Bedford
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Bloom
          </surname>
          <given-names>
           J.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Within-host evolution of human Influenza virus
        </article-title>
        <source>
         Trends Microbiol.
        </source>
        <volume>
         0
        </volume>
        <year>
         2018
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         13
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0920">
       <label>
        184
       </label>
       <element-citation id="sbref0920" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gallimore
          </surname>
          <given-names>
           C.I.
          </given-names>
         </name>
         <name>
          <surname>
           Taylor
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Gennery
          </surname>
          <given-names>
           A.R.
          </given-names>
         </name>
         <name>
          <surname>
           Cant
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Galloway
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Xerry
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Adigwe
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gray
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contamination of the hospital environment with gastroenteric viruses: comparison of two pediatric wards over a winter season
        </article-title>
        <source>
         J. Clin. Microbiol.
        </source>
        <volume>
         46
        </volume>
        <year>
         2008
        </year>
        <fpage>
         3112
        </fpage>
        <lpage>
         3115
        </lpage>
        <pub-id pub-id-type="pmid">
         18614656
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0925">
       <label>
        185
       </label>
       <element-citation id="sbref0925" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gallimore
          </surname>
          <given-names>
           C.I.
          </given-names>
         </name>
         <name>
          <surname>
           Taylor
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Gennery
          </surname>
          <given-names>
           A.R.
          </given-names>
         </name>
         <name>
          <surname>
           Cant
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Galloway
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Iturriza-gomara
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Gray
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental monitoring for gastroenteric viruses in a pediatric primary immunode ciency unit
        </article-title>
        <source>
         Society
        </source>
        <volume>
         44
        </volume>
        <year>
         2006
        </year>
        <fpage>
         395
        </fpage>
        <lpage>
         399
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0930">
       <label>
        186
       </label>
       <element-citation id="sbref0930" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheesbrough
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gallimore
          </surname>
          <given-names>
           C.I.
          </given-names>
         </name>
         <name>
          <surname>
           Wright
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           D.W.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Widespread environmental contamination with Norwalk-like viruses (NLV) detected in a prolonged hotel outbreak of gastroenteritis
        </article-title>
        <source>
         Epidemiol. Infect.
        </source>
        <volume>
         125
        </volume>
        <year>
         2000
        </year>
        <fpage>
         93
        </fpage>
        <lpage>
         98
        </lpage>
        <pub-id pub-id-type="pmid">
         11057964
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0935">
       <label>
        187
       </label>
       <element-citation id="sbref0935" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           G.W.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Treffiletti
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Hrsak
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Shugart
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Vinjé
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of a new environmental sampling protocol for detection of human norovirus on inanimate surfaces
        </article-title>
        <source>
         Appl. Environ. Microbiol.
        </source>
        <volume>
         81
        </volume>
        <year>
         2015
        </year>
        <fpage>
         5987
        </fpage>
        <lpage>
         5992
        </lpage>
        <pub-id pub-id-type="pmid">
         26116675
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0940">
       <label>
        188
       </label>
       <element-citation id="sbref0940" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Biscaro
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Piccinelli
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Gargiulo
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Ianiro
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Caruso
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Caccuri
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           De Francesco
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy
        </article-title>
        <source>
         Infect. Genet. Evol.
        </source>
        <year>
         2018
        </year>
       </element-citation>
      </ref>
      <ref id="bib0945">
       <label>
        189
       </label>
       <element-citation id="sbref0945" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           De Oliveira
          </surname>
          <given-names>
           F.P.
          </given-names>
         </name>
         <name>
          <surname>
           Pires
          </surname>
          <given-names>
           B.M.F.B.
          </given-names>
         </name>
         <name>
          <surname>
           De Cássia Ferreira De Almeida Silva
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           De Carvalho
          </surname>
          <given-names>
           B.T.F.
          </given-names>
         </name>
         <name>
          <surname>
           Teixeira
          </surname>
          <given-names>
           L.A.
          </given-names>
         </name>
         <name>
          <surname>
           De Paula
          </surname>
          <given-names>
           G.R.
          </given-names>
         </name>
         <name>
          <surname>
           De Oliveira
          </surname>
          <given-names>
           B.G.R.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Prevalence, antimicrobial susceptibility, and clonal diversity of pseudomonas aeruginosa in chronic wounds
        </article-title>
        <source>
         J. Wound Ostomy Cont. Nurs.
        </source>
        <volume>
         44
        </volume>
        <year>
         2017
        </year>
        <fpage>
         528
        </fpage>
        <lpage>
         535
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0950">
       <label>
        190
       </label>
       <element-citation id="sbref0950" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Heward
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Cullen
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Hobson
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbiology and antimicrobial susceptibility of otitis externa: a changing pattern of antimicrobial resistance
        </article-title>
        <source>
         J. Laryngol. Otol.
        </source>
        <year>
         2018
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         4
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0955">
       <label>
        191
       </label>
       <element-citation id="sbref0955" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nazareth
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Gonçalves-Pereira
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Tavares
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Miragaia
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           de Lencastre
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Silvestre
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Freitas
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Gonçalves
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Martins
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Mendes
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Tapadinhas
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Póvoa
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Community-associated methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         infection in Portugal
        </article-title>
        <source>
         Rev. Port. Pneumol.
        </source>
        <volume>
         18
        </volume>
        <year>
         2012
        </year>
        <fpage>
         34
        </fpage>
        <lpage>
         38
        </lpage>
        <pub-id pub-id-type="pmid">
         21802892
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0960">
       <label>
        192
       </label>
       <element-citation id="sbref0960" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yetkin
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Otlu
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Cicek
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Kuzucu
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Durmaz
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical, microbiologic, and epidemiologic characteristics of
         <italic>
          Pseudomonas aeruginosa
         </italic>
         infections in a University Hospital, Malatya, Turkey
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         34
        </volume>
        <year>
         2006
        </year>
        <fpage>
         188
        </fpage>
        <lpage>
         192
        </lpage>
        <pub-id pub-id-type="pmid">
         16679175
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0965">
       <label>
        193
       </label>
       <element-citation id="sbref0965" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ganime
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Leite
          </surname>
          <given-names>
           J.P.G.
          </given-names>
         </name>
         <name>
          <surname>
           Figueiredo
          </surname>
          <given-names>
           C.E.D.S.
          </given-names>
         </name>
         <name>
          <surname>
           Carvalho-Costa
          </surname>
          <given-names>
           F.A.
          </given-names>
         </name>
         <name>
          <surname>
           Melgaço
          </surname>
          <given-names>
           F.G.
          </given-names>
         </name>
         <name>
          <surname>
           Malta
          </surname>
          <given-names>
           F.C.
          </given-names>
         </name>
         <name>
          <surname>
           Fumian
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Miagostovich
          </surname>
          <given-names>
           M.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Dissemination of human adenoviruses and rotavirus species A on fomites of hospital pediatric units
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         44
        </volume>
        <year>
         2016
        </year>
        <fpage>
         1411
        </fpage>
        <lpage>
         1413
        </lpage>
        <pub-id pub-id-type="pmid">
         27217348
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0970">
       <label>
        194
       </label>
       <element-citation id="sbref0970" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ganime
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Carvalho-Costa
          </surname>
          <given-names>
           F.A.
          </given-names>
         </name>
         <name>
          <surname>
           Mendonça
          </surname>
          <given-names>
           M.C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Vieira
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Santos
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Costa Filho
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Miagostovich
          </surname>
          <given-names>
           M.P.
          </given-names>
         </name>
         <name>
          <surname>
           Leite
          </surname>
          <given-names>
           J.P.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Group A rotavirus detection on environmental surfaces in a hospital intensive care unit
        </article-title>
        <source>
         Am. J. Infect. Control
        </source>
        <volume>
         40
        </volume>
        <year>
         2012
        </year>
        <fpage>
         544
        </fpage>
        <lpage>
         547
        </lpage>
        <pub-id pub-id-type="pmid">
         22018841
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0975">
       <label>
        195
       </label>
       <element-citation id="sbref0975" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barker
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Bloomfield
          </surname>
          <given-names>
           S.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of
         <italic>
          Salmonella
         </italic>
         in bathrooms and toilets in domestic homes following salmonellosis
        </article-title>
        <source>
         J. Appl. Microbiol.
        </source>
        <volume>
         89
        </volume>
        <year>
         2000
        </year>
        <fpage>
         137
        </fpage>
        <lpage>
         144
        </lpage>
        <pub-id pub-id-type="pmid">
         10945790
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0980">
       <label>
        196
       </label>
       <element-citation id="sbref0980" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Da Fonseca
          </surname>
          <given-names>
           T.A.P.
          </given-names>
         </name>
         <name>
          <surname>
           Pessôa
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Felix
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Sanabani
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Diversity of bacterial communities on four frequently used surfaces in a large Brazilian teaching hospital
        </article-title>
        <source>
         Int. J. Environ. Res. Public Health
        </source>
        <volume>
         13
        </volume>
        <year>
         2016
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         11
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0985">
       <label>
        197
       </label>
       <element-citation id="sbref0985" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bhetwal
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Maharjan
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Khanal
          </surname>
          <given-names>
           P.R.
          </given-names>
         </name>
         <name>
          <surname>
           Parajuli
          </surname>
          <given-names>
           N.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Enteric fever caused by
         <italic>
          Salmonella enterica
         </italic>
         serovars with reduced susceptibility of fluoroquinolones at a community based teaching hospital of Nepal
        </article-title>
        <source>
         Int. J. Microbiol.
        </source>
        <volume>
         2017
        </volume>
        <year>
         2017
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0990">
       <label>
        198
       </label>
       <element-citation id="sbref0990" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rodríguez
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Valero
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Posada-Izquierdo
          </surname>
          <given-names>
           G.D.
          </given-names>
         </name>
         <name>
          <surname>
           Carrasco
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Zurera
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of food handler practices and microbiological status of ready-to-eat foods in long-term care facilities in the andalusia region of Spain
        </article-title>
        <source>
         J. Food Prot.
        </source>
        <volume>
         74
        </volume>
        <year>
         2011
        </year>
        <fpage>
         1504
        </fpage>
        <lpage>
         1512
        </lpage>
        <pub-id pub-id-type="pmid">
         21902920
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0995">
       <label>
        199
       </label>
       <element-citation id="sbref0995" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lawrence
          </surname>
          <given-names>
           K.R.
          </given-names>
         </name>
         <name>
          <surname>
           Golik
          </surname>
          <given-names>
           M.V.
          </given-names>
         </name>
         <name>
          <surname>
           Davidson
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant staphylococcus aureus skin and soft tissue infections
        </article-title>
        <source>
         Am. J. Ther.
        </source>
        <volume>
         16
        </volume>
        <year>
         2009
        </year>
        <fpage>
         333
        </fpage>
        <lpage>
         338
        </lpage>
        <pub-id pub-id-type="pmid">
         19617720
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib1000">
       <label>
        200
       </label>
       <element-citation id="sbref1000" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pham
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Asif
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Hamarshi
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Community-acquired Pneumonia with methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         in a patient admitted to the intensive care unit: a therapeutic challenge
        </article-title>
        <source>
         Cureus
        </source>
        <volume>
         10
        </volume>
        <year>
         2018
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         7
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib1005">
       <label>
        201
       </label>
       <element-citation id="sbref1005" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zakhour
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Chaftari
          </surname>
          <given-names>
           A.-M.
          </given-names>
         </name>
         <name>
          <surname>
           Raad
          </surname>
          <given-names>
           I.I.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies
        </article-title>
        <source>
         Lancet Infect. Dis.
        </source>
        <volume>
         16
        </volume>
        <year>
         2016
        </year>
        <fpage>
         e241
        </fpage>
        <lpage>
         e250
        </lpage>
        <pub-id pub-id-type="pmid">
         27788992
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
     <ack id="ack0005">
      <title>
       Acknowledgments
      </title>
      <p>
       The authors acknowledge the funding provided by
       <funding-source id="gs0005">
        Fundação para a Ciência e a Tecnologia
       </funding-source>
       (FCT - Portugal) through the scholarship SFRH/BD/130203/2017 (Micaela Machado Querido) and the project “
       <funding-source id="gs0010">
        B-SAFECOAT - Desenvolvimento de novas tintas com propriedades auto-desinfetantes
       </funding-source>
       ” (POCI-01-0247-FEDER-017875).
      </p>
     </ack>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Clin Infect Dis
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Clin. Infect. Dis
      </journal-id>
      <journal-id journal-id-type="hwp">
       cid
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       cid
      </journal-id>
      <journal-title-group>
       <journal-title>
        Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       1058-4838
      </issn>
      <issn pub-type="epub">
       1537-6591
      </issn>
      <publisher>
       <publisher-name>
        The University of Chicago Press
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       16142653
      </article-id>
      <article-id pub-id-type="pmc">
       7107832
      </article-id>
      <article-id pub-id-type="doi">
       10.1086/433186
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Electronic Articles
        </subject>
        <subj-group subj-group-type="category-toc-heading">
         <subject>
          Major Articles
         </subject>
        </subj-group>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Survival of Severe Acute Respiratory Syndrome Coronavirus
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Lai
         </surname>
         <given-names>
          Mary Y. Y.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Cheng
         </surname>
         <given-names>
          Peter K. C.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Lim
         </surname>
         <given-names>
          Wilina W. L.
         </given-names>
        </name>
        <xref ref-type="corresp" rid="cor1">
        </xref>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
        <!--<email>Wllim@pacific.net.hk</email>-->
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        1
       </label>
       <institution>
        Virology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health
       </institution>
       ,
       <addr-line>
        Hong Kong, China
       </addr-line>
      </aff>
      <author-notes>
       <corresp id="cor1">
        Reprints or correspondence: Dr. Wilina W. L. Lim, Virology Div., Rm. 901, Public Health Laboratory Centre, 382 Nam Cheong St., Shek Kip Mei, Kowloon, Hong Kong, China (
        <email>
         Wllim@pacific.net.hk
        </email>
        ).
       </corresp>
      </author-notes>
      <pub-date pub-type="ppub">
       <day>
        1
       </day>
       <month>
        10
       </month>
       <year>
        2005
       </year>
      </pub-date>
      <pub-date iso-8601-date="2005-10-01" pub-type="epub">
       <day>
        1
       </day>
       <month>
        10
       </month>
       <year>
        2005
       </year>
      </pub-date>
      <pub-date pub-type="pmc-release">
       <day>
        1
       </day>
       <month>
        10
       </month>
       <year>
        2005
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>
       41
      </volume>
      <issue>
       7
      </issue>
      <fpage>
       e67
      </fpage>
      <lpage>
       e71
      </lpage>
      <history>
       <date date-type="received">
        <day>
         18
        </day>
        <month>
         3
        </month>
        <year>
         2005
        </year>
       </date>
       <date date-type="accepted">
        <day>
         15
        </day>
        <month>
         6
        </month>
        <year>
         2005
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © 2005 by the Infectious Diseases Society of America
       </copyright-statement>
       <copyright-year>
        2005
       </copyright-year>
       <license>
        <license-p>
         This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
        </license-p>
       </license>
      </permissions>
      <self-uri xlink:href="41-7-e67.pdf">
      </self-uri>
      <abstract>
       <title>
        Abstract
       </title>
       <p>
        <bold>
         <italic>
          Background.
         </italic>
        </bold>
        The primary modes of transmission of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) appear to be direct mucus membrane contact with infectious droplets and through exposure to formites. Knowledge of the survival characteristics of the virus is essential for formulating appropriate infection-control measures.
       </p>
       <p>
        <bold>
         <italic>
          Methods.
         </italic>
        </bold>
        Survival of SARS-CoV strain GVU6109 was studied in stool and respiratory specimens. Survival of the virus on different environmental surfaces, including a laboratory request form, an impervious disposable gown, and a cotton nondisposable gown, was investigated. The virucidal effects of sodium hypochlorite, house detergent, and a peroxygen compound (Virkon S; Antec International) on the virus were also studied.
       </p>
       <p>
        <bold>
         <italic>
          Results.
         </italic>
        </bold>
        SARS-CoV GVU6109 can survive for 4 days in diarrheal stool samples with an alkaline pH, and it can remain infectious in respiratory specimens for &gt;7 days at room temperature. Even at a relatively high concentration (10
        <sup>
         4
        </sup>
        tissue culture infective doses/mL), the virus could not be recovered after drying of a paper request form, and its infectivity was shown to last longer on the disposable gown than on the cotton gown. All disinfectants tested were shown to be able to reduce the virus load by &gt;3 log within 5 min.
       </p>
       <p>
        <bold>
         <italic>
          Conclusions.
         </italic>
        </bold>
        Fecal and respiratory samples can remain infectious for a long period of time at room temperature. The risk of infection via contact with droplet-contaminated paper is small. Absorbent material, such as cotton, is preferred to nonabsorptive material for personal protective clothing for routine patient care where risk of large spillage is unlikely. The virus is easily inactivated by commonly used disinfectants.
       </p>
      </abstract>
     </article-meta>
    </front>
    <p>
     In the early spring of 2003, a mysterious outbreak of severe pneumonia occurred in southern China and rapidly spread throughout the world. The causative agent was later found to be a novel coronavirus and was designated “severe acute respiratory syndrome (SARS) coronavirus” (SARS-CoV) [
     <xref ref-type="bibr" rid="ref1">
      1–3
     </xref>
     ]. As of 31 December 2003, a total of 8096 cases had been reported, of which 774 were fatal [
     <xref ref-type="bibr" rid="ref4">
      4
     </xref>
     ]. Altogether, 1706 health care workers were affected. More than 20% of the patients with SARS were themselves health care workers, which could be explained by the unique shedding pattern of SARS-CoV, with viral loads reaching a peak ∼2 weeks after onset of disease, when patients were in hospital care [
     <xref ref-type="bibr" rid="ref5">
      5
     </xref>
     ]. This shedding pattern of SARS-CoV also highlights the importance of control of nosocomial spread of the disease.
    </p>
    <p>
     Soon after the isolation of SARS-CoV in our laboratory, we were able to perform a survival study of the virus, and partial results were reported on the World Health Organization Communicable Disease Surveillance and Response Web site on SARS [
     <xref ref-type="bibr" rid="ref6">
      6
     </xref>
     ]. Here, we provide a full report of our study of the survival characteristics of SARS-CoV in different clinical sample matrices, as well as on various environmental surfaces in the laboratory and hospital. The risk of acquisition of SARS-CoV attributed to the inanimate environment is also discussed. We also report the virucidal effect of 3 common liquid disinfectants on SARS-CoV.
    </p>
    <sec id="sec1" sec-type="materials|methods">
     <title>
      Materials and Methods
     </title>
     <p>
      <bold>
       <italic>
        Viruses and cell line.
       </italic>
      </bold>
      SARS-CoV strain GVU6109 was used in the present study. GVU6109 was isolated from a lung tissue specimen obtained from a patient during the SARS outbreak in 2003. The virus was inoculated into the Vero E6 cell line, which was grown in minimum essential medium (MEM) with 2% fetal calf serum at 37°C. All virus culture experiments were performed in a biosafety level 3 laboratory.
     </p>
     <p>
      <bold>
       <italic>
        Survival of SARS-CoV in different stool specimens.
       </italic>
      </bold>
      Four different stool samples were used. The samples tested negative for SARS-CoV, norovirus, rotavirus, and other viral agents. Stool sample A was a normal stool specimen obtained from a 6-month-old baby, and samples B and C were 2 normal stool specimens obtained from adults. Sample D was a diarrheal stool specimen obtained from an adult. A 10% suspension of each stool specimen was prepared in PBS (pH, 7.4). After centrifugation at 1500
      <italic>
       g
      </italic>
      for 20 min, the supernatant was collected, and the pH was checked with pH paper. Stool sample A had a pH of 6–7, sample B had a pH of 7–8, sample C had a pH of 8, and sample D had a pH of 9.
     </p>
     <p>
      A total of 1.8 mL of each 10% stool suspension was spiked with 0.2 mL of virus stock GVU6109 (10
      <sup>
       7
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL). As a control, 1.8 mL of viral transport medium was also spiked with 0.2 mL of the virus stock. The samples were incubated in closed containers at room temperature (20°C) for 0.5 h, 1 h, 3 h, 6 h, 1 day, 2 days, 4 days, 5 days, 6 days, and 7 days. Serial 10-fold dilutions of a different stool suspension and control were prepared in Earl's diluent. Fifty microliters of each dilution was inoculated into 4 wells of a 96-well plate. One hundred microliters of Vero E6 (10
      <sup>
       5
      </sup>
      cells/mL) was added to each well, and the plates were sealed and incubated at 37°C in 5% CO
      <sub>
       2
      </sub>
      for 4 days. Virus concentration (in TCID
      <sub>
       50
      </sub>
      /50 µL) for each stool suspension at a different time was calculated on the basis of the Kärber method [
      <xref ref-type="bibr" rid="ref7">
       7
      </xref>
      ]. The whole experiment was repeated using a trivalent poliovirus vaccine to compare the effect of pH on a nonenveloped RNA virus.
     </p>
     <p>
      <bold>
       <italic>
        Survival of SARS-CoV in different respiratory specimens.
       </italic>
      </bold>
      A total of 0.3 mL of virus stock GVU6109 (10
      <sup>
       7
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL) was added to 2.7 mL of a nasopharyngeal aspirate (NPA) specimen, throat and nasal swab (TNS) specimens, and viral transport medium as a control. The respiratory specimens had been determined to be negative for respiratory viruses. They were then incubated in closed containers at room temperature or 4°C for 3 h, 6 h, and 1, 3, 4, 5, 7, and 10 days. The virus concentration (TCID
      <sub>
       50
      </sub>
      /50µL) for each sample at various time points was determined as above.
     </p>
     <p>
      <bold>
       <italic>
        Survival of SARS-CoV on paper, impervious disposable gowns, and cotton nondisposable gowns.
       </italic>
      </bold>
      To simulate the event of large droplets that contain SARS-CoV falling on paper and on cotton and disposable gowns, experiments were performed to determine whether SARS-CoV survived on these surfaces.
     </p>
     <p>
      <bold>
       <italic>
        Paper.
       </italic>
      </bold>
      A paper laboratory request form was cut into small pieces (area, 1 × 1 cm), which were sterilized by autoclave at 121°C for 15 min. Stock virus GVU6109 (10
      <sup>
       7
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL) was serially diluted to 10
      <sup>
       4
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL with PBS. At each virus dilution, 5 µL was applied to the surface of each piece of sterilized paper. The sample was allowed to be absorbed at room temperature, and the paper pieces were left to stand for different durations (5 min, 1 h, 2 h, 3 h, 6 h, 1 day, and 2 days). Each piece of paper was then placed into a Vero E6 cell culture tube. For each virus dilution and at different intervals after absorption, 4 pieces of paper were inoculated into 4 cell culture tubes. All of the tubes were incubated at 37°C and were examined after 4 days. Sterilized paper without virus suspension was also included in the study to check for any toxicity to cell culture.
     </p>
     <p>
      <bold>
       <italic>
        Disposable gown.
       </italic>
      </bold>
      For the disposable gown, the whole process used for paper was repeated, except that a disposable gown was used after treatment by irradiating it under UV light for 1 h. The gown is part of the personal protection equipment used in our laboratory when handling specimens that are potentially contaminated with SARS-CoV. It is made of polypropylene material (35 g/m
      <sup>
       2
      </sup>
      ) coated with a polyethylene film (15 g/m
      <sup>
       2
      </sup>
      ), and the waist and neck are tied when the gown is used to provide full-body protection.
     </p>
     <p>
      <bold>
       <italic>
        Cotton gown.
       </italic>
      </bold>
      For testing of the cotton gown, a large piece of cloth cut from an ordinary cotton laboratory coat was soaked in distilled water overnight and was then boiled for 1 h. The whole process was repeated 3 times to remove chemical residue that was found to be toxic to the cell culture. After drying, the cloth was cut into small pieces (area, 1 × 1 cm). The pieces were then sterilized by autoclaving. The sterilized cotton cloth was then tested in the manner used for the paper and the disposable gown.
     </p>
     <p>
      <bold>
       <italic>
        Effect of different disinfectants and detergents on the survival of SARS-CoV.
       </italic>
      </bold>
      Different dilutions of sodium hypochlorite solution (1 : 50 and 1 : 100 of the stock solution, which contains 50,000 ppm of active chlorine); a household detergent containing sodium lauryl ether sulphate, alkyl polyglycosides, and coco-fatty acid diethanolamide (1 : 50 and 1 : 100; AXE brand); and Virkon S (1%; Antec International) were made by dilution with distilled water. Fifty microliters of stock virus GVU6109 (10
      <sup>
       7
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL) was added to 450 µL of different dilutions of the hypochlorite solution, household detergent, and Virkon S and to viral transport medium as a control. After standing at room temperature for 5 min, 10 min, 20 min, and 30 min, serial 10-fold dilutions of different disinfectants or controls were made in Earl's diluent. Fifty microliters of each virus dilution was added to each of 4 wells of a 96-well plate. A total of 50 µL of MEM was added to each well. After adding 100 µL of Vero E6 cells to each well, the plates were sealed and incubated at 37°C in a 5% CO
      <sub>
       2
      </sub>
      incubator. Cytopathic effect was recorded at day 4, and residual virus TCID
      <sub>
       50
      </sub>
      was calculated from wells without showing cell toxicity.
     </p>
    </sec>
    <sec id="sec2" sec-type="results">
     <title>
      Results
     </title>
     <p>
      <bold>
       <italic>
        Survival of SARS-CoV in different stool specimens.
       </italic>
      </bold>
      <xref ref-type="fig" rid="fig1">
       Figure 1
      </xref>
      shows the duration of SARS-CoV survival after incubation in stool specimens at different pHs. The virus was not recoverable within 1 day after incubation in normal adult stool specimens or within 3 h after incubation in the baby stool specimen with a slightly acidic pH. However, the virus survived for 4 days in a diarrheal stool specimen with a pH of 9. Poliovirus did not show these survival characteristics. Poliovirus spiked in the same baby stool specimen survived for &gt;4 days, and it survived for even longer in the diarrheal stool specimen (data not shown). The duration of survival for SARS-CoV in the stool suspension was retested in another 2 diarrheal stool specimens, with the same results (data not shown).
     </p>
     <fig id="fig1" orientation="portrait" position="float">
      <label>
       Figure 1
      </label>
      <caption>
       <p>
        Survival time of severe acute respiratory syndrome coronavirus in different stool specimens at room temperature. VTM, viral transport medium.
       </p>
      </caption>
      <graphic xlink:href="41-7-e67-fig001">
      </graphic>
     </fig>
     <p>
      <bold>
       <italic>
        Survival of SARS-CoV in different respiratory specimens.
       </italic>
      </bold>
      The virus can remain alive in respiratory specimens, such as NPA or TNS specimens, for &gt;7 days at room temperature and for &gt;20 days at 4°C (
      <xref ref-type="fig" rid="fig2">
       figure 2
      </xref>
      ).
     </p>
     <fig id="fig2" orientation="portrait" position="float">
      <label>
       Figure 2
      </label>
      <caption>
       <p>
        Survival time of severe acute respiratory syndrome coronavirus in nasopharyngeal aspirate (NPA) specimens, throat and nasal swab (TNS) specimens, or viral transport medium (VTM) at room temperature (RT) and at 4°C.
       </p>
      </caption>
      <graphic xlink:href="41-7-e67-fig002">
      </graphic>
     </fig>
     <p>
      <bold>
       <italic>
        Survival of SARS-CoV on paper, the impervious disposable gown, and the cotton nondisposable gown.
       </italic>
      </bold>
      <xref ref-type="fig" rid="tab1">
       Table 1
      </xref>
      shows the duration of survival for SARS-CoV on different materials. Even with a relatively high virus load in the droplet, rapid loss of infectivity was observed for paper and cotton material. Inactivation on impervious surface took much longer. No cell culture toxicity was observed for the paper, disposable gown, or cotton nondisposable gown.
     </p>
     <fig id="tab1" orientation="portrait" position="float">
      <label>
       Table 1
      </label>
      <caption>
       <p>
        Duration of survival of severe acute respiratory syndrome coronavirus (SARS-CoV) on paper, a disposable gown, and a cotton gown.
       </p>
      </caption>
      <graphic xlink:href="41-7-e67-tbl001">
      </graphic>
     </fig>
     <p>
      <bold>
       <italic>
        Effect of different disinfectants and detergents on SARS-CoV.
       </italic>
      </bold>
      After incubation with various disinfectants, a reduction in the virus load of &gt;3 log was taken to indicate inactivation (
      <xref ref-type="fig" rid="tab2">
       table 2
      </xref>
      ). All disinfectants reduced the virus load by &gt;3 log within 5 min after incubation. Cell toxicity was observed in wells inoculated with a virus/disinfectant mixture at a 1 : 10 dilution. Thus, when trying to calculate the residual TCID
      <sub>
       50
      </sub>
      , results from wells with dilutions starting from 1 : 100 were used.
     </p>
     <fig id="tab2" orientation="portrait" position="float">
      <label>
       Table 2
      </label>
      <caption>
       <p>
        Effect of disinfectants on severe acute respiratory syndrome coronavirus.
       </p>
      </caption>
      <graphic xlink:href="41-7-e67-tbl002">
      </graphic>
     </fig>
    </sec>
    <sec id="sec3" sec-type="discussion">
     <title>
      Discussion
     </title>
     <p>
      A recent study showed evidence that SARS-CoV has contaminated a variety of environmental surfaces in some hospital settings [
      <xref ref-type="bibr" rid="ref8">
       8
      </xref>
      ]. The presence of SARS-CoV on surfaces is always a concern, although few studies in which live virus has been successfully isolated from an environmental surface have been reported. Surfaces were usually contaminated with patient's droplets or by indirect transfer of virus from gloves that were contaminated with excreted virus. The increase in the isolation rate of methicillin-resistant
      <italic>
       Staphylococcus aureus
      </italic>
      at the intensive care unit of a Hong Kong hospital during the SARS outbreak suggested that increased cross-contamination could occur if gloves and gowns were worn all of the time [
      <xref ref-type="bibr" rid="ref9">
       9
      </xref>
      ]. It is important to gather evidence of the survival of SARS-CoV on surfaces so that appropriate infection-control measures can be taken.
     </p>
     <p>
      The present study demonstrates that SARS-CoV can survive in respiratory samples for 5 days at room temperature and for up to 3 weeks at 4°C. Although normal fecal material seems to have a deleterious effect on its survival, the present study shows that the virus could have a prolonged survival when present in diarrheal stool. The virus can survive for 4 days at room temperature after being spiked in diarrheal stool with an alkaline pH. This observation lends evidence that fecal droplets containing SARS-CoV remain infectious for a period of time. This may explain the Amoy Gardens outbreaks, in which the drainage and sewage system was implicated in facilitating the spread of SARS, as was pointed out in the SARS Expert Committee study [
      <xref ref-type="bibr" rid="ref10">
       10
      </xref>
      ] and in a simulation study by Yu et al. [
      <xref ref-type="bibr" rid="ref11">
       11
      </xref>
      ].
     </p>
     <p>
      On the basis of quantitative data obtained from our own study [
      <xref ref-type="bibr" rid="ref5">
       5
      </xref>
      ], stool samples contain a much higher viral load than do NPA samples. The mean virus concentration may reach 10
      <sup>
       5
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL at 2 weeks after onset of disease in stool samples, compared with 10
      <sup>
       2.2
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL for NPA samples. Our present data show that, at a high concentration of virus (10
      <sup>
       6
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL), SARS-CoV can survive for 4–5 days at room temperature in both respiratory and diarrheal stool samples. From the point of view of infection control of SARS, it is important to know that excreta from patients with SARS (especially those who have diarrhea) may remain highly infectious for a considerably long period, and appropriate precautions must be taken to prevent formation of aerosols, because of probable airborne transmission of SARS.
     </p>
     <p>
      During the SARS outbreak in 2003, contamination of paper documents was a concern for health care workers, who frequently had to handle such documents in their daily work. The present study simulates a situation in which large respiratory droplets (volume, 5 µL; radius, ∼1 mm) that contain the virus fall onto paper. Even with a higher concentration of virus (10
      <sup>
       4
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL) than would normally occur in NPA samples (10
      <sup>
       2.2
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL), no virus infectivity remained after the paper was dried. Paper contaminated with a higher concentration of virus (equivalent to that of fecal excreta [i.e., 10
      <sup>
       5
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL]) was not infectious after 3 h, and no viral infectivity was shown after 24 h, even with a concentration of 10
      <sup>
       6
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL. Our study shows that the risk of infection through contact with a droplet-contaminated paper is small. Standard infection-control measures, such as hand washing after touching any potential infectious material, are effective against nosocomial transmission of SARS [
      <xref ref-type="bibr" rid="ref12">
       12
      </xref>
      ].
     </p>
     <p>
      A previous study reported that coronavirus 229E and OC43 can survive for a few hours after drying on 3 different surfaces (aluminium, cotton gauze sponges, and latex gloves) [
      <xref ref-type="bibr" rid="ref13">
       13
      </xref>
      ]. In the present study, we compared the survival of SARS-CoV on 2 types of gowns: disposable gowns and cotton gowns. Our results showed that, even with a high concentration of virus (10
      <sup>
       5
      </sup>
      TCID
      <sub>
       50
      </sub>
      /mL), the droplets will lose all infectivity after 1 h on cloth, compared with 24 h needed for the disposable gown. Apparently, droplets will be absorbed more quickly on cotton material than on fluid-repellent material. The present data show that an ordinary cotton gown offers reasonable protection against small droplets containing SARS-CoV. Our study also raises the possibility that any droplets that hang on a nonabsorbent disposable gown may pose a risk of contaminating the environment when health care workers wear the gown all of the time or when they try to remove the gown. A similar conclusion may also be drawn for gloves, although gloves were not tested in the present study. A specially designed disposable garment with a fluid-repellent lamination that has an outer fluid-absorbing sheet may offer better protection for the personnel.
     </p>
     <p>
      Finally, our study shows that 3 common liquid detergents/disinfectants are equally effective against the SARS-CoV. All demonstrated a minimum 10
      <sup>
       3
      </sup>
      -fold reduction in the initial virus titer within 5 min after incubation in solution [
      <xref ref-type="bibr" rid="ref14">
       14
      </xref>
      ]. The household detergents tested in this study were shown to be effective against the SARS-CoV with a lipid envelope and could be used for cleaning common items and surfaces that are not grossly contaminated with secretions or excreta.
     </p>
     <p>
      Although we did not perform specific neutralizing steps for the 3 detergents/disinfectants, the fact that the wells that we examined to calculate the residual virus TCID
      <sub>
       50
      </sub>
      were free of cell toxicity highly suggests that nonneutralized disinfectants also have no effect on the virus during the 4 days of incubation.
     </p>
     <p>
      The SARS-CoV is a newly discovered virus. Thus far, there have only been a few reports of its survival characteristics [
      <xref ref-type="bibr" rid="ref15">
       15
      </xref>
      ]. Here, we demonstrate that this deadly virus can remain infectious for a long period in stool specimens. The samples that we spiked with SARS-CoV were incubated in closed containers during the entire period of incubation, simulating the conditions in a sewage drainage pipe. Thus, our results showed that, in this situation, droplets may be a concern with regard to disease transmission, as occurred in the Amoy Gardens outbreaks. This has significant implications for sewage treatment in both domestic and hospital environments. Fortunately, this virus is also susceptible to drying. We showed that, when virus-containing droplets were dried, the virus was inactivated rapidly on paper and cotton cloth. Transmission through droplet-contaminated paper and cotton gowns is unlikely, and common household detergents can be effective decontaminating agents for use in the laboratory and hospital.
     </p>
    </sec>
    <back>
     <ack>
      <title>
       Acknowledgments
      </title>
      <p>
       <bold>
        <italic>
         Potential conflicts of interest.
        </italic>
       </bold>
       All authors: no conflicts.
      </p>
     </ack>
     <ref-list>
      <title>
       References
      </title>
      <ref id="ref1">
       <label>
        1
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Gunther
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Identification of a novel coronavirus in patients with severe acute respiratory syndrome
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1967
        </fpage>
        <lpage>
         76
        </lpage>
        <pub-id pub-id-type="pmid">
         12690091
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref2">
       <label>
        2
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           ST
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Coronavirus as a possible cause of severe acute respiratory syndrome. SARS study group
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1319
        </fpage>
        <lpage>
         25
        </lpage>
        <pub-id pub-id-type="pmid">
         12711465
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref3">
       <label>
        3
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ksiazek
          </surname>
          <given-names>
           TG
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Goldsmith
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A novel coronavirus associated with severe acute respiratory syndrome. SARS Working Group
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1953
        </fpage>
        <lpage>
         66
        </lpage>
        <pub-id pub-id-type="pmid">
         12690092
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref4">
       <label>
        4
       </label>
       <element-citation publication-type="book">
        <collab>
         World Health Organization
        </collab>
        <source>
         Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003
        </source>
        <year>
         2005
        </year>
        <comment>
         Available at:
         <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/country/table2004_04_21/en/">
          http://www.who.int/csr/sars/country/table2004_04_21/en/
         </ext-link>
         . Accessed 12 August 2005
        </comment>
       </element-citation>
      </ref>
      <ref id="ref5">
       <label>
        5
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           PK
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           DA
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           LK
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2004
        </year>
        <volume>
         363
        </volume>
        <fpage>
         1699
        </fpage>
        <lpage>
         700
        </lpage>
        <pub-id pub-id-type="pmid">
         15158632
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref6">
       <label>
        6
       </label>
       <element-citation publication-type="book">
        <collab>
         World Health Organization
        </collab>
        <source>
         First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network
        </source>
        <comment>
         Available at:
         <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/survival_2003_05-04/en/">
          http://www.who.int/csr/sars/survival_2003_05-04/en/
         </ext-link>
         . Accessed 22 December 2004
        </comment>
       </element-citation>
      </ref>
      <ref id="ref7">
       <label>
        7
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="editor">
         <name>
          <surname>
           Schmidt
          </surname>
          <given-names>
           NJ
          </given-names>
         </name>
         <name>
          <surname>
           Emmons
          </surname>
          <given-names>
           RW
          </given-names>
         </name>
        </person-group>
        <source>
         Diagnostic procedures for viral, rickettsial and chlamydial infections
        </source>
        <year>
         1989
        </year>
        <edition>
         6th ed.
        </edition>
        <publisher-loc>
         Washington, DC
        </publisher-loc>
        <publisher-name>
         American Public Health Association
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="ref8">
       <label>
        8
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dowell
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           DD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus on hospital surfaces
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2004
        </year>
        <volume>
         39
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         15356778
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref9">
       <label>
        9
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yap
          </surname>
          <given-names>
           FHY
          </given-names>
         </name>
         <name>
          <surname>
           Gomersall
          </surname>
          <given-names>
           CD
          </given-names>
         </name>
         <name>
          <surname>
           Fung
          </surname>
          <given-names>
           KSC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Increase in methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2004
        </year>
        <volume>
         39
        </volume>
        <fpage>
         511
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         15356814
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref10">
       <label>
        10
       </label>
       <element-citation publication-type="book">
        <collab>
         SARS Expert Committee
        </collab>
        <source>
         SARS in Hong Kong: from experience to action. Report of the SARS Expert Committee
        </source>
        <year>
         2003
        </year>
        <publisher-loc>
         Hong Kong
        </publisher-loc>
        <publisher-name>
         Health, Welfare, and Food Bureau, Hong Kong Government
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="ref11">
       <label>
        11
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           ITS
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           TW
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evidence of airborne transmission of the severe acute respiratory syndrome virus
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2004
        </year>
        <volume>
         350
        </volume>
        <fpage>
         1731
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="pmid">
         15102999
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref12">
       <label>
        12
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           WH
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           RWH
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Advisors of Expert SARS group of Hospital Authority
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1519
        </fpage>
        <lpage>
         20
        </lpage>
        <pub-id pub-id-type="pmid">
         12737864
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref13">
       <label>
        13
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           MWN
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           PJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of human coronavirus 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2000
        </year>
        <volume>
         46
        </volume>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="pmid">
         11023724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref14">
       <label>
        14
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Russell
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
         <name>
          <surname>
           Hugo
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         <name>
          <surname>
           Ayliffe
          </surname>
          <given-names>
           GAJ
          </given-names>
         </name>
        </person-group>
        <source>
         Principles and practice of disinfection, preservation and sterilization
        </source>
        <year>
         1992
        </year>
        <edition>
         2nd ed.
        </edition>
        <publisher-loc>
         Oxford, UK
        </publisher-loc>
        <publisher-name>
         Blackwell Scientific Publications
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="ref15">
       <label>
        15
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           HF
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Bauer
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           HW
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability and inactivation of SARS coronavirus
        </article-title>
        <source>
         Med Microbiol Immunol (Berl)
        </source>
        <year>
         2005
        </year>
        <volume>
         194
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         15118911
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Viruses
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Viruses
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       viruses
      </journal-id>
      <journal-title-group>
       <journal-title>
        Viruses
       </journal-title>
      </journal-title-group>
      <issn pub-type="epub">
       1999-4915
      </issn>
      <publisher>
       <publisher-name>
        MDPI
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       23202515
      </article-id>
      <article-id pub-id-type="pmc">
       3509683
      </article-id>
      <article-id pub-id-type="doi">
       10.3390/v4113044
      </article-id>
      <article-id pub-id-type="publisher-id">
       viruses-04-03044
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Review
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Geller
         </surname>
         <given-names>
          Chloé
         </given-names>
        </name>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Varbanov
         </surname>
         <given-names>
          Mihayl
         </given-names>
        </name>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Duval
         </surname>
         <given-names>
          Raphaël E.
         </given-names>
        </name>
        <xref ref-type="corresp" rid="c1-viruses-04-03044">
         *
        </xref>
       </contrib>
      </contrib-group>
      <aff id="af1-viruses-04-03044">
       UMR 7565, SRSMC, Université de Lorraine – CNRS, Faculty of Pharmacy, 5 rue Albert Lebrun, BP 80403, 54001 Nancy Cedex, FRANCE; Email:
       <email>
        chloe.geller@univ-lorraine.fr
       </email>
       (C.G.);
       <email>
        mihayl.varbanov@univ-lorraine.fr
       </email>
       (M.V.)
      </aff>
      <author-notes>
       <corresp id="c1-viruses-04-03044">
        <label>
         *
        </label>
        Author to whom correspondence should be addressed; Email:
        <email>
         raphael.duval@univ-lorraine.fr
        </email>
        ; Tel.: +33-3-83-68-23-36; Fax: +33-3-83-68-23-01.
       </corresp>
      </author-notes>
      <pub-date pub-type="epub">
       <day>
        12
       </day>
       <month>
        11
       </month>
       <year>
        2012
       </year>
      </pub-date>
      <pub-date pub-type="collection">
       <month>
        11
       </month>
       <year>
        2012
       </year>
      </pub-date>
      <volume>
       4
      </volume>
      <issue>
       11
      </issue>
      <fpage>
       3044
      </fpage>
      <lpage>
       3068
      </lpage>
      <history>
       <date date-type="received">
        <day>
         05
        </day>
        <month>
         10
        </month>
        <year>
         2012
        </year>
       </date>
       <date date-type="rev-recd">
        <day>
         31
        </day>
        <month>
         10
        </month>
        <year>
         2012
        </year>
       </date>
       <date date-type="accepted">
        <day>
         02
        </day>
        <month>
         11
        </month>
        <year>
         2012
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © 2012 by the authors; licensee MDPI, Basel, Switzerland.
       </copyright-statement>
       <copyright-year>
        2012
       </copyright-year>
       <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
        <license-p>
         <!--CREATIVE COMMONS-->
         This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (
         <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          http://creativecommons.org/licenses/by/3.0/
         </ext-link>
         ).
        </license-p>
       </license>
      </permissions>
      <abstract>
       <p>
        The
        <italic>
         Coronaviridae
        </italic>
        family, an enveloped RNA virus family, and, more particularly, human coronaviruses (HCoV), were historically known to be responsible for a large portion of common colds and other upper respiratory tract infections. HCoV are now known to be involved in more serious respiratory diseases, i.e. bronchitis, bronchiolitis or pneumonia, especially in young children and neonates, elderly people and immunosuppressed patients. They have also been involved in nosocomial viral infections. In 2002–2003, the outbreak of severe acute respiratory syndrome (SARS), due to a newly discovered coronavirus, the SARS-associated coronavirus (SARS-CoV); led to a new awareness of the medical importance of the
        <italic>
         Coronaviridae
        </italic>
        family. This pathogen, responsible for an emerging disease in humans, with high risk of fatal outcome; underline the pressing need for new approaches to the management of the infection, and primarily to its prevention. Another interesting feature of coronaviruses is their potential environmental resistance, despite the accepted fragility of enveloped viruses. Indeed, several studies have described the ability of HCoVs (i.e. HCoV 229E, HCoV OC43 (also known as betacoronavirus 1), NL63, HKU1 or SARS-CoV) to survive in different environmental conditions (e.g. temperature and humidity), on different supports found in hospital settings such as aluminum, sterile sponges or latex surgical gloves or in biological fluids. Finally, taking into account the persisting lack of specific antiviral treatments (there is, in fact, no specific treatment available to fight coronaviruses infections), the
        <italic>
         Coronaviridae
        </italic>
        specificities (i.e. pathogenicity, potential environmental resistance) make them a challenging model for the development of efficient means of prevention, as an adapted antisepsis-disinfection, to prevent the environmental spread of such infective agents. This review will summarize current knowledge on the capacity of human coronaviruses to survive in the environment and the efficacy of well-known antiseptic-disinfectants against them, with particular focus on the development of new methodologies to evaluate the activity of new antiseptic-disinfectants on viruses.
       </p>
      </abstract>
      <kwd-group>
       <kwd>
        human coronaviruses
       </kwd>
       <kwd>
        environmental survival
       </kwd>
       <kwd>
        antiseptics-disinfectants
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <sec>
     <title>
      1. Introduction
     </title>
     <p>
      The worldwide epidemic of SARS (Severe Acute Respiratory Syndrome) in 2002–2003, due to a newly discovered coronavirus, the SARS-CoV (SARS-associated coronavirus), reinforced the interest into the
      <italic>
       Coronaviridae
      </italic>
      family. Human coronaviruses 229E and OC43 (HCoV 229E and OC43) were previously already known to be responsible for mild and upper respiratory tract diseases. Since then, two further members of this family have been identified (HCoV HUK1 and NL63) and HCoVs have been involved in more serious respiratory tract infections. Moreover, these viruses show an environmental resistance that increases their probability of transfer between contaminated hosts
      <italic>
       via
      </italic>
      surfaces, hands,
      <italic>
       etc
      </italic>
      . This resistance leads to the urgent need for development of efficient and targeted modes of prevention. As no treatment or vaccines are available to cure HCoVs infections, it is fundamental to dispose of adapted antiseptics-disinfectants, whose efficiency should be rigorously evaluated.
     </p>
    </sec>
    <sec>
     <title>
      2. Epidemiology and Impact of Coronaviruses in Human Health
     </title>
     <sec>
      <title>
       2.1. Human Coronaviruses Except SARS-CoV
      </title>
      <sec>
       <title>
        2.1.1. Respiratory Diseases
       </title>
       <p>
        The HCoV 229E and the HCoV OC43, now called betacoronavirus 1 [
        <xref ref-type="bibr" rid="B1-viruses-04-03044">
         1
        </xref>
        ], were the first human coronaviruses to be identified. Since the late sixties, they were recognized as being responsible for upper and mild respiratory tract infections such as the common cold [
        <xref ref-type="bibr" rid="B2-viruses-04-03044">
         2
        </xref>
        ,
        <xref ref-type="bibr" rid="B3-viruses-04-03044">
         3
        </xref>
        ,
        <xref ref-type="bibr" rid="B4-viruses-04-03044">
         4
        </xref>
        ,
        <xref ref-type="bibr" rid="B5-viruses-04-03044">
         5
        </xref>
        ,
        <xref ref-type="bibr" rid="B6-viruses-04-03044">
         6
        </xref>
        ].
       </p>
       <p>
        Following the identification of new members of coronaviruses that infect humans, the NL63 in 2004 [
        <xref ref-type="bibr" rid="B7-viruses-04-03044">
         7
        </xref>
        ,
        <xref ref-type="bibr" rid="B8-viruses-04-03044">
         8
        </xref>
        ,
        <xref ref-type="bibr" rid="B9-viruses-04-03044">
         9
        </xref>
        ] and the HKU1 in 2005 [
        <xref ref-type="bibr" rid="B10-viruses-04-03044">
         10
        </xref>
        ] and, of course, the SARS-CoV in 2003 [
        <xref ref-type="bibr" rid="B11-viruses-04-03044">
         11
        </xref>
        ,
        <xref ref-type="bibr" rid="B12-viruses-04-03044">
         12
        </xref>
        ,
        <xref ref-type="bibr" rid="B13-viruses-04-03044">
         13
        </xref>
        ,
        <xref ref-type="bibr" rid="B14-viruses-04-03044">
         14
        </xref>
        ], new studies have been conducted on the clinical features of HCoVs infections. Indeed, before 2003, very few studies and routine monitoring dealt with the role of coronaviruses in humans. Thus, epidemiological data were rare and it is likely that, as a result, the precise role that HCoVs played in respiratory tract infections was greatly underestimated.
       </p>
       <p>
        It is important to note that these viruses have been identified worldwide [
        <xref ref-type="bibr" rid="B15-viruses-04-03044">
         15
        </xref>
        ,
        <xref ref-type="bibr" rid="B16-viruses-04-03044">
         16
        </xref>
        ,
        <xref ref-type="bibr" rid="B17-viruses-04-03044">
         17
        </xref>
        ,
        <xref ref-type="bibr" rid="B18-viruses-04-03044">
         18
        </xref>
        ,
        <xref ref-type="bibr" rid="B19-viruses-04-03044">
         19
        </xref>
        ,
        <xref ref-type="bibr" rid="B20-viruses-04-03044">
         20
        </xref>
        ,
        <xref ref-type="bibr" rid="B21-viruses-04-03044">
         21
        </xref>
        ,
        <xref ref-type="bibr" rid="B22-viruses-04-03044">
         22
        </xref>
        ]. Human coronavirus infections occur mainly in winter, with a short incubation time [
        <xref ref-type="bibr" rid="B19-viruses-04-03044">
         19
        </xref>
        ,
        <xref ref-type="bibr" rid="B23-viruses-04-03044">
         23
        </xref>
        ,
        <xref ref-type="bibr" rid="B24-viruses-04-03044">
         24
        </xref>
        ]. They are recovered in 3 to 11% of patients sampled with a respiratory tract infection, depending on the studied population and the HCoV strain [
        <xref ref-type="bibr" rid="B19-viruses-04-03044">
         19
        </xref>
        ,
        <xref ref-type="bibr" rid="B21-viruses-04-03044">
         21
        </xref>
        ,
        <xref ref-type="bibr" rid="B23-viruses-04-03044">
         23
        </xref>
        ,
        <xref ref-type="bibr" rid="B24-viruses-04-03044">
         24
        </xref>
        ,
        <xref ref-type="bibr" rid="B25-viruses-04-03044">
         25
        </xref>
        ]. Coronaviruses occupy the fourth or fifth place, behind influenzaviruses, respiratory syncytial virus, adenoviruses and rhinoviruses and their proportion is generally equivalent to the ones of metapneumovirus and parainfluenzaviruses [
        <xref ref-type="bibr" rid="B23-viruses-04-03044">
         23
        </xref>
        ,
        <xref ref-type="bibr" rid="B24-viruses-04-03044">
         24
        </xref>
        ].
       </p>
       <p>
        They have since been implicated in more serious diseases of the lower respiratory tract as bronchitis, bronchiolitis or pneumonia [
        <xref ref-type="bibr" rid="B10-viruses-04-03044">
         10
        </xref>
        ,
        <xref ref-type="bibr" rid="B26-viruses-04-03044">
         26
        </xref>
        ,
        <xref ref-type="bibr" rid="B27-viruses-04-03044">
         27
        </xref>
        ,
        <xref ref-type="bibr" rid="B28-viruses-04-03044">
         28
        </xref>
        ,
        <xref ref-type="bibr" rid="B29-viruses-04-03044">
         29
        </xref>
        ,
        <xref ref-type="bibr" rid="B30-viruses-04-03044">
         30
        </xref>
        ,
        <xref ref-type="bibr" rid="B31-viruses-04-03044">
         31
        </xref>
        ] or croup in the case of the HCoV NL63 [
        <xref ref-type="bibr" rid="B18-viruses-04-03044">
         18
        </xref>
        ,
        <xref ref-type="bibr" rid="B30-viruses-04-03044">
         30
        </xref>
        ]. These infections concern predominantly weak patients such as newborns or infants [
        <xref ref-type="bibr" rid="B23-viruses-04-03044">
         23
        </xref>
        ,
        <xref ref-type="bibr" rid="B24-viruses-04-03044">
         24
        </xref>
        ,
        <xref ref-type="bibr" rid="B26-viruses-04-03044">
         26
        </xref>
        ,
        <xref ref-type="bibr" rid="B30-viruses-04-03044">
         30
        </xref>
        ,
        <xref ref-type="bibr" rid="B32-viruses-04-03044">
         32
        </xref>
        ,
        <xref ref-type="bibr" rid="B33-viruses-04-03044">
         33
        </xref>
        ], elderly people [
        <xref ref-type="bibr" rid="B34-viruses-04-03044">
         34
        </xref>
        ,
        <xref ref-type="bibr" rid="B35-viruses-04-03044">
         35
        </xref>
        ] or immunosuppressed patients [
        <xref ref-type="bibr" rid="B23-viruses-04-03044">
         23
        </xref>
        ,
        <xref ref-type="bibr" rid="B36-viruses-04-03044">
         36
        </xref>
        ,
        <xref ref-type="bibr" rid="B37-viruses-04-03044">
         37
        </xref>
        ]. They have also been implicated in nosocomial infections notably in neonatal care unit [
        <xref ref-type="bibr" rid="B32-viruses-04-03044">
         32
        </xref>
        ,
        <xref ref-type="bibr" rid="B33-viruses-04-03044">
         33
        </xref>
        ].
       </p>
      </sec>
      <sec>
       <title>
        2.1.2. Involvement of Coronaviruses in Other Human Diseases
       </title>
       <p>
        HCoVs are suspected to cause digestive dysfunctions. First, they have been associated with necrotizing enterocolitis in newborns [
        <xref ref-type="bibr" rid="B38-viruses-04-03044">
         38
        </xref>
        ], and diarrhea or other gastrointestinal symptoms have been shown to accompany coronavirus infections [
        <xref ref-type="bibr" rid="B17-viruses-04-03044">
         17
        </xref>
        ,
        <xref ref-type="bibr" rid="B24-viruses-04-03044">
         24
        </xref>
        ,
        <xref ref-type="bibr" rid="B27-viruses-04-03044">
         27
        </xref>
        ,
        <xref ref-type="bibr" rid="B30-viruses-04-03044">
         30
        </xref>
        ,
        <xref ref-type="bibr" rid="B39-viruses-04-03044">
         39
        </xref>
        ]. Then, other findings such as the detection of viral particles and coronavirus RNA in stool samples [
        <xref ref-type="bibr" rid="B39-viruses-04-03044">
         39
        </xref>
        ,
        <xref ref-type="bibr" rid="B40-viruses-04-03044">
         40
        </xref>
        ], or the presence of HCoV OC43 antibodies in children with gastroenteritis, support this idea. However, despite these arguments, their implication in human intestinal infections is still controversial but should be considered to evaluate the potential routes of HCoVs spread.
       </p>
       <p>
        Another debate is the potential involvement of HCoVs in central nervous system diseases such as multiple sclerosis. This is supported by a body of evidence, e.g. neurological symptoms in some HCoV OC43 infected patients [
        <xref ref-type="bibr" rid="B29-viruses-04-03044">
         29
        </xref>
        ], experimental infection of neural cells with HCoV 229E and OC43 [
        <xref ref-type="bibr" rid="B41-viruses-04-03044">
         41
        </xref>
        ,
        <xref ref-type="bibr" rid="B42-viruses-04-03044">
         42
        </xref>
        ,
        <xref ref-type="bibr" rid="B43-viruses-04-03044">
         43
        </xref>
        ], detection of HCoV 229E and OC43 RNAs and antigens in brain of multiple sclerosis patients [
        <xref ref-type="bibr" rid="B44-viruses-04-03044">
         44
        </xref>
        ,
        <xref ref-type="bibr" rid="B45-viruses-04-03044">
         45
        </xref>
        ,
        <xref ref-type="bibr" rid="B46-viruses-04-03044">
         46
        </xref>
        ], or, more recently, neuroinvasive properties of HCoV OC43 after intranasal inoculation in mice [
        <xref ref-type="bibr" rid="B47-viruses-04-03044">
         47
        </xref>
        ]. However, the precise and real implication of HCoVs in neural diseases has not yet been clearly demonstrated.
       </p>
       <p>
        Furthermore, some studies reported also some heart troubles associated with HCoVs infections [
        <xref ref-type="bibr" rid="B29-viruses-04-03044">
         29
        </xref>
        ,
        <xref ref-type="bibr" rid="B48-viruses-04-03044">
         48
        </xref>
        ].
       </p>
      </sec>
     </sec>
     <sec>
      <title>
       2.2. A Highly Pathogenic Coronavirus: the SARS-Associated Coronavirus
      </title>
      <p>
       The epidemic outbreak due to the SARS-CoV was the first worldwide epidemic of the 21st century. It began in Guangdong province of China in November 2002 and spread all over the world within just a few months. This new coronavirus was quickly identified thanks to a concerted international effort [
       <xref ref-type="bibr" rid="B12-viruses-04-03044">
        12
       </xref>
       ,
       <xref ref-type="bibr" rid="B13-viruses-04-03044">
        13
       </xref>
       ,
       <xref ref-type="bibr" rid="B14-viruses-04-03044">
        14
       </xref>
       ,
       <xref ref-type="bibr" rid="B49-viruses-04-03044">
        49
       </xref>
       ,
       <xref ref-type="bibr" rid="B50-viruses-04-03044">
        50
       </xref>
       ].
      </p>
      <p>
       From November 2002 to July 2003, SARS-CoV affected more than 8000 people in all five continents and caused about 800 deaths [
       <xref ref-type="bibr" rid="B51-viruses-04-03044">
        51
       </xref>
       ]. One of the striking features of this epidemic was its nosocomial propagation and the heavy burden of the health care workers [
       <xref ref-type="bibr" rid="B49-viruses-04-03044">
        49
       </xref>
       ,
       <xref ref-type="bibr" rid="B52-viruses-04-03044">
        52
       </xref>
       ,
       <xref ref-type="bibr" rid="B53-viruses-04-03044">
        53
       </xref>
       ,
       <xref ref-type="bibr" rid="B54-viruses-04-03044">
        54
       </xref>
       ]. Moreover, the mortality rate was higher than 50% in aged (&gt;60-year-old) populations [
       <xref ref-type="bibr" rid="B55-viruses-04-03044">
        55
       </xref>
       ,
       <xref ref-type="bibr" rid="B56-viruses-04-03044">
        56
       </xref>
       ,
       <xref ref-type="bibr" rid="B57-viruses-04-03044">
        57
       </xref>
       ].
      </p>
      <p>
       SARS-CoV infection in humans typically causes an influenza-like syndrome such as malaise, rigors, tiredness and high fevers. In one-third of the infected patients, the clinical symptoms regress and patients recover, with, for some of them, persistent pulmonary lesions. In the remaining two-thirds of the infected patients, the disease progresses to an atypical pneumonia. Respiratory insufficiency leading to respiratory failure is the most common cause of death among those infected with SARS-CoV [
       <xref ref-type="bibr" rid="B52-viruses-04-03044">
        52
       </xref>
       ,
       <xref ref-type="bibr" rid="B54-viruses-04-03044">
        54
       </xref>
       ,
       <xref ref-type="bibr" rid="B58-viruses-04-03044">
        58
       </xref>
       ,
       <xref ref-type="bibr" rid="B59-viruses-04-03044">
        59
       </xref>
       ]. Many of these patients also develop watery diarrhea with active virus shedding (until several weeks), which might increase the transmissibility of the virus and add another evidence of gastrointestinal tropism of HCoVs [
       <xref ref-type="bibr" rid="B57-viruses-04-03044">
        57
       </xref>
       ]. Moreover, the SARS-CoV receptor, the angiotensin-converting enzyme 2 ACE-2, is present in lungs but also in the gastrointestinal tract [
       <xref ref-type="bibr" rid="B60-viruses-04-03044">
        60
       </xref>
       ,
       <xref ref-type="bibr" rid="B61-viruses-04-03044">
        61
       </xref>
       ].
      </p>
      <p>
       SARS-CoV seemed predominantly transmitted by respiratory droplets over a relatively close distance [
       <xref ref-type="bibr" rid="B62-viruses-04-03044">
        62
       </xref>
       ]. However, direct and indirect contact with respiratory secretions, feces or animal vectors could also lead to transmission, at least under some circumstances [
       <xref ref-type="bibr" rid="B59-viruses-04-03044">
        59
       </xref>
       ,
       <xref ref-type="bibr" rid="B63-viruses-04-03044">
        63
       </xref>
       ].
      </p>
     </sec>
     <sec>
      <title>
       2.3. Evolutionary Ability of Coronaviruses
      </title>
      <p>
       Besides these pathogenic properties, coronaviruses represent another risk for human population through their interspecies jumping capacity. This is suspected for the HCoV OC43 that may have evolved from the bovine coronavirus, which is responsible for gastrointestinal infections in cattle [
       <xref ref-type="bibr" rid="B64-viruses-04-03044">
        64
       </xref>
       ]. Similarly, the SARS-CoV is a zoonotic virus that crossed the species barrier. Phylogenetic analysis of SARS-CoV isolates from animals and humans strongly suggest that the virus originated from animals, most likely bats [
       <xref ref-type="bibr" rid="B65-viruses-04-03044">
        65
       </xref>
       ,
       <xref ref-type="bibr" rid="B66-viruses-04-03044">
        66
       </xref>
       ,
       <xref ref-type="bibr" rid="B67-viruses-04-03044">
        67
       </xref>
       ,
       <xref ref-type="bibr" rid="B68-viruses-04-03044">
        68
       </xref>
       ], was amplified in palm civets, and transmitted to human population
       <italic>
        via
       </italic>
       live animal markets [
       <xref ref-type="bibr" rid="B69-viruses-04-03044">
        69
       </xref>
       ].
      </p>
      <p>
       This potency of coronaviruses may be responsible for new disastrous outbreaks and therefore should be kept in mind.
      </p>
     </sec>
     <sec>
      <title>
       2.4. Vaccines and Therapy
      </title>
      <p>
       No treatment or vaccine is available to fight HCoVs infections. In the case of SARS-CoV, various approaches were used during the epidemic, but none was really successful and targeted. Treatment was essentially empiric and symptomatic and depended upon the severity of the illness.
      </p>
      <p>
       Since then, studies have been conducted to identify potent anti-SARS-CoV treatment. Standard molecules used in viral infections such as ribavirine, interferon or hydrocortisone, were used, leading to diverging, and not so conclusive, results as they were tested
       <italic>
        in vivo
       </italic>
       or
       <italic>
        in vitro
       </italic>
       [
       <xref ref-type="bibr" rid="B57-viruses-04-03044">
        57
       </xref>
       ,
       <xref ref-type="bibr" rid="B70-viruses-04-03044">
        70
       </xref>
       ,
       <xref ref-type="bibr" rid="B71-viruses-04-03044">
        71
       </xref>
       ,
       <xref ref-type="bibr" rid="B72-viruses-04-03044">
        72
       </xref>
       ,
       <xref ref-type="bibr" rid="B73-viruses-04-03044">
        73
       </xref>
       ]. Development of strategies with monoclonal antibodies, siRNAs or molecules such as glycyrrhizin or nelfinavir, have been conducted
       <italic>
        in vitro
       </italic>
       but still need to be improved [
       <xref ref-type="bibr" rid="B71-viruses-04-03044">
        71
       </xref>
       ,
       <xref ref-type="bibr" rid="B74-viruses-04-03044">
        74
       </xref>
       ,
       <xref ref-type="bibr" rid="B75-viruses-04-03044">
        75
       </xref>
       ,
       <xref ref-type="bibr" rid="B76-viruses-04-03044">
        76
       </xref>
       ].
      </p>
      <p>
       The emergence of the SARS-CoV has also led to the development of new vaccine strategies, including expression of SARS-CoV spike protein in other viruses [
       <xref ref-type="bibr" rid="B77-viruses-04-03044">
        77
       </xref>
       ,
       <xref ref-type="bibr" rid="B78-viruses-04-03044">
        78
       </xref>
       ,
       <xref ref-type="bibr" rid="B79-viruses-04-03044">
        79
       </xref>
       ,
       <xref ref-type="bibr" rid="B80-viruses-04-03044">
        80
       </xref>
       ,
       <xref ref-type="bibr" rid="B81-viruses-04-03044">
        81
       </xref>
       ,
       <xref ref-type="bibr" rid="B82-viruses-04-03044">
        82
       </xref>
       ,
       <xref ref-type="bibr" rid="B83-viruses-04-03044">
        83
       </xref>
       ,
       <xref ref-type="bibr" rid="B84-viruses-04-03044">
        84
       </xref>
       ,
       <xref ref-type="bibr" rid="B85-viruses-04-03044">
        85
       </xref>
       ], inactivated SARS-CoV particles [
       <xref ref-type="bibr" rid="B82-viruses-04-03044">
        82
       </xref>
       ,
       <xref ref-type="bibr" rid="B86-viruses-04-03044">
        86
       </xref>
       ,
       <xref ref-type="bibr" rid="B87-viruses-04-03044">
        87
       </xref>
       ,
       <xref ref-type="bibr" rid="B88-viruses-04-03044">
        88
       </xref>
       ,
       <xref ref-type="bibr" rid="B89-viruses-04-03044">
        89
       </xref>
       ,
       <xref ref-type="bibr" rid="B90-viruses-04-03044">
        90
       </xref>
       ,
       <xref ref-type="bibr" rid="B91-viruses-04-03044">
        91
       </xref>
       ] or DNA vaccines [
       <xref ref-type="bibr" rid="B92-viruses-04-03044">
        92
       </xref>
       ,
       <xref ref-type="bibr" rid="B93-viruses-04-03044">
        93
       </xref>
       ,
       <xref ref-type="bibr" rid="B94-viruses-04-03044">
        94
       </xref>
       ,
       <xref ref-type="bibr" rid="B95-viruses-04-03044">
        95
       </xref>
       ]. However, an early concern for application of a SARS-CoV vaccine was the experience with animal coronavirus vaccines, which induced enhanced disease and immunopathology in animals when challenged with infectious virus [
       <xref ref-type="bibr" rid="B96-viruses-04-03044">
        96
       </xref>
       ]. Indeed, a similar immunopathologic reaction has been described in mice vaccinated with a SARS-CoV vaccine and subsequently challenged with SARS-CoV [
       <xref ref-type="bibr" rid="B97-viruses-04-03044">
        97
       </xref>
       ,
       <xref ref-type="bibr" rid="B98-viruses-04-03044">
        98
       </xref>
       ,
       <xref ref-type="bibr" rid="B99-viruses-04-03044">
        99
       </xref>
       ,
       <xref ref-type="bibr" rid="B100-viruses-04-03044">
        100
       </xref>
       ,
       <xref ref-type="bibr" rid="B101-viruses-04-03044">
        101
       </xref>
       ]. Thus, safety concerns related to effectiveness and safety for vaccinated persons, especially if exposed to other coronaviruses, should be carefully examined.
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      3. HCoVs: Enveloped, but not that Fragile
     </title>
     <p>
      In this section, we highlight the potency of coronaviruses to survive in different conditions, despite their enveloped nature. This knowledge is essential for a better understanding of the possibility of virus transfer and cross-contamination, and for formulating appropriate infection-control measures. Indeed, despite the fact that transmission was believed to be mainly achieved by direct physical contact with infected patient or by respiratory droplets, several well-described clusters of infection were difﬁcult to explain by these routes. Examples include transmission to 22 persons on an aircraft [
      <xref ref-type="bibr" rid="B102-viruses-04-03044">
       102
      </xref>
      ], to 13 guests sharing the same ﬂoor of a hotel, and more than 300 persons in an apartment complex [
      <xref ref-type="bibr" rid="B103-viruses-04-03044">
       103
      </xref>
      ]. These observations led to some speculations about a possible transmission by other means including surfaces, hands,
      <italic>
       etc
      </italic>
      ., and to the study of SARS-CoV (and other HCoVs) survival in different conditions.
     </p>
     <p>
      Despite the fact that this review is devoted to human coronaviruses, some data concerning the murine hepatitis virus (MHV) and the transmissible gastroenteritis virus (TGEV), now called alphacoronavirus 1 [
      <xref ref-type="bibr" rid="B1-viruses-04-03044">
       1
      </xref>
      ], are recorded here because they have been used as SARS-CoV surrogates.
     </p>
     <sec>
      <title>
       3.1. Survival Under Different Conditions of Humidity and Temperature
      </title>
      <p>
       Some decades ago, a study compared the survival rates of the HCoV 229E to the ones of a non-enveloped virus, the type 1-poliovirus, under different conditions of temperature and humidity. Results are reported in
       <xref ref-type="table" rid="viruses-04-03044-t001">
        Table 1
       </xref>
       .
      </p>
      <table-wrap id="viruses-04-03044-t001" position="float">
       <object-id pub-id-type="pii">
        viruses-04-03044-t001_Table 1
       </object-id>
       <label>
        Table 1
       </label>
       <caption>
        <p>
         Survival rates of the HCoV 229E and the poliovirus, type 1, under different conditions of temperature and humidity [
         <xref ref-type="bibr" rid="B104-viruses-04-03044">
          104
         </xref>
         ].
        </p>
       </caption>
       <table frame="hsides" rules="all" style="border:solid thin">
        <thead>
         <tr>
          <th align="center" colspan="1" rowspan="1" style="background:#BFBFBF">
          </th>
          <th align="center" colspan="6" rowspan="1" style="background:#BFBFBF">
           <italic>
            HCoV 229E
           </italic>
          </th>
          <th align="center" colspan="4" rowspan="1" style="background:#BFBFBF">
           <italic>
            Type 1-Poliovirus
           </italic>
           ,
           <italic>
            Sabin strain
           </italic>
          </th>
         </tr>
         <tr>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            Relative humidity
           </italic>
          </th>
          <th align="center" colspan="4" rowspan="1" style="background:#D9D9D9">
           <italic>
            20 °C
           </italic>
          </th>
          <th align="center" colspan="2" rowspan="1" style="background:#D9D9D9">
           <italic>
            6 °C
           </italic>
          </th>
          <th align="center" colspan="2" rowspan="1" style="background:#D9D9D9">
           <italic>
            20 °C
           </italic>
          </th>
          <th align="center" colspan="2" rowspan="1" style="background:#D9D9D9">
           <italic>
            6 °C
           </italic>
          </th>
         </tr>
         <tr>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            15 min
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            24 h
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            72 h
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            6 days
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            15 min
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            24 h
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            15 min
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            24 h
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            15 min
           </italic>
          </th>
          <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            24 h
           </italic>
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            30%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             87%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             65%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             &gt;50%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            91%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            65%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             0%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             0%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
         </tr>
         <tr>
          <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            50%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             90.9%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             75%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             &gt;50%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             20%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            96.5%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            80%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             0%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             0%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
         </tr>
         <tr>
          <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
           <italic>
            80%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            55%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            3%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            0%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             104.8%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="color:red; background: #F2F2F2">
           <bold>
            <italic>
             86%
            </italic>
           </bold>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            90%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            30%
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
          <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           <italic>
            n.d.
           </italic>
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          (n.d.: not done)
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
      <p>
       Thus, at 20 °C, aerosolized HCoV 229E was found to better survive at 50% relative humidity than at 30%. Indeed, nearly 20% of the original infectious virus was still detectable after six days. High relative humidity seemed less favorable to the virus, unless the temperature came down to 6 °C. At this temperature, the survival of the HCoV 229E was significantly enhanced whatever the rate of relative humidity. This enhanced survival rate at high relative humidity and low temperature may explain the winter propagation of coronaviruses. Moreover, the HCoV 229E survival was significantly higher at 30% and 50% of relative humidity than those of the poliovirus in the same experimental conditions, which could be a striking result according to its non-enveloped nature [
       <xref ref-type="bibr" rid="B104-viruses-04-03044">
        104
       </xref>
       ].
      </p>
      <p>
       Sensitivity of SARS-CoV to temperature has also been assayed. The exposure of the virus to a temperature of 56 °C over 30 min reduced virus titer under an undetectable level, except if SARS-CoV is associated with proteins, such as 20% fetal calf serum (FCS), which bring a protection for the virus. In this case, the temperature needs to reach 60 °C over 30 min to bring virus titer below the detection limit. This emphasizes the importance of organic material in which viruses could be embedded in the real conditions and could protect the virus, mostly from disinfection procedures. When the virus was placed at 4 °C, there was no loss of infectivity [
       <xref ref-type="bibr" rid="B105-viruses-04-03044">
        105
       </xref>
       ]. Another study confirms the viral stability at 4 °C, and also at 20 °C and 37 °C for at least 2 hrs, but SARS-CoV lost its infectivity after 90, 60 and 30 min exposure at 56 °C, 67 °C and 75 °C, respectively [
       <xref ref-type="bibr" rid="B106-viruses-04-03044">
        106
       </xref>
       ].
      </p>
     </sec>
     <sec>
      <title>
       3.2. Suspension vs. Desiccation
      </title>
      <p>
       Coronaviruses also well survive in suspension. At 37 °C, HCoV 229E and OC43 displayed survival rates of 80% and 100%, respectively, in phosphate buffered saline (PBS) over three days and of 30% and 55%, respectively, over six days. These survival rates came down to 50% for HCoV 229E and 30% for HCoV OC43 after three days in culture medium and after ten days, they were of 0% and 10% for each virus, respectively. The same study also showed that desiccation has a more severe effect on coronaviruses. Indeed, in standard environmental conditions (21 °C and 50% to 70% of relative humidity), HCoV 229E infectivity came down to 30% after three hrs of desiccation on various surfaces that can be found in hospital settings, such as aluminum, sterile sponges or surgical latex gloves. HCoV OC43 was more sensitive to desiccation, since its infectivity was below the detectable threshold after three hrs of drying [
       <xref ref-type="bibr" rid="B107-viruses-04-03044">
        107
       </xref>
       ].
      </p>
      <p>
       Rabenau
       <italic>
        et al
       </italic>
       . made a comparative study on the stability of different viruses, i.e. SARS-CoV, HCoV 229E, type 1-herpes simplex virus (HSV-1) and the type 3-adenovirus, in suspension and after drying. In medium culture, with and without 10% FCS, the HCoV 229E progressively lost its infectivity over nine days, which is consistent with the previous study. The infectious titers of the three other viruses, including the SARS-CoV, were stable over nine days, with and without proteins. After drying on a plastic surface, the HCoV 229E and the HSV-1 lost their infectivity in 72 hrs, in the presence or absence of FCS. In contrast, the SARS-CoV retained its infectivity for as long as six days, with a further protecting effect of proteins. It took nine days in a dried state, for SARS-CoV to completely lose its infectivity. The adenovirus was the most stable virus assayed as it conserved its infectivity throughout the nine days of the experiment [
       <xref ref-type="bibr" rid="B105-viruses-04-03044">
        105
       </xref>
       ].
      </p>
      <p>
       Some other studies confirm these results. SARS-CoV has been shown to survive after drying on different kinds of materials or diluted in water, revealing a decreased infectivity only after 72 to 96 hrs, depending on the conditions. However, its infectivity is reduced more rapidly if it is deposited on porous surfaces such as cotton or paper [
       <xref ref-type="bibr" rid="B106-viruses-04-03044">
        106
       </xref>
       ,
       <xref ref-type="bibr" rid="B108-viruses-04-03044">
        108
       </xref>
       ].
      </p>
      <p>
       Thus, RNA of SARS-CoV was found on different environment samples, such as chair, elevator, computer mouse,
       <italic>
        etc
       </italic>
       ., and this may have contributed to contamination of health-care workers who had not been in direct contact with SARS-patients [
       <xref ref-type="bibr" rid="B109-viruses-04-03044">
        109
       </xref>
       ,
       <xref ref-type="bibr" rid="B110-viruses-04-03044">
        110
       </xref>
       ].
      </p>
      <p>
       A more recent study implicated water and sewage in the transmission of SARS-CoV, taking the MHV and the TGEV as surrogates for their experiments. At 25 °C, the time required for 99% reduction in water was 22 days for TGEV and 17 days for MHV, and, in sewage, it took nine days for TGEV and seven days for MHV. After four weeks in almost the same conditions but at 4 °C, there was less than &lt;1 log
       <sub>
        10
       </sub>
       infectivity decrease for both viruses. The authors concluded that in case of SARS-CoV re-emergence water contaminated with fecal waste should be considered as a potential vehicle of transmission [
       <xref ref-type="bibr" rid="B111-viruses-04-03044">
        111
       </xref>
       ].
      </p>
      <p>
       These studies firmly illustrated the potency of coronaviruses and especially the SARS-CoV, to be transmitted via other routes than respiratory droplets and the likely risk of contamination via surfaces and fomites. It should also be noticed that the residual infectivity of those enveloped viruses in different conditions can almost reach the one of non-enveloped viruses. This reappraises the environmental stability of these two types of viruses.
      </p>
     </sec>
     <sec>
      <title>
       3.3. Influence of pH Conditions on Coronaviruses Survival
      </title>
      <p>
       The sensitivity of coronaviruses to pH variations has been established for a number of them. They are more stable at slightly acidic pH (6 – 6.5) than at alkaline pH (8). This has been shown for the HCoV 229E [
       <xref ref-type="bibr" rid="B112-viruses-04-03044">
        112
       </xref>
       ], the MHV [
       <xref ref-type="bibr" rid="B113-viruses-04-03044">
        113
       </xref>
       ,
       <xref ref-type="bibr" rid="B114-viruses-04-03044">
        114
       </xref>
       ], the TGEV [
       <xref ref-type="bibr" rid="B115-viruses-04-03044">
        115
       </xref>
       ] and the canine coronavirus [
       <xref ref-type="bibr" rid="B116-viruses-04-03044">
        116
       </xref>
       ].
      </p>
     </sec>
     <sec>
      <title>
       3.4. Survival in Biological Fluids
      </title>
      <p>
       As it has been noted earlier, HCoVs are excreted in respiratory secretions but also in other biological fluids such as feces. Knowing and understanding viral survival is then essential to estimate the risk of potential transmission through this route.
      </p>
      <p>
       Studies have been conducted on SARS-CoV, which was shown to survive at least 96 hrs in sputum, serum and feces. Its infectivity level is nevertheless lower when it is suspended in urines [
       <xref ref-type="bibr" rid="B106-viruses-04-03044">
        106
       </xref>
       ]. It is noteworthy that SARS-CoV survival depends on the kind of feces whose pH may vary. Some studies have shown certain surprising results in regard of the previously quoted studies. Indeed, SARS-CoV did not survive beyond 24 hrs in normal feces of an adult or beyond three hrs in newborns’ feces, which is slightly acidic. In contrast, it could survive longer, up to four days, in diarrheic feces whose pH could reach pH 9. The same study revealed a SARS-CoV survival until four to five days in respiratory specimen [
       <xref ref-type="bibr" rid="B108-viruses-04-03044">
        108
       </xref>
       ,
       <xref ref-type="bibr" rid="B117-viruses-04-03044">
        117
       </xref>
       ].
      </p>
      <p>
       According to these data, transfer of viruses and cross-contamination should be carefully considered. Indeed, under certain circumstances, for instance in health-care settings, contamination of inanimate materials or other people by infectious respiratory secretions or other body fluids (saliva, urine or feces) seems to play a role in SARS-CoV transmission, and it is likely the same for the other HCoVs. Thus, it is essential to dispose of adapted, targeted and efficient ways of disinfection whose efficiency has to be correctly evaluated.
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      4. Antisepsis-Disinfection: An Efficient Weapon, with Room for Improvement
     </title>
     <sec>
      <title>
       4.1. How Prevention Measures Halted the Propagation of SARS-CoV
      </title>
      <p>
       The absence of treatment, the high mortality rate and the transmission patterns of SARS-CoV involved the setting of powerful and coordinated means of prevention to stop the worldwide spread of this virus. Indeed, the SARS-CoV epidemic has been brought under control thanks to basic public health measures, including rapid case detection and isolation, contact tracing, quarantine and good precautionary control measures (hand washing, use of personal protective equipment) [
       <xref ref-type="bibr" rid="B54-viruses-04-03044">
        54
       </xref>
       ,
       <xref ref-type="bibr" rid="B59-viruses-04-03044">
        59
       </xref>
       ]. Additionally, the WHO expressed recommendations for travelers coming from areas affected by the SARS with screening of potential cases and in-flight care of suspected cases followed by aircraft disinfection [
       <xref ref-type="bibr" rid="B121-viruses-04-03044">
        121
       </xref>
       ].
      </p>
      <p>
       Thus, besides these standard measures, our knowledge on HCoVs sensitivity to antiseptics-disinfectants should improve, in order to use these fundamental prevention tools in a targeted and coherent manner.
      </p>
     </sec>
     <sec>
      <title>
       4.2 What is Antisepsis-Disinfection and how do we Evaluate its Efficiency?
      </title>
      <p>
       Facing the lack in a speciﬁc antiviral treatment, it is necessary to develop new means of prevention and to ensure that the existing ones are efficient according to the field situation. Proper evaluation of the efficiency of antiseptics-disinfectants on viruses is thus crucial.
      </p>
      <p>
       Essentially, antiseptic-disinfectant antiviral activity is evaluated by combining viruses and the product to be tested for an appropriately deﬁned and precise contact time, according to the expected use of the product (surface or hands disinfection, for instance). Product activity and its eventual cytotoxicity are then neutralized and the loss of viral infectivity due to the product activity is estimated. Neutralization of the antiseptic-disinfectant activity plays a key role in the test procedure; it ensures a precise contact time, the elimination of the residual activity and cytotoxicity of the tested product, and the successful recovery of viruses that are not killed by the product. These tests require appropriate controls, especially to check the absence of interference on viral infectivity, due to the test itself. It is also important to test the efﬁciency of neutralization, removal of cytotoxicity under reproducible and well-deﬁned test conditions (e.g., contact time and environmental temperature). A germicide can be considered to have an efﬁcient antiseptic-disinfectant antiviral activity if it induces, in a well-deﬁned contact time, a reduction in viral titers higher than 3 or 4 log
       <sub>
        10
       </sub>
       , depending on American and European regulatory agencies, respectively [
       <xref ref-type="bibr" rid="B122-viruses-04-03044">
        122
       </xref>
       ,
       <xref ref-type="bibr" rid="B123-viruses-04-03044">
        123
       </xref>
       ].
      </p>
     </sec>
     <sec>
      <title>
       4.3. Critical Parameters in Antiviral Antiseptic-Disinfectant Efficiency Evaluation
      </title>
      <p>
       Some parameters have to be checked particularly carefully to ensure the validity of the results.
      </p>
      <sec>
       <title>
        4.3.1. Neutralization Step and Contact Time
       </title>
       <p>
        The neutralization step plays a key role in this methodology. Several different methods exist to achieve neutralization. The first one is the neutralization by dilution. Theoretically, it allows an instantaneous arrest of the activity of the tested product and the elimination of its cytotoxicity. However, it requires viruses with very high titers in order to observe a reduction in viral titers afterwards. In that case, it is frequently observed that the cytotoxicity is not eliminated thoroughly, making impossible the titration of the virus. Two other techniques are available to counter these drawbacks. Chemical neutralization associates dilution and chemical inactivation of the tested product and its cytotoxicity. However, few neutralizers are available, especially when taking into account the huge number of antiseptics-disinfectants. The gel filtration method allows the retention of antiseptic-disinfectant molecules (and so, their antiviral activity and their cytotoxicity), and the release of viral particles, which could then be tittered. Yet, this method may lengthen the contact time and lead to an overestimation of the product’s activity. Indeed, a precise contact time is fundamental to respect future use conditions and to reflect the real activity of the product in the field.
       </p>
      </sec>
      <sec>
       <title>
        4.3.2. Mimics of Field Conditions
       </title>
       <p>
        Different factors should be considered in order to represent the future use conditions of the product as closely as possible. Different types of tests exist with different levels of evidence: (i) suspension tests, which are useful to screen molecules efficiency and cytotoxicity, (ii) carrier tests, which allow monitoring of the efficiency of the product after viruses have dried on different kinds of surfaces and (iii) in-field tests, for instance, in hospital settings. These are rarely performed because of cost and standardization problems.
       </p>
       <p>
        In all these tests, organic material (FCS, feces, albumin,
        <italic>
         etc
        </italic>
        .) could, even should, be added. Indeed, viruses are normally founded embedded in such material protecting them from the action of antiseptics-disinfectants Moreover, a significant part of antiseptics-disinfectants, such as chlorine derived compounds, are inactivated by organic materials. Finally, viruses are known to aggregate themselves and this might be enhanced by the presence of organic material, making them even more resistant to the action of antiseptics-disinfectants.
       </p>
      </sec>
     </sec>
     <sec>
      <title>
       4.4. International Standardization Context
      </title>
      <p>
       One of the challenges of antiviral antiseptics-disinfectants testing is the standardization to obtain valuable and comparable results. This is illustrated in the next section, where, even if the results concerning the activity of antiseptics-disinfectants on HCoVs are generally consistent with each other, they are still difficult to compare. It is then extremely important to set standards to test these antiseptic activities.
      </p>
      <p>
       To date, only one European Standard (NF EN 14476+A1) on virucidal antiseptic-disinfectant activity testing in human medicine has been published [
       <xref ref-type="bibr" rid="B122-viruses-04-03044">
        122
       </xref>
       ]. This protocol, from January 2007, speciﬁes the test method and the minimum requirements to establish virucidal activity according to the potential use of the products tested, e.g. disinfection of surfaces and instruments, hygienic hand wash or thermochemical disinfection. Virus strains, temperatures, contact times and interfering substances are speciﬁed for each potential use. According to this standard, a product is considered to have an antiseptic-disinfectant antiviral activity if it induces a loss of infectivity of at least 4 log
       <sub>
        10
       </sub>
       in viral titers during an accurate contact time.
      </p>
      <p>
       In the United States, the principal standard is relatively close to the European one but it specifies an efficacy criterion of 3 log
       <sub>
        10
       </sub>
       . Several standards have been then published to cover the different field situations such as two standards concerning the evaluation of hygienic hand wash, a standard concerning the evaluation of efficacy of virucidal agents intended for inanimate environmental surfaces and, finally, a specific standard concerning the neutralization step [
       <xref ref-type="bibr" rid="B123-viruses-04-03044">
        123
       </xref>
       ,
       <xref ref-type="bibr" rid="B124-viruses-04-03044">
        124
       </xref>
       ,
       <xref ref-type="bibr" rid="B125-viruses-04-03044">
        125
       </xref>
       ,
       <xref ref-type="bibr" rid="B126-viruses-04-03044">
        126
       </xref>
       ,
       <xref ref-type="bibr" rid="B127-viruses-04-03044">
        127
       </xref>
       ].
      </p>
     </sec>
     <sec>
      <title>
       4.5. Sensitivity of HCoVs to Antiseptics-Disinfectants
      </title>
      <sec>
       <title>
        4.5.1. Sensitivity of “Classic” HCoVs (other than SARS-CoV) to Antiseptics-Disinfectants
       </title>
       <p>
        A study, by Sattar
        <italic>
         et al
        </italic>
        ., evaluated the efficiency of 15 antiseptics-disinfectants of various chemical families on four different viruses: two non-enveloped viruses (type b-coxsackievirus and type 5-adenovirus) and two enveloped viruses (HCoV 229E and type 3-parainfluenzavirus). With this aim in view, viral inocula were suspended in feces or mucin to mimic organic matter and left to dry on stainless-steel disks. The contact time was 1 min and the efficacy criterion was a reduction in viral titers of 3 log
        <sub>
         10
        </sub>
        . Results are gathered in
        <xref ref-type="table" rid="viruses-04-03044-t002">
         Table 2
        </xref>
        .
       </p>
       <table-wrap id="viruses-04-03044-t002" position="float">
        <object-id pub-id-type="pii">
         viruses-04-03044-t002_Table 2
        </object-id>
        <label>
         Table 2
        </label>
        <caption>
         <p>
          Comparison of non-enveloped and enveloped viruses (HCoV 229E, type 3-parainfluenzavirus, type b-coxsackievirus and type 5-adenovirus) sensitivity to different antiseptics-disinfectants formulations, thanks to carrier tests [
          <xref ref-type="bibr" rid="B128-viruses-04-03044">
           128
          </xref>
          ].
         </p>
         <p>
          <italic>
           The efficiency is validated if the reduction in viral titers after a contact-time of 1 min is ≥ 3 log
           <sub>
            10
           </sub>
          </italic>
          .
         </p>
        </caption>
        <table frame="hsides" rules="all" style="border:solid thin">
         <thead>
          <tr>
           <th align="center" colspan="1" rowspan="2" style="background:#D9D9D9" valign="middle">
            Tested antiseptics-disinfectants
           </th>
           <th align="center" colspan="1" rowspan="2" style="background:#D9D9D9" valign="middle">
            Concentration (%) - (pH at used concentration)
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            HCoV 229E
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Type 3-parainfluenzavirus
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Type B-Coxsackievirus
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Type 5-Adenovirus
           </th>
          </tr>
          <tr>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Enveloped
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Enveloped
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Non-enveloped
           </th>
           <th align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="middle">
            Non-enveloped
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
            <bold>
             Halogenous compounds
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2">
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            Sodium hypochlorite
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.01 (8.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.10 (9.4)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.50 (11.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            Chloramine T
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.01 (7.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.10 (8.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.30 (8.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            Sodium hypochlorite and potassium bromide
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.01 (10.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.05 (11.5)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.10 (12.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            Povidone-iodine
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            10.0 (3.0) (1% available iodine)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
             Ethanol
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            70.0 (4.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
             Glutaraldehyde
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            2.0 (7.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
             Quaternary ammonium compounds
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             n
            </italic>
            -alkyl-dimethylbenzyl chloride
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.04 (6.0)
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             n
            </italic>
            -alkyl-dimethylbenzyl chloride
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.04 (1.0)
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + HCl
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            7.00
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             n
            </italic>
            -alkyl-dimethylbenzyl chloride
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.04 (5.0)
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            70.0
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             n
            </italic>
            -alkyl-dimethylbenzyl chloride
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.04 (11.0)
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + sodium metasilicate
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.5
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
             Chlorhexidine gluconate
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.008 (5.0)
           </td>
           <td align="center" colspan="1" rowspan="2" style="background:#D9D9D9" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="2" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + cetrimide
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.08
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            Chlorhexidine gluconate
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.05 (4.5)
           </td>
           <td align="center" colspan="1" rowspan="3" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="3" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="3" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + cetrimide
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.50
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            70.0
           </td>
          </tr>
          <tr>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
             Phenolic compounds
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#D9D9D9" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <bold>
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             o
            </italic>
            -phenylphenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.02 (9.0)
           </td>
           <td align="center" colspan="1" rowspan="3" style="background:#D9D9D9" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="3" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +
            <italic>
             o
            </italic>
            -benzyl-chlorophenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.03
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +
            <italic>
             p
            </italic>
            -tert-amylphenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.01
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             o
            </italic>
            -phenylphenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.02 (9.0)
           </td>
           <td align="center" colspan="1" rowspan="4" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="4" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="4" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="4" style="background:#F2F2F2" valign="top">
            No
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +
            <italic>
             o
            </italic>
            -benzyl-chlorophenol
l
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.03
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +
            <italic>
             p
            </italic>
            -tert-amylpheno
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.01
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + SDS
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.60
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            <italic>
             o
            </italic>
            -phenylphenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.02 (9.0)
           </td>
           <td align="center" colspan="1" rowspan="4" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="4" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="4" style="background:#F2F2F2" valign="top">
            No
           </td>
           <td align="center" colspan="1" rowspan="4" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +
            <italic>
             o
            </italic>
            -benzyl-chlorophenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.03
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +
            <italic>
             p
            </italic>
            -tert-amylphenol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.01
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            + ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            70.0
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            Sodium
            <italic>
             o
            </italic>
            -benzyl-
            <italic>
             p
            </italic>
            -chlorophenate
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.50 (13.0)
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#D9D9D9" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="2" style="color:red; background:#F2F2F2" valign="top">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            +Sodium dodecyl sulfate
           </td>
           <td align="center" colspan="1" rowspan="1" style="background:#F2F2F2" valign="top">
            0.60
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
       <p>
        This study highlighted the fact that enveloped viruses are more sensitive than non-enveloped viruses to the action of antiseptics-disinfectants, despite sensitivity discrepancies within each group. However, enveloped viruses are not that fragile and they are not inactivated by a number of antiseptics-disinfectants such as quaternary ammoniums compounds or phenolic compounds. The association chlorhexidine and cetrimide, widely used in human medicine, did not seem to be effective on HCoV 229E, except if ethanol is added [
        <xref ref-type="bibr" rid="B128-viruses-04-03044">
         128
        </xref>
        ].
       </p>
       <p>
        A more recent study investigated the action of antiseptics-disinfectants on HCoVs 229E and OC43 with suspension tests and contact times of 5 min. The neutralization step was achieved by dilution in medium culture. The povidone-iodine (0.75% free iodine) caused a 50% reduction in infectivity of both of the viruses, which is not enough to claim a virucidal activity. Moreover, to obtain a 50% reduction in HCoV 229E titers, tenfold increase in concentration of povidone-iodine was required. Some other products (70% ethanol, soap or 5% bleach) were assayed but without success because they interfered with the biological viral titration assay [
        <xref ref-type="bibr" rid="B107-viruses-04-03044">
         107
        </xref>
        ].
       </p>
       <p>
        This also highlights the importance of the neutralization step and the necessity of developing means to eliminate the toxicity of the tested products.
       </p>
       <p>
        This result was also confirmed on the SARS-CoV by Kariwa
        <italic>
         et al
        </italic>
        . who tested different formulations of povidone-iodine with suspensions tests and contact times of 1 and 2 min. The neutralization step was achieved chemically by the addition of sodium thiosulfate. All formulations reduced the viral infectivity under the detectable level after 2 min of contact-time. The same result was obtained with 70% ethanol in 1 min [
        <xref ref-type="bibr" rid="B129-viruses-04-03044">
         129
        </xref>
        ].
       </p>
       <p>
        Two other studies conducted in our laboratory concerned the HCoV 229E and its sensitivity to two widely used antiseptics, chlorhexidine and hexamidine, but also to new molecules belonging to the calixarene family [
        <xref ref-type="bibr" rid="B130-viruses-04-03044">
         130
        </xref>
        ,
        <xref ref-type="bibr" rid="B131-viruses-04-03044">
         131
        </xref>
        ]. In these studies, antiseptic antiviral activities were assayed thanks to suspension tests and the efficacy criterion was a reduction of 4 log
        <sub>
         10
        </sub>
        , as recommended by the European Standard [
        <xref ref-type="bibr" rid="B122-viruses-04-03044">
         122
        </xref>
        ]. A novel methodology of gel filtration for the neutralization step was developed in these studies, using homemade and reproducible Sephadex™ columns.
       </p>
       <p>
        Chlorhexidine was shown to have a time and concentration-dependent anti-HCoV 229E activity allowing a 3 log
        <sub>
         10
        </sub>
        reduction, but only after a 60 min contact time (
        <xref ref-type="fig" rid="viruses-04-03044-f001">
         Figure 1
        </xref>
        a). It was then not sufficient to claim an antiseptic anti-HCoV 229E activity. Hexamidine did not show any activity against HCoV 229E [
        <xref ref-type="bibr" rid="B130-viruses-04-03044">
         130
        </xref>
        ,
        <xref ref-type="bibr" rid="B131-viruses-04-03044">
         131
        </xref>
        ]. These results highlighted the necessity of (i) evaluating the activity of commonly used antiseptics-disinfectants against different viruses, to be sure of their efficiency and to develop a targeted antisepsis, and (ii) developing new active noncytotoxic molecules.
       </p>
       <p>
        The second study concerned the antiseptic anti-HCoV 229E activity of two calixarenic compounds, i.e. the tetra-para-sulfonato-calix[4]arene (C[4]S) and the 1,3-bis(bithiazolyl)-tetra-para-sulfonato-calix[4]arene (C[4]S-BTZ) [
        <xref ref-type="bibr" rid="B130-viruses-04-03044">
         130
        </xref>
        ,
        <xref ref-type="bibr" rid="B131-viruses-04-03044">
         131
        </xref>
        ]. These molecules were attractive targets at first because they did not show any cytotoxicity. Then, the C[4]S-BTZ showed an equivalent, and even better, activity than that of chlorhexidine. Indeed, its activity reached almost 3 log
        <sub>
         10
        </sub>
        reduction in viral titers from 5 min of contact time (
        <xref ref-type="fig" rid="viruses-04-03044-f001">
         Figure 1
        </xref>
        b). Some further studies are needed, but calixarenes appear as interesting candidates to be new antiseptics-disinfectants.
       </p>
       <fig id="viruses-04-03044-f001" position="anchor">
        <label>
         Figure 1
        </label>
        <caption>
         <p>
          Evaluation of antiseptic HCoV 229E activity of
          <bold>
           (a)
          </bold>
          chlorhexidine (CHX) and
          <bold>
           (b)
          </bold>
          the 1,3-bis(bithiazolyl)-tetra-para-sulfonato-calix[4]arene (C[4]S-BTZ) [
          <xref ref-type="bibr" rid="B130-viruses-04-03044">
           130
          </xref>
          ,
          <xref ref-type="bibr" rid="B131-viruses-04-03044">
           131
          </xref>
          ].
         </p>
        </caption>
        <graphic xlink:href="viruses-04-03044-g001">
        </graphic>
       </fig>
      </sec>
      <sec>
       <title>
        4.5.2. SARS-CoV Sensitivity to Antiseptics-Disinfectants
       </title>
       <p>
        Rabenau
        <italic>
         et al.
        </italic>
        achieved a study using suspension tests with different organic loads (albumin, FCS or sheep erythrocytes) and following the recommendations of the European Standard [
        <xref ref-type="bibr" rid="B122-viruses-04-03044">
         122
        </xref>
        ]. Most of the tested alcoholic-based solutions (isopropanol or ethanol) has been shown to allow a reduction &gt; 4 log
        <sub>
         10
        </sub>
        in viral titers over 30 sec, whatever the added organic load. They also investigated the activity of three surface and instrument disinfectants (one based on benzalkonium chloride and laurylamine; one based on benzalkonium chloride, glutaraldehyde and didecyldimonium chloride; and one based on magnesium monoperphthalate). Contact times were then, still in accordance to the European Standard, 30 and 60 min. SARS-CoV was inactivated by all the disinfectants to below the limit of detection (the smaller reduction factor was 3.25 log
        <sub>
         10
        </sub>
        ), regardless of the type of organic load [
        <xref ref-type="bibr" rid="B132-viruses-04-03044">
         132
        </xref>
        ]. The same team pursued its investigation evaluating the SARS-CoV virucidal activity of different disinfectants based on alcohols (propanol, ethanol used for hands disinfection), aldehydes (formaldehyde, glutardialdehyde), glucoprotamin and wine vinegar. The methodology was the same that previously described, except for the organic load, which was FCS. In case of cytotoxic effect after the dilution-neutralization step, the virus-disinfectant mixture was membrane filtered. This allowed the concentration of the viral particles, which could then be tittered, while retaining the disinfectant. The results are recorded in
        <xref ref-type="table" rid="viruses-04-03044-t003">
         Table 3
        </xref>
        . The variation in reduction factors was due to the filtration used as neutralization step when disinfectant toxicity was too strong [
        <xref ref-type="bibr" rid="B105-viruses-04-03044">
         105
        </xref>
        ].
       </p>
       <table-wrap id="viruses-04-03044-t003" position="float">
        <object-id pub-id-type="pii">
         viruses-04-03044-t003_Table 3
        </object-id>
        <label>
         Table 3
        </label>
        <caption>
         <p>
          Virucidal activity on SARS-CoV of different hand-rub formulations and surfaces disinfectants thanks to suspension tests [
          <xref ref-type="bibr" rid="B105-viruses-04-03044">
           105
          </xref>
          ].
         </p>
        </caption>
        <table frame="hsides" rules="groups">
         <thead>
          <tr style="background:#D9D9D9">
           <th align="center" colspan="1" rowspan="1" valign="middle">
            Tested formulations
           </th>
           <th align="center" colspan="1" rowspan="1" valign="middle">
            Contact times
           </th>
           <th align="center" colspan="1" rowspan="1" valign="middle">
            Minimal reduction factor (log10)
           </th>
          </tr>
         </thead>
         <tbody>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            100% 2-propanol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            30 s
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 3.31
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            70% 2-propanol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            30 s
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 3.31
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            78% ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            30 s
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 5.01
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            45% 2-propanol, 30% 1-propanol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            30 s
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 2.78
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            Wine vinegar
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            60 s
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 3.0
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            0.7% formaldehyde
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            2 min
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 3.01
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            1.0% formaldehyde
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            2 min
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 3.01
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            0.5% glutardialdehyde
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            2 min
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 4.01
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            26% glucoprotamin
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            2 min
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            ≥ 1.68
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
       <p>
        Recently, a study used MHV and TGEV as SARS-CoV surrogates. Thanks to carrier tests on stainless steel surfaces and a chemical neutralization step, the anti-SARS-CoV efficacy of six different formulations was evaluated. The efficacy criterion was a reduction of 3 log
        <sub>
         10
        </sub>
        in viral titers after 1 min contact time. Results are reported in
        <xref ref-type="table" rid="viruses-04-03044-t004">
         Table 4
        </xref>
        .
       </p>
       <table-wrap id="viruses-04-03044-t004" position="float">
        <object-id pub-id-type="pii">
         viruses-04-03044-t004_Table 4
        </object-id>
        <label>
         Table 4
        </label>
        <caption>
         <p>
          Virucidal activity on MHV and TGEV, used as SARS-CoV surrogates, of different hand-rub formulations and surface disinfectants using carrier test methodology [
          <xref ref-type="bibr" rid="B133-viruses-04-03044">
           133
          </xref>
          ]
          <italic>
           (MHV: Murine hepatitis virus
          </italic>
          ,
          <italic>
           TGEV: Transmissible gastro-enteritis virus).
          </italic>
         </p>
        </caption>
        <table frame="hsides" rules="groups">
         <thead>
          <tr style="background:#D9D9D9">
           <th align="center" colspan="1" rowspan="1" valign="middle">
            Concentration of active ingredients of the tested commercial formulations
           </th>
           <th align="center" colspan="1" rowspan="1" valign="middle">
            MHV
           </th>
           <th align="center" colspan="1" rowspan="1" valign="middle">
            TGEV
           </th>
          </tr>
         </thead>
         <tbody>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            Bleach (6% sodium hypochlorite – use dilution: 1:100, ≈ 600 mg/mL)
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            9.09% o-phenylphenol, 7.66% p-tertiary amylphenol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            0.55% ortho-phthalaldehyde
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            70% ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red" valign="middle">
            <bold>
             Yes
            </bold>
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red" valign="middle">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            62% ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red" valign="middle">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
          <tr style="background:#F2F2F2">
           <td align="center" colspan="1" rowspan="1" valign="middle">
            71% ethanol
           </td>
           <td align="center" colspan="1" rowspan="1" valign="middle">
            No
           </td>
           <td align="center" colspan="1" rowspan="1" style="color:red" valign="middle">
            <bold>
             Yes
            </bold>
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
       <p>
        This study revealed first that there were some behavioral differences between the two viruses chosen as surrogates. This raises the question of the pertinence of surrogates use. However, SARS-CoV is a virus which requires a level 3 containment laboratory. Therefore, virus surrogates allow laboratories, which do not dispose of this type of equipment, to conduct studies and produce precious data without working on a virus, which had already caused a worldwide epidemic.
       </p>
       <p>
        Another important point revealed by this study is the inefficiency of bleach, a widely used disinfectant, when applied at the 1:100 (0.06%) use-dilution prescribed by the manufacturer. Sattar
        <italic>
         et al.
        </italic>
        , whose results are recorded in
        <xref ref-type="table" rid="viruses-04-03044-t002">
         Table 2
        </xref>
        , have found higher reductions of HCoV 229E viral titers with concentrations of hypochlorite greater than the one tested here. These results are then consistent with a concentration-dependent effect [
        <xref ref-type="bibr" rid="B133-viruses-04-03044">
         133
        </xref>
        ].
       </p>
       <p>
        Another recent study used MHV as the SARS-CoV surrogate, and carrier tests on Petri dishes. Antiseptic antiviral activity of common household disinfectants or antiseptics, containing either 0.05% of triclosan, 0.12% of chloroxylenol, 0.21% of sodium hypochlorite, 0.23% of pine oil, or 0.10% of a quaternary compound with 79.0% of ethanol, were investigated. All of them provided at least a 3 log
        <sub>
         10
        </sub>
        reduction in viral titers within a 30 sec contact time, which is consistent with the previous results [
        <xref ref-type="bibr" rid="B134-viruses-04-03044">
         134
        </xref>
        ].
       </p>
       <p>
        Despite the fact that these studies bring vital information, they also highlight the necessity of standardization of the antiseptics-disinfectants activity evaluation. We should also develop in-field tests in order to have a better appreciation of the true action of antiseptics-disinfectants.
       </p>
      </sec>
     </sec>
    </sec>
    <sec>
     <title>
      5. Conclusions
     </title>
     <p>
      The four HCoVs 229E, OC43, NL63 and HKU1 cause mild respiratory illnesses compared to SARS-CoV, but these infectious agents are involved in 10 to 20% of hospitalizations of young children and immunocompromised adults with respiratory tract illness and they are also involved in nosocomial infections. Moreover, although the SARS-epidemic has been contained, the possibility of re-emergence of SARS-CoV or emergence of another zoonotic strain remains.
     </p>
     <p>
      Besides the absence of specific treatment and vaccine, HCoVs are now known to show a significant environmental resistance. Their survival in different biological fluids such as respiratory secretions or feces has been proved. Furthermore, some parameters seem of benefit for HCoVs such as the stabilizing effect of low temperature and high relative humidity or the protective action of organic materials. This protective effect should be carefully considered when developing antiseptic-disinfection strategies. Indeed, this often involves a higher quantity and/or concentration of the antiseptic-disinfectant product and so, a higher toxicity. Thus, an efficient disinfection process should include a precleaning step to get rid of these organic materials. The old well-known principle of antisepsis-disinfection that only clean things can be efficiently disinfected is still valuable.
     </p>
     <p>
      Finally, in regard to the different studies on HCoVs’s sensitivity to antiseptics-disinfectants, only few formulations are efficient within an adapted contact time and without a too-strong toxicity. For instance, considering their lack of efficiency against HCoVs, and also their toxicity, products only based on quaternary ammoniums or phenolic compounds should be avoided. Some largely used antiseptics-disinfectants such as ethanol or bleach show a significant activity on the HCoVs. However, some critical parameters should be considered, especially in the case of chlorine-derived compounds, such as the presence of organic materials that could prevent their antiseptic activity, or their dose-dependent effect on the HCoVs. The povidone-iodine or the chlorhexidine, when associated to ethanol and/or cetrimide, could be recommended when there is a risk of HCoVs contamination, contrary to another widely used antiseptic, the hexamidine.
     </p>
     <p>
      It is now essential to pursue investigations on (i) HCoVs’s environmental stability and the role of inanimate material in their spread, (ii) their sensitivity to antiseptics-disinfectants formulations in standardized and targeted conditions, and (iii) the development of new efficient and nontoxic antiseptic-disinfectant molecules such as the calixarenic compounds.
     </p>
    </sec>
    <back>
     <ack>
      <title>
       Acknowledgments
      </title>
      <p>
       Financial support was provided by the French Ministry for Education and Research and the French National Scientific Research Center.
      </p>
     </ack>
     <notes>
      <title>
       Conflict of Interest
      </title>
      <p>
       The authors declare no conflict of interest.
      </p>
     </notes>
     <ref-list>
      <title>
       References
      </title>
      <ref id="B1-viruses-04-03044">
       <label>
        1.
       </label>
       <element-citation publication-type="webpage">
        <collab>
         ICTV (International Committee on Taxonomy on Viruses)
        </collab>
        <article-title>
         Virus Taxonomy: 2011 Release (current)
        </article-title>
        <date-in-citation>
         (Accessed on 24 September 2012)
        </date-in-citation>
        <comment>
         Available online:
         <ext-link ext-link-type="uri" xlink:href="http://ictvonline.org/virusTaxonomy.asp?version=2011">
          http://ictvonline.org/virusTaxonomy.asp?version=2011
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B2-viruses-04-03044">
       <label>
        2.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Almeida
          </surname>
          <given-names>
           J.D.
          </given-names>
         </name>
         <name>
          <surname>
           Tyrrell
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <year>
         1967
        </year>
        <volume>
         1
        </volume>
        <fpage>
         175
        </fpage>
        <lpage>
         178
        </lpage>
        <pub-id pub-id-type="doi">
         10.1099/0022-1317-1-2-175
        </pub-id>
        <pub-id pub-id-type="pmid">
         4293939
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B3-viruses-04-03044">
       <label>
        3.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bradburne
          </surname>
          <given-names>
           A.F.
          </given-names>
         </name>
         <name>
          <surname>
           Bynoe
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Tyrrell
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effects of a "new" human respiratory virus in volunteers
        </article-title>
        <source>
         Br. Med. J.
        </source>
        <year>
         1967
        </year>
        <volume>
         3
        </volume>
        <fpage>
         767
        </fpage>
        <lpage>
         769
        </lpage>
        <pub-id pub-id-type="doi">
         10.1136/bmj.3.5568.767
        </pub-id>
        <pub-id pub-id-type="pmid">
         6043624
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B4-viruses-04-03044">
       <label>
        4.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hamre
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Procknow
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A new virus isolated from the human respiratory tract
        </article-title>
        <source>
         Proc. Soc. Exp. Biol. Med.
        </source>
        <year>
         1966
        </year>
        <volume>
         121
        </volume>
        <fpage>
         190
        </fpage>
        <lpage>
         193
        </lpage>
        <pub-id pub-id-type="pmid">
         4285768
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B5-viruses-04-03044">
       <label>
        5.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McIntosh
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Dees
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Becker
          </surname>
          <given-names>
           W.B.
          </given-names>
         </name>
         <name>
          <surname>
           Kapikian
          </surname>
          <given-names>
           A.Z.
          </given-names>
         </name>
         <name>
          <surname>
           Chanock
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease
        </article-title>
        <source>
         Proc. Natl. Acad. Sci. USA
        </source>
        <year>
         1967
        </year>
        <volume>
         57
        </volume>
        <fpage>
         933
        </fpage>
        <lpage>
         940
        </lpage>
        <pub-id pub-id-type="doi">
         10.1073/pnas.57.4.933
        </pub-id>
        <pub-id pub-id-type="pmid">
         5231356
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B6-viruses-04-03044">
       <label>
        6.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Larson
          </surname>
          <given-names>
           H.E.
          </given-names>
         </name>
         <name>
          <surname>
           Reed
          </surname>
          <given-names>
           S.E.
          </given-names>
         </name>
         <name>
          <surname>
           Tyrrell
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation of rhinoviruses and coronaviruses from 38 colds in adults
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         1980
        </year>
        <volume>
         5
        </volume>
        <fpage>
         221
        </fpage>
        <lpage>
         229
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.1890050306
        </pub-id>
        <pub-id pub-id-type="pmid">
         6262450
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B7-viruses-04-03044">
       <label>
        7.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Esper
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Weibel
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Ferguson
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Landry
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Kahn
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         191
        </volume>
        <fpage>
         492
        </fpage>
        <lpage>
         498
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/428138
        </pub-id>
        <pub-id pub-id-type="pmid">
         15655770
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B8-viruses-04-03044">
       <label>
        8.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Hartwig
          </surname>
          <given-names>
           N.G.
          </given-names>
         </name>
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Niemeyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           de Jong
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
         <name>
          <surname>
           Simon
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A previously undescribed coronavirus associated with respiratory disease in humans
        </article-title>
        <source>
         Proc. Natl. Acad. Sci. USA
        </source>
        <year>
         2004
        </year>
        <volume>
         101
        </volume>
        <fpage>
         6212
        </fpage>
        <lpage>
         6216
        </lpage>
        <pub-id pub-id-type="pmid">
         15073334
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B9-viruses-04-03044">
       <label>
        9.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Van der Hoek
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Pyrc
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Jebbink
          </surname>
          <given-names>
           M.F.
          </given-names>
         </name>
         <name>
          <surname>
           Vermeulen-Oost
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Berkhout
          </surname>
          <given-names>
           R.J.
          </given-names>
         </name>
         <name>
          <surname>
           Wolthers
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Wertheim-van Dillen
          </surname>
          <given-names>
           P.M.
          </given-names>
         </name>
         <name>
          <surname>
           Kaandorp
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Spaargaren
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Berkhout
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Identification of a new human coronavirus
        </article-title>
        <source>
         Nat. Med.
        </source>
        <year>
         2004
        </year>
        <volume>
         10
        </volume>
        <fpage>
         368
        </fpage>
        <lpage>
         373
        </lpage>
        <pub-id pub-id-type="pmid">
         15034574
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B10-viruses-04-03044">
       <label>
        10.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cai
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
         <name>
          <surname>
           Luk
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         79
        </volume>
        <fpage>
         884
        </fpage>
        <lpage>
         895
        </lpage>
        <pub-id pub-id-type="pmid">
         15613317
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B11-viruses-04-03044">
       <label>
        11.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Gunther
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           van der Werf
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Brodt
          </surname>
          <given-names>
           H.R.
          </given-names>
         </name>
         <name>
          <surname>
           Becker
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Panning
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kolesnikova
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Identification of a novel coronavirus in patients with severe acute respiratory syndrome
        </article-title>
        <source>
         N. Engl. J. Med.
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1967
        </fpage>
        <lpage>
         1976
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa030747
        </pub-id>
        <pub-id pub-id-type="pmid">
         12690091
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B12-viruses-04-03044">
       <label>
        12.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ksiazek
          </surname>
          <given-names>
           T.G.
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Goldsmith
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           S.R.
          </given-names>
         </name>
         <name>
          <surname>
           Peret
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Emery
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Urbani
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Comer
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A novel coronavirus associated with severe acute respiratory syndrome
        </article-title>
        <source>
         N. Engl. J. Med.
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1953
        </fpage>
        <lpage>
         1966
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa030781
        </pub-id>
        <pub-id pub-id-type="pmid">
         12690092
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B13-viruses-04-03044">
       <label>
        13.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yam
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Nicholls
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Yee
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yan
          </surname>
          <given-names>
           W.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           M.T.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Coronavirus as a possible cause of severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1319
        </fpage>
        <lpage>
         1325
        </lpage>
        <pub-id pub-id-type="pmid">
         12711465
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B14-viruses-04-03044">
       <label>
        14.
       </label>
       <element-citation publication-type="journal">
        <collab>
         WHO multicentre collaborative network for Severe Acute Respiratory Syndrome diagnosis
        </collab>
        <article-title>
         A multicentre collaboration to investigate the cause of severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1730
        </fpage>
        <lpage>
         1733
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(03)13376-4
        </pub-id>
        <pub-id pub-id-type="pmid">
         12767752
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B15-viruses-04-03044">
       <label>
        15.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arden
          </surname>
          <given-names>
           K.E.
          </given-names>
         </name>
         <name>
          <surname>
           Nissen
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Sloots
          </surname>
          <given-names>
           T.P.
          </given-names>
         </name>
         <name>
          <surname>
           Mackay
          </surname>
          <given-names>
           I.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         75
        </volume>
        <fpage>
         455
        </fpage>
        <lpage>
         462
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.20288
        </pub-id>
        <pub-id pub-id-type="pmid">
         15648064
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B16-viruses-04-03044">
       <label>
        16.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bastien
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Hart
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Van Caeseele
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Brandt
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Milley
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Hatchette
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Weiss
          </surname>
          <given-names>
           E.C.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human coronavirus NL63 infection in Canada
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         191
        </volume>
        <fpage>
         503
        </fpage>
        <lpage>
         506
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/426869
        </pub-id>
        <pub-id pub-id-type="pmid">
         15655772
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B17-viruses-04-03044">
       <label>
        17.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Mourez
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Dina
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           van der Hoek
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Gouarin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Petitjean
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Brouard
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human coronavirus NL63, France
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         11
        </volume>
        <fpage>
         1225
        </fpage>
        <lpage>
         1229
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1108.050110
        </pub-id>
        <pub-id pub-id-type="pmid">
         16102311
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B18-viruses-04-03044">
       <label>
        18.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Van der Hoek
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Sure
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Ihorst
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Stang
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Pyrc
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Jebbink
          </surname>
          <given-names>
           M.F.
          </given-names>
         </name>
         <name>
          <surname>
           Petersen
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Forster
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Berkhout
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Uberla
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Croup is associated with the novel coronavirus NL63
        </article-title>
        <source>
         PLoS Med.
        </source>
        <year>
         2005
        </year>
        <volume>
         2
        </volume>
        <fpage>
         e240
        </fpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pmed.0020240
        </pub-id>
        <pub-id pub-id-type="pmid">
         16104827
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B19-viruses-04-03044">
       <label>
        19.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gerna
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Percivalle
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Sarasini
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Campanini
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Piralla
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Rovida
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Genini
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Marchi
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Baldanti
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
        </article-title>
        <source>
         J. Clin. Virol.
        </source>
        <year>
         2007
        </year>
        <volume>
         38
        </volume>
        <fpage>
         244
        </fpage>
        <lpage>
         250
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jcv.2006.12.008
        </pub-id>
        <pub-id pub-id-type="pmid">
         17222582
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B20-viruses-04-03044">
       <label>
        20.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sloots
          </surname>
          <given-names>
           T.P.
          </given-names>
         </name>
         <name>
          <surname>
           McErlean
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Speicher
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Arden
          </surname>
          <given-names>
           K.E.
          </given-names>
         </name>
         <name>
          <surname>
           Nissen
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Mackay
          </surname>
          <given-names>
           I.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence of human coronavirus HKU1 and human bocavirus in Australian children
        </article-title>
        <source>
         J. Clin. Virol.
        </source>
        <year>
         2006
        </year>
        <volume>
         35
        </volume>
        <fpage>
         99
        </fpage>
        <lpage>
         102
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jcv.2005.09.008
        </pub-id>
        <pub-id pub-id-type="pmid">
         16257260
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B21-viruses-04-03044">
       <label>
        21.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chiu
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           K.W.
          </given-names>
         </name>
         <name>
          <surname>
           Kwan
          </surname>
          <given-names>
           S.W.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         40
        </volume>
        <fpage>
         1721
        </fpage>
        <lpage>
         1729
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/430301
        </pub-id>
        <pub-id pub-id-type="pmid">
         15909257
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B22-viruses-04-03044">
       <label>
        22.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kon
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Watanabe
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Tazawa
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Tamura
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Tsukagoshi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Noda
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kimura
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Mizuta
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of human coronavirus NL63 and OC43 in children with acute respiratory infections in Niigata, Japan, between 2010 and 2011
        </article-title>
        <source>
         Jpn. J. Infect. Dis.
        </source>
        <year>
         2012
        </year>
        <volume>
         65
        </volume>
        <fpage>
         270
        </fpage>
        <lpage>
         272
        </lpage>
        <pub-id pub-id-type="doi">
         10.7883/yoken.65.270
        </pub-id>
        <pub-id pub-id-type="pmid">
         22627314
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B23-viruses-04-03044">
       <label>
        23.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gerna
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Campanini
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Rovida
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Percivalle
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Sarasini
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Marchi
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Baldanti
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         2006
        </year>
        <volume>
         78
        </volume>
        <fpage>
         938
        </fpage>
        <lpage>
         949
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.20645
        </pub-id>
        <pub-id pub-id-type="pmid">
         16721849
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B24-viruses-04-03044">
       <label>
        24.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Esposito
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Bosis
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Niesters
          </surname>
          <given-names>
           H.G.
          </given-names>
         </name>
         <name>
          <surname>
           Tremolati
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Begliatti
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Rognoni
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Tagliabue
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Principi
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Impact of human coronavirus infections in otherwise healthy children who attended an emergency department
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         2006
        </year>
        <volume>
         78
        </volume>
        <fpage>
         1609
        </fpage>
        <lpage>
         1615
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.20745
        </pub-id>
        <pub-id pub-id-type="pmid">
         17063525
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B25-viruses-04-03044">
       <label>
        25.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Dina
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gouarin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Petitjean
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Tripey
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Brouard
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France
        </article-title>
        <source>
         J. Paediatr. Child. Health.
        </source>
        <year>
         2008
        </year>
        <volume>
         44
        </volume>
        <fpage>
         176
        </fpage>
        <lpage>
         181
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/j.1440-1754.2007.01246.x
        </pub-id>
        <pub-id pub-id-type="pmid">
         17999671
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B26-viruses-04-03044">
       <label>
        26.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           H.K.
          </given-names>
         </name>
         <name>
          <surname>
           Shepherd
          </surname>
          <given-names>
           B.E.
          </given-names>
         </name>
         <name>
          <surname>
           Crowe
          </surname>
          <given-names>
           J.E.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
         <name>
          <surname>
           Griffin
          </surname>
          <given-names>
           M.R.
          </given-names>
         </name>
         <name>
          <surname>
           Edwards
          </surname>
          <given-names>
           K.M.
          </given-names>
         </name>
         <name>
          <surname>
           Podsiad
          </surname>
          <given-names>
           A.B.
          </given-names>
         </name>
         <name>
          <surname>
           Tollefson
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
         <name>
          <surname>
           Wright
          </surname>
          <given-names>
           P.F.
          </given-names>
         </name>
         <name>
          <surname>
           Williams
          </surname>
          <given-names>
           J.V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The pediatric burden of human coronaviruses evaluated for twenty years
        </article-title>
        <source>
         Pediatr. Infect. Dis. J.
        </source>
        <year>
         2009
        </year>
        <volume>
         28
        </volume>
        <fpage>
         682
        </fpage>
        <lpage>
         687
        </lpage>
        <pub-id pub-id-type="doi">
         10.1097/INF.0b013e31819d0d27
        </pub-id>
        <pub-id pub-id-type="pmid">
         19633513
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B27-viruses-04-03044">
       <label>
        27.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Mourez
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Gouarin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Petitjean
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         An outbreak of coronavirus OC43 respiratory infection in Normandy, France
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2003
        </year>
        <volume>
         36
        </volume>
        <fpage>
         985
        </fpage>
        <lpage>
         989
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/374222
        </pub-id>
        <pub-id pub-id-type="pmid">
         12684910
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B28-viruses-04-03044">
       <label>
        28.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Van Elden
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           van Loon
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           van Alphen
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Hendriksen
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
         <name>
          <surname>
           Hoepelman
          </surname>
          <given-names>
           A.I.
          </given-names>
         </name>
         <name>
          <surname>
           van Kraaij
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Oosterheert
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
         <name>
          <surname>
           Schipper
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Schuurman
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Nijhuis
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <year>
         2004
        </year>
        <volume>
         189
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         657
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/381207
        </pub-id>
        <pub-id pub-id-type="pmid">
         14767819
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B29-viruses-04-03044">
       <label>
        29.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Riski
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Hovi
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus infections of man associated with diseases other than the common cold
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         1980
        </year>
        <volume>
         6
        </volume>
        <fpage>
         259
        </fpage>
        <lpage>
         265
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.1890060309
        </pub-id>
        <pub-id pub-id-type="pmid">
         6262459
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B30-viruses-04-03044">
       <label>
        30.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           H.K.
          </given-names>
         </name>
         <name>
          <surname>
           Crowe
          </surname>
          <given-names>
           J.E.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
         <name>
          <surname>
           Edwards
          </surname>
          <given-names>
           K.M.
          </given-names>
         </name>
         <name>
          <surname>
           Griffin
          </surname>
          <given-names>
           M.R.
          </given-names>
         </name>
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Weinberg
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
         <name>
          <surname>
           Szilagyi
          </surname>
          <given-names>
           P.G.
          </given-names>
         </name>
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Podsiad
          </surname>
          <given-names>
           A.B.
          </given-names>
         </name>
         <name>
          <surname>
           Iwane
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Coronavirus infection and hospitalizations for acute respiratory illness in young children
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         2009
        </year>
        <volume>
         81
        </volume>
        <fpage>
         853
        </fpage>
        <lpage>
         856
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.21443
        </pub-id>
        <pub-id pub-id-type="pmid">
         19319948
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B31-viruses-04-03044">
       <label>
        31.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Luk
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           G.K.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         192
        </volume>
        <fpage>
         1898
        </fpage>
        <lpage>
         1907
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/497151
        </pub-id>
        <pub-id pub-id-type="pmid">
         16267760
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B32-viruses-04-03044">
       <label>
        32.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gagneur
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Vallet
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Legr
          </surname>
          <given-names>
           M.C.
          </given-names>
         </name>
         <name>
          <surname>
           Picard
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <year>
         2002
        </year>
        <volume>
         51
        </volume>
        <fpage>
         59
        </fpage>
        <lpage>
         64
        </lpage>
        <pub-id pub-id-type="doi">
         10.1053/jhin.2002.1179
        </pub-id>
        <pub-id pub-id-type="pmid">
         12009822
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B33-viruses-04-03044">
       <label>
        33.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Soupre
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Legrand
          </surname>
          <given-names>
           M.C.
          </given-names>
         </name>
         <name>
          <surname>
           Giroux
          </surname>
          <given-names>
           J.D.
          </given-names>
         </name>
         <name>
          <surname>
           Rubio
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Cauvin
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chastel
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Alix
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           de Parscau
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Neonatal nosocomial respiratory infection with coronavirus: a prospective study in a neonatal intensive care unit
        </article-title>
        <source>
         Acta Paediatr.
        </source>
        <year>
         1995
        </year>
        <volume>
         84
        </volume>
        <fpage>
         617
        </fpage>
        <lpage>
         620
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/j.1651-2227.1995.tb13710.x
        </pub-id>
        <pub-id pub-id-type="pmid">
         7670241
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B34-viruses-04-03044">
       <label>
        34.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Falsey
          </surname>
          <given-names>
           A.R.
          </given-names>
         </name>
         <name>
          <surname>
           Walsh
          </surname>
          <given-names>
           E.E.
          </given-names>
         </name>
         <name>
          <surname>
           Hayden
          </surname>
          <given-names>
           F.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Rhinovirus and coronavirus infection-associated hospitalizations among older adults
        </article-title>
        <source>
         J. Infect. Dis.
        </source>
        <year>
         2002
        </year>
        <volume>
         185
        </volume>
        <fpage>
         1338
        </fpage>
        <lpage>
         1341
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/339881
        </pub-id>
        <pub-id pub-id-type="pmid">
         12001053
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B35-viruses-04-03044">
       <label>
        35.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nicholson
          </surname>
          <given-names>
           K.G.
          </given-names>
         </name>
         <name>
          <surname>
           Kent
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Hammersley
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Cancio
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden
        </article-title>
        <source>
         BMJ
        </source>
        <year>
         1997
        </year>
        <volume>
         315
        </volume>
        <fpage>
         1060
        </fpage>
        <lpage>
         1064
        </lpage>
        <pub-id pub-id-type="doi">
         10.1136/bmj.315.7115.1060
        </pub-id>
        <pub-id pub-id-type="pmid">
         9366736
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B36-viruses-04-03044">
       <label>
        36.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pene
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Merlat
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Rozenberg
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Buzyn
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Dreyfus
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Cariou
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Lebon
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus 229E-related pneumonia in immunocompromised patients
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2003
        </year>
        <volume>
         37
        </volume>
        <fpage>
         929
        </fpage>
        <lpage>
         932
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/377612
        </pub-id>
        <pub-id pub-id-type="pmid">
         13130404
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B37-viruses-04-03044">
       <label>
        37.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Folz
          </surname>
          <given-names>
           R.J.
          </given-names>
         </name>
         <name>
          <surname>
           Elkordy
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer
        </article-title>
        <source>
         Chest
        </source>
        <year>
         1999
        </year>
        <volume>
         115
        </volume>
        <fpage>
         901
        </fpage>
        <lpage>
         905
        </lpage>
        <pub-id pub-id-type="doi">
         10.1378/chest.115.3.901
        </pub-id>
        <pub-id pub-id-type="pmid">
         10084516
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B38-viruses-04-03044">
       <label>
        38.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chany
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Moscovici
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Lebon
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Rousset
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Association of coronavirus infection with neonatal necrotizing enterocolitis
        </article-title>
        <source>
         Pediatrics
        </source>
        <year>
         1982
        </year>
        <volume>
         69
        </volume>
        <fpage>
         209
        </fpage>
        <lpage>
         214
        </lpage>
        <pub-id pub-id-type="pmid">
         6276855
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B39-viruses-04-03044">
       <label>
        39.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Dina
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gouarin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Petitjean
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Corbet
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of the new human coronavirus HKU1: a report of 6 cases
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2006
        </year>
        <volume>
         42
        </volume>
        <fpage>
         634
        </fpage>
        <lpage>
         639
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/500136
        </pub-id>
        <pub-id pub-id-type="pmid">
         16447108
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B40-viruses-04-03044">
       <label>
        40.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           X.M.
          </given-names>
         </name>
         <name>
          <surname>
           Herbst
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Kousoulas
          </surname>
          <given-names>
           K.G.
          </given-names>
         </name>
         <name>
          <surname>
           Storz
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child
        </article-title>
        <source>
         J. Med. Virol.
        </source>
        <year>
         1994
        </year>
        <volume>
         44
        </volume>
        <fpage>
         152
        </fpage>
        <lpage>
         161
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/jmv.1890440207
        </pub-id>
        <pub-id pub-id-type="pmid">
         7852955
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B41-viruses-04-03044">
       <label>
        41.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arbour
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Cote
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Lachance
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Tardieu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Cashman
          </surname>
          <given-names>
           N.R.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acute and persistent infection of human neural cell lines by human coronavirus OC43
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         1999
        </year>
        <volume>
         73
        </volume>
        <fpage>
         3338
        </fpage>
        <lpage>
         3350
        </lpage>
        <pub-id pub-id-type="pmid">
         10074188
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B42-viruses-04-03044">
       <label>
        42.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arbour
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Ekande
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Cote
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Lachance
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Chagnon
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Tardieu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Cashman
          </surname>
          <given-names>
           N.R.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         1999
        </year>
        <volume>
         73
        </volume>
        <fpage>
         3326
        </fpage>
        <lpage>
         3337
        </lpage>
        <pub-id pub-id-type="pmid">
         10074187
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B43-viruses-04-03044">
       <label>
        43.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bonavia
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Arbour
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Yong
          </surname>
          <given-names>
           V.W.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         1997
        </year>
        <volume>
         71
        </volume>
        <fpage>
         800
        </fpage>
        <lpage>
         806
        </lpage>
        <pub-id pub-id-type="pmid">
         8985420
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B44-viruses-04-03044">
       <label>
        44.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arbour
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Day
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Newcombe
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Neuroinvasion by human respiratory coronaviruses
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2000
        </year>
        <volume>
         74
        </volume>
        <fpage>
         8913
        </fpage>
        <lpage>
         8921
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.74.19.8913-8921.2000
        </pub-id>
        <pub-id pub-id-type="pmid">
         10982334
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B45-viruses-04-03044">
       <label>
        45.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Murray
          </surname>
          <given-names>
           R.S.
          </given-names>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Brian
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Cabirac
          </surname>
          <given-names>
           G.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of coronavirus RNA and antigen in multiple sclerosis brain
        </article-title>
        <source>
         Ann. Neurol.
        </source>
        <year>
         1992
        </year>
        <volume>
         31
        </volume>
        <fpage>
         525
        </fpage>
        <lpage>
         533
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/ana.410310511
        </pub-id>
        <pub-id pub-id-type="pmid">
         1596089
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B46-viruses-04-03044">
       <label>
        46.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Stewart
          </surname>
          <given-names>
           J.N.
          </given-names>
         </name>
         <name>
          <surname>
           Mounir
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human coronavirus gene expression in the brains of multiple sclerosis patients
        </article-title>
        <source>
         Virology
        </source>
        <year>
         1992
        </year>
        <volume>
         191
        </volume>
        <fpage>
         502
        </fpage>
        <lpage>
         505
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/0042-6822(92)90220-J
        </pub-id>
        <pub-id pub-id-type="pmid">
         1413524
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B47-viruses-04-03044">
       <label>
        47.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           St-Jean
          </surname>
          <given-names>
           J.R.
          </given-names>
         </name>
         <name>
          <surname>
           Jacomy
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Desforges
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human respiratory coronavirus OC43: genetic stability and neuroinvasion
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2004
        </year>
        <volume>
         78
        </volume>
        <fpage>
         8824
        </fpage>
        <lpage>
         8834
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.78.16.8824-8834.2004
        </pub-id>
        <pub-id pub-id-type="pmid">
         15280490
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B48-viruses-04-03044">
       <label>
        48.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Riski
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Hovi
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Frick
          </surname>
          <given-names>
           M.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Carditis associated with coronavirus infection
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         1980
        </year>
        <volume>
         2
        </volume>
        <fpage>
         100
        </fpage>
        <lpage>
         101
        </lpage>
        <pub-id pub-id-type="pmid">
         6105240
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B49-viruses-04-03044">
       <label>
        49.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hsu
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ang
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Paton
          </surname>
          <given-names>
           N.I.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Villacian
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
         <name>
          <surname>
           Earnest
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Leo
          </surname>
          <given-names>
           Y.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2003
        </year>
        <volume>
         9
        </volume>
        <fpage>
         713
        </fpage>
        <lpage>
         717
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid0906.030264
        </pub-id>
        <pub-id pub-id-type="pmid">
         12781012
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B50-viruses-04-03044">
       <label>
        50.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poutanen
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Low
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Henry
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Finkelstein
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rose
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Tellier
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Draker
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Adachi
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Ayers
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Identification of severe acute respiratory syndrome in Canada
        </article-title>
        <source>
         N. Engl. J. Med.
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1995
        </fpage>
        <lpage>
         2005
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa030634
        </pub-id>
        <pub-id pub-id-type="pmid">
         12671061
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B51-viruses-04-03044">
       <label>
        51.
       </label>
       <element-citation publication-type="webpage">
        <collab>
         WHO (World Health Organization)
        </collab>
        <source>
         Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July
        </source>
        <date-in-citation>
         (Accessed on 21 February 2010)
        </date-in-citation>
        <comment>
         Available online:
         <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/country/table2004_04_21/en/index.html">
          http://www.who.int/csr/sars/country/table2004_04_21/en/index.html
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B52-viruses-04-03044">
       <label>
        52.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Cameron
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Joynt
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Ahuja
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           M.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           To
          </surname>
          <given-names>
           K.F.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A major outbreak of severe acute respiratory syndrome in Hong Kong
        </article-title>
        <source>
         N. Engl. J. Med.
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1986
        </fpage>
        <lpage>
         1994
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa030685
        </pub-id>
        <pub-id pub-id-type="pmid">
         12682352
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B53-viruses-04-03044">
       <label>
        53.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Varia
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Sarwal
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           McGeer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Gournis
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Galanis
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Henry
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada
        </article-title>
        <source>
         CMAJ
        </source>
        <year>
         2003
        </year>
        <volume>
         169
        </volume>
        <fpage>
         285
        </fpage>
        <lpage>
         292
        </lpage>
        <pub-id pub-id-type="pmid">
         12925421
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B54-viruses-04-03044">
       <label>
        54.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Zhong
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Cai
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Yin
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Deng
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Wei
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China
        </article-title>
        <source>
         J. Med. Microbiol.
        </source>
        <year>
         2003
        </year>
        <volume>
         52
        </volume>
        <fpage>
         715
        </fpage>
        <lpage>
         720
        </lpage>
        <pub-id pub-id-type="doi">
         10.1099/jmm.0.05320-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         12867568
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B55-viruses-04-03044">
       <label>
        55.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Booth
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Matukas
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Tomlinson
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
         <name>
          <surname>
           Rachlis
          </surname>
          <given-names>
           A.R.
          </given-names>
         </name>
         <name>
          <surname>
           Rose
          </surname>
          <given-names>
           D.B.
          </given-names>
         </name>
         <name>
          <surname>
           Dwosh
          </surname>
          <given-names>
           H.A.
          </given-names>
         </name>
         <name>
          <surname>
           Walmsley
          </surname>
          <given-names>
           S.L.
          </given-names>
         </name>
         <name>
          <surname>
           Mazzulli
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Avendano
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Derkach
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
        </article-title>
        <source>
         JAMA
        </source>
        <year>
         2003
        </year>
        <volume>
         289
        </volume>
        <fpage>
         2801
        </fpage>
        <lpage>
         2809
        </lpage>
        <pub-id pub-id-type="doi">
         10.1001/jama.289.21.JOC30885
        </pub-id>
        <pub-id pub-id-type="pmid">
         12734147
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B56-viruses-04-03044">
       <label>
        56.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Donnelly
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ghani
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Hedley
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Fraser
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Riley
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Abu-Raddad
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Thach
          </surname>
          <given-names>
           T.Q.
          </given-names>
         </name>
         <name>
          <surname>
           Chau
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1761
        </fpage>
        <lpage>
         1766
        </lpage>
        <pub-id pub-id-type="pmid">
         12781533
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B57-viruses-04-03044">
       <label>
        57.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Law
          </surname>
          <given-names>
           K.I.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Hon
          </surname>
          <given-names>
           T.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1767
        </fpage>
        <lpage>
         1772
        </lpage>
        <pub-id pub-id-type="pmid">
         12781535
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B58-viruses-04-03044">
       <label>
        58.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
         <name>
          <surname>
           Stohr
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The severe acute respiratory syndrome
        </article-title>
        <source>
         N. Engl. J. Med.
        </source>
        <year>
         2003
        </year>
        <volume>
         349
        </volume>
        <fpage>
         2431
        </fpage>
        <lpage>
         2441
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMra032498
        </pub-id>
        <pub-id pub-id-type="pmid">
         14681510
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B59-viruses-04-03044">
       <label>
        59.
       </label>
       <element-citation publication-type="webpage">
        <collab>
         WHO (World Health Organization)
        </collab>
        <article-title>
         Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)
        </article-title>
        <date-in-citation>
         (Accessed on 25-09-12)
        </date-in-citation>
        <comment>
         Available online:
         <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/en/WHOconsensus.pdf">
          http://www.who.int/csr/sars/en/WHOconsensus.pdf
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B60-viruses-04-03044">
       <label>
        60.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hamming
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Timens
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Bulthuis
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Lely
          </surname>
          <given-names>
           A.T.
          </given-names>
         </name>
         <name>
          <surname>
           Navis
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           van Goor
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
        </article-title>
        <source>
         J. Pathol.
        </source>
        <year>
         2004
        </year>
        <volume>
         203
        </volume>
        <fpage>
         631
        </fpage>
        <lpage>
         637
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/path.1570
        </pub-id>
        <pub-id pub-id-type="pmid">
         15141377
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B61-viruses-04-03044">
       <label>
        61.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Moore
          </surname>
          <given-names>
           M.J.
          </given-names>
         </name>
         <name>
          <surname>
           Vasilieva
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Sui
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Berne
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Somasundaran
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Sullivan
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Luzuriaga
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Greenough
          </surname>
          <given-names>
           T.C.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
        </article-title>
        <source>
         Nature
        </source>
        <year>
         2003
        </year>
        <volume>
         426
        </volume>
        <fpage>
         450
        </fpage>
        <lpage>
         454
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/nature02145
        </pub-id>
        <pub-id pub-id-type="pmid">
         14647384
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B62-viruses-04-03044">
       <label>
        62.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dwosh
          </surname>
          <given-names>
           H.A.
          </given-names>
         </name>
         <name>
          <surname>
           Hong
          </surname>
          <given-names>
           H.H.
          </given-names>
         </name>
         <name>
          <surname>
           Austgarden
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Herman
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Schabas
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Identification and containment of an outbreak of SARS in a community hospital
        </article-title>
        <source>
         CMAJ
        </source>
        <year>
         2003
        </year>
        <volume>
         168
        </volume>
        <fpage>
         1415
        </fpage>
        <lpage>
         1420
        </lpage>
        <pub-id pub-id-type="pmid">
         12771070
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B63-viruses-04-03044">
       <label>
        63.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Possible role of an animal vector in the SARS outbreak at Amoy Gardens
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         362
        </volume>
        <fpage>
         570
        </fpage>
        <lpage>
         572
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(03)14121-9
        </pub-id>
        <pub-id pub-id-type="pmid">
         12932393
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B64-viruses-04-03044">
       <label>
        64.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vijgen
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Keyaerts
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Moes
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Thoelen
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Wollants
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Lemey
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Vandamme
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Van Ranst
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         79
        </volume>
        <fpage>
         1595
        </fpage>
        <lpage>
         1604
        </lpage>
        <pub-id pub-id-type="pmid">
         15650185
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B65-viruses-04-03044">
       <label>
        65.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           S.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
        </article-title>
        <source>
         Proc. Natl. Acad. Sci. USA
        </source>
        <year>
         2005
        </year>
        <volume>
         102
        </volume>
        <fpage>
         14040
        </fpage>
        <lpage>
         14045
        </lpage>
        <pub-id pub-id-type="pmid">
         16169905
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B66-viruses-04-03044">
       <label>
        66.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Shi
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ren
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Epstein
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Crameri
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Hu
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Bats are natural reservoirs of SARS-like coronaviruses
        </article-title>
        <source>
         Science
        </source>
        <year>
         2005
        </year>
        <volume>
         310
        </volume>
        <fpage>
         676
        </fpage>
        <lpage>
         679
        </lpage>
        <pub-id pub-id-type="doi">
         10.1126/science.1118391
        </pub-id>
        <pub-id pub-id-type="pmid">
         16195424
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B67-viruses-04-03044">
       <label>
        67.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           D.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           O.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ellis
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           Y.H.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Suen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Identification of a novel coronavirus in bats
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         79
        </volume>
        <fpage>
         2001
        </fpage>
        <lpage>
         2009
        </lpage>
        <pub-id pub-id-type="pmid">
         15681402
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B68-viruses-04-03044">
       <label>
        68.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Yip
          </surname>
          <given-names>
           B.C.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Molecular diversity of coronaviruses in bats
        </article-title>
        <source>
         Virology
        </source>
        <year>
         2006
        </year>
        <volume>
         351
        </volume>
        <fpage>
         180
        </fpage>
        <lpage>
         187
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virol.2006.02.041
        </pub-id>
        <pub-id pub-id-type="pmid">
         16647731
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B69-viruses-04-03044">
       <label>
        69.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kan
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Jing
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Yan
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Liang
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Zheng
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Wan
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         79
        </volume>
        <fpage>
         11892
        </fpage>
        <lpage>
         11900
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.79.18.11892-11900.2005
        </pub-id>
        <pub-id pub-id-type="pmid">
         16140765
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B70-viruses-04-03044">
       <label>
        70.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
         <name>
          <surname>
           Michaelis
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells
        </article-title>
        <source>
         Int. J. Mol. Med.
        </source>
        <year>
         2005
        </year>
        <volume>
         15
        </volume>
        <fpage>
         323
        </fpage>
        <lpage>
         327
        </lpage>
        <pub-id pub-id-type="pmid">
         15647850
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B71-viruses-04-03044">
       <label>
        71.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bauer
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Chandra
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         2045
        </fpage>
        <lpage>
         2046
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0140-6736(03)13615-X
        </pub-id>
        <pub-id pub-id-type="pmid">
         12814717
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B72-viruses-04-03044">
       <label>
        72.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Michaelis
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Baer
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
        </person-group>
        <article-title>
         Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
        </article-title>
        <source>
         Biochem. Biophys. Res. Commun.
        </source>
        <year>
         2005
        </year>
        <volume>
         326
        </volume>
        <fpage>
         905
        </fpage>
        <lpage>
         908
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.bbrc.2004.11.128
        </pub-id>
        <pub-id pub-id-type="pmid">
         15607755
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B73-viruses-04-03044">
       <label>
        73.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mazzulli
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Farcas
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
         <name>
          <surname>
           Poutanen
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Willey
          </surname>
          <given-names>
           B.M.
          </given-names>
         </name>
         <name>
          <surname>
           Low
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Butany
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Asa
          </surname>
          <given-names>
           S.L.
          </given-names>
         </name>
         <name>
          <surname>
           Kain
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome-associated coronavirus in lung tissue
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2004
        </year>
        <volume>
         10
        </volume>
        <fpage>
         20
        </fpage>
        <lpage>
         24
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1001.030404
        </pub-id>
        <pub-id pub-id-type="pmid">
         15078592
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B74-viruses-04-03044">
       <label>
        74.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yamamoto
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Yoshinaka
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Amari
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Nakano
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Hunsmann
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Otaka
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
        </article-title>
        <source>
         Biochem. Biophys. Res. Commun.
        </source>
        <year>
         2004
        </year>
        <volume>
         318
        </volume>
        <fpage>
         719
        </fpage>
        <lpage>
         725
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.bbrc.2004.04.083
        </pub-id>
        <pub-id pub-id-type="pmid">
         15144898
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B75-viruses-04-03044">
       <label>
        75.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
          <suffix>
           Jr.
          </suffix>
         </name>
         <name>
          <surname>
           Michaelis
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Hoever
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of antiviral therapy for severe acute respiratory syndrome
        </article-title>
        <source>
         Antiviral Res.
        </source>
        <year>
         2005
        </year>
        <volume>
         66
        </volume>
        <fpage>
         81
        </fpage>
        <lpage>
         97
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.antiviral.2005.03.002
        </pub-id>
        <pub-id pub-id-type="pmid">
         15878786
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B76-viruses-04-03044">
       <label>
        76.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           B.L.
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronaviruses and their therapy
        </article-title>
        <source>
         Antiviral Res.
        </source>
        <year>
         2006
        </year>
        <volume>
         71
        </volume>
        <fpage>
         397
        </fpage>
        <lpage>
         403
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.antiviral.2006.05.019
        </pub-id>
        <pub-id pub-id-type="pmid">
         16837072
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B77-viruses-04-03044">
       <label>
        77.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bisht
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Roberts
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Vogel
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Bukreyev
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Collins
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
         <name>
          <surname>
           Murphy
          </surname>
          <given-names>
           B.R.
          </given-names>
         </name>
         <name>
          <surname>
           Subbarao
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Moss
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
        </article-title>
        <source>
         Proc. Natl. Acad. Sci. USA.
        </source>
        <year>
         2004
        </year>
        <volume>
         101
        </volume>
        <fpage>
         6641
        </fpage>
        <lpage>
         6646
        </lpage>
        <pub-id pub-id-type="pmid">
         15096611
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B78-viruses-04-03044">
       <label>
        78.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kapadia
          </surname>
          <given-names>
           S.U.
          </given-names>
         </name>
         <name>
          <surname>
           Rose
          </surname>
          <given-names>
           J.K.
          </given-names>
         </name>
         <name>
          <surname>
           Lamirande
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Vogel
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Subbarao
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Roberts
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
        </article-title>
        <source>
         Virology
        </source>
        <year>
         2005
        </year>
        <volume>
         340
        </volume>
        <fpage>
         174
        </fpage>
        <lpage>
         182
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virol.2005.06.016
        </pub-id>
        <pub-id pub-id-type="pmid">
         16043204
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B79-viruses-04-03044">
       <label>
        79.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Qin
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Ba
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Yi
          </surname>
          <given-names>
           C.E.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Wei
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           He
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         79
        </volume>
        <fpage>
         2678
        </fpage>
        <lpage>
         2688
        </lpage>
        <pub-id pub-id-type="pmid">
         15708987
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B80-viruses-04-03044">
       <label>
        80.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bukreyev
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Lamirande
          </surname>
          <given-names>
           E.W.
          </given-names>
         </name>
         <name>
          <surname>
           Buchholz
          </surname>
          <given-names>
           U.J.
          </given-names>
         </name>
         <name>
          <surname>
           Vogel
          </surname>
          <given-names>
           L.N.
          </given-names>
         </name>
         <name>
          <surname>
           Elkins
          </surname>
          <given-names>
           W.R.
          </given-names>
         </name>
         <name>
          <surname>
           St Claire
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Murphy
          </surname>
          <given-names>
           B.R.
          </given-names>
         </name>
         <name>
          <surname>
           Subbarao
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Collins
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2004
        </year>
        <volume>
         363
        </volume>
        <fpage>
         2122
        </fpage>
        <lpage>
         2127
        </lpage>
        <pub-id pub-id-type="pmid">
         15220033
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B81-viruses-04-03044">
       <label>
        81.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ishii
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Hasegawa
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Nagata
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Mizutani
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Morikawa
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Suzuki
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Taguchi
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Tashiro
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Takemori
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Miyamura
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
        </article-title>
        <source>
         Virology
        </source>
        <year>
         2006
        </year>
        <volume>
         351
        </volume>
        <fpage>
         368
        </fpage>
        <lpage>
         380
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virol.2006.03.020
        </pub-id>
        <pub-id pub-id-type="pmid">
         16678878
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B82-viruses-04-03044">
       <label>
        82.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           See
          </surname>
          <given-names>
           R.H.
          </given-names>
         </name>
         <name>
          <surname>
           Zakhartchouk
          </surname>
          <given-names>
           A.N.
          </given-names>
         </name>
         <name>
          <surname>
           Petric
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Lawrence
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Mok
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
         <name>
          <surname>
           Hogan
          </surname>
          <given-names>
           R.J.
          </given-names>
         </name>
         <name>
          <surname>
           Rowe
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Zitzow
          </surname>
          <given-names>
           L.A.
          </given-names>
         </name>
         <name>
          <surname>
           Karunakaran
          </surname>
          <given-names>
           K.P.
          </given-names>
         </name>
         <name>
          <surname>
           Hitt
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <year>
         2006
        </year>
        <volume>
         87
        </volume>
        <fpage>
         641
        </fpage>
        <lpage>
         650
        </lpage>
        <pub-id pub-id-type="doi">
         10.1099/vir.0.81579-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         16476986
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B83-viruses-04-03044">
       <label>
        83.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Czub
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Weingartl
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Czub
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           He
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Cao
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
        </article-title>
        <source>
         Vaccine
        </source>
        <year>
         2005
        </year>
        <volume>
         23
        </volume>
        <fpage>
         2273
        </fpage>
        <lpage>
         2279
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.vaccine.2005.01.033
        </pub-id>
        <pub-id pub-id-type="pmid">
         15755610
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B84-viruses-04-03044">
       <label>
        84.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           He
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Heck
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Lustigman
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2006
        </year>
        <volume>
         80
        </volume>
        <fpage>
         5757
        </fpage>
        <lpage>
         5767
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.00083-06
        </pub-id>
        <pub-id pub-id-type="pmid">
         16731915
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B85-viruses-04-03044">
       <label>
        85.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Post
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Chubet
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Holtz
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           McPherson
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Petric
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Cox
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
        </article-title>
        <source>
         Vaccine
        </source>
        <year>
         2006
        </year>
        <volume>
         24
        </volume>
        <fpage>
         3624
        </fpage>
        <lpage>
         3631
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.vaccine.2006.01.059
        </pub-id>
        <pub-id pub-id-type="pmid">
         16497416
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B86-viruses-04-03044">
       <label>
        86.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           He
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Siddiqui
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
        </article-title>
        <source>
         Biochem. Biophys. Res. Commun.
        </source>
        <year>
         2004
        </year>
        <volume>
         325
        </volume>
        <fpage>
         445
        </fpage>
        <lpage>
         452
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.bbrc.2004.10.052
        </pub-id>
        <pub-id pub-id-type="pmid">
         15530413
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B87-viruses-04-03044">
       <label>
        87.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Spruth
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kistner
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Savidis-Dacho
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Hitter
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Crowe
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Gerencer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Bruhl
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Grillberger
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Reiter
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Tauer
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
        </article-title>
        <source>
         Vaccine
        </source>
        <year>
         2006
        </year>
        <volume>
         24
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         661
        </lpage>
        <pub-id pub-id-type="pmid">
         16214268
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B88-viruses-04-03044">
       <label>
        88.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Qin
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ding
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Shi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Fang
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice
        </article-title>
        <source>
         DNA Cell Biol.
        </source>
        <year>
         2004
        </year>
        <volume>
         23
        </volume>
        <fpage>
         391
        </fpage>
        <lpage>
         394
        </lpage>
        <pub-id pub-id-type="doi">
         10.1089/104454904323145272
        </pub-id>
        <pub-id pub-id-type="pmid">
         15231072
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B89-viruses-04-03044">
       <label>
        89.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Xiong
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Y.F.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           M.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           X.J.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           C.H.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Qian
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           J.X.
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wan
          </surname>
          <given-names>
           Z.Y.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Immunogenicity of SARS inactivated vaccine in BALB/c mice
        </article-title>
        <source>
         Immunol. Lett.
        </source>
        <year>
         2004
        </year>
        <volume>
         95
        </volume>
        <fpage>
         139
        </fpage>
        <lpage>
         143
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.imlet.2004.06.014
        </pub-id>
        <pub-id pub-id-type="pmid">
         15388253
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B90-viruses-04-03044">
       <label>
        90.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Takasuka
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Fujii
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Takahashi
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kasai
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Morikawa
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Itamura
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Ishii
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Sakaguchi
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ohnishi
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Ohshima
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
        </article-title>
        <source>
         Int. Immunology
        </source>
        <year>
         2004
        </year>
        <volume>
         16
        </volume>
        <fpage>
         1423
        </fpage>
        <lpage>
         1430
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/intimm/dxh143
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B91-viruses-04-03044">
       <label>
        91.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Stadler
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Roberts
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Becker
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Vogel
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Eickmann
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Kolesnikova
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Klenk
          </surname>
          <given-names>
           H.D.
          </given-names>
         </name>
         <name>
          <surname>
           Murphy
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Rappuoli
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Abrignani
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         SARS vaccine protective in mice
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         11
        </volume>
        <fpage>
         1312
        </fpage>
        <lpage>
         1314
        </lpage>
        <pub-id pub-id-type="pmid">
         16110580
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B92-viruses-04-03044">
       <label>
        92.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Z.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           J.K.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           L.P.
          </given-names>
         </name>
         <name>
          <surname>
           He
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
        </article-title>
        <source>
         Vaccine
        </source>
        <year>
         2005
        </year>
        <volume>
         23
        </volume>
        <fpage>
         4959
        </fpage>
        <lpage>
         4968
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.vaccine.2005.05.023
        </pub-id>
        <pub-id pub-id-type="pmid">
         15993989
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B93-viruses-04-03044">
       <label>
        93.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Z.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kong
          </surname>
          <given-names>
           W.P.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Roberts
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Murphy
          </surname>
          <given-names>
           B.R.
          </given-names>
         </name>
         <name>
          <surname>
           Subbarao
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Nabel
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
        </article-title>
        <source>
         Nature
        </source>
        <year>
         2004
        </year>
        <volume>
         428
        </volume>
        <fpage>
         561
        </fpage>
        <lpage>
         564
        </lpage>
        <pub-id pub-id-type="pmid">
         15024391
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B94-viruses-04-03044">
       <label>
        94.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Ke
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Qin
          </surname>
          <given-names>
           Z.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ren
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           J.G.
          </given-names>
         </name>
         <name>
          <surname>
           Gao
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           S.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Qi
          </surname>
          <given-names>
           Z.T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         DNA vaccine of SARS-Cov S gene induces antibody response in mice
        </article-title>
        <source>
         Acta Biochim. Biophys. Sin.
        </source>
        <year>
         2004
        </year>
        <volume>
         36
        </volume>
        <fpage>
         37
        </fpage>
        <lpage>
         41
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/abbs/36.1.37
        </pub-id>
        <pub-id pub-id-type="pmid">
         14732873
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B95-viruses-04-03044">
       <label>
        95.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Yuan
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Matsumoto
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Hengge
          </surname>
          <given-names>
           U.R.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           Y.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice
        </article-title>
        <source>
         Biochem. Biophys. Res. Commun.
        </source>
        <year>
         2005
        </year>
        <volume>
         327
        </volume>
        <fpage>
         130
        </fpage>
        <lpage>
         135
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.bbrc.2004.11.147
        </pub-id>
        <pub-id pub-id-type="pmid">
         15629440
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B96-viruses-04-03044">
       <label>
        96.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Perlman
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Dandekar
          </surname>
          <given-names>
           A.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Immunopathogenesis of coronavirus infections: implications for SARS
        </article-title>
        <source>
         Nat. Rev. Immunol.
        </source>
        <year>
         2005
        </year>
        <volume>
         5
        </volume>
        <fpage>
         917
        </fpage>
        <lpage>
         927
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/nri1732
        </pub-id>
        <pub-id pub-id-type="pmid">
         16322745
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B97-viruses-04-03044">
       <label>
        97.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bolles
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Deming
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Long
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Agnihothram
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Whitmore
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Ferris
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Funkhouser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Gralinski
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Totura
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Heise
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2011
        </year>
        <volume>
         85
        </volume>
        <fpage>
         12201
        </fpage>
        <lpage>
         12215
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.06048-11
        </pub-id>
        <pub-id pub-id-type="pmid">
         21937658
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B98-viruses-04-03044">
       <label>
        98.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Deming
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Sheahan
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Heise
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Yount
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Davis
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Sims
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Suthar
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Harkema
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Whitmore
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Pickles
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
        </article-title>
        <source>
         PLoS Med.
        </source>
        <year>
         2006
        </year>
        <volume>
         3
        </volume>
        <fpage>
         e525
        </fpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pmed.0030525
        </pub-id>
        <pub-id pub-id-type="pmid">
         17194199
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B99-viruses-04-03044">
       <label>
        99.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lokugamage
          </surname>
          <given-names>
           K.G.
          </given-names>
         </name>
         <name>
          <surname>
           Yoshikawa-Iwata
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Ito
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Watts
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Wyde
          </surname>
          <given-names>
           P.R.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Newman
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Kent Tseng
          </surname>
          <given-names>
           C.T.
          </given-names>
         </name>
         <name>
          <surname>
           Peters
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
         <name>
          <surname>
           Makino
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
        </article-title>
        <source>
         Vaccine
        </source>
        <year>
         2008
        </year>
        <volume>
         26
        </volume>
        <fpage>
         797
        </fpage>
        <lpage>
         808
        </lpage>
        <pub-id pub-id-type="pmid">
         18191004
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B100-viruses-04-03044">
       <label>
        100.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yasui
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Kai
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Kitabatake
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Inoue
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Yoneda
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Yokochi
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Kase
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Sekiguchi
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Morita
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Hishima
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV
        </article-title>
        <source>
         J. Immunol.
        </source>
        <year>
         2008
        </year>
        <volume>
         181
        </volume>
        <fpage>
         6337
        </fpage>
        <lpage>
         6348
        </lpage>
        <pub-id pub-id-type="pmid">
         18941225
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B101-viruses-04-03044">
       <label>
        101.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tseng
          </surname>
          <given-names>
           C.T.
          </given-names>
         </name>
         <name>
          <surname>
           Sbrana
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Iwata-Yoshikawa
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Newman
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Garron
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Atmar
          </surname>
          <given-names>
           R.L.
          </given-names>
         </name>
         <name>
          <surname>
           Peters
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
         <name>
          <surname>
           Couch
          </surname>
          <given-names>
           R.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus
        </article-title>
        <source>
         PLoS ONE.
        </source>
        <year>
         2012
        </year>
        <volume>
         7
        </volume>
        <fpage>
         e35421
        </fpage>
        <pub-id pub-id-type="pmid">
         22536382
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B102-viruses-04-03044">
       <label>
        102.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Olsen
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           H.L.
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           T.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           A.F.
          </given-names>
         </name>
         <name>
          <surname>
           Fisk
          </surname>
          <given-names>
           T.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ooi
          </surname>
          <given-names>
           S.P.
          </given-names>
         </name>
         <name>
          <surname>
           Kuo
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Jiang
          </surname>
          <given-names>
           D.D.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           K.T.
          </given-names>
         </name>
         <name>
          <surname>
           Lando
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Transmission of the severe acute respiratory syndrome on aircraft
        </article-title>
        <source>
         N. Engl. J. Med.
        </source>
        <year>
         2003
        </year>
        <volume>
         349
        </volume>
        <fpage>
         2416
        </fpage>
        <lpage>
         2422
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa031349
        </pub-id>
        <pub-id pub-id-type="pmid">
         14681507
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B103-viruses-04-03044">
       <label>
        103.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           S.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The SARS epidemic in Hong Kong
        </article-title>
        <source>
         J. Epidemiol. Community Health.
        </source>
        <year>
         2003
        </year>
        <volume>
         57
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         654
        </lpage>
        <pub-id pub-id-type="doi">
         10.1136/jech.57.9.652
        </pub-id>
        <pub-id pub-id-type="pmid">
         12933765
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B104-viruses-04-03044">
       <label>
        104.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ijaz
          </surname>
          <given-names>
           M.K.
          </given-names>
         </name>
         <name>
          <surname>
           Brunner
          </surname>
          <given-names>
           A.H.
          </given-names>
         </name>
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Nair
          </surname>
          <given-names>
           R.C.
          </given-names>
         </name>
         <name>
          <surname>
           Johnson-Lussenburg
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival characteristics of airborne human coronavirus 229E
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <year>
         1985
        </year>
        <volume>
         66 ( Pt 12)
        </volume>
       </element-citation>
      </ref>
      <ref id="B105-viruses-04-03044">
       <label>
        105.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.F.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bauer
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability and inactivation of SARS coronavirus
        </article-title>
        <source>
         Med. Microbiol. Immunol.
        </source>
        <year>
         2005
        </year>
        <volume>
         194
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s00430-004-0219-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         15118911
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B106-viruses-04-03044">
       <label>
        106.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Duan
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           X.S.
          </given-names>
         </name>
         <name>
          <surname>
           Wen
          </surname>
          <given-names>
           R.F.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
         <name>
          <surname>
           Pi
          </surname>
          <given-names>
           G.H.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           S.X.
          </given-names>
         </name>
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Bi
          </surname>
          <given-names>
           S.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ruan
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Dong
          </surname>
          <given-names>
           X.P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation
        </article-title>
        <source>
         Biomed. Environ. Sci.
        </source>
        <year>
         2003
        </year>
        <volume>
         16
        </volume>
        <fpage>
         246
        </fpage>
        <lpage>
         255
        </lpage>
        <pub-id pub-id-type="pmid">
         14631830
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B107-viruses-04-03044">
       <label>
        107.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M.W.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <year>
         2000
        </year>
        <volume>
         46
        </volume>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="doi">
         10.1053/jhin.2000.0795
        </pub-id>
        <pub-id pub-id-type="pmid">
         11023724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B108-viruses-04-03044">
       <label>
        108.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           M.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of severe acute respiratory syndrome coronavirus
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         41
        </volume>
        <fpage>
         e67
        </fpage>
        <lpage>
         71
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/433186
        </pub-id>
        <pub-id pub-id-type="pmid">
         16142653
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B109-viruses-04-03044">
       <label>
        109.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y.C.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Su
          </surname>
          <given-names>
           C.P.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           Y.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           W.J.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           F.Y.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         SARS in hospital emergency room
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2004
        </year>
        <volume>
         10
        </volume>
        <fpage>
         782
        </fpage>
        <lpage>
         788
        </lpage>
        <pub-id pub-id-type="pmid">
         15200809
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B110-viruses-04-03044">
       <label>
        110.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dowell
          </surname>
          <given-names>
           S.F.
          </given-names>
         </name>
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D.D.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chaovavanich
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Javadi
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           J.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus on hospital surfaces
        </article-title>
        <source>
         Clin. Infect. Dis.
        </source>
        <year>
         2004
        </year>
        <volume>
         39
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         657
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/422652
        </pub-id>
        <pub-id pub-id-type="pmid">
         15356778
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B111-viruses-04-03044">
       <label>
        111.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of surrogate coronaviruses in water
        </article-title>
        <source>
         Water Res.
        </source>
        <year>
         2009
        </year>
        <volume>
         43
        </volume>
        <fpage>
         1893
        </fpage>
        <lpage>
         1898
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.watres.2009.02.002
        </pub-id>
        <pub-id pub-id-type="pmid">
         19246070
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B112-viruses-04-03044">
       <label>
        112.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lamarre
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effect of pH and temperature on the infectivity of human coronavirus 229E
        </article-title>
        <source>
         Can. J. Microbiol.
        </source>
        <year>
         1989
        </year>
        <volume>
         35
        </volume>
        <fpage>
         972
        </fpage>
        <lpage>
         974
        </lpage>
        <pub-id pub-id-type="pmid">
         2819602
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B113-viruses-04-03044">
       <label>
        113.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sturman
          </surname>
          <given-names>
           L.S.
          </given-names>
         </name>
         <name>
          <surname>
           Ricard
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <name>
          <surname>
           Holmes
          </surname>
          <given-names>
           K.V.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         1990
        </year>
        <volume>
         64
        </volume>
        <fpage>
         3042
        </fpage>
        <lpage>
         3050
        </lpage>
        <pub-id pub-id-type="pmid">
         2159562
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B114-viruses-04-03044">
       <label>
        114.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Daniel
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Physico-chemical properties of murine hepatitis virus, strain A 59. Brief report
        </article-title>
        <source>
         Arch. Virol.
        </source>
        <year>
         1987
        </year>
        <volume>
         96
        </volume>
        <fpage>
         241
        </fpage>
        <lpage>
         248
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/BF01320963
        </pub-id>
        <pub-id pub-id-type="pmid">
         2821963
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B115-viruses-04-03044">
       <label>
        115.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pocock
          </surname>
          <given-names>
           D.H.
          </given-names>
         </name>
         <name>
          <surname>
           Garwes
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The influence of pH on the growth and stability of transmissible gastroenteritis virus in vitro
        </article-title>
        <source>
         Arch. Virol.
        </source>
        <year>
         1975
        </year>
        <volume>
         49
        </volume>
        <fpage>
         239
        </fpage>
        <lpage>
         247
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/BF01317542
        </pub-id>
        <pub-id pub-id-type="pmid">
         2142
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B116-viruses-04-03044">
       <label>
        116.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pratelli
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Canine coronavirus inactivation with physical and chemical agents
        </article-title>
        <source>
         Vet. J.
        </source>
        <year>
         2008
        </year>
        <volume>
         177
        </volume>
        <fpage>
         71
        </fpage>
        <lpage>
         79
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.tvjl.2007.03.019
        </pub-id>
        <pub-id pub-id-type="pmid">
         17513145
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B117-viruses-04-03044">
       <label>
        117.
       </label>
       <element-citation publication-type="webpage">
        <collab>
         WHO (World Health Organization)
        </collab>
        <article-title>
         First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network
        </article-title>
        <date-in-citation>
         (Accessed on 16 February 2010)
        </date-in-citation>
        <comment>
         Available online:
         <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/survival_2003_05_04/en/index.html">
          http://www.who.int/csr/sars/survival_2003_05_04/en/index.html
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B118-viruses-04-03044">
       <label>
        118.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lipsitch
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Cohen
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Cooper
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Robins
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           James
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Gopalakrishna
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Chew
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tan
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Samore
          </surname>
          <given-names>
           M.H.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Transmission dynamics and control of severe acute respiratory syndrome
        </article-title>
        <source>
         Science
        </source>
        <year>
         2003
        </year>
        <volume>
         300
        </volume>
        <fpage>
         1966
        </fpage>
        <lpage>
         1970
        </lpage>
        <pub-id pub-id-type="pmid">
         12766207
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B119-viruses-04-03044">
       <label>
        119.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Riley
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Fraser
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Donnelly
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ghani
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Abu-Raddad
          </surname>
          <given-names>
           L.J.
          </given-names>
         </name>
         <name>
          <surname>
           Hedley
          </surname>
          <given-names>
           A.J.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           T.H.
          </given-names>
         </name>
         <name>
          <surname>
           Thach
          </surname>
          <given-names>
           T.Q.
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions
        </article-title>
        <source>
         Science
        </source>
        <year>
         2003
        </year>
        <volume>
         300
        </volume>
        <fpage>
         1961
        </fpage>
        <lpage>
         1966
        </lpage>
        <pub-id pub-id-type="pmid">
         12766206
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B120-viruses-04-03044">
       <label>
        120.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Ching
          </surname>
          <given-names>
           T.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           T.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1519
        </fpage>
        <lpage>
         1520
        </lpage>
        <pub-id pub-id-type="pmid">
         12737864
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B121-viruses-04-03044">
       <label>
        121.
       </label>
       <element-citation publication-type="journal">
        <collab>
         WHO (World Health Organization)
        </collab>
        <article-title>
         Global surveillance for Severe Acute Respiratory Syndrome (SARS)
        </article-title>
        <source>
         Wkly. Epidemiol. Rec.
        </source>
        <year>
         2003
        </year>
        <volume>
         78
        </volume>
        <fpage>
         100
        </fpage>
        <lpage>
         109
        </lpage>
        <pub-id pub-id-type="pmid">
         12723282
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B122-viruses-04-03044">
       <label>
        122.
       </label>
       <element-citation publication-type="other">
        <collab>
         AFNOR
        </collab>
        <article-title>
         Chemical disinfectants and- Virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine - Test method and requirements (phase 2, step 1). NF EN 14476+A1
        </article-title>
        <year>
         2007
        </year>
       </element-citation>
      </ref>
      <ref id="B123-viruses-04-03044">
       <label>
        123.
       </label>
       <element-citation publication-type="other">
        <collab>
         ASTM
        </collab>
        <article-title>
         Standard Test Method for Efficacy of Virucidal Agents Intended for Inanimate Environmental Surfaces. E1053-97 (last reapproval in 2002)
        </article-title>
        <year>
         1997
        </year>
       </element-citation>
      </ref>
      <ref id="B124-viruses-04-03044">
       <label>
        124.
       </label>
       <element-citation publication-type="other">
        <collab>
         ASTM
        </collab>
        <source>
         Standard Test Method for Efficacy of Antimicrobial Agents Against Viruses in Suspension. E1052-96 (last reapproval in 2002)
        </source>
        <year>
         1996
        </year>
       </element-citation>
      </ref>
      <ref id="B125-viruses-04-03044">
       <label>
        125.
       </label>
       <element-citation publication-type="other">
        <collab>
         ASTM
        </collab>
        <article-title>
         Standard Test Method for Neutralization of Virucidal Agents in Virucidal Efficacy Evaluations. E1482-04
        </article-title>
        <year>
         2004
        </year>
       </element-citation>
      </ref>
      <ref id="B126-viruses-04-03044">
       <label>
        126.
       </label>
       <element-citation publication-type="other">
        <collab>
         ASTM (American Society for Testing and Materials)
        </collab>
        <article-title>
         Standard Test Method for Determining the Virus-Eliminating Effectiveness of Liquid Hygienic Handwash and Handrub Agents Using the Fingerpads of Adult Volunteers. E1838-02
        </article-title>
        <year>
         2002
        </year>
       </element-citation>
      </ref>
      <ref id="B127-viruses-04-03044">
       <label>
        127.
       </label>
       <element-citation publication-type="other">
        <collab>
         ASTM (American Society for Testing and Materials)
        </collab>
        <article-title>
         Standard Test Method for Evaluation of Hygienic Handwash and Handrub Formulations for Virus-Eliminating Activity Using the Entire Hand. E2011-09
        </article-title>
        <year>
         2009
        </year>
       </element-citation>
      </ref>
      <ref id="B128-viruses-04-03044">
       <label>
        128.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Springthorpe
          </surname>
          <given-names>
           V.S.
          </given-names>
         </name>
         <name>
          <surname>
           Karim
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Loro
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses
        </article-title>
        <source>
         Epidemiol. Infect.
        </source>
        <year>
         1989
        </year>
        <volume>
         102
        </volume>
        <fpage>
         493
        </fpage>
        <lpage>
         505
        </lpage>
        <pub-id pub-id-type="doi">
         10.1017/S0950268800030211
        </pub-id>
        <pub-id pub-id-type="pmid">
         2737256
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B129-viruses-04-03044">
       <label>
        129.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kariwa
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Fujii
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Takashima
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents
        </article-title>
        <source>
         Dermatology.
        </source>
        <year>
         2006
        </year>
        <volume>
         212 Suppl 1
        </volume>
        <fpage>
         119
        </fpage>
        <lpage>
         123
        </lpage>
        <pub-id pub-id-type="pmid">
         16490989
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B130-viruses-04-03044">
       <label>
        130.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Geller
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Fontanay
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Finance
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Duval
          </surname>
          <given-names>
           R.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A new Sephadex-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model
        </article-title>
        <source>
         J. Virol. Methods.
        </source>
        <year>
         2009
        </year>
        <volume>
         159
        </volume>
        <fpage>
         217
        </fpage>
        <lpage>
         226
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jviromet.2009.03.023
        </pub-id>
        <pub-id pub-id-type="pmid">
         19490977
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B131-viruses-04-03044">
       <label>
        131.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Geller
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Fontanay
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Mourer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Dibama
          </surname>
          <given-names>
           H.M.
          </given-names>
         </name>
         <name>
          <surname>
           Regnouf-de-Vains
          </surname>
          <given-names>
           J.B.
          </given-names>
         </name>
         <name>
          <surname>
           Finance
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Duval
          </surname>
          <given-names>
           R.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E
        </article-title>
        <source>
         Antiviral Res.
        </source>
        <year>
         2010
        </year>
        <volume>
         88
        </volume>
        <fpage>
         343
        </fpage>
        <lpage>
         346
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.antiviral.2010.09.009
        </pub-id>
        <pub-id pub-id-type="pmid">
         20854844
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B132-viruses-04-03044">
       <label>
        132.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.F.
          </given-names>
         </name>
         <name>
          <surname>
           Kampf
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Efficacy of various disinfectants against SARS coronavirus
        </article-title>
        <source>
         J. Hosp. Infect.
        </source>
        <year>
         2005
        </year>
        <volume>
         61
        </volume>
        <fpage>
         107
        </fpage>
        <lpage>
         111
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2004.12.023
        </pub-id>
        <pub-id pub-id-type="pmid">
         15923059
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B133-viruses-04-03044">
       <label>
        133.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hulkower
          </surname>
          <given-names>
           R.L.
          </given-names>
         </name>
         <name>
          <surname>
           Casanova
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of surrogate coronaviruses on hard surfaces by health care germicides
        </article-title>
        <source>
         Am. J. Infect. Control.
        </source>
        <year>
         2011
        </year>
        <volume>
         39
        </volume>
        <fpage>
         401
        </fpage>
        <lpage>
         407
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2010.08.011
        </pub-id>
        <pub-id pub-id-type="pmid">
         21256627
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B134-viruses-04-03044">
       <label>
        134.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dellanno
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Vega
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Boesenberg
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus
        </article-title>
        <source>
         Am. J. Infect. Control.
        </source>
        <year>
         2009
        </year>
        <volume>
         37
        </volume>
        <fpage>
         649
        </fpage>
        <lpage>
         652
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2009.03.012
        </pub-id>
        <pub-id pub-id-type="pmid">
         19692148
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Int J Biol Sci
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Int. J. Biol. Sci
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       ijbs
      </journal-id>
      <journal-title-group>
       <journal-title>
        International Journal of Biological Sciences
       </journal-title>
      </journal-title-group>
      <issn pub-type="epub">
       1449-2288
      </issn>
      <publisher>
       <publisher-name>
        Ivyspring International Publisher
       </publisher-name>
       <publisher-loc>
        Sydney
       </publisher-loc>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       32226295
      </article-id>
      <article-id pub-id-type="pmc">
       7098028
      </article-id>
      <article-id pub-id-type="doi">
       10.7150/ijbs.45134
      </article-id>
      <article-id pub-id-type="publisher-id">
       ijbsv16p1753
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Review
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        COVID-19: what has been learned and to be learned about the novel coronavirus disease
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Yi
         </surname>
         <given-names>
          Ye
         </given-names>
        </name>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Lagniton
         </surname>
         <given-names>
          Philip N.P.
         </given-names>
        </name>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Ye
         </surname>
         <given-names>
          Sen
         </given-names>
        </name>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Enqin
         </given-names>
        </name>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Xu
         </surname>
         <given-names>
          Ren-He
         </given-names>
        </name>
        <xref ref-type="corresp" rid="FNA_envelop">
         ✉
        </xref>
       </contrib>
      </contrib-group>
      <aff>
       Institute of Translational Medicine, and Centre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.
      </aff>
      <author-notes>
       <corresp id="FNA_envelop">
        ✉ Corresponding author: Ren-He Xu, Faculty of Health Sciences, University of Macau, Taipa, Macau, China. Tel: 853-8822-4993; Fax: 853-8822-8345; Email address:
        <email>
         renhexu@um.edu.mo
        </email>
        .
       </corresp>
       <fn fn-type="COI-statement">
        <p>
         Competing Interests: R.X. is a founder of ImStem Biotechnology, Inc., a stem cell company. The other authors declare no competing financial interests.
        </p>
       </fn>
      </author-notes>
      <pub-date pub-type="collection">
       <year>
        2020
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        15
       </day>
       <month>
        3
       </month>
       <year>
        2020
       </year>
      </pub-date>
      <volume>
       16
      </volume>
      <issue>
       10
      </issue>
      <fpage>
       1753
      </fpage>
      <lpage>
       1766
      </lpage>
      <history>
       <date date-type="received">
        <day>
         20
        </day>
        <month>
         2
        </month>
        <year>
         2020
        </year>
       </date>
       <date date-type="accepted">
        <day>
         29
        </day>
        <month>
         2
        </month>
        <year>
         2020
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © The author(s)
       </copyright-statement>
       <copyright-year>
        2020
       </copyright-year>
       <license license-type="open-access">
        <license-p>
         This is an open access article distributed under the terms of the Creative Commons Attribution License (
         <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          https://creativecommons.org/licenses/by/4.0/
         </ext-link>
         ). See
         <ext-link ext-link-type="uri" xlink:href="http://ivyspring.com/terms">
          http://ivyspring.com/terms
         </ext-link>
         for full terms and conditions.
        </license-p>
       </license>
      </permissions>
      <abstract>
       <p>
        The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans. Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism. However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women. In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject. We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease. Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease.
       </p>
      </abstract>
      <kwd-group>
       <kwd>
        Coronavirus
       </kwd>
       <kwd>
        pneumonia
       </kwd>
       <kwd>
        outbreak
       </kwd>
       <kwd>
        SARS-CoV-2
       </kwd>
       <kwd>
        COVID-19
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <sec sec-type="intro">
     <title>
      Introduction
     </title>
     <p>
      The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease. The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19)
      <xref ref-type="bibr" rid="B1">
       1
      </xref>
      . The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world. As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died. WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism
      <xref ref-type="bibr" rid="B2">
       2
      </xref>
      .
     </p>
     <p>
      According to PubMed (
      <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/">
       https://www.ncbi.nlm.nih.gov/pubmed/
      </ext-link>
      ), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients
      <xref ref-type="bibr" rid="B3">
       3
      </xref>
      . This review attempts to summarize the research progress in the new and swiftly developing subject area. Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012). We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions.
     </p>
    </sec>
    <sec>
     <title>
      The outbreak
     </title>
     <p>
      CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds
      <xref ref-type="bibr" rid="B4">
       4
      </xref>
      . However, in this century, we have encountered highly pathogenic human CoVs twice,
      <italic>
       i.e.
      </italic>
      , SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality
      <xref ref-type="bibr" rid="B5">
       5
      </xref>
      . Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans.
     </p>
     <p>
      As shown in Fig.
      <xref ref-type="fig" rid="F1">
       1
      </xref>
      , clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission
      <xref ref-type="bibr" rid="B6">
       6
      </xref>
      . Seven days later the sequence of the CoV was released
      <xref ref-type="bibr" rid="B7">
       7
      </xref>
      . On January 15, 2020 the first fatal case from Wuhan was reported
      <xref ref-type="bibr" rid="B6">
       6
      </xref>
      . Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries. On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible
      <xref ref-type="bibr" rid="B8">
       8
      </xref>
      . On January 23, the city of Wuhan was locked down with all its public transportation stopped. On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source
      <xref ref-type="bibr" rid="B6">
       6
      </xref>
      . On January 30, WHO declared the outbreak a global health emergency. By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig.
      <xref ref-type="fig" rid="F2">
       2
      </xref>
      ). As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined.
     </p>
     <p>
      On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (
      <ext-link ext-link-type="uri" xlink:href="https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA">
       https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA
      </ext-link>
      ).
      <list list-type="bullet">
       <list-item>
        <p>
         SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65. Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10.
        </p>
       </list-item>
       <list-item>
        <p>
         SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000).
        </p>
       </list-item>
       <list-item>
        <p>
         COVID-19 expanded in clusters mainly in and around Hubei.
        </p>
       </list-item>
       <list-item>
        <p>
         COVID-19 took an average of 5 (2-9) days from onset to diagnosis. The average incubation period was 4.8 (3.0-7.2) days. The average time from onset to death was 9.5 (4.8-13) days.
        </p>
       </list-item>
       <list-item>
        <p>
         The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82.
        </p>
       </list-item>
       <list-item>
        <p>
         The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China.
        </p>
       </list-item>
       <list-item>
        <p>
         The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%).
        </p>
       </list-item>
       <list-item>
        <p>
         Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia.
        </p>
       </list-item>
      </list>
     </p>
    </sec>
    <sec>
     <title>
      SARS-CoV-2
     </title>
     <sec>
      <title>
       Etiology
      </title>
      <p>
       CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA. They can be divided into four genera,
       <italic>
        i.e
       </italic>
       ., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans
       <xref ref-type="bibr" rid="B11">
        11
       </xref>
       . The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs
       <xref ref-type="bibr" rid="B12">
        12
       </xref>
       . The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus
       <xref ref-type="bibr" rid="B13">
        13
       </xref>
       .
      </p>
      <p>
       The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020
       <xref ref-type="bibr" rid="B3">
        3
       </xref>
       . SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan. SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV
       <xref ref-type="bibr" rid="B14">
        14
       </xref>
       -
       <xref ref-type="bibr" rid="B16">
        16
       </xref>
       . Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium
       <xref ref-type="bibr" rid="B17">
        17
       </xref>
       . Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV
       <xref ref-type="bibr" rid="B16">
        16
       </xref>
       ,
       <xref ref-type="bibr" rid="B18">
        18
       </xref>
       ,
       <xref ref-type="bibr" rid="B19">
        19
       </xref>
       . However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV
       <xref ref-type="bibr" rid="B14">
        14
       </xref>
       .
      </p>
      <p>
       SARS-CoV-2 can also form a novel short protein encoded by
       <italic>
        orf3b
       </italic>
       and a secreted protein encoded by
       <italic>
        orf8
       </italic>
       . The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of
       <italic>
        IFNβ
       </italic>
       ; however, orf8 does not contain any known functional domain or motif
       <xref ref-type="bibr" rid="B20">
        20
       </xref>
       . On February 18, 2020, Zhou,
       <italic>
        et al.
       </italic>
       , reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B
       <sup>
        0
       </sup>
       AT1
       <xref ref-type="bibr" rid="B21">
        21
       </xref>
       . They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B
       <sup>
        0
       </sup>
       AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection. B
       <sup>
        0
       </sup>
       AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection.
      </p>
     </sec>
     <sec>
      <title>
       The origin and intermediate host
      </title>
      <p>
       It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively. Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21
       <xref ref-type="bibr" rid="B14">
        14
       </xref>
       -
       <xref ref-type="bibr" rid="B16">
        16
       </xref>
       ,
       <xref ref-type="bibr" rid="B19">
        19
       </xref>
       . However, what intermediate host helped the virus cross the species barrier to infect humans remains unknown, and the transmission route is yet to be elucidated. Ji,
       <italic>
        et al
       </italic>
       ., proposed snakes as a carrier of the virus from bats to humans which involved homologous recombination within the S protein
       <xref ref-type="bibr" rid="B22">
        22
       </xref>
       . According to a study, researchers in Guangzhou, China, suggested that pangolins - long-snouted, ant-eating mammals often used in traditional Chinese medicine - are the potential intermediate host of SARS-CoV-2 based on 99% genetic homology in a CoV discovered in pangolins and SARS-CoV-2
       <xref ref-type="bibr" rid="B23">
        23
       </xref>
       . However, 1% difference spread all over two genomes is still a big difference; thus, conclusive results for concrete evidence are awaited (Fig.
       <xref ref-type="fig" rid="F3">
        3
       </xref>
       ).
      </p>
     </sec>
     <sec>
      <title>
       Physicochemical properties
      </title>
      <p>
       The physicochemical properties of SARS-CoV-2 are largely not yet known. SARS-CoV and MERS-CoV can survive
       <italic>
        in vitro
       </italic>
       for 48 hours in a dry environment and up to 5 days under 20 °C and 40%-50% humidity
       <xref ref-type="bibr" rid="B24">
        24
       </xref>
       -
       <xref ref-type="bibr" rid="B26">
        26
       </xref>
       . SARS-CoV-2 may possess similar properties. It has been reported that SARS-CoV-2 is sensitive to ultraviolet rays and heat at 56 °C for 30 minutes; ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid, chloroform, and other fatty solvents, but not chlorhexidine, can effectively inactivate the virus
       <xref ref-type="bibr" rid="B27">
        27
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Immune responses to CoVs
      </title>
      <p>
       The entire human population generally lacks immunity to SARS-CoV-2 and hence is susceptible to the novel virus. Currently, no detailed study has been reported regarding the immunological response to SARS-CoV-2. Thus, we can only refer to previous studies on other CoVs, especially SARS-CoV and MERS-CoV (Fig.
       <xref ref-type="fig" rid="F4">
        4
       </xref>
       ). In general, after a virus invades the host, it is first recognized by the host innate immune system through pattern recognition receptors (PRRs) including C-type lectin-like receptors, Toll-like receptor (TLR), NOD-like receptor (NLR), and RIG-I-like receptor (RLR)
       <xref ref-type="bibr" rid="B28">
        28
       </xref>
       . Through different pathways, the virus induces the expression of inflammatory factors, maturation of dendritic cells, and synthesis of type I interferons (IFNs) which limit the spreading of the virus and accelerate macrophage phagocytosis of viral antigens
       <xref ref-type="bibr" rid="B28">
        28
       </xref>
       . However, the N protein of SARS-CoV can help the virus escape from the immune responses
       <xref ref-type="bibr" rid="B29">
        29
       </xref>
       .
      </p>
      <p>
       Soon, the adaptive immune response joins the fight against the virus. T lymphocytes including CD4
       <sup>
        +
       </sup>
       and CD8
       <sup>
        +
       </sup>
       T cells play an important role in the defense. CD4
       <sup>
        +
       </sup>
       T cells stimulate B cells to produce virus-specific antibodies, and CD8
       <sup>
        +
       </sup>
       T cells directly kill virus-infected cells. T helper cells produce proinflammatory cytokines to help the defending cells. However, CoV can inhibit T cell functions by inducing apoptosis of T cells. The humoral immunity including complements such as C3a and C5a and antibodies is also essential in combating the viral infection
       <xref ref-type="bibr" rid="B30">
        30
       </xref>
       ,
       <xref ref-type="bibr" rid="B31">
        31
       </xref>
       . For example, antibodies isolated from a recovered patient neutralized MERS-CoV
       <xref ref-type="bibr" rid="B32">
        32
       </xref>
       . On the other hand, an overreaction of the immune system generates a large number of free radicals locally that can cause severe damages to the lungs and other organs, and, in the worst scenario, multi-organ failure and even death
       <xref ref-type="bibr" rid="B33">
        33
       </xref>
       .
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      Clinical features
     </title>
     <sec>
      <title>
       The incubation periods
      </title>
      <p>
       The SARS-CoV-2 infection, featured by clustering onset, is more likely to affect elderly people with comorbidities and pregnant women
       <xref ref-type="bibr" rid="B8">
        8
       </xref>
       . It is common that for people who are exposed to a large number of viruses or whose immune functions are compromised, they have higher chance to be infected than others. The estimated mean incubation period of SARS-CoV-2 is 1-14 days, mostly 3-7 days based on a study of the first 425 cases in Wuhan
       <xref ref-type="bibr" rid="B36">
        36
       </xref>
       . However, a study on 1,099 cases demonstrates that the incubation period was 3 days on average and ranged from 0 to 24 days
       <xref ref-type="bibr" rid="B8">
        8
       </xref>
       . A more recent study, as described above, demonstrates that the incubation period was 4.8 (3.0-7.2) days based on the demography of 8,866 cases
       <xref ref-type="bibr" rid="B37">
        37
       </xref>
       . It is very important for health authorities to adjust the effective quarantine time based on the most accurate incubation period, thus preventing infected but symptomless people from transmitting the virus to others
       <xref ref-type="bibr" rid="B38">
        38
       </xref>
       . As a common practice, individuals exposed to, or infected by, the virus are usually required to be quarantined for 14 days. Should the quarantine time be extended to 24 days?
      </p>
     </sec>
     <sec>
      <title>
       Symptoms
      </title>
      <p>
       Fever is often the major and initial symptom of COVID-19, which can be accompanied by no symptom or other symptoms such as dry cough, shortness of breath, muscle ache, dizziness, headache, sore throat, rhinorrhea, chest pain, diarrhea, nausea, and vomiting. Some patients experienced dyspnea and/or hypoxemia one week after the onset of the disease
       <xref ref-type="bibr" rid="B8">
        8
       </xref>
       . In severe cases, patients quickly progressed to develop acute respiratory syndrome, septic shock, metabolic acidosis, and coagulopathy. Patients with fever and/or respiratory symptoms and acute fever, even without pulmonary imaging abnormalities, should be screened for the virus for early diagnosis
       <xref ref-type="bibr" rid="B39">
        39
       </xref>
       -
       <xref ref-type="bibr" rid="B41">
        41
       </xref>
       .
      </p>
      <p>
       A demographic study in late December of 2019 showed that the percentages of the symptoms were 98% for fever, 76% for dry cough, 55% for dyspnea, and 3% for diarrhea; 8% of the patients required ventilation support
       <xref ref-type="bibr" rid="B42">
        42
       </xref>
       . Similar findings were reported in two recent studies of a family cluster and a cluster caused by transmission from an asymptomatic individual
       <xref ref-type="bibr" rid="B43">
        43
       </xref>
       ,
       <xref ref-type="bibr" rid="B44">
        44
       </xref>
       . Comparably, a demographic study in 2012 showed that MERS-CoV patients also had fever (98%), dry cough (47%), and dyspnea (55%) as their main symptoms. However, 80% of them required ventilation support, much more than COVID-19 patients and consistent with the higher lethality of MERS than of COVID-19. Diarrhea (26%) and sore throat (21%) were also observed with MERS patients. In SARS patients, it has been demonstrated that fever (99%-100%), dry cough (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), and sore throat (13-25%) were the major symptoms and ventilation support was required for approximately 14%-20% of the patients
       <xref ref-type="bibr" rid="B45">
        45
       </xref>
       .
      </p>
      <p>
       By February 14, the mortality of COVID-19 was 2% when the confirmed cases reached 66,576 globally. Comparably, the mortality of SARS by November 2002 was 10% of 8,096 confirmed cases
       <xref ref-type="bibr" rid="B46">
        46
       </xref>
       . For MERS, based on a demographic study in June 2012, the mortality was 37% of 2,494 confirmed cases
       <xref ref-type="bibr" rid="B47">
        47
       </xref>
       . An earlier study reported that the R0 of SARS-CoV-2 was as high as 6.47 with a 95% confidence interval (CI) of 5.71-7.23
       <xref ref-type="bibr" rid="B48">
        48
       </xref>
       , whereas the R0 of SARS-CoV only ranged from 2 to 4
       <xref ref-type="bibr" rid="B49">
        49
       </xref>
       . A comparison of SARS-CoV-2 with MERS-CoV and SARA-CoV regarding their symptoms, mortality, and R0 is presented in Table
       <xref ref-type="table" rid="T1">
        1
       </xref>
       . The above figures suggest that SARS-CoV-2 has a higher ability to spread than MERS-CoV and SARS-CoV, but it is less lethal than the latter two
       <xref ref-type="bibr" rid="B6">
        6
       </xref>
       . Thus, it is much more challenging to control the epidemic of SARS-CoV-2 than those of MERS-CoV and SARS-CoV.
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      Diagnosis
     </title>
     <sec>
      <title>
       Patient history
      </title>
      <p>
       Clustered onset often happens in the same family or from the same gathering or vehicle such as a cruise ship. Patients often have a history of travel or residence in Wuhan or other affected areas or contact with infected individuals or patients in the recent two weeks before the onset
       <xref ref-type="bibr" rid="B50">
        50
       </xref>
       . However, it has been reported that people can carry the virus without symptoms longer than two weeks and cured patients discharged from hospitals can carry the virus again
       <xref ref-type="bibr" rid="B51">
        51
       </xref>
       , which sends out an alarm to increase the time for quarantine.
      </p>
     </sec>
     <sec>
      <title>
       Laboratory results
      </title>
      <p>
       Patients have normal or reduced number of peripheral white blood cells (especially lymphocytes) at the early stage. For example, lymphopenia with white blood cell count &lt; 4×10
       <sup>
        9
       </sup>
       /L including lymphocyte count &lt; 1×10
       <sup>
        9
       </sup>
       /L, and elevated aspartate aminotransferase levels and viremia were found in 1,099 COVID-19 patients
       <xref ref-type="bibr" rid="B8">
        8
       </xref>
       . The levels of liver and muscle enzymes and myoglobin were increased in the blood of some patients, and C-reactive protein and erythrocyte sedimentation were increased in the blood of most patients
       <xref ref-type="bibr" rid="B52">
        52
       </xref>
       . In patients with severe cases, the level of D-dimer, a fibrin degradation product present in the blood, was elevated, and lymphocyte count was progressively reduced
       <xref ref-type="bibr" rid="B34">
        34
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Radiography
      </title>
      <p>
       Abnormalities in chest radiography are found in most COVID-19 patients and featured by bilateral patchy shadows or ground glass opacity in the lungs. Patients often develop an atypical pneumonia, acute lung injury, and acute respiratory distress syndrome (ARDS)
       <xref ref-type="bibr" rid="B34">
        34
       </xref>
       . When ARDS happens, uncontrolled inflammation, fluid accumulation, and progressive fibrosis severely compromise the gas exchange. Dysfunction of type-I and type-II pneumocytes decreases the surfactant level and increases surface tension, thus reducing the ability of the lungs to expand and heightening the risk of lung collapse
       <xref ref-type="bibr" rid="B53">
        53
       </xref>
       ,
       <xref ref-type="bibr" rid="B54">
        54
       </xref>
       . Therefore, the worst chest radiographic findings often parallel the most severe extent of the disease
       <xref ref-type="bibr" rid="B55">
        55
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Pathology
      </title>
      <p>
       On February 18, 2020, the first pathological analysis of COVID-19 demonstrated the desquamation of pneumocytes, hyaline membrane formation, and interstitial lymphocyte infiltration, and multinucleated syncytial cells in the lungs of a patient who died of the disease, consistent with the pathology of viral infection and ARDS
       <xref ref-type="bibr" rid="B56">
        56
       </xref>
       and similar to that of SARS and MERS patients
       <xref ref-type="bibr" rid="B57">
        57
       </xref>
       ,
       <xref ref-type="bibr" rid="B58">
        58
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Nuclear acid assays
      </title>
      <p>
       The detection of SARS-CoV-2 RNA via reverse-transcriptase polymerase chain reaction (RT-PCR) was used as the major criteria for the diagnosis of COVID-19. However, due to the high false-negative rate, which may accelerate the epidemic, clinical manifestations started to be used for diagnosis (which no longer solely relied on RT-PCR) in China on February 13, 2020. A similar situation also occurred with the diagnosis of SARS
       <xref ref-type="bibr" rid="B59">
        59
       </xref>
       . Therefore, a combination of disease history, clinical manifestations, laboratory tests, and radiological findings is essential and imperative for making an effective diagnosis. On February 14, 2020, the Feng Zhang group described a protocol of using the CRISPR-based SHERLOCK technique to detect SARS-CoV-2, which detects synthetic SARS-CoV-2 RNA fragments at 20 × 10
       <sup>
        -18
       </sup>
       mol/L to 200 × 10
       <sup>
        -18
       </sup>
       mol/L (10-100 copies per microliter of input) using a dipstick in less than an hour without requiring elaborate instrumentation
       <xref ref-type="bibr" rid="B60">
        60
       </xref>
       . Hopefully, the new technique can dramatically enhance the sensitivity and convenience if verified in clinical samples.
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      Treatment
     </title>
     <p>
      Due to the lack of experience with the novel CoV, physicians can mainly provide supportive care to COVID-19 patients, while attempting a variety of therapies that have been used or proposed before for the treatment of other CoVs such as SARS-CoV and MERS-CoV and other viral diseases (Table
      <xref ref-type="table" rid="T2">
       2
      </xref>
      ). These therapies include current and potential treatments with antiviral drugs, immunosuppressants, steroids, plasma from recovered patients, Chinese medicine, and psychological support. Even plasma from recovered patients was proposed to be used for treatment
      <xref ref-type="bibr" rid="B61">
       61
      </xref>
      . Pharmaceutical companies are racing to develop antibodies and vaccines against the virus
      <xref ref-type="bibr" rid="B62">
       62
      </xref>
      .
     </p>
     <sec>
      <title>
       Supportive care
      </title>
      <p>
       SARS-CoV-2 mainly attacks the lungs in the beginning and probably also attacks, to a lesser degree, other organs that express ACE2, such as the gastrointestinal system and the kidneys. Nevertheless, respiratory dysfunction and failure are the major threat to the patients and the major cause of death. Thus, respiratory support is critical to relieve the symptoms and save lives and includes general oxygen therapy, high-flow oxygen, noninvasive ventilation, and invasive mechanical ventilation depending on the severity of the disease. Patients with severe respiratory symptoms have to be supported by extracorporeal membrane oxygenation (ECMO), a modified cardiopulmonary bypass technique used for the treatment of life-threatening cardiac or respiratory failure. In addition, the maintenance of electrolyte balance, the prevention and treatment of secondary infection and septic shock, and the protection of the functions of the vital organs are also essential for SARS-CoV-2 patients
       <xref ref-type="bibr" rid="B7">
        7
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Tackling cytokine storms
      </title>
      <p>
       It has been known that a cytokine storm results from an overreaction of the immune system in SARS and MERS patients
       <xref ref-type="bibr" rid="B33">
        33
       </xref>
       . Cytokine storm is a form of systemic inflammatory response featured by the release of a series of cytokines including TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, and MCP-1. These cytokines induce immune cells to release a vast number of free radicals which are the major cause of ARDS and multiple organ failure
       <xref ref-type="bibr" rid="B67">
        67
       </xref>
       . Immunosuppression is essential in the treatment of cytokine storms, especially in severe patients.
      </p>
      <p>
       Corticosteroids and tocilizumab, an anti-IL6 monoclonal antibody, have been used to treat cytokine storm
       <xref ref-type="bibr" rid="B68">
        68
       </xref>
       . Other immunosuppression treatments for cytokine storm include the modulation of T cell-directed immune response; the blockade of IFN-γ, IL-1, and TNF; JAK inhibition
       <xref ref-type="bibr" rid="B69">
        69
       </xref>
       ; blinatumomab
       <xref ref-type="bibr" rid="B70">
        70
       </xref>
       ; suppressor of cytokine signaling 4
       <xref ref-type="bibr" rid="B71">
        71
       </xref>
       ; and HDAC inhibitors
       <xref ref-type="bibr" rid="B72">
        72
       </xref>
       .
      </p>
      <p>
       Steroids, as immunosuppressants, were widely used in the treatment of SARS to reduce the severity of inflammatory damage
       <xref ref-type="bibr" rid="B65">
        65
       </xref>
       . However, steroids at high dosages were not beneficial to severe lung injury in SARS and COVID-19 patients
       <xref ref-type="bibr" rid="B59">
        59
       </xref>
       ,
       <xref ref-type="bibr" rid="B73">
        73
       </xref>
       . Instead, they may cause severe side effects, especially avascular osteonecrosis, dramatically affecting the prognosis
       <xref ref-type="bibr" rid="B74">
        74
       </xref>
       . Nevertheless, short courses of corticosteroids at low-to-moderate doses have been recommended to be used prudently for critically ill COVID-19 patients
       <xref ref-type="bibr" rid="B75">
        75
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Antiviral therapy
      </title>
      <p>
       At the time of writing, no effective antiviral therapy has been confirmed. However, intravenous administration with remdesivir, a nucleotide analog, has been found to be efficacious in an American patient with COVID-19
       <xref ref-type="bibr" rid="B64">
        64
       </xref>
       . Remdesivir is a novel antiviral drug developed by Gilead initially for the treatment of diseases caused by Ebola and Marlburg viruses
       <xref ref-type="bibr" rid="B76">
        76
       </xref>
       . Later, remdesivir also demonstrated possible inhibition of other single stranded RNA viruses including MERS and SARS viruses
       <xref ref-type="bibr" rid="B77">
        77
       </xref>
       ,
       <xref ref-type="bibr" rid="B78">
        78
       </xref>
       . Based on these, Gilead has provided the compound to China to conduct a pair of trials on SARS-CoV-2-infected individuals
       <xref ref-type="bibr" rid="B79">
        79
       </xref>
       , and the results are highly anticipated.
      </p>
      <p>
       In addition, baricitinb, interferon-α, lopinavir/ritonavir, and ribavirin have been suggested as potential therapies for patients with acute respiratory symptoms
       <xref ref-type="bibr" rid="B80">
        80
       </xref>
       ,
       <xref ref-type="bibr" rid="B81">
        81
       </xref>
       . Diarrhea, nausea, vomiting, liver damage, and other adverse reactions can occur following combined therapy with lopinavir/ritonavir
       <xref ref-type="bibr" rid="B80">
        80
       </xref>
       . The interaction of these treatments with other drugs used in the patients should be monitored carefully.
      </p>
     </sec>
     <sec>
      <title>
       Plasma from recovered patients and antibody generation
      </title>
      <p>
       The collection of the blood from patients who recovered from a contagious disease to treat other patients suffering from the same disease or to protect healthy individuals from catching the disease has a long history
       <xref ref-type="bibr" rid="B82">
        82
       </xref>
       . Indeed, recovered patients often have a relatively high level of antibodies against the pathogen in their blood. Antibodies are an immunoglobulin (Ig) produced by B lymphocytes to fight pathogens and other foreign objects and they recognize unique molecules in the pathogens and neutralize them directly
       <xref ref-type="bibr" rid="B83">
        83
       </xref>
       . Based on this, plasma was collected from the blood of a group of patients who recovered from COVID-19 and was injected into 10 seriously ill patients. Their symptoms improved within 24 hours, accompanied by reduced inflammation and viral loads and improved oxygen saturation in the blood. However, verification and clarification are necessary to propose the method for large-scale use before specific therapies are not yet developed.
      </p>
      <p>
       In addition, given the therapeutic effects, some disadvantages associated with the plasma should be considered carefully. For example, antibodies can overstimulate the immune response and cause cytokine release syndrome, which is potentially a life-threatening toxicity
       <xref ref-type="bibr" rid="B84">
        84
       </xref>
       . The concentration of antibodies in the blood is usually low, and the demand for the plasma is large to treat critically ill patients. It is difficult to develop and produce specific antibodies rapidly enough to fight against a global epidemic
       <xref ref-type="bibr" rid="B62">
        62
       </xref>
       . Thus, it is more critical and practical to isolate B cells from recovered patients and identify the genetic codes encoding effective antibodies or screen for effective antibodies against essential proteins of the virus. This way, we can readily scale up the production of the antibodies.
      </p>
     </sec>
     <sec>
      <title>
       Traditional Chinese medicine (TCM)
      </title>
      <p>
       TCM has been used to treat a variety of diseases in China for thousands of years. However, its effects largely rely on a combination of multiple components in a formula that varies depending on the diagnosis of a disease based on the theories of TCM. Most of the effective components remain unknown or are vague as it is difficult to extract and verify such components or their optimal combinations. Currently, due to the lack of effective and specific therapy for COVID-19, TCM has become one of the major alternative treatments for patients with light to moderate symptoms or for those who have recovered from severe stages
       <xref ref-type="bibr" rid="B85">
        85
       </xref>
       . For example, Shu Feng Jie Du capsules and Lian Hua Qing Wen capsules were found to be effective for COVID-19 treatment
       <xref ref-type="bibr" rid="B86">
        86
       </xref>
       . Top cure rates in the treatment of COVID-19 patients were observed in several provinces in China that used TCM in 87% of their patients, including Gansu (63.7%), Ningxia (50%), and Hunan (50%), whereas Hubei province, which used TCM in only approximately 30% of its COVID-19 patients, had the lowest cure rate (13%)
       <xref ref-type="bibr" rid="B87">
        87
       </xref>
       . However, this is quite a rough comparison as many other impact factors such as the number and severity of the patients should be included in the evaluation.
      </p>
      <p>
       On February 18, 2020, Boli Zhang and coworkers published a study to compare western medicine (WM) treatment alone with combined treatment of WM and TCM
       <xref ref-type="bibr" rid="B88">
        88
       </xref>
       . They found that the times needed for body temperature recovery, symptom disappearance, and hospitalization were remarkably shorter in the WM+TCM group than in the WM only group. Most impressively, the rate for symptomatic worsening (from light to severe) was remarkably lower for the WM+TCM group than for the WM only group (7.4% versus 46.2%) and the mortality was lower in the WM+TCM group than WM only group (8.8% versus 39%). Nevertheless, the efficacy and safety of TCM still await more well-controlled trials at larger scales and in more centers. It would also be intriguing to characterize the mechanism of actions and clarify the effective components of TCM treatments or their combinations if possible.
      </p>
     </sec>
     <sec>
      <title>
       Mental health care
      </title>
      <p>
       Patients with suspected or confirmed COVID-19 mostly experience great fear of the highly contagious and even fatal disease, and quarantined people also experience boredom, loneliness, and anger. Furthermore, symptoms of the infection such as fever, hypoxia, and cough as well as adverse effects of the treatments such as insomnia caused by corticosteroids can lead to more anxiety and mental distress. In the early phase of the SARS outbreak, a range of psychiatric morbidities including persistent depression, anxiety, panic attacks, psychomotor excitement, psychotic symptoms, delirium, and even suicidality were reported
       <xref ref-type="bibr" rid="B89">
        89
       </xref>
       ,
       <xref ref-type="bibr" rid="B90">
        90
       </xref>
       . Mandatory contact tracing and quarantine, as a part of the public health responses to the COVID-19 outbreak, can make people more anxious and guilty about the effects of the contagion, quarantine, and stigma on their families and friends
       <xref ref-type="bibr" rid="B66">
        66
       </xref>
       .
      </p>
      <p>
       Thus, mental health care should be provided to COVID-19 patients, suspected individuals, and people in contact with them as well as the general public who are in need. The psychological support should include the establishment of multidisciplinary mental health teams, clear communications with regular and accurate updates about the SARS-CoV-2 outbreak and treatment plans and the use of professional electronic devices and applications to avoid close contact with each other
       <xref ref-type="bibr" rid="B66">
        66
       </xref>
       .
      </p>
     </sec>
     <sec>
      <title>
       Vaccination
      </title>
      <p>
       Effective vaccines are essential for interrupting the chain of transmission from animal reservoirs and infected humans to susceptible hosts and are often complementary to antiviral treatment in the control of epidemics caused by emerging viruses. Efforts have been made to develop S protein-based vaccines to generate long-term and potent neutralizing antibodies and/or protective immunity against SARS-CoV
       <xref ref-type="bibr" rid="B81">
        81
       </xref>
       ,
       <xref ref-type="bibr" rid="B91">
        91
       </xref>
       . Live-attenuated vaccines have been evaluated in animal models for SARS
       <xref ref-type="bibr" rid="B92">
        92
       </xref>
       . However, the
       <italic>
        in vivo
       </italic>
       efficacy of these vaccine candidates in elderly individuals and lethal-challenge models and their protection against zoonotic virus infection have yet to be determined before a clinical study is initiated. This is probably because SARS died down 17 years ago and no new case has been reported since.
      </p>
      <p>
       In contrast, sporadic cases and clusters of MERS continue to occur in the Middle East and spread to other regions owing to the persistence of zoonotic sources in endemic areas. Vaccination strategies have been developed for MERS by using inactivated virus, DNA plasmids, viral vectors, nanoparticles, virus-like particles and recombinant protein subunits and some have been evaluated in animal models
       <xref ref-type="bibr" rid="B93">
        93
       </xref>
       . The development of a safe and effective vaccine against SARS-CoV-2 for non-immune individuals is an urgent and critical task for controlling the ongoing epidemic. However, it is challenging to overcome the difficulty because of the long period of time (averaged 18 months) needed for vaccine development and the dynamic variations of CoVs.
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      Prognosis
     </title>
     <sec>
      <title>
       Prognosis of patients
      </title>
      <p>
       As a novel disease, COVID-19 has just started to manifest its full clinical course throughout thousands of patients. In most cases, patients can recover gradually without sequelae. However, similar to SARS and MERS, COVID-19 is also associated with high morbidity and mortality in patients with severe cases. Therefore, building a prognosis model for the disease is essential for health-care agencies to prioritize their services, especially in resource-constrained areas. Based on clinical studies reported thus far, the following factors may affect or be associated with the prognosis of COVID-19 patients (Table
       <xref ref-type="table" rid="T3">
        3
       </xref>
       ):
       <list list-type="bullet">
        <list-item>
         <p>
          <bold>
           Age:
          </bold>
          Age was the most important factor for the prognosis of SARS
          <xref ref-type="bibr" rid="B99">
           99
          </xref>
          , which is also true for COVID-19. COVID-19 mainly happened at the age of 30-65 with 47.7% of those patients being over 50 in a study of 8,866 cases as described above
          <xref ref-type="bibr" rid="B37">
           37
          </xref>
          . Patients who required intensive care were more likely to have underlying comorbidities and complications and were significantly older than those who did not (at the median age of 66 versus 51)
          <xref ref-type="bibr" rid="B34">
           34
          </xref>
          , suggesting age as a prognostic factor for the outcome of COVID-19 patients.
         </p>
        </list-item>
        <list-item>
         <p>
          <bold>
           Sex:
          </bold>
          SARS-CoV-2 has infected more men than women (0.31/100,000 versus 0.27/100,000), as described above
          <xref ref-type="bibr" rid="B37">
           37
          </xref>
          .
         </p>
        </list-item>
        <list-item>
         <p>
          <bold>
           Comorbidities and complications:
          </bold>
          Patients with COVID-19 who require intensive care are more likely to suffer from acute cardiac injury and arrhythmia
          <xref ref-type="bibr" rid="B34">
           34
          </xref>
          . Cardiac events were also the main reason for death in SARS patients
          <xref ref-type="bibr" rid="B55">
           55
          </xref>
          ,
          <xref ref-type="bibr" rid="B65">
           65
          </xref>
          ,
          <xref ref-type="bibr" rid="B99">
           99
          </xref>
          . It has been reported that SARS-CoV-2 can also bind to ACE2-positive cholangiocytes, which might lead to liver dysfunctions in COVID-19 patients
          <xref ref-type="bibr" rid="B100">
           100
          </xref>
          . It is worth noting that age and underlying disease are strongly correlated and might interfere with each other
          <xref ref-type="bibr" rid="B55">
           55
          </xref>
          .
         </p>
        </list-item>
        <list-item>
         <p>
          <bold>
           Abnormal laboratory findings
          </bold>
          : The C-reactive protein (CRP) level in blood reflects the severity of inflammation or tissue injury and has been proposed to be a potential prognostic factor for disease, response to therapy, and ultimate recovery
          <xref ref-type="bibr" rid="B101">
           101
          </xref>
          . The correlation of CRP level to the severity and prognosis of COVID-19 has also been proposed
          <xref ref-type="bibr" rid="B101">
           101
          </xref>
          . In addition, elevated lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) may also help predict the outcome. These enzymes are expressed extensively in multiple organs, especially in the heart and liver, and are released during tissue damage
          <xref ref-type="bibr" rid="B102">
           102
          </xref>
          ,
          <xref ref-type="bibr" rid="B103">
           103
          </xref>
          . Thus, they are traditional markers for heart or liver dysfunctions.
         </p>
        </list-item>
        <list-item>
         <p>
          <bold>
           Major clinical symptoms:
          </bold>
          Chest radiography and temporal progression of clinical symptoms should be considered together with the other issues for the prediction of outcomes and complications of COVID-19.
         </p>
        </list-item>
        <list-item>
         <p>
          <bold>
           Use of steroids:
          </bold>
          As described above, steroids are immunosuppressant commonly used as an adjunctive therapy for infectious diseases to reduce the severity of inflammatory damage
          <xref ref-type="bibr" rid="B104">
           104
          </xref>
          . Since a high dosage of corticosteroids was widely used in severe SARS patients, many survivors suffered from avascular osteonecrosis with life-long disability and poor life quality
          <xref ref-type="bibr" rid="B105">
           105
          </xref>
          . Thus, if needed, steroids should be used at low dosage and for a short time in COVID-19 patients.
         </p>
        </list-item>
        <list-item>
         <p>
          <bold>
           Mental stress:
          </bold>
          As described above, during the COVID-19 outbreak many patients have suffered from extraordinary stress as they often endured long periods of quarantine and extreme uncertainty and witnessed the death of close family members and fellow patients. It is imperative to provide psychological counseling and long-term support to help these patients recover from the stress and return to normal life
          <xref ref-type="bibr" rid="B66">
           66
          </xref>
          .
         </p>
        </list-item>
       </list>
      </p>
     </sec>
     <sec>
      <title>
       Prognosis of the epidemic
      </title>
      <p>
       According to demographic studies so far, COVID-19 seems to have different epidemiological features from SARS. In addition to replicating in the lower respiratory tract, SARS-CoV-2 can efficiently replicate in the upper respiratory tract and causes mild or no symptoms in the early phase of infection, similar to other CoVs that cause common colds
       <xref ref-type="bibr" rid="B106">
        106
       </xref>
       . Therefore, infected patients at the early phase or incubation period can produce a large amount of virus during daily activities, causing great difficulty for the control of the epidemic. However, the transmission of SARS-CoV was considered to occur when the patients are severely ill, while most transmission did not happen at the early phase
       <xref ref-type="bibr" rid="B107">
        107
       </xref>
       . Thus, the current outbreak of COVID-19 is much more severe and difficult to control than the outbreak of SARS.
      </p>
      <p>
       Great efforts are currently underway in China including the lockdown of Wuhan and surrounding cities and continuous quarantine of almost the entire population in hopes of interrupting the transmission of SARS-CoV-2. Although these actions have been dramatically damaging the economy and other sectors of the country, the number of new patients is declining, indicating the slowdown of the epidemic. The most optimistic estimate is that the outbreak will end by March and the downswing phase will last for 3-4 months
       <xref ref-type="bibr" rid="B108">
        108
       </xref>
       . However, some other experts are not that optimistic. Paul Hunter,
       <italic>
        et al.
       </italic>
       , estimated that COVID-19, which seems substantially more infectious than SARS, will not end in 2020
       <xref ref-type="bibr" rid="B109">
        109
       </xref>
       . Ira Longini,
       <italic>
        et al.
       </italic>
       , established a model to predict the outcome of the epidemic and suggested that SARS-CoV-2 could infect two-thirds of the global population
       <xref ref-type="bibr" rid="B110">
        110
       </xref>
       .
      </p>
      <p>
       A Canadian group reported that SARS-CoV-2 was detected in both mid-turbinate and throat swabs of patients who recovered and left the hospital 2 weeks earlier
       <xref ref-type="bibr" rid="B111">
        111
       </xref>
       , which indicates that the newly identified virus could become a cyclical episode similar to influenza. However, promising signs have occurred in China based on the declining number of new cases, indicating the current strategies might have been working. Ebola was originally predicted to cause up to a million cases with half a million deaths. However, via strict quarantine and isolation, the disease has eventually been put under control
       <xref ref-type="bibr" rid="B112">
        112
       </xref>
       ,
       <xref ref-type="bibr" rid="B113">
        113
       </xref>
       . It is possible, similar to SARS-CoV, that SARS-CoV-2 might become weaker in infectivity and eventually die down or become a less pathogenic virus co-existent with humans. A comparison of the epidemic of COVID-19 with that of SARS and MERS is provided below (Fig.
       <xref ref-type="fig" rid="F5">
        5
       </xref>
       ).
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      Prevention
     </title>
     <p>
      SARS-CoV-2 is highly transmittable through coughing or sneezing, and possibly also through direct contact with materials contaminated by the virus
      <xref ref-type="bibr" rid="B12">
       12
      </xref>
      . The virus was also found in feces, which raises a new possibility of feces-to-mouth transmission
      <xref ref-type="bibr" rid="B114">
       114
      </xref>
      . A recent study on 138 cases reported that 41% of the cases were possibly caused by nosocomial infections, including 17 patients with other prior diseases and 40 health-care providers
      <xref ref-type="bibr" rid="B115">
       115
      </xref>
      . Thus, great precaution should be used to protect humans, especially health-care providers, social workers, family members, colleagues, and even bystanders in contact with patients or infected people.
     </p>
     <sec>
      <title>
       Personal role
      </title>
      <p>
       The first line of defense that could be used to lower the risk of infection is through wearing face masks; both the use of surgical masks and N95 respirator masks (series # 1860s) helps control the spread of viruses
       <xref ref-type="bibr" rid="B116">
        116
       </xref>
       . Surgical face masks prevent liquid droplets from a potentially infected individual from traveling through the air or sticking onto surfaces of materials, where they could be passed on to others
       <xref ref-type="bibr" rid="B117">
        117
       </xref>
       . However, only N95 (series # 1860s) masks can protect against the inhalation of virions as small as 10 to 80 nm, with only 5% of the virions being able to penetrate completely; SARS-CoV-2 is similar to SARS-CoV in size and both are approximately 85 nm
       <xref ref-type="bibr" rid="B117">
        117
       </xref>
       . Since particles can penetrate even five surgical masks stacked together, health-care providers in direct contact with patients must wear N95 (series # 1860s) masks but not surgical masks
       <xref ref-type="bibr" rid="B118">
        118
       </xref>
       .
      </p>
      <p>
       In addition to masks, health-care providers should wear fitted isolation gowns in order to further reduce contact with viruses. Viruses can also infect an individual through the eyes. On January 22, 2020, a doctor was infected with SARS-CoV-2 although he wore an N95 mask; the virus might have entered his body through his inflammatory eyes
       <xref ref-type="bibr" rid="B119">
        119
       </xref>
       . Thus, health-care providers should also wear transparent face shields or goggles while working with patients.
      </p>
      <p>
       For the general public in affected or potentially affected areas, it is highly suggested that everybody wash their hands with disinfectant soaps more often than usual, try to stay indoors for self-quarantine and limit contact with potentially infected individuals. Three feet is considered an appropriate distance for people to stay away from a patient
       <xref ref-type="bibr" rid="B120">
        120
       </xref>
       . These actions are effective methods to lower the risk of infection as well as prevent the spread of the virus.
      </p>
     </sec>
     <sec>
      <title>
       Governmental role
      </title>
      <p>
       Although SARS-CoV-2 came as a new virus to the human world, its high homology to SARS-CoV as reported on 7 January 2020
       <xref ref-type="bibr" rid="B3">
        3
       </xref>
       should have caused high alert to China based on her deep memory of the SARS outbreak in 2003. However, not until 19 January 2020 did the director of the Center of Disease Control of Wuhan comfort the citizens by saying that the novel virus has low contagiousness and limited reproductivity from human to human and that it is not a problem to prevent and contain the disease. This message remarkably relaxed the alarm of the public, especially when the entire country was preparing for the Spring Festival, and the critical time was missed to contain the disease at its minimal scale in Wuhan.
      </p>
      <p>
       The disease control agencies in China may take this hard lesson and make critical improvements in the future. For example, these agencies should be (1) more careful when making public announcements as every word counts to citizens and can change their attitude and decisions; (2) more sensitive and reactive to unusual information from clinics rather than waiting for formal reports from doctors or officials; (3) more restrictive to contain a potential epidemic at its early stage rather than attempting to comfort the public; and (4) more often to issue targeted and effective drills to increase the public's awareness about epidemic diseases and to test and improve the response system of the society periodically.
      </p>
     </sec>
    </sec>
    <sec>
     <title>
      Concluding remarks
     </title>
     <p>
      The outbreak of COVID-19 caused by the novel virus SARS-CoV-2 started in the end of December 2019. In less than two months, it has spread all over China and near 50 other countries globally at the time of this writing. Since the virus is very similar to SARS-CoV and the symptoms are also similar between COVID-19 and SARS, the outbreak of COVID-19 has created a sense of SARS recurring. However, there are some remarkable differences between COVID-19 and SARS, which are essential for containing the epidemic and treating the patients.
      <list list-type="bullet">
       <list-item>
        <p>
         COVID-19 affects more elderly individuals than youth and more men than women, and the severity and death rate are also higher in elderly individual than in youth.
        </p>
       </list-item>
       <list-item>
        <p>
         SARS has higher mortality than COVID-19 (10.91% versus 1.44%).
        </p>
       </list-item>
       <list-item>
        <p>
         COVID-19 patients transmit the virus even when they are symptomless whereas SARS patients do so usually when they are severely ill, which causes much greater difficulty to contain the spread of COVID-19 than SARS. This partially explains why SARS-CoV-2 spread much faster and broader than SARS-CoV.
        </p>
       </list-item>
       <list-item>
        <p>
         The regular RNA assay for SARS-CoV-2 can be negative in some COVID-19 patients. On the other hand, cured patients can be positive for the virus again. These findings dramatically increase the risk of virus spreading.
        </p>
       </list-item>
      </list>
     </p>
     <p>
      Given such rapid progress in research on COVID-19, several critical issues remain to be solved, as follows:
      <list list-type="bullet">
       <list-item>
        <p>
         Where did SARS-CoV-2 come from? Although 96% genetic homolog was found between SARS-CoV-2 and two bat SARS-like CoVs, we still cannot conclude that SARS-CoV-2 is from bats.
        </p>
       </list-item>
       <list-item>
        <p>
         What animal was the intermediate species to transmit the virus from the original host, say bats, to humans? Without knowing answers to #1 and 2, we cannot efficiently cut the transmission, and the outbreak can relapse at any time.
        </p>
       </list-item>
       <list-item>
        <p>
         Although molecular modeling and biochemical assays have demonstrated that SARS-CoV-2 binds to ACE2, how exactly does the virus enter the airway cells and cause subsequent pathological changes? Does the virus also bind ACE2-expressing cells in other organs
         <xref ref-type="bibr" rid="B121">
          121
         </xref>
         ? Without clear answers to these questions, we cannot achieve fast and accurate diagnosis and effective treatment.
        </p>
       </list-item>
       <list-item>
        <p>
         How long will the epidemic last? How is the virus genetically evolving during transmission among humans? Will it become a pandemic worldwide, die down like SARS or relapse periodically like the flu?
        </p>
       </list-item>
      </list>
     </p>
     <p>
      It is essential but may take some time to search for answers to the above and many other questions. However, with whatever expense it may demand, we have no other choice but to stop the epidemic as soon as possible and bring our life back to normal.
     </p>
    </sec>
    <back>
     <ack>
      <p>
       This work was supported by University of Macau Research Committee funds MYRG #2016-00070-FHS, and #2017-00124-FHS, Macau Science and Technology Development Fund (FDCT) #095/2017/A1 and 0112-2018-A3, and FDCT-National Natural Science Foundation of China joint grant #0008-2019-AFJ to R.X.
      </p>
      <sec>
       <title>
        Author contributions
       </title>
       <p>
        Y.Y. and R.X. conceived and designed the manuscript. Y.Y., P.L., S.Y., E.L. and R.X. wrote the manuscript. R.X gave the final approval of the manuscript.
       </p>
      </sec>
     </ack>
     <ref-list>
      <ref id="B1">
       <label>
        1
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Velavan
         </surname>
         <given-names>
          TP
         </given-names>
        </name>
        <name>
         <surname>
          Meyer
         </surname>
         <given-names>
          CG
         </given-names>
        </name>
        <article-title>
         The COVID-19 epidemic
        </article-title>
        <source>
         Trop Med Int Health
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: https://doi.org/10.1111/tmi.13383
        </comment>
       </element-citation>
      </ref>
      <ref id="B2">
       <label>
        2
       </label>
       <element-citation publication-type="webpage">
        <source>
         NEWS A: WHO warns coronavirus, now dubbed COVID-19, is 'public enemy number 1' and potentially more powerful than terrorism
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.abc.net.au/news/2020-02-12/coronavirus-public-enemy-number-one-vaccine/11956446">
          https://www.abc.net.au/news/2020-02-12/coronavirus-public-enemy-number-one-vaccine/11956446
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B3">
       <label>
        3
       </label>
       <element-citation publication-type="webpage">
        <source>
         Zhang Y-Z. Novel 2019 coronavirus genome
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="http://virological.org/t/novel-2019-coronavirus-genome/319">
          http://virological.org/t/novel-2019-coronavirus-genome/319
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B4">
       <label>
        4
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          de Wit
         </surname>
         <given-names>
          E
         </given-names>
        </name>
        <name>
         <surname>
          van Doremalen
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Falzarano
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Munster
         </surname>
         <given-names>
          VJ
         </given-names>
        </name>
        <article-title>
         SARS and MERS: recent insights into emerging coronaviruses
        </article-title>
        <source>
         Nat Rev Microbiol
        </source>
        <year>
         2016
        </year>
        <volume>
         14
        </volume>
        <fpage>
         523
        </fpage>
        <lpage>
         34
        </lpage>
        <pub-id pub-id-type="pmid">
         27344959
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B5">
       <label>
        5
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Paules
         </surname>
         <given-names>
          CI
         </given-names>
        </name>
        <name>
         <surname>
          Marston
         </surname>
         <given-names>
          HD
         </given-names>
        </name>
        <name>
         <surname>
          Fauci
         </surname>
         <given-names>
          AS
         </given-names>
        </name>
        <article-title>
         Coronavirus Infections-More Than Just the Common Cold
        </article-title>
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1001/jama.2020.0757
        </comment>
       </element-citation>
      </ref>
      <ref id="B6">
       <label>
        6
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Horby
         </surname>
         <given-names>
          PW
         </given-names>
        </name>
        <name>
         <surname>
          Hayden
         </surname>
         <given-names>
          FG
         </given-names>
        </name>
        <name>
         <surname>
          Gao
         </surname>
         <given-names>
          GF
         </given-names>
        </name>
        <article-title>
         A novel coronavirus outbreak of global health concern
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        <volume>
         395
        </volume>
        <fpage>
         470
        </fpage>
        <lpage>
         473
        </lpage>
        <pub-id pub-id-type="pmid">
         31986257
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B7">
       <label>
        7
       </label>
       <element-citation publication-type="webpage">
        <source>
         CDC: 2019 Novel Coronavirus, Wuhan, China
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/index.html">
          https://www.cdc.gov/coronavirus/2019-ncov/index.html
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B8">
       <label>
        8
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Guan
         </surname>
         <given-names>
          W-j
         </given-names>
        </name>
        <name>
         <surname>
          Ni
         </surname>
         <given-names>
          Z-y
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Liang
         </surname>
         <given-names>
          W-h
         </given-names>
        </name>
        <name>
         <surname>
          Ou
         </surname>
         <given-names>
          C-q
         </given-names>
        </name>
        <name>
         <surname>
          He
         </surname>
         <given-names>
          J-x
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical Characteristics of Coronavirus Disease 2019 in China
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: 10.1056/NEJMoa2002032
        </comment>
       </element-citation>
      </ref>
      <ref id="B9">
       <label>
        9
       </label>
       <element-citation publication-type="webpage">
        <source>
         Reliefweb: Johns Hopki University. Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://reliefweb.int/report/world/coronavirus-covid-19-global-cases-johns-hopkins-csse">
          https://reliefweb.int/report/world/coronavirus-covid-19-global-cases-johns-hopkins-csse
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B10">
       <label>
        10
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Dong
         </surname>
         <given-names>
          E
         </given-names>
        </name>
        <name>
         <surname>
          Du
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Gardner
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <article-title>
         An interactive web-based dashboard to track COVID-19 in real time
        </article-title>
        <source>
         The Lancet Infect Dis
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: 10.1016/S1473-3099(20)30120-1
        </comment>
       </element-citation>
      </ref>
      <ref id="B11">
       <label>
        11
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          de Wilde
         </surname>
         <given-names>
          AH
         </given-names>
        </name>
        <name>
         <surname>
          Snijder
         </surname>
         <given-names>
          EJ
         </given-names>
        </name>
        <name>
         <surname>
          Kikkert
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          van Hemert
         </surname>
         <given-names>
          MJ
         </given-names>
        </name>
        <article-title>
         Host Factors in Coronavirus Replication
        </article-title>
        <source>
         Curr Top Microbiol Immunol
        </source>
        <year>
         2018
        </year>
        <volume>
         419
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         42
        </lpage>
        <pub-id pub-id-type="pmid">
         28643204
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B12">
       <label>
        12
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Raj
         </surname>
         <given-names>
          VS
         </given-names>
        </name>
        <name>
         <surname>
          Mou
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Smits
         </surname>
         <given-names>
          SL
         </given-names>
        </name>
        <name>
         <surname>
          Dekkers
         </surname>
         <given-names>
          DH
         </given-names>
        </name>
        <name>
         <surname>
          Muller
         </surname>
         <given-names>
          MA
         </given-names>
        </name>
        <name>
         <surname>
          Dijkman
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
        </article-title>
        <source>
         Nature
        </source>
        <year>
         2013
        </year>
        <volume>
         495
        </volume>
        <fpage>
         251
        </fpage>
        <lpage>
         4
        </lpage>
        <pub-id pub-id-type="pmid">
         23486063
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B13">
       <label>
        13
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Sevajol
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Subissi
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Decroly
         </surname>
         <given-names>
          E
         </given-names>
        </name>
        <name>
         <surname>
          Canard
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Imbert
         </surname>
         <given-names>
          I
         </given-names>
        </name>
        <article-title>
         Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
        </article-title>
        <source>
         Virus Res
        </source>
        <year>
         2014
        </year>
        <volume>
         194
        </volume>
        <fpage>
         90
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="pmid">
         25451065
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B14">
       <label>
        14
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Dong
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Ye
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Chen
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          EW-C
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020
        </article-title>
        <source>
         Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. DOI: https://doi.org/10.1101/2020.01.20.913368
        </source>
       </element-citation>
      </ref>
      <ref id="B15">
       <label>
        15
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Xu
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Chen
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Feng
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020
        </article-title>
        <source>
         Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. SCIENCE CHINA Life Sciences. Doi: https://doi.org/10.1007/s11427-020-1637-5
        </source>
       </element-citation>
      </ref>
      <ref id="B16">
       <label>
        16
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Niu
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Wu
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
        </article-title>
        <source>
         The Lancet
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: https://doi.org/10.1016/S0140-6736(20)30251-8
        </comment>
       </element-citation>
      </ref>
      <ref id="B17">
       <label>
        17
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Zhu
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Song
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         A Novel Coronavirus from Patients with Pneumonia in China, 2019
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1056/NEJMoa2001017
        </comment>
       </element-citation>
      </ref>
      <ref id="B18">
       <label>
        18
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Letko
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Munster
         </surname>
         <given-names>
          V
         </given-names>
        </name>
        <article-title>
         2020. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV
        </article-title>
        <source>
         bioRxiv
        </source>
        <comment>
         DOI: 10.1101/2020.01.22.915660
        </comment>
       </element-citation>
      </ref>
      <ref id="B19">
       <label>
        19
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          X-L
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          X-G
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
        </article-title>
        <source>
         bioRxiv
        </source>
        <comment>
         DOI: 10.1101/2020.01.22.914952
        </comment>
       </element-citation>
      </ref>
      <ref id="B20">
       <label>
        20
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          JF
         </given-names>
        </name>
        <name>
         <surname>
          Kok
         </surname>
         <given-names>
          KH
         </given-names>
        </name>
        <name>
         <surname>
          Zhu
         </surname>
         <given-names>
          Z
         </given-names>
        </name>
        <name>
         <surname>
          Chu
         </surname>
         <given-names>
          KK
         </given-names>
        </name>
        <name>
         <surname>
          Yuan
         </surname>
         <given-names>
          TS
         </given-names>
        </name>
        <name>
         <surname>
          Yuen
         </surname>
         <given-names>
          KY
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microb
        </article-title>
        <source>
         Infect
        </source>
        <year>
         2020
        </year>
        <volume>
         9
        </volume>
        <fpage>
         221
        </fpage>
        <lpage>
         36
        </lpage>
       </element-citation>
      </ref>
      <ref id="B21">
       <label>
        21
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          Q
         </given-names>
        </name>
        <name>
         <surname>
          Yan
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Xia
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <article-title>
         2020
        </article-title>
        <source>
         Structure of dimeric full-length human ACE2 in complex with B0AT1. bioRxiv. DOI: https://doi.org/10.1101/2020.02.17.951848
        </source>
       </element-citation>
      </ref>
      <ref id="B22">
       <label>
        22
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Ji
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Zai
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <article-title>
         2020. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human
        </article-title>
        <source>
         J Med Virol
        </source>
        <comment>
         DOI:10.1002/jmv.25682
        </comment>
       </element-citation>
      </ref>
      <ref id="B23">
       <label>
        23
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Xiao
         </surname>
         <given-names>
          KP
         </given-names>
        </name>
        <name>
         <surname>
          Zhai
         </surname>
         <given-names>
          JQ
         </given-names>
        </name>
        <name>
         <surname>
          Feng
         </surname>
         <given-names>
          YY
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Zou
         </surname>
         <given-names>
          JJ
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020
        </article-title>
        <source>
         Isolation and characterization of 2019-nCoV-like coronavirus from Malayan Pangolins. bioRxiv. DOI: http://doi.org/10.1101/2020.02.17.951335
        </source>
       </element-citation>
      </ref>
      <ref id="B24">
       <label>
        24
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Duan
         </surname>
         <given-names>
          S-M
         </given-names>
        </name>
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          X-S
         </given-names>
        </name>
        <name>
         <surname>
          Wen
         </surname>
         <given-names>
          R-F
         </given-names>
        </name>
        <name>
         <surname>
          Huang
         </surname>
         <given-names>
          J-J
         </given-names>
        </name>
        <name>
         <surname>
          Pi
         </surname>
         <given-names>
          G-H
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          S-X
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation
        </article-title>
        <source>
         Biomed Environ Sci
        </source>
        <year>
         2003
        </year>
        <volume>
         16
        </volume>
        <fpage>
         246
        </fpage>
        <lpage>
         55
        </lpage>
        <pub-id pub-id-type="pmid">
         14631830
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B25">
       <label>
        25
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Geller
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Varbanov
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Duval
         </surname>
         <given-names>
          RE
         </given-names>
        </name>
        <article-title>
         Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies
        </article-title>
        <source>
         Viruses
        </source>
        <year>
         2012
        </year>
        <volume>
         4
        </volume>
        <fpage>
         3044
        </fpage>
        <lpage>
         68
        </lpage>
        <pub-id pub-id-type="pmid">
         23202515
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B26">
       <label>
        26
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Rabenau
         </surname>
         <given-names>
          HF
         </given-names>
        </name>
        <name>
         <surname>
          Cinatl
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Morgenstern
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Bauer
         </surname>
         <given-names>
          G
         </given-names>
        </name>
        <name>
         <surname>
          Preiser
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Doerr
         </surname>
         <given-names>
          HW
         </given-names>
        </name>
        <article-title>
         Stability and inactivation of SARS coronavirus
        </article-title>
        <source>
         Medical Microbiology and Immunology
        </source>
        <year>
         2004
        </year>
        <volume>
         194
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
       </element-citation>
      </ref>
      <ref id="B27">
       <label>
        27
       </label>
       <element-citation publication-type="webpage">
        <source>
         NHC: Diagnosis and treatment of pneumonia caused by 2019 new coronavirus (trial version5)
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="http://www.nhc.gov.cn/yzygj/s7652m/202002/e84bd30142ab4d8982326326e4db22ea.shtml">
          http://www.nhc.gov.cn/yzygj/s7652m/202002/e84bd30142ab4d8982326326e4db22ea.shtml
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B28">
       <label>
        28
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Ben Addi
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Lefort
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Hua
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Libert
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Communi
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Ledent
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor
        </article-title>
        <source>
         European journal of immunology
        </source>
        <year>
         2008
        </year>
        <volume>
         38
        </volume>
        <fpage>
         1610
        </fpage>
        <lpage>
         20
        </lpage>
        <pub-id pub-id-type="pmid">
         18465770
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B29">
       <label>
        29
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Pan
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Tao
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Guo
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <article-title>
         SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism
        </article-title>
        <source>
         Virus Genes
        </source>
        <year>
         2011
        </year>
        <volume>
         42
        </volume>
        <fpage>
         37
        </fpage>
        <lpage>
         45
        </lpage>
        <pub-id pub-id-type="pmid">
         20976535
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B30">
       <label>
        30
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Mathern
         </surname>
         <given-names>
          DR
         </given-names>
        </name>
        <name>
         <surname>
          Heeger
         </surname>
         <given-names>
          PS
         </given-names>
        </name>
        <article-title>
         Molecules Great and Small: The Complement System
        </article-title>
        <source>
         Clin J Am Soc Nephrol
        </source>
        <year>
         2015
        </year>
        <volume>
         10
        </volume>
        <fpage>
         1636
        </fpage>
        <lpage>
         50
        </lpage>
        <pub-id pub-id-type="pmid">
         25568220
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B31">
       <label>
        31
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Traggiai
         </surname>
         <given-names>
          E
         </given-names>
        </name>
        <name>
         <surname>
          Becker
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Subbarao
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          Kolesnikova
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Uematsu
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Gismondo
         </surname>
         <given-names>
          MR
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
        </article-title>
        <source>
         Nat Med
        </source>
        <year>
         2004
        </year>
        <volume>
         10
        </volume>
        <fpage>
         871
        </fpage>
        <lpage>
         5
        </lpage>
        <pub-id pub-id-type="pmid">
         15247913
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B32">
       <label>
        32
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Niu
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Huang
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Deng
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Qin
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
        </article-title>
        <source>
         J Infect Dis
        </source>
        <year>
         2018
        </year>
        <volume>
         218
        </volume>
        <fpage>
         1249
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="pmid">
         29846635
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B33">
       <label>
        33
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Channappanavar
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Perlman
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <article-title>
         Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
        </article-title>
        <source>
         Seminars in Immunopathology
        </source>
        <year>
         2017
        </year>
        <volume>
         39
        </volume>
        <fpage>
         529
        </fpage>
        <lpage>
         39
        </lpage>
        <pub-id pub-id-type="pmid">
         28466096
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B34">
       <label>
        34
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Zhu
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Liu
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
        </article-title>
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1001/jama.2020.1585
        </comment>
       </element-citation>
      </ref>
      <ref id="B35">
       <label>
        35
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          G
         </given-names>
        </name>
        <name>
         <surname>
          Fan
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Lai
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Han
         </surname>
         <given-names>
          T
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Z
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Coronavirus infections and immune responses
        </article-title>
        <source>
         J Med Virol
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: https://doi.org/10.1002/jmv.25685
        </comment>
       </element-citation>
      </ref>
      <ref id="B36">
       <label>
        36
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Q
         </given-names>
        </name>
        <name>
         <surname>
          Guan
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Wu
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Tong
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
        </article-title>
        <source>
         2020. DOI:10.1056/NEJMoa2001316
        </source>
       </element-citation>
      </ref>
      <ref id="B37">
       <label>
        37
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          Q
         </given-names>
        </name>
        <name>
         <surname>
          Liu
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Jalali
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          et
         </surname>
         <given-names>
          al.2020
         </given-names>
        </name>
        <article-title>
         Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
        </article-title>
        <source>
         medRxiv. DOI: https://doi.org/10.1101/2020.02.10.20021675
        </source>
       </element-citation>
      </ref>
      <ref id="B38">
       <label>
        38
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Chang
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Lin
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Wei
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China
        </article-title>
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1001/jama.2020.1623
        </comment>
       </element-citation>
      </ref>
      <ref id="B39">
       <label>
        39
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Chen
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Dong
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Qu
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Gong
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Han
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020
        </article-title>
        <source>
         Epidemiological and clinical characteristics of 99 cases of
        </source>
        <year>
         2019
        </year>
        <comment>
         novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. DOI:10.1016/S0140-6736(20)30211-7
        </comment>
       </element-citation>
      </ref>
      <ref id="B40">
       <label>
        40
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Alexander
         </surname>
         <given-names>
          E
         </given-names>
        </name>
        <article-title>
         Gorbalenya, Susan C
        </article-title>
        <source>
         Baker, Ralph S. Baric, et al
        </source>
        <year>
         2020
        </year>
        <comment>
         Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group. medRxiv. DOI: https://doi.org/10.1101/2020.02.07.937862
        </comment>
       </element-citation>
      </ref>
      <ref id="B41">
       <label>
        41
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Ren
         </surname>
         <given-names>
          LL
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          YM
         </given-names>
        </name>
        <name>
         <surname>
          Wu
         </surname>
         <given-names>
          ZQ
         </given-names>
        </name>
        <name>
         <surname>
          Xiang
         </surname>
         <given-names>
          ZC
         </given-names>
        </name>
        <name>
         <surname>
          Guo
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Xu
         </surname>
         <given-names>
          T
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
        </article-title>
        <source>
         Chin Med J (Engl)
        </source>
        <comment>
         DOI:10.1097/CM9.0000000000000722
        </comment>
       </element-citation>
      </ref>
      <ref id="B42">
       <label>
        42
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Huang
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        <volume>
         6736
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         10
        </lpage>
       </element-citation>
      </ref>
      <ref id="B43">
       <label>
        43
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Rothe
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Schunk
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Sothmann
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Bretzel
         </surname>
         <given-names>
          G
         </given-names>
        </name>
        <name>
         <surname>
          Froeschl
         </surname>
         <given-names>
          G
         </given-names>
        </name>
        <name>
         <surname>
          Wallrauch
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1056/NEJMc2001468
        </comment>
       </element-citation>
      </ref>
      <ref id="B44">
       <label>
        44
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Phan
         </surname>
         <given-names>
          LT
         </given-names>
        </name>
        <name>
         <surname>
          Nguyen
         </surname>
         <given-names>
          TV
         </given-names>
        </name>
        <name>
         <surname>
          Luong
         </surname>
         <given-names>
          QC
         </given-names>
        </name>
        <name>
         <surname>
          Nguyen
         </surname>
         <given-names>
          TV
         </given-names>
        </name>
        <name>
         <surname>
          Nguyen
         </surname>
         <given-names>
          HT
         </given-names>
        </name>
        <name>
         <surname>
          Le
         </surname>
         <given-names>
          HQ
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1056/NEJMc2001272
        </comment>
       </element-citation>
      </ref>
      <ref id="B45">
       <label>
        45
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Pan
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Guan
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <article-title>
         Imaging changes in patients with 2019-nCov
        </article-title>
        <source>
         Eur Radiol
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: http://doi.org/10.1007/s00330-020-06713-z
        </comment>
       </element-citation>
      </ref>
      <ref id="B46">
       <label>
        46
       </label>
       <element-citation publication-type="webpage">
        <source>
         WHO: Geneva, Switzerland. Summary of probable SARS cases with onset of illness from 1 Nvember 2002 to 31 July 2003
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/sars/country/table2003_09_23/en/">
          https://www.who.int/csr/sars/country/table2003_09_23/en/
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B47">
       <label>
        47
       </label>
       <element-citation publication-type="webpage">
        <source>
         WHO: MERS SITUATION UPDATE
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="http://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&amp;ua=1&amp;ua=1">
          http://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&amp;ua=1&amp;ua=1
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B48">
       <label>
        48
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Tang
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Q
         </given-names>
        </name>
        <name>
         <surname>
          Bragazzi
         </surname>
         <given-names>
          NL
         </given-names>
        </name>
        <name>
         <surname>
          Tang
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Xiao
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions
        </article-title>
        <source>
         J Clin Med
        </source>
        <year>
         2020
        </year>
        <comment>
         9, 462
        </comment>
       </element-citation>
      </ref>
      <ref id="B49">
       <label>
        49
       </label>
       <element-citation publication-type="webpage">
        <source>
         WHO: Consensus Document on the Epidemiology of SARS. Wkly Epidemiol Rec. 2003; 78: 373-5
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/sars/en/WHOconsensus.pdf">
          https://www.who.int/csr/sars/en/WHOconsensus.pdf
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B50">
       <label>
        50
       </label>
       <element-citation publication-type="webpage">
        <source>
         WHO: Organizaition WH. Global Surveillance for human infection with novel coronavirus (2019-nCoV)
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov)">
          https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov)
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B51">
       <label>
        51
       </label>
       <element-citation publication-type="webpage">
        <source>
         CHANGDE-NHC: Epidemic Bulletin
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="http://wjw.changde.gov.cn/zhdt/wjdt/content_720891">
          http://wjw.changde.gov.cn/zhdt/wjdt/content_720891
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B52">
       <label>
        52
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Chen
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Dong
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Qu
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Gong
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Han
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        <volume>
         395
        </volume>
        <fpage>
         507
        </fpage>
        <lpage>
         13
        </lpage>
        <pub-id pub-id-type="pmid">
         32007143
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B53">
       <label>
        53
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Gunther
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Ruppert
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Schmidt
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Markart
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Grimminger
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Walmrath
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Surfactant alteration and replacement in acute respiratory distress syndrome
        </article-title>
        <source>
         Respir Res
        </source>
        <year>
         2001
        </year>
        <volume>
         2
        </volume>
        <fpage>
         353
        </fpage>
        <lpage>
         64
        </lpage>
        <pub-id pub-id-type="pmid">
         11737935
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B54">
       <label>
        54
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Gralinski
         </surname>
         <given-names>
          LE
         </given-names>
        </name>
        <name>
         <surname>
          Baric
         </surname>
         <given-names>
          RS
         </given-names>
        </name>
        <article-title>
         Molecular pathology of emerging coronavirus infections
        </article-title>
        <source>
         The Journal of pathology
        </source>
        <year>
         2015
        </year>
        <volume>
         235
        </volume>
        <fpage>
         185
        </fpage>
        <lpage>
         95
        </lpage>
        <pub-id pub-id-type="pmid">
         25270030
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B55">
       <label>
        55
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          JT
         </given-names>
        </name>
        <name>
         <surname>
          Sheng
         </surname>
         <given-names>
          WH
         </given-names>
        </name>
        <name>
         <surname>
          Fang
         </surname>
         <given-names>
          CT
         </given-names>
        </name>
        <name>
         <surname>
          Chen
         </surname>
         <given-names>
          YC
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          JL
         </given-names>
        </name>
        <name>
         <surname>
          Yu
         </surname>
         <given-names>
          CJ
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2004
        </year>
        <volume>
         10
        </volume>
        <fpage>
         818
        </fpage>
        <lpage>
         24
        </lpage>
        <pub-id pub-id-type="pmid">
         15200814
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B56">
       <label>
        56
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Zhe
         </surname>
         <given-names>
          Xu
         </given-names>
        </name>
        <name>
         <surname>
          Lei
         </surname>
         <given-names>
          Shi
         </given-names>
        </name>
        <name>
         <surname>
          Yijin
         </surname>
         <given-names>
          Wang
         </given-names>
        </name>
        <name>
         <surname>
          Jiyuan
         </surname>
         <given-names>
          Zhang
         </given-names>
        </name>
        <name>
         <surname>
          Lei
         </surname>
         <given-names>
          Huang
         </given-names>
        </name>
        <name>
         <surname>
          Chao
         </surname>
         <given-names>
          Zhang
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lacet Respir Med
        </article-title>
        <source>
         2020; DOI:https://doi.org/10.1016/S2213-2600(20)30076-X
        </source>
       </element-citation>
      </ref>
      <ref id="B57">
       <label>
        57
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Ding
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Shen
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Z
         </given-names>
        </name>
        <name>
         <surname>
          Geng
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Han
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
        </article-title>
        <source>
         The Journal of pathology
        </source>
        <year>
         2003
        </year>
        <volume>
         200
        </volume>
        <fpage>
         282
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="pmid">
         12845623
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B58">
       <label>
        58
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Ng
         </surname>
         <given-names>
          DL
         </given-names>
        </name>
        <name>
         <surname>
          Al Hosani
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Keating
         </surname>
         <given-names>
          MK
         </given-names>
        </name>
        <name>
         <surname>
          Gerber
         </surname>
         <given-names>
          SI
         </given-names>
        </name>
        <name>
         <surname>
          Jones
         </surname>
         <given-names>
          TL
         </given-names>
        </name>
        <name>
         <surname>
          Metcalfe
         </surname>
         <given-names>
          MG
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014
        </article-title>
        <source>
         The American journal of pathology
        </source>
        <year>
         2016
        </year>
        <volume>
         186
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         26857507
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B59">
       <label>
        59
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Chang
         </surname>
         <given-names>
          SC
         </given-names>
        </name>
        <article-title>
         Clinical findings, treatment and prognosis in patients with severe acute respiratory syndrome (SARS)
        </article-title>
        <source>
         J Chin Med Assoc
        </source>
        <year>
         2005
        </year>
        <volume>
         68
        </volume>
        <fpage>
         106
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         15813242
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B60">
       <label>
        60
       </label>
       <element-citation publication-type="webpage">
        <source>
         Zhang F, OOA, JSG. A protocol for detection of COVID-19 using CRISPR diagnostics
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf">
          https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B61">
       <label>
        61
       </label>
       <element-citation publication-type="webpage">
        <source>
         BLOOMBERG: China Seeks Plasma From Recovered Patients as Virus Treatment
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://time.com/5784286/covid-19-china-plasma-treatment/">
          https://time.com/5784286/covid-19-china-plasma-treatment/
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B62">
       <label>
        62
       </label>
       <element-citation publication-type="webpage">
        <source>
         WIRED: NIILER E. Darpa Cranks Up Antibody Research to Stall Coronavirus
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.wired.com/story/darpa-cranks-up-antibody-research-to-stall-coronavirus/">
          https://www.wired.com/story/darpa-cranks-up-antibody-research-to-stall-coronavirus/
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B63">
       <label>
        63
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Majeski
         </surname>
         <given-names>
          EI
         </given-names>
        </name>
        <name>
         <surname>
          Harley
         </surname>
         <given-names>
          RA
         </given-names>
        </name>
        <name>
         <surname>
          Bellum
         </surname>
         <given-names>
          SC
         </given-names>
        </name>
        <name>
         <surname>
          London
         </surname>
         <given-names>
          SD
         </given-names>
        </name>
        <name>
         <surname>
          London
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <article-title>
         Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome
        </article-title>
        <source>
         Am J Respir Cell Mol Biol
        </source>
        <year>
         2003
        </year>
        <volume>
         28
        </volume>
        <fpage>
         208
        </fpage>
        <lpage>
         17
        </lpage>
        <pub-id pub-id-type="pmid">
         12540488
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B64">
       <label>
        64
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Holshue
         </surname>
         <given-names>
          ML
         </given-names>
        </name>
        <name>
         <surname>
          DeBolt
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Lindquist
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Lofy
         </surname>
         <given-names>
          KH
         </given-names>
        </name>
        <name>
         <surname>
          Wiesman
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Bruce
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         First Case of 2019 Novel Coronavirus in the United States
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1056/NEJMoa2001191
        </comment>
       </element-citation>
      </ref>
      <ref id="B65">
       <label>
        65
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Booth
         </surname>
         <given-names>
          CM
         </given-names>
        </name>
        <name>
         <surname>
          Matukas
         </surname>
         <given-names>
          LM
         </given-names>
        </name>
        <name>
         <surname>
          Tomlinson
         </surname>
         <given-names>
          GA
         </given-names>
        </name>
        <name>
         <surname>
          Rachlis
         </surname>
         <given-names>
          AR
         </given-names>
        </name>
        <name>
         <surname>
          Rose
         </surname>
         <given-names>
          DB
         </given-names>
        </name>
        <name>
         <surname>
          Dwosh
         </surname>
         <given-names>
          HA
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
        </article-title>
        <source>
         JAMA
        </source>
        <year>
         2003
        </year>
        <volume>
         289
        </volume>
        <fpage>
         2801
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="pmid">
         12734147
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B66">
       <label>
        66
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Xiang
         </surname>
         <given-names>
          YT
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          Q
         </given-names>
        </name>
        <name>
         <surname>
          Cheung
         </surname>
         <given-names>
          T
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed
        </article-title>
        <source>
         Lancet Psychiatry
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: https://doi.org/10.1016/S2215-0366(20)30046-8
        </comment>
       </element-citation>
      </ref>
      <ref id="B67">
       <label>
        67
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Tisoncik
         </surname>
         <given-names>
          JR
         </given-names>
        </name>
        <name>
         <surname>
          Korth
         </surname>
         <given-names>
          MJ
         </given-names>
        </name>
        <name>
         <surname>
          Simmons
         </surname>
         <given-names>
          CP
         </given-names>
        </name>
        <name>
         <surname>
          Farrar
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Martin
         </surname>
         <given-names>
          TR
         </given-names>
        </name>
        <name>
         <surname>
          Katze
         </surname>
         <given-names>
          MG
         </given-names>
        </name>
        <article-title>
         Into the eye of the cytokine storm
        </article-title>
        <source>
         Microbiol Mol Biol Rev
        </source>
        <year>
         2012
        </year>
        <volume>
         76
        </volume>
        <fpage>
         16
        </fpage>
        <lpage>
         32
        </lpage>
        <pub-id pub-id-type="pmid">
         22390970
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B68">
       <label>
        68
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Lee
         </surname>
         <given-names>
          DW
         </given-names>
        </name>
        <name>
         <surname>
          Gardner
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Porter
         </surname>
         <given-names>
          DL
         </given-names>
        </name>
        <name>
         <surname>
          Louis
         </surname>
         <given-names>
          CU
         </given-names>
        </name>
        <name>
         <surname>
          Ahmed
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Jensen
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Current concepts in the diagnosis and management of cytokine release syndrome
        </article-title>
        <source>
         Blood
        </source>
        <year>
         2014
        </year>
        <volume>
         124
        </volume>
        <fpage>
         188
        </fpage>
        <lpage>
         95
        </lpage>
        <pub-id pub-id-type="pmid">
         24876563
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B69">
       <label>
        69
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Behrens
         </surname>
         <given-names>
          EM
         </given-names>
        </name>
        <name>
         <surname>
          Koretzky
         </surname>
         <given-names>
          GA
         </given-names>
        </name>
        <article-title>
         Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
        </article-title>
        <source>
         Arthritis Rheumatol
        </source>
        <year>
         2017
        </year>
        <volume>
         69
        </volume>
        <fpage>
         1135
        </fpage>
        <lpage>
         43
        </lpage>
        <pub-id pub-id-type="pmid">
         28217930
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B70">
       <label>
        70
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Shimabukuro-Vornhagen
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Godel
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Subklewe
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Stemmler
         </surname>
         <given-names>
          HJ
         </given-names>
        </name>
        <name>
         <surname>
          Schlosser
         </surname>
         <given-names>
          HA
         </given-names>
        </name>
        <name>
         <surname>
          Schlaak
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Cytokine release syndrome
        </article-title>
        <source>
         J Immunother Cancer
        </source>
        <year>
         2018
        </year>
        <volume>
         6
        </volume>
        <fpage>
         56
        </fpage>
        <pub-id pub-id-type="pmid">
         29907163
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B71">
       <label>
        71
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          L
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          EM
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          TB
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          EB
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          NL
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          BT
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection
        </article-title>
        <source>
         PLoS pathogens
        </source>
        <year>
         2014
        </year>
        <volume>
         10
        </volume>
        <fpage>
         e1004134
        </fpage>
        <pub-id pub-id-type="pmid">
         24809749
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B72">
       <label>
        72
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Kirschbaum
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Lin
         </surname>
         <given-names>
          CL
         </given-names>
        </name>
        <name>
         <surname>
          Todorov
         </surname>
         <given-names>
          I
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen
        </article-title>
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <year>
         2008
        </year>
        <volume>
         105
        </volume>
        <fpage>
         4796
        </fpage>
        <lpage>
         801
        </lpage>
        <pub-id pub-id-type="pmid">
         18347343
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B73">
       <label>
        73
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Clark D Russell
         </surname>
         <given-names>
          JEM
         </given-names>
        </name>
        <name>
         <surname>
          J Kenneth
         </surname>
         <given-names>
          Baillie
         </given-names>
        </name>
        <article-title>
         Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI: https://doi.org/10.1016/S0140-6736(20)30317-2
        </comment>
       </element-citation>
      </ref>
      <ref id="B74">
       <label>
        74
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Griffith
         </surname>
         <given-names>
          JF
         </given-names>
        </name>
        <name>
         <surname>
          Antonio
         </surname>
         <given-names>
          GE
         </given-names>
        </name>
        <name>
         <surname>
          Kumta
         </surname>
         <given-names>
          SM
         </given-names>
        </name>
        <name>
         <surname>
          Hui
         </surname>
         <given-names>
          DSC
         </given-names>
        </name>
        <name>
         <surname>
          Wong
         </surname>
         <given-names>
          JKT
         </given-names>
        </name>
        <name>
         <surname>
          Joynt
         </surname>
         <given-names>
          GM
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids
        </article-title>
        <source>
         Radiology
        </source>
        <year>
         2005
        </year>
        <volume>
         235
        </volume>
        <fpage>
         168
        </fpage>
        <lpage>
         75
        </lpage>
        <pub-id pub-id-type="pmid">
         15703312
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B75">
       <label>
        75
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Shang
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Du
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Cao
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <article-title>
         On the use of corticosteroids for 2019-nCoV pneumonia
        </article-title>
        <source>
         The Lancet
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:https://doi.org/10.1016/S0140-6736(20)30361-5
        </comment>
       </element-citation>
      </ref>
      <ref id="B76">
       <label>
        76
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Warren
         </surname>
         <given-names>
          TK
         </given-names>
        </name>
        <name>
         <surname>
          Jordan
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Lo
         </surname>
         <given-names>
          MK
         </given-names>
        </name>
        <name>
         <surname>
          Ray
         </surname>
         <given-names>
          AS
         </given-names>
        </name>
        <name>
         <surname>
          Mackman
         </surname>
         <given-names>
          RL
         </given-names>
        </name>
        <name>
         <surname>
          Soloveva
         </surname>
         <given-names>
          V
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
        </article-title>
        <source>
         Nature
        </source>
        <year>
         2016
        </year>
        <volume>
         531
        </volume>
        <fpage>
         381
        </fpage>
        <lpage>
         5
        </lpage>
        <pub-id pub-id-type="pmid">
         26934220
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B77">
       <label>
        77
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Lo
         </surname>
         <given-names>
          MK
         </given-names>
        </name>
        <name>
         <surname>
          Jordan
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Arvey
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Sudhamsu
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Shrivastava-Ranjan
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Hotard
         </surname>
         <given-names>
          AL
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
        </article-title>
        <source>
         Sci Rep
        </source>
        <year>
         2017
        </year>
        <volume>
         7
        </volume>
        <fpage>
         43395
        </fpage>
        <pub-id pub-id-type="pmid">
         28262699
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B78">
       <label>
        78
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Sheahan
         </surname>
         <given-names>
          TP
         </given-names>
        </name>
        <name>
         <surname>
          Sims
         </surname>
         <given-names>
          AC
         </given-names>
        </name>
        <name>
         <surname>
          Graham
         </surname>
         <given-names>
          RL
         </given-names>
        </name>
        <name>
         <surname>
          Menachery
         </surname>
         <given-names>
          VD
         </given-names>
        </name>
        <name>
         <surname>
          Gralinski
         </surname>
         <given-names>
          LE
         </given-names>
        </name>
        <name>
         <surname>
          Case
         </surname>
         <given-names>
          JB
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
        </article-title>
        <source>
         Sci Transl Med
        </source>
        <year>
         2017
        </year>
        <comment>
         9
        </comment>
       </element-citation>
      </ref>
      <ref id="B79">
       <label>
        79
       </label>
       <element-citation publication-type="webpage">
        <source>
         The New York Times: Denise Grady. China Begins Teating an Antiviral Drug in Coronavirus Patients
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.nytimes.com/2020/02/06/health/coronavirus-treatments.html">
          https://www.nytimes.com/2020/02/06/health/coronavirus-treatments.html
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B80">
       <label>
        80
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Hirsch
         </surname>
         <given-names>
          HH
         </given-names>
        </name>
        <name>
         <surname>
          Martino
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Ward
         </surname>
         <given-names>
          KN
         </given-names>
        </name>
        <name>
         <surname>
          Boeckh
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Einsele
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Ljungman
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <article-title>
         Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         56
        </volume>
        <fpage>
         258
        </fpage>
        <lpage>
         66
        </lpage>
        <pub-id pub-id-type="pmid">
         23024295
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B81">
       <label>
        81
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Zumla
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          JF
         </given-names>
        </name>
        <name>
         <surname>
          Azhar
         </surname>
         <given-names>
          EI
         </given-names>
        </name>
        <name>
         <surname>
          Hui
         </surname>
         <given-names>
          DS
         </given-names>
        </name>
        <name>
         <surname>
          Yuen
         </surname>
         <given-names>
          KY
         </given-names>
        </name>
        <article-title>
         Coronaviruses - drug discovery and therapeutic options
        </article-title>
        <source>
         Nat Rev Drug Discov
        </source>
        <year>
         2016
        </year>
        <volume>
         15
        </volume>
        <fpage>
         327
        </fpage>
        <lpage>
         47
        </lpage>
        <pub-id pub-id-type="pmid">
         26868298
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B82">
       <label>
        82
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Etzioni
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Ochs
         </surname>
         <given-names>
          HD
         </given-names>
        </name>
        <article-title>
         Primary Immunodeficiency Disorders: A Historic and Scientific Perspective: Elsevier Science
        </article-title>
        <source>
         USA: Academic Press
        </source>
        <year>
         2014
        </year>
       </element-citation>
      </ref>
      <ref id="B83">
       <label>
        83
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Kreil
         </surname>
         <given-names>
          TR
         </given-names>
        </name>
        <name>
         <surname>
          Farcet
         </surname>
         <given-names>
          MR
         </given-names>
        </name>
        <article-title>
         Immunoglobulins and virus antibody titers: of past needs, current requirements, and future options
        </article-title>
        <source>
         Transfusion
        </source>
        <year>
         2018
        </year>
        <volume>
         58
        </volume>
        <issue>
         Suppl 3
        </issue>
        <fpage>
         3090
        </fpage>
        <lpage>
         5
        </lpage>
        <pub-id pub-id-type="pmid">
         30536431
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B84">
       <label>
        84
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Lee
         </surname>
         <given-names>
          DW
         </given-names>
        </name>
        <name>
         <surname>
          Gardner
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Porter
         </surname>
         <given-names>
          DL
         </given-names>
        </name>
        <name>
         <surname>
          Louis
         </surname>
         <given-names>
          CU
         </given-names>
        </name>
        <name>
         <surname>
          Ahmed
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Jensen
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Current concepts in the diagnosis and management of cytokine release syndrome
        </article-title>
        <source>
         Blood
        </source>
        <year>
         2014
        </year>
        <volume>
         124
        </volume>
        <fpage>
         188
        </fpage>
        <lpage>
         95
        </lpage>
        <pub-id pub-id-type="pmid">
         24876563
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B85">
       <label>
        85
       </label>
       <element-citation publication-type="webpage">
        <source>
         Korea Biomedical Review: Song S. Traditional Chinese medicine harmed new coronavirus control
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="http://www.koreabiomed.com/news/articleView.html?idxno=7370">
          http://www.koreabiomed.com/news/articleView.html?idxno=7370
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B86">
       <label>
        86
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <article-title>
         Drug treatment options for the 2019-new coronavirus (2019-nCoV)
        </article-title>
        <source>
         Biosci Trends
        </source>
        <year>
         2020
        </year>
        <fpage>
         10
        </fpage>
        <lpage>
         12
        </lpage>
       </element-citation>
      </ref>
      <ref id="B87">
       <label>
        87
       </label>
       <element-citation publication-type="webpage">
        <source>
         DXY.cn: COVIND-19 Epidemic Situation in Real Time. 2020
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://ncov.dxy.cn/ncovh5/view/pneumonia">
          https://ncov.dxy.cn/ncovh5/view/pneumonia
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B88">
       <label>
        88
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Xia
         </surname>
         <given-names>
          WG
         </given-names>
        </name>
        <name>
         <surname>
          An
         </surname>
         <given-names>
          CQ
         </given-names>
        </name>
        <name>
         <surname>
          Zheng
         </surname>
         <given-names>
          CJ
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          JX
         </given-names>
        </name>
        <name>
         <surname>
          Huang
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical study on 34 cases of COVID-19 treated with combined traditional Chinese and western medicine (in Chinese)
        </article-title>
        <source>
         Journal of Tranditional Chinese Medicine
        </source>
        <year>
         2020
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         7
        </lpage>
       </element-citation>
      </ref>
      <ref id="B89">
       <label>
        89
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Cheung
         </surname>
         <given-names>
          YT
         </given-names>
        </name>
        <name>
         <surname>
          Chau
         </surname>
         <given-names>
          PH
         </given-names>
        </name>
        <name>
         <surname>
          Yip
         </surname>
         <given-names>
          PSF
         </given-names>
        </name>
        <article-title>
         A revisit on older adults suicides and Severe Acute Respiratory Syndrome (SARS) epidemic in Hong Kong
        </article-title>
        <source>
         Int J Geriatr Psychiatry
        </source>
        <year>
         2008
        </year>
        <volume>
         23
        </volume>
        <fpage>
         1231
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         18500689
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B90">
       <label>
        90
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Su
         </surname>
         <given-names>
          T-P
         </given-names>
        </name>
        <name>
         <surname>
          Lien
         </surname>
         <given-names>
          T-C
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          C-Y
         </given-names>
        </name>
        <name>
         <surname>
          Su
         </surname>
         <given-names>
          YL
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          J-H
         </given-names>
        </name>
        <name>
         <surname>
          Tsai
         </surname>
         <given-names>
          S-L
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS caring unit during outbreak: a prospective and periodic assessment study in Taiwan
        </article-title>
        <source>
         J Psychiatr Res
        </source>
        <year>
         2007
        </year>
        <volume>
         41
        </volume>
        <fpage>
         119
        </fpage>
        <lpage>
         30
        </lpage>
        <pub-id pub-id-type="pmid">
         16460760
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B91">
       <label>
        91
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Du
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          He
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Liu
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Zheng
         </surname>
         <given-names>
          BJ
         </given-names>
        </name>
        <name>
         <surname>
          Jiang
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <article-title>
         The spike protein of SARS-CoV-a target for vaccine and therapeutic development
        </article-title>
        <source>
         Nat Rev Microbiol
        </source>
        <year>
         2009
        </year>
        <volume>
         7
        </volume>
        <fpage>
         226
        </fpage>
        <lpage>
         36
        </lpage>
        <pub-id pub-id-type="pmid">
         19198616
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B92">
       <label>
        92
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Roper
         </surname>
         <given-names>
          RL
         </given-names>
        </name>
        <name>
         <surname>
          Rehm
         </surname>
         <given-names>
          KE
         </given-names>
        </name>
        <article-title>
         SARS vaccines: where are we? Expert Rev
        </article-title>
        <source>
         Vaccines
        </source>
        <year>
         2009
        </year>
        <volume>
         8
        </volume>
        <fpage>
         887
        </fpage>
        <lpage>
         98
        </lpage>
       </element-citation>
      </ref>
      <ref id="B93">
       <label>
        93
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Xu
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <name>
         <surname>
          Jia
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          P
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Shi
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Antibodies and vaccines against Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         Emerg Microbes Infect
        </source>
        <year>
         2019
        </year>
        <volume>
         8
        </volume>
        <fpage>
         841
        </fpage>
        <lpage>
         56
        </lpage>
        <pub-id pub-id-type="pmid">
         31169078
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B94">
       <label>
        94
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Peiris
         </surname>
         <given-names>
          JS
         </given-names>
        </name>
        <name>
         <surname>
          Chu
         </surname>
         <given-names>
          CM
         </given-names>
        </name>
        <name>
         <surname>
          Cheng
         </surname>
         <given-names>
          VC
         </given-names>
        </name>
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          KS
         </given-names>
        </name>
        <name>
         <surname>
          Hung
         </surname>
         <given-names>
          IF
         </given-names>
        </name>
        <name>
         <surname>
          Poon
         </surname>
         <given-names>
          LL
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1767
        </fpage>
        <lpage>
         72
        </lpage>
        <pub-id pub-id-type="pmid">
         12781535
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B95">
       <label>
        95
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Alraddadi
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Bawareth
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Omar
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Alsalmi
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Alshukairi
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Qushmaq
         </surname>
         <given-names>
          I
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital
        </article-title>
        <source>
         Ann Thorac Med
        </source>
        <year>
         2016
        </year>
        <volume>
         11
        </volume>
        <fpage>
         128
        </fpage>
        <lpage>
         31
        </lpage>
        <pub-id pub-id-type="pmid">
         27168861
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B96">
       <label>
        96
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Garbati
         </surname>
         <given-names>
          MA
         </given-names>
        </name>
        <name>
         <surname>
          Fagbo
         </surname>
         <given-names>
          SF
         </given-names>
        </name>
        <name>
         <surname>
          Fang
         </surname>
         <given-names>
          VJ
         </given-names>
        </name>
        <name>
         <surname>
          Skakni
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Joseph
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Wani
         </surname>
         <given-names>
          TA
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes
        </article-title>
        <source>
         PloS one
        </source>
        <year>
         2016
        </year>
        <volume>
         11
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         12
        </lpage>
       </element-citation>
      </ref>
      <ref id="B97">
       <label>
        97
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Momattin
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Mohammed
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          Zumla
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Memish
         </surname>
         <given-names>
          ZA
         </given-names>
        </name>
        <name>
         <surname>
          Al-Tawfiq
         </surname>
         <given-names>
          JA
         </given-names>
        </name>
        <article-title>
         Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         17
        </volume>
        <fpage>
         e792
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         23993766
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B98">
       <label>
        98
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Hwang
         </surname>
         <given-names>
          SM
         </given-names>
        </name>
        <name>
         <surname>
          Na
         </surname>
         <given-names>
          BJ
         </given-names>
        </name>
        <name>
         <surname>
          Jung
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Lim
         </surname>
         <given-names>
          HS
         </given-names>
        </name>
        <name>
         <surname>
          Seo
         </surname>
         <given-names>
          JE
         </given-names>
        </name>
        <name>
         <surname>
          Park
         </surname>
         <given-names>
          SA
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection
        </article-title>
        <source>
         Jpn J Infect Dis
        </source>
        <year>
         2019
        </year>
        <volume>
         72
        </volume>
        <fpage>
         160
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         30584196
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B99">
       <label>
        99
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Cowling
         </surname>
         <given-names>
          BJ
         </given-names>
        </name>
        <name>
         <surname>
          Muller
         </surname>
         <given-names>
          MP
         </given-names>
        </name>
        <name>
         <surname>
          Wong
         </surname>
         <given-names>
          IO
         </given-names>
        </name>
        <name>
         <surname>
          Ho
         </surname>
         <given-names>
          LM
         </given-names>
        </name>
        <name>
         <surname>
          Lo
         </surname>
         <given-names>
          SV
         </given-names>
        </name>
        <name>
         <surname>
          Tsang
         </surname>
         <given-names>
          T
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings
        </article-title>
        <source>
         Arch Intern Med
        </source>
        <year>
         2006
        </year>
        <volume>
         166
        </volume>
        <fpage>
         1505
        </fpage>
        <lpage>
         11
        </lpage>
        <pub-id pub-id-type="pmid">
         16864761
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B100">
       <label>
        100
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Chai
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Han
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          Z
         </given-names>
        </name>
        <name>
         <surname>
          Ke
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         2020. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
        </article-title>
        <source>
         bioRxiv
        </source>
        <comment>
         DOI:10.1101/2020.02.03.931766
        </comment>
       </element-citation>
      </ref>
      <ref id="B101">
       <label>
        101
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Johnson
         </surname>
         <given-names>
          HL
         </given-names>
        </name>
        <name>
         <surname>
          Chiou
         </surname>
         <given-names>
          CC
         </given-names>
        </name>
        <name>
         <surname>
          Cho
         </surname>
         <given-names>
          CT
         </given-names>
        </name>
        <article-title>
         Applications of acute phase reactants in infectious diseases
        </article-title>
        <source>
         J Microbiol Immunol Infect
        </source>
        <year>
         1999
        </year>
        <volume>
         32
        </volume>
        <fpage>
         73
        </fpage>
        <lpage>
         82
        </lpage>
        <pub-id pub-id-type="pmid">
         11561579
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B102">
       <label>
        102
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Wrenger
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Muller
         </surname>
         <given-names>
          IB
         </given-names>
        </name>
        <name>
         <surname>
          Silber
         </surname>
         <given-names>
          AM
         </given-names>
        </name>
        <name>
         <surname>
          Jordanova
         </surname>
         <given-names>
          R
         </given-names>
        </name>
        <name>
         <surname>
          Lamzin
         </surname>
         <given-names>
          VS
         </given-names>
        </name>
        <name>
         <surname>
          Groves
         </surname>
         <given-names>
          MR
         </given-names>
        </name>
        <article-title>
         Aspartate aminotransferase: bridging carbohydrate and energy metabolism in Plasmodium falciparum
        </article-title>
        <source>
         Curr Drug Metab
        </source>
        <year>
         2012
        </year>
        <volume>
         13
        </volume>
        <fpage>
         332
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         22455555
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B103">
       <label>
        103
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Stankovic Stojanovic
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          Lionnet
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <article-title>
         Lactate dehydrogenase in sickle cell disease
        </article-title>
        <source>
         Clinica chimica acta; international journal of clinical chemistry
        </source>
        <year>
         2016
        </year>
        <volume>
         458
        </volume>
        <fpage>
         99
        </fpage>
        <lpage>
         102
        </lpage>
        <pub-id pub-id-type="pmid">
         27138446
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B104">
       <label>
        104
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Cheung
         </surname>
         <given-names>
          CY
         </given-names>
        </name>
        <name>
         <surname>
          Poon
         </surname>
         <given-names>
          LL
         </given-names>
        </name>
        <name>
         <surname>
          Lau
         </surname>
         <given-names>
          AS
         </given-names>
        </name>
        <name>
         <surname>
          Luk
         </surname>
         <given-names>
          W
         </given-names>
        </name>
        <name>
         <surname>
          Lau
         </surname>
         <given-names>
          YL
         </given-names>
        </name>
        <name>
         <surname>
          Shortridge
         </surname>
         <given-names>
          KF
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2002
        </year>
        <volume>
         360
        </volume>
        <fpage>
         1831
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         12480361
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B105">
       <label>
        105
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Hong
         </surname>
         <given-names>
          N
         </given-names>
        </name>
        <name>
         <surname>
          Du
         </surname>
         <given-names>
          XK
         </given-names>
        </name>
        <article-title>
         Avascular necrosis of bone in severe acute respiratory syndrome
        </article-title>
        <source>
         Clinical radiology
        </source>
        <year>
         2004
        </year>
        <volume>
         59
        </volume>
        <fpage>
         602
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         15208066
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B106">
       <label>
        106
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          JF
         </given-names>
        </name>
        <name>
         <surname>
          Yuan
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Kok
         </surname>
         <given-names>
          KH
         </given-names>
        </name>
        <name>
         <surname>
          To
         </surname>
         <given-names>
          KK
         </given-names>
        </name>
        <name>
         <surname>
          Chu
         </surname>
         <given-names>
          H
         </given-names>
        </name>
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        <volume>
         395
        </volume>
        <fpage>
         514
        </fpage>
        <lpage>
         523
        </lpage>
        <pub-id pub-id-type="pmid">
         31986261
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B107">
       <label>
        107
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Peiris
         </surname>
         <given-names>
          JS
         </given-names>
        </name>
        <name>
         <surname>
          Yuen
         </surname>
         <given-names>
          KY
         </given-names>
        </name>
        <name>
         <surname>
          Osterhaus
         </surname>
         <given-names>
          AD
         </given-names>
        </name>
        <name>
         <surname>
          Stohr
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <article-title>
         The severe acute respiratory syndrome
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2003
        </year>
        <volume>
         349
        </volume>
        <fpage>
         2431
        </fpage>
        <lpage>
         41
        </lpage>
        <pub-id pub-id-type="pmid">
         14681510
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B108">
       <label>
        108
       </label>
       <element-citation publication-type="webpage">
        <source>
         Terence:Rubin, Baden. Reality and Future about COVID-19
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://mp.weixin.qq.com/s/o3Dd61yN0GtdosCtrD-CrQ">
          https://mp.weixin.qq.com/s/o3Dd61yN0GtdosCtrD-CrQ
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B109">
       <label>
        109
       </label>
       <element-citation publication-type="webpage">
        <source>
         ALJAZEERA: Casey R. How long will COVID-19 outbreak last; how can you stay protected? https://
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="http://www.aljazeera.com/news/2020/02/long-covid-19-outbreak-stay-protected-200212140216674.html">
          www.aljazeera.com/news/2020/02/long-covid-19-outbreak-stay-protected-200212140216674.html
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B110">
       <label>
        110
       </label>
       <element-citation publication-type="webpage">
        <source>
         BLOOMBERG: Lauerman J. Coronavirus Could Infect Two-Thirds of Globe, Research Shows
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.bloomberg.com/news/articles/2020-02-13/coronavirus-could-infect-two-thirds-of-globe-researcher-says">
          https://www.bloomberg.com/news/articles/2020-02-13/coronavirus-could-infect-two-thirds-of-globe-researcher-says
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B111">
       <label>
        111
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Silverstein
         </surname>
         <given-names>
          WK
         </given-names>
        </name>
        <name>
         <surname>
          Stroud
         </surname>
         <given-names>
          L
         </given-names>
        </name>
        <name>
         <surname>
          Cleghorn
         </surname>
         <given-names>
          GE
         </given-names>
        </name>
        <name>
         <surname>
          Leis
         </surname>
         <given-names>
          JA
         </given-names>
        </name>
        <article-title>
         First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia
        </article-title>
        <source>
         Lancet (London, England)
        </source>
        <year>
         2020
        </year>
        <volume>
         6736
        </volume>
        <issue>
         20
        </issue>
        <fpage>
         30370
        </fpage>
       </element-citation>
      </ref>
      <ref id="B112">
       <label>
        112
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Bradol
         </surname>
         <given-names>
          JH
         </given-names>
        </name>
        <article-title>
         Ebola, the Day after
        </article-title>
        <source>
         Rev Prat
        </source>
        <year>
         2017
        </year>
        <volume>
         67
        </volume>
        <fpage>
         841
        </fpage>
        <lpage>
         4
        </lpage>
        <pub-id pub-id-type="pmid">
         30512809
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B113">
       <label>
        113
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Waheed
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Malik
         </surname>
         <given-names>
          S
         </given-names>
        </name>
        <name>
         <surname>
          Khan
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Najmi
         </surname>
         <given-names>
          MH
         </given-names>
        </name>
        <article-title>
         The World after Ebola: An Overview of Ebola Complications, Vaccine Development, Lessons Learned, Financial Losses, and Disease Preparedness
        </article-title>
        <source>
         Crit Rev Eukaryot Gene Expr
        </source>
        <year>
         2019
        </year>
        <volume>
         29
        </volume>
        <fpage>
         77
        </fpage>
        <lpage>
         84
        </lpage>
        <pub-id pub-id-type="pmid">
         31002597
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B114">
       <label>
        114
       </label>
       <element-citation publication-type="webpage">
        <source>
         Sciencealert: Latest Study Suggests The New Coronavirus Is Also Spreading Via Feces
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://www.sciencealert.com/latest-coronavirus-study-suggests-it-can-also-be-spread-through-poop">
          https://www.sciencealert.com/latest-coronavirus-study-suggests-it-can-also-be-spread-through-poop
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B115">
       <label>
        115
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          D
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          B
         </given-names>
        </name>
        <name>
         <surname>
          Hu
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Zhu
         </surname>
         <given-names>
          F
         </given-names>
        </name>
        <name>
         <surname>
          Liu
         </surname>
         <given-names>
          X
         </given-names>
        </name>
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <etal>
        </etal>
        <article-title>
         Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
        </article-title>
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        <comment>
         DOI:10.1001/jama.2020.1585
        </comment>
       </element-citation>
      </ref>
      <ref id="B116">
       <label>
        116
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Johnson
         </surname>
         <given-names>
          DF
         </given-names>
        </name>
        <name>
         <surname>
          Druce
         </surname>
         <given-names>
          JD
         </given-names>
        </name>
        <name>
         <surname>
          Birch
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Grayson
         </surname>
         <given-names>
          ML
         </given-names>
        </name>
        <article-title>
         A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2009
        </year>
        <volume>
         49
        </volume>
        <fpage>
         275
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         19522650
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B117">
       <label>
        117
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Balazy
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Toivola
         </surname>
         <given-names>
          M
         </given-names>
        </name>
        <name>
         <surname>
          Adhikari
         </surname>
         <given-names>
          A
         </given-names>
        </name>
        <name>
         <surname>
          Sivasubramani
         </surname>
         <given-names>
          SK
         </given-names>
        </name>
        <name>
         <surname>
          Reponen
         </surname>
         <given-names>
          T
         </given-names>
        </name>
        <name>
         <surname>
          Grinshpun
         </surname>
         <given-names>
          SA
         </given-names>
        </name>
        <article-title>
         Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks?
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2006
        </year>
        <volume>
         34
        </volume>
        <fpage>
         51
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="pmid">
         16490606
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B118">
       <label>
        118
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Derrick
         </surname>
         <given-names>
          JL
         </given-names>
        </name>
        <name>
         <surname>
          Gomersall
         </surname>
         <given-names>
          CD
         </given-names>
        </name>
        <article-title>
         Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2005
        </year>
        <volume>
         59
        </volume>
        <fpage>
         365
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         15749326
        </pub-id>
       </element-citation>
      </ref>
      <ref id="B119">
       <label>
        119
       </label>
       <element-citation publication-type="other">
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          CW
         </given-names>
        </name>
        <name>
         <surname>
          Liu
         </surname>
         <given-names>
          XF
         </given-names>
        </name>
        <name>
         <surname>
          Jia
         </surname>
         <given-names>
          ZF
         </given-names>
        </name>
        <article-title>
         2019-nCoV transmission through the ocular surface must not be ignored
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        <comment>
         https://doi.org/10.1016/S01406736(20)303135
        </comment>
       </element-citation>
      </ref>
      <ref id="B120">
       <label>
        120
       </label>
       <element-citation publication-type="webpage">
        <source>
         CDC: Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007)
        </source>
        <comment>
         <ext-link ext-link-type="uri" xlink:href="https://stacks.cdc.gov/view/cdc/61187">
          https://stacks.cdc.gov/view/cdc/61187
         </ext-link>
        </comment>
       </element-citation>
      </ref>
      <ref id="B121">
       <label>
        121
       </label>
       <element-citation publication-type="journal">
        <name>
         <surname>
          Fan
         </surname>
         <given-names>
          C
         </given-names>
        </name>
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          K
         </given-names>
        </name>
        <name>
         <surname>
          Ding
         </surname>
         <given-names>
          Y
         </given-names>
        </name>
        <name>
         <surname>
          Lu
         </surname>
         <given-names>
          WL
         </given-names>
        </name>
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          J
         </given-names>
        </name>
        <article-title>
         2020. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection
        </article-title>
        <source>
         medRxiv
        </source>
        <comment>
         DOI: 10.1101/2020.02.12.20022418
        </comment>
       </element-citation>
      </ref>
     </ref-list>
    </back>
    <floats-group>
     <fig id="F1" position="float">
      <label>
       Figure 1
      </label>
      <caption>
       <p>
        Major events that occurred thus far during the outbreak of COVID-19.
       </p>
      </caption>
      <graphic xlink:href="ijbsv16p1753g001">
      </graphic>
     </fig>
     <fig id="F2" position="float">
      <label>
       Figure 2
      </label>
      <caption>
       <p>
        Worldwide distribution of COVID-19 cases on 26 Feb. 2020, according to a coronavirus monitoring system of Johns Hopkins University
        <xref ref-type="bibr" rid="B9">
         9
        </xref>
        ,
        <xref ref-type="bibr" rid="B10">
         10
        </xref>
        .
       </p>
      </caption>
      <graphic xlink:href="ijbsv16p1753g002">
      </graphic>
     </fig>
     <fig id="F3" position="float">
      <label>
       Figure 3
      </label>
      <caption>
       <p>
        The origins and intermediate hosts of SARS-CoV-2, SARS-CoV, and MERS-CoV.
       </p>
      </caption>
      <graphic xlink:href="ijbsv16p1753g003">
      </graphic>
     </fig>
     <fig id="F4" position="float">
      <label>
       Figure 4
      </label>
      <caption>
       <p>
        Immune response of the host to coronavirus infection
        <xref ref-type="bibr" rid="B4">
         4
        </xref>
        ,
        <xref ref-type="bibr" rid="B32">
         32
        </xref>
        -
        <xref ref-type="bibr" rid="B34">
         34
        </xref>
        .
       </p>
      </caption>
      <graphic xlink:href="ijbsv16p1753g004">
      </graphic>
     </fig>
     <fig id="F5" position="float">
      <label>
       Figure 5
      </label>
      <caption>
       <p>
        Comparison of epidemic of COVID-19, SARS, and MERS.
       </p>
      </caption>
      <graphic xlink:href="ijbsv16p1753g005">
      </graphic>
     </fig>
     <table-wrap id="T1" position="float">
      <label>
       Table 1
      </label>
      <caption>
       <p>
        Comparison of SARS-CoV-2 with SARS-CoV and MERS-CoV
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead valign="top">
        <tr>
         <th colspan="1" rowspan="1">
          Comparison items
         </th>
         <th colspan="1" rowspan="1">
          SARS-CoV-2
         </th>
         <th colspan="1" rowspan="1">
          MERS-CoV
         </th>
         <th colspan="1" rowspan="1">
          SARS-CoV
         </th>
         <th colspan="1" rowspan="1">
          Reference
         </th>
        </tr>
       </thead>
       <tbody valign="top">
        <tr>
         <td colspan="1" rowspan="1">
          <bold>
           Characteristics
          </bold>
         </td>
         <td colspan="1" rowspan="1">
         </td>
         <td colspan="1" rowspan="1">
         </td>
         <td colspan="1" rowspan="1">
         </td>
         <td colspan="1" rowspan="7">
          <xref ref-type="bibr" rid="B6">
           6
          </xref>
          ,
          <xref ref-type="bibr" rid="B37">
           37
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Date extracted from
         </td>
         <td colspan="1" rowspan="1">
          Dec. 2020 - Feb. 2020
         </td>
         <td colspan="1" rowspan="1">
          Sept. 2012
         </td>
         <td colspan="1" rowspan="1">
          Dec. 2003
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Place of origin
         </td>
         <td colspan="1" rowspan="1">
          Wuhan, China
         </td>
         <td colspan="1" rowspan="1">
          Jeddah, Saudi Arabia
         </td>
         <td colspan="1" rowspan="1">
          Guangdong China
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Age range
         </td>
         <td colspan="1" rowspan="1">
          56 (22-92)
         </td>
         <td colspan="1" rowspan="1">
          56 (14-94)
         </td>
         <td colspan="1" rowspan="1">
          39.9 (1-91)
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Male/Female sex ratio
         </td>
         <td colspan="1" rowspan="1">
          1:3:1
         </td>
         <td colspan="1" rowspan="1">
          3.3:1
         </td>
         <td colspan="1" rowspan="1">
          1.1.25
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Mortality rate
         </td>
         <td colspan="1" rowspan="1">
          2%
         </td>
         <td colspan="1" rowspan="1">
          34%
         </td>
         <td colspan="1" rowspan="1">
          9.6%
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Confirmed cases (Global)
         </td>
         <td colspan="1" rowspan="1">
          24554
         </td>
         <td colspan="1" rowspan="1">
          2494
         </td>
         <td colspan="1" rowspan="1">
          8096
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          R
          <sub>
           0
          </sub>
         </td>
         <td colspan="1" rowspan="1">
          4.7 - 6.6
         </td>
         <td colspan="1" rowspan="1">
          0.45 - 0.91
         </td>
         <td colspan="1" rowspan="1">
          0.86 - 1.88
         </td>
         <td colspan="1" rowspan="2">
          <xref ref-type="bibr" rid="B37">
           37
          </xref>
          ,
          <xref ref-type="bibr" rid="B42">
           42
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Incubation period (day)
         </td>
         <td colspan="1" rowspan="1">
          7 - 14
         </td>
         <td colspan="1" rowspan="1">
          5.0 - 6.9
         </td>
         <td colspan="1" rowspan="1">
          4.4 - 6.9
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          <bold>
           Symptoms
          </bold>
         </td>
         <td colspan="1" rowspan="1">
         </td>
         <td colspan="1" rowspan="1">
         </td>
         <td colspan="1" rowspan="1">
         </td>
         <td colspan="1" rowspan="6">
          <xref ref-type="bibr" rid="B6">
           6
          </xref>
          ,
          <xref ref-type="bibr" rid="B34">
           34
          </xref>
          ,
          <xref ref-type="bibr" rid="B37">
           37
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Fever
         </td>
         <td colspan="1" rowspan="1">
          258 (93%)
         </td>
         <td colspan="1" rowspan="1">
          98%
         </td>
         <td colspan="1" rowspan="1">
          99-100%
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Dry cough
         </td>
         <td colspan="1" rowspan="1">
          194 (70%)
         </td>
         <td colspan="1" rowspan="1">
          47%
         </td>
         <td colspan="1" rowspan="1">
          29-75%
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Dyspnea
         </td>
         <td colspan="1" rowspan="1">
          96 (35%)
         </td>
         <td colspan="1" rowspan="1">
          72%
         </td>
         <td colspan="1" rowspan="1">
          40-42%
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Diarrhea
         </td>
         <td colspan="1" rowspan="1">
          17 (6%)
         </td>
         <td colspan="1" rowspan="1">
          26%
         </td>
         <td colspan="1" rowspan="1">
          20-25%
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Sore throat
         </td>
         <td colspan="1" rowspan="1">
          10 (4%)
         </td>
         <td colspan="1" rowspan="1">
          21%
         </td>
         <td colspan="1" rowspan="1">
          13-25%
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
     <table-wrap id="T2" position="float">
      <label>
       Table 2
      </label>
      <caption>
       <p>
        Treatments of COVID-19
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead valign="top">
        <tr>
         <th colspan="1" rowspan="1">
          Treatment
         </th>
         <th colspan="1" rowspan="1">
          Efficacy
         </th>
         <th colspan="1" rowspan="1">
          References
         </th>
        </tr>
       </thead>
       <tbody valign="top">
        <tr>
         <td colspan="1" rowspan="1">
          General oxygen therapy, high-flow oxygen/noninvasive ventilation, and invasive mechanical ventilation, conservation fluid management, management of septic shock, infection control
         </td>
         <td colspan="1" rowspan="1">
          Respiratory supports
         </td>
         <td colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B7">
           7
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Antiviral therapy
         </td>
         <td colspan="1" rowspan="1">
          Reduce the viral load
         </td>
         <td colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B63">
           63
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Remdesivir
         </td>
         <td colspan="1" rowspan="1">
          -
         </td>
         <td colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B64">
           64
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Steroids
         </td>
         <td colspan="1" rowspan="1">
          Reduce the severity of inflammatory damage
         </td>
         <td colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B65">
           65
          </xref>
         </td>
        </tr>
        <tr>
         <td colspan="1" rowspan="1">
          Psychological supports
         </td>
         <td colspan="1" rowspan="1">
          Relieve stress and improve mental health
         </td>
         <td colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B66">
           66
          </xref>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
     <table-wrap id="T3" position="float">
      <label>
       Table 3
      </label>
      <caption>
       <p>
        Prognostic factors for COVID-19 in comparison with SARS and MERS
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead valign="top">
        <tr>
         <th align="center" colspan="1" rowspan="1">
          Disease
         </th>
         <th align="center" colspan="1" rowspan="1">
          Laboratory results
         </th>
         <th align="center" colspan="1" rowspan="1">
          Chest radiography
         </th>
         <th align="center" colspan="1" rowspan="1">
          Others
         </th>
         <th align="center" colspan="1" rowspan="1">
          Reference
         </th>
        </tr>
       </thead>
       <tbody valign="top">
        <tr>
         <td align="center" colspan="1" rowspan="1">
          COVID-19
         </td>
         <td align="center" colspan="1" rowspan="1">
          CRP
          <break>
          </break>
          AST
          <break>
          </break>
          ALT
          <break>
          </break>
          CK
          <break>
          </break>
          LDH
          <break>
          </break>
          D-dimer
          <break>
          </break>
          Lymphopenia
         </td>
         <td align="center" colspan="1" rowspan="1">
          Chest radiography
         </td>
         <td align="center" colspan="1" rowspan="1">
          Age
          <break>
          </break>
          Gender
          <break>
          </break>
          Pregnancy
          <break>
          </break>
          Viral load
          <break>
          </break>
          Underlying disease
         </td>
         <td align="center" colspan="1" rowspan="1">
         </td>
        </tr>
        <tr>
         <td align="center" colspan="1" rowspan="1">
          SARS
         </td>
         <td align="center" colspan="1" rowspan="1">
          CRP
          <break>
          </break>
          AST
          <break>
          </break>
          ALT
          <break>
          </break>
          CK
          <break>
          </break>
          LDH
          <break>
          </break>
          D-dimer
          <break>
          </break>
          Low platelet
          <break>
          </break>
          Plasma electrolyte
         </td>
         <td align="center" colspan="1" rowspan="1">
          Chest radiography
         </td>
         <td align="center" colspan="1" rowspan="1">
          Age
          <break>
          </break>
          Gender
          <break>
          </break>
          Pregnancy
          <break>
          </break>
          Underlying diseases
         </td>
         <td align="center" colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B55">
           55
          </xref>
          ,
          <xref ref-type="bibr" rid="B59">
           59
          </xref>
          ,
          <xref ref-type="bibr" rid="B65">
           65
          </xref>
          ,
          <xref ref-type="bibr" rid="B94">
           94
          </xref>
         </td>
        </tr>
        <tr>
         <td align="center" colspan="1" rowspan="1">
          MERS
         </td>
         <td align="center" colspan="1" rowspan="1">
          Neutrophilia
          <break>
          </break>
          Lymphopenia
          <break>
          </break>
          Serum creatinine
          <break>
          </break>
          LDH
         </td>
         <td align="center" colspan="1" rowspan="1">
          The diffuse or brochopneumonia
         </td>
         <td align="center" colspan="1" rowspan="1">
          Age,
          <break>
          </break>
          Chronic kidney disease,
          <break>
          </break>
          Hypertension,
          <break>
          </break>
          Viral load
         </td>
         <td align="center" colspan="1" rowspan="1">
          <xref ref-type="bibr" rid="B95">
           95
          </xref>
          -
          <xref ref-type="bibr" rid="B98">
           98
          </xref>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
    </floats-group>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Pathog Glob Health
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Pathog Glob Health
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       YPGH
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       ypgh20
      </journal-id>
      <journal-title-group>
       <journal-title>
        Pathogens and Global Health
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       2047-7724
      </issn>
      <issn pub-type="epub">
       2047-7732
      </issn>
      <publisher>
       <publisher-name>
        Taylor &amp; Francis
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       26924345
      </article-id>
      <article-id pub-id-type="pmc">
       4809235
      </article-id>
      <article-id pub-id-type="publisher-id">
       1122852
      </article-id>
      <article-id pub-id-type="doi">
       10.1080/20477724.2015.1122852
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Review
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction
       </article-title>
       <alt-title alt-title-type="running-title">
        MERS-CoV: animal to human interaction
       </alt-title>
       <alt-title alt-title-type="running-authors">
        Omrani et al.
       </alt-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Omrani
         </surname>
         <given-names>
          Ali S.
         </given-names>
        </name>
        <xref ref-type="aff" rid="AFF0001">
         <sup>
          1
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Al-Tawfiq
         </surname>
         <given-names>
          Jaffar A.
         </given-names>
        </name>
        <xref ref-type="aff" rid="AFF0002">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="aff" rid="AFF0003">
         <sup>
          3
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Memish
         </surname>
         <given-names>
          Ziad A.
         </given-names>
        </name>
        <xref ref-type="aff" rid="AFF0004">
         <sup>
          4
         </sup>
        </xref>
        <xref ref-type="corresp" rid="COR0001">
        </xref>
       </contrib>
       <aff id="AFF0001">
        <label>
         1
        </label>
        <institution>
         Department of Medicine, Section of Infectious Diseases, King Faisal Specialist Hospital and Research Centre
        </institution>
        , Riyadh,
        <country>
         Saudi Arabia
        </country>
       </aff>
       <aff id="AFF0002">
        <label>
         2
        </label>
        <institution>
         Johns Hopkins Aramco Healthcare
        </institution>
        , Dhahran,
        <country>
         Saudi Arabia
        </country>
       </aff>
       <aff id="AFF0003">
        <label>
         3
        </label>
        <institution>
         Indiana University School of Medicine
        </institution>
        , Indianapolis, IN,
        <country>
         USA
        </country>
       </aff>
       <aff id="AFF0004">
        <label>
         4
        </label>
        <institution>
         Ministry of Health &amp; College of Medicine, Alfaisal University
        </institution>
        , Riyadh,
        <country>
         Saudi Arabia
        </country>
       </aff>
      </contrib-group>
      <author-notes>
       <corresp id="COR0001">
        Correspondence to: Ziad A. Memish, Ministry of Health &amp; College of Medicine, Alfaisal University, P.O. Box 54146, Riyadh 11514, Kingdom of Saudi Arabia. Email:
        <email>
         zmemish@yahoo.com
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="collection">
       <year>
        2015
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        18
       </day>
       <month>
        2
       </month>
       <year>
        2016
       </year>
      </pub-date>
      <volume>
       109
      </volume>
      <issue>
       8
      </issue>
      <fpage seq="2">
       354
      </fpage>
      <lpage>
       362
      </lpage>
      <permissions>
       <copyright-statement>
        © 2016 Taylor &amp; Francis
       </copyright-statement>
       <copyright-year>
        2016
       </copyright-year>
       <copyright-holder>
        Taylor &amp; Francis
       </copyright-holder>
       <license>
        <license-p>
         This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
        </license-p>
       </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="YPGH_109_1122852.pdf">
      </self-uri>
      <abstract>
       <p>
        The Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel enzootic betacoronavirus that was first described in September 2012. The clinical spectrum of MERS-CoV infection in humans ranges from an asymptomatic or mild respiratory illness to severe pneumonia and multi-organ failure; overall mortality is around 35.7%. Bats harbour several betacoronaviruses that are closely related to MERS-CoV but more research is needed to establish the relationship between bats and MERS-CoV. The seroprevalence of MERS-CoV antibodies is very high in dromedary camels in Eastern Africa and the Arabian Peninsula. MERS-CoV RNA and viable virus have been isolated from dromedary camels, including some with respiratory symptoms. Furthermore, near-identical strains of MERS-CoV have been isolated from epidemiologically linked humans and camels, confirming inter-transmission, most probably from camels to humans. Though inter-human spread within health care settings is responsible for the majority of reported MERS-CoV cases, the virus is incapable at present of causing sustained human-to-human transmission. Clusters can be readily controlled with implementation of appropriate infection control procedures. Phylogenetic and sequencing data strongly suggest that MERS-CoV originated from bat ancestors after undergoing a recombination event in the spike protein, possibly in dromedary camels in Africa, before its exportation to the Arabian Peninsula along the camel trading routes. MERS-CoV serosurveys are needed to investigate possible unrecognized human infections in Africa. Amongst the important measures to control MERS-CoV spread are strict regulation of camel movement, regular herd screening and isolation of infected camels, use of personal protective equipment by camel handlers and enforcing rules banning all consumption of unpasteurized camel milk and urine.
       </p>
      </abstract>
      <kwd-group kwd-group-type="author">
       <title>
        Keywords
       </title>
       <kwd>
        MERS-CoV
       </kwd>
       <kwd>
        Coronavirus
       </kwd>
       <kwd>
        Middle East
       </kwd>
       <kwd>
        Animal
       </kwd>
       <kwd>
        Dromedary
       </kwd>
       <kwd>
        Camel
       </kwd>
       <kwd>
        Bat
       </kwd>
       <kwd>
        Zoonosis
       </kwd>
      </kwd-group>
      <counts>
       <fig-count count="2">
       </fig-count>
       <table-count count="2">
       </table-count>
       <equation-count count="0">
       </equation-count>
       <ref-count count="103">
       </ref-count>
       <page-count count="9">
       </page-count>
      </counts>
     </article-meta>
    </front>
    <sec id="S0001">
     <title>
      Introduction
     </title>
     <p>
      The Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated from a 60-year man who died in a hospital in Jeddah, Saudi Arabia, in June 2012 with severe pneumonia and multi-organ failure.
      <xref ref-type="bibr" rid="CIT0001">
       <sup>
        1
       </sup>
      </xref>
      Thus far, the majority of MERS-CoV cases have originated in countries in the Middle East, including Saudi Arabia, the United Arab Emirates (UAE), Qatar, Oman, Kuwait and Iran.
      <xref ref-type="bibr" rid="CIT0002">
       <sup>
        2
       </sup>
      </xref>
      Clinical illness associated with MERS-CoV ranges from mild upper respiratory symptoms to fulminant pneumonia and multi-system failure.
      <xref ref-type="bibr" rid="CIT0003">
       <sup>
        3, 4
       </sup>
      </xref>
      <sup>
       −
      </sup>
      <xref ref-type="bibr" rid="CIT0005">
       <sup>
        5
       </sup>
      </xref>
      Human-to-human transmission of MERS-CoV is well documented in family clusters, community settings and more often in health care settings.
      <xref ref-type="bibr" rid="CIT0003">
       <sup>
        3, 6–8
       </sup>
      </xref>
      Larger hospital outbreaks have been driven by a combination of late recognition, over-crowding and inadequate infection control precautions.
      <xref ref-type="bibr" rid="CIT0005">
       <sup>
        5, 9, 10
       </sup>
      </xref>
      However, MERS-CoV inter-human transmissibility is thought to be relatively limited.
      <xref ref-type="bibr" rid="CIT0011">
       <sup>
        11
       </sup>
      </xref>
      <sup>
       −13
      </sup>
     </p>
     <p>
      Up to 12 August 2015, a total of 1401 laboratory-confirmed MERS-CoV infections, including 500 associated deaths, have been reported to the World Health Organization.
      <xref ref-type="bibr" rid="CIT0014">
       <sup>
        14
       </sup>
      </xref>
      As with many emerging viral infections, a zoonotic source was suspected soon after the identification of MERS-CoV.
      <xref ref-type="bibr" rid="CIT0015">
       <sup>
        15
       </sup>
      </xref>
      We herein review the available evidence that associates MERS-CoV with animal sources and the probable directions of transmission.
     </p>
    </sec>
    <sec id="S0002">
     <title>
      Host Susceptibility
     </title>
     <p>
      MERS-CoV entry into their host cells is mediated by binding of a receptor-binding domain on their spike (S) proteins to specific cellular receptors known as dipeptidyl peptidase 4 (DPP4).
      <xref ref-type="bibr" rid="CIT0016">
       <sup>
        16
       </sup>
      </xref>
      DPP4 is expressed on the epithelial and endothelial cells of most human organs; an observation that might explain the multi-system clinical spectrum of MERS-CoV infection.
      <xref ref-type="bibr" rid="CIT0018">
       <sup>
        18
       </sup>
      </xref>
      DPP4 of small animals such as mice, ferrets and hamsters do not support MERS-CoV cell entry, and hence, such animals are not susceptible to MERS-CoV infection.
      <xref ref-type="bibr" rid="CIT0019">
       <sup>
        19
       </sup>
      </xref>
      However, mice are susceptible to MERS-CoV once transduced with recombinant adenovirus expressing human DPP4 receptors.
      <sup>
       20
      </sup>
      On the other hand, experimental inoculation of rhesus macaques and marmosets resulted in viral replication, cytopathic cellular changes and mild to severe respiratory illness.
      <xref ref-type="bibr" rid="CIT0021">
       <sup>
        21–24
       </sup>
      </xref>
      <sup>
       −
      </sup>
      <xref ref-type="bibr" rid="CIT0024">
       <sup>
        24
       </sup>
      </xref>
      MERS-CoV can also be detected in lungs of inoculated rabbits, but without any associated symptoms or histopathological changes.
      <xref ref-type="bibr" rid="CIT0025">
       <sup>
        25
       </sup>
      </xref>
      Macaques and marmosets have already proved useful animal models for the investigation of potential MERS-CoV therapeutic agents.
      <xref ref-type="bibr" rid="CIT0026">
       <sup>
        26, 27
       </sup>
      </xref>
      Notably, MERS-CoV can utilize DPP4 expressed on cell lines derived from goats, sheep and cows making these animals’ potential reservoirs or intermediate hosts for MERS-CoV.
      <xref ref-type="bibr" rid="CIT0019">
       <sup>
        19, 28
       </sup>
      </xref>
      However, MERS-CoV antibodies have never been identified in any such animals.
      <xref ref-type="bibr" rid="CIT0029">
       <sup>
        29–33
       </sup>
      </xref>
      <sup>
       −
      </sup>
      <xref ref-type="bibr" rid="CIT0034">
       <sup>
        34
       </sup>
      </xref>
     </p>
    </sec>
    <sec id="S0003">
     <title>
      Bats as Putative Origin of MERS-CoV
     </title>
     <p>
      Bats are known natural reservoirs for several emerging viral infections in humans including rabies, Nipah virus, Hendra virus and Ebola virus.
      <xref ref-type="bibr" rid="CIT0035">
       <sup>
        35
       </sup>
      </xref>
      Several features enable bats to be efficient sources of emerging human viral infections. As an extremely diverse species with a long evolutionary history, bats have co-evolved with a variety of viruses.
      <xref ref-type="bibr" rid="CIT0036">
       <sup>
        36
       </sup>
      </xref>
      Their lack of B-cell-mediated immune responses allows them to carry viruses without showing overt signs of illness.
      <xref ref-type="bibr" rid="CIT0037">
       <sup>
        37
       </sup>
      </xref>
      Low metabolic rate and suppressed immune response during bats’ hibernation result in delayed viral clearance.
      <xref ref-type="bibr" rid="CIT0038">
       <sup>
        38
       </sup>
      </xref>
      Bats live closely together in extremely large numbers facilitating stable circulation of viruses amongst them.
      <xref ref-type="bibr" rid="CIT0039">
       <sup>
        39, 40
       </sup>
      </xref>
      Furthermore, bats are capable of flying and hence carrying potentially infectious pathogens over considerable distances.
      <xref ref-type="bibr" rid="CIT0041">
       <sup>
        41
       </sup>
      </xref>
      A pertinent feature of bats is that they chew fruits to absorb their sugars and spit out the remains.
      <xref ref-type="bibr" rid="CIT0042">
       <sup>
        42
       </sup>
      </xref>
      The discarded fruits can be contaminated with viruses from the oral cavity, urine and faeces providing a ready source for transmission to other potential hosts such animals and humans.
      <xref ref-type="bibr" rid="CIT0037">
       <sup>
        37, 42
       </sup>
      </xref>
     </p>
     <p>
      Severe acute respiratory syndrome coronavirus (SARS-CoV), which emerged in China in 2003 and caused over 8000 human infections, originated in horseshoe bats (
      <italic>
       Rhinolophus sinicus
      </italic>
      ) and was transmitted to humans via palm civets as intermediate hosts.
      <xref ref-type="bibr" rid="CIT0043">
       <sup>
        43
       </sup>
      </xref>
      <sup>
       −
      </sup>
      <xref ref-type="bibr" rid="CIT0046">
       <sup>
        46
       </sup>
      </xref>
      Moreover, MERS-CoV belongs to
      <italic>
       Betacoronavirus
      </italic>
      clade c, along with bat coronaviruses HKU4 and HKU5.
      <xref ref-type="bibr" rid="CIT0047">
       <sup>
        47, 48
       </sup>
      </xref>
      It is therefore not surprising that initial efforts to identify the origins of MERS-CoV focused on bats.
      <xref ref-type="bibr" rid="CIT0041">
       <sup>
        41, 49
       </sup>
      </xref>
     </p>
     <p>
      Throat swabs, urine, faeces and serum samples were collected from wild bats in Saudi Arabia including the area where the first MERS-CoV patient had lived and worked. Several coronaviruses were identified in 227 of 1003 samples. A 190-nucleotide fragment of the RNA-dependent RNA polymerase (RdRp) region of MERS-CoV genome was detected in one faecal pellet from an Egyptian tomb bat (
      <italic>
       Taphozous perforates
      </italic>
      ).
      <sup>
       50
      </sup>
      The sequenced amplification product was identical to that of the MERS-CoV sequence obtained from the first index human case.
      <xref ref-type="bibr" rid="CIT0001">
       <sup>
        1
       </sup>
      </xref>
      Unfortunately, the quality of the samples deteriorated when the cold chain was interrupted for more than 48 hours during their transport from Saudi Arabia to Columbia University in the United States, and it was hence not possible to produce the full genomic sequence of the isolate.
      <sup>
       50
      </sup>
     </p>
     <p>
      Away from the Arabian Peninsula, novel MERS-CoV-related coronaviruses were detected in slit-faced bats (
      <italic>
       Nycteris gambiensis
      </italic>
      ) from Ghana and pipistrelle bats (
      <italic>
       Pipistrellus pipistrellus, P. kuhlii, P. nathusii, P. pipistrellus and P. pygmaeus
      </italic>
      ) from Germany, the Netherlands, Romania and Ukraine.
      <sup>
       51
      </sup>
      The 816-nucleotide RdRp amino acid sequence of the novel
      <italic>
       Pipistrellus
      </italic>
      and
      <italic>
       Nycteris
      </italic>
      bat viruses differed from that of MERS-CoV by only 1.8% and 7.5%, respectively. Novel betacoronaviruses closely related to MERS-CoV have also been identified from Asian particoloured bats (
      <italic>
       Vespertilio superans
      </italic>
      ) in China, serotine bats (
      <italic>
       Eptesicus serotinus
      </italic>
      ) in Italy and broad-eared bat (
      <italic>
       Nyctinomops laticaudatus
      </italic>
      ) in Mexico, in addition to bat guano fertilizer from Thailand.
      <sup>
       52−55
      </sup>
     </p>
     <p>
      More recently, a novel betacoronavirus named NeoCoV was identified in a vesper bat (
      <italic>
       Neoromicia capensis
      </italic>
      ) from South Africa. The sequenced 816-nucleotide RdRp fragment from NeoCoV differed from that of MERS-CoV by only one amino acid.
      <sup>
       56
      </sup>
      The close relatedness of MERS-CoV and various bat viruses allows speculation that its ancestors might exist in Old World bats.
      <sup>
       57
      </sup>
     </p>
     <p>
      Though S protein of the bat coronavirus HKU4 can recognize human DPP4, it is not activated by human proteases and therefore cannot mediate viral entry into human cells.
      <xref ref-type="bibr" rid="CIT0058">
       <sup>
        58, 59
       </sup>
      </xref>
      However, the introduction of two mutations which are already present in MERS-CoV S protein, S746R and N762A, into HKU4 S protein enabled its activation by human proteases and entry into human cells.
      <sup>
       60
      </sup>
      It had been previously shown that two mutations in S protein allowed SARS-CoV to be transmitted from civets to humans.
      <sup>
       61
      </sup>
      A similar event in bat coronaviruses could explain the emergence of MERS-CoV and its ability to cross the species barrier between bats and humans, directly or through an intermediate host.
      <xref ref-type="bibr" rid="CIT0062">
       <sup>
        62, 63
       </sup>
      </xref>
     </p>
    </sec>
    <sec id="S0004">
     <title>
      Dromedary Camels as Reservoirs for MERS-CoV
     </title>
     <p>
      Camels are large mammals with distinctive humps. Two species of camels are in current existence; the two-humped bactrians (
      <italic>
       Camelus bactrianus
      </italic>
      ) and the one-humped dromedaries (
      <italic>
       Camelus dromedarius
      </italic>
      ).
      <xref ref-type="bibr" rid="CIT0064">
       <sup>
        64
       </sup>
      </xref>
      Bactrian camels inhabit Central Asia and constitute around five per cent of the world’s camel population.
      <xref ref-type="bibr" rid="CIT0064">
       <sup>
        64
       </sup>
      </xref>
      On the other hand, the majority of dromedary camels are found in Eastern Africa, from where they are exported to countries in the Arabian Peninsula.
      <xref ref-type="bibr" rid="CIT0064">
       <sup>
        64, 65
       </sup>
      </xref>
      Saudi Arabia, UAE, Qatar and Yemen have the largest populations of dromedary camels in the Middle East.
      <sup>
       66
      </sup>
      In this region, camels have prominent economic, cultural and recreational significance. In addition to being a source of milk and meat, dromedary camels are involved in racing, parades and annual festivals.
      <xref ref-type="bibr" rid="CIT0067">
       <sup>
        67
       </sup>
      </xref>
      Consumption of unpasteurized camel milk is not uncommon, and camel urine is widely believed to have medicinal benefits.
      <xref ref-type="bibr" rid="CIT0067">
       <sup>
        67
       </sup>
      </xref>
      Socio-economic development and rapid urbanization in the region has resulted in camel farms becoming gradually concentrated in close proximity to major cities.
      <xref ref-type="bibr" rid="CIT0065">
       <sup>
        65, 68
       </sup>
      </xref>
      There are therefore ample opportunities in the Middle East for direct human contact with camels and their products.
     </p>
     <p>
      Multiple lines of evidence implicate dromedary camels in the emergence and transmission of MERS-CoV. Firstly, MERS-CoV antibodies are highly prevalent in dromedary camels from across the Arabian Peninsula, North Africa and Eastern Africa (Figure
      <xref ref-type="fig" rid="F0001">
       1
      </xref>
      and Table
      <xref ref-type="table" rid="T0001">
       1
      </xref>
      ).
      <xref ref-type="bibr" rid="CIT0029">
       <sup>
        29–31, 34, 70
       </sup>
      </xref>
      MERS-CoV antibodies were detected in stored camel sera dating as far back as early 1990s, suggesting that MERS-CoV may have been circulating in dromedaries for over 20 years before it was first recognized as a cause of human infection.
      <xref ref-type="bibr" rid="CIT0032">
       <sup>
        32
       </sup>
      </xref>
      <sup>
       ,71,72
      </sup>
      The prevalence of MERS-CoV antibodies is significantly higher in older camels compared with those aged two years or less.
      <xref ref-type="bibr" rid="CIT0031">
       <sup>
        31, 32
       </sup>
      </xref>
      Interestingly, despite the high overall prevalence of MERS-CoV seropositivity in dromedary camels from Kenya, no MERS-CoV antibodies were detected in those from the North Eastern region where dromedaries have been raised largely in isolation from those in the rest of the country.
      <sup>
       71
      </sup>
      Similarly, all dromedaries raised at the Dubai Central Veterinary Research Laboratory, which had no contact with other camels, were seronegative for MERS-CoV.
      <sup>
       75
      </sup>
      Also noteworthy is that 15 of 105 dromedary camels from the Canary Islands were seropositive for MERS-CoV. Although the majority of camels in the herd were born and bred in the Canary Islands, the group included three camels that were imported from Morocco.
      <xref ref-type="bibr" rid="CIT0029">
       <sup>
        29
       </sup>
      </xref>
      In contrast, no MERS-CoV antibodies were detected in dromedary camels from Australia, Canada, the United States of America, Germany, the Netherlands or Japan.
      <xref ref-type="bibr" rid="CIT0029">
       <sup>
        29, 34
       </sup>
      </xref>
      The high prevalence of MERS-CoV seropositivity in Africa and the Middle East suggests that animal movement has facilitated the transmission and circulation of MERS-CoV amongst dromedary camels in these regions. MERS-CoV antibodies have neither been found in Mongolian or Dutch bactrian camels, nor in South American camelids such as lamas, alpacas and guanacos.
      <xref ref-type="bibr" rid="CIT0029">
       <sup>
        29
       </sup>
      </xref>
     </p>
     <fig id="F0001" orientation="portrait" position="float">
      <label>
       Figure 1
      </label>
      <caption>
       <p>
        Countries with primary human MERS-CoV infections and MERS-CoV antibody and RNA detection in dromedary camels.
       </p>
      </caption>
      <graphic xlink:href="YPGH_A_1122852_F0001_OC">
      </graphic>
     </fig>
     <table-wrap id="T0001" orientation="portrait" position="float">
      <label>
       Table 1
      </label>
      <caption>
       <title>
        Summary of studies reporting prevalence of MERS-CoV antibodies in dromedary camels
       </title>
      </caption>
      <!--OASIS TABLE HERE-->
      <table frame="hsides" rules="groups">
       <colgroup>
        <col width="1*"/>
        <col width="1*"/>
        <col width="1*"/>
        <col char="." width="1*"/>
        <col char="." width="1*"/>
       </colgroup>
       <thead>
        <tr valign="top">
         <th align="left" valign="top">
          Location
         </th>
         <th align="left" valign="top">
          Sampling year(s)
         </th>
         <th align="left" valign="top">
          Camel age
         </th>
         <th align="center" char="." valign="top">
          Number
         </th>
         <th align="center" char="." valign="top">
          % Positive
          <xref ref-type="table-fn" rid="TFN0002">
           *
          </xref>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr valign="top">
         <td align="left" valign="top">
          Saudi Arabia
          <xref ref-type="bibr" rid="CIT0031">
           <sup>
            31
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2012–2013
         </td>
         <td align="left" valign="top">
          &lt;1 to &gt;5 years
         </td>
         <td align="char" char="." valign="top">
          310
         </td>
         <td align="char" char="." valign="top">
          90.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="3" valign="top">
          Saudi Arabia
          <xref ref-type="bibr" rid="CIT0032">
           <sup>
            32
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          1992–1996
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          132
         </td>
         <td align="char" char="." valign="top">
          93.2
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          2004–2010
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          132
         </td>
         <td align="char" char="." valign="top">
          81.1
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          203
         </td>
         <td align="char" char="." valign="top">
          73.9
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Saudi Arabia
          <xref ref-type="bibr" rid="CIT0085">
           <sup>
            85
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          9
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Qatar
          <sup>
           89
          </sup>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          14
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Qatar
          <sup>
           79
          </sup>
         </td>
         <td align="left" rowspan="2" valign="top">
          2014
         </td>
         <td align="left" valign="top">
          76 aged ≤1 year
         </td>
         <td align="char" char="." rowspan="2" valign="top">
          105
         </td>
         <td align="char" char="." rowspan="2" valign="top">
          97
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          29 aged &gt;1 year
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          UAE
          <xref ref-type="bibr" rid="CIT0034">
           <sup>
            34
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2005
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          11
         </td>
         <td align="char" char="." valign="top">
          81.8
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          UAE
          <sup>
           75
          </sup>
         </td>
         <td align="left" valign="top">
          2003
         </td>
         <td align="left" valign="top">
          Adult
         </td>
         <td align="char" char="." valign="top">
          151
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          2–8 years
         </td>
         <td align="char" char="." valign="top">
          500
         </td>
         <td align="char" char="." valign="top">
          97.2
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="5" valign="top">
          UAE
          <sup>
           74
          </sup>
         </td>
         <td align="left" rowspan="5" valign="top">
          2014
         </td>
         <td align="left" valign="top">
          &lt;1 year
         </td>
         <td align="char" char="." valign="top">
          108
         </td>
         <td align="char" char="." valign="top">
          85.2
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          2–4 years
         </td>
         <td align="char" char="." valign="top">
          340
         </td>
         <td align="char" char="." valign="top">
          96.5
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          &gt;4 years
         </td>
         <td align="char" char="." valign="top">
          310
         </td>
         <td align="char" char="." valign="top">
          96.1
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Unknown
         </td>
         <td align="char" char="." valign="top">
          85
         </td>
         <td align="char" char="." valign="top">
          80.0
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          All ages
         </td>
         <td align="char" char="." valign="top">
          843
         </td>
         <td align="char" char="." valign="top">
          93.2
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          UAE
          <sup>
           83
          </sup>
         </td>
         <td align="left" valign="top">
          2015
         </td>
         <td align="left" valign="top">
          4–10 years
         </td>
         <td align="char" char="." valign="top">
          8
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Oman
          <xref ref-type="bibr" rid="CIT0029">
           <sup>
            29
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          8–12 years
         </td>
         <td align="char" char="." valign="top">
          50
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Jordan
          <xref ref-type="bibr" rid="CIT0030">
           <sup>
            30
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          3–14 months
         </td>
         <td align="char" char="." valign="top">
          11
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Egypt
          <sup>
           82
          </sup>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          &gt;6 years
         </td>
         <td align="char" char="." valign="top">
          52
         </td>
         <td align="char" char="." valign="top">
          92.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Egypt
          <xref ref-type="bibr" rid="CIT0033">
           <sup>
            33
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          5–7 years
         </td>
         <td align="char" char="." valign="top">
          110
         </td>
         <td align="char" char="." valign="top">
          98.2
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Egypt
          <sup>
           103
          </sup>
         </td>
         <td align="left" valign="top">
          1997
         </td>
         <td align="left" valign="top">
          &gt;6 years
         </td>
         <td align="char" char="." valign="top">
          43
         </td>
         <td align="char" char="." valign="top">
          81.4
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Tunisia
          <sup>
           69
          </sup>
         </td>
         <td align="left" rowspan="2" valign="top">
          2009
         </td>
         <td align="left" valign="top">
          ≤2 years
         </td>
         <td align="char" char="." valign="top">
          46
         </td>
         <td align="char" char="." valign="top">
          30
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          &gt;2 years
         </td>
         <td align="char" char="." valign="top">
          158
         </td>
         <td align="char" char="." valign="top">
          54
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Ethiopia
          <sup>
           69
          </sup>
         </td>
         <td align="left" valign="top">
          2010–2011
         </td>
         <td align="left" valign="top">
          ≤2 years
         </td>
         <td align="char" char="." valign="top">
          31
         </td>
         <td align="char" char="." valign="top">
          93
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
         </td>
         <td align="left" valign="top">
         </td>
         <td align="left" valign="top">
          &gt;2 years
         </td>
         <td align="char" char="." valign="top">
          157
         </td>
         <td align="char" char="." valign="top">
          97
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Nigeria
          <sup>
           69
          </sup>
         </td>
         <td align="left" valign="top">
          2010–2011
         </td>
         <td align="left" valign="top">
          &gt;2 years
         </td>
         <td align="char" char="." valign="top">
          358
         </td>
         <td align="char" char="." valign="top">
          94
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Somalia
          <sup>
           103
          </sup>
         </td>
         <td align="left" valign="top">
          1983–1984
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          86
         </td>
         <td align="char" char="." valign="top">
          83.7
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Sudan
          <sup>
           103
          </sup>
         </td>
         <td align="left" valign="top">
          1984
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          60
         </td>
         <td align="char" char="." valign="top">
          86.7
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Kenya
          <sup>
           71
          </sup>
         </td>
         <td align="left" valign="top">
          1992–2013
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          774
         </td>
         <td align="char" char="." valign="top">
          29.5
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Canary Islands
          <xref ref-type="bibr" rid="CIT0029">
           <sup>
            29
           </sup>
          </xref>
         </td>
         <td align="left" rowspan="2" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          17 aged ≤4 years
         </td>
         <td align="char" char="." rowspan="2" valign="top">
          105
         </td>
         <td align="char" char="." rowspan="2" valign="top">
          14.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          88 aged &gt;4 years
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <fn id="TFN0001">
        <p>
         NA: not available; UAE: United Arab Emirates.
        </p>
       </fn>
       <fn id="TFN0002">
        <label>
         *
        </label>
        <p>
         The highest proportion positive by any serological assay used in the study
        </p>
       </fn>
      </table-wrap-foot>
     </table-wrap>
     <p>
      The second line of evidence is the reported detection of MERS-CoV by RT-PCR in oro-nasal and faecal samples from dromedary camels in multiple locations in the Arabian Peninsula (Figure
      <xref ref-type="fig" rid="F0001">
       1
      </xref>
      and Table
      <xref ref-type="table" rid="T0002">
       2
      </xref>
      ).
      <xref ref-type="bibr" rid="CIT0032">
       <sup>
        32, 70, 78
       </sup>
      </xref>
      The four of 110 dromedary camels in which MERS-CoV RNA was detected in Egypt were all imported from Sudan or Ethiopia for slaughter.
      <sup>
       82
      </sup>
      Of particular concern is the particularly high rate of MERS-CoV RNA detection in camels presented for slaughter in Eastern Saudi Arabia and Qatar; the latter was in the vicinity of a market in Doha to which two prior human cases were linked.
      <xref ref-type="bibr" rid="CIT0078">
       <sup>
        78
       </sup>
      </xref>
      Overall, MERS-CoV is more commonly detected and in higher viral loads in nasal swabs than in faecal samples.
      <xref ref-type="bibr" rid="CIT0032">
       <sup>
        32
       </sup>
      </xref>
      Another notable observation is that sequences from MERS-CoV strains isolated several months apart within the same location are often identical to one another, indicating that MERS-CoV circulation in dromedary herds is very stable.
      <sup>
       73,74
      </sup>
     </p>
     <table-wrap id="T0002" orientation="portrait" position="float">
      <label>
       Table 2
      </label>
      <caption>
       <title>
        Summary of MERS-CoV RT-PCR studies in dromedary camels
       </title>
      </caption>
      <!--OASIS TABLE HERE-->
      <table frame="hsides" rules="groups">
       <colgroup>
        <col width="1*"/>
        <col width="1*"/>
        <col width="1*"/>
        <col char="." width="1*"/>
        <col width="1*"/>
        <col char="." width="1*"/>
       </colgroup>
       <thead>
        <tr valign="top">
         <th align="left" valign="top">
          Location
         </th>
         <th align="left" valign="top">
          Sampling year(s)
         </th>
         <th align="left" valign="top">
          Sample type
         </th>
         <th align="center" char="." valign="top">
          Number
         </th>
         <th align="left" valign="top">
          Camel age
         </th>
         <th align="center" char="." valign="top">
          RT-PCR (% positive)
         </th>
        </tr>
       </thead>
       <tbody>
        <tr valign="top">
         <td align="left" rowspan="4" valign="top">
          Saudi Arabia
          <xref ref-type="bibr" rid="CIT0078">
           <sup>
            78
           </sup>
          </xref>
         </td>
         <td align="left" rowspan="4" valign="top">
          2013–2014
         </td>
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          36
         </td>
         <td align="left" valign="top">
          &lt;4 years
         </td>
         <td align="char" char="." valign="top">
          41.7
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          60
         </td>
         <td align="left" valign="top">
          ≥4 years
         </td>
         <td align="char" char="." valign="top">
          21.7
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          LT
         </td>
         <td align="char" char="." valign="top">
          28
         </td>
         <td align="left" valign="top">
          &lt;4 years
         </td>
         <td align="char" char="." valign="top">
          82.1
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          LT
         </td>
         <td align="char" char="." valign="top">
          63
         </td>
         <td align="left" valign="top">
          ≥4 years
         </td>
         <td align="char" char="." valign="top">
          52.4
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Saudi Arabia
          <xref ref-type="bibr" rid="CIT0032">
           <sup>
            32
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" rowspan="2" valign="top">
          B, NS and RS
         </td>
         <td align="char" char="." valign="top">
          104
         </td>
         <td align="left" valign="top">
          ≤2 years
         </td>
         <td align="char" char="." valign="top">
          34.6
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          2013
         </td>
         <td align="char" char="." valign="top">
          98
         </td>
         <td align="left" valign="top">
          &gt;2 years
         </td>
         <td align="char" char="." valign="top">
          15.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Saudi Arabia
          <sup>
           73
          </sup>
         </td>
         <td align="left" rowspan="2" valign="top">
          2013–2014
         </td>
         <td align="left" rowspan="2" valign="top">
          B, NS, OS and RS
         </td>
         <td align="char" char="." valign="top">
          27
         </td>
         <td align="left" valign="top">
          ≤1 year
         </td>
         <td align="char" char="." valign="top">
          25.9
         </td>
        </tr>
        <tr valign="top">
         <td align="char" char="." valign="top">
          14
         </td>
         <td align="left" valign="top">
          &gt;1 years
         </td>
         <td align="char" char="." valign="top">
          14.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Saudi Arabia
          <xref ref-type="bibr" rid="CIT0085">
           <sup>
            85
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          9
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          22.2
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Saudi Arabia
          <sup>
           86
          </sup>
         </td>
         <td align="left" rowspan="2" valign="top">
          2013
         </td>
         <td align="left" rowspan="2" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          3
         </td>
         <td align="left" valign="top">
          ≤1 year
         </td>
         <td align="char" char="." valign="top">
          33.3
         </td>
        </tr>
        <tr valign="top">
         <td align="char" char="." valign="top">
          6
         </td>
         <td align="left" valign="top">
          &gt;1 year
         </td>
         <td align="char" char="." valign="top">
          0
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Qatar
          <sup>
           89
          </sup>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          B, NS and RS
         </td>
         <td align="char" char="." valign="top">
          14
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          35.7
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Qatar
          <sup>
           80
          </sup>
         </td>
         <td align="left" valign="top">
          2014
         </td>
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          53
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          1.8
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="2" valign="top">
          Qatar
          <sup>
           79
          </sup>
         </td>
         <td align="left" rowspan="2" valign="top">
          2014
         </td>
         <td align="left" rowspan="2" valign="top">
          NS, OS, RS and LNT
         </td>
         <td align="char" char="." rowspan="2" valign="top">
          105
         </td>
         <td align="left" valign="top">
          76 aged ≤1 year
         </td>
         <td align="char" char="." rowspan="2" valign="top">
          59.0
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          29 aged &gt;1 year
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          UAE
          <sup>
           81
          </sup>
         </td>
         <td align="left" valign="top">
          2015
         </td>
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          7,803
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          1.6
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          UAE
          <xref ref-type="bibr" rid="CIT0034">
           <sup>
            34
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2005
         </td>
         <td align="left" valign="top">
          B
         </td>
         <td align="char" char="." valign="top">
          11
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          0
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          UAE
          <sup>
           75
          </sup>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          F
         </td>
         <td align="char" char="." valign="top">
          182
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          0
         </td>
        </tr>
        <tr valign="top">
         <td align="left" rowspan="5" valign="top">
          UAE
          <sup>
           74
          </sup>
         </td>
         <td align="left" rowspan="5" valign="top">
          2014
         </td>
         <td align="left" valign="top">
          B, NS
         </td>
         <td align="char" char="." valign="top">
          250
         </td>
         <td align="left" valign="top">
          &gt;4 years
         </td>
         <td align="char" char="." valign="top">
          0
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
         </td>
         <td align="char" char="." valign="top">
          344
         </td>
         <td align="left" valign="top">
          2–4 years
         </td>
         <td align="char" char="." valign="top">
          2.9
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
         </td>
         <td align="char" char="." valign="top">
          68
         </td>
         <td align="left" valign="top">
          &lt;1 years
         </td>
         <td align="char" char="." valign="top">
          35.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
         </td>
         <td align="char" char="." valign="top">
          209
         </td>
         <td align="left" valign="top">
          Unknown
         </td>
         <td align="char" char="." valign="top">
          5.3
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
         </td>
         <td align="char" char="." valign="top">
          871
         </td>
         <td align="left" valign="top">
          All ages
         </td>
         <td align="char" char="." valign="top">
          5.1
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          UAE
          <sup>
           83
          </sup>
         </td>
         <td align="left" valign="top">
          2015
         </td>
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          8
         </td>
         <td align="left" valign="top">
          4–10 years
         </td>
         <td align="char" char="." valign="top">
          100
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Oman
          <xref ref-type="bibr" rid="CIT0070">
           <sup>
            70
           </sup>
          </xref>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          CS, NS
         </td>
         <td align="char" char="." valign="top">
          76
         </td>
         <td align="left" valign="top">
          NA
         </td>
         <td align="char" char="." valign="top">
          6.6
         </td>
        </tr>
        <tr valign="top">
         <td align="left" valign="top">
          Egypt
          <sup>
           82
          </sup>
         </td>
         <td align="left" valign="top">
          2013
         </td>
         <td align="left" valign="top">
          NS
         </td>
         <td align="char" char="." valign="top">
          110
         </td>
         <td align="left" valign="top">
          &gt;6 years
         </td>
         <td align="char" char="." valign="top">
          3.6
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <fn id="TFN0003">
        <p>
         B: blood; CS: conjunctival swab; F: faeces; LT: lung tissue; LNT: lymph node tissue; NA: not available; NS: nasal swab; OS: oral swab; RS: rectal swab; S: serum; UAE: United Arab Emirates
        </p>
       </fn>
      </table-wrap-foot>
     </table-wrap>
     <p>
      Interestingly, the prevalence of MERS-CoV RNA shedding is significantly higher in juvenile than in adult camels.
      <xref ref-type="bibr" rid="CIT0032">
       <sup>
        32, 78
       </sup>
      </xref>
      In one prospective study, MERS-CoV detection by RT-PCR in dromedary camels was highest in the period between the months of November and January, coinciding with the dromedaries’ calving season.
      <xref ref-type="bibr" rid="CIT0078">
       <sup>
        78
       </sup>
      </xref>
      This, along with the observed increased incidence of human MERS-CoV infection during the period between March and May, suggests that juvenile camels are an important source of new infections in camels and potentially humans.
      <xref ref-type="bibr" rid="CIT0078">
       <sup>
        78
       </sup>
      </xref>
     </p>
     <p>
      MERS-CoV RNA prevalence data also indicate that animal movement may facilitate the introduction of MERS-CoV into herds of dromedaries. For example, phylogenetic analysis of MERS-CoV strains that were detected in a herd of dromedary camels in Dubai showed that they were closely related to those circulating in Eastern Saudi Arabia, where some of the camels had recently grazed.
      <sup>
       74
      </sup>
      In another example, a group of camels imported from Oman was screened by RT-PCR on arrival in UAE and was found positive for MERS-CoV.
      <sup>
       83
      </sup>
      Moreover, MERS-CoV strains isolated from dromedary camels in Eastern Saudi Arabia were phylogenetically related to those isolated from camels several hundred kilometres away in Buraidah, central Saudi Arabia.
      <sup>
       73
      </sup>
      Most significantly, phylogenetic analyses of partial and whole MERS-CoV genomes from dromedary camels show that they are clustered within human isolates, supporting possible camel–human inter-transmission.
      <xref ref-type="bibr" rid="CIT0032">
       <sup>
        32, 70, 78, 84
       </sup>
      </xref>
      RT-PCR was positive in camels that had prior evidence of MERS-CoV seropositivity, indicating that animal re-infection is possible.
      <sup>
       73,74,79,83
      </sup>
     </p>
     <p>
      The third level of evidence is the demonstration of active MERS-CoV infection in dromedary camels through documented rises in anti-MERS-CoV antibody titres.
      <xref ref-type="bibr" rid="CIT0085">
       <sup>
        85
       </sup>
      </xref>
      MERS-CoV was also detected by RT-PCR in symptomatic camels.
      <xref ref-type="bibr" rid="CIT0078">
       <sup>
        78, 85
       </sup>
      </xref>
      Dromedaries with active MERS-CoV infection exhibited symptoms such muco-purulent nasal and lachrymal discharge, cough, sneezing, fever and loss of appetite.
      <xref ref-type="bibr" rid="CIT0078">
       <sup>
        78, 85
       </sup>
      </xref>
     </p>
     <p>
      It was initially argued that detection of MERS-CoV in camels by RT-PCR is not necessarily evidence of shedding of infectious virus and thus transmissibility of MERS-CoV between dromedaries and humans.
      <xref ref-type="bibr" rid="CIT0087">
       <sup>
        87, 88
       </sup>
      </xref>
      However, several groups have since been able to isolate viable MERS-CoV in cell cultures of nasal and faecal samples from dromedary camels.
      <xref ref-type="bibr" rid="CIT0084">
       <sup>
        84
       </sup>
      </xref>
      Moreover, the potential infectiousness of MERS-CoV recovered from dromedary camels was evident by its capability to cause ex-vivo infection in human respiratory cells and human hepatoma cells (Huh-7).
      <sup>
       80,90
      </sup>
      Successful MERS-CoV cultures usually coincide with corresponding high viral loads in the same specimens.
      <xref ref-type="bibr" rid="CIT0084">
       <sup>
        84
       </sup>
      </xref>
     </p>
     <p>
      The fifth level of evidence is the successful experimental MERS-CoV infection of dromedary camels with resultant mild clinical infection manifesting as fever and rhinorrhea.
      <sup>
       91
      </sup>
      Three MERS-CoV seronegative adult dromedary camels were inoculated via intranasal, intra-tracheal and conjunctival routes with a total dose of 10
      <sup>
       7
      </sup>
      50% tissue culture infective dose (TCID
      <sub>
       50
      </sub>
      ) of MERS-CoV. Clinical symptoms appeared within 2 days and persisted for up to 2 weeks. Submucosal inflammation and necrosis were evident in the upper and lower respiratory tracts, but not the alveoli. MERS-CoV antibodies were detected within 14 days of inoculation. Shedding of infectious MERS-CoV in oral and nasal secretions, as determined by plaque assay titres, continued for up 5 and 7 days, respectively. MERS-CoV was detectable by quantitative PCR for up to 35 days.
      <sup>
       91
      </sup>
      Under certain condition, MERS-CoV can survive on plastic and steel surfaces for up to 30 hours.
      <xref ref-type="bibr" rid="CIT0092">
       <sup>
        92
       </sup>
      </xref>
      Moreover, MERS-CoV RNA can be detected in milk expressed from MERS-CoV infected camels.
      <sup>
       93
      </sup>
      Whether MERS-CoV is secreted in camel milk or it is contaminated from the animal’s other body secretions is probably immaterial as viable MERS-CoV can be recovered from dromedary camel milk stored at 22 degrees Celsius for up to 48 hours.
      <xref ref-type="bibr" rid="CIT0094">
       <sup>
        94
       </sup>
      </xref>
      It is therefore possible to envisage that in the absence of appropriate precautions, the environment surrounding a MERS-CoV infected camel can become extensively contaminated with viable, potentially infectious virus.
     </p>
    </sec>
    <sec id="S0005">
     <title>
      Camel–Human MERS-CoV Inter-transmission
     </title>
     <p>
      The strongest direct evidence yet of transmissibility of MERS-CoV between dromedary camels and humans is the simultaneous isolation of near-identical MERS-CoV strains from epidemiologically linked humans and dromedary camels. In October 2013, a 61-year-old owner of a herd of dromedary camels in Qatar and his 23-year-old co-worker were diagnosed with laboratory-confirmed MERS-CoV infection. MERS-CoV was detected by RT-PCR in five of their 14 camels.
      <sup>
       89
      </sup>
      Alignment of six MERS-CoV genomic fragments, covering 4.2 kb of the MERS-CoV genome, from the camels and the human cases showed that they differed by one nucleotide each in ORF1a and ORF4b regions.
      <sup>
       89
      </sup>
     </p>
     <p>
      In November 2013, a 43-year-old man died in a hospital in Jeddah, Saudi Arabia, with severe MERS-CoV infection. He had owned a herd of nine dromedary camels, some of which were reported to have had recent respiratory symptoms. MERS-CoV was detected by PCR and culture of nasal specimens from one camel.
      <xref ref-type="bibr" rid="CIT0085">
       <sup>
        85
       </sup>
      </xref>
      Partial MERS-CoV sequence of 4.6 kb from the camel and the linked human isolates differed in only two positions.
      <xref ref-type="bibr" rid="CIT0085">
       <sup>
        85
       </sup>
      </xref>
      Whole MERS-CoV genome sequences obtained from viral cultures of the human and camel isolates were 100% identical.
      <sup>
       86
      </sup>
      Importantly, 4-fold rise in MERS-CoV antibody titres was documented in the camels, indicating that active MERS-CoV infection was probably circulating in the dromedary herd.
      <xref ref-type="bibr" rid="CIT0085">
       <sup>
        85
       </sup>
      </xref>
      Later, rising MERS-CoV antibodies were documented in the patient, suggesting that MERS-CoV infection was transmitted from the camels to the human and not vice versa.
      <sup>
       86
      </sup>
     </p>
     <p>
      In May 2015, MERS-CoV was detected in eight asymptomatic dromedary camels at entry into UAE from Oman. Two asymptomatic men, aged 29 and 33 years, who were in contact with the camels were found to be positive for MERS-CoV RNA in their respiratory samples.
      <sup>
       83
      </sup>
      Partial sequences of MERS-CoV spike, ORF3-4a and nucleocapsid regions from the human and linked camels were identical.
      <sup>
       83
      </sup>
      Within 4–8 days from diagnosis, both patients had undetectable MERS-CoV RNA. All dromedaries were seropositive for MERS-CoV antibodies. However, two juvenile camels had high MERS-CoV viral loads in their nasal specimens and were last to become RT-PCR negative.
      <sup>
       83
      </sup>
      The sequence of events strongly suggests that MERS-CoV infection occurred in the dromedary camels before the human cases.
     </p>
     <p>
      MERS-CoV seroprevalence studies in humans with close contact with camels have yielded inconsistent results. A national serosurvey in Saudi Arabia found prevalence of MERS-CoV antibodies that was 15 times higher in camel shepherds (
      <italic>
       P
      </italic>
      = 0.0004) and 23 times higher in slaughterhouse workers (
      <italic>
       P
      </italic>
      &lt; 0.0001), compared with the general population.
      <sup>
       95
      </sup>
      Likewise, individuals who had occupational exposure to dromedary camels in Qatar were seropositive for MERS-CoV but not those without such exposure.
      <sup>
       96
      </sup>
      However, none of 191 persons who had close occupational contacts with MERS-CoV infected camels were seropositive for MERS-CoV.
      <xref ref-type="bibr" rid="CIT0097">
       <sup>
        97
       </sup>
      </xref>
      Similarly, MERS-CoV antibodies were not detected in any of 114 animal workers in contact with MERS-CoV RNA positive camels in Egypt.
      <sup>
       82
      </sup>
      Slaughterhouse and other animal workers in Western and Southern Saudi Arabia were also seronegative for MERS-CoV antibodies.
      <sup>
       98,99
      </sup>
      Collectively, the available data indicate that MERS-CoV is highly prevalent in dromedary camels in the Arabian Peninsula and that transmission of infection from camels to humans, although inefficient, does occur.
     </p>
    </sec>
    <sec id="S0006">
     <title>
      Connecting the Dots
     </title>
     <p>
      The sequenced full genomes of NeoCoV, the novel betacoronavirus that was isolated from vesper bats in South Africa and MERS-CoV strains from dromedary camels and humans confirm that they all belong to the same species.
      <sup>
       57
      </sup>
      NeoCoV is at the root of their phylogenetic tree, with evidence of genetic evolution of MERS-CoV in camels before humans.
      <sup>
       57
      </sup>
      Furthermore, the high similarity of NeoCoV and MERS-CoV with genetic divergence in NeoCoV spike gene suggests that a recombination event within this region may have resulted in the emergence of MERS-CoV.
      <sup>
       57
      </sup>
      The high seroprevalence of MERS-CoV in camels in Eastern Africa indicates that such recombination event might have taken place in dromedaries, or another yet unidentified intermediate host, in Eastern Africa and that MERS-CoV followed the camel trading routes to emerge in humans in the Arabian Peninsula (Figure
      <xref ref-type="fig" rid="F0002">
       2
      </xref>
      ).
      <xref ref-type="bibr" rid="CIT0041">
       <sup>
        41, 42
       </sup>
      </xref>
      The fact that MERS-CoV antibodies have been detected in camel sera from Eastern Africa and the Arabian Peninsula dating back to the early 1990s supports such a hypothesis. Once established in dromedary camels, occasional transmission to humans is evident.
     </p>
     <fig id="F0002" orientation="portrait" position="float">
      <label>
       Figure 2
      </label>
      <caption>
       <p>
        Documented and theorized transmission directions of MERS-CoV between bats, camels and humans.
       </p>
      </caption>
      <graphic content-type="black-white" xlink:href="YPGH_A_1122852_F0002_B">
      </graphic>
     </fig>
     <p>
      In a large seroprevalence survey in Saudi Arabia conducted between December 2012 and December 2013, anti-MERS-CoV antibodies were detected in 0.15% of 10,009 samples. The authors extrapolated that around 45,000 individuals in Saudi Arabia could be seropositive for MERS-CoV.
      <sup>
       95
      </sup>
      It therefore appears that human MERS-CoV infection had taken place in the region for some considerable time before it was identified. The recent identification of MERS-CoV infection in asymptomatic human contacts of MERS-CoV infected camels in UAE provides significant insight into the possible chain of events following such exposure.
      <sup>
       83
      </sup>
      It is reasonable to theorize that infection from such asymptomatic individuals may be transmitted to others. A person admitted to a health care facility with unrecognized MERS-CoV infection can trigger clusters of various sizes. Indeed, the appearance of several community and hospital MERS-CoV clusters in the first half of the year 2013 without identifiable human or animal sources led to speculations that individuals with no or only mild respiratory symptoms might have a role in MERS-CoV transmissions.
      <xref ref-type="bibr" rid="CIT0003">
       <sup>
        3, 4, 7
       </sup>
      </xref>
      Memish
      <italic>
       et al.
      </italic>
      showed that MERS-CoV was detectable for up to 12 days in 30% of asymptomatic contacts.
      <xref ref-type="bibr" rid="CIT0100">
       <sup>
        100
       </sup>
      </xref>
      In another report, an asymptomatic health care worker had detectable MERS-CoV for over five weeks.
      <xref ref-type="bibr" rid="CIT0101">
       <sup>
        101
       </sup>
      </xref>
      Although MERS-CoV transmission from an asymptomatic individual is a strong probability, this has never been documented.
      <sup>
       12,13
      </sup>
     </p>
    </sec>
    <sec id="S0007">
     <title>
      MERS-CoV Control at the Animal–Human Interface
     </title>
     <p>
      In countries where MERS-CoV is already established in dromedary camels, preventive strategies are unlikely to succeed without addressing such sources. Key elements for MERS-CoV control in animals should include the following:
      <list list-type="simple">
       <list-item>
        <label>
         (1)
        </label>
        <p>
         Strict regulation of camel movement with imposition of requirement for MERS-CoV clearance prior to importation and transport of camels, including those that are presented for slaughter. Camels with detectable MERS-CoV RNA should be quarantined and tested at regular intervals.
        </p>
       </list-item>
       <list-item>
        <label>
         (2)
        </label>
        <p>
         Enforcing the use of personal protective equipment while handling dromedary camels.
        </p>
       </list-item>
       <list-item>
        <label>
         (3)
        </label>
        <p>
         Efforts to increase awareness amongst camel owners and the general public of the risks of consuming unpasteurized camel milk and urine. This may prove challenging, given the depth of customs and beliefs in some areas.
        </p>
       </list-item>
       <list-item>
        <label>
         (4)
        </label>
        <p>
         Accelerated development of safe and effective MERS-CoV vaccines for animal or human use.
         <sup>
          102
         </sup>
        </p>
       </list-item>
      </list>
     </p>
    </sec>
    <sec id="S0008">
     <title>
      Conclusion
     </title>
     <p>
      MERS-CoV is a zoonotic disease with bats and dromedary camels playing important parts in its emergence and epidemiology. Camel to human MERS-CoV transmission is well documented but is generally not very efficient. The exact mechanism of transmission is not clear, including whether other intermediate hosts are involved. Serosurveys in humans across Africa are urgently needed to investigate the possibility of unrecognized MERS-CoV infections in the continent. Furthermore, bats in Eastern Africa should be screened for betacoronaviruses that may provide better understanding of the genetic history of MERS-CoV. Finally, case-control studies of humans with sporadic MERS-CoV infection are urgently needed to identify risk factors and exposures that might explain the chains of transmission from camels and other possible zoonotic or environmental sources of human infections.
     </p>
    </sec>
    <back>
     <ref-list>
      <title>
       References
      </title>
      <ref id="CIT0001">
       <label>
        1
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zaki
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bestebroer
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Osterhaus
          </surname>
          <given-names>
           ADME
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fouchier
          </surname>
          <given-names>
           RAM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2012
        </year>
        ;
        <volume>
         367
        </volume>
        :
        <fpage>
         1814
        </fpage>
        –
        <lpage>
         1820
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0002">
       <label>
        2
       </label>
       <mixed-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          World Health Organization
         </collab>
        </person-group>
        <source>
         Middle East respiratory syndrome coronavirus (MERS-CoV); Summary of Current Situation, Literature Update and Risk Assessment 7 July 2015
        </source>
        .
        <publisher-loc>
         Geneva
        </publisher-loc>
        :
        <publisher-name>
         WHO
        </publisher-name>
        ;
        <year>
         2015
        </year>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0003">
       <label>
        3
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Hakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Stephens
          </surname>
          <given-names>
           GM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         368
        </volume>
        :
        <fpage>
         2487
        </fpage>
        –
        <lpage>
         2494
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0004">
       <label>
        4
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Omrani
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Matin
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Haddad
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Nakhli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Albarrak
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        <article-title>
         A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         17
        </volume>
        :
        <fpage>
         e668
        </fpage>
        –
        <lpage>
         e672
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23916548
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0005">
       <label>
        5
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Oboho
          </surname>
          <given-names>
           IK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tomczyk
          </surname>
          <given-names>
           SM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Asmari
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Banjar
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Mugti
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Aloraini
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         2014 MERS-CoV outbreak in Jeddah – a link to health care facilities
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         372
        </volume>
        :
        <fpage>
         846
        </fpage>
        –
        <lpage>
         854
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0006">
       <label>
        6
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kellam
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         23
        </volume>
        :
        <fpage>
         63
        </fpage>
        –
        <lpage>
         68
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24699184
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0007">
       <label>
        7
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           McGeer
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perl
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Price
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cummings
          </surname>
          <given-names>
           DA
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Hospital outbreak of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         369
        </volume>
        :
        <fpage>
         407
        </fpage>
        –
        <lpage>
         416
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0008">
       <label>
        8
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Guery
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poissy
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           el Mansouf
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sejourne
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ettahar
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lemaire
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
        </article-title>
        .
        <source>
         Lancet
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         381
        </volume>
        :
        <fpage>
         2265
        </fpage>
        –
        <lpage>
         2272
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23727167
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0009">
       <label>
        9
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Saad
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Omrani
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Baig
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bahloul
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Elzein
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Matin
          </surname>
          <given-names>
           FA
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         29
        </volume>
        :
        <fpage>
         301
        </fpage>
        –
        <lpage>
         306
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25303830
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0010">
       <label>
        10
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           NS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Probable transmission chains of MERS-CoV and the multiple generations of secondary infections in South Korea
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         38
        </volume>
        :
        <fpage>
         65
        </fpage>
        –
        <lpage>
         67
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26216766
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0011">
       <label>
        11
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Breban
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Riou
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fontanet
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
        </article-title>
        .
        <source>
         Lancet
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         382
        </volume>
        :
        <fpage>
         694
        </fpage>
        –
        <lpage>
         699
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23831141
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0012">
       <label>
        12
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hossain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Transmission of MERS-coronavirus in household contacts
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         371
        </volume>
        :
        <fpage>
         828
        </fpage>
        –
        <lpage>
         835
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0013">
       <label>
        13
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Makhdoom
          </surname>
          <given-names>
           HQ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhakeem
          </surname>
          <given-names>
           RF
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study
        </article-title>
        .
        <source>
         Clin Microbiol Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         469
        </fpage>
        –
        <lpage>
         474
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0014">
       <label>
        14
       </label>
       <mixed-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          World Health Organization
         </collab>
        </person-group>
        <source>
         Middle East Respiratory Syndrome coronavirus (MERS-CoV) – Saudi Arabia 12 August 2015
        </source>
        .
        <publisher-loc>
         Geneva
        </publisher-loc>
        :
        <publisher-name>
         WHO
        </publisher-name>
        ;
        <year>
         2015
        </year>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0015">
       <label>
        15
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Albarrak
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Stephens
          </surname>
          <given-names>
           GM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hewson
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recovery from severe novel coronavirus infection
        </article-title>
        .
        <source>
         Saudi Med J
        </source>
        .
        <year>
         2012
        </year>
        ;
        <volume>
         33
        </volume>
        :
        <fpage>
         1265
        </fpage>
        –
        <lpage>
         1269
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23232672
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0016">
       <label>
        16
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Belouzard
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Millet
          </surname>
          <given-names>
           JK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Licitra
          </surname>
          <given-names>
           BN
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Whittaker
          </surname>
          <given-names>
           GR
          </given-names>
         </name>
        </person-group>
        <article-title>
         Mechanisms of coronavirus cell entry mediated by the viral spike protein
        </article-title>
        .
        <source>
         Viruses
        </source>
        .
        <year>
         2012
        </year>
        ;
        <volume>
         4
        </volume>
        :
        <fpage>
         1011
        </fpage>
        –
        <lpage>
         1033
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         22816037
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0017">
       <label>
        17
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mou
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Smits
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dekkers
          </surname>
          <given-names>
           DH
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dijkman
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
        </article-title>
        .
        <source>
         Nature
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         495
        </volume>
        :
        <fpage>
         251
        </fpage>
        –
        <lpage>
         254
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23486063
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0018">
       <label>
        18
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hui
          </surname>
          <given-names>
           DS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perlman
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome
        </article-title>
        .
        <source>
         Lancet
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         386
        </volume>
        :
        <fpage>
         995
        </fpage>
        –
        <lpage>
         1007
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26049252
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0019">
       <label>
        19
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Miazgowicz
          </surname>
          <given-names>
           KL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Milne-Price
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Robertson
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Scott
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         9220
        </fpage>
        –
        <lpage>
         9232
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24899185
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0020">
       <label>
        20
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wohlford-Lenane
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Agnihothram
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fett
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhao
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Rapid generation of a mouse model for Middle East respiratory syndrome
        </article-title>
        .
        <source>
         Proc Natl Acad Sci USA
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         111
        </volume>
        :
        <fpage>
         4970
        </fpage>
        –
        <lpage>
         4975
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24599590
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0021">
       <label>
        21
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Feldmann
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Brining
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques
        </article-title>
        .
        <source>
         Proc Natl Acad Sci USA
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         110
        </volume>
        :
        <fpage>
         16598
        </fpage>
        –
        <lpage>
         16603
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24062443
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0022">
       <label>
        22
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Yao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bao
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Deng
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Xu
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lv
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         209
        </volume>
        :
        <fpage>
         236
        </fpage>
        –
        <lpage>
         242
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24218506
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0023">
       <label>
        23
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Feldmann
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pneumonia from human coronavirus in a macaque model
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         368
        </volume>
        :
        <fpage>
         1560
        </fpage>
        –
        <lpage>
         1562
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0024">
       <label>
        24
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Feldmann
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Okumura
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peng
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Infection with MERS-CoV causes lethal pneumonia in the common marmoset
        </article-title>
        .
        <source>
         PLoS Pathog
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         10
        </volume>
        :
        <fpage>
         e1004250
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         25144235
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0025">
       <label>
        25
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van den Brand
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Provacia
          </surname>
          <given-names>
           LB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Stittelaar
          </surname>
          <given-names>
           KJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Getu
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         89
        </volume>
        :
        <fpage>
         6131
        </fpage>
        –
        <lpage>
         6135
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25810539
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0026">
       <label>
        26
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Falzarano
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rasmussen
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Feldmann
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Okumura
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Scott
          </surname>
          <given-names>
           DP
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
        </article-title>
        .
        <source>
         Nature Med
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1313
        </fpage>
        –
        <lpage>
         1317
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24013700
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0027">
       <label>
        27
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yao
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yeung
          </surname>
          <given-names>
           ML
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Deng
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bao
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jia
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         212
        </volume>
        :
        <fpage>
         1904
        </fpage>
        –
        <lpage>
         1913
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26198719
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0028">
       <label>
        28
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lenk
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ulrich
          </surname>
          <given-names>
           RG
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Replicative capacity of MERS coronavirus in livestock cell lines
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         276
        </fpage>
        –
        <lpage>
         279
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24457147
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0029">
       <label>
        29
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gutierrez
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         13
        </volume>
        :
        <fpage>
         859
        </fpage>
        –
        <lpage>
         866
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23933067
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0030">
       <label>
        30
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ababneh
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Eljarah
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Abutarbush
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20662
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24342516
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0031">
       <label>
        31
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhammadi
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Siu
          </surname>
          <given-names>
           LY
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20659
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24342517
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0032">
       <label>
        32
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Alagaili
          </surname>
          <given-names>
           AN
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Briese
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kapoor
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sameroff
          </surname>
          <given-names>
           SC
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Burbelo
          </surname>
          <given-names>
           PD
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia
        </article-title>
        .
        <source>
         mBio
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e00884-14
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24570370
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0033">
       <label>
        33
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gomaa
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           El-Shesheny
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kandeil
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bagato
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         pii 574
        </fpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0034">
       <label>
        34
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Alexandersen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kobinger
          </surname>
          <given-names>
           GP
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Soule
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005
        </article-title>
        .
        <source>
         Transbound Emerg Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         61
        </volume>
        :
        <fpage>
         105
        </fpage>
        –
        <lpage>
         108
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24456414
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0035">
       <label>
        35
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Han
          </surname>
          <given-names>
           HJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wen
          </surname>
          <given-names>
           HL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhou
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chen
          </surname>
          <given-names>
           FF
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Luo
          </surname>
          <given-names>
           LM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liu
          </surname>
          <given-names>
           JW
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Bats as reservoirs of severe emerging infectious diseases
        </article-title>
        .
        <source>
         Virus Res
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         205
        </volume>
        :
        <fpage>
         1
        </fpage>
        –
        <lpage>
         6
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25997928
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0036">
       <label>
        36
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Karesh
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dobson
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lloyd-Smith
          </surname>
          <given-names>
           JO
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lubroth
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dixon
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bennett
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Ecology of zoonoses: natural and unnatural histories
        </article-title>
        .
        <source>
         Lancet
        </source>
        .
        <year>
         2012
        </year>
        ;
        <volume>
         380
        </volume>
        :
        <fpage>
         1936
        </fpage>
        –
        <lpage>
         1945
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23200502
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0037">
       <label>
        37
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Dobson
          </surname>
          <given-names>
           AP
          </given-names>
         </name>
        </person-group>
        <article-title>
         What links bats to emerging infectious diseases?
        </article-title>
        <source>
         Science
        </source>
        .
        <year>
         2005
        </year>
        ;
        <volume>
         310
        </volume>
        :
        <fpage>
         628
        </fpage>
        –
        <lpage>
         629
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         16254175
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0038">
       <label>
        38
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           George
          </surname>
          <given-names>
           DB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Webb
          </surname>
          <given-names>
           CT
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farnsworth
          </surname>
          <given-names>
           ML
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           O'Shea
          </surname>
          <given-names>
           TJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bowen
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Smith
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Host and viral ecology determine bat rabies seasonality and maintenance
        </article-title>
        .
        <source>
         Proc Natl Acad Sci USA
        </source>
        .
        <year>
         2011
        </year>
        ;
        <volume>
         108
        </volume>
        :
        <fpage>
         10208
        </fpage>
        –
        <lpage>
         10213
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         21646516
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0039">
       <label>
        39
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Calisher
          </surname>
          <given-names>
           CH
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Childs
          </surname>
          <given-names>
           JE
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Field
          </surname>
          <given-names>
           HE
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Holmes
          </surname>
          <given-names>
           KV
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Schountz
          </surname>
          <given-names>
           T
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bats: important reservoir hosts of emerging viruses
        </article-title>
        .
        <source>
         Clin Microbiol Rev
        </source>
        .
        <year>
         2006
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         531
        </fpage>
        –
        <lpage>
         545
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         16847084
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0040">
       <label>
        40
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Luis
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hayman
          </surname>
          <given-names>
           DTS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           O’Shea
          </surname>
          <given-names>
           TJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cryan
          </surname>
          <given-names>
           PM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gilbert
          </surname>
          <given-names>
           AT
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pulliam
          </surname>
          <given-names>
           JRC
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?
        </article-title>
        <source>
         Proc R Soc Lond B Biol Sci
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         280
        </volume>
        :
        <fpage>
         20122753
        </fpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0041">
       <label>
        41
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Drexler
          </surname>
          <given-names>
           JF
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
        </article-title>
        .
        <source>
         Antiviral Res
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         101
        </volume>
        :
        <fpage>
         45
        </fpage>
        –
        <lpage>
         56
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24184128
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0042">
       <label>
        42
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Brook
          </surname>
          <given-names>
           CE
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dobson
          </surname>
          <given-names>
           AP
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bats as ‘special’ reservoirs for emerging zoonotic pathogens
        </article-title>
        .
        <source>
         Trends Microbiol
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         23
        </volume>
        :
        <fpage>
         172
        </fpage>
        –
        <lpage>
         180
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25572882
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0043">
       <label>
        43
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Günther
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Preiser
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van der Werf
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Brodt
          </surname>
          <given-names>
           H-R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Becker
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Identification of a novel coronavirus in patients with severe acute respiratory syndrome
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2003
        </year>
        ;
        <volume>
         348
        </volume>
        :
        <fpage>
         1967
        </fpage>
        –
        <lpage>
         1976
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0044">
       <label>
        44
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Ge
          </surname>
          <given-names>
           X-Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           J-L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yang
          </surname>
          <given-names>
           X-L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chmura
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhu
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Epstein
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
        </article-title>
        .
        <source>
         Nature
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         503
        </volume>
        :
        <fpage>
         535
        </fpage>
        –
        <lpage>
         538
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24172901
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0045">
       <label>
        45
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Guan
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zheng
          </surname>
          <given-names>
           BJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           He
          </surname>
          <given-names>
           YQ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liu
          </surname>
          <given-names>
           XL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhuang
          </surname>
          <given-names>
           ZX
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheung
          </surname>
          <given-names>
           CL
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China
        </article-title>
        .
        <source>
         Science
        </source>
        .
        <year>
         2003
        </year>
        ;
        <volume>
         302
        </volume>
        :
        <fpage>
         276
        </fpage>
        –
        <lpage>
         278
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         12958366
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0046">
       <label>
        46
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Woo
          </surname>
          <given-names>
           PCY
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           KSM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Huang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tsoi
          </surname>
          <given-names>
           H-W
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           BHL
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
        </article-title>
        .
        <source>
         Proc Natl Acad Sci USA
        </source>
        .
        <year>
         2005
        </year>
        ;
        <volume>
         102
        </volume>
        :
        <fpage>
         14040
        </fpage>
        –
        <lpage>
         14045
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         16169905
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0047">
       <label>
        47
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Woo
          </surname>
          <given-names>
           PCY
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Xu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           RWS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Guo
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2007
        </year>
        ;
        <volume>
         81
        </volume>
        :
        <fpage>
         1574
        </fpage>
        –
        <lpage>
         1585
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         17121802
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0048">
       <label>
        48
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kallies
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Philipps
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gopner
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Eckerle
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Characterization of a novel betacoronavirus related to Middle East respiratory syndrome coronavirus in European hedgehogs
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         717
        </fpage>
        –
        <lpage>
         724
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24131722
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0049">
       <label>
        49
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Lelli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Papetti
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sabelli
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rosti
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Moreno
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Boniotti
          </surname>
          <given-names>
           MB
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of coronaviruses in bats of various species in Italy
        </article-title>
        .
        <source>
         Viruses
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         2679
        </fpage>
        –
        <lpage>
         2689
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24184965
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0050">
       <label>
        50
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Olival
          </surname>
          <given-names>
           KJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fagbo
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kapoor
          </surname>
          <given-names>
           V
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Epstein
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in bats
        </article-title>
        .
        <source>
         Saudi Arabia. Emerg Infect Dis
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1819
        </fpage>
        –
        <lpage>
         1823
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24206838
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0051">
       <label>
        51
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Annan
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Baldwin
          </surname>
          <given-names>
           HJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Klose
          </surname>
          <given-names>
           SM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Owusu
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Nkrumah
          </surname>
          <given-names>
           EE
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Human betacoronavirus 2c EMC/2012-related viruses in bats
        </article-title>
        .
        <source>
         Ghana and Europe. Emerg Infect Dis
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         456
        </fpage>
        –
        <lpage>
         459
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23622767
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0052">
       <label>
        52
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Yang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wu
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ren
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yang
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhang
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           He
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         MERS-related betacoronavirus in vespertilio superans bats
        </article-title>
        .
        <source>
         China. Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1260
        </fpage>
        –
        <lpage>
         1262
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24960574
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0053">
       <label>
        53
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           De Benedictis
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Marciano
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Scaravelli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Priori
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zecchin
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Capua
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Alpha and lineage C betaCoV infections in Italian bats
        </article-title>
        .
        <source>
         Virus Genes
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         48
        </volume>
        :
        <fpage>
         366
        </fpage>
        –
        <lpage>
         371
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24242847
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0054">
       <label>
        54
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Anthony
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ojeda-Flores
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rico-Chavez
          </surname>
          <given-names>
           O
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Navarrete-Macias
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zambrana-Torrelio
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rostal
          </surname>
          <given-names>
           MK
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Coronaviruses in bats from Mexico
        </article-title>
        .
        <source>
         J Gen Virol
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         94
        </volume>
        :
        <fpage>
         1028
        </fpage>
        –
        <lpage>
         1038
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23364191
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0055">
       <label>
        55
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Wacharapluesadee
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sintunawa
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kaewpom
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Khongnomnan
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Olival
          </surname>
          <given-names>
           KJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Epstein
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Group C betacoronavirus in bat guano fertilizer
        </article-title>
        .
        <source>
         Thailand. Emerg Infect Dis
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1349
        </fpage>
        –
        <lpage>
         1352
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         23880503
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0056">
       <label>
        56
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Ithete
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Stoffberg
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cottontail
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Richards
          </surname>
          <given-names>
           LR
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Schoeman
          </surname>
          <given-names>
           MC
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Close relative of human Middle East respiratory syndrome coronavirus in bat
        </article-title>
        .
        <source>
         South Africa. Emerg Infect Dis
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         1697
        </fpage>
        –
        <lpage>
         1699
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24050621
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0057">
       <label>
        57
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ithete
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Richards
          </surname>
          <given-names>
           LR
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Schoeman
          </surname>
          <given-names>
           MC
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Preiser
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         88
        </volume>
        :
        <fpage>
         11297
        </fpage>
        –
        <lpage>
         11303
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25031349
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0058">
       <label>
        58
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Yang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liu
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ma
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tang
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
        </article-title>
        .
        <source>
         Proc Natl Acad Sci USA
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         111
        </volume>
        :
        <fpage>
         12516
        </fpage>
        –
        <lpage>
         12521
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25114257
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0059">
       <label>
        59
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Qi
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuan
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Xuan
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Han
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wan
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26
        </article-title>
        .
        <source>
         Cell Host Microbe
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         16
        </volume>
        :
        <fpage>
         328
        </fpage>
        –
        <lpage>
         337
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25211075
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0060">
       <label>
        60
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Yang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liu
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jiang
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Shi
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Baric
          </surname>
          <given-names>
           RS
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Two mutations were critical for bat-to-human transmission of Middle East Respiratory Syndrome Coronavirus
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         89
        </volume>
        :
        <fpage>
         9119
        </fpage>
        –
        <lpage>
         9123
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26063432
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0061">
       <label>
        61
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhang
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sui
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kuhn
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Moore
          </surname>
          <given-names>
           MJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Luo
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
        </article-title>
        .
        <source>
         EMBO J
        </source>
        .
        <year>
         2005
        </year>
        ;
        <volume>
         24
        </volume>
        :
        <fpage>
         1634
        </fpage>
        –
        <lpage>
         1643
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         15791205
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0062">
       <label>
        62
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Lu
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gao
          </surname>
          <given-names>
           GF
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
        </article-title>
        .
        <source>
         Trends Microbiol
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         23
        </volume>
        :
        <fpage>
         468
        </fpage>
        –
        <lpage>
         478
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26206723
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0063">
       <label>
        63
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Graham
          </surname>
          <given-names>
           RL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Baric
          </surname>
          <given-names>
           RS
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission
        </article-title>
        .
        <source>
         J Virol
        </source>
        .
        <year>
         2010
        </year>
        ;
        <volume>
         84
        </volume>
        :
        <fpage>
         3134
        </fpage>
        –
        <lpage>
         3146
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         19906932
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0064">
       <label>
        64
       </label>
       <mixed-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          Wikemedia Foundation
         </collab>
        </person-group>
        <source>
         Camel
        </source>
        .
        <publisher-loc>
         San Diego, CA
        </publisher-loc>
        :
        <publisher-name>
         Wikimedia
        </publisher-name>
        ;
        <year>
         2015
        </year>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0065">
       <label>
        65
       </label>
       <mixed-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          French Agricultural Research and International Cooperation Organization
         </collab>
        </person-group>
        <source>
         Camels and dromedaries: a rapidly changing sector supported by dynamic research
        </source>
        .
        <publisher-loc>
         Paris
        </publisher-loc>
        :
        <publisher-name>
         CIRAD
        </publisher-name>
        ;
        <year>
         2013
        </year>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0066">
       <label>
        66
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Gossner
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Danielson
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gervelmeyer
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Berthe
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Faye
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kaasik Aaslav
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East Respiratory Syndrome Coronavirus infection
        </article-title>
        .
        <source>
         Zoo Public Health
        </source>
        .
        <comment>
         Epub 2014 Dec 27
        </comment>
        . doi:
        <pub-id pub-id-type="doi">
         10.1111/zph.12171
        </pub-id>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0067">
       <label>
        67
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Mackay
          </surname>
          <given-names>
           IM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Arden
          </surname>
          <given-names>
           KE
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome: an emerging coronavirus infection tracked by the crowd
        </article-title>
        .
        <source>
         Virus Res
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         202
        </volume>
        :
        <fpage>
         60
        </fpage>
        –
        <lpage>
         88
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25656066
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0068">
       <label>
        68
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Abdallah
          </surname>
          <given-names>
           HR
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Faye
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        <article-title>
         Typology of camel farming system in Saudi Arabia
        </article-title>
        .
        <source>
         Emir J Food Agric
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         25
        </volume>
        :
        <fpage>
         250
        </fpage>
        –
        <lpage>
         260
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0069">
       <label>
        69
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Messadi
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Feyisa
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ularamu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Danmarwa
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Geographic distribution of MERS coronavirus among dromedary camels
        </article-title>
        .
        <source>
         Africa. Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1370
        </fpage>
        –
        <lpage>
         1374
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25062254
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0070">
       <label>
        70
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Nowotny
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kolodziejek
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20781
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24786259
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0071">
       <label>
        71
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jores
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Younan
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liljander
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Said
          </surname>
          <given-names>
           MY
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1319
        </fpage>
        –
        <lpage>
         1322
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25075637
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0072">
       <label>
        72
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Jassim
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kayali
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Siu
          </surname>
          <given-names>
           LY
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20828
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24957744
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0073">
       <label>
        73
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhammadi
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ng
          </surname>
          <given-names>
           HY
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         MERS coronavirus in dromedary camel herd
        </article-title>
        .
        <source>
         Saudi Arabia. Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1231
        </fpage>
        –
        <lpage>
         1234
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24964193
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0074">
       <label>
        74
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Wernery
          </surname>
          <given-names>
           U
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           EY
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tsang
          </surname>
          <given-names>
           AK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lau
          </surname>
          <given-names>
           SK
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Acute Middle East respiratory syndrome coronavirus infection in livestock Dromedaries, Dubai, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         1019
        </fpage>
        –
        <lpage>
         1022
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25989145
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0075">
       <label>
        75
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ritz
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         552
        </fpage>
        –
        <lpage>
         559
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24655412
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0076">
       <label>
        76
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Shirato
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Azumano
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Nakao
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hagihara
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ishida
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tamai
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection not found in camels in Japan
        </article-title>
        .
        <source>
         Jpn J Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         68
        </volume>
        :
        <fpage>
         256
        </fpage>
        –
        <lpage>
         258
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25993975
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0077">
       <label>
        77
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           SM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Damdinjav
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Khishgee
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Enkhbold
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Absence of MERS-coronavirus in bactrian camels, Southern Mongolia, November 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         1269
        </fpage>
        –
        <lpage>
         1271
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26080032
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0078">
       <label>
        78
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Khalafalla
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Mubarak
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dalab
          </surname>
          <given-names>
           AH
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Busadah
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Erdman
          </surname>
          <given-names>
           DD
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS-CoV in upper respiratory tract and lungs of dromedary camels, Saudi Arabia, 2013-2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         1153
        </fpage>
        –
        <lpage>
         1158
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26079346
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0079">
       <label>
        79
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mohran
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014
        </article-title>
        .
        <source>
         Infect Ecol Epidemiol
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         28305
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         26183160
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0080">
       <label>
        80
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lamers
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Voermans
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1339
        </fpage>
        –
        <lpage>
         1342
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25075761
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0081">
       <label>
        81
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Yusof
          </surname>
          <given-names>
           MF
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Eltahir
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Serhan
          </surname>
          <given-names>
           WS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hashem
          </surname>
          <given-names>
           FM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Elsayed
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Marzoug
          </surname>
          <given-names>
           BA
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate
        </article-title>
        .
        <source>
         United Arab Emirates. Virus Genes
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         50
        </volume>
        :
        <fpage>
         509
        </fpage>
        –
        <lpage>
         513
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25653016
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0082">
       <label>
        82
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gomaa
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Shehata
          </surname>
          <given-names>
           MM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Abu Zeid
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         MERS coronaviruses in dromedary camels
        </article-title>
        .
        <source>
         Egypt. Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1049
        </fpage>
        –
        <lpage>
         1053
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24856660
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0083">
       <label>
        83
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Al Hammadi
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           DKW
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Eltahir
          </surname>
          <given-names>
           YM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Hosani
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Mulla
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tarnini
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Asymptomatic MERS-CoV infection in humans possibly linked to infected camels imported from Oman to United Arab Emirates, May 2015
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0084">
       <label>
        84
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Briese
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mishra
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jain
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zalmout
          </surname>
          <given-names>
           IS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jabado
          </surname>
          <given-names>
           OJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Karesh
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia
        </article-title>
        .
        <source>
         mBio
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e01146-14
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24781747
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0085">
       <label>
        85
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cotten
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Watson
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alsahafi
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           AA
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1012
        </fpage>
        –
        <lpage>
         1015
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24857749
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0086">
       <label>
        86
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           El-Kafrawy
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farraj
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hassan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Saeed
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hashem
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Evidence for camel-to-human transmission of MERS coronavirus
        </article-title>
        .
        <source>
         N Eng J Med
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         370
        </volume>
        :
        <fpage>
         2499
        </fpage>
        –
        <lpage>
         2505
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0087">
       <label>
        87
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Nishiura
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ejima
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mizumoto
          </surname>
          <given-names>
           K
          </given-names>
         </name>
        </person-group>
        <article-title>
         Missing information in animal surveillance of MERS-CoV
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         100
        </fpage>
        .
       </mixed-citation>
      </ref>
      <ref id="CIT0088">
       <label>
        88
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Samara
          </surname>
          <given-names>
           EM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Abdoun
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Concerns about misinterpretation of recent scientific data implicating dromedary camels in epidemiology of Middle East respiratory syndrome (MERS)
        </article-title>
        .
        <source>
         mBio
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         5
        </volume>
        :
        <fpage>
         e01430-14
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         25006231
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0089">
       <label>
        89
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Dhahiry
          </surname>
          <given-names>
           SH
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           VS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Galiano
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Myers
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         14
        </volume>
        :
        <fpage>
         140
        </fpage>
        –
        <lpage>
         145
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24355866
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0090">
       <label>
        90
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           RW
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kayali
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           DK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alnaeem
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study
        </article-title>
        .
        <source>
         Lancet Respir Med
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         2
        </volume>
        :
        <fpage>
         813
        </fpage>
        –
        <lpage>
         822
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25174549
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0091">
       <label>
        91
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Adney
          </surname>
          <given-names>
           DR
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Brown
          </surname>
          <given-names>
           VR
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Scott
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Wit
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1999
        </fpage>
        –
        <lpage>
         2005
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25418529
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0092">
       <label>
        92
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2013
        </year>
        ;
        <volume>
         18
        </volume>
        :
        <fpage>
         20590
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24084338
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0093">
       <label>
        93
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jonges
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           El-Sayed
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pas
          </surname>
          <given-names>
           SD
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014
        </article-title>
        .
        <source>
         Euro Surveill
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         19
        </volume>
        :
        <fpage>
         20829
        </fpage>
        .
        <pub-id pub-id-type="pmid">
         24957745
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0094">
       <label>
        94
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Karesh
          </surname>
          <given-names>
           WB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Munster
          </surname>
          <given-names>
           VJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus in milk
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         1263
        </fpage>
        –
        <lpage>
         1264
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24960335
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0095">
       <label>
        95
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Masri
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Turkestani
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ritz
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
        </article-title>
        .
        <source>
         Lancet Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         15
        </volume>
        :
        <fpage>
         559
        </fpage>
        –
        <lpage>
         564
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25863564
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0096">
       <label>
        96
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           CB
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farag
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Haagmans
          </surname>
          <given-names>
           BL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mohran
          </surname>
          <given-names>
           KA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Godeke
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013–2014
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         1422
        </fpage>
        –
        <lpage>
         1425
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         26196891
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0097">
       <label>
        97
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Hemida
          </surname>
          <given-names>
           MG
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Naeem
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perera
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chin
          </surname>
          <given-names>
           AW
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peiris
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of Middle East respiratory syndrome coronavirus transmission from infected camels
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         21
        </volume>
        :
        <fpage>
         699
        </fpage>
        –
        <lpage>
         701
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25811546
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0098">
       <label>
        98
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Aburizaiza
          </surname>
          <given-names>
           AS
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mattes
          </surname>
          <given-names>
           FM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Azhar
          </surname>
          <given-names>
           EI
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hassan
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muth
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Investigation of anti-Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012
        </article-title>
        .
        <source>
         J Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         209
        </volume>
        :
        <fpage>
         243
        </fpage>
        –
        <lpage>
         246
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24218504
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0099">
       <label>
        99
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alsahly
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Masri
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Heil
          </surname>
          <given-names>
           GL
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Anderson
          </surname>
          <given-names>
           BD
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peiris
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012
        </article-title>
        .
        <source>
         Influenza Other Respir Viruses
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         9
        </volume>
        :
        <fpage>
         64
        </fpage>
        –
        <lpage>
         67
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25470665
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0100">
       <label>
        100
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications
        </article-title>
        .
        <source>
         Int J Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         29
        </volume>
        :
        <fpage>
         307
        </fpage>
        –
        <lpage>
         308
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25448335
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0101">
       <label>
        101
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Al-Gethamy
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hussain
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           ZA
          </given-names>
         </name>
        </person-group>
        <article-title>
         A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker
        </article-title>
        .
        <source>
         Clin Infect Dis
        </source>
        .
        <year>
         2015
        </year>
        ;
        <volume>
         60
        </volume>
        :
        <fpage>
         973
        </fpage>
        –
        <lpage>
         974
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25516193
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0102">
       <label>
        102
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Hotez
          </surname>
          <given-names>
           PJ
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bottazzi
          </surname>
          <given-names>
           ME
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tseng
          </surname>
          <given-names>
           C-TK
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhan
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lustigman
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Du
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         Calling for rapid development of a safe and effective MERS vaccine
        </article-title>
        .
        <source>
         Microbes Infect
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         16
        </volume>
        :
        <fpage>
         529
        </fpage>
        –
        <lpage>
         531
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         24931059
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="CIT0103">
       <label>
        103
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Müller
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           VM
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jores
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Younan
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liljander
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         ,
         <etal>
          et al
         </etal>
        </person-group>
        <article-title>
         MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983–1997
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        .
        <year>
         2014
        </year>
        ;
        <volume>
         20
        </volume>
        :
        <fpage>
         2093
        </fpage>
        –
        <lpage>
         2095
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         25425139
        </pub-id>
       </mixed-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       J Hosp Infect
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       J. Hosp. Infect
      </journal-id>
      <journal-title-group>
       <journal-title>
        The Journal of Hospital Infection
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0195-6701
      </issn>
      <issn pub-type="epub">
       1532-2939
      </issn>
      <publisher>
       <publisher-name>
        The Healthcare Infection Society. Published by Elsevier Ltd.
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       26452615
      </article-id>
      <article-id pub-id-type="pmc">
       7114843
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0195-6701(15)00306-0
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.jhin.2015.08.002
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn?
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="au1">
        <name>
         <surname>
          Omrani
         </surname>
         <given-names>
          A.S.
         </given-names>
        </name>
        <email>
         asomrani@kfshrc.edu.sa
        </email>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
        <xref ref-type="corresp" rid="cor1">
         ∗
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au2">
        <name>
         <surname>
          Shalhoub
         </surname>
         <given-names>
          S.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        a
       </label>
       Department of Medicine, Section of Infectious Diseases, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
      </aff>
      <aff id="aff2">
       <label>
        b
       </label>
       Department of Medicine, Division of Infectious Diseases, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia
      </aff>
      <author-notes>
       <corresp id="cor1">
        <label>
         ∗
        </label>
        Corresponding author. Address: Department of Medicine, Section of Infectious Diseases, King Faisal Specialist Hospital and Research Centre, PO Box 3354, MBC 46, Riyadh 11211, Saudi Arabia. Tel.: +966 11 216 2919x27494; fax: +966 11 476 9330.
        <email>
         asomrani@kfshrc.edu.sa
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        22
       </day>
       <month>
        8
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <month>
        11
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        22
       </day>
       <month>
        8
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <volume>
       91
      </volume>
      <issue>
       3
      </issue>
      <fpage>
       188
      </fpage>
      <lpage>
       196
      </lpage>
      <history>
       <date date-type="received">
        <day>
         7
        </day>
        <month>
         8
        </month>
        <year>
         2015
        </year>
       </date>
       <date date-type="accepted">
        <day>
         10
        </day>
        <month>
         8
        </month>
        <year>
         2015
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2015
       </copyright-year>
       <copyright-holder>
        The Healthcare Infection Society
       </copyright-holder>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract id="abs0010">
       <title>
        Summary
       </title>
       <p>
        The Middle East Respiratory Coronavirus (MERS-CoV) was first isolated from a patient who died with severe pneumonia in June 2012. As of 19 June 2015, a total of 1,338 MERS-CoV infections have been notified to the World Health Organization (WHO). Clinical illness associated with MERS-CoV ranges from mild upper respiratory symptoms to rapidly progressive pneumonia and multi-organ failure. A significant proportion of patients present with non-respiratory symptoms such as headache, myalgia, vomiting and diarrhoea. A few potential therapeutic agents have been identified but none have been conclusively shown to be clinically effective. Human to human transmission is well documented, but the epidemic potential of MERS-CoV remains limited at present. Healthcare-associated clusters of MERS-CoV have been responsible for the majority of reported cases. The largest outbreaks have been driven by delayed diagnosis, overcrowding and poor infection control practices. However, chains of MERS-CoV transmission can be readily interrupted with implementation of appropriate control measures. As with any emerging infectious disease, guidelines for MERS-CoV case identification and surveillance evolved as new data became available. Sound clinical judgment is required to identify unusual presentations and trigger appropriate control precautions.
       </p>
       <p>
        Evidence from multiple sources implicates dromedary camels as natural hosts of MERS-CoV. Camel to human transmission has been demonstrated, but the exact mechanism of infection remains uncertain. The ubiquitously available social media have facilitated communication and networking amongst healthcare professionals and eventually proved to be important channels for presenting the public with factual material, timely updates and relevant advice.
       </p>
      </abstract>
     </article-meta>
    </front>
    <sec id="sec1">
     <title>
      Introduction
     </title>
     <p id="p0010">
      The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was first identified in September 2012. As of 19 June 2015, a total of 1,338 MERS-CoV infections have been reported to the World Health Organization (WHO).
      <xref ref-type="bibr" rid="bib1">
       <sup>
        1
       </sup>
      </xref>
      Despite an accumulation of clinical experience and scientific knowledge, new MERS-CoV infections continue to be reported almost on daily basis. What lessons can we learn after three years of clinical experience and scientific research?
     </p>
    </sec>
    <sec id="sec2">
     <title>
      Lesson one: no substitute for continuous vigilance
     </title>
     <p id="p0020">
      A 60-year-old man was admitted on June 13th, 2012, to a hospital in Jeddah, Saudi Arabia, with severe pneumonia and multi-organ failure. The patient died after 11 days of hospitalization.
      <xref ref-type="bibr" rid="bib2">
       <sup>
        2
       </sup>
      </xref>
      Indirect immunofluorescence assays and real-time polymerase chain reaction (PCR) for widely occurring respiratory viruses failed to identify an infective aetiology. Interestingly, cytopathic changes consistent with viral replication were noted in LLC-MK2 and Vero cell cultures of the patient’s respiratory samples. Slides of the infected cell cultures reacted strongly with the patient’s serum but not with any of 2400 control sera stored in the same hospital. However, pan-coronavirus PCR yielded positive results. The PCR fragments were sequenced at the Erasmus Medical Centre in Rotterdam, The Netherlands, and phylogenetic analysis showed that the novel coronavirus belonged to lineage C of the genus betacoronavirus.
      <xref ref-type="bibr" rid="bib2">
       2
      </xref>
      ,
      <xref ref-type="bibr" rid="bib3">
       3
      </xref>
      On 20 September 2012, an email was posted on Program for Monitoring Emerging Diseases Mail (ProMED-mail) announcing the discovery of a novel human coronavirus.
      <xref ref-type="bibr" rid="bib4">
       <sup>
        4
       </sup>
      </xref>
     </p>
     <p id="p0025">
      Meanwhile, a critically ill 49-year-old Qatari man was transferred by air ambulance on September 11th, 2012, to a hospital in England.
      <xref ref-type="bibr" rid="bib5">
       <sup>
        5
       </sup>
      </xref>
      He had developed respiratory symptoms on September 3rd followed by multi-organ failure. His upper and lower respiratory tract samples were negative for influenza A/B, parainfluenza 1–4, RSV A/B, human metapneumovirus, enterovirus, rhinovirus, adenovirus, human bocavirus, and the human coronaviruses (NL63, 229E, OC43, HKU1). On September 21st, 2012, one day after the above ProMED-mail posting, the patient’s respiratory samples tested positive by pan-coronavirus PCR. Once sequenced, a 250 base-pair fragment from this isolate showed 99.5% homology with the Erasmus Medical Centre’s isolate.
      <xref ref-type="bibr" rid="bib5">
       <sup>
        5
       </sup>
      </xref>
      The third patient was a 45-year-old man who presented to a hospital in Riyadh, Saudi Arabia, on October 10th, 2012, with severe pneumonia and renal failure. MERS-CoV was detected in samples from the patient's upper and lower respiratory tract.
      <xref ref-type="bibr" rid="bib6">
       <sup>
        6
       </sup>
      </xref>
     </p>
     <p id="p0030">
      Prior to all of this, an outbreak of respiratory illness was reported in April 2012 from an intensive care unit in a hospital in Zarqa, Jordan.
      <xref ref-type="bibr" rid="bib7">
       <sup>
        7
       </sup>
      </xref>
      A retrospective epidemiological investigation in November 2012 identified 13 probable cases, two of whom had died. MERS-CoV was detected by reverse transcription (RT)–PCR in stored samples from the two deceased patients.
      <xref ref-type="bibr" rid="bib8">
       <sup>
        8
       </sup>
      </xref>
      Seven more were subsequently confirmed by serological testing.
      <xref ref-type="bibr" rid="bib9">
       <sup>
        9
       </sup>
      </xref>
     </p>
     <p id="p0035">
      A pattern began to emerge, characterized by severe pneumonia, multi-organ failure, and an epidemiological link to a country in the Middle East. In May 2013, the virus, which had been initially known as human coronavirus–Erasmus Medical Centre (hCoV-EMC), was named the Middle East respiratory syndrome coronavirus (MERS-CoV).
      <xref ref-type="bibr" rid="bib10">
       <sup>
        10
       </sup>
      </xref>
     </p>
     <p id="p0040">
      Notably, phylogenetic analysis of the first five available MERS-CoV sequences suggested a common ancestor dating back to mid-2011.
      <xref ref-type="bibr" rid="bib11">
       <sup>
        11
       </sup>
      </xref>
      Furthermore, anti-MERS-CoV antibodies were detected in 15 out of 10,009 serum samples [0.15%; 95% confidence interval (CI): 0.09–0.24%] obtained between December 2012 and December 2013 from 13 provinces in Saudi Arabia.
      <xref ref-type="bibr" rid="bib12">
       <sup>
        12
       </sup>
      </xref>
      The authors extrapolated that just fewer than 45,000 individuals (44,951; 95% CI: 26,971–71,922) in Saudi Arabia could be seropositive for MERS-CoV.
      <xref ref-type="bibr" rid="bib12">
       <sup>
        12
       </sup>
      </xref>
      It is therefore reasonable to assume that human MERS-CoV infections had taken place in the region for some considerable time before it was identified. It is possible that the identification of the virus might have been delayed even more, had it not been for the meticulous investigation by a single virologist, Dr A.M. Zaki, of the first reported case of MERS-CoV.
      <xref ref-type="bibr" rid="bib2">
       <sup>
        2
       </sup>
      </xref>
      The first lesson one has to learn from MERS-CoV and its discovery is that continuous vigilance and perseverance with diagnostic investigation of undiagnosed infectious diseases are essential to identify emerging pathogens.
     </p>
    </sec>
    <sec id="sec3">
     <title>
      Lesson two: yet again, prevention is better than cure
     </title>
     <p id="p0045">
      Clinically, MERS-CoV infection may range from an asymptomatic or mild upper respiratory illness to a rapidly progressive and fatal disease.
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      ,
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib15">
       15
      </xref>
      The majority of hospitalized patients with MERS-CoV infection present with fever and respiratory symptoms including cough and shortness of breath with clinical and radiological evidence of pneumonia.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      Fatigue, myalgia, headache, and gastrointestinal symptoms such as vomiting and diarrhoea are also frequent.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      Respiratory and renal failure are frequent complications of severe MERS-CoV infection, in addition to acute liver injury, cardiac dysrhythmias, and coagulopathy.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib19">
       19
      </xref>
      ,
      <xref ref-type="bibr" rid="bib20">
       20
      </xref>
      Overall mortality is around 35.6%, but exceeds 70% in critically ill patients and in those with significant comorbidities.
      <xref ref-type="bibr" rid="bib1">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib19">
       19
      </xref>
      ,
      <xref ref-type="bibr" rid="bib20">
       20
      </xref>
      ,
      <xref ref-type="bibr" rid="bib21">
       21
      </xref>
      ,
      <xref ref-type="bibr" rid="bib22">
       22
      </xref>
      For reasons yet to be understood, MERS-CoV infection is rare in children.
      <xref ref-type="bibr" rid="bib23">
       23
      </xref>
      ,
      <xref ref-type="bibr" rid="bib24">
       24
      </xref>
     </p>
     <p id="p0050">
      In-vitro studies have identified numerous agents with anti-MERS-CoV activity including interferon, ribavirin, mycophenolate, cyclosporine and lopinavir.
      <xref ref-type="bibr" rid="bib25">
       <sup>
        25
       </sup>
      </xref>
      The combination of interferon and ribavirin showed promising results in experimentally infected macaques.
      <xref ref-type="bibr" rid="bib26">
       <sup>
        26
       </sup>
      </xref>
      However, in retrospective clinical studies the combination was not associated with significantly improved overall survival.
      <xref ref-type="bibr" rid="bib21">
       21
      </xref>
      ,
      <xref ref-type="bibr" rid="bib22">
       22
      </xref>
      Treatment of patients with MERS-CoV infections remains largely dependent on supportive measures.
      <xref ref-type="bibr" rid="bib27">
       <sup>
        27
       </sup>
      </xref>
     </p>
     <p id="p0055">
      Diagnosis is confirmed by detection of MERS-CoV RNA in respiratory samples by real-time PCR targeting the upE and ORF 1b genes.
      <xref ref-type="bibr" rid="bib28">
       <sup>
        28
       </sup>
      </xref>
      Samples obtained from the lower respiratory tract have higher viral loads and better diagnostic yield than those obtained from the throat or nasopharynx.
      <xref ref-type="bibr" rid="bib11">
       11
      </xref>
      ,
      <xref ref-type="bibr" rid="bib29">
       29
      </xref>
      ,
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      Moreover, viral shedding is considerably prolonged in symptomatic and severely ill MERS-CoV patients compared with asymptomatic infected contacts.
      <xref ref-type="bibr" rid="bib31">
       <sup>
        31
       </sup>
      </xref>
      Interestingly, detection of MERS-CoV in blood has been associated with worse clinical outcome.
      <xref ref-type="bibr" rid="bib22">
       22
      </xref>
      ,
      <xref ref-type="bibr" rid="bib32">
       32
      </xref>
      MERS-CoV may also be detected in stool for up 16 days and in urine for up to 13 days from disease onset.
      <xref ref-type="bibr" rid="bib11">
       <sup>
        11
       </sup>
      </xref>
      Under certain conditions, MERS-CoV can survive on plastic and steel surfaces for up to 30 h.
      <xref ref-type="bibr" rid="bib33">
       <sup>
        33
       </sup>
      </xref>
      In the absence of appropriate precautions, the environment surrounding a symptomatic MERS-CoV patient can therefore become extensively contaminated with viable, potentially infectious virus.
     </p>
     <p id="p0060">
      Human-to-human transmission of MERS-CoV has been well documented in family clusters, community settings and more often in healthcare settings.
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      ,
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib15">
       15
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib20">
       20
      </xref>
      ,
      <xref ref-type="bibr" rid="bib34">
       34
      </xref>
      Common denominators in the largest hospital outbreaks have been overcrowding, especially in emergency departments, and poor adherence to infection control standards.
      <xref ref-type="bibr" rid="bib15">
       15
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib36">
       36
      </xref>
      However, MERS-CoV continues to have relatively limited infectiousness. For example, screening identified secondary MERS-CoV infections in only 4% of 280 close family contacts and 2% of 5065 healthcare contacts.
      <xref ref-type="bibr" rid="bib37">
       37
      </xref>
      ,
      <xref ref-type="bibr" rid="bib38">
       38
      </xref>
      Moreover, no secondary cases were identified following extensive epidemiological investigations of imported cases in the UK, Germany, France, Greece, The Netherlands, and the USA.
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="bib40">
       40
      </xref>
      ,
      <xref ref-type="bibr" rid="bib41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="bib42">
       42
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="bib45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="bib46">
       46
      </xref>
     </p>
     <p id="p0065">
      It has been phylogenetically demonstrated that MERS-CoV transmission chains have not extended beyond two to three months and that the virus has remained genetically stable over the past three years.
      <xref ref-type="bibr" rid="bib47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="bib48">
       48
      </xref>
      Given an effective reproduction number (R
      <sub>
       0
      </sub>
      ) of less than one, human-to-human MERS-CoV could be readily interrupted with effective preventive interventions.
      <xref ref-type="bibr" rid="bib49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="bib50">
       50
      </xref>
      Indeed, even the most explosive hospital outbreaks of MERS-CoV infection, such those that occurred in Jeddah and Riyadh in April to May 2014, were brought under control through a strategy based on early case detection and implementation of appropriate infection prevention and control measures; namely contact and droplet precautions for general care in addition to airborne precautions for aerosol-generating procedures such as intubation and respiratory tract suctioning.
      <xref ref-type="bibr" rid="bib51">
       51
      </xref>
      ,
      <xref ref-type="bibr" rid="bib52">
       52
      </xref>
      ,
      <xref ref-type="bibr" rid="bib53">
       53
      </xref>
     </p>
     <p id="p0070">
      The poor prognosis associated with MERS-CoV, especially in patients with multiple comorbidities, and the lack of effective anti-viral therapy make appropriate infection prevention and control all-important. Just as is true for most infectious diseases, MERS-CoV reminds us again that prevention is better than cure.
     </p>
    </sec>
    <sec id="sec4">
     <title>
      Lesson three: guidelines should not prevail over sound clinical judgement
     </title>
     <p id="p0075">
      The initial case definitions for MERS-CoV case finding and reporting focused on patients who are hospitalized, had evidence of acute pulmonary disease with an epidemiological link to confirmed cases or to countries in the Middle East.
      <xref ref-type="bibr" rid="bib54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="bib55">
       55
      </xref>
      As more clinical experience and epidemiological data became available, updated definitions removed the requirement for hospitalization.
      <xref ref-type="bibr" rid="bib56">
       <sup>
        56
       </sup>
      </xref>
      The reporting of several community and hospital clusters during the first half of the year 2013, often without identifiable human or animal sources, led to speculation that individuals with no or only mild respiratory symptoms might have a role in MERS-CoV transmissions.
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      ,
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib20">
       20
      </xref>
      This was reflected in the WHO revised interim definition published in July 2013 where patients with acute febrile illness of any severity were included; in addition to a recommendation to proactively test asymptomatic close contacts of confirmed MERS-CoV infections.
      <xref ref-type="bibr" rid="bib57">
       <sup>
        57
       </sup>
      </xref>
      Memish
      <italic>
       et al.
      </italic>
      later showed that MERS-CoV was detectable for up to 12 days in 30% of 12 asymptomatic contacts.
      <xref ref-type="bibr" rid="bib31">
       <sup>
        31
       </sup>
      </xref>
      In another report, an asymptomatic healthcare worker had detectable MERS-CoV for more than five weeks.
      <xref ref-type="bibr" rid="bib58">
       <sup>
        58
       </sup>
      </xref>
      Although MERS-CoV transmission from an asymptomatic individual remains a strong probability, this has never been documented.
      <xref ref-type="bibr" rid="bib37">
       37
      </xref>
      ,
      <xref ref-type="bibr" rid="bib38">
       38
      </xref>
     </p>
     <p id="p0080">
      In the meantime, clinicians were becoming increasingly aware that MERS-CoV infections were being diagnosed in patients whose clinical presentations did not conform to those definitions, including the absence of fever, lack of respiratory involvement and the predominance of gastrointestinal or non-specific generalized symptoms.
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib22">
       22
      </xref>
      ,
      <xref ref-type="bibr" rid="bib59">
       59
      </xref>
      In the aftermath of the surge of MERS-CoV infection in Jeddah and Riyadh in April and May 2014, the Ministry of Health in Saudi Arabia revised its case definition and surveillance guidance to recommend MERS-CoV testing in any of four patient categories:
      <list id="ulist0010" list-type="simple">
       <list-item id="u0010">
        <label>
         –
        </label>
        <p id="p0085">
         patients with clinical or radiological evidence of community-acquired pneumonia;
        </p>
       </list-item>
       <list-item id="u0015">
        <label>
         –
        </label>
        <p id="p0090">
         patients with clinical or radiological evidence of healthcare-associated pneumonia;
        </p>
       </list-item>
       <list-item id="u0020">
        <label>
         –
        </label>
        <p id="p0095">
         patients with acute febrile illness and myalgia, headache, diarrhoea, nausea, or vomiting, and unexplained leucopenia or thrombocytopenia;
        </p>
       </list-item>
       <list-item id="u0025">
        <label>
         –
        </label>
        <p id="p0100">
         contacts of individuals with confirmed or probable MERS-CoV infection who develop upper or lower respiratory symptoms within two weeks of exposure.
         <xref ref-type="bibr" rid="bib60">
          <sup>
           60
          </sup>
         </xref>
        </p>
       </list-item>
      </list>
     </p>
     <p id="p0105">
      As better understanding of the epidemiology of MERS-CoV developed, it became obvious that a considerable proportion of cases were probably missed.
      <xref ref-type="bibr" rid="bib12">
       12
      </xref>
      ,
      <xref ref-type="bibr" rid="bib50">
       50
      </xref>
      During the steep learning curve of an emerging infectious disease, regularly updated guidelines are important. Such guidelines are inevitably based on incomplete evidence and hence may not be comprehensive or applicable in all situations. Clinical acumen and heightened medical awareness are essential for early detection of unusual MERS-CoV cases and to prevent delays in diagnosis and to mitigate additional exposures.
      <xref ref-type="bibr" rid="bib61">
       <sup>
        61
       </sup>
      </xref>
     </p>
    </sec>
    <sec id="sec5">
     <title>
      Lesson four: MERS-CoV is another zoonotic infection
     </title>
     <p id="p0110">
      A zoonotic origin was suspected soon after the identification of MERS-CoV.
      <xref ref-type="bibr" rid="bib6">
       <sup>
        6
       </sup>
      </xref>
      Bats are known natural hosts for several coronaviruses and hence were the initial target for investigation.
      <xref ref-type="bibr" rid="bib62">
       62
      </xref>
      ,
      <xref ref-type="bibr" rid="bib63">
       63
      </xref>
      More than 1000 faecal samples were collected from wild bats in the area around where the first MERS-CoV patient lived. A 190-nucleotide fragment of MERS-CoV RNA was detected in one faecal pellet from an Egyptian tomb bat. The sequenced amplification product was genetically identical to the MERS-CoV sequence obtained from the index human case.
      <xref ref-type="bibr" rid="bib64">
       <sup>
        64
       </sup>
      </xref>
      More recently, a closely related coronavirus was isolated from bats in South Africa, suggesting that MERS-CoV ancestors might exist in Old World bats.
      <xref ref-type="bibr" rid="bib65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="bib66">
       66
      </xref>
      To date, no further evidence is available to confirm the role of bats as natural hosts or reservoirs for MERS-CoV.
     </p>
     <p id="p0115">
      On the other hand, the evidence implicating dromedary camels in MERS-CoV epidemiology is more consistent. A role for dromedary camels is supported by the following observations:
      <list id="ulist0015" list-type="simple">
       <list-item id="u0030">
        <label>
         −
        </label>
        <p id="p0120">
         Neutralizing MERS-CoV antibodies are highly prevalent in dromedary camels from across the Arabian Peninsula, North Africa, and Eastern Africa.
         <xref ref-type="bibr" rid="bib67">
          67
         </xref>
         ,
         <xref ref-type="bibr" rid="bib68">
          68
         </xref>
         ,
         <xref ref-type="bibr" rid="bib69">
          69
         </xref>
         ,
         <xref ref-type="bibr" rid="bib70">
          70
         </xref>
         ,
         <xref ref-type="bibr" rid="bib71">
          71
         </xref>
         ,
         <xref ref-type="bibr" rid="bib72">
          72
         </xref>
         ,
         <xref ref-type="bibr" rid="bib73">
          73
         </xref>
         MERS-CoV antibodies were detected in stored camel sera dating as far back as the early 1990s.
         <xref ref-type="bibr" rid="bib73">
          73
         </xref>
         ,
         <xref ref-type="bibr" rid="bib74">
          74
         </xref>
         ,
         <xref ref-type="bibr" rid="bib75">
          75
         </xref>
         The prevalence of MERS-CoV seropositivity is significantly higher in camels aged more than two years than in juvenile camels.
         <xref ref-type="bibr" rid="bib68">
          68
         </xref>
         ,
         <xref ref-type="bibr" rid="bib74">
          74
         </xref>
         ,
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
        </p>
       </list-item>
       <list-item id="u0035">
        <label>
         −
        </label>
        <p id="p0125">
         Several groups have reported the detection of MERS-CoV by RT–PCR in nasal and faecal samples from dromedary camels in the Arabian Peninsula.
         <xref ref-type="bibr" rid="bib72">
          72
         </xref>
         ,
         <xref ref-type="bibr" rid="bib74">
          74
         </xref>
         ,
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
         ,
         <xref ref-type="bibr" rid="bib77">
          77
         </xref>
         ,
         <xref ref-type="bibr" rid="bib78">
          78
         </xref>
         ,
         <xref ref-type="bibr" rid="bib79">
          79
         </xref>
         One study reported MERS-CoV positivity in more than 60% of lung tissue samples obtained from dromedary camel carcasses.
         <xref ref-type="bibr" rid="bib79">
          <sup>
           79
          </sup>
         </xref>
         RT–PCR was positive in camels that had prior evidence of MERS-CoV seropositivity, indicating that animal reinfection is possible.
         <xref ref-type="bibr" rid="bib76">
          <sup>
           76
          </sup>
         </xref>
         Interestingly, the prevalence of MERS-CoV RNA is significantly higher in juvenile than in adult camels.
         <xref ref-type="bibr" rid="bib74">
          74
         </xref>
         ,
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
         ,
         <xref ref-type="bibr" rid="bib79">
          79
         </xref>
         Furthermore, all MERS-CoV strains obtained from dromedary camels are phylogenetically clustered within human isolates, supporting possible animal–human intertransmission.
         <xref ref-type="bibr" rid="bib72">
          72
         </xref>
         ,
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
         ,
         <xref ref-type="bibr" rid="bib77">
          77
         </xref>
         ,
         <xref ref-type="bibr" rid="bib78">
          78
         </xref>
         ,
         <xref ref-type="bibr" rid="bib79">
          79
         </xref>
         ,
         <xref ref-type="bibr" rid="bib80">
          80
         </xref>
         ,
         <xref ref-type="bibr" rid="bib81">
          81
         </xref>
        </p>
       </list-item>
       <list-item id="u0040">
        <label>
         −
        </label>
        <p id="p0130">
         Viable MERS-CoV was isolated from nasal and faecal samples from dromedary camels.
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
         ,
         <xref ref-type="bibr" rid="bib82">
          82
         </xref>
         MERS-CoV recovered from dromedary camels is capable of causing ex-vivo infection in human respiratory cells.
         <xref ref-type="bibr" rid="bib83">
          <sup>
           83
          </sup>
         </xref>
        </p>
       </list-item>
       <list-item id="u0045">
        <label>
         −
        </label>
        <p id="p0135">
         Acute infection in dromedary camels has been demonstrated by documented rises in anti-MERS-CoV antibody titres, and by RT–PCR in symptomatic animals.
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
         ,
         <xref ref-type="bibr" rid="bib81">
          81
         </xref>
         ,
         <xref ref-type="bibr" rid="bib82">
          82
         </xref>
        </p>
       </list-item>
       <list-item id="u0050">
        <label>
         −
        </label>
        <p id="p0140">
         Experimental MERS-CoV infection of dromedary camels resulted in clinical infection manifesting as fever and rhinorrhoea.
         <xref ref-type="bibr" rid="bib84">
          <sup>
           84
          </sup>
         </xref>
         Viable MERS-CoV was recovered in cultures of nasal samples for up to seven days post-inoculation; a period during which infectiousness is theoretically possible. MERS-CoV seroconversion was documented within 14 days of inoculation.
         <xref ref-type="bibr" rid="bib84">
          <sup>
           84
          </sup>
         </xref>
        </p>
       </list-item>
       <list-item id="u0055">
        <label>
         −
        </label>
        <p id="p0145">
         Almost identical MERS-CoV strains were recovered from epidemiologically linked human cases and camels with which they had close contact in Qatar, and in Saudi Arabia.
         <xref ref-type="bibr" rid="bib80">
          80
         </xref>
         ,
         <xref ref-type="bibr" rid="bib81">
          81
         </xref>
         ,
         <xref ref-type="bibr" rid="bib85">
          85
         </xref>
        </p>
       </list-item>
      </list>
     </p>
     <p id="p0150">
      It is important to note, however, that MERS-CoV seroprevalence studies in individuals with close contact with camels have yielded inconsistent results. A national serosurvey in Saudi Arabia found prevalence of MERS-CoV antibodies that was 15 times higher in camel shepherds (
      <italic>
       P
      </italic>
      = 0.0004) and 23 times higher in slaughterhouse workers (
      <italic>
       P
      </italic>
      &lt; 0.0001), compared with the general population.
      <xref ref-type="bibr" rid="bib12">
       <sup>
        12
       </sup>
      </xref>
      Similarly, MERS-CoV serology was positive in individuals who had occupational exposure to dromedary camels in Qatar but not in those without such exposure.
      <xref ref-type="bibr" rid="bib86">
       <sup>
        86
       </sup>
      </xref>
      On the other hand, MERS-CoV antibodies were not detected in sera obtained from individuals who had close contact with camels that had documented MERS-CoV infection two to three months earlier.
      <xref ref-type="bibr" rid="bib87">
       <sup>
        87
       </sup>
      </xref>
      Likewise, screened slaughterhouse workers and other animal workers in Western and Southern Saudi Arabia were all seronegative for MERS-CoV antibodies.
      <xref ref-type="bibr" rid="bib88">
       88
      </xref>
      ,
      <xref ref-type="bibr" rid="bib89">
       89
      </xref>
     </p>
     <p id="p0155">
      Collectively, the available data strongly suggest that MERS-CoV is highly prevalent in dromedary camels in the Arabian Peninsula and that transmission of infection from camels to humans, although inefficient, does occur. However, the exact mechanism and route of infection it is still unclear. Even less clear is the role of bats as possible natural reservoirs for MERS-CoV. Moreover, only a small proportion of patients with confirmed MERS-CoV infection report close contact with camels.
      <xref ref-type="bibr" rid="bib17">
       <sup>
        17
       </sup>
      </xref>
      Even though camels are probably important in the transmission cycle of sporadic MERS-CoV infection, human-to-human transmission remains the likely source of the majority of reported MERS-CoV infections.
     </p>
    </sec>
    <sec id="sec6">
     <title>
      Lesson five: the world is getting smaller
     </title>
     <p id="p0160">
      MERS-CoV infections have been reported from a total of 26 countries around the world (
      <xref ref-type="fig" rid="fig1">
       Figure 1
      </xref>
      ). Cases outside the Middle East include individuals who travelled to Europe or the Far East for medical care, expatriates returning home from countries in the Middle East or short-term visitors to the region.
      <xref ref-type="bibr" rid="bib5">
       5
      </xref>
      ,
      <xref ref-type="bibr" rid="bib11">
       11
      </xref>
      ,
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      ,
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="bib90">
       90
      </xref>
      ,
      <xref ref-type="bibr" rid="bib91">
       91
      </xref>
      ,
      <xref ref-type="bibr" rid="bib92">
       92
      </xref>
      ,
      <xref ref-type="bibr" rid="bib93">
       93
      </xref>
      ,
      <xref ref-type="bibr" rid="bib94">
       94
      </xref>
      ,
      <xref ref-type="bibr" rid="bib95">
       95
      </xref>
      ,
      <xref ref-type="bibr" rid="bib96">
       96
      </xref>
      On some occasions, travel-related MERS-CoV infections resulted in small clusters of secondary infections.
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      ,
      <xref ref-type="bibr" rid="bib94">
       94
      </xref>
      ,
      <xref ref-type="bibr" rid="bib95">
       95
      </xref>
      ,
      <xref ref-type="bibr" rid="bib97">
       97
      </xref>
      One pertinent cause for concern has been the potential global spread of MERS-CoV during the annual Hajj pilgrimage when millions of Muslims from around the world gather in Mecca, Saudi Arabia.
      <xref ref-type="bibr" rid="bib98">
       98
      </xref>
      ,
      <xref ref-type="bibr" rid="bib99">
       99
      </xref>
      ,
      <xref ref-type="bibr" rid="bib100">
       100
      </xref>
      ,
      <xref ref-type="bibr" rid="bib101">
       101
      </xref>
      ,
      <xref ref-type="bibr" rid="bib102">
       102
      </xref>
      Though those concerns are well founded, several surveillance studies over the past three years have not identified any MERS-CoV infections among Hajj pilgrims while they are in Saudi Arabia or after their return to their home countries.
      <xref ref-type="bibr" rid="bib103">
       103
      </xref>
      ,
      <xref ref-type="bibr" rid="bib104">
       104
      </xref>
      ,
      <xref ref-type="bibr" rid="bib105">
       105
      </xref>
      ,
      <xref ref-type="bibr" rid="bib106">
       106
      </xref>
      ,
      <xref ref-type="bibr" rid="bib107">
       107
      </xref>
      ,
      <xref ref-type="bibr" rid="bib108">
       108
      </xref>
      <fig id="fig1">
       <label>
        Figure 1
       </label>
       <caption>
        <p>
         Countries and numbers of Middle East respiratory syndrome coronavirus (MERS-CoV) cases reported as of July 7th, 2015.
        </p>
       </caption>
       <graphic xlink:href="gr1_lrg">
       </graphic>
      </fig>
     </p>
     <p id="p0165">
      The situation was entirely different in the recent outbreak in South Korea where a single imported case resulted in a total of 186 laboratory-confirmed cases of MERS-CoV infection, including 36 deaths.
      <xref ref-type="bibr" rid="bib109">
       <sup>
        109
       </sup>
      </xref>
      The index patient was a 68-year-old man who developed respiratory symptoms seven days after returning to Seoul from a two-week visit to Bahrain, Saudi Arabia, United Arab Emirates, and Qatar.
      <xref ref-type="bibr" rid="bib35">
       <sup>
        35
       </sup>
      </xref>
      He sought medical care in several hospitals before he was diagnosed with MERS-CoV infection.
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib110">
       110
      </xref>
      A combination of late recognition, overcrowding in emergency departments and hospital wards, multiple incidents of patient movement between different healthcare facilities, and delayed implementation of adequate infection control precautions culminated in the largest single outbreak of MERS-CoV infection.
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="bib110">
       110
      </xref>
      ,
      <xref ref-type="bibr" rid="bib111">
       111
      </xref>
      ,
      <xref ref-type="bibr" rid="bib112">
       112
      </xref>
      The outbreak involved patients, visitors, care-givers and healthcare workers, and spanned across six different hospitals in three South Korean cities.
      <xref ref-type="bibr" rid="bib110">
       110
      </xref>
      ,
      <xref ref-type="bibr" rid="bib113">
       113
      </xref>
      Notably, phylogenetic analysis of MERS-CoV strains from South Korea revealed no significant biological changes compared to previously sequenced viruses.
      <xref ref-type="bibr" rid="bib114">
       <sup>
        114
       </sup>
      </xref>
     </p>
     <p id="p0170">
      The outbreak in South Korea was eventually controlled through a series of measures including aggressive contact identification, screening and strict isolation, and rigorous infection control precautions.
      <xref ref-type="bibr" rid="bib111">
       111
      </xref>
      ,
      <xref ref-type="bibr" rid="bib115">
       115
      </xref>
      ,
      <xref ref-type="bibr" rid="bib116">
       116
      </xref>
      Within a few weeks, South Korea went from a country with no reported MERS-CoV cases to one that has the second largest number in the world.
      <xref ref-type="bibr" rid="bib116">
       116
      </xref>
      ,
      <xref ref-type="bibr" rid="bib117">
       117
      </xref>
     </p>
     <p id="p0175">
      With air travel becoming readily accessible and affordable, the South Korean experience demonstrates vividly that in the context of an infectious respiratory illness, there is simply no room for complacency. Adequate assessment of patients presenting with febrile illness must include their recent travel history to enable early application of proper control measures and to expedite laboratory confirmation and appropriate clinical management.
     </p>
    </sec>
    <sec id="sec7">
     <title>
      Lesson six: we live in the era of social media
     </title>
     <p id="p0180">
      The past decade has witnessed an exponential rise in internet-based social media sites such as Facebook, Twitter, and YouTube.
      <xref ref-type="bibr" rid="bib118">
       <sup>
        118
       </sup>
      </xref>
      Healthcare professionals are increasingly using social media applications to follow medical developments and emerging scientific literature and to share their own research findings, observations, and opinion.
      <xref ref-type="bibr" rid="bib119">
       <sup>
        119
       </sup>
      </xref>
      The general public often uses these tools as news outlets to seek and share medical and scientific information.
      <xref ref-type="bibr" rid="bib120">
       <sup>
        120
       </sup>
      </xref>
      However, in the context of MERS-CoV, social media have been a double-edged sword. For example, social media were at some point rife with inaccurate information that included rumours of hospitals closed due to MERS-CoV outbreaks and certain social events being nodes for MERS-CoV transmission. The authors are aware of examples of information and photos shared on social media resulting in patients losing their right to privacy and confidentiality. Patients often cancelled their clinic appointments or scheduled surgical procedures for fear of acquiring MERS-CoV while in hospital. Some avoided attending emergency departments despite having acute problems that required medical attention. Some individuals posted videos and messages challenging the suggestion that camels may be a source of MERS-CoV infection. Scepticism and mistrust in governmental agencies and the medical community were sometimes promoted and propagated.
     </p>
     <p id="p0185">
      On the other hand, various government agencies, scientific organizations and healthcare professionals used social media to enhance networking and facilitate communication of epidemiological, medical and scientific developments; in addition to presenting the public with factual material, timely updates, and relevant advice.
      <xref ref-type="bibr" rid="bib121">
       <sup>
        121
       </sup>
      </xref>
      The Saudi Ministry of Health, for example, posts daily updates on its website and through social media outlining details of current MERS-CoV cases. The Korean Ministry of Health and Welfare did the same during their MERS-CoV outbreak. Such steps are important to gain the public’s trust and to remove barriers to appropriate sources of information. Taking on board the surging role of social media and using them effectively to disseminate appropriate information turns them into invaluable tools for controlling an emerging infectious disease such as MERS-CoV.
     </p>
    </sec>
    <sec id="sec8">
     <title>
      Conclusion
     </title>
     <p id="p0190">
      MERS-CoV is an emerging infectious disease of probable animal origin. Sustained human-to-human infection has not occurred and its potential for causing widespread epidemic remains limited. Vigilance, early recognition, and institution of appropriate protective measures are the most effective control measures.
     </p>
    </sec>
    <sec id="sec9">
     <title>
      Conflict of interest
     </title>
     <p id="p0195">
      None declared.
     </p>
    </sec>
    <sec id="sec10">
     <title>
      Funding sources
     </title>
     <p id="p0200">
      None.
     </p>
    </sec>
    <back>
     <ref-list id="cebib0010">
      <title>
       References
      </title>
      <ref id="bib1">
       <label>
        1
       </label>
       <element-citation id="sref1" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV); Summary of current situation, literature update and risk assessment 7 July 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0010" xlink:href="http://apps.who.int/iris/bitstream/10665/179184/2/WHO_MERS_RA_15.1_eng.pdf?ua=1">
         http://apps.who.int/iris/bitstream/10665/179184/2/WHO_MERS_RA_15.1_eng.pdf?ua=1
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib2">
       <label>
        2
       </label>
       <element-citation id="sref2" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Bestebroer
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.M.E.
          </given-names>
         </name>
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           R.A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
        </article-title>
        <source>
         N Eng J Med
        </source>
        <volume>
         367
        </volume>
        <year>
         2012
        </year>
        <fpage>
         1814
        </fpage>
        <lpage>
         1820
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib3">
       <label>
        3
       </label>
       <element-citation id="sref3" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           de Graaf
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Lauber
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans
        </article-title>
        <source>
         mBio
        </source>
        <volume>
         3
        </volume>
        <year>
         2012
        </year>
        <fpage>
         e00473
        </fpage>
        <lpage>
         00412
        </lpage>
        <pub-id pub-id-type="pmid">
         23170002
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib4">
       <label>
        4
       </label>
       <element-citation id="sref4" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           ProMED-mail
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Novel coronavirus – Saudi Arabia: human isolate. Archive Number: 20120920.1302733; 20 September 2012 21:51:30 CEST
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         International Society for Infectious Diseases
        </publisher-name>
        <publisher-loc>
         Washington DC
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0015" xlink:href="http://www.promedmail.org/direct.php?id=20120920.1302733">
         http://www.promedmail.org/direct.php?id=20120920.1302733
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib5">
       <label>
        5
       </label>
       <element-citation id="sref5" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bermingham
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Chand
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         17
        </volume>
        <year>
         2012
        </year>
        <fpage>
         20290
        </fpage>
        <pub-id pub-id-type="pmid">
         23078800
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib6">
       <label>
        6
       </label>
       <element-citation id="sref6" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Stephens
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Hewson
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Recovery from severe novel coronavirus infection
        </article-title>
        <source>
         Saudi Med J
        </source>
        <volume>
         33
        </volume>
        <year>
         2012
        </year>
        <fpage>
         1265
        </fpage>
        <lpage>
         1269
        </lpage>
        <pub-id pub-id-type="pmid">
         23232672
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib7">
       <label>
        7
       </label>
       <element-citation id="sref7" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           European Centre for Disease Prevention and Control
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Communicable Disease Threats Report, Week 18, 29 April–5 May 2012. Severe respiratory disease of unknown origin – Jordan – outbreak in ICU
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         ECDC
        </publisher-name>
        <publisher-loc>
         Stockholm
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0020" xlink:href="http://www.ecdc.europa.eu/en/publications/Publications/CDTR.pdf">
         http://www.ecdc.europa.eu/en/publications/Publications/CDTR.pdf
        </ext-link>
        <comment>
         online version 4 May 2012 [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib8">
       <label>
        8
       </label>
       <element-citation id="sref8" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hijawi
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Abdallat
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Sayaydeh
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Novel coronavirus infections in Jordan, April 2012
        </article-title>
        <source>
         East Mediterr Health J
        </source>
        <volume>
         19
        </volume>
        <year>
         2013
        </year>
        <fpage>
         S12
        </fpage>
        <lpage>
         18
        </lpage>
        <pub-id pub-id-type="pmid">
         23888790
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib9">
       <label>
        9
       </label>
       <element-citation id="sref9" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Abdallat
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           D.C.
          </given-names>
         </name>
         <name>
          <surname>
           Alqasrawi
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         59
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1225
        </fpage>
        <lpage>
         1233
        </lpage>
        <pub-id pub-id-type="pmid">
         24829216
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib10">
       <label>
        10
       </label>
       <element-citation id="sref10" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Groot
          </surname>
          <given-names>
           R.J.
          </given-names>
         </name>
         <name>
          <surname>
           Baker
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
         <name>
          <surname>
           Baric
          </surname>
          <given-names>
           R.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         87
        </volume>
        <year>
         2013
        </year>
        <fpage>
         7790
        </fpage>
        <lpage>
         7792
        </lpage>
        <pub-id pub-id-type="pmid">
         23678167
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib11">
       <label>
        11
       </label>
       <element-citation id="sref11" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Seilmaier
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         13
        </volume>
        <year>
         2013
        </year>
        <fpage>
         745
        </fpage>
        <lpage>
         751
        </lpage>
        <pub-id pub-id-type="pmid">
         23782859
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib12">
       <label>
        12
       </label>
       <element-citation id="sref12" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         15
        </volume>
        <year>
         2015
        </year>
        <fpage>
         559
        </fpage>
        <lpage>
         564
        </lpage>
        <pub-id pub-id-type="pmid">
         25863564
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib13">
       <label>
        13
       </label>
       <element-citation id="sref13" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A.I.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Hakeem
          </surname>
          <given-names>
           R.F.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           A.A.
          </given-names>
         </name>
         <name>
          <surname>
           Stephens
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections
        </article-title>
        <source>
         N Eng J Med
        </source>
        <volume>
         368
        </volume>
        <year>
         2013
        </year>
        <fpage>
         2487
        </fpage>
        <lpage>
         2494
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib14">
       <label>
        14
       </label>
       <element-citation id="sref14" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Matin
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Haddad
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Nakhli
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Albarrak
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognised asymptomatic or mild case
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <volume>
         17
        </volume>
        <year>
         2013
        </year>
        <fpage>
         e668
        </fpage>
        <lpage>
         672
        </lpage>
        <pub-id pub-id-type="pmid">
         23916548
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib15">
       <label>
        15
       </label>
       <element-citation id="sref15" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Oboho
          </surname>
          <given-names>
           I.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tomczyk
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Asmari
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         2014 MERS-CoV outbreak in Jeddah – a link to health care facilities
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         372
        </volume>
        <year>
         2015
        </year>
        <fpage>
         846
        </fpage>
        <lpage>
         854
        </lpage>
        <pub-id pub-id-type="pmid">
         25714162
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib16">
       <label>
        16
       </label>
       <element-citation id="sref16" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           A.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         13
        </volume>
        <year>
         2013
        </year>
        <fpage>
         752
        </fpage>
        <lpage>
         761
        </lpage>
        <pub-id pub-id-type="pmid">
         23891402
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib17">
       <label>
        17
       </label>
       <element-citation id="sref17" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Baig
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <volume>
         29
        </volume>
        <year>
         2014
        </year>
        <fpage>
         301
        </fpage>
        <lpage>
         306
        </lpage>
        <pub-id pub-id-type="pmid">
         25303830
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib18">
       <label>
        18
       </label>
       <element-citation id="sref18" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Hameed
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Wahla
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Siddiqui
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia
        </article-title>
        <source>
         J Intensive Care Med
        </source>
        <year>
         2015
        </year>
       </element-citation>
      </ref>
      <ref id="bib19">
       <label>
        19
       </label>
       <element-citation id="sref19" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arabi
          </surname>
          <given-names>
           Y.M.
          </given-names>
         </name>
         <name>
          <surname>
           Arifi
          </surname>
          <given-names>
           A.A.
          </given-names>
         </name>
         <name>
          <surname>
           Balkhy
          </surname>
          <given-names>
           H.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection
        </article-title>
        <source>
         Ann Int Med
        </source>
        <volume>
         160
        </volume>
        <year>
         2014
        </year>
        <fpage>
         389
        </fpage>
        <lpage>
         397
        </lpage>
        <pub-id pub-id-type="pmid">
         24474051
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib20">
       <label>
        20
       </label>
       <element-citation id="sref20" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           McGeer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Perl
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital outbreak of Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         N Eng J Med
        </source>
        <volume>
         369
        </volume>
        <year>
         2013
        </year>
        <fpage>
         407
        </fpage>
        <lpage>
         416
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib21">
       <label>
        21
       </label>
       <element-citation id="sref21" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Baig
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         14
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1090
        </fpage>
        <lpage>
         1095
        </lpage>
        <pub-id pub-id-type="pmid">
         25278221
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib22">
       <label>
        22
       </label>
       <element-citation id="sref22" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shalhoub
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Farahat
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Jiffri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
        </article-title>
        <source>
         J Antimicrob Chemother
        </source>
        <volume>
         70
        </volume>
        <year>
         2015
        </year>
        <fpage>
         2129
        </fpage>
        <lpage>
         2132
        </lpage>
        <pub-id pub-id-type="pmid">
         25900158
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib23">
       <label>
        23
       </label>
       <element-citation id="sref23" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khuri-Bulos
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Payne
          </surname>
          <given-names>
           D.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus not detected in children hospitalised with acute respiratory illness in Amman, Jordan, March 2010 to September 2012
        </article-title>
        <source>
         Clin Microbiol Infect
        </source>
        <volume>
         20
        </volume>
        <year>
         2013
        </year>
        <fpage>
         678
        </fpage>
        <lpage>
         682
        </lpage>
        <pub-id pub-id-type="pmid">
         24313317
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib24">
       <label>
        24
       </label>
       <element-citation id="sref24" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus disease in children
        </article-title>
        <source>
         Pediatr Infect Dis J
        </source>
        <volume>
         33
        </volume>
        <year>
         2014
        </year>
        <fpage>
         904
        </fpage>
        <lpage>
         906
        </lpage>
        <pub-id pub-id-type="pmid">
         24763193
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib25">
       <label>
        25
       </label>
       <element-citation id="sref25" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omrani
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV) infection: how close are we?
        </article-title>
        <source>
         Curr Treat Options Infect Dis
        </source>
        <year>
         2015
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         15
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib26">
       <label>
        26
       </label>
       <element-citation id="sref26" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Falzarano
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           de Wit
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           A.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
        </article-title>
        <source>
         Nature Med
        </source>
        <volume>
         19
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1313
        </fpage>
        <lpage>
         1317
        </lpage>
        <pub-id pub-id-type="pmid">
         24013700
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib27">
       <label>
        27
       </label>
       <element-citation id="sref27" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected; interim guidance updated 2 July 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0025" xlink:href="http://apps.who.int/iris/bitstream/10665/178529/1/WHO_MERS_Clinical_15.1_eng.pdf?ua=1">
         http://apps.who.int/iris/bitstream/10665/178529/1/WHO_MERS_Clinical_15.1_eng.pdf?ua=1
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib28">
       <label>
        28
       </label>
       <element-citation id="sref28" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Costabel
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         17
        </volume>
        <year>
         2012
        </year>
        <fpage>
         20334
        </fpage>
        <pub-id pub-id-type="pmid">
         23231891
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib29">
       <label>
        29
       </label>
       <element-citation id="sref29" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           H.Q.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         210
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1590
        </fpage>
        <lpage>
         1594
        </lpage>
        <pub-id pub-id-type="pmid">
         24837403
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib30">
       <label>
        30
       </label>
       <element-citation id="sref30" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guery
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           el Mansouf
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         381
        </volume>
        <year>
         2013
        </year>
        <fpage>
         2265
        </fpage>
        <lpage>
         2272
        </lpage>
        <pub-id pub-id-type="pmid">
         23727167
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib31">
       <label>
        31
       </label>
       <element-citation id="sref31" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <volume>
         29
        </volume>
        <year>
         2014
        </year>
        <fpage>
         307
        </fpage>
        <lpage>
         308
        </lpage>
        <pub-id pub-id-type="pmid">
         25448335
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib32">
       <label>
        32
       </label>
       <element-citation id="sref32" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Faure
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Poissy
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Goffard
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?
        </article-title>
        <source>
         PloS One
        </source>
        <volume>
         9
        </volume>
        <year>
         2014
        </year>
        <fpage>
         e88716
        </fpage>
        <pub-id pub-id-type="pmid">
         24551142
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib33">
       <label>
        33
       </label>
       <element-citation id="sref33" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Munster
          </surname>
          <given-names>
           V.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <fpage>
         20590
        </fpage>
        <pub-id pub-id-type="pmid">
         24084338
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib34">
       <label>
        34
       </label>
       <element-citation id="sref34" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <volume>
         23
        </volume>
        <year>
         2014
        </year>
        <fpage>
         63
        </fpage>
        <lpage>
         68
        </lpage>
        <pub-id pub-id-type="pmid">
         24699184
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib35">
       <label>
        35
       </label>
       <element-citation id="sref35" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           H.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           E.J.
          </given-names>
         </name>
         <name>
          <surname>
           Ryu
          </surname>
          <given-names>
           Y.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         20
        </volume>
        <year>
         2015
        </year>
        <fpage>
         21169
        </fpage>
        <pub-id pub-id-type="pmid">
         26132766
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib36">
       <label>
        36
       </label>
       <element-citation id="sref36" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           N.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Probable transmission chains of MERS-CoV and the multiple generations of secondary infections in South Korea
        </article-title>
        <source>
         Int J Infect Dis
        </source>
        <year>
         2015
        </year>
       </element-citation>
      </ref>
      <ref id="bib37">
       <label>
        37
       </label>
       <element-citation id="sref37" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Transmission of MERS-coronavirus in household contacts
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         371
        </volume>
        <year>
         2014
        </year>
        <fpage>
         828
        </fpage>
        <lpage>
         835
        </lpage>
        <pub-id pub-id-type="pmid">
         25162889
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib38">
       <label>
        38
       </label>
       <element-citation id="sref38" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Makhdoom
          </surname>
          <given-names>
           H.Q.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study
        </article-title>
        <source>
         Clin Microbiol Infect
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         469
        </fpage>
        <lpage>
         474
        </lpage>
        <pub-id pub-id-type="pmid">
         24460984
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib39">
       <label>
        39
       </label>
       <element-citation id="sref39" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pebody
          </surname>
          <given-names>
           R.G.
          </given-names>
         </name>
         <name>
          <surname>
           Chand
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Thomas
          </surname>
          <given-names>
           H.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         17
        </volume>
        <year>
         2012
        </year>
        <fpage>
         20292
        </fpage>
        <pub-id pub-id-type="pmid">
         23078799
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib40">
       <label>
        40
       </label>
       <element-citation id="sref40" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Parry-Ford
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Boddington
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Pebody
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Phin
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Public health response to two incidents of confirmed MERS-CoV cases travelling on flights through London Heathrow Airport in 2014 – lessons learnt
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         20
        </volume>
        <year>
         2015
        </year>
        <fpage>
         21114
        </fpage>
        <pub-id pub-id-type="pmid">
         25990234
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib41">
       <label>
        41
       </label>
       <element-citation id="sref41" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reuss
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Litterst
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contact investigation for imported case of Middle East respiratory syndrome, Germany
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         620
        </fpage>
        <lpage>
         625
        </lpage>
        <pub-id pub-id-type="pmid">
         24655721
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib42">
       <label>
        42
       </label>
       <element-citation id="sref42" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Buchholz
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Nitsche
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October–November 2012
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <fpage>
         20406
        </fpage>
        <pub-id pub-id-type="pmid">
         23449231
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib43">
       <label>
        43
       </label>
       <element-citation id="sref43" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mailles
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Blanckaert
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Chaud
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <fpage>
         20502
        </fpage>
        <pub-id pub-id-type="pmid">
         23787161
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib44">
       <label>
        44
       </label>
       <element-citation id="sref44" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsiodras
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Baka
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Mentis
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A case of imported Middle East respiratory syndrome coronavirus infection and public health response, Greece, April 2014
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         19
        </volume>
        <year>
         2014
        </year>
        <fpage>
         20782
        </fpage>
        <pub-id pub-id-type="pmid">
         24786258
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib45">
       <label>
        45
       </label>
       <element-citation id="sref45" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kraaij-Dirkzwager
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Timen
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Dirksen
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         19
        </volume>
        <year>
         2014
        </year>
        <fpage>
         20817
        </fpage>
        <pub-id pub-id-type="pmid">
         24906375
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib46">
       <label>
        46
       </label>
       <element-citation id="sref46" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Breakwell
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Pringle
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Chea
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of transmission among close contacts of patient with case of Middle East respiratory syndrome imported into the United States, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         21
        </volume>
        <year>
         2015
        </year>
        <fpage>
         1128
        </fpage>
        <lpage>
         1134
        </lpage>
        <pub-id pub-id-type="pmid">
         26079176
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib47">
       <label>
        47
       </label>
       <element-citation id="sref47" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           S.J.
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A.I.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus
        </article-title>
        <source>
         mBio
        </source>
        <volume>
         5
        </volume>
        <year>
         2014
        </year>
        <fpage>
         e01062
        </fpage>
        <lpage>
         01013
        </lpage>
        <pub-id pub-id-type="pmid">
         24549846
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib48">
       <label>
        48
       </label>
       <element-citation id="sref48" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Muth
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         60
        </volume>
        <year>
         2015
        </year>
        <fpage>
         369
        </fpage>
        <lpage>
         377
        </lpage>
        <pub-id pub-id-type="pmid">
         25323704
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib49">
       <label>
        49
       </label>
       <element-citation id="sref49" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Breban
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Riou
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Fontanet
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         382
        </volume>
        <year>
         2013
        </year>
        <fpage>
         694
        </fpage>
        <lpage>
         699
        </lpage>
        <pub-id pub-id-type="pmid">
         23831141
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib50">
       <label>
        50
       </label>
       <element-citation id="sref50" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cauchemez
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Fraser
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Van Kerkhove
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         14
        </volume>
        <year>
         2014
        </year>
        <fpage>
         50
        </fpage>
        <lpage>
         56
        </lpage>
        <pub-id pub-id-type="pmid">
         24239323
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib51">
       <label>
        51
       </label>
       <element-citation id="sref51" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Infection prevention and control during health care for probable or confirmed cases of novel coronavirus (nCoV) infection; interim guidance
        </chapter-title>
        <year>
         2013
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0030" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/IPCnCoVguidance_06May13.pdf">
         http://www.who.int/csr/disease/coronavirus_infections/IPCnCoVguidance_06May13.pdf
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib52">
       <label>
        52
       </label>
       <element-citation id="sref52" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ministry of Health, Saudi Arabia
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Infection prevention/control and management guidelines for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection
        </chapter-title>
        <edition>
         2nd ed.
        </edition>
        <year>
         2014
        </year>
        <publisher-name>
         Ministry of Health, Saudi Arabia
        </publisher-name>
        <publisher-loc>
         Riyadh
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0035" xlink:href="http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/Documents/GuidelinesforCoronaPatients.pdf">
         http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/Documents/GuidelinesforCoronaPatients.pdf
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib53">
       <label>
        53
       </label>
       <element-citation id="sref53" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Madani
          </surname>
          <given-names>
           T.A.
          </given-names>
         </name>
         <name>
          <surname>
           Althaqafi
          </surname>
          <given-names>
           A.O.
          </given-names>
         </name>
         <name>
          <surname>
           Alraddadi
          </surname>
          <given-names>
           B.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Infection prevention and control guidelines for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection
        </article-title>
        <source>
         Saudi Med J
        </source>
        <volume>
         35
        </volume>
        <year>
         2014
        </year>
        <fpage>
         897
        </fpage>
        <lpage>
         913
        </lpage>
        <pub-id pub-id-type="pmid">
         25129197
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib54">
       <label>
        54
       </label>
       <element-citation id="sref54" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Case definition for case finding severe respiratory disease associated with novel coronavirus. Interim case definition as of 25 September 2012
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0040" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition_25_09_2012/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition_25_09_2012/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib55">
       <label>
        55
       </label>
       <element-citation id="sref55" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Revised interim case definition – novel coronavirus. Interim case definition as of 16 January 2013
        </chapter-title>
        <year>
         2013
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0045" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition_16_01_2013/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition_16_01_2013/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib56">
       <label>
        56
       </label>
       <element-citation id="sref56" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Revised interim case definition for reporting to WHO – Middle East respiratory syndrome coronavirus (MERS-CoV). Interim case definition as of 19 February 2013
        </chapter-title>
        <year>
         2013
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0050" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition_19_02_2013/en/">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition_19_02_2013/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib57">
       <label>
        57
       </label>
       <element-citation id="sref57" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Revised interim case definition for reporting to WHO – Middle East respiratory syndrome coronavirus (MERS-CoV). Interim case definition as of 3 July 2013
        </chapter-title>
        <year>
         2013
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0055" xlink:href="http://www.who.int/csr/don/03-july-2015-mers-saudi-arabia/en/">
         http://www.who.int/csr/don/03-july-2015-mers-saudi-arabia/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib58">
       <label>
        58
       </label>
       <element-citation id="sref58" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Al-Gethamy
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Hussain
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         60
        </volume>
        <year>
         2015
        </year>
        <fpage>
         973
        </fpage>
        <lpage>
         974
        </lpage>
        <pub-id pub-id-type="pmid">
         25516193
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib59">
       <label>
        59
       </label>
       <element-citation id="sref59" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shalhoub
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           AlZahrani
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Simhairi
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Mushtaq
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Successful recovery of MERS-CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report
        </article-title>
        <source>
         J Clin Virol
        </source>
        <volume>
         62
        </volume>
        <year>
         2015
        </year>
        <fpage>
         69
        </fpage>
        <lpage>
         71
        </lpage>
        <pub-id pub-id-type="pmid">
         25542475
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib60">
       <label>
        60
       </label>
       <element-citation id="sref60" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Madani
          </surname>
          <given-names>
           T.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Case definition and management of patients with MERS coronavirus in Saudi Arabia
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         14
        </volume>
        <year>
         2014
        </year>
        <fpage>
         911
        </fpage>
        <lpage>
         913
        </lpage>
        <pub-id pub-id-type="pmid">
         25253396
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib61">
       <label>
        61
       </label>
       <element-citation id="sref61" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Investigation of cases of human infection with Middle East respiratory syndrome coronavirus (MERS-CoV); interim guidance updated 3 July 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0060" xlink:href="http://apps.who.int/iris/bitstream/10665/178252/1/WHO_MERS_SUR_15.2_eng.pdf?ua=1">
         http://apps.who.int/iris/bitstream/10665/178252/1/WHO_MERS_SUR_15.2_eng.pdf?ua=1
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib62">
       <label>
        62
       </label>
       <element-citation id="sref62" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drexler
          </surname>
          <given-names>
           J.F.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
        </article-title>
        <source>
         Antiviral Res
        </source>
        <volume>
         101
        </volume>
        <year>
         2014
        </year>
        <fpage>
         45
        </fpage>
        <lpage>
         56
        </lpage>
        <pub-id pub-id-type="pmid">
         24184128
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib63">
       <label>
        63
       </label>
       <element-citation id="sref63" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lelli
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Papetti
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sabelli
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Rosti
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Moreno
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Boniotti
          </surname>
          <given-names>
           M.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of coronaviruses in bats of various species in Italy
        </article-title>
        <source>
         Viruses
        </source>
        <volume>
         5
        </volume>
        <year>
         2013
        </year>
        <fpage>
         2679
        </fpage>
        <lpage>
         2689
        </lpage>
        <pub-id pub-id-type="pmid">
         24184965
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib64">
       <label>
        64
       </label>
       <element-citation id="sref64" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Olival
          </surname>
          <given-names>
           K.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in bats, Saudi Arabia
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         19
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1819
        </fpage>
        <lpage>
         1823
        </lpage>
        <pub-id pub-id-type="pmid">
         24206838
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib65">
       <label>
        65
       </label>
       <element-citation id="sref65" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ithete
          </surname>
          <given-names>
           N.L.
          </given-names>
         </name>
         <name>
          <surname>
           Stoffberg
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         19
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1697
        </fpage>
        <lpage>
         1699
        </lpage>
        <pub-id pub-id-type="pmid">
         24050621
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib66">
       <label>
        66
       </label>
       <element-citation id="sref66" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Ithete
          </surname>
          <given-names>
           N.L.
          </given-names>
         </name>
         <name>
          <surname>
           Richards
          </surname>
          <given-names>
           L.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Rooting the phylogenetic tree of MERS-Coronavirus by characterization of a conspecific virus from an African Bat
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         88
        </volume>
        <year>
         2014
        </year>
        <fpage>
         11297
        </fpage>
        <lpage>
         11303
        </lpage>
        <pub-id pub-id-type="pmid">
         25031349
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib67">
       <label>
        67
       </label>
       <element-citation id="sref67" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           B.L.
          </given-names>
         </name>
         <name>
          <surname>
           Muller
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         13
        </volume>
        <year>
         2013
        </year>
        <fpage>
         859
        </fpage>
        <lpage>
         866
        </lpage>
        <pub-id pub-id-type="pmid">
         23933067
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib68">
       <label>
        68
       </label>
       <element-citation id="sref68" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <fpage>
         20659
        </fpage>
        <pub-id pub-id-type="pmid">
         24342517
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib69">
       <label>
        69
       </label>
       <element-citation id="sref69" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Ababneh
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           V.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <fpage>
         20662
        </fpage>
        <pub-id pub-id-type="pmid">
         24342516
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib70">
       <label>
        70
       </label>
       <element-citation id="sref70" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Messadi
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Feyisa
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Geographic distribution of MERS coronavirus among dromedary camels, Africa
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1370
        </fpage>
        <lpage>
         1374
        </lpage>
        <pub-id pub-id-type="pmid">
         25062254
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib71">
       <label>
        71
       </label>
       <element-citation id="sref71" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alexandersen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Kobinger
          </surname>
          <given-names>
           G.P.
          </given-names>
         </name>
         <name>
          <surname>
           Soule
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005
        </article-title>
        <source>
         Transbound Emerg Dis
        </source>
        <volume>
         61
        </volume>
        <year>
         2014
        </year>
        <fpage>
         105
        </fpage>
        <lpage>
         108
        </lpage>
        <pub-id pub-id-type="pmid">
         24456414
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib72">
       <label>
        72
       </label>
       <element-citation id="sref72" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nowotny
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Kolodziejek
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         19
        </volume>
        <year>
         2014
        </year>
        <fpage>
         20781
        </fpage>
        <pub-id pub-id-type="pmid">
         24786259
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib73">
       <label>
        73
       </label>
       <element-citation id="sref73" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Jores
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1319
        </fpage>
        <lpage>
         1322
        </lpage>
        <pub-id pub-id-type="pmid">
         25075637
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib74">
       <label>
        74
       </label>
       <element-citation id="sref74" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alagaili
          </surname>
          <given-names>
           A.N.
          </given-names>
         </name>
         <name>
          <surname>
           Briese
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Mishra
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia
        </article-title>
        <source>
         mBio
        </source>
        <volume>
         5
        </volume>
        <year>
         2014
        </year>
        <fpage>
         e00884
        </fpage>
        <lpage>
         00814
        </lpage>
        <pub-id pub-id-type="pmid">
         24570370
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib75">
       <label>
        75
       </label>
       <element-citation id="sref75" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Al Jassim
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         19
        </volume>
        <year>
         2014
        </year>
        <fpage>
         20828
        </fpage>
        <pub-id pub-id-type="pmid">
         24957744
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib76">
       <label>
        76
       </label>
       <element-citation id="sref76" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           D.K.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS coronavirus in dromedary camel herd, Saudi Arabia
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1231
        </fpage>
        <lpage>
         1234
        </lpage>
        <pub-id pub-id-type="pmid">
         24964193
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib77">
       <label>
        77
       </label>
       <element-citation id="sref77" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           D.K.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Gomaa
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS coronaviruses in dromedary camels, Egypt
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1049
        </fpage>
        <lpage>
         1053
        </lpage>
        <pub-id pub-id-type="pmid">
         24856660
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib78">
       <label>
        78
       </label>
       <element-citation id="sref78" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raj
          </surname>
          <given-names>
           V.S.
          </given-names>
         </name>
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           E.A.
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1339
        </fpage>
        <lpage>
         1342
        </lpage>
        <pub-id pub-id-type="pmid">
         25075761
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib79">
       <label>
        79
       </label>
       <element-citation id="sref79" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khalafalla
          </surname>
          <given-names>
           A.I.
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Mubarak
          </surname>
          <given-names>
           A.I.
          </given-names>
         </name>
         <name>
          <surname>
           Dalab
          </surname>
          <given-names>
           A.H.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Busadah
          </surname>
          <given-names>
           K.A.
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         MERS-CoV in upper respiratory tract and lungs of dromedary camels, Saudi Arabia, 2013–2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         21
        </volume>
        <year>
         2015
        </year>
        <fpage>
         1153
        </fpage>
        <lpage>
         1158
        </lpage>
        <pub-id pub-id-type="pmid">
         26079346
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib80">
       <label>
        80
       </label>
       <element-citation id="sref80" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           B.L.
          </given-names>
         </name>
         <name>
          <surname>
           Al Dhahiry
          </surname>
          <given-names>
           S.H.
          </given-names>
         </name>
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         14
        </volume>
        <year>
         2014
        </year>
        <fpage>
         140
        </fpage>
        <lpage>
         145
        </lpage>
        <pub-id pub-id-type="pmid">
         24355866
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib81">
       <label>
        81
       </label>
       <element-citation id="sref81" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Cotten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1012
        </fpage>
        <lpage>
         1015
        </lpage>
        <pub-id pub-id-type="pmid">
         24857749
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib82">
       <label>
        82
       </label>
       <element-citation id="sref82" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wernery
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           E.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acute Middle East respiratory syndrome coronavirus infection in livestock dromedaries, Dubai, 2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         21
        </volume>
        <year>
         2015
        </year>
        <fpage>
         1019
        </fpage>
        <lpage>
         1022
        </lpage>
        <pub-id pub-id-type="pmid">
         25989145
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib83">
       <label>
        83
       </label>
       <element-citation id="sref83" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Kayali
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study
        </article-title>
        <source>
         Lancet Resp Med
        </source>
        <volume>
         2
        </volume>
        <year>
         2014
        </year>
        <fpage>
         813
        </fpage>
        <lpage>
         822
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib84">
       <label>
        84
       </label>
       <element-citation id="sref84" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Adney
          </surname>
          <given-names>
           D.R.
          </given-names>
         </name>
         <name>
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           V.R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1999
        </fpage>
        <lpage>
         2005
        </lpage>
        <pub-id pub-id-type="pmid">
         25418529
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib85">
       <label>
        85
       </label>
       <element-citation id="sref85" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Madani
          </surname>
          <given-names>
           T.A.
          </given-names>
         </name>
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           E.I.
          </given-names>
         </name>
         <name>
          <surname>
           Hashem
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence for camel-to-human transmission of MERS coronavirus
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         371
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1360
        </fpage>
        <pub-id pub-id-type="pmid">
         25271614
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib86">
       <label>
        86
       </label>
       <element-citation id="sref86" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Reusken
          </surname>
          <given-names>
           C.B.
          </given-names>
         </name>
         <name>
          <surname>
           Farag
          </surname>
          <given-names>
           E.A.
          </given-names>
         </name>
         <name>
          <surname>
           Haagmans
          </surname>
          <given-names>
           B.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013–2014
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         21
        </volume>
        <year>
         2015
        </year>
        <fpage>
         1422
        </fpage>
        <lpage>
         1425
        </lpage>
        <pub-id pub-id-type="pmid">
         26196891
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib87">
       <label>
        87
       </label>
       <element-citation id="sref87" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemida
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Naeem
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Perera
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Chin
          </surname>
          <given-names>
           A.W.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of Middle East respiratory syndrome coronavirus transmission from infected camels
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         21
        </volume>
        <year>
         2015
        </year>
        <fpage>
         699
        </fpage>
        <lpage>
         701
        </lpage>
        <pub-id pub-id-type="pmid">
         25811546
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib88">
       <label>
        88
       </label>
       <element-citation id="sref88" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aburizaiza
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
         <name>
          <surname>
           Mattes
          </surname>
          <given-names>
           F.M.
          </given-names>
         </name>
         <name>
          <surname>
           Azhar
          </surname>
          <given-names>
           E.I.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Investigation of anti-Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         209
        </volume>
        <year>
         2014
        </year>
        <fpage>
         243
        </fpage>
        <lpage>
         246
        </lpage>
        <pub-id pub-id-type="pmid">
         24218504
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib89">
       <label>
        89
       </label>
       <element-citation id="sref89" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Alsahly
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Masri
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012
        </article-title>
        <source>
         Influenza Other Respir Viruses
        </source>
        <volume>
         9
        </volume>
        <year>
         2015
        </year>
        <fpage>
         64
        </fpage>
        <lpage>
         67
        </lpage>
        <pub-id pub-id-type="pmid">
         25470665
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib90">
       <label>
        90
       </label>
       <element-citation id="sref90" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) – Thailand. Disease Outbreak News 20 June 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0065" xlink:href="http://www.who.int/csr/don/20-june-2015-mers-thailand/en/">
         http://www.who.int/csr/don/20-june-2015-mers-thailand/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib91">
       <label>
        91
       </label>
       <element-citation id="sref91" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) – Austria
        </chapter-title>
        <year>
         2014
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0070" xlink:href="http://www.who.int/csr/don/02-october-2014-mers-austria/en/">
         http://www.who.int/csr/don/02-october-2014-mers-austria/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib92">
       <label>
        92
       </label>
       <element-citation id="sref92" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kapoor
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Pringle
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Kumar
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         59
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1511
        </fpage>
        <lpage>
         1518
        </lpage>
        <pub-id pub-id-type="pmid">
         25100864
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib93">
       <label>
        93
       </label>
       <element-citation id="sref93" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) – The Philippines
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0075" xlink:href="http://www.who.int/csr/don/13-february-2015-mers/en/">
         http://www.who.int/csr/don/13-february-2015-mers/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib94">
       <label>
        94
       </label>
       <element-citation id="sref94" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Puzelli
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Azzi
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Santini
          </surname>
          <given-names>
           M.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <issue>
         34
        </issue>
        <year>
         2013
        </year>
       </element-citation>
      </ref>
      <ref id="bib95">
       <label>
        95
       </label>
       <element-citation id="sref95" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abroug
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Slim
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Ouanes-Besbes
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1527
        </fpage>
        <lpage>
         1530
        </lpage>
        <pub-id pub-id-type="pmid">
         25148113
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib96">
       <label>
        96
       </label>
       <element-citation id="sref96" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Premila Devi
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Noraini
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Norhayati
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         19
        </volume>
        <year>
         2014
        </year>
        <fpage>
         20797
        </fpage>
        <pub-id pub-id-type="pmid">
         24832116
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib97">
       <label>
        97
       </label>
       <element-citation id="sref97" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Health Protection Agency UK Novel Coronavirus Investigation Team
          </surname>
         </name>
        </person-group>
        <article-title>
         Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         18
        </volume>
        <year>
         2013
        </year>
        <fpage>
         20427
        </fpage>
        <pub-id pub-id-type="pmid">
         23517868
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib98">
       <label>
        98
       </label>
       <element-citation id="sref98" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gardner
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Rey
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Heywood
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj
        </article-title>
        <source>
         Risk Anal
        </source>
        <volume>
         34
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1391
        </fpage>
        <lpage>
         1400
        </lpage>
        <pub-id pub-id-type="pmid">
         25041625
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib99">
       <label>
        99
       </label>
       <element-citation id="sref99" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome (MERS) coronavirus. What travel health advice should be given to Hajj pilgrims?
        </article-title>
        <source>
         Travel Med Infect Dis
        </source>
        <volume>
         11
        </volume>
        <year>
         2013
        </year>
        <fpage>
         263
        </fpage>
        <lpage>
         265
        </lpage>
        <pub-id pub-id-type="pmid">
         24055442
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib100">
       <label>
        100
       </label>
       <element-citation id="sref100" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Benkouiten
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Salaheddine
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Parola
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Brouqui
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Preventive measures against MERS-CoV for Hajj pilgrims
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         13
        </volume>
        <year>
         2013
        </year>
        <fpage>
         829
        </fpage>
        <lpage>
         831
        </lpage>
        <pub-id pub-id-type="pmid">
         24070554
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib101">
       <label>
        101
       </label>
       <element-citation id="sref101" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Mwaba
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Bates
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Maeurer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The Hajj pilgrimage and surveillance for Middle East respiratory syndrome coronavirus in pilgrims from African countries
        </article-title>
        <source>
         Trop Med Int Health
        </source>
        <volume>
         19
        </volume>
        <year>
         2014
        </year>
        <fpage>
         838
        </fpage>
        <lpage>
         840
        </lpage>
        <pub-id pub-id-type="pmid">
         24750482
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib102">
       <label>
        102
       </label>
       <element-citation id="sref102" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Sears
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Hu
          </surname>
          <given-names>
           V.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Potential for the international spread of Middle East respiratory syndrome in association with mass gatherings in Saudi Arabia
        </article-title>
        <source>
         PLoS Curr
        </source>
        <volume>
         5
        </volume>
        <year>
         2013
        </year>
       </element-citation>
      </ref>
      <ref id="bib103">
       <label>
        103
       </label>
       <element-citation id="sref103" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Belhouchat
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms
        </article-title>
        <source>
         Clin Microbiol Infect
        </source>
        <volume>
         19
        </volume>
        <year>
         2013
        </year>
        <fpage>
         e315
        </fpage>
        <lpage>
         317
        </lpage>
        <pub-id pub-id-type="pmid">
         23452263
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib104">
       <label>
        104
       </label>
       <element-citation id="sref104" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Benkouiten
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         726
        </fpage>
        <lpage>
         728
        </lpage>
        <pub-id pub-id-type="pmid">
         24655815
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib105">
       <label>
        105
       </label>
       <element-citation id="sref105" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memish
          </surname>
          <given-names>
           Z.A.
          </given-names>
         </name>
         <name>
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Almasri
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         210
        </volume>
        <year>
         2014
        </year>
        <fpage>
         1067
        </fpage>
        <lpage>
         1072
        </lpage>
        <pub-id pub-id-type="pmid">
         24620019
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib106">
       <label>
        106
       </label>
       <element-citation id="sref106" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Raoult
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Gautret
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Parola
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         From the Hajj: it's the flu, idiot
        </article-title>
        <source>
         Clin Microbiol Infect
        </source>
        <volume>
         20
        </volume>
        <year>
         2014
        </year>
        <fpage>
         O1
        </fpage>
        <pub-id pub-id-type="pmid">
         24256052
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib107">
       <label>
        107
       </label>
       <element-citation id="sref107" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Annan
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Owusu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Marfo
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013
        </article-title>
        <source>
         Trop Med Int Health
        </source>
        <volume>
         20
        </volume>
        <year>
         2015
        </year>
        <fpage>
         807
        </fpage>
        <lpage>
         812
        </lpage>
        <pub-id pub-id-type="pmid">
         25688471
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib108">
       <label>
        108
       </label>
       <element-citation id="sref108" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Benkouiten
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Charrel
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Belhouchat
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         57
        </volume>
        <year>
         2013
        </year>
        <fpage>
         992
        </fpage>
        <lpage>
         1000
        </lpage>
        <pub-id pub-id-type="pmid">
         23839997
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib109">
       <label>
        109
       </label>
       <element-citation id="sref109" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           ProMED-mail
          </surname>
         </name>
        </person-group>
        <chapter-title>
         MERS-CoV (100): Saudi Arabia, South Korea. Archive Number: 20150804.3558326. 04-08-2015 21:27:59
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         International Society for Infectious Diseases
        </publisher-name>
        <publisher-loc>
         Washington DC
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0080" xlink:href="http://www.promedmail.org/direct.php?id=3558326">
         http://www.promedmail.org/direct.php?id=3558326
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib110">
       <label>
        110
       </label>
       <element-citation id="sref110" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cowling
          </surname>
          <given-names>
           B.J.
          </given-names>
         </name>
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Fang
          </surname>
          <given-names>
           V.J.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           J.T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         20
        </volume>
        <year>
         2015
        </year>
        <fpage>
         21163
        </fpage>
        <pub-id pub-id-type="pmid">
         26132767
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib111">
       <label>
        111
       </label>
       <element-citation id="sref111" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Farooqui
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Kelvin
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lessons to learn from MERS-CoV outbreak in South Korea
        </article-title>
        <source>
         J Infect Dev Ctries
        </source>
        <volume>
         9
        </volume>
        <year>
         2015
        </year>
        <fpage>
         543
        </fpage>
        <lpage>
         546
        </lpage>
        <pub-id pub-id-type="pmid">
         26142661
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib112">
       <label>
        112
       </label>
       <element-citation id="sref112" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           D.S.
          </given-names>
         </name>
         <name>
          <surname>
           Perlman
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Zumla
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Spread of MERS to South Korea and China
        </article-title>
        <source>
         Lancet Resp Med
        </source>
        <volume>
         3
        </volume>
        <year>
         2015
        </year>
        <fpage>
         509
        </fpage>
        <lpage>
         510
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib113">
       <label>
        113
       </label>
       <element-citation id="sref113" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ministry of Health and Welfare (MOHW) and Korean Centers for Disease Control and Prevention (KCDC)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         List of hospitals with known MERS exposure; 22 June 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         MOHW and KCDC
        </publisher-name>
        <publisher-loc>
         Seoul
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0085" xlink:href="http://cdc.go.kr/CDC/info/CdcKrHealth0298.jsp?menuIds=HOME001-MNU1132-MNU1013&amp;fid=5767&amp;q_type=&amp;q_value=&amp;cid=63640&amp;pageNum">
         http://cdc.go.kr/CDC/info/CdcKrHealth0298.jsp?menuIds=HOME001-MNU1132-MNU1013&amp;fid=5767&amp;q_type=&amp;q_value=&amp;cid=63640&amp;pageNum
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib114">
       <label>
        114
       </label>
       <element-citation id="sref114" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Preliminary data from sequencing of viruses in the Republic of Korea and the People's Republic of China. MERS-CoV situation assessment 9 June 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0090" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/mers-situation-assessment09-06.pdf?ua=1">
         http://www.who.int/csr/disease/coronavirus_infections/mers-situation-assessment09-06.pdf?ua=1
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib115">
       <label>
        115
       </label>
       <element-citation id="sref115" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Managing contacts in the MERS-CoV outbreak in the Republic of Korea; briefing notes on MERS-CoV 1 July 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0095" xlink:href="http://www.who.int/mediacentre/news/mers/briefing-notes/update-1-july-2015/en/">
         http://www.who.int/mediacentre/news/mers/briefing-notes/update-1-july-2015/en/
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib116">
       <label>
        116
       </label>
       <element-citation id="sref116" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV): Summary and risk assessment of current situation in the Republic of Korea and China – as of 19 June 2015
        </chapter-title>
        <year>
         2015
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" id="intref0100" xlink:href="http://www.who.int/emergencies/mers-cov/mers-cov-republic-of-korea-and-china-risk-assessment-19-june-2015.pdf?ua=1">
         http://www.who.int/emergencies/mers-cov/mers-cov-republic-of-korea-and-china-risk-assessment-19-june-2015.pdf?ua=1
        </ext-link>
        <comment>
         [last accessed August 2015]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib117">
       <label>
        117
       </label>
       <element-citation id="sref117" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Korean Society of Infectious Diseases
          </surname>
         </name>
        </person-group>
        <article-title>
         Korean Society for Healthcare-associated Infection Control and Prevention. An unexpected outbreak of Middle East Respiratory syndrome coronavirus infection in the Republic of Korea, 2015
        </article-title>
        <source>
         Infect Chemother
        </source>
        <volume>
         47
        </volume>
        <year>
         2015
        </year>
        <fpage>
         120
        </fpage>
        <lpage>
         122
        </lpage>
        <pub-id pub-id-type="pmid">
         26157591
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib118">
       <label>
        118
       </label>
       <element-citation id="sref118" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           George
          </surname>
          <given-names>
           D.R.
          </given-names>
         </name>
         <name>
          <surname>
           Rovniak
          </surname>
          <given-names>
           L.S.
          </given-names>
         </name>
         <name>
          <surname>
           Kraschnewski
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Dangers and opportunities for social media in medicine
        </article-title>
        <source>
         Clin Obstet Gynecol
        </source>
        <volume>
         56
        </volume>
        <year>
         2013
        </year>
        <fpage>
         453
        </fpage>
        <lpage>
         462
        </lpage>
        <pub-id pub-id-type="pmid">
         23903375
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib119">
       <label>
        119
       </label>
       <element-citation id="sref119" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ventola
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Social media and health care professionals: benefits, risks, and best practices
        </article-title>
        <source>
         Pharm Therapeut (P T)
        </source>
        <volume>
         39
        </volume>
        <year>
         2014
        </year>
        <fpage>
         491
        </fpage>
        <lpage>
         520
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib120">
       <label>
        120
       </label>
       <element-citation id="sref120" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chretien
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Kind
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Social media and clinical care: ethical, professional, and social implications
        </article-title>
        <source>
         Circulation
        </source>
        <volume>
         127
        </volume>
        <year>
         2013
        </year>
        <fpage>
         1413
        </fpage>
        <lpage>
         1421
        </lpage>
        <pub-id pub-id-type="pmid">
         23547180
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib121">
       <label>
        121
       </label>
       <element-citation id="sref121" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mackay
          </surname>
          <given-names>
           I.M.
          </given-names>
         </name>
         <name>
          <surname>
           Arden
          </surname>
          <given-names>
           K.E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Middle East respiratory syndrome: an emerging coronavirus infection tracked by the crowd
        </article-title>
        <source>
         Virus Res
        </source>
        <volume>
         202
        </volume>
        <year>
         2015
        </year>
        <fpage>
         60
        </fpage>
        <lpage>
         88
        </lpage>
        <pub-id pub-id-type="pmid">
         25656066
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Sci Rep
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Sci Rep
      </journal-id>
      <journal-title-group>
       <journal-title>
        Scientific Reports
       </journal-title>
      </journal-title-group>
      <issn pub-type="epub">
       2045-2322
      </issn>
      <publisher>
       <publisher-name>
        Nature Publishing Group UK
       </publisher-name>
       <publisher-loc>
        London
       </publisher-loc>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       26607834
      </article-id>
      <article-id pub-id-type="pmc">
       4660426
      </article-id>
      <article-id pub-id-type="publisher-id">
       BFsrep17155
      </article-id>
      <article-id pub-id-type="doi">
       10.1038/srep17155
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Tang
         </surname>
         <given-names>
          Qin
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Song
         </surname>
         <given-names>
          Yulong
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Shi
         </surname>
         <given-names>
          Mijuan
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Cheng
         </surname>
         <given-names>
          Yingyin
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Zhang
         </surname>
         <given-names>
          Wanting
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Xia
         </surname>
         <given-names>
          Xiao-Qin
         </given-names>
        </name>
        <address>
         <email>
          xqxia@ihb.ac.cn
         </email>
        </address>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
       </contrib>
       <aff id="Aff1">
        <label>
         1
        </label>
        <institution-wrap>
         <institution-id institution-id-type="GRID">
          grid.429211.d
         </institution-id>
         <institution-id institution-id-type="ISNI">
          0000 0004 1792 6029
         </institution-id>
         <institution>
          Center for Molecular and Cellular Biology of Aquatic Organisms, Institute of Hydrobiology, the Chinese Academy of Sciences,
         </institution>
        </institution-wrap>
        Wuhan, 430072 China
       </aff>
       <aff id="Aff2">
        <label>
         2
        </label>
        <institution-wrap>
         <institution-id institution-id-type="GRID">
          grid.410726.6
         </institution-id>
         <institution-id institution-id-type="ISNI">
          0000 0004 1797 8419
         </institution-id>
         <institution>
          University of Chinese Academy of Sciences,
         </institution>
        </institution-wrap>
        Beijing, China
       </aff>
      </contrib-group>
      <pub-date pub-type="epub">
       <day>
        26
       </day>
       <month>
        11
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <pub-date pub-type="pmc-release">
       <day>
        26
       </day>
       <month>
        11
       </month>
       <year>
        2015
       </year>
      </pub-date>
      <pub-date pub-type="collection">
       <year>
        2015
       </year>
      </pub-date>
      <volume>
       5
      </volume>
      <elocation-id>
       17155
      </elocation-id>
      <history>
       <date date-type="received">
        <day>
         11
        </day>
        <month>
         1
        </month>
        <year>
         2015
        </year>
       </date>
       <date date-type="accepted">
        <day>
         26
        </day>
        <month>
         10
        </month>
        <year>
         2015
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © The Author(s) 2015
       </copyright-statement>
       <license license-type="OpenAccess">
        <license-p>
         This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit
         <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          http://creativecommons.org/licenses/by/4.0/
         </ext-link>
        </license-p>
       </license>
      </permissions>
      <abstract id="Abs1">
       <p>
        Many coronaviruses are capable of interspecies transmission. Some of them have caused worldwide panic as emerging human pathogens in recent years, e.g., severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). In order to assess their threat to humans, we explored to infer the potential hosts of coronaviruses using a dual-model approach based on nineteen parameters computed from spike genes of coronaviruses. Both the support vector machine (SVM) model and the Mahalanobis distance (MD) discriminant model achieved high accuracies in leave-one-out cross-validation of training data consisting of 730 representative coronaviruses (99.86% and 98.08% respectively). Predictions on 47 additional coronaviruses precisely conformed to conclusions or speculations by other researchers. Our approach is implemented as a web server that can be accessed at
        <ext-link ext-link-type="uri" xlink:href="http://bioinfo.ihb.ac.cn/seq2hosts">
         http://bioinfo.ihb.ac.cn/seq2hosts
        </ext-link>
        .
       </p>
       <sec>
        <title>
         Electronic supplementary material
        </title>
        <p>
         The online version of this article (doi:10.1038/srep17155) contains supplementary material, which is available to authorized users.
        </p>
       </sec>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
       <title>
        Subject terms
       </title>
       <kwd>
        Viral evolution
       </kwd>
       <kwd>
        Viral transmission
       </kwd>
      </kwd-group>
      <custom-meta-group>
       <custom-meta>
        <meta-name>
         issue-copyright-statement
        </meta-name>
        <meta-value>
         © The Author(s) 2015
        </meta-value>
       </custom-meta>
      </custom-meta-group>
     </article-meta>
    </front>
    <sec id="Sec1">
     <title>
      Introduction
     </title>
     <p>
      Emerging infectious diseases (EIDs) and their determinants have recently attracted substantial scientific and popular attention. Over 75% of EIDs consist of zoonosis
      <sup>
       <xref ref-type="bibr" rid="CR1">
        1
       </xref>
      </sup>
      . Among these pathogens are a group of viruses that belong to
      <italic>
       Coronaviridae
      </italic>
      .
      <italic>
       Coronaviridae
      </italic>
      is a family of enveloped, positive-sense, single-stranded RNA viruses that are usually characterized by an enveloped, spherical particle with a diameter in the range of 120–160 nm and a crown-like appearance
      <sup>
       <xref ref-type="bibr" rid="CR2">
        2
       </xref>
      </sup>
      . Coronaviruses usually cause respiratory tract infections, pneumonia, gastroenteritis, epidemic diarrhoea, enteric infections, hepatitis, encephalomyelitis and kidney failure. Their hosts include humans, porcines, bovines, murines, avians and other animals. In the past 12 years, two emerging infectious diseases—severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)—attacked humans and animals worldwide and caused approximately 774 human deaths and 315 human deaths, respectively (
      <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/country/table2004_04_21/en/">
       http://www.who.int/csr/sars/country/table2004_04_21/en/
      </ext-link>
      ,
      <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/2014_07_23_mers/en/">
       http://www.who.int/csr/don/2014_07_23_mers/en/
      </ext-link>
      ). Especially MERS is still persistently bringing human infections and deaths in the outbreak in Korea recently (http://www.who.int/csr/don/19-june-2015-mers-korea/en/). These diseases, which are spread by respiratory means, caused significant panic around the world.
     </p>
     <p>
      Coronaviruses are currently classified into four major genera or groups: the alpha-coronavirus, the beta-coronavirus, the gamma-coronavirus and the delta-coronavirus
      <sup>
       <xref ref-type="bibr" rid="CR1">
        1
       </xref>
       ,
       <xref ref-type="bibr" rid="CR2">
        2
       </xref>
       ,
       <xref ref-type="bibr" rid="CR3">
        3
       </xref>
       ,
       <xref ref-type="bibr" rid="CR4">
        4
       </xref>
      </sup>
      . Alpha-coronavirus and beta-coronavirus usually infect mammalians, whereas gamma-coronavirus and delta-coronavirus usually infect birds
      <sup>
       <xref ref-type="bibr" rid="CR5">
        5
       </xref>
      </sup>
      . Among all proteins encoded by the coronavirus, the spike protein on the virion surface is the most critical protein, as it mediates both cell attachment and membrane fusion; a few nucleotide changes on the spike gene can cause interspecies transmission
      <sup>
       <xref ref-type="bibr" rid="CR6">
        6
       </xref>
      </sup>
      . The spike protein primarily consists of three segments, i.e., an ectodomain, a transmembrane anchor and a short intracellular tail. The ectodomain has two subunits for invading hosts: S1 is responsible for binding receptors and S2 is responsible for membrane fusion
      <sup>
       <xref ref-type="bibr" rid="CR7">
        7
       </xref>
      </sup>
      . A receptor-binding domain (RBD) near the C-terminal of S1 is primarily responsible for receptor recognition. Coronaviruses recognize a variety of molecules as receptors, including proteins, sugars and heparan sulfates on surfaces of host cells
      <sup>
       <xref ref-type="bibr" rid="CR8">
        8
       </xref>
      </sup>
      . As the spike gene mediates host recognition and invasion, its sequence must encode the information related to specific hosts; therefore, it is especially useful in identifying hosts of given coronaviruses.
     </p>
     <p>
      As the result of natural selection and evolution, different genomes are characterized with different preferences for nucleotides. According to probability principles, a shorter nucleotide fragment has a lower chance of variation due to evolution and the copies of this fragment in a genome tend not to change significantly. This phenomenon is helpful for evolutionary analysis. Dinucleotides are the most stable of these fragments because they are the shortest and their bias values are usually diverse among species and they are highly invariant for a given individual genome
      <sup>
       <xref ref-type="bibr" rid="CR9">
        9
       </xref>
      </sup>
      . Dinucleotide abundance has been proven to be reliable in the identification and classification of sequences from viral genomes
      <sup>
       <xref ref-type="bibr" rid="CR10">
        10
       </xref>
       ,
       <xref ref-type="bibr" rid="CR11">
        11
       </xref>
       ,
       <xref ref-type="bibr" rid="CR12">
        12
       </xref>
       ,
       <xref ref-type="bibr" rid="CR13">
        13
       </xref>
       ,
       <xref ref-type="bibr" rid="CR14">
        14
       </xref>
       ,
       <xref ref-type="bibr" rid="CR15">
        15
       </xref>
       ,
       <xref ref-type="bibr" rid="CR16">
        16
       </xref>
       ,
       <xref ref-type="bibr" rid="CR17">
        17
       </xref>
      </sup>
      .
     </p>
     <p>
      Support vector machines (SVMs) are a group of supervised machine learning methods that were originally introduced by Vapnik as a linear classifier
      <sup>
       <xref ref-type="bibr" rid="CR18">
        18
       </xref>
      </sup>
      . Their current standard incarnation (soft margin) comprises associated learning algorithms for classification and regression analysis
      <sup>
       <xref ref-type="bibr" rid="CR19">
        19
       </xref>
      </sup>
      . The basic principle of class separation for a SVM is mapping vectors into a high-dimensional feature space and finding an optimal separating hyperplane between the two classes in this space by maximizing the margin between the classes’ closest points. The points on the boundaries are referred to as support vectors and the middle of the margin is the optimal separating hyperplane, which forms the largest gap between two sets of data
      <sup>
       <xref ref-type="bibr" rid="CR20">
        20
       </xref>
      </sup>
      . Based on this gap, the points of different attributes fall into different classes. Several types of algorithms exist for a SVM to address classification problems for multiple classes and high-dimension data. SVMs perform well in multiple areas of biological analysis, including the evaluation of microarray expression data, the detection of remote protein homologies and the recognition of translation initiation sites
      <sup>
       <xref ref-type="bibr" rid="CR21">
        21
       </xref>
      </sup>
      . Instances in which the established classification is questionable or wrong can be identified if an SVM is used for prediction of training samples.
     </p>
     <p>
      Mahalanobis distance (MD) discrimination is a classical and accurate method that is extensively applied in cluster analysis and classification techniques
      <sup>
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
      </sup>
      . MD measures the distance between a point and a population and considers the variance of the population distribution; the points are sorted to the closest population in distance. Another method—Fisher’s linear discriminant analysis—has been applied to infer hosts for three novel Picorna-like viruses
      <sup>
       <xref ref-type="bibr" rid="CR23">
        23
       </xref>
      </sup>
      . As it requires data that have a normal distribution, which is not the case for our data, MD is adopted in this study.
     </p>
     <p>
      Previous studies of coronaviruses were primarily focused on the evolution of genomes or specific genes, serum-neutralization assays for identification of receptors and crystal structure analysis of spike protein and receptor binding domains. In this study, we analysed the compositions of mononucleotides and dinucleotides in coronavirus spike genes. Based on the data matrix of nucleotide composition, the MD and SVM were applied to predict hosts of coronaviruses. The results of this technique may provide hints regarding natural hosts or potential hosts of the virus and can be used to guide the selection of the cells for virus isolation or to explore the probability of interspecies transmission of coronaviruses.
     </p>
    </sec>
    <sec id="Sec2">
     <title>
      Results
     </title>
     <sec id="Sec3">
      <title>
       Nucleotide composition analysis
      </title>
      <p>
       Nineteen parameters, including three mononucleotide frequencies (G, C and T) and 16 dinucleotide biases, were computed from 777 spike gene sequences (see
       <xref ref-type="media" rid="MOESM1">
        Supplementary Table S1
       </xref>
       ). All parameters show significant differences across the host groups (Kruskal-Wallis tests,
       <italic>
        p
       </italic>
       &lt; 2.2e–16); therefore, they were subsequently employed as factors in statistical models for discriminant analyses. Empirically, a dinucleotide relative abundance or dinucleotide bias (e.g.,
       <inline-formula id="IEq1">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq1_HTML.gif">
        </inline-graphic>
       </inline-formula>
       ) is significantly high if
       <inline-formula id="IEq2">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq2_HTML.gif">
        </inline-graphic>
       </inline-formula>
       or extremely low if
       <inline-formula id="IEq3">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq3_HTML.gif">
        </inline-graphic>
       </inline-formula>
       <sup>
        <xref ref-type="bibr" rid="CR24">
         24
        </xref>
       </sup>
       . Among the 16 dinucleotides in this study, the CpA and TpG show an average abundance that is significantly higher than the expected values (
       <inline-formula id="IEq4">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq4_HTML.gif">
        </inline-graphic>
       </inline-formula>
       = 1.29,
       <inline-formula id="IEq5">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq5_HTML.gif">
        </inline-graphic>
       </inline-formula>
       = 1.28), whereas the average bias of CpG is extremely low (
       <inline-formula id="IEq6">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq6_HTML.gif">
        </inline-graphic>
       </inline-formula>
       = 0.44). This result indicates that the observed abundances of CpA and TpG are significantly higher than their expected values, and the observed abundance of CpG is significantly lower than the expected value. The G+C content is minimal (31–47%). This finding indicates that coronaviruses exhibit a low density of nucleotide sequences and may be sensitive to heat or alkali. The low G+C content also indicates a preference for codons ending with A or T and a higher mutability.
      </p>
     </sec>
     <sec id="Sec4">
      <title>
       Training and validation of statistical models
      </title>
      <p>
       The data matrix with 19 factors as columns and 730 samples as rows was fitted to SVM and MD models, all predictions in leave-one-out cross-validations were listed in
       <xref ref-type="media" rid="MOESM2">
        Supplementary Table S2
       </xref>
       and summarized in
       <xref ref-type="table" rid="Tab1">
        Table 1
       </xref>
       according to host species. The validations indicate that both models achieved high accuracies on the training data set: 99.86% for the SVM and 98.08% for the MD. All incorrect cases in unsupervised predictions are listed in
       <xref ref-type="table" rid="Tab2">
        Table 2
       </xref>
       . The only incorrect prediction by the SVM is sample NC_016996.1, which is isolated from an avian species but was predicted to infect humans. Among all 14 incorrect predictions by MD, bats are the common predicted hosts. No sample was incorrectly predicted by both models.
       <table-wrap id="Tab1">
        <label>
         Table 1
        </label>
        <caption>
         <p>
          Summary of the hosts predicted for the 730 samples by MD in leave-one-out cross-validation.
         </p>
        </caption>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th>
            Host species
           </th>
           <th align="center">
            Viruses isolated (A)
           </th>
           <th align="center">
            Other viruses (B = 730 − A)
           </th>
           <th align="center">
            Total predictions (C)
           </th>
           <th align="center">
            Infectivity probability (P = C/730)
           </th>
           <th align="center">
            Predictions in others (D = C – A)
           </th>
           <th align="center">
            Percentage in others (E = D/B × 100%)
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td>
            avian
           </td>
           <td>
            173
           </td>
           <td>
            557
           </td>
           <td>
            377
           </td>
           <td>
            0.5164
           </td>
           <td>
            204
           </td>
           <td>
            36.62%
           </td>
          </tr>
          <tr>
           <td>
            bat
           </td>
           <td>
            74
           </td>
           <td>
            656
           </td>
           <td>
            494
           </td>
           <td>
            0.6767
           </td>
           <td>
            420
           </td>
           <td>
            64.02%
           </td>
          </tr>
          <tr>
           <td>
            bovine
           </td>
           <td>
            77
           </td>
           <td>
            653
           </td>
           <td>
            77
           </td>
           <td>
            0.1055
           </td>
           <td>
            0
           </td>
           <td>
            0
           </td>
          </tr>
          <tr>
           <td>
            human
           </td>
           <td>
            196
           </td>
           <td>
            534
           </td>
           <td>
            202
           </td>
           <td>
            0.2767
           </td>
           <td>
            6
           </td>
           <td>
            1.12%
           </td>
          </tr>
          <tr>
           <td>
            murine
           </td>
           <td>
            28
           </td>
           <td>
            702
           </td>
           <td>
            28
           </td>
           <td>
            0.0384
           </td>
           <td>
            0
           </td>
           <td>
            0
           </td>
          </tr>
          <tr>
           <td>
            porcine
           </td>
           <td>
            182
           </td>
           <td>
            548
           </td>
           <td>
            185
           </td>
           <td>
            0.2534
           </td>
           <td>
            3
           </td>
           <td>
            0.55%
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
       <table-wrap id="Tab2">
        <label>
         Table 2
        </label>
        <caption>
         <p>
          The incorrect predictions of MD and SVM in leave-one-out cross-validation.
         </p>
        </caption>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th>
            NCBI Access No.
           </th>
           <th align="center">
            Virus sources
           </th>
           <th align="center">
            Wrong predictions by MD
           </th>
           <th align="center">
            Wrong predictions by SVM
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td align="center">
            AB008940.1; AB551247.1; AF190406.1;AF201929.1; AF208066.1; FJ647223.1;FJ647224.1;FJ938068.1;JF792616.1
           </td>
           <td>
            murine
           </td>
           <td>
            9 (bat)
           </td>
           <td>
           </td>
          </tr>
          <tr>
           <td align="center">
            NC_011549.1; NC_011550.1; NC_016993.1;NC_016994.1; NC_016995.1
           </td>
           <td>
            avian
           </td>
           <td>
            5 (bat)
           </td>
           <td>
           </td>
          </tr>
          <tr>
           <td align="center">
            NC_016996.1
           </td>
           <td>
            avian
           </td>
           <td>
           </td>
           <td>
            1 (human)
           </td>
          </tr>
          <tr>
           <td align="center">
            In total
           </td>
           <td>
           </td>
           <td>
            14
           </td>
           <td>
            1
           </td>
          </tr>
          <tr>
           <td align="center">
            Accuracy rate
           </td>
           <td>
           </td>
           <td>
            (730–14)/730 = 98.08%
           </td>
           <td>
            (730–1)/730 = 99.86%
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
      </p>
     </sec>
     <sec id="Sec5">
      <title>
       Predictions for viruses capable of interspecies transmission
      </title>
      <p>
       The trained models were applied to 47 additional samples and the predictions unveiled clues regarding potential interspecies transmission (See
       <xref ref-type="table" rid="Tab3">
        Table 3
       </xref>
       ). Sequences 1–31 comprise spike genes of coronaviruses that were primarily isolated from palm civets from restaurants, animal markets, or farms in southern China when SARS wreaked havoc in 2003. The sequences of these coronaviruses (civet-CoVs) are similar not only to each other but also to SARS-CoV. Cross-host evolution research of SARS-CoV in palm civet and humans indicated that the variations in spike genes seemed to be essential for the transition of coronavirus from animal-to-human transmission to human-to-human transmission
       <sup>
        <xref ref-type="bibr" rid="CR25">
         25
        </xref>
       </sup>
       . In addition to cross-neutralization with SARS-CoV, these SARS-like civet-CoVs can use human ACE2 as an entry receptor
       <sup>
        <xref ref-type="bibr" rid="CR26">
         26
        </xref>
       </sup>
       . Bats are the reservoir hosts of a number of coronaviruses and a recent study also suggests that bats are natural reservoirs of these SARS-like coronaviruses, whereas palm civets and humans are intermediate hosts
       <sup>
        <xref ref-type="bibr" rid="CR1">
         1
        </xref>
       </sup>
       . All hosts predicted by the SVM are humans, which supports the previously mentioned research. The MD identified both bats and humans as hosts of these samples, but bats are the preferable hosts for samples 1–26 and the second choice for samples 27–31. This finding is also expected as bats are considered to be natural hosts of these viruses.
       <table-wrap id="Tab3">
        <label>
         Table 3
        </label>
        <caption>
         <p>
          The isolate sources and predicted hosts of 47 coronaviruses.
         </p>
        </caption>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th>
            Serial number
           </th>
           <th align="center">
            Test sample AccNum
           </th>
           <th align="center">
            SVM prediction
           </th>
           <th align="center">
            MD prediction
           </th>
           <th align="center">
            Isolate source
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td>
            1
           </td>
           <td>
            AY572034.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            2
           </td>
           <td>
            AY572036.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            3
           </td>
           <td>
            AY572037.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            4
           </td>
           <td>
            AY687355.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            5
           </td>
           <td>
            AY687356.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            6
           </td>
           <td>
            AY687358.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            raccoon dog
           </td>
          </tr>
          <tr>
           <td>
            7
           </td>
           <td>
            AY687359.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            8
           </td>
           <td>
            AY687360.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            9
           </td>
           <td>
            AY687361.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            10
           </td>
           <td>
            AY687362.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            11
           </td>
           <td>
            AY687363.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            12
           </td>
           <td>
            AY687365.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            13
           </td>
           <td>
            AY687367.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            14
           </td>
           <td>
            AY687368.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            15
           </td>
           <td>
            AY687369.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            16
           </td>
           <td>
            AY687370.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            17
           </td>
           <td>
            AY687371.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            18
           </td>
           <td>
            AY687372.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            19
           </td>
           <td>
            AY627044.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            20
           </td>
           <td>
            AY627045.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            21
           </td>
           <td>
            AY627046.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            22
           </td>
           <td>
            AY627047.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            23
           </td>
           <td>
            AY627048.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            24
           </td>
           <td>
            AY613952.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            25
           </td>
           <td>
            AY613951.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            26
           </td>
           <td>
            AY525636.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , human
            <sup>
             *
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            27
           </td>
           <td>
            DQ514528.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            28
           </td>
           <td>
            DQ514529.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            29
           </td>
           <td>
            DQ514530.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            30
           </td>
           <td>
            DQ514531.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            31
           </td>
           <td>
            DQ514532.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            palm civet
           </td>
          </tr>
          <tr>
           <td>
            32
           </td>
           <td>
            KJ477102.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             *
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            33
           </td>
           <td>
            KJ650098.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            34
           </td>
           <td>
            KJ650295.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            35
           </td>
           <td>
            KJ713295.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            36
           </td>
           <td>
            KJ713296.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            37
           </td>
           <td>
            KJ713297.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            38
           </td>
           <td>
            KJ713298.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            39
           </td>
           <td>
            KJ713299.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            40
           </td>
           <td>
            KF917527.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             **
            </sup>
           </td>
           <td>
            dromedary
           </td>
          </tr>
          <tr>
           <td>
            41
           </td>
           <td>
            AY654624.1
           </td>
           <td>
            human
            <sup>
             *
            </sup>
            , bat, avian, porcine
           </td>
           <td>
            human
            <sup>
             **
            </sup>
            , bat
            <sup>
             *
            </sup>
            , avian, porcine
           </td>
           <td>
            porcine
           </td>
          </tr>
          <tr>
           <td>
            42
           </td>
           <td>
            KC881005.1
           </td>
           <td>
            bat
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
            , avian
            <sup>
             *
            </sup>
           </td>
           <td>
            bat
           </td>
          </tr>
          <tr>
           <td>
            43
           </td>
           <td>
            KC881006.1
           </td>
           <td>
            human, bat
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
           </td>
           <td>
            bat
           </td>
          </tr>
          <tr>
           <td>
            44
           </td>
           <td>
            KC881007.1
           </td>
           <td>
            human, bat
           </td>
           <td>
            bat
            <sup>
             **
            </sup>
           </td>
           <td>
            bat
           </td>
          </tr>
          <tr>
           <td>
            45
           </td>
           <td>
            DQ915164.2
           </td>
           <td>
            bovine
            <sup>
             *
            </sup>
           </td>
           <td>
            bovine
            <sup>
             **
            </sup>
            , avian
            <sup>
             *
            </sup>
            , bat
            <sup>
             *
            </sup>
           </td>
           <td>
            alpaca
           </td>
          </tr>
          <tr>
           <td>
            46
           </td>
           <td>
            FJ415324.1
           </td>
           <td>
            bovine
            <sup>
             *
            </sup>
            , human
           </td>
           <td>
            bovine
            <sup>
             **
            </sup>
            , avian
            <sup>
             *
            </sup>
            , bat, human
           </td>
           <td>
            human
           </td>
          </tr>
          <tr>
           <td>
            47
           </td>
           <td>
            FJ938067.1
           </td>
           <td>
            bovine
            <sup>
             *
            </sup>
            , human
           </td>
           <td>
            bovine
            <sup>
             **
            </sup>
            , avian
            <sup>
             *
            </sup>
            , bat, human
           </td>
           <td>
            human, bovine
           </td>
          </tr>
         </tbody>
        </table>
        <table-wrap-foot>
         <p>
          Predictions consist of hosts with minimal MD or
          <italic>
           p
          </italic>
          values, those with MD &lt;= 200 or
          <italic>
           p
          </italic>
          &lt;= 0.05 for SVM, and those with MD or
          <italic>
           p
          </italic>
          values no greater than corresponding values of isolate sources if the isolate sources are among the six categories of hosts. All predictions are listed in ascending of MD or
          <italic>
           p
          </italic>
          values.
          <sup>
           *
          </sup>
          <italic>
           p
          </italic>
          &lt;= 0.05 or MD &lt;= 200.
          <sup>
           **
          </sup>
          <italic>
           p
          </italic>
          &lt;= 0.01 or MD &lt;= 100.
         </p>
        </table-wrap-foot>
       </table-wrap>
      </p>
      <p>
       Sequences 32–40 comprise spike genes of MERS-CoVs from dromedaries after the outbreak in the Middle East in 2012. MERS-CoVs are similar to the bat coronaviruses HKU5 and HKU4 in their amino acid sequences
       <sup>
        <xref ref-type="bibr" rid="CR27">
         27
        </xref>
       </sup>
       , and they can use human DPP4 as an entry receptor
       <sup>
        <xref ref-type="bibr" rid="CR28">
         28
        </xref>
       </sup>
       . MERS-CoVs was assumed to originate from HKU5 in pipistrelle, which is a type of Japanese bat
       <sup>
        <xref ref-type="bibr" rid="CR3">
         3
        </xref>
       </sup>
       . In our study, these MERS-CoVs isolated from camels were predicted to be capable of infecting humans; and bats are also likely hosts next to humans in predictions by MD. This result is obviously consistent with above speculations and also supports the WHO advices about avoiding close contact with camels (
       <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/2014_07_23_mers/en/">
        http://www.who.int/csr/don/2014_07_23_mers/en/
       </ext-link>
       ).
      </p>
      <p>
       The 41st sample was a SARS-associated coronavirus that was transmitted from human to pig
       <sup>
        <xref ref-type="bibr" rid="CR29">
         29
        </xref>
       </sup>
       and both SVM and MD detected its threat to humans. Bat and avian might be potential hosts since both models suggest that they are more vulnerable than porcine. Samples 42–44 (RsSHC014, Rs3367 and SL-CoV-WIV1) consist of three SARS-like coronaviruses from bats
       <sup>
        <xref ref-type="bibr" rid="CR30">
         30
        </xref>
       </sup>
       . Analyses based on the sequence similarities and cultures in the cell lines suggest that Rs3367 and SL-CoV-WIV1 are capable of using a SARS-CoV receptor for cell entry and pose a threat to humans, whereas RsSHC014 cannot
       <sup>
        <xref ref-type="bibr" rid="CR30">
         30
        </xref>
       </sup>
       . Our study provides a precise support to these conclusions. The MD correctly predicts bats as the natural hosts of the three viruses and the SVM indicates that Rs3367 and SL-CoV-WIV1 are harmful to humans.
      </p>
      <p>
       The 45th sample was isolated from an alpaca by Jin
       <italic>
        et al.
       </italic>
       in 2007 with a serotype of bovine; the phylogenetic analysis suggests that it shares the same ancestor with bovine-coronaviruses
       <sup>
        <xref ref-type="bibr" rid="CR31">
         31
        </xref>
       </sup>
       . Our analysis supports the finding that this coronavirus is capable of infecting bovine. These analyses imply that this strain is capable of interspecies transmission between bovines and alpacas. Samples 46 and 47 are enteric coronaviruses from bovines and humans; they have been identified as the same strain named “Human enteric coronavirus 4408” in the NCBI database due to the similarity between their spike protein sequences of 99.9%. Although they are similar to the human coronavirus OC43 and the bovine coronavirus, evidences from morphological, immunological and genomic studies indicate that they are closer to bovine coronavirus than to human coronavirus (unpublished research, from personal communication). This finding is consistent with our analysis. In addition, avian and bat are worthy of attentions as potential hosts due to the small MD values.
      </p>
     </sec>
     <sec id="Sec6">
      <title>
       Tendencies of MD and SVM in predictions
      </title>
      <p>
       Two groups of two-dimensional data are plotted in
       <xref ref-type="fig" rid="Fig1">
        Fig. 1
       </xref>
       . The blue points represent a “loose” population with a larger standard deviation (SD) of
       <italic>
        N
       </italic>
       (1, 1) and the red points represent a “tight” population with a smaller SD of
       <italic>
        N
       </italic>
       (3.5, 0.5). The red line separates the two groups classified by the MD and the groups predicted by the SVM are delimited by the blue line. In this figure, two individuals (the red triangles between the two lines) from the “tight” population were classified into the “loose” group by the MD, whereas the SVM accidentally excluded four points (the blue reversed triangles between the two lines) from the “loose” population. This example shows that MD and SVM have inverse tendencies in some cases, i.e., when a “loose” population is close to a “tight” population, MD intends to classify outliers of the “tight” population into the former. The opposite situation is valid for the SVM.
       <fig id="Fig1">
        <label>
         Figure 1
        </label>
        <caption>
         <p>
          Tendencies of MD and SVM models.
         </p>
        </caption>
        <graphic id="d29e1892" xlink:href="41598_2015_Article_BFsrep17155_Fig1_HTML">
        </graphic>
       </fig>
      </p>
     </sec>
    </sec>
    <sec id="Sec7">
     <title>
      Discussion
     </title>
     <p>
      Nucleotide composition analysis revealed the overrepresentation of CpA and TpG dinucleotides and the suppression of CpG dinucleotides (see
      <xref ref-type="media" rid="MOESM1">
       Supplementary Table S1
      </xref>
      ), which indicates that coronaviruses generally prefer motifs that contain CpAs and TpGs and avoid CpGs in sequences. These dinucleotide biases are common characteristics of RNA viruses in vertebrates
      <sup>
       <xref ref-type="bibr" rid="CR11">
        11
       </xref>
       ,
       <xref ref-type="bibr" rid="CR12">
        12
       </xref>
       ,
       <xref ref-type="bibr" rid="CR15">
        15
       </xref>
       ,
       <xref ref-type="bibr" rid="CR16">
        16
       </xref>
      </sup>
      . As most vertebrates exhibit a very low CpG representation in genomes, RNA viruses may gradually adapt to the accumulation of host mutations and mimic the host gene’s dinucleotide patterns for survival
      <sup>
       <xref ref-type="bibr" rid="CR11">
        11
       </xref>
      </sup>
      . For DNA viruses, the most-accepted mechanisms for the suppression of CpG dinucleotides are the methylation of CpG nucleotides and the subsequent deamination of 5-methylcytosine, which renders CpG a mutational hotspot
      <sup>
       <xref ref-type="bibr" rid="CR24">
        24
       </xref>
      </sup>
      . For RNA viruses, a different hypothesis is that the RNA viruses encounter different selection pressures when they switch to a new host, and viral RNA genes mimic host mRNAs to avoid immune detection
      <sup>
       <xref ref-type="bibr" rid="CR11">
        11
       </xref>
      </sup>
      . Similar to other human ssRNA viruses, coronaviruses show a strong correlation between CpG pressure and C+G content (Pearson’s correlation coefficient, r = 0.5443,
      <italic>
       p
      </italic>
      &lt; 2.2e-16, our data). A lower C+G content usually indicates that the nucleotide sequence of the virus is unstable or is highly variable under evolutionary selection pressure. Considering that the mutation rates for RNA viruses are significantly higher than the mutation rates for DNA viruses
      <sup>
       <xref ref-type="bibr" rid="CR32">
        32
       </xref>
      </sup>
      , mutational pressure may be the most important determinant of the bias in codon usage in human RNA viruses, such as coronaviruses
      <sup>
       <xref ref-type="bibr" rid="CR14">
        14
       </xref>
      </sup>
      .
     </p>
     <p>
      The capabilities to bind with receptors and to replicate in host cells are essential for any virus to infect hosts. Different genes contribute to these biological processes. Variations on these genes may enable a virus to transmit cross-species. One famous example would be the polymerase 2 (PB2) of influenza A virus, in which amino acid change from E to K at its 627th position would render the virus to replicate in mammalian cells
      <sup>
       <xref ref-type="bibr" rid="CR33">
        33
       </xref>
       ,
       <xref ref-type="bibr" rid="CR34">
        34
       </xref>
       ,
       <xref ref-type="bibr" rid="CR35">
        35
       </xref>
      </sup>
      . In coronaviruses, the spike protein is functionally associated with recognition of hosts and the RNA-dependent RNA polymerase (RdRp) is related to proliferation of virus. However, there are two obstacles limiting the use of RdRp gene: (1) The similarities among nucleotide sequences is too high to train MD model, i.e., the variation rate of RdRp sequence is slower and cannot provide enough resolution to discriminate different coronaviruses; (2) Even worse, available full-length CDSs in public databases are very limited — only 23 or so. On the contrary, the spike gene perfectly satisfied the requirements for variation rate and availability, therefore was adopted as markers in this study.
     </p>
     <p>
      MD and SVM show opposite tendencies in judging outliers (See
      <xref ref-type="fig" rid="Fig1">
       Fig. 1
      </xref>
      ), which reflects the different principles of the two classification approaches. Unlike the Euclidian distance (ED), which measures the absolute distance between points or mass centres in space, the Mahalanobis distance considers the variances within a population and the covariance between variables. In some cases, especially when a population with individuals who are scattered across a wide range is located close to a “tight” population with smaller internal variations, the MD may classify marginal individuals from the latter into the “loose” population even if they are “close” to a “tight” population according to the ED. The MD enables “loose” populations to have a greater number of points. The SVM has a different philosophy. SVM separates populations by finding a hyperplane that maximizes the distances between populations. When a “loose” population is close to the boundary of a “tight” population, SVM is more likely to find this hyperplane within the former. This finding explains SVM’s tendency to exclude outliers from a “loose” population.
     </p>
     <p>
      Bats are the reservoir hosts of a number of coronaviruses that can survive in bats and accumulate variations in the long evolutionary process
      <sup>
       <xref ref-type="bibr" rid="CR1">
        1
       </xref>
       ,
       <xref ref-type="bibr" rid="CR36">
        36
       </xref>
       ,
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
      </sup>
      . Thus, coronaviruses in bats constitute a “loose” population with larger internal gaps. We assume that some strains of viruses in bats gain sufficient variation to enable them to infect other organisms; these viruses form a new “tight” population at the edge of the original group. In this case, the MD emphasizes the connection of a virus with the original source, whereas the SVM may be more sensitive to the possibility of infecting new hosts. Therefore, the incorporation of analyses using the MD and SVM can be especially helpful for revealing the profile of interspecies transmission.
     </p>
     <p>
      According to the predictions by MD, bats are not only the hosts in all 14 incorrect cases from training data set (See
      <xref ref-type="table" rid="Tab2">
       Table 2
      </xref>
      ), but also in the host list of each coronaviruses for testing (See
      <xref ref-type="table" rid="Tab3">
       Table 3
      </xref>
      ). Furthermore, bats were predicted to host of 64.02% training samples isolated from other hosts (See
      <xref ref-type="table" rid="Tab1">
       Table 1
      </xref>
      ). These facts convincingly support the notion that these viruses originated from bats and shifted to other hosts.
     </p>
     <p>
      Next to bats, avians could be infected by 36.64% samples from other hosts. If bats are the only reservoir hosts and coronaviruses spread from bats to avians and other animals, according to the stochastic event model, the probability of co-infectivity to both bat and avian can be the product of the infectivity probabilities to each of them, i.e., 0.3494 (0.5164 × 0.6767, see
      <xref ref-type="table" rid="Tab1">
       Table 1
      </xref>
      ), then 255 (0.3494 × 730) samples are expected to be of co-infectivity. However, only 173 samples were predicted to be of co-infectivity to bats and avians. So avians might be the second independent source of coronavirus in parallel to bats. If this speculation is true, people will have to maintain vigilance to avian coronaviruses apart from avian influenza viruses. Especially, due to the high accuracy of the SVM in cross-validation, we should seriously consider its only “wrong” prediction: perhaps it is sensible to investigate whether the NC_016996.1 virus from avian is capable of infecting humans.
     </p>
     <p>
      For the viruses that are capable of spreading across a host species barrier, the combination of the MD and the SVM is valuable for assessing their potential threat. The origin and interspecies transmission of coronaviruses have been extensively discussed in the past ten years and the coronaviruses of most mammals are believed to originate from their ancestors in bats
      <sup>
       <xref ref-type="bibr" rid="CR1">
        1
       </xref>
       ,
       <xref ref-type="bibr" rid="CR36">
        36
       </xref>
       ,
       <xref ref-type="bibr" rid="CR37">
        37
       </xref>
      </sup>
      . Our analysis with dual statistical models support the finding that SARS-CoVs and MERS-CoVs spread from bats to humans and other animals. In most cases, our approach provided convincing predictions. The dual-model approach can be expected to become a useful tool in future studies. Typically, when a novel coronavirus is isolated, the combination of the MD and the SVM may provide meaningful hints regarding its origin and potential threat to humans or other animals. As soon as more virus genomes are sequenced, this approach can be applied to investigate the interspecies transmission route of other threatening viruses, including the recent Ebola outbreak in West Africa.
     </p>
    </sec>
    <sec id="Sec8">
     <title>
      Methods
     </title>
     <sec id="Sec9">
      <title>
       Data preparation
      </title>
      <p>
       All genome sequences and complete coding sequences (CDSs) of spike genes were downloaded from the National Centre for Biotechnology Information (NCBI) database (
       <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">
        http://www.ncbi.nlm.nih.gov/
       </ext-link>
       ) on July 17, 2014. Sequences of spike genes were extracted from the 1044 coronavirus genomes and pooled with 1380 downloaded CDSs. Then, we removed replicate sequences and sequences that contained non-standard bases or were incapable of coding complete products. The length of each sequence is longer than 3,000 bases. Among all 777 valid nucleotide sequences that are listed in
       <xref ref-type="media" rid="MOESM3">
        Supplementary Data S1
       </xref>
       , 730 sequences fall into six categories according to different hosts: 196 for humans, 182 for porcines, 77 for bovines, 74 for bats, 28 for murines and 173 for avians. The majority of the remaining 47 viruses were isolated from the two epidemic diseases caused by the coronavirus in the past 12 years. Although we only listed the hosts from which they were isolated, these viruses have been verified or suspected to have the ability to infect different hosts; thus, all 47 sequences were employed to explore interspecies transmission of coronaviruses. Viruses from other mammals, including canines, felines, rabbits, equines, alpacas and whales, were excluded from the data set as the number of spike sequences for each host is insufficient for establishing a separate group.
      </p>
     </sec>
     <sec id="Sec10">
      <title>
       Nucleotide composition analysis
      </title>
      <p>
       The mononucleotide frequencies and dinucleotide biases of the spike sequences were computed using our original Python scripts. Dinucleotide bias is the ratio of the observed value to the expected frequency of each of the 16 dinucleotides:
       <inline-formula id="IEq7">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq7_HTML.gif">
        </inline-graphic>
       </inline-formula>
       , where
       <inline-formula id="IEq8">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq8_HTML.gif">
        </inline-graphic>
       </inline-formula>
       is the dinucleotide bias,
       <italic>
        f
       </italic>
       <sub>
        <italic>
         XY
        </italic>
       </sub>
       is the frequency of dinucleotide XY,
       <italic>
        f
       </italic>
       <sub>
        <italic>
         X
        </italic>
       </sub>
       and
       <italic>
        f
       </italic>
       <sub>
        <italic>
         Y
        </italic>
       </sub>
       are the frequencies of nucleotide X and nucleotide Y
       <sup>
        <xref ref-type="bibr" rid="CR38">
         38
        </xref>
       </sup>
       , respectively.
      </p>
      <p>
       In this study, we considered 19 factors, including three mononucleotide frequencies (G, C and T) and 16 dinucleotide biases. As none of the frequencies has a normal distribution, the nonparametric “Kruskal-Wallis Test” was employed to investigate the difference in each factor among six categories. As a result, significant differences across categories were detected for each factor; thus, all 19 factors were employed for modelling.
      </p>
     </sec>
     <sec id="Sec11">
      <title>
       Modelling, validation and prediction
      </title>
      <p>
       As a classifier, the SVM can efficiently perform a nonlinear classification using a kernel technique that is rooted in structural risk minimization. In this study, the R package e1071 (Version: 1.6–3)
       <sup>
        <xref ref-type="bibr" rid="CR20">
         20
        </xref>
       </sup>
       was employed for the SVM analysis. “C-classification” was adopted as the model type and “Radial” was adopted as the SVM kernel in our analysis. The MD is a measure of the distance from a point to the centre of a distribution; the principle of this discriminant is that individuals belong to the closest group in the distance. The MD is defined as
       <inline-formula id="IEq9">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq9_HTML.gif">
        </inline-graphic>
       </inline-formula>
       , where
       <italic>
        X
       </italic>
       denotes the population,
       <italic>
        x
       </italic>
       denotes the individual, μ is the mean value of the population,
       <italic>
        T
       </italic>
       denotes the matrix transpose and
       <inline-formula id="IEq10">
        <inline-graphic xlink:href="41598_2015_Article_BFsrep17155_IEq10_HTML.gif">
        </inline-graphic>
       </inline-formula>
       denotes the covariance matrix of population
       <sup>
        <xref ref-type="bibr" rid="CR39">
         39
        </xref>
       </sup>
       . The R program “distinguish.distance.R”
       <sup>
        <xref ref-type="bibr" rid="CR40">
         40
        </xref>
       </sup>
       was employed in the MD analysis. Leave-one-out cross-validation was employed for both SVM and MD analyses.
      </p>
      <p>
       When the trained models are applied to a sequence for testing, each of the six categories of hosts will obtain a
       <italic>
        p
       </italic>
       value from SVM and a MD value. Based on
       <italic>
        p
       </italic>
       values and MD values, three steps will be taken to determine candidate hosts. First, the host of minimal
       <italic>
        p
       </italic>
       value or MD value is reasonably regarded as the preferable host. Then, two adjustable empirical thresholds can be used for each model to pick out other potential hosts. In this study, we adopted 0.05 and 0.01 for
       <italic>
        p
       </italic>
       value, 200 and 100 for MD value; i.e., likely hosts were determined if
       <italic>
        p
       </italic>
       &lt;= 0.05 or MD &lt;= 200 and very likely hosts were defined by
       <italic>
        p
       </italic>
       &lt;= 0.01 or MD &lt;= 100. The two steps are unsupervised prediction. In case that the isolate source is among the six host groups for modelling, a supervised prediction can be applied as the third step, i.e., all host species with
       <italic>
        p
       </italic>
       values or MD values no more than those of the observed host will be listed as potential hosts, which can be practical references for researchers to evaluate a virus’s threats to human or other animals.
      </p>
     </sec>
     <sec id="Sec12">
      <title>
       Compare the tendencies of MD and SVM in predictions
      </title>
      <p>
       Two groups of two-dimensional vectors were generated
       <italic>
        in silico
       </italic>
       as two populations. The number of vectors in the first population are randomly generated from the normal distribution
       <italic>
        N
       </italic>
       (1, 1) and the number of vectors in the second population are randomly generated from
       <italic>
        N
       </italic>
       (3.5, 0.5). As the first population has a larger standard deviation (SD), we refer to it as the “loose” population and refer to the second population as the “tight” population. The two groups of data are employed for the leave-one-out cross-validations of MD and SVM.
      </p>
      <p>
       All Python and R scripts employed in this study are available from the authors upon request. The prediction can be performed using the spike gene sequences of the coronaviruses on our web server, which is available to the public at no cost at
       <ext-link ext-link-type="uri" xlink:href="http://bioinfo.ihb.ac.cn/seq2hosts">
        http://bioinfo.ihb.ac.cn/seq2hosts
       </ext-link>
       .
      </p>
     </sec>
    </sec>
    <sec id="Sec13">
     <title>
      Additional Information
     </title>
     <p>
      <bold>
       How to cite this article
      </bold>
      : Tang, Q.
      <italic>
       et al.
      </italic>
      Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition.
      <italic>
       Sci. Rep.
      </italic>
      <bold>
       5
      </bold>
      , 17155; doi: 10.1038/srep17155 (2015).
     </p>
    </sec>
    <sec sec-type="supplementary-material">
     <title>
      Electronic supplementary material
     </title>
     <sec id="Sec14">
      <p>
       <supplementary-material content-type="local-data" id="MOESM1">
        <media xlink:href="41598_2015_BFsrep17155_MOESM1_ESM.xls">
         <caption>
          <p>
           Supplementary Table S1
          </p>
         </caption>
        </media>
       </supplementary-material>
      </p>
      <p>
       <supplementary-material content-type="local-data" id="MOESM2">
        <media xlink:href="41598_2015_BFsrep17155_MOESM2_ESM.xls">
         <caption>
          <p>
           Supplementary Table S2
          </p>
         </caption>
        </media>
       </supplementary-material>
      </p>
      <p>
       <supplementary-material content-type="local-data" id="MOESM3">
        <media xlink:href="41598_2015_BFsrep17155_MOESM3_ESM.pdf">
         <caption>
          <p>
           Supplementary Data S1
          </p>
         </caption>
        </media>
       </supplementary-material>
      </p>
     </sec>
    </sec>
    <back>
     <ack>
      <title>
       Acknowledgements
      </title>
      <p>
       This work was supported by the 100-talent program grant from the Chinese Academy of Sciences.
      </p>
     </ack>
     <notes notes-type="author-contribution">
      <title>
       Author Contributions
      </title>
      <p>
       Q.T. designed the research, collected and analyzed data and wrote the paper. Y.S., M.S., Y.C. and W.Z. analyzed data, X.-Q.X. designed the research, re-analyzed data, wrote the paper and created the web server. All authors reviewed the manuscript.
      </p>
     </notes>
     <notes notes-type="COI-statement">
      <title>
       Competing interests
      </title>
      <p>
       The authors declare no competing financial interests.
      </p>
     </notes>
     <ref-list id="Bib1">
      <title>
       References
      </title>
      <ref id="CR1">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           JFW
          </given-names>
         </name>
         <name>
          <surname>
           To
          </surname>
          <given-names>
           KKW
          </given-names>
         </name>
         <name>
          <surname>
           Tse
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           DY
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           KY
          </given-names>
         </name>
        </person-group>
        <article-title>
         Interspecies transmission and emergence of novel viruses: lessons from bats and birds
        </article-title>
        <source>
         Trends Microbiol.
        </source>
        <year>
         2013
        </year>
        <volume>
         21
        </volume>
        <fpage>
         544
        </fpage>
        <lpage>
         555
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.tim.2013.05.005
        </pub-id>
        <pub-id pub-id-type="pmid">
         23770275
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR2">
       <mixed-citation publication-type="other">
        King, A. M. Q., Adams, M. J., Carstens, E. B. &amp; Lefkowitz, E. J. Virus taxonomy, the Ninth Report of the International Committee on Taxonomy of Viruses 810–814 (Academic Press, San Diego, CA., 2012).
       </mixed-citation>
      </ref>
      <ref id="CR3">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Genetic characterization of betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of Pipistrellus bat coronavirus HKU5 in Japanese Pipistrelle: Implications for the origin of the novel Middle East Respiratory Syndrome Coronavirus
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2013
        </year>
        <volume>
         87
        </volume>
        <fpage>
         8638
        </fpage>
        <lpage>
         8650
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.01055-13
        </pub-id>
        <pub-id pub-id-type="pmid">
         23720729
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR4">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Graham
          </surname>
          <given-names>
           RL
          </given-names>
         </name>
         <name>
          <surname>
           Donaldson
          </surname>
          <given-names>
           EF
          </given-names>
         </name>
         <name>
          <surname>
           Baric
          </surname>
          <given-names>
           RS
          </given-names>
         </name>
        </person-group>
        <article-title>
         A decade after SARS: strategies for controlling emerging coronaviruses
        </article-title>
        <source>
         Nat. Rev. Microbiol.
        </source>
        <year>
         2013
        </year>
        <volume>
         11
        </volume>
        <fpage>
         836
        </fpage>
        <lpage>
         848
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/nrmicro3143
        </pub-id>
        <pub-id pub-id-type="pmid">
         24217413
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR5">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           PCY
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           SKP
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           KY
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus genomics and bioinformatics analysis
        </article-title>
        <source>
         Viruses-Basel.
        </source>
        <year>
         2010
        </year>
        <volume>
         2
        </volume>
        <fpage>
         1804
        </fpage>
        <lpage>
         1820
        </lpage>
        <pub-id pub-id-type="doi">
         10.3390/v2081803
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR6">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           W
          </given-names>
         </name>
         <name>
          <surname>
           Farzan
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Harrison
          </surname>
          <given-names>
           SC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
        </article-title>
        <source>
         Science
        </source>
        <year>
         2005
        </year>
        <volume>
         309
        </volume>
        <fpage>
         1864
        </fpage>
        <lpage>
         1868
        </lpage>
        <pub-id pub-id-type="doi">
         10.1126/science.1116480
        </pub-id>
        <pub-id pub-id-type="pmid">
         16166518
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR7">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           F
          </given-names>
         </name>
        </person-group>
        <article-title>
         Receptor recognition and cross-species infections of SARS coronavirus
        </article-title>
        <source>
         Antivir. Res.
        </source>
        <year>
         2013
        </year>
        <volume>
         100
        </volume>
        <fpage>
         246
        </fpage>
        <lpage>
         254
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.antiviral.2013.08.014
        </pub-id>
        <pub-id pub-id-type="pmid">
         23994189
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR8">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Perlman
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Netland
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronaviruses post-SARS: update on replication and pathogenesis
        </article-title>
        <source>
         Nat. Rev. Microbiol.
        </source>
        <year>
         2009
        </year>
        <volume>
         7
        </volume>
        <fpage>
         439
        </fpage>
        <lpage>
         450
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/nrmicro2147
        </pub-id>
        <pub-id pub-id-type="pmid">
         19430490
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR9">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lobo
          </surname>
          <given-names>
           FP
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Virus-host coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hosts
        </article-title>
        <source>
         PLoS ONE
        </source>
        <year>
         2009
        </year>
        <volume>
         4
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         14
        </lpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.pone.0006282
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR10">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dunham
          </surname>
          <given-names>
           EJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Different evolutionary trajectories of European Avian-Like and classical Swine H1N1 influenza A viruses
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2009
        </year>
        <volume>
         83
        </volume>
        <fpage>
         5485
        </fpage>
        <lpage>
         5494
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.02565-08
        </pub-id>
        <pub-id pub-id-type="pmid">
         19297491
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR11">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Greenbaum
          </surname>
          <given-names>
           BD
          </given-names>
         </name>
         <name>
          <surname>
           Levine
          </surname>
          <given-names>
           AJ
          </given-names>
         </name>
         <name>
          <surname>
           Bhanot
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Rabadan
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        <article-title>
         Patterns of evolution and host gene mimicry in influenza and other RNA viruses
        </article-title>
        <source>
         PLoS Pathog.
        </source>
        <year>
         2008
        </year>
        <volume>
         4
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="doi">
         10.1371/journal.ppat.1000079
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR12">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chantawannakul
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Cutler
          </surname>
          <given-names>
           RW
          </given-names>
         </name>
        </person-group>
        <article-title>
         Convergent host-parasite codon usage between honeybee and bee associated viral genomes
        </article-title>
        <source>
         J. Invertebr. Pathol.
        </source>
        <year>
         2008
        </year>
        <volume>
         98
        </volume>
        <fpage>
         206
        </fpage>
        <lpage>
         210
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jip.2008.02.016
        </pub-id>
        <pub-id pub-id-type="pmid">
         18397791
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR13">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Shackelton
          </surname>
          <given-names>
           LA
          </given-names>
         </name>
         <name>
          <surname>
           Parrish
          </surname>
          <given-names>
           CR
          </given-names>
         </name>
         <name>
          <surname>
           Holmes
          </surname>
          <given-names>
           EC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evolutionary basis of codon usage and nucleotide composition bias in vertebrate DNA viruses
        </article-title>
        <source>
         J. Mol. Evol.
        </source>
        <year>
         2006
        </year>
        <volume>
         62
        </volume>
        <fpage>
         551
        </fpage>
        <lpage>
         563
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s00239-005-0221-1
        </pub-id>
        <pub-id pub-id-type="pmid">
         16557338
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR14">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gu
          </surname>
          <given-names>
           WJ
          </given-names>
         </name>
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Ma
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
         <name>
          <surname>
           Sun
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           ZH
          </given-names>
         </name>
        </person-group>
        <article-title>
         Analysis of synonymous codon usage in SARS Coronavirus and other viruses in the Nidovirales
        </article-title>
        <source>
         Virus Res.
        </source>
        <year>
         2004
        </year>
        <volume>
         101
        </volume>
        <fpage>
         155
        </fpage>
        <lpage>
         161
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virusres.2004.01.006
        </pub-id>
        <pub-id pub-id-type="pmid">
         15041183
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR15">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Berkhout
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Grigoriev
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Bakker
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Lukashov
          </surname>
          <given-names>
           VV
          </given-names>
         </name>
        </person-group>
        <article-title>
         Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure
        </article-title>
        <source>
         Aids Res. Hum. Retrov.
        </source>
        <year>
         2002
        </year>
        <volume>
         18
        </volume>
        <fpage>
         133
        </fpage>
        <lpage>
         141
        </lpage>
        <pub-id pub-id-type="doi">
         10.1089/08892220252779674
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR16">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jenkins
          </surname>
          <given-names>
           GM
          </given-names>
         </name>
         <name>
          <surname>
           Pagel
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Gould
          </surname>
          <given-names>
           EA
          </given-names>
         </name>
         <name>
          <surname>
           Zanotto
          </surname>
          <given-names>
           PMD
          </given-names>
         </name>
         <name>
          <surname>
           Holmes
          </surname>
          <given-names>
           EC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evolution of base composition and codon usage bias in the genus Flavivirus
        </article-title>
        <source>
         J. Mol. Evol.
        </source>
        <year>
         2001
        </year>
        <volume>
         52
        </volume>
        <fpage>
         383
        </fpage>
        <lpage>
         390
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s002390010168
        </pub-id>
        <pub-id pub-id-type="pmid">
         11343134
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR17">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rima
          </surname>
          <given-names>
           BK
          </given-names>
         </name>
         <name>
          <surname>
           McFerran
          </surname>
          <given-names>
           NV
          </given-names>
         </name>
        </person-group>
        <article-title>
         Dinucleotide and stop codon frequencies in single-stranded RNA viruses
        </article-title>
        <source>
         J. Gen. Virol.
        </source>
        <year>
         1997
        </year>
        <volume>
         78
        </volume>
        <fpage>
         2859
        </fpage>
        <lpage>
         2870
        </lpage>
        <pub-id pub-id-type="doi">
         10.1099/0022-1317-78-11-2859
        </pub-id>
        <pub-id pub-id-type="pmid">
         9367373
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR18">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vapnik
          </surname>
          <given-names>
           VN
          </given-names>
         </name>
         <name>
          <surname>
           Chervone
          </surname>
          <given-names>
           Ay
          </given-names>
         </name>
        </person-group>
        <article-title>
         On a class of pattern-recognition learning algorithms
        </article-title>
        <source>
         Automat. Rem. Contr+.
        </source>
        <year>
         1965
        </year>
        <volume>
         25
        </volume>
        <fpage>
         838
        </fpage>
       </element-citation>
      </ref>
      <ref id="CR19">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cortes
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Vapnik
          </surname>
          <given-names>
           V
          </given-names>
         </name>
        </person-group>
        <article-title>
         Support-vector networks
        </article-title>
        <source>
         Mach. Learn.
        </source>
        <year>
         1995
        </year>
        <volume>
         20
        </volume>
        <fpage>
         273
        </fpage>
        <lpage>
         297
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR20">
       <mixed-citation publication-type="other">
        Meyer, D. Support Vector Machines—the Interface to libsvm in package e1071. (2014). Available at:
        <ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/web/packages/e1071/">
         http://cran.r-project.org/web/packages/e1071/
        </ext-link>
        .
       </mixed-citation>
      </ref>
      <ref id="CR21">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Furey
          </surname>
          <given-names>
           TS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Support vector machine classification and validation of cancer tissue samples using microarray expression data
        </article-title>
        <source>
         Bioinformatics
        </source>
        <year>
         2000
        </year>
        <volume>
         16
        </volume>
        <fpage>
         906
        </fpage>
        <lpage>
         914
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/bioinformatics/16.10.906
        </pub-id>
        <pub-id pub-id-type="pmid">
         11120680
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR22">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           De Maesschalck
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <name>
          <surname>
           Jouan-Rimbaud
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Massart
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
        </person-group>
        <article-title>
         The Mahalanobis distance
        </article-title>
        <source>
         Chemometr. Intell. Lab.
        </source>
        <year>
         2000
        </year>
        <volume>
         50
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         18
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0169-7439(99)00047-7
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR23">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kapoor
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Simmonds
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Lipkin
          </surname>
          <given-names>
           WI
          </given-names>
         </name>
         <name>
          <surname>
           Zaidi
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Delwart
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        <article-title>
         Use of nucleotide composition analysis to infer hosts for three novel Picorna-like viruses
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2010
        </year>
        <volume>
         84
        </volume>
        <fpage>
         10322
        </fpage>
        <lpage>
         10328
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.00601-10
        </pub-id>
        <pub-id pub-id-type="pmid">
         20668077
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR24">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Karlin
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Mrazek
          </surname>
          <given-names>
           J
          </given-names>
         </name>
        </person-group>
        <article-title>
         Compositional differences within and between eukaryotic genomes
        </article-title>
        <source>
         P. Natl. Acad. Sci. USA
        </source>
        <year>
         1997
        </year>
        <volume>
         94
        </volume>
        <fpage>
         10227
        </fpage>
        <lpage>
         10232
        </lpage>
        <pub-id pub-id-type="doi">
         10.1073/pnas.94.19.10227
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR25">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           HD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
        </article-title>
        <source>
         P. Natl. Acad. Sci. USA
        </source>
        <year>
         2005
        </year>
        <volume>
         102
        </volume>
        <fpage>
         2430
        </fpage>
        <lpage>
         2435
        </lpage>
        <pub-id pub-id-type="doi">
         10.1073/pnas.0409608102
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR26">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2007
        </year>
        <volume>
         81
        </volume>
        <fpage>
         4694
        </fpage>
        <lpage>
         4700
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.02389-06
        </pub-id>
        <pub-id pub-id-type="pmid">
         17314167
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR27">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans
        </article-title>
        <source>
         Mbio.
        </source>
        <year>
         2012
        </year>
        <volume>
         3
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/mBio.00473-12
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR28">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           NS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
        </article-title>
        <source>
         Cell Res.
        </source>
        <year>
         2013
        </year>
        <volume>
         23
        </volume>
        <fpage>
         986
        </fpage>
        <lpage>
         993
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/cr.2013.92
        </pub-id>
        <pub-id pub-id-type="pmid">
         23835475
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR29">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           WJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         SARS-associated coronavirus transmitted from human to pig
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2005
        </year>
        <volume>
         11
        </volume>
        <fpage>
         446
        </fpage>
        <lpage>
         448
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1103.040824
        </pub-id>
        <pub-id pub-id-type="pmid">
         15757562
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR30">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ge
          </surname>
          <given-names>
           XY
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
        </article-title>
        <source>
         Nature
        </source>
        <year>
         2013
        </year>
        <volume>
         503
        </volume>
        <fpage>
         535
        </fpage>
        <pub-id pub-id-type="doi">
         10.1038/nature12711
        </pub-id>
        <pub-id pub-id-type="pmid">
         24172901
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR31">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Analysis of the genome sequence of an alpaca coronavirus
        </article-title>
        <source>
         Virology
        </source>
        <year>
         2007
        </year>
        <volume>
         365
        </volume>
        <fpage>
         198
        </fpage>
        <lpage>
         203
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.virol.2007.03.035
        </pub-id>
        <pub-id pub-id-type="pmid">
         17459444
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR32">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Drake
          </surname>
          <given-names>
           JW
          </given-names>
         </name>
         <name>
          <surname>
           Holland
          </surname>
          <given-names>
           JJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Mutation rates among RNA viruses
        </article-title>
        <source>
         P. Natl. Acad. Sci. USA
        </source>
        <year>
         1999
        </year>
        <volume>
         96
        </volume>
        <fpage>
         13910
        </fpage>
        <lpage>
         13913
        </lpage>
        <pub-id pub-id-type="doi">
         10.1073/pnas.96.24.13910
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR33">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           GW
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Genomic signatures of human versus avian influenza A viruses
        </article-title>
        <source>
         Emerg. Infect. Dis.
        </source>
        <year>
         2006
        </year>
        <volume>
         12
        </volume>
        <fpage>
         1353
        </fpage>
        <lpage>
         1360
        </lpage>
        <pub-id pub-id-type="doi">
         10.3201/eid1209.060276
        </pub-id>
        <pub-id pub-id-type="pmid">
         17073083
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR34">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Manz
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Brunotte
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Reuther
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Schwemmle
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells
        </article-title>
        <source>
         Nat. Commun.
        </source>
        <year>
         2012
        </year>
        <volume>
         3
        </volume>
        <fpage>
         802
        </fpage>
        <pub-id pub-id-type="doi">
         10.1038/ncomms1804
        </pub-id>
        <pub-id pub-id-type="pmid">
         22549831
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR35">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Romero-Tejeda
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Capua
          </surname>
          <given-names>
           I
          </given-names>
         </name>
        </person-group>
        <article-title>
         Virus-specific factors associated with zoonotic and pandemic potential
        </article-title>
        <source>
         Influenza Other Respi. Viruses
        </source>
        <year>
         2013
        </year>
        <volume>
         7
        </volume>
        <fpage>
         4
        </fpage>
        <lpage>
         14
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/irv.12075
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR36">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           PCY
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2012
        </year>
        <volume>
         86
        </volume>
        <fpage>
         3995
        </fpage>
        <lpage>
         4008
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.06540-11
        </pub-id>
        <pub-id pub-id-type="pmid">
         22278237
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR37">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Vijgen
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Complete genomic sequence of human coronavirus OC43: Molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event
        </article-title>
        <source>
         J. Virol.
        </source>
        <year>
         2005
        </year>
        <volume>
         79
        </volume>
        <fpage>
         1595
        </fpage>
        <lpage>
         1604
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JVI.79.3.1595-1604.2005
        </pub-id>
        <pub-id pub-id-type="pmid">
         15650185
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR38">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Burge
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Campbell
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Karlin
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Over-representation and under-representation of short oligonucleotides in DNA-sequences
        </article-title>
        <source>
         P. Natl. Acad. Sci. USA
        </source>
        <year>
         1992
        </year>
        <volume>
         89
        </volume>
        <fpage>
         1358
        </fpage>
        <lpage>
         1362
        </lpage>
        <pub-id pub-id-type="doi">
         10.1073/pnas.89.4.1358
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR39">
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McLachlan
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Mahalanobis distance
        </article-title>
        <source>
         Resonance
        </source>
        <year>
         1999
        </year>
        <volume>
         4
        </volume>
        <fpage>
         20
        </fpage>
        <lpage>
         26
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/BF02834632
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR40">
       <mixed-citation publication-type="other">
        Xue, Y. &amp; Chen, L. P. Statistical modeling and R software, 383–384 (Tsinghua University Press, Beijing, China, 2007).
       </mixed-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Sci Adv
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Sci Adv
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       SciAdv
      </journal-id>
      <journal-id journal-id-type="hwp">
       advances
      </journal-id>
      <journal-title-group>
       <journal-title>
        Science Advances
       </journal-title>
      </journal-title-group>
      <issn pub-type="epub">
       2375-2548
      </issn>
      <publisher>
       <publisher-name>
        American Association for the Advancement of Science
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       29152574
      </article-id>
      <article-id pub-id-type="pmc">
       5687858
      </article-id>
      <article-id pub-id-type="publisher-id">
       aao4966
      </article-id>
      <article-id pub-id-type="doi">
       10.1126/sciadv.aao4966
      </article-id>
      <article-categories>
       <subj-group subj-group-type="article-type">
        <subject>
         Research Article
        </subject>
       </subj-group>
       <subj-group subj-group-type="heading">
        <subject>
         Research Articles
        </subject>
       </subj-group>
       <subj-group subj-group-type="legacy-article-type">
        <subject>
         SciAdv r-articles
        </subject>
       </subj-group>
       <subj-group subj-group-type="field">
        <subject>
         Health and Medicine
        </subject>
        <subject>
         Virology
        </subject>
       </subj-group>
       <subj-group subj-group-type="overline">
        <subject>
         Virology
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          Jie
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0002-2948-3873
        </contrib-id>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
         <sup>
          3
         </sup>
        </xref>
        <xref ref-type="author-notes" rid="afn1">
         *
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Cun
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0003-3003-0000
        </contrib-id>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="author-notes" rid="afn1">
         *
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          Guangyu
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         <sup>
          4
         </sup>
        </xref>
        <xref ref-type="author-notes" rid="afn1">
         *
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Chu
         </surname>
         <given-names>
          Hin
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
         <sup>
          3
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          Dong
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Yan
         </surname>
         <given-names>
          Helen Hoi-Ning
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff5">
         <sup>
          5
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Poon
         </surname>
         <given-names>
          Vincent Kwok-Man
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Wen
         </surname>
         <given-names>
          Lei
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Wong
         </surname>
         <given-names>
          Bosco Ho-Yin
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Zhao
         </surname>
         <given-names>
          Xiaoyu
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0002-0347-9104
        </contrib-id>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Chiu
         </surname>
         <given-names>
          Man Chun
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0001-9503-6396
        </contrib-id>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          Dong
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Wang
         </surname>
         <given-names>
          Yixin
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Au-Yeung
         </surname>
         <given-names>
          Rex K. H.
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0002-3137-0886
        </contrib-id>
        <xref ref-type="aff" rid="aff5">
         <sup>
          5
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          Ivy Hau-Yee
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff6">
         <sup>
          6
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Sun
         </surname>
         <given-names>
          Shihui
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         <sup>
          4
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          Jasper Fuk-Woo
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
         <sup>
          3
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff7">
         <sup>
          7
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff8">
         <sup>
          8
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          To
         </surname>
         <given-names>
          Kelvin Kai-Wang
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0002-1921-5824
        </contrib-id>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
         <sup>
          3
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff7">
         <sup>
          7
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff8">
         <sup>
          8
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Memish
         </surname>
         <given-names>
          Ziad A.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff9">
         <sup>
          9
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff10">
         <sup>
          10
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Corman
         </surname>
         <given-names>
          Victor M.
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0002-3605-0136
        </contrib-id>
        <xref ref-type="aff" rid="aff11">
         <sup>
          11
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff12">
         <sup>
          12
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Drosten
         </surname>
         <given-names>
          Christian
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff11">
         <sup>
          11
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff12">
         <sup>
          12
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Hung
         </surname>
         <given-names>
          Ivan Fan-Ngai
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff13">
         <sup>
          13
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Zhou
         </surname>
         <given-names>
          Yusen
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         <sup>
          4
         </sup>
        </xref>
        <xref ref-type="author-notes" rid="afn2">
         †
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Leung
         </surname>
         <given-names>
          Suet Yi
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff5">
         <sup>
          5
         </sup>
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Yuen
         </surname>
         <given-names>
          Kwok-Yung
         </given-names>
        </name>
        <contrib-id authenticated="false" contrib-id-type="orcid">
         http://orcid.org/0000-0002-2948-3873
        </contrib-id>
        <xref ref-type="aff" rid="aff1">
         <sup>
          1
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff2">
         <sup>
          2
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
         <sup>
          3
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff7">
         <sup>
          7
         </sup>
        </xref>
        <xref ref-type="aff" rid="aff8">
         <sup>
          8
         </sup>
        </xref>
        <xref ref-type="author-notes" rid="afn2">
         †
        </xref>
        <xref ref-type="corresp" rid="cor1">
         ‡
        </xref>
       </contrib>
       <aff id="aff1">
        <label>
         1
        </label>
        State Key Laboratory of Emerging Infectious Diseases, University of Hong Kong, Hong Kong, China.
       </aff>
       <aff id="aff2">
        <label>
         2
        </label>
        Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China.
       </aff>
       <aff id="aff3">
        <label>
         3
        </label>
        Research Centre of Infection and Immunology, University of Hong Kong, Hong Kong, China.
       </aff>
       <aff id="aff4">
        <label>
         4
        </label>
        State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
       </aff>
       <aff id="aff5">
        <label>
         5
        </label>
        Department of Pathology, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China.
       </aff>
       <aff id="aff6">
        <label>
         6
        </label>
        Department of Surgery, Queen Mary Hospital, Hong Kong, China.
       </aff>
       <aff id="aff7">
        <label>
         7
        </label>
        Carol Yu Centre for Infection, University of Hong Kong, Hong Kong, China.
       </aff>
       <aff id="aff8">
        <label>
         8
        </label>
        Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, University of Hong Kong, Hong Kong, China.
       </aff>
       <aff id="aff9">
        <label>
         9
        </label>
        Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
       </aff>
       <aff id="aff10">
        <label>
         10
        </label>
        Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
       </aff>
       <aff id="aff11">
        <label>
         11
        </label>
        Institute of Virology, Charité–Universitätsmedizin Berlin, Berlin, Germany.
       </aff>
       <aff id="aff12">
        <label>
         12
        </label>
        German Centre for Infection Research (DZIF), Berlin, Germany.
       </aff>
       <aff id="aff13">
        <label>
         13
        </label>
        Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
       </aff>
      </contrib-group>
      <author-notes>
       <fn fn-type="equal" id="afn1">
        <label>
         *
        </label>
        <p>
         These authors contributed equally to this work.
        </p>
       </fn>
       <fn fn-type="equal" id="afn2">
        <label>
         †
        </label>
        <p>
         These authors contributed equally to this work.
        </p>
       </fn>
       <corresp id="cor1">
        <label>
         ‡
        </label>
        Corresponding author. Email:
        <email xlink:href="kyyuen@hku.hk">
         kyyuen@hku.hk
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="collection">
       <month>
        11
       </month>
       <year>
        2017
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        15
       </day>
       <month>
        11
       </month>
       <year>
        2017
       </year>
      </pub-date>
      <volume>
       3
      </volume>
      <issue>
       11
      </issue>
      <elocation-id>
       eaao4966
      </elocation-id>
      <history>
       <date date-type="received">
        <day>
         27
        </day>
        <month>
         7
        </month>
        <year>
         2017
        </year>
       </date>
       <date date-type="accepted">
        <day>
         20
        </day>
        <month>
         10
        </month>
        <year>
         2017
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
       </copyright-statement>
       <copyright-year>
        2017
       </copyright-year>
       <copyright-holder>
        The Authors
       </copyright-holder>
       <license id="p-2" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>
         This is an open-access article distributed under the terms of the
         <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          Creative Commons Attribution-NonCommercial license
         </ext-link>
         , which permits use, distribution, and reproduction in any medium, so long as the resultant use is
         <bold>
          not
         </bold>
         for commercial advantage and provided the original work is properly cited.
        </license-p>
       </license>
      </permissions>
      <abstract abstract-type="teaser">
       <p>
        Human intestinal tract as an alternative route to acquire MERS-CoV infection.
       </p>
      </abstract>
      <abstract>
       <p>
        Middle East respiratory syndrome coronavirus (MERS-CoV) has caused human respiratory infections with a high case fatality rate since 2012. However, the mode of virus transmission is not well understood. The findings of epidemiological and virological studies prompted us to hypothesize that the human gastrointestinal tract could serve as an alternative route to acquire MERS-CoV infection. We demonstrated that human primary intestinal epithelial cells, small intestine explants, and intestinal organoids were highly susceptible to MERS-CoV and can sustain robust viral replication. We also identified the evidence of enteric MERS-CoV infection in the stool specimen of a clinical patient. MERS-CoV was considerably resistant to fed-state gastrointestinal fluids but less tolerant to highly acidic fasted-state gastric fluid. In polarized Caco-2 cells cultured in Transwell inserts, apical MERS-CoV inoculation was more effective in establishing infection than basolateral inoculation. Notably, direct intragastric inoculation of MERS-CoV caused a lethal infection in human DPP4 transgenic mice. Histological examination revealed MERS-CoV enteric infection in all inoculated mice, as shown by the presence of virus-positive cells, progressive inflammation, and epithelial degeneration in small intestines, which were exaggerated in the mice pretreated with the proton pump inhibitor pantoprazole. With the progression of the enteric infection, inflammation, virus-positive cells, and live viruses emerged in the lung tissues, indicating the development of sequential respiratory infection. Taken together, these data suggest that the human intestinal tract may serve as an alternative infection route for MERS-CoV.
       </p>
      </abstract>
      <funding-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           Ministry of Science and Technology of China
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award353208
        </award-id>
        <award-id>
         2014ZX10004001004
        </award-id>
       </award-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           NSFC/RGC Joint Research Scheme
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award341714
        </award-id>
        <award-id>
         N_HKU728/14
        </award-id>
       </award-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           Food and Health Bureau, Hong Kong Special Administrative Region
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award341712
        </award-id>
        <award-id>
         14131392, 15140762
        </award-id>
       </award-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           Theme-Based Research Scheme,Research Grants Council
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award341716
        </award-id>
        <award-id>
         T11/707/15
        </award-id>
       </award-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           Collaborative Research Fund, Research Grants Council
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award341715
        </award-id>
        <award-id>
         C7011-15R
        </award-id>
       </award-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           The German Research Foundation
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award353209
        </award-id>
        <award-id>
         Deutsche Forschungsgemeinschaft grant DR772/12-1 and DR772/7-2
        </award-id>
       </award-group>
       <award-group>
        <funding-source>
         <institution-wrap>
          <institution>
           European Commission project PREPARE
          </institution>
         </institution-wrap>
        </funding-source>
        <award-id>
         award353210
        </award-id>
        <award-id>
         contract number 602525
        </award-id>
       </award-group>
      </funding-group>
      <custom-meta-group>
       <custom-meta>
        <meta-name>
         Copyeditor
        </meta-name>
        <meta-value>
         Justin Noriel
        </meta-value>
       </custom-meta>
      </custom-meta-group>
     </article-meta>
    </front>
    <sec disp-level="1" sec-type="introduction">
     <title>
      INTRODUCTION
     </title>
     <p>
      Middle East respiratory syndrome coronavirus (MERS-CoV) was identified as a novel zoonotic virus causing human respiratory infection in 2012 (
      <xref ref-type="bibr" rid="R1">
       <italic>
        1
       </italic>
      </xref>
      ). As of July 2017, MERS-CoV has caused 2037 laboratory-confirmed infection cases, including 710 deaths, with a crude case fatality rate of about 35% (
      <xref ref-type="bibr" rid="R2">
       <italic>
        2
       </italic>
      </xref>
      ). The clinical spectrum of MERS ranged from asymptomatic or mild respiratory disease to acute fulminant pneumonia with respiratory distress syndrome or multiorgan failure resulting in a fatal outcome. Common symptoms were fever, cough, and shortness of breath. Gastrointestinal symptoms were among the most commonly reported extrapulmonary clinical features of MERS; about one-third of MERS patients had gastrointestinal tract symptoms such as abdominal pain, nausea, vomiting, and diarrhea (
      <xref ref-type="bibr" rid="R3">
       <italic>
        3
       </italic>
      </xref>
      ,
      <xref ref-type="bibr" rid="R4">
       <italic>
        4
       </italic>
      </xref>
      ).
     </p>
     <p>
      It has been reported that up to 20% of MERS cases are considered as primary infections due to contact with camels (
      <xref ref-type="bibr" rid="R5">
       <italic>
        5
       </italic>
      </xref>
      ). MERS-CoV–infected camels, especially the juvenile ones, were found to shed a large amount of the virus from the upper respiratory tract (
      <xref ref-type="bibr" rid="R6">
       <italic>
        6
       </italic>
      </xref>
      ). Camel milk may also play a role in the transmission of MERS-CoV. MERS-CoV could be detected in 41.7% of milk samples collected from lactating camels, which also actively shed the virus in nasal secretion and/or feces (
      <xref ref-type="bibr" rid="R7">
       <italic>
        7
       </italic>
      </xref>
      ). In addition, MERS-CoV can survive in camel milk for a prolonged period (
      <xref ref-type="bibr" rid="R8">
       <italic>
        8
       </italic>
      </xref>
      ). The consumption of unpasteurized camel milk was found to be a source of infection in some MERS patients (
      <xref ref-type="bibr" rid="R9">
       <italic>
        9
       </italic>
      </xref>
      ). Thus, it is generally believed that primary infection, that is, MERS-CoV transmission from camel to human, is mediated via respiratory droplet and/or saliva during direct contact with camels or through consumption of camel milk or undercooked camel meat (
      <xref ref-type="bibr" rid="R10">
       <italic>
        10
       </italic>
      </xref>
      ).
     </p>
     <p>
      Meanwhile, a large proportion of MERS cases occurred in healthcare settings, in which respiratory droplets of MERS patients as well as direct or indirect contact have been postulated to be important for virus transmission (
      <xref ref-type="bibr" rid="R3">
       <italic>
        3
       </italic>
      </xref>
      ,
      <xref ref-type="bibr" rid="R11">
       <italic>
        11
       </italic>
      </xref>
      ). Theoretically, human-to-human virus transmission mediated by respiratory droplets (&gt;5 μm in size) occurs within 1 to 2 m from a source patient. However, history of direct contact can be inferred in only about 10% of patients in the largest hospital-associated MERS outbreak reported so far, which occurred in the Republic of Korea, with 186 infection cases in 2015 (
      <xref ref-type="bibr" rid="R12">
       <italic>
        12
       </italic>
      </xref>
      ). Most of the cases in this large-scale outbreak were those who shared the same healthcare environment without direct contact with MERS patients. Therefore, fomite transmission may explain a significant proportion of the infections (
      <xref ref-type="bibr" rid="R12">
       <italic>
        12
       </italic>
      </xref>
      ). The virological evidence to support fomite transmission is that MERS-CoV remains stable at low temperatures and low humidity, and could be recovered after exposure to the environment for 48 hours (
      <xref ref-type="bibr" rid="R13">
       <italic>
        13
       </italic>
      </xref>
      ). Accordingly, viral RNA can be extensively detected in the environmental surfaces in rooms of MERS patients (
      <xref ref-type="bibr" rid="R14">
       <italic>
        14
       </italic>
      </xref>
      ). Given that fomite transmission may play a role in the outbreak in healthcare settings, acquisition of MERS-CoV infection via the gastrointestinal tract should be seriously considered. Collectively, in both camel-to-human transmission and human-to-human transmission, there is a possibility that humans may acquire MERS-CoV infection upon exposure to the virus through the gastrointestinal tract.
     </p>
     <p>
      A protein intrinsic disorder–based model was previously established to classify transmission behaviors of coronaviruses by measuring the percentage of intrinsic disorder in the two major shell (matrix and nucleocapsid) proteins of coronaviruses (
      <xref ref-type="bibr" rid="R15">
       <italic>
        15
       </italic>
      </xref>
      ). The analysis of protein sequences of these two proteins of MERS-CoV suggests that MERS-CoV belongs to a category of coronaviruses that have relatively hard inner and outer shells; therefore, it may persist in the environment for a prolonged period and may have an oral-fecal transmission ability (
      <xref ref-type="bibr" rid="R16">
       <italic>
        16
       </italic>
      </xref>
      ). The bioinformatically predicted MERS-CoV survival upon environmental exposure has been experimentally corroborated (
      <xref ref-type="bibr" rid="R13">
       <italic>
        13
       </italic>
      </xref>
      ). Here, we sought to elucidate whether the gastrointestinal tract could be an alternative infection route for MERS-CoV and whether the exposure of MERS-CoV to the gastrointestinal tract can subsequently lead to a respiratory infection. To this end, we performed in vitro studies in human primary intestinal epithelial cells, intestinal explants, polarized Caco-2 cells, and human intestinal organoids, as well as an in vivo study in human dipeptidyl peptidase 4 (hDPP4) transgenic mice.
     </p>
    </sec>
    <sec disp-level="1" sec-type="results">
     <title>
      RESULTS
     </title>
     <sec disp-level="2">
      <title>
       Susceptibility of human primary intestinal epithelial cells and small intestine explants to MERS-CoV, and evidence of alimentary infection in clinical MERS patients
      </title>
      <p>
       To address whether the human gastrointestinal tract could serve as an infection route for MERS-CoV, we examined the susceptibility of human primary intestinal epithelial cells to MERS-CoV. To this end, human primary intestinal epithelial cells were cultured for 1 week for differentiation. The differentiated epithelial cells were inoculated with MERS-CoV and were fixed at 24 hours post-infection (hpi) for immunofluorescence staining to identify the virus-positive cell. Almost all the inoculated intestinal epithelial cells highly expressed MERS-CoV NP, whereas no viral protein was detectable in mock-infected cells (
       <xref ref-type="fig" rid="F1">
        Fig. 1A
       </xref>
       ). In addition, the infected cells underwent significant membrane fusion and formed syncytia. Consistent with the intensive expression of viral protein, the viral load increased by more than 1 log in the MERS-CoV–inoculated epithelial cells (fig. S1). To further verify the infectivity of MERS-CoV in human intestinal epithelium, normal human small intestine from a surgical resection was obtained with informed consent and used for MERS-CoV inoculation. Despite tissue degradation, immunofluorescence staining explicitly revealed NP-positive enterocytes in the infected intestine (
       <xref ref-type="fig" rid="F1">
        Fig. 1B
       </xref>
       ) at 20 hpi. The infected enterocytes formed syncytia similar to those in the primary cells. Although only patchy areas of epithelium were infected, we observed an increased viral load of about 1 log in the Matrigel and medium, as well as in the infected explants (
       <xref ref-type="fig" rid="F1">
        Fig. 1C
       </xref>
       ). Thus, human primary intestinal epithelial cells and small intestine can be infected by MERS-CoV and support viral replication.
      </p>
      <fig fig-type="figure" id="F1" orientation="portrait" position="float">
       <label>
        Fig. 1
       </label>
       <caption>
        <title>
         Susceptibility of human primary intestinal cells, intestine explants to MERS-CoV, and identification of the replication intermediate in the stool specimen of a MERS patient.
        </title>
        <p>
         (
         <bold>
          A
         </bold>
         ) Human primary intestinal cells were inoculated with MERS-CoV (left and middle) or mock-infected (right). At 24 hpi, cells were fixed and applied to immunofluorescence staining of MERS-CoV nucleocapsid protein (NP). Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (blue). The images show the representative results of one experiment. (
         <bold>
          B
         </bold>
         and
         <bold>
          C
         </bold>
         ) Normal human small intestine explants were inoculated with MERS-CoV, as described in Materials and Methods. The data show representative results of the experiments independently performed twice. (B) The infected (left and middle) and mock-infected (right) explants were fixed at 20 hpi for immunofluorescence staining of MERS-CoV NP and the enterocyte marker CK19. Syncytia formation can be observed in the infected intestinal epithelium (middle). (C) At the indicated hpi, the explants (Tissue) and Matrigel together with culture medium (Matrigel) were harvested for the quantification of viral load. Data are means ± SD of viral loads in duplicated samples. (
         <bold>
          D
         </bold>
         ) Chromatograph of the N gene sgRNA recovered from the stool specimen of a MERS patient show fusion of leader sequence, TRS, and N gene element.
        </p>
       </caption>
       <graphic xlink:href="aao4966-F1">
       </graphic>
      </fig>
      <p>
       In an earlier study, we reported that 12 of 82 stool specimens of MERS patients were positive for MERS-CoV RNA (
       <xref ref-type="bibr" rid="R17">
        <italic>
         17
        </italic>
       </xref>
       ), suggesting the possible MERS-CoV infection in the gastrointestinal tract of these patients. To gather more evidence doe alimentary infection in MERS patients, these positive specimens were analyzed with a quantitative reverse transcription polymerase chain reaction (RT-qPCR) assay for the detection of subgenomic RNA (sgRNA) of the nucleocapsid (N) gene, an intermediate in the replication cycle of MERS-CoV. Notably, N sgRNA was detected in the specimen and was confirmed by sequencing the qPCR product, which showed a typical sgRNA sequence with fused leader sequence, the predicted transcription regulatory site (TRS), and the body element of N gene (
       <xref ref-type="fig" rid="F1">
        Fig. 1D
       </xref>
       ). The presence of N sgRNA in the stool specimen suggested that MERS-CoV probably infected and replicated in the alimentary tract of the MERS patient. Together, the results in human primary intestinal epithelial cells and small intestine explants, together with the examination of the MERS patient’s specimen, indicated that MERS-CoV can infect and replicate in human intestinal epithelium.
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       Highly productive MERS-CoV infection in human intestinal organoids
      </title>
      <p>
       Generation of intestinal organoids from LGR5
       <sup>
        +
       </sup>
       tissue-resident adult stem cells in human intestines has been a major breakthrough in the past years. The differentiated intestinal organoids harbor all types of epithelial cells in human intestine and can simulate most morphological and functional properties of in vivo tissues (
       <xref ref-type="bibr" rid="R18">
        <italic>
         18
        </italic>
       </xref>
       ). Therefore, three-dimensional cultured intestinal organoids, also known as intestinoids or mini-gut, have been used to model human diseases (
       <xref ref-type="bibr" rid="R19">
        <italic>
         19
        </italic>
       </xref>
       ), including the infection of enteric viruses and bacteria (
       <xref ref-type="bibr" rid="R20">
        <italic>
         20
        </italic>
       </xref>
       ,
       <xref ref-type="bibr" rid="R21">
        <italic>
         21
        </italic>
       </xref>
       ).
      </p>
      <p>
       We characterized MERS-CoV infectivity and replication kinetics in human intestinoids. At 48 hours after inoculation, viral loads increased by about 3 log units in the intestinoids and in the Matrigel and medium (
       <xref ref-type="fig" rid="F2">
        Fig. 2A
       </xref>
       ) after inoculation with a multiplicity of infection (MOI) of 1. The infected intestinoids developed progressive cytopathic effects over time. Thus, normalized viral loads in the infected intestinoids exhibited a constant increment within the 48-hour observation window (
       <xref ref-type="fig" rid="F2">
        Fig. 2B
       </xref>
       ). Accordingly, plaque assays revealed a significantly increased viral titer of 3 log units in the Matrigel and medium at 48 hpi (
       <xref ref-type="fig" rid="F2">
        Fig. 2C
       </xref>
       ). The infection efficiency of MERS-CoV in intestinoids, that is, the percentage of MERS-CoV–infected intestinal epithelial cells, was also examined with flow cytometry. At 2 hpi, about 5% of the cells within the intestinoids were MERS-CoV NP–positive. The percentage of NP-positive cells significantly increased to approximately 25% at 24 hpi (
       <xref ref-type="fig" rid="F2">
        Fig. 2
       </xref>
       , D and E), suggesting a productive virus infection and spread in the intestinoids. The productive MERS-CoV infection in intestinoids was also evidenced by a strong signal of viral NP in the virus-inoculated intestinoids, albeit absent in the mock-infected organoids (
       <xref ref-type="fig" rid="F2">
        Fig. 2F
       </xref>
       ). In addition, we verified the expression of the MERS-CoV receptor DPP4, a major determinant for tissue tropism of MERS-CoV, in intestinal epithelial cells by immunofluorescence staining (fig. S2). Together, human intestinal organoids were highly susceptible to MERS-CoV and supported robust viral replication.
      </p>
      <fig fig-type="figure" id="F2" orientation="portrait" position="float">
       <label>
        Fig. 2
       </label>
       <caption>
        <title>
         MERS-CoV infection and replication in human intestinal organoids.
        </title>
        <p>
         The differentiated intestinoids were inoculated with MERS-CoV (MOI ≈ 0.05) in duplicate and then re-embedded in Matrigel and maintained in culture medium. (
         <bold>
          A
         </bold>
         ) At the indicated hpi, intestinoids (Intestinoid), cell-free Matrigel, and culture medium (Matrigel) were harvested for the quantification of viral load with RT-qPCR. Serially diluted MERS-CoV NP plasmids were used to generate a standard curve for the quantification. (
         <bold>
          B
         </bold>
         ) The absolute viral loads in intestinoids were normalized with GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA transcripts. (
         <bold>
          C
         </bold>
         ) The dissolved Matrigel and culture medium were applied to viral titration with plaque assay. Data are means ± SD of one representative experiment independently repeated three times. (
         <bold>
          D
         </bold>
         and
         <bold>
          E
         </bold>
         ) At 24 hpi, the infected and mock-infected intestinoids were fixed after disassociation and stained with the MERS-CoV NP antiserum and then applied to flow cytometry to evaluate the percentage of NP-positive cells. The histogram shows the results of one representative experiment. (E) Data are means and SD of three independent experiments. Student’s
         <italic>
          t
         </italic>
         test was used for data analysis. **
         <italic>
          P
         </italic>
         ≤ 0.01. (
         <bold>
          F
         </bold>
         ) At 24 hpi, the infected (MERS-CoV) and mock-infected intestinoids, after fixation and immunofluorescence staining of MERS-CoV NP and CK19, were whole-mounted and imaged with a confocal microscope.
        </p>
       </caption>
       <graphic xlink:href="aao4966-F2">
       </graphic>
      </fig>
     </sec>
     <sec disp-level="2">
      <title>
       Viability of MERS-CoV in gastrointestinal fluids
      </title>
      <p>
       The ability to retain viability in gastrointestinal fluids is a prerequisite for a microbe to establish infection in the human alimentary tract. In this regard, we assessed whether MERS-CoV can maintain infectivity in simulated human gastrointestinal fluids. As shown in
       <xref ref-type="fig" rid="F3">
        Fig. 3
       </xref>
       , MERS-CoV rapidly lost most of the infectivity in fasted-state simulated gastric fluid (FaSSGF; pH 2.0). We assume that, in a real-life scenario, the virus is more likely to be exposed to fed-state gastrointestinal fluids because it is supposed to access the stomach during food intake. Thus, we tested the infectivity of MERS-CoV after exposure to fed-state simulated gastric fluid (FeSSGF) or fed-state simulated intestinal fluid (FeSSIF), which contains a high concentration of bile salts that solubilize the lipid membrane of enveloped viruses. The results showed that MERS-CoV survived FeSSGF while being less tolerant to FeSSIF. Nevertheless, a small proportion of the virus can survive FeSSIF after treatment for 2 hours. As a control, EV71, a prototype human enterovirus, was generally resistant to all the tested gastrointestinal fluids. Another human coronavirus, hCoV-229E, which often causes mild respiratory infection, showed a comparable sensitivity to FaSSGF and FeSSGF to MERS-CoV, but was much less resistant to the intestinal fluid than MERS-CoV. All viruses exhibited considerable stability in Dulbecco's modified Eagle’s medium (DMEM) over a period of 2 hours. Collectively, MERS-CoV was able to resist, to some extent, the digestive enzymes and bile salts in the human gastrointestinal tract, although the virus was less tolerant to the high acidity of fasted-state gastric fluid.
      </p>
      <fig fig-type="figure" id="F3" orientation="portrait" position="float">
       <label>
        Fig. 3
       </label>
       <caption>
        <title>
         MERS-CoV treatment with simulated gastrointestinal fluids.
        </title>
        <p>
         MERS-CoV solution [7.5 × 10
         <sup>
          6
         </sup>
         plaque-forming units (PFU), 500 μl] was mixed with 5 ml of FaSSGF, FeSSGF, FeSSIF, or DMEM and then incubated at 37°C for the indicated minutes. An aliquot (1 ml) of the virus/fluid mixture was sampled for virus titration in Vero-E6 cells in triplicate after neutralization with sodium hydroxide. The enterovirus EV71 and the human coronavirus hCoV-229E were treated with the same gastrointestinal fluids and titrated with TCID
         <sub>
          5
         </sub>
         <sub>
          0
         </sub>
         (median tissue culture infectious dose) assay in RD cells and plaque assay in Huh7 cells, respectively. Data are from a representative experiment independently performed three times.
        </p>
       </caption>
       <graphic xlink:href="aao4966-F3">
       </graphic>
      </fig>
     </sec>
     <sec disp-level="2">
      <title>
       MERS-CoV infection and virus release in polarized intestinal epithelial cells
      </title>
      <p>
       Caco-2 cells cultured in Transwell inserts can undergo spontaneous differentiation, display morphological and functional features of enterocytes, and form an intact permeability barrier, which could be reflected by heightened transepithelial electronic resistance (TEER), blockage of fluorescent molecule penetration, and formation of cell adhesion architecture (
       <xref ref-type="bibr" rid="R22">
        <italic>
         22
        </italic>
       </xref>
       ). Thus, polarized Caco-2 cells in Transwell culture have been used to model human gastrointestinal epithelium and cellular barrier across the epithelium (
       <xref ref-type="bibr" rid="R22">
        <italic>
         22
        </italic>
       </xref>
       ). We used the polarized Caco-2 cells to recapitulate the kinetics of viral growth and pattern of virus release in human intestinal epithelium after MERS-CoV inoculation.
      </p>
      <p>
       After 2 weeks of Transwell culture, the polarized Caco-2 cells formed an intact epithelial barrier, as shown in fig. S3. The cell monolayers were then apically or basolaterally inoculated with MERS-CoV at an MOI of 0.1. Cell-free media in the upper and bottom chambers were harvested at the indicated time points for viral load quantification. Because of the formation of an intact epithelial barrier in the polarized Caco-2 cells, the viral loads detected from the media of the upper and bottom chambers can reflect the genuine pattern of virus release. As shown in
       <xref ref-type="fig" rid="F4">
        Fig. 4A
       </xref>
       , after both apical and basolateral inoculation, the virus significantly replicated and bilaterally released into the media in the upper and bottom chambers. No infectious virus was detectable in the culture media at 2 hpi, whereas progeny virions were released from the apical and basolateral sides in both inoculation routes at 24 hpi (
       <xref ref-type="fig" rid="F4">
        Fig. 4B
       </xref>
       ). In addition, apical inoculation was more effective in establishing infection than basolateral inoculation. At 24 hours after a high MOI (2.0) inoculation, the infection rate, that is, the percentage of MERS-CoV NP–positive cells in apical inoculation, was significantly higher than that in basolateral inoculation (
       <italic>
        P
       </italic>
       = 0.038,
       <xref ref-type="fig" rid="F4">
        Fig. 4C
       </xref>
       ). Accordingly, the active caspase-3–positive cells, which underwent virus-induced apoptosis, were significantly more abundant in apical inoculation than in basolateral inoculation (
       <italic>
        P
       </italic>
       = 0.001). The higher infection efficiency in apical inoculation was further substantiated in immunofluorescence staining, which markedly revealed more abundant NP-positive cells via apical inoculation than basolateral inoculation (
       <xref ref-type="fig" rid="F4">
        Fig. 4D
       </xref>
       ). Collectively, both apical and basolateral inoculations of MERS-CoV resulted in robust viral replication in the polarized Caco-2 cells. Progeny virions were released bilaterally upon infection. Moreover, apical MERS-CoV inoculation was more effective in establishing infection than basolateral inoculation.
      </p>
      <fig fig-type="figure" id="F4" orientation="portrait" position="float">
       <label>
        Fig. 4
       </label>
       <caption>
        <title>
         MERS-CoV replication and cell apoptosis in the polarized Caco-2 cells.
        </title>
        <p>
         (
         <bold>
          A
         </bold>
         and
         <bold>
          B
         </bold>
         ) The polarized Caco-2 cells were inoculated with MERS-CoV in duplicate from the apical or basolateral side of the monolayer with an MOI of 0.1. At the indicated hpi, cell-free media were harvested from the upper and bottom chambers for viral load quantification. The experiments were independently performed twice. A representative experiment is presented. (A) Viral gene copy number in the medium collected from the upper chamber (Apical release) and bottom chamber (Basolateral release) after apical inoculation (Apical inoc) and basolateral inoculation (Basolateral inoc). (B) Viral titer in the media harvested at 24 hpi detected by plaque assay. No plaque was detected in the media at 2 hpi. (
         <bold>
          C
         </bold>
         and
         <bold>
          D
         </bold>
         ) The polarized Caco-2 cells were inoculated from the apical or basolateral side with MERS-CoV at an MOI of 2 or mock-inoculated. (C) At 24 hpi, cells were fixed after dissociation and applied to flow cytometry to detect the expression of MERS-CoV NP and activated caspase-3. The left and middle panels are the histograms of one representative experiment. The right panel presents means and SD of three independent experiments. *
         <italic>
          P
         </italic>
         ≤ 0.05. (D) At 24 hpi, the polarized Caco-2 cells seeded on polycarbonate membranes were fixed and applied to immunofluorescence staining of MERS-CoV NP (red) and imaged en face.
        </p>
       </caption>
       <graphic xlink:href="aao4966-F4">
       </graphic>
      </fig>
     </sec>
     <sec disp-level="2">
      <title>
       MERS-CoV infection in hDPP4 transgenic mice
      </title>
      <p>
       We proceeded to evaluate whether direct intragastric MERS-CoV inoculation in the hDPP4 transgenic mouse can cause gastrointestinal infection and whether the gastrointestinal infection is followed by a respiratory infection. The hDPP4 mouse experiments were performed using our previously established mouse model of MERS-CoV infection (
       <xref ref-type="bibr" rid="R23">
        <italic>
         23
        </italic>
       </xref>
       ). First, nine female mice were inoculated with 10
       <sup>
        5
       </sup>
       PFU of MERS-CoV via intragastric gavage; three of them were pretreated with a proton pump inhibitor, pantoprazole, to improve the viability of MERS-CoV in the mouse stomach because the in vitro experiment suggested the acid lability of MERS-CoV. At day 5 after virus inoculation, three pantoprazole-pretreated mice and three phosphate-buffered saline (PBS)–pretreated mice were sacrificed. At day 8 after inoculation, two mice lost more than 10% of their body weight and were sacrificed, whereas one mouse succumbed to the infection. Thus, direct intragastric MERS-CoV inoculation in hDPP4 mice may result in a lethal infection. To characterize the early events after intragastric MERS-CoV inoculation, nine female hDPP4 mice were inoculated via intragastric gavage; three mice were sacrificed at days 1, 3, and 5 after challenge, respectively. In addition, to exclude possible virus access to the airway during intragastric gavage, we directly injected 10
       <sup>
        5
       </sup>
       PFU of MERS-CoV into the stomach (intragastric injection hereafter) of 12 hDPP4 mice after a minor laparotomy. Six mice were pretreated with pantoprazole or mock-treated with PBS before the inoculation; three mice of each group were sacrificed at days 3 and 5 after inoculation.
      </p>
      <p>
       Histopathological examination revealed that small intestines of all intragastrically inoculated mice displayed increased mononuclear cell infiltration in the lamina propria, with broadening of the intestinal villi and increased sloughing of surface epithelium. The intervening mucosa was basically normal.
       <xref ref-type="fig" rid="F5">
        Figure 5A
       </xref>
       (a to c) shows the pathology of small intestines in the mice sacrificed at days 1, 3, and 5 after inoculation, respectively, indicating deteriorating inflammation and epithelial degeneration after virus inoculation. The pantoprazole-treated mice sacrificed at day 5 displayed more extensive and more prominent pathology in small intestine than the PBS-treated mice (
       <xref ref-type="fig" rid="F5">
        Fig. 5A
       </xref>
       , d and e). The mock-infected mouse showed a negligible pathological change in the intestines (
       <xref ref-type="fig" rid="F5">
        Fig. 5A
       </xref>
       , f). Immunofluorescence staining was performed to identify the viral antigen (NP)–positive cell in the intestines of the inoculated mice. It was shown that intestinal epithelial cells were intensively infected at day 1 after inoculation (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , a to c). The infected cells were patchily distributed in the surface epithelia of small intestines (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , a and b). In some areas, the infected enterocytes formed syncytia (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , c, and fig. S4, A and B). At days 5 and 8 after inoculation, the NP-positive cells were distributed more widely in small intestines and emerged in the lamina propria (arrows in
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , d to f) and Peyer’s patch (arrowhead in
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , d). Double staining of viral NP and CD68 revealed that some infected cells in the lamina propria were macrophages (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , f). Consistent with the massive inflammatory infiltration in small intestines of the inoculated mice as shown by hematoxylin and eosin (H&amp;E) staining, CD3-positive lymphocytes were more abundant in the infected mice (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , a, b, and e) than those in the mock-infected mouse (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , h). Although there was no overt pathology in colon epithelium, NP-positive epithelial cells were nevertheless sparsely distributed in colon epithelium of infected mice (
       <xref ref-type="fig" rid="F5">
        Fig. 5B
       </xref>
       , g). The viral load increased in small intestines of intragastrically injected mice, especially in the pantoprazole-pretreated mice (
       <xref ref-type="fig" rid="F5">
        Fig. 5C
       </xref>
       ), indicating a correlation between viral replication and intestinal pathology. However, the attempt to identify live virus from the intestine failed because the inoculation of the intestine homogenates, even the diluted homogenates, caused significant cell death and detachment of the monolayers.
      </p>
      <fig fig-type="figure" id="F5" orientation="portrait" position="float">
       <label>
        Fig. 5
       </label>
       <caption>
        <title>
         MERS-CoV enteric infection in hDPP4 transgenic mice.
        </title>
        <p>
         hDPP4 mice were inoculated with MERS-CoV via direct intragastric gavage or intragastrically injected as described in Materials and Methods. (
         <bold>
          A
         </bold>
         ) (a to c) Representative histopathology in small intestines at days 1, 3, and 5 after inoculation, respectively. (d and e) Small intestines of pantoprazole-pretreated mice at day 5 after inoculation. (f) Small intestine of a mock-infected mouse. H&amp;E staining, magnification ×200. (
         <bold>
          B
         </bold>
         ) Identification of MERS-CoV–infected cells in the intestines of the inoculated hDPP4 mice with immunostaining of NP and cell type markers. (a to c) Virus-positive enterocytes in mice at day 1 after inoculation. The infected enterocytes (c) form syncytia. (d to f) Virus-infected cells in mouse intestines at days 5 and 8 after inoculation, respectively. Arrows show NP-positive cells in the lamina propria, including the NP/CD68 double-positive macrophage (f). The arrowhead (in d) indicates virus-positive cells in Peyer’s patch. (g) Virus-positive cells in the colon of an inoculated mouse. (h) Costaining of NP/CD3 in the mock-infected mouse. (
         <bold>
          C
         </bold>
         ) Three intragastrically injected mice of the indicated groups were sacrificed at the indicated day after inoculation; intestine homogenates were applied for the quantification of viral load by RT-qPCR. The gray and black bars represent the viral loads of the mice pretreated with pantoprazole and mock-treated with PBS, respectively. Data are means and SD of three mice.
        </p>
       </caption>
       <graphic xlink:href="aao4966-F5">
       </graphic>
      </fig>
      <p>
       In the early phase up to day 5 after virus inoculation, the lung tissues of the inoculated mice showed minimal degree of inflammation (
       <xref ref-type="fig" rid="F6">
        Fig. 6A
       </xref>
       , a). However, the pantoprazole-pretreated mice, which were sacrificed at the same day after inoculation, exhibited prominent pulmonary inflammation (
       <xref ref-type="fig" rid="F6">
        Fig. 6A
       </xref>
       , b and c). Histological examination revealed marked infiltration of mononuclear cells and lymphocytes in the alveolar septa, indicating interstitial inflammation. Without pantoprazole pretreatment, the mice also exhibited inflammatory infiltration in the lung tissue at day 8 after intragastric gavage (
       <xref ref-type="fig" rid="F6">
        Fig. 6A
       </xref>
       , d). Notably, NP-positive pneumocytes were identified in these mice (
       <xref ref-type="fig" rid="F6">
        Fig. 6A
       </xref>
       , f). As expected, the abundance and distribution of virus-positive cells in the lung tissues of intragastrically inoculated mice were more limited than those in the intranasally inoculated mouse (fig. S4C). Consistent with the viral propagation in small intestines of intragastrically injected mice, viral load was elevated in the lung tissues of these mice at day 5 after inoculation, particularly in the pantoprazole-pretreated mice (
       <xref ref-type="fig" rid="F6">
        Fig. 6B
       </xref>
       ). Notably, infectious virions were detected in the lung homogenates of the intragastrically injected mice at day 5 after inoculation by plaque assay (fig. S5), which further verified the lung infection in these mice (
       <xref ref-type="fig" rid="F6">
        Fig. 6A
       </xref>
       ). We and others (
       <xref ref-type="bibr" rid="R24">
        <italic>
         24
        </italic>
       </xref>
       ,
       <xref ref-type="bibr" rid="R25">
        <italic>
         25
        </italic>
       </xref>
       ) observed brain infection in the intranasally inoculated hDPP4 mice. Likewise, the intragastrically injected mice also developed brain infection. Infectious virions were detected in the brain homogenates at day 5 after infection (fig. S5). The infected mice exhibited increased viral loads in the brain tissues. In summary, the direct intragastric MERS-CoV inoculation initiated an infection in the intestinal mucosa, leading to progressive inflammation and epithelial degeneration. With the progression of intestinal MERS-CoV infection, a sequential respiratory infection occurred.
      </p>
      <fig fig-type="figure" id="F6" orientation="portrait" position="float">
       <label>
        Fig. 6
       </label>
       <caption>
        <title>
         Inflammation and MERS-CoV infection in the lung tissues of hDPP4 mice.
        </title>
        <p>
         (
         <bold>
          A
         </bold>
         ) Lung tissues in the mice without pantoprazole pretreatment (a) versus those in pantoprazole pretreatment (b and c) at day 5 after intragastric MERS-CoV inoculation. (d) Lung pathology in an inoculated mouse at day 8 after intragastric inoculation without pantoprazole pretreatment. (f) Lung tissue of a mock-infected mouse. H&amp;E staining, magnification ×200. (e) Immunostaining shows virus-positive cells (green) in the lung tissue of a mouse at day 8 after intragastric inoculation. (
         <bold>
          B
         </bold>
         ) Lung tissues were harvested from three intragastrically injected mice at the indicated day after inoculation and homogenized for the quantification of viral load by RT-qPCR. The gray and black bars represent the viral loads of the mice pretreated with pantoprazole and mock-treated with PBS, respectively. Data are means and SD of three mice.
        </p>
       </caption>
       <graphic xlink:href="aao4966-F6">
       </graphic>
      </fig>
     </sec>
    </sec>
    <sec disp-level="1" sec-type="discussion">
     <title>
      DISCUSSION
     </title>
     <p>
      The MERS epidemic has persisted for about 5 years. However, important issues related to the public health, such as mode of virus transmission and infection route, remain poorly understood. Because MERS primarily manifests as a respiratory infection, airway exposure is intuitively assumed to be the infection route, which contributes substantially to human MERS infections (
      <xref ref-type="bibr" rid="R3">
       <italic>
        3
       </italic>
      </xref>
      ,
      <xref ref-type="bibr" rid="R26">
       <italic>
        26
       </italic>
      </xref>
      ). Epidemiological studies, biological evaluation of the virus, and bioinformatic prediction collectively suggested that humans may also acquire MERS-CoV infection via the gastrointestinal tract. Here, we aimed to elucidate whether the gastrointestinal tract could serve as an alternative route to acquire MERS-CoV infection and whether gastrointestinal tract exposure to MERS-CoV may eventually lead to a respiratory infection.
     </p>
     <p>
      We demonstrated that human primary intestinal epithelial cells were highly susceptible to MERS-CoV and could support viral replication (
      <xref ref-type="fig" rid="F1">
       Fig. 1A
      </xref>
      ). MERS-CoV infection and replication were further verified in an ex vivo culture of human small intestine (
      <xref ref-type="fig" rid="F1">
       Fig. 1
      </xref>
      , B and C) and reinforced by identification of the viral replication intermediate in the stool specimen of a MERS patient (
      <xref ref-type="fig" rid="F1">
       Fig. 1D
      </xref>
      ). We further characterized MERS-CoV infection and replication in human intestinoids (
      <xref ref-type="fig" rid="F2">
       Fig. 2
      </xref>
      ), a novel ex vivo model system that can faithfully simulate the in vivo human intestinal epithelium. Notably, MERS-CoV replicated more robustly in human intestinoids than in primary respiratory epithelial cells and ex vivo lung tissues (
      <xref ref-type="bibr" rid="R27">
       <italic>
        27
       </italic>
      </xref>
      ,
      <xref ref-type="bibr" rid="R28">
       <italic>
        28
       </italic>
      </xref>
      ). The MERS-CoV receptor DPP4 is known as the major determinant of host and tissue tropisms in MERS-CoV (
      <xref ref-type="bibr" rid="R29">
       <italic>
        29
       </italic>
      </xref>
      ). According to the public database Human Protein Atlas, human small intestine expresses the highest level of DPP4 mRNA and protein among all human organs, including lung and bronchus. Thus, the abundantly expressed DPP4 in human intestine may account for high susceptibility of these cells to MERS-CoV.
     </p>
     <p>
      We also showed that MERS-CoV lost infectivity in highly acidic fasted-state gastric fluid, whereas it was considerably resistant to fed-state gastric fluid and intestinal fluid, which contains a large amount of digestive enzymes and bile salts (
      <xref ref-type="fig" rid="F3">
       Fig. 3
      </xref>
      ). It was documented that enveloped coronaviruses, unlike most enveloped viruses, are notably resistant to bile salts (
      <xref ref-type="bibr" rid="R30">
       <italic>
        30
       </italic>
      </xref>
      ). Here, we verified the stability of MERS-CoV in bile salts in a very stringent setting, where the viruses were incubated with 10 volumes of FeSSIF containing a high concentration of bile salts. However, the acid instability of MERS-CoV shown in
      <xref ref-type="fig" rid="F3">
       Fig. 3
      </xref>
      seemed paradoxical, now that the intragastric inoculation of MERS-CoV caused the enteric infection in hDPP4 mice. Coincidently, an earlier study with a similar experimental setting documented the acid lability of rotavirus (
      <xref ref-type="bibr" rid="R31">
       <italic>
        31
       </italic>
      </xref>
      ), a typical gastrointestinal virus that commonly causes gastroenteritis in mammals. In our study, apart from the same pH of 2.0 as in the previous study, pepsin was additionally supplemented to better simulate the authentic fasted-state gastric fluid. Thus, the lability of MERS-CoV in highly acidic FaSSGF, as shown in the in vitro assay, was probably an exaggerated result. In a real-life scenario, especially during food intake, the virus may not be exposed to such a large volume of pure gastrointestinal fluids as in the experimental setting.
     </p>
     <p>
      MERS-CoV intestinal infection was hinted in an earlier study of intranasally inoculated hDPP4 mice (
      <xref ref-type="bibr" rid="R24">
       <italic>
        24
       </italic>
      </xref>
      ), in which an increasing viral load was observed in mouse intestines after MERS-CoV inoculation. Here, we characterized MERS-CoV enteric infection in hDPP4 transgenic mice. After intragastric inoculation, the hDPP4 mice displayed viral antigen (NP)–positive cells, deteriorating inflammation, and epithelial degeneration in small intestines (
      <xref ref-type="fig" rid="F5">
       Fig. 5
      </xref>
      , A and B). The viral NP-positive cells, which were distributed focally at day 1 after inoculation, became more diffuse in intestinal mucosa over time (
      <xref ref-type="fig" rid="F5">
       Fig. 5B
      </xref>
      ). In Transwell culture, the infected Caco-2 cells can release progeny virions apically and basolaterally (
      <xref ref-type="fig" rid="F4">
       Fig. 4
      </xref>
      ). Thus, it was not unexpected that NP-positive cells appeared in the lamina propria and lymphoid tissue of small intestine as the enteric infection progressed (
      <xref ref-type="fig" rid="F5">
       Fig. 5B
      </xref>
      ). Likewise, it is conceivable that the viruses produced in the intestinal mucosa of hDPP4 mouse may access the lymph flow and/or the bloodstream via the abundant lymphatic vessels and venules in the lamina propria of small intestine, respectively; they could be further transported to right heart via the thoracic duct and superior vena cava, and are disseminated to the lungs. The intragastrically inoculated mice exhibited minimal lung pathology at the early phase. Interstitial pneumonia occurred as the enteric infection developed; meanwhile, NP-positive cells emerged in the pulmonary parenchyma (
      <xref ref-type="fig" rid="F6">
       Fig. 6A
      </xref>
      ). Correspondingly, live viruses were identified in the lung homogenates of intragastrically injected mice, in which aspiration of the virus inoculum into airway was basically excluded. Consistent with the possibility of hematogenous viral trafficking, the lung tissues of intragastrically inoculated mice showed prominent interstitial pneumonia with thickened alveolar septa and mononuclear cell filtration. As frequently reported in the intranasally inoculated hDPP4 mice, brain infection also occurred in our intragastrically infected mice (fig. S5). Thus, further investigation is required to exclude the possibility that the dysfunctional brainstem due to brain infection may be attributable to the lung infection. Nevertheless, our results indicated that the MERS-CoV pulmonary infection in hDPP4 mice was secondary to the intestinal infection. Clinically, respiratory symptoms may not be the initial presentations of MERS patients (
      <xref ref-type="bibr" rid="R32">
       <italic>
        32
       </italic>
      </xref>
      ,
      <xref ref-type="bibr" rid="R33">
       <italic>
        33
       </italic>
      </xref>
      ). Respiratory infection as a subsequent manifestation was documented in some MERS patients, whose onset of symptoms was diarrhea and fever. In a case report, lung inflammation was an incidental finding on chest radiograph. The patient subsequently developed severe respiratory disease and died (
      <xref ref-type="bibr" rid="R34">
       <italic>
        34
       </italic>
      </xref>
      ).
     </p>
     <p>
      Virus dissemination and infection of other organs after gastrointestinal tract exposure occur in other viruses. For example, the direct intragastric inoculation of the avian influenza virus H5N1 in ferrets and hamsters caused systemic viral dissemination via the bloodstream (
      <xref ref-type="bibr" rid="R35">
       <italic>
        35
       </italic>
      </xref>
      ). Human picornavirus, hepatitis A virus, enters the bloodstream after infecting human intestinal epithelium and ultimately establishes infection in the liver (
      <xref ref-type="bibr" rid="R36">
       <italic>
        36
       </italic>
      </xref>
      ). Apart from the respiratory tract, the human alimentary tract is another common site for viral entry. Enteric viruses and even some non-enteric viruses can bypass the physical barriers and infect susceptible cells in the alimentary tract. To date, six human coronaviruses have been identified as the causative agents of mild or severe respiratory infections. The concomitant gastrointestinal symptoms are frequently observed in some human coronaviruses. For example, the human coronavirus OC43, which is closely related to bovine coronavirus phylogenetically, caused gastrointestinal symptoms in up to 57% of the infected patients (
      <xref ref-type="bibr" rid="R37">
       <italic>
        37
       </italic>
      </xref>
      ). Notably, enteric involvement was verified in human infection of severe acute respiratory syndrome coronavirus (SARS-CoV), which caused a large-scale epidemic with more than 8000 human infections in 2002–2003 (
      <xref ref-type="bibr" rid="R38">
       <italic>
        38
       </italic>
      </xref>
      ). Active SARS-CoV replication was identified in the small and large intestine specimens from colonoscopy biopsy and autopsy (
      <xref ref-type="bibr" rid="R39">
       <italic>
        39
       </italic>
      </xref>
      ). A significant portion of SARS patients had gastrointestinal symptoms; the viral load was the highest in stool specimens, followed by nasopharyngeal aspiration specimens (
      <xref ref-type="bibr" rid="R40">
       <italic>
        40
       </italic>
      </xref>
      ). Thus, the human gastrointestinal tract was speculated to be the primary infection site of SARS-CoV (
      <xref ref-type="bibr" rid="R41">
       <italic>
        41
       </italic>
      </xref>
      ), which raised a fearsome concern of dual infectivity of SARS-CoV as being both a respiratory and gastrointestinal pathogen. However, no serious study has been reported to address the important issue. In contrast to the ambiguity of virus acquisition via the alimentary tract in human coronaviruses, it has been known that most animal coronaviruses, such as bovine coronavirus and porcine transmissible gastroenteritis virus, can primarily infect either the enteric or respiratory tract or sometimes translocate between sites (
      <xref ref-type="bibr" rid="R42">
       <italic>
        42
       </italic>
      </xref>
      ,
      <xref ref-type="bibr" rid="R43">
       <italic>
        43
       </italic>
      </xref>
      ). Until now, however, whether human and animal coronaviruses share similarity in terms of a dual acquisition route has remained unanswered. Here, we addressed this long-standing question in human intestinal epithelial cells, intestinal organoids, and hDPP4 transgenic mice. We demonstrate that the human intestinal tract serves as an alternative infection route for MERS-CoV. The knowledge obtained from this study will provide a scientific basis for the implementation of effective intervention/prevention strategies to halt the continuing MERS epidemic.
     </p>
    </sec>
    <sec disp-level="1" sec-type="materials|methods">
     <title>
      MATERIALS AND METHODS
     </title>
     <sec disp-level="2">
      <title>
       Virus infection in human primary intestinal epithelial cells, small intestine explants, intestinal organoids, and polarized Caco-2 cells
      </title>
      <p>
       MERS-CoV of the EMC/2012 strain was provided by R. Fouchier (Erasmus Medical Center) (
       <xref ref-type="bibr" rid="R1">
        <italic>
         1
        </italic>
       </xref>
       ). Clonetics normal human intestinal epithelial cells (InEpC, Lonza) were cultured in SmGM-2 Bullet medium with growth supplements. At 24 hours after MERS-CoV inoculation with an MOI of about 10, cells seeded on chamber slides were fixed with 4% paraformaldehyde and applied to immunofluorescence staining; cell-free medium and cells in a 96-well plate were harvested for the quantification of viral load with viral RNA extraction and RT-qPCR, as we described previously (
       <xref ref-type="bibr" rid="R44">
        <italic>
         44
        </italic>
       </xref>
       ). Under the protocol approved by Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB, UW 13-364), normal small intestine was obtained for virus inoculation from a patient who underwent surgical resection. The full-thickness tissue was excised into about 0.3 cm × 0.6 cm strips, positioned in a 12-well culture plate, and incubated with 10
       <sup>
        7
       </sup>
       PFU of MERS-CoV at 37°C for 2 hours. After the inoculated explants were rinsed with MEM supplemented with antibiotics, they were positioned onto Transwell inserts precoated with Matrigel. More Matrigel was applied to brace around the explants, with mucosa facing upward. The bottom chamber contained 1 ml of DMEM supplemented with six antibiotics (detailed information will be provided upon request). At the indicated hpi, the explants were harvested for the quantification of viral load and immunofluorescence staining after fixation.
      </p>
      <p>
       Intestinal organoids derived from normal human colon were cultured, and differentiation was induced as described elsewhere (
       <xref ref-type="bibr" rid="R18">
        <italic>
         18
        </italic>
       </xref>
       ). The differentiated intestinoids were mechanically sheared with Pasteur pipettes and incubated with MERS-CoV at 37°C for 2 hours with the addition of 10 μM Rho-associated coiled-coil–containing protein kinase (ROCK) inhibitor Y-27632 (STEMCELL Technologies) to inhibit spontaneous apoptosis during the inoculation. An inoculum of 10
       <sup>
        5
       </sup>
       PFU of MERS-CoV was used to infect one droplet of intestinoids (containing 50 to 100 intestinoids), with an estimated MOI of 0.05. After the inoculum was removed, the virus-inoculated intestinoids were rinsed with PBS and then re-embedded in Matrigel and cultured in a 24-well plate with culture medium. At the indicated hpi, the intestinoids were harvested for the quantification of viral load with RNA extraction and RT-qPCR, whereas cell-free Matrigel and culture medium were used for viral load detection and viral titration with plaque assay. In addition, infected or mock-infected intestinoids were fixed with 4% paraformaldehyde at 24 hpi, followed by immunofluorescence staining and confocal imaging. Moreover, a proportion of infected or mock-infected intestinoids, after fixation and antibody staining, were applied to flow cytometry for the examination of infection rate.
      </p>
      <p>
       Caco-2 cells were seeded on polycarbonate inserts (0.4 μm pore size) of a 12-well Transwell plate (Corning) at a cell density of 10
       <sup>
        5
       </sup>
       cells/cm
       <sup>
        2
       </sup>
       in DMEM supplemented with 10% fetal bovine serum (FBS). Culture medium was changed every 3 days. The TEER was measured every 3 days using Millicell ERS-2 Volt-Ohm Meter (EMD Millipore). To monitor the integrity of the Caco-2 monolayer as an epithelial barrier, at the indicated day after seeding, fluorescein isothiocyanate–dextran with a molecular weight of 10 k (Sigma-Aldrich) was added in the culture medium of the upper chamber at a concentration of 1 mg/ml and incubated at 37°C for 4 hours. Subsequently, the culture media were harvested from the upper and bottom chambers to detect the fluorescence intensity using the Victor XIII Multilabel Reader (PerkinElmer). When TEER and epithelial integrity reached a plateau after 2 weeks of Transwell culture, the polarized Caco-2 cells were inoculated with MERS-CoV from the apical or basolateral side of the monolayer at an MOI of 0.1 and then maintained in DMEM without FBS. At the indicated time points after inoculation, cell-free media were harvested from the upper and bottom chambers for viral load quantification and viral titration. To examine the MERS-CoV infection efficiency in the polarized Caco-2 cells, the cells were inoculated from the apical or basolateral side with MERS-CoV at an MOI of 2 or mock-inoculated. At 24 hpi, Caco-2 monolayers were disassociated into a single-cell suspension after incubation with 0.25% trypsin-EDTA for 30 min and then fixed for flow cytometry analysis after antibody staining. The polarized Caco-2 cells seeded on polycarbonate membranes were fixed and then excited from Transwell inserts for immunofluorescence staining.
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       Detection of subgenomic RNA in stool specimens of MERS patients
      </title>
      <p>
       We applied RT-PCR assays, using a leader-specific primer, and primer and probe targeting sequence downstream of the start codon of the most abundant N gene sgRNA to test whether sgRNA, the replication intermediate, is detectable in MERS-CoV RNA–positive stool specimens collected from MERS patients (
       <xref ref-type="bibr" rid="R17">
        <italic>
         17
        </italic>
       </xref>
       ). Oligonucleotide sequences are as follows: MERS-sgRNA-rtF, ACTTCCCCTCGTTCTCTTGCAG; MERS-sgRNA-rtP, FAM-CACGAGCTGCACCAAATAACACTGTCTC-BHQ; and MERS-sgRNA-rtR, GTAAGAGGGACTTTCCCGTGTTG. SSIII RT-PCR kit (Thermo Fisher Scientific) was used with 400 nM of each of the primers and 200 nM of the probe. Thermal cycling involved 10 min at 55°C for reverse transcription, followed by 3 min at 95°C and 45 cycles of 10 s at 95°C, 10 s at 56°C, and 20 s at 72°C. The products of sgRNA RT-PCR assay were analyzed on agarose gel, and tentative bands were sequenced.
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       MERS-CoV treatment with simulated gastrointestinal fluids
      </title>
      <p>
       FaSSGF, FeSSGF, and FeSSIF powders (Biorelevant) were prepared into solutions according to the manufacturer’s instruction. FaSSGF was additionally supplemented with pepsin (0.1 mg/ml; Sigma-Aldrich). A volume of 500 μl of MERS-CoV solution (7.5 × 10
       <sup>
        6
       </sup>
       PFU) was mixed with 5 ml of FaSSGF, FeSSIF, FeSSGF, or DMEM and then incubated at 37°C for the indicated minutes. An aliquot (1 ml) of the virus/fluid mixture was then sampled for virus titration in Vero-E6 cells after neutralization to pH 7.0 with 2.5 M sodium hydroxide. Human enterovirus EV71 and human coronavirus hCoV-229E were treated with the stimulated gastrointestinal fluids for comparison.
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       MERS-CoV infection in hDPP4 transgenic mice
      </title>
      <p>
       First, nine female hDPP4 mice, 8 to 9 weeks old, were inoculated with 10
       <sup>
        5
       </sup>
       PFU of MERS-CoV (200 μl) via direct intragastric gavage. Three mice were administered with the proton pump inhibitor pantoprazole (40 mg/kg body weight) or PBS via intraperitoneal injection 2 hours before the virus challenge. At day 5 after virus inoculation, three pantoprazole-treated and three PBS-treated mice were sacrificed to harvest the lung and intestine for histopathological examination and viral load detection. Next, nine female hDPP4 mice were infected via intragastric gavage to characterize the early events after MERS-CoV inoculation. At days 1, 3, and 5 after intragastric gavage of MERS-CoV, three mice were sacrificed to harvest the lung and intestine. To exclude the possible aspiration to the mouse airway during the intragastric gavage, 12 female mice, 6 of them pretreated with pantoprazole or mock-treated with PBS, were directly injected with 10
       <sup>
        5
       </sup>
       PFU of MERS-CoV (100 μl) into the mouse stomach after a 0.5-cm incision was made in the abdominal wall to expose the mouse stomach. Three pantoprazole- and PBS-treated mice were sacrificed at days 3 and 5 after infection. Mouse small intestine, lung, and brain were homogenized to detect live virus with plaque assay and quantify viral load with RT-qPCR. In each experiment, at least one mouse was inoculated with PBS as the mock infection control. The animal experiments were approved by the Institutional Animal Care and Use Committee of the Laboratory Animal Center, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology (BIME 2015-0025).
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       Immunofluorescence staining of the infected cells, intestinoids, and tissues
      </title>
      <p>
       To identify virus-positive cells, cells on chamber slides and Transwell inserts, human intestinoids, slides of human small intestine, or mouse tissues were subjected to immunofluorescence staining, as described previously (
       <xref ref-type="bibr" rid="R45">
        <italic>
         45
        </italic>
       </xref>
       ). Briefly, after permeabilization and blocking, cells, intestinoids, and tissues were stained with a guinea pig antiserum against MERS-CoV NP, followed with secondary antibodies including goat anti–guinea pig Alexa Fluor 488 immunoglobulin G (IgG) or goat anti–guinea pig Alexa Fluor 594 IgG (Abcam). For intestine explants and intestinoids, CK19 (YM3051, ImmunoWay), a marker of intestinal epithelial cell, was costained with an anti-NP antibody. To define the identity of the viral NP-positive cells in the tissues of infected hDPP4 mice, apart from the labeling of MERS-CoV NP, double staining was performed using a rat anti-mouse monoclonal CD68 antibody (FA-11, Abcam) and Alexa Fluor 568 goat anti-rat IgG (Life Technologies). After staining, intestinoids were whole-mounted with VECTASHIELD HardSet Antifade Mounting Medium (Vector Laboratories). The whole-mounted intestinoids, chamber slides, Transwell inserts, and tissue slides were imaged using a Carl Zeiss LSM 780 or 800 confocal microscope.
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       Flow cytometry analysis
      </title>
      <p>
       MERS-CoV–infected human intestinoids and Transwell-cultured Caco-2 cells were digested into a single-cell suspension and fixed with 4% paraformaldehyde. MERS-CoV–positive cell was detected with the same MERS-CoV NP antiserum and goat anti–guinea pig Alexa Fluor 488 IgG, as described above. Active caspase-3 was detected with an Alexa Fluor 647–conjugated rabbit anti-human active caspase-3 antibody (BD Pharmingen). Cell permeabilization for intracellular staining was performed with 0.1% Triton X-100 in PBS. Immunostaining for flow cytometry was performed following standard procedures (
       <xref ref-type="bibr" rid="R46">
        <italic>
         46
        </italic>
       </xref>
       ). The flow cytometry was performed using the FACSCanto II Analyzer (BD Biosciences), and data were analyzed using FlowJo vX (Tree Star).
      </p>
     </sec>
     <sec disp-level="2">
      <title>
       Statistical analysis
      </title>
      <p>
       Student’s
       <italic>
        t
       </italic>
       test was used for data analysis.
       <italic>
        P
       </italic>
       &lt; 0.05 was considered to be statistically significant.
      </p>
     </sec>
    </sec>
    <sec sec-type="supplementary-material">
     <title>
      Supplementary Material
     </title>
     <supplementary-material content-type="local-data" id="PMC_1">
      <caption>
       <title>
        http://advances.sciencemag.org/cgi/content/full/3/11/eaao4966/DC1
       </title>
      </caption>
      <media mime-subtype="html" mimetype="text" xlink:href="supp_3_11_eaao4966__index.html">
      </media>
      <media mime-subtype="pdf" mimetype="application" xlink:href="aao4966_SM.pdf" xlink:role="associated-file">
      </media>
     </supplementary-material>
    </sec>
    <back>
     <ack>
      <title>
       Acknowledgments
      </title>
      <p>
       We thank H. Clevers (Hubrecht Institute) for providing the reagents for organoid cultures. We also thank C. C. Y. Yip, J.-P. Cai, and Faculty Core Facility (Li Ka Shing Faculty of Medicine, University of Hong Kong) for technical assistance.
       <bold>
        Funding:
       </bold>
       The study is partly supported by the Health and Medical Research Fund (reference nos.14131392 and 15140762) of Food and Health Bureau; the National Natural Science Foundation of China/Research Grants Council Joint Research Scheme (N_HKU728/14); the Collaborative Research Fund (C7011-15R) of the Research Grants Council; the Theme-Based Research Scheme (T11/707/15) of the Research Grants Council, Hong Kong Special Administrative Region; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Ministry of Education of China; the National Project of Infectious Disease (2014ZX10004001004), Ministry of Science and Technology of China; the German Research Foundation (Deutsche Forschungsgemeinschaft grants DR772/12-1 and DR772/7-2); and the European Commission project PREPARE (contract number 602525).
       <bold>
        Author contributions:
       </bold>
       J.Z. and K.-Y.Y. designed the study. J.Z., C.L., H.C., D.W., V.K.-M.P., B.H.-Y.W., X.Z., M.C.C., D.Y., and Y.W. performed the in vitro experiments. H.H.-N.Y. and S.Y.L. provided the intestinal organoids. G.Z. and S.S. performed the animal experiments. J.Z., C.L., H.C., D.W., L.W., J.F.-W.C., K.K.-W.T., and I.F.-N.H. analyzed and interpreted the data. R.K.H.A.-Y. reviewed histopathology. I.H.-Y.C. provided the normal human intestine. Z.A.M., V.M.C., and C.D. examined the specimens of MERS patients. Y.Z. provided the hDPP4 mice. J.Z., H.C., J.F.-W.C., K.K.-W.T., and K.-Y.Y. wrote and revised the manuscript.
       <bold>
        Competing interests:
       </bold>
       S.Y.L. has received research sponsorship from Pfizer, Merck, and Servier. The sponsors were not involved in the study design, data collection, and analysis. The other authors declare that they have no competing interests.
       <bold>
        Data and materials availability:
       </bold>
       All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.
      </p>
     </ack>
     <app-group>
      <app>
       <title>
        SUPPLEMENTARY MATERIALS
       </title>
       <supplementary-material content-type="local-data">
        <p>
         Supplementary material for this article is available at
         <ext-link ext-link-type="uri" xlink:href="http://advances.sciencemag.org/cgi/content/full/3/11/eaao4966/DC1">
          http://advances.sciencemag.org/cgi/content/full/3/11/eaao4966/DC1
         </ext-link>
        </p>
        <p>
         fig. S1. MERS-CoV replication in human primary intestinal epithelial cells.
        </p>
        <p>
         fig. S2. Expression of human DPP4 on the surface of epithelial cells in intestinoids.
        </p>
        <p>
         fig. S3. Formation of intact epithelial barrier in the polarized Caco-2 cells after Transwell culture.
        </p>
        <p>
         fig. S4. The virus-positive cells in small intestine of an intragastrically inoculated mouse and those in the lung tissue of an intranasally inoculated mouse.
        </p>
        <p>
         fig. S5. Identification of live viruses in the lung and brain homogenates and increased viral load in the brain tissues of intragastrically injected mice.
        </p>
       </supplementary-material>
      </app>
     </app-group>
     <ref-list>
      <title>
       REFERENCES AND NOTES
      </title>
      <ref id="R1">
       <label>
        1
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zaki
          </surname>
          <given-names>
           A. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van Boheemen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bestebroer
          </surname>
          <given-names>
           T. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A. D. M. E.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fouchier
          </surname>
          <given-names>
           R. A. M.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
        </article-title>
        .
        <source>
         N. Engl. J. Med.
        </source>
        <volume>
         367
        </volume>
        ,
        <fpage>
         1814
        </fpage>
        –
        <lpage>
         1820
        </lpage>
        (
        <year>
         2012
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23075143
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R2">
       <label>
        2
       </label>
       <mixed-citation publication-type="web">
        World Health Organization,
        <italic>
         MERS-CoV Outbreak Update
        </italic>
        (World Health Organization, 2017);
        <ext-link ext-link-type="uri" xlink:href="www.who.int/emergencies/mers-cov/en/">
         www.who.int/emergencies/mers-cov/en/
        </ext-link>
        .
       </mixed-citation>
      </ref>
      <ref id="R3">
       <label>
        3
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           A. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Rabiah
          </surname>
          <given-names>
           F. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Hajjar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Barrak
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Flemban
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Nassir
          </surname>
          <given-names>
           W. N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Balkhy
          </surname>
          <given-names>
           H. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Hakeem
          </surname>
          <given-names>
           R. F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Makhdoom
          </surname>
          <given-names>
           H. Q.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           A. I.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study
        </article-title>
        .
        <source>
         Lancet Infect. Dis.
        </source>
        <volume>
         13
        </volume>
        ,
        <fpage>
         752
        </fpage>
        –
        <lpage>
         761
        </lpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23891402
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R4">
       <label>
        4
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           J. F. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lau
          </surname>
          <given-names>
           S. K. P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           To
          </surname>
          <given-names>
           K. K. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheng
          </surname>
          <given-names>
           V. C. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Woo
          </surname>
          <given-names>
           P. C. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K.-Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease
        </article-title>
        .
        <source>
         Clin. Microbiol. Rev.
        </source>
        <volume>
         28
        </volume>
        ,
        <fpage>
         465
        </fpage>
        –
        <lpage>
         522
        </lpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         25810418
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R5">
       <label>
        5
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Cauchemez
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Nouvellet
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cori
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jombart
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Garske
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Clapham
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Moore
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mills
          </surname>
          <given-names>
           H. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Salje
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Collins
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rodriquez-Barraquer
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Riley
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Truelove
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Algarni
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhakeem
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           AlHarbi
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Turkistani
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Aguas
          </surname>
          <given-names>
           R. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cummings
          </surname>
          <given-names>
           D. A. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Van Kerkhove
          </surname>
          <given-names>
           M. D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Donnelly
          </surname>
          <given-names>
           C. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lessler
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fraser
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Barrak
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ferguson
          </surname>
          <given-names>
           N. M.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Unraveling the drivers of MERS-CoV transmission
        </article-title>
        .
        <source>
         Proc. Natl. Acad. Sci. U.S.A.
        </source>
        <volume>
         113
        </volume>
        ,
        <fpage>
         9081
        </fpage>
        –
        <lpage>
         9086
        </lpage>
        (
        <year>
         2016
        </year>
        ).
        <pub-id pub-id-type="pmid">
         27457935
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R6">
       <label>
        6
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Adney
          </surname>
          <given-names>
           D. R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Brown
          </surname>
          <given-names>
           V. R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Scott
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Wit
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bowen
          </surname>
          <given-names>
           R. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Munster
          </surname>
          <given-names>
           V. J.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels
        </article-title>
        .
        <source>
         Emerg. Infect. Dis.
        </source>
        <volume>
         20
        </volume>
        ,
        <fpage>
         1999
        </fpage>
        –
        <lpage>
         2005
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         25418529
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R7">
       <label>
        7
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Reusken
          </surname>
          <given-names>
           C. B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farag
          </surname>
          <given-names>
           E. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jonges
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Godeke
          </surname>
          <given-names>
           G. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           El-Sayed
          </surname>
          <given-names>
           A. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pas
          </surname>
          <given-names>
           S. D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Raj
          </surname>
          <given-names>
           V. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mohran
          </surname>
          <given-names>
           K. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Moussa
          </surname>
          <given-names>
           H. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ghobashy
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhajri
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ibrahim
          </surname>
          <given-names>
           A. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bosch
          </surname>
          <given-names>
           B. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pasha
          </surname>
          <given-names>
           S. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Romaihi
          </surname>
          <given-names>
           H. E.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Thani
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Marri
          </surname>
          <given-names>
           S. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           AlHajri
          </surname>
          <given-names>
           M. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Haagmans
          </surname>
          <given-names>
           B. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Koopmans
          </surname>
          <given-names>
           M. P.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014
        </article-title>
        .
        <source>
         Euro. Surveill.
        </source>
        <volume>
         19
        </volume>
        ,
        <fpage>
         20829
        </fpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         24957745
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R8">
       <label>
        8
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Karesh
          </surname>
          <given-names>
           W. B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Munster
          </surname>
          <given-names>
           V. J.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus in milk
        </article-title>
        .
        <source>
         Emerg. Infect. Dis.
        </source>
        <volume>
         20
        </volume>
        ,
        <fpage>
         1263
        </fpage>
        –
        <lpage>
         1264
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         24960335
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R9">
       <label>
        9
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cotten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Watson
          </surname>
          <given-names>
           S. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alsahafi
          </surname>
          <given-names>
           A. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Rabeeah
          </surname>
          <given-names>
           A. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           V. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sieberg
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Makhdoom
          </surname>
          <given-names>
           H. Q.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Masri
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Aldabbagh
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bosch
          </surname>
          <given-names>
           B.-J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Beer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Müller
          </surname>
          <given-names>
           M. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kellam
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
        </article-title>
        .
        <source>
         Emerg. Infect. Dis.
        </source>
        <volume>
         20
        </volume>
        ,
        <fpage>
         1012
        </fpage>
        –
        <lpage>
         1015
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         24857749
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R10">
       <label>
        10
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Durai
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Batool
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Shah
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Choi
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus: Transmission, virology and therapeutic targeting to aid in outbreak control
        </article-title>
        .
        <source>
         Exp. Mol. Med.
        </source>
        <volume>
         47
        </volume>
        ,
        <fpage>
         e181
        </fpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26315600
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R11">
       <label>
        11
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus: Epidemiology and disease control measures
        </article-title>
        .
        <source>
         Infect. Drug Resist.
        </source>
        <volume>
         7
        </volume>
        ,
        <fpage>
         281
        </fpage>
        –
        <lpage>
         287
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         25395865
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R12">
       <label>
        12
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           S. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           N. S.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea
        </article-title>
        .
        <source>
         Int. J. Infect. Dis.
        </source>
        <volume>
         38
        </volume>
        ,
        <fpage>
         65
        </fpage>
        –
        <lpage>
         67
        </lpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26216766
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R13">
       <label>
        13
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           van Doremalen
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bushmaker
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Munster
          </surname>
          <given-names>
           V. J.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions
        </article-title>
        .
        <source>
         Euro. Surveill.
        </source>
        <volume>
         18
        </volume>
        ,
        <fpage>
         20590
        </fpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         24084338
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R14">
       <label>
        14
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Bin
          </surname>
          <given-names>
           S. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Heo
          </surname>
          <given-names>
           J. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Song
          </surname>
          <given-names>
           M.-S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kim
          </surname>
          <given-names>
           E.-H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Park
          </surname>
          <given-names>
           S. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kwon
          </surname>
          <given-names>
           H. I.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kim
          </surname>
          <given-names>
           S. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kim
          </surname>
          <given-names>
           Y.-i.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Si
          </surname>
          <given-names>
           Y.-J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           I.-W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Baek
          </surname>
          <given-names>
           Y. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Choi
          </surname>
          <given-names>
           W.-S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Min
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jeong
          </surname>
          <given-names>
           H. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Choi
          </surname>
          <given-names>
           Y. K.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea
        </article-title>
        .
        <source>
         Clin. Infect. Dis.
        </source>
        <volume>
         62
        </volume>
        ,
        <fpage>
         755
        </fpage>
        –
        <lpage>
         760
        </lpage>
        (
        <year>
         2016
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26679623
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R15">
       <label>
        15
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Goh
          </surname>
          <given-names>
           G. K.-M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dunker
          </surname>
          <given-names>
           A. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Uversky
          </surname>
          <given-names>
           V. N.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Understanding viral transmission behavior via protein intrinsic disorder prediction: Coronaviruses
        </article-title>
        .
        <source>
         J. Pathog.
        </source>
        <volume>
         2012
        </volume>
        ,
        <fpage>
         738590
        </fpage>
        (
        <year>
         2012
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23097708
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R16">
       <label>
        16
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Goh
          </surname>
          <given-names>
           G. K.-M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dunker
          </surname>
          <given-names>
           A. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Uversky
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission
        </article-title>
        .
        <source>
         PLOS Curr.
        </source>
        <volume>
         5
        </volume>
        (
        <year>
         2013
        </year>
        ).
       </mixed-citation>
      </ref>
      <ref id="R17">
       <label>
        17
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Corman
          </surname>
          <given-names>
           V. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Albarrak
          </surname>
          <given-names>
           A. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Omrani
          </surname>
          <given-names>
           A. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Albarrak
          </surname>
          <given-names>
           M. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Farah
          </surname>
          <given-names>
           M. E.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Almasri
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Muth
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sieberg
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyer
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           A. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Binger
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Steinhagen
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lattwein
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Müller
          </surname>
          <given-names>
           M. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection
        </article-title>
        .
        <source>
         Clin. Infect. Dis.
        </source>
        <volume>
         62
        </volume>
        ,
        <fpage>
         477
        </fpage>
        –
        <lpage>
         483
        </lpage>
        (
        <year>
         2016
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26565003
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R18">
       <label>
        18
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Sato
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Stange
          </surname>
          <given-names>
           D. E.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ferrante
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Vries
          </surname>
          <given-names>
           R. G.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Van Es
          </surname>
          <given-names>
           J. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Van den Brink
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Van Houdt
          </surname>
          <given-names>
           W. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pronk
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Van Gorp
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Siersema
          </surname>
          <given-names>
           P. D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Clevers
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium
        </article-title>
        .
        <source>
         Gastroenterology
        </source>
        <volume>
         141
        </volume>
        ,
        <fpage>
         1762
        </fpage>
        –
        <lpage>
         1772
        </lpage>
        (
        <year>
         2011
        </year>
        ).
        <pub-id pub-id-type="pmid">
         21889923
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R19">
       <label>
        19
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           S. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Xu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           S. P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yan
          </surname>
          <given-names>
           H. H. N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Shi
          </surname>
          <given-names>
           S. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Siu
          </surname>
          <given-names>
           H. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Deng
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           K. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Law
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           K. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           A. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tsui
          </surname>
          <given-names>
           W. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ho
          </surname>
          <given-names>
           S. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           A. K. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Man
          </surname>
          <given-names>
           J. L. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Foglizzo
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ng
          </surname>
          <given-names>
           M. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           A. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ching
          </surname>
          <given-names>
           Y. P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheng
          </surname>
          <given-names>
           G. H. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Xie
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fernandez
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           V. S. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Clevers
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Rejto
          </surname>
          <given-names>
           P. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mao
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Leung
          </surname>
          <given-names>
           S. Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
        </article-title>
        .
        <source>
         Nat. Genet.
        </source>
        <volume>
         46
        </volume>
        ,
        <fpage>
         573
        </fpage>
        –
        <lpage>
         582
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         24816253
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R20">
       <label>
        20
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Yin
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Bijvelds
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dang
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Xu
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van der Eijk
          </surname>
          <given-names>
           A. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Knipping
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tuysuz
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Dekkers
          </surname>
          <given-names>
           J. F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Jonge
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sprengers
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van der Laan
          </surname>
          <given-names>
           L. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Beekman
          </surname>
          <given-names>
           J. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ten Berge
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Metselaar
          </surname>
          <given-names>
           H. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           de Jonge
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Koopmans
          </surname>
          <given-names>
           M. P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peppelenbosch
          </surname>
          <given-names>
           M. P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Pan
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Modeling rotavirus infection and antiviral therapy using primary intestinal organoids
        </article-title>
        .
        <source>
         Antiviral Res.
        </source>
        <volume>
         123
        </volume>
        ,
        <fpage>
         120
        </fpage>
        –
        <lpage>
         131
        </lpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26408355
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R21">
       <label>
        21
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Finkbeiner
          </surname>
          <given-names>
           S. R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zeng
          </surname>
          <given-names>
           X.-L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Utama
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Atmar
          </surname>
          <given-names>
           R. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Shroyer
          </surname>
          <given-names>
           N. F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Estes
          </surname>
          <given-names>
           M. K.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Stem cell-derived human intestinal organoids as an infection model for rotaviruses
        </article-title>
        .
        <source>
         MBio
        </source>
        <volume>
         3
        </volume>
        ,
        <fpage>
         e00159-12
        </fpage>
        (
        <year>
         2012
        </year>
        ).
        <pub-id pub-id-type="pmid">
         22761392
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R22">
       <label>
        22
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Kauffman
          </surname>
          <given-names>
           A. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gyurdieva
          </surname>
          <given-names>
           A. V.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mabus
          </surname>
          <given-names>
           J. R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ferguson
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yan
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hornby
          </surname>
          <given-names>
           P. J.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Alternative functional in vitro models of human intestinal epithelia
        </article-title>
        .
        <source>
         Front. Pharmacol.
        </source>
        <volume>
         4
        </volume>
        ,
        <fpage>
         79
        </fpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23847534
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R23">
       <label>
        23
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zhao
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jiang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Qiu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gao
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zeng
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Guo
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kou
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Du
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tan
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jiang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sun
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhou
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus
        </article-title>
        .
        <source>
         PLOS ONE
        </source>
        <volume>
         10
        </volume>
        ,
        <fpage>
         e0145561
        </fpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26701103
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R24">
       <label>
        24
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Tao
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Garron
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Agrawal
          </surname>
          <given-names>
           A. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Algaissi
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peng
          </surname>
          <given-names>
           B.-H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wakamiya
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           T.-S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lu
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Du
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jiang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Couch
          </surname>
          <given-names>
           R. B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tseng
          </surname>
          <given-names>
           C.-T.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Characterization and demonstration of the value of a lethal mouse model of Middle East respiratory syndrome coronavirus infection and disease
        </article-title>
        .
        <source>
         J. Virol.
        </source>
        <volume>
         90
        </volume>
        ,
        <fpage>
         57
        </fpage>
        –
        <lpage>
         67
        </lpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26446606
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R25">
       <label>
        25
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wohlford-Lenane
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perlman
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhao
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jewell
          </surname>
          <given-names>
           A. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Reznikov
          </surname>
          <given-names>
           L. R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gibson-Corley
          </surname>
          <given-names>
           K. N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Meyerholz
          </surname>
          <given-names>
           D. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           McCray
          </surname>
          <given-names>
           P. B.
          </given-names>
          <suffix>
           Jr
          </suffix>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4
        </article-title>
        .
        <source>
         J. Infect. Dis.
        </source>
        <volume>
         213
        </volume>
        ,
        <fpage>
         712
        </fpage>
        –
        <lpage>
         722
        </lpage>
        (
        <year>
         2016
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26486634
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R26">
       <label>
        26
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Gautret
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gray
          </surname>
          <given-names>
           G. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Charrel
          </surname>
          <given-names>
           R. N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Odezulu
          </surname>
          <given-names>
           N. G.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Emerging viral respiratory tract infections—Environmental risk factors and transmission
        </article-title>
        .
        <source>
         Lancet Infect. Dis.
        </source>
        <volume>
         14
        </volume>
        ,
        <fpage>
         1113
        </fpage>
        –
        <lpage>
         1122
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         25189350
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R27">
       <label>
        27
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zielecki
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Weber
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Eickmann
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Spiegelberg
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zaki
          </surname>
          <given-names>
           A. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Matrosovich
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Becker
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Weber
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         J. Virol.
        </source>
        <volume>
         87
        </volume>
        ,
        <fpage>
         5300
        </fpage>
        –
        <lpage>
         5304
        </lpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23449793
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R28">
       <label>
        28
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           R. W. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           M. C. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Agnihothram
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           L. L. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kuok
          </surname>
          <given-names>
           D. I. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Fong
          </surname>
          <given-names>
           J. H. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           L. L. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Baric
          </surname>
          <given-names>
           R. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Nicholls
          </surname>
          <given-names>
           J. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peiris
          </surname>
          <given-names>
           J. S. M.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures
        </article-title>
        .
        <source>
         J. Virol.
        </source>
        <volume>
         87
        </volume>
        ,
        <fpage>
         6604
        </fpage>
        –
        <lpage>
         6614
        </lpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23552422
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R29">
       <label>
        29
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zhou
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           J. F.-W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K.-Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus infection: Virus-host cell interactions and implications on pathogenesis
        </article-title>
        .
        <source>
         Virol. J.
        </source>
        <volume>
         12
        </volume>
        ,
        <fpage>
         218
        </fpage>
        (
        <year>
         2015
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26690369
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R30">
       <label>
        30
       </label>
       <mixed-citation publication-type="book">
        P. J. Quin, B. K. Markey, F. C. Leonard, E. S. Fitzpatrick, S. Fanning, P. Hartigan,
        <italic>
         Veterinary Microbiology and Microbial Disease
        </italic>
        (Wiley-Blackwell, ed. 2, 2011).
       </mixed-citation>
      </ref>
      <ref id="R31">
       <label>
        31
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Weiss
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Clark
          </surname>
          <given-names>
           H. F.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice
        </article-title>
        .
        <source>
         J. Gen. Virol.
        </source>
        <volume>
         66
        </volume>
        (
        <issue>
         Pt. 12
        </issue>
        ),
        <fpage>
         2725
        </fpage>
        –
        <lpage>
         2730
        </lpage>
        (
        <year>
         1985
        </year>
        ).
        <pub-id pub-id-type="pmid">
         2999315
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R32">
       <label>
        32
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Assiri
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           McGeer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Perl
          </surname>
          <given-names>
           T. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Price
          </surname>
          <given-names>
           C. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al Rabeeah
          </surname>
          <given-names>
           A. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cummings
          </surname>
          <given-names>
           D. A. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alabdullatif
          </surname>
          <given-names>
           Z. N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Assad
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Almulhim
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Makhdoom
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Madani
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Alhakeem
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Tawfiq
          </surname>
          <given-names>
           J. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cotten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Watson
          </surname>
          <given-names>
           S. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kellam
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           A. I.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
        </person-group>
        ;
        <collab>
         KSA MERS-CoV Investigation Team
        </collab>
        ,
        <article-title>
         Hospital outbreak of Middle East respiratory syndrome coronavirus
        </article-title>
        .
        <source>
         N. Engl. J. Med.
        </source>
        <volume>
         369
        </volume>
        ,
        <fpage>
         407
        </fpage>
        –
        <lpage>
         416
        </lpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23782161
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R33">
       <label>
        33
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Memish
          </surname>
          <given-names>
           Z. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zumla
          </surname>
          <given-names>
           A. I.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Hakeem
          </surname>
          <given-names>
           R. F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Al-Rabeeah
          </surname>
          <given-names>
           A. A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Stephens
          </surname>
          <given-names>
           G. M.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Family cluster of Middle East respiratory syndrome coronavirus infections
        </article-title>
        .
        <source>
         N. Engl. J. Med.
        </source>
        <volume>
         368
        </volume>
        ,
        <fpage>
         2487
        </fpage>
        –
        <lpage>
         2494
        </lpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23718156
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R34">
       <label>
        34
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Mailles
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Blanckaert
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chaud
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           van der Werf
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lina
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Caro
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Campese
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Guéry
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Prouvost
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lemaire
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Paty
          </surname>
          <given-names>
           M. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Haeghebaert
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Antoine
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ettahar
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Noel
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Behillil
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hendricx
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Manuguerra
          </surname>
          <given-names>
           J. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Enouf
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           La Ruche
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Semaille
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Coignard
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lévy-Bruhl
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Weber
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Saura
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Che
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        ;
        <collab>
         Collective The investigation team
        </collab>
        ,
        <article-title>
         First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013
        </article-title>
        .
        <source>
         Euro. Surveill.
        </source>
        <volume>
         18
        </volume>
        ,
        <fpage>
         20502
        </fpage>
        (
        <year>
         2013
        </year>
        ).
        <pub-id pub-id-type="pmid">
         23787161
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R35">
       <label>
        35
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Shinya
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Makino
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tanaka
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hatta
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Watanabe
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Le
          </surname>
          <given-names>
           M. Q.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Imai
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kawaoka
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Systemic dissemination of H5N1 influenza A viruses in ferrets and hamsters after direct intragastric inoculation
        </article-title>
        .
        <source>
         J. Virol.
        </source>
        <volume>
         85
        </volume>
        ,
        <fpage>
         4673
        </fpage>
        –
        <lpage>
         4678
        </lpage>
        (
        <year>
         2011
        </year>
        ).
        <pub-id pub-id-type="pmid">
         21411541
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R36">
       <label>
        36
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Martin
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lemon
          </surname>
          <given-names>
           S. M.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Hepatitis A virus: From discovery to vaccines
        </article-title>
        .
        <source>
         Hepatology
        </source>
        <volume>
         43
        </volume>
        ,
        <fpage>
         S164
        </fpage>
        –
        <lpage>
         S172
        </lpage>
        (
        <year>
         2006
        </year>
        ).
        <pub-id pub-id-type="pmid">
         16447259
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R37">
       <label>
        37
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Vabret
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Mourez
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Gouarin
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Petitjean
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Freymuth
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         An outbreak of coronavirus OC43 respiratory infection in Normandy, France
        </article-title>
        .
        <source>
         Clin. Infect. Dis.
        </source>
        <volume>
         36
        </volume>
        ,
        <fpage>
         985
        </fpage>
        –
        <lpage>
         989
        </lpage>
        (
        <year>
         2003
        </year>
        ).
        <pub-id pub-id-type="pmid">
         12684910
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R38">
       <label>
        38
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Peiris
          </surname>
          <given-names>
           J. S. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lai
          </surname>
          <given-names>
           S. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           L. L. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yam
          </surname>
          <given-names>
           L. Y. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lim
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Nicholls
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yee
          </surname>
          <given-names>
           W. K. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yan
          </surname>
          <given-names>
           W. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheung
          </surname>
          <given-names>
           M. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheng
          </surname>
          <given-names>
           V. C. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           K. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tsang
          </surname>
          <given-names>
           D. N. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yung
          </surname>
          <given-names>
           R. W. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ng
          </surname>
          <given-names>
           T. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K. Y.
          </given-names>
         </name>
        </person-group>
        :
        <collab>
         SARS study group
        </collab>
        ,
        <article-title>
         Coronavirus as a possible cause of severe acute respiratory syndrome
        </article-title>
        .
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        ,
        <fpage>
         1319
        </fpage>
        –
        <lpage>
         1325
        </lpage>
        (
        <year>
         2003
        </year>
        ).
        <pub-id pub-id-type="pmid">
         12711465
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R39">
       <label>
        39
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Leung
          </surname>
          <given-names>
           W. K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           To
          </surname>
          <given-names>
           K.-f.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           P. K. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           H. L. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wu
          </surname>
          <given-names>
           A. K. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sung
          </surname>
          <given-names>
           J. J. Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection
        </article-title>
        .
        <source>
         Gastroenterology
        </source>
        <volume>
         125
        </volume>
        ,
        <fpage>
         1011
        </fpage>
        –
        <lpage>
         1017
        </lpage>
        (
        <year>
         2003
        </year>
        ).
        <pub-id pub-id-type="pmid">
         14517783
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R40">
       <label>
        40
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Hung
          </surname>
          <given-names>
           I. F. N.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheng
          </surname>
          <given-names>
           V. C. C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wu
          </surname>
          <given-names>
           A. K. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tang
          </surname>
          <given-names>
           B. S. F.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           K. H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           C. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           M. M. L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hui
          </surname>
          <given-names>
           W. T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           L. L. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tse
          </surname>
          <given-names>
           D. M. W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           K. S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Woo
          </surname>
          <given-names>
           P. C. Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lau
          </surname>
          <given-names>
           S. K. P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Peiris
          </surname>
          <given-names>
           J. S. M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K. Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Viral loads in clinical specimens and SARS manifestations
        </article-title>
        .
        <source>
         Emerg. Infect. Dis.
        </source>
        <volume>
         10
        </volume>
        ,
        <fpage>
         1550
        </fpage>
        –
        <lpage>
         1557
        </lpage>
        (
        <year>
         2004
        </year>
        ).
        <pub-id pub-id-type="pmid">
         15498155
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R41">
       <label>
        41
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Ding
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           He
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhang
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Huang
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Che
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Hou
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Shen
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Qiu
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Geng
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cai
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Han
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Kang
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Weng
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Liang
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Jiang
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways
        </article-title>
        .
        <source>
         J. Pathol.
        </source>
        <volume>
         203
        </volume>
        ,
        <fpage>
         622
        </fpage>
        –
        <lpage>
         630
        </lpage>
        (
        <year>
         2004
        </year>
        ).
        <pub-id pub-id-type="pmid">
         15141376
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R42">
       <label>
        42
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Openshaw
          </surname>
          <given-names>
           P. J.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Crossing barriers: Infections of the lung and the gut
        </article-title>
        .
        <source>
         Mucosal Immunol.
        </source>
        <volume>
         2
        </volume>
        ,
        <fpage>
         100
        </fpage>
        –
        <lpage>
         102
        </lpage>
        (
        <year>
         2009
        </year>
        ).
        <pub-id pub-id-type="pmid">
         19129753
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R43">
       <label>
        43
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Saif
          </surname>
          <given-names>
           L. J.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Bovine respiratory coronavirus
        </article-title>
        .
        <source>
         Vet. Clin. North Am. Food Anim. Pract.
        </source>
        <volume>
         26
        </volume>
        ,
        <fpage>
         349
        </fpage>
        –
        <lpage>
         364
        </lpage>
        (
        <year>
         2010
        </year>
        ).
        <pub-id pub-id-type="pmid">
         20619189
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R44">
       <label>
        44
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zhou
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           B. H.-Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheng
          </surname>
          <given-names>
           Z.-S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Poon
          </surname>
          <given-names>
           V. K.-M.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Sun
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lau
          </surname>
          <given-names>
           C. C.-Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           K.-K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           J. Y.-W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           J. F.-W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           To
          </surname>
          <given-names>
           K. K.-W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           K.-H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zheng
          </surname>
          <given-names>
           B.-J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K.-Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis
        </article-title>
        .
        <source>
         J. Infect. Dis.
        </source>
        <volume>
         209
        </volume>
        ,
        <fpage>
         1331
        </fpage>
        –
        <lpage>
         1342
        </lpage>
        (
        <year>
         2014
        </year>
        ).
        <pub-id pub-id-type="pmid">
         24065148
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R45">
       <label>
        45
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Zhou
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tan
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Tian
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zheng
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ou
          </surname>
          <given-names>
           J.-H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Huang
          </surname>
          <given-names>
           E. J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yen
          </surname>
          <given-names>
           T. S. B.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Krüppel-like factor 15 activates hepatitis B virus gene expression and replication
        </article-title>
        .
        <source>
         Hepatology
        </source>
        <volume>
         54
        </volume>
        ,
        <fpage>
         109
        </fpage>
        –
        <lpage>
         121
        </lpage>
        (
        <year>
         2011
        </year>
        ).
        <pub-id pub-id-type="pmid">
         21503941
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R46">
       <label>
        46
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name name-style="western">
          <surname>
           Chu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zhou
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wong
          </surname>
          <given-names>
           B. H.-Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           J. F.-W.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cheng
          </surname>
          <given-names>
           Z.-S.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yang
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Wang
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Lee
          </surname>
          <given-names>
           A. C.-Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Li
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yeung
          </surname>
          <given-names>
           M.-L.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Cai
          </surname>
          <given-names>
           J.-P.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Chan
          </surname>
          <given-names>
           I. H.-Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Ho
          </surname>
          <given-names>
           W.-K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           To
          </surname>
          <given-names>
           K.-K.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Zheng
          </surname>
          <given-names>
           B.-J.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yao
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Qin
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         ,
         <name name-style="western">
          <surname>
           Yuen
          </surname>
          <given-names>
           K.-Y.
          </given-names>
         </name>
        </person-group>
        ,
        <article-title>
         Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways
        </article-title>
        .
        <source>
         J. Infect. Dis.
        </source>
        <volume>
         213
        </volume>
        ,
        <fpage>
         904
        </fpage>
        –
        <lpage>
         914
        </lpage>
        (
        <year>
         2016
        </year>
        ).
        <pub-id pub-id-type="pmid">
         26203058
        </pub-id>
       </mixed-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Am J Infect Control
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Am J Infect Control
      </journal-id>
      <journal-title-group>
       <journal-title>
        American Journal of Infection Control
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0196-6553
      </issn>
      <issn pub-type="epub">
       1527-3296
      </issn>
      <publisher>
       <publisher-name>
        Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc.
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       29803593
      </article-id>
      <article-id pub-id-type="pmc">
       7115331
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0196-6553(18)30521-2
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.ajic.2018.04.223
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Evaluation of the antimicrobial efficacy and skin safety of a novel color additive in combination with chlorine disinfectants
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="au0010">
        <name>
         <surname>
          Tyan
         </surname>
         <given-names>
          Kevin
         </given-names>
        </name>
        <degrees>
         BA
        </degrees>
        <email>
         kevin@kinnos.us
        </email>
        <xref ref-type="aff" rid="af0010">
         a
        </xref>
        <xref ref-type="corresp" rid="co0010">
         *
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au0015">
        <name>
         <surname>
          Kang
         </surname>
         <given-names>
          Jason
         </given-names>
        </name>
        <degrees>
         BSc
        </degrees>
        <xref ref-type="aff" rid="af0010">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au0020">
        <name>
         <surname>
          Jin
         </surname>
         <given-names>
          Katherine
         </given-names>
        </name>
        <degrees>
         BA
        </degrees>
        <xref ref-type="aff" rid="af0010">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au0025">
        <name>
         <surname>
          Kyle
         </surname>
         <given-names>
          Aaron M.
         </given-names>
        </name>
        <degrees>
         PhD
        </degrees>
        <xref ref-type="aff" rid="af0015">
         b
        </xref>
       </contrib>
      </contrib-group>
      <aff id="af0010">
       <label>
        a
       </label>
       Kinnos Inc., 760 Parkside Avenue, Suite 215, Brooklyn, NY 11226
      </aff>
      <aff id="af0015">
       <label>
        b
       </label>
       Department of Biomedical Engineering, Columbia University, New York, New York
      </aff>
      <author-notes>
       <corresp id="co0010">
        <label>
         *
        </label>
        Address correspondence to Kevin Tyan, BA, Kinnos Inc., 760 Parkside Avenue, Suite 215, Brooklyn, NY 11226. (K. Tyan).
        <email>
         kevin@kinnos.us
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        24
       </day>
       <month>
        5
       </month>
       <year>
        2018
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <month>
        11
       </month>
       <year>
        2018
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        24
       </day>
       <month>
        5
       </month>
       <year>
        2018
       </year>
      </pub-date>
      <volume>
       46
      </volume>
      <issue>
       11
      </issue>
      <fpage>
       1254
      </fpage>
      <lpage>
       1261
      </lpage>
      <permissions>
       <copyright-statement>
        © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2018
       </copyright-year>
       <copyright-holder>
        Association for Professionals in Infection Control and Epidemiology, Inc.
       </copyright-holder>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract abstract-type="author-highlights" id="ab0010">
       <title>
        Highlights
       </title>
       <p>
        <list id="ulist0010" list-type="simple">
         <list-item id="u0010">
          <label>
           •
          </label>
          <p id="p0010">
           Novel color additive for chlorine disinfectants aids visibility and coverage.
          </p>
         </list-item>
         <list-item id="u0015">
          <label>
           •
          </label>
          <p id="p0015">
           Chlorine with and without color additive achieved the same antimicrobial efficacy.
          </p>
         </list-item>
         <list-item id="u0020">
          <label>
           •
          </label>
          <p id="p0020">
           The color additive improved the efficacy of 0.5% sodium hypochlorite against coronavirus.
          </p>
         </list-item>
         <list-item id="u0025">
          <label>
           •
          </label>
          <p id="p0025">
           Chlorine with and without color additive were negligible skin irritants.
          </p>
         </list-item>
         <list-item id="u0030">
          <label>
           •
          </label>
          <p id="p0030">
           The color additive did not adversely affect efficacy or skin safety of chlorine.
          </p>
         </list-item>
        </list>
       </p>
      </abstract>
      <abstract id="ab0015">
       <sec>
        <title>
         Objective
        </title>
        <p>
         A novel color additive colorizes chlorine disinfectants blue to improve visibility and enhance spray surface coverage, and it fades to colorless to indicate elapsed contact time. We investigated its interactions with 3 chlorine disinfectants to determine if the additive would adversely affect the disinfectants' antimicrobial efficacy or skin safety.
        </p>
       </sec>
       <sec>
        <title>
         Methods
        </title>
        <p>
         We tested 0.5% sodium hypochlorite, 0.2% calcium hypochlorite, and 0.5% sodium dichloroisocyanurate (NaDCC) alone versus with color additive. An independent laboratory tested efficacy against
         <italic>
          Staphylococcus aureus
         </italic>
         ,
         <italic>
          Pseudomonas aeruginosa
         </italic>
         ,
         <italic>
          Vibrio cholerae
         </italic>
         , and human coronavirus 229E. An independent laboratory also tested direct skin irritation.
        </p>
       </sec>
       <sec>
        <title>
         Results
        </title>
        <p>
         Chlorine disinfectants with and without color additive achieved equal levels of efficacy against the tested pathogens. Against
         <italic>
          S. aureus
         </italic>
         , 0.5% sodium hypochlorite with and without color additive met Environmental Protection Agency criteria for disinfection success. Against human coronavirus 229E, 0.5% sodium hypochlorite alone failed disinfection success criteria, whereas 0.5% sodium hypochlorite with color additive achieved full viral inactivation (≥4.50 log
         <sub>
          10
         </sub>
         reduction). Against
         <italic>
          V. cholerae
         </italic>
         , 0.2% calcium hypochlorite alone and with color additive achieved 5.99 log
         <sub>
          10
         </sub>
         and &gt;6.03 log
         <sub>
          10
         </sub>
         reductions, respectively. Against
         <italic>
          S. aureus
         </italic>
         and
         <italic>
          P. aeruginosa,
         </italic>
         0.5% NaDCC with and without color additive achieved &gt;4.9 log
         <sub>
          10
         </sub>
         and &gt;3.54 log
         <sub>
          10
         </sub>
         reductions, respectively. All 3 chlorine disinfectants with color additive tested as negligible skin irritants.
        </p>
       </sec>
       <sec>
        <title>
         Conclusions
        </title>
        <p>
         This color additive can be combined with chlorine disinfectants without adversely affecting antimicrobial efficacy or skin safety.
        </p>
       </sec>
      </abstract>
      <kwd-group id="kwd0010">
       <title>
        Key Words
       </title>
       <kwd>
        Chlorine disinfectant
       </kwd>
       <kwd>
        Color additive
       </kwd>
       <kwd>
        Efficacy test
       </kwd>
       <kwd>
        Skin irritation
       </kwd>
       <kwd>
        Antimicrobial efficacy
       </kwd>
       <kwd>
        Skin safety
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <p id="p0035">
     Environmental surface cleaning is a key tenet of infection prevention programs, and its proper execution has been shown to reduce healthcare-associated infections (HAIs).
     <xref ref-type="bibr" rid="bib0010">
      <sup>
       1
      </sup>
     </xref>
     However, current disinfection practices often fail because of human error, lack of protocol compliance, and the difficulty of monitoring cleaning techniques.
     <xref ref-type="bibr" rid="bib0015">
      <sup>
       2
      </sup>
     </xref>
     Furthermore, the optimal use of disinfectants in accordance with manufacturer guidelines is typically infeasible in real-world settings, as spray disinfectants have been shown to cover less than 33% of a surface or evaporate in less than 2 minutes, without reaching required wet-contact times.
     <xref ref-type="bibr" rid="bib0020">
      3
     </xref>
     ,
     <xref ref-type="bibr" rid="bib0025">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="bib0030">
      5
     </xref>
    </p>
    <p id="p0040">
     These shortfalls severely limit the effectiveness of environmental surface cleaning as an infection prevention strategy. Less than 50% of high-touch surfaces in healthcare facilities are properly cleaned.
     <xref ref-type="bibr" rid="bib0035">
      <sup>
       6
      </sup>
     </xref>
     One study found that despite housekeepers being instructed to use 10% bleach to clean rooms with
     <italic>
      Clostridium difficile
     </italic>
     -infected patients, 78% of these rooms still tested positive for
     <italic>
      C. difficile
     </italic>
     after terminal cleaning.
     <xref ref-type="bibr" rid="bib0040">
      <sup>
       7
      </sup>
     </xref>
     There is a consensus that improving compliance with disinfection protocols and techniques is critical to reducing HAIs.
     <xref ref-type="bibr" rid="bib0015">
      2
     </xref>
     ,
     <xref ref-type="bibr" rid="bib0040">
      7
     </xref>
     ,
     <xref ref-type="bibr" rid="bib0045">
      8
     </xref>
     ,
     <xref ref-type="bibr" rid="bib0050">
      9
     </xref>
    </p>
    <p id="p0045">
     A novel color additive, Highlight
     <sup>
      ®
     </sup>
     (Kinnos Inc, Brooklyn, New York), colorizes chlorine disinfectants blue to allow for improved visibility and thoroughness of application. Upon spraying on a surface, chlorine disinfectants with the color additive fade from blue to colorless to indicate when the proper contact time has been met. They also exhibit lowered surface tension that improves spray surface coverage to &gt;99.9%.
     <xref ref-type="bibr" rid="bib0025">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="bib0055">
      10
     </xref>
     This novel additive addresses the major shortfalls of environmental cleaning by ensuring compliance with wet-contact time, improving coverage of sprayed surfaces, and providing real-time ability to monitor cleaning techniques.
    </p>
    <p id="p0050">
     This color additive is considered an adjuvant under U.S. Environmental Protection Agency (EPA) guidelines and does not require registration as a pesticide.
     <xref ref-type="bibr" rid="bib0060">
      <sup>
       11
      </sup>
     </xref>
     However, given the novel nature of this product, it is important to demonstrate that its addition to chlorine disinfectants does not compromise antimicrobial efficacy or pose any safety risks. We evaluated the effect of color additive on the antimicrobial efficacy and skin safety of 3 major chlorine disinfectants: 0.5% sodium hypochlorite, 0.2% calcium hypochlorite and 0.5% sodium dichloroisocyanurate (NaDCC). This study presents the efficacy test results of an independent Good Laboratory Practice (GLP)-compliant facility against
     <italic>
      Staphylococcus aureus
     </italic>
     ,
     <italic>
      Pseudomonas aeruginosa
     </italic>
     ,
     <italic>
      Vibrio cholerae
     </italic>
     , and human coronavirus 229E. This study also presents results from another independent GLP-compliant laboratory that tested skin irritation from chlorine disinfectants with and without color additive. Our results confirm that when added to chlorine disinfectants, the color additive does not reduce antimicrobial efficacy or cause skin irritation.
    </p>
    <sec id="s0010">
     <title>
      METHODS
     </title>
     <p id="p0055">
      An independent GLP-compliant facility, Microchem Laboratory (Round Rock, Texas), performed efficacy tests in accordance with test methods established by the Association of Official Analytical Chemists (AOAC) and the American Society for Testing and Materials (ASTM), as outlined in
      <xref ref-type="table" rid="t0010">
       Table 1
      </xref>
      . Another independent GLP-compliant facility, Toxikon Corporation (Bedford, Massachusetts), performed skin irritation studies in accordance with test methods established by the International Organization for Standardization (ISO). The same batches of commercially produced chlorine disinfectants were tested with or without the addition of the Highlight
      <sup>
       ®
      </sup>
      color additive to directly compare efficacy and skin safety results. Detailed test methods used in these studies are detailed in
      <xref ref-type="sec" rid="s0085">
       Appendix 1
      </xref>
      .
      <table-wrap id="t0010" position="float">
       <label>
        Table 1
       </label>
       <caption>
        <p>
         Overview of efficacy test methodology and organisms for 3 chlorine disinfectants with and without color additive
        </p>
       </caption>
       <alt-text id="atte0025">
        Table 1
       </alt-text>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th align="left">
           Test Substances
          </th>
          <th align="left">
           Test Organisms
          </th>
          <th align="left">
           Contact Time
          </th>
          <th align="left">
           Test Method
          </th>
          <th align="left">
           Study ID Number
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td align="left" rowspan="3">
           <bold>
            0.5% sodium hypochlorite
           </bold>
           vs.
           <bold>
            0.5% sodium hypochlorite with color additive
           </bold>
          </td>
          <td align="left">
           <italic>
            Staphylococcus aureus
           </italic>
           (ATCC 6538)
          </td>
          <td align="char">
           10 min ± 5 sec
          </td>
          <td align="left">
           AOAC 961.02
          </td>
          <td align="left">
           GLP1540+GLP1550
          </td>
         </tr>
         <tr>
          <td align="left">
           Human coronavirus 229E (ATCC VR-740)
          </td>
          <td align="char">
           10 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0010" xlink:href="astm:E1053">
            E1053
           </ext-link>
          </td>
          <td align="left">
           GLP1536+GLP1538
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Pseudomonas aeruginosa
           </italic>
           (ATCC 15442)
          </td>
          <td align="char">
           5 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0015" xlink:href="astm:E1153">
            E1153
           </ext-link>
          </td>
          <td align="left">
           NG8698
           <xref ref-type="table-fn" rid="tn0010">
            *
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="3">
           <bold>
            0.2% calcium hypochlorite
           </bold>
           vs.
           <bold>
            0.2% calcium hypochlorite with color additive
           </bold>
          </td>
          <td align="left">
           <italic>
            Vibrio cholerae
           </italic>
           (ATCC 39050)
          </td>
          <td align="char">
           3 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0020" xlink:href="astm:E2315">
            E2315
           </ext-link>
          </td>
          <td align="left">
           NG8285
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Vibrio cholerae
           </italic>
           (ATCC 39050)
          </td>
          <td align="char">
           3 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0025" xlink:href="astm:E2315">
            E2315
           </ext-link>
          </td>
          <td align="left">
           NG9676
           <xref ref-type="table-fn" rid="tn0010">
            *
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Pseudomonas aeruginosa
           </italic>
           (ATCC 15442)
          </td>
          <td align="char">
           5 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0030" xlink:href="astm:E1153">
            E1153
           </ext-link>
          </td>
          <td align="left">
           NG8698
           <xref ref-type="table-fn" rid="tn0010">
            *
           </xref>
          </td>
         </tr>
         <tr>
          <td align="left" rowspan="3">
           <bold>
            0.5% NaDCC control
           </bold>
           vs.
           <bold>
            0.5% NaDCC with color additive
           </bold>
          </td>
          <td align="left">
           <italic>
            Staphylococcus aureus
           </italic>
           (ATCC 6538)
          </td>
          <td align="char">
           5 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0035" xlink:href="astm:E1153">
            E1153
           </ext-link>
          </td>
          <td align="left">
           NG8156
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Pseudomonas aeruginosa
           </italic>
           (ATCC 15442)
          </td>
          <td align="char">
           5 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0040" xlink:href="astm:E1153">
            E1153
           </ext-link>
          </td>
          <td align="left">
           NG8156
          </td>
         </tr>
         <tr>
          <td align="left">
           <italic>
            Pseudomonas aeruginosa
           </italic>
           (ATCC 15442)
          </td>
          <td align="char">
           5 min ± 5 sec
          </td>
          <td align="left">
           ASTM
           <ext-link ext-link-type="uri" id="iw0045" xlink:href="astm:E1153">
            E1153
           </ext-link>
          </td>
          <td align="left">
           NG9375
           <xref ref-type="table-fn" rid="tn0010">
            *
           </xref>
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          <italic>
           NaDCC
          </italic>
          = sodium dichloroisocyanurate.
         </p>
        </fn>
       </table-wrap-foot>
       <table-wrap-foot>
        <fn id="tn0010">
         <label>
          *
         </label>
         <p id="np0020">
          Studies in which the test substances were prepared and left at room temperature for four hours prior to efficacy testing.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
     </p>
     <sec id="s0015">
      <title>
       Efficacy test against
       <italic>
        S. aureus
       </italic>
       using AOAC method 961.02
      </title>
      <p id="p0060">
       This study was conducted using a previously described protocol, AOAC 961.02.
       <xref ref-type="bibr" rid="bib0065">
        12
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0070">
        13
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0075">
        14
       </xref>
       Three lots of 0.5% sodium hypochlorite were tested against
       <italic>
        S. aureus
       </italic>
       (ATCC 6538) at the contact time of 10 minutes, based on the label claims of a common household bleach.
       <xref ref-type="bibr" rid="bib0080">
        <sup>
         15
        </sup>
       </xref>
       First, 0.5% sodium hypochlorite was prepared by diluting regular bleach (Clorox, Oakland, California) in sterile AOAC hard water. This study was repeated using 3 lots of the color additive mixed into the same lots of 0.5% sodium hypochlorite solution immediately before testing. Next, 60 carriers inoculated with dried
       <italic>
        S. aureus
       </italic>
       were sprayed with the test substance and left undisturbed for a contact time of 10 minutes ± 5 seconds. After neutralization, the carriers were transferred into tubes and assessed for growth.
      </p>
     </sec>
     <sec id="s0020">
      <title>
       Efficacy test against human coronavirus 229E using ASTM method E1053
      </title>
      <p id="p0065">
       This study was conducted using a previously described protocol, ASTM
       <ext-link ext-link-type="uri" id="iw0050" xlink:href="astm:E1053">
        E1053
       </ext-link>
       .
       <xref ref-type="bibr" rid="bib0085">
        16
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0090">
        17
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0095">
        18
       </xref>
       Two lots of 0.5% sodium hypochlorite were tested against human coronavirus strain 229E (ATCC VR-740) at the contact time of 10 minutes, based on the label claims of a common household bleach.
       <xref ref-type="bibr" rid="bib0080">
        <sup>
         15
        </sup>
       </xref>
       This test was repeated using the same lots of 0.5% sodium hypochlorite mixed with 2 lots of the color additive. Carriers of dried human coronavirus 229E film were sprayed with the test substance and left undisturbed for 10 minutes ± 5 seconds, then neutralized and filtered. Serial 10-fold dilutions of the resultant filtrate were then prepared and applied in quadruplicate to multi-well plates containing normal lung fibroblast cell monolayers. After incubation, each well was examined for cytopathic effects indicating infectious virus. The Spearman-Karber method was used to quantify the amount of infectious virus recovered.
      </p>
     </sec>
     <sec id="s0025">
      <title>
       Efficacy test against V. cholerae using ASTM method E2315
      </title>
      <p id="p0070">
       A suspension efficacy test was performed using a previously described protocol, ASTM
       <ext-link ext-link-type="uri" id="iw0055" xlink:href="astm:E2315">
        E2315
       </ext-link>
       .
       <xref ref-type="bibr" rid="bib0100">
        19
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0105">
        20
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0110">
        21
       </xref>
       Calcium hypochlorite was tested against
       <italic>
        V. cholerae
       </italic>
       (ATCC 39050) with a 0.2% concentration based on World Health Organization and U.S. Centers for Disease Control and Prevention cholera guidelines and a contact time of 3 minutes, based on the standard practices of a nongovernmental organization that field-tested the color additive during the 2017 Haiti outbreak.
       <xref ref-type="bibr" rid="bib0115">
        22
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0120">
        23
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0125">
        24
       </xref>
       The suspension test method is commonly used for efficacy testing against pathogens like
       <italic>
        V. cholerae
       </italic>
       that cannot survive the drying phase of standard hard surface tests.
       <xref ref-type="bibr" rid="bib0130">
        <sup>
         25
        </sup>
       </xref>
      </p>
      <p id="p0075">
       For study NG8285, 0.2% calcium hypochlorite was prepared by dissolving 68% Calcium Hypochlorite Granular (Lonza, Basel, Switzerland) in AOAC hard water immediately before efficacy testing. This test was repeated using the same lot of 0.2% calcium hypochlorite combined with color additive. For study NG9676, both test substances were prepared and allowed to rest at room temperature for 4 hours before testing to determine if the color additive affected antimicrobial efficacy of 0.2% calcium hypochlorite over time. Ten mL of test substance was inoculated with 0.5 mL of
       <italic>
        V. cholerae
       </italic>
       culture for 3 minutes, neutralized, then plated and enumerated for colony-forming units (CFU) to determine log reduction after exposure.
      </p>
     </sec>
     <sec id="s0030">
      <title>
       Efficacy tests against S. aureus and P. aeruginosa using ASTM method E1153
      </title>
      <p id="p0080">
       This study was conducted using a previously established protocol, ASTM
       <ext-link ext-link-type="uri" id="iw0060" xlink:href="astm:E1153">
        E1153
       </ext-link>
       .
       <xref ref-type="bibr" rid="bib0135">
        26
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0140">
        27
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0145">
        28
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0150">
        29
       </xref>
       In study NG8156, 0.5% NaDCC was tested against both
       <italic>
        S. aureus
       </italic>
       and
       <italic>
        P. aeruginosa
       </italic>
       (ATCC 15442) with a contact time of 5 minutes, based on the label claims of an existing 0.5% chlorine NaDCC disinfectant.
       <xref ref-type="bibr" rid="bib0155">
        <sup>
         30
        </sup>
       </xref>
       This test was repeated using the same lot of 0.5% NaDCC with the addition of color additive. 0.5% NaDCC was prepared by dissolving OASIS NaDCC Granules (Hydrachem, West Sussex, United Kingdom) in sterile AOAC hard water.
      </p>
      <p id="p0085">
       In study NG8698, 4 test substances were prepared (0.5% sodium hypochlorite and 0.2% calcium hypochlorite, both with and without color additive) and allowed to rest at room temperature for 4 hours. Then, efficacy testing against
       <italic>
        P. aeruginosa
       </italic>
       was conducted with a contact time of 5 minutes to determine if prolonged exposure to the color additive interfered with the ability of these chlorine solutions to meet the ASTM
       <ext-link ext-link-type="uri" id="iw0065" xlink:href="astm:E1153">
        E1153
       </ext-link>
       passing criteria of &gt;3 log
       <sub>
        10
       </sub>
       reduction. Similarly, in study NG9375, 0.5% NaDCC solutions with and without color additive were prepared, allowed to rest at room temperature for 4 hours, then tested against
       <italic>
        P. aeruginosa
       </italic>
       with a contact time of 5 minutes. Test carriers inoculated with dried pathogen were sprayed with the test substance, neutralized, then plated and enumerated to determine log reduction after exposure.
      </p>
     </sec>
     <sec id="s0035">
      <title>
       Direct primary skin irritation test using ISO 10993-10
      </title>
      <p id="p0090">
       We evaluated the potential for 6 test substances (0.5% sodium hypochlorite, 0.5% calcium hypochlorite, and 0.5% NaDCC either alone or in combination with their formula of the color additive) to produce primary dermal irritation after 4 hours of direct exposure. An independent GLP-compliant facility, Toxikon Corporation, performed these studies in accordance with U.S. Food and Drug Administration (FDA)-recognized test methods established by the ISO.
       <xref ref-type="bibr" rid="bib0160">
        31
       </xref>
       ,
       <xref ref-type="bibr" rid="bib0165">
        32
       </xref>
      </p>
      <p id="p0095">
       Three New Zealand white rabbits for each test substance were acclimatized for a minimum of 5 days before treatment. Then, 0.5 mL of test substance was applied directly to 2 test sites per animal, which were then bandaged. Two control sites per animal were left untreated and bandaged in the same manner as the test sites. After 4 hours, the dressings were removed and sites observed for signs of erythema and edema after 1, 24, 48, and 72 hours. Signs of erythema and edema were both scored from 0 to 4. The final Primary Irritation Index (PII) of each test substance was determined by summing erythema and edema scores and averaging across time points (3), number of test sites (2), and number of animals (3).
      </p>
     </sec>
    </sec>
    <sec id="s0040">
     <title>
      RESULTS
     </title>
     <sec id="s0045">
      <title>
       Effect of color additive on 0.5% sodium hypochlorite efficacy against
       <italic>
        S. aureus
       </italic>
       using AOAC 961.02
      </title>
      <p id="p0100">
       <xref ref-type="table" rid="t0015">
        Table 2
       </xref>
       shows the results of studies GLP1540 and GLP1550, in which 0.5% sodium hypochlorite was tested alone and in combination with color additive against
       <italic>
        S. aureus
       </italic>
       at a contact time of 10 minutes. To pass EPA performance criteria for successful disinfection, 3 lots of the test substance must be tested, with at least 59 of the 60 test carriers for each lot confirmed negative for any surviving
       <italic>
        S. aureus
       </italic>
       . Three lots of 0.5% sodium hypochlorite successfully disinfected 60, 60, and 59 of the 60 carriers. Three lots of 0.5% sodium hypochlorite with color additive successfully disinfected 60, 60, and 59 of the 60 carriers. Both met EPA efficacy performance guidelines.
       <table-wrap id="t0015" position="float">
        <label>
         Table 2
        </label>
        <caption>
         <p>
          Study GLP1540 &amp; GLP1550: efficacy of 0.5% sodium hypochlorite with and without color additive against
          <italic>
           S. aureus
          </italic>
          after 10 minutes ± 5 seconds contact time
         </p>
        </caption>
        <alt-text id="atte0030">
         Table 2
        </alt-text>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th align="left" rowspan="2">
            Test substance
           </th>
           <th align="left" rowspan="2">
            Lot number
           </th>
           <th align="left" rowspan="2">
            Test organism
           </th>
           <th align="left" colspan="3">
            Number of carriers
            <hr/>
           </th>
           <th align="left" rowspan="2">
            Carriers disinfected
           </th>
          </tr>
          <tr>
           <th align="left">
            Treated
           </th>
           <th align="left">
            Showing growth
           </th>
           <th align="left">
            Confirmed as test organism
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td align="left" rowspan="3">
            0.5% sodium hypochlorite
           </td>
           <td align="left">
            E616050
           </td>
           <td align="left" rowspan="3">
            <italic>
             S. aureus
            </italic>
            (ATCC 6538)
           </td>
           <td align="left">
            60
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            60/60
           </td>
          </tr>
          <tr>
           <td align="left">
            E616060
           </td>
           <td align="left">
            60
           </td>
           <td align="left">
            1
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            60/60
           </td>
          </tr>
          <tr>
           <td align="left">
            E615306
           </td>
           <td align="left">
            60
           </td>
           <td align="left">
            1
           </td>
           <td align="left">
            1
           </td>
           <td align="left">
            59/60
           </td>
          </tr>
          <tr>
           <td align="left" rowspan="3">
            0.5% sodium hypochlorite with color additive
           </td>
           <td align="left">
            3-16-HLTS1
           </td>
           <td align="left" rowspan="3">
            <italic>
             S. aureus
            </italic>
            (ATCC 6538)
           </td>
           <td align="left">
            60
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            60/60
           </td>
          </tr>
          <tr>
           <td align="left">
            3-16-HLTS2
           </td>
           <td align="left">
            60
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            0
           </td>
           <td align="left">
            60/60
           </td>
          </tr>
          <tr>
           <td align="left">
            3-16-HLTS3
           </td>
           <td align="left">
            60
           </td>
           <td align="left">
            1
           </td>
           <td align="left">
            1
           </td>
           <td align="left">
            59/60
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
      </p>
     </sec>
     <sec id="s0050">
      <title>
       Effect of color additive on 0.5% sodium hypochlorite efficacy against human coronavirus 229E using ASTM E1053
      </title>
      <p id="p0105">
       <xref ref-type="table" rid="t0020">
        Table 3
       </xref>
       and
       <xref ref-type="table" rid="t0025">
        Table 4
       </xref>
       show the results of studies GLP1538 and GLP1536, in which 0.5% sodium hypochlorite was tested alone and in combination with color additive against human coronavirus 229E at a contact time of 10 minutes. To pass EPA performance criteria for virucidal efficacy, test substances must demonstrate complete inactivation of the virus at all dilutions.
       <table-wrap id="t0020" position="float">
        <label>
         Table 3
        </label>
        <caption>
         <p>
          Study GLP1538: efficacy of 0.5% sodium hypochlorite after 10 minutes ± 5 seconds contact time to human coronavirus strain 229E dried on inanimate surface
         </p>
        </caption>
        <alt-text id="atte0035">
         Table 3
        </alt-text>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th align="left" colspan="5">
           </th>
           <th align="left" colspan="4">
            0.5% sodium hypochlorite: Lot E616050
           </th>
           <th align="left" colspan="4">
            0.5% sodium hypochlorite: Lot E616060
           </th>
          </tr>
          <tr>
           <th align="left">
            Dilution
           </th>
           <th align="left" colspan="4">
            Dried Virus Plate Recovery Control
           </th>
           <th align="left" colspan="4">
            Human Coronavirus 229E Test Film
           </th>
           <th align="left" colspan="4">
            Human Coronavirus 229E Test Film
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td align="left">
            10
            <sup>
             −1
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −2
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −3
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −4
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −5
            </sup>
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −6
            </sup>
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            <bold>
             TCID
             <sub>
              50
             </sub>
             /1.0 mL
            </bold>
           </td>
           <td align="left" colspan="4">
            3.75 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            0.75 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≤0.50 log
            <sub>
             10
            </sub>
           </td>
          </tr>
          <tr>
           <td align="left">
            <bold>
             TCID
             <sub>
              50
             </sub>
             /carrier
            </bold>
           </td>
           <td align="left" colspan="4">
            4.35 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            1.35 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≤1.10 log
            <sub>
             10
            </sub>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="5">
            <bold>
             Reduction of virus due to inactivation by test substance:
            </bold>
           </td>
           <td align="left" colspan="4">
            3.00 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≥3.25 log
            <sub>
             10
            </sub>
           </td>
          </tr>
         </tbody>
        </table>
        <table-wrap-foot>
         <fn>
          <p>
           Recovery of 229E virus (
           <bold>
            +
           </bold>
           ) or absence of 229E virus and cytotoxicity (
           <bold>
            O
           </bold>
           ) in wells containing MRC-5 host cells. 229E virus (200 µL) was previously dried on an inanimate surface, treated with a control media or test substance, neutralized and filtered, and then serially diluted in quadruplicate.
          </p>
         </fn>
        </table-wrap-foot>
       </table-wrap>
       <table-wrap id="t0025" position="float">
        <label>
         Table 4
        </label>
        <caption>
         <p>
          Study GLP1536: efficacy of 0.5% sodium hypochlorite with color additive after 10 minutes ± 5 seconds contact time to human coronavirus strain 229E dried on inanimate surface
         </p>
        </caption>
        <alt-text id="atte0040">
         Table 4
        </alt-text>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th align="left" colspan="5" rowspan="2">
           </th>
           <th align="left" colspan="4">
            Color additive: Lot HLT 3-16-HLTS1
           </th>
           <th align="left" colspan="4">
            Color additive: Lot HLT 3-16-HLTS1
           </th>
          </tr>
          <tr>
           <th align="left" colspan="4">
            0.5% sodium hypochlorite: Lot E616050
           </th>
           <th align="left" colspan="4">
            0.5% sodium hypochlorite: Lot E616060
           </th>
          </tr>
          <tr>
           <th align="left">
            Dilution
           </th>
           <th align="left" colspan="4">
            Dried Virus Plate Recovery Control
           </th>
           <th align="left" colspan="4">
            Human Coronavirus 229E Test Film
           </th>
           <th align="left" colspan="4">
            Human Coronavirus 229E Test Film
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td align="left">
            10
            <sup>
             −1
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −2
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −3
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −4
            </sup>
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −5
            </sup>
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            10
            <sup>
             −6
            </sup>
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            +
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
           <td align="left">
            O
           </td>
          </tr>
          <tr>
           <td align="left">
            <bold>
             TCID
             <sub>
              50
             </sub>
             /1.0 mL
            </bold>
           </td>
           <td align="left" colspan="4">
            5.00 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≤0.50 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≤0.50 log
            <sub>
             10
            </sub>
           </td>
          </tr>
          <tr>
           <td align="left">
            <bold>
             TCID
             <sub>
              50
             </sub>
             /carrier
            </bold>
           </td>
           <td align="left" colspan="4">
            5.60 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≤1.10 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≤1.10 log
            <sub>
             10
            </sub>
           </td>
          </tr>
          <tr>
           <td align="left" colspan="5">
            <bold>
             Reduction of virus due to inactivation by test substance:
            </bold>
           </td>
           <td align="left" colspan="4">
            ≥4.50 log
            <sub>
             10
            </sub>
           </td>
           <td align="left" colspan="4">
            ≥4.50 log
            <sub>
             10
            </sub>
           </td>
          </tr>
         </tbody>
        </table>
        <table-wrap-foot>
         <fn>
          <p>
           Recovery of 229E virus (
           <bold>
            +
           </bold>
           ), or absence of both 229E virus and cytotoxicity (
           <bold>
            O
           </bold>
           ) in wells containing MRC-5 host cells. 229E virus (200 µL) was previously dried on an inanimate surface, treated with a control media or test substance, neutralized and filtered, and then serially diluted in quadruplicate.
          </p>
         </fn>
        </table-wrap-foot>
       </table-wrap>
      </p>
      <p id="p0110">
       The 2 lots of 0.5% sodium hypochlorite alone demonstrated 3.00 log
       <sub>
        10
       </sub>
       and ≥3.25 log
       <sub>
        10
       </sub>
       reduction of virus, and infectious viral particles were recovered in 1 of the 10
       <sup>
        −1
       </sup>
       dilution wells. The 2 lots of 0.5% sodium hypochlorite with color additive both demonstrated ≥4.50 log
       <sub>
        10
       </sub>
       reduction of virus. Under these test conditions, the combination of 0.5% sodium hypochlorite with color additive completely inactivated human coronavirus 229E and met EPA performance criteria for virucidal efficacy, whereas 0.5% sodium hypochlorite alone failed the disinfection success criteria due to recovery of infectious viral particles from 1 lot.
      </p>
     </sec>
     <sec id="s0055">
      <title>
       Effect of color additive on 0.2% calcium hypochlorite efficacy against
       <italic>
        V. cholerae
       </italic>
       using ASTM E2315
      </title>
      <p id="p0115">
       <xref ref-type="fig" rid="f0010">
        Figure 1
       </xref>
       shows the results of studies NG8285 and NG9679, in which 0.2% calcium hypochlorite was tested alone and in combination with color additive against
       <italic>
        V. cholerae
       </italic>
       at a contact time of 3 minutes. 0.2% calcium hypochlorite alone and with color additive were prepared immediately before efficacy testing and demonstrated 5.99 log
       <sub>
        10
       </sub>
       and &gt;6.03 log
       <sub>
        10
       </sub>
       reduction of
       <italic>
        V. cholerae
       </italic>
       , respectively. For study NG9679, both test substances were prepared and allowed to rest at room temperature 4 hours before efficacy testing, and both demonstrated 6.58 log
       <sub>
        10
       </sub>
       reduction.
       <fig id="f0010">
        <label>
         Fig 1
        </label>
        <caption>
         <p>
          Studies NG8285 and NG9676: log
          <sub>
           10
          </sub>
          reduction of
          <italic>
           V. cholerae
          </italic>
          when treated with 0.2% calcium hypochlorite with and without color additive for 3 minutes ± 5 seconds. Test solutions were tested for efficacy either immediately or 4 hours after preparation.
         </p>
        </caption>
        <alt-text id="atte0010">
         Fig 1
        </alt-text>
        <graphic xlink:href="ymic4843-fig-0001_lrg">
        </graphic>
       </fig>
      </p>
     </sec>
     <sec id="s0060">
      <title>
       Effect of color additive on 0.5% NaDCC efficacy against
       <italic>
        P. aeruginosa
       </italic>
       and
       <italic>
        S. aureus
       </italic>
       using ASTM E1153
      </title>
      <p id="p0120">
       <xref ref-type="fig" rid="f0015">
        Figure 2
       </xref>
       shows the results of study NG8156, in which 0.5% NaDCC was tested alone and with color additive against
       <italic>
        P. aeruginosa
       </italic>
       and
       <italic>
        S. aureus
       </italic>
       at a contact time of 5 minutes. Against
       <italic>
        S. aureus,
       </italic>
       0.5% NaDCC alone and with color additive both reduced the bacteria below detectable limits, with a reduction of &gt;4.9 log
       <sub>
        10
       </sub>
       (&gt;99.9988%). Against
       <italic>
        P. aeruginosa
       </italic>
       , both test substances demonstrated &gt;3.54 log
       <sub>
        10
       </sub>
       (&gt;99.97%) reduction. Overall, the efficacy results of 0.5% NaDCC with and without color additive both met ASTM passing criteria of &gt;3 log
       <sub>
        10
       </sub>
       reduction.
       <fig id="f0015">
        <label>
         Fig 2
        </label>
        <caption>
         <p>
          Study NG8156: efficacy of 0.5% NaDCC with and without color additive after 5 minutes ± 5 seconds contact time against
          <italic>
           S. aureus
          </italic>
          and
          <italic>
           P. aeruginosa
          </italic>
          . The ASTM
          <ext-link ext-link-type="uri" id="iw0070" xlink:href="astm:E1153">
           E1153
          </ext-link>
          passing criterion of 3 log
          <sub>
           10
          </sub>
          reduction is represented by the dashed line.
         </p>
        </caption>
        <alt-text id="atte0015">
         Fig 2
        </alt-text>
        <graphic xlink:href="ymic4843-fig-0002_lrg">
        </graphic>
       </fig>
      </p>
     </sec>
     <sec id="s0065">
      <title>
       Effect of color additive on chlorine disinfectant efficacy against
       <italic>
        P. aeruginosa
       </italic>
       after 4-hour resting time using ASTM E1153
      </title>
      <p id="p0125">
       <xref ref-type="fig" rid="f0020">
        Figure 3
       </xref>
       shows the results of studies NG8698 and NG9375, in which 0.5% sodium hypochlorite, 0.2% calcium hypochlorite, and 0.5% NaDCC were prepared alone and in combination with their respective formulas of color additive, allowed to rest for 4 hours, then tested against
       <italic>
        P. aeruginosa
       </italic>
       using a contact time of 5 minutes. 0.5% sodium hypochlorite alone and with color additive achieved &gt;4.1 log
       <sub>
        10
       </sub>
       (&gt;99.992%) and 3.8 log
       <sub>
        10
       </sub>
       (99.98%) reduction, respectively. 0.2% calcium hypochlorite alone and with color additive both demonstrated 3.8 log
       <sub>
        10
       </sub>
       (99.98%) reduction. 0.5% NaDCC alone and with color additive both achieved &gt;4.34 log
       <sub>
        10
       </sub>
       (&gt;99.995%) reduction. Overall, the addition of color additive to all 3 chlorine solutions did not affect their ability to achieve the ASTM-required &gt;3 log
       <sub>
        10
       </sub>
       reduction, even after prolonged resting time.
       <fig id="f0020">
        <label>
         Fig 3
        </label>
        <caption>
         <p>
          Studies NG8698 and NG9375: efficacy of chlorine disinfectants with and without color additive after 5 minutes ± 5 seconds contact time against
          <italic>
           P. aeruginosa
          </italic>
          , when prepared and allowed to rest 4 hours in advance of efficacy testing. The ASTM
          <ext-link ext-link-type="uri" id="iw0075" xlink:href="astm:E1153">
           E1153
          </ext-link>
          passing criterion of 3 log
          <sub>
           10
          </sub>
          reduction is represented by the dashed line.
         </p>
        </caption>
        <alt-text id="atte0020">
         Fig 3
        </alt-text>
        <graphic xlink:href="ymic4843-fig-0003_lrg">
        </graphic>
       </fig>
      </p>
     </sec>
     <sec id="s0070">
      <title>
       Skin irritation profile of chlorine disinfectants with and without color additive
      </title>
      <p id="p0130">
       <xref ref-type="table" rid="t0030">
        Table 5
       </xref>
       shows the results of direct primary skin irritation tests performed on rabbits using the 3 chlorine disinfectants alone or with color additive. The PII is a quantitative evaluation of the ability of a test substance to provoke inflammatory response in the skin and is determined based on triplicate testing of animals on 2 test sites through 3 time points. Any PII score above 0 indicates that erythema or edema occurred at least once during the observation period. Based on FDA evaluation criteria, test substances with a PII score of less than 0.5 are considered negligible irritants; a PII score of 0.5-&lt;2.0 indicates a slight irritant; and a PII score of 2.0-&lt;5.0 indicates a moderate irritant. Substances with a PII score of &gt;5.0 are considered severe irritants.
       <xref ref-type="bibr" rid="bib0160">
        <sup>
         31
        </sup>
       </xref>
       <table-wrap id="t0030" position="float">
        <label>
         Table 5
        </label>
        <caption>
         <p>
          Skin irritation testing: erythema and edema irritation scores of individual rabbits after 4-hour substance exposure
         </p>
        </caption>
        <alt-text id="atte0045">
         Table 5
        </alt-text>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th align="left" rowspan="3">
            Test substance
           </th>
           <th align="left" rowspan="3">
            Animal no.
           </th>
           <th align="left" colspan="8">
            Primary Irritation Index (PII) score (erythema/edema)
            <xref ref-type="table-fn" rid="tn0015">
             *
            </xref>
            <hr/>
           </th>
           <th align="left" rowspan="3">
            Final PII
            <xref ref-type="table-fn" rid="tn0025">
             ‡
            </xref>
           </th>
          </tr>
          <tr>
           <th align="left" colspan="2">
            1 hour
            <xref ref-type="table-fn" rid="tn0020">
             †
            </xref>
            <hr/>
           </th>
           <th align="left" colspan="2">
            24 hours
            <hr/>
           </th>
           <th align="left" colspan="2">
            48 hours
            <hr/>
           </th>
           <th align="left" colspan="2">
            72 hours
            <hr/>
           </th>
          </tr>
          <tr>
           <th align="left">
            Test site 1
           </th>
           <th align="left">
            Test site 2
           </th>
           <th align="left">
            Test site 1
           </th>
           <th align="left">
            Test site 2
           </th>
           <th align="left">
            Test site 1
           </th>
           <th align="left">
            Test site 2
           </th>
           <th align="left">
            Test site 1
           </th>
           <th align="left">
            Test site 2
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td align="left" rowspan="3">
            0.5% sodium hypochlorite
           </td>
           <td align="left">
            60135
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left">
            60136
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0.0
           </td>
          </tr>
          <tr>
           <td align="left">
            60137
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left" rowspan="3">
            0.5% sodium hypochlorite + color additive
           </td>
           <td align="left">
            60073
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left">
            60074
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0.0
           </td>
          </tr>
          <tr>
           <td align="left">
            60075
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left" rowspan="3">
            0.5% calcium hypochlorite
           </td>
           <td align="left">
            60615
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left">
            60616
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0.1
           </td>
          </tr>
          <tr>
           <td align="left">
            60617
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            2/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left" rowspan="3">
            0.5% calcium hypochlorite + color additive
           </td>
           <td align="left">
            60612
           </td>
           <td align="left">
            1/0
           </td>
           <td align="left">
            1/0
           </td>
           <td align="left">
            1/0
           </td>
           <td align="left">
            1/0
           </td>
           <td align="left">
            1/0
           </td>
           <td align="left">
            1/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left">
            60613
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0.2
           </td>
          </tr>
          <tr>
           <td align="left">
            60614
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left" rowspan="3">
            0.5% NaDCC
           </td>
           <td align="left">
            60702
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left">
            60704
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0.0
           </td>
          </tr>
          <tr>
           <td align="left">
            60706
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left" rowspan="3">
            0.5% NaDCC +  color additive
           </td>
           <td align="left">
            60696
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
          <tr>
           <td align="left">
            60698
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0.0
           </td>
          </tr>
          <tr>
           <td align="left">
            60700
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
            0/0
           </td>
           <td align="left">
           </td>
          </tr>
         </tbody>
        </table>
        <table-wrap-foot>
         <fn>
          <p>
           <italic>
            NaDCC
           </italic>
           = sodium dichloroisocyanurate.
          </p>
         </fn>
        </table-wrap-foot>
        <table-wrap-foot>
         <fn id="tn0015">
          <label>
           *
          </label>
          <p id="np0025">
           All readings were taken after the dressing removal.
          </p>
         </fn>
        </table-wrap-foot>
        <table-wrap-foot>
         <fn id="tn0020">
          <label>
           †
          </label>
          <p id="np0030">
           1-hour scores are not included in determining PII.
          </p>
         </fn>
        </table-wrap-foot>
        <table-wrap-foot>
         <fn id="tn0025">
          <label>
           ‡
          </label>
          <p id="np0035">
           PII = sum of (erythema + edema scores) / (2 test sites x 3 observation points) for each animal / 3 animals.
          </p>
         </fn>
        </table-wrap-foot>
       </table-wrap>
      </p>
      <p id="p0135">
       No signs of erythema or edema were found on any of the untreated bandaged control sites for every animal. 0.5% sodium hypochlorite alone or with color additive and 0.5% NaDCC alone or with color additive produced no signs of erythema or edema on any animal, thus yielding a PII score of 0. For 0.5% calcium hypochlorite alone, a small area of moderate erythema (score of 2) was found on Test Site 1 of Animal 60617 at the 72-hour time point, yielding a final PII score of 0.1 when averaged across all animals and test sites. For 0.5% calcium hypochlorite in combination with color additive, 1 rabbit (Animal 60612) was observed with slight erythema (score of 1) on both test sites at the 1-, 24-, and 48-hour time points, yielding a final PII score of 0.2. All test substances yielded PII scores of below 0.5 and were considered negligible irritants.
      </p>
     </sec>
    </sec>
    <sec id="s0075">
     <title>
      DISCUSSION
     </title>
     <p id="p0140">
      Efficacy testing performed by an independent GLP-compliant laboratory confirmed across a variety of test methods and pathogens that the addition of the color additive did not adversely affect the antimicrobial efficacy of 3 major chlorine disinfectants. In these studies, chlorine disinfectants with color additive achieved the same level of disinfection as the chlorine disinfectants alone and passed different efficacy criteria established by EPA and ASTM guidelines.
     </p>
     <p id="p0145">
      Both 0.5% sodium hypochlorite with and without color additive met EPA criteria for disinfection of
      <italic>
       S. aureus
      </italic>
      at a 10-minute contact time. 0.5% sodium hypochlorite combined with color additive also fully inactivated human coronavirus 229E after a 10-minute contact time. Interestingly, 0.5% sodium hypochlorite alone failed due to recovery of infectious viral particles in 1 of the lots. This result may have been due to factors such as inconsistencies in spray application and coverage between lots. Given the design of this study, in which a plate of dried virus film was sprayed with the disinfectant, it is possible that the surface coverage-improving properties of the color additive contributed to improved efficacy compared to 0.5% sodium hypochlorite alone, which tends to bead up and form droplets when sprayed.
      <xref ref-type="bibr" rid="bib0170">
       <sup>
        33
       </sup>
      </xref>
      A recent study demonstrated that typical bleach disinfectants cover &lt;33% of a sprayed surface and lose coverage over the duration of the contact time, whereas the addition of color additive improved bleach surface coverage to &gt;99.9% and maintained this level of coverage for 15 minutes.
      <xref ref-type="bibr" rid="bib0025">
       <sup>
        4
       </sup>
      </xref>
      When used in real-world settings, this color additive may maximize the efficacy of bleach disinfectants due to superior spray coverage.
     </p>
     <p id="p0150">
      Both 0.2% calcium hypochlorite with and without color additive demonstrated equal efficacy against
      <italic>
       V. cholerae
      </italic>
      , achieving &gt;6.03 log
      <sub>
       10
      </sub>
      and 5.99 log
      <sub>
       10
      </sub>
      reduction. Also, 0.5% NaDCC with and without color additive were equally efficacious against
      <italic>
       S. aureus
      </italic>
      and
      <italic>
       P. aeruginosa
      </italic>
      after a contact time of 5 minutes, passing the ASTM criteria for disinfection success of &gt;3.00 log
      <sub>
       10
      </sub>
      reduction.
     </p>
     <p id="p0155">
      We were interested to see if chlorine solutions remained efficacious when combined with the color additive for a prolonged period of time, given that its blue coloration is stable for 4–6 hours in bulk solution. We therefore conducted studies in which chlorine disinfectants were prepared with or without the color additive and allowed to rest at room temperature for 4 hours before efficacy testing. After the resting period, all 3 chlorine disinfectants, with and without color additive, met the ASTM criteria of &gt;3.00 log
      <sub>
       10
      </sub>
      reduction for disinfection success against
      <italic>
       P. aeruginosa
      </italic>
      after a contact time of 5 minutes. Although disposal of the chlorine solutions is recommended once the blue color has faded, additional testing is warranted on the effect of the color additive on long-term shelf-life.
     </p>
     <p id="p0160">
      Evaluating the skin safety of the color additive in combination with chlorine disinfectants was a major priority, given the risk of occupational exposure to disinfectants and skin diseases in healthcare personnel.
      <xref ref-type="bibr" rid="bib0175">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0180">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0185">
       36
      </xref>
      An independent GLP-compliant facility conducted direct primary skin irritation studies on all 3 chlorine disinfectants with and without color additive and found all to be negligible irritants. Thus, the addition of color additive to chlorine disinfectants does not increase their potential to cause skin irritation.
     </p>
     <p id="p0165">
      While the adoption of multifaceted infection prevention programs has helped combat HAIs, significant work remains to be done to ensure the proper execution of standard prevention practices.
      <xref ref-type="bibr" rid="bib0190">
       <sup>
        37
       </sup>
      </xref>
      Environmental surface cleaning is a critical component of these programs, but there is a consensus that current cleaning and disinfection practices are suboptimal.
      <xref ref-type="bibr" rid="bib0010">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0015">
       2
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0020">
       3
      </xref>
      Lack of adherence to protocol and poor techniques can be mitigated with careful monitoring and educational interventions. One study detailing the successful reduction of
      <italic>
       C. difficile
      </italic>
      contamination from 78% to 11% concluded that environmental cleaning interventions should provide a way to both monitor cleaning techniques and provide feedback to housekeeping staff.
      <xref ref-type="bibr" rid="bib0040">
       <sup>
        7
       </sup>
      </xref>
      However, these monitoring programs are difficult to enforce and sustain given that housekeeper turnover reaches up to 50% in some facilities.
      <xref ref-type="bibr" rid="bib0195">
       38
      </xref>
      ,
      <xref ref-type="bibr" rid="bib0200">
       39
      </xref>
     </p>
     <p id="p0170">
      The color-fading properties of the color additive allow it to function as a visible, real-time feedback mechanism for thoroughness of cleaning and adherence to wet-contact times. One recent study found that healthcare personnel were more successful in correctly identifying surfaces that had been sprayed with bleach if the color additive had been added.
      <xref ref-type="bibr" rid="bib0205">
       <sup>
        40
       </sup>
      </xref>
      Another study demonstrated that the color additive improved the surface coverage properties of bleach sprays from &lt;33% to &gt;99.9%.
      <xref ref-type="bibr" rid="bib0025">
       <sup>
        4
       </sup>
      </xref>
      We recently found that workers at Ebola treatment units in Liberia and Guinea reported increased coverage and confidence of disinfection when combining the color additive with their currently used chlorine solutions.
      <xref ref-type="bibr" rid="bib0055">
       <sup>
        10
       </sup>
      </xref>
      Although this color additive is suggested for use only on hard, nonporous surfaces, as is similarly recommended for chlorine disinfectants, it has potential applications in other settings like veterinarian clinics, food sanitation, and forensic restoration.
     </p>
    </sec>
    <sec id="s0080">
     <title>
      CONCLUSIONS
     </title>
     <p id="p0175">
      This study provided a comprehensive evaluation of the antimicrobial efficacy and skin safety profile of chlorine solutions in combination with this color additive. In conjunction with data from a recent study showing that the color additive did not adversely affect the efficacy of commercial bleach against
      <italic>
       C. difficile
      </italic>
      spores, our study demonstrated that this color additive is highly compatible with chlorine disinfectants.
      <xref ref-type="bibr" rid="bib0205">
       <sup>
        40
       </sup>
      </xref>
      This novel color additive could play a significant role in improving cleaning compliance and environmental surface disinfection, and further studies on its ability to enhance cleaning practices in healthcare settings are warranted.
     </p>
    </sec>
    <back>
     <ref-list id="bb0010">
      <title>
       References
      </title>
      <ref id="bib0010">
       <label>
        1
       </label>
       <element-citation id="sr0010" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Donskey
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Does improving surface cleaning and disinfection reduce health care-associated infections?
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         41
        </volume>
        <year>
         2013
        </year>
        <fpage>
         S12
        </fpage>
        <lpage>
         S19
        </lpage>
        <pub-id pub-id-type="pmid">
         23465603
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0015">
       <label>
        2
       </label>
       <element-citation id="sr0015" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boyce
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals
        </article-title>
        <source>
         Antimicrob Resist Infect Control
        </source>
        <volume>
         5
        </volume>
        <year>
         2016
        </year>
        <fpage>
         10
        </fpage>
        <pub-id pub-id-type="pmid">
         27069623
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0020">
       <label>
        3
       </label>
       <element-citation id="sr0020" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Sullivan
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Leas
          </surname>
          <given-names>
           B.F.
          </given-names>
         </name>
         <name>
          <surname>
           Pegues
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
         <name>
          <surname>
           Kaczmarek
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Umscheid
          </surname>
          <given-names>
           C.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cleaning hospital room surfaces to prevent health care-associated infections. A technical brief
        </article-title>
        <source>
         Ann Intern Med
        </source>
        <volume>
         163
        </volume>
        <year>
         2015
        </year>
        <fpage>
         598
        </fpage>
        <lpage>
         607
        </lpage>
        <pub-id pub-id-type="pmid">
         26258903
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0025">
       <label>
        4
       </label>
       <element-citation id="sr0025" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tyan
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Kyle
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Novel color additive for chlorine disinfectants corrects deficiencies in spray surface coverage and wet-contact time, and checks for correct chlorine concentration
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         46
        </volume>
        <year>
         2018
        </year>
        <fpage>
         624
        </fpage>
        <lpage>
         627
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0030">
       <label>
        5
       </label>
       <element-citation id="sr0030" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.A.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Selection of the ideal disinfectant
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <volume>
         35
        </volume>
        <year>
         2014
        </year>
        <fpage>
         855
        </fpage>
        <lpage>
         865
        </lpage>
        <pub-id pub-id-type="pmid">
         24915214
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0035">
       <label>
        6
       </label>
       <element-citation id="sr0035" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carling
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Bartley
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluating hygienic cleaning in healthcare settings: what you do not know can harm your patients
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         38
        </volume>
        <year>
         2010
        </year>
        <fpage>
         S41
        </fpage>
        <lpage>
         S50
        </lpage>
        <pub-id pub-id-type="pmid">
         20569855
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0040">
       <label>
        7
       </label>
       <element-citation id="sr0040" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Eckstein
          </surname>
          <given-names>
           B.C.
          </given-names>
         </name>
         <name>
          <surname>
           Adams
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
         <name>
          <surname>
           Eckstein
          </surname>
          <given-names>
           E.C.
          </given-names>
         </name>
         <name>
          <surname>
           Rao
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sethi
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yadavalli
          </surname>
          <given-names>
           G.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Reduction of
         <italic>
          Clostridium difficile
         </italic>
         and vancomycin-resistant
         <italic>
          Enterococcus
         </italic>
         contamination of environmental surfaces after an intervention to improve cleaning methods
        </article-title>
        <source>
         BMC Infect Dis
        </source>
        <volume>
         7
        </volume>
        <year>
         2007
        </year>
        <fpage>
         61
        </fpage>
        <pub-id pub-id-type="pmid">
         17584935
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0045">
       <label>
        8
       </label>
       <element-citation id="sr0045" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ramphal
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Suzuki
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           McCracken
          </surname>
          <given-names>
           I.M.
          </given-names>
         </name>
         <name>
          <surname>
           Addai
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Improving hospital staff compliance with environmental cleaning behavior
        </article-title>
        <source>
         Proc (Bayl Univ Med Cent)
        </source>
        <volume>
         27
        </volume>
        <year>
         2014
        </year>
        <fpage>
         88
        </fpage>
        <lpage>
         91
        </lpage>
        <pub-id pub-id-type="pmid">
         24688183
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0050">
       <label>
        9
       </label>
       <element-citation id="sr0050" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Watson
          </surname>
          <given-names>
           L.R.
          </given-names>
         </name>
         <name>
          <surname>
           Torress-Cook
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Efficacy of a hospital-wide environmental cleaning protocol on hospital-acquired methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         rates
        </article-title>
        <source>
         J Infect Prev
        </source>
        <volume>
         17
        </volume>
        <year>
         2016
        </year>
        <fpage>
         171
        </fpage>
        <lpage>
         176
        </lpage>
        <pub-id pub-id-type="pmid">
         28989476
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0055">
       <label>
        10
       </label>
       <element-citation id="sr0055" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Tyan
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Kyle
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Field-testing of a novel color indicator added to chlorine solutions used for decontamination of surfaces in Ebola Treatment Units
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         99
        </volume>
        <year>
         2018
        </year>
        <fpage>
         188
        </fpage>
        <lpage>
         191
        </lpage>
        <pub-id pub-id-type="pmid">
         29162492
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0060">
       <label>
        11
       </label>
       <element-citation id="sr0060" publication-type="other">
        <person-group person-group-type="author">
         <name>
          <surname>
           United States Environmental Protection Agency
          </surname>
         </name>
        </person-group>
        <article-title>
         Inert Ingredient Frequently Asked Questions
        </article-title>
        <comment>
         Published; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0095" xlink:href="https://www.epa.gov/sites/production/files/2014-05/documents/faqs.pdf">
         https://www.epa.gov/sites/production/files/2014-05/documents/faqs.pdf
        </ext-link>
        <year>
         2014
        </year>
       </element-citation>
      </ref>
      <ref id="bib0065">
       <label>
        12
       </label>
       <element-citation id="sr0065" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           AOAC International
          </surname>
         </name>
        </person-group>
        <chapter-title>
         AOAC Official Method 961.02 Germicidal spray products as disinfectants
        </chapter-title>
        <source>
         Official methods of analysis of AOAC International
        </source>
        <year>
         2016
        </year>
        <comment>
         Chapter 6
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0070">
       <label>
        13
       </label>
       <element-citation id="sr0070" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Grant
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         GLP1550: GLP AOAC Germicidal Spray Products Test
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2016
        </year>
       </element-citation>
      </ref>
      <ref id="bib0075">
       <label>
        14
       </label>
       <element-citation id="sr0075" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Grant
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         GLP1540: GLP AOAC Germicidal Spray Products Test
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2016
        </year>
       </element-citation>
      </ref>
      <ref id="bib0080">
       <label>
        15
       </label>
       <element-citation id="sr0080" publication-type="other">
        <person-group person-group-type="author">
         <name>
          <surname>
           US EPA
          </surname>
         </name>
        </person-group>
        <article-title>
         Pesticide Product Label, CLOROX BLEACH. United States Environmental Protection Agency website
        </article-title>
        <comment>
         Published; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0100" xlink:href="https://www3.epa.gov/pesticides/chem_search/ppls/005813-00001-20110913.pdf">
         https://www3.epa.gov/pesticides/chem_search/ppls/005813-00001-20110913.pdf
        </ext-link>
        <year>
         2011
        </year>
       </element-citation>
      </ref>
      <ref id="bib0085">
       <label>
        16
       </label>
       <element-citation id="sr0085" publication-type="book">
        <comment>
         ASTM
        </comment>
        <ext-link ext-link-type="uri" id="iw0105" xlink:href="astm:E1053">
         E1053-11
        </ext-link>
        <source>
         Standard Test Method to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces
        </source>
        <year>
         2011
        </year>
        <comment>
         ASTM International, West Conshohocken, PA; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0110" xlink:href="http://www.astm.org">
         www.astm.org
        </ext-link>
        <comment>
         Accessed March 8, 2018
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0090">
       <label>
        17
       </label>
       <element-citation id="sr0090" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guin
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         GLP1536: GLP ASTM E1053 Modified for Spray Products
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0095">
       <label>
        18
       </label>
       <element-citation id="sr0095" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guin
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         GLP1538: GLP ASTM E1053 Modified for Spray Products
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0100">
       <label>
        19
       </label>
       <element-citation id="sr0100" publication-type="book">
        <comment>
         ASTM
        </comment>
        <ext-link ext-link-type="uri" id="iw0115" xlink:href="astm:E2315">
         E2315-03
        </ext-link>
        <source>
         Standard Guide for Assessment of Antimicrobial Activity Using a Time-Kill Procedure
        </source>
        <year>
         2008
        </year>
        <comment>
         ASTM International, West Conshohocken, PA; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0120" xlink:href="http://www.astm.org">
         www.astm.org
        </ext-link>
        <comment>
         Accessed March 8, 2018
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0105">
       <label>
        20
       </label>
       <element-citation id="sr0105" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         NG8285: Antibacterial Efficacy of Kinnos's Test Substances Using a Suspension Time-Kill Procedure
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0110">
       <label>
        21
       </label>
       <element-citation id="sr0110" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weeks
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         NG9676: Antibacterial Efficacy of Kinnos' Test Substances Using a Suspension Time-Kill Procedure
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0115">
       <label>
        22
       </label>
       <element-citation id="sr0115" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           International Medical Corps, Haiti
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Feedback on the Use of the “Highlights” at two Cholera Treatment Units in Haiti
        </chapter-title>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0120">
       <label>
        23
       </label>
       <element-citation id="sr0120" publication-type="other">
        <person-group person-group-type="author">
         <name>
          <surname>
           United States Centers for Disease Control and Prevention
          </surname>
         </name>
        </person-group>
        <article-title>
         Infection Control for Cholera in Health Care Settings
        </article-title>
        <comment>
         Updated; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0125" xlink:href="https://www.cdc.gov/cholera/infection-control-hcp.html">
         https://www.cdc.gov/cholera/infection-control-hcp.html
        </ext-link>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0125">
       <label>
        24
       </label>
       <element-citation id="sr0125" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Essential environmental health standards in health care
        </chapter-title>
        <year>
         2008
        </year>
        <publisher-name>
         World Health Organization
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
       </element-citation>
      </ref>
      <ref id="bib0130">
       <label>
        25
       </label>
       <element-citation id="sr0130" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jones
          </surname>
          <given-names>
           M.V.
          </given-names>
         </name>
         <name>
          <surname>
           Wood
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Herd
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Comparative sensitivity of
         <italic>
          Vibrio cholerae
         </italic>
         01 E1 Tor and
         <italic>
          Escherichia coli
         </italic>
         to disinfectants
        </article-title>
        <source>
         Lett Appl Microbiol
        </source>
        <volume>
         14
        </volume>
        <year>
         1992
        </year>
        <fpage>
         51
        </fpage>
        <lpage>
         53
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0135">
       <label>
        26
       </label>
       <element-citation id="sr0135" publication-type="book">
        <comment>
         ASTM
        </comment>
        <ext-link ext-link-type="uri" id="iw0130" xlink:href="astm:E1153">
         E1153-14
        </ext-link>
        <source>
         Standard Test Method for Efficacy of Sanitizers Recommended for Inanimate, Hard, Nonporous Non-Food Contact Surfaces
        </source>
        <year>
         2014
        </year>
        <comment>
         ASTM International, West Conshohocken, PA; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0135" xlink:href="http://www.astm.org">
         www.astm.org
        </ext-link>
        <comment>
         Accessed March 8, 2018
        </comment>
       </element-citation>
      </ref>
      <ref id="bib0140">
       <label>
        27
       </label>
       <element-citation id="sr0140" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saad
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         NG8156: Antibacterial Activity and Sanitizing Efficacy of Kinnos Inc.'s Test Substances against
         <italic>
          S. aureus
         </italic>
         &amp;
         <italic>
          P. aeruginosa
         </italic>
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0145">
       <label>
        28
       </label>
       <element-citation id="sr0145" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lutz
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         NG8698: Antibacterial Activity and Sanitizing Efficacy of Kinnos Inc.'s Test Substances against
         <italic>
          P. aeruginosa
         </italic>
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0150">
       <label>
        29
       </label>
       <element-citation id="sr0150" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Grant
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         NG9375: Antibacterial Activity and Sanitizing Efficacy of Kinnos, Inc.'s Test Substances
        </chapter-title>
        <comment>
         Microchem Laboratory, Round Rock, TX
        </comment>
        <year>
         2017
        </year>
       </element-citation>
      </ref>
      <ref id="bib0155">
       <label>
        30
       </label>
       <element-citation id="sr0155" publication-type="other">
        <person-group person-group-type="author">
         <name>
          <surname>
           US EPA
          </surname>
         </name>
        </person-group>
        <article-title>
         Pesticide Product Label, XHC-S. United States Environmental Protection Agency website
        </article-title>
        <comment>
         Published; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0140" xlink:href="https://www3.epa.gov/pesticides/chem_search/ppls/001677-00255-20160629.pdf">
         https://www3.epa.gov/pesticides/chem_search/ppls/001677-00255-20160629.pdf
        </ext-link>
        <year>
         2016
        </year>
       </element-citation>
      </ref>
      <ref id="bib0160">
       <label>
        31
       </label>
       <element-citation id="sr0160" publication-type="other">
        <person-group person-group-type="author">
         <name>
          <surname>
           ISO 10993-10:2010
          </surname>
         </name>
        </person-group>
        <article-title>
         Biological evaluation of medical devices – Part 10: Tests for irritation and skin sensitization. International Organization for Standardization website
        </article-title>
        <comment>
         Published; Available from:
        </comment>
        <ext-link ext-link-type="uri" id="iw0145" xlink:href="https://www.iso.org/standard/40884.html">
         https://www.iso.org/standard/40884.html
        </ext-link>
        <year>
         2010
        </year>
       </element-citation>
      </ref>
      <ref id="bib0165">
       <label>
        32
       </label>
       <element-citation id="sr0165" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lister
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Final GLP Reports
        </chapter-title>
        <comment>
         Toxikon Corporation, Bedford, MA
        </comment>
        <year>
         2016
        </year>
       </element-citation>
      </ref>
      <ref id="bib0170">
       <label>
        33
       </label>
       <element-citation id="sr0170" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Omidbakhsh
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Theoretical and experimental aspects of microbicidal activities of hard surface disinfectants: are their label claims based on testing under field conditions?
        </article-title>
        <source>
         J AOAC Int
        </source>
        <volume>
         93
        </volume>
        <year>
         2010
        </year>
        <fpage>
         1944
        </fpage>
        <lpage>
         1951
        </lpage>
        <pub-id pub-id-type="pmid">
         21313824
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0175">
       <label>
        34
       </label>
       <element-citation id="sr0175" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Stingni
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Lapomarda
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Lisi
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Occupational hand dermatitis in hospital environments
        </article-title>
        <source>
         Contact Dermatitis
        </source>
        <volume>
         33
        </volume>
        <year>
         1995
        </year>
        <fpage>
         172
        </fpage>
        <lpage>
         176
        </lpage>
        <pub-id pub-id-type="pmid">
         8565458
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0180">
       <label>
        35
       </label>
       <element-citation id="sr0180" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Singgih
          </surname>
          <given-names>
           S.I.R.
          </given-names>
         </name>
         <name>
          <surname>
           Lantinga
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Nater
          </surname>
          <given-names>
           J.P.
          </given-names>
         </name>
         <name>
          <surname>
           Woest
          </surname>
          <given-names>
           T.E.
          </given-names>
         </name>
         <name>
          <surname>
           Kruyt-Gaspersz
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Occupational hand dermatoses in hospital cleaning personnel
        </article-title>
        <source>
         Contact Dermatitis
        </source>
        <volume>
         14
        </volume>
        <year>
         1986
        </year>
        <fpage>
         14
        </fpage>
        <lpage>
         19
        </lpage>
        <pub-id pub-id-type="pmid">
         2936557
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0185">
       <label>
        36
       </label>
       <element-citation id="sr0185" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Quinn
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Henneberger
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Cleaning and disinfecting environmental surfaces in health care: toward an integrated framework for infection and occupational illness prevention
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         43
        </volume>
        <year>
         2015
        </year>
        <fpage>
         424
        </fpage>
        <lpage>
         434
        </lpage>
        <pub-id pub-id-type="pmid">
         25792102
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0190">
       <label>
        37
       </label>
       <element-citation id="sr0190" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dick
          </surname>
          <given-names>
           A.W.
          </given-names>
         </name>
         <name>
          <surname>
           Perencevich
          </surname>
          <given-names>
           E.N.
          </given-names>
         </name>
         <name>
          <surname>
           Pogorzelska-Maziarz
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Zwanziger
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Larson
          </surname>
          <given-names>
           E.L.
          </given-names>
         </name>
         <name>
          <surname>
           Stone
          </surname>
          <given-names>
           P.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A decade of investment in infection prevention: a cost-effectiveness analysis
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         43
        </volume>
        <year>
         2015
        </year>
        <fpage>
         4
        </fpage>
        <lpage>
         9
        </lpage>
        <pub-id pub-id-type="pmid">
         25564117
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0195">
       <label>
        38
       </label>
       <element-citation id="sr0195" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zoutman
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Ford
          </surname>
          <given-names>
           B.D.
          </given-names>
         </name>
         <name>
          <surname>
           Sopha
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Environmental cleaning resources and activities in Canadian acute care hospitals
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         42
        </volume>
        <year>
         2014
        </year>
        <fpage>
         490
        </fpage>
        <lpage>
         494
        </lpage>
        <pub-id pub-id-type="pmid">
         24773787
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib0200">
       <label>
        39
       </label>
       <element-citation id="sr0200" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Appelbaum
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Berg
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Frost
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Preuss
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Appelbaum
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         The effects of work restructuring on low-wage, low-skilled workers in U.S. hospitals
        </chapter-title>
        <person-group person-group-type="editor">
         <name>
          <surname>
           Bernhadt
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Murnane
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <source>
         Low-wage America: how employers are reshaping opportunity in the workplace
        </source>
        <year>
         2003
        </year>
        <publisher-name>
         Russel Sage Foundation
        </publisher-name>
        <publisher-loc>
         New York (NY)
        </publisher-loc>
        <fpage>
         77
        </fpage>
        <lpage>
         117
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib0205">
       <label>
        40
       </label>
       <element-citation id="sr0205" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mustapha
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Cadnum
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Alhmidi
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Donskey
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of novel chemical additive that colorizes chlorine-based disinfectants to improve visualization of surface coverage
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         46
        </volume>
        <year>
         2018
        </year>
        <fpage>
         119
        </fpage>
        <lpage>
         121
        </lpage>
        <pub-id pub-id-type="pmid">
         29110900
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
     <sec id="s0085">
      <label>
       Appendix 1
      </label>
      <title>
       Detailed efficacy test and skin irritation test methods
      </title>
      <sec id="s0090">
       <title>
        AOAC method 961.02
       </title>
       <p id="p0180">
        AOAC Method 961.02, or the AOAC Germicidal Spray Test, is a standard test protocol specified by the EPA for antimicrobial pesticide registration. This protocol, followed for studies GLP1540 and GLP1550, was conducted in agreement with EPA guideline OCSPP 810.2200 and GLP requirements, as defined in 40 CFR § 160.
        <xref ref-type="bibr" rid="bib0065">
         <sup>
          12
         </sup>
        </xref>
       </p>
       <p id="p0185">
        A daily culture of
        <italic>
         S. aureus
        </italic>
        was prepared from frozen stock culture, and test cultures were initiated in 20x150-mm tubes containing 10 mL AOAC Synthetic Broth. After a 48-hour incubation at 36°C ± 1°C, all test culture tubes were pooled together with the addition of 5% ± 0.1% (v/v) fetal bovine serum (FBS) as organic bioburden. Carriers were prepared by placing autoclaved 18x36-mm glass slides into sterile petri dishes matted with sterile 9-cm filter rounds. Each carrier was inoculated by evenly spreading 10 µL of pooled test culture onto the glass slide and drying for 30–40 minutes at 36°C ± 1°C. Two sets of 3 inoculated carriers were selected for enumeration of the amount of
        <italic>
         S. aureus
        </italic>
        present on the carriers, with 1 set harvested before and after the test.
       </p>
       <p id="p0190">
        Sixty inoculated carriers were treated with 3 sprays of the test substance (0.5% sodium hypochlorite with or without color additive) on mist setting at a distance of 6–8 inches and an angle of 45° and left undisturbed for a contact time of 10 minutes ± 5 seconds. The treated carriers were then individually transferred into 25x150-mm test tubes containing Letheen Broth supplemented with 0.1% sodium thiosulfate and 0.5% Tween 80, to both neutralize the test substance and allow any surviving
        <italic>
         S. aureus
        </italic>
        to grow. After a 48-hour incubation at 36°C ± 1°C, the 60 test tubes were assessed for growth. Any tubes showing growth were confirmed to not be a result of contamination by plating on growth media and testing for
        <italic>
         S. aureus.
        </italic>
        Three lots of each test substance were tested, with 60 carriers for each lot test.
       </p>
       <p id="p0195">
        All of the EPA-specified criteria for experimental success were met in these studies. The set of carriers from each lot that were enumerated for
        <italic>
         S. aureus
        </italic>
        before and after the test all demonstrated the required mean log
        <sub>
         10
        </sub>
        density of between 5.0 and 6.5. Additional details around the control criteria that were met for this study to proceed (media sterility control, viability growth control, and neutralization control) may be found in the cited study protocols.
        <xref ref-type="bibr" rid="bib0070">
         13
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0075">
         14
        </xref>
       </p>
      </sec>
      <sec id="s0095">
       <title>
        ASTM Method E1053
       </title>
       <p id="p0200">
        ASTM
        <ext-link ext-link-type="uri" id="iw0080" xlink:href="astm:E1053">
         E1053
        </ext-link>
        , or Standard Test Method for Efficacy of Virucidal Agents Intended for Inanimate Environmental Surfaces, is the primary testing method accepted by the EPA for virucidal claims. This protocol, followed for studies GLP1536 and GLP1538, was conducted in agreement with EPA guideline OCSPP 810.2200 and GLP requirements, as defined in 40 CFR § 158.
        <xref ref-type="bibr" rid="bib0085">
         <sup>
          16
         </sup>
        </xref>
       </p>
       <p id="p0205">
        Stock aliquots of human coronavirus 229E were thawed on the day of use, and viral inoculum was prepared by combining the viral suspension to a 5% protein organic soil load composed of phosphate buffered saline (PBS), bovine serum albumin, bovine mucin, and yeast extract. Carriers were prepared by autoclaving 100x15-mm glass petri dishes. Then, 200 µL of viral inoculum was spread evenly inside the bottom surfaces of the carriers using a sterile cell scraper, then left to dry for 20 minutes under ambient conditions. Three carriers were prepared: 1 as a plate recovery control to determine the baseline dried virus titer and 1 for each of the 2 lots of test substance to determine levels of infectious virus after exposure to the test substance.
       </p>
       <p id="p0210">
        One dried virus test film carrier for each lot of test substance was treated with 3 sprays of the test substance (0.5% sodium hypochlorite with or without color additive) on mist setting at a distance of 6–8 inches and an angle of 45° and left undisturbed for 10 minutes ± 5 seconds. The treated carriers were then neutralized with 2 mL of 0.1% lecithin in 10% FBS Eagle's Minimum Essential Medium. The virus films were then mechanically detached from the carriers using sterile cell scrapers and filtered through pre-equilibrated Sephacryl (S-1000 SF) gel filtration columns for secondary neutralization. Serial 10-fold dilutions of the filtrate were then prepared from 10
        <sup>
         −1
        </sup>
        to 10
        <sup>
         −6
        </sup>
        , and each dilution was applied in quadruplicate to multi-well cell culture plates containing monolayers of normal lung fibroblast (MRC-5) cells (ATCC CCL-171).
       </p>
       <p id="p0215">
        Assay plates were incubated at 37°C ± 2°C, 5% ± 1% CO
        <sub>
         2
        </sub>
        , for 7 days, and then each well was examined under a microscope for cytopathic effects, indicating presence of infectious virus. The Spearman-Karber method was used to quantify the amount of infectious virus recovered at the end of the assays.
       </p>
       <p id="p0220">
        The virus stock titer, cell culture, cytotoxicity, and test substance neutralization controls were all assayed concurrently with the plate recovery control and virus-substance exposure tests and met all criteria necessary to validate this study, additional details of which may be found in the cited study protocols.
        <xref ref-type="bibr" rid="bib0090">
         17
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0095">
         18
        </xref>
       </p>
      </sec>
      <sec id="s0100">
       <title>
        ASTM Method E2315
       </title>
       <p id="p0225">
        ASTM
        <ext-link ext-link-type="uri" id="iw0085" xlink:href="astm:E2315">
         E2315
        </ext-link>
        , or Assessment of Antimicrobial Activity Using a Time-Kill Procedure, is used to quantify the log reduction of a test microorganism after exposure in an antimicrobial suspension.
        <xref ref-type="bibr" rid="bib0100">
         <sup>
          19
         </sup>
        </xref>
        The suspension test method is commonly used for efficacy testing against pathogens like
        <italic>
         V. cholerae
        </italic>
        that cannot survive the drying phase of standard hard surface tests.
        <xref ref-type="bibr" rid="bib0130">
         <sup>
          25
         </sup>
        </xref>
       </p>
       <p id="p0230">
        A culture of
        <italic>
         V. cholerae
        </italic>
        was prepared in tryptic soy broth medium as the inoculum. Ten mL of the test substance and 10 mL of the control substance (PBS) were dispensed into separate sterile tubes. Both the test and control substances were then inoculated with 500 µL of
        <italic>
         V. cholerae
        </italic>
        in growth medium and mixed. One mL of the inoculated control substance was immediately harvested to determine the starting concentration of the microorganism. After the contact time of 3 minutes ± 5 seconds, 1 mL of the inoculated test substance was harvested and chemically neutralized with 9 mL of Dey/Engley broth supplemented with 0.5% sodium thiosulfate, 0.5% lecithin, and 0.5% Tween 80. The neutralized test solution was plated on tryptic soy agar for 48 hours at 36°C ± 1°C, then enumerated to determine the number of CFUs. The surviving microbial population from the test substance exposure was compared to the population recovered from the control to determine the log reduction.
       </p>
       <p id="p0235">
        The appropriate controls (positive/growth, negative/purity, neutralization, and media sterility) were performed and confirmed to validate these studies, additional details of which may be found in the cited study protocols.
        <xref ref-type="bibr" rid="bib0105">
         20
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0110">
         21
        </xref>
       </p>
      </sec>
      <sec id="s0105">
       <title>
        ASTM Method E1153
       </title>
       <p id="p0240">
        ASTM
        <ext-link ext-link-type="uri" id="iw0090" xlink:href="astm:E1153">
         E1153
        </ext-link>
        , or Efficacy of Sanitizers Recommended for Inanimate Non-Food Contact Surfaces, is a test method typically performed to substantiate sanitizer claims for registered disinfectants. This protocol was followed for studies NG8156, NG8698, and NG9375.
        <xref ref-type="bibr" rid="bib0140">
         27
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0145">
         28
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0150">
         29
        </xref>
       </p>
       <p id="p0245">
        Cultures of
        <italic>
         S. aureus
        </italic>
        and
        <italic>
         P. aeruginosa
        </italic>
        were initiated from stock in tubes containing 10 mL of tryptic soy broth and AOAC synthetic broth, respectively. After a 24-hour incubation at 37°C ± 2°C, a 4-mm transfer loop was used to transfer the culture into 10 mL of fresh broth. Three consecutive daily transfers were made, with the final transfer of
        <italic>
         S. aureus
        </italic>
        incubated for 24 hours and the final transfer of
        <italic>
         P. aeruginosa
        </italic>
        incubated for 48 hours. Carriers were prepared by placing autoclaved 18x36-mm glass slides into sterile petri dishes. Each carrier was then inoculated with 10 µL of the culture, then dried for 30 minutes ± 2 minutes at 36°C ± 1°C. Test carriers were then treated with approximately 5 mL of the test substance by spraying 6 times from a distance of 6–8 inches at a 45° angle. Control carriers were treated with 5 mL of PBS. After a contact time of 5 minutes ± 5 seconds in ambient conditions, all carriers were chemically neutralized with 20 mL of Dey/Engley broth supplemented with 0.5% sodium thiosulfate and 0.5% Tween 80. Using standard pour-plate techniques, the neutralized substances were plated on nutrient agar and incubated for 48 hours at 36°C ± 1°C. The surviving microbial populations (CFU) on the test plates were compared to the controls to determine log reduction.
       </p>
       <p id="p0250">
        The appropriate controls (positive/growth, negative/purity, neutralization, and media sterility) were performed and confirmed to validate these studies, additional details of which may be found in the cited study protocols.
        <xref ref-type="bibr" rid="bib0135">
         26
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0140">
         27
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0145">
         28
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0150">
         29
        </xref>
       </p>
      </sec>
      <sec id="s0110">
       <title>
        Direct primary skin irritation test
       </title>
       <p id="p0255">
        Toxikon Corporation performed direct primary skin irritation studies in accordance with FDA-recognized test methods established by the ISO. The studies were based on standard protocols ISO 10993-10, ISO 10993-12, and ISO/IEC 17025 and conducted in agreement with GLP requirements, as defined in 21 CFR § 58.
        <xref ref-type="bibr" rid="bib0160">
         31
        </xref>
        ,
        <xref ref-type="bibr" rid="bib0165">
         32
        </xref>
       </p>
       <p id="p0260">
        Three 2–4 kg New Zealand white rabbits were purchased from Covance Laboratories (Denver, Pennsylvania) for each test substance, for a total of 18 rabbits. The rabbits were maintained at 20°C ± 3°C under 30%–70% humidity, fed ad libitum, and acclimatized for a minimum of 5 days before treatment. The trunk of each rabbit was clipped free of hair within 24 hours before application of the test substance. Four application sites were designated, with 2 sites for the test substance and 2 sites for untreated control. 0.5 mL of the test substance was then applied directly to the 2 test sites, which were then covered with non-occlusive dressing and wrapped with a semi-occlusive bandage. The control sites were left untreated and wrapped in the same manner as the test sites. After a 4-hour contact period, the dressings were removed, the application sites were marked, and any residual test substance was rinsed off with sterile water.
       </p>
       <p id="p0265">
        The rabbits were observed for signs of erythema and edema at 1, 24, 48, and 72 hours after the dressings were removed. Signs of erythema and edema were both scored from 0 to 4 according to the ISO 10993-10 scoring system for skin reaction.
        <xref ref-type="bibr" rid="bib0160">
         <sup>
          31
         </sup>
        </xref>
        The observation values for each animal were obtained by adding the erythema and edema scores at the 24-, 48-, and 72-hour time points and dividing the sum by 6 (2 test sites x 3 observation time points). The same was done for the control sites of each animal. The control scores were then subtracted from the test site scores. To obtain the final PII score of a test substance, the calculated values of the 3 animals were totaled and divided by 3.
       </p>
      </sec>
     </sec>
     <fn-group>
      <fn id="d32e1901">
       <p id="np0010">
        Funding/support: This work was supported by the
        <funding-source id="gsp0010">
         United States Agency for International Development Fighting Ebola Grand Challenge
        </funding-source>
        (Grant no. AID-OAA-F-15-00026). The funding source played no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or in the decision to submit the paper for publication.
       </p>
      </fn>
      <fn id="d32e1910">
       <p id="np0015">
        Conflicts of interest: KT, JK, and KJ are founders and shareholders of Kinnos Inc. and have patents pending on the Highlight
        <sup>
         ®
        </sup>
        technology. AMK declares no conflicts of interest relevant to this article. All authors declare no relationship or conflicts of interest with the manufacturers of chlorine disinfectants used in this study.
       </p>
      </fn>
     </fn-group>
    </back>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Eur J Clin Microbiol Infect Dis
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Eur. J. Clin. Microbiol. Infect. Dis
      </journal-id>
      <journal-title-group>
       <journal-title>
        European Journal of Clinical Microbiology &amp; Infectious Diseases
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0934-9723
      </issn>
      <issn pub-type="epub">
       1435-4373
      </issn>
      <publisher>
       <publisher-name>
        Springer Berlin Heidelberg
       </publisher-name>
       <publisher-loc>
        Berlin/Heidelberg
       </publisher-loc>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       28647859
      </article-id>
      <article-id pub-id-type="pmc">
       7087772
      </article-id>
      <article-id pub-id-type="publisher-id">
       3042
      </article-id>
      <article-id pub-id-type="doi">
       10.1007/s10096-017-3042-4
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Review
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        High-touch surfaces: microbial neighbours at hand
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">
         http://orcid.org/0000-0002-0763-9769
        </contrib-id>
        <name>
         <surname>
          Cobrado
         </surname>
         <given-names>
          L.
         </given-names>
        </name>
        <address>
         <email>
          lcobrado@med.up.pt
         </email>
        </address>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff2">
         2
        </xref>
        <xref ref-type="aff" rid="Aff3">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Silva-Dias
         </surname>
         <given-names>
          A.
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff3">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Azevedo
         </surname>
         <given-names>
          M. M.
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff3">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Rodrigues
         </surname>
         <given-names>
          A. G.
         </given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">
         1
        </xref>
        <xref ref-type="aff" rid="Aff2">
         2
        </xref>
        <xref ref-type="aff" rid="Aff3">
         3
        </xref>
       </contrib>
       <aff id="Aff1">
        <label>
         1
        </label>
        <institution-wrap>
         <institution-id institution-id-type="ISNI">
          0000 0001 1503 7226
         </institution-id>
         <institution-id institution-id-type="GRID">
          grid.5808.5
         </institution-id>
         <institution>
          Division of Microbiology, Department of Pathology, Faculty of Medicine,
         </institution>
         <institution>
          University of Porto,
         </institution>
        </institution-wrap>
        Alameda Prof. Hernâni Monteiro, 4200 Porto, Portugal
       </aff>
       <aff id="Aff2">
        <label>
         2
        </label>
        <institution-wrap>
         <institution-id institution-id-type="ISNI">
          0000 0000 9375 4688
         </institution-id>
         <institution-id institution-id-type="GRID">
          grid.414556.7
         </institution-id>
         <institution>
          Burn Unit, Department of Plastic and Reconstructive Surgery,
         </institution>
         <institution>
          Centro Hospitalar São João,
         </institution>
        </institution-wrap>
        Porto, Portugal
       </aff>
       <aff id="Aff3">
        <label>
         3
        </label>
        <institution-wrap>
         <institution-id institution-id-type="ISNI">
          0000 0001 1503 7226
         </institution-id>
         <institution-id institution-id-type="GRID">
          grid.5808.5
         </institution-id>
         <institution>
          CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine,
         </institution>
         <institution>
          University of Porto,
         </institution>
        </institution-wrap>
        Porto, Portugal
       </aff>
      </contrib-group>
      <pub-date pub-type="epub">
       <day>
        25
       </day>
       <month>
        6
       </month>
       <year>
        2017
       </year>
      </pub-date>
      <pub-date pub-type="ppub">
       <year>
        2017
       </year>
      </pub-date>
      <volume>
       36
      </volume>
      <issue>
       11
      </issue>
      <fpage>
       2053
      </fpage>
      <lpage>
       2062
      </lpage>
      <history>
       <date date-type="received">
        <day>
         27
        </day>
        <month>
         4
        </month>
        <year>
         2017
        </year>
       </date>
       <date date-type="accepted">
        <day>
         4
        </day>
        <month>
         6
        </month>
        <year>
         2017
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © Springer-Verlag GmbH Germany 2017
       </copyright-statement>
       <license>
        <license-p>
         This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
        </license-p>
       </license>
      </permissions>
      <abstract id="Abs1">
       <p id="Par1">
        Despite considerable efforts, healthcare-associated infections (HAIs) continue to be globally responsible for serious morbidity, increased costs and prolonged length of stay. Among potentially preventable sources of microbial pathogens causing HAIs, patient care items and environmental surfaces frequently touched play an important role in the chain of transmission. Microorganisms contaminating such high-touch surfaces include Gram-positive and Gram-negative bacteria, viruses, yeasts and parasites, with improved cleaning and disinfection effectively decreasing the rate of HAIs. Manual and automated surface cleaning strategies used in the control of infectious outbreaks are discussed and current trends concerning the prevention of contamination by the use of antimicrobial surfaces are taken into consideration in this manuscript.
       </p>
      </abstract>
      <custom-meta-group>
       <custom-meta>
        <meta-name>
         issue-copyright-statement
        </meta-name>
        <meta-value>
         © Springer-Verlag GmbH Germany 2017
        </meta-value>
       </custom-meta>
      </custom-meta-group>
     </article-meta>
    </front>
    <sec id="Sec1">
     <title>
      Introduction
     </title>
     <p id="Par2">
      In spite of the growing global commitment towards an effective reduction of healthcare-associated infections (HAIs), it is unfortunately certain that such infections will continue to be responsible for very high morbidity, increased costs and length of stay (LOS) for the coming decades [
      <xref ref-type="bibr" rid="CR1">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="CR2">
       2
      </xref>
      ].
     </p>
     <p id="Par3">
      Among potential sources of pathogens causing HAIs, the most frequent are the patient’s microbiota and the hands of healthcare personnel [
      <xref ref-type="bibr" rid="CR3">
       3
      </xref>
      ]. Additionally, evidence that high-touch surfaces (HTS) will work as an extra source of microbial pathogens accumulated over the years, e.g., several microorganisms can survive on medical equipment for hours to months, improved cleaning and disinfection of surfaces decrease the rate of HAI, and hospital environmental screening results and the study of clonal outbreaks, all have given support to the role of contaminated HTS in the transmission of pathogens between patients and healthcare personnel [
      <xref ref-type="bibr" rid="CR4">
       4
      </xref>
      ]. From surfaces, microbial transmission may occur either through direct patient contact or, indirectly, through healthcare personnel hands or gloves [
      <xref ref-type="bibr" rid="CR5">
       5
      </xref>
      ]. Therefore, upon potentially preventable sources of microorganisms, contaminated HTS deserve strong consideration.
     </p>
     <p id="Par4">
      Microbial pathogens most frequently involved in the contamination of hospital environmental surfaces are (methicillin-resistant)
      <italic>
       Staphylococcus aureus
      </italic>
      (MRSA), vancomycin-resistant enterococci (VRE),
      <italic>
       Clostridium difficile
      </italic>
      , multidrug resistant Gramme-negative bacilli (such as
      <italic>
       Pseudomonas
      </italic>
      ,
      <italic>
       Acinetobacter
      </italic>
      and
      <italic>
       Enterobacteriaceae
      </italic>
      ), Norovirus, Coronavirus and
      <italic>
       Candida
      </italic>
      species [
      <xref ref-type="bibr" rid="CR6">
       6
      </xref>
      –
      <xref ref-type="bibr" rid="CR10">
       10
      </xref>
      ].
     </p>
     <p id="Par5">
      Strategies for cleaning contaminated HTS may include manual and automated techniques. Wipes and cloths with application of detergents or disinfectants are examples of manual techniques, while automated methods may involve UV light, hydrogen peroxide, steam vapour, ozone and HINS (high-intensity narrow-spectrum light). On the other side, in order to prevent contamination of HTS, antimicrobial surfaces are being developed. The inhibition of microbial adhesion with repellent films is a possible strategy, as it is the surface treatment with antimicrobial coatings of silver, copper, polycations, triclosan, bacteriophages or, even, light-activated biotoxic radicals.
     </p>
     <p id="Par6">
      The aim of this manuscript is to review the role of high-touch surfaces in healthcare-associated infections, from the aetiology to strategies for surface cleaning and addressing preventive trends.
     </p>
    </sec>
    <sec id="Sec2">
     <title>
      Types of surfaces
     </title>
     <p id="Par7">
      As early as 1972, Spaulding proposed a classification of inanimate surfaces into three general categories based on the risk of infection if the surfaces were contaminated at the time of use [
      <xref ref-type="bibr" rid="CR11">
       11
      </xref>
      ]. These categories can be applied to devices or instruments as follows: critical (exposed to normally sterile areas of the body; require sterilization), semi-critical (touch mucous membranes; may be sterilized or disinfected), and non-critical (touch skin or come into contact with people only indirectly; can be either cleaned and then disinfected with an intermediate-level disinfectant, sanitized with a low-level disinfectant or, simply, cleaned with water and soap). In 1991, the CDC proposed environmental surfaces (floors, walls and other “housekeeping surfaces” that do not make direct contact with a person’s skin) as an additional category [
      <xref ref-type="bibr" rid="CR12">
       12
      </xref>
      ]. More recently, the CDC’s and Healthcare Infection Control Practices Advisory Committee’s Guidelines for Environmental Infection Control in Healthcare Facilities [
      <xref ref-type="bibr" rid="CR13">
       13
      </xref>
      ] divided surfaces into patient care items and environmental surfaces. Environmental surfaces were further divided into medical equipment and patient room surfaces (Table
      <xref ref-type="table" rid="Tab1">
       1
      </xref>
      ).
      <table-wrap id="Tab1">
       <label>
        Table 1
       </label>
       <caption>
        <p>
         Types of healthcare-associated surfaces
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <tbody>
         <tr>
          <td colspan="2">
           Patient care items
          </td>
          <td>
           <p>
            Blood pressure cuff
           </p>
           <p>
            Pulse oximeter
           </p>
           <p>
            Thermometer
           </p>
           <p>
            Glucometer
           </p>
           <p>
            Stethoscope
           </p>
           <p>
            Venipuncture tourniquets
           </p>
          </td>
         </tr>
         <tr>
          <td rowspan="2">
           Environmental surfaces
          </td>
          <td>
           Medical equipment
          </td>
          <td>
           <p>
            Monitor touch screen, controls and cables
           </p>
           <p>
            Ventilator control panel
           </p>
           <p>
            Oxygen flow meter and suction regulator
           </p>
           <p>
            Intravenous pump control and pole
           </p>
           <p>
            Supply cart
           </p>
          </td>
         </tr>
         <tr>
          <td>
           Patient room
          </td>
          <td>
           <p>
            Bed rails/controls
           </p>
           <p>
            Bedside table/handles
           </p>
           <p>
            Over-bed table
           </p>
           <p>
            Chair
           </p>
           <p>
            Call box/button
           </p>
           <p>
            Telephone and TV remote
           </p>
           <p>
            Privacy curtain
           </p>
           <p>
            Window blinds and control
           </p>
           <p>
            Light switches
           </p>
           <p>
            Door and closet knobs/plates
           </p>
           <p>
            Toilet seat, flush handle and bedpan cleaner
           </p>
           <p>
            Sinks and soap dispensers
           </p>
           <p>
            Handrails
           </p>
           <p>
            Trash can
           </p>
          </td>
         </tr>
        </tbody>
       </table>
      </table-wrap>
     </p>
     <p id="Par8">
      Over the years, research has been done in order to better target room disinfection practices. Following recommendations made by the CDC to clean and disinfect HTS more frequently than minimal-touch surfaces, data published in 2010 by Huslage et al., based on the real frequency of contact, defined the top five most touched surfaces in hospitals: bed rails, bed surface, supply cart, over-bed table and intravenous pump [
      <xref ref-type="bibr" rid="CR14">
       14
      </xref>
      ]. HTS may be classified as non-critical items (the contact occurs with intact skin that effectively acts as a barrier to most pathogens, but not with mucous membranes) and must be subject to cleaning and disinfection procedures as recommended, but with no absolute need for sterilization [
      <xref ref-type="bibr" rid="CR15">
       15
      </xref>
      ].
     </p>
    </sec>
    <sec id="Sec3">
     <title>
      Microbial pathogens
     </title>
     <p id="Par9">
      Many pathogens may thrive on healthcare-associated equipment and environmental surfaces. Among such organisms, MRSA, VRE,
      <italic>
       C. difficile
      </italic>
      ,
      <italic>
       P. aeruginosa
      </italic>
      ,
      <italic>
       A. baumannii
      </italic>
      ,
      <italic>
       Enterobacteriaceae
      </italic>
      ,
      <italic>
       Stenotrophomonas maltophilia
      </italic>
      ,
      <italic>
       Burkholderia cepacia
      </italic>
      , Norovirus, Coronavirus and
      <italic>
       Candida
      </italic>
      spp. may persist and contribute to the infection risk to which patients are systematically exposed.
     </p>
     <sec id="Sec4">
      <title>
       Methicillin-resistant
       <italic>
        Staphylococcus aureus
       </italic>
      </title>
      <p id="Par10">
       Several studies have demonstrated that basic cleaning leads to MRSA elimination from environmental surfaces and enhanced cleaning may terminate outbreaks in intensive care units, with cost savings of $45,000 up to $51,000 per year [
       <xref ref-type="bibr" rid="CR16">
        16
       </xref>
       –
       <xref ref-type="bibr" rid="CR19">
        19
       </xref>
       ]. Recently, two studies reported positively about pulsed xenon UV and hydrogen peroxide methods to boost the decontamination of patient rooms, contributing towards a reduction of MRSA bioburden [
       <xref ref-type="bibr" rid="CR20">
        20
       </xref>
       ,
       <xref ref-type="bibr" rid="CR21">
        21
       </xref>
       ].
      </p>
     </sec>
     <sec id="Sec5">
      <title>
       Vancomycin-resistant enterococci
      </title>
      <p id="Par11">
       Its inherent ability to resist certain antimicrobial agents (such as cephalosporins and aminoglycosides) allied to a great capacity to acquire determinants of antibiotic resistance (like gene clusters of vancomycin resistance) turn enterococci into a versatile nosocomial multidrug-resistant pathogen. The number of VRE infections has been increasing worldwide, most frequently afflicting patients with serious comorbidities or undergoing prolonged hospitalization [
       <xref ref-type="bibr" rid="CR22">
        22
       </xref>
       ].
      </p>
      <p id="Par12">
       VRE are known to survive for a long time in the hospital environment. Viability on surfaces may range from 5 days to 4 months [
       <xref ref-type="bibr" rid="CR23">
        23
       </xref>
       ]. Moreover, enterococci are tolerant to heat, chlorine and some alcohol preparations, making them very resilient to conventional cleaning practices, thus becoming easily disseminated among healthcare facilities [
       <xref ref-type="bibr" rid="CR24">
        24
       </xref>
       ]. Therefore, besides thorough environmental cleaning several times a day with disinfectants, VRE management protocols should include strict adoption of contact precautions and implementation of comprehensive educational programs for staff [
       <xref ref-type="bibr" rid="CR25">
        25
       </xref>
       ,
       <xref ref-type="bibr" rid="CR26">
        26
       </xref>
       ].
      </p>
      <sec id="Sec6">
       <title>
        Clostridium difficile
       </title>
       <p id="Par13">
        Spores of
        <italic>
         C. difficile
        </italic>
        can hold on to a healthcare environment for more than 5 months [
        <xref ref-type="bibr" rid="CR23">
         23
        </xref>
        ,
        <xref ref-type="bibr" rid="CR27">
         27
        </xref>
        ]. Fortunately, the use of chlorine-releasing disinfectants reduces the amount of spores in the environment, with some evidence suggesting that it may reduce the risk of recurrence and transmission of
        <italic>
         C. difficile
        </italic>
        -associated infections [
        <xref ref-type="bibr" rid="CR28">
         28
        </xref>
        ].
       </p>
      </sec>
      <sec id="Sec7">
       <title>
        Pseudomonas aeruginosa
       </title>
       <p id="Par14">
        Transmission of
        <italic>
         P. aeruginosa
        </italic>
        may easily occur from contaminated sinks to hands of healthcare personnel during washing, since this organism may thrive in biofilms that are adherent to sink traps, pipes, water lines and hospital drains [
        <xref ref-type="bibr" rid="CR29">
         29
        </xref>
        ], turning these fashion-organized bacteria more prone to resist to disinfectants [
        <xref ref-type="bibr" rid="CR30">
         30
        </xref>
        ]. Additionally,
        <italic>
         P. aeruginosa
        </italic>
        can resist 6 hours to 16 months on dry inanimate surfaces [
        <xref ref-type="bibr" rid="CR23">
         23
        </xref>
        ]. Programs to control transmission should include, therefore, repeated cleaning with chlorine-based disinfectants, physical removal of persistent biofilm, replacement of components whenever feasible and regular inspection [
        <xref ref-type="bibr" rid="CR31">
         31
        </xref>
        ,
        <xref ref-type="bibr" rid="CR32">
         32
        </xref>
        ].
       </p>
      </sec>
      <sec id="Sec8">
       <title>
        Acinetobacter baumannii
       </title>
       <p id="Par15">
        The increase in the number of HAIs caused by
        <italic>
         A. baumannii
        </italic>
        might be explained not only by its ability to persist from 5 days to more than 5 months in undisturbed surfaces of healthcare equipment [
        <xref ref-type="bibr" rid="CR23">
         23
        </xref>
        ], but also by its high resilience to cleaning with conventional detergent and alcohol disinfectants [
        <xref ref-type="bibr" rid="CR33">
         33
        </xref>
        ]. Hence, outbreaks in hospital or other healthcare settings are difficult to contain because of the easy environmental contamination by this pathogen [
        <xref ref-type="bibr" rid="CR34">
         34
        </xref>
        –
        <xref ref-type="bibr" rid="CR36">
         36
        </xref>
        ]. Targeted infection control measures may be needed, including intensive cleaning with sodium hypochlorite and subsequent measurement of cleanliness, hand hygiene training, adoption of barrier precautions and contact isolation, as well as patient surveillance [
        <xref ref-type="bibr" rid="CR37">
         37
        </xref>
        ,
        <xref ref-type="bibr" rid="CR38">
         38
        </xref>
        ].
       </p>
      </sec>
      <sec id="Sec9">
       <title>
        Enterobacteriaceae
       </title>
       <p id="Par16">
        There has been a growing concern about
        <italic>
         Klebsiella pneumoniae
        </italic>
        infections, mainly because of its extensive β-lactamase resistance.
        <italic>
         K. pneumoniae
        </italic>
        are usual colonizers of the human gastrointestinal tract, pharynx and skin that may cause wound infections, pneumonia and sepsis, particularly in immunocompromised patients [
        <xref ref-type="bibr" rid="CR39">
         39
        </xref>
        ]. More recently, given its wide dissemination and selective advantage to resist to carbapenem antibiotics,
        <italic>
         K. pneumoniae
        </italic>
        have been showing a propensity to cause outbreaks in healthcare institutions [
        <xref ref-type="bibr" rid="CR40">
         40
        </xref>
        ]. It is known that
        <italic>
         K. pneumoniae
        </italic>
        may survive for more than 30 months in the healthcare environment [
        <xref ref-type="bibr" rid="CR23">
         23
        </xref>
        ] and that the origin of some outbreaks has been related to sinks and related pipes [
        <xref ref-type="bibr" rid="CR41">
         41
        </xref>
        ,
        <xref ref-type="bibr" rid="CR42">
         42
        </xref>
        ].
       </p>
       <p id="Par17">
        Another member of the
        <italic>
         Enterobacteriaceae
        </italic>
        family,
        <italic>
         Serratia marcescens
        </italic>
        , are known to cause pneumonia, meningitis, urinary tract and bloodstream infections. MDR isolates, including colistin resistant [
        <xref ref-type="bibr" rid="CR43">
         43
        </xref>
        ], have been responsible for serious outbreaks among intensive care units and critically ill neonates [
        <xref ref-type="bibr" rid="CR44">
         44
        </xref>
        –
        <xref ref-type="bibr" rid="CR46">
         46
        </xref>
        ].
        <italic>
         S. marcescens
        </italic>
        are known to survive up to 2 months on dry inanimate surfaces [
        <xref ref-type="bibr" rid="CR23">
         23
        </xref>
        ] and have frequently been recovered from water pipes and hospital disinfectants [
        <xref ref-type="bibr" rid="CR47">
         47
        </xref>
        ].
       </p>
       <p id="Par18">
        Because of the easy transmission and environmental persistence of
        <italic>
         Enterobacteriaceae
        </italic>
        in healthcare facilities, adequate solutions aiming its eradication should ensure comprehensive educational interventions, hand hygiene training, chlorine-based cleaning and even the replacement of sinks and pipes [
        <xref ref-type="bibr" rid="CR42">
         42
        </xref>
        ,
        <xref ref-type="bibr" rid="CR48">
         48
        </xref>
        ,
        <xref ref-type="bibr" rid="CR49">
         49
        </xref>
        ].
       </p>
      </sec>
      <sec id="Sec10">
       <title>
        Stenotrophomonas maltophilia
       </title>
       <p id="Par19">
        Similarly to other bacteria, it can persist in biofilms that may turn cleaning products and disinfectants more ineffective [
        <xref ref-type="bibr" rid="CR30">
         30
        </xref>
        ]. Long-term control of
        <italic>
         S. maltophilia
        </italic>
        will be dependent upon the integration of an efficient cleaning strategy into a targeted healthcare facilities maintenance program [
        <xref ref-type="bibr" rid="CR50">
         50
        </xref>
        ].
       </p>
      </sec>
      <sec id="Sec11">
       <title>
        Burkholderia cepacia
       </title>
       <p id="Par20">
        It is widely distributed in soil and water habitats and recent healthcare-associated outbreaks have been linked to
        <italic>
         B. cepacia
        </italic>
        persistence in disinfectants, drugs, medical devices (e.g., respiratory nebulizers), sinks and contiguous aerator filters [
        <xref ref-type="bibr" rid="CR51">
         51
        </xref>
        –
        <xref ref-type="bibr" rid="CR53">
         53
        </xref>
        ]. Strict and repeated cleaning and replacement of aerators with flow straighteners may be required to stop outbreaks [
        <xref ref-type="bibr" rid="CR51">
         51
        </xref>
        ,
        <xref ref-type="bibr" rid="CR54">
         54
        </xref>
        ].
       </p>
      </sec>
     </sec>
     <sec id="Sec12">
      <title>
       Norovirus
      </title>
      <p id="Par21">
       The origin of Norovirus outbreaks in healthcare facilities has been traced not only to sites near bathroom showers and toilets but also to sites near patients, including clinical equipment (e.g., blood pressure and pulse oximeter monitors), thermometers, trolleys and soap and alcohol gel containers [
       <xref ref-type="bibr" rid="CR55">
        55
       </xref>
       ]. After suspected or confirmed case contact, use of soap and running water is recommended [
       <xref ref-type="bibr" rid="CR56">
        56
       </xref>
       ], probably with a superior efficacy than ethanol-based sanitizers [
       <xref ref-type="bibr" rid="CR57">
        57
       </xref>
       ]. However, detergent-based cleaning may be insufficient to eliminate Norovirus from the environment and, therefore, hypochlorite solutions of at least 1000 ppm for an appropriate contact time represent a better strategy for cleaning [
       <xref ref-type="bibr" rid="CR56">
        56
       </xref>
       ,
       <xref ref-type="bibr" rid="CR58">
        58
       </xref>
       ].
      </p>
     </sec>
     <sec id="Sec13">
      <title>
       Coronavirus
      </title>
      <p id="Par22">
       Human Coronavirus, usually responsible for acute respiratory syndromes, have been causing increased concern due to contact transmission during healthcare-associated outbreaks. Viral persistence on doorknobs and surgical boom shelves has already been identified, with a presumed viability of 48 h; scrupulous environmental cleaning is certainly highly advisable in reducing the spread [
       <xref ref-type="bibr" rid="CR59">
        59
       </xref>
       ,
       <xref ref-type="bibr" rid="CR60">
        60
       </xref>
       ]. Moreover, biocidal surfaces based on copper alloys are very effective in inactivating Coronavirus and could be employed in high touch surfaces in order to prevent the transmission of this respiratory virus [
       <xref ref-type="bibr" rid="CR61">
        61
       </xref>
       ].
      </p>
      <sec id="Sec14">
       <title>
        Candida
       </title>
       <p id="Par23">
        Although
        <italic>
         Candida
        </italic>
        spp. are more resistant to germicidal chemicals than most vegetative bacteria, there are no specific recommendations other than general healthcare surface decontamination with disinfectants. Nevertheless, in order to control a recent outbreak by a MDR
        <italic>
         C. auris
        </italic>
        , measures implemented included isolation of cases and contacts, protective clothing, screening of all other ward patients, skin decontamination with chlorhexidine, environmental cleaning with chlorine-based disinfectants and hydrogen peroxide vapour [
        <xref ref-type="bibr" rid="CR62">
         62
        </xref>
        ]. A clinical alert issued in June 2016 by the CDC on the global emergence of invasive infections caused by the MDR
        <italic>
         C. auris
        </italic>
        recommended thorough daily and terminal cleaning and disinfection of patient rooms using an EPA-registered hospital grade disinfectant with a fungal claim.
       </p>
      </sec>
     </sec>
    </sec>
    <sec id="Sec15">
     <title>
      Preventing the environmental surface transmission of healthcare-associated pathogens
     </title>
     <sec id="Sec16">
      <title>
       General strategies
      </title>
      <p id="Par24">
       Based on patterns of microbial resistance to physical and chemical germicidal agents and on the instrument/surface classification, Spaulding has proposed three levels of disinfection [
       <xref ref-type="bibr" rid="CR11">
        11
       </xref>
       ]: high-level disinfection, that inactivates all vegetative bacteria, mycobacteria, viruses, fungi and some bacterial spores by the action of chemicals such as glutaraldehyde, peracetic acid and hydrogen peroxide; intermediate-level disinfection, which is effective against vegetative bacteria, some spores, mycobacteria, fungi, lipid and medium size viruses, but not against all nonlipid and small size viruses (e.g., sodium hypochlorite, alcohols, some phenolics and some iodophors); and low-level disinfection, that inactivates vegetative bacteria, fungi, enveloped viruses and some non-enveloped viruses (e.g., adenoviruses) by the action of quaternary ammonium compounds, some phenolics and some iodophors [
       <xref ref-type="bibr" rid="CR12">
        12
       </xref>
       ].
      </p>
      <p id="Par25">
       In order to prevent the persistence of microbial pathogens on medical equipment and environmental surfaces, education of healthcare staff, checklists and assessment of the adequacy of cleaning (by direct observation, use of fluorescent markers, of ATP bioluminescence systems, swab cultures or agar slide cultures) with feedback to the staff are general interventions that need to be implemented to improve the frequency of adequate cleaning [
       <xref ref-type="bibr" rid="CR63">
        63
       </xref>
       –
       <xref ref-type="bibr" rid="CR65">
        65
       </xref>
       ].
      </p>
     </sec>
     <sec id="Sec17">
      <title>
       Strategies for high-touch surfaces
      </title>
      <sec id="Sec18">
       <title>
        Patient care items
       </title>
       <p id="Par26">
        As general principles, all patient care items should be cleaned and/or decontaminated before and after use, for all patients [
        <xref ref-type="bibr" rid="CR66">
         66
        </xref>
        ,
        <xref ref-type="bibr" rid="CR67">
         67
        </xref>
        ]; whenever these items come into contact with blood or other body fluids, stringent cleaning and disinfection is warranted before and after use [
        <xref ref-type="bibr" rid="CR68">
         68
        </xref>
        ].
       </p>
       <p id="Par27">
        Manufacturers of medical equipment usually provide care and maintenance instructions regarding servicing decontamination, compatibility with germicidal agents and water-resistance. In the absence of such instructions, the CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) recommend non-critical medical equipment (e.g., stethoscopes, blood pressure cuffs, equipment knobs and controls) to be subject to low or intermediate-level disinfection after cleansing, depending on the nature and degree of contamination. For instance, ethyl or isopropyl alcohol (60–90%
        <italic>
         v
        </italic>
        /v) may be used to disinfect small surfaces (e.g., rubber stoppers of multiple-dose medication vials and thermometers) and surfaces of healthcare equipment (e.g., stethoscopes and ventilators) [
        <xref ref-type="bibr" rid="CR69">
         69
        </xref>
        ], while for large surfaces it may be impractical due to the rapid evaporation of alcohol and absence of the adequate contact time [
        <xref ref-type="bibr" rid="CR12">
         12
        </xref>
        ].
       </p>
      </sec>
      <sec id="Sec19">
       <title>
        Environmental surfaces
       </title>
       <p id="Par28">
        As a whole, frequently touched environmental surfaces benefit from enhanced cleaning. Routine decontamination and disinfection are practices normally included within institutional cleaning policies. Nevertheless, evidence has been built in order to favour the use of less toxic detergents over disinfectants in non-outbreak situations, without losing cleaning efficacy or adding costs [
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
        ]. Detergents are less likely to contribute to the accumulation or dispersal of tolerance or resistance genes among healthcare-associated microbial isolates [
        <xref ref-type="bibr" rid="CR71">
         71
        </xref>
        ,
        <xref ref-type="bibr" rid="CR72">
         72
        </xref>
        ].
       </p>
       <p id="Par29">
        According to the CDC, for medical equipment (particularly in the case of monitor touch screens, controls and cables), a disposable plastic barrier protection can be useful whenever these surfaces, touched frequently by gloved hands, may become contaminated with body fluids or present difficulties to cleaning.
       </p>
       <sec id="FPar1">
        <title>
         Manual cleaning
        </title>
        <p id="Par30">
         The physical removal of soil is a very important step in the cleaning process since its presence will impede the microbicidal activity of disinfectants, if needed. In order to control the bioburden on regular wards,
         <bold>
          daily
         </bold>
         cleaning with neutral detergent wipes is usually sufficient. However, more attention is essential on high-risk intensive care units because of the easiness of microbial recontamination [
         <xref ref-type="bibr" rid="CR73">
          73
         </xref>
         ]. Moreover, patients colonized or infected with specific pathogens may demand cleaning regimens with disinfectants with registered label claims [
         <xref ref-type="bibr" rid="CR68">
          68
         </xref>
         ].
        </p>
        <p id="Par31">
         After patient discharge, terminal or deep cleaning is usually performed by removal of all detachable objects from the room and systematically wiping all surfaces downward to the floor level, with detergent cloths or disinfectant wipes.
        </p>
        <p id="Par32">
         New liquid disinfectants are under development and include: improved hydrogen peroxide disinfectants, effective in reducing bacterial levels on surfaces [
         <xref ref-type="bibr" rid="CR74">
          74
         </xref>
         ,
         <xref ref-type="bibr" rid="CR75">
          75
         </xref>
         ], related to fewer HAIs [
         <xref ref-type="bibr" rid="CR76">
          76
         </xref>
         ] and able to reduce contamination by MDR pathogens on soft surfaces such as bedside curtains [
         <xref ref-type="bibr" rid="CR77">
          77
         </xref>
         ]; peracetic acid and hydrogen peroxide disinfectants, a sporicidal combination that was shown to lower bacterial levels on surfaces and to reduce the contamination by MRSA, VRE and
         <italic>
          C. difficile
         </italic>
         as effectively as sodium hypochlorite [
         <xref ref-type="bibr" rid="CR78">
          78
         </xref>
         ]; electrolyzed water (hypochlorous acid) disinfectant, which may reduce bacterial levels on surfaces near patients in a higher degree than quaternary ammonium disinfectants [
         <xref ref-type="bibr" rid="CR79">
          79
         </xref>
         ]; further promising, electrolyzed water has been sprayed onto medical equipment (with a short contact time and without the need for wiping because no toxic residue remains on surfaces) with a reduction of aerobic bacteria and
         <italic>
          C. difficile
         </italic>
         spores [
         <xref ref-type="bibr" rid="CR80">
          80
         </xref>
         ]; cold-air atmospheric pressure plasma systems, which generate reactive oxygen species (ROS) with bactericidal activity and have potential use as surface disinfectants [
         <xref ref-type="bibr" rid="CR81">
          81
         </xref>
         ,
         <xref ref-type="bibr" rid="CR82">
          82
         </xref>
         ]; nebulized polymeric guanidine, under investigation for its antimicrobial activity against several healthcare-associated pathogens [
         <xref ref-type="bibr" rid="CR83">
          83
         </xref>
         ].
        </p>
        <p id="Par33">
         Together with disinfectants, novel materials for liquid application such as microfiber cloths or mops and ultramicrofiber cloths are under development. When used according to manufacturers’ instructions, an increased cleaning efficacy is to be expected as compared to standard cotton cloths or mops [
         <xref ref-type="bibr" rid="CR84">
          84
         </xref>
         ].
        </p>
       </sec>
       <sec id="FPar2">
        <title>
         Automated cleaning
        </title>
        <p id="Par34">
         On the pathway to improve quality and ease of cleaning environmental surfaces, considerable efforts have been dedicated towards the development of automated devices. However, because of yet unsolved safety risks, mainly for patients, automated solutions are invariably targeting terminal cleaning. In most instances, these solutions do not preclude preliminary manual cleaning of surfaces to remove residual debris and reduce the bioburden.
        </p>
        <p id="Par35">
         The microbicidal effect of UV light has been in use for disinfection of environmental surfaces, instruments and air. By damaging the molecular bonds in DNA, a reduction in contamination by MRSA, VRE and
         <italic>
          C. difficile
         </italic>
         on high-touch surfaces has been achieved [
         <xref ref-type="bibr" rid="CR85">
          85
         </xref>
         ]. Automated mobile UV light devices are easy to use, with minimal need for special staff training. Nonetheless, several issues have been raised that may hinder its efficacy, namely, the time and intensity of light exposure and potential barriers that may exist between the lamp and its target surface. As such, UV light is regarded as an effective adjunct, but not a stand-alone strategy for disinfection [
         <xref ref-type="bibr" rid="CR86">
          86
         </xref>
         ].
        </p>
        <p id="Par36">
         By producing free radicals that lead to oxidation of DNA, proteins and membrane lipids [
         <xref ref-type="bibr" rid="CR87">
          87
         </xref>
         ], vapour and aerosol hydrogen peroxide systems have already been shown to be effective against MRSA, VRE, MDR Gramme-negative bacilli,
         <italic>
          C. difficile
         </italic>
         , viruses and fungi [
         <xref ref-type="bibr" rid="CR88">
          88
         </xref>
         –
         <xref ref-type="bibr" rid="CR93">
          93
         </xref>
         ]. This excellent wide spectrum antimicrobial activity is not without drawbacks, such as toxicity after accidental exposure, minor erosion of environmental polymers and damage of electronic equipment. In addition, there is the need for trained operators, long cycle times for disinfection and the cost is high [
         <xref ref-type="bibr" rid="CR94">
          94
         </xref>
         ]. Experiments suggest that vapour-phase hydrogen peroxide is a more potent oxidizer of protein than liquid-phase hydrogen peroxide [
         <xref ref-type="bibr" rid="CR87">
          87
         </xref>
         ] and, when supplementing other strategies, micro-condensation hydrogen peroxide vapour systems may have contributed to control outbreaks by MRSA, MDR Gramme-negative bacteria and
         <italic>
          C. difficile
         </italic>
         in intensive care units, surgical wards and long-term care facilities [
         <xref ref-type="bibr" rid="CR89">
          89
         </xref>
         ,
         <xref ref-type="bibr" rid="CR95">
          95
         </xref>
         –
         <xref ref-type="bibr" rid="CR99">
          99
         </xref>
         ]. A novel silver-stabilized hydrogen peroxide is under investigation for its enhanced biocidal activity towards Gramme positive and negative bacteria capable of producing catalase, both in planktonic and biofilm cultures. Silver probably helps to stabilize and target hydrogen peroxide to the bacterial cell surface acting, therefore, synergistically [
         <xref ref-type="bibr" rid="CR100">
          100
         </xref>
         ]. In fact, a previous report on the effect of a dry-mist system using a mixture of hydrogen peroxide (5%) and silver cations (&lt;50 ppm) was effective in decontaminating burn patient rooms, as well as a fungal research laboratory: a reduction in growth of at least two log was observed for tested bacteria, mycobacteria and fungi [
         <xref ref-type="bibr" rid="CR101">
          101
         </xref>
         ].
        </p>
        <p id="Par37">
         Steam cleaning is a non-toxic and rapid method that may reduce the total bioburden from environmental surfaces by more than 90% [
         <xref ref-type="bibr" rid="CR102">
          102
         </xref>
         ], with effectiveness against MRSA, VRE and Gramme-negative bacilli [
         <xref ref-type="bibr" rid="CR103">
          103
         </xref>
         ]. Concerns about security when steam is applied to electrical items such as switches and buttons and risk of burns and scalds when cleaning a crowded ward are the reasons precluding its widespread use in healthcare facilities [
         <xref ref-type="bibr" rid="CR104">
          104
         </xref>
         ].
        </p>
        <p id="Par38">
         The oxidizing capacity of ozone justifies its previous evaluation as a gaseous decontaminant for controlling
         <italic>
          C. difficile
         </italic>
         on environmental surfaces and
         <italic>
          E.coli
         </italic>
         in hospital laundries [
         <xref ref-type="bibr" rid="CR105">
          105
         </xref>
         ,
         <xref ref-type="bibr" rid="CR106">
          106
         </xref>
         ]. While it seems highly effective against vegetative bacterial cells, a smaller impact has been found in case of bacterial spores and fungi [
         <xref ref-type="bibr" rid="CR107">
          107
         </xref>
         ]. Moreover, corrosiveness and toxicity issues may restrain further the use of ozone in healthcare settings [
         <xref ref-type="bibr" rid="CR108">
          108
         </xref>
         ].
        </p>
        <p id="Par39">
         By targeting intracellular porphyrins that absorb the light and produce ROS with bactericidal activity [
         <xref ref-type="bibr" rid="CR109">
          109
         </xref>
         ], high-intensity narrow-spectrum (HINS) light stands as another light-based method with possible application for decontamination of high-touch surfaces, although its efficacy is lower than UV light. As clear advantages, HINS light is safe for patients, allowing continuous decontamination of the clinical environment [
         <xref ref-type="bibr" rid="CR110">
          110
         </xref>
         ] and it exhibits a wide-range microbicidal activity that includes MRSA,
         <italic>
          P. aeruginosa
         </italic>
         and
         <italic>
          A. baumannii
         </italic>
         [
         <xref ref-type="bibr" rid="CR111">
          111
         </xref>
         ,
         <xref ref-type="bibr" rid="CR112">
          112
         </xref>
         ]. However, HINS light has yet to prove its effectiveness in clinical settings and benefits upon HAI rates, given the small range of published studies [
         <xref ref-type="bibr" rid="CR110">
          110
         </xref>
         ,
         <xref ref-type="bibr" rid="CR112">
          112
         </xref>
         ,
         <xref ref-type="bibr" rid="CR113">
          113
         </xref>
         ].
        </p>
       </sec>
       <sec id="FPar3">
        <title>
         Antimicrobial surfaces
        </title>
        <p id="Par40">
         Instead of focusing on the reduction of the bioburden on surfaces solely by cleaning, there are solutions designed to prevent surfaces from working as a microbial reservoir and that may be used as an adjunct to other strategies in reducing HAIs.
        </p>
        <p id="Par41">
         Antiadhesive surfaces target microbial adhesion usually by the interaction of antagonist physicochemical properties. Easy-clean surfaces that are hydrophobic repel bacteria better than glass-coated controls [
         <xref ref-type="bibr" rid="CR114">
          114
         </xref>
         ], while hydrophilic surfaces favour water sheeting and subsequent cleaning. Similarly, polyethylene glycol coated surfaces promote a hydrophilic interaction against bacteria, preventing attachment [
         <xref ref-type="bibr" rid="CR115">
          115
         </xref>
         ]. The use of diamond-like carbon films has already been tried for medical implanted devices such as joint prostheses and stents in order to repel microbial adhesion [
         <xref ref-type="bibr" rid="CR116">
          116
         </xref>
         ]. Despite being non-toxic and appealing, the lack of biocidal properties may turn discouraging a more generalized implementation of such easy-clean technologies.
        </p>
        <p id="Par42">
         Currently, there are available antimicrobial coatings that can produce a microbicidal effect and could lead to an effective reduction of high-touch surface bioburden. For instance, inorganic metals have been investigated for a long time and it is known that silver binds with disulphide and sulfhydryl groups present in proteins of microbial cell wall leading to death [
         <xref ref-type="bibr" rid="CR117">
          117
         </xref>
         ], inhibiting not only environmental contamination but also colonization of medical implanted devices [
         <xref ref-type="bibr" rid="CR118">
          118
         </xref>
         ,
         <xref ref-type="bibr" rid="CR119">
          119
         </xref>
         ]; copper and copper alloys may form reactive oxygen radicals that damage nucleic acid and proteins [
         <xref ref-type="bibr" rid="CR117">
          117
         </xref>
         ] and have already demonstrated a potent antimicrobial effect when applied to surfaces, reducing the rate of healthcare-associated infections [
         <xref ref-type="bibr" rid="CR120">
          120
         </xref>
         ,
         <xref ref-type="bibr" rid="CR121">
          121
         </xref>
         ]. Polycationic surfaces, such as those coated with polyethyleneimines, hydrophobically attract and kill bacteria by physically damaging the cell wall [
         <xref ref-type="bibr" rid="CR122">
          122
         </xref>
         ]. Triclosan has been in use for more than 30 years in detergents, soaps and cosmetics. At lower concentrations, it is bacteriostatic by inhibiting an enzyme involved in fatty acid synthesis and, at higher concentrations, it is bactericidal by destabilizing microbial membranes. Compatibilization of triclosan with polymers may extend the duration of its wide-spectrum antimicrobial activity [
         <xref ref-type="bibr" rid="CR123">
          123
         </xref>
         ] and could prove effective in reducing environmental surface load of pathogens. Bacteriophages applied to surfaces and targeting specific microorganisms have been attempted and mixtures of phages have been further suggested in order to effectively reduce the environmental bioburden. Particularly interesting in healthcare settings is the fact that MDR pathogens keep vulnerable to the lytic action of phages [
         <xref ref-type="bibr" rid="CR124">
          124
         </xref>
         ,
         <xref ref-type="bibr" rid="CR125">
          125
         </xref>
         ]. Light-activated antimicrobial surfaces, such as those coated with titanium dioxide and activated by UV light [
         <xref ref-type="bibr" rid="CR126">
          126
         </xref>
         ], generate reactive oxygen radicals with nonselective toxicity towards both bacteria and yeasts [
         <xref ref-type="bibr" rid="CR127">
          127
         </xref>
         ]. Similarly, photosensitized surfaces could reduce the healthcare bioburden without promoting microbial drug resistance mechanisms. Although antimicrobial coatings may seem very promising, especially as an adjunct measure to more traditional and proven cleaning strategies, some concerns keep hindering its wider use in healthcare settings. Robust cost-effectiveness studies are still lacking since reliable information about antimicrobial coatings durability, resistance and possible toxicity is yet somewhat insufficient [
         <xref ref-type="bibr" rid="CR50">
          50
         </xref>
         ,
         <xref ref-type="bibr" rid="CR68">
          68
         </xref>
         ].
        </p>
       </sec>
      </sec>
     </sec>
    </sec>
    <sec id="Sec20">
     <title>
      Conclusion
     </title>
     <p id="Par43">
      Given the high morbidity and costs associated with HAIs, improved strategies are urgently needed to reduce effectively the rate of infection. Certainly, one good step forward would be the blockade of transmission from environmental high-touch surfaces. At the moment, manual and automated techniques for cleaning surfaces exhibit variable success. Concerns over durability, resistance and toxicity may be precluding a much wider application of the novel antimicrobial coatings. Admitting an albeit limited performance of the traditional cleaning methods, the supplementation with newer technology should be indicated. Hence, more randomized controlled trials and cost-effectiveness studies are needed and further investigation on antimicrobial surfaces is welcomed in order to face the challenge imposed by the global advance of antimicrobial drug resistance and the pressure to reduce bed turnover times with shortages in nursing personnel, housekeeping staff and budgets.
     </p>
    </sec>
    <back>
     <notes notes-type="ethics">
      <title>
       Compliance with ethical standards
      </title>
      <notes notes-type="funding">
       <title>
        Funding
       </title>
       <p id="Par44">
        None to declare.
       </p>
      </notes>
      <notes notes-type="COI-statement">
       <title>
        Conflict of interest
       </title>
       <p id="Par45">
        None to declare.
       </p>
      </notes>
      <notes>
       <title>
        Ethical approval
       </title>
       <p id="Par46">
        This type of study does not involve human participants and/or animals.
       </p>
      </notes>
      <notes>
       <title>
        Informed consent
       </title>
       <p id="Par47">
        For this type of study, informed consent is not required.
       </p>
      </notes>
     </notes>
     <ref-list id="Bib1">
      <title>
       References
      </title>
      <ref id="CR1">
       <label>
        1.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Magill
          </surname>
          <given-names>
           SS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Multistate point-prevalence survey of health care-associated infections
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2014
        </year>
        <volume>
         370
        </volume>
        <issue>
         13
        </issue>
        <fpage>
         1198
        </fpage>
        <lpage>
         1208
        </lpage>
        <pub-id pub-id-type="doi">
         10.1056/NEJMoa1306801
        </pub-id>
        <pub-id pub-id-type="pmid">
         24670166
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR2">
       <label>
        2.
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <collab>
          Point Prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals
         </collab>
        </person-group>
        <source>
         European Centre for Disease Prevention and Control
        </source>
        <year>
         2013
        </year>
        <publisher-loc>
         Stockholm
        </publisher-loc>
        <publisher-name>
         ECDC
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="CR3">
       <label>
        3.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weinstein
          </surname>
          <given-names>
           RA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiology and control of nosocomial infections in adult intensive-care units
        </article-title>
        <source>
         Am J Med
        </source>
        <year>
         1991
        </year>
        <volume>
         91
        </volume>
        <fpage>
         S179
        </fpage>
        <lpage>
         S184
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/0002-9343(91)90366-6
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR4">
       <label>
        4.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
        </person-group>
        <article-title>
         The role of the surface environment in healthcare-associated infections
        </article-title>
        <source>
         Curr Opin Infect Dis
        </source>
        <year>
         2013
        </year>
        <volume>
         26
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         338
        </fpage>
        <lpage>
         344
        </lpage>
        <pub-id pub-id-type="doi">
         10.1097/QCO.0b013e3283630f04
        </pub-id>
        <pub-id pub-id-type="pmid">
         23743816
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR5">
       <label>
        5.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           JH
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Cleaning hospital room surfaces to prevent health care-associated infections: a technical brief
        </article-title>
        <source>
         Ann Intern Med
        </source>
        <year>
         2015
        </year>
        <volume>
         163
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         598
        </fpage>
        <lpage>
         607
        </lpage>
        <pub-id pub-id-type="doi">
         10.7326/M15-1192
        </pub-id>
        <pub-id pub-id-type="pmid">
         26258903
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR6">
       <label>
        6.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Importance of the environment in meticillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         acquisition: the case for hospital cleaning
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <year>
         2008
        </year>
        <volume>
         8
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         101
        </fpage>
        <lpage>
         113
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S1473-3099(07)70241-4
        </pub-id>
        <pub-id pub-id-type="pmid">
         17974481
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR7">
       <label>
        7.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Martinez
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit
        </article-title>
        <source>
         Arch Intern Med
        </source>
        <year>
         2003
        </year>
        <volume>
         163
        </volume>
        <issue>
         16
        </issue>
        <fpage>
         1905
        </fpage>
        <lpage>
         1912
        </lpage>
        <pub-id pub-id-type="doi">
         10.1001/archinte.163.16.1905
        </pub-id>
        <pub-id pub-id-type="pmid">
         12963563
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR8">
       <label>
        8.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tankovic
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Characterization of a hospital outbreak of imipenem-resistant Acinetobacter Baumannii by phenotypic and genotypic typing methods
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <year>
         1994
        </year>
        <volume>
         32
        </volume>
        <issue>
         11
        </issue>
        <fpage>
         2677
        </fpage>
        <lpage>
         2681
        </lpage>
        <pub-id pub-id-type="pmid">
         7852555
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR9">
       <label>
        9.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         1998
        </year>
        <volume>
         39
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         39
        </fpage>
        <lpage>
         45
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0195-6701(98)90241-9
        </pub-id>
        <pub-id pub-id-type="pmid">
         9617683
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR10">
       <label>
        10.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kaatz
          </surname>
          <given-names>
           GW
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Acquisition of Clostridium difficile from the hospital environment
        </article-title>
        <source>
         Am J Epidemiol
        </source>
        <year>
         1988
        </year>
        <volume>
         127
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         1289
        </fpage>
        <lpage>
         1294
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/oxfordjournals.aje.a114921
        </pub-id>
        <pub-id pub-id-type="pmid">
         2835900
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR11">
       <label>
        11.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <collab>
          Spaulding
         </collab>
        </person-group>
        <article-title>
         Chemical disinfection and antisepsis in the hospital
        </article-title>
        <source>
         J Hosp Res
        </source>
        <year>
         1972
        </year>
        <volume>
         9
        </volume>
        <fpage>
         5
        </fpage>
        <lpage>
         31
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR12">
       <label>
        12.
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bond
          </surname>
          <given-names>
           W
          </given-names>
         </name>
        </person-group>
        <person-group person-group-type="editor">
         <name>
          <surname>
           Favero
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Block
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Chemical disinfection of medical and surgical material, in disinfection, sterilization and preservation
        </article-title>
        <source>
         Lippencott
        </source>
        <year>
         2001
        </year>
        <publisher-loc>
         Williams and Wilkens
        </publisher-loc>
        <publisher-name>
         Philadelphia
        </publisher-name>
        <fpage>
         881
        </fpage>
        <lpage>
         917
        </lpage>
       </element-citation>
      </ref>
      <ref id="CR13">
       <label>
        13.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sehulster
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the healthcare infection control practices Advisory Committee (HICPAC)
        </article-title>
        <source>
         MMWR Recomm Rep
        </source>
        <year>
         2003
        </year>
        <volume>
         52
        </volume>
        <issue>
         RR-10
        </issue>
        <fpage>
         1
        </fpage>
        <lpage>
         42
        </lpage>
        <pub-id pub-id-type="pmid">
         12836624
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR14">
       <label>
        14.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Huslage
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A quantitative approach to defining “high-touch” surfaces in hospitals
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2010
        </year>
        <volume>
         31
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         850
        </fpage>
        <lpage>
         853
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/655016
        </pub-id>
        <pub-id pub-id-type="pmid">
         20569115
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR15">
       <label>
        15.
       </label>
       <mixed-citation publication-type="other">
        Rutala W, Weber D, the Healthcare Infection Control Practices Advisory Committee (2008) Guideline for disinfection and sterilization in healthcare facilities. Centers for Disease Control and Prevention
       </mixed-citation>
      </ref>
      <ref id="CR16">
       <label>
        16.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Layton
          </surname>
          <given-names>
           MC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         An outbreak of mupirocin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         on a dermatology ward associated with an environmental reservoir
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         1993
        </year>
        <volume>
         14
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         369
        </fpage>
        <lpage>
         375
        </lpage>
        <pub-id pub-id-type="doi">
         10.2307/30148318
        </pub-id>
        <pub-id pub-id-type="pmid">
         8354867
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR17">
       <label>
        17.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Lassence
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate
         <italic>
          Staphylococcus aureus
         </italic>
         in an intensive care unit
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2006
        </year>
        <volume>
         42
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         170
        </fpage>
        <lpage>
         178
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/498898
        </pub-id>
        <pub-id pub-id-type="pmid">
         16355325
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR18">
       <label>
        18.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rampling
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evidence that hospital hygiene is important in the control of methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2001
        </year>
        <volume>
         49
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         109
        </fpage>
        <lpage>
         116
        </lpage>
        <pub-id pub-id-type="doi">
         10.1053/jhin.2001.1013
        </pub-id>
        <pub-id pub-id-type="pmid">
         11567555
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR19">
       <label>
        19.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study
        </article-title>
        <source>
         BMC Med
        </source>
        <year>
         2009
        </year>
        <volume>
         7
        </volume>
        <fpage>
         28
        </fpage>
        <pub-id pub-id-type="doi">
         10.1186/1741-7015-7-28
        </pub-id>
        <pub-id pub-id-type="pmid">
         19505316
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR20">
       <label>
        20.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jinadatha
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
        </article-title>
        <source>
         BMC Infect Dis
        </source>
        <year>
         2014
        </year>
        <volume>
         14
        </volume>
        <fpage>
         187
        </fpage>
        <pub-id pub-id-type="doi">
         10.1186/1471-2334-14-187
        </pub-id>
        <pub-id pub-id-type="pmid">
         24708734
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR21">
       <label>
        21.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Mitchell
          </surname>
          <given-names>
           BG
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Controlling methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis
        </article-title>
        <source>
         BMJ Open
        </source>
        <year>
         2014
        </year>
        <volume>
         4
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         e004522
        </fpage>
        <pub-id pub-id-type="doi">
         10.1136/bmjopen-2013-004522
        </pub-id>
        <pub-id pub-id-type="pmid">
         24747791
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR22">
       <label>
        22.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Arias
          </surname>
          <given-names>
           CA
          </given-names>
         </name>
         <name>
          <surname>
           Murray
          </surname>
          <given-names>
           BE
          </given-names>
         </name>
        </person-group>
        <article-title>
         The rise of the enterococcus: beyond vancomycin resistance
        </article-title>
        <source>
         Nat Rev Microbiol
        </source>
        <year>
         2012
        </year>
        <volume>
         10
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         266
        </fpage>
        <lpage>
         278
        </lpage>
        <pub-id pub-id-type="doi">
         10.1038/nrmicro2761
        </pub-id>
        <pub-id pub-id-type="pmid">
         22421879
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR23">
       <label>
        23.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kramer
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Schwebke
          </surname>
          <given-names>
           I
          </given-names>
         </name>
         <name>
          <surname>
           Kampf
          </surname>
          <given-names>
           G
          </given-names>
         </name>
        </person-group>
        <article-title>
         How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
        </article-title>
        <source>
         BMC Infect Dis
        </source>
        <year>
         2006
        </year>
        <volume>
         6
        </volume>
        <fpage>
         130
        </fpage>
        <pub-id pub-id-type="doi">
         10.1186/1471-2334-6-130
        </pub-id>
        <pub-id pub-id-type="pmid">
         16914034
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR24">
       <label>
        24.
       </label>
       <mixed-citation publication-type="other">
        Werner G et al (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13(47)
       </mixed-citation>
      </ref>
      <ref id="CR25">
       <label>
        25.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rossini
          </surname>
          <given-names>
           FAF
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Successful prevention of the transmission of vancomycin-resistant enterococci in a Brazilian public teaching hospital
        </article-title>
        <source>
         Rev Soc Bras Med Trop
        </source>
        <year>
         2012
        </year>
        <volume>
         45
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         184
        </fpage>
        <lpage>
         188
        </lpage>
        <pub-id pub-id-type="doi">
         10.1590/S0037-86822012000200009
        </pub-id>
        <pub-id pub-id-type="pmid">
         22534989
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR26">
       <label>
        26.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yoon
          </surname>
          <given-names>
           YK
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units
        </article-title>
        <source>
         Yonsei Med J
        </source>
        <year>
         2009
        </year>
        <volume>
         50
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         637
        </fpage>
        <lpage>
         643
        </lpage>
        <pub-id pub-id-type="doi">
         10.3349/ymj.2009.50.5.637
        </pub-id>
        <pub-id pub-id-type="pmid">
         19881966
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR27">
       <label>
        27.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lawley
          </surname>
          <given-names>
           TD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <year>
         2010
        </year>
        <volume>
         76
        </volume>
        <issue>
         20
        </issue>
        <fpage>
         6895
        </fpage>
        <lpage>
         6900
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/AEM.00718-10
        </pub-id>
        <pub-id pub-id-type="pmid">
         20802075
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR28">
       <label>
        28.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Macleod-Glover
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Sadowski
          </surname>
          <given-names>
           C
          </given-names>
         </name>
        </person-group>
        <article-title>
         Efficacy of cleaning products for
         <italic>
          C. difficile
         </italic>
         : environmental strategies to reduce the spread of Clostridium Difficile-associated diarrhea in geriatric rehabilitation
        </article-title>
        <source>
         Can Fam Physician
        </source>
        <year>
         2010
        </year>
        <volume>
         56
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         417
        </fpage>
        <lpage>
         423
        </lpage>
        <pub-id pub-id-type="pmid">
         20463269
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR29">
       <label>
        29.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Doring
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Distribution and transmission of Pseudomonas Aeruginosa and Burkholderia cepacia in a hospital ward
        </article-title>
        <source>
         Pediatr Pulmonol
        </source>
        <year>
         1996
        </year>
        <volume>
         21
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         90
        </fpage>
        <lpage>
         100
        </lpage>
        <pub-id pub-id-type="doi">
         10.1002/(SICI)1099-0496(199602)21:2&lt;90::AID-PPUL5&gt;3.0.CO;2-T
        </pub-id>
        <pub-id pub-id-type="pmid">
         8882212
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR30">
       <label>
        30.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Costerton
          </surname>
          <given-names>
           JW
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Bacterial biofilms in nature and disease
        </article-title>
        <source>
         Annu Rev Microbiol
        </source>
        <year>
         1987
        </year>
        <volume>
         41
        </volume>
        <fpage>
         435
        </fpage>
        <lpage>
         464
        </lpage>
        <pub-id pub-id-type="doi">
         10.1146/annurev.mi.41.100187.002251
        </pub-id>
        <pub-id pub-id-type="pmid">
         3318676
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR31">
       <label>
        31.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hota
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Outbreak of multidrug-resistant Pseudomonas Aeruginosa colonization and infection secondary to imperfect intensive care unit room design
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2009
        </year>
        <volume>
         30
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         25
        </fpage>
        <lpage>
         33
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/592700
        </pub-id>
        <pub-id pub-id-type="pmid">
         19046054
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR32">
       <label>
        32.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kerr
          </surname>
          <given-names>
           KG
          </given-names>
         </name>
         <name>
          <surname>
           Snelling
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pseudomonas Aeruginosa: a formidable and ever-present adversary
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2009
        </year>
        <volume>
         73
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         338
        </fpage>
        <lpage>
         344
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2009.04.020
        </pub-id>
        <pub-id pub-id-type="pmid">
         19699552
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR33">
       <label>
        33.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Strassle
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         The effect of terminal cleaning on environmental contamination rates of multidrug-resistant Acinetobacter Baumannii
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2012
        </year>
        <volume>
         40
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         1005
        </fpage>
        <lpage>
         1007
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2012.05.027
        </pub-id>
        <pub-id pub-id-type="pmid">
         23199726
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR34">
       <label>
        34.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fournier
          </surname>
          <given-names>
           PE
          </given-names>
         </name>
         <name>
          <surname>
           Richet
          </surname>
          <given-names>
           H
          </given-names>
         </name>
        </person-group>
        <article-title>
         The epidemiology and control of Acinetobacter Baumannii in health care facilities
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2006
        </year>
        <volume>
         42
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         692
        </fpage>
        <lpage>
         699
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/500202
        </pub-id>
        <pub-id pub-id-type="pmid">
         16447117
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR35">
       <label>
        35.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Maragakis
          </surname>
          <given-names>
           LL
          </given-names>
         </name>
         <name>
          <surname>
           Perl
          </surname>
          <given-names>
           TM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acinetobacter Baumannii: epidemiology, antimicrobial resistance, and treatment options
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2008
        </year>
        <volume>
         46
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         1254
        </fpage>
        <lpage>
         1263
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/529198
        </pub-id>
        <pub-id pub-id-type="pmid">
         18444865
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR36">
       <label>
        36.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Villegas
          </surname>
          <given-names>
           MV
          </given-names>
         </name>
         <name>
          <surname>
           Hartstein
          </surname>
          <given-names>
           AI
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acinetobacter outbreaks, 1977–2000
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2003
        </year>
        <volume>
         24
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         284
        </fpage>
        <lpage>
         295
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/502205
        </pub-id>
        <pub-id pub-id-type="pmid">
         12725359
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR37">
       <label>
        37.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Apisarnthanarak
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A multifaceted intervention to reduce pandrug-resistant Acinetobacter Baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2008
        </year>
        <volume>
         47
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         760
        </fpage>
        <lpage>
         767
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/591134
        </pub-id>
        <pub-id pub-id-type="pmid">
         18684100
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR38">
       <label>
        38.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           La Forgia
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Management of a multidrug-resistant Acinetobacter Baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2010
        </year>
        <volume>
         38
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         259
        </fpage>
        <lpage>
         263
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2009.07.012
        </pub-id>
        <pub-id pub-id-type="pmid">
         19900737
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR39">
       <label>
        39.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Montgomerie
          </surname>
          <given-names>
           JZ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiology of Klebsiella and hospital-associated infections
        </article-title>
        <source>
         Rev Infect Dis
        </source>
        <year>
         1979
        </year>
        <volume>
         1
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         736
        </fpage>
        <lpage>
         753
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/clinids/1.5.736
        </pub-id>
        <pub-id pub-id-type="pmid">
         396632
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR40">
       <label>
        40.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Asensio
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Outbreak of a multiresistant
         <italic>
          Klebsiella pneumoniae
         </italic>
         strain in an intensive care unit: antibiotic use as risk factor for colonization and infection
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <year>
         2000
        </year>
        <volume>
         30
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/313590
        </pub-id>
        <pub-id pub-id-type="pmid">
         10619733
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR41">
       <label>
        41.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hobson
          </surname>
          <given-names>
           RP
          </given-names>
         </name>
         <name>
          <surname>
           MacKenzie
          </surname>
          <given-names>
           FM
          </given-names>
         </name>
         <name>
          <surname>
           Gould
          </surname>
          <given-names>
           IM
          </given-names>
         </name>
        </person-group>
        <article-title>
         An outbreak of multiply-resistant
         <italic>
          Klebsiella pneumoniae
         </italic>
         in the Grampian region of Scotland
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         1996
        </year>
        <volume>
         33
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         249
        </fpage>
        <lpage>
         262
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0195-6701(96)90011-0
        </pub-id>
        <pub-id pub-id-type="pmid">
         8864938
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR42">
       <label>
        42.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Starlander
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Melhus
          </surname>
          <given-names>
           A
          </given-names>
         </name>
        </person-group>
        <article-title>
         Minor outbreak of extended-spectrum beta-lactamase-producing
         <italic>
          Klebsiella pneumoniae
         </italic>
         in an intensive care unit due to a contaminated sink
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2012
        </year>
        <volume>
         82
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         122
        </fpage>
        <lpage>
         124
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2012.07.004
        </pub-id>
        <pub-id pub-id-type="pmid">
         22871394
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR43">
       <label>
        43.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Merkier
          </surname>
          <given-names>
           AK
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Outbreak of a cluster with epidemic behavior due to Serratia Marcescens after Colistin Administration in a Hospital Setting
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <year>
         2013
        </year>
        <volume>
         51
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         2295
        </fpage>
        <lpage>
         2302
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/JCM.03280-12
        </pub-id>
        <pub-id pub-id-type="pmid">
         23698525
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR44">
       <label>
        44.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Krawczyk
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evaluation and comparison of random amplification of polymorphic DNA, pulsed-field gel electrophoresis and ADSRRS-fingerprinting for typing Serratia Marcescens outbreaks
        </article-title>
        <source>
         FEMS Immunol Med Microbiol
        </source>
        <year>
         2003
        </year>
        <volume>
         38
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         241
        </fpage>
        <lpage>
         248
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0928-8244(03)00149-4
        </pub-id>
        <pub-id pub-id-type="pmid">
         14522459
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR45">
       <label>
        45.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Villari
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Molecular epidemiology of an outbreak of Serratia Marcescens in a neonatal intensive care unit
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2001
        </year>
        <volume>
         22
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         630
        </fpage>
        <lpage>
         634
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/501834
        </pub-id>
        <pub-id pub-id-type="pmid">
         11776349
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR46">
       <label>
        46.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gastmeier
          </surname>
          <given-names>
           P
          </given-names>
         </name>
        </person-group>
        <article-title>
         Serratia Marcescens: an outbreak experience
        </article-title>
        <source>
         Front Microbiol
        </source>
        <year>
         2014
        </year>
        <volume>
         5
        </volume>
        <fpage>
         81
        </fpage>
        <pub-id pub-id-type="doi">
         10.3389/fmicb.2014.00081
        </pub-id>
        <pub-id pub-id-type="pmid">
         24639671
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR47">
       <label>
        47.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hejazi
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Falkiner
          </surname>
          <given-names>
           FR
          </given-names>
         </name>
        </person-group>
        <article-title>
         Serratia marcescens
        </article-title>
        <source>
         J Med Microbiol
        </source>
        <year>
         1997
        </year>
        <volume>
         46
        </volume>
        <issue>
         11
        </issue>
        <fpage>
         903
        </fpage>
        <lpage>
         912
        </lpage>
        <pub-id pub-id-type="doi">
         10.1099/00222615-46-11-903
        </pub-id>
        <pub-id pub-id-type="pmid">
         9368530
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR48">
       <label>
        48.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Virgincar
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         <italic>
          Klebsiella pneumoniae
         </italic>
         producing KPC carbapenemase in a district general hospital in the UK
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2011
        </year>
        <volume>
         78
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         293
        </fpage>
        <lpage>
         296
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2011.03.016
        </pub-id>
        <pub-id pub-id-type="pmid">
         21641083
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR49">
       <label>
        49.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Soulier
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Decreased transmission of Enterobacteriaceae with extended-Spectrum Beta-lactamases in an intensive-care unit by nursing reorganization
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         1995
        </year>
        <volume>
         31
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         89
        </fpage>
        <lpage>
         97
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/0195-6701(95)90163-9
        </pub-id>
        <pub-id pub-id-type="pmid">
         8551026
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR50">
       <label>
        50.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital cleaning in the 21st century
        </article-title>
        <source>
         Eur J Clin Microbiol Infect Dis
        </source>
        <year>
         2011
        </year>
        <volume>
         30
        </volume>
        <issue>
         12
        </issue>
        <fpage>
         1473
        </fpage>
        <lpage>
         1481
        </lpage>
        <pub-id pub-id-type="doi">
         10.1007/s10096-011-1250-x
        </pub-id>
        <pub-id pub-id-type="pmid">
         21499954
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR51">
       <label>
        51.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lucero
          </surname>
          <given-names>
           CA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2011
        </year>
        <volume>
         39
        </volume>
        <issue>
         9
        </issue>
        <fpage>
         775
        </fpage>
        <lpage>
         778
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2010.12.005
        </pub-id>
        <pub-id pub-id-type="pmid">
         21664002
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR52">
       <label>
        52.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dias
          </surname>
          <given-names>
           MBS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Multi-institutional outbreak of Burkholderia cepacia complex associated with contaminated mannitol solution prepared in compounding pharmacy
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2013
        </year>
        <volume>
         41
        </volume>
        <issue>
         11
        </issue>
        <fpage>
         1038
        </fpage>
        <lpage>
         1042
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2013.01.033
        </pub-id>
        <pub-id pub-id-type="pmid">
         23663863
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR53">
       <label>
        53.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ko
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         An outbreak of Burkholderia cepacia complex pseudobacteremia associated with intrinsically contaminated commercial 0.5% chlorhexidine solution
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2015
        </year>
        <volume>
         43
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         266
        </fpage>
        <lpage>
         268
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2014.11.010
        </pub-id>
        <pub-id pub-id-type="pmid">
         25557770
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR54">
       <label>
        54.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Uses of inorganic hypochlorite (bleach) in health-care facilities
        </article-title>
        <source>
         Clin Microbiol Rev
        </source>
        <year>
         1997
        </year>
        <volume>
         10
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         597
        </fpage>
        <pub-id pub-id-type="pmid">
         9336664
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR55">
       <label>
        55.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Morter
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Norovirus in the hospital setting: virus introduction and spread within the hospital environment
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2011
        </year>
        <volume>
         77
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         106
        </fpage>
        <lpage>
         112
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2010.09.035
        </pub-id>
        <pub-id pub-id-type="pmid">
         21167622
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR56">
       <label>
        56.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           MacCannell
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2011
        </year>
        <volume>
         32
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         939
        </fpage>
        <lpage>
         969
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/662025
        </pub-id>
        <pub-id pub-id-type="pmid">
         21931246
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR57">
       <label>
        57.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           PB
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <year>
         2010
        </year>
        <volume>
         76
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         394
        </fpage>
        <lpage>
         399
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/AEM.01729-09
        </pub-id>
        <pub-id pub-id-type="pmid">
         19933337
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR58">
       <label>
        58.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Barker
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Vipond
          </surname>
          <given-names>
           IB
          </given-names>
         </name>
         <name>
          <surname>
           Bloomfield
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
        </person-group>
        <article-title>
         Effects of cleaning and disinfection in reducing the spread of norovirus contamination via environmental surfaces
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2004
        </year>
        <volume>
         58
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         42
        </fpage>
        <lpage>
         49
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2004.04.021
        </pub-id>
        <pub-id pub-id-type="pmid">
         15350713
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR59">
       <label>
        59.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Khan
          </surname>
          <given-names>
           RM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Middle East respiratory syndrome coronavirus on inanimate surfaces: a risk for health care transmission
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2016
        </year>
        <volume>
         44
        </volume>
        <issue>
         11
        </issue>
        <fpage>
         1387
        </fpage>
        <lpage>
         1389
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2016.05.006
        </pub-id>
        <pub-id pub-id-type="pmid">
         27339792
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR60">
       <label>
        60.
       </label>
       <mixed-citation publication-type="other">
        van Doremalen N, Bushmaker T, Munster VJ (2013) Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 18(38)
       </mixed-citation>
      </ref>
      <ref id="CR61">
       <label>
        61.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Warnes
          </surname>
          <given-names>
           SL
          </given-names>
         </name>
         <name>
          <surname>
           Little
          </surname>
          <given-names>
           ZR
          </given-names>
         </name>
         <name>
          <surname>
           Keevil
          </surname>
          <given-names>
           CW
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human coronavirus 229E remains infectious on common touch surface materials
        </article-title>
        <source>
         MBio
        </source>
        <year>
         2015
        </year>
        <volume>
         6
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         e01697
        </fpage>
        <lpage>
         e01615
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/mBio.01697-15
        </pub-id>
        <pub-id pub-id-type="pmid">
         26556276
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR62">
       <label>
        62.
       </label>
       <mixed-citation publication-type="other">
        Schelenz S et al (2016) First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5
       </mixed-citation>
      </ref>
      <ref id="CR63">
       <label>
        63.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carling
          </surname>
          <given-names>
           PC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2008
        </year>
        <volume>
         29
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         1
        </fpage>
        <lpage>
         7
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/524329
        </pub-id>
        <pub-id pub-id-type="pmid">
         18171180
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR64">
       <label>
        64.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Goodman
          </surname>
          <given-names>
           ER
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Impact of an environmental cleaning intervention on the presence of methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         and vancomycin-resistant enterococci on surfaces in intensive care unit rooms
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2008
        </year>
        <volume>
         29
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         593
        </fpage>
        <lpage>
         599
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/588566
        </pub-id>
        <pub-id pub-id-type="pmid">
         18624666
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR65">
       <label>
        65.
       </label>
       <mixed-citation publication-type="other">
        Boyce JM (2016) Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control 5
       </mixed-citation>
      </ref>
      <ref id="CR66">
       <label>
        66.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Anderson
          </surname>
          <given-names>
           RE
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Cleanliness audit of clinical surfaces and equipment: who cleans what?
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2011
        </year>
        <volume>
         78
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         178
        </fpage>
        <lpage>
         181
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2011.01.030
        </pub-id>
        <pub-id pub-id-type="pmid">
         21497943
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR67">
       <label>
        67.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Schabrun
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Chipchase
          </surname>
          <given-names>
           L
          </given-names>
         </name>
        </person-group>
        <article-title>
         Healthcare equipment as a source of nosocomial infection: a systematic review
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2006
        </year>
        <volume>
         63
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         239
        </fpage>
        <lpage>
         245
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2005.10.013
        </pub-id>
        <pub-id pub-id-type="pmid">
         16516340
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR68">
       <label>
        68.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination
        </article-title>
        <source>
         Clin Microbiol Rev
        </source>
        <year>
         2014
        </year>
        <volume>
         27
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         665
        </fpage>
        <lpage>
         690
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/CMR.00020-14
        </pub-id>
        <pub-id pub-id-type="pmid">
         25278571
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR69">
       <label>
        69.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
        </person-group>
        <article-title>
         APIC guideline for selection and use of disinfectants
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         1996
        </year>
        <volume>
         24
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         313
        </fpage>
        <lpage>
         342
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0196-6553(96)90066-8
        </pub-id>
        <pub-id pub-id-type="pmid">
         8870916
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR70">
       <label>
        70.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Maillard
          </surname>
          <given-names>
           JY
          </given-names>
         </name>
        </person-group>
        <article-title>
         The crucial role of wiping in decontamination of high-touch environmental surfaces: review of current status and directions for the future
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2013
        </year>
        <volume>
         41
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         S97
        </fpage>
        <lpage>
         S104
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2012.10.032
        </pub-id>
        <pub-id pub-id-type="pmid">
         23622759
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR71">
       <label>
        71.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Promises and pitfalls of recent advances in chemical means of preventing the spread of nosocomial infections by environmental surfaces
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2010
        </year>
        <volume>
         38
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         S34
        </fpage>
        <lpage>
         S40
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2010.04.207
        </pub-id>
        <pub-id pub-id-type="pmid">
         20569854
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR72">
       <label>
        72.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Russell
          </surname>
          <given-names>
           AD
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2004
        </year>
        <volume>
         57
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         97
        </fpage>
        <lpage>
         104
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2004.01.004
        </pub-id>
        <pub-id pub-id-type="pmid">
         15183238
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR73">
       <label>
        73.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aldeyab
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evaluation of the efficacy of a conventional cleaning regimen in removing methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         from contaminated surfaces in an intensive care unit
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2009
        </year>
        <volume>
         30
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         304
        </fpage>
        <lpage>
         306
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/595964
        </pub-id>
        <pub-id pub-id-type="pmid">
         19215198
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR74">
       <label>
        74.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
         <name>
          <surname>
           Gergen
          </surname>
          <given-names>
           MF
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Efficacy of improved hydrogen peroxide against important healthcare-associated pathogens
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2012
        </year>
        <volume>
         33
        </volume>
        <issue>
         11
        </issue>
        <fpage>
         1159
        </fpage>
        <lpage>
         1161
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/668014
        </pub-id>
        <pub-id pub-id-type="pmid">
         23041817
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR75">
       <label>
        75.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boyce
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
         <name>
          <surname>
           Havill
          </surname>
          <given-names>
           NL
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of a new hydrogen peroxide wipe disinfectant
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2013
        </year>
        <volume>
         34
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         521
        </fpage>
        <lpage>
         523
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/670212
        </pub-id>
        <pub-id pub-id-type="pmid">
         23571371
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR76">
       <label>
        76.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Alfa
          </surname>
          <given-names>
           MJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Use of a daily disinfectant cleaner instead of a daily cleaner reduced hospital-acquired infection rates
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2015
        </year>
        <volume>
         43
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         141
        </fpage>
        <lpage>
         146
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2014.10.016
        </pub-id>
        <pub-id pub-id-type="pmid">
         25534117
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR77">
       <label>
        77.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Effectiveness of improved hydrogen peroxide in decontaminating privacy curtains contaminated with multidrug-resistant pathogens
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2014
        </year>
        <volume>
         42
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         426
        </fpage>
        <lpage>
         428
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2013.11.022
        </pub-id>
        <pub-id pub-id-type="pmid">
         24679570
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR78">
       <label>
        78.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Carling
          </surname>
          <given-names>
           PC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evaluating a new paradigm for comparing surface disinfection in clinical practice
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2014
        </year>
        <volume>
         35
        </volume>
        <issue>
         11
        </issue>
        <fpage>
         1349
        </fpage>
        <lpage>
         1355
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/678424
        </pub-id>
        <pub-id pub-id-type="pmid">
         25333429
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR79">
       <label>
        79.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Meakin
          </surname>
          <given-names>
           NS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Comparison of cleaning efficacy between in-use disinfectant and electrolysed water in an English residential care home
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2012
        </year>
        <volume>
         80
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         122
        </fpage>
        <lpage>
         127
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2011.10.015
        </pub-id>
        <pub-id pub-id-type="pmid">
         22196853
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR80">
       <label>
        80.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fertelli
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Effectiveness of an electrochemically activated saline solution for disinfection of hospital equipment
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2013
        </year>
        <volume>
         34
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         543
        </fpage>
        <lpage>
         544
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/670226
        </pub-id>
        <pub-id pub-id-type="pmid">
         23571379
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR81">
       <label>
        81.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cahill
          </surname>
          <given-names>
           OJ
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Cold air plasma to decontaminate inanimate surfaces of the hospital environment
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <year>
         2014
        </year>
        <volume>
         80
        </volume>
        <issue>
         6
        </issue>
        <fpage>
         2004
        </fpage>
        <lpage>
         2010
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/AEM.03480-13
        </pub-id>
        <pub-id pub-id-type="pmid">
         24441156
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR82">
       <label>
        82.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           O’connor
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections?
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2014
        </year>
        <volume>
         88
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         59
        </fpage>
        <lpage>
         65
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2014.06.015
        </pub-id>
        <pub-id pub-id-type="pmid">
         25146226
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR83">
       <label>
        83.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Unal
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Evaluation of the efficacy of akacid plus (R) fogging in eradicating causative microorganism in nosocomial infections
        </article-title>
        <source>
         Int J Clin Exp Med
        </source>
        <year>
         2014
        </year>
        <volume>
         7
        </volume>
        <issue>
         12
        </issue>
        <fpage>
         5867
        </fpage>
        <lpage>
         5871
        </lpage>
        <pub-id pub-id-type="pmid">
         25664122
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR84">
       <label>
        84.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
         <name>
          <surname>
           Gergen
          </surname>
          <given-names>
           MF
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbiologic evaluation of microfiber mops for surface disinfection
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2007
        </year>
        <volume>
         35
        </volume>
        <issue>
         9
        </issue>
        <fpage>
         569
        </fpage>
        <lpage>
         573
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2007.02.009
        </pub-id>
        <pub-id pub-id-type="pmid">
         17980233
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR85">
       <label>
        85.
       </label>
       <mixed-citation publication-type="other">
        Nerandzic MM et al (2010) Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. Bmc Infect Dis 10
       </mixed-citation>
      </ref>
      <ref id="CR86">
       <label>
        86.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Memarzadeh
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Olmsted
          </surname>
          <given-names>
           RN
          </given-names>
         </name>
         <name>
          <surname>
           Bartley
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Applications of ultraviolet germicidal irradiation disinfection in health care facilities: effective adjunct, but not stand-alone technology
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2010
        </year>
        <volume>
         38
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         S13
        </fpage>
        <lpage>
         S24
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2010.04.208
        </pub-id>
        <pub-id pub-id-type="pmid">
         20569852
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR87">
       <label>
        87.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Linley
          </surname>
          <given-names>
           E
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action
        </article-title>
        <source>
         J Antimicrob Chemother
        </source>
        <year>
         2012
        </year>
        <volume>
         67
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         1589
        </fpage>
        <lpage>
         1596
        </lpage>
        <pub-id pub-id-type="doi">
         10.1093/jac/dks129
        </pub-id>
        <pub-id pub-id-type="pmid">
         22532463
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR88">
       <label>
        88.
       </label>
       <mixed-citation publication-type="other">
        Mitchell BG et al (2014) Controlling methicillin-resistant
        <italic>
         Staphylococcus aureus
        </italic>
        (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis. Bmj Open 4(4)
       </mixed-citation>
      </ref>
      <ref id="CR89">
       <label>
        89.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chmielarczyk
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Control of an outbreak of Acinetobacter Baumannii infections using vaporized hydrogen peroxide
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2012
        </year>
        <volume>
         81
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         239
        </fpage>
        <lpage>
         245
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2012.05.010
        </pub-id>
        <pub-id pub-id-type="pmid">
         22727825
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR90">
       <label>
        90.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Falagas
          </surname>
          <given-names>
           ME
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2011
        </year>
        <volume>
         78
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         171
        </fpage>
        <lpage>
         177
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2010.12.006
        </pub-id>
        <pub-id pub-id-type="pmid">
         21392848
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR91">
       <label>
        91.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bentley
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Hydrogen peroxide vapour decontamination of surfaces artificially contaminated with norovirus surrogate feline calicivirus
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2012
        </year>
        <volume>
         80
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         116
        </fpage>
        <lpage>
         121
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2011.10.010
        </pub-id>
        <pub-id pub-id-type="pmid">
         22169115
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR92">
       <label>
        92.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Boyce
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Impact of hydrogen peroxide vapor room decontamination on Clostridium Difficile environmental contamination and transmission in a healthcare setting
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2008
        </year>
        <volume>
         29
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         723
        </fpage>
        <lpage>
         729
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/589906
        </pub-id>
        <pub-id pub-id-type="pmid">
         18636950
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR93">
       <label>
        93.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hall
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor
        </article-title>
        <source>
         Med Mycol
        </source>
        <year>
         2008
        </year>
        <volume>
         46
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         189
        </fpage>
        <lpage>
         191
        </lpage>
        <pub-id pub-id-type="doi">
         10.1080/13693780701744809
        </pub-id>
        <pub-id pub-id-type="pmid">
         18324500
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR94">
       <label>
        94.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Floor wars: the battle for ‘clean’ surfaces
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2013
        </year>
        <volume>
         84
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         339
        </fpage>
        <lpage>
         340
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2013.01.015
        </pub-id>
        <pub-id pub-id-type="pmid">
         23806838
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR95">
       <label>
        95.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jeanes
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Eradication of persistent environmental MRSA
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2005
        </year>
        <volume>
         61
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         85
        </fpage>
        <lpage>
         86
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2005.01.001
        </pub-id>
        <pub-id pub-id-type="pmid">
         16054946
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR96">
       <label>
        96.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dryden
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         outbreak on a surgical ward
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2008
        </year>
        <volume>
         68
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         190
        </fpage>
        <lpage>
         192
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2007.11.003
        </pub-id>
        <pub-id pub-id-type="pmid">
         18192078
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR97">
       <label>
        97.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Otter
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2010
        </year>
        <volume>
         38
        </volume>
        <issue>
         9
        </issue>
        <fpage>
         754
        </fpage>
        <lpage>
         756
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2010.03.010
        </pub-id>
        <pub-id pub-id-type="pmid">
         20605263
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR98">
       <label>
        98.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cooper
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital trust
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2011
        </year>
        <volume>
         78
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         238
        </fpage>
        <lpage>
         240
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2010.12.013
        </pub-id>
        <pub-id pub-id-type="pmid">
         21392849
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR99">
       <label>
        99.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ray
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter Baumannii infection at a long-term acute care hospital
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2010
        </year>
        <volume>
         31
        </volume>
        <issue>
         12
        </issue>
        <fpage>
         1236
        </fpage>
        <lpage>
         1241
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/657139
        </pub-id>
        <pub-id pub-id-type="pmid">
         20973723
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR100">
       <label>
        100.
       </label>
       <mixed-citation publication-type="other">
        Martin NL, Bass P, Liss SN (2015) Antibacterial properties and mechanism of activity of a novel silver-stabilized hydrogen peroxide. Plos One 10(7)
       </mixed-citation>
      </ref>
      <ref id="CR101">
       <label>
        101.
       </label>
       <mixed-citation publication-type="other">
        Silva AP et al (2010) Efficacy of hydrogen peroxide dry-mist disinfection system for hospital environment disinfection. J Hosp Infect 76(Suppl 1):S23
       </mixed-citation>
      </ref>
      <ref id="CR102">
       <label>
        102.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sexton
          </surname>
          <given-names>
           JD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Reduction in the microbial load on high-touch surfaces in hospital rooms by treatment with a portable saturated steam vapor disinfection system
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2011
        </year>
        <volume>
         39
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         655
        </fpage>
        <lpage>
         662
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2010.11.009
        </pub-id>
        <pub-id pub-id-type="pmid">
         21641089
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR103">
       <label>
        103.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tanner
          </surname>
          <given-names>
           BD
          </given-names>
         </name>
        </person-group>
        <article-title>
         Reduction in infection risk through treatment of microbially contaminated surfaces with a novel, portable, saturated steam vapor disinfection system
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2009
        </year>
        <volume>
         37
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         20
        </fpage>
        <lpage>
         27
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2008.03.008
        </pub-id>
        <pub-id pub-id-type="pmid">
         18834748
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR104">
       <label>
        104.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Griffith
          </surname>
          <given-names>
           CJ
          </given-names>
         </name>
         <name>
          <surname>
           Dancer
          </surname>
          <given-names>
           SJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hospital cleaning: problems with steam cleaning and microfibre
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2009
        </year>
        <volume>
         72
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         360
        </fpage>
        <lpage>
         361
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2009.04.009
        </pub-id>
        <pub-id pub-id-type="pmid">
         19540620
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR105">
       <label>
        105.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sharma
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Hudson
          </surname>
          <given-names>
           JB
          </given-names>
         </name>
        </person-group>
        <article-title>
         Ozone gas is an effective and practical antibacterial agent
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2008
        </year>
        <volume>
         36
        </volume>
        <issue>
         8
        </issue>
        <fpage>
         559
        </fpage>
        <lpage>
         563
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2007.10.021
        </pub-id>
        <pub-id pub-id-type="pmid">
         18926308
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR106">
       <label>
        106.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cardoso
          </surname>
          <given-names>
           CC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Disinfection of hospital laundry using ozone: microbiological evaluation
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2000
        </year>
        <volume>
         21
        </volume>
        <issue>
         4
        </issue>
        <fpage>
         248
        </fpage>
        <lpage>
         248
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/503216
        </pub-id>
        <pub-id pub-id-type="pmid">
         10782581
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR107">
       <label>
        107.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           de Boer
          </surname>
          <given-names>
           HEL
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Use of gaseous ozone for eradication of methicillin-resistant
         <italic>
          Staphylococcus aureus
         </italic>
         from the home environment of a colonized hospital employee
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2006
        </year>
        <volume>
         27
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         1120
        </fpage>
        <lpage>
         1122
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/507966
        </pub-id>
        <pub-id pub-id-type="pmid">
         17006820
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR108">
       <label>
        108.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Davies
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2011
        </year>
        <volume>
         77
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         199
        </fpage>
        <lpage>
         203
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2010.08.012
        </pub-id>
        <pub-id pub-id-type="pmid">
         21130521
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR109">
       <label>
        109.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hamblin
          </surname>
          <given-names>
           MR
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light
        </article-title>
        <source>
         Antimicrob Agents Chemother
        </source>
        <year>
         2005
        </year>
        <volume>
         49
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         2822
        </fpage>
        <lpage>
         2827
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/AAC.49.7.2822-2827.2005
        </pub-id>
        <pub-id pub-id-type="pmid">
         15980355
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR110">
       <label>
        110.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Maclean
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2010
        </year>
        <volume>
         76
        </volume>
        <issue>
         3
        </issue>
        <fpage>
         247
        </fpage>
        <lpage>
         251
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2010.07.010
        </pub-id>
        <pub-id pub-id-type="pmid">
         20864210
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR111">
       <label>
        111.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Maclean
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         High-intensity narrow-spectrum light inactivation and wavelength sensitivity of
         <italic>
          Staphylococcus aureus
         </italic>
        </article-title>
        <source>
         FEMS Microbiol Lett
        </source>
        <year>
         2008
        </year>
        <volume>
         285
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         227
        </fpage>
        <lpage>
         232
        </lpage>
        <pub-id pub-id-type="doi">
         10.1111/j.1574-6968.2008.01233.x
        </pub-id>
        <pub-id pub-id-type="pmid">
         18557942
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR112">
       <label>
        112.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Maclean
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode Array
        </article-title>
        <source>
         Appl Environ Microbiol
        </source>
        <year>
         2009
        </year>
        <volume>
         75
        </volume>
        <issue>
         7
        </issue>
        <fpage>
         1932
        </fpage>
        <lpage>
         1937
        </lpage>
        <pub-id pub-id-type="doi">
         10.1128/AEM.01892-08
        </pub-id>
        <pub-id pub-id-type="pmid">
         19201962
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR113">
       <label>
        113.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bache
          </surname>
          <given-names>
           SE
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical studies of the high-intensity narrow-Spectrum light environmental decontamination system (HINS-light EDS), for continuous disinfection in the burn unit inpatient and outpatient settings
        </article-title>
        <source>
         Burns
        </source>
        <year>
         2012
        </year>
        <volume>
         38
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         69
        </fpage>
        <lpage>
         76
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.burns.2011.03.008
        </pub-id>
        <pub-id pub-id-type="pmid">
         22103991
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR114">
       <label>
        114.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Parkin
          </surname>
          <given-names>
           IP
          </given-names>
         </name>
         <name>
          <surname>
           Palgrave
          </surname>
          <given-names>
           RG
          </given-names>
         </name>
        </person-group>
        <article-title>
         Self-cleaning coatings
        </article-title>
        <source>
         J Mater Chem
        </source>
        <year>
         2005
        </year>
        <volume>
         15
        </volume>
        <issue>
         17
        </issue>
        <fpage>
         1689
        </fpage>
        <lpage>
         1695
        </lpage>
        <pub-id pub-id-type="doi">
         10.1039/b412803f
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR115">
       <label>
        115.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Park
          </surname>
          <given-names>
           KD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Bacterial adhesion on PEG modified polyurethane surfaces
        </article-title>
        <source>
         Biomaterials
        </source>
        <year>
         1998
        </year>
        <volume>
         19
        </volume>
        <issue>
         7–9
        </issue>
        <fpage>
         851
        </fpage>
        <lpage>
         859
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0142-9612(97)00245-7
        </pub-id>
        <pub-id pub-id-type="pmid">
         9663762
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR116">
       <label>
        116.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hauert
          </surname>
          <given-names>
           R
          </given-names>
         </name>
        </person-group>
        <article-title>
         A review of modified DLC coatings for biological applications
        </article-title>
        <source>
         Diam Relat Mater
        </source>
        <year>
         2003
        </year>
        <volume>
         12
        </volume>
        <issue>
         3–7
        </issue>
        <fpage>
         583
        </fpage>
        <lpage>
         589
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/S0925-9635(03)00081-5
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR117">
       <label>
        117.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           WA
          </given-names>
         </name>
        </person-group>
        <article-title>
         Self-disinfecting surfaces: review of current methodologies and future prospects
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <year>
         2013
        </year>
        <volume>
         41
        </volume>
        <issue>
         5 Suppl
        </issue>
        <fpage>
         S31
        </fpage>
        <lpage>
         S35
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.ajic.2012.12.005
        </pub-id>
        <pub-id pub-id-type="pmid">
         23622745
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR118">
       <label>
        118.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lansdown
          </surname>
          <given-names>
           AB
          </given-names>
         </name>
        </person-group>
        <article-title>
         Silver in health care: antimicrobial effects and safety in use
        </article-title>
        <source>
         Curr Probl Dermatol
        </source>
        <year>
         2006
        </year>
        <volume>
         33
        </volume>
        <fpage>
         17
        </fpage>
        <lpage>
         34
        </lpage>
        <pub-id pub-id-type="doi">
         10.1159/000093928
        </pub-id>
        <pub-id pub-id-type="pmid">
         16766878
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR119">
       <label>
        119.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Stobie
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Dual-action hygienic coatings: benefits of hydrophobicity and silver ion release for protection of environmental and clinical surfaces
        </article-title>
        <source>
         J Colloid Interface Sci
        </source>
        <year>
         2010
        </year>
        <volume>
         345
        </volume>
        <issue>
         2
        </issue>
        <fpage>
         286
        </fpage>
        <lpage>
         292
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jcis.2010.02.009
        </pub-id>
        <pub-id pub-id-type="pmid">
         20211472
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR120">
       <label>
        120.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Salgado
          </surname>
          <given-names>
           CD
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2013
        </year>
        <volume>
         34
        </volume>
        <issue>
         5
        </issue>
        <fpage>
         479
        </fpage>
        <lpage>
         486
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/670207
        </pub-id>
        <pub-id pub-id-type="pmid">
         23571364
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR121">
       <label>
        121.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Casey
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Role of copper in reducing hospital environment contamination
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2010
        </year>
        <volume>
         74
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         72
        </fpage>
        <lpage>
         77
        </lpage>
        <pub-id pub-id-type="doi">
         10.1016/j.jhin.2009.08.018
        </pub-id>
        <pub-id pub-id-type="pmid">
         19931938
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR122">
       <label>
        122.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Klibanov
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Permanently microbicidal materials coatings
        </article-title>
        <source>
         J Mater Chem
        </source>
        <year>
         2007
        </year>
        <volume>
         17
        </volume>
        <issue>
         24
        </issue>
        <fpage>
         2479
        </fpage>
        <lpage>
         2482
        </lpage>
        <pub-id pub-id-type="doi">
         10.1039/b702079a
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR123">
       <label>
        123.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Petersen
          </surname>
          <given-names>
           RC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Triclosan antimicrobial polymers
        </article-title>
        <source>
         Aims Mol Sci
        </source>
        <year>
         2016
        </year>
        <volume>
         3
        </volume>
        <issue>
         1
        </issue>
        <fpage>
         88
        </fpage>
        <lpage>
         103
        </lpage>
        <pub-id pub-id-type="doi">
         10.3934/molsci.2016.1.88
        </pub-id>
        <pub-id pub-id-type="pmid">
         27280150
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR124">
       <label>
        124.
       </label>
       <mixed-citation publication-type="other">
        Chen LK et al (2013) Potential of bacteriophage phi AB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. Bmc Microbiol 13
       </mixed-citation>
      </ref>
      <ref id="CR125">
       <label>
        125.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Page
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <name>
          <surname>
           Parkin
          </surname>
          <given-names>
           IP
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections
        </article-title>
        <source>
         J Mater Chem
        </source>
        <year>
         2009
        </year>
        <volume>
         19
        </volume>
        <issue>
         23
        </issue>
        <fpage>
         3819
        </fpage>
        <lpage>
         3831
        </lpage>
        <pub-id pub-id-type="doi">
         10.1039/b818698g
        </pub-id>
       </element-citation>
      </ref>
      <ref id="CR126">
       <label>
        126.
       </label>
       <mixed-citation publication-type="other">
        Bogdan J, Zarzynska J, Plawinska-Czarnak J (2015) Comparison of infectious agents susceptibility to photocatalytic effects of nanosized titanium and zinc oxides: a practical approach. Nanosc Res Lett 10
       </mixed-citation>
      </ref>
      <ref id="CR127">
       <label>
        127.
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           M
          </given-names>
         </name>
        </person-group>
        <article-title>
         Light-activated antimicrobial coating for the continuous disinfection of surfaces
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2003
        </year>
        <volume>
         24
        </volume>
        <issue>
         10
        </issue>
        <fpage>
         782
        </fpage>
        <lpage>
         784
        </lpage>
        <pub-id pub-id-type="doi">
         10.1086/502136
        </pub-id>
        <pub-id pub-id-type="pmid">
         14587947
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Clin Infect Dis
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Clin. Infect. Dis
      </journal-id>
      <journal-id journal-id-type="hwp">
       cid
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       cid
      </journal-id>
      <journal-title-group>
       <journal-title>
        Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       1058-4838
      </issn>
      <issn pub-type="epub">
       1537-6591
      </issn>
      <publisher>
       <publisher-name>
        The University of Chicago Press
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       15356778
      </article-id>
      <article-id pub-id-type="pmc">
       7107915
      </article-id>
      <article-id pub-id-type="doi">
       10.1086/422652
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Major Articles
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Severe Acute Respiratory Syndrome Coronavirus on Hospital Surfaces
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Dowell
         </surname>
         <given-names>
          Scott F.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
        <xref ref-type="aff" rid="aff2">
         2
        </xref>
        <xref ref-type="corresp" rid="cor1">
        </xref>
        <!--<email>scottd@tuc.or.th</email>-->
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Simmerman
         </surname>
         <given-names>
          James M.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
        <xref ref-type="aff" rid="aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Erdman
         </surname>
         <given-names>
          Dean D.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Wu
         </surname>
         <given-names>
          Jiunn-Shyan Julian
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         4
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Chaovavanich
         </surname>
         <given-names>
          Achara
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
         3
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Javadi
         </surname>
         <given-names>
          Massoud
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         1
        </xref>
        <xref ref-type="aff" rid="aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Yang
         </surname>
         <given-names>
          Jyh-Yuan
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff4">
         4
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Anderson
         </surname>
         <given-names>
          Larry J.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Tong
         </surname>
         <given-names>
          Suxiang
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         2
        </xref>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Ho
         </surname>
         <given-names>
          Mei Shang
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff5">
         5
        </xref>
        <xref ref-type="aff" rid="aff6">
         6
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        1
       </label>
       <institution>
        International Emerging Infections Program, Centers for Disease Control and Prevention
       </institution>
       ,
       <addr-line>
        Atlanta, Georgia
       </addr-line>
      </aff>
      <aff id="aff2">
       <label>
        2
       </label>
       <institution>
        Ministry of Public Health
       </institution>
       ,
       <addr-line>
        Nonthaburi, Thailand
       </addr-line>
      </aff>
      <aff id="aff3">
       <label>
        3
       </label>
       <institution>
        Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention
       </institution>
       ,
       <addr-line>
        Atlanta, Georgia
       </addr-line>
      </aff>
      <aff id="aff4">
       <label>
        4
       </label>
       <institution>
        Department of Disease Control, Ministry of Public Health
       </institution>
       ,
       <addr-line>
        Nonthaburi, Thailand
       </addr-line>
      </aff>
      <aff id="aff5">
       <label>
        5
       </label>
       <institution>
        Centers for Disease Control, Academia Sinica
       </institution>
       ,
       <addr-line>
        Taipei, Taiwan
       </addr-line>
      </aff>
      <aff id="aff6">
       <label>
        6
       </label>
       <institution>
        Institute of Biomedical Sciences, Academia Sinica
       </institution>
       ,
       <addr-line>
        Taipei, Taiwan
       </addr-line>
      </aff>
      <author-notes>
       <corresp id="cor1">
        Reprints or correspondence: Dr. Scott F. Dowell, International Emerging Infections Program, Dept. of Disease Control, Bldg. 7, Ministry of Public Health, Tivanon Rd., Nonthaburi 11000, Thailand (
        <email>
         scottd@tuc.or.th
        </email>
        ).
       </corresp>
      </author-notes>
      <pub-date pub-type="ppub">
       <day>
        1
       </day>
       <month>
        9
       </month>
       <year>
        2004
       </year>
      </pub-date>
      <pub-date iso-8601-date="2004-09-01" pub-type="epub">
       <day>
        1
       </day>
       <month>
        9
       </month>
       <year>
        2004
       </year>
      </pub-date>
      <pub-date pub-type="pmc-release">
       <day>
        1
       </day>
       <month>
        9
       </month>
       <year>
        2004
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>
       39
      </volume>
      <issue>
       5
      </issue>
      <fpage>
       652
      </fpage>
      <lpage>
       657
      </lpage>
      <history>
       <date date-type="received">
        <day>
         15
        </day>
        <month>
         2
        </month>
        <year>
         2004
        </year>
       </date>
       <date date-type="accepted">
        <day>
         31
        </day>
        <month>
         3
        </month>
        <year>
         2004
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © 2004 by the Infectious Diseases Society of America
       </copyright-statement>
       <copyright-year>
        2004
       </copyright-year>
       <license>
        <license-p>
         This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
        </license-p>
       </license>
      </permissions>
      <self-uri xlink:href="39-5-652.pdf">
      </self-uri>
      <abstract>
       <title>
        Abstract
       </title>
       <p>
        <bold>
         <italic>
          Background.
         </italic>
        </bold>
        Health care workers continued to contract severe acute respiratory syndrome (SARS), even after barrier precautions were widely implemented.
       </p>
       <p>
        <bold>
         <italic>
          Methods.
         </italic>
        </bold>
        We explored the possible contribution of contaminated hospital surfaces to SARS transmission by swabbing surfaces in 2 hospitals and testing the swab samples by reverse-transcriptase polymerase chain reaction (RT-PCR) and viral culture.
       </p>
       <p>
        <bold>
         <italic>
          Results.
         </italic>
        </bold>
        Twenty-six of 94 swab samples tested positive for viral RNA. Swab samples of respiratory secretions from each of the 4 patients examined tested positive by RT-PCR, as were 12 of 43 swabs from patient rooms and 10 of 47 swabs from other parts of the hospital, including the computer mouses at 2 nursing stations and the handrail of the public elevator. Specimens from areas with patients with SARS in the most infectious phase of illness (days 5–15 after onset) were more likely to be RNA positive than were swab specimens from elsewhere (24 of 63 samples vs. 2 of 31 samples;
        <italic>
         P
        </italic>
        = .001). All cultures showed no growth.
       </p>
       <p>
        <bold>
         <italic>
          Conclusions.
         </italic>
        </bold>
        Although the viruses identified may have been noninfectious, health care workers should be aware that SARS coronavirus can contaminate environmental surfaces in the hospital, and fomites should be considered to be a possible mode of transmission of SARS.
       </p>
      </abstract>
     </article-meta>
    </front>
    <p>
     During the 2003 outbreak of severe acute respiratory syndrome (SARS), 21% of cases worldwide were in health care workers, varying from 3% in the United States to 43% in Canada [
     <xref ref-type="bibr" rid="ref1">
      1
     </xref>
     ]. Transmission was believed to be mainly by direct physical contact with ill persons or by large-droplet spread. Several well-described clusters of infection were difficult to explain by these routes, including transmission to 22 persons on an aircraft [
     <xref ref-type="bibr" rid="ref2">
      2
     </xref>
     ], to 13 guests sharing the same floor of a hotel [
     <xref ref-type="bibr" rid="ref3">
      3
     </xref>
     ], and to &gt;300 persons in an apartment complex [
     <xref ref-type="bibr" rid="ref4">
      4
     </xref>
     ]. In addition, many health care workers were infected even after the widespread availability of recommendations on proper barrier-nursing precautions, the availability of personal protective equipment, and the apparent implementation of World Health Organization infection-control guidelines [
     <xref ref-type="bibr" rid="ref1">
      1
     </xref>
     ,
     <xref ref-type="bibr" rid="ref5">
      5
     </xref>
     ,
     <xref ref-type="bibr" rid="ref6">
      6
     </xref>
     ]. These observations led some to speculate about the possible role of more-remote transmission, including airborne spread by small droplets or true aerosols and fomite spread after contact with environmental surfaces possibly contaminated with SARS coronavirus (SARS CoV) [
     <xref ref-type="bibr" rid="ref2">
      2
     </xref>
     ,
     <xref ref-type="bibr" rid="ref6">
      6
     </xref>
     ]. Environmental contamination and fomite spread has been occasionally implicated in hospital transmission of other viruses, such as rotavirus, and bacteria, such as
     <italic>
      Entero
     </italic>
     <italic>
      bacter cloacae
     </italic>
     [
     <xref ref-type="bibr" rid="ref7">
      7
     </xref>
     ,
     <xref ref-type="bibr" rid="ref8">
      8
     </xref>
     ]. There is experimental evidence that the SARS CoV can survive for several hours on a dried microscope slide and possibly for longer in stool [
     <xref ref-type="bibr" rid="ref1">
      1
     </xref>
     ,
     <xref ref-type="bibr" rid="ref9">
      9
     </xref>
     ], but the extent to which environmental surfaces were contaminated with SARS CoV during the course of the actual outbreak has not been described.
    </p>
    <sec id="sec1" sec-type="methods">
     <title>
      Methods
     </title>
     <p>
      Samples were obtained from surfaces in 2 hospitals, one in Bangkok, Thailand (hospital A), and the other in Taipei, Taiwan (hospital B). Information about the SARS CoV infection status of the patients and the clinical stage of illness at the time of swabbing was recorded.
     </p>
     <p>
      Hospital A was the main designated SARS hospital for the Thai Ministry of Public Health and provided care for several patients with suspected SARS, including one who had SARS CoV infection confirmed by positive culture results, seroconversion, and positive RT-PCR results using multiple primer sets on different samples. This patient died on 29 March 2003 (day 18 after fever onset) after multiple attempts at resuscitation, and environmental swabs were obtained from surfaces in his room and in the nurses' station within 2 h after the death and before any postmortem cleaning of the room or body was performed. At the time of sampling, health care workers in hospital A were consistently using full personal protective equipment, segregating the patient room from other parts of the ward, and consistently applying an effective disinfectant with use of procedures recommended in the most recent Healthcare Infection Control Practices Advisory Committee guidelines [
      <xref ref-type="bibr" rid="ref10">
       10
      </xref>
      ].
     </p>
     <p>
      Hospital B, in Taipei, was the origin of the major outbreak of SARS in Taiwan [
      <xref ref-type="bibr" rid="ref11">
       11
      </xref>
      ]. This 500-bed municipal facility consists of 2 buildings connected by a walkway. On 24 April 2003, the hospital was hastily closed after recognizing an ongoing widespread nosocomial outbreak of SARS among health care workers and patients. All patients, visitors, and health care workers were quarantined, and all patients with recognized cases of SARS were cohorted on the sixth and eighth floors of building 1. On 28 April and 1 May, swab samples were obtained from surfaces on these 2 floors, where more than two-dozen patients with SARS were housed. Swab samples were also obtained from the medical intensive care unit on the fifth floor in building 2, where a single patient in his second week of illness was housed, and from the first floor of building 1, including a public lobby area that served as a SARS-response coordinating center and transfer station and the emergency room department where patients with possible SARS were evaluated and triaged. At the time of swabbing, health care workers in hospital B were using personal protective equipment inconsistently, and ventilation standards and environmental cleaning as recommended by the available guidelines were being established but were not consistently applied [
      <xref ref-type="bibr" rid="ref10">
       10
      </xref>
      ]. Patients from each of the 5 rooms that were swabbed were confirmed as having SARS CoV infection at some time during the course of their illness, either by RT-PCR, neutralizing antibody testing, or both. The day of illness on which these patients were confirmed as having SARS CoV infection ranged from day 5, for the patient in room 618, to day 12, for the patient in room 5303. Patients remained in the rooms when the surfaces were swabbed.
     </p>
     <p>
      At the time of the first round of swabbing on 28 April 2003, the entire hospital had been contained for 5 days, a cordon of police officers had quarantined the hospital, and a total of 44 SARS cases had been reported among health care workers. The air conditioner had been turned off, the laundry and garbage removal services were not able to function, and there were early problems with the supply and distribution of personal protective equipment. In this chaotic environment, some hospital workers were observed wearing the same pair of gloves to care for multiple patients, patients with SARS were transported in the main elevators for radiography and other procedures, and family members quarantined inside the hospital continued to provide personal care for some patients with SARS.
     </p>
     <p>
      Surfaces for swabbing were selected sequentially, beginning with the surfaces believed to be least likely to harbor virus and working towards those surfaces more likely to be contaminated, to minimize the possibility of cross-contamination. Procedures for swabbing were similar though not identical for the 3 sampling events. Personnel doing the swabbing were dressed in full protective clothing, including N-95 respirator, surgical head-and-neck hood, operating gown, clean outer plastic gown, 2 layers of disposable foot covering, and 2 sets of latex gloves. Meticulous care was taken to avoid cross-contamination of swabs. Each set of sterile swabs was opened separately, and viral transport media was closed and the used swab discarded before proceeding to the next surface. A new set of outer gloves was used for each new sample, and outer gowns were changed between rooms. A circular area ∼5 cm in diameter was swabbed with a sterile Dacron or cotton applicator moistened in viral transport media. The applicators were then twirled in a screw top vial, pressed against the side, and discarded.
     </p>
     <p>
      The vials of viral transport media were brought in a portable cooler on wet ice, removed for the duration of swabbing (∼30 min), placed back in the cooler, and then returned to a -70°C freezer within 90 min after swabbing. The samples were then collected, labeled, packaged, and shipped on dry ice within 7 days after swabbing, according to guidelines issued by the International Air Transport Association.
     </p>
     <p>
      Swabs were tested by RT-PCR [
      <xref ref-type="bibr" rid="ref12">
       12
      </xref>
      ] and viral culture [
      <xref ref-type="bibr" rid="ref13">
       13
      </xref>
      ] in separate laboratories, according to previously published methods. Specimens from Thailand and the samples collected on 28 April in Taiwan were tested in the United States at the Centers for Disease Control and Prevention (CDC; Atlanta, GA), and swabs obtained on 1 May were tested at the Centers for Disease Control in Taipei, Taiwan, using similar methods. In brief, aliquots of viral transport medium were inoculated onto Vero E6 cells and incubated for 2 weeks, with periodic examination for cytopathic effect. Real-time RT-PCR was conducted with use of 3 primer/probe sets complimentary to independent targets on the SARS CoV genome. Each run included a positive control and negative water controls for both RNA extraction and amplification steps. Samples were considered to be PCR-positive if there were positive results for ⩾2 of the 3 RT-PCR targets. To assess for the presence of RT-PCR inhibitors in the samples, all samples were also tested using a primer/probe set complimentary to the 16s ribosomal RNA included in the reaction mixture. Confirmatory analysis of samples that tested positive for SARS CoV was performed in an independent laboratory using 3 different primer/probe sets, and all samples with positive RT-PCR results were retested from new extracts of a previously unopened aliquot from the original sample. PCR products were sequenced and compared with the sequence of the strain of SARS CoV cultured in the laboratory.
     </p>
     <p>
      Analysis was primarily descriptive. We defined “areas with patients in the most infectious phase” as those areas, including hospital rooms or the associated nursing stations, where there were patients with confirmed SARS CoV infection who had been ill for 5–15 days [
      <xref ref-type="bibr" rid="ref9">
       9
      </xref>
      ]. χ
      <sup>
       2
      </sup>
      tests were used for comparison of proportions, and a
      <italic>
       P
      </italic>
      value of &lt;.05 was considered to be significant.
     </p>
    </sec>
    <sec id="sec2" sec-type="results">
     <title>
      Results
     </title>
     <p>
      One of 18 swabs from hospital A in Bangkok tested positive for SARS CoV, as were 16 of 28 swabs collected at hospital B in Taipei on 28 April and 9 of 48 swabs collected at hospital B in Taipei on 1 May (
      <xref ref-type="fig" rid="tab1 tab3">
       table 1–3
      </xref>
      ). Swab samples of the respiratory secretions of 4 patients were obtained during this exercise, and each patient had ⩾1 swab sample with a positive test result, including 3 swab samples from endotracheal tubes of living patients and 1 swab sample from the nasopharynx of a deceased person obtained &lt;2 h after death. Swab samples with positive test results were obtained from 12 (28%) of 43 surfaces in patient rooms but were also obtained from 10 (21%) of 47 surfaces elsewhere in the hospital (
      <italic>
       P
      </italic>
      = .5).
     </p>
     <fig id="tab1" orientation="portrait" position="float">
      <label>
       Table 1
      </label>
      <caption>
       <p>
        Results of RT-PCR of environmental and patient swab samples obtained from hospital A in Thailand within 2 h after the death of a patient with severe acute respiratory syndrome (SARS).
       </p>
      </caption>
      <graphic xlink:href="39-5-652-tbl001">
      </graphic>
     </fig>
     <fig id="tab3" orientation="portrait" position="float">
      <label>
       Table 3
      </label>
      <caption>
       <p>
        Results of RT-PCR of environmental swab samples obtained on 1 May 2003 from hospital B in Taiwan in which numerous patients with severe acute respiratory syndrome (SARS) were being treated.
       </p>
      </caption>
      <graphic xlink:href="39-5-652-tbl003">
      </graphic>
     </fig>
     <p>
      Viral genome was detected in 24 of 63 samples obtained from areas with patients in the most infectious phase of SARS, which included the patient rooms, nursing stations, and the emergency department of hospital B in Taiwan. On the other hand, only 2 of 31 samples from the public areas of hospital B and from hospital A in Thailand tested positive (
      <italic>
       P
      </italic>
      = .001). Patients with SARS were present only transiently in the public areas of hospital B, and the samples from the patient in Thailand were obtained on day 18 after the onset of fever.
     </p>
     <p>
      All swabs had cultures that showed no growth. The results of sequencing of the PCR products from Taiwan indicated that these strains were genetically distinct from the strain of SARS CoV routinely used in the CDC laboratory in the United States. All water and swab negative controls had negative RT-PCR results, and all samples had detectable 16S ribosomal RNA, indicating that false-negative results caused by RT-PCR inhibition were unlikely.
     </p>
    </sec>
    <sec id="sec3" sec-type="discussion">
     <title>
      Discussion
     </title>
     <p>
      We found evidence of SARS CoV contaminating a variety of environmental surfaces in some hospital settings but not others. These findings are consistent with observations from previous work with human coronaviruses that these agents can survive on dried inert surfaces and are consistent with proposals that contaminated fomites or hospital surfaces might contribute to spread [
      <xref ref-type="bibr" rid="ref14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="ref15">
       15
      </xref>
      ]. Surface contamination with infectious virus could explain transmission to health care workers who used appropriate barrier and airborne precautions when working directly with patients but not when working in other parts of the hospital, and it could explain some transmission to persons without close contact exposures to patients with SARS.
     </p>
     <p>
      The presence of SARS CoV RNA on surfaces is clearly a concern. These data provide a reminder that surfaces can be easily contaminated, especially under stressful and chaotic situations. Surface contamination may occur by direct landing of droplets expelled during patient coughing or sneezing or as a result of indirect transfer from hands contaminated with excreted virus. The risk of contaminating surfaces with SARS CoV should be emphasized in guidelines for hand washing practices and for the safe removal and disposal of personal protective equipment when leaving areas potentially contaminated with SARS CoV. It also suggests that monitoring and reinforcing strict compliance with infection-control practices should be part of SARS prevention strategies [
      <xref ref-type="bibr" rid="ref10">
       10
      </xref>
      ]. Additionally, the possibility of environmental contamination following emergency resuscitation procedures and other events where infection-control practices may not have been followed should be addressed.
     </p>
     <p>
      The differences in the extent of surface contamination between the hospitals in Taiwan and Thailand are worth considering. The surfaces in the Taiwan hospital were swabbed at a chaotic time. The hospital had just been quarantined, and most ancillary and support services were not functioning; this is the type of setting in which one would expect that a breakdown in infection control might occur. It is reassuring that no surfaces tested positive in the hospital in Thailand, perhaps implying that, in a nonchaotic setting, attention to standard quarantine procedures minimizes surface contamination. It is, however, also possible that some of the differences in rates of PCR positivity may be due to patient-specific factors and not to differences in infection control practices. The surfaces swabbed in the Thailand hospital were located in an area that had only 1 SARS CoV—positive patient, who had died at day 18 after the onset of illness, a time when viral load would be expected to be low. In contrast, the surfaces swabbed in the Taiwan hospital were located in areas where a number of SARS CoV—infected patients with durations of illness of between 5 and 15 days, when viral shedding is expected to be at its peak [
      <xref ref-type="bibr" rid="ref9">
       9
      </xref>
      ], had received treatment.
     </p>
     <p>
      If contamination of hospital surfaces was widespread, and if the viruses were sometimes infectious, these findings might help to explain why health care workers continued to become infected long after the recommendations for strict barrier and airborne precautions were available [
      <xref ref-type="bibr" rid="ref1">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="ref5">
       5
      </xref>
      ,
      <xref ref-type="bibr" rid="ref14">
       14
      </xref>
      ]. It is important to distinguish between the availability of appropriate recommendations for infection-control and their consistent application. In the early days after recognition of the outbreak in the Taiwan hospital, SARS and general infection control guidelines were not consistently applied, and if protective equipment, environmental controls, and appropriate hand hygiene had been consistently applied [
      <xref ref-type="bibr" rid="ref10">
       10
      </xref>
      ], it is likely that any impact from possible environmental contamination would have been minimized.
     </p>
     <p>
      We emphasize that none of the specimens was culture positive, indicating the possibility that what we identified was noninfectious viral genome in many, most, or all of the cases. It is also possible that there was viable virus on the surfaces but that it failed to grow after the initial handling, inconsistent refrigeration, or prolonged shipping time to the laboratories in Atlanta and Taipei. Other investigators have demonstrated that SARS CoV can survive dried on microscope slides for several hours and that viable virus can be cultured even after several days in a moist or stable environment, such as in stool samples [
      <xref ref-type="bibr" rid="ref1">
       1
      </xref>
      ].
     </p>
     <p>
      Although the number of surfaces contaminated outside of the areas associated with patients with SARS was low, we did detect virus in the public elevator, and there appeared to be more contamination of surfaces in the nursing stations on both the sixth and eighth floors of the hospital in Taiwan. Comparisons of the proportion of swab samples that tested positive for SARS CoV should be interpreted with caution, because the selection of the type and number of surfaces to sample was done nonsystematically and in a chaotic environment and is therefore open to a variety of potential biases. Nevertheless, visitors and staff working in hospitals with patients who have SARS should be aware of the possibility of virus being present outside of the rooms of such patients, despite efforts to contain the spread.
     </p>
     <p>
      Current dogma holds that SARS is transmitted mainly by direct contact with ill persons and by large-droplet spread [
      <xref ref-type="bibr" rid="ref1">
       1
      </xref>
      ]. Indeed, much of the epidemiology of the SARS epidemic can be well explained by these modes of transmission [
      <xref ref-type="bibr" rid="ref16">
       16
      </xref>
      ]. Transmission by more-remote means, such as airborne routes or through contaminated fomites, has been postulated as a way of explaining unusual clusters, such as transmission aboard an aircraft [
      <xref ref-type="bibr" rid="ref2">
       2
      </xref>
      ], on a hotel floor [
      <xref ref-type="bibr" rid="ref3">
       3
      </xref>
      ], or throughout an apartment complex [
      <xref ref-type="bibr" rid="ref4">
       4
      </xref>
      ]. Contamination of environmental surfaces may play a more important role in transmission than is currently appreciated, and the epidemiologic patterns associated with transmission from fomites, if clustered in patient-care areas with a high level of traffic, such as we found here, might be difficult to distinguish from the patterns predicted by person-to-person or large-droplet spread.
     </p>
    </sec>
    <back>
     <ack>
      <title>
       Acknowledgments
      </title>
      <p>
       We acknowledge with gratitude the contributions of James A. Comer, for viral culture; Chwan-Chuen King, Ruey Jen-Su, David Wong, and James Lando, for assistance with the response in Taiwan; and the dedication of the many health care workers in both hospitals, for carrying on their work despite the real threat to their health and lives.
      </p>
      <p>
       <bold>
        <italic>
         Financial support
        </italic>
       </bold>
       . The study was conducted during an acute outbreak and had no dedicated funding, but investigators were supported by the government of Taiwan and by the US Centers for Disease Control and Prevention.
      </p>
      <p>
       <bold>
        <italic>
         Conflict of interest
        </italic>
       </bold>
       . All authors: No conflict.
      </p>
     </ack>
     <ref-list>
      <title>
       References
      </title>
      <ref id="ref1">
       <label>
        1
       </label>
       <element-citation publication-type="book">
        <collab>
         World Health Organization
        </collab>
        <source>
         Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)
        </source>
        <year>
         2003
        </year>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <publisher-name>
         World Health Organization
        </publisher-name>
       </element-citation>
      </ref>
      <ref id="ref2">
       <label>
        2
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Olsen
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Transmission of the severe acute respiratory syndrome on aircraft
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2003
        </year>
        <volume>
         349
        </volume>
        <fpage>
         2416
        </fpage>
        <lpage>
         2422
        </lpage>
        <pub-id pub-id-type="pmid">
         14681507
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref3">
       <label>
        3
       </label>
       <element-citation publication-type="journal">
        <collab>
         Centers for Disease Control Prevention
        </collab>
        <article-title>
         Update: outbreak of severe acute respiratory syndrome—worldwide, 2003
        </article-title>
        <source>
         MMWR Morb Mortal Wkly Rep
        </source>
        <year>
         2003
        </year>
        <volume>
         52
        </volume>
        <fpage>
         241
        </fpage>
        <lpage>
         6
        </lpage>
        <comment>
         248
        </comment>
        <pub-id pub-id-type="pmid">
         12680518
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref4">
       <label>
        4
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           SH
          </given-names>
         </name>
        </person-group>
        <article-title>
         The SARS epidemic in Hong Kong
        </article-title>
        <source>
         J Epidemiol Community Health
        </source>
        <year>
         2003
        </year>
        <volume>
         57
        </volume>
        <fpage>
         652
        </fpage>
        <lpage>
         4
        </lpage>
        <pub-id pub-id-type="pmid">
         12933765
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref5">
       <label>
        5
       </label>
       <element-citation publication-type="journal">
        <collab>
         Centers for Disease Control Prevention
        </collab>
        <article-title>
         Cluster of severe acute respiratory syndrome cases among protected health care workers—Toronto, Canada, April 2003
        </article-title>
        <source>
         MMWR Morb Mortal Wkly Rep
        </source>
        <year>
         2003
        </year>
        <volume>
         52
        </volume>
        <fpage>
         433
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         12807083
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref6">
       <label>
        6
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Scales
          </surname>
          <given-names>
           DC
          </given-names>
         </name>
        </person-group>
        <article-title>
         Illness in intensive care staff after brief exposure to severe acute respiratory syndrome
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2003
        </year>
        <volume>
         9
        </volume>
        <fpage>
         1205
        </fpage>
        <lpage>
         10
        </lpage>
        <pub-id pub-id-type="pmid">
         14609453
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref7">
       <label>
        7
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Widdowson
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           van Doornum
          </surname>
          <given-names>
           GJ
          </given-names>
         </name>
         <name>
          <surname>
           van der Poel
          </surname>
          <given-names>
           WH
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: investigation using both epidemiologic and microbiological methods
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <year>
         2002
        </year>
        <volume>
         23
        </volume>
        <fpage>
         665
        </fpage>
        <lpage>
         70
        </lpage>
        <pub-id pub-id-type="pmid">
         12452294
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref8">
       <label>
        8
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           WL
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           HS
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           HC
          </given-names>
         </name>
         <name>
          <surname>
           Peng
          </surname>
          <given-names>
           CT
          </given-names>
         </name>
         <name>
          <surname>
           Tsai
          </surname>
          <given-names>
           CH
          </given-names>
         </name>
        </person-group>
        <article-title>
         Outbreak investigation of nosocomial enterobacter cloacae bacteraemia in a neonatal intensive care unit
        </article-title>
        <source>
         Scand J Infect Dis
        </source>
        <year>
         2000
        </year>
        <volume>
         32
        </volume>
        <fpage>
         293
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         10879601
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref9">
       <label>
        9
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           JS
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           VC
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1767
        </fpage>
        <lpage>
         72
        </lpage>
        <pub-id pub-id-type="pmid">
         12781535
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref10">
       <label>
        10
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sehulster
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Chinn
          </surname>
          <given-names>
           RY
          </given-names>
         </name>
        </person-group>
        <article-title>
         Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)
        </article-title>
        <source>
         MMWR Recomm Rep
        </source>
        <year>
         2003
        </year>
        <volume>
         52
        </volume>
        <fpage>
         1
        </fpage>
        <lpage>
         42
        </lpage>
       </element-citation>
      </ref>
      <ref id="ref11">
       <label>
        11
       </label>
       <element-citation publication-type="journal">
        <collab>
         Centers for Disease Control Prevention
        </collab>
        <article-title>
         Severe acute respiratory syndrome—Taiwan, 2003
        </article-title>
        <source>
         MMWR Morb Mortal Wkly Rep
        </source>
        <year>
         2003
        </year>
        <volume>
         52
        </volume>
        <fpage>
         461
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         12807078
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref12">
       <label>
        12
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Emery
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Meyer
          </surname>
          <given-names>
           R
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Real-time reverse-transcriptase polymerase chain reaction assay for the SARS-associated Coronavirus
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2004
        </year>
        <volume>
         10
        </volume>
        <fpage>
         311
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         15030703
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref13">
       <label>
        13
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ksiazek
          </surname>
          <given-names>
           TG
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Goldsmith
          </surname>
          <given-names>
           CS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A novel coronavirus associated with severe acute respiratory syndrome
        </article-title>
        <source>
         N Engl J Med
        </source>
        <year>
         2003
        </year>
        <volume>
         348
        </volume>
        <fpage>
         1953
        </fpage>
        <lpage>
         66
        </lpage>
        <pub-id pub-id-type="pmid">
         12690092
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref14">
       <label>
        14
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           MW
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           PJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source of hospital-acquired infections
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <year>
         2000
        </year>
        <volume>
         46
        </volume>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="pmid">
         11023724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref15">
       <label>
        15
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ijaz
          </surname>
          <given-names>
           MK
          </given-names>
         </name>
         <name>
          <surname>
           Brunner
          </surname>
          <given-names>
           AH
          </given-names>
         </name>
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Nair
          </surname>
          <given-names>
           RC
          </given-names>
         </name>
         <name>
          <surname>
           Johnson-Lussenburg
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival characteristics of airborne human coronavirus 229E
        </article-title>
        <source>
         J Gen Virol
        </source>
        <year>
         1985
        </year>
        <volume>
         66
        </volume>
        <fpage>
         2743
        </fpage>
        <lpage>
         8
        </lpage>
        <pub-id pub-id-type="pmid">
         2999318
        </pub-id>
       </element-citation>
      </ref>
      <ref id="ref16">
       <label>
        16
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           WH
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           RW
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)
        </article-title>
        <source>
         Lancet
        </source>
        <year>
         2003
        </year>
        <volume>
         361
        </volume>
        <fpage>
         1519
        </fpage>
        <lpage>
         20
        </lpage>
        <pub-id pub-id-type="pmid">
         12737864
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
    </back>
    <floats-group>
     <fig id="tab2" orientation="portrait" position="float">
      <label>
       Table 2
      </label>
      <caption>
       <p>
        Results of RT-PCR of environmental swab samples obtained on 28 April 2003 from hospital B in Taiwan in which numerous patients with severe acute respiratory syndrome (SARS) were being treated.
       </p>
      </caption>
      <graphic xlink:href="39-5-652-tbl002">
      </graphic>
     </fig>
    </floats-group>
   </article>
   <article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       J Infect
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       J. Infect
      </journal-id>
      <journal-title-group>
       <journal-title>
        The Journal of Infection
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0163-4453
      </issn>
      <issn pub-type="epub">
       1532-2742
      </issn>
      <publisher>
       <publisher-name>
        The British Infection Association. Published by Elsevier Ltd.
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       23072791
      </article-id>
      <article-id pub-id-type="pmc">
       7112628
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0163-4453(12)00288-5
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.jinf.2012.10.002
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="au1">
        <name>
         <surname>
          Chan
         </surname>
         <given-names>
          Jasper F.W.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au2">
        <name>
         <surname>
          Li
         </surname>
         <given-names>
          Kenneth S.M.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au3">
        <name>
         <surname>
          To
         </surname>
         <given-names>
          Kelvin K.W.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au4">
        <name>
         <surname>
          Cheng
         </surname>
         <given-names>
          Vincent C.C.
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au5">
        <name>
         <surname>
          Chen
         </surname>
         <given-names>
          Honglin
         </given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au6">
        <name>
         <surname>
          Yuen
         </surname>
         <given-names>
          Kwok-Yung
         </given-names>
        </name>
        <email>
         kyyuen@hkucc.hku.hk
        </email>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
        <xref ref-type="corresp" rid="cor1">
         ∗
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        a
       </label>
       State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Queen Mary Hospital, Hong Kong
      </aff>
      <aff id="aff2">
       <label>
        b
       </label>
       Department of Microbiology, The University of Hong Kong, Queen Mary Hospital, Hong Kong
      </aff>
      <aff id="aff3">
       <label>
        c
       </label>
       Research Centre of Infection and Immunology, The University of Hong Kong, Queen Mary Hospital, Hong Kong
      </aff>
      <author-notes>
       <corresp id="cor1">
        <label>
         ∗
        </label>
        Corresponding author. Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong. Tel.: +852 22554892; fax: +852 28551241.
        <email>
         kyyuen@hkucc.hku.hk
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        13
       </day>
       <month>
        10
       </month>
       <year>
        2012
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <month>
        12
       </month>
       <year>
        2012
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        13
       </day>
       <month>
        10
       </month>
       <year>
        2012
       </year>
      </pub-date>
      <volume>
       65
      </volume>
      <issue>
       6
      </issue>
      <fpage>
       477
      </fpage>
      <lpage>
       489
      </lpage>
      <history>
       <date date-type="accepted">
        <day>
         5
        </day>
        <month>
         10
        </month>
        <year>
         2012
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        Copyright © 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2012
       </copyright-year>
       <copyright-holder>
        The British Infection Association
       </copyright-holder>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract>
       <title>
        Summary
       </title>
       <p>
        Fouchier et al. reported the isolation and genome sequencing of a novel coronavirus tentatively named “human betacoronavirus 2c EMC/2012 (HCoV-EMC)” from a Saudi patient presenting with pneumonia and renal failure in June 2012. Genome sequencing showed that this virus belongs to the group C species of the genus betacoronavirus and phylogenetically related to the bat coronaviruses HKU4 and HKU5 previously found in lesser bamboo bat and Japanese Pipistrelle bat of Hong Kong respectively. Another patient from Qatar with similar clinical presentation and positive RT-PCR test was reported in September 2012. We compare and contrast the clinical presentation, laboratory diagnosis and management of infection due to this novel coronavirus and that of SARS coronavirus despite the paucity of published information on the former. Since 70% of all emerging infectious pathogens came from animals, the emergence of this novel virus may represent another instance of interspecies jumping of betacoronavirus from animals to human similar to the group A coronavirus OC43 possibly from a bovine source in the 1890s and the group B SARS coronavirus in 2003 from bat to civet and human. Despite the apparently low transmissibility of the virus at this stage, research preparedness against another SARS-like pandemic is an important precautionary strategy.
       </p>
      </abstract>
      <kwd-group>
       <title>
        Keywords
       </title>
       <kwd>
        Coronavirus
       </kwd>
       <kwd>
        Novel
       </kwd>
       <kwd>
        Human betacoronavirus 2c EMC/2012
       </kwd>
       <kwd>
        SARS
       </kwd>
       <kwd>
        Pneumonia
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <sec id="sec1">
     <title>
      Introduction and the evolution of events
     </title>
     <p id="p0010">
      In 2003, the world witnessed the first pandemic of the new millennium. Instead of the anticipated influenza virus, the pandemic was caused by, for the first time, a novel coronavirus which was subsequently named the severe acute respiratory syndrome (SARS) coronavirus (CoV).
      <xref ref-type="bibr" rid="bib1">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="bib2">
       2
      </xref>
      ,
      <xref ref-type="bibr" rid="bib3">
       3
      </xref>
      ,
      <xref ref-type="bibr" rid="bib4">
       4
      </xref>
      ,
      <xref ref-type="bibr" rid="bib5">
       5
      </xref>
      ,
      <xref ref-type="bibr" rid="bib6">
       6
      </xref>
      Within a few months, the virus caused a total of 8422 cases of SARS with 916 deaths in over 30 countries among five continents, with a crude fatality rate of around 11%.
      <xref ref-type="bibr" rid="bib7">
       <sup>
        7
       </sup>
      </xref>
      The outbreak had left a lasting impact not only in the lives of those who were infected, but also the frontline healthcare workers, public health officials, and even general public. To many, the slightest hint of the potential re-emergence of SARS would be the beginning of another nightmare. On 23 September 2012, less than a decade after the SARS pandemic, the World Health Organization (WHO) reported two cases of severe community-acquired pneumonia which bear significant reminisce with SARS (
      <xref ref-type="table" rid="tbl1">
       Table 1
      </xref>
      ).
      <xref ref-type="bibr" rid="bib8">
       8
      </xref>
      ,
      <xref ref-type="bibr" rid="bib9">
       9
      </xref>
      ,
      <xref ref-type="bibr" rid="bib10">
       10
      </xref>
      ,
      <xref ref-type="bibr" rid="bib11">
       11
      </xref>
      ,
      <xref ref-type="bibr" rid="bib12">
       12
      </xref>
      ,
      <xref ref-type="bibr" rid="bib13">
       13
      </xref>
      Subsequent laboratory tests revealed a novel human coronavirus, the human betacoronavirus 2c EMC/2012 (HCoV-EMC).
      <xref ref-type="bibr" rid="bib14">
       14
      </xref>
      ,
      <xref ref-type="bibr" rid="bib15">
       15
      </xref>
      <table-wrap id="tbl1" position="float">
       <label>
        Table 1
       </label>
       <caption>
        <p>
         Sequence of important events related to human betacoronavirus 2c EMC/2012 (HCoV-EMC).
         <xref ref-type="bibr" rid="bib8">
          8
         </xref>
         ,
         <xref ref-type="bibr" rid="bib9">
          9
         </xref>
         ,
         <xref ref-type="bibr" rid="bib10">
          10
         </xref>
         ,
         <xref ref-type="bibr" rid="bib11">
          11
         </xref>
         ,
         <xref ref-type="bibr" rid="bib12">
          12
         </xref>
         ,
         <xref ref-type="bibr" rid="bib13">
          13
         </xref>
         ,
         <xref ref-type="bibr" rid="bib14">
          14
         </xref>
         ,
         <xref ref-type="bibr" rid="bib15">
          15
         </xref>
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
          </th>
          <th>
           Important events
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td>
           19 Apr 2012
          </td>
          <td>
           Ministry of Health in Jordan reported an outbreak (11 patients: 7 nurses &amp; 1 doctor) of severe respiratory disease in a hospital ICU in Zarga, Jordan
           <break>
           </break>
           One nurse died; no virological confirmation yet
          </td>
         </tr>
         <tr>
          <td>
           26 Apr 2012
          </td>
          <td>
           The ECDC reported the outbreak in Jordan
          </td>
         </tr>
         <tr>
          <td>
           6 Jun 2012
          </td>
          <td>
           Case 1: M/60 in Jeddah, KSA, presented with acute community-acquired pneumonia
          </td>
         </tr>
         <tr>
          <td>
           13 Jun 2012
          </td>
          <td>
           Case 1: Admitted to a regional hospital for severe pneumonia, and later developed acute renal failure
          </td>
         </tr>
         <tr>
          <td>
           24 Jun 2012
          </td>
          <td>
           Case 1: The patient died. Post-mortem lung tissue was negative for flu A/B, PIF, enteroviruses, adenoviruses; positive for coronavirus by pancoronavirus RT-PCR. EMC: sequencing showed evidence of a novel betacoronavirus
          </td>
         </tr>
         <tr>
          <td>
           13 Jul-18 Aug 2012
          </td>
          <td>
           Case 2: M/49 in Qatar, good past health, travelled to KSA, had self-limiting respiratory illness (rhinorrhoea and fever) along with his friends. Kept camels and sheep in a farm in Qatar
          </td>
         </tr>
         <tr>
          <td>
           21 Jul-3 Aug 2012
          </td>
          <td>
           Case 2: Remained clinically well after recovering from the mild respiratory illness
          </td>
         </tr>
         <tr>
          <td>
           3 Sep 2012
          </td>
          <td>
           Case 2: Developed cough, myalgia and arthralgia
          </td>
         </tr>
         <tr>
          <td>
           8 Sep 2012
          </td>
          <td>
           Case 2: Admitted to an ICU in Doha, Qatar, for fever and hypoxia, CXR: bilateral lower zone consolidation; Rx: ceftriaxone, azithromycin, oseltamivir
          </td>
         </tr>
         <tr>
          <td>
           11 Sep 2012
          </td>
          <td>
           Case 2: Required mechanical ventilation and was transferred to ICU in UK by air ambulance. Cr 353umol/L on admission. Deterioration despite broad-spectrum antimicrobials and corticosteroids
          </td>
         </tr>
         <tr>
          <td>
           14 Sep 2012
          </td>
          <td>
           Case 2: HPA (UK) Imported Fever Service notified. Haemofiltration started
          </td>
         </tr>
         <tr>
          <td>
           17–20 Sep 2012
          </td>
          <td>
           Case 2: URT and LRT samples were negative for flu A/B, hMPV, RSV, human coronaviruses OC43, NL63, 229E, and SARS CoV
          </td>
         </tr>
         <tr>
          <td>
           20 Sep 2012
          </td>
          <td>
           Case 1: Reported to the WHO through ProMED-mail. Case 2: ECMO started
          </td>
         </tr>
         <tr>
          <td>
           21 Sep 2012
          </td>
          <td>
           Case 2: 2 LRT samples were positive for coronavirus by pancoronavirus RT-PCR with amplicon sequence almost identical to case 1
          </td>
         </tr>
         <tr>
          <td>
           22 Sep 2012
          </td>
          <td>
           Case 2: Reported to the WHO by the HPA (UK)
          </td>
         </tr>
         <tr>
          <td>
           23 Sep 2012
          </td>
          <td>
           The WHO reported 2 laboratory-confirmed cases of severe respiratory disease associated with a novel coronavirus. The nucleotide BLAST search: 80% homology to bat coronaviruses HKU-4 and HKU-5. Their 250 bp PCR fragment showed 99.5% sequence homology (1 nucleotide difference)
          </td>
         </tr>
         <tr>
          <td>
           24 Sep 2012
          </td>
          <td>
           ECDC recommendation on the rapid risk assessment of severe respiratory disease associated with a novel coronavirus published
           <break>
           </break>
           Case 2: The HPA (UK) reported no illness among contacts of case 2, including healthcare workers and the medical evacuation company personnel who managed case 2 on their follow up
          </td>
         </tr>
         <tr>
          <td>
           25 Sep 2012
          </td>
          <td>
           WHO issued an interim case definition for severe respiratory disease associated with the novel coronavirus (
           <xref ref-type="table" rid="tbl2">
            Table 2
           </xref>
           )
          </td>
         </tr>
         <tr>
          <td>
           26 Sep 2012
          </td>
          <td>
           The HPA (UK) issued infection control advice for suspected or confirmed novel coronavirus cases
          </td>
         </tr>
         <tr>
          <td>
           27 Sep 2012
          </td>
          <td>
           Complete genome of the novel coronavirus, human betacoronavirus 2c EMC/2012, was available in the GenBank (accession number: JX869059)
          </td>
         </tr>
         <tr>
          <td>
           28 Sep 2012
          </td>
          <td>
           The HPA (UK) issued algorithms for investigation and management of possible cases and close contacts of confirmed cases of severe acute respiratory illness associated with the novel coronavirus
          </td>
         </tr>
         <tr>
          <td>
           29 Sep 2012
          </td>
          <td>
           The WHO issued a revised interim case definition for severe respiratory disease associated with the novel coronavirus (
           <xref ref-type="table" rid="tbl2">
            Table 2
           </xref>
           )
          </td>
         </tr>
         <tr>
          <td>
           2 Oct 2012
          </td>
          <td>
           Case 2: Remained stable but fully dependent on ECMO
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          CXR, chest radiograph; Cr, creatinine; ECDC, European Centre for Disease Prevention and Control; ECMO, extracorporeal membrane oxygenation; EMC, Erasmus Medical Center; flu, influenza; hMPV, human metapneumovirus; HPA, Health Protection Agency; ICU, intensive care unit; KSA, the Kingdom of Saudi Arabia; LRT, lower respiratory tract; M, male; PIF, parainfluenza; RSV, respiratory syncytial virus; RT-PCR, reverse transcription-polymerase chain reaction; Rx, treatment; SARS CoV, severe acute respiratory syndrome coronavirus; UK, the United Kingdom; URT, upper respiratory tract.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
     </p>
     <p id="p0015">
      The emergence of these two cases of HCoV-EMC infection at this stage may represent one of the four possible scenarios. Firstly, HCoV-EMC may be similar to the seasonal human coronavirus HKU1 which was detected in less than 5% of samples from those with respiratory tract infections while 22%–59.2% of the general population is seropositive due to mild or asymptomatic infections in the past.
      <xref ref-type="bibr" rid="bib16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib18">
       18
      </xref>
      ,
      <xref ref-type="bibr" rid="bib19">
       19
      </xref>
      ,
      <xref ref-type="bibr" rid="bib20">
       20
      </xref>
      ,
      <xref ref-type="bibr" rid="bib21">
       21
      </xref>
      ,
      <xref ref-type="bibr" rid="bib22">
       22
      </xref>
      Even human coronavirus HKU1 was occasionally associated with mortality in those with underlying multiple co-morbidities who presented with acute community-acquired pneumonia.
      <xref ref-type="bibr" rid="bib23">
       <sup>
        23
       </sup>
      </xref>
      Therefore these two severe cases of HCoV-EMC may just represent the tip of an iceberg due to another previously unknown seasonal coronavirus. Secondly, it may be analogous to the situation of avian influenza H5N1 in which there are occasional transmissions of the virus from poultry to humans manifesting with severe disease and a mortality of over 50%.
      <xref ref-type="bibr" rid="bib24">
       24
      </xref>
      ,
      <xref ref-type="bibr" rid="bib25">
       25
      </xref>
      ,
      <xref ref-type="bibr" rid="bib26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="bib27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="bib28">
       28
      </xref>
      ,
      <xref ref-type="bibr" rid="bib29">
       29
      </xref>
      ,
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      ,
      <xref ref-type="bibr" rid="bib31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="bib32">
       32
      </xref>
      ,
      <xref ref-type="bibr" rid="bib33">
       33
      </xref>
      ,
      <xref ref-type="bibr" rid="bib34">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="bib35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="bib36">
       36
      </xref>
      Thirdly, this is a rare instance of a few isolated zoonotic infections which are dead-ends. The fourth situation, the most dangerous one, is that this is the beginning of another SARS-like pandemic in which there will be increasing animal-to-human and subsequent human-to-human transmissions. When the suitable environmental conditions and opportunities for transmission associated with lapse in biosafety and infection control measures are present, the virus may cause an explosive outbreak as in the case of SARS. It would therefore be important to review the current knowledge on the clinical features, epidemiology, virology, and laboratory diagnosis of this novel coronavirus, and most importantly, to formulate possible treatment options and infection control measures based on comparisons made with other coronaviruses including SARS CoV.
     </p>
    </sec>
    <sec id="sec2">
     <title>
      Taxonomy and virology
     </title>
     <p id="p0020">
      There are four genera in the family
      <italic>
       Coronaviridae
      </italic>
      within the order
      <italic>
       Nidovirales
      </italic>
      (
      <xref ref-type="fig" rid="fig1">
       Fig. 1
      </xref>
      A).
      <xref ref-type="bibr" rid="bib37">
       <sup>
        37
       </sup>
      </xref>
      The genus alphacoronavirus contains the human coronavirus 229E and NL63 which are associated with common cold, and the genera gammacoronavirus and deltacoronavirus which contain viruses that affect only animals especially the avian species. The genus betacoronavirus contains four groups. Group A contains human coronavirus OC43, which is associated with respiratory tract infections. Group B contains SARS-CoV, which is associated with severe pneumonia. HCoV-EMC belongs to the group C betacoronavirus. Group D betacoronavirus contains the Rousettus bat coronavirus HKU9. Members of
      <italic>
       Coronaviridae
      </italic>
      are known causes of respiratory, intestinal, hepatic and neurological diseases of varying severity in humans and animals. Similar to other coronaviruses, HCoV-EMC is an enveloped positive-sense single-stranded RNA virus with a genome size of about 30 kb. It is classified as a group 2c coronavirus by previous nomenclature, and was named as such by the Erasmus Medical Center in Rotterdam, the Netherlands, which was the first institution to sequence the viral genome. It is most closely related to the bat coronaviruses HKU4 and HKU5 found in the lesser bamboo bats (
      <italic>
       Tylonycteris pachypus
      </italic>
      ) (
      <xref ref-type="fig" rid="fig2">
       Fig. 2
      </xref>
      A and B) and Japanese Pipistrelle bat (
      <italic>
       Pipistrellus abramus
      </italic>
      ) (
      <xref ref-type="fig" rid="fig2">
       Fig. 2
      </xref>
      C and D) respectively as shown in the phylogenetic tree (
      <xref ref-type="fig" rid="fig1">
       Fig. 1
      </xref>
      A).
      <xref ref-type="bibr" rid="bib38">
       38
      </xref>
      ,
      <xref ref-type="bibr" rid="bib39">
       39
      </xref>
      As expected, their genome arrangements are also similar to those of the members of group C betacoronavirus but different from other groups.
      <xref ref-type="bibr" rid="bib40">
       <sup>
        40
       </sup>
      </xref>
      The gene order from 5′ to 3′ is Orf1ab containing the highly conserved polymerase and helicase genes, followed by the highly variable gene encoding Spike, five other accessory proteins, and then the more conserved Envelope, Membrane and Nucleoprotein (
      <xref ref-type="fig" rid="fig1">
       Fig. 1
      </xref>
      B). The polymerase gene (RdRp) of HCoV-EMC has 90–92% amino acid identity with that of bat coronaviruses HKU4 or 5 while its spike gene (S) has only 64–67% amino acid identity with that of bat coronaviruses HKU4 or 5. The environmental stability of the virus is not known at this stage but might be important in determining its potential for further dissemination. In the case of SARS CoV, the virus had a higher degree of stability in the environment than other human coronaviruses, and could survive for at least two to three days on dry surfaces at room temperature and two to four days in stool.
      <xref ref-type="bibr" rid="bib41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="bib42">
       42
      </xref>
      Further studies should be conducted to obtain the key basic virological information including its life cycle and molecular evolution in order to understand its clinical and epidemiological significance.
      <fig id="fig1">
       <label>
        Figure 1
       </label>
       <caption>
        <p>
         (A) Phylogenetic tree of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) and other coronaviruses. The tree was constructed by the neighbour-joining method using clustalX 2.0.12. The scale bar indicates the estimated number of substitutions per 20 nucleotides. ALCCoV, Asian leopard cat coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:EF584908">
          EF584908
         </ext-link>
         ); AntelopeCoV, sable antelope coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:EF424621">
          EF424621
         </ext-link>
         ); BCoV, bovine coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_003045">
          NC_003045
         </ext-link>
         ); BuCoV HKU11, bulbul coronavirus HKU11 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:FJ376619">
          FJ376619
         </ext-link>
         ); BWCoV-SW1, beluga whale coronavirus SW1 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_010646">
          NC_010646
         </ext-link>
         ); CCoV, canine coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:GQ477367">
          GQ477367
         </ext-link>
         ); CMCoV HKU21, common moorhen coronavirus HKU21 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016996">
          NC_016996
         </ext-link>
         ); ECoV, equine coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_010327">
          NC_010327
         </ext-link>
         ); FIPV, feline infectious peritonitis virus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:AY994055">
          AY994055
         </ext-link>
         ); GiCoV, giraffe coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:EF424622">
          EF424622
         </ext-link>
         ); HCoV-EMC, human betacoronavirus 2c EMC/2012; HCoV-229E, human coronavirus 229E (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_002645">
          NC_002645
         </ext-link>
         ); HCoV-HKU1, human coronavirus HKU1 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_006577">
          NC_006577
         </ext-link>
         ); HCoV-NL63, human coronavirus NL63 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_005831">
          NC_005831
         </ext-link>
         ); HCoV-OC43, human coronavirus OC43 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_005147">
          NC_005147
         </ext-link>
         ); Hi-BatCoV HKU10,
         <italic>
          Hipposideros
         </italic>
         bat coronavirus HKU10 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:JQ989269">
          JQ989269
         </ext-link>
         ); IBV, infectious bronchitis virus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_001451">
          NC_001451
         </ext-link>
         ); IBV-partridge, partridge coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:AY646283">
          AY646283
         </ext-link>
         ); IBV-peafowl, peafowl coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:AY641576">
          AY641576
         </ext-link>
         ); MHV, murine hepatitis virus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_001846">
          NC_001846
         </ext-link>
         ); Mi-BatCoV 1A,
         <italic>
          Miniopterus
         </italic>
         bat coronavirus 1A (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_010437">
          NC_010437
         </ext-link>
         ); Mi-BatCoV 1B,
         <italic>
          Miniopterus
         </italic>
         bat coronavirus 1B (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_010436">
          NC_010436
         </ext-link>
         ); Mi-BatCoV HKU8,
         <italic>
          Miniopterus
         </italic>
         bat coronavirus HKU8 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_010438">
          NC_010438
         </ext-link>
         ); MRCoV HKU18, magpie robin coronavirus HKU18 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016993">
          NC_016993
         </ext-link>
         ); MunCoV HKU13, munia coronavirus HKU13 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:FJ376622">
          FJ376622
         </ext-link>
         ); NHCoV HKU19, night heron coronavirus HKU19 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016994">
          NC_016994
         </ext-link>
         ); PEDV, porcine epidemic diarrhoea virus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_003436">
          NC_003436
         </ext-link>
         ); PHEV, porcine haemagglutinating encephalomyelitis virus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_007732">
          NC_007732
         </ext-link>
         ); Pi-BatCoV-HKU5,
         <italic>
          Pipistrellus
         </italic>
         bat coronavirus HKU5 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_009020">
          NC_009020
         </ext-link>
         ); PorCoV HKU15, porcine coronavirus HKU15 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016990">
          NC_016990
         </ext-link>
         ); PRCV, porcine respiratory coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:DQ811787">
          DQ811787
         </ext-link>
         ); RbCoV HKU14, rabbit coronavirus HKU14 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_017083">
          NC_017083
         </ext-link>
         ); RCoV, rat coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_012936">
          NC_012936
         </ext-link>
         ); Rh-BatCoV HKU2,
         <italic>
          Rhinolophus
         </italic>
         bat coronavirus HKU2 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:EF203064">
          EF203064
         </ext-link>
         ); Ro-BatCoV-HKU9,
         <italic>
          Rousettus
         </italic>
         bat coronavirus HKU9 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_009021">
          NC_009021
         </ext-link>
         ); Ro-BatCoV HKU10,
         <italic>
          Rousettus
         </italic>
         bat coronavirus HKU10 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:JQ989270">
          JQ989270
         </ext-link>
         ); SARS CoV, SARS-related human coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_004718">
          NC_004718
         </ext-link>
         ); SARSr-CiCoV, SARS-related palm civet coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:AY304488">
          AY304488
         </ext-link>
         ); SARSr CoV CFB, SARS-related Chinese ferret badger coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:AY545919">
          AY545919
         </ext-link>
         ); SARSr-Rh-BatCoV HKU3, SARS-related
         <italic>
          Rhinolophus
         </italic>
         bat coronavirus HKU3 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:DQ022305">
          DQ022305
         </ext-link>
         ); Sc-BatCoV 512,
         <italic>
          Scotophilus
         </italic>
         bat coronavirus 512 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_009657">
          NC_009657
         </ext-link>
         ); SpCoV HKU17, sparrow coronavirus HKU17 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016992">
          NC_016992
         </ext-link>
         ); TCoV, turkey coronavirus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_010800">
          NC_010800
         </ext-link>
         ); TGEV, transmissible gastroenteritis virus (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_002306">
          NC_002306
         </ext-link>
         ); ThCoV HKU12, thrush coronavirus HKU12 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:FJ376621">
          FJ376621
         </ext-link>
         ); Ty-BatCoV-HKU4,
         <italic>
          Tylonycteris
         </italic>
         bat coronavirus HKU4 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_009019">
          NC_009019
         </ext-link>
         ); WECoV HKU16, white-eye coronavirus HKU16 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016991">
          NC_016991
         </ext-link>
         ); WiCoV HKU20, wigeon coronavirus HKU20 (
         <ext-link ext-link-type="uri" xlink:href="ncbi-n:NC_016995">
          NC_016995
         </ext-link>
         ). (B) Genome organizations of members of group B and group C betacoronaviruses showing that the novel HCoV-EMC has similar genome arrangements to other group C betacoronaviruses but different from other group B betacoronaviruses. PL, papain-like protease; 3CL, chymotrypsin-like protease; RdRp, RNA-dependent RNA polymerase; Hel, helicase; S, spike; E, envelope; M, membrane; N, nucleocapsid.
        </p>
       </caption>
       <graphic xlink:href="gr1_lrg">
       </graphic>
      </fig>
      <fig id="fig2">
       <label>
        Figure 2
       </label>
       <caption>
        <p>
         (A) and (B) Lesser bamboo bat (
         <italic>
          Tylonycteris pachypus
         </italic>
         ), often found dwelling in hollows of bamboo plants in South East Asia, from which bat coronavirus HKU4 was first discovered. (C) and (D) Japanese Pipistrelle (
         <italic>
          Pipistrelle abramus
         </italic>
         ), often found at ceilings and roof tops of residential houses in South East Asia, from which bat coronavirus HKU5 was first discovered.
        </p>
       </caption>
       <graphic xlink:href="gr2_lrg">
       </graphic>
      </fig>
     </p>
    </sec>
    <sec id="sec3">
     <title>
      Clinical features and disease spectrum
     </title>
     <p id="p0025">
      The clinical presentation of both laboratory-confirmed cases of infection associated with HCoV-EMC is an acute severe community-acquired pneumonia with acute renal failure (
      <xref ref-type="table" rid="tbl1">
       Table 1
      </xref>
      ). In case 2, a preceding period of mild respiratory symptoms of fever and rhinorrhoea (from 14 August 2012 to 21 August 2012) was followed by a period of clinical stability (from 21 August 2012 to 3 Sept 2012) prior to the re-emergence of symptoms including cough, arthralgia, myalgia, and deterioration with severe pneumonia with acute renal failure. It is currently unknown whether the initial mild symptoms were caused by this novel virus, or related to another mild viral infection as no microbiological diagnosis was made. Of note, some friends of case 2 who travelled on the same trip also developed the initial mild symptoms, but all recovered without subsequent deterioration. It remains to be seen whether this novel coronavirus can cause mild infections especially as specific virological diagnostic tests are not performed routinely in most places.
     </p>
     <p id="p0030">
      From the limited clinical information released up to this stage, their clinical presentation of HCoV-EMC infection is unusual among the human coronaviruses 229E, NL63, OC43, and HKU1 which cause predominantly an acute self-limited upper respiratory tract infection without renal failure. The only exception is SARS CoV which causes an acute community- or hospital-acquired pneumonia with rapid respiratory deterioration. Besides the presenting symptoms of fever, chills, myalgia, malaise, and nonproductive cough, clinical deteriorations typically occurred one week after the onset of symptoms in SARS and were usually accompanied by watery diarrhoea.
      <xref ref-type="bibr" rid="bib5">
       5
      </xref>
      ,
      <xref ref-type="bibr" rid="bib6">
       6
      </xref>
      ,
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="bib45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="bib46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="bib47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="bib48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="bib49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="bib50">
       50
      </xref>
      ,
      <xref ref-type="bibr" rid="bib51">
       51
      </xref>
      ,
      <xref ref-type="bibr" rid="bib52">
       52
      </xref>
      ,
      <xref ref-type="bibr" rid="bib53">
       53
      </xref>
      Physical findings were indiscriminative from other causes of atypical pneumonia. Common chest radiograph findings included ground-glass opacities, focal consolidations with a predilection for involvement of the periphery and subpleural regions of the lower zones, progressive involvement of bilateral lung fields, and spontaneous pneumomediastinum.
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="bib54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="bib55">
       55
      </xref>
      ,
      <xref ref-type="bibr" rid="bib56">
       56
      </xref>
      ,
      <xref ref-type="bibr" rid="bib57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="bib58">
       58
      </xref>
      The most prominent histopathological features in SARS patients who died before and after the tenth day of symptom onset were acute diffuse alveolar damage with air space oedema, and mixture of acute changes with organizing phase of diffuse alveolar damage respectively.
      <xref ref-type="bibr" rid="bib59">
       59
      </xref>
      ,
      <xref ref-type="bibr" rid="bib60">
       60
      </xref>
      ,
      <xref ref-type="bibr" rid="bib61">
       61
      </xref>
      Less commonly, haemophagocytosis in the alveolar exudates, thrombosis of venules, secondary bacterial and fungal pneumonia,
      <xref ref-type="bibr" rid="bib62">
       <sup>
        62
       </sup>
      </xref>
      and systemic vasculitis involving the walls of small veins have also been reported.
      <xref ref-type="bibr" rid="bib63">
       <sup>
        63
       </sup>
      </xref>
      Unfortunately, the post-mortem histopathological findings in case 1 are not available for comparison at this stage.
     </p>
     <p id="p0035">
      The other unusual clinical feature observed in both cases of infection associated with HCoV-EMC was the presence of acute renal failure. Acute renal failure with histological evidence of acute tubular necrosis was present in 6.9% of patients with SARS which is possibly due to hypoxic kidney damage,
      <xref ref-type="bibr" rid="bib64">
       <sup>
        64
       </sup>
      </xref>
      and was a poor prognostic factor.
      <xref ref-type="bibr" rid="bib65">
       <sup>
        65
       </sup>
      </xref>
      However, 28.8% of SARS patients' urine had viral load detectable by quantitative reverse transcription-polymerase chain reaction (RT-PCR) which correlated with abnormal urinalysis.
      <xref ref-type="bibr" rid="bib66">
       <sup>
        66
       </sup>
      </xref>
      It would be important to know the relative contribution of the direct HCoV-EMC induced cytolysis and the indirect pneumonia-related hypoxic damage to the severity of the renal pathology. In broiler chickens suffering from infection by the avian nephropathogenic infectious bronchitis virus, severe renal swelling and accumulation of urate in the tubules were commonly seen.
      <xref ref-type="bibr" rid="bib67">
       <sup>
        67
       </sup>
      </xref>
      Histological findings included lymphoplasmacytic interstitial nephritis with characteristic tubular epithelial degeneration and sloughing. Minimal respiratory involvement was noted with this nephropathogenic coronavirus. Important differential causes of viral pneumonia with acute renal failure which should be considered when the initial sepsis work-up of a compatible case is unrevealing include hantaviruses, agents of viral haemorrhagic fever, and influenza viruses. Other extrapulmonary manifestations of SARS including lymphopenia, diarrhoea, hepatic dysfunction, diastolic cardiac impairment, pulmonary arterial thrombosis, bleeding diathesis, myositis, neuromuscular abnormalities, and epileptic fits should also be looked for in the two cases of HCoV-EMC infection.
      <xref ref-type="bibr" rid="bib43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="bib68">
       68
      </xref>
      ,
      <xref ref-type="bibr" rid="bib69">
       69
      </xref>
      ,
      <xref ref-type="bibr" rid="bib70">
       70
      </xref>
      ,
      <xref ref-type="bibr" rid="bib71">
       71
      </xref>
      ,
      <xref ref-type="bibr" rid="bib72">
       72
      </xref>
      ,
      <xref ref-type="bibr" rid="bib73">
       73
      </xref>
      ,
      <xref ref-type="bibr" rid="bib74">
       74
      </xref>
     </p>
     <p id="p0040">
      Because of the lack of knowledge on the spectrum of disease severity, the WHO's interim case definitions for case finding may only be appropriate for notification but not for frontline clinical management and triage because the initial presentation may be a milder form of acute respiratory infection with or without subsequent deterioration (
      <xref ref-type="table" rid="tbl2">
       Table 2
      </xref>
      ). In elderly and young children with SARS, atypical presentation with the absence of fever and respiratory symptoms, and mild form of infection were occasionally reported.
      <xref ref-type="bibr" rid="bib77">
       77
      </xref>
      ,
      <xref ref-type="bibr" rid="bib78">
       78
      </xref>
      ,
      <xref ref-type="bibr" rid="bib79">
       79
      </xref>
      ,
      <xref ref-type="bibr" rid="bib80">
       80
      </xref>
      ,
      <xref ref-type="bibr" rid="bib81">
       81
      </xref>
      ,
      <xref ref-type="bibr" rid="bib82">
       82
      </xref>
      Furthermore, co-infection with other causative agents of community-acquired pneumonia may lead to a false sense of security when other agents of acute respiratory disease were found as in the case of SARS when co-infection by human metapneumovirus was reported in 12.5%–66.7% of such patients.
      <xref ref-type="bibr" rid="bib53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="bib83">
       83
      </xref>
      Therefore, applying the WHO interim case definitions in the investigation of patients without individualized risk assessment may lead to a significant proportion of patients with atypical presentation, mild disease, or co-infections being missed. In order to better understand the full spectrum of clinical features, to promptly provide the necessary treatment, and to apply the appropriate infection control measures to stop further dissemination of this novel coronavirus, a working algorithm with less stringent criteria for investigation in areas where resources are available can be considered (
      <xref ref-type="fig" rid="fig3">
       Fig. 3
      </xref>
      ). In Hong Kong, we recommend to investigate patients based on an individualized risk assessment approach, in which immunocompetent adult patients who have travelled to or resided in an area where infection with HCoV-EMC has been reported, or who are close contact within the last 10 days before the onset of illness with a probable or confirmed case while the case was ill, and who present with fever and respiratory symptoms, should receive a baseline chest radiograph for assessment of lower respiratory tract involvement, urinalysis and renal function tests to detect renal impairment. In immunocompromised, elderly, and paediatric patients who may have atypical or mild forms of the infection, the decision for further investigations should be more liberal.
      <table-wrap id="tbl2" position="float">
       <label>
        Table 2
       </label>
       <caption>
        <p>
         Interim case definitions for case finding and reporting of infection associated with human betacoronavirus 2c EMC/2012 by the World Health Organization and Health Protection Agency of the United Kingdom.
         <xref ref-type="bibr" rid="bib75">
          75
         </xref>
         ,
         <xref ref-type="bibr" rid="bib76">
          76
         </xref>
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
          </th>
          <th>
           WHO (29 September 2012)
          </th>
          <th>
           HPA (26 September 2012)
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td colspan="3">
           <italic>
            Case finding
           </italic>
          </td>
         </tr>
         <tr>
          <td>
           Clinical
          </td>
          <td>
           <list id="olist0010" list-type="simple">
            <list-item id="o0010">
             <label>
              1.
             </label>
             <p id="p0110">
              A person with acute respiratory infection, which may include fever (≥38 °C, 100.4 °F) and cough; AND
             </p>
            </list-item>
            <list-item id="o0015">
             <label>
              2.
             </label>
             <p id="p0115">
              Suspicion of pulmonary parenchymal disease (e.g.: pneumonia or ARDS) based on clinical or radiological evidence of consolidation; AND
             </p>
            </list-item>
            <list-item id="o0020">
             <label>
              3.
             </label>
             <p id="p0120">
              Travel to or residence in an area (Qatar or KSA) where infection with human betacoronavirus 2c EMC/2012 has recently been reported or where transmission could have occurred; AND
             </p>
            </list-item>
            <list-item id="o0025">
             <label>
              4.
             </label>
             <p id="p0125">
              Not already explained by any other infection or aetiology, including all clinically indicated tests for community-acquired pneumonia according to local management guidelines
             </p>
            </list-item>
           </list>
          </td>
          <td>
           <list id="olist0015" list-type="simple">
            <list-item id="o0030">
             <label>
              1.
             </label>
             <p id="p0130">
              Any person with acute respiratory syndrome which includes fever (≥38 °C) or history of fever and cough; AND
             </p>
            </list-item>
            <list-item id="o0035">
             <label>
              2.
             </label>
             <p id="p0135">
              Requiring hospitalization; OR
             </p>
            </list-item>
            <list-item id="o0040">
             <label>
              3.
             </label>
             <p id="p0140">
              With suspicion of lower airway involvement (clinical or radiological evidence of consolidation) not explained by another infection or aetiology
             </p>
            </list-item>
           </list>
          </td>
         </tr>
         <tr>
          <td>
           Epidemiological
          </td>
          <td>
          </td>
          <td>
           <list id="olist0020" list-type="simple">
            <list-item id="o0045">
             <label>
              1.
             </label>
             <p id="p0145">
              Close contact during the 10 days before onset of illness with a confirmed or probable case while the case was ill; OR
             </p>
            </list-item>
            <list-item id="o0050">
             <label>
              2.
             </label>
             <p id="p0150">
              Travel to or residence in an area (Qatar or KSA) where infection with human betacoronavirus 2c EMC/2012 has recently been reported or where transmission could have occurred in the ten days before onset of illness
             </p>
            </list-item>
           </list>
          </td>
         </tr>
         <tr>
          <td colspan="3">
           <italic>
            Case reporting
           </italic>
          </td>
         </tr>
         <tr>
          <td>
           Possible
          </td>
          <td>
          </td>
          <td>
           Any person meeting the clinical and epidemiological criteria
          </td>
         </tr>
         <tr>
          <td>
           Probable
          </td>
          <td>
           <list id="olist0025" list-type="simple">
            <list-item id="o0055">
             <label>
              1.
             </label>
             <p id="p0155">
              A person fitting the definition above for case finding with clinical, radiological, or histological evidence of pulmonary parenchyma disease (e.g.: pneumonia or ARDS) but no possibility of laboratory confirmation either because the patient or samples are not available or there is no testing available for other respiratory infections, OR
             </p>
            </list-item>
            <list-item id="o0060">
             <label>
              2.
             </label>
             <p id="p0160">
              Close contact with a laboratory confirmed case, OR
             </p>
            </list-item>
            <list-item id="o0065">
             <label>
              3.
             </label>
             <p id="p0165">
              Not already explained by any other infection or aetiology, including all clinically indicated tests for community-acquired pneumonia according to local management guidelines
             </p>
            </list-item>
           </list>
          </td>
          <td>
           <list id="olist0030" list-type="simple">
            <list-item id="o0070">
             <label>
              1.
             </label>
             <p id="p0170">
              Any person meeting the possible case criteria; AND
             </p>
            </list-item>
            <list-item id="o0075">
             <label>
              2.
             </label>
             <p id="p0175">
              Negative results for seasonal respiratory virus screen
             </p>
            </list-item>
           </list>
          </td>
         </tr>
         <tr>
          <td>
           Confirmed
          </td>
          <td>
           A person with laboratory confirmation of infection with human betacoronavirus 2c EMC/2012
          </td>
          <td>
           Any person with positive laboratory confirmation of infection with human betacoronavirus 2c EMC/2012
          </td>
         </tr>
         <tr>
          <td>
           Closed contact
          </td>
          <td>
           <list id="olist0035" list-type="simple">
            <list-item id="o0080">
             <label>
              1.
             </label>
             <p id="p0180">
              Anyone who provided care for the patient including a healthcare worker or family member, or had other similarly close physical contact; OR
             </p>
            </list-item>
            <list-item id="o0085">
             <label>
              2.
             </label>
             <p id="p0185">
              Anyone who stayed at the same place (e.g.: lived with, visited) as a probable or confirmed case while the case was symptomatic
             </p>
            </list-item>
           </list>
           Closed contacts who developed symptoms within the first 10 days after the last contact should be investigated
          </td>
          <td>
           From date of illness onset in index case and throughout their symptomatic period.
           <list id="olist0040" list-type="simple">
            <list-item id="o0090">
             <label>
              1.
             </label>
             <p id="p0190">
              Health and social care workers: provided direct care or examination of a symptomatic confirmed case or within close vicinity of an aerosol generating procedure (&lt;3 feet) AND not wearing full PPE at the time (correctly fitted high filtration mask, gown, gloves, and eye protection)
             </p>
            </list-item>
            <list-item id="o0095">
             <label>
              2.
             </label>
             <p id="p0195">
              Household: prolonged face-to-face contact (&gt;15 min) with the confirmed case(s) any time during the illness after onset in a household setting
             </p>
            </list-item>
            <list-item id="o0100">
             <label>
              3.
             </label>
             <p id="p0200">
              Other close contact: prolonged face-to-face contact (&gt;15 min) with a confirmed case in any other enclosed setting and not wearing a mask (e.g.: school, visitor to the hospital to the bed side)
             </p>
            </list-item>
           </list>
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          ARDS, acute respiratory distress syndrome; PPE, personal protective equipment.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
      <fig id="fig3">
       <label>
        Figure 3
       </label>
       <caption>
        <p>
         Proposed working algorithm for the diagnosis, management, and infection control of suspected and confirmed cases of HCoV-EMC infection.
        </p>
       </caption>
       <graphic xlink:href="gr3_lrg">
       </graphic>
      </fig>
     </p>
    </sec>
    <sec id="sec4">
     <title>
      Laboratory diagnosis and gene targets
     </title>
     <p id="p0045">
      Definitive diagnosis of infection associated with HCoV-EMC requires laboratory confirmation as its clinical features are not pathognomonic. Similar to SARS CoV, a positive viral culture from respiratory, faecal, urine, or tissue specimens, or a fourfold rise in the neutralizing antibody titre in serum samples taken at 14–21 days apart should be the most definitive evidence of infection. However, their uses during the acute stage of the illness are limited by the long turnaround time, absence of access to designated biosafety level 3 laboratories for viral culture, or the need for convalescent samples. HCoV-EMC can be cultured by Zaki et al. on monkey kidney cells such as the Vero and LLC-MK cell lines.
      <xref ref-type="bibr" rid="bib11">
       <sup>
        11
       </sup>
      </xref>
     </p>
     <p id="p0050">
      In both cases, the laboratory diagnosis was made by nucleic acid detection by a pancoronavirus RT-PCR followed by viral genome sequencing. The development of specific quantitative real-time RT-PCR, with a turnaround time of a few hours, is expected soon but the low number of cases will impede the validation of such tests. Taking the experience from SARS CoV diagnostics, two specific gene targets, namely the polymerase gene and the nucleoprotein gene, should be considered as they are both well conserved in coronaviruses and less subject to variation with different clinical strains.
      <xref ref-type="bibr" rid="bib84">
       84
      </xref>
      ,
      <xref ref-type="bibr" rid="bib85">
       85
      </xref>
      ,
      <xref ref-type="bibr" rid="bib86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="bib87">
       87
      </xref>
      ,
      <xref ref-type="bibr" rid="bib88">
       88
      </xref>
      ,
      <xref ref-type="bibr" rid="bib89">
       89
      </xref>
      ,
      <xref ref-type="bibr" rid="bib90">
       90
      </xref>
      ,
      <xref ref-type="bibr" rid="bib91">
       91
      </xref>
      ,
      <xref ref-type="bibr" rid="bib92">
       92
      </xref>
      ,
      <xref ref-type="bibr" rid="bib93">
       93
      </xref>
      However the use of the accessory protein gene sequence upstream the Envelope gene (E) present only in HCoV-EMC was reported to be highly specific.
      <xref ref-type="bibr" rid="bib14">
       <sup>
        14
       </sup>
      </xref>
      The nucleoprotein gene has the theoretical advantage of being more sensitive as its subgenomic RNA copy number is more abundant in infected cells, but clinical studies with SARS CoV did not definitively prove this advantage. Since the timing of the peak viral load of HCoV-EMC has not been determined, repeating the test in suspected cases with an initial negative result is necessary to avoid a false-negative result because the viral load of SARS CoV in nasopharyngeal aspirate (NPA) peaked at day 10 of symptom onset.
      <xref ref-type="bibr" rid="bib44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="bib84">
       84
      </xref>
      Since the implications of a positive case are significant, positive test results from a single sample should be confirmed by a second test which detects a different region of the viral genome on the same sample in order to avoid false-positive results due to amplicon carryover.
     </p>
     <p id="p0055">
      As the two cases both presented with severe pneumonia with lower respiratory tract involvement, lower tract specimens including sputum, bronchoalveolar lavage, endotracheal aspirate, and even lung tissue as in case 1, are the preferred specimen types to be collected and put into viral transport medium. However, in suspected cases where only upper respiratory tract involvement is clinically apparent, NPA, nasopharyngeal swab, throat swab and/or expectorated sputum should be obtained, and if initially negative, should be repeated with deterioration of symptoms and at day 7 to day 10 of symptom onset (
      <xref ref-type="fig" rid="fig3">
       Fig. 3
      </xref>
      ). As in the case of SARS and other coronaviruses, feces,
      <xref ref-type="bibr" rid="bib66">
       66
      </xref>
      ,
      <xref ref-type="bibr" rid="bib94">
       94
      </xref>
      urine,
      <xref ref-type="bibr" rid="bib64">
       64
      </xref>
      ,
      <xref ref-type="bibr" rid="bib66">
       66
      </xref>
      and sera
      <xref ref-type="bibr" rid="bib95">
       <sup>
        95
       </sup>
      </xref>
      might be useful and should be collected for further testing as clinically indicated.
     </p>
     <p id="p0060">
      Besides RT-PCR, serum antigen detection with monoclonal antibodies or monospecific polyclonal antibody against the viral N protein was also shown to be a sensitive and specific test in the sero-diagnosis of SARS before the onset of neutralizing antibody response,
      <xref ref-type="bibr" rid="bib96">
       96
      </xref>
      ,
      <xref ref-type="bibr" rid="bib97">
       97
      </xref>
      ,
      <xref ref-type="bibr" rid="bib98">
       98
      </xref>
      and might also be useful for infections associated with HCoV-EMC especially in areas where RT-PCR is not available. As the spectrum of clinical manifestations, epidemiology, and potential for further dissemination of this new disease are still poorly understood, antibody detection assays would be useful for seroepidemiological studies which would be highly useful in determining the exact situation and in planning of the relevant infection control strategies to contain the infection at an early stage.
     </p>
    </sec>
    <sec id="sec5">
     <title>
      Epidemiology and animal contact
     </title>
     <p id="p0065">
      The information on the epidemiology of infections associated with HCoV-EMC is mainly derived from the sequence of important events which is summarized in
      <xref ref-type="table" rid="tbl1">
       Table 1
      </xref>
      . The most important epidemiological linkage at present seems to be the travelling to or the residence in areas where the infection has been reported, namely Qatar and the Kingdom of Saudi Arabia, in the preceding 10 days prior to the onset of illness. Case 2 had history of contact with camels and sheep.
      <xref ref-type="bibr" rid="bib10">
       <sup>
        10
       </sup>
      </xref>
      Given the close phylogenetic relationships between HCoV-EMC and the bat coronaviruses HKU4 and HKU5 (
      <xref ref-type="fig" rid="fig1">
       Fig. 1
      </xref>
      A), our speculation is that wild animals including bat may serve as the natural reservoir of many group B or C betacoronaviruses which jump into one or more intermediate hosts of food or game animals dwelling closely to human as in the case of infection due to SARS CoV (civet), Hendra (horses), Nipah (swine), and Ebola (primates) viruses.
      <xref ref-type="bibr" rid="bib99">
       99
      </xref>
      ,
      <xref ref-type="bibr" rid="bib100">
       100
      </xref>
      While pipistrelles, the natural reservoir of bat coronavirus HKU5, can be found in the Kingdom of Saudi Arabia, they are also seen in many other parts of the world. One possible reason why cases of infection associated with HCoV-EMC have not been reported in other areas may be explained by drawing an analogy to SARS CoV, whose transmission from the horseshoe bat (
      <italic>
       Rhinolophus sp.
      </italic>
      ) to human was enhanced by intermediate animal hosts in palm civets and raccoon dogs. In Hong Kong, the regular surveillance of coronaviruses in patients' specimens or non-bat animal specimens in the past 5 years did not reveal a single case of infection by group C betacoronaviruses using consensus coronavirus primers and amplicon sequencing.
      <xref ref-type="bibr" rid="bib101">
       <sup>
        101
       </sup>
      </xref>
      This might be related to the absence of the necessary intermediate hosts for amplifying the novel virus in our locality and the high level of biosecurity measures adopted at our farms and markets. Further studies are required to prove these postulations concerning animal-to-human transmission.
     </p>
     <p id="p0070">
      In contrast to SARS, person-to-person transmission has so far not been observed in infections associated with HCoV-EMC. In case 2, no clinically apparent infection was seen in the healthcare workers and personnel of the medical escort company involved in the care and transfer of the patient from Qatar to the United Kingdom. Furthermore, the two confirmed cases were separated by three months temporally, and had no specific epidemiological linkage except for both having been in the Kingdom of Saudi Arabia prior to the onset of illness. There have been no further cases reported which might signify the absence of ongoing transmission in the community. However, if the outbreak of severe respiratory illness that occurred in a Jordanian hospital in April 2012, which involved a total of 11 people with eight of them being healthcare workers and one fatal case, was subsequently confirmed to be associated with HCoV-EMC, then person-to-person transmission, and particularly nosocomial transmission, would be possible (
      <xref ref-type="table" rid="tbl1">
       Table 1
      </xref>
      ). In the case of SARS, person-to-person transmission by direct or indirect contact of the mucosae with infectious respiratory droplets or fomites was considered to be the primary mode of spread, although airborne transmission under special circumstances has been reported.
      <xref ref-type="bibr" rid="bib102">
       <sup>
        102
       </sup>
      </xref>
      Nosocomial transmission, facilitated by the use of nebulizers, suction, intubation, bronchoscopy, and cardiopulmonary resuscitation, was also well documented.
      <xref ref-type="bibr" rid="bib49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="bib103">
       103
      </xref>
      ,
      <xref ref-type="bibr" rid="bib104">
       104
      </xref>
      Importantly, unlike those with influenza, patients with SARS were most infectious on or after the fifth day after the onset of symptoms, and the viral load in nasopharyngeal secretions usually peaked on the tenth day.
      <xref ref-type="bibr" rid="bib44">
       <sup>
        44
       </sup>
      </xref>
      Therefore, if the novel virus was truly capable of causing person-to-person spread, the optimal infection control strategies might need to be further reviewed. As the Hajj is approaching, recommendations on whether travel restrictions or additional infection control measures are required are urgently needed. It would be disastrous if the phenomenon of super-spreading events observed in SARS was also encountered in infections associated with HCoV-EMC. An example was the large community outbreak that occurred in Amoy Garden of Hong Kong in which dried U traps of sewage drains facilitated the contaminated aerosols generated in toilets by exhaust fans to ascend the light well connecting different floors and resulted in a massive outbreak affecting hundreds of residents.
      <xref ref-type="bibr" rid="bib105">
       105
      </xref>
      ,
      <xref ref-type="bibr" rid="bib106">
       106
      </xref>
     </p>
     <p id="p0075">
      In terms of the hosts at risk of developing severe disease, no conclusion could be made at present. Both patients were reported to be free of chronic medical conditions prior to the infection.
      <xref ref-type="bibr" rid="bib107">
       <sup>
        107
       </sup>
      </xref>
      Another poorly defined characteristic of the infections associated with the novel virus is the incubation period. Neither case gave an accurate account of the incubation period prior to the onset of symptoms as they were both considered to be sporadic cases. In general, the incubation period of human non-SARS coronaviruses is 2–5 days and that of SARS CoV is 2–14 days.
      <xref ref-type="bibr" rid="bib108">
       108
      </xref>
      ,
      <xref ref-type="bibr" rid="bib109">
       109
      </xref>
      A well documented incubation period of this novel infection is critical for setting up the appropriate case definition for case finding, optimizing the timing of laboratory tests and number of tests required, and deciding on the necessary periods of medical surveillance and quarantine required for contact and confirmed cases respectively.
     </p>
    </sec>
    <sec id="sec6">
     <title>
      Treatment and ECMO
     </title>
     <p id="p0080">
      There is no proven effective antiviral agent against coronaviruses including SARS and HCoV-EMC.
      <xref ref-type="bibr" rid="bib3">
       3
      </xref>
      ,
      <xref ref-type="bibr" rid="bib110">
       110
      </xref>
      No animal model for satisfying Koch's postulates or for testing antiviral treatment or immunization is yet reported for HCoV-EMC. Clinical management is therefore mainly supportive, with particular emphasis on organ support for respiratory and renal failure. The recent advances made in the use of extracorporeal membrane oxygenation (ECMO) in the intensive care unit has been shown to improve survival rates to up to 50–70% in cases of acute respiratory failure.
      <xref ref-type="bibr" rid="bib111">
       111
      </xref>
      ,
      <xref ref-type="bibr" rid="bib112">
       112
      </xref>
      ,
      <xref ref-type="bibr" rid="bib113">
       113
      </xref>
      ,
      <xref ref-type="bibr" rid="bib114">
       114
      </xref>
      As for renal failure, continuous venous–venous haemofiltration is commonly used in the intensive care unit with the aim of tiding the patient over the initial critical stage. Broad-spectrum antimicrobial coverage against typical and atypical agents of severe community-acquired pneumonia, such as a regimen consisting of a β-lactam, a macrolide, and an antiviral against influenza, should be instituted while awaiting the laboratory diagnosis. The antimicrobial treatment should be stopped when the diagnosis of HCoV-EMC associated pneumonia is made, unless in situations where nosocomial infections or immunosuppressive states coexist.
      <xref ref-type="bibr" rid="bib115">
       <sup>
        115
       </sup>
      </xref>
     </p>
     <p id="p0085">
      Specific antiviral agents including interferons (interferon-alfacon-1), ribavirin, and lopinavir-ritonavir with or without high-dose corticosteroid have been used in patients with SARS.
      <xref ref-type="bibr" rid="bib3">
       <sup>
        3
       </sup>
      </xref>
      But their use was limited by a lack of evidence from randomized control trials and their potential side effects especially for ribavirin and steroid. Many other agents have shown in-vitro activities against SARS CoV, and included protease inhibitors such as nelfinavir and others, angiotensin-converting enzyme 2 analogues, helicase inhibitors and nucleoside analogues. However, their in-vivo activity and clinical utility for SARS and other coronaviruses remain elusive.
      <xref ref-type="bibr" rid="bib3">
       <sup>
        3
       </sup>
      </xref>
      Corticosteroid should no longer be considered since patients with severe pneumonia and respiratory failure can be supported by ECMO till the cytokine storm is over.
     </p>
     <p id="p0090">
      Immunomodulating therapy with IgM-enriched immunoglobulin or convalescent plasma with neutralizing antibodies has been used in a small number of patients with SARS.
      <xref ref-type="bibr" rid="bib116">
       116
      </xref>
      ,
      <xref ref-type="bibr" rid="bib117">
       117
      </xref>
      ,
      <xref ref-type="bibr" rid="bib118">
       118
      </xref>
      ,
      <xref ref-type="bibr" rid="bib119">
       119
      </xref>
      The data generated from these studies were limited by the small number of patients involved and the lack of randomized control trials conducted. Convalescent plasma is relatively free of side effect and might be considered should the novel virus continue to cause severe infections in a larger number of patients. However, if there were only a few convalescent patients, the preparation of convalescent plasma would not be feasible.
     </p>
    </sec>
    <sec id="sec7">
     <title>
      Infection control and viral load
     </title>
     <p id="p0095">
      There is currently no specific international guideline for the infection control of HCoV-EMC. The WHO recommends strategies discussed in the WHO interim guideline for “infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in heath care”.
      <xref ref-type="bibr" rid="bib120">
       <sup>
        120
       </sup>
      </xref>
      These include the practice of Standard, Contact, and Airborne Precautions before the route of transmission is better defined. The HPA of the United Kingdom recommends a similarly stringent approach.
      <xref ref-type="bibr" rid="bib76">
       <sup>
        76
       </sup>
      </xref>
      Besides these recommendations, a second virological test should be considered as the patient deteriorates or at day 7 to day 10 of symptom onset in symptomatic contacts who have an initial negative test result because the viral load may peak at day 10 as in the case of SARS CoV. While there is no travel restrictions imposed at present, the subsequent development of events associated with HCoV-EMC must be closely monitored especially as the Hajj is approaching. There is no recommendation on the infection control measures regarding animal contact. Simple personal hygienic measures such as hand hygiene after contact with animals and their excreta should be taken.
     </p>
    </sec>
    <sec id="sec8">
     <title>
      Conclusion
     </title>
     <p id="p0100">
      One of the major reasons why the SARS CoV successfully caused a devastating pandemic was the lack of anticipation by the global health community. Although the currently available information about HCoV-EMC seems to suggest that it has a lower transmissibility than that of SARS CoV, many important epidemiological, clinical and scientific questions remain unresolved. Healthcare authorities should not discard the potential of this novel virus to cause another SARS-like pandemic before such answers are available. While over-reactions are unnecessary, appropriate preparations and collaborations by international and local health agencies are important.
     </p>
    </sec>
    <back>
     <ref-list id="cebib0010">
      <title>
       References
      </title>
      <ref id="bib1">
       <label>
        1
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Kuiken
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Schutten
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           van Amerongen
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           van Doornum
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           van den Hoogen
          </surname>
          <given-names>
           B.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Aetiology: Koch's postulates fulfilled for SARS virus
        </article-title>
        <source>
         Nature
        </source>
        <volume>
         423
        </volume>
        <issue>
         6937
        </issue>
        <year>
         2003
        </year>
        <fpage>
         240
        </fpage>
        <pub-id pub-id-type="pmid">
         12748632
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib2">
       <label>
        2
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Osterhaus
          </surname>
          <given-names>
           A.D.
          </given-names>
         </name>
         <name>
          <surname>
           Fouchier
          </surname>
          <given-names>
           R.A.
          </given-names>
         </name>
         <name>
          <surname>
           Kuiken
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The aetiology of SARS: Koch's postulates fulfilled
        </article-title>
        <source>
         Philos Trans R Soc Lond B Biol Sci
        </source>
        <volume>
         359
        </volume>
        <issue>
         1447
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1081
        </fpage>
        <lpage>
         1082
        </lpage>
        <pub-id pub-id-type="pmid">
         15306393
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib3">
       <label>
        3
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
        </article-title>
        <source>
         Clin Microbiol Rev
        </source>
        <volume>
         20
        </volume>
        <issue>
         4
        </issue>
        <year>
         2007
        </year>
        <fpage>
         660
        </fpage>
        <lpage>
         694
        </lpage>
        <pub-id pub-id-type="pmid">
         17934078
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib4">
       <label>
        4
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Nicholls
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The aetiology, origins, and diagnosis of severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         4
        </volume>
        <issue>
         11
        </issue>
        <year>
         2004
        </year>
        <fpage>
         663
        </fpage>
        <lpage>
         671
        </lpage>
        <pub-id pub-id-type="pmid">
         15522678
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib5">
       <label>
        5
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           K.W.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ooi
          </surname>
          <given-names>
           G.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yee
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Chan-Yeung
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A cluster of cases of severe acute respiratory syndrome in Hong Kong
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         348
        </volume>
        <issue>
         20
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1977
        </fpage>
        <lpage>
         1985
        </lpage>
        <pub-id pub-id-type="pmid">
         12671062
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib6">
       <label>
        6
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yam
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus as a possible cause of severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9366
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1319
        </fpage>
        <lpage>
         1325
        </lpage>
        <pub-id pub-id-type="pmid">
         12711465
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib7">
       <label>
        7
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization (WHO)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         WHO final summary SARS, 15 August 2003: summary table of SARS cases by country, 1 November 2002–7 August 2003
        </chapter-title>
        <year>
         2003
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/country/2003_08_15/en/index.html">
         http://www.who.int/csr/sars/country/2003_08_15/en/index.html
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib8">
       <label>
        8
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Global alert and response (GAR): novel coronavirus infection in the United Kingdom
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         World Health Organization
        </publisher-name>
        <publisher-loc>
         Geneva, Switzerland
        </publisher-loc>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/2012_09_23/en/index.html">
         http://www.who.int/csr/don/2012_09_23/en/index.html
        </ext-link>
        <comment>
         accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib9">
       <label>
        9
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bermingham
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Chand
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Brown
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <name>
          <surname>
           Aarons
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Langrish
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         17
        </volume>
        <issue>
         40
        </issue>
        <year>
         2012
        </year>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.eurosurveillance.org/ViewArticle.aspx%3fArticleId%3d20290">
         http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20290
        </ext-link>
        <comment>
         [accessed 04.10.12], pii = 20290
        </comment>
       </element-citation>
      </ref>
      <ref id="bib10">
       <label>
        10
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Pebody
          </surname>
          <given-names>
           R.G.
          </given-names>
         </name>
         <name>
          <surname>
           Chand
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Thomas
          </surname>
          <given-names>
           H.L.
          </given-names>
         </name>
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           H.K.
          </given-names>
         </name>
         <name>
          <surname>
           Boddington
          </surname>
          <given-names>
           N.L.
          </given-names>
         </name>
         <name>
          <surname>
           Carvalho
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         17
        </volume>
        <issue>
         40
        </issue>
        <year>
         2012
        </year>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.eurosurveillance.org/ViewArticle.aspx%3fArticleId%3d20292">
         http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20292
        </ext-link>
        <comment>
         [accessed 04.10.12], pii = 20292
        </comment>
       </element-citation>
      </ref>
      <ref id="bib11">
       <label>
        11
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           ProMED-mail
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Novel coronavirus – Saudi Arabia: human isolate
        </chapter-title>
        <comment>
         Archive Number: 20120920.1302733
        </comment>
        <year>
         20 September 2012
        </year>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.promedmail.org/%3fp%3d2400:1000">
         http://www.promedmail.org/?p=2400:1000
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib12">
       <label>
        12
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           European Centre for Disease Prevention and Control (ECDC)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Rapid risk assessment: severe respiratory disease associated with a novel coronavirus
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         ECDC
        </publisher-name>
        <publisher-loc>
         Stockholm, Sweden
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://ecdc.europa.eu/en/publications/Publications/RRA-Novel-coronavirus-final20120924.pdf">
         http://ecdc.europa.eu/en/publications/Publications/RRA-Novel-coronavirus-final20120924.pdf
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib13">
       <label>
        13
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           European Centres for Disease Control (ECDC)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Communicable disease threats report (week 18, 29 April–5 May 2012)
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         ECDC
        </publisher-name>
        <publisher-loc>
         Stockholm
        </publisher-loc>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://ecdc.europa.eu/en/publications/Publications/CDTR%20online%20version%204%20May%202012.pdf">
         http://ecdc.europa.eu/en/publications/Publications/CDTR%20online%20version%204%20May%202012.pdf
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib14">
       <label>
        14
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Corman
          </surname>
          <given-names>
           V.M.
          </given-names>
         </name>
         <name>
          <surname>
           Eckerle
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Bleicker
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
         <name>
          <surname>
           Zaki
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Landt
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Eschbach-Bludau
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
        </article-title>
        <source>
         Euro Surveill
        </source>
        <volume>
         17
        </volume>
        <issue>
         39
        </issue>
        <year>
         2012
        </year>
        <comment>
         Available online:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.eurosurveillance.org/ViewArticle.aspx%3fArticleId%3d20285">
         http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20285
        </ext-link>
        <comment>
         [accessed 04.10.12], pii = 20285
        </comment>
       </element-citation>
      </ref>
      <ref id="bib15">
       <label>
        15
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Health Protection Agency (HPA)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Partial genetic sequence information for scientists about the novel coronavirus
        </chapter-title>
        <comment>
         [accessed 02.10.12]
        </comment>
        <year>
         2012
        </year>
        <publisher-name>
         HPA
        </publisher-name>
        <publisher-loc>
         London
        </publisher-loc>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/NovelCoronavirus2012/respPartialgeneticsequenceofnovelcoronavirus">
         http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/NovelCoronavirus2012/respPartialgeneticsequenceofnovelcoronavirus
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib16">
       <label>
        16
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         79
        </volume>
        <issue>
         2
        </issue>
        <year>
         2005
        </year>
        <fpage>
         884
        </fpage>
        <lpage>
         895
        </lpage>
        <pub-id pub-id-type="pmid">
         15613317
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib17">
       <label>
        17
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia
        </article-title>
        <source>
         Arch Virol
        </source>
        <volume>
         150
        </volume>
        <issue>
         11
        </issue>
        <year>
         2005
        </year>
        <fpage>
         2299
        </fpage>
        <lpage>
         2311
        </lpage>
        <pub-id pub-id-type="pmid">
         15986174
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib18">
       <label>
        18
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus genomics and bioinformatics analysis
        </article-title>
        <source>
         Viruses
        </source>
        <volume>
         2
        </volume>
        <issue>
         8
        </issue>
        <year>
         2010
        </year>
        <fpage>
         1804
        </fpage>
        <lpage>
         1820
        </lpage>
        <comment>
         [Epub 2010 Aug 24]
        </comment>
        <pub-id pub-id-type="pmid">
         21994708
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib19">
       <label>
        19
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and molecular epidemiology of coronavirus-HKU1-associated community-acquired pneumonia
        </article-title>
        <source>
         Hong Kong Med J
        </source>
        <volume>
         15
        </volume>
        <issue>
         Suppl. 9
        </issue>
        <year>
         2009
        </year>
        <fpage>
         46
        </fpage>
        <lpage>
         47
        </lpage>
        <pub-id pub-id-type="pmid">
         20393227
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib20">
       <label>
        20
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study
        </article-title>
        <source>
         Hong Kong Med J
        </source>
        <volume>
         18
        </volume>
        <issue>
         Suppl. 2
        </issue>
        <year>
         2012
        </year>
        <fpage>
         22
        </fpage>
        <lpage>
         24
        </lpage>
        <pub-id pub-id-type="pmid">
         22311356
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib21">
       <label>
        21
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yip
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Tse
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus HKU1 and other coronavirus infections in Hong Kong
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <volume>
         44
        </volume>
        <issue>
         6
        </issue>
        <year>
         2006
        </year>
        <fpage>
         2063
        </fpage>
        <lpage>
         2071
        </lpage>
        <pub-id pub-id-type="pmid">
         16757599
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib22">
       <label>
        22
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Severance
          </surname>
          <given-names>
           E.G.
          </given-names>
         </name>
         <name>
          <surname>
           Bossis
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Dickerson
          </surname>
          <given-names>
           F.B.
          </given-names>
         </name>
         <name>
          <surname>
           Stallings
          </surname>
          <given-names>
           C.R.
          </given-names>
         </name>
         <name>
          <surname>
           Origoni
          </surname>
          <given-names>
           A.E.
          </given-names>
         </name>
         <name>
          <surname>
           Sullens
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population
        </article-title>
        <source>
         Clin Vaccine Immunol
        </source>
        <volume>
         15
        </volume>
        <issue>
         12
        </issue>
        <year>
         2008
        </year>
        <fpage>
         1805
        </fpage>
        <lpage>
         1810
        </lpage>
        <pub-id pub-id-type="pmid">
         18945884
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib23">
       <label>
        23
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia
        </article-title>
        <source>
         J Infect Dis
        </source>
        <volume>
         192
        </volume>
        <issue>
         11
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1898
        </fpage>
        <lpage>
         1907
        </lpage>
        <pub-id pub-id-type="pmid">
         16267760
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib24">
       <label>
        24
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           D.N.
          </given-names>
         </name>
         <name>
          <surname>
           Que
          </surname>
          <given-names>
           T.L.
          </given-names>
         </name>
         <name>
          <surname>
           Shortridge
          </surname>
          <given-names>
           K.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         351
        </volume>
        <issue>
         9101
        </issue>
        <year>
         1998
        </year>
        <fpage>
         467
        </fpage>
        <lpage>
         471
        </lpage>
        <pub-id pub-id-type="pmid">
         9482437
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib25">
       <label>
        25
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human infection by avian influenza A H5N1
        </article-title>
        <source>
         Hong Kong Med J
        </source>
        <volume>
         11
        </volume>
        <issue>
         3
        </issue>
        <year>
         2005
        </year>
        <fpage>
         189
        </fpage>
        <lpage>
         199
        </lpage>
        <pub-id pub-id-type="pmid">
         15951584
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib26">
       <label>
        26
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           W.C.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           C.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           W.F.
          </given-names>
         </name>
         <name>
          <surname>
           Nicholls
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Re-emergence of fatal human influenza A subtype H5N1 disease
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         363
        </volume>
        <issue>
         9409
        </issue>
        <year>
         2004
        </year>
        <fpage>
         617
        </fpage>
        <lpage>
         619
        </lpage>
        <pub-id pub-id-type="pmid">
         14987888
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib27">
       <label>
        27
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           C.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Ellis
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lim
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Lipatov
          </surname>
          <given-names>
           A.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         H5N1 influenza: a protean pandemic threat
        </article-title>
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <volume>
         101
        </volume>
        <issue>
         21
        </issue>
        <year>
         2004
        </year>
        <fpage>
         8156
        </fpage>
        <lpage>
         8161
        </lpage>
        <pub-id pub-id-type="pmid">
         15148370
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib28">
       <label>
        28
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Avian influenza virus infections in humans
        </article-title>
        <source>
         Chest
        </source>
        <volume>
         129
        </volume>
        <issue>
         1
        </issue>
        <year>
         2006
        </year>
        <fpage>
         156
        </fpage>
        <lpage>
         168
        </lpage>
        <pub-id pub-id-type="pmid">
         16424427
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib29">
       <label>
        29
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Avian influenza A/H5N1 virus: management in human and bird
        </article-title>
        <source>
         Hong Kong Med J
        </source>
        <volume>
         14
        </volume>
        <issue>
         4
        </issue>
        <year>
         2008
        </year>
        <fpage>
         252
        </fpage>
        <lpage>
         254
        </lpage>
        <pub-id pub-id-type="pmid">
         18685155
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib30">
       <label>
        30
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections
        </article-title>
        <source>
         Curr Opin Infect Dis
        </source>
        <volume>
         19
        </volume>
        <issue>
         5
        </issue>
        <year>
         2006
        </year>
        <fpage>
         401
        </fpage>
        <lpage>
         407
        </lpage>
        <pub-id pub-id-type="pmid">
         16940861
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib31">
       <label>
        31
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           K.M.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           K.Z.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans?
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         77
        </volume>
        <issue>
         12
        </issue>
        <year>
         2003
        </year>
        <fpage>
         6988
        </fpage>
        <lpage>
         6994
        </lpage>
        <pub-id pub-id-type="pmid">
         12768017
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib32">
       <label>
        32
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           K.M.
          </given-names>
         </name>
         <name>
          <surname>
           Duan
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia
        </article-title>
        <source>
         Nature
        </source>
        <volume>
         430
        </volume>
        <issue>
         6996
        </issue>
        <year>
         2004
        </year>
        <fpage>
         209
        </fpage>
        <lpage>
         213
        </lpage>
        <pub-id pub-id-type="pmid">
         15241415
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib33">
       <label>
        33
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Fan
          </surname>
          <given-names>
           X.H.
          </given-names>
         </name>
         <name>
          <surname>
           Rayner
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control
        </article-title>
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <volume>
         103
        </volume>
        <issue>
         8
        </issue>
        <year>
         2006
        </year>
        <fpage>
         2845
        </fpage>
        <lpage>
         2850
        </lpage>
        <pub-id pub-id-type="pmid">
         16473931
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib34">
       <label>
        34
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Smith
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           Zhou
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Qiu
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           W.L.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Avian influenza A (H5N1) infection in a patient in China, 2006
        </article-title>
        <source>
         Influenza Other Respir Virus
        </source>
        <volume>
         1
        </volume>
        <issue>
         5–6
        </issue>
        <year>
         2007
        </year>
        <fpage>
         207
        </fpage>
        <lpage>
         213
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib35">
       <label>
        35
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Systemic infection of avian influenza A virus H5N1 subtype in humans
        </article-title>
        <source>
         Hum Pathol
        </source>
        <volume>
         40
        </volume>
        <issue>
         5
        </issue>
        <year>
         2009
        </year>
        <fpage>
         735
        </fpage>
        <lpage>
         739
        </lpage>
        <pub-id pub-id-type="pmid">
         19121843
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib36">
       <label>
        36
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Beigel
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Farrar
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Hayden
          </surname>
          <given-names>
           F.G.
          </given-names>
         </name>
         <name>
          <surname>
           Hyer
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           de Jong
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Avian influenza A (H5N1) infection in humans
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         353
        </volume>
        <issue>
         13
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1374
        </fpage>
        <lpage>
         1385
        </lpage>
        <comment>
         [Erratum in: N Engl J Med 2006;354(8):884]
        </comment>
        <pub-id pub-id-type="pmid">
         16192482
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib37">
       <label>
        37
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus diversity, phylogeny and interspecies jumping
        </article-title>
        <source>
         Exp Biol Med (Maywood)
        </source>
        <volume>
         234
        </volume>
        <issue>
         10
        </issue>
        <year>
         2009
        </year>
        <fpage>
         1117
        </fpage>
        <lpage>
         1127
        </lpage>
        <pub-id pub-id-type="pmid">
         19546349
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib38">
       <label>
        38
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Molecular diversity of coronaviruses in bats
        </article-title>
        <source>
         Virology
        </source>
        <volume>
         351
        </volume>
        <issue>
         1
        </issue>
        <year>
         2006
        </year>
        <fpage>
         180
        </fpage>
        <lpage>
         187
        </lpage>
        <pub-id pub-id-type="pmid">
         16647731
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib39">
       <label>
        39
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
        </article-title>
        <source>
         Proc Natl Acad Sci U S A
        </source>
        <volume>
         102
        </volume>
        <issue>
         39
        </issue>
        <year>
         2005
        </year>
        <fpage>
         14040
        </fpage>
        <lpage>
         14045
        </lpage>
        <pub-id pub-id-type="pmid">
         16169905
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib40">
       <label>
        40
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Guo
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         81
        </volume>
        <issue>
         4
        </issue>
        <year>
         2007
        </year>
        <fpage>
         1574
        </fpage>
        <lpage>
         1585
        </lpage>
        <pub-id pub-id-type="pmid">
         17121802
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib41">
       <label>
        41
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Duan
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           X.S.
          </given-names>
         </name>
         <name>
          <surname>
           Wen
          </surname>
          <given-names>
           R.F.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
         <name>
          <surname>
           Pi
          </surname>
          <given-names>
           G.H.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           S.X.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation
        </article-title>
        <source>
         Biomed Environ Sci
        </source>
        <volume>
         16
        </volume>
        <issue>
         3
        </issue>
        <year>
         2003
        </year>
        <fpage>
         246
        </fpage>
        <lpage>
         255
        </lpage>
        <pub-id pub-id-type="pmid">
         14631830
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib42">
       <label>
        42
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.F.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bauer
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability and inactivation of SARS coronavirus
        </article-title>
        <source>
         Med Microbiol Immunol
        </source>
        <volume>
         194
        </volume>
        <issue>
         1–2
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         15118911
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib43">
       <label>
        43
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           M.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         38
        </volume>
        <issue>
         4
        </issue>
        <year>
         2004
        </year>
        <fpage>
         467
        </fpage>
        <lpage>
         475
        </lpage>
        <pub-id pub-id-type="pmid">
         14765337
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib44">
       <label>
        44
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9371
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1767
        </fpage>
        <lpage>
         1772
        </lpage>
        <pub-id pub-id-type="pmid">
         12781535
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib45">
       <label>
        45
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Avendano
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Derkach
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Swan
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical course and management of SARS in health care workers in Toronto: a case series
        </article-title>
        <source>
         CMAJ
        </source>
        <volume>
         168
        </volume>
        <issue>
         13
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1649
        </fpage>
        <lpage>
         1660
        </lpage>
        <pub-id pub-id-type="pmid">
         12821618
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib46">
       <label>
        46
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Booth
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Matukas
          </surname>
          <given-names>
           L.M.
          </given-names>
         </name>
         <name>
          <surname>
           Tomlinson
          </surname>
          <given-names>
           G.A.
          </given-names>
         </name>
         <name>
          <surname>
           Rachlis
          </surname>
          <given-names>
           A.R.
          </given-names>
         </name>
         <name>
          <surname>
           Rose
          </surname>
          <given-names>
           D.B.
          </given-names>
         </name>
         <name>
          <surname>
           Dwosh
          </surname>
          <given-names>
           H.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
        </article-title>
        <source>
         JAMA
        </source>
        <volume>
         289
        </volume>
        <issue>
         21
        </issue>
        <year>
         2003
        </year>
        <fpage>
         2801
        </fpage>
        <lpage>
         2809
        </lpage>
        <pub-id pub-id-type="pmid">
         12734147
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib47">
       <label>
        47
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ip
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Rickjason
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome-associated coronavirus infection
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         9
        </volume>
        <issue>
         11
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1453
        </fpage>
        <lpage>
         1454
        </lpage>
        <pub-id pub-id-type="pmid">
         14718090
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib48">
       <label>
        48
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hsu
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ang
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Paton
          </surname>
          <given-names>
           N.I.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         9
        </volume>
        <issue>
         6
        </issue>
        <year>
         2003
        </year>
        <fpage>
         713
        </fpage>
        <lpage>
         717
        </lpage>
        <pub-id pub-id-type="pmid">
         12781012
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib49">
       <label>
        49
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Cameron
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Joynt
          </surname>
          <given-names>
           G.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A major outbreak of severe acute respiratory syndrome in Hong Kong
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         348
        </volume>
        <issue>
         20
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1986
        </fpage>
        <lpage>
         1994
        </lpage>
        <pub-id pub-id-type="pmid">
         12682352
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib50">
       <label>
        50
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rainer
          </surname>
          <given-names>
           T.H.
          </given-names>
         </name>
         <name>
          <surname>
           Cameron
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Smit
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Ong
          </surname>
          <given-names>
           K.L.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           A.N.
          </given-names>
         </name>
         <name>
          <surname>
           Nin
          </surname>
          <given-names>
           D.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study
        </article-title>
        <source>
         BMJ
        </source>
        <volume>
         326
        </volume>
        <issue>
         7403
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1354
        </fpage>
        <lpage>
         1358
        </lpage>
        <pub-id pub-id-type="pmid">
         12816820
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib51">
       <label>
        51
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         The severe acute respiratory syndrome
        </chapter-title>
        <person-group person-group-type="editor">
         <name>
          <surname>
           Fong
          </surname>
          <given-names>
           I.W.
          </given-names>
         </name>
         <name>
          <surname>
           Alibek
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <source>
         New and evolving infections of the 21st century
        </source>
        <edition>
         1st ed.
        </edition>
        <year>
         2007
        </year>
        <publisher-name>
         Springer Press
        </publisher-name>
        <publisher-loc>
         New York, NY
        </publisher-loc>
        <fpage>
         163
        </fpage>
        <lpage>
         183
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib52">
       <label>
        52
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhao
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Zhong
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Cai
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China
        </article-title>
        <source>
         J Med Microbiol
        </source>
        <volume>
         52
        </volume>
        <issue>
         Pt 8
        </issue>
        <year>
         2003
        </year>
        <fpage>
         715
        </fpage>
        <lpage>
         720
        </lpage>
        <pub-id pub-id-type="pmid">
         12867568
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib53">
       <label>
        53
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poutanen
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Low
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Henry
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Finkelstein
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rose
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Green
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Identification of severe acute respiratory syndrome in Canada
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         348
        </volume>
        <issue>
         20
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1995
        </fpage>
        <lpage>
         2003
        </lpage>
        <pub-id pub-id-type="pmid">
         12671061
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib54">
       <label>
        54
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Grinblat
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Shulman
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Glickman
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Matukas
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Paul
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada
        </article-title>
        <source>
         Radiology
        </source>
        <volume>
         228
        </volume>
        <issue>
         3
        </issue>
        <year>
         2003
        </year>
        <fpage>
         802
        </fpage>
        <lpage>
         809
        </lpage>
        <pub-id pub-id-type="pmid">
         12853655
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib55">
       <label>
        55
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hsieh
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           W.P.
          </given-names>
         </name>
         <name>
          <surname>
           Chien
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           W.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yao
          </surname>
          <given-names>
           M.S.
          </given-names>
         </name>
         <name>
          <surname>
           Choi
          </surname>
          <given-names>
           W.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Radiographic appearance and clinical outcome correlates in 26 patients with severe acute respiratory syndrome
        </article-title>
        <source>
         AJR Am J Roentgenol
        </source>
        <volume>
         182
        </volume>
        <issue>
         5
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1119
        </fpage>
        <lpage>
         1122
        </lpage>
        <pub-id pub-id-type="pmid">
         15100105
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib56">
       <label>
        56
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           E.K.
          </given-names>
         </name>
         <name>
          <surname>
           Deif
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           LaMere
          </surname>
          <given-names>
           E.A.
          </given-names>
         </name>
         <name>
          <surname>
           Pham
          </surname>
          <given-names>
           D.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wolff
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Ward
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome: quantitative assessment from chest radiographs with clinical and prognostic correlation
        </article-title>
        <source>
         AJR Am J Roentgenol
        </source>
        <volume>
         184
        </volume>
        <issue>
         1
        </issue>
        <year>
         2005
        </year>
        <fpage>
         255
        </fpage>
        <lpage>
         263
        </lpage>
        <pub-id pub-id-type="pmid">
         15615985
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib57">
       <label>
        57
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           K.T.
          </given-names>
         </name>
         <name>
          <surname>
           Antonio
          </surname>
          <given-names>
           G.E.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           D.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           E.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients
        </article-title>
        <source>
         Radiology
        </source>
        <volume>
         228
        </volume>
        <issue>
         2
        </issue>
        <year>
         2003
        </year>
        <fpage>
         401
        </fpage>
        <lpage>
         406
        </lpage>
        <pub-id pub-id-type="pmid">
         12759474
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib58">
       <label>
        58
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           Y.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           J.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           V.L.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           W.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome
        </article-title>
        <source>
         Eur Respir J
        </source>
        <volume>
         23
        </volume>
        <issue>
         6
        </issue>
        <year>
         2004
        </year>
        <fpage>
         802
        </fpage>
        <lpage>
         804
        </lpage>
        <pub-id pub-id-type="pmid">
         15218989
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib59">
       <label>
        59
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Franks
          </surname>
          <given-names>
           T.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chong
          </surname>
          <given-names>
           P.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chui
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Galvin
          </surname>
          <given-names>
           J.R.
          </given-names>
         </name>
         <name>
          <surname>
           Lourens
          </surname>
          <given-names>
           R.M.
          </given-names>
         </name>
         <name>
          <surname>
           Reid
          </surname>
          <given-names>
           A.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore
        </article-title>
        <source>
         Hum Pathol
        </source>
        <volume>
         34
        </volume>
        <issue>
         8
        </issue>
        <year>
         2003
        </year>
        <fpage>
         743
        </fpage>
        <lpage>
         748
        </lpage>
        <comment>
         [Erratum in: Hum Pathol 2004;35(1):138]
        </comment>
        <pub-id pub-id-type="pmid">
         14506633
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib60">
       <label>
        60
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Nicholls
          </surname>
          <given-names>
           J.M.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           W.F.
          </given-names>
         </name>
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Lung pathology of fatal severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9371
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1773
        </fpage>
        <lpage>
         1778
        </lpage>
        <pub-id pub-id-type="pmid">
         12781536
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib61">
       <label>
        61
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hwang
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chamberlain
          </surname>
          <given-names>
           D.W.
          </given-names>
         </name>
         <name>
          <surname>
           Poutanen
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Low
          </surname>
          <given-names>
           D.E.
          </given-names>
         </name>
         <name>
          <surname>
           Asa
          </surname>
          <given-names>
           S.L.
          </given-names>
         </name>
         <name>
          <surname>
           Butany
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pulmonary pathology of severe acute respiratory syndrome in Toronto
        </article-title>
        <source>
         Mod Pathol
        </source>
        <volume>
         18
        </volume>
        <issue>
         1
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         10
        </lpage>
        <pub-id pub-id-type="pmid">
         15272286
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib62">
       <label>
        62
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Ding
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Kang
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Fatal aspergillosis in a patient with SARS who was treated with corticosteroids
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         349
        </volume>
        <issue>
         5
        </issue>
        <year>
         2003
        </year>
        <fpage>
         507
        </fpage>
        <lpage>
         508
        </lpage>
        <pub-id pub-id-type="pmid">
         12890854
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib63">
       <label>
        63
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ding
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Shen
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Geng
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Han
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
        </article-title>
        <source>
         J Pathol
        </source>
        <volume>
         200
        </volume>
        <issue>
         3
        </issue>
        <year>
         2003
        </year>
        <fpage>
         282
        </fpage>
        <lpage>
         289
        </lpage>
        <pub-id pub-id-type="pmid">
         12845623
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib64">
       <label>
        64
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           M.F.
          </given-names>
         </name>
         <name>
          <surname>
           Lai
          </surname>
          <given-names>
           F.M.
          </given-names>
         </name>
         <name>
          <surname>
           To
          </surname>
          <given-names>
           K.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
        </article-title>
        <source>
         Kidney Int
        </source>
        <volume>
         67
        </volume>
        <issue>
         2
        </issue>
        <year>
         2005
        </year>
        <fpage>
         698
        </fpage>
        <lpage>
         705
        </lpage>
        <pub-id pub-id-type="pmid">
         15673319
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib65">
       <label>
        65
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Huang
          </surname>
          <given-names>
           J.W.
          </given-names>
         </name>
         <name>
          <surname>
           Hsueh
          </surname>
          <given-names>
           P.R.
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           Y.F.
          </given-names>
         </name>
         <name>
          <surname>
           Tsai
          </surname>
          <given-names>
           H.B.
          </given-names>
         </name>
         <name>
          <surname>
           Kan
          </surname>
          <given-names>
           W.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome
        </article-title>
        <source>
         Am J Kidney Dis
        </source>
        <volume>
         45
        </volume>
        <issue>
         1
        </issue>
        <year>
         2005
        </year>
        <fpage>
         88
        </fpage>
        <lpage>
         95
        </lpage>
        <pub-id pub-id-type="pmid">
         15696447
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib66">
       <label>
        66
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viral loads in clinical specimens and SARS manifestations
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         9
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1550
        </fpage>
        <lpage>
         1557
        </lpage>
        <pub-id pub-id-type="pmid">
         15498155
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib67">
       <label>
        67
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ziegler
          </surname>
          <given-names>
           A.F.
          </given-names>
         </name>
         <name>
          <surname>
           Ladman
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Dunn
          </surname>
          <given-names>
           P.A.
          </given-names>
         </name>
         <name>
          <surname>
           Schneider
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Davison
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Miller
          </surname>
          <given-names>
           P.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Nephropathogenic infectious bronchitis in Pennsylvania chickens 1997–2000
        </article-title>
        <source>
         Avian Dis
        </source>
        <volume>
         46
        </volume>
        <issue>
         4
        </issue>
        <year>
         2002
        </year>
        <fpage>
         847
        </fpage>
        <lpage>
         858
        </lpage>
        <pub-id pub-id-type="pmid">
         12495045
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib68">
       <label>
        68
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chau
          </surname>
          <given-names>
           T.N.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yao
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           T.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chow
          </surname>
          <given-names>
           T.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yeung
          </surname>
          <given-names>
           Y.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases
        </article-title>
        <source>
         Hepatology
        </source>
        <volume>
         39
        </volume>
        <issue>
         2
        </issue>
        <year>
         2004
        </year>
        <fpage>
         302
        </fpage>
        <lpage>
         310
        </lpage>
        <pub-id pub-id-type="pmid">
         14767982
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib69">
       <label>
        69
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           K.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           W.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
         <name>
          <surname>
           Sheng
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Possible central nervous system infection by SARS coronavirus
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         2
        </issue>
        <year>
         2004
        </year>
        <fpage>
         342
        </fpage>
        <lpage>
         344
        </lpage>
        <pub-id pub-id-type="pmid">
         15030709
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib70">
       <label>
        70
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           S.S.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Fu
          </surname>
          <given-names>
           C.L.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           Y.H.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           M.P.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           J.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study
        </article-title>
        <source>
         Circulation
        </source>
        <volume>
         108
        </volume>
        <issue>
         15
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1798
        </fpage>
        <lpage>
         1803
        </lpage>
        <pub-id pub-id-type="pmid">
         14504188
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib71">
       <label>
        71
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           C.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           C.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome
        </article-title>
        <source>
         Postgrad Med J
        </source>
        <volume>
         81
        </volume>
        <issue>
         956
        </issue>
        <year>
         2005
        </year>
        <fpage>
         e3
        </fpage>
        <pub-id pub-id-type="pmid">
         15937197
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib72">
       <label>
        72
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tsai
          </surname>
          <given-names>
           L.K.
          </given-names>
         </name>
         <name>
          <surname>
           Hsieh
          </surname>
          <given-names>
           S.T.
          </given-names>
         </name>
         <name>
          <surname>
           Chao
          </surname>
          <given-names>
           C.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           Y.H.
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Neuromuscular disorders in severe acute respiratory syndrome
        </article-title>
        <source>
         Arch Neurol
        </source>
        <volume>
         61
        </volume>
        <issue>
         11
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1669
        </fpage>
        <lpage>
         1673
        </lpage>
        <pub-id pub-id-type="pmid">
         15534177
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib73">
       <label>
        73
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           J.L.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           J.T.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           C.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y.C.
          </given-names>
         </name>
         <name>
          <surname>
           Hsueh
          </surname>
          <given-names>
           P.R.
          </given-names>
         </name>
         <name>
          <surname>
           Hsiao
          </surname>
          <given-names>
           C.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Rhabdomyolysis associated with probable SARS
        </article-title>
        <source>
         Am J Med
        </source>
        <volume>
         115
        </volume>
        <issue>
         5
        </issue>
        <year>
         2003
        </year>
        <fpage>
         421
        </fpage>
        <lpage>
         422
        </lpage>
        <pub-id pub-id-type="pmid">
         14553890
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib74">
       <label>
        74
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           E.B.
          </given-names>
         </name>
         <name>
          <surname>
           Sung
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9368
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1520
        </fpage>
        <lpage>
         1521
        </lpage>
        <pub-id pub-id-type="pmid">
         12737865
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib75">
       <label>
        75
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Global alert and response (GAR): revised interim case definition—novel coronavirus
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         World Health Organization
        </publisher-name>
        <publisher-loc>
         Geneva, Switzerland
        </publisher-loc>
        <comment>
         Available at:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/index.html">
         http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/index.html
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib76">
       <label>
        76
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Health protection Agency (HPA)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Infection control advice – novel coronavirus cases
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         HPA
        </publisher-name>
        <publisher-loc>
         London
        </publisher-loc>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317136232722">
         http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317136232722
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib77">
       <label>
        77
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chow
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           C.E.
          </given-names>
         </name>
         <name>
          <surname>
           Ling
          </surname>
          <given-names>
           M.L.
          </given-names>
         </name>
         <name>
          <surname>
           Heng
          </surname>
          <given-names>
           D.M.
          </given-names>
         </name>
         <name>
          <surname>
           Yap
          </surname>
          <given-names>
           S.G.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: epidemiological study
        </article-title>
        <source>
         BMJ
        </source>
        <volume>
         328
        </volume>
        <issue>
         7433
        </issue>
        <year>
         2004
        </year>
        <fpage>
         195
        </fpage>
        <pub-id pub-id-type="pmid">
         14726369
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib78">
       <label>
        78
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           K.C.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report
        </article-title>
        <source>
         J Bone Jt Surg Am
        </source>
        <volume>
         85-A
        </volume>
        <issue>
         7
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1339
        </fpage>
        <lpage>
         1342
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib79">
       <label>
        79
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bitnun
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Allen
          </surname>
          <given-names>
           U.
          </given-names>
         </name>
         <name>
          <surname>
           Heurter
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           King
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Opavsky
          </surname>
          <given-names>
           M.A.
          </given-names>
         </name>
         <name>
          <surname>
           Ford-Jones
          </surname>
          <given-names>
           E.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Children hospitalized with severe acute respiratory syndrome-related illness in Toronto
        </article-title>
        <source>
         Pediatrics
        </source>
        <volume>
         112
        </volume>
        <issue>
         4
        </issue>
        <year>
         2003
        </year>
        <fpage>
         e261
        </fpage>
        <pub-id pub-id-type="pmid">
         14523209
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib80">
       <label>
        80
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hon
          </surname>
          <given-names>
           K.L.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           W.T.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           W.C.
          </given-names>
         </name>
         <name>
          <surname>
           Kwan
          </surname>
          <given-names>
           Y.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical presentations and outcome of severe acute respiratory syndrome in children
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9370
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1701
        </fpage>
        <lpage>
         1703
        </lpage>
        <pub-id pub-id-type="pmid">
         12767737
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib81">
       <label>
        81
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kwan
          </surname>
          <given-names>
           M.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           W.M.
          </given-names>
         </name>
         <name>
          <surname>
           Ko
          </surname>
          <given-names>
           P.W.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chiu
          </surname>
          <given-names>
           M.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome can be mild in children
        </article-title>
        <source>
         Pediatr Infect Dis J
        </source>
        <volume>
         23
        </volume>
        <issue>
         12
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1172
        </fpage>
        <lpage>
         1174
        </lpage>
        <pub-id pub-id-type="pmid">
         15626963
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib82">
       <label>
        82
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Che
          </surname>
          <given-names>
           X.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         363
        </volume>
        <issue>
         9412
        </issue>
        <year>
         2004
        </year>
        <fpage>
         841
        </fpage>
        <lpage>
         845
        </lpage>
        <pub-id pub-id-type="pmid">
         15031027
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib83">
       <label>
        83
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tam
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           C.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Human metapneumovirus detection in patients with severe acute respiratory syndrome
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         9
        </volume>
        <issue>
         9
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1058
        </fpage>
        <lpage>
         1063
        </lpage>
        <pub-id pub-id-type="pmid">
         14519240
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib84">
       <label>
        84
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Kong
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of SARS coronavirus in patients with suspected SARS
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         2
        </issue>
        <year>
         2004
        </year>
        <fpage>
         294
        </fpage>
        <lpage>
         299
        </lpage>
        <pub-id pub-id-type="pmid">
         15030700
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib85">
       <label>
        85
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Che
          </surname>
          <given-names>
           X.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           G.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         SARS coronavirus detection methods
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         11
        </volume>
        <issue>
         7
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1108
        </fpage>
        <lpage>
         1111
        </lpage>
        <pub-id pub-id-type="pmid">
         16022791
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib86">
       <label>
        86
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           O.K.
          </given-names>
         </name>
         <name>
          <surname>
           Yam
          </surname>
          <given-names>
           W.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Early diagnosis of SARS coronavirus infection by real time RT-PCR
        </article-title>
        <source>
         J Clin Virol
        </source>
        <volume>
         28
        </volume>
        <issue>
         3
        </issue>
        <year>
         2003
        </year>
        <fpage>
         233
        </fpage>
        <lpage>
         238
        </lpage>
        <pub-id pub-id-type="pmid">
         14522060
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib87">
       <label>
        87
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           O.K.
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           T.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Zheng
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays
        </article-title>
        <source>
         Clin Chem
        </source>
        <volume>
         50
        </volume>
        <issue>
         1
        </issue>
        <year>
         2004
        </year>
        <fpage>
         67
        </fpage>
        <lpage>
         72
        </lpage>
        <pub-id pub-id-type="pmid">
         14709637
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib88">
       <label>
        88
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors
        </article-title>
        <source>
         J Clin Virol
        </source>
        <volume>
         30
        </volume>
        <issue>
         3
        </issue>
        <year>
         2004
        </year>
        <fpage>
         214
        </fpage>
        <lpage>
         217
        </lpage>
        <pub-id pub-id-type="pmid">
         15135737
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib89">
       <label>
        89
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           L.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ip
          </surname>
          <given-names>
           S.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lo
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           C.S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         363
        </volume>
        <issue>
         9422
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1699
        </fpage>
        <lpage>
         1700
        </lpage>
        <pub-id pub-id-type="pmid">
         15158632
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib90">
       <label>
        90
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hui
          </surname>
          <given-names>
           R.K.
          </given-names>
         </name>
         <name>
          <surname>
           Zeng
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Peiris
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           F.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <volume>
         42
        </volume>
        <issue>
         5
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1994
        </fpage>
        <lpage>
         1999
        </lpage>
        <pub-id pub-id-type="pmid">
         15131160
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib91">
       <label>
        91
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           W.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           S.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           I.J.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           Y.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H.L.
          </given-names>
         </name>
         <name>
          <surname>
           Yang
          </surname>
          <given-names>
           C.F.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         7
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1213
        </fpage>
        <lpage>
         1219
        </lpage>
        <pub-id pub-id-type="pmid">
         15324540
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib92">
       <label>
        92
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           H.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chiu
          </surname>
          <given-names>
           S.C.
          </given-names>
         </name>
         <name>
          <surname>
           Tseng
          </surname>
          <given-names>
           T.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           S.F.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
         <name>
          <surname>
           Hsu
          </surname>
          <given-names>
           Y.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         2
        </issue>
        <year>
         2004
        </year>
        <fpage>
         304
        </fpage>
        <lpage>
         310
        </lpage>
        <pub-id pub-id-type="pmid">
         15030702
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib93">
       <label>
        93
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yam
          </surname>
          <given-names>
           W.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           L.L.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <volume>
         41
        </volume>
        <issue>
         10
        </issue>
        <year>
         2003
        </year>
        <fpage>
         4521
        </fpage>
        <lpage>
         4524
        </lpage>
        <pub-id pub-id-type="pmid">
         14532176
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib94">
       <label>
        94
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Risku
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Lappalainen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Räsänen
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Vesikari
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of human coronaviruses in children with acute gastroenteritis
        </article-title>
        <source>
         J Clin Virol
        </source>
        <volume>
         48
        </volume>
        <issue>
         1
        </issue>
        <year>
         2010
        </year>
        <fpage>
         27
        </fpage>
        <lpage>
         30
        </lpage>
        <pub-id pub-id-type="pmid">
         20233673
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib95">
       <label>
        95
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Grant
          </surname>
          <given-names>
           P.R.
          </given-names>
         </name>
         <name>
          <surname>
           Garson
          </surname>
          <given-names>
           J.A.
          </given-names>
         </name>
         <name>
          <surname>
           Tedder
          </surname>
          <given-names>
           R.S.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Tam
          </surname>
          <given-names>
           J.S.
          </given-names>
         </name>
         <name>
          <surname>
           Sung
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of SARS coronavirus in plasma by real-time RT-PCR
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         349
        </volume>
        <issue>
         25
        </issue>
        <year>
         2003
        </year>
        <fpage>
         2468
        </fpage>
        <lpage>
         2469
        </lpage>
        <pub-id pub-id-type="pmid">
         14681520
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib96">
       <label>
        96
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           B.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           H.W.
          </given-names>
         </name>
         <name>
          <surname>
           Fung
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <volume>
         42
        </volume>
        <issue>
         5
        </issue>
        <year>
         2004
        </year>
        <fpage>
         2306
        </fpage>
        <lpage>
         2309
        </lpage>
        <pub-id pub-id-type="pmid">
         15131220
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib97">
       <label>
        97
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Che
          </surname>
          <given-names>
           X.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Hao
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Di
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Yin
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Xu
          </surname>
          <given-names>
           Y.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Nucleocapsid protein as early diagnostic marker for SARS
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         11
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1947
        </fpage>
        <lpage>
         1949
        </lpage>
        <pub-id pub-id-type="pmid">
         15550204
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib98">
       <label>
        98
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Che
          </surname>
          <given-names>
           X.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Qiu
          </surname>
          <given-names>
           L.W.
          </given-names>
         </name>
         <name>
          <surname>
           Pan
          </surname>
          <given-names>
           Y.X.
          </given-names>
         </name>
         <name>
          <surname>
           Wen
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Hao
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <volume>
         42
        </volume>
        <issue>
         6
        </issue>
        <year>
         2004
        </year>
        <fpage>
         2629
        </fpage>
        <lpage>
         2635
        </lpage>
        <pub-id pub-id-type="pmid">
         15184444
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib99">
       <label>
        99
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Leroy
          </surname>
          <given-names>
           E.M.
          </given-names>
         </name>
         <name>
          <surname>
           Kumulungui
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Pourrut
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Rouquet
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Hassanin
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Yaba
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Fruit bats as reservoirs of Ebola virus
        </article-title>
        <source>
         Nature
        </source>
        <volume>
         438
        </volume>
        <issue>
         7068
        </issue>
        <year>
         2005
        </year>
        <fpage>
         575
        </fpage>
        <lpage>
         576
        </lpage>
        <pub-id pub-id-type="pmid">
         16319873
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib100">
       <label>
        100
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Bats as a continuing source of emerging infections in humans
        </article-title>
        <source>
         Rev Med Virol
        </source>
        <volume>
         17
        </volume>
        <issue>
         2
        </issue>
        <year>
         2007
        </year>
        <fpage>
         67
        </fpage>
        <lpage>
         91
        </lpage>
        <pub-id pub-id-type="pmid">
         17042030
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib101">
       <label>
        101
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           S.K.
          </given-names>
         </name>
         <name>
          <surname>
           Woo
          </surname>
          <given-names>
           P.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses
        </article-title>
        <source>
         Hong Kong Med J
        </source>
        <volume>
         18
        </volume>
        <issue>
         Suppl. 2
        </issue>
        <year>
         2012
        </year>
        <fpage>
         25
        </fpage>
        <lpage>
         26
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib102">
       <label>
        102
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Seto
          </surname>
          <given-names>
           W.H.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
         <name>
          <surname>
           Ching
          </surname>
          <given-names>
           T.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           T.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9368
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1519
        </fpage>
        <lpage>
         1520
        </lpage>
        <pub-id pub-id-type="pmid">
         12737864
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib103">
       <label>
        103
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Christian
          </surname>
          <given-names>
           M.D.
          </given-names>
         </name>
         <name>
          <surname>
           Loutfy
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           McDonald
          </surname>
          <given-names>
           L.C.
          </given-names>
         </name>
         <name>
          <surname>
           Martinez
          </surname>
          <given-names>
           K.F.
          </given-names>
         </name>
         <name>
          <surname>
           Ofner
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           T.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Possible SARS coronavirus transmission during cardiopulmonary resuscitation
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         10
        </volume>
        <issue>
         2
        </issue>
        <year>
         2004
        </year>
        <fpage>
         287
        </fpage>
        <lpage>
         293
        </lpage>
        <pub-id pub-id-type="pmid">
         15030699
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib104">
       <label>
        104
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Varia
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Wilson
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Sarwal
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           McGeer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Gournis
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Galanis
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada
        </article-title>
        <source>
         CMAJ
        </source>
        <volume>
         169
        </volume>
        <issue>
         4
        </issue>
        <year>
         2003
        </year>
        <fpage>
         285
        </fpage>
        <lpage>
         292
        </lpage>
        <pub-id pub-id-type="pmid">
         12925421
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib105">
       <label>
        105
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Hung
          </surname>
          <given-names>
           I.F.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           K.S.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Tsang
          </surname>
          <given-names>
           T.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Viral load distribution in SARS outbreak
        </article-title>
        <source>
         Emerg Infect Dis
        </source>
        <volume>
         11
        </volume>
        <issue>
         12
        </issue>
        <year>
         2005
        </year>
        <fpage>
         1882
        </fpage>
        <lpage>
         1886
        </lpage>
        <pub-id pub-id-type="pmid">
         16485474
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib106">
       <label>
        106
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           I.T.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           T.W.
          </given-names>
         </name>
         <name>
          <surname>
           Tam
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           A.T.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           J.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Evidence of airborne transmission of the severe acute respiratory syndrome virus
        </article-title>
        <source>
         N Engl J Med
        </source>
        <volume>
         350
        </volume>
        <issue>
         17
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1731
        </fpage>
        <lpage>
         1739
        </lpage>
        <pub-id pub-id-type="pmid">
         15102999
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib107">
       <label>
        107
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Centers for Disease Control and Prevention (CDC)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Morbidity and mortality weekly report (MMWR) – severe respiratory illness associated with a novel coronavirus – Saudi Arabia and Qatar, 2012
        </chapter-title>
        <year>
         2012
        </year>
        <publisher-name>
         CDC
        </publisher-name>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm61e1004a1.htm%3fs_cid%3dmm61e1004a1_w">
         http://www.cdc.gov/mmwr/preview/mmwrhtml/mm61e1004a1.htm?s_cid=mm61e1004a1_w
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
      <ref id="bib108">
       <label>
        108
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lessler
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Reich
          </surname>
          <given-names>
           N.G.
          </given-names>
         </name>
         <name>
          <surname>
           Brookmeyer
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Perl
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Nelson
          </surname>
          <given-names>
           K.E.
          </given-names>
         </name>
         <name>
          <surname>
           Cummings
          </surname>
          <given-names>
           D.A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Incubation periods of acute respiratory viral infections: a systematic review
        </article-title>
        <source>
         Lancet Infect Dis
        </source>
        <volume>
         9
        </volume>
        <issue>
         5
        </issue>
        <year>
         2009
        </year>
        <fpage>
         291
        </fpage>
        <lpage>
         300
        </lpage>
        <pub-id pub-id-type="pmid">
         19393959
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib109">
       <label>
        109
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           W.M.
          </given-names>
         </name>
         <name>
          <surname>
           Kwan
          </surname>
          <given-names>
           Y.W.
          </given-names>
         </name>
         <name>
          <surname>
           Wan
          </surname>
          <given-names>
           H.S.
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           C.W.
          </given-names>
         </name>
         <name>
          <surname>
           Chiu
          </surname>
          <given-names>
           M.C.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Epidemiologic linkage and public health implication of a cluster of severe acute respiratory syndrome in an extended family
        </article-title>
        <source>
         Pediatr Infect Dis J
        </source>
        <volume>
         23
        </volume>
        <issue>
         12
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1156
        </fpage>
        <lpage>
         1159
        </lpage>
        <pub-id pub-id-type="pmid">
         15626956
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib110">
       <label>
        110
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           V.C.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           B.S.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           C.M.
          </given-names>
         </name>
         <name>
          <surname>
           Yuen
          </surname>
          <given-names>
           K.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Medical treatment of viral pneumonia including SARS in immunocompetent adult
        </article-title>
        <source>
         J Infect
        </source>
        <volume>
         49
        </volume>
        <issue>
         4
        </issue>
        <year>
         2004
        </year>
        <fpage>
         262
        </fpage>
        <lpage>
         273
        </lpage>
        <pub-id pub-id-type="pmid">
         15474623
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib111">
       <label>
        111
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Peek
          </surname>
          <given-names>
           G.J.
          </given-names>
         </name>
         <name>
          <surname>
           Moore
          </surname>
          <given-names>
           H.M.
          </given-names>
         </name>
         <name>
          <surname>
           Moore
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Sosnowski
          </surname>
          <given-names>
           A.W.
          </given-names>
         </name>
         <name>
          <surname>
           Firmin
          </surname>
          <given-names>
           R.K.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Extracorporeal membrane oxygenation for adult respiratory failure
        </article-title>
        <source>
         Chest
        </source>
        <volume>
         112
        </volume>
        <issue>
         3
        </issue>
        <year>
         1997
        </year>
        <fpage>
         759
        </fpage>
        <lpage>
         764
        </lpage>
        <pub-id pub-id-type="pmid">
         9315812
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib112">
       <label>
        112
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lewandowski
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Rossaint
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Pappert
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Gerlach
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Slama
          </surname>
          <given-names>
           K.J.
          </given-names>
         </name>
         <name>
          <surname>
           Weidemann
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation
        </article-title>
        <source>
         Intensive Care Med
        </source>
        <volume>
         23
        </volume>
        <issue>
         8
        </issue>
        <year>
         1997
        </year>
        <fpage>
         819
        </fpage>
        <lpage>
         835
        </lpage>
        <pub-id pub-id-type="pmid">
         9310799
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib113">
       <label>
        113
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hemmila
          </surname>
          <given-names>
           M.R.
          </given-names>
         </name>
         <name>
          <surname>
           Rowe
          </surname>
          <given-names>
           S.A.
          </given-names>
         </name>
         <name>
          <surname>
           Boules
          </surname>
          <given-names>
           T.N.
          </given-names>
         </name>
         <name>
          <surname>
           Miskulin
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           McGillicuddy
          </surname>
          <given-names>
           J.W.
          </given-names>
         </name>
         <name>
          <surname>
           Schuerer
          </surname>
          <given-names>
           D.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Extracorporeal life support for severe acute respiratory distress syndrome in adults
        </article-title>
        <source>
         Ann Surg
        </source>
        <volume>
         240
        </volume>
        <issue>
         4
        </issue>
        <year>
         2004
        </year>
        <fpage>
         595
        </fpage>
        <lpage>
         605
        </lpage>
        <comment>
         [discussion 605–7]
        </comment>
        <pub-id pub-id-type="pmid">
         15383787
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib114">
       <label>
        114
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Brogan
          </surname>
          <given-names>
           T.V.
          </given-names>
         </name>
         <name>
          <surname>
           Thiagarajan
          </surname>
          <given-names>
           R.R.
          </given-names>
         </name>
         <name>
          <surname>
           Rycus
          </surname>
          <given-names>
           P.T.
          </given-names>
         </name>
         <name>
          <surname>
           Bartlett
          </surname>
          <given-names>
           R.H.
          </given-names>
         </name>
         <name>
          <surname>
           Bratton
          </surname>
          <given-names>
           S.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database
        </article-title>
        <source>
         Intensive Care Med
        </source>
        <volume>
         35
        </volume>
        <issue>
         12
        </issue>
        <year>
         2009
        </year>
        <fpage>
         2105
        </fpage>
        <lpage>
         2114
        </lpage>
        <pub-id pub-id-type="pmid">
         19768656
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib115">
       <label>
        115
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           So
          </surname>
          <given-names>
           L.K.
          </given-names>
         </name>
         <name>
          <surname>
           Lau
          </surname>
          <given-names>
           A.C.
          </given-names>
         </name>
         <name>
          <surname>
           Yam
          </surname>
          <given-names>
           L.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Cheung
          </surname>
          <given-names>
           T.M.
          </given-names>
         </name>
         <name>
          <surname>
           Poon
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Yung
          </surname>
          <given-names>
           R.W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Development of a standard treatment protocol for severe acute respiratory syndrome
        </article-title>
        <source>
         Lancet
        </source>
        <volume>
         361
        </volume>
        <issue>
         9369
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1615
        </fpage>
        <lpage>
         1617
        </lpage>
        <pub-id pub-id-type="pmid">
         12747883
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib116">
       <label>
        116
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           V.W.
          </given-names>
         </name>
         <name>
          <surname>
           Dai
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.K.
          </given-names>
         </name>
         <name>
          <surname>
           Sung
          </surname>
          <given-names>
           J.J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Treatment of severe acute respiratory syndrome with convalescent plasma
        </article-title>
        <source>
         Hong Kong Med J
        </source>
        <volume>
         9
        </volume>
        <issue>
         3
        </issue>
        <year>
         2003
        </year>
        <fpage>
         199
        </fpage>
        <lpage>
         201
        </lpage>
        <pub-id pub-id-type="pmid">
         12777656
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib117">
       <label>
        117
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yeh
          </surname>
          <given-names>
           K.M.
          </given-names>
         </name>
         <name>
          <surname>
           Chiueh
          </surname>
          <given-names>
           T.S.
          </given-names>
         </name>
         <name>
          <surname>
           Siu
          </surname>
          <given-names>
           L.K.
          </given-names>
         </name>
         <name>
          <surname>
           Lin
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
         <name>
          <surname>
           Chan
          </surname>
          <given-names>
           P.K.
          </given-names>
         </name>
         <name>
          <surname>
           Peng
          </surname>
          <given-names>
           M.Y.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
        </article-title>
        <source>
         J Antimicrob Chemother
        </source>
        <volume>
         56
        </volume>
        <issue>
         5
        </issue>
        <year>
         2005
        </year>
        <fpage>
         919
        </fpage>
        <lpage>
         922
        </lpage>
        <pub-id pub-id-type="pmid">
         16183666
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib118">
       <label>
        118
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cheng
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Soo
          </surname>
          <given-names>
           Y.O.
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           W.S.
          </given-names>
         </name>
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           C.K.
          </given-names>
         </name>
         <name>
          <surname>
           Ng
          </surname>
          <given-names>
           M.H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Use of convalescent plasma therapy in SARS patients in Hong Kong
        </article-title>
        <source>
         Eur J Clin Microbiol Infect Dis
        </source>
        <volume>
         24
        </volume>
        <issue>
         1
        </issue>
        <year>
         2005
        </year>
        <fpage>
         44
        </fpage>
        <lpage>
         46
        </lpage>
        <pub-id pub-id-type="pmid">
         15616839
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib119">
       <label>
        119
       </label>
       <element-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           J.C.
          </given-names>
         </name>
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           A.Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Ooi
          </surname>
          <given-names>
           G.C.
          </given-names>
         </name>
         <name>
          <surname>
           Khong
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
         <name>
          <surname>
           Ho
          </surname>
          <given-names>
           P.L.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Pentaglobin in steroid-resistant severe acute respiratory syndrome
        </article-title>
        <source>
         Int J Tuberc Lung Dis
        </source>
        <volume>
         8
        </volume>
        <issue>
         10
        </issue>
        <year>
         2004
        </year>
        <fpage>
         1173
        </fpage>
        <lpage>
         1179
        </lpage>
        <pub-id pub-id-type="pmid">
         15527148
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib120">
       <label>
        120
       </label>
       <element-citation publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           World Health Organization (WHO)
          </surname>
         </name>
        </person-group>
        <chapter-title>
         Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care
        </chapter-title>
        <year>
         2003
        </year>
        <publisher-name>
         WHO
        </publisher-name>
        <publisher-loc>
         Geneva
        </publisher-loc>
        <comment>
         Available from:
        </comment>
        <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_6c.pdf">
         http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_6c.pdf
        </ext-link>
        <comment>
         [accessed 04.10.12]
        </comment>
       </element-citation>
      </ref>
     </ref-list>
     <ack>
      <title>
       Acknowledgements
      </title>
      <p>
       We thanked Mr. C.T. Shek and the Agriculture, Fishery and Conservation Department for the photo in
       <xref ref-type="fig" rid="fig2">
        Fig. 2
       </xref>
       . The study was partly supported by the
       <funding-source id="gs1">
        Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease of the HKSAR Department of Health
       </funding-source>
       .
      </p>
     </ack>
    </back>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <?properties manuscript?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">
       0255562
      </journal-id>
      <journal-id journal-id-type="pubmed-jr-id">
       5985
      </journal-id>
      <journal-id journal-id-type="nlm-ta">
       N Engl J Med
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       N. Engl. J. Med.
      </journal-id>
      <journal-title-group>
       <journal-title>
        The New England journal of medicine
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0028-4793
      </issn>
      <issn pub-type="epub">
       1533-4406
      </issn>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       28177862
      </article-id>
      <article-id pub-id-type="pmc">
       5362064
      </article-id>
      <article-id pub-id-type="doi">
       10.1056/NEJMsr1408795
      </article-id>
      <article-id pub-id-type="manuscript">
       EMS71785
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Middle East Respiratory Syndrome
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Arabi
         </surname>
         <given-names>
          Yaseen M.
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Balkhy
         </surname>
         <given-names>
          Hanan H.
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Hayden
         </surname>
         <given-names>
          Frederick G.
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Bouchama
         </surname>
         <given-names>
          Abderrezak
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Luke
         </surname>
         <given-names>
          Thomas
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Baillie
         </surname>
         <given-names>
          J. Kenneth
         </given-names>
        </name>
        <degrees>
         M.D., Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Al-Omari
         </surname>
         <given-names>
          Awad
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Hajeer
         </surname>
         <given-names>
          Ali H.
         </given-names>
        </name>
        <degrees>
         Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Senga
         </surname>
         <given-names>
          Mikiko
         </given-names>
        </name>
        <degrees>
         Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Denison
         </surname>
         <given-names>
          Mark R.
         </given-names>
        </name>
        <degrees>
         M.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Nguyen-Van-Tam
         </surname>
         <given-names>
          Jonathan S.
         </given-names>
        </name>
        <degrees>
         D.M.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Shindo
         </surname>
         <given-names>
          Nahoko
         </given-names>
        </name>
        <degrees>
         M.D., Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author" deceased="yes">
        <name>
         <surname>
          Bermingham
         </surname>
         <given-names>
          Alison
         </given-names>
        </name>
        <degrees>
         Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Chappell
         </surname>
         <given-names>
          James D.
         </given-names>
        </name>
        <degrees>
         M.D., Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Van Kerkhove
         </surname>
         <given-names>
          Maria D.
         </given-names>
        </name>
        <degrees>
         Ph.D.
        </degrees>
       </contrib>
       <contrib contrib-type="author">
        <name>
         <surname>
          Fowler
         </surname>
         <given-names>
          Robert A.
         </given-names>
        </name>
        <degrees>
         M.D., C.M., M.S. (Epi)
        </degrees>
       </contrib>
       <aff id="A1">
        From the Departments of Intensive Care (Y.M.A., A. Bouchama), Infection
Prevention and Control (H.H.B.), and Pathology and Laboratory (A.H.H.), King
Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences,
King Abdullah International Medical Research Center (Y.M.A., H.H.B., A.
Bouchama, A.H.H.), the Department of Intensive Care, Dr. Sulaiman Al-Habib Group
Hospitals (A.A.-O.), and Alfaisal University (A.A.-O.) — all in Riyadh,
Saudi Arabia; the Department of Medicine, Division of Infectious Diseases and
International Health, University of Virginia School of Medicine, Charlottesville
(F.G.H.); the Department of Viral and Rickettsial Diseases, Naval Medical
Research Center, Silver Spring, MD (T.L.); the Roslin Institute, University of
Edinburgh, and Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh
(J.K.B.), the Health Protection and Influenza Research Group, Division of
Epidemiology and Public Health, University of Nottingham, Nottingham
(J.S.N.-V.-T.), and the Virus Reference Laboratory, Public Health England,
London (A. Bermingham) — all in the United Kingdom; the Department of
Pandemic and Epidemic Diseases, World Health Organization, Geneva (M.S., N.S.,
R.A.F.); the Department of Pediatrics, Vanderbilt University School of Medicine,
Nashville (M.R.D., J.D.C.); the Center for Global Health, Institut Pasteur,
Paris (M.D.V.K.); and the Institute of Health Policy Management and Evaluation,
University of Toronto, and the Department of Critical Care Medicine and
Department of Medicine, Sunnybrook Health Sciences Centre — both in
Toronto (R.A.F.).
       </aff>
      </contrib-group>
      <author-notes>
       <corresp id="CR1">
        Address reprint requests to Dr. Arabi at King Saud bin Abdulaziz
University for Health Sciences, King Abdulaziz Medical City, P.O. Box 22490,
Riyadh, 11426, Saudi Arabia, or at
        <email>
         arabi@ngha.med.sa
        </email>
       </corresp>
       <fn fn-type="deceased" id="FN4">
        <p id="P39">
         Dr. Bermingham is deceased.
        </p>
       </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
       <day>
        21
       </day>
       <month>
        3
       </month>
       <year>
        2017
       </year>
      </pub-date>
      <pub-date pub-type="ppub">
       <day>
        09
       </day>
       <month>
        2
       </month>
       <year>
        2017
       </year>
      </pub-date>
      <pub-date pub-type="pmc-release">
       <day>
        09
       </day>
       <month>
        8
       </month>
       <year>
        2017
       </year>
      </pub-date>
      <volume>
       376
      </volume>
      <issue>
       6
      </issue>
      <fpage>
       584
      </fpage>
      <lpage>
       594
      </lpage>
      <!--elocation-id from pubmed: 10.1056/NEJMsr1408795-->
      <abstract>
       <title>
        Summary
       </title>
       <p id="P1">
        Between September 2012 and January 20, 2017, the World Health
Organization (WHO) received reports from 27 countries of 1879
laboratory-confirmed cases in humans of the Middle East respiratory syndrome
(MERS) caused by infection with the MERS coronavirus (MERS-CoV) and at least 659
related deaths. Cases of MERS-CoV infection continue to occur, including
sporadic zoonotic infections in humans across the Arabian Peninsula, occasional
importations and associated clusters in other regions, and outbreaks of
nonsustained human-to-human transmission in health care settings. Dromedary
camels are considered to be the most likely source of animal-to-human
transmission. MERS-CoV enters host cells after binding the dipeptidyl peptidase
4 (DPP-4) receptor and the carcinoembryonic antigen–related cell-adhesion
molecule 5 (CEACAM5) cofactor ligand, and it replicates efficiently in the human
respiratory epithelium. Illness begins after an incubation period of 2 to 14
days and frequently results in hypoxemic respiratory failure and the need for
multiorgan support. However, asymptomatic and mild cases also occur. Real-time
reverse-transcription–polymerase-chain-reaction (RT-PCR) testing of
respiratory secretions is the mainstay for diagnosis, and samples from the lower
respiratory tract have the greatest yield among seriously ill patients. There is
no antiviral therapy of proven efficacy, and thus treatment remains largely
supportive; potential vaccines are at an early developmental stage. There are
multiple gaps in knowledge regarding the evolution and transmission of the
virus, disease pathogenesis, treatment, and prospects for a vaccine. The ongoing
occurrence of MERS in humans and the associated high mortality call for a
continued collaborative approach toward gaining a better understanding of the
infection both in humans and in animals.
       </p>
       <p id="P2">
        MERS-CoV was first identified in September 2012
        <xref ref-type="bibr" rid="R1">
         1
        </xref>
        in a patient from Saudi Arabia who had hypoxemic
respiratory failure and multiorgan illness. Subsequent cases have included
infections in humans across the Arabian Peninsula, occasional importations and
associated clusters in other regions, and outbreaks of nonsustained
human-to-human transmission in health care settings (
        <xref ref-type="fig" rid="F1">
         Fig. 1
        </xref>
        ).
       </p>
      </abstract>
     </article-meta>
    </front>
   </article>
   <article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Am J Infect Control
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Am J Infect Control
      </journal-id>
      <journal-title-group>
       <journal-title>
        American Journal of Infection Control
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0196-6553
      </issn>
      <issn pub-type="epub">
       1527-3296
      </issn>
      <publisher>
       <publisher-name>
        Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc.
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       21256627
      </article-id>
      <article-id pub-id-type="pmc">
       7132663
      </article-id>
      <article-id pub-id-type="publisher-id">
       S0196-6553(10)00900-4
      </article-id>
      <article-id pub-id-type="doi">
       10.1016/j.ajic.2010.08.011
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Article
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Inactivation of surrogate coronaviruses on hard surfaces by health care germicides
       </article-title>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author" id="au1">
        <name>
         <surname>
          Hulkower
         </surname>
         <given-names>
          Rachel L.
         </given-names>
        </name>
        <degrees>
         MSPH
        </degrees>
        <xref ref-type="aff" rid="aff1">
         a
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au2">
        <name>
         <surname>
          Casanova
         </surname>
         <given-names>
          Lisa M.
         </given-names>
        </name>
        <degrees>
         PhD
        </degrees>
        <email>
         lcasanova@gsu.edu
        </email>
        <xref ref-type="aff" rid="aff2">
         b
        </xref>
        <xref ref-type="corresp" rid="cor1">
         ∗
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au3">
        <name>
         <surname>
          Rutala
         </surname>
         <given-names>
          William A.
         </given-names>
        </name>
        <degrees>
         PhD
        </degrees>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au4">
        <name>
         <surname>
          Weber
         </surname>
         <given-names>
          David J.
         </given-names>
        </name>
        <degrees>
         MD, MPH
        </degrees>
        <xref ref-type="aff" rid="aff3">
         c
        </xref>
       </contrib>
       <contrib contrib-type="author" id="au5">
        <name>
         <surname>
          Sobsey
         </surname>
         <given-names>
          Mark D.
         </given-names>
        </name>
        <degrees>
         PhD
        </degrees>
        <xref ref-type="aff" rid="aff4">
         d
        </xref>
       </contrib>
      </contrib-group>
      <aff id="aff1">
       <label>
        a
       </label>
       Centers for Disease Control and Prevention, Atlanta, GA
      </aff>
      <aff id="aff2">
       <label>
        b
       </label>
       Institute of Public Health, Georgia State University, Atlanta, GA
      </aff>
      <aff id="aff3">
       <label>
        c
       </label>
       Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC
      </aff>
      <aff id="aff4">
       <label>
        d
       </label>
       Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina Chapel Hill, Chapel Hill, NC
      </aff>
      <author-notes>
       <corresp id="cor1">
        <label>
         ∗
        </label>
        Address correspondence to Lisa M. Casanova, PhD, Institute of Public Health, Georgia State University, P.O. Box 3995, Atlanta, GA 30302.
        <email>
         lcasanova@gsu.edu
        </email>
       </corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
       <day>
        22
       </day>
       <month>
        1
       </month>
       <year>
        2011
       </year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
       <month>
        6
       </month>
       <year>
        2011
       </year>
      </pub-date>
      <pub-date pub-type="epub">
       <day>
        22
       </day>
       <month>
        1
       </month>
       <year>
        2011
       </year>
      </pub-date>
      <volume>
       39
      </volume>
      <issue>
       5
      </issue>
      <fpage>
       401
      </fpage>
      <lpage>
       407
      </lpage>
      <permissions>
       <copyright-statement>
        Copyright © 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2011
       </copyright-year>
       <copyright-holder>
        Association for Professionals in Infection Control and Epidemiology, Inc.
       </copyright-holder>
       <license>
        <license-p>
         Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
        </license-p>
       </license>
      </permissions>
      <abstract>
       <sec>
        <title>
         Background
        </title>
        <p>
         In the 2003 severe acute respiratory syndrome outbreak, finding viral nucleic acids on hospital surfaces suggested surfaces could play a role in spread in health care environments. Surface disinfection may interrupt transmission, but few data exist on the effectiveness of health care germicides against coronaviruses on surfaces.
        </p>
       </sec>
       <sec>
        <title>
         Methods
        </title>
        <p>
         The efficacy of health care germicides against 2 surrogate coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), was tested using the quantitative carrier method on stainless steel surfaces. Germicides were o-phenylphenol/p-tertiary amylphenol) (a phenolic), 70% ethanol, 1:100 sodium hypochlorite, ortho-phthalaldehyde (OPA), instant hand sanitizer (62% ethanol), and hand sanitizing spray (71% ethanol).
        </p>
       </sec>
       <sec>
        <title>
         Results
        </title>
        <p>
         After 1-minute contact time, for TGEV, there was a log
         <sub>
          10
         </sub>
         reduction factor of 3.2 for 70% ethanol, 2.0 for phenolic, 2.3 for OPA, 0.35 for 1:100 hypochlorite, 4.0 for 62% ethanol, and 3.5 for 71% ethanol. For MHV, log
         <sub>
          10
         </sub>
         reduction factors were 3.9 for 70% ethanol, 1.3 for phenolic, 1.7 for OPA, 0.62 for 1:100 hypochlorite, 2.7 for 62% ethanol, and 2.0 for 71% ethanol.
        </p>
       </sec>
       <sec>
        <title>
         Conclusion
        </title>
        <p>
         Only ethanol reduced infectivity of the 2 coronaviruses by &gt;3-log
         <sub>
          10
         </sub>
         after 1 minute. Germicides must be chosen carefully to ensure they are effective against viruses such as severe acute respiratory syndrome coronavirus.
        </p>
       </sec>
      </abstract>
      <kwd-group>
       <title>
        Key Words
       </title>
       <kwd>
        Coronavirus
       </kwd>
       <kwd>
        disinfection
       </kwd>
       <kwd>
        surfaces
       </kwd>
       <kwd>
        severe acute respiratory syndrome
       </kwd>
       <kwd>
        SARS
       </kwd>
       <kwd>
        environmental
       </kwd>
      </kwd-group>
     </article-meta>
    </front>
    <p id="p0010">
     Health care-associated infections are responsible for thousands of deaths worldwide each year.
     <xref ref-type="bibr" rid="bib1">
      <sup>
       1
      </sup>
     </xref>
     Approximately 5% of all nosocomial infections are because of viral exposure,
     <xref ref-type="bibr" rid="bib2">
      <sup>
       2
      </sup>
     </xref>
     and, in pediatric wards, viruses account for at least 30% of health care-associated infections. Studies have shown viruses to be common in health care environments and capable of surviving for extended periods of time on environmental surfaces.
     <xref ref-type="bibr" rid="bib3">
      <sup>
       3
      </sup>
     </xref>
     In these settings, health care workers, medical devices, and environmental surfaces can act as both a reservoir for infection and a mode of transmission of infection to patients and staff.
     <xref ref-type="bibr" rid="bib4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="bib5">
      5
     </xref>
    </p>
    <p id="p0015">
     In 2003, the nosocomial transmission of viral disease proved to be a major contributor to a worldwide outbreak of severe acute respiratory syndrome (SARS), caused by a novel human coronavirus (CoV) (SARS-CoV). Outbreaks of SARS occurred in multiple health care facilities, infecting patients, staff, visitors, and volunteers.
     <xref ref-type="bibr" rid="bib6">
      <sup>
       6
      </sup>
     </xref>
     SARS-CoV was also found on environmental surfaces in hospitals where outbreaks occurred,
     <xref ref-type="bibr" rid="bib7">
      <sup>
       7
      </sup>
     </xref>
     and studies demonstrated that it could survive on surfaces for 24 to 72 hours.
     <xref ref-type="bibr" rid="bib8">
      <sup>
       8
      </sup>
     </xref>
     Airborne transmission was the main route of spread; however, Rabenau et al
     <xref ref-type="bibr" rid="bib9">
      <sup>
       9
      </sup>
     </xref>
     observed that “there are a number of instances when transmission occurred through other means that are often still not well defined,” and other studies of outbreak settings showed that providing handwashing facilities reduced transmission in hospitals,
     <xref ref-type="bibr" rid="bib10">
      <sup>
       10
      </sup>
     </xref>
     suggesting that hands and surfaces could have played a role in transmission. The outbreak highlighted the need for effective and quick evaluation of means for controlling the spread of nosocomial infection.
     <xref ref-type="bibr" rid="bib11">
      <sup>
       11
      </sup>
     </xref>
    </p>
    <p id="p0020">
     Disinfection of hospital surfaces is an effective measure for reducing the risk of exposure for health care workers and patients;
     <xref ref-type="bibr" rid="bib12">
      <sup>
       12
      </sup>
     </xref>
     appropriate disinfection of contaminated surfaces and equipment is crucial in interrupting the spread of viruses such as SARS-CoV.
     <xref ref-type="bibr" rid="bib8">
      8
     </xref>
     ,
     <xref ref-type="bibr" rid="bib13">
      13
     </xref>
     ,
     <xref ref-type="bibr" rid="bib14">
      14
     </xref>
     ,
     <xref ref-type="bibr" rid="bib15">
      15
     </xref>
     However, to assist in the selection of appropriate germicidal agents for use against coronaviruses on hospital surfaces and equipment, data are needed on the effectiveness of commonly used hospital germicides against coronaviruses. These data must accurately reflect disinfectant efficacy against viruses under the conditions in which they occur on surfaces, such as desiccation and embedding in proteinaceous matrices. Many previous disinfection studies have used liquid suspension methods for testing germicide efficacy.
     <xref ref-type="bibr" rid="bib16">
      16
     </xref>
     ,
     <xref ref-type="bibr" rid="bib17">
      17
     </xref>
     ,
     <xref ref-type="bibr" rid="bib18">
      18
     </xref>
     These studies report greater efficacy against viruses than studies performed with carrier methods. Viruses may be more resistant on surfaces than in suspension because they can adsorb to the surface or become embedded in organic material
     <xref ref-type="bibr" rid="bib19">
      <sup>
       19
      </sup>
     </xref>
     and may be more difficult to inactivate with chemical germicides than viruses suspended in liquid. Thus, it is possible that suspension tests overestimate the level of antimicrobial activity of germicides against viruses on surfaces. Carrier-based methods may more closely resemble real environmental conditions in which viruses contaminate surfaces and provide a more conservative estimate of germicide activity against viruses that are dried onto environmental surfaces.
    </p>
    <p id="p0025">
     This study was undertaken using the carrier method to evaluate 6 chemical germicides commonly used in health care settings for their efficacy in reducing infectivity of coronaviruses on environmental surfaces. The germicides selected were 4 surface germicides and 2 hand sanitizers. Although hand sanitizers are not used for surface disinfection, the quantitative carrier test can help determine whether or not the active ingredients are effective against coronaviruses. Germicide evaluation was done using 2 non-human coronaviruses as surrogates for the
     <italic>
      Coronaviridae
     </italic>
     family and pathogenic human coronavirus such as SARS-CoV. The family
     <italic>
      Coronaviridae
     </italic>
     is divided into 3 groups. Groups I and II include human, mammalian, and avian coronaviruses, and group III consists of avian coronaviruses. Although SARS is thought to be related to the group 2 coronaviruses,
     <xref ref-type="bibr" rid="bib20">
      <sup>
       20
      </sup>
     </xref>
     and phylogenetic analyses have indicated it may be closely related to mouse hepatitis virus (MHV),
     <xref ref-type="bibr" rid="bib21">
      <sup>
       21
      </sup>
     </xref>
     there is still disagreement about the exact placement of SARS-CoV within the coronavirus family.
     <xref ref-type="bibr" rid="bib22">
      <sup>
       22
      </sup>
     </xref>
     Based on this uncertainty, 1 representative of each group of mammalian coronaviruses was included in the study to determine whether there was any difference in their survival and persistence in water. The 2 viruses included in the study were transmissible gastroenteritis virus (TGEV), a diarrheal pathogen of swine and a member of the group I coronaviruses, and mouse hepatitis virus (MHV), a pathogen of laboratory mice and a member of the group II coronaviruses.
     <xref ref-type="bibr" rid="bib20">
      <sup>
       20
      </sup>
     </xref>
    </p>
    <sec id="sec2">
     <title>
      Materials and methods
     </title>
     <sec id="sec2.1">
      <title>
       Preparation of viral stocks
      </title>
      <p id="p0030">
       MHV and TGEV were kindly provided by R. Baric, University of North Carolina, Chapel Hill. TGEV was grown in swine testicular cell cultures. MHV was grown in delayed brain tumor cell cultures. Viral stocks were propagated by infecting confluent layers of host cell cultures in flasks, harvesting cell lysates, clarifying by centrifugation (3,000
       <italic>
        g
       </italic>
       , 30 minutes, 4°C), and storing resulting supernatants as virus stock at −80°C. Viral titers were determined by the plaque assay method on confluent host cell layers in 60-mm Petri dishes with overlay medium consisting of 1% agarose, Eagle’s minimum essential medium, 10% bovine serum replacement (Fetal Clone II; Hyclone, Logan, UT), 10% lactalbumin hydrolysate, and gentamicin (0.1 mg/mL)/kanamycin (0.05 mg/mL). Cell layers were stained with a second overlay containing 1% neutral red at 48 hours postinfection, and plaques were visualized at 72 hours postinfection.
      </p>
     </sec>
     <sec id="sec2.2">
      <title>
       Preparation of hard water
      </title>
      <p id="p0035">
       Hard water was prepared according to the USEPA OPP microbiology laboratory standard operating procedure for disinfectant sample preparation
       <xref ref-type="bibr" rid="bib23">
        <sup>
         23
        </sup>
       </xref>
       from 2 stock solutions: solution A (14.01 g of NaHCO
       <sub>
        3
       </sub>
       , 250 mL of sterile deionized water) and solution B (16.94 g MgCL
       <sub>
        2
       </sub>
       -6H
       <sub>
        2
       </sub>
       O, 18.50 g CaCl
       <sub>
        2
       </sub>
       , 250 mL sterile deionized water). Solution A was filter sterilized using 0.22-μm pore size filters; solution B was autoclaved at 121°C for 30 minutes.
      </p>
      <p id="p0040">
       For hard water preparation 12 mL of solution A and 12 mL of solution B were added to a volumetric flask and brought up to 1 L with sterile deionized water. This solution was diluted with 2 additional liters of sterile deionized water. Final solution was adjusted to pH 7.6 to 8.0 by drop wise addition of sodium hydroxide or citric acid. A hardness testing kit (Hach Model 5-EP mg/L No. 1454-01; Hach Corp, Loveland, CO) was used to confirm that hardness of the prepared water was 380 to 400 mg/L CaCO
       <sub>
        3
       </sub>
       .
      </p>
     </sec>
     <sec id="sec2.3">
      <title>
       Germicides
      </title>
      <p id="p0045">
       Six hospital-grade germicides were tested. The germicide types, active ingredients, and use-dilutions are summarized in
       <xref ref-type="table" rid="tbl1">
        Table 1
       </xref>
       . Germicides requiring dilution were prepared on the day of the experiment, using hard water as the diluent. All germicides were used by the manufacturer’s expiration date.
       <table-wrap id="tbl1" position="float">
        <label>
         Table 1
        </label>
        <caption>
         <p>
          Germicides tested
         </p>
        </caption>
        <table frame="hsides" rules="groups">
         <thead>
          <tr>
           <th>
            Germicide
           </th>
           <th>
            Type
           </th>
           <th>
            Active ingredient
           </th>
           <th>
            Use-dilution
           </th>
          </tr>
         </thead>
         <tbody>
          <tr>
           <td>
            Steris Vesphene IIse Non-sterile disinfectant cleaner
           </td>
           <td>
            Phenol
           </td>
           <td>
            9.09% O-phenylphenol, 7.66% P-tertiary amylphenol
           </td>
           <td>
            1:128
           </td>
          </tr>
          <tr>
           <td>
            Chlorine bleach
           </td>
           <td>
            Halogen
           </td>
           <td>
            6% Sodium hypochlorite
           </td>
           <td>
            1:100 (∼600 mg/L)
           </td>
          </tr>
          <tr>
           <td>
            Cidex OPA
           </td>
           <td>
            Aldehyde
           </td>
           <td>
            0.55% Ortho-phthalaldehyde
           </td>
           <td>
            Undiluted
           </td>
          </tr>
          <tr>
           <td>
            70% Ethanol
           </td>
           <td>
            Alcohol
           </td>
           <td>
            70% Ethanol
           </td>
           <td>
            Undiluted
           </td>
          </tr>
          <tr>
           <td>
            Purell hand sanitizer
           </td>
           <td>
            Alcohol
           </td>
           <td>
            62% Ethanol
           </td>
           <td>
            Undiluted
           </td>
          </tr>
          <tr>
           <td>
            Clorox Anywhere hand sanitizing spray
           </td>
           <td>
            Alcohol
           </td>
           <td>
            71% Ethanol
           </td>
           <td>
            Undiluted
           </td>
          </tr>
         </tbody>
        </table>
       </table-wrap>
      </p>
     </sec>
     <sec id="sec2.4">
      <title>
       Neutralizing solutions
      </title>
      <p id="p0050">
       Neutralizing solutions were used to inactivate germicide activity after the experimental contact time. Vesphene IIse (Steris Corp, Mentor, OH), 70% ethanol, Clorox Anywhere spray (Clorox Co, Oakland, CA), and Purell Sanitizing Hand Gel (Johnson &amp; Johnson Inc, New Brunswick, NJ) were neutralized using 3% glycine. Chlorine bleach was neutralized with 0.1% thiosulfate and Cidex-OPA (Johnson &amp; Johnson Inc, New Brunswick, NJ) with 0.5% sodium bisulfite. To prevent cytotoxicity in cell culture assays, each neutralizing solution, with the exception of 3% glycine, was prepared as a stock solution and diluted to the use concentration with cell culture medium. Glycine was prepared by adding 2.5 mL cell culture medium to 47.5 mL of a 3% glycine solution. Sodium thiosulfate was prepared as a 10% (wt/vol) stock solution and diluted with cell culture medium to a use concentration of 0.1%. Sodium bisulfite was prepared as a 5% stock solution and diluted in cell culture medium to a use concentration of 0.5%.
      </p>
     </sec>
     <sec id="sec2.5">
      <title>
       Disc-based quantitative carrier test method for virus disinfection
      </title>
      <p id="p0055">
       Test surfaces were 1-cm
       <sup>
        2
       </sup>
       stainless steel carriers with a No. 4 polish. The quantitative carrier test method used was adapted from Sattar et al.
       <xref ref-type="bibr" rid="bib19">
        <sup>
         19
        </sup>
       </xref>
       Each germicide experiment used 3 control carriers (no germicide applied) and 3 test carriers (germicide applied). Each experiment was performed in duplicate. Each carrier was placed in a 24-well plate, and 20 μL of virus suspension was applied. The virus was allowed to dry for 2 hours. After drying, 50 μL of use-dilution germicide was placed on the dried virus suspension on 3 test carriers, and 50 μL of cell culture medium was placed on 3 control carriers. After 1-minute contact time, 950 μL of neutralizing solution was added to the 3 test carriers to halt virucidal activity, and 950 μL of cell culture medium was added to the control carriers. To elute viruses from carriers, 150 μL of 15% beef extract (pH 7.5) was then added to all 6 carriers. Carriers were agitated on a shaking platform (60 rpm) for 20 minutes. The liquid from each well was then recovered, diluted, and assayed for virus infectivity as previously described. To determine the reduction in virus infectivity, the concentration of virus per 20-μL sample volume was calculated. Reduction in viral titer was calculated using difference in virus concentration between test carriers and control carriers. Log
       <sub>
        10
       </sub>
       reductions were calculated for each germicide based on 6 independent exposure trials.
      </p>
     </sec>
     <sec id="sec2.6">
      <title>
       Statistical analysis
      </title>
      <p id="p0060">
       Statistical analysis was performed using SAS 9.1 (2008; SAS Institute Inc, Cary, NC). A 1-way analysis of variance (ANOVA) was used to compare the log
       <sub>
        10
       </sub>
       reduction among germicides. Additionally, a 2-way ANOVA was performed to compare the efficacy of all surface germicides between the 2 virus types.
      </p>
     </sec>
    </sec>
    <sec id="sec3">
     <title>
      Results
     </title>
     <p id="p0065">
      Reductions of MHV and TGEV infectivity on surfaces by hospital germicides are shown in
      <xref ref-type="table" rid="tbl2">
       Table 2
      </xref>
      . For MHV, only 70% ethanol and Purell Hand Gel (62% ethanol) produced a log
      <sub>
       10
      </sub>
      infectious virus titer reduction factor &gt;2.5 after 1-minute contact time. Hypochlorite (1:100 use dilution) was least effective, producing a log
      <sub>
       10
      </sub>
      reduction factor &lt;1. Hypochlorite, Vesphene IIse, Cidex-OPA, and Clorox Anywhere spray each produced a log
      <sub>
       10
      </sub>
      reduction factor of &lt;2.5, with log
      <sub>
       10
      </sub>
      reduction factors of 0.62, 1.33, 1.71, and 1.98, respectively. Statistical analysis using 1-way ANOVA showed that the mean log
      <sub>
       10
      </sub>
      reduction factors for the 6 germicides differed significantly (
      <italic>
       P
      </italic>
      &lt; .0001).
      <table-wrap id="tbl2" position="float">
       <label>
        Table 2
       </label>
       <caption>
        <p>
         Disinfection efficacy against MHV and TGEV on carrier surfaces
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
          </th>
          <th colspan="2">
           Log
           <sub>
            10
           </sub>
           infectivity reduction (95% CI)
           <hr/>
          </th>
         </tr>
         <tr>
          <th>
           Germicide
          </th>
          <th>
           MHV
          </th>
          <th>
           TGEV
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td>
           Chlorine bleach
          </td>
          <td align="char">
           0.62 (0.52-0.72)
          </td>
          <td align="char">
           0.35 (0.24-0.45)
          </td>
         </tr>
         <tr>
          <td>
           Vesphene IIse
          </td>
          <td align="char">
           1.33 (1.16-1.51)
          </td>
          <td align="char">
           2.03 (0.89-3.17)
          </td>
         </tr>
         <tr>
          <td>
           Cidex-OPA
          </td>
          <td align="char">
           1.71 (1.35-20.7)
          </td>
          <td align="char">
           2.27 (2.09-2.45)
          </td>
         </tr>
         <tr>
          <td>
           70% Ethanol
          </td>
          <td align="char">
           3.92 (3.32-4.53)
          </td>
          <td align="char">
           3.19 (2.97-3.40)
          </td>
         </tr>
         <tr>
          <td>
           Purell hand sanitizer
          </td>
          <td align="char">
           2.66 (1.77-3.56)
          </td>
          <td align="char">
           4.04 (3.57-4.51)
          </td>
         </tr>
         <tr>
          <td>
           Clorox Anywhere hand sanitizing spray
          </td>
          <td align="char">
           1.98 (1.68-2.27)
          </td>
          <td align="char">
           3.51 (3.29-3.73)
          </td>
         </tr>
        </tbody>
       </table>
       <table-wrap-foot>
        <fn>
         <p>
          <italic>
           CI
          </italic>
          , confidence interval.
         </p>
        </fn>
       </table-wrap-foot>
      </table-wrap>
     </p>
     <p id="p0070">
      For TGEV, infectivity reduction factors of &gt;3-log
      <sub>
       10
      </sub>
      were observed for 70% ethanol (3.19), Purell Hand Gel (4.04), and Clorox Anywhere spray (3.57). Vesphene and Cidex against TGEV produced intermediate log
      <sub>
       10
      </sub>
      infectivity reduction factors of 2.03 and 2.27, respectively. As seen with MHV, hypochlorite exposure resulted in an infectious TGEV titer log
      <sub>
       10
      </sub>
      reduction factor &lt;1 (0.35). Statistical analysis using 1-way ANOVA showed that the mean log
      <sub>
       10
      </sub>
      reduction factors were significantly different (
      <italic>
       P
      </italic>
      &lt; .0001) among the 6 germicides.
     </p>
     <p id="p0075">
      Analysis of the mean log
      <sub>
       10
      </sub>
      reductions of MHV and TGEV by germicides was done using the Tukey multiple comparison test to determine whether reductions by individual germicides significantly differed from one another (
      <italic>
       P
      </italic>
      &lt; .05) (
      <xref ref-type="table" rid="tbl3">
       Table 3
      </xref>
      ). In addition, 2-way ANOVA was used to compare 2 independent variables, germicide and virus type, and their influence on the log
      <sub>
       10
      </sub>
      virus reduction factor. This analysis aids in determining how much of the variability in reduction is explained by each of these 2 variables, as well as potential interaction between them. Using 2-way ANOVA, infectivity reduction results are statistically significant (
      <italic>
       P
      </italic>
      &lt; .0001). A type III sum of squares test was used to examine variation among mean reduction results. Germicide had a greater influence on log
      <sub>
       10
      </sub>
      viral reduction (
      <italic>
       P
      </italic>
      &lt; .0001) than did the virus type (TGEV vs MHV) (
      <italic>
       P
      </italic>
      = .0008). Additionally, when interaction between germicide and virus type was evaluated using the ANOVA test, it was determined that there is a statistically significant interaction between virus type and germicide type (
      <italic>
       P
      </italic>
      = .0001).
      <table-wrap id="tbl3" position="float">
       <label>
        Table 3
       </label>
       <caption>
        <p>
         Statistical comparison of disinfectant efficacy for TGEV and MHV
        </p>
       </caption>
       <table frame="hsides" rules="groups">
        <thead>
         <tr>
          <th>
          </th>
          <th colspan="2">
           Significant (
           <italic>
            P
           </italic>
           &lt; .05)
           <hr/>
          </th>
         </tr>
         <tr>
          <th>
           Comparison
          </th>
          <th>
           MHV
          </th>
          <th>
           TGEV
          </th>
         </tr>
        </thead>
        <tbody>
         <tr>
          <td>
           Bleach vs Vesphene
          </td>
          <td>
           No
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Bleach vs Cidex
          </td>
          <td>
           Yes
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Bleach vs 70% ethanol
          </td>
          <td>
           Yes
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Bleach vs Purell
          </td>
          <td>
           Yes
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Bleach vs Clorox spray
          </td>
          <td>
           Yes
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Vesphene vs Cidex
          </td>
          <td>
           No
          </td>
          <td>
           No
          </td>
         </tr>
         <tr>
          <td>
           Vesphene vs 70% ethanol
          </td>
          <td>
           Yes
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Vesphene vs Purell
          </td>
          <td>
           Yes
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Vesphene vs Clorox spray
          </td>
          <td>
           No
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Cidex vs 70% ethanol
          </td>
          <td>
           Yes
          </td>
          <td>
           No
          </td>
         </tr>
         <tr>
          <td>
           Cidex vs Purell
          </td>
          <td>
           No
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           Cidex vs Clorox spray
          </td>
          <td>
           No
          </td>
          <td>
           Yes
          </td>
         </tr>
         <tr>
          <td>
           70% Ethanol vs Purell
          </td>
          <td>
           Yes
          </td>
          <td>
           No
          </td>
         </tr>
         <tr>
          <td>
           70% Ethanol vs Clorox spray
          </td>
          <td>
           Yes
          </td>
          <td>
           No
          </td>
         </tr>
         <tr>
          <td>
           Purell vs Clorox spray
          </td>
          <td>
           No
          </td>
          <td>
           No
          </td>
         </tr>
        </tbody>
       </table>
      </table-wrap>
     </p>
    </sec>
    <sec id="sec4">
     <title>
      Discussion
     </title>
     <p id="p0080">
      Health care-associated transmission can play an important role in the spread of coronavirus infection, and coronavirus nucleic acids have been found on hospital surfaces in outbreak settings.
      <xref ref-type="bibr" rid="bib7">
       <sup>
        7
       </sup>
      </xref>
      Data from surrogate coronaviruses suggest that these viruses can survive for long periods on hard surfaces, potentially posing a continued risk of infection if health care surfaces are not adequately disinfected. The efficacy of 6 hospital surface germicides was tested against 2 coronaviruses, MHV and TGEV, used as surrogates for SARS-CoV. These findings expand the available data on disinfection beyond what has been previously studied using other surrogates such as human coronavirus 229E. Although 229E shares some tissue tropism with SARS, there are important differences. Studies of SARS patients and outbreaks demonstrated that SARS-CoV is also a fecally shed virus, with intestinal tissue tropism; 229E lacks this. This may indicate important differences in resistance to environmental stressors because fecally shed viruses must be able to survive the conditions in the gastrointestinal tract, including extremes of pH, abundance of other microbes, and bile salts. This gastrointestinal tropism has played an important role in at least 1 major outbreak; this suggests that surrogates such as MHV (a virus with multiple tropisms) and TGEV (an enteric virus) that reflect this diversity in tissue tropism are necessary.
     </p>
     <p id="p0085">
      A log
      <sub>
       10
      </sub>
      viral reduction factor of &gt;3 has been previously suggested as a benchmark for effective virucidal activity against coronaviruses and other viruses on surfaces.
      <xref ref-type="bibr" rid="bib3">
       3
      </xref>
      ,
      <xref ref-type="bibr" rid="bib15">
       15
      </xref>
      ,
      <xref ref-type="bibr" rid="bib17">
       17
      </xref>
      ,
      <xref ref-type="bibr" rid="bib24">
       24
      </xref>
      The results of this study show that, of the commonly used hospital germicides tested, only the ethanol-based germicides were able to achieve this level of reduction of infectious virus after 1 minute of contact time. For MHV, the 3 ethanol-based germicides (71%, 70%, and 62% ethanol) gave the greatest reduction in infectivity, with log
      <sub>
       10
      </sub>
      reduction factors ranging from 1.5 to 4.9. This was greater than the reductions observed with hypochlorite, phenolic, and orthophthalaldehyde based germicides. These same performance trends are evident in tests of these germicides against TGEV. The ethanol-based germicides gave log
      <sub>
       10
      </sub>
      infectivity reduction factors ranging from 2.9 to 4.6, greater than those observed for hypochlorite, phenolic, and orthophthalaldehyde germicides. The phenolic and orthophthalaldehyde germicides had greater virucidal activity against TGEV than against MHV. However, only the reductions in infectivity by orthophthalaldehyde were significantly different between MHV and TGEV. Statistical analysis indicates that mean log
      <sub>
       10
      </sub>
      viral reductions differed significantly based on both the type of germicide and the type of virus tested and that there are interaction effects between germicide and virus type. Hence, both the selection of germicide and the type of virus will influence the resultant magnitude of reduction of virus infectivity titer.
     </p>
     <p id="p0090">
      Several previous studies have determined that surface disinfection is an important method for preventing viral transmission from surfaces to humans.
      <xref ref-type="bibr" rid="bib17">
       <sup>
        17
       </sup>
      </xref>
      The risk of acquiring infection decreases proportionately to the amount of viral agent present on surfaces.
      <xref ref-type="bibr" rid="bib3">
       <sup>
        3
       </sup>
      </xref>
      This study shows that ethanol-based germicides achieve the greatest reduction in viral titer on surfaces. These findings are consistent with previous studies of coronavirus disinfection, but this study provides more precise estimates of inactivation on surfaces than have been previously observed with other human coronaviruses, such as 229E.
     </p>
     <p id="p0095">
      Some previous studies of chemical disinfection of 229E have been limited by cytotoxicity problems that limited the ability to measure infectious virus reduction.
      <xref ref-type="bibr" rid="bib25">
       <sup>
        25
       </sup>
      </xref>
      Sattar et al
      <xref ref-type="bibr" rid="bib26">
       <sup>
        26
       </sup>
      </xref>
      found that 70% ethanol reduced human coronavirus 229E dried onto a stainless steel surface by &gt;99.9%. This study shows that the actual reduction is slightly greater than 3-log
      <sub>
       10
      </sub>
      (3.9 for TGEV and 3.19 for MHV). The available data on disinfection of SARS-CoV itself are not extensive, partly because of the challenges of working with SARS. Much of the available data focuses on alcohols. Seventy percent ethanol was found in 1 study to inactivate SARS by &gt;3 log
      <sub>
       10
      </sub>
      .
      <xref ref-type="bibr" rid="bib27">
       <sup>
        27
       </sup>
      </xref>
      Rabenau et al
      <xref ref-type="bibr" rid="bib9">
       <sup>
        9
       </sup>
      </xref>
      reported a log
      <sub>
       10
      </sub>
      reduction factor of &gt;5 after 30-second contact time using 78% ethanol and 70% propoanol, a reduction that was actually greater than what they observed with other germicides classified as chemical steriliants. These results support the findings of this study that ethanol-based disinfectants are efficacious against coronaviruses. However, flammability limits the use of ethanol for spills or contamination events involving large surface areas.
     </p>
     <p id="p0100">
      Other studies show that disinfectant efficacy can vary by virus type, with nonenveloped viruses such as adenovirus differing from enveloped viruses such as the coronaviruses. Studies of hospital germicide efficacy against adenovirus 8 using the same carrier-based method with 1-minute contact times found greater log
      <sub>
       10
      </sub>
      reduction factors by OPA (4.37) than were observed in this study for TGEV (2.27) and MHV (1.71). In contrast, Vesphene IIse reduced adenovirus 8 by a log
      <sub>
       10
      </sub>
      reduction factor of only 0.41, compared with 1.33 for MHV and 2.03 for TGEV in this study. Reduction of adenovirus 8 by 70% ethanol was similar to that observed for coronavirus in this study, but 0.12% hypochlorite reduced adenovirus 8 approximately 4-log
      <sub>
       10
      </sub>
      greater than reductions observed for coronaviruses with 0.06% hypochlorite.
      <xref ref-type="bibr" rid="bib5">
       <sup>
        5
       </sup>
      </xref>
      This suggests that disinfection efficacy may differ greatly by virus type and that nonenveloped viruses may not be appropriate surrogates for predicting the effects of disinfectants on enveloped viruses such as coronavirus and influenza.
     </p>
     <p id="p0105">
      Hypochlorite demonstrated a log
      <sub>
       10
      </sub>
      reduction factor &lt;1 after 1 minute for both TGEV and MHV when applied at the 1:100 (0.06%) use-dilution prescribed by the manufacturer. Previous studies of coronavirus disinfection have found higher reductions with concentrations of hypochlorite greater than the recommended use-dilution, suggesting these results are consistent with a concentration-dependent effect. Sattar et al
      <xref ref-type="bibr" rid="bib26">
       <sup>
        26
       </sup>
      </xref>
      reported 99.9% reduction of viral titer for human coronavirus 229E when 0.10% and 0.50% sodium hypochlorite solutions were tested with 1-minute contact times. Commercial marketers of sodium hypochlorite recommend contact time of 5 minutes. In actual use, it is likely that contact times are shorter than this, and increases in concentration may be necessary to offset the use of shorter contact times. The results of this study suggest that the 1:100 use-dilution should not be recommended for use on surfaces with suspected contamination by coronaviruses. Hypochlorite is an important environmental surface disinfectant in health care; without the flammability and rapid evaporation of ethanol, it is suitable for large surface area spills. Increases in both sodium hypochlorite concentration and contact time should be evaluated to determine whether these factors would improve virucidal activity of hypochlorite on hard surfaces to achieve a &gt;3-log
      <sub>
       10
      </sub>
      reduction performance target.
     </p>
     <p id="p0110">
      Organic matter may play an important role in the poor performance of hypochlorite on surfaces observed in this study. A concentration of 600 mg/L on a surface produced a log
      <sub>
       10
      </sub>
      reduction factor &lt;1 of MHV and TGEV in this study. The poor performance of hypochlorite against viruses dried into surfaces may be due to the high oxidant demand exerted by the proteinaceous cell culture medium matrix in which the viruses were suspended. This results in consumption of available hypochlorite by the proteins and other organic compounds (eg, amino acids) present in the matrix, rendering it unavailable for disinfection. Use of viruses suspended in a proteinaceous matrix simulates the real world conditions under which viruses shed by human hosts occur in health care environments. Viruses are not shed by an infected host as single purified particles; they occur as aggregates, surrounded by membranes and embedded in feces, mucus, and other proteinaceous matrices. Together, these results suggest that changing the recommended use-dilution of hypochlorite may address the problem of oxidant demand exerted by proteinaceous material such as body fluids and result in effective inactivation of coronaviruses shed from human hosts.
     </p>
     <p id="p0115">
      Hypochlorite, phenolic, and OPA disinfectants tested reduced infectious viral titer by &lt;3 log
      <sub>
       10
      </sub>
      after 1-minute contact time. OPA is used as a high-level disinfectant for semicritical equipment such as endoscopes;
      <xref ref-type="bibr" rid="bib28">
       <sup>
        28
       </sup>
      </xref>
      viruses can be deposited on the surfaces of semicritical equipment items during patient care. These results suggest that sufficient contact time is crucial to ensure that inactivation of viruses on the surfaces of semicritical equipment items takes place. According to the manufacturer, the phenolic disinfectant tested demonstrated a 3- to 4-log
      <sub>
       10
      </sub>
      reduction in viral titer after 10 minutes contact time when tested against another surrogate coronavirus, avian infectious bronchitis virus. The results from this study, using 1-minute contact time, suggest that virucidal efficacy is greatly compromised if germicides are not used according to label directions and contact time is shorter than manufacturer recommended contact times.
     </p>
     <p id="p0120">
      Enveloped viruses of great nosocomial importance and pandemic potential, such as SARS CoV and avian influenza, are extremely challenging to work with in the laboratory. In the event of re-emergence of SARS-CoV, and in the context of pandemic influenza control, data are needed to guide decisions on appropriate disinfection of health care surfaces for control of viral transmission. TGEV and MHV are nonpathogenic to humans and easily propagated and assayed in cell culture by plaque and quantal MPN assays.
      <xref ref-type="bibr" rid="bib29">
       29
      </xref>
      ,
      <xref ref-type="bibr" rid="bib30">
       30
      </xref>
      This study shows that these types of surrogate viruses can help expand our knowledge of practical aspects of virus control, such as inactivation by disinfectants, for viruses of public health importance.
     </p>
     <p id="p0125">
      It also increases the available data both for disinfectants that have previously been studied with SARS Co-V and disinfectants that have not. Previous studies using SARS have evaluated benzalkonium chloride and magnesium monoperphthalate-based products,
      <xref ref-type="bibr" rid="bib16">
       <sup>
        16
       </sup>
      </xref>
      povidone iodine,
      <xref ref-type="bibr" rid="bib27">
       <sup>
        27
       </sup>
      </xref>
      formalin, and glutaraldehyde.
      <xref ref-type="bibr" rid="bib31">
       <sup>
        31
       </sup>
      </xref>
      This current study included sodium hypochlorite and a phenolic, which have not been evaluated in previous studies. Previous investigators have tested several types and concentrations of alcohols, including isopropanol, propanol, and ethanol, for which varying results have been observed in studies of SARS. The data from this study can add to existing knowledge to help clarify how effective alcohols are against coronaviruses on surfaces.
     </p>
     <p id="p0130">
      Four of the 6 germicides tested showed greater reductions of TGEV compared with MHV. This suggests that MHV is potentially a more conservative surrogate for evaluating disinfectant efficacy against SARS-CoV. These studies should be replicated using SARS-CoV to determine which surrogate virus is a more suitable model for the response of SARS to these germicides. There is still an important role to be played by surrogate viruses, especially for the evaluation of new disinfectants or the re-evaluation of use of current disinfectants (such as changes in dose and contact time); the available data suggest that both TGEV and MHV may serve as conservative surrogates for modeling control of SARS-CoV by health care germicides in worst case scenarios.
     </p>
    </sec>
    <back>
     <ref-list id="cebib0010">
      <title>
       References
      </title>
      <ref id="bib1">
       <label>
        1
       </label>
       <element-citation id="reference0005" publication-type="book">
        <person-group person-group-type="author">
         <name>
          <surname>
           Saif
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Denison
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Guan
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
        </person-group>
        <chapter-title>
         Microbiology, ecology and natural history of coronaviruses
        </chapter-title>
        <person-group person-group-type="editor">
         <name>
          <surname>
           Knobler
          </surname>
          <given-names>
           A.M.
          </given-names>
         </name>
         <name>
          <surname>
           Lemon
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Mack
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Sivitz
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Oberholtzer
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
        </person-group>
        <source>
         Learning from SARS: Preparing for the next disease outbreak
        </source>
        <year>
         2004
        </year>
        <publisher-name>
         Institute of Medicine of the National Academies
        </publisher-name>
        <publisher-loc>
         Washington, DC
        </publisher-loc>
       </element-citation>
      </ref>
      <ref id="bib2">
       <label>
        2
       </label>
       <element-citation id="reference0010" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Aitken
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Jeffries
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Nosocomial spread of viral disease
        </article-title>
        <source>
         Clin Microbiol Rev
        </source>
        <volume>
         14
        </volume>
        <year>
         2001
        </year>
        <fpage>
         528
        </fpage>
        <pub-id pub-id-type="pmid">
         11432812
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib3">
       <label>
        3
       </label>
       <element-citation id="reference0015" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Microbicides and the environmental control of nosocomial viral infections
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         56
        </volume>
        <year>
         2004
        </year>
        <fpage>
         64
        </fpage>
        <lpage>
         69
        </lpage>
        <pub-id pub-id-type="pmid">
         14706273
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib4">
       <label>
        4
       </label>
       <element-citation id="reference0020" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Cozad
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Jones
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Disinfection and prevention of infectious disease
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         31
        </volume>
        <year>
         2003
        </year>
        <fpage>
         243
        </fpage>
        <lpage>
         254
        </lpage>
        <pub-id pub-id-type="pmid">
         12806363
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib5">
       <label>
        5
       </label>
       <element-citation id="reference0025" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Peacock
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Gergen
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities
        </article-title>
        <source>
         Antimicrob Agents Chemother
        </source>
        <volume>
         50
        </volume>
        <year>
         2006
        </year>
        <fpage>
         1419
        </fpage>
        <pub-id pub-id-type="pmid">
         16569860
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib6">
       <label>
        6
       </label>
       <element-citation id="reference0030" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lee
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Sung
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Nosocomial transmission of SARS
        </article-title>
        <source>
         Curr Infect Dis Rep
        </source>
        <volume>
         5
        </volume>
        <year>
         2003
        </year>
        <fpage>
         473
        </fpage>
        <lpage>
         476
        </lpage>
        <pub-id pub-id-type="pmid">
         14642187
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib7">
       <label>
        7
       </label>
       <element-citation id="reference0035" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dowell
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Simmerman
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Erdman
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
         <name>
          <surname>
           Julian Wu
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Chaovavanich
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Javadi
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus on hospital surfaces
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         39
        </volume>
        <year>
         2004
        </year>
        <fpage>
         652
        </fpage>
        <lpage>
         657
        </lpage>
        <pub-id pub-id-type="pmid">
         15356778
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib8">
       <label>
        8
       </label>
       <element-citation id="reference0040" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hota
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Weinstein
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         39
        </volume>
        <year>
         2004
        </year>
        <fpage>
         1182
        </fpage>
        <lpage>
         1189
        </lpage>
        <pub-id pub-id-type="pmid">
         15486843
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib9">
       <label>
        9
       </label>
       <element-citation id="reference0045" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Morgenstern
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Bauer
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Stability and inactivation of SARS coronavirus
        </article-title>
        <source>
         Med Microbiol Immunol
        </source>
        <volume>
         194
        </volume>
        <year>
         2005
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         6
        </lpage>
        <pub-id pub-id-type="pmid">
         15118911
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib10">
       <label>
        10
       </label>
       <element-citation id="reference0050" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
         <name>
          <surname>
           Xie
          </surname>
          <given-names>
           Z.
          </given-names>
         </name>
         <name>
          <surname>
           Tsoi
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Chiu
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Lok
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?
        </article-title>
        <source>
         Clin Infect Dis
        </source>
        <volume>
         44
        </volume>
        <year>
         2007
        </year>
        <fpage>
         1017
        </fpage>
        <lpage>
         1025
        </lpage>
        <pub-id pub-id-type="pmid">
         17366443
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib11">
       <label>
        11
       </label>
       <element-citation id="reference0055" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Berger
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Drosten
          </surname>
          <given-names>
           C.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Stürmer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Preiser
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome (SARS): paradigm of an emerging viral infection
        </article-title>
        <source>
         J Clin Virol
        </source>
        <volume>
         29
        </volume>
        <year>
         2004
        </year>
        <fpage>
         13
        </fpage>
        <lpage>
         22
        </lpage>
        <pub-id pub-id-type="pmid">
         14675864
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib12">
       <label>
        12
       </label>
       <element-citation id="reference0060" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Dettenkofer
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Spencer
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Importance of environmental decontamination: a critical view
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         65
        </volume>
        <year>
         2007
        </year>
        <fpage>
         55
        </fpage>
        <lpage>
         57
        </lpage>
        <pub-id pub-id-type="pmid">
         17540243
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib13">
       <label>
        13
       </label>
       <element-citation id="reference0065" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Ansari
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Springthorpe
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rivard
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Rahman
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14
        </article-title>
        <source>
         J Clin Microbiol
        </source>
        <volume>
         29
        </volume>
        <year>
         1991
        </year>
        <fpage>
         2115
        </fpage>
        <pub-id pub-id-type="pmid">
         1658033
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib14">
       <label>
        14
       </label>
       <element-citation id="reference0070" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Hierarchy of susceptibility of viruses to environmental surface disinfectants: a predictor of activity against new and emerging viral pathogens
        </article-title>
        <source>
         J AOAC Int
        </source>
        <volume>
         90
        </volume>
        <year>
         2007
        </year>
        <fpage>
         1655
        </fpage>
        <lpage>
         1658
        </lpage>
        <pub-id pub-id-type="pmid">
         18193744
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib15">
       <label>
        15
       </label>
       <element-citation id="reference0075" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sehulster
          </surname>
          <given-names>
           L.
          </given-names>
         </name>
         <name>
          <surname>
           Chinn
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Arduino
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Carpenter
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Donlan
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Ashford
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Guidelines for environmental infection control in health-care facilities
        </article-title>
        <source>
         MMWR Recomm Rep
        </source>
        <volume>
         52
        </volume>
        <issue>
         RR10
        </issue>
        <year>
         2003
        </year>
        <fpage>
         1
        </fpage>
        <lpage>
         42
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib16">
       <label>
        16
       </label>
       <element-citation id="reference0080" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rabenau
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Kampf
          </surname>
          <given-names>
           G.
          </given-names>
         </name>
         <name>
          <surname>
           Cinatl
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Doerr
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Efficacy of various disinfectants against SARS coronavirus
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         61
        </volume>
        <year>
         2005
        </year>
        <fpage>
         107
        </fpage>
        <lpage>
         111
        </lpage>
        <pub-id pub-id-type="pmid">
         15923059
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib17">
       <label>
        17
       </label>
       <element-citation id="reference0085" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
         <name>
          <surname>
           Barbee
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Aguiar
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Sobsey
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Weber
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Antimicrobial activity of home disinfectants and natural products against potential human pathogens
        </article-title>
        <source>
         Infect Control Hosp Epidemiol
        </source>
        <volume>
         21
        </volume>
        <year>
         2000
        </year>
        <fpage>
         33
        </fpage>
        <lpage>
         38
        </lpage>
        <pub-id pub-id-type="pmid">
         10656352
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib18">
       <label>
        18
       </label>
       <element-citation id="reference0090" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           X.
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Zhen
          </surname>
          <given-names>
           B.
          </given-names>
         </name>
         <name>
          <surname>
           Kong
          </surname>
          <given-names>
           Q.
          </given-names>
         </name>
         <name>
          <surname>
           Song
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Study on the resistance of severe acute respiratory syndrome-associated coronavirus
        </article-title>
        <source>
         J Virol Methods
        </source>
        <volume>
         126
        </volume>
        <year>
         2005
        </year>
        <fpage>
         171
        </fpage>
        <lpage>
         177
        </lpage>
        <pub-id pub-id-type="pmid">
         15847934
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib19">
       <label>
        19
       </label>
       <element-citation id="reference0095" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Springthorpe
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Adegbunrin
          </surname>
          <given-names>
           O.
          </given-names>
         </name>
         <name>
          <surname>
           Zafer
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Busa
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         A disc-based quantitative carrier test method to assess the virucidal activity of chemical germicides
        </article-title>
        <source>
         J Virol Methods
        </source>
        <volume>
         112
        </volume>
        <year>
         2003
        </year>
        <fpage>
         3
        </fpage>
        <lpage>
         12
        </lpage>
        <pub-id pub-id-type="pmid">
         12951207
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib20">
       <label>
        20
       </label>
       <element-citation id="reference0100" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jackwood
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         The relationship of severe acute respiratory syndrome coronavirus with avian and other coronaviruses
        </article-title>
        <source>
         Avian Diseases
        </source>
        <volume>
         50
        </volume>
        <year>
         2006
        </year>
        <fpage>
         315
        </fpage>
        <lpage>
         320
        </lpage>
        <pub-id pub-id-type="pmid">
         17039827
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib21">
       <label>
        21
       </label>
       <element-citation id="reference0105" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
         <name>
          <surname>
           Goldman
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Phylogenomics and bioinformatics of SARS-CoV
        </article-title>
        <source>
         Trends Microbiol
        </source>
        <volume>
         12
        </volume>
        <year>
         2004
        </year>
        <fpage>
         106
        </fpage>
        <lpage>
         111
        </lpage>
        <pub-id pub-id-type="pmid">
         15058277
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib22">
       <label>
        22
       </label>
       <element-citation id="reference0110" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Gorbalenya
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Snijder
          </surname>
          <given-names>
           E.
          </given-names>
         </name>
         <name>
          <surname>
           Spaan
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Severe acute respiratory syndrome coronavirus phylogeny: toward consensus
        </article-title>
        <source>
         J Virol
        </source>
        <volume>
         78
        </volume>
        <year>
         2004
        </year>
        <fpage>
         7863
        </fpage>
        <pub-id pub-id-type="pmid">
         15254158
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib23">
       <label>
        23
       </label>
       <mixed-citation id="other-ref0005" publication-type="other">
        USEPA. OPP microbiology laboratory standard operating procedure for disinfectant sample preparation. Cincinnati (OH): USEPA; 2008.
       </mixed-citation>
      </ref>
      <ref id="bib24">
       <label>
        24
       </label>
       <element-citation id="reference0115" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Abad
          </surname>
          <given-names>
           F.
          </given-names>
         </name>
         <name>
          <surname>
           Pintó
          </surname>
          <given-names>
           R.
          </given-names>
         </name>
         <name>
          <surname>
           Bosch
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Disinfection of human enteric viruses on fomites
        </article-title>
        <source>
         FEMS Microbiol Lett
        </source>
        <volume>
         156
        </volume>
        <year>
         1997
        </year>
        <fpage>
         107
        </fpage>
        <lpage>
         111
        </lpage>
        <pub-id pub-id-type="pmid">
         9368367
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib25">
       <label>
        25
       </label>
       <element-citation id="reference0120" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sizun
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Talbot
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source of hospital-acquired infections
        </article-title>
        <source>
         J Hosp Infect
        </source>
        <volume>
         46
        </volume>
        <year>
         2000
        </year>
        <fpage>
         55
        </fpage>
        <lpage>
         60
        </lpage>
        <pub-id pub-id-type="pmid">
         11023724
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib26">
       <label>
        26
       </label>
       <element-citation id="reference0125" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Sattar
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Springthorpe
          </surname>
          <given-names>
           V.
          </given-names>
         </name>
         <name>
          <surname>
           Karim
          </surname>
          <given-names>
           Y.
          </given-names>
         </name>
         <name>
          <surname>
           Loro
          </surname>
          <given-names>
           P.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses
        </article-title>
        <source>
         Epidemiol Infect
        </source>
        <volume>
         102
        </volume>
        <year>
         1989
        </year>
        <fpage>
         493
        </fpage>
        <lpage>
         505
        </lpage>
        <pub-id pub-id-type="pmid">
         2737256
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib27">
       <label>
        27
       </label>
       <element-citation id="reference0130" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kariwa
          </surname>
          <given-names>
           H.
          </given-names>
         </name>
         <name>
          <surname>
           Fujii
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Takashima
          </surname>
          <given-names>
           I.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents
        </article-title>
        <source>
         Dermatology
        </source>
        <volume>
         212
        </volume>
        <year>
         2007
        </year>
        <fpage>
         119
        </fpage>
        <lpage>
         123
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib28">
       <label>
        28
       </label>
       <element-citation id="reference0135" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rutala
          </surname>
          <given-names>
           W.
          </given-names>
         </name>
        </person-group>
        <article-title>
         APIC guideline for selection and use of disinfectants
        </article-title>
        <source>
         Am J Infect Control
        </source>
        <volume>
         24
        </volume>
        <year>
         1996
        </year>
        <fpage>
         313
        </fpage>
        <lpage>
         342
        </lpage>
        <pub-id pub-id-type="pmid">
         8870916
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib29">
       <label>
        29
       </label>
       <element-citation id="reference0140" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Hirano
          </surname>
          <given-names>
           N.
          </given-names>
         </name>
         <name>
          <surname>
           Fujiwara
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Hino
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Matumoto
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture
        </article-title>
        <source>
         Arch Virol
        </source>
        <volume>
         44
        </volume>
        <year>
         1974
        </year>
        <fpage>
         298
        </fpage>
        <lpage>
         302
        </lpage>
       </element-citation>
      </ref>
      <ref id="bib30">
       <label>
        30
       </label>
       <element-citation id="reference0145" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           McClurkin
          </surname>
          <given-names>
           A.
          </given-names>
         </name>
         <name>
          <surname>
           Norman
          </surname>
          <given-names>
           J.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Studies on transmissible gastroenteritis of swine: II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis
        </article-title>
        <source>
         Can J Comp Med Vet Sci
        </source>
        <volume>
         30
        </volume>
        <year>
         1966
        </year>
        <fpage>
         190
        </fpage>
        <pub-id pub-id-type="pmid">
         4224292
        </pub-id>
       </element-citation>
      </ref>
      <ref id="bib31">
       <label>
        31
       </label>
       <element-citation id="reference0150" publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Darnell
          </surname>
          <given-names>
           M.
          </given-names>
         </name>
         <name>
          <surname>
           Subbarao
          </surname>
          <given-names>
           K.
          </given-names>
         </name>
         <name>
          <surname>
           Feinstone
          </surname>
          <given-names>
           S.
          </given-names>
         </name>
         <name>
          <surname>
           Taylor
          </surname>
          <given-names>
           D.
          </given-names>
         </name>
        </person-group>
        <article-title>
         Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
        </article-title>
        <source>
         J Virol Methods
        </source>
        <volume>
         121
        </volume>
        <year>
         2004
        </year>
        <fpage>
         85
        </fpage>
        <lpage>
         91
        </lpage>
        <pub-id pub-id-type="pmid">
         15350737
        </pub-id>
       </element-citation>
      </ref>
     </ref-list>
     <fn-group>
      <fn id="d32e658">
       <p>
        Supported by the
        <funding-source>
         Centers for Disease Control and Prevention,
        </funding-source>
        Atlanta, GA.
       </p>
      </fn>
      <fn id="d32e664">
       <p>
        Conflicts of interest: None to report.
       </p>
      </fn>
     </fn-group>
    </back>
   </article>
   <article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <?properties open_access?>
    <front>
     <journal-meta>
      <journal-id journal-id-type="nlm-ta">
       Obstet Gynecol
      </journal-id>
      <journal-id journal-id-type="iso-abbrev">
       Obstet Gynecol
      </journal-id>
      <journal-id journal-id-type="publisher-id">
       ong
      </journal-id>
      <journal-title-group>
       <journal-title>
        Obstetrics and Gynecology
       </journal-title>
      </journal-title-group>
      <issn pub-type="ppub">
       0029-7844
      </issn>
      <issn pub-type="epub">
       1873-233X
      </issn>
      <publisher>
       <publisher-name>
        Lippincott Williams &amp; Wilkins
       </publisher-name>
      </publisher>
     </journal-meta>
     <article-meta>
      <article-id pub-id-type="pmid">
       32213786
      </article-id>
      <article-id pub-id-type="pmc">
       7141586
      </article-id>
      <article-id pub-id-type="publisher-id">
       ONG-20-535
      </article-id>
      <article-id pub-id-type="doi">
       10.1097/AOG.0000000000003873
      </article-id>
      <article-categories>
       <subj-group subj-group-type="heading">
        <subject>
         Current Commentary
        </subject>
       </subj-group>
      </article-categories>
      <title-group>
       <article-title>
        Coronavirus Disease 2019 (COVID-19) and Pregnancy
       </article-title>
       <subtitle>
        Responding to a Rapidly Evolving Situation
       </subtitle>
      </title-group>
      <contrib-group>
       <contrib contrib-type="author">
        <name>
         <surname>
          Rasmussen
         </surname>
         <given-names>
          Sonja A.
         </given-names>
        </name>
        <degrees>
         MD, MS
        </degrees>
       </contrib>
       <contrib contrib-type="author" corresp="yes">
        <name>
         <surname>
          Jamieson
         </surname>
         <given-names>
          Denise J.
         </given-names>
        </name>
        <degrees>
         MD, MPH
        </degrees>
       </contrib>
       <aff>
        Departments of Pediatrics and Epidemiology, University of Florida College of Medicine &amp; College of Public Health and Health Professions, Gainesville, Florida; and the Department of Gynecology and Obstetrics, Emory University, Atlanta, Georgia.
       </aff>
      </contrib-group>
      <author-notes>
       <corresp>
        Corresponding author: Denise J. Jamieson, MD, MPH, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA; email:
        <email>
         djamieson@emory.edu
        </email>
        .
       </corresp>
      </author-notes>
      <pub-date pub-type="epub">
       <day>
        16
       </day>
       <month>
        3
       </month>
       <year>
        2020
       </year>
      </pub-date>
      <elocation-id>
       999
      </elocation-id>
      <history>
       <date date-type="received">
        <day>
         08
        </day>
        <month>
         3
        </month>
        <year>
         2020
        </year>
       </date>
       <date date-type="rev-recd">
        <day>
         12
        </day>
        <month>
         3
        </month>
        <year>
         2020
        </year>
       </date>
       <date date-type="accepted">
        <day>
         12
        </day>
        <month>
         3
        </month>
        <year>
         2020
        </year>
       </date>
      </history>
      <permissions>
       <copyright-statement>
        © 2020 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
       </copyright-statement>
       <copyright-year>
        2020
       </copyright-year>
       <license license-type="NIH OGC">
        <license-p>
         This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
        </license-p>
       </license>
      </permissions>
      <self-uri xlink:href="ong-135-999.pdf" xlink:type="simple">
      </self-uri>
      <abstract abstract-type="toc">
       <p>
        As coronavirus disease 2019 (COVID-19) rapidly spreads, obstetricians must keep up to date on the latest information; although guidelines for pregnant women have been rapidly developed, many questions remain.
       </p>
      </abstract>
      <abstract>
       <p>
        As the world confronts coronavirus disease 2019 (COVID-19), an illness caused by yet another emerging pathogen (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), obstetric care providers are asking what this means for pregnant women. The global spread has been swift, and many key questions remain. The case-fatality rate for persons cared for in the United States and whether asymptomatic persons transmit the virus are examples of questions that need to be answered to inform public health control measures. There are also unanswered questions specific to pregnant women, such as whether pregnant women are more severely affected and whether intrauterine transmission occurs. Although guidelines for pregnant women from the American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention have been rapidly developed based on the best available evidence, additional information is critically needed to inform key decisions, such as whether pregnant health care workers should receive special consideration, whether to temporarily separate infected mothers and their newborns, and whether it is safe for infected women to breastfeed. Some current recommendations are well supported, based largely on what we know from seasonal influenza: patients should avoid contact with ill persons, avoid touching their face, cover coughs and sneezes, wash hands frequently, disinfect contaminated surfaces, and stay home when sick. Prenatal clinics should ensure all pregnant women and their visitors are screened for fever and respiratory symptoms, and symptomatic women should be isolated from well women and required to wear a mask. As the situation with COVID-19 rapidly unfolds, it is critical that obstetricians keep up to date.
       </p>
      </abstract>
     </article-meta>
    </front>
    <p>
     In December 2019, a cluster of cases of pneumonia of unknown cause began to emerge in Wuhan, China. On December 31, 2019, China notified the World Health Organization (WHO) of the outbreak, and shortly thereafter, on January 7, 2020, a novel coronavirus was identified as the causative pathogen. Just 2 days later, Chinese investigators shared the genetic sequence of the virus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) because of its sequence similarity to the virus that caused a worldwide outbreak of severe acute respiratory syndrome (SARS) in 2002–2003. On January 30, 2020, the WHO declared the outbreak of illness with this novel coronavirus (now known as
     <italic>
      coronavirus disease 2019
     </italic>
     or
     <italic>
      COVID-19
     </italic>
     ) a Public Health Emergency of International Concern.
     <sup>
      <xref ref-type="bibr" rid="R1">
       1
      </xref>
     </sup>
     On March 11, the WHO declared a pandemic, indicating global spread of this novel coronavirus.
    </p>
    <p>
     This situation is rapidly evolving. As of March 17, 2020, more than 189,000 persons have been diagnosed with COVID-19 globally, with more than 7,500 deaths and spread to more than 150 countries and regions, including more than 5,000 cases identified in the United States.
     <sup>
      <xref ref-type="bibr" rid="R2">
       2
      </xref>
     </sup>
     Community transmission (cases without connection to travel) is now well documented in the United States. However, these cases likely represent the tip of the iceberg given the limitations on testing in the United States thus far. More than 700 publications have appeared in the medical literature and document the most common symptoms of fever, fatigue, and dry cough. Laboratory findings include lymphopenia, prolonged prothrombin time, and elevated lactate dehydrogenase; radiography findings include bilateral patchy shadows or ground glass opacity of the lungs on chest computed tomography scan.
     <sup>
      <xref ref-type="bibr" rid="R3">
       3
      </xref>
     </sup>
     Diagnostic testing using real-time reverse transcription-polymerase chain reaction has moved from the Centers for Disease Control and Prevention (CDC) to include state public health laboratories and, most recently, commercial laboratory options,
     <sup>
      <xref ref-type="bibr" rid="R4">
       4
      </xref>
     </sup>
     and work to develop a serology test for COVID-19 has begun.
     <sup>
      <xref ref-type="bibr" rid="R5">
       5
      </xref>
     </sup>
     Fortunately, pregnant women have not been forgotten. Three case series, for a total of 31 pregnancies affected by COVID-19, have been published,
     <sup>
      <xref ref-type="bibr" rid="R6">
       6
      </xref>
      –
      <xref ref-type="bibr" rid="R8">
       8
      </xref>
     </sup>
     and a WHO report from China provides limited information on 147 pregnancies.
     <sup>
      <xref ref-type="bibr" rid="R9">
       9
      </xref>
     </sup>
     Reviews examining features during pregnancy of diseases caused by other coronaviruses (eg, SARS and Middle East respiratory syndrome [MERS]), in the context of limited information on COVID-19 during pregnancy, have been published.
     <sup>
      <xref ref-type="bibr" rid="R1">
       1
      </xref>
      ,
      <xref ref-type="bibr" rid="R10">
       10
      </xref>
     </sup>
     Guidelines for pregnant women have quickly been made available through the American College of Obstetricians and Gynecologists (ACOG),
     <sup>
      <xref ref-type="bibr" rid="R11">
       11
      </xref>
     </sup>
     and responses to frequently asked questions about COVID-19 and pregnancy have been posted by the CDC.
     <sup>
      <xref ref-type="bibr" rid="R12">
       12
      </xref>
     </sup>
    </p>
    <p>
     However, many key questions remain about COVID-19 in general and specific to pregnant women. One critical question about COVID-19 relates to the case-fatality rate of the disease. Early data from Wuhan, China, suggested that 4.3% of 138 hospitalized patients with COVID-19 died
     <sup>
      <xref ref-type="bibr" rid="R3">
       3
      </xref>
     </sup>
     ; however, it was recognized that early estimates can overestimate the case-fatality rate because mild or asymptomatic cases are often missed early in an outbreak. Later data from the Chinese Center for Disease Control and Prevention based on more than 70,000 cases suggested a lower case-fatality rate of 2.3%
     <sup>
      <xref ref-type="bibr" rid="R13">
       13
      </xref>
     </sup>
     ; recent data reported in the media from Iran have suggested a higher case-fatality rate of just less than 9%.
     <sup>
      <xref ref-type="bibr" rid="R14">
       14
      </xref>
     </sup>
     South Korea has reported 75 deaths among 8,236 confirmed cases for a lower case-fatality rate of 0.9%.
     <sup>
      <xref ref-type="bibr" rid="R15">
       15
      </xref>
     </sup>
     The case-fatality rate depends not only on the disease and complete ascertainment of cases, but on the health care provided to affected patients and the age and health of the population studied. Given the small number of cases in the United States and the limited testing performed thus far, the case-fatality rate for persons cared for in the United States is unknown.
    </p>
    <p>
     Important questions regarding transmission of SARS-CoV-2 also remain. One vital question is whether persons who are asymptomatic can transmit the virus; case reports have suggested asymptomatic transmission is possible, but how often this occurs is unknown.
     <sup>
      <xref ref-type="bibr" rid="R16">
       16
      </xref>
      ,
      <xref ref-type="bibr" rid="R17">
       17
      </xref>
     </sup>
     Because of the possibility of SARS-CoV-2 transmission when a person touches a contaminated surface, another critical issue is how long the virus can survive on surfaces. A recent review article suggests that coronaviruses could survive as long as 9 days depending on the surface and the type of coronavirus.
     <sup>
      <xref ref-type="bibr" rid="R18">
       18
      </xref>
     </sup>
     Answers to these questions are essential to guidance on infection control and disinfection and other public health control measures and will require careful study, including examination of seroprevalence among patients who never show symptoms and additional studies of virus persistence and inactivation.
    </p>
    <p>
     Likewise, several questions remain about pregnant women and their newborns. Preliminary information suggests that pregnant women are not more severely affected than the general population
     <sup>
      <xref ref-type="bibr" rid="R1">
       1
      </xref>
     </sup>
     ; however, the numbers of pregnant women reported have been small, and comparison is needed with nonpregnant women of similar age rather than with all persons with COVID-19, a population that is older (median age is approximately 50 years) and has underlying conditions. A small study that compared pregnant women with a matched control group of nonpregnant women of similar age suggests that pregnant women with SARS may have an increased risk of severe disease and death.
     <sup>
      <xref ref-type="bibr" rid="R19">
       19
      </xref>
     </sup>
     Whether intrauterine or perinatal transmission occurs is also unknown. Among the small number of pregnancies reported thus far, no evidence of transmission to the neonate has been observed; however, these women were nearly all infected in the third trimester and most underwent cesarean delivery.
     <sup>
      <xref ref-type="bibr" rid="R6">
       6
      </xref>
      –
      <xref ref-type="bibr" rid="R8">
       8
      </xref>
     </sup>
     The effects of the virus earlier in pregnancy are completely unknown; no neonates have been delivered to women infected in the first and second trimesters of pregnancy.
    </p>
    <p>
     The paucity of evidence challenges some of the key decisions that need to be addressed. For example, one question that has arisen is whether pregnant health care workers should receive special consideration. During the 2009 H1N1 influenza pandemic, in which pregnant women were more likely to develop complications than nonpregnant women,
     <sup>
      <xref ref-type="bibr" rid="R20">
       20
      </xref>
      ,
      <xref ref-type="bibr" rid="R21">
       21
      </xref>
     </sup>
     the CDC recommended that pregnant women should strictly adhere to the same measures that were recommended for all health care personnel, although certain work accommodations, such as avoidance of aerosol-generating procedures on infected patients, could be offered as an option.
     <sup>
      <xref ref-type="bibr" rid="R22">
       22
      </xref>
     </sup>
     In contrast, the CDC recommended that pregnant health care workers not care for patients with Ebola virus disease, given the severity of illness in mothers and their neonates, the high risk of transmission, and the challenges related to the required personal protective equipment for Ebola care.
     <sup>
      <xref ref-type="bibr" rid="R23">
       23
      </xref>
     </sup>
     Whether special accommodations should be made for COVID-19 require better data on the severity of COVID-19 in pregnant women.
    </p>
    <p>
     Other areas of controversy relate to temporary separation of infected mothers and their newborns. Preliminary data suggest that children are mildly affected with COVID-19,
     <sup>
      <xref ref-type="bibr" rid="R24">
       24
      </xref>
     </sup>
     but the level of risk to a newborn is largely unknown.
    </p>
    <p>
     Another question is related to breastfeeding. Limited data have suggested that SARS-CoV-2 is not transmitted through breast milk,
     <sup>
      <xref ref-type="bibr" rid="R6">
       6
      </xref>
     </sup>
     but numbers on which to determine evidence-based recommendations are too small.
    </p>
    <p>
     So where does this leave obstetricians and their pregnant patients? As with previous emerging pathogens, we need to base recommendations on the best information available now, recognizing that data are limited and recommendations will likely change in the future. Certain recommendations are well supported. The best way to prevent the spread of COVID-19 is to implement measures that we use every year to limit the spread of seasonal influenza. Patients should be instructed to avoid contact with ill persons, avoid touching their face, cover coughs and sneezes, wash hands frequently, disinfect contaminated surfaces, and stay home when sick. Prenatal clinics should ensure all pregnant women and their visitors are screened for fever and respiratory symptoms, and symptomatic women should be isolated from well women and required to wear a mask.
    </p>
    <p>
     Additional measures, such as limiting visitors in labor and delivery units and postpartum wards, might be appropriate depending on levels of community transmission.
     <sup>
      <xref ref-type="bibr" rid="R1">
       1
      </xref>
     </sup>
     In areas of widespread transmission, community mitigation strategies such as cancellation of mass gatherings, school closures, and promotion of teleworking have been implemented,
     <sup>
      <xref ref-type="bibr" rid="R25">
       25
      </xref>
     </sup>
     and ensuring that pregnant women and their families have preparedness plans that address how their families respond to these measures is appropriate.
     <sup>
      <xref ref-type="bibr" rid="R26">
       26
      </xref>
     </sup>
     Given that pregnant women are relatively unique in that prenatal care requires frequent, routine health care visits, which might place them at greater risk of having contact with ill persons, adjustments to the health care system might also be necessary. During the SARS epidemic in 2002–2003, some health care systems in Canada had well pregnant women use separate facilities for labor and delivery.
     <sup>
      <xref ref-type="bibr" rid="R27">
       27
      </xref>
     </sup>
     Finally, owing to possible disruptions to health care delivery, pregnant women might benefit from having copies of their health care records.
     <sup>
      <xref ref-type="bibr" rid="R26">
       26
      </xref>
     </sup>
    </p>
    <p>
     As the situation with COVID-19 rapidly unfolds, it is critical that obstetricians keep up to date on transmission in their area and on national guidance. Obstetricians should know who to contact at their hospital as well as their local or state health department if questions about testing or management arise. Obstetricians should regularly check the CDC website (
     <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/">
      www.cdc.gov
     </ext-link>
     ) for clinical updates and sign up to receive Health Alert Network messages (
     <ext-link ext-link-type="uri" xlink:href="https://emergency.cdc.gov/han/updates.asp">
      https://emergency.cdc.gov/han/updates.asp
     </ext-link>
     ), the CDC's primary method for sharing urgent public health information by email. The CDC website has a wide range of information for health professionals on a number of topics, including clinical care (eg, availability of investigational therapeutics such as remdesivir), infection control, guidance for evaluating persons suspected of having COVID-19, and inpatient obstetric health care guidance, among others. This information is regularly updated as new information becomes available. Staying up to date on local disease activity by following state or local health department websites is also necessary. Obstetricians should also regularly check updated information on ACOG's website (
     <ext-link ext-link-type="uri" xlink:href="http://www.acog.org/">
      www.acog.org
     </ext-link>
     ), including Practice Advisories, which are brief, focused statements that are rapidly issued in response to urgent clinical issues. The websites for both ACOG and
     <italic>
      Obstetrics &amp; Gynecology
     </italic>
     (
     <ext-link ext-link-type="uri" xlink:href="http://greenjournal.org">
      greenjournal.org
     </ext-link>
     ) provide direct links to the CDC for easy access to these critical resources.
    </p>
    <p>
     COVID-19 is the latest in a series of diseases caused by emerging pathogens in the past two decades, from SARS to 2009 H1N1 influenza to Ebola and Zika virus disease. As with those previous outbreaks, we must work to stay up to date with the latest data and recommendations, share what we know and do not know with our patients, and continue to be strong advocates for our patients, ensuring that their needs are addressed. Our patients deserve nothing less.
    </p>
    <back>
     <fn-group>
      <fn fn-type="financial-disclosure">
       <p>
        <bold>
         Financial Disclosure
        </bold>
        Sonja A. Rasmussen reports serving on the Teva Pregnancy Registry Advisory Committee, the Solriamfetol Pregnancy Registry Advisory Committee, and the Steering Committee for the Gilenya Pregnancy Registry. She hasn't received payment for any of these committees as of March 2020, but may receive payments in the future. In addition, she serves as a litigation consultant on behalf of Hoffmann-La Roche for a product liability claim regarding an alleged birth defect. These are not relevant to this article or COVID-19. The other author did not report any potential conflicts of interest.
       </p>
      </fn>
      <fn fn-type="other">
       <p>
        Each author has confirmed compliance with the journal's requirements for authorship.
       </p>
      </fn>
      <fn fn-type="other">
       <p>
        Peer reviews and author correspondence are available at
        <ext-link ext-link-type="uri" xlink:href="http://links.lww.com/AOG/B822">
         http://links.lww.com/AOG/B822
        </ext-link>
        .
       </p>
      </fn>
     </fn-group>
     <ref-list>
      <title>
       REFERENCES
      </title>
      <ref id="R1">
       <label>
        1.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Smulian
          </surname>
          <given-names>
           JC
          </given-names>
         </name>
         <name>
          <surname>
           Lednicky
          </surname>
          <given-names>
           JA
          </given-names>
         </name>
         <name>
          <surname>
           Wen
          </surname>
          <given-names>
           TS
          </given-names>
         </name>
         <name>
          <surname>
           Jamieson
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
        </article-title>
        .
        <source>
         Am J Obstet Gynecol
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R2">
       <label>
        2.
       </label>
       <mixed-citation publication-type="webpage">
        <collab>
         Johns Hopkins Center for Systems Science and Engineering
        </collab>
        .
        <article-title>
         Coronavirus COVID-19 global cases
        </article-title>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6">
         https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
        </ext-link>
        . Retrieved March 17, 2020.
       </mixed-citation>
      </ref>
      <ref id="R3">
       <label>
        3.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Hu
          </surname>
          <given-names>
           B
          </given-names>
         </name>
         <name>
          <surname>
           Hu
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China
        </article-title>
        .
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R4">
       <label>
        4.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         U.S. Food and Drug Administration
        </collab>
        .
        <source>
         Coronavirus (COVID-19) update: FDA issues new policy to help expedite availability of diagnostics
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics">
         https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics
        </ext-link>
        . Retrieved March 12, 2020.
       </mixed-citation>
      </ref>
      <ref id="R5">
       <label>
        5.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         Centers for Disease Control and Prevention
        </collab>
        .
        <source>
         CDC tests for COVID-19
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html">
         https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html
        </ext-link>
        . Retrieved March 12, 2020.
       </mixed-citation>
      </ref>
      <ref id="R6">
       <label>
        6.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Guo
          </surname>
          <given-names>
           J
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Luo
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           X
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
        </article-title>
        .
        <source>
         Lancet
        </source>
        <year>
         2020
        </year>
        ;
        <volume>
         395
        </volume>
        :
        <fpage>
         809
        </fpage>
        –
        <lpage>
         15
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         32151335
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R7">
       <label>
        7.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Zhu
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Fang
          </surname>
          <given-names>
           C
          </given-names>
         </name>
         <name>
          <surname>
           Peng
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Zhang
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Chang
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
        </article-title>
        .
        <source>
         Transl Pediatr
        </source>
        <year>
         2020
        </year>
        ;
        <volume>
         9
        </volume>
        :
        <fpage>
         51
        </fpage>
        –
        <lpage>
         60
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         32154135
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R8">
       <label>
        8.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Liu
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           H
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Guo
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        <article-title>
         Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy
        </article-title>
        .
        <source>
         J Infect
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R9">
       <label>
        9.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         World Health Organization
        </collab>
        .
        <source>
         Report of the WHO–China joint mission on coronavirus disease 2019 (COVID-19)
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf">
         https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
        </ext-link>
        . Retrieved March 8, 2020.
       </mixed-citation>
      </ref>
      <ref id="R10">
       <label>
        10.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Schwartz
          </surname>
          <given-names>
           DA
          </given-names>
         </name>
         <name>
          <surname>
           Graham
          </surname>
          <given-names>
           AL
          </given-names>
         </name>
        </person-group>
        <article-title>
         Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections
        </article-title>
        .
        <source>
         Viruses
        </source>
        <year>
         2020
        </year>
        ;
        <volume>
         12
        </volume>
        :
        <fpage>
         194
        </fpage>
        .
       </mixed-citation>
      </ref>
      <ref id="R11">
       <label>
        11.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         American College of Obstetricians and Gynecologists
        </collab>
        .
        <source>
         Practice advisory: novel coronavirus 2019 (COVID-19)
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Novel-Coronavirus2019">
         https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Novel-Coronavirus2019
        </ext-link>
        . Retrieved March 8, 2020.
       </mixed-citation>
      </ref>
      <ref id="R12">
       <label>
        12.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         Centers for Disease Control and Prevention
        </collab>
        .
        <source>
         Frequently asked questions and answers: coronavirus disease 2019 (COVID-19) and pregnancy
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/pregnancy-faq.html">
         https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/pregnancy-faq.html
        </ext-link>
        . Retrieved March 8, 2020.
       </mixed-citation>
      </ref>
      <ref id="R13">
       <label>
        13.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Wu
          </surname>
          <given-names>
           Z
          </given-names>
         </name>
         <name>
          <surname>
           McGoogan
          </surname>
          <given-names>
           JM
          </given-names>
         </name>
        </person-group>
        <article-title>
         Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention
        </article-title>
        .
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R14">
       <label>
        14.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         NBC News
        </collab>
        .
        <source>
         Why is Iran's reported mortality rate for coronavirus higher than in other countries?
        </source>
        Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.nbcnews.com/health/health-news/why-iran-s-reported-mortality-rate-coronavirus-higher-other-countries-n1142646">
         https://www.nbcnews.com/health/health-news/why-iran-s-reported-mortality-rate-coronavirus-higher-other-countries-n1142646
        </ext-link>
        . Retrieved March 8, 2020.
       </mixed-citation>
      </ref>
      <ref id="R15">
       <label>
        15.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         Statista
        </collab>
        .
        <source>
         Number of coronavirus (COVID-19) confirmed, recovered, and test cases in South Korea as of March 16, 2020
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.statista.com/statistics/1095848/south-korea-confirmed-and-suspected-coronavirus-cases/">
         https://www.statista.com/statistics/1095848/south-korea-confirmed-and-suspected-coronavirus-cases/
        </ext-link>
        . Retrieved March 17, 2020.
       </mixed-citation>
      </ref>
      <ref id="R16">
       <label>
        16.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Tong
          </surname>
          <given-names>
           ZD
          </given-names>
         </name>
         <name>
          <surname>
           Tang
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           KF
          </given-names>
         </name>
         <name>
          <surname>
           Li
          </surname>
          <given-names>
           P
          </given-names>
         </name>
         <name>
          <surname>
           Wang
          </surname>
          <given-names>
           HL
          </given-names>
         </name>
         <name>
          <surname>
           Yi
          </surname>
          <given-names>
           JP
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020
        </article-title>
        .
        <source>
         Emerg Infect Dis
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R17">
       <label>
        17.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Bai
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
         <name>
          <surname>
           Yao
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <name>
          <surname>
           Wei
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Tian
          </surname>
          <given-names>
           F
          </given-names>
         </name>
         <name>
          <surname>
           Jin
          </surname>
          <given-names>
           DY
          </given-names>
         </name>
         <name>
          <surname>
           Chen
          </surname>
          <given-names>
           L
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Presumed asymptomatic carrier transmission of COVID-19
        </article-title>
        .
        <source>
         JAMA
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R18">
       <label>
        18.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Kampf
          </surname>
          <given-names>
           G
          </given-names>
         </name>
         <name>
          <surname>
           Todt
          </surname>
          <given-names>
           D
          </given-names>
         </name>
         <name>
          <surname>
           Pfaender
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Steinmann
          </surname>
          <given-names>
           E
          </given-names>
         </name>
        </person-group>
        <article-title>
         Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
        </article-title>
        .
        <source>
         J Hosp Infect
        </source>
        <year>
         2020
        </year>
        ;
        <volume>
         104
        </volume>
        :
        <fpage>
         246
        </fpage>
        –
        <lpage>
         51
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         32035997
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R19">
       <label>
        19.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lam
          </surname>
          <given-names>
           CM
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           SF
          </given-names>
         </name>
         <name>
          <surname>
           Leung
          </surname>
          <given-names>
           TN
          </given-names>
         </name>
         <name>
          <surname>
           Chow
          </surname>
          <given-names>
           KM
          </given-names>
         </name>
         <name>
          <surname>
           Yu
          </surname>
          <given-names>
           WC
          </given-names>
         </name>
         <name>
          <surname>
           Wong
          </surname>
          <given-names>
           TY
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome
        </article-title>
        .
        <source>
         BJOG
        </source>
        <year>
         2004
        </year>
        ;
        <volume>
         111
        </volume>
        :
        <fpage>
         771
        </fpage>
        –
        <lpage>
         4
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         15270922
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R20">
       <label>
        20.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Jamieson
          </surname>
          <given-names>
           DJ
          </given-names>
         </name>
         <name>
          <surname>
           Honein
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Williams
          </surname>
          <given-names>
           JL
          </given-names>
         </name>
         <name>
          <surname>
           Swerdlow
          </surname>
          <given-names>
           DL
          </given-names>
         </name>
         <name>
          <surname>
           Biggerstaff
          </surname>
          <given-names>
           MS
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         H1N1 2009 influenza virus infection during pregnancy in the USA
        </article-title>
        .
        <source>
         Lancet
        </source>
        <year>
         2009
        </year>
        ;
        <volume>
         374
        </volume>
        :
        <fpage>
         451
        </fpage>
        –
        <lpage>
         8
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         19643469
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R21">
       <label>
        21.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Siston
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Honein
          </surname>
          <given-names>
           MA
          </given-names>
         </name>
         <name>
          <surname>
           Fry
          </surname>
          <given-names>
           AM
          </given-names>
         </name>
         <name>
          <surname>
           Seib
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Callaghan
          </surname>
          <given-names>
           WM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States
        </article-title>
        .
        <source>
         JAMA
        </source>
        <year>
         2010
        </year>
        ;
        <volume>
         303
        </volume>
        :
        <fpage>
         1517
        </fpage>
        –
        <lpage>
         25
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         20407061
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R22">
       <label>
        22.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Rasmussen
          </surname>
          <given-names>
           SA
          </given-names>
         </name>
         <name>
          <surname>
           Kissin
          </surname>
          <given-names>
           DM
          </given-names>
         </name>
         <name>
          <surname>
           Yeung
          </surname>
          <given-names>
           LF
          </given-names>
         </name>
         <name>
          <surname>
           MacFarlane
          </surname>
          <given-names>
           K
          </given-names>
         </name>
         <name>
          <surname>
           Chu
          </surname>
          <given-names>
           SY
          </given-names>
         </name>
         <name>
          <surname>
           Turcios-Ruiz
          </surname>
          <given-names>
           RM
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns
        </article-title>
        .
        <source>
         Am J Obstet Gynecol
        </source>
        <year>
         2011
        </year>
        ;
        <volume>
         204
        </volume>
        :
        <fpage>
         S13
        </fpage>
        –
        <lpage>
         20
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         21333967
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R23">
       <label>
        23.
       </label>
       <mixed-citation publication-type="book">
        <collab>
         Centers for Disease Control and Prevention
        </collab>
        .
        <source>
         Guidance for screening and caring for pregnant women with Ebola virus disease for healthcare providers in U.S. hospitals
        </source>
        . Available at:
        <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/vhf/ebola/clinicians/evd/pregnant-women.html">
         https://www.cdc.gov/vhf/ebola/clinicians/evd/pregnant-women.html
        </ext-link>
        . Retrieved March 8, 2020.
       </mixed-citation>
      </ref>
      <ref id="R24">
       <label>
        24.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Lu
          </surname>
          <given-names>
           Q
          </given-names>
         </name>
         <name>
          <surname>
           Shi
          </surname>
          <given-names>
           Y
          </given-names>
         </name>
        </person-group>
        <article-title>
         Coronavirus disease (COVID-19) and neonate: what neonatologist need to know
        </article-title>
        .
        <source>
         J Med Virol
        </source>
        <year>
         2020
        </year>
        [Epub ahead of print].
       </mixed-citation>
      </ref>
      <ref id="R25">
       <label>
        25.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Qualls
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Levitt
          </surname>
          <given-names>
           A
          </given-names>
         </name>
         <name>
          <surname>
           Kanade
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Wright-Jegede
          </surname>
          <given-names>
           N
          </given-names>
         </name>
         <name>
          <surname>
           Dopson
          </surname>
          <given-names>
           S
          </given-names>
         </name>
         <name>
          <surname>
           Biggerstaff
          </surname>
          <given-names>
           M
          </given-names>
         </name>
         <etal>
         </etal>
        </person-group>
        <article-title>
         Community mitigation guidelines to prevent pandemic influenza—United States, 2017
        </article-title>
        .
        <source>
         MMWR Recomm Rep
        </source>
        <year>
         2017
        </year>
        ;
        <volume>
         66
        </volume>
        :
        <fpage>
         1
        </fpage>
        –
        <lpage>
         34
        </lpage>
        .
       </mixed-citation>
      </ref>
      <ref id="R26">
       <label>
        26.
       </label>
       <mixed-citation publication-type="journal">
        <article-title>
         Preparing for disasters: perspectives on women. Committee Opinion No. 457. American College of Obstetricians and Gynecologists
        </article-title>
        .
        <source>
         Obstet Gynecol
        </source>
        <year>
         2010
        </year>
        ;
        <volume>
         115
        </volume>
        :
        <fpage>
         1339
        </fpage>
        –
        <lpage>
         42
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         20502312
        </pub-id>
       </mixed-citation>
      </ref>
      <ref id="R27">
       <label>
        27.
       </label>
       <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
         <name>
          <surname>
           Owolabi
          </surname>
          <given-names>
           T
          </given-names>
         </name>
         <name>
          <surname>
           Kwolek
          </surname>
          <given-names>
           S
          </given-names>
         </name>
        </person-group>
        <article-title>
         Managing obstetrical patients during severe acute respiratory syndrome outbreak
        </article-title>
        .
        <source>
         J Obstet Gynaecol Can
        </source>
        <year>
         2004
        </year>
        ;
        <volume>
         26
        </volume>
        :
        <fpage>
         35
        </fpage>
        –
        <lpage>
         41
        </lpage>
        .
        <pub-id pub-id-type="pmid">
         14715124
        </pub-id>
       </mixed-citation>
      </ref>
     </ref-list>
    </back>
   </article>
  </pmc-articleset>
 </body>
</html>